The	O
data	O
demonstrate	O
that	O
the	O
BCV	B-SPEC
genome	O
contains	O
a	O
sequence	O
that	O
is	O
conserved	O
at	O
both	O
the	O
sequence	O
and	O
functional	O
levels	O
,	O
thus	O
broadening	O
our	O
insight	O
into	O
coronavirus	B-SPEC
packaging	O
.	O

Using	O
targeted	O
RNA	O
recombination	O
,	O
we	O
constructed	O
a	O
mutant	O
of	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
in	O
which	O
the	O
ectodomain	O
of	O
the	O
spike	O
glycoprotein	O
(	O
S	O
)	O
was	O
replaced	O
with	O
the	O
highly	O
divergent	O
ectodomain	O
of	O
the	O
S	O
protein	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
.	O

Immunophenotyping	O
of	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
infiltrates	O
revealed	O
that	O
CD4	O
(-/-)	O
mice	B-SPEC
had	O
a	O
significant	O
reduction	O
in	O
numbers	O
of	O
activated	O
macrophages	O
/	O
microglial	O
cells	O
in	O
the	O
brain	O
compared	O
to	O
the	O
numbers	O
in	O
CD8	O
(-/-)	O
and	O
C57BL	O
/	O
6	O
mice	B-SPEC
,	O
indicating	O
a	O
role	O
for	O
these	O
cells	O
in	O
myelin	O
destruction	O
.	O

Furthermore	O
,	O
CD4	O
(-/-)	O
mice	B-SPEC
displayed	O
lower	O
levels	O
of	O
RANTES	O
(	O
a	O
C	O
-	O
C	O
chemokine	O
)	O
mRNA	O
transcripts	O
and	O
protein	O
,	O
suggesting	O
a	O
role	O
for	O
this	O
molecule	O
in	O
the	O
pathogenesis	O
of	O
MHV	B-SPEC
-	O
induced	O
neurologic	O
disease	O
.	O

These	O
data	O
indicate	O
that	O
CD4	O
(+)	O
T	O
cells	O
have	O
a	O
pivotal	O
role	O
in	O
accelerating	O
CNS	O
inflammation	O
and	O
demyelination	O
within	O
infected	O
mice	B-SPEC
,	O
possibly	O
by	O
regulating	O
RANTES	O
expression	O
,	O
which	O
in	O
turn	O
coordinates	O
the	O
trafficking	O
of	O
macrophages	O
into	O
the	O
CNS	O
,	O
leading	O
to	O
myelin	O
destruction	O
.	O

Animal	B-SPEC
study	O
at	O
the	O
Asan	O
Institute	O
for	O
Life	O
Sciences	O
,	O
Seoul	O
,	O
Korea	O
.	O

Twelve	O
rabbits	B-SPEC
in	O
which	O
dependent	O
lung	O
-	O
dominant	O
lung	O
injury	O
was	O
created	O
by	O
a	O
modified	O
saline	O
solution	O
lavage	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
genetic	O
pattern	O
of	O
feline	B-SPEC
coronaviruses	O
in	O
urban	O
cat	B-SPEC
populations	O
.	O

ABSTRACT	O
:	O
The	O
prevalence	O
and	O
phylogeny	O
of	O
feline	B-SPEC
coronaviruses	O
were	O
studied	O
in	O
urban	O
cat	B-SPEC
populations	O
by	O
sampling	O
of	O
113	O
clinically	O
healthy	O
cats	B-SPEC
.	O

More	O
than	O
30	O
%	O
of	O
the	O
sampled	O
animals	B-SPEC
proved	O
positive	O
for	O
the	O
presence	O
of	O
feline	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
High	O
affinity	O
interaction	O
between	O
nucleocapsid	O
protein	O
and	O
leader	O
/	O
intergenic	O
sequence	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
RNA	O
.	O

ABSTRACT	O
:	O
The	O
results	O
of	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
n	O
-	O
PCR	O
)	O
assays	O
for	O
the	O
diagnosis	O
of	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
)	O
infection	O
,	O
and	O
the	O
comparison	O
with	O
other	O
diagnostic	O
techniques	O
,	O
such	O
as	O
electron	O
microscopy	O
(	O
EM	O
)	O
and	O
virus	B-SPEC
isolation	O
using	O
A	O
-	O
72	O
cell	O
line	O
are	O
reported	O
.	O

In	O
contrast	O
to	O
the	O
parental	O
virus	B-SPEC
,	O
the	O
mutants	O
were	O
unable	O
to	O
bind	O
to	O
porcine	B-SPEC
submandibulary	O
mucin	O
,	O
a	O
substrate	O
rich	O
in	O
sialic	O
acid	O
.	O

This	O
reaction	O
disappeared	O
after	O
treatment	O
of	O
FK50	O
-	O
4	O
with	O
protein	O
A	O
.	O
The	O
neutralizing	O
activity	O
of	O
FK50	O
-	O
4	O
was	O
also	O
effective	O
on	O
feline	B-SPEC
macrophages	O
after	O
the	O
cells	O
were	O
inoculated	O
with	O
FIPV	O
.	O

Twenty	O
-	O
two	O
patients	O
with	O
severe	O
sepsis	B-SPEC
(	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
15	O
-	O
34	O
)	O
and	O
eight	O
patients	O
with	O
major	O
trauma	O
(	O
Injury	O
Severity	O
Score	O
26	O
-	O
50	O
).	O

Sequence	O
analysis	O
of	O
the	O
genomic	O
RNA	O
from	O
the	O
four	O
heterologous	O
IBV	B-SPEC
strains	O
(	O
M41	O
,	O
H120	O
,	O
HV10	O
and	O
D207	O
)	O
identified	O
nucleotide	O
differences	O
of	O
up	O
to	O
17	O
%	O
within	O
the	O
leader	O
sequence	O
and	O
up	O
to	O
4	O
.	O
3	O
%	O
within	O
the	O
whole	O
of	O
the	O
adjacent	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
).	O

We	O
have	O
reported	O
alterations	O
of	O
cellular	O
functions	O
by	O
macrophages	O
(	O
Mphi	O
)	O
exposed	O
to	O
cocaine	O
in	O
vitro	O
,	O
including	O
the	O
inhibition	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
replication	O
.	O

Three	O
transgenic	O
plant	B-SPEC
lines	O
were	O
generated	O
expressing	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
a	O
protein	O
crucial	O
for	O
establishing	O
mucosal	O
immunity	O
.	O

Antigens	O
from	O
all	O
three	O
transgenic	O
plant	B-SPEC
lines	O
induced	O
TGEV	B-SPEC
-	O
specific	O
immune	O
responses	O
in	O
pigs	B-SPEC
as	O
determined	O
by	O
virus	B-SPEC
neutralization	O
and	O
ELISA	O
,	O
and	O
the	O
resultant	O
antibody	O
titers	O
for	O
all	O
three	O
constructs	O
were	O
similar	O
.	O

Observe	O
symptoms	O
exhibited	O
by	O
pigs	B-SPEC
,	O
i	O
.	O
e	O
.,	O
huddling	O
,	O
fecal	O
material	O
around	O
perineum	O
,	O
extreme	O
thirst	O
,	O
etc	O
.	O

The	O
animals	B-SPEC
were	O
mechanically	O
ventilated	O
with	O
a	O
tidal	O
volume	O
of	O
10	O
mL	O
/	O
kg	O
and	O
an	O
Fio2	O
of	O
0	O
.	O
4	O
,	O
and	O
thereafter	O
,	O
they	O
were	O
randomly	O
assigned	O
to	O
three	O
groups	O
.	O

The	O
animals	B-SPEC
were	O
followed	O
for	O
10	O
d	O
,	O
then	O
killed	O
for	O
histologic	O
examination	O
of	O
the	O
lungs	O
.	O

These	O
were	O
classified	O
either	O
as	O
""""	O
atypical	O
sleep	O
""""	O
(	O
n	O
=	O
5	O
),	O
characterized	O
by	O
transitions	O
from	O
stage	O
1	O
NREM	O
to	O
slow	O
wave	O
sleep	O
with	O
a	O
virtual	O
absence	O
of	O
stage	O
2	O
NREM	O
and	O
reduced	O
stage	O
REM	O
sleep	O
,	O
or	O
""""	O
coma	B-SPEC
""""	O
(	O
n	O
=	O
7	O
),	O
characterized	O
by	O
>	O
50	O
%	O
delta	O
or	O
theta	O
EEG	O
activity	O
with	O
(	O
n	O
=	O
5	O
)	O
and	O
without	O
(	O
n	O
=	O
2	O
)	O
evidence	O
of	O
EEG	O
activation	O
either	O
spontaneously	O
or	O
in	O
response	O
to	O
deep	O
painful	O
stimuli	O
.	O

Assays	O
have	O
been	O
developed	O
to	O
identify	O
Gray	O
strain	O
IBV	B-SPEC
-	O
specific	O
cytotoxic	O
T	O
lymphocyte	O
(	O
CTL	O
)	O
responses	O
using	O
viral	O
infected	O
antigen	O
presenting	O
cells	O
(	O
APC	O
)	O
and	O
using	O
the	O
Semliki	B-SPEC
Forest	I-SPEC
virus	I-SPEC
vector	O
infected	O
APC	O
expressing	O
individual	O
viral	O
polypeptides	O
.	O

Adoptive	O
transfer	O
of	O
immune	O
T	O
cells	O
to	O
chicks	O
prior	O
to	O
infection	O
demonstrated	O
that	O
IBV	B-SPEC
primed	O
CD8	O
(+),	O
alphabeta	O
T	O
lymphocytes	O
could	O
protect	O
chicks	O
from	O
acute	O
infection	O
.	O

Inoculation	O
of	O
DNA	O
plasmid	O
expressing	O
the	O
carboxyl	O
terminus	O
of	O
Gray	O
strain	O
N	O
resulted	O
in	O
induction	O
of	O
CTL	O
that	O
cross	O
-	O
react	O
with	O
two	O
distinct	O
IBV	B-SPEC
strains	O
.	O

Lymphocytes	O
collected	O
10	O
days	O
postinfection	O
were	O
transferred	O
to	O
naive	O
chicks	O
before	O
challenge	O
with	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
membrane	O
(	O
M	O
)	O
proteins	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
MHV	B-SPEC
)	O
strains	O
have	O
been	O
reported	O
to	O
contain	O
only	O
O	O
-	O
linked	O
oligosaccharides	O
.	O

Bovine	B-SPEC
IgA	O
and	O
IgM	O
antibodies	O
in	O
milk	O
and	O
serum	O
showed	O
high	O
stability	O
towards	O
freezing	O
and	O
thawing	O
and	O
storage	O
at	O
room	O
temperature	O
.	O

The	O
activation	O
of	O
specific	O
and	O
cross	O
-	O
reactive	O
T	O
lymphocytes	O
by	O
both	O
virus	B-SPEC
and	O
anti	O
-	O
Id	O
in	O
immunized	O
mice	B-SPEC
and	O
the	O
absence	O
of	O
adoptive	O
transfer	O
of	O
protection	O
by	O
splenocytes	O
suggested	O
the	O
participation	O
of	O
T	O
helper	O
activity	O
in	O
the	O
induction	O
of	O
protective	O
virus	B-SPEC
-	O
neutralizing	O
Ab3	O
.	O

This	O
study	O
suggests	O
that	O
the	O
26	O
IBV	B-SPEC
isolates	O
that	O
are	O
genetically	O
closely	O
related	O
to	O
the	O
vaccine	O
strain	O
may	O
be	O
derived	O
from	O
the	O
vaccine	O
strain	O
by	O
point	O
mutation	O
.	O

TITLE	O
:	O
A	O
rapid	O
-	O
plate	O
hemagglutination	O
assay	O
for	O
the	O
detection	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

The	O
rapid	O
-	O
plate	O
HA	O
assay	O
of	O
neuraminidase	O
-	O
treated	O
allantoic	O
fluid	O
correlated	O
with	O
the	O
RT	O
-	O
PCR	O
during	O
the	O
early	O
stages	O
of	O
IBV	B-SPEC
detection	O
,	O
identification	O
,	O
and	O
isolation	O
in	O
embryonated	O
eggs	O
.	O

One	O
died	O
of	O
sepsis	B-SPEC
,	O
and	O
the	O
other	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
without	O
a	O
recovery	O
in	O
bone	O
marrow	O
.	O

In	O
order	B-SPEC
to	O
test	O
the	O
correlation	O
between	O
genotype	O
and	O
serotype	O
,	O
a	O
one	O
-	O
way	O
neutralization	O
test	O
was	O
used	O
to	O
compare	O
9	O
Taiwan	O
isolates	O
selected	O
from	O
different	O
genotypes	O
with	O
Massachusetts	O
(	O
Mass	O
)	O
(	O
H120	O
)	O
and	O
Connecticut	O
(	O
Conn	O
)	O
standard	O
strains	O
.	O

As	O
revealed	O
by	O
class	B-SPEC
I	O
tetramer	O
technology	O
the	O
paralytic	O
variant	O
was	O
superior	O
in	O
inducing	O
specific	O
CD8	O
+	O
T	O
cells	O
during	O
the	O
acute	O
disease	O
.	O

However	O
,	O
after	O
infectious	O
virus	B-SPEC
was	O
cleared	O
,	O
twice	O
as	O
many	O
virus	B-SPEC
-	O
specific	O
IFN	O
-	O
gamma	O
-	O
secreting	O
CD8	O
+	O
T	O
cells	O
were	O
recovered	O
from	O
the	O
brains	O
of	O
asymptomatic	O
mice	B-SPEC
compared	O
with	O
mice	B-SPEC
undergoing	O
demyelination	O
,	O
suggesting	O
that	O
IFN	O
-	O
gamma	O
ameliorates	O
rather	O
than	O
perpetuates	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
-	O
induced	O
demyelination	O
.	O

Surprisingly	O
,	O
the	O
TGEV	B-SPEC
nucleoprotein	O
(	O
N	O
)	O
underwent	O
proteolysis	O
in	O
parallel	O
with	O
the	O
activation	O
of	O
caspases	O
within	O
the	O
host	O
cell	O
.	O

We	O
show	O
that	O
IBV	B-SPEC
E	O
is	O
an	O
integral	O
membrane	O
protein	O
when	O
expressed	O
in	O
cells	O
from	O
cDNA	O
.	O

TITLE	O
:	O
Ten	O
-	O
year	O
long	O
monitoring	O
of	O
laboratory	O
mouse	B-SPEC
and	O
rat	B-SPEC
colonies	O
in	O
French	O
facilities	O
:	O
a	O
retrospective	O
study	O
.	O

All	O
cis	B-SPEC
-	O
acting	O
frameshift	O
signals	O
encoded	O
in	O
mRNAs	O
are	O
minimally	O
composed	O
of	O
two	O
functional	O
elements	O
:	O
a	O
heptanucleotide	O
""""	O
slippery	O
sequence	O
""""	O
conforming	O
to	O
the	O
general	O
form	O
X	O
XXY	O
YYZ	O
,	O
followed	O
by	O
an	O
RNA	O
structural	O
element	O
,	O
usually	O
an	O
H	O
-	O
type	O
RNA	O
pseudoknot	O
,	O
positioned	O
an	O
optimal	O
number	O
of	O
nucleotides	O
(	O
5	O
to	O
9	O
)	O
downstream	O
.	O

NF	O
-	O
kappaB	O
activation	O
was	O
detected	O
at	O
1	O
hour	O
in	O
both	O
liver	O
and	O
lung	O
tissue	O
samples	O
of	O
animals	B-SPEC
undergoing	O
cryoablation	O
but	O
not	O
after	O
RFA	O
,	O
and	O
serum	O
cytokine	O
levels	O
were	O
significantly	O
elevated	O
in	O
cryoablation	O
versus	O
RFA	O
animals	B-SPEC
.	O

An	O
immunohistochemical	O
method	O
using	O
a	O
new	O
recombinant	O
antibody	O
produced	O
by	O
a	O
phage	O
antibody	O
system	O
(	O
PAS16	O
)	O
kit	O
was	O
investigated	O
and	O
compared	O
with	O
that	O
using	O
a	O
monoclonal	O
antibody	O
for	O
PEDV	B-SPEC
detection	O
in	O
PEDV	B-SPEC
-	O
infected	O
piglets	O
.	O

TITLE	O
:	O
Genetic	O
manipulation	O
of	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
using	O
full	O
-	O
length	O
cDNA	O
clones	O
:	O
separation	O
of	O
overlapping	O
genes	O
and	O
expression	O
of	O
a	O
foreign	O
epitope	O
.	O

In	O
contrast	O
,	O
the	O
polypeptide	O
fragment	O
from	O
the	O
middle	O
region	O
,	O
residues	O
101	O
-	O
283	O
,	O
did	O
not	O
interact	O
with	O
these	O
3	O
'	O
IBV	B-SPEC
RNAs	O
.	O

Both	O
infants	O
'	O
parents	O
were	O
first	O
degree	O
cousins	O
and	O
belonged	O
to	O
the	O
same	O
small	O
Bedouin	O
tribe	B-SPEC
,	O
and	O
neither	O
they	O
nor	O
the	O
infants	O
'	O
siblings	O
had	O
polycystic	O
kidneys	O
or	O
renal	O
insufficiency	O
,	O
pointing	O
to	O
either	O
a	O
possible	O
genetic	O
etiology	O
or	O
a	O
common	O
external	O
toxic	O
exposure	O
.	O

TITLE	O
:	O
Proinflammatory	O
cytokines	O
and	O
viral	O
respiratory	O
disease	O
in	O
pigs	B-SPEC
.	O

In	O
single	O
SIV	B-SPEC
infections	O
,	O
typical	O
signs	O
of	O
swine	B-SPEC
""""	O
flu	O
""""	O
were	O
tightly	O
correlated	O
with	O
an	O
excessive	O
and	O
coordinate	O
production	O
of	O
the	O
3	O
cytokines	O
examined	O
.	O

TITLE	O
:	O
Experiences	O
with	O
severe	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
malaria	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

CONCLUSIONS	O
:	O
As	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
is	O
a	O
potentially	O
life	O
-	O
threatening	O
disease	O
,	O
reliable	O
criteria	O
for	O
ICU	O
admission	O
should	O
be	O
defined	O
and	O
risk	O
factors	O
identified	O
.	O

The	O
coronavirus	B-SPEC
genome	O
is	O
capped	O
at	O
the	O
5	O
'	O
end	O
and	O
has	O
a	O
3	O
'	O
UTR	O
that	O
consists	O
of	O
300	O
to	O
500	O
nucleotides	O
(	O
nt	O
)	O
plus	O
a	O
poly	O
(	O
A	O
)	O
tail	O
.	O

Specific	O
host	O
protein	O
interactions	O
with	O
the	O
BCV	B-SPEC
3	O
'	O
UTR	O
[	O
287	O
nt	O
plus	O
poly	O
(	O
A	O
)	O
tail	O
]	O
were	O
identified	O
using	O
gel	O
mobility	O
shift	O
assays	O
.	O

TITLE	O
:	O
Decontamination	O
of	O
human	B-SPEC
xenotransplantable	O
tumor	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
by	O
implantation	O
in	O
nude	O
rat	B-SPEC
:	O
a	O
case	O
report	O
.	O

TITLE	O
:	O
Engineering	O
the	O
largest	O
RNA	O
virus	B-SPEC
genome	O
as	O
an	O
infectious	O
bacterial	O
artificial	O
chromosome	O
.	O

This	O
demonstration	O
opens	O
up	O
the	O
possibility	O
of	O
employing	O
this	O
infectious	O
cDNA	O
as	O
a	O
vector	O
for	O
vaccine	O
development	O
in	O
human	B-SPEC
,	O
porcine	B-SPEC
,	O
canine	O
,	O
and	O
feline	B-SPEC
species	B-SPEC
susceptible	O
to	O
group	O
1	O
coronaviruses	O
.	O

The	O
average	O
time	O
from	O
the	O
DNR	O
order	B-SPEC
to	O
death	O
was	O
2	O
days	O
.	O

TITLE	O
:	O
Long	O
-	O
term	O
impact	O
on	O
a	O
closed	O
household	O
of	O
pet	O
cats	B-SPEC
of	O
natural	O
infection	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
feline	B-SPEC
leukaemia	O
virus	B-SPEC
and	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
.	O

The	O
FeLV	O
infection	O
was	O
self	O
-	O
limiting	O
because	O
all	O
seven	O
of	O
the	O
initially	O
viraemic	O
cats	B-SPEC
died	O
within	O
five	O
years	O
and	O
the	O
remainder	O
were	O
immune	O
.	O

Nine	O
cats	B-SPEC
were	O
initially	O
FIV	B-SPEC
-	O
positive	O
and	O
six	O
more	O
cats	B-SPEC
became	O
infected	O
during	O
the	O
course	O
of	O
the	O
study	O
,	O
without	O
evidence	O
of	O
having	O
been	O
bitten	O
.	O

TITLE	O
:	O
Gill	B-SPEC
-	I-SPEC
associated	I-SPEC
virus	I-SPEC
of	O
Penaeus	B-SPEC
monodon	I-SPEC
prawns	O
:	O
an	O
invertebrate	O
virus	B-SPEC
with	O
ORF1a	O
and	O
ORF1b	O
genes	O
related	O
to	O
arteri	O
-	O
and	O
coronaviruses	O
.	O

The	O
ORFs	O
are	O
structurally	O
related	O
to	O
the	O
ORF1a	O
and	O
ORF1ab	O
polyproteins	O
of	O
coronaviruses	O
and	O
arteriviruses	B-SPEC
.	O

Three	O
in	O
vitro	O
virus	B-SPEC
-	O
neutralizing	O
and	O
in	O
vivo	O
protective	O
mAbs	O
against	O
either	O
continuous	O
or	O
discontinuous	O
epitopes	O
on	O
the	O
S	O
glycoprotein	O
were	O
used	O
to	O
screen	O
12	O
different	O
peptide	O
libraries	O
expressed	O
on	O
the	O
pVIII	O
major	O
coat	O
protein	O
of	O
the	O
fd	O
filamentous	B-SPEC
bacteriophage	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
replicase	O
gene	O
(	O
gene	O
1	O
)	O
is	O
translated	O
into	O
two	O
co	O
-	O
amino	O
-	O
terminal	O
polyproteins	O
that	O
are	O
proteolytically	O
processed	O
to	O
yield	O
more	O
than	O
15	O
mature	O
proteins	O
.	O

Patients	O
were	O
returned	O
to	O
CMV	B-SPEC
when	O
their	O
mean	O
airway	O
pressure	O
were	O
between	O
15	O
and	O
20	O
cmH2O	O
,	O
FiO2	O
<	O
0	O
.	O
6	O
,	O
had	O
no	O
evidence	O
of	O
air	O
-	O
leak	O
and	O
/	O
or	O
improved	O
chest	O
X	O
-	O
rays	B-SPEC
,	O
and	O
did	O
not	O
desaturated	O
during	O
airway	O
suctioning	O
.	O

During	O
the	O
1998	O
outbreak	O
,	O
bovine	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
was	O
isolated	O
from	O
2	O
cattle	B-SPEC
at	O
the	O
order	B-SPEC
-	O
buyer	O
'	O
s	O
barn	O
and	O
on	O
arrival	O
at	O
the	O
feedlot	O
and	O
from	O
5	O
cattle	B-SPEC
7	O
and	O
14	O
days	O
after	O
arrival	O
at	O
the	O
feedlot	O
,	O
and	O
parainfluenza	O
virus	B-SPEC
3	O
was	O
isolated	O
from	O
1	O
animal	B-SPEC
the	O
day	O
of	O
,	O
and	O
from	O
18	O
cattle	B-SPEC
7	O
and	O
14	O
days	O
after	O
,	O
arrival	O
at	O
the	O
feedlot	O
.	O

High	O
-	O
pressure	O
infusion	O
of	O
normal	O
saline	O
into	O
the	O
biliopancreatic	O
duct	O
of	O
rats	B-SPEC
results	O
in	O
significant	O
pancreatic	O
and	O
lung	O
alterations	O
.	O

A	O
34	O
-	O
year	O
-	O
old	O
African	O
-	O
American	O
man	B-SPEC
was	O
admitted	O
to	O
the	O
hospital	O
for	O
pneumococcal	O
pneumonia	O
and	O
sepsis	B-SPEC
.	O

Rotavirus	B-SPEC
was	O
the	O
only	O
enteropathogen	O
detected	O
in	O
39	O
of	O
the	O
93	O
(	O
41	O
.	O
9	O
%)	O
diarrheic	O
calves	O
positive	O
to	O
this	O
agent	O
.	O

The	O
detection	O
rates	O
of	O
the	O
other	O
enteropathogens	O
considered	O
in	O
calves	O
with	O
rotavirus	B-SPEC
infection	O
were	O
20	O
.	O
4	O
%	O
for	O
coronavirus	B-SPEC
,	O
85	O
.	O
2	O
%	O
for	O
Cryptosporidium	B-SPEC
,	O
16	O
.	O
7	O
%	O
for	O
F5	O
+	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
1	O
.	O
8	O
%	O
for	O
Salmonella	B-SPEC
.	O

TITLE	O
:	O
Localization	O
of	O
linear	O
B	O
-	O
cell	O
epitopes	O
on	O
infectious	O
bronchitis	O
virus	B-SPEC
nucleocapsid	O
protein	O
.	O

Sera	O
against	O
Australia	O
T	O
,	O
China	O
Ch5	O
,	O
Singapore	O
P4	O
,	O
USA	O
M41	O
and	O
China	O
T3	O
isolates	O
were	O
used	O
to	O
study	O
the	O
conservation	O
and	O
localization	O
of	O
the	O
antigenic	O
region	O
on	O
the	O
IBV	B-SPEC
nucleocapsid	O
protein	O
.	O

Panleukopenia	O
virus	B-SPEC
was	O
identified	O
by	O
PCR	O
in	O
10	O
of	O
31	O
cats	B-SPEC
with	O
cardiomyopathy	O
but	O
in	O
none	O
of	O
the	O
controls	O
.	O

The	O
membrane	O
gene	O
of	O
PEDV	B-SPEC
and	O
the	O
nucleocapsid	O
gene	O
of	O
TGEV	B-SPEC
were	O
chosen	O
as	O
targets	O
.	O

The	O
results	O
of	O
the	O
assay	O
correlated	O
well	O
with	O
the	O
results	O
of	O
virus	B-SPEC
isolation	O
.	O

The	O
occurrence	O
of	O
both	O
cleavage	O
events	O
in	O
intact	O
cells	O
is	O
potentially	O
rapid	O
and	O
efficient	O
,	O
as	O
no	O
intermediate	O
cleavage	O
products	O
covering	O
the	O
proteinase	O
were	O
detected	O
in	O
either	O
IBV	B-SPEC
-	O
infected	O
or	O
transfected	O
cells	O
.	O

TITLE	O
:	O
Two	O
cases	O
of	O
fulminant	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
pneumonia	O
within	O
4	O
months	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
the	O
thymus	B-SPEC
of	O
infected	O
birds	B-SPEC
harbors	O
the	O
agent	O
(	O
s	O
)	O
that	O
can	O
reproduce	O
a	O
PEMS	O
-	O
like	O
disease	O
in	O
turkey	B-SPEC
poults	O
.	O

TITLE	O
:	O
A	O
potential	O
role	O
for	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
in	O
synergy	O
between	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
and	O
bacterial	O
lipopolysaccharide	O
in	O
the	O
induction	O
of	O
respiratory	O
disease	O
in	O
pigs	B-SPEC
.	O

TITLE	O
:	O
Primary	O
structure	O
of	O
the	O
sialodacryoadenitis	O
virus	B-SPEC
genome	O
:	O
sequence	O
of	O
the	O
structural	O
-	O
protein	O
region	O
and	O
its	O
application	O
for	O
differential	O
diagnosis	O
.	O

As	O
with	O
mouse	B-SPEC
hepatitis	O
coronaviruses	O
(	O
MHVs	O
),	O
the	O
SDAV	O
genome	O
was	O
able	O
to	O
code	O
for	O
a	O
spike	O
protein	O
,	O
a	O
small	O
membrane	O
protein	O
,	O
a	O
membrane	O
-	O
associated	O
protein	O
,	O
and	O
a	O
nucleocapsid	O
protein	O
.	O

This	O
68	O
-	O
nucleotide	O
structure	O
is	O
composed	O
of	O
six	O
stem	O
segments	O
interrupted	O
by	O
five	O
bulges	O
,	O
and	O
its	O
structure	O
,	O
but	O
not	O
its	O
primary	O
sequence	O
,	O
is	O
entirely	O
conserved	O
in	O
the	O
related	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

Infections	O
by	O
these	O
srr	O
mutants	O
in	O
BHK	O
-	O
R2	O
cells	O
were	O
0	O
.	O
7	O
to	O
1	O
.	O
5	O
log10	O
less	O
efficient	O
than	O
those	O
of	O
wt	O
virus	B-SPEC
.	O

This	O
suggests	O
that	O
the	O
most	O
likely	O
reason	O
for	O
inefficient	O
infection	O
by	O
mutants	O
in	O
BHK	O
-	O
R2	O
is	O
impaired	O
virus	B-SPEC
entry	O
into	O
cells	O
.	O

TITLE	O
:	O
Activation	O
of	O
glial	O
cells	O
by	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
infection	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
a	O
coronavirus	B-SPEC
,	O
replicates	O
in	O
intestinal	O
enterocytes	O
and	O
causes	O
diarrhea	O
in	O
young	O
pigs	B-SPEC
.	O

Specific	O
PCR	O
products	O
for	O
TGEV	B-SPEC
/	O
PRCV	O
were	O
detected	O
only	O
with	O
the	O
homologous	O
reference	O
or	O
field	O
coronaviruses	O
and	O
for	O
10	O
-	O
14	O
DPI	O
of	O
pigs	B-SPEC
with	O
TGEV	B-SPEC
(	O
feces	O
)	O
or	O
PRCV	O
(	O
nasal	O
samples	O
).	O

Nevertheless	O
,	O
regional	O
increases	O
in	O
vascular	O
resistance	O
can	O
occur	O
that	O
may	O
predispose	O
mammals	B-SPEC
to	O
organ	O
dysfunction	O
,	O
including	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Because	O
inflammatory	O
mediators	O
such	O
as	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
alpha	O
and	O
nitric	O
oxide	O
(	O
NO	O
)	O
produced	O
within	O
the	O
lungs	O
have	O
been	O
implicated	O
in	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
role	O
of	O
these	O
mediators	O
in	O
pancreatitis	O
-	O
induced	O
ARDS	O
using	O
a	O
model	O
whereby	O
ascites	O
from	O
animals	B-SPEC
with	O
pancreatitis	O
is	O
transferred	O
to	O
otherwise	O
healthy	O
animals	B-SPEC
resulting	O
in	O
pulmonary	O
injury	O
.	O

Each	O
of	O
these	O
variables	O
of	O
pulmonary	O
injury	O
was	O
lessened	O
in	O
animals	B-SPEC
receiving	O
CNI	O
-	O
1493	O
and	O
intravenous	O
ascites	O
(	O
p	O
<	O
.	O
05	O
vs	O
.	O
vehicle	O
).	O

A	O
component	O
of	O
pancreatic	O
ascites	O
other	O
than	O
endotoxin	O
,	O
bacteria	B-SPEC
,	O
or	O
cytokines	O
(	O
IL	O
-	O
1beta	O
,	O
TNF	O
,	O
interferon	O
-	O
gamma	O
,	O
or	O
IL	O
-	O
6	O
)	O
is	O
capable	O
of	O
inducing	O
ARDS	O
in	O
healthy	O
animals	B-SPEC
.	O

Macrophage	O
infiltration	O
into	O
the	O
gray	O
matter	O
of	O
CD4	O
T	O
cell	O
-	O
enriched	O
recipients	O
was	O
greater	O
than	O
that	O
observed	O
in	O
mice	B-SPEC
receiving	O
undepleted	O
splenocytes	O
.	O

MHV	B-SPEC
-	O
JHM	O
-	O
infected	O
RAG1	O
-/-	O
mice	B-SPEC
receiving	O
donors	O
depleted	O
of	O
both	O
CD4	O
and	O
CD8	O
T	O
cells	O
did	O
not	O
develop	O
demyelination	O
.	O

The	O
data	O
indicate	O
that	O
residual	O
virus	B-SPEC
from	O
a	O
primary	O
CNS	O
infection	O
is	O
a	O
vital	O
component	O
in	O
mediating	O
local	O
retention	O
of	O
both	O
CD8	O
(+)	O
and	O
CD4	O
(+)	O
T	O
cells	O
and	O
that	O
once	O
minimal	O
thresholds	O
of	O
stimuli	O
are	O
lost	O
,	O
T	O
cells	O
within	O
the	O
CNS	O
cannot	O
survive	O
in	O
an	O
autonomous	O
fashion	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
coronavirus	B-SPEC
M	O
protein	O
and	O
nucleocapsid	O
interaction	O
in	O
infected	O
cells	O
.	O

We	O
studied	O
the	O
macromolecular	O
interactions	O
involved	O
in	O
coronavirus	B-SPEC
assembly	O
in	O
cells	O
infected	O
with	O
a	O
murine	B-SPEC
coronavirus	I-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

Coimmunoprecipitation	O
analyses	O
further	O
revealed	O
that	O
M	O
protein	O
interacted	O
with	O
only	O
genomic	O
-	O
length	O
MHV	B-SPEC
mRNA	O
,	O
mRNA	O
1	O
,	O
while	O
N	O
protein	O
interacted	O
with	O
all	O
MHV	B-SPEC
mRNAs	O
.	O

TITLE	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Isolation	O
and	O
identification	O
of	O
IBV	B-SPEC
is	O
needed	O
for	O
positive	O
diagnosis	O
.	O

ABSTRACT	O
:	O
Scientific	O
knowledge	O
of	O
ostrich	B-SPEC
diseases	O
is	O
incomplete	O
and	O
very	O
fragmented	O
,	O
with	O
specific	O
details	O
on	O
technical	O
aspects	O
of	O
diagnostic	O
and	O
/	O
or	O
screening	O
tests	O
completely	O
absent	O
in	O
most	O
cases	O
.	O

Campylobacter	B-SPEC
jejuni	I-SPEC
and	O
Chlamydia	B-SPEC
psittaci	I-SPEC
are	O
occasionally	O
reported	O
,	O
mainly	O
in	O
young	O
ostriches	B-SPEC
,	O
but	O
both	O
remain	O
a	O
diagnostic	O
challenge	O
.	O

Ostriches	B-SPEC
of	O
all	O
ages	O
are	O
susceptible	O
to	O
challenge	O
by	O
velogenic	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
but	O
standard	O
inactivated	O
La	O
Sota	O
poultry	O
vaccines	O
can	O
stimulate	O
protective	O
immunity	O
lasting	O
over	O
six	O
months	O
.	O

ABSTRACT	O
:	O
Nasopharyngeal	O
swabs	O
of	O
50	O
asthmatic	O
children	O
in	O
the	O
symptom	O
-	O
free	O
period	O
were	O
examined	O
for	O
the	O
presence	O
of	O
adenoviruses	B-SPEC
,	O
rhinoviruses	B-SPEC
and	O
coronaviruses	O
.	O

Gnotobiotic	O
pig	B-SPEC
inoculation	O
and	O
histopathological	O
results	O
revealed	O
that	O
this	O
TGEV	B-SPEC
isolate	O
retained	O
virulence	O
even	O
though	O
in	O
the	O
field	O
outbreak	O
the	O
diarrheal	O
disease	O
was	O
of	O
reduced	O
severity	O
.	O

119	O
ferrets	B-SPEC
with	O
epizootic	O
diarrhea	O
of	O
presumed	O
viral	O
cause	O
and	O
5	O
control	O
ferrets	B-SPEC
.	O

TITLE	O
:	O
Seroprevalence	O
of	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
in	O
selected	O
Korean	O
pigs	B-SPEC
.	O

The	O
development	O
of	O
apoptosis	O
,	O
regulative	O
gene	O
expression	O
,	O
and	O
viral	O
clearance	O
were	O
similar	O
in	O
both	O
retinal	O
degeneration	O
-	O
susceptible	O
(	O
BALB	O
/	O
c	O
)	O
and	O
-	O
resistant	O
(	O
CD	O
-	O
1	O
)	O
mice	B-SPEC
.	O

Eighteen	O
normal	O
control	O
cattle	B-SPEC
also	O
were	O
sampled	O
at	O
the	O
beginning	O
of	O
the	O
epizootics	O
as	O
well	O
as	O
at	O
weekly	O
intervals	O
for	O
4	O
weeks	O
.	O

RESULTS	O
:	O
Samples	O
from	O
12	O
groups	O
of	O
cattle	B-SPEC
entering	O
7	O
feedlots	O
during	O
a	O
3	O
-	O
year	O
period	O
revealed	O
that	O
78	O
of	O
1	O
,	O
074	O
(	O
7	O
.	O
3	O
%)	O
cattle	B-SPEC
were	O
shedding	O
BCV	B-SPEC
(	O
range	O
,	O
0	O
to	O
35	O
.	O
9	O
%	O
within	O
specific	O
groups	O
).	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
association	O
between	O
respiratory	O
tract	O
infection	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
),	O
treatment	O
for	O
respiratory	O
tract	O
disease	O
,	O
pulmonary	O
lesions	O
at	O
slaughter	O
,	O
and	O
average	O
daily	O
gain	O
in	O
cattle	B-SPEC
in	O
feedlots	O
.	O

TITLE	O
:	O
Serologic	O
survey	O
of	O
selected	O
viral	O
agents	O
in	O
recently	O
captured	O
wild	O
North	O
American	O
river	B-SPEC
otters	I-SPEC
(	O
Lontra	B-SPEC
canadensis	I-SPEC
).	O

No	O
interferon	O
was	O
detected	O
in	O
the	O
inoculum	O
used	O
for	O
MHV	B-SPEC
infection	O
.	O

Addition	O
of	O
anti	O
-	O
interferon	O
antibody	O
to	O
MHV	B-SPEC
-	O
infected	O
cells	O
did	O
not	O
inhibit	O
28S	O
rRNA	O
cleavage	O
.	O

These	O
results	O
are	O
discussed	O
in	O
relation	O
to	O
the	O
interconnected	O
functions	O
required	O
for	O
different	O
steps	O
of	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Demyelination	O
is	O
the	O
pathologic	O
hallmark	O
of	O
the	O
human	B-SPEC
immune	O
-	O
mediated	O
neurologic	O
disease	O
multiple	O
sclerosis	O
,	O
which	O
may	O
be	O
triggered	O
or	O
exacerbated	O
by	O
viral	O
infections	O
.	O

Similar	O
results	O
were	O
noted	O
when	O
the	O
virus	B-SPEC
was	O
applied	O
to	O
cultured	O
human	B-SPEC
tracheal	O
explants	O
.	O

18	O
cohorts	O
(	O
30	O
to	O
35	O
pigs	B-SPEC
/	O
cohort	O
)	O
of	O
pigs	B-SPEC
on	O
/	O
farms	O
.	O

TITLE	O
:	O
Nascent	O
synthesis	O
of	O
leader	O
sequence	O
-	O
containing	O
subgenomic	O
mRNAs	O
in	O
coronavirus	B-SPEC
genome	O
-	O
length	O
replicative	O
intermediate	O
RNA	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
coronavirus	B-SPEC
results	O
in	O
the	O
accumulation	O
of	O
genomic	O
-	O
sized	O
mRNA	O
and	O
six	O
to	O
eight	O
subgenomic	O
mRNAs	O
that	O
make	O
up	O
a	O
3	O
'	O
coterminal	O
nested	O
-	O
set	O
structure	O
.	O

ABSTRACT	O
:	O
The	O
arterivirus	B-SPEC
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
nonstructural	O
protein	O
10	O
(	O
nsp10	O
)	O
has	O
previously	O
been	O
predicted	O
to	O
contain	O
a	O
Zn	O
finger	O
structure	O
linked	O
to	O
a	O
superfamily	B-SPEC
1	O
(	O
SF1	O
)	O
helicase	O
domain	O
.	O

Transgenic	O
potato	B-SPEC
plants	B-SPEC
were	O
created	O
that	O
express	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
glycoprotein	O
S	O
(	O
N	O
-	O
gS	O
)	O
from	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
),	O
containing	O
the	O
major	O
antigenic	O
sites	O
of	O
the	O
protein	O
.	O

The	O
ELISA	O
results	O
of	O
serum	O
samples	O
collected	O
from	O
turkeys	B-SPEC
experimentally	O
infected	O
with	O
TCV	B-SPEC
were	O
comparable	O
to	O
that	O
of	O
the	O
IFA	O
assay	O
.	O

TITLE	O
:	O
Emergence	O
of	O
subtype	O
strains	O
of	O
the	O
Arkansas	O
serotype	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Delmarva	O
broiler	O
chickens	B-SPEC
.	O

Antigenic	O
(	O
VN	O
)	O
comparisons	O
and	O
S	O
-	O
1	O
gene	O
analysis	O
confirmed	O
that	O
the	O
five	O
RT	O
-	O
PCR	O
Ark	O
-	O
positive	O
field	O
isolates	O
were	O
of	O
the	O
Ark	O
serotype	O
but	O
also	O
revealed	O
that	O
the	O
viruses	B-SPEC
could	O
be	O
readily	O
distinguished	O
from	O
Ark	O
reference	O
strains	O
.	O

These	O
flocks	O
(	O
14	O
chicken	B-SPEC
and	O
1	O
quail	O
)	O
were	O
experiencing	O
a	O
variety	O
of	O
IB	O
-	O
like	O
conditions	O
including	O
respiratory	O
disease	O
,	O
digestive	O
and	O
kidney	O
problems	O
,	O
and	O
drops	O
in	O
egg	O
production	O
.	O

The	O
RT	O
-	O
PCR	O
,	O
MAb	O
-	O
based	O
fluorescent	O
antibody	O
(	O
FA	O
),	O
and	O
MAb	O
-	O
based	O
immunoperoxidase	O
(	O
IP	O
)	O
procedures	O
were	O
compared	O
with	O
virus	B-SPEC
isolation	O
(	O
VI	O
)	O
for	O
detection	O
of	O
TCV	B-SPEC
in	O
experimentally	O
infected	O
turkeys	B-SPEC
.	O

A	O
total	O
of	O
455	O
ICU	O
patients	O
who	O
met	O
consensus	O
criteria	O
for	O
severe	O
sepsis	B-SPEC
(	O
178	O
of	O
whom	O
developed	O
ARDS	O
)	O
from	O
a	O
recently	O
completed	O
prospective	O
clinical	O
trial	O
.	O

Case	O
#	O
2	O
:	O
A	O
previously	O
healthy	O
4	O
yr	O
-	O
old	O
girl	O
was	O
admitted	O
to	O
the	O
PICU	B-SPEC
for	O
respiratory	O
failure	O
.	O

Length	O
of	O
mechanical	O
ventilation	O
was	O
16	O
days	O
and	O
length	O
of	O
stay	O
in	O
PICU	B-SPEC
was	O
3	O
wks	O
.	O

Although	O
there	O
are	O
significant	O
differences	O
among	O
species	B-SPEC
in	O
the	O
basal	O
rates	O
of	O
sodium	O
and	O
fluid	O
transport	O
,	O
the	O
basic	O
mechanism	O
seems	O
to	O
depend	O
on	O
sodium	O
uptake	O
by	O
channels	O
on	O
the	O
apical	O
membrane	O
of	O
alveolar	O
type	O
II	O
cells	O
,	O
followed	O
by	O
extrusion	O
of	O
sodium	O
on	O
the	O
basolateral	O
surface	O
by	O
Na	O
,	O
K	O
-	O
ATPase	O
.	O

Exogenous	O
catecholamines	O
can	O
increase	O
the	O
rate	O
of	O
alveolar	O
fluid	O
clearance	O
in	O
several	O
species	B-SPEC
,	O
including	O
the	O
human	B-SPEC
lung	O
,	O
and	O
it	O
is	O
also	O
apparent	O
that	O
release	O
of	O
endogenous	O
catecholamines	O
can	O
upregulate	O
alveolar	O
fluid	O
clearance	O
in	O
animals	B-SPEC
with	O
septic	O
or	O
hypovolemic	O
shock	O
.	O

CRRTs	O
have	O
certainly	O
made	O
the	O
management	O
of	O
critically	O
ill	O
patients	O
with	O
acute	O
renal	O
failure	O
(	O
ARF	O
)	O
combined	O
with	O
cardiovascular	O
instability	O
,	O
severe	O
fluid	O
overload	O
,	O
hypercatabolism	O
,	O
cerebral	O
edema	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
lactic	O
acidosis	O
,	O
sepsis	B-SPEC
or	O
other	O
inflammatory	O
syndromes	O
,	O
crush	O
syndrome	O
,	O
congestive	O
heart	O
failure	O
,	O
and	O
cardiopulmonary	O
bypass	O
easier	O
.	O

Cardiorespiratory	O
parameters	O
were	O
measured	O
using	O
a	O
Swan	B-SPEC
-	O
Ganz	O
catheter	O
,	O
the	O
pressure	O
-	O
volume	O
(	O
PV	O
)	O
curve	O
was	O
measured	O
using	O
the	O
gross	O
syringe	O
method	O
,	O
and	O
fast	O
spiral	O
computed	O
tomography	O
(	O
CT	O
)	O
was	O
performed	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
is	O
a	O
noncurable	O
viral	O
disease	O
affecting	O
cats	B-SPEC
worldwide	O
.	O

Recent	O
evidence	O
suggests	O
that	O
the	O
FIPV	O
has	O
evolved	O
as	O
a	O
deletion	O
mutation	O
of	O
FECV	B-SPEC
.	O

Applying	O
indicator	B-SPEC
-	O
dilution	O
techniques	O
,	O
we	O
measured	O
single	O
-	O
pass	O
transpulmonary	O
hydrolysis	O
of	O
the	O
synthetic	O
ACE	O
substrate	O
(	O
3	O
)	O
H	O
-	O
benzoyl	O
-	O
Phe	O
-	O
Ala	O
-	O
Pro	O
(	O
BPAP	O
)	O
in	O
33	O
mechanically	O
ventilated	O
,	O
critically	O
ill	O
patients	O
with	O
a	O
lung	O
injury	O
score	O
(	O
LIS	O
)	O
ranging	O
from	O
0	O
(	O
no	O
lung	O
injury	O
)	O
to	O
3	O
.	O
7	O
(	O
severe	O
lung	O
injury	O
)	O
and	O
calculated	O
the	O
kinetic	O
parameter	O
A	O
(	O
max	O
)/	O
K	O
(	O
m	O
).	O

Each	O
clone	O
was	O
engineered	O
with	O
unique	O
flanking	O
interconnecting	O
junctions	O
which	O
determine	O
a	O
precise	O
systematic	O
assembly	O
with	O
only	O
the	O
adjacent	O
cDNA	O
subclones	O
,	O
resulting	O
in	O
an	O
intact	O
TGEV	B-SPEC
cDNA	O
construct	O
of	O
approximately	O
28	O
.	O
5	O
kb	O
in	O
length	O
.	O

Transcripts	O
derived	O
from	O
the	O
full	O
-	O
length	O
TGEV	B-SPEC
construct	O
were	O
infectious	O
,	O
and	O
progeny	O
virions	O
were	O
serially	O
passaged	O
in	O
permissive	O
host	O
cells	O
.	O

The	O
apparently	O
increased	O
risk	O
of	O
respiratory	O
tract	O
infection	O
was	O
limited	O
to	O
children	O
who	O
were	O
seronegative	O
for	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
(	O
P	O
value	O
for	O
interaction	O
=.	O
07	O
).	O

Serologic	O
and	O
virus	B-SPEC
genetic	O
analyses	O
of	O
rodents	B-SPEC
trapped	O
in	O
the	O
area	O
showed	O
Oligoryzomys	B-SPEC
fulvescens	I-SPEC
to	O
be	O
the	O
likely	O
reservoir	O
for	O
the	O
HPS	O
-	O
associated	O
Choclo	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Ten	O
calves	O
which	O
had	O
contracted	O
acute	O
diarrhoea	O
caused	O
by	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
Cryptosporidium	B-SPEC
were	O
used	O
to	O
test	O
the	O
hypothesis	O
that	O
feeding	O
lactose	O
-	O
hydrolysed	O
cow	B-SPEC
'	O
s	O
milk	O
instead	O
of	O
unprocessed	O
cow	B-SPEC
'	O
s	O
milk	O
improves	O
sugar	O
absorption	O
in	O
diarrhoeic	O
calves	O
.	O

The	O
most	O
common	O
foods	O
associated	O
with	O
melon	O
allergy	O
were	O
avocado	B-SPEC
(	O
n	O
=	O
7	O
),	O
banana	B-SPEC
(	O
n	O
=	O
7	O
),	O
kiwi	O
(	O
n	O
=	O
6	O
),	O
watermelon	B-SPEC
(	O
n	O
=	O
6	O
),	O
and	O
peach	B-SPEC
(	O
n	O
=	O
5	O
).	O

An	O
HFOV	O
protocol	O
was	O
established	O
with	O
the	O
following	O
inclusion	O
criteria	O
:	O
severe	O
respiratory	O
insufficiency	O
of	O
any	O
origin	O
(	O
infectious	O
,	O
inhalatory	O
,	O
etc	O
.)	O
with	O
an	O
oxygenation	O
index	O
(	O
OI	O
)	O
>	O
13	O
in	O
two	O
arterial	O
blood	O
gases	O
within	O
a	O
6	O
-	O
hour	O
interval	O
,	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
severe	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
pneumonia	O
,	O
and	O
gross	O
airleak	O
syndromes	O
(	O
pneumothorax	O
,	O
pneumoperitoneum	O
,	O
pneumomediastinum	O
,	O
etc	O
.).	O

Rescue	O
of	O
CD	O
-	O
61	O
was	O
also	O
demonstrated	O
for	O
the	O
first	O
time	O
in	O
mammalian	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
The	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
5B19	O
.	O
2	O
,	O
which	O
has	O
virus	B-SPEC
-	O
neutralizing	O
and	O
fusion	O
inhibition	O
activities	O
,	O
binds	O
to	O
an	O
epitope	O
(	O
S2A	O
)	O
consisting	O
of	O
nine	O
hydrophobic	O
amino	O
acids	O
in	O
the	O
S2	O
subunit	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
spike	O
(	O
S	O
)	O
protein	O
.	O

This	O
suggests	O
that	O
the	O
S2A	O
epitope	O
may	O
be	O
involved	O
in	O
binding	O
the	O
virus	B-SPEC
to	O
the	O
MHV	B-SPEC
receptor	O
and	O
/	O
or	O
in	O
virus	B-SPEC
-	O
cell	O
fusion	O
.	O

Those	O
two	O
viruses	B-SPEC
had	O
high	O
nucleotide	O
similarity	O
in	O
Gene	O
4	O
.	O

The	O
genome	O
of	O
five	O
IBV	B-SPEC
strains	O
,	O
of	O
which	O
the	O
complete	O
sequence	O
of	O
the	O
3	O
'	O
end	O
of	O
the	O
genome	O
has	O
been	O
determined	O
,	O
were	O
divided	O
at	O
an	O
intergenic	O
(	O
IG	O
)	O
consensus	O
sequence	O
(	O
CTGAACAA	O
or	O
CTTAACAA	O
)	O
and	O
compared	O
phylogenetically	O
.	O

These	O
""""	O
treatment	O
related	O
clinical	O
fluctuations	O
""""	O
are	O
more	O
frequently	O
seen	O
in	O
relatively	O
young	O
patients	O
with	O
severe	O
motor	O
and	O
sensory	O
involvement	O
associated	O
with	O
a	O
preceding	O
and	O
possibly	O
ongoing	O
cytomegalovirus	B-SPEC
infection	O
.	O

Indirect	O
fluorescent	O
-	O
antibody	O
assay	O
procedures	O
and	O
virus	B-SPEC
neutralization	O
assays	O
demonstrated	O
a	O
close	O
antigenic	O
relationship	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
and	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
mammalian	B-SPEC
group	O
2	O
coronaviruses	O
).	O

Institution	O
of	O
invasive	O
therapeutic	O
methods	O
:	O
continuous	O
mandatory	O
ventilation	O
(	O
CMV	B-SPEC
)	O
with	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
and	O
plasmapheresis	O
,	O
together	O
with	O
antibioticotherapy	O
resulted	O
in	O
complete	O
recovery	O
.	O

To	O
determine	O
the	O
sensitivity	O
of	O
the	O
cell	O
lines	O
to	O
murine	B-SPEC
coronaviruses	O
,	O
the	O
50	O
%	O
tissue	O
culture	O
infectious	O
dose	O
of	O
the	O
coronaviruses	O
was	O
determined	O
with	O
B16	O
,	O
DBT	O
,	O
IC	O
-	O
21	O
and	O
J774A	O
.	O
1	O
cells	O
,	O
and	O
compared	O
to	O
that	O
with	O
DBT	O
cells	O
.	O

Transfection	O
of	O
the	O
reporter	O
RNA	O
into	O
MHV	B-SPEC
-	O
infected	O
cells	O
resulted	O
in	O
synthesis	O
of	O
a	O
CAT	B-SPEC
-	O
specific	O
subgenomic	O
mRNA	O
detected	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

We	O
examined	O
by	O
confocal	O
microscopy	O
the	O
subcellular	O
localization	O
of	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
N	O
protein	O
both	O
in	O
the	O
absence	O
and	O
in	O
the	O
context	O
of	O
an	O
infected	O
cell	O
and	O
found	O
that	O
N	O
protein	O
localizes	O
both	O
to	O
the	O
cytoplasmic	O
and	O
nucleolar	O
compartments	O
.	O

None	O
of	O
the	O
pigs	B-SPEC
showed	O
clinical	O
signs	O
and	O
the	O
virus	B-SPEC
was	O
recovered	O
from	O
rectal	O
swabs	O
until	O
6	O
-	O
7	O
days	O
post	O
-	O
infection	O
.	O

One	O
assay	O
used	O
p	O
-	O
nitrophenyl	O
acetate	O
(	O
PNPA	O
)	O
as	O
substrate	O
and	O
detected	O
serine	O
-	O
esterase	O
activity	O
;	O
the	O
second	O
assay	O
monitored	O
AE	O
function	O
with	O
bovine	B-SPEC
submaxillary	O
mucin	O
(	O
BSM	O
)	O
as	O
substrate	O
.	O

ABSTRACT	O
:	O
Viral	O
induced	O
demyelination	O
,	O
in	O
both	O
humans	B-SPEC
and	O
rodent	B-SPEC
models	O
,	O
has	O
provided	O
unique	O
insights	O
into	O
the	O
cell	O
biology	O
of	O
oligodendroglia	O
,	O
their	O
complex	O
cell	O
-	O
cell	O
interactions	O
and	O
mechanisms	O
of	O
myelin	O
destruction	O
.	O

Positioning	O
therapy	O
was	O
administered	O
in	O
group	O
3	O
in	O
order	B-SPEC
to	O
prevent	O
atelectases	O
,	O
and	O
respirator	O
-	O
induced	O
lung	O
injuries	O
during	O
a	O
foreseeable	O
,	O
relatively	O
long	O
period	O
in	O
the	O
intensive	O
care	O
unit	O
in	O
view	O
of	O
the	O
severity	O
of	O
the	O
trauma	O
.	O

To	O
determine	O
functional	O
significance	O
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
-	O
infected	O
mice	B-SPEC
were	O
treated	O
with	O
anti	O
-	O
Mig	O
antisera	O
,	O
and	O
the	O
severity	O
of	O
disease	O
was	O
evaluated	O
.	O

As	O
a	O
result	O
,	O
antibodies	O
to	O
eight	O
or	O
ten	O
kinds	O
of	O
pathogens	O
were	O
detected	O
in	O
SPF	O
chickens	B-SPEC
on	O
each	O
farm	O
.	O

Thus	O
36	O
paediatric	O
or	O
neonatal	O
patients	O
were	O
examined	O
for	O
circulatory	O
,	O
respiratory	O
or	O
neurological	O
disorders	O
with	O
clinical	O
examination	O
,	O
echocardiography	O
,	O
chest	O
X	O
-	O
ray	B-SPEC
and	O
a	O
capillary	O
blood	O
sample	O
.	O

Underlying	O
causes	O
of	O
chyloperitoneum	O
in	O
cats	B-SPEC
and	O
humans	B-SPEC
are	O
discussed	O
,	O
and	O
possible	O
pathogenesis	O
of	O
the	O
chyloperitoneum	O
in	O
association	O
with	O
a	O
vasculitis	O
such	O
as	O
FIP	O
is	O
discussed	O
.	O

Rotavirus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
are	O
the	O
most	O
frequent	O
.	O

Cattle	B-SPEC
nasally	O
shedding	O
RBCV	O
at	O
the	O
beginning	O
of	O
the	O
epizootic	O
experienced	O
characteristic	O
primary	O
immune	O
responses	O
with	O
specific	O
antibodies	O
for	O
hemagglutinin	O
-	O
esterase	O
(	O
HE	O
)	O
and	O
spike	O
(	O
S	O
)	O
glycoproteins	O
.	O

Virus	B-SPEC
shedding	O
in	O
nasal	O
secretions	O
of	O
the	O
majority	O
of	O
the	O
cattle	B-SPEC
ceased	O
between	O
days	O
7	O
and	O
14	O
with	O
the	O
appearance	O
of	O
HE	O
-	O
and	O
S	O
-	O
specific	O
antibodies	O
.	O

ABSTRACT	O
:	O
Structure	O
activity	O
relationships	O
(	O
SARs	O
)	O
of	O
product	O
-	O
based	O
inhibitors	O
of	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
NS3	O
protease	O
were	O
evaluated	O
using	O
an	O
in	O
vitro	O
assay	O
system	O
comprising	O
the	O
native	O
bifunctional	O
full	O
-	O
length	O
NS3	O
(	O
protease	O
-	O
helicase	O
/	O
NTPase	O
).	O

TITLE	O
:	O
Septic	O
shock	O
and	O
acute	O
lung	O
injury	O
in	O
rabbits	B-SPEC
with	O
peritonitis	O
:	O
failure	O
of	O
the	O
neutrophil	O
response	O
to	O
localized	O
infection	O
.	O

At	O
a	O
dose	O
of	O
10	O
(	O
8	O
)	O
cfu	O
/	O
clot	O
the	O
animals	B-SPEC
had	O
resolving	O
infection	O
,	O
and	O
a	O
dose	O
of	O
10	O
(	O
9	O
)	O
cfu	O
/	O
clot	O
resulted	O
in	O
persistent	O
infection	O
at	O
24	O
h	O
,	O
with	O
minimal	O
systemic	O
manifestations	O
.	O

Phylogenetic	O
analysis	O
,	O
based	O
on	O
both	O
nucleotide	O
and	O
amino	O
acid	O
sequence	O
,	O
showed	O
that	O
IBV	B-SPEC
isolates	O
were	O
divided	O
into	O
two	O
distinct	O
groups	O
.	O

TITLE	O
:	O
Orchitis	O
in	O
a	O
cat	B-SPEC
associated	O
with	O
coronavirus	B-SPEC
infection	O
.	O

In	O
considering	O
the	O
possible	O
role	O
of	O
this	O
hyperactive	O
membrane	O
fusion	O
activity	O
in	O
neurovirulence	O
,	O
we	O
discovered	O
that	O
the	O
growth	O
of	O
JHM	O
in	O
tissue	O
culture	O
selected	O
for	O
variants	O
that	O
had	O
lost	O
murine	B-SPEC
CEACAM	O
-	O
independent	O
fusion	O
activity	O
.	O

Each	O
mutation	O
was	O
separately	O
introduced	O
into	O
cDNA	O
encoding	O
the	O
prototype	O
JHM	O
spike	O
,	O
and	O
the	O
set	O
of	O
cDNAs	O
was	O
expressed	O
using	O
vaccinia	B-SPEC
virus	I-SPEC
vectors	O
.	O

We	O
suggest	O
that	O
cultured	O
cells	O
,	O
unlike	O
certain	O
in	O
vivo	O
environments	O
,	O
select	O
for	O
S	O
proteins	O
with	O
delayed	O
,	O
CEACAM	O
-	O
dependent	O
fusion	O
activities	O
that	O
may	O
increase	O
the	O
likelihood	O
of	O
virus	B-SPEC
internalization	O
prior	O
to	O
the	O
irreversible	O
uncoating	O
process	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
neutralizing	O
monoclonal	O
antibody	O
expressed	O
in	O
milk	O
of	O
transgenic	B-SPEC
mice	I-SPEC
provides	O
full	O
protection	O
against	O
virus	B-SPEC
-	O
induced	O
encephalitis	O
.	O

Milk	O
from	O
these	O
transgenic	B-SPEC
mice	I-SPEC
contained	O
up	O
to	O
0	O
.	O
7	O
mg	O
of	O
recombinant	O
antibody	O
/	O
ml	O
.	O

In	O
vitro	O
analysis	O
of	O
milk	O
derived	O
from	O
different	O
transgenic	O
lines	O
revealed	O
a	O
linear	O
correlation	O
between	O
antibody	O
expression	O
and	O
virus	B-SPEC
-	O
neutralizing	O
activity	O
,	O
indicating	O
that	O
the	O
recombinant	O
antibody	O
is	O
the	O
major	O
determinant	O
of	O
MHV	B-SPEC
-	O
JHM	O
neutralization	O
in	O
murine	B-SPEC
milk	O
.	O

Offspring	O
of	O
transgenic	O
and	O
control	O
mice	B-SPEC
were	O
challenged	O
with	O
a	O
lethal	O
dose	O
of	O
MHV	B-SPEC
-	O
JHM	O
.	O

ABSTRACT	O
:	O
The	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
causes	O
acute	O
encephalitis	O
and	O
chronic	O
demyelinating	O
encephalomyelitis	O
in	O
rodents	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
23	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
HIV	B-SPEC
-	O
infection	O
and	O
recently	O
diagnosed	O
hepatitis	O
B	O
infection	O
developed	O
painful	O
swelling	O
and	O
palpable	O
purpura	B-SPEC
in	O
the	O
limbs	O
.	O

ABSTRACT	O
:	O
Serial	O
passage	O
of	O
virulent	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
through	O
cell	O
culture	O
reduced	O
its	O
virulence	O
in	O
3	O
-	O
day	O
-	O
old	O
piglets	O
.	O

In	O
situ	O
hybridization	O
for	O
the	O
detection	O
of	O
TGEV	B-SPEC
in	O
formalin	O
-	O
fixed	O
,	O
paraffin	O
-	O
embedded	O
tissues	O
provides	O
a	O
rapid	O
means	O
of	O
confirmation	O
of	O
a	O
histopathological	O
diagnosis	O
of	O
TGEV	B-SPEC
without	O
virus	B-SPEC
isolation	O
,	O
or	O
when	O
only	O
formalin	O
-	O
fixed	O
intestinal	O
specimens	O
were	O
available	O
.	O

Three	O
groups	O
of	O
mice	B-SPEC
were	O
examined	O
.	O

Evaluation	O
of	O
the	O
change	O
in	O
pulmonary	O
function	O
after	O
24	O
hours	O
demonstrated	O
that	O
EL	O
alone	O
induces	O
a	O
significant	O
decrease	O
in	O
pulmonary	O
function	O
,	O
whereas	O
two	O
-	O
hit	O
mice	B-SPEC
did	O
not	O
exhibit	O
a	O
potentiated	O
response	O
.	O

TITLE	O
:	O
Canine	O
coronavirus	B-SPEC
in	O
Australian	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
estimate	O
the	O
frequency	O
of	O
serum	O
antibodies	O
(	O
IgG	O
and	O
IgM	O
)	O
to	O
canine	O
coronavirus	B-SPEC
(	O
CCV	B-SPEC
)	O
in	O
the	O
Australian	O
dog	B-SPEC
population	O
and	O
evaluate	O
the	O
role	O
of	O
CCV	B-SPEC
as	O
a	O
causative	O
agent	O
of	O
gastroenteritis	O
.	O

A	O
serological	O
survey	O
of	O
antibodies	O
to	O
CCV	O
among	O
different	O
dog	B-SPEC
populations	O
.	O

Samples	O
were	O
divided	O
into	O
two	O
categories	O
on	O
the	O
basis	O
of	O
the	O
number	O
of	O
dogs	B-SPEC
housed	O
together	O
.	O

Sera	O
from	O
15	O
.	O
8	O
%	O
of	O
the	O
open	O
population	O
and	O
40	O
.	O
8	O
%	O
of	O
kennelled	O
dogs	B-SPEC
were	O
positive	O
for	O
CCV	O
antibodies	O
.	O

In	O
comparison	O
,	O
for	O
those	O
dogs	B-SPEC
presented	O
without	O
any	O
history	O
of	O
gastroenteritis	O
only	O
15	O
%	O
were	O
positive	O
for	O
IgM	O
and	O
30	O
%	O
positive	O
for	O
IgG	O
.	O
CONCLUSIONS	O
:	O
Serological	O
evidence	O
indicates	O
that	O
infection	O
with	O
CCV	O
in	O
dogs	B-SPEC
is	O
widespread	O
throughout	O
the	O
Australian	O
mainland	O
.	O

TITLE	O
:	O
Plant	B-SPEC
-	O
based	O
vaccines	O
:	O
unique	O
advantages	O
.	O

Studies	O
in	O
B	O
-	O
cell	O
-	O
deficient	O
mice	B-SPEC
suggest	O
that	O
antibodies	O
are	O
required	O
to	O
prevent	O
virus	B-SPEC
recrudescence	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
small	O
envelope	O
protein	O
E	O
has	O
two	O
known	O
biological	O
functions	O
:	O
it	O
plays	O
a	O
pivotal	O
role	O
in	O
virus	B-SPEC
envelope	O
formation	O
,	O
and	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
E	O
protein	O
induces	O
apoptosis	O
in	O
E	O
protein	O
-	O
expressing	O
cultured	O
cells	O
.	O

Percutaneous	O
pharmacokinetic	O
studies	O
showed	O
low	O
skin	O
penetration	O
,	O
with	O
lowest	O
values	O
measured	O
in	O
vitro	O
in	O
rats	B-SPEC
and	O
human	B-SPEC
skin	O
.	O

Compared	O
to	O
the	O
previous	O
series	O
,	O
it	O
was	O
observed	O
that	O
the	O
few	O
Pneumocystis	B-SPEC
carinii	I-SPEC
pneumonia	O
patients	O
that	O
need	O
intensive	O
care	O
still	O
have	O
a	O
bad	O
prognosis	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
proportions	O
of	O
cats	B-SPEC
in	O
which	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
was	O
diagnosed	O
on	O
an	O
annual	O
,	O
monthly	O
,	O
and	O
regional	O
basis	O
and	O
identify	O
unique	O
characteristics	O
of	O
cats	B-SPEC
with	O
FIP	O
.	O

Records	O
of	O
all	O
feline	B-SPEC
accessions	O
to	O
veterinary	O
medical	O
teaching	O
hospitals	O
(	O
VMTH	O
)	O
recorded	O
in	O
the	O
Veterinary	O
Medical	O
Data	O
Base	O
between	O
January	O
1986	O
and	O
December	O
1995	O
and	O
of	O
all	O
feline	B-SPEC
accessions	O
for	O
necropsy	O
or	O
histologic	O
examination	O
at	O
4	O
veterinary	O
diagnostic	O
laboratories	O
.	O

Cats	B-SPEC
with	O
FIP	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
young	O
,	O
purebred	O
,	O
and	O
sexually	O
intact	O
males	O
and	O
significantly	O
less	O
likely	O
to	O
be	O
spayed	O
females	O
and	O
discharged	O
alive	O
than	O
were	O
control	O
cats	B-SPEC
.	O

RESULTS	O
:	O
Approximately	O
1	O
of	O
every	O
200	O
new	O
feline	B-SPEC
and	O
1	O
of	O
every	O
300	O
total	O
feline	B-SPEC
accessions	O
at	O
VMTH	O
in	O
North	O
America	O
and	O
approximately	O
1	O
of	O
every	O
100	O
accessions	O
at	O
the	O
diagnostic	O
laboratories	O
represented	O
cats	B-SPEC
with	O
FIP	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCV	B-SPEC
)	O
was	O
amplified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
,	O
cloned	O
,	O
and	O
expressed	O
in	O
the	O
baculovirus	B-SPEC
expression	O
system	O
.	O

TITLE	O
:	O
Experimental	O
bovine	B-SPEC
coronavirus	B-SPEC
in	O
turkey	B-SPEC
poults	O
and	O
young	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
DB2	O
calf	O
strain	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
was	O
used	O
to	O
inoculate	O
1	O
-	O
day	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
turkey	B-SPEC
poults	O
in	O
three	O
trials	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
five	O
field	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
similar	O
to	O
,	O
but	O
genetically	O
distinct	O
from	O
,	O
the	O
DE072	O
serotype	O
were	O
isolated	O
from	O
several	O
states	O
in	O
the	O
United	O
States	O
from	O
1990	O
through	O
1999	O
and	O
were	O
examined	O
molecularly	O
and	O
antigenically	O
.	O

TITLE	O
:	O
Feeding	O
behavior	O
during	O
sialodacryoadenitis	O
viral	O
infection	O
in	O
rats	B-SPEC
.	O

To	O
determine	O
the	O
involvement	O
of	O
individual	O
MMPs	O
in	O
the	O
development	O
of	O
lung	O
injury	O
,	O
mice	B-SPEC
genetically	O
deficient	O
in	O
gelatinase	O
B	O
(	O
MMP	O
-	O
9	O
)	O
and	O
stromelysin	O
1	O
(	O
MMP	O
-	O
3	O
)	O
were	O
acutely	O
injured	O
with	O
immunoglobulin	O
G	O
immune	O
complexes	O
and	O
the	O
intensity	O
of	O
the	O
lung	O
injury	O
was	O
compared	O
with	O
genetically	O
identical	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-SPEC
with	O
normal	O
MMP	O
activities	O
.	O

It	O
also	O
provides	O
a	O
starting	O
point	O
for	O
the	O
development	O
of	O
a	O
new	O
class	B-SPEC
of	O
eukaryotic	O
,	O
multi	O
-	O
gene	O
RNA	O
vectors	O
that	O
are	O
able	O
to	O
express	O
several	O
proteins	O
simultaneously	O
.	O

Within	O
each	O
ventilator	O
group	O
,	O
animals	B-SPEC
were	O
randomized	O
to	O
supine	O
positioning	O
(	O
S	O
)	O
or	O
rotational	O
positioning	O
with	O
alternation	O
between	O
supine	O
and	O
prone	O
position	O
(	O
R	O
)	O
during	O
incremental	O
dosing	O
of	O
three	O
5	O
-	O
mL	O
/	O
kg	O
doses	O
of	O
perflubron	O
.	O

There	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
oxygenation	O
index	O
from	O
baseline	O
to	O
end	O
lavage	O
in	O
both	O
CMV	B-SPEC
groups	O
,	O
as	O
well	O
as	O
all	O
of	O
the	O
animals	B-SPEC
that	O
were	O
rotated	O
.	O

TITLE	O
:	O
Bovine	B-SPEC
coronaviruses	O
associated	O
with	O
enteric	O
and	O
respiratory	O
diseases	O
in	O
Canadian	O
dairy	O
cattle	B-SPEC
display	O
different	O
reactivities	O
to	O
anti	O
-	O
HE	O
monoclonal	O
antibodies	O
and	O
distinct	O
amino	O
acid	O
changes	O
in	O
their	O
HE	O
,	O
S	O
and	O
ns4	O
.	O
9	O
protein	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
isolates	O
associated	O
with	O
recent	O
outbreaks	O
of	O
respiratory	O
disease	O
in	O
Ontario	O
and	O
Quebec	O
dairy	O
farms	O
were	O
compared	O
to	O
reference	O
strains	O
known	O
to	O
be	O
responsible	O
for	O
neonatal	O
calf	O
diarrhea	O
(	O
NCD	O
)	O
or	O
winter	O
dysentery	O
(	O
WD	O
)	O
of	O
adult	O
cattle	B-SPEC
.	O

In	O
respect	O
to	O
their	O
hemagglutinating	O
properties	O
and	O
their	O
higher	O
RDE	O
activities	O
with	O
rat	B-SPEC
erythrocytes	O
,	O
WDBCoV	O
strains	O
differed	O
from	O
NCDBCoV	O
strains	O
and	O
respiratory	O
bovine	B-SPEC
coronaviruses	O
RBCoV	O
strains	O
.	O

The	O
cows	B-SPEC
showed	O
a	O
more	O
severe	O
general	O
diseases	O
than	O
seronegative	O
calves	O
infected	O
concurrently	O
.	O

In	O
cell	O
culture	O
,	O
some	O
of	O
the	O
2	O
-	O
aminothiophenes	O
exhibited	O
moderate	O
and	O
selective	O
activity	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
with	O
2	O
-	O
amino	O
-	O
3	O
-(	O
2	O
-	O
nitrophenylsulfonyl	O
)	O
thiophene	O
(	O
7e	O
)	O
being	O
most	O
attractive	O
(	O
EC	O
(	O
50	O
)=	O
3	O
.	O
8	O
microg	O
/	O
mL	O
,	O
CC	O
(	O
50	O
)=>	O
100	O
microg	O
/	O
mL	O
).	O

Unfortunately	O
,	O
most	O
of	O
these	O
compounds	O
displayed	O
significant	O
cytotoxicity	O
against	O
human	B-SPEC
fibroblasts	O
,	O
the	O
cells	O
supporting	O
CMV	B-SPEC
and	O
VZV	B-SPEC
replication	O
,	O
and	O
thus	O
selectivity	O
indices	O
were	O
low	O
.	O

This	O
genetic	O
module	O
was	O
inserted	O
into	O
the	O
recently	O
obtained	O
mutant	O
infectious	O
EAV	B-SPEC
cDNA	O
clone	O
pBRNX1	O
.	O
38	O
-	O
5	O
/	O
6	O
(	O
A	O
.	O
A	O
.	O
F	O
.	O
de	O
Vries	O
,	O
et	O
al	O
.,	O
2000	O
,	O
Virology	O
270	O
,	O
84	O
-	O
97	O
)	O
between	O
the	O
genes	O
for	O
the	O
M	O
and	O
the	O
G	O
(	O
L	O
)	O
proteins	O
.	O

Mapping	O
of	O
the	O
leader	O
-	O
to	O
-	O
body	O
junctions	O
of	O
the	O
ninth	O
mRNA	O
indicated	O
that	O
the	O
3	O
'	O
part	O
of	O
the	O
GFP	O
gene	O
contains	O
cryptic	O
transcription	O
signals	O
which	O
gave	O
rise	O
to	O
at	O
least	O
five	O
different	O
RNA	O
species	B-SPEC
ranging	O
in	O
size	O
from	O
1277	O
to	O
1439	O
nt	O
[	O
without	O
oligo	O
(	O
A	O
)	O
tract	O
].	O

The	O
7b	O
ORFs	O
were	O
intact	O
and	O
similar	O
among	O
all	O
virus	B-SPEC
isolates	O
,	O
although	O
point	O
mutations	O
resulting	O
in	O
amino	O
acid	O
changes	O
were	O
present	O
.	O

It	O
was	O
found	O
that	O
the	O
two	O
TCV	B-SPEC
isolates	O
were	O
identical	O
with	O
five	O
IBV	B-SPEC
strains	O
by	O
90	O
.	O
1	O
-	O
94	O
.	O
1	O
%	O
at	O
the	O
N	O
gene	O
level	O
.	O

TITLE	O
:	O
Use	O
of	O
a	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
for	O
monitoring	O
the	O
shedding	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
by	O
healthy	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
pattern	O
of	O
shedding	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
was	O
established	O
in	O
155	O
naturally	O
infected	O
pet	O
cats	B-SPEC
from	O
29	O
households	O
over	O
periods	O
of	O
up	O
to	O
five	O
years	O
.	O

Virus	B-SPEC
entry	O
appeared	O
to	O
occur	O
preferentially	O
through	O
the	O
apical	O
membrane	O
,	O
similar	O
to	O
the	O
entry	O
of	O
the	O
related	O
porcine	B-SPEC
coronavirus	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
into	O
these	O
cells	O
.	O

However	O
,	O
whereas	O
TGEV	B-SPEC
is	O
released	O
apically	O
,	O
feline	B-SPEC
and	O
canine	O
coronaviruses	O
were	O
found	O
to	O
be	O
released	O
from	O
the	O
basolateral	O
side	O
of	O
the	O
epithelial	O
cells	O
.	O

A	O
patient	O
was	O
treated	O
with	O
thoracic	O
radiotherapy	O
for	O
non	O
-	O
small	O
-	O
cell	O
lung	O
cancer	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
integrase	O
(	O
IN	O
)	O
catalyzes	O
the	O
integration	O
of	O
HIV	B-SPEC
DNA	O
copy	O
into	O
the	O
host	O
cell	O
DNA	O
.	O

Most	O
frequently	O
detected	O
in	O
both	O
diarrheal	O
and	O
normal	O
feces	O
were	O
canine	O
coronavirus	B-SPEC
(	O
55	O
.	O
4	O
%)	O
and	O
G	B-SPEC
.	I-SPEC
lamblia	I-SPEC
(	O
48	O
.	O
2	O
%).	O

Screening	O
of	O
11	O
IBV	B-SPEC
-	O
encoded	O
proteins	O
suggested	O
that	O
a	O
58	O
-	O
kDa	O
mature	O
cleavage	O
product	O
could	O
induce	O
apoptotic	O
changes	O
in	O
cells	O
transiently	O
expressing	O
the	O
protein	O
.	O

This	O
study	O
adds	O
one	O
more	O
example	O
to	O
the	O
growing	O
list	O
of	O
animal	B-SPEC
viruses	B-SPEC
that	O
induce	O
apoptosis	O
during	O
their	O
replication	O
cycles	O
.	O

ABSTRACT	O
:	O
A	O
stable	O
recombinant	O
fowl	O
poxvirus	B-SPEC
(	O
rFPV	O
)	O
expressing	O
the	O
C	O
-	O
terminal	O
region	O
(	O
119	O
amino	O
acids	O
)	O
of	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
Ch3	O
was	O
constructed	O
by	O
inserting	O
the	O
coding	O
sequence	O
within	O
the	O
thymidine	O
kinase	O
gene	O
of	O
fowl	O
poxvirus	B-SPEC
(	O
FPV	B-SPEC
)	O
by	O
homologous	O
recombination	O
.	O

A	O
homologous	O
IBV	B-SPEC
strain	O
(	O
Ch3	O
)	O
and	O
two	O
heterologous	O
IBV	B-SPEC
strains	O
(	O
Ch5	O
and	O
H4	O
)	O
were	O
used	O
to	O
inoculate	O
SPF	O
chickens	B-SPEC
in	O
a	O
challenge	O
to	O
examine	O
the	O
protective	O
efficacy	O
of	O
the	O
rFPV	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
glycoprotein	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
coronavirus	B-SPEC
,	O
is	O
translated	O
as	O
a	O
precursor	O
protein	O
(	O
So	O
),	O
then	O
cleaved	O
into	O
two	O
subunits	O
(	O
S1	O
and	O
S2	O
)	O
by	O
host	O
cell	O
serine	O
proteases	O
.	O

TITLE	O
:	O
Characterization	O
of	O
three	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
from	O
China	O
associated	O
with	O
proventriculus	O
in	O
vaccinated	O
chickens	B-SPEC
.	O

Hospital	O
mortality	O
of	O
the	O
total	O
population	O
of	O
operated	O
lung	O
cancer	B-SPEC
patients	O
in	O
the	O
same	O
period	O
was	O
2	O
.	O
8	O
%	O
(	O
34	O
patients	O
).	O

RESULTS	O
:	O
ALI	O
/	O
ARDS	O
occurred	O
in	O
2	O
.	O
2	O
%	O
of	O
our	O
operated	O
lung	O
cancer	B-SPEC
patients	O
.	O

Electron	O
microscopy	O
of	O
the	O
feces	O
demonstrated	O
corona	B-SPEC
-	O
like	O
virus	B-SPEC
particles	O
.	O

The	O
PLpro	O
-	O
containing	O
proteins	O
have	O
been	O
recently	O
implicated	O
in	O
the	O
control	O
of	O
coronavirus	B-SPEC
subgenomic	O
mRNA	O
synthesis	O
(	O
transcription	O
).	O

TITLE	O
:	O
Surfactant	O
and	O
inhaled	O
nitric	O
oxide	O
in	O
rats	B-SPEC
alleviate	O
acute	O
lung	O
injury	O
induced	O
by	O
intestinal	O
ischemia	O
and	O
reperfusion	O
.	O

All	O
60	O
sera	O
positive	O
for	O
NT	O
antibody	O
were	O
positive	O
for	O
IP	O
antibody	O
,	O
and	O
all	O
180	O
sera	O
negative	O
for	O
NT	O
antibody	O
were	O
negative	O
for	O
IP	O
antibody	O
in	O
the	O
healthy	O
dogs	B-SPEC
.	O

0	O
.	O
447	O
)	O
(	O
p	O
<	O
0	O
.	O
0001	O
),	O
the	O
NT	O
titre	O
being	O
negative	O
or	O
very	O
low	O
,	O
despite	O
a	O
high	O
IP	O
titre	O
in	O
many	O
diarrhoeic	O
dogs	B-SPEC
.	O

TITLE	O
:	O
Murine	B-SPEC
cytomegalovirus	I-SPEC
is	O
regulated	O
by	O
a	O
discrete	O
subset	O
of	O
natural	O
killer	O
cells	O
reactive	O
with	O
monoclonal	O
antibody	O
to	O
Ly49H	O
.	O

ABSTRACT	O
:	O
Antiviral	O
roles	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
subsets	O
were	O
examined	O
in	O
C57BL	O
/	O
6	O
mice	B-SPEC
infected	O
with	O
murine	B-SPEC
cytomegalovirus	I-SPEC
(	O
MCMV	B-SPEC
)	O
and	O
other	O
viruses	B-SPEC
,	O
including	O
lymphocytic	B-SPEC
choriomeningitis	I-SPEC
virus	I-SPEC
(	O
LCMV	B-SPEC
),	O
vaccinia	B-SPEC
virus	I-SPEC
(	O
VV	O
),	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

Depletion	O
of	O
1F8	O
(+)	O
but	O
not	O
5E6	O
(+)	O
cells	O
in	O
vivo	O
by	O
mAb	O
injections	O
enhanced	O
MCMV	B-SPEC
titers	O
by	O
20	O
-	O
1	O
,	O
000	O
-	O
fold	O
in	O
the	O
spleen	O
and	O
approximately	O
fivefold	O
in	O
the	O
liver	O
.	O

TITLE	O
:	O
Susceptibility	O
of	O
rats	B-SPEC
of	O
different	O
ages	O
to	O
inoculation	O
with	O
swine	B-SPEC
haemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
a	O
coronavirus	B-SPEC
)	O
by	O
various	O
routes	O
.	O

ABSTRACT	O
:	O
Although	O
leading	O
suppliers	O
of	O
laboratory	O
mice	B-SPEC
and	O
rats	B-SPEC
continue	O
to	O
use	O
filtered	O
shipping	O
boxes	O
to	O
protect	O
their	O
animals	B-SPEC
from	O
contamination	O
during	O
transport	O
to	O
the	O
end	O
user	O
,	O
no	O
information	O
had	O
been	O
available	O
in	O
the	O
literature	O
to	O
demonstrate	O
that	O
any	O
of	O
these	O
boxes	O
actually	O
accomplish	O
this	O
task	O
.	O

TITLE	O
:	O
Passive	O
protection	O
against	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
virus	B-SPEC
in	O
piglets	O
by	O
colostrum	O
from	O
immunized	O
cows	B-SPEC
.	O

In	O
cats	B-SPEC
with	O
EUE	O
,	O
myeloid	O
/	O
histiocyte	O
antigen	O
-	O
positive	O
macrophages	O
were	O
relatively	O
numerous	O
,	O
suggesting	O
recruitment	O
of	O
peripheral	O
blood	O
monocytes	O
.	O

Bone	O
marrow	O
activity	O
was	O
decreased	O
in	O
cats	B-SPEC
with	O
PV	O
enteritis	O
;	O
in	O
cats	B-SPEC
with	O
FAE	O
or	O
EUE	O
and	O
in	O
FeLV	O
-	O
positive	O
cats	B-SPEC
without	O
enterocyte	O
alterations	O
,	O
activity	O
was	O
slightly	O
increased	O
.	O

Both	O
CAV	B-SPEC
-	O
1	O
and	O
CCV	O
were	O
isolated	O
from	O
tissue	O
or	O
swab	O
samples	O
.	O

Results	O
demonstrated	O
the	O
serious	O
consequences	O
which	O
may	O
occur	O
with	O
dual	O
infections	O
by	O
CAV	B-SPEC
-	O
1	O
and	O
CCV	O
in	O
assembled	O
groups	O
of	O
dogs	B-SPEC
that	O
are	O
housed	O
in	O
poorly	O
managed	O
kennels	O
with	O
inadequate	O
vaccination	O
programmes	O
.	O

Furthermore	O
,	O
these	O
monoclonal	O
antibodies	O
were	O
useful	O
for	O
boosting	O
the	O
efficacy	O
of	O
TGEV	B-SPEC
-	O
neutralizing	O
colostrum	O
,	O
which	O
by	O
itself	O
was	O
ineffective	O
.	O

We	O
obtained	O
one	O
line	O
of	O
mice	B-SPEC
in	O
which	O
the	O
insert	O
in	O
the	O
Ceacam1a	O
gene	O
had	O
sustained	O
a	O
recombination	O
event	O
.	O

p	O
/	O
p	O
mice	B-SPEC
survived	O
a	O
dose	O
100	O
-	O
fold	O
higher	O
than	O
the	O
lethal	O
dose	O
of	O
virus	B-SPEC
for	O
+/+	O
mice	B-SPEC
.	O

Impaired	O
fat	O
digestibility	O
and	O
dietary	O
energy	O
utilization	O
in	O
PEMS	O
-	O
afflicted	O
birds	B-SPEC
are	O
likely	O
contributors	O
to	O
stunted	O
growth	O
and	O
reduced	O
recovery	O
rates	O
.	O

Recent	O
work	O
has	O
shown	O
that	O
either	O
virus	B-SPEC
-	O
specific	O
CD4	O
(+)	O
or	O
CD8	O
(+)	O
T	O
cells	O
are	O
able	O
to	O
mediate	O
demyelination	O
and	O
also	O
that	O
the	O
antibody	O
response	O
is	O
crucial	O
for	O
clearing	O
infectious	O
virus	B-SPEC
.	O

In	O
contrast	O
,	O
in	O
response	O
to	O
the	O
gram	O
-	O
positive	O
cocci	B-SPEC
,	O
the	O
lpr	O
animals	B-SPEC
had	O
similar	O
or	O
lower	O
numbers	O
of	O
PMN	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
a	O
closely	O
related	O
strain	O
,	O
MHV	B-SPEC
-	O
2	O
,	O
which	O
is	O
only	O
weakly	O
neurotropic	O
.	O

To	O
better	O
understand	O
the	O
molecular	O
basis	O
of	O
neurotropism	O
of	O
MHVs	O
,	O
we	O
compared	O
the	O
pathogenesis	O
and	O
genomic	O
sequence	O
of	O
MHV	B-SPEC
-	O
2	O
with	O
that	O
of	O
MHV	B-SPEC
-	O
A59	O
.	O

This	O
information	O
provides	O
the	O
basis	O
for	O
further	O
studies	O
exploring	O
the	O
mechanism	O
of	O
viral	O
neurotropism	O
and	O
virus	B-SPEC
-	O
induced	O
demyelination	O
.	O

TITLE	O
:	O
Serological	O
,	O
colostral	O
and	O
milk	O
responses	O
of	O
cows	B-SPEC
vaccinated	O
with	O
a	O
single	O
dose	O
of	O
a	O
combined	O
vaccine	O
against	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
Escherichia	B-SPEC
coli	I-SPEC
F5	O
(	O
K99	O
).	O

There	O
was	O
a	O
significant	O
increase	O
in	O
the	O
mean	O
specific	O
antibody	O
titre	O
against	O
all	O
three	O
antigens	O
in	O
the	O
serum	O
of	O
the	O
vaccinated	O
animals	B-SPEC
(	O
even	O
in	O
the	O
presence	O
of	O
pre	O
-	O
existing	O
antibody	O
)	O
which	O
was	O
accompanied	O
by	O
increased	O
levels	O
of	O
protective	O
antibodies	O
to	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
E	O
coli	O
F5	O
(	O
K99	O
)	O
in	O
their	O
colostrum	O
and	O
milk	O
for	O
at	O
least	O
28	O
days	O
.	O

Fifty	O
three	O
patients	O
were	O
found	O
to	O
develop	O
ALL	O
and	O
ARDS	O
in	O
the	O
presence	O
of	O
severe	O
pneumonia	O
,	O
postperfusion	O
lung	O
disorders	O
,	O
reperfusion	O
syndrome	O
,	O
pulmonary	O
embolism	O
,	O
long	O
-	O
term	O
artificial	O
ventilation	O
,	O
combined	O
car	B-SPEC
accident	O
injury	O
and	O
gunshot	O
wounds	O
of	O
the	O
chest	O
,	O
heroine	O
intoxication	O
,	O
septic	O
shock	O
,	O
sepsis	B-SPEC
,	O
postoperative	O
sequels	O
in	O
cancer	B-SPEC
patients	O
,	O
and	O
after	O
hepatic	O
transplantation	O
or	O
massive	O
aspiration	O
of	O
gastric	O
contents	O
.	O

It	O
is	O
hypothesized	O
that	O
an	O
experimental	O
infection	O
with	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
),	O
the	O
second	O
most	O
prevalent	O
common	O
cold	O
virus	B-SPEC
,	O
would	O
cause	O
lower	O
respiratory	O
tract	O
(	O
LRT	O
)	O
changes	O
in	O
adults	O
with	O
a	O
history	O
of	O
viral	O
wheeze	O
.	O

Four	O
samples	O
,	O
collected	O
from	O
a	O
dog	B-SPEC
presenting	O
a	O
long	O
-	O
duration	O
shedding	O
of	O
CCV	O
,	O
and	O
a	O
sample	O
from	O
another	O
diarrhoeic	O
dog	B-SPEC
,	O
were	O
found	O
positive	O
by	O
PCR	O
but	O
negative	O
by	O
n	O
-	O
PCR	O
.	O

In	O
the	O
base	O
population	O
,	O
the	O
basic	O
reproductive	O
ratio	O
,	O
R0	O
(	O
i	O
.	O
e	O
.,	O
the	O
expected	O
number	O
of	O
secondary	O
cases	O
after	O
the	O
introduction	O
of	O
a	O
single	O
infected	O
animal	B-SPEC
)	O
was	O
2	O
.	O
24	O
,	O
in	O
agreement	O
with	O
previous	O
studies	O
.	O

In	O
keeping	O
with	O
this	O
explanation	O
,	O
the	O
lower	O
Vuip	O
and	O
Crs	O
were	O
before	O
HV	O
,	O
the	O
more	O
severe	O
HV	O
-	O
induced	O
edema	O
was	O
in	O
alpha	O
-	O
naphthylthiourea	O
-	O
injected	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
produces	O
a	O
genome	O
-	O
length	O
mRNA	O
,	O
mRNA	O
1	O
,	O
and	O
six	O
or	O
seven	O
species	B-SPEC
of	O
subgenomic	O
mRNAs	O
in	O
infected	O
cells	O
.	O

TITLE	O
:	O
Viruses	B-SPEC
of	O
lower	O
vertebrates	B-SPEC
.	O

This	O
sequon	O
is	O
within	O
the	O
region	O
that	O
determines	O
receptor	O
activity	O
for	O
porcine	B-SPEC
and	O
feline	B-SPEC
coronaviruses	O
.	O

Thus	O
,	O
certain	O
differences	O
in	O
glycosylation	O
between	O
coronavirus	B-SPEC
receptors	O
from	O
different	O
species	B-SPEC
are	O
critical	O
determinants	O
in	O
the	O
species	B-SPEC
specificity	O
of	O
infection	O
.	O

In	O
contrast	O
,	O
only	O
10	O
/	O
175	O
(	O
6	O
%)	O
paired	O
nasal	O
swab	O
specimens	O
and	O
fecal	O
samples	O
negative	O
for	O
BECV	B-SPEC
were	O
positive	O
for	O
BRCV	O
.	O

Seroconversion	O
to	O
BCV	B-SPEC
during	O
the	O
21	O
days	O
after	O
arrival	O
was	O
detected	O
in	O
95	O
%	O
of	O
the	O
cattle	B-SPEC
tested	O
.	O

We	O
concluded	O
that	O
IBV	B-SPEC
vaccination	O
strategies	O
should	O
aim	O
at	O
high	O
and	O
uniform	O
antibody	O
titers	O
in	O
the	O
broiler	O
breeders	O
.	O

For	O
comparison	O
,	O
tissues	O
from	O
14	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
cats	B-SPEC
and	O
seven	O
cats	B-SPEC
infected	O
with	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
;	O
as	O
the	O
result	O
of	O
long	O
-	O
term	O
exposure	O
)	O
but	O
free	O
from	O
FIP	O
were	O
examined	O
.	O

In	O
cats	B-SPEC
with	O
FIP	O
,	O
the	O
precardial	O
mediastinum	O
(	O
including	O
site	O
of	O
the	O
thymus	B-SPEC
)	O
and	O
mesenteric	O
lymph	O
node	O
parenchyma	O
were	O
often	O
affected	O
by	O
granulomatous	O
-	O
necrotizing	O
processes	O
.	O

In	O
contrast	O
,	O
the	O
FIPV	O
-	O
exposed	O
cats	B-SPEC
without	O
FIP	O
generally	O
showed	O
a	O
distinct	O
lymphoid	O
hyperplasia	O
.	O

The	O
present	O
case	O
demonstrated	O
that	O
HIV	B-SPEC
infection	O
was	O
not	O
an	O
essential	O
factor	O
in	O
the	O
development	O
of	O
bullous	O
changes	O
.	O

Using	O
targeted	O
recombination	O
we	O
previously	O
demonstrated	O
that	O
the	O
S	O
gene	O
of	O
the	O
highly	O
neurovirulent	O
MHV	B-SPEC
-	O
4	O
conferred	O
a	O
dramatic	O
increase	O
in	O
neurovirulence	O
to	O
the	O
mildly	O
neurovirulent	O
MHV	B-SPEC
-	O
A59	O
.	O

We	O
set	O
out	O
to	O
precisely	O
define	O
which	O
central	O
nervous	O
system	O
cells	O
express	O
MHC	O
molecules	O
in	O
vivo	O
during	O
infection	O
with	O
a	O
strain	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
that	O
causes	O
a	O
chronic	O
,	O
inflammatory	O
demyelinating	O
disease	O
.	O

CONCLUSIONS	O
:	O
ARF	O
necessitating	O
dialysis	B-SPEC
was	O
seen	O
in	O
92	O
%	O
of	O
patients	O
with	O
ARF	O
in	O
malaria	O
.	O

TITLE	O
:	O
Lack	O
of	O
CCR2	O
results	O
in	O
increased	O
mortality	O
and	O
impaired	O
leukocyte	O
activation	O
and	O
trafficking	O
following	O
infection	O
of	O
the	O
central	O
nervous	O
system	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
.	O

An	O
orchestrated	O
expression	O
of	O
chemokines	O
,	O
including	O
the	O
CCR2	O
ligands	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
/	O
CCL2	O
and	O
monocyte	O
chemoattractant	O
protein	O
-	O
3	O
/	O
CCL7	O
,	O
occurs	O
within	O
the	O
CNS	O
following	O
infection	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

We	O
have	O
used	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
apositive	O
-	O
strand	O
RNA	O
virus	B-SPEC
,	O
infection	O
of	O
the	O
CNS	O
to	O
understand	O
the	O
dynamic	O
interaction	O
between	O
viral	O
replication	O
,	O
protection	O
,	O
and	O
pathology	O
with	O
an	O
emphasis	O
on	O
understanding	O
how	O
chemokines	O
participate	O
in	O
these	O
interrelated	O
processes	O
.	O

We	O
have	O
used	O
intranasal	O
inoculation	O
with	O
an	O
olfactory	O
bulb	O
line	O
variant	O
of	O
MHV	B-SPEC
to	O
study	O
the	O
consequences	O
of	O
viral	O
infection	O
on	O
peripheral	O
olfactory	O
structures	O
.	O

Following	O
a	O
1	O
month	O
rest	O
,	O
untreated	O
and	O
inoculated	O
animals	B-SPEC
were	O
again	O
tested	O
on	O
their	O
respective	O
air	O
versus	O
odor	O
discrimination	O
task	O
.	O

Untreated	O
animals	B-SPEC
immediately	O
performed	O
at	O
criterion	O
levels	O
.	O

TITLE	O
:	O
Origin	O
and	O
evolution	O
of	O
Georgia	O
98	O
(	O
GA98	O
),	O
a	O
new	O
serotype	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

A	O
complementary	O
DNA	O
of	O
the	O
entire	O
N	O
gene	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
inserted	O
into	O
a	O
mammalian	B-SPEC
expression	O
vector	O
(	O
pcDNA3	O
.	O
1	O
)	O
to	O
construct	O
a	O
recombinant	O
plasmid	O
(	O
pcDNA	O
/	O
N	O
).	O

In	O
Experiment	O
3	O
,	O
the	O
IgG	O
isotype	O
antibody	O
response	O
to	O
TCV	B-SPEC
was	O
markedly	O
increased	O
after	O
21	O
d	O
PI	O
and	O
remained	O
high	O
until	O
63	O
d	O
PI	O
.	O

The	O
IgM	O
isotype	O
antibody	O
response	O
to	O
TCV	B-SPEC
was	O
1	O
.	O
40	O
and	O
0	O
.	O
91	O
at	O
7	O
and	O
14	O
d	O
PI	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Intracerebral	O
inoculation	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
results	O
in	O
viral	O
replication	O
in	O
the	O
CNS	O
and	O
liver	O
.	O

Viral	O
persistence	O
was	O
not	O
detected	O
in	O
FcR	O
or	O
complement	O
knockout	O
mice	B-SPEC
.	O

Fish	B-SPEC
Shellfish	O
Immunol	O
.	O

TITLE	O
:	O
Effects	O
of	O
C1	O
inhibitor	O
and	O
r	O
-	O
SP	O
-	O
C	O
surfactant	O
on	O
oxygenation	O
and	O
histology	O
in	O
rats	B-SPEC
with	O
lavage	O
-	O
induced	O
acute	O
lung	O
injury	O
.	O

TITLE	O
:	O
Auricular	O
chondritis	O
in	O
a	O
cat	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
four	O
-	O
year	O
-	O
old	O
male	O
neutered	O
domestic	O
shorthaired	O
cat	B-SPEC
developed	O
bilateral	O
thickening	O
of	O
the	O
pinnae	O
,	O
with	O
slight	O
curling	O
,	O
intense	O
erythema	O
and	O
pain	O
.	O

The	O
cat	B-SPEC
reported	O
had	O
a	O
history	O
of	O
corneal	O
damage	O
,	O
resulting	O
in	O
corneal	O
vascularisation	O
and	O
opacity	O
,	O
eyelid	O
distortion	O
,	O
necessitating	O
an	O
entropion	O
operation	O
,	O
and	O
radiological	O
evidence	O
of	O
mild	O
cardiac	O
enlargement	O
.	O

ABSTRACT	O
:	O
The	O
protein	O
encoded	O
by	O
ORF	O
4	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
is	O
not	O
required	O
for	O
growth	O
of	O
some	O
strains	O
in	O
tissue	O
culture	O
cells	O
,	O
but	O
its	O
role	O
in	O
pathogenesis	O
in	O
the	O
murine	B-SPEC
host	O
has	O
not	O
been	O
defined	O
previously	O
in	O
a	O
controlled	O
manner	O
.	O

Virus	B-SPEC
lacking	O
gene	O
4	O
expression	O
replicated	O
in	O
tissue	O
culture	O
cells	O
with	O
similar	O
kinetics	O
to	O
recombinant	O
virus	B-SPEC
in	O
which	O
gene	O
4	O
expression	O
was	O
not	O
disrupted	O
.	O

Sixteen	O
Yucatan	O
miniature	O
swine	B-SPEC
(	O
Sus	B-SPEC
scrofa	I-SPEC
).	O

Fifty	O
percent	O
of	O
the	O
animals	B-SPEC
with	O
lung	O
injury	O
had	O
altitude	O
-	O
induced	O
hypoxia	O
that	O
was	O
resistant	O
to	O
increases	O
in	O
FiO2	O
.	O

TITLE	O
:	O
Secondary	O
structural	O
elements	O
within	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHM	O
genomic	O
RNA	O
.	O

ABSTRACT	O
:	O
The	O
difference	O
in	O
membrane	O
(	O
M	O
)	O
protein	O
compositions	O
between	O
the	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
virion	O
and	O
the	O
core	O
has	O
been	O
studied	O
.	O

The	O
existence	O
of	O
a	O
population	O
of	O
M	O
molecules	O
adopting	O
a	O
Nexo	O
-	O
Cexo	O
topology	O
in	O
the	O
virion	O
envelope	O
was	O
demonstrated	O
by	O
(	O
i	O
)	O
immunopurification	O
of	O
(	O
35	O
)	O
S	O
-	O
labeled	O
TGEV	B-SPEC
virions	O
using	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
specific	O
for	O
the	O
M	O
protein	O
carboxy	O
terminus	O
(	O
this	O
immunopurification	O
was	O
inhibited	O
only	O
by	O
deletion	O
mutant	O
M	O
proteins	O
that	O
maintained	O
an	O
intact	O
carboxy	O
terminus	O
),	O
(	O
ii	O
)	O
direct	O
binding	O
of	O
M	O
-	O
specific	O
MAbs	O
to	O
the	O
virus	B-SPEC
surface	O
,	O
and	O
(	O
iii	O
)	O
mass	O
spectrometry	O
analysis	O
of	O
peptides	O
released	O
from	O
trypsin	O
-	O
treated	O
virions	O
.	O

TITLE	O
:	O
Reverse	O
genetics	O
system	O
for	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Infectious	O
IBV	B-SPEC
RNA	O
was	O
generated	O
in	O
situ	O
after	O
the	O
transfection	O
of	O
restricted	O
recombinant	O
vaccinia	B-SPEC
virus	I-SPEC
DNA	O
into	O
primary	O
chick	O
kidney	O
cells	O
previously	O
infected	O
with	O
a	O
recombinant	O
fowlpox	B-SPEC
virus	I-SPEC
expressing	O
T7	O
RNA	O
polymerase	O
.	O

ABSTRACT	O
:	O
To	O
find	O
out	O
if	O
pretreatment	O
with	O
taurine	O
would	O
reduce	O
the	O
severity	O
of	O
endotoxin	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
a	O
large	O
animal	B-SPEC
model	O
.	O

Vascular	O
catheters	O
were	O
placed	O
in	O
the	O
femoral	O
artery	O
and	O
vein	O
and	O
a	O
Swan	B-SPEC
-	O
Ganz	O
catheter	O
in	O
the	O
external	O
jugular	O
vein	O
under	O
general	O
anaesthetic	O
.	O

In	O
animals	B-SPEC
,	O
urea	O
treatment	O
has	O
been	O
clearly	O
shown	O
to	O
protect	O
again	O
ODS	O
,	O
this	O
protective	O
effect	O
could	O
be	O
due	O
to	O
its	O
ability	O
to	O
induce	O
quickly	O
brain	O
""""	O
organic	O
osmolytes	O
""""	O
reaccumulation	O
.	O

Thus	O
,	O
the	O
effective	O
differential	O
detection	O
of	O
TGE	O
virus	B-SPEC
and	O
PED	O
virus	B-SPEC
is	O
required	O
.	O

Among	O
90	O
clinical	O
samples	O
,	O
7	O
TGE	O
viruses	B-SPEC
and	O
2	O
PED	O
viruses	B-SPEC
were	O
detected	O
by	O
the	O
duplex	O
RT	O
-	O
PCR	O
.	O

Purified	O
viruses	B-SPEC
hemagglutinated	O
rabbit	B-SPEC
erythrocytes	O
with	O
a	O
titer	O
of	O
16	O
.	O

The	O
patterns	O
of	O
protein	O
bands	O
were	O
consistent	O
with	O
those	O
of	O
Minnesota	O
or	O
Quebec	O
turkey	B-SPEC
coronavirus	B-SPEC
isolates	O
.	O

TITLE	O
:	O
How	O
RNA	O
viruses	B-SPEC
exchange	O
their	O
genetic	O
material	O
.	O

Antibody	O
levels	O
to	O
SRBC	O
were	O
higher	O
in	O
birds	B-SPEC
supplemented	O
with	O
50	O
IU	O
of	O
VE	O
/	O
kg	O
compared	O
to	O
those	O
supplemented	O
with	O
0	O
or	O
200	O
IU	O
/	O
kg	O
of	O
VE	O
.	O

All	O
patients	O
had	O
positive	O
pretransplantation	O
tests	O
for	O
Toxoplasma	B-SPEC
gondii	I-SPEC
and	O
were	O
therefore	O
at	O
risk	O
to	O
develop	O
toxoplasmosis	O
reactivation	O
.	O

ABSTRACT	O
:	O
The	O
surface	O
-	O
functionalization	O
of	O
shell	O
cross	O
-	O
linked	O
(	O
SCK	O
)	O
nanoparticles	O
with	O
the	O
oligomeric	O
peptide	O
sequence	O
YGRKKRRQRRR	O
,	O
the	O
protein	O
transduction	O
domain	O
(	O
PTD	O
)	O
from	O
the	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
TAT	O
protein	O
,	O
is	O
described	O
,	O
and	O
the	O
cell	O
binding	O
interactions	O
these	O
nanobioconjugates	O
exhibit	O
are	O
demonstrated	O
.	O

TITLE	O
:	O
Adverse	O
effects	O
of	O
feline	B-SPEC
IL	O
-	O
12	O
during	O
DNA	O
vaccination	O
against	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Cell	O
-	O
mediated	O
immunity	O
is	O
thought	O
to	O
play	O
a	O
decisive	O
role	O
in	O
protecting	O
cats	B-SPEC
against	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
progressive	O
and	O
lethal	O
coronavirus	B-SPEC
disease	O
.	O

TITLE	O
:	O
Effect	O
of	O
methylprednisolone	O
on	O
phospholipase	O
A	O
(	O
2	O
)	O
activity	O
and	O
lung	O
surfactant	O
degradation	O
in	O
acute	O
lung	O
injury	O
in	O
rabbits	B-SPEC
.	O

After	O
electrophoretic	O
analysis	O
,	O
each	O
isolated	O
strain	O
,	O
showed	O
a	O
distinctive	O
long	O
dsRNA	O
electropherotype	O
characteristic	O
of	O
group	B-SPEC
A	I-SPEC
rotaviruses	I-SPEC
(	O
4	O
:	O
2	O
:	O
3	O
:	O
2	O
).	O

Following	O
transfection	O
of	O
baby	O
hamster	B-SPEC
kidney	O
(	O
BHK	O
)	O
cells	O
,	O
a	O
recombinant	O
TGEV	B-SPEC
(	O
TGEV	B-SPEC
-	O
GFP2	O
)	O
was	O
isolated	O
that	O
replicated	O
efficiently	O
and	O
expressed	O
GFP	O
.	O

Infection	O
and	O
sepsis	B-SPEC
were	O
observed	O
in	O
223	O
(	O
34	O
.	O
9	O
%)	O
and	O
121	O
(	O
18	O
.	O
9	O
%)	O
patients	O
,	O
respectively	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
novel	O
antigenic	O
subtype	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
serotype	O
DE072	O
.	O

Ten	O
flocks	O
experienced	O
PEMS	O
and	O
tested	O
positive	O
for	O
TCV	B-SPEC
,	O
whereas	O
13	O
flocks	O
experienced	O
PEMS	O
and	O
did	O
not	O
test	O
positive	O
for	O
TCV	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
picornavirus	B-SPEC
and	O
coronavirus	B-SPEC
RNA	O
in	O
nasopharynx	O
of	O
children	O
without	O
concurrent	O
respiratory	O
symptoms	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
CD8	O
(+)	O
cytotoxic	O
T	O
lymphocytes	O
(	O
CTL	O
)	O
are	O
critical	O
in	O
controlling	O
acute	O
IBV	B-SPEC
infection	O
,	O
but	O
the	O
role	O
of	O
innate	O
immunity	O
is	O
unknown	O
.	O

In	O
addition	O
,	O
the	O
spleen	O
cell	O
-	O
derived	O
supernatants	O
(	O
natural	O
IFN	O
)	O
inhibited	O
tracheal	O
ring	O
ciliostasis	O
mediated	O
by	O
the	O
Gray	O
strain	O
of	O
IBV	B-SPEC
.	O

Administration	O
of	O
exogenous	O
ONOO	O
(-)	O
caused	O
dose	O
-	O
dependent	O
increase	O
in	O
LC	O
,	O
W	O
/	O
D	O
,	O
ater	O
and	O
EB	O
contents	O
and	O
in	O
the	O
number	O
of	O
MB	O
-	O
labelled	O
blood	O
vessels	O
in	O
rat	B-SPEC
lungs	O
,	O
together	O
with	O
significant	O
pathological	O
alterations	O
such	O
as	O
diffuse	O
alveolar	O
collapse	O
,	O
capillary	O
congestion	O
in	O
the	O
septa	O
and	O
focal	O
hemorrhage	O
.	O

Multiple	O
studies	O
have	O
addressed	O
this	O
issue	O
with	O
patients	O
with	O
cardiac	O
disease	O
,	O
sepsis	B-SPEC
,	O
pulmonary	O
disease	O
(	O
e	O
.	O
g	O
.	O
acute	O
respiratory	O
distress	O
syndrome	O
)	O
or	O
severe	O
infection	O
,	O
or	O
with	O
burn	O
and	O
trauma	O
patients	O
.	O

Virus	B-SPEC
clearance	O
followed	O
similar	O
kinetics	O
in	O
all	O
mice	B-SPEC
,	O
confirming	O
initial	O
control	O
of	O
virus	B-SPEC
replication	O
by	O
cellular	O
immunity	O
.	O

Nevertheless	O
,	O
virus	B-SPEC
reemerged	O
within	O
the	O
CNS	O
of	O
all	O
Ab	O
-	O
deficient	O
mice	B-SPEC
.	O

Altered	O
tropism	O
coincided	O
with	O
distinct	O
regulation	O
of	O
CNS	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
T	O
cells	O
.	O

Epidemiological	O
data	O
revealed	O
that	O
all	O
cases	O
were	O
healthy	O
men	O
aged	O
between	O
40	O
-	O
49	O
,	O
residing	O
in	O
the	O
same	O
geographical	O
area	O
and	O
had	O
a	O
history	O
of	O
raw	O
pork	O
or	O
uncooked	O
pig	B-SPEC
'	O
s	O
blood	O
consumption	O
prior	O
to	O
their	O
illnesses	O
.	O

In	O
late	O
convalescence	O
severe	O
complications	O
may	O
accompany	O
leptospiral	B-SPEC
jaundice	O
.	O

TITLE	O
:	O
The	O
sialate	O
-	O
4	O
-	O
O	O
-	O
acetylesterases	O
of	O
coronaviruses	O
related	O
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
:	O
a	O
proposal	O
to	O
reorganize	O
group	O
2	O
Coronaviridae	B-SPEC
.	O

The	O
esterases	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strains	O
S	O
and	O
JHM	O
and	O
puffinosis	O
virus	B-SPEC
(	O
PV	O
)	O
specifically	O
hydrolysed	O
5	O
-	O
N	O
-	O
acetyl	O
-	O
4	O
-	O
O	O
-	O
acetylneuraminic	O
acid	O
(	O
Neu4	O
,	O
5Ac2	O
)	O
as	O
well	O
as	O
the	O
synthetic	O
substrates	O
p	O
-	O
nitrophenyl	O
acetate	O
,	O
4	O
-	O
methylumbelliferyl	O
acetate	O
and	O
fluorescein	O
diacetate	O
.	O

All	O
calves	O
developed	O
diarrhea	O
after	O
inoculation	O
and	O
BCV	B-SPEC
antigen	O
(	O
ELISA	O
)	O
or	O
RNA	O
(	O
RT	O
-	O
PCR	O
)	O
was	O
detected	O
in	O
the	O
diarrheic	O
fecal	O
samples	O
or	O
the	O
corresponding	O
nasal	O
swab	O
samples	O
.	O

Therefore	O
,	O
these	O
assays	O
should	O
be	O
useful	O
to	O
diagnose	O
BCV	B-SPEC
infections	O
in	O
calves	O
and	O
adult	O
cows	B-SPEC
.	O

A	O
total	O
number	O
of	O
28	O
eleven	O
-	O
day	O
-	O
old	O
conventional	O
pigs	B-SPEC
were	O
orally	O
inoculated	O
with	O
the	O
field	O
isolate	O
of	O
the	O
PEDV	B-SPEC
strain	O
CV	O
-	O
777	O
.	O

Serum	O
IgG	O
and	O
IgA	O
antibodies	O
to	O
PEDV	B-SPEC
were	O
detected	O
by	O
isotype	O
ELISA	O
from	O
PID	O
12	O
and	O
15	O
,	O
respectively	O
,	O
reaching	O
maximum	O
values	O
at	O
PID	O
32	O
(	O
IgG	O
)	O
and	O
21	O
(	O
IgA	O
).	O

ABSTRACT	O
:	O
A	O
helper	O
-	O
dependent	O
expression	O
system	O
based	O
on	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
has	O
been	O
developed	O
using	O
a	O
minigenome	O
of	O
3	O
.	O
9	O
kb	O
(	O
M39	O
).	O

We	O
tested	O
the	O
hypothesis	O
that	O
adenovectors	O
could	O
efficiently	O
transduce	O
injured	O
alveoli	O
by	O
exposing	O
adult	O
,	O
male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
to	O
100	O
%	O
oxygen	O
for	O
48	O
or	O
60	O
h	O
before	O
endotracheal	O
instillation	O
of	O
either	O
1	O
x	O
10	O
(	O
9	O
)	O
or	O
4	O
x	O
10	O
(	O
9	O
)	O
plaque	O
-	O
forming	O
units	O
of	O
an	O
adenovirus	B-SPEC
that	O
expresses	O
an	O
Escherichia	B-SPEC
coli	I-SPEC
lac	O
Z	O
gene	O
(	O
adbeta	O
-	O
gal	O
)	O
in	O
a	O
surfactant	O
-	O
based	O
vehicle	O
(	O
Survanta	O
).	O

ABSTRACT	O
:	O
Using	O
the	O
whole	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
for	O
detecting	O
the	O
antibody	O
against	O
IBV	B-SPEC
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
is	O
a	O
routine	O
work	O
in	O
poultry	O
industry	O
.	O

To	O
examine	O
the	O
role	O
of	O
other	O
host	O
factors	O
in	O
MHV	B-SPEC
infection	O
in	O
mice	B-SPEC
,	O
IFN	O
-	O
gamma	O
-	O
deficient	O
mice	B-SPEC
with	O
a	O
BALB	O
/	O
c	O
background	O
(	O
BALB	O
-	O
GKO	O
)	O
were	O
infected	O
intraperitoneally	O
with	O
MHV	B-SPEC
and	O
compared	O
with	O
B6	O
-	O
GKO	O
mice	B-SPEC
.	O

These	O
results	O
indicate	O
that	O
BALB	O
-	O
GKO	O
and	O
B6	O
-	O
GKO	O
mice	B-SPEC
clearly	O
show	O
different	O
diseases	O
following	O
MHV	B-SPEC
infection	O
,	O
although	O
wild	O
type	O
counterparts	O
of	O
both	O
mice	B-SPEC
apparently	O
showed	O
the	O
same	O
clinical	O
course	O
after	O
MHV	B-SPEC
infection	O
.	O

Two	O
prospective	O
studies	O
conducted	O
in	O
a	O
neonatal	O
and	O
paediatric	O
intensive	O
care	O
unit	O
demonstrated	O
a	O
significant	O
association	O
of	O
coronavirus	B-SPEC
-	O
positive	O
nasopharyngal	O
samples	O
with	O
respiratory	O
illness	O
in	O
hospitalised	O
preterm	O
neonates	O
.	O

TITLE	O
:	O
Embryonic	O
exposure	O
to	O
lead	O
:	O
comparison	O
of	O
immune	O
and	O
cellular	O
responses	O
in	O
unchallenged	O
and	O
virally	O
stressed	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Infection	O
by	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
produces	O
an	O
acute	O
demyelinating	O
encephalomyelitis	O
.	O

While	O
cellular	O
immunity	O
initially	O
eliminates	O
infectious	O
virus	B-SPEC
,	O
CNS	O
viral	O
persistence	O
is	O
predominantly	O
controlled	O
by	O
humoral	O
immunity	O
.	O

Serum	O
antiviral	O
Ab	O
and	O
CNS	O
virus	B-SPEC
-	O
specific	O
ASC	O
became	O
prominent	O
only	O
during	O
final	O
elimination	O
of	O
infectious	O
virus	B-SPEC
.	O

Rapid	O
recruitment	O
of	O
B	O
cells	O
in	O
the	O
absence	O
of	O
specific	O
Ab	O
secretion	O
supports	O
a	O
potential	O
Ab	O
-	O
independent	O
effector	O
function	O
involving	O
lysis	O
of	O
virus	B-SPEC
-	O
infected	O
cells	O
.	O

ABSTRACT	O
:	O
It	O
is	O
unclear	O
whether	O
respiratory	O
and	O
enteric	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BoCV	O
)	O
strains	O
are	O
distinctive	O
in	O
biological	O
,	O
antigenic	O
and	O
genetic	O
characteristics	O
.	O

Specific	O
IgE	O
levels	O
to	O
P	B-SPEC
.	I-SPEC
acerifolia	I-SPEC
pollen	O
extract	O
and	O
food	O
allergens	O
tested	O
were	O
measured	O
.	O

RESULTS	O
:	O
Of	O
the	O
720	O
patients	O
evaluated	O
,	O
61	O
(	O
8	O
.	O
48	O
%)	O
were	O
sensitized	O
to	O
P	B-SPEC
.	I-SPEC
acerifolia	I-SPEC
pollen	O
.	O

T	O
cell	O
proliferation	O
to	O
allogeneic	O
and	O
antigenic	O
stimulation	O
and	O
IFN	O
-	O
gamma	O
secretion	O
in	O
response	O
to	O
antigenic	O
challenge	O
were	O
impaired	O
in	O
IP	O
-	O
10	O
(-/-)	O
mice	B-SPEC
.	O

This	O
was	O
associated	O
with	O
decreased	O
recruitment	O
of	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
lymphocytes	O
into	O
the	O
brain	O
,	O
reduced	O
levels	O
of	O
IFN	O
-	O
gamma	O
and	O
the	O
IFN	O
-	O
gamma	O
-	O
induced	O
chemokines	O
monokine	O
induced	O
by	O
IFN	O
-	O
gamma	O
(	O
Mig	O
,	O
CXCL9	O
)	O
and	O
IFN	O
-	O
inducible	O
T	O
cell	O
alpha	O
chemoattractant	O
(	O
I	O
-	O
TAC	O
,	O
CXCL11	O
)	O
in	O
the	O
brain	O
,	O
decreased	O
numbers	O
of	O
virus	B-SPEC
-	O
specific	O
IFN	O
-	O
gamma	O
-	O
secreting	O
CD8	O
(+)	O
cells	O
in	O
the	O
spleen	O
,	O
and	O
reduced	O
levels	O
of	O
demyelination	O
in	O
the	O
CNS	O
.	O

ABSTRACT	O
:	O
The	O
replication	O
complexes	O
(	O
RCs	O
)	O
of	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
are	O
intimately	O
associated	O
with	O
cellular	O
membranes	O
.	O

Furthermore	O
,	O
MHV	B-SPEC
gene	O
1	O
products	O
p290	O
,	O
p210	O
,	O
and	O
p150	O
and	O
the	O
p150	O
cleavage	O
product	O
membrane	O
protein	O
1	O
(	O
MP1	O
,	O
also	O
called	O
p44	O
)	O
were	O
resistant	O
to	O
extraction	O
with	O
Triton	O
X	O
-	O
114	O
,	O
indicating	O
that	O
they	O
are	O
integral	O
membrane	O
proteins	O
.	O

To	O
determine	O
whether	O
MHV	B-SPEC
proteins	O
and	O
viral	O
RNA	O
were	O
associated	O
with	O
the	O
DMVs	O
,	O
we	O
performed	O
immunocytochemistry	O
electron	O
microscopy	O
(	O
IEM	O
).	O

Neither	O
method	O
provided	O
any	O
evidence	O
that	O
the	O
GAV	O
sgmRNAs	O
are	O
fused	O
to	O
genomic	O
5	O
'-	O
leader	O
RNA	O
sequences	O
as	O
is	O
the	O
case	O
with	O
vertebrate	B-SPEC
coronaviruses	O
and	O
arteriviruses	B-SPEC
.	O

TITLE	O
:	O
Pharmacodynamics	O
and	O
pharmacokinetics	O
of	O
inhaled	O
nitric	O
oxide	O
in	O
dogs	B-SPEC
with	O
septic	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
pharmacodynamics	O
and	O
pharmacokinetics	O
of	O
inhaled	O
nitric	O
oxide	O
(	O
iNO	O
)	O
in	O
dogs	B-SPEC
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
Methods	O
to	O
detect	O
infectious	O
agents	O
in	O
laboratory	O
animals	B-SPEC
have	O
traditionally	O
been	O
serological	O
and	O
culture	O
based	O
.	O

Molecular	O
methods	O
to	O
detect	O
infectious	O
agents	O
in	O
laboratory	O
animals	B-SPEC
are	O
being	O
used	O
more	O
routinely	O
.	O

TITLE	O
:	O
Persistent	O
transmission	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
by	O
transgenic	B-SPEC
mice	I-SPEC
.	O

Our	O
observation	O
,	O
together	O
with	O
the	O
constantly	O
expanding	O
varieties	O
of	O
immune	O
-	O
impaired	O
or	O
poorly	O
characterized	O
murine	B-SPEC
hosts	O
and	O
the	O
burgeoning	O
dissemination	O
of	O
these	O
animals	B-SPEC
throughout	O
the	O
biomedical	O
research	O
community	O
,	O
indicate	O
that	O
unexpected	O
pathophysiologic	O
presentations	O
of	O
common	O
murine	B-SPEC
viral	O
diseases	O
may	O
present	O
new	O
challenges	O
to	O
the	O
biomedical	O
research	O
community	O
in	O
the	O
future	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
LPS	O
-	O
induced	O
chemokine	O
production	O
in	O
human	B-SPEC
lung	O
endothelial	O
cells	O
by	O
lipid	O
conjugates	O
anchored	O
to	O
the	O
membrane	O
.	O

TITLE	O
:	O
Murine	B-SPEC
hepatitis	O
virus	B-SPEC
--	O
a	O
model	O
for	O
virus	B-SPEC
-	O
induced	O
CNS	O
demyelination	O
.	O

However	O
,	O
several	O
murine	B-SPEC
strains	O
are	O
tropic	O
for	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
and	O
cause	O
encephalitis	O
with	O
subsequent	O
CNS	O
demyelination	O
.	O

ABSTRACT	O
:	O
A	O
commercially	O
available	O
blocking	O
ELISA	O
was	O
analyzed	O
for	O
its	O
ability	O
to	O
identify	O
antibodies	O
to	O
porcine	B-SPEC
coronaviruses	O
(	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
[	O
TGEV	B-SPEC
]	O
or	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
[	O
PRCV	O
]),	O
to	O
differentiate	O
antibodies	O
to	O
TGEV	B-SPEC
and	O
PRCV	O
,	O
and	O
to	O
identify	O
TGEV	B-SPEC
-	O
infected	O
herds	O
.	O

Sera	O
from	O
100	O
commercial	O
swine	B-SPEC
herds	O
(	O
1	O
,	O
783	O
sera	O
;	O
median	O
15	O
per	O
herd	O
)	O
were	O
similarly	O
evaluated	O
using	O
both	O
tests	O
.	O

The	O
blocking	O
ELISA	O
and	O
the	O
VN	O
showed	O
good	O
agreement	O
(	O
kappa	O
0	O
.	O
84	O
)	O
for	O
the	O
detection	O
of	O
porcine	B-SPEC
coronavirus	B-SPEC
antibody	O
(	O
TGEV	B-SPEC
or	O
PRCV	O
).	O

The	O
sensitivity	O
(	O
0	O
.	O
933	O
)	O
of	O
the	O
ELISA	O
to	O
identify	O
TGEV	B-SPEC
-	O
infected	O
herds	O
was	O
good	O
when	O
considered	O
on	O
a	O
herd	O
basis	O
.	O

TITLE	O
:	O
[	O
The	O
optimal	O
pressure	O
of	O
sustained	O
inflation	O
for	O
alveolar	O
recruitment	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
rabbit	B-SPEC
model	O
].	O

TITLE	O
:	O
Interaction	O
of	O
the	O
coronavirus	B-SPEC
nucleoprotein	O
with	O
nucleolar	O
antigens	O
and	O
the	O
host	O
cell	O
.	O

We	O
have	O
found	O
that	O
fibrillarin	O
is	O
reorganized	O
in	O
primary	O
cells	O
infected	O
with	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
in	O
continuous	O
cell	O
lines	O
that	O
express	O
either	O
IBV	B-SPEC
or	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
N	O
protein	O
.	O

Pull	O
-	O
down	O
assays	O
demonstrated	O
that	O
IBV	B-SPEC
N	O
protein	O
interacted	O
with	O
nucleolin	O
and	O
therefore	O
provided	O
a	O
possible	O
explanation	O
as	O
to	O
how	O
coronavirus	B-SPEC
N	O
proteins	O
localize	O
to	O
the	O
nucleolus	O
.	O

Postpartum	O
,	O
thrombocytopenia	O
,	O
and	O
microangiopathic	O
hemolytic	O
anemia	B-SPEC
worsened	O
.	O

Rhinovirus	B-SPEC
was	O
found	O
in	O
48	O
%	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
in	O
14	O
%.	O

ABSTRACT	O
:	O
Reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
immunohistochemistry	O
,	O
and	O
in	O
situ	O
hybridization	O
were	O
compared	O
for	O
the	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

Clinical	O
observations	O
have	O
suggested	O
that	O
patients	O
with	O
allergic	O
rhinitis	O
and	O
asthma	O
experience	O
more	O
pronounced	O
symptoms	O
during	O
a	O
viral	O
URI	O
than	O
patients	O
who	O
do	O
not	O
have	O
allergies	O
and	O
who	O
are	O
infected	O
with	O
the	O
same	O
virus	B-SPEC
under	O
similar	O
circumstances	O
.	O

Virological	O
studies	O
were	O
performed	O
,	O
using	O
indirect	O
immunofluorescence	O
,	O
for	O
HCoV	O
strains	O
229E	O
and	O
OC43	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
types	O
A	O
and	O
B	O
,	O
paramyxoviruses	O
types	O
1	O
,	O
2	O
and	O
3	O
and	O
adenovirus	B-SPEC
.	O

Experiments	O
with	O
a	O
specific	O
inhibitor	O
of	O
p38	O
MAPK	O
,	O
SB	O
203580	O
,	O
demonstrated	O
that	O
MHV	B-SPEC
-	O
induced	O
p38	O
MAPK	O
activation	O
resulted	O
in	O
the	O
accumulation	O
of	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
mRNAs	O
and	O
an	O
increase	O
in	O
the	O
production	O
of	O
IL	O
-	O
6	O
,	O
regardless	O
of	O
MHV	B-SPEC
-	O
induced	O
general	O
host	O
protein	O
synthesis	O
inhibition	O
.	O

Furthermore	O
,	O
MHV	B-SPEC
production	O
was	O
suppressed	O
in	O
SB	O
203580	O
-	O
treated	O
cells	O
,	O
demonstrating	O
that	O
activated	O
p38	O
MAPK	O
played	O
a	O
role	O
in	O
MHV	B-SPEC
replication	O
.	O

TITLE	O
:	O
Binding	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
to	O
cell	O
surface	O
sialoglycoproteins	O
.	O

This	O
concept	O
is	O
discussed	O
in	O
the	O
context	O
of	O
other	O
viruses	B-SPEC
that	O
use	O
two	O
different	O
receptors	O
to	O
infect	O
cells	O
.	O

Bronchoscopic	O
administration	O
of	O
large	O
quantities	O
of	O
natural	O
bovine	B-SPEC
surfactant	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
causes	O
far	O
-	O
reaching	O
restoration	O
of	O
biochemical	O
surfactant	O
properties	O
and	O
significant	O
improvement	O
,	O
however	O
not	O
full	O
normalization	O
,	O
of	O
biophysical	O
surfactant	O
function	O
.	O

All	O
patients	O
requiring	O
decompressive	O
laparotomies	O
died	O
either	O
from	O
sepsis	B-SPEC
or	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Communication	O
between	O
S1N330	O
and	O
a	O
region	O
in	O
S2	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
spike	O
protein	O
is	O
important	O
for	O
virus	B-SPEC
entry	O
into	O
cells	O
expressing	O
CEACAM1b	O
receptor	O
.	O

The	O
prevalence	O
of	O
antibodies	O
to	O
FIV	B-SPEC
was	O
10	O
.	O
4	O
per	O
cent	O
in	O
all	O
the	O
cats	B-SPEC
,	O
4	O
.	O
9	O
per	O
cent	O
in	O
healthy	O
cats	B-SPEC
and	O
16	O
.	O
7	O
per	O
cent	O
in	O
sick	O
cats	B-SPEC
.	O

The	O
prevalence	O
of	O
FIV	B-SPEC
antibodies	O
was	O
significantly	O
higher	O
in	O
entire	O
males	O
and	O
neutered	O
males	O
than	O
in	O
females	O
,	O
in	O
cats	B-SPEC
over	O
two	O
years	O
old	O
compared	O
with	O
younger	O
cats	B-SPEC
,	O
and	O
in	O
cats	B-SPEC
suffering	O
disease	O
of	O
non	O
-	O
traumatic	O
origin	O
rather	O
than	O
in	O
healthy	O
cats	B-SPEC
or	O
cats	B-SPEC
suffering	O
only	O
from	O
trauma	O
.	O

ABSTRACT	O
:	O
In	O
a	O
case	O
-	O
control	O
study	O
of	O
the	O
infectious	O
agents	O
associated	O
with	O
natural	O
outbreaks	O
of	O
respiratory	O
disease	O
in	O
pheasants	O
,	O
28	O
batches	O
of	O
birds	B-SPEC
from	O
sites	O
affected	O
by	O
disease	O
and	O
eight	O
batches	O
of	O
birds	B-SPEC
from	O
unaffected	O
sites	O
were	O
examined	O
by	O
six	O
veterinary	O
laboratories	O
in	O
England	O
,	O
Wales	O
and	O
Scotland	O
,	O
and	O
tested	O
for	O
mycoplasmas	B-SPEC
,	O
other	O
bacteria	B-SPEC
and	O
viruses	B-SPEC
.	O

They	O
were	O
genetically	O
close	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
but	O
differed	O
in	O
their	O
gene	O
sequence	O
from	O
all	O
the	O
serotypes	O
of	O
IBV	B-SPEC
previously	O
identified	O
in	O
domestic	O
fowl	O
,	O
and	O
serological	O
tests	O
with	O
six	O
known	O
IBV	B-SPEC
types	O
showed	O
little	O
cross	O
reactivity	O
.	O

ABSTRACT	O
:	O
A	O
competitive	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
cELISA	O
)	O
was	O
developed	O
for	O
detection	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCV	B-SPEC
)	O
antibodies	O
.	O

The	O
findings	O
indicate	O
that	O
the	O
cELISA	O
is	O
a	O
rapid	O
,	O
sensitive	O
,	O
and	O
specific	O
serologic	O
test	O
for	O
detection	O
of	O
TCV	B-SPEC
antibodies	O
in	O
turkeys	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
the	O
prevalence	O
of	O
EPEC	O
in	O
PEMS	O
-	O
affected	O
turkeys	B-SPEC
was	O
examined	O
retrospectively	O
with	O
archived	O
tissues	O
and	O
intestinal	O
contents	O
collected	O
from	O
12	O
PEMS	O
-	O
affected	O
turkey	B-SPEC
flocks	O
in	O
1998	O
.	O

AE	O
lesions	O
were	O
identified	O
by	O
light	O
microscopy	O
in	O
Giemsa	O
-	O
stained	O
intestines	O
from	O
7	O
of	O
12	O
PEMS	O
-	O
affected	O
turkey	B-SPEC
flocks	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
verify	O
a	O
commonly	O
held	O
assumption	O
that	O
only	O
Massachusetts	O
(	O
Mass	O
)	O
serotype	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
prevalent	O
in	O
the	O
United	O
States	O
between	O
the	O
1930s	O
(	O
when	O
IBV	B-SPEC
was	O
first	O
isolated	O
)	O
and	O
the	O
1950s	O
(	O
when	O
the	O
use	O
of	O
commercial	O
IBV	B-SPEC
vaccines	O
began	O
),	O
we	O
examined	O
40	O
IBV	B-SPEC
field	O
isolates	O
from	O
the	O
1940s	O
.	O

Thirty	O
-	O
eight	O
of	O
those	O
isolates	O
were	O
recognized	O
as	O
Mass	O
serotype	O
viruses	B-SPEC
based	O
on	O
their	O
reactivity	O
to	O
Mass	O
-	O
specific	O
monoclonal	O
antibody	O
(	O
Mab	O
)	O
and	O
neutralization	O
by	O
Mass	O
-	O
specific	O
chicken	B-SPEC
serum	O
.	O

Seventeen	O
isolates	O
of	O
TCV	B-SPEC
were	O
recovered	O
from	O
intestinal	O
samples	O
submitted	O
to	O
Animal	B-SPEC
Disease	O
Diagnostic	O
Laboratory	O
,	O
Purdue	O
University	O
,	O
from	O
turkey	B-SPEC
farms	O
located	O
in	O
different	O
geographic	O
areas	O
.	O

Antibodies	O
to	O
BCV	B-SPEC
or	O
TGEV	B-SPEC
were	O
not	O
reactive	O
with	O
any	O
of	O
the	O
TCV	B-SPEC
isolates	O
.	O

Reactivity	O
of	O
antibodies	O
to	O
unrelated	O
virus	B-SPEC
,	O
rotavirus	B-SPEC
,	O
reovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
or	O
enterovirus	B-SPEC
with	O
different	O
TCV	B-SPEC
isolates	O
was	O
all	O
negative	O
,	O
except	O
positive	O
response	O
was	O
seen	O
between	O
enterovirus	B-SPEC
antibody	O
and	O
a	O
TCV	B-SPEC
western	O
North	O
Carolina	O
isolate	O
,	O
suggesting	O
coinfection	O
of	O
turkeys	B-SPEC
with	O
TCV	B-SPEC
and	O
enterovirus	B-SPEC
in	O
that	O
particular	O
case	O
.	O

TITLE	O
:	O
In	O
vivo	O
studies	O
on	O
cytokine	O
involvement	O
during	O
acute	O
viral	O
respiratory	O
disease	O
of	O
swine	B-SPEC
:	O
troublesome	O
but	O
rewarding	O
.	O

Multifactorial	O
respiratory	O
disease	O
was	O
reproduced	O
by	O
combined	O
inoculations	O
with	O
PRCV	O
or	O
PRRSV	B-SPEC
followed	O
by	O
LPS	O
from	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

At	O
2	O
wk	O
of	O
age	O
,	O
female	O
line	O
P2a	O
White	O
Leghorn	O
-	O
type	O
chickens	B-SPEC
were	O
randomly	O
assigned	O
to	O
one	O
of	O
three	O
diets	O
with	O
different	O
arginine	O
levels	O
:	O
a	O
marginally	O
deficient	O
diet	O
(	O
0	O
.	O
5	O
%),	O
an	O
adequate	O
diet	O
(	O
1	O
.	O
0	O
%),	O
and	O
a	O
diet	O
containing	O
a	O
high	O
level	O
of	O
arginine	O
(	O
3	O
.	O
0	O
%).	O

The	O
molecular	O
mechanisms	O
governing	O
leukocyte	O
trafficking	O
and	O
accumulation	O
within	O
the	O
CNS	O
of	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
are	O
just	O
now	O
being	O
understood	O
and	O
recent	O
studies	O
indicate	O
that	O
chemokines	O
and	O
chemokine	O
receptors	O
have	O
an	O
important	O
role	O
in	O
this	O
process	O
.	O

On	O
d	O
0	O
,	O
all	O
calves	O
were	O
orally	O
challenged	O
with	O
1	O
x	O
10	O
(	O
7	O
)	O
plaque	O
-	O
forming	O
units	O
of	O
virulent	O
coronavirus	B-SPEC
isolate	O
.	O

More	O
than	O
50	O
%	O
of	O
the	O
mice	B-SPEC
were	O
breeding	O
mice	B-SPEC
,	O
and	O
30	O
%	O
were	O
genetically	O
altered	O
.	O

Each	O
row	O
of	O
cages	O
also	O
contained	O
one	O
standard	O
cage	O
(	O
no	O
filter	O
top	O
)	O
of	O
uninoculated	O
mice	B-SPEC
at	O
various	O
distances	O
from	O
the	O
infected	O
cage	O
.	O

At	O
2	O
,	O
4	O
,	O
and	O
6	O
weeks	O
after	O
infection	O
of	O
the	O
mice	B-SPEC
in	O
the	O
test	O
cages	O
,	O
uninoculated	O
mice	B-SPEC
in	O
22	O
cages	O
were	O
tested	O
by	O
serology	O
,	O
and	O
at	O
8	O
weeks	O
the	O
uninoculated	O
mice	B-SPEC
in	O
54	O
cages	O
were	O
tested	O
by	O
serology	O
and	O
those	O
in	O
24	O
cages	O
were	O
tested	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
of	O
fecal	O
samples	O
to	O
assess	O
transmission	O
of	O
infection	O
.	O

Our	O
findings	O
also	O
suggest	O
that	O
long	O
-	O
term	O
use	O
of	O
automatic	O
watering	O
in	O
static	O
filter	O
-	O
top	O
cages	O
handled	O
using	O
conventional	O
husbandry	O
techniques	O
may	O
not	O
prevent	O
transmission	O
in	O
the	O
vicinity	O
of	O
high	O
virus	B-SPEC
concentrations	O
or	O
open	O
caging	O
.	O

This	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
phase	O
II	O
study	O
added	O
low	O
-	O
dose	O
(	O
3	O
mcg	O
/	O
kg	O
)	O
intravenous	O
recombinant	O
human	B-SPEC
GM	O
-	O
CSF	O
daily	O
for	O
5	O
days	O
to	O
conventional	O
therapy	O
in	O
10	O
patients	O
,	O
with	O
a	O
further	O
eight	O
patients	O
receiving	O
placebo	O
.	O

Similarly	O
,	O
the	O
adverse	O
effects	O
of	O
immunosuppressive	O
therapy	O
may	O
be	O
diminished	O
by	O
improved	O
,	O
perhaps	O
molecular	O
,	O
techniques	O
to	O
detect	O
microbial	O
pathogens	O
and	O
permit	B-SPEC
differentiation	O
between	O
Systemic	O
inflammatory	O
response	O
syndrome	O
and	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
Diagnostic	O
dilemmas	O
in	O
acute	O
intermittent	O
porphyria	B-SPEC
.	O

All	O
samples	O
ELISA	O
positive	O
for	O
BCV	B-SPEC
were	O
matched	O
with	O
an	O
equal	O
number	O
of	O
BCV	B-SPEC
ELISA	O
-	O
negative	O
samples	O
and	O
analyzed	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
of	O
the	O
N	O
gene	O
.	O

Information	O
on	O
clinical	O
signs	O
,	O
treatments	O
provided	O
,	O
and	O
cattle	B-SPEC
weights	O
were	O
collected	O
.	O

The	O
overall	O
rates	O
of	O
BCV	B-SPEC
nasal	O
and	O
fecal	O
shedding	O
were	O
48	O
%	O
(	O
41	O
/	O
85	O
)	O
and	O
53	O
%	O
(	O
45	O
/	O
85	O
)	O
by	O
ELISA	O
and	O
84	O
%	O
(	O
71	O
/	O
85	O
)	O
and	O
96	O
%	O
(	O
82	O
/	O
85	O
)	O
by	O
RT	O
-	O
PCR	O
,	O
respectively	O
.	O

Twenty	O
-	O
eight	O
respiratory	O
and	O
7	O
enteric	O
BCV	B-SPEC
strains	O
were	O
isolated	O
from	O
nasal	O
and	O
fetal	O
samples	O
of	O
32	O
cattle	B-SPEC
in	O
HRT	O
-	O
18	O
cell	O
cultures	O
.	O

A	O
patient	O
recovering	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
developed	O
septic	O
shock	O
from	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
bacteremia	O
while	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
.	O

The	O
role	O
of	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
)	O
in	O
mediating	O
the	O
ALI	O
associated	O
with	O
secretagogue	O
-	O
induced	O
experimental	O
pancreatitis	O
was	O
evaluated	O
with	O
GM	O
-	O
CSF	O
knockout	O
mice	B-SPEC
(	O
GM	O
-	O
CSF	O
-/-).	O

In	O
conclusion	O
,	O
sialodacryoadenitis	O
virus	B-SPEC
infection	O
in	O
rats	B-SPEC
was	O
associated	O
with	O
increased	O
frequency	O
of	O
hepatic	O
mtDNA	O
deletions	O
.	O

Chickens	B-SPEC
immunized	O
with	O
the	O
hybrid	O
recombinants	O
produced	O
specific	O
antibodies	O
against	O
the	O
S2	O
glycoprotein	O
of	O
MHV	B-SPEC
and	O
completely	O
lacked	O
antibodies	O
directed	O
against	O
the	O
NP	O
-	O
IDE	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
situ	O
hybridization	O
and	O
immunohistochemistry	O
were	O
utilized	O
to	O
identify	O
tissues	O
infected	O
in	O
ovo	B-SPEC
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
digoxigenin	O
-	O
labeled	O
antisense	O
S1	O
riboprobe	O
detected	O
viral	O
mRNA	O
in	O
the	O
cytoplasm	O
of	O
respiratory	O
epithelial	O
cells	O
in	O
the	O
primary	O
bronchus	B-SPEC
at	O
24	O
,	O
48	O
,	O
and	O
72	O
HPI	O
.	O

TITLE	O
:	O
Tissue	O
distribution	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
following	O
in	O
ovo	B-SPEC
inoculation	O
of	O
chicken	B-SPEC
embryos	O
examined	O
by	O
in	O
situ	O
hybridization	O
with	O
antisense	O
digoxigenin	O
-	O
labeled	O
universal	O
riboprobe	O
.	O

The	O
animal	B-SPEC
had	O
diarrhea	O
for	O
5	O
days	O
and	O
died	O
despite	O
symptomatic	O
treatment	O
.	O

To	O
directly	O
analyze	O
progenitor	O
differentiation	O
,	O
glial	O
cultures	O
from	O
spinal	O
cords	O
of	O
wild	O
-	O
type	O
mice	B-SPEC
undergoing	O
remyelination	O
after	O
MHV	B-SPEC
-	O
A59	O
demyelination	O
were	O
treated	O
for	O
3	O
d	O
with	O
either	O
exogenous	O
FGF2	O
or	O
an	O
FGF2	O
neutralizing	O
antibody	O
.	O

These	O
in	O
vitro	O
results	O
are	O
consistent	O
with	O
enhanced	O
progenitor	O
differentiation	O
in	O
FGF2	O
-/-	O
mice	B-SPEC
.	O

After	O
tracheostomy	O
was	O
performed	O
,	O
sheep	B-SPEC
were	O
connected	O
to	O
a	O
volume	O
-	O
controlled	O
ventilator	O
.	O

ABSTRACT	O
:	O
The	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
spike	O
glycoprotein	O
is	O
a	O
major	O
determinant	O
of	O
neurovirulence	O
.	O

In	O
apparent	O
contradiction	O
to	O
these	O
results	O
,	O
robust	O
demyelination	O
is	O
detected	O
in	O
MHV	B-SPEC
-	O
infected	O
young	O
nude	O
(	O
athymic	O
)	O
mice	B-SPEC
.	O

Herein	O
,	O
we	O
show	O
that	O
demyelination	O
in	O
nude	B-SPEC
mice	I-SPEC
was	O
mediated	O
by	O
gamma	O
delta	O
T	O
cells	O
.	O

Seven	O
contiguous	O
cDNA	O
clones	O
that	O
spanned	O
the	O
31	O
.	O
5	O
-	O
kb	O
MHV	B-SPEC
genome	O
were	O
isolated	O
.	O

Full	O
-	O
length	O
infectious	O
constructs	O
of	O
MHV	B-SPEC
-	O
A59	O
will	O
permit	B-SPEC
genetic	O
modifications	O
of	O
the	O
entire	O
coronavirus	B-SPEC
genome	O
,	O
particularly	O
in	O
the	O
replicase	O
gene	O
.	O

The	O
small	O
nonenveloped	O
viruses	B-SPEC
,	O
such	O
as	O
HAV	O
and	O
parvovirus	B-SPEC
B19	I-SPEC
(	O
B19	O
),	O
are	O
evidently	O
more	O
difficult	O
to	O
remove	O
than	O
the	O
larger	O
enveloped	O
viruses	B-SPEC
.	O

These	O
enlarged	O
viruses	B-SPEC
should	O
be	O
easier	O
to	O
remove	O
by	O
nanofiltration	O
than	O
naked	O
viruses	B-SPEC
.	O

This	O
virus	B-SPEC
cross	O
-	O
reacts	O
with	O
antibodies	O
in	O
pooled	O
human	B-SPEC
IgG	O
solutions	O
but	O
persists	O
as	O
free	O
virions	O
in	O
albumin	O
solutions	O
.	O

Virus	B-SPEC
removal	O
was	O
assessed	O
by	O
in	O
vitro	O
infectivity	O
assays	O
.	O

The	O
primers	O
were	O
derived	O
from	O
the	O
corresponding	O
sequences	O
of	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Gene	O
5	O
containing	O
two	O
overlapping	O
open	O
reading	O
frames	O
(	O
ORFs	O
),	O
5a	O
and	O
5b	O
,	O
was	O
localized	O
between	O
M	O
and	O
N	O
genes	O
of	O
TCV	B-SPEC
.	O

ABSTRACT	O
:	O
Replication	O
-	O
competent	O
propagation	O
-	O
deficient	O
virus	B-SPEC
vectors	O
based	O
on	O
the	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
genome	O
that	O
are	O
deficient	O
in	O
the	O
essential	O
E	O
gene	O
have	O
been	O
developed	O
by	O
complementation	O
within	O
E	O
(+)	O
packaging	O
cell	O
lines	O
.	O

The	O
method	O
,	O
based	O
on	O
the	O
titration	O
of	O
antibodies	O
to	O
semipurified	O
FAH	O
from	O
rat	B-SPEC
liver	O
,	O
is	O
easy	O
,	O
economical	O
,	O
and	O
does	O
not	O
require	O
the	O
isolation	O
of	O
viral	O
proteins	O
from	O
large	O
MHV	B-SPEC
stocks	O
.	O

TITLE	O
:	O
Molecular	O
epizootiology	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Sweden	O
indicating	O
the	O
involvement	O
of	O
a	O
vaccine	O
strain	O
.	O

TITLE	O
:	O
Enhanced	O
green	O
fluorescent	O
protein	O
expression	O
may	O
be	O
used	O
to	O
monitor	O
murine	B-SPEC
coronavirus	I-SPEC
spread	O
in	O
vitro	O
and	O
in	O
the	O
mouse	B-SPEC
central	O
nervous	O
system	O
.	O

The	O
EGFP	O
gene	O
was	O
inserted	O
into	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
genome	O
in	O
place	O
of	O
the	O
nonessential	O
gene	O
4	O
.	O

Expression	O
of	O
EGFP	O
remained	O
stable	O
through	O
at	O
least	O
six	O
passages	O
in	O
tissue	O
culture	O
and	O
during	O
acute	O
infection	O
in	O
the	O
mouse	B-SPEC
central	O
nervous	O
system	O
.	O

MHV	B-SPEC
-	O
2	O
causes	O
only	O
acute	O
hepatitis	O
and	O
meningitis	O
,	O
whereas	O
Penn98	O
-	O
1	O
produces	O
acute	O
hepatitis	O
and	O
meningoencephalitis	O
without	O
demyelination	O
.	O

Because	O
the	O
application	O
of	O
exogenous	O
surfactant	O
has	O
been	O
proposed	O
as	O
a	O
treatment	O
for	O
ARDS	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
surfactant	O
on	O
ventilation	O
-	O
induced	O
release	O
of	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
6	O
-	O
keto	O
-	O
PGF	O
(	O
1	O
alpha	O
)	O
(	O
the	O
stable	O
metabolite	O
of	O
prostacyclin	O
)	O
in	O
isolated	O
perfused	O
mouse	B-SPEC
lungs	O
ventilated	O
with	O
high	O
end	O
-	O
inspiratory	O
pressures	O
.	O

Apoptosis	O
correlated	O
with	O
the	O
differential	O
release	O
of	O
infectious	O
virus	B-SPEC
.	O

A	O
cl	O
-	O
2	O
mutant	O
,	O
srr7	O
,	O
of	O
the	O
MHV	B-SPEC
JHM	O
virus	B-SPEC
(	O
JHMV	O
)	O
was	O
digested	O
with	O
proteinase	O
K	O
after	O
treatment	O
with	O
soMHVR	O
,	O
and	O
the	O
resultant	O
S	O
protein	O
was	O
analyzed	O
by	O
Western	O
blotting	O
using	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
10G	O
,	O
specific	O
for	O
the	O
membrane	O
-	O
anchored	O
S2	O
subunit	O
.	O

This	O
is	O
the	O
first	O
report	O
on	O
receptor	O
-	O
induced	O
conformational	O
changes	O
of	O
the	O
membrane	O
-	O
anchored	O
fragment	O
of	O
the	O
coronavirus	B-SPEC
S	O
protein	O
.	O

The	O
results	O
showed	O
that	O
the	O
feline	B-SPEC
cells	O
were	O
permissive	O
to	O
IBV	B-SPEC
but	O
the	O
hamster	B-SPEC
cells	O
were	O
not	O
.	O

ABSTRACT	O
:	O
A	O
field	O
study	O
of	O
a	O
vaccine	O
;	O
prepared	O
by	O
solubilizing	O
cells	O
infected	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
Triton	O
X	O
-	O
100	O
,	O
and	O
mixing	O
with	O
an	O
oil	O
adjuvant	O
,	O
was	O
performed	O
at	O
9	O
farms	O
over	O
4	O
prefectures	O
.	O

The	O
geometric	O
mean	O
of	O
the	O
hemagglutination	O
inhibition	O
antibody	O
titer	O
was	O
34	O
.	O
2	O
before	O
vaccination	O
in	O
test	O
cows	B-SPEC
.	O

TITLE	O
:	O
Coronaviruses	O
from	O
pheasants	O
(	O
Phasianus	B-SPEC
colchicus	I-SPEC
)	O
are	O
genetically	O
closely	O
related	O
to	O
coronaviruses	O
of	O
domestic	O
fowl	O
(	O
infectious	O
bronchitis	O
virus	B-SPEC
)	O
and	O
turkeys	B-SPEC
.	O

TITLE	O
:	O
Non	O
-	O
immune	O
acute	O
graft	O
injury	O
after	O
lung	O
transplantation	O
and	O
the	O
risk	O
of	O
subsequent	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	B-SPEC
).	O

We	O
hypothesized	O
that	O
acute	O
non	O
-	O
immune	O
injury	O
in	O
the	O
lung	O
allograft	O
may	O
impact	O
,	O
not	O
only	O
on	O
early	O
survival	O
,	O
but	O
also	O
on	O
longer	O
term	O
survival	O
by	O
increasing	O
the	O
incidence	O
of	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	B-SPEC
).	O

Serial	O
measurements	O
of	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
FEV	B-SPEC
(	O
1	O
))	O
in	O
long	O
-	O
term	O
follow	O
-	O
up	O
defined	O
the	O
incidence	O
of	O
BOS	B-SPEC
.	O

The	O
incidence	O
of	O
subsequent	O
BOS	B-SPEC
over	O
the	O
follow	O
-	O
up	O
period	O
was	O
not	O
significantly	O
different	O
in	O
those	O
with	O
and	O
without	O
DAD	O
on	O
early	O
biopsy	O
at	O
46	O
%	O
and	O
59	O
%,	O
respectively	O
(	O
hazards	O
ratio	O
0	O
.	O
88	O
[	O
0	O
.	O
48	O
to	O
1	O
.	O
62	O
];	O
p	O
=	O
0	O
.	O
22	O
,	O
chi	O
-	O
square	O
test	O
).	O

BOS	B-SPEC
did	O
not	O
occur	O
any	O
earlier	O
in	O
the	O
DAD	O
group	O
(	O
median	O
953	O
days	O
,	O
range	O
152	O
to	O
1	O
,	O
393	O
)	O
days	O
compared	O
with	O
the	O
non	O
-	O
DAD	O
group	O
(	O
median	O
665	O
days	O
,	O
range	O
52	O
to	O
4	O
,	O
299	O
)	O
(	O
p	O
=	O
0	O
.	O
48	O
,	O
Fisher	B-SPEC
'	O
s	O
exact	O
test	O
).	O

We	O
have	O
investigated	O
the	O
significance	O
of	O
this	O
remarkable	O
conservation	O
by	O
rearrangement	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
genome	O
through	O
targeted	O
recombination	O
.	O

Thus	O
,	O
viruses	B-SPEC
were	O
prepared	O
with	O
the	O
following	O
gene	O
order	B-SPEC
:	O
5	O
'-	O
pol	O
-	O
S	O
-	O
M	O
-	O
E	O
-	O
N	O
-	O
3	O
',	O
5	O
'-	O
pol	O
-	O
S	O
-	O
N	O
-	O
E	O
-	O
M	O
-	O
3	O
',	O
5	O
'-	O
pol	O
-	O
M	O
-	O
S	O
-	O
E	O
-	O
N	O
-	O
3	O
',	O
and	O
5	O
'-	O
pol	O
-	O
E	O
-	O
M	O
-	O
S	O
-	O
N	O
-	O
3	O
'.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
in	O
murine	B-SPEC
17Cl	O
-	O
1	O
cells	O
results	O
in	O
apoptotic	O
cell	O
death	O
.	O

ABSTRACT	O
:	O
The	O
targeted	O
RNA	O
recombination	O
was	O
attempted	O
to	O
substitute	O
the	O
membrane	O
(	O
M	O
)	O
protein	O
gene	O
and	O
part	O
of	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
gene	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
with	O
the	O
corresponding	O
sequences	O
from	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

Further	O
analysis	O
of	O
the	O
recombinant	O
viruses	B-SPEC
indicated	O
that	O
there	O
combination	O
had	O
taken	O
place	O
within	O
the	O
region	O
of	O
222	O
nucleotides	O
between	O
positions	O
916	O
and	O
1	O
,	O
137	O
of	O
the	O
N	O
gene	O
.	O

Mode	O
of	O
ventilation	O
(	O
HFOV	O
or	O
CMV	B-SPEC
)	O
was	O
determined	O
by	O
the	O
patient	O
'	O
s	O
physician	O
based	O
on	O
guidelines	O
to	O
maximize	O
oxygenation	O
.	O

After	O
72	O
hrs	O
,	O
treatment	O
with	O
HFOV	O
alone	O
resulted	O
in	O
a	O
greater	O
improvement	O
in	O
Pao2	O
/	O
Fio2	O
ratio	O
than	O
either	O
CMV	B-SPEC
alone	O
or	O
CMV	B-SPEC
plus	O
iNO	O
(	O
p	O
=.	O
03	O
).	O

Main	O
risk	O
factors	O
were	O
:	O
sepsis	B-SPEC
(	O
44	O
%,	O
including	O
65	O
pneumonia	O
cases	O
),	O
shock	O
(	O
15	O
%),	O
trauma	O
(	O
11	O
%),	O
gastric	O
aspiration	O
(	O
10	O
%),	O
and	O
other	O
(	O
34	O
%).	O

The	O
best	O
studied	O
nidoviruses	B-SPEC
,	O
the	O
corona	B-SPEC
-	O
and	O
arteriviruses	B-SPEC
,	O
employ	O
a	O
unique	O
transcription	O
mechanism	O
,	O
which	O
involves	O
discontinuous	O
RNA	O
synthesis	O
,	O
a	O
process	O
resembling	O
similarity	O
-	O
assisted	O
copy	O
-	O
choice	O
RNA	O
recombination	O
.	O

Our	O
findings	O
have	O
important	O
implications	O
for	O
the	O
understanding	O
of	O
the	O
mechanism	O
and	O
evolution	O
of	O
nidovirus	B-SPEC
transcription	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
recombinant	O
gene	O
technologies	O
by	O
the	O
vaccine	O
industry	O
has	O
revolutionized	O
the	O
way	O
antigens	O
are	O
generated	O
,	O
and	O
has	O
provided	O
safer	O
,	O
more	O
effective	O
means	O
of	O
protecting	O
animals	B-SPEC
and	O
humans	B-SPEC
against	O
bacterial	O
and	O
viral	O
pathogens	O
.	O

Transgenic	O
plants	B-SPEC
are	O
now	O
recognized	O
as	O
legitimate	O
sources	O
for	O
these	O
proteins	O
,	O
especially	O
in	O
the	O
developing	O
area	O
of	O
oral	O
vaccines	O
,	O
because	O
antigens	O
have	O
been	O
shown	O
to	O
be	O
correctly	O
processed	O
in	O
plants	B-SPEC
into	O
forms	O
that	O
elicit	O
immune	O
responses	O
when	O
fed	O
to	O
animals	B-SPEC
or	O
humans	B-SPEC
.	O

To	O
further	O
characterize	O
the	O
function	O
of	O
PTB	O
in	O
MHV	B-SPEC
replication	O
,	O
we	O
generated	O
dominant	O
-	O
negative	O
mutant	O
cell	O
lines	O
that	O
express	O
a	O
full	O
-	O
length	O
PTB	O
or	O
a	O
truncated	O
form	O
of	O
PTB	O
,	O
which	O
includes	O
only	O
the	O
N	O
-	O
terminal	O
half	O
of	O
the	O
protein	O
,	O
retaining	O
its	O
protein	O
-	O
dimerization	O
domain	O
.	O

Given	O
that	O
PTB	O
interacts	O
with	O
the	O
viral	O
N	O
protein	O
,	O
which	O
is	O
one	O
of	O
the	O
components	O
of	O
the	O
MHV	B-SPEC
replication	O
complex	O
,	O
PTB	O
may	O
exert	O
its	O
function	O
on	O
viral	O
replication	O
/	O
transcription	O
by	O
association	O
with	O
viral	O
RNA	O
as	O
well	O
as	O
other	O
viral	O
and	O
cellular	O
factors	O
in	O
the	O
replication	O
complex	O
.	O

TITLE	O
:	O
Construction	O
and	O
immunogenicity	O
studies	O
of	O
recombinant	O
fowl	O
poxvirus	B-SPEC
containing	O
the	O
S1	O
gene	O
of	O
Massachusetts	O
41	O
strain	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Later	O
,	O
in	O
vivo	O
expression	O
was	O
demonstrated	O
by	O
the	O
detection	O
of	O
IBV	B-SPEC
-	O
specific	O
serum	O
immunoglobulin	O
G	O
and	O
neutralization	O
antibodies	O
in	O
the	O
sera	O
of	O
chickens	B-SPEC
immunized	O
with	O
rFPV	O
-	O
S1	O
.	O

Confirmatory	O
diagnosis	O
of	O
NIB	O
was	O
made	O
by	O
IBV	B-SPEC
antigen	O
-	O
specific	O
immunohistochemical	O
staining	O
of	O
the	O
renal	O
tubular	O
epithelium	O
and	O
virus	B-SPEC
isolation	O
.	O

TITLE	O
:	O
Protection	O
of	O
chickens	B-SPEC
after	O
live	O
and	O
inactivated	O
virus	B-SPEC
vaccination	O
against	O
challenge	O
with	O
nephropathogenic	O
infectious	O
bronchitis	O
virus	B-SPEC
PA	O
/	O
Wolgemuth	O
/	O
98	O
.	O

Vaccinations	O
with	O
combinations	O
of	O
live	O
attenuated	O
strains	O
Massachusetts	O
(	O
Mass	O
)	O
+	O
Connecticut	O
(	O
Conn	O
)	O
or	O
Mass	O
+	O
Arkansas	O
(	O
Ark	O
)	O
were	O
given	O
by	O
eyedrop	O
to	O
2	O
-	O
wk	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
leghorn	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Passive	O
immunization	O
by	O
oral	O
administration	O
of	O
specific	O
antibodies	O
has	O
been	O
an	O
attractive	O
approach	O
against	O
gastrointestinal	O
(	O
GI	O
)	O
pathogens	O
in	O
both	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

After	O
immunization	O
,	O
the	O
specific	O
antibodies	O
(	O
called	O
IgY	O
)	O
are	O
transported	O
to	O
the	O
egg	O
yolk	O
,	O
from	O
which	O
the	O
IgY	O
then	O
can	O
be	O
separated	O
without	O
sacrificing	O
chickens	B-SPEC
.	O

On	O
virions	O
,	O
the	O
180	O
-	O
kDa	O
S	O
glycoprotein	O
of	O
the	O
MHV	B-SPEC
-	O
A59	O
strain	O
can	O
be	O
cleaved	O
by	O
trypsin	O
to	O
form	O
the	O
90	O
-	O
kDa	O
N	O
-	O
terminal	O
receptor	O
-	O
binding	O
subunit	O
(	O
S1	O
)	O
and	O
the	O
90	O
-	O
kDa	O
membrane	O
-	O
anchored	O
fusion	O
subunit	O
(	O
S2	O
).	O

Incubation	O
of	O
virions	O
with	O
purified	O
,	O
soluble	O
CEACAM1a	O
receptor	O
proteins	O
at	O
37	O
degrees	O
C	O
and	O
pH	O
6	O
.	O
5	O
neutralizes	O
virus	B-SPEC
infectivity	O
(	O
B	O
.	O
D	O
.	O
Zelus	B-SPEC
,	O
D	O
.	O
R	O
.	O
Wessner	O
,	O
R	O
.	O
K	O
.	O
Williams	O
,	O
M	O
.	O
N	O
.	O
Pensiero	O
,	O
F	O
.	O
T	O
.	O
Phibbs	O
,	O
M	O
.	O
deSouza	O
,	O
G	O
.	O
S	O
.	O
Dveksler	O
,	O
and	O
K	O
.	O
V	O
.	O
Holmes	O
,	O
J	O
.	O
Virol	O
.	O

A	O
novel	O
120	O
-	O
kDa	O
subunit	O
was	O
formed	O
following	O
incubation	O
of	O
the	O
receptor	O
-	O
triggered	O
S	O
(	O
A59	O
)	O
H716D	O
virions	O
with	O
trypsin	O
at	O
4	O
degrees	O
C	O
.	O
The	O
data	O
show	O
that	O
unlike	O
class	B-SPEC
1	O
fusion	O
glycoproteins	O
of	O
other	O
enveloped	O
viruses	B-SPEC
,	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
S	O
protein	O
can	O
be	O
triggered	O
to	O
a	O
membrane	O
-	O
binding	O
conformation	O
at	O
37	O
degrees	O
C	O
either	O
by	O
soluble	O
receptor	O
at	O
neutral	O
pH	O
or	O
by	O
alkaline	O
pH	O
alone	O
,	O
without	O
requiring	O
previous	O
activation	O
by	O
cleavage	O
between	O
S1	O
and	O
S2	O
.	O

ABSTRACT	O
:	O
Gill	B-SPEC
-	I-SPEC
associated	I-SPEC
virus	I-SPEC
(	O
GAV	B-SPEC
),	O
a	O
positive	O
-	O
stranded	O
RNA	O
virus	B-SPEC
of	O
prawns	O
,	O
is	O
the	O
prototype	O
of	O
newly	O
recognized	O
taxa	O
(	O
genus	B-SPEC
Okavirus	I-SPEC
,	O
family	B-SPEC
Roniviridae	I-SPEC
)	O
within	O
the	O
order	B-SPEC
NIDOVIRALES	I-SPEC
:	O
In	O
this	O
study	O
,	O
a	O
putative	O
GAV	B-SPEC
cysteine	O
proteinase	O
(	O
3C	O
-	O
like	O
proteinase	O
[	O
3CL	O
(	O
pro	O
)]),	O
which	O
is	O
predicted	O
to	O
be	O
the	O
key	O
enzyme	O
involved	O
in	O
processing	O
of	O
the	O
GAV	B-SPEC
replicase	O
polyprotein	O
precursors	O
,	O
pp1a	O
and	O
pp1ab	O
,	O
was	O
characterized	O
.	O

Analysis	O
of	O
the	O
proteolytic	O
activities	O
of	O
MBP	O
-	O
3CL	O
(	O
pro	O
)	O
fusion	O
proteins	O
carrying	O
replacements	O
of	O
putative	O
active	O
-	O
site	O
residues	O
provided	O
evidence	O
that	O
,	O
in	O
contrast	O
to	O
most	O
other	O
3C	O
/	O
3CL	O
(	O
pro	O
)	O
s	O
but	O
in	O
common	O
with	O
coronavirus	B-SPEC
3CL	O
(	O
pro	O
)	O
s	O
,	O
the	O
GAV	O
3CL	O
(	O
pro	O
)	O
employs	O
a	O
Cys	O
(	O
2968	O
)-	O
His	O
(	O
2879	O
)	O
catalytic	O
dyad	O
.	O

TITLE	O
:	O
Inside	O
-	O
Out	O
versus	O
Outside	O
-	O
In	O
models	O
for	O
virus	B-SPEC
induced	O
demyelination	O
:	O
axonal	O
damage	O
triggering	O
demyelination	O
.	O

TITLE	O
:	O
M	O
gene	O
evolution	O
of	O
canine	O
coronavirus	B-SPEC
in	O
naturally	O
infected	O
dogs	B-SPEC
.	O

Sequence	O
analysis	O
of	O
a	O
fragment	O
of	O
the	O
gene	O
encoding	O
the	O
M	O
protein	O
revealed	O
that	O
the	O
viruses	B-SPEC
detected	O
at	O
the	O
onset	O
of	O
the	O
infection	O
were	O
very	O
similar	O
to	O
typical	O
strains	O
of	O
CCoV	O
,	O
whereas	O
from	O
42	O
days	O
after	O
infection	O
in	O
pup	O
A	O
and	O
40	O
days	O
after	O
infection	O
in	O
pup	O
B	O
the	O
viruses	B-SPEC
had	O
nucleotide	O
and	O
amino	O
acid	O
mutations	O
resembling	O
sequences	O
in	O
feline	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Dengue	O
hemorrhagic	O
fever	O
(	O
DHF	O
)	O
is	O
caused	O
by	O
dengue	B-SPEC
virus	I-SPEC
.	O

Previously	O
,	O
these	O
patients	O
were	O
treated	O
with	O
oxygen	O
on	O
a	O
nasal	O
cannula	B-SPEC
,	O
or	O
if	O
necessary	O
with	O
tracheal	O
intubation	O
and	O
mechanical	O
ventilation	O
.	O

STAT1	O
and	O
STAT3	O
activation	O
in	O
spleen	O
increased	O
24	O
to	O
72	O
hr	O
following	O
MHV	B-SPEC
-	O
3	O
infections	O
in	O
both	O
sensitive	O
and	O
resistant	O
mouse	B-SPEC
strains	O
.	O

Activated	O
STAT1	O
alpha	O
/	O
beta	O
and	O
STAT3	O
alpha	O
/	O
beta	O
ratio	O
in	O
liver	O
were	O
similar	O
in	O
resistant	O
and	O
sensitive	O
mouse	B-SPEC
strains	O
.	O

Serological	O
tests	O
for	O
Chlamydia	B-SPEC
pneumoniae	I-SPEC
and	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
were	O
performed	O
.	O

Serological	O
tests	O
for	O
atypical	O
bacteria	B-SPEC
were	O
positive	O
in	O
10	O
%	O
of	O
patients	O
(	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
5	O
%;	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
5	O
%).	O

In	O
conclusion	O
,	O
we	O
confirmed	O
the	O
high	O
incidence	O
of	O
viral	O
infection	O
in	O
acute	O
exacerbations	O
of	O
asthma	O
,	O
especially	O
enteroviruses	B-SPEC
or	O
rhinoviruses	B-SPEC
.	O

TITLE	O
:	O
Serologic	O
survey	O
for	O
viral	O
and	O
bacterial	O
infections	O
in	O
western	O
populations	O
of	O
Canada	B-SPEC
lynx	I-SPEC
(	O
Lynx	B-SPEC
canadensis	I-SPEC
).	O

ABSTRACT	O
:	O
A	O
serologic	O
survey	O
for	O
exposure	O
to	O
pathogens	O
in	O
Canada	B-SPEC
lynx	I-SPEC
(	O
Lynx	B-SPEC
canadensis	I-SPEC
)	O
in	O
western	O
North	O
America	O
was	O
conducted	O
.	O

A	O
subset	O
of	O
samples	O
was	O
tested	O
for	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
;	O
all	O
were	O
negative	O
.	O

Serologic	O
evidence	O
for	O
FPV	B-SPEC
was	O
found	O
in	O
all	O
six	O
areas	O
but	O
was	O
more	O
common	O
in	O
southern	O
populations	O
.	O

ABSTRACT	O
:	O
Although	O
known	O
as	O
common	O
causes	O
of	O
upper	O
respiratory	O
infections	O
,	O
rhinoviruses	B-SPEC
,	O
enteroviruses	B-SPEC
,	O
and	O
corona	B-SPEC
-	O
viruses	B-SPEC
are	O
poorly	O
studied	O
as	O
inducers	O
of	O
wheezing	O
in	O
infants	O
,	O
and	O
their	O
possible	O
role	O
in	O
the	O
development	O
of	O
childhood	O
asthma	O
has	O
not	O
been	O
investigated	O
.	O

Our	O
results	O
present	O
rhinoviruses	B-SPEC
as	O
important	O
inducers	O
of	O
wheezing	O
even	O
in	O
infancy	O
.	O

The	O
association	O
with	O
atopy	O
and	O
subsequent	O
asthma	O
calls	O
for	O
reevaluation	O
of	O
the	O
role	O
of	O
rhinoviruses	B-SPEC
in	O
the	O
development	O
of	O
asthma	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
California	B-SPEC
variants	O
isolated	O
between	O
1988	O
and	O
2001	O
based	O
on	O
the	O
S1	O
subunit	O
of	O
the	O
spike	O
glycoprotein	O
.	O

California	B-SPEC
variants	O
were	O
grouped	O
according	O
to	O
production	O
type	O
of	O
chicken	B-SPEC
,	O
by	O
comparison	O
with	O
public	O
access	O
sequence	O
databases	O
(	O
NCBI	O
GenBank	O
and	O
EMBL	O
),	O
or	O
based	O
on	O
phylogenetic	O
analysis	O
.	O

Fisher	B-SPEC
'	O
s	O
Exact	O
test	O
was	O
used	O
to	O
compare	O
mutations	O
per	O
year	O
,	O
purifying	O
and	O
positive	O
selection	O
,	O
predictive	O
antigenicity	O
,	O
and	O
a	O
>	O
or	O
=	O
6	O
bp	O
deletion	O
between	O
California	B-SPEC
variant	O
groups	O
.	O

The	O
purpose	O
of	O
the	O
experiments	O
presented	O
here	O
was	O
to	O
examine	O
the	O
in	O
vivo	O
effects	O
of	O
thymulin	O
on	O
avian	B-SPEC
NK	O
cell	O
activity	O
in	O
response	O
to	O
a	O
viral	O
infection	O
.	O

TITLE	O
:	O
Differential	O
role	O
for	O
T	O
cells	O
in	O
the	O
development	O
of	O
fibrotic	O
lesions	O
associated	O
with	O
reovirus	B-SPEC
1	O
/	O
L	O
-	O
induced	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
versus	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

In	O
contrast	O
,	O
CBA	O
/	O
J	O
mice	B-SPEC
infected	O
with	O
1	O
x	O
10	O
(	O
7	O
)	O
pfu	O
reovirus	B-SPEC
1	O
/	O
L	O
develop	O
histologic	O
characteristics	O
of	O
ARDS	O
including	O
diffuse	O
alveolar	O
damage	O
,	O
hyaline	O
membranes	O
,	O
and	O
intra	O
-	O
alveolar	O
fibrosis	O
.	O

Neonatally	O
thymectomized	O
CBA	O
/	O
J	O
mice	B-SPEC
infected	O
with	O
1	O
x	O
10	O
(	O
7	O
)	O
pfu	O
(	O
ARDS	O
)	O
reovirus	B-SPEC
1	O
/	O
L	O
still	O
develop	O
the	O
hallmark	O
characteristics	O
of	O
ARDS	O
,	O
including	O
a	O
severe	O
viral	O
pneumonia	O
with	O
cellular	O
infiltrates	O
comprised	O
mainly	O
of	O
macrophages	O
and	O
neutrophils	O
,	O
hyaline	O
membrane	O
formation	O
,	O
and	O
hemorrhage	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
and	O
persistent	O
intra	O
-	O
alveolar	O
fibrosis	O
during	O
the	O
chronic	O
phase	O
of	O
the	O
disease	O
.	O

To	O
identify	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
the	O
viral	O
spike	O
glycoprotein	O
(	O
S	O
),	O
we	O
expressed	O
soluble	O
truncated	O
histidine	O
-	O
tagged	O
S	O
glycoproteins	O
by	O
using	O
baculovirus	B-SPEC
expression	O
vectors	O
.	O

1a	O
,	O
which	O
encodes	O
RNA	O
capping	O
and	O
helicase	O
-	O
like	O
domains	O
,	O
localizes	O
to	O
endoplasmic	O
reticulum	O
membranes	O
,	O
recruits	O
BMV	B-SPEC
2a	O
polymerase	O
and	O
viral	O
RNA	O
templates	O
,	O
and	O
forms	O
membrane	O
-	O
bound	O
,	O
capsid	O
-	O
like	O
spherules	O
in	O
which	O
RNA	O
replication	O
occurs	O
.	O

ABSTRACT	O
:	O
CD8	O
+	O
T	O
cells	O
control	O
acute	O
infection	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
by	O
neurotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
but	O
do	O
not	O
suffice	O
to	O
achieve	O
sterile	O
immunity	O
.	O

To	O
determine	O
the	O
lag	O
between	O
T	O
-	O
cell	O
priming	O
and	O
optimal	O
activity	O
within	O
the	O
CNS	O
,	O
the	O
accumulation	O
of	O
virus	B-SPEC
-	O
specific	O
CD8	O
+	O
T	O
cells	O
in	O
the	O
CNS	O
relative	O
to	O
that	O
in	O
peripheral	O
lymphoid	O
organs	O
was	O
assessed	O
by	O
using	O
gamma	O
interferon	O
-	O
specific	O
ELISPOT	O
assays	O
and	O
class	B-SPEC
I	O
tetramer	O
staining	O
.	O

Virus	B-SPEC
-	O
specific	O
CD8	O
+	O
T	O
cells	O
were	O
first	O
detected	O
in	O
the	O
cervical	O
lymph	O
nodes	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
a	O
manifestation	O
of	O
acute	O
injury	O
to	O
the	O
lung	O
,	O
commonly	O
resulting	O
from	O
sepsis	B-SPEC
,	O
trauma	O
,	O
and	O
severe	O
pulmonary	O
infections	O
.	O

TITLE	O
:	O
Leptospiral	B-SPEC
nephropathy	O
.	O

In	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
a	O
selective	O
interaction	O
between	O
the	O
viral	O
transmembrane	O
envelope	O
protein	O
M	O
and	O
the	O
viral	O
ribonucleoprotein	O
complex	O
,	O
composed	O
of	O
N	O
protein	O
and	O
viral	O
RNA	O
containing	O
a	O
short	O
cis	B-SPEC
-	O
acting	O
RNA	O
element	O
,	O
the	O
packaging	O
signal	O
,	O
determines	O
the	O
selective	O
RNA	O
packaging	O
into	O
virus	B-SPEC
particles	O
.	O

TITLE	O
:	O
Treatment	O
with	O
bovine	B-SPEC
surfactant	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
children	O
:	O
a	O
randomized	O
multicenter	O
study	O
.	O

Administration	O
of	O
100	O
mg	O
/	O
kg	O
bovine	B-SPEC
surfactant	O
intratracheally	O
under	O
continuous	O
ventilation	O
and	O
PEEP	O
,	O
as	O
soon	O
as	O
the	O
PaO	O
(	O
2	O
)/	O
FIO	O
(	O
2	O
)	O
ratio	O
dropped	O
to	O
less	O
than	O
100	O
for	O
2	O
h	O
(	O
in	O
the	O
pilot	O
study	O
increments	O
of	O
50	O
mg	O
/	O
kg	O
as	O
long	O
as	O
the	O
PaO	O
(	O
2	O
)/	O
FIO	O
(	O
2	O
)	O
did	O
not	O
increase	O
by	O
20	O
%).	O

RESULTS	O
:	O
HHV8	B-SPEC
infection	O
was	O
not	O
significantly	O
higher	O
in	O
men	O
(	O
9	O
.	O
0	O
%,	O
95	O
%	O
CI	O
:	O
3	O
.	O
4	O
-	O
14	O
.	O
6	O
)	O
than	O
in	O
women	O
(	O
6	O
.	O
0	O
%,	O
95	O
%	O
CI	O
:	O
1	O
.	O
3	O
-	O
10	O
.	O
7	O
).	O

TITLE	O
:	O
Detection	O
and	O
estimation	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
antigen	O
by	O
a	O
novel	O
indirect	O
liquid	O
-	O
phase	O
blocking	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
using	O
chicken	B-SPEC
and	O
rabbit	B-SPEC
affinity	O
purified	O
immunoglobulins	O
.	O

ABSTRACT	O
:	O
An	O
indirect	O
liquid	O
-	O
phase	O
blocking	O
(	O
LPB	O
)	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
using	O
chicken	B-SPEC
and	O
rabbit	B-SPEC
affinity	O
purified	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
has	O
been	O
developed	O
to	O
detect	O
and	O
estimate	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
antigen	O
concentration	O
directly	O
in	O
infected	O
allantoic	O
fluid	O
.	O

The	O
immunoglobulins	O
are	O
chicken	B-SPEC
N	O
-	O
terminal	O
S2	O
peplomeric	O
protein	O
-	O
specific	O
IgG	O
isolated	O
by	O
immunoaffinity	O
chromatography	O
on	O
synthetic	O
peptide	O
coupled	O
to	O
CNBr	O
-	O
activated	O
Sepharose	O
4B	O
or	O
rabbit	B-SPEC
polyclonal	O
IgG	O
purified	O
from	O
the	O
serum	O
using	O
Protein	O
A	O
Sepharose	O
4B	O
.	O

The	O
relative	O
sensitivity	O
of	O
the	O
test	O
ranged	O
between	O
10	O
(	O
5	O
)	O
and	O
10	O
(	O
6	O
)	O
median	O
egg	O
infectious	O
doses	O
(	O
EID	O
(	O
50	O
))	O
for	O
chicken	B-SPEC
IgG	O
and	O
between	O
10	O
(	O
3	O
)	O
and	O
10	O
(	O
4	O
)	O
EID	O
(	O
50	O
)	O
for	O
rabbit	B-SPEC
IgG	O
,	O
depending	O
on	O
the	O
test	O
strain	O
.	O

We	O
have	O
reported	O
recently	O
that	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
from	O
strains	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
-	O
3	O
,	O
MHV	B-SPEC
-	O
A59	O
),	O
which	O
cause	O
massive	O
hepatocellular	O
necrosis	O
but	O
not	O
from	O
strains	O
(	O
MHV	B-SPEC
-	O
JHM	O
,	O
MHV	B-SPEC
-	O
2	O
)	O
which	O
do	O
not	O
produce	O
serious	O
liver	O
disease	O
,	O
induces	O
transcription	O
of	O
fgl2	O
.	O

ABSTRACT	O
:	O
Anemia	B-SPEC
is	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
patients	O
with	O
sickle	O
cell	O
anemia	B-SPEC
.	O

Young	O
children	O
between	O
the	O
ages	O
of	O
2	O
and	O
4	O
years	O
were	O
found	O
to	O
be	O
at	O
the	O
greatest	O
risk	O
of	O
developing	O
anemic	O
crises	O
(	O
severe	O
anemia	B-SPEC
).	O

ABSTRACT	O
:	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
(	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
)	O
pneumonia	O
is	O
a	O
common	O
disease	O
which	O
usually	O
shows	O
a	O
good	O
prognosis	O
,	O
however	O
,	O
it	O
can	O
develop	O
a	O
very	O
serious	O
state	O
such	O
as	O
respiratory	O
distress	O
syndrome	O
.	O

There	O
have	O
been	O
several	O
reports	O
that	O
hyperimmune	O
reaction	O
may	O
be	O
related	O
with	O
the	O
worse	O
course	O
of	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
pnuemonia	O
.	O

TITLE	O
:	O
Serum	O
levels	O
of	O
mannan	O
-	O
binding	O
lectin	O
in	O
chickens	B-SPEC
prior	O
to	O
and	O
during	O
experimental	O
infection	O
with	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Mannan	O
-	O
binding	O
lectin	O
(	O
MBL	O
)	O
is	O
a	O
glycoprotein	O
and	O
a	O
member	O
of	O
the	O
C	O
-	O
type	O
lectin	O
super	O
family	B-SPEC
,	O
the	O
collectin	O
family	B-SPEC
,	O
and	O
the	O
acute	O
phase	O
protein	O
family	B-SPEC
.	O

We	O
investigated	O
the	O
MBL	O
concentrations	O
in	O
serum	O
during	O
experimental	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infections	O
in	O
chickens	B-SPEC
.	O

The	O
acute	O
phase	O
response	O
in	O
chickens	B-SPEC
challenged	O
after	O
12	O
h	O
of	O
activity	O
peaked	O
after	O
4	O
.	O
6	O
d	O
with	O
an	O
increase	O
of	O
24	O
%,	O
whereas	O
the	O
acute	O
phase	O
response	O
in	O
chickens	B-SPEC
challenged	O
after	O
12	O
h	O
of	O
rest	O
peaked	O
after	O
3	O
.	O
1	O
d	O
with	O
an	O
increase	O
of	O
51	O
%.	O

ABSTRACT	O
:	O
CD8	O
(+)	O
T	O
cells	O
infiltrating	O
the	O
CNS	O
control	O
infection	O
by	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

Untreated	O
PKO	O
/	O
GKO	O
mice	B-SPEC
were	O
unable	O
to	O
control	O
the	O
infection	O
and	O
died	O
of	O
lethal	O
encephalomyelitis	O
within	O
16	O
days	O
,	O
despite	O
substantially	O
higher	O
CD8	O
(+)	O
T	O
cell	O
accumulation	O
in	O
the	O
CNS	O
compared	O
with	O
controls	O
.	O

CD8	O
(+)	O
T	O
cells	O
from	O
perforin	O
-	O
deficient	O
and	O
wild	O
-	O
type	O
donors	O
reduced	O
virus	B-SPEC
replication	O
in	O
PKO	O
/	O
GKO	O
recipients	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
evolution	O
of	O
severe	O
ventilator	O
-	O
induced	O
lung	O
injury	O
associated	O
with	O
lethal	O
systemic	O
capillary	O
leak	O
syndrome	O
,	O
when	O
sheep	B-SPEC
were	O
ventilated	O
at	O
a	O
peak	O
inspiratory	O
pressure	O
of	O
50	O
cm	O
H2O	O
,	O
at	O
a	O
respiratory	O
rate	O
of	O
8	O
breaths	O
.	O
min	O
,	O
with	O
an	O
inspiratory	O
time	O
of	O
2	O
.	O
5	O
secs	O
.	O
A	O
prospective	O
laboratory	O
animal	B-SPEC
study	O
.	O

This	O
sheep	B-SPEC
model	O
was	O
characterized	O
by	O
a	O
rapidly	O
evolving	O
massive	O
anasarca	O
,	O
hemoconcentration	O
,	O
cardiac	O
dysfunction	O
,	O
multiple	O
system	O
organ	O
failure	O
,	O
and	O
severe	O
ventilator	O
-	O
induced	O
lung	O
injury	O
.	O

Sheep	B-SPEC
in	O
both	O
groups	O
progressively	O
deteriorated	O
and	O
died	O
with	O
cardiocirculatory	O
failure	O
and	O
multiple	O
system	O
organ	O
failure	O
within	O
12	O
-	O
24	O
hrs	O
from	O
start	O
of	O
treatment	O
.	O

This	O
happened	O
at	O
a	O
younger	O
age	O
among	O
the	O
more	O
heavily	O
infected	O
sculpins	B-SPEC
at	O
Torbjrnskjaer	O
than	O
at	O
Vega	O
,	O
and	O
we	O
interpret	O
this	O
as	O
density	O
dependence	O
in	O
the	O
fish	B-SPEC
host	O
.	O

The	O
mortality	O
rates	O
were	O
influenced	O
primarily	O
by	O
the	O
chick	O
strain	O
,	O
but	O
also	O
by	O
age	O
and	O
dose	O
of	O
virus	B-SPEC
.	O

After	O
inoculation	O
with	O
a	O
low	O
dose	O
of	O
virus	B-SPEC
at	O
2	O
and	O
4	O
weeks	O
of	O
age	O
,	O
mortality	O
was	O
90	O
and	O
45	O
%,	O
respectively	O
.	O

In	O
addition	O
,	O
macrophage	O
accumulation	O
within	O
the	O
CNS	O
was	O
significantly	O
decreased	O
in	O
infected	O
CCL3	O
(-/-)	O
mice	B-SPEC
,	O
correlating	O
with	O
reduced	O
demyelination	O
.	O

To	O
further	O
investigate	O
the	O
role	O
of	O
memory	O
T	O
cells	O
in	O
protection	O
,	O
T	O
lymphocytes	O
collected	O
from	O
B19	O
/	O
B19	O
chicken	B-SPEC
spleens	O
at	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
weeks	O
p	O
.	O
i	O
.	O

During	O
48	O
hours	O
,	O
control	O
sheep	B-SPEC
developed	O
multiple	O
signs	O
of	O
ARDS	O
.	O

Despite	O
two	O
major	O
advances	O
in	O
treatment	O
,	O
low	O
VT	O
ventilation	O
for	O
ALI	O
/	O
ARDS	O
and	O
activated	O
protein	O
C	O
for	O
severe	O
sepsis	B-SPEC
(	O
the	O
leading	O
cause	O
of	O
ALI	O
/	O
ARDS	O
),	O
additional	O
research	O
is	O
needed	O
to	O
develop	O
specific	O
treatments	O
and	O
improve	O
understanding	O
of	O
the	O
pathogenesis	O
of	O
these	O
syndromes	O
.	O

In	O
this	O
two	O
-	O
step	O
process	O
,	O
we	O
first	O
constructed	O
by	O
targeted	O
recombination	O
a	O
mutant	O
of	O
FIPV	O
,	O
designated	O
mFIPV	O
,	O
in	O
which	O
the	O
ectodomain	O
of	O
the	O
spike	O
glycoprotein	O
was	O
replaced	O
by	O
that	O
of	O
MHV	B-SPEC
.	O

In	O
a	O
second	O
,	O
reverse	O
process	O
,	O
mFIPV	O
was	O
used	O
as	O
the	O
recipient	O
,	O
and	O
the	O
reintroduction	O
of	O
the	O
FIPV	O
spike	O
now	O
allowed	O
for	O
selection	O
of	O
candidate	O
recombinants	O
by	O
their	O
regained	O
ability	O
to	O
grow	O
in	O
feline	B-SPEC
cells	O
.	O

We	O
have	O
now	O
been	O
able	O
to	O
obtain	O
a	O
viable	O
MHV	B-SPEC
mutant	O
in	O
which	O
the	O
entire	O
E	O
gene	O
,	O
as	O
well	O
as	O
the	O
nonessential	O
upstream	O
genes	O
4	O
and	O
5a	O
,	O
has	O
been	O
deleted	O
.	O

ABSTRACT	O
:	O
A	O
multiplex	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
was	O
developed	O
to	O
amplify	O
the	O
S1	O
and	O
S2	O
genes	O
of	O
vaccine	O
and	O
recent	O
Taiwanese	O
isolates	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

This	O
suggested	O
that	O
there	O
were	O
multiple	O
groups	O
of	O
viruses	B-SPEC
cocirculating	O
in	O
Taiwan	O
.	O

The	O
role	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
or	O
both	O
requires	O
further	O
investigation	O
.	O

Fever	O
followed	O
by	O
rapidly	O
progressive	O
respiratory	O
compromise	O
is	O
the	O
key	O
complex	O
of	O
signs	O
and	O
symptoms	O
from	O
which	O
the	O
syndrome	O
derives	O
its	O
name	B-SPEC
.	O

Pigs	B-SPEC
inoculated	O
with	O
1894	O
developed	O
mild	O
respiratory	O
disease	O
and	O
pigs	B-SPEC
inoculated	O
with	O
AR310	O
and	O
LEPP	O
developed	O
moderate	O
respiratory	O
disease	O
from	O
four	O
to	O
10	O
days	O
after	O
they	O
were	O
inoculated	O
,	O
but	O
all	O
the	O
pigs	B-SPEC
recovered	O
fully	O
by	O
14	O
days	O
after	O
inoculation	O
.	O

Soluble	O
thrombomodulin	O
has	O
been	O
shown	O
to	O
improve	O
ALI	O
in	O
animals	B-SPEC
,	O
and	O
it	O
is	O
currently	O
being	O
evaluated	O
in	O
humans	B-SPEC
with	O
sepsis	B-SPEC
.	O

After	O
the	O
induction	O
of	O
acute	O
lung	O
injury	O
by	O
wood	O
smoke	O
inhalation	O
,	O
animals	B-SPEC
were	O
randomly	O
assigned	O
to	O
receive	O
either	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
or	O
PLV	O
with	O
or	O
without	O
ESS	O
pretreatment	O
.	O

After	O
many	O
disappointments	O
with	O
strategies	O
to	O
manipulate	O
the	O
inflammatory	O
response	O
,	O
modulation	O
of	O
coagulation	O
cascade	O
to	O
decrease	O
sepsis	B-SPEC
mortality	O
has	O
become	O
a	O
clinical	O
reality	O
.	O

The	O
biology	O
of	O
MHV	B-SPEC
-	O
2	O
is	O
quite	O
different	O
from	O
that	O
of	O
human	B-SPEC
hepatitis	O
viruses	B-SPEC
;	O
however	O
,	O
these	O
results	O
suggest	O
the	O
beneficial	O
combined	O
therapy	O
of	O
IFN	O
-	O
alpha	O
and	O
IFN	O
-	O
gamma	O
for	O
the	O
treatment	O
of	O
human	B-SPEC
viral	O
hepatitis	O
.	O

The	O
virus	B-SPEC
was	O
isolated	O
in	O
cell	O
culture	O
,	O
and	O
a	O
sequence	O
300	O
nucleotides	O
in	O
length	O
was	O
obtained	O
by	O
a	O
polymerase	O
-	O
chain	O
-	O
reaction	O
(	O
PCR	O
)-	O
based	O
random	O
-	O
amplification	O
procedure	O
.	O

This	O
virus	B-SPEC
may	O
never	O
before	O
have	O
circulated	O
in	O
the	O
U	O
.	O
S	O
.	O
population	O
.	O

TITLE	O
:	O
Association	O
of	O
enteric	O
shedding	O
of	O
bovine	B-SPEC
torovirus	I-SPEC
(	O
Breda	B-SPEC
virus	B-SPEC
)	O
and	O
other	O
enteropathogens	O
with	O
diarrhea	O
in	O
veal	O
calves	O
.	O

At	O
the	O
hospitals	O
where	O
the	O
first	O
cases	O
were	O
treated	O
the	O
disease	O
spread	O
quickly	O
among	O
healthcare	O
workers	O
,	O
and	O
then	O
out	O
into	O
the	O
community	O
as	O
family	B-SPEC
members	O
became	O
infected	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
contains	O
eight	O
overlapping	O
genes	O
that	O
are	O
expressed	O
from	O
a	O
3	O
'-	O
coterminal	O
nested	O
set	O
of	O
leader	O
-	O
containing	O
mRNAs	O
.	O

The	O
recombinant	O
TGEV	B-SPEC
(	O
rTGEV	O
)	O
replicated	O
in	O
cell	O
culture	O
with	O
similar	O
efficiency	O
to	O
the	O
wild	O
-	O
type	O
virus	B-SPEC
and	O
stably	O
maintained	O
the	O
modifications	O
introduced	O
into	O
the	O
genome	O
.	O

The	O
purified	O
recombinant	O
protein	O
was	O
then	O
evaluated	O
for	O
its	O
antigenicity	O
and	O
reliability	O
in	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
for	O
detection	O
of	O
CCoV	O
antibodies	O
in	O
dog	B-SPEC
sera	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
as	O
a	O
possible	O
cause	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

TITLE	O
:	O
Mechanical	O
transmission	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
by	O
domestic	O
houseflies	O
(	O
Musca	B-SPEC
domestica	I-SPEC
Linnaeaus	O
).	O

TCV	B-SPEC
was	O
not	O
detected	O
in	O
dissected	O
intestinal	O
tissues	O
collected	O
from	O
exposed	O
or	O
sham	O
-	O
exposed	O
flies	B-SPEC
at	O
any	O
time	O
postexposure	O
.	O

The	O
potential	O
of	O
the	O
housefly	O
to	O
directly	O
transmit	O
TCV	B-SPEC
to	O
live	O
turkey	B-SPEC
poults	O
was	O
examined	O
by	O
placing	O
7	O
-	O
day	O
-	O
old	O
turkey	B-SPEC
poults	O
in	O
contact	O
with	O
TCV	B-SPEC
-	O
exposed	O
houseflies	O
3	O
hr	O
after	O
flies	B-SPEC
consumed	O
TCV	B-SPEC
inoculum	O
.	O

Six	O
animals	B-SPEC
were	O
treated	O
2	O
hours	O
after	O
the	O
live	O
bacteria	B-SPEC
with	O
site	O
-	O
inactivated	O
Factor	O
VIIa	O
,	O
a	O
competitive	O
tissue	O
factor	O
inhibitor	O
,	O
and	O
six	O
animals	B-SPEC
were	O
vehicle	O
-	O
treated	O
sepsis	B-SPEC
control	O
subjects	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
the	O
impact	O
of	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
)	O
and	O
coronavirus	B-SPEC
infections	O
in	O
hematopoietic	O
stem	O
cell	O
transplant	O
(	O
HSCT	O
)	O
recipients	O
.	O

TITLE	O
:	O
The	O
Genome	O
sequence	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
sequenced	O
the	O
29	O
,	O
751	O
-	O
base	O
genome	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
known	O
as	O
the	O
Tor2	O
isolate	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
predicted	O
viral	O
proteins	O
indicates	O
that	O
the	O
virus	B-SPEC
does	O
not	O
closely	O
resemble	O
any	O
of	O
the	O
three	O
previously	O
known	O
groups	O
of	O
coronaviruses	O
.	O

This	O
report	O
updates	O
information	O
on	O
U	O
.	O
S	O
.	O
residents	O
with	O
SARS	O
and	O
summarizes	O
the	O
clinical	O
histories	O
of	O
the	O
five	O
U	O
.	O
S	O
.	O
residents	O
identified	O
as	O
of	O
April	O
9	O
,	O
2003	O
,	O
who	O
have	O
both	O
suspected	O
SARS	O
and	O
laboratory	O
evidence	O
of	O
infection	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
bovine	B-SPEC
torovirus	I-SPEC
(	O
BoTV	B-SPEC
)	O
in	O
bovine	B-SPEC
fecal	O
samples	O
from	O
diarrhea	O
cases	O
submitted	O
to	O
the	O
Ohio	O
Animal	B-SPEC
Disease	O
Diagnostic	O
Laboratory	O
(	O
ADDL	O
)	O
and	O
to	O
assess	O
if	O
a	O
relationship	O
exists	O
between	O
BoTV	B-SPEC
and	O
the	O
other	O
enteric	O
pathogens	O
detected	O
.	O

TITLE	O
:	O
Efficacy	O
of	O
an	O
inactivated	O
canine	O
coronavirus	B-SPEC
vaccine	O
in	O
pups	O
.	O

Two	O
dogs	B-SPEC
were	O
maintained	O
non	O
-	O
vaccinated	O
.	O

In	O
all	O
patients	O
admitted	O
for	O
eclampsia	O
between	O
January	O
1997	O
et	O
December	O
1999	O
,	O
the	O
following	O
parameters	O
were	O
studied	O
:	O
age	O
,	O
parity	O
,	O
interval	O
between	O
disease	O
et	O
admission	O
,	O
post	O
-	O
eclampsia	O
Glasgow	O
Coma	B-SPEC
Scale	O
(	O
GCS	O
),	O
time	O
of	O
occurrence	O
of	O
eclampsia	O
during	O
pregnancy	O
,	O
delivery	O
route	O
,	O
blood	O
pressure	O
data	O
at	O
admission	O
,	O
the	O
occurrence	O
of	O
complications	O
at	O
admission	O
or	O
during	O
hospital	O
stay	O
.	O

TITLE	O
:	O
[	O
Congenital	O
tracheal	O
stenosis	B-SPEC
due	O
to	O
complete	O
cartilage	O
rings	O
with	O
right	O
pulmonary	O
agenesis	O
].	O

Staff	O
were	O
adversely	O
affected	O
by	O
fear	O
of	O
contagion	O
and	O
of	O
infecting	O
family	B-SPEC
,	O
friends	O
and	O
colleagues	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
main	O
proteinase	O
(	O
3CLpro	O
)	O
structure	O
:	O
basis	O
for	O
design	O
of	O
anti	O
-	O
SARS	O
drugs	O
.	O

Secretion	O
of	O
a	O
coronavirus	B-SPEC
could	O
be	O
detected	O
in	O
respiratory	O
samples	O
during	O
the	O
febrile	O
phase	O
and	O
in	O
feces	O
for	O
a	O
longer	O
time	O
.	O

Replications	O
of	O
virus	B-SPEC
occurs	O
in	O
plasma	O
of	O
the	O
thymic	O
epithelial	O
reticular	O
cells	O
,	O
and	O
no	O
RCV	O
can	O
be	O
detected	O
in	O
the	O
thymocytes	O
.	O

The	O
RNAs	O
of	O
the	O
virus	B-SPEC
contained	O
in	O
the	O
sputum	O
samples	O
from	O
established	O
SARS	O
patients	O
were	O
extracted	O
and	O
reversely	O
transcripted	O
,	O
followed	O
by	O
nested	O
PCR	O
using	O
the	O
reversely	O
transcripted	O
cDNA	O
as	O
the	O
template	O
.	O

Sequence	O
analysis	O
has	O
confirmed	O
the	O
existence	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
in	O
the	O
sputum	O
samples	O
of	O
SARS	O
patients	O
,	O
and	O
nested	O
RT	O
-	O
PCR	O
is	O
a	O
quick	O
,	O
easy	O
,	O
and	O
convenient	O
way	O
for	O
the	O
detection	O
of	O
the	O
virus	B-SPEC
.	O

The	O
BNI109	O
fragment	O
showed	O
75	O
%	O
homology	O
with	O
BCV	B-SPEC
and	O
MHV	B-SPEC
at	O
amino	O
acid	O
level	O
.	O

CONCLUSIONS	O
:	O
The	O
polymerase	O
fragment	O
BNI109	O
of	O
SARS	O
coronavirus	B-SPEC
is	O
highly	O
conservative	O
and	O
is	O
suitable	O
for	O
detecting	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
using	O
RT	O
-	O
PCR	O
method	O
.	O

During	O
distal	O
anastomosis	O
,	O
the	O
catheter	O
occluded	O
the	O
aorta	O
with	O
continuous	O
perfusion	O
of	O
the	O
lower	O
half	O
of	O
the	O
body	O
through	O
an	O
arterial	O
cannula	B-SPEC
inserted	O
into	O
the	O
femoral	O
artery	O
.	O

ABSTRACT	O
:	O
CDC	O
'	O
s	O
interim	O
surveillance	O
case	O
definition	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
been	O
updated	O
to	O
include	O
laboratory	O
criteria	O
for	O
evidence	O
of	O
infection	O
with	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
(	O
Figure	O
,	O
Box	O
).	O

The	O
network	O
has	O
identified	O
a	O
new	O
coronavirus	B-SPEC
,	O
consistently	O
detected	O
in	O
samples	O
of	O
SARS	O
patients	O
from	O
several	O
countries	O
,	O
and	O
conclusively	O
named	O
it	O
as	O
the	O
causative	O
agent	O
of	O
SARS	O
;	O
the	O
strain	O
is	O
unlike	O
any	O
other	O
known	O
member	O
of	O
the	O
genus	B-SPEC
Coronavirus	B-SPEC
.	O

TITLE	O
:	O
Effects	O
of	O
albumin	O
and	O
Ringer	O
'	O
s	O
lactate	O
on	O
production	O
of	O
lung	O
cytokines	O
and	O
hydrogen	O
peroxide	O
after	O
resuscitated	O
hemorrhage	O
and	O
endotoxemia	O
in	O
rats	B-SPEC
.	O

A	O
virus	B-SPEC
from	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
has	O
been	O
identified	O
as	O
the	O
cause	O
,	O
but	O
the	O
pathogenesis	O
is	O
still	O
unclear	O
.	O

Evidence	O
of	O
infection	O
with	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
was	O
sought	O
by	O
reverse	O
-	O
transcriptase	O
PCR	O
and	O
serology	O
.	O

Whole	O
genome	O
sequence	O
analysis	O
of	O
various	O
isolates	O
might	O
provide	O
an	O
indication	O
of	O
potential	O
strain	O
differences	O
of	O
this	O
new	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
describe	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
occurring	O
after	O
chemotherapy	O
for	O
non	O
-	O
seminomatous	O
germ	O
-	O
cell	O
tumors	O
(	O
NSGCT	O
)	O
with	O
diffuse	O
lung	O
metastases	O
,	O
we	O
conducted	O
a	O
retrospective	O
study	O
in	O
a	O
15	O
-	O
bed	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
in	O
a	O
comprehensive	O
cancer	B-SPEC
center	O
.	O

TITLE	O
:	O
Detection	O
of	O
sendai	B-SPEC
virus	I-SPEC
and	O
pneumonia	B-SPEC
virus	I-SPEC
of	I-SPEC
mice	I-SPEC
by	O
use	O
of	O
fluorogenic	O
nuclease	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
analysis	O
.	O

Therefore	O
,	O
fnRT	O
-	O
PCR	O
assays	O
specific	O
for	O
Sendai	B-SPEC
virus	I-SPEC
and	O
PVM	B-SPEC
were	O
developed	O
by	O
targeting	O
primer	O
andprobe	O
sequences	O
to	O
unique	O
regions	O
of	O
the	O
Sendai	B-SPEC
virus	I-SPEC
nucleocapsid	O
(	O
NP	O
)	O
gene	O
and	O
the	O
PVM	B-SPEC
attachment	O
(	O
G	O
)	O
gene	O
,	O
respectively	O
.	O

These	O
relatively	O
healthy	O
carrier	O
animals	B-SPEC
were	O
a	O
source	O
of	O
virus	B-SPEC
for	O
contact	O
animals	B-SPEC
.	O

We	O
observed	O
that	O
the	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
)	O
markedly	O
enhances	O
the	O
expression	O
of	O
MHC	O
class	B-SPEC
II	O
DR	O
in	O
PMNs	O
.	O

The	O
putative	O
genomic	O
packaging	O
signal	O
of	O
SARS	O
-	O
CoV	O
locates	O
at	O
the	O
3	O
'	O
end	O
of	O
ORF1b	O
near	O
that	O
of	O
MHV	B-SPEC
and	O
BCoV	O
,	O
where	O
is	O
the	O
most	O
variable	O
region	O
of	O
this	O
gene	O
.	O

The	O
RNA	O
secondary	O
structure	O
of	O
SARS	O
-	O
CoV	O
genomic	O
packaging	O
signal	O
is	O
very	O
similar	O
to	O
that	O
of	O
MHV	B-SPEC
and	O
BCoV	O
.	O
The	O
same	O
result	O
was	O
also	O
obtained	O
in	O
studying	O
the	O
genomic	O
packaging	O
signals	O
of	O
PEDV	B-SPEC
and	O
HCoV	O
229E	O
.	O

RESULTS	O
:	O
The	O
putative	O
genomic	O
packaging	O
signal	O
of	O
SARS	O
-	O
CoV	O
locates	O
at	O
the	O
3	O
'	O
end	O
of	O
ORF1b	O
near	O
that	O
of	O
MHV	B-SPEC
and	O
BCoV	O
,	O
where	O
is	O
the	O
most	O
variable	O
region	O
of	O
this	O
gene	O
.	O

Sequence	O
alignment	O
indicated	O
that	O
the	O
SARS	O
-	O
CoV	O
3CL	O
proteinase	O
was	O
extremely	O
homologous	O
to	O
TGEV	B-SPEC
Mpro	O
,	O
especially	O
the	O
substrate	O
-	O
binding	O
pocket	O
(	O
active	O
site	O
).	O

The	O
tested	O
virtual	O
screening	O
indicated	O
that	O
73	O
available	O
proteinase	O
inhibitors	O
in	O
the	O
MDDR	O
database	O
might	O
dock	B-SPEC
into	O
both	O
the	O
binding	O
pockets	O
of	O
the	O
TGEV	B-SPEC
Mpro	O
and	O
the	O
SARS	O
-	O
CoV	O
3CL	O
proteinase	O
.	O

CONCLUSIONS	O
:	O
The	O
success	O
of	O
expressing	O
the	O
SARS	O
E	O
protein	O
is	O
a	O
good	O
starting	O
point	O
for	O
investigating	O
the	O
structure	O
and	O
functions	O
of	O
this	O
protein	O
and	O
SARS	O
coronavirus	B-SPEC
itself	O
as	O
well	O
.	O

Ten	O
healthy	O
subjects	O
were	O
studied	O
in	O
a	O
human	B-SPEC
centrifuge	O
while	O
exposed	O
to	O
1	O
and	O
5	O
times	O
normal	O
gravity	O
(	O
1	O
G	O
,	O
5	O
G	O
)	O
in	O
the	O
anterioposterior	O
(	O
supine	O
)	O
and	O
posterioanterior	O
(	O
prone	O
)	O
direction	O
.	O

ABSTRACT	O
:	O
After	O
infecting	O
the	O
Vero	O
E6	O
cells	O
by	O
nasal	O
/	O
throat	O
swabs	O
collected	O
from	O
SARS	O
patients	O
,	O
we	O
studied	O
the	O
SARS	O
-	O
associated	O
virus	B-SPEC
by	O
electron	O
microscopy	O
and	O
molecular	O
biological	O
technique	O
.	O

The	O
virus	B-SPEC
was	O
proved	O
to	O
be	O
a	O
new	O
coronavirus	B-SPEC
by	O
RT	O
-	O
PCR	O
and	O
it	O
responded	O
positively	O
to	O
convalescent	O
-	O
phase	O
serum	O
specimen	O
from	O
SARS	O
patients	O
,	O
which	O
is	O
the	O
evidence	O
that	O
this	O
new	O
virus	B-SPEC
is	O
etiologically	O
linked	O
to	O
the	O
outbreak	O
of	O
SARS	O
.	O

The	O
morphogenesis	O
and	O
distribution	O
of	O
the	O
virus	B-SPEC
are	O
also	O
discussed	O
in	O
this	O
article	O
.	O

ABSTRACT	O
:	O
The	O
3D	O
jury	O
system	O
has	O
predicted	O
the	O
methyltransferase	O
fold	O
for	O
the	O
nsp13	O
protein	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
disease	O
was	O
spread	O
over	O
more	O
than	O
30	O
states	O
all	O
over	O
the	O
globe	O
by	O
SARS	O
-	O
virus	B-SPEC
-	O
infected	O
travelers	O
.	O

The	O
virus	B-SPEC
has	O
spread	O
from	O
South	O
East	O
Asia	O
to	O
many	O
countries	O
of	O
the	O
world	O
.	O

The	O
culprit	O
organism	O
was	O
identified	O
as	O
a	O
new	O
coronavirus	B-SPEC
.	O

Essential	O
steps	O
to	O
prevent	O
further	O
dissemination	O
of	O
the	O
virus	B-SPEC
are	O
rapid	O
identification	O
,	O
and	O
treatment	O
in	O
an	O
isolation	O
unit	O
.	O

However	O
,	O
consumption	O
of	O
the	O
antioxidant	O
in	O
drinking	O
water	O
for	O
3	O
or	O
30	O
days	O
prior	O
to	O
CEES	O
exposure	O
significantly	O
inhibited	O
the	O
induction	O
of	O
TNF	O
-	O
alpha	O
,	O
activation	O
of	O
neutral	O
and	O
acid	O
sphingomyelinases	O
,	O
production	O
of	O
ceramides	O
,	O
activation	O
of	O
caspases	O
,	O
leakage	O
of	O
(	O
125	O
)	O
I	O
-	O
bovine	B-SPEC
serum	O
albumin	O
((	O
125	O
)	O
I	O
-	O
BSA	O
)	O
into	O
lung	O
tissue	O
,	O
and	O
histological	O
alterations	O
in	O
lung	O
.	O

Family	B-SPEC
and	O
hospital	O
aggregation	O
of	O
patients	O
comprised	O
the	O
another	O
two	O
important	O
characteristics	O
of	O
SARS	O
(	O
account	O
for	O
37	O
.	O
1	O
%	O
of	O
the	O
total	O
patients	O
).	O

Data	O
regarding	O
the	O
clustering	O
features	O
of	O
cases	O
showed	O
that	O
there	O
were	O
42	O
families	O
having	O
2	O
or	O
more	O
cases	O
in	O
one	O
family	B-SPEC
,	O
while	O
277	O
health	O
workers	O
suffered	O
from	O
SARS	O
were	O
concentrated	O
in	O
28	O
hospitals	O
.	O

Based	O
on	O
previous	O
reports	O
and	O
on	O
our	O
own	O
experience	O
in	O
HIV	B-SPEC
,	O
we	O
propose	O
here	O
pentoxifylline	O
(	O
PTX	O
),	O
a	O
drug	O
commonly	O
used	O
in	O
vascular	O
indications	O
,	O
as	O
a	O
possible	O
treatment	O
for	O
SARS	O
due	O
to	O
its	O
interesting	O
properties	O
.	O

Further	O
characterization	O
of	O
the	O
two	O
isolates	O
demonstrated	O
that	O
p36c12	O
showed	O
growth	O
advantage	O
over	O
p20c22	O
in	O
both	O
Vero	O
cells	O
and	O
chicken	B-SPEC
embryos	O
and	O
was	O
more	O
virulent	O
in	O
chicken	B-SPEC
embryos	O
than	O
p20c22	O
.	O

Helminths	O
isolated	O
in	O
37	O
%	O
of	O
the	O
villages	O
investigated	O
were	O
Heterakis	B-SPEC
,	O
Ascaridia	B-SPEC
and	O
Capillaria	B-SPEC
species	B-SPEC
.	O

The	O
red	O
fowl	O
mite	O
(	O
Dermanyssus	B-SPEC
gallinae	I-SPEC
)	O
was	O
isolated	O
from	O
some	O
of	O
the	O
birds	B-SPEC
and	O
their	O
nests	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
relationship	O
between	O
corticosteroid	O
therapy	O
and	O
kinetic	O
changes	O
in	O
chest	O
X	O
-	O
ray	B-SPEC
in	O
five	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
recently	O
recognized	O
as	O
a	O
new	O
human	B-SPEC
infectious	O
disease	O
.	O

We	O
postulate	O
that	O
hematopoietic	O
growth	O
factors	O
such	O
as	O
G	O
-	O
CSF	O
,	O
by	O
mobilizing	O
endogenous	O
blood	O
stem	O
cells	O
and	O
endogenous	O
cytokines	O
,	O
could	O
become	O
a	O
hematological	O
treatment	O
for	O
SARS	O
patients	O
,	O
which	O
may	O
enhance	O
the	O
immune	O
system	O
against	O
these	O
virus	B-SPEC
.	O

Out	O
of	O
the	O
44	O
social	O
acquaintances	O
and	O
38	O
of	O
the	O
family	B-SPEC
members	O
who	O
had	O
contacts	O
with	O
the	O
index	O
patients	O
during	O
the	O
incubation	O
period	O
,	O
no	O
one	O
was	O
found	O
ill	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
the	O
epidemiological	O
characteristics	O
and	O
related	O
factors	O
of	O
SARS	O
in	O
Shanxi	O
in	O
order	B-SPEC
to	O
provide	O
scientific	O
basis	O
for	O
prevention	O
and	O
control	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Case	O
identification	O
at	O
early	O
stage	O
as	O
well	O
as	O
taking	O
measures	O
to	O
decrease	O
the	O
chance	O
of	O
transmission	O
were	O
strategically	O
crucial	O
for	O
controlling	O
the	O
spread	O
of	O
SARS	O
virus	B-SPEC
in	O
the	O
community	O
.	O

The	O
main	O
symptoms	O
and	O
signs	O
of	O
the	O
SARS	O
patients	O
would	O
include	O
fever	O
,	O
cough	O
and	O
chest	O
X	O
-	O
ray	B-SPEC
changes	O
.	O

The	O
etiology	O
of	O
SARS	O
is	O
likely	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
To	O
assess	O
serum	O
antibody	O
responses	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
to	O
nucleocapsid	O
(	O
N	O
)	O
antigen	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
rapid	O
and	O
efficient	O
method	O
for	O
preparing	O
monoclonal	O
antibodies	O
(	O
mAb	O
)	O
against	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
Cov	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

The	O
exposure	O
to	O
respiratory	O
droplets	O
and	O
the	O
contact	O
with	O
biologic	O
fluids	O
(	O
respiratory	O
and	O
gastrointestinal	O
secretions	O
)	O
represent	O
the	O
most	O
efficient	O
transmission	O
modality	O
of	O
the	O
SARS	O
-	O
related	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
report	O
updates	O
reported	O
cases	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
worldwide	O
and	O
in	O
the	O
United	O
States	O
,	O
describes	O
a	O
change	O
in	O
the	O
recommended	O
timing	O
of	O
collection	O
of	O
a	O
convalescent	O
-	O
phase	O
serum	O
specimen	O
to	O
test	O
for	O
antibody	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
introduces	O
a	O
new	O
case	O
exclusion	O
criterion	O
based	O
on	O
negative	O
SARS	O
-	O
CoV	O
serology	O
.	O

The	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
alignment	O
between	O
this	O
coronavirus	B-SPEC
and	O
others	O
was	O
not	O
more	O
than	O
40	O
%	O
and	O
70	O
%	O
to	O
82	O
%,	O
respectively	O
,	O
while	O
the	O
nucleotide	O
sequence	O
cloned	O
from	O
the	O
6	O
patients	O
were	O
identical	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
a	O
porcine	B-SPEC
coronavirus	B-SPEC
that	O
causes	O
diarrhea	O
,	O
leading	O
to	O
near	O
100	O
%	O
mortality	O
in	O
neonatal	O
piglets	O
with	O
corresponding	O
devastating	O
economic	O
consequences	O
.	O

The	O
macrophage	O
-	O
inducible	O
Salmonella	B-SPEC
ssaH	O
and	O
spiC	O
/	O
ssaB	O
promoters	O
were	O
compared	O
for	O
their	O
ability	O
to	O
express	O
the	O
TGEV	B-SPEC
C	O
and	O
A	O
epitopes	O
in	O
the	O
context	O
of	O
the	O
heterologous	O
987P	O
fimbriae	O
on	O
Salmonella	B-SPEC
vaccines	O
.	O

TITLE	O
:	O
The	O
complete	O
genome	O
sequence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
strain	O
HKU	O
-	O
39849	O
(	O
HK	O
-	O
39	O
).	O

SimPlot	O
analysis	O
supports	O
this	O
finding	O
,	O
and	O
also	O
suggests	O
that	O
this	O
novel	O
virus	B-SPEC
is	O
not	O
a	O
product	O
of	O
a	O
recent	O
recombinant	O
from	O
any	O
of	O
the	O
known	O
characterized	O
CoVs	O
.	O

Together	O
,	O
these	O
results	O
confirm	O
that	O
HK	O
-	O
39	O
is	O
a	O
novel	O
and	O
distinct	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
,	O
with	O
unknown	O
origin	O
.	O

RESULTS	O
:	O
(	O
1	O
)	O
SARS	O
appears	O
to	O
have	O
high	O
infectivity	O
;	O
(	O
2	O
)	O
the	O
most	O
common	O
symptom	O
is	O
fever	O
;	O
(	O
3	O
)	O
the	O
count	O
of	O
leukocyte	O
is	O
normal	O
or	O
decreased	O
;	O
(	O
4	O
)	O
most	O
patients	O
(	O
35	O
/	O
45	O
,	O
77	O
.	O
8	O
%)	O
had	O
experienced	O
a	O
24	O
-	O
hour	O
fever	O
prior	O
to	O
the	O
abnormal	O
chest	O
X	O
-	O
ray	B-SPEC
changes	O
which	O
showed	O
progression	O
of	O
pulmonary	O
infiltrates	O
within	O
48	O
hours	O
in	O
71	O
.	O
1	O
%	O
(	O
32	O
/	O
45	O
)	O
of	O
the	O
patients	O
and	O
,	O
(	O
5	O
)	O
the	O
percentage	O
of	O
patients	O
who	O
developed	O
severe	O
pneumonia	O
(	O
24	O
.	O
4	O
%)	O
is	O
higher	O
than	O
those	O
who	O
developed	O
typical	O
pneumonia	O
.	O

Among	O
the	O
patients	O
who	O
survived	O
over	O
20	O
years	O
,	O
37	O
patients	O
had	O
the	O
cardiac	O
functional	O
status	O
returned	O
to	O
Class	B-SPEC
II	O
,	O
13	O
Class	B-SPEC
III	O
,	O
and	O
Class	B-SPEC
IV	O
.	O

The	O
earliest	O
symptom	O
of	O
all	O
3	O
cases	O
was	O
hyperpyrexia	O
and	O
followed	O
by	O
progressive	O
dyspnea	O
and	O
appearance	O
of	O
lung	O
field	O
shadows	O
in	O
X	O
rays	B-SPEC
findings	O
.	O

Under	O
the	O
electronic	O
microscopy	O
observation	O
,	O
virus	B-SPEC
-	O
like	O
particles	O
with	O
80	O
-	O
160	O
nm	O
diameter	O
and	O
halo	O
or	O
garland	O
envelope	O
were	O
found	O
in	O
mononuclear	O
macrophage	O
and	O
cytoplasm	O
of	O
alveolar	O
epithelium	O
.	O

According	O
to	O
the	O
virus	B-SPEC
-	O
like	O
particles	O
found	O
in	O
lung	O
of	O
the	O
SARS	O
case	O
,	O
it	O
is	O
considered	O
that	O
these	O
virus	B-SPEC
-	O
like	O
particles	O
may	O
be	O
a	O
new	O
kind	O
of	O
coronavirus	B-SPEC
which	O
caused	O
the	O
""""	O
atypical	O
pneumonia	O
"""."	O

Under	O
the	O
electronic	O
microscopy	O
observation	O
,	O
virus	B-SPEC
-	O
like	O
particles	O
with	O
80	O
-	O
160	O
nm	O
diameter	O
and	O
halo	O
or	O
garland	O
envelope	O
were	O
found	O
in	O
mononuclear	O
macrophage	O
and	O
cytoplasm	O
of	O
alveolar	O
epithelium	O
.	O

In	O
retinal	O
degeneration	O
-	O
resistant	O
CD	O
-	O
1	O
mice	B-SPEC
,	O
only	O
the	O
acute	O
infection	O
is	O
seen	O
.	O

The	O
180	O
-	O
kDa	O
oligomeric	O
S	O
protein	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
is	O
posttranslationally	O
cleaved	O
into	O
an	O
S1	O
receptor	O
binding	O
unit	O
and	O
an	O
S2	O
membrane	O
fusion	O
unit	O
.	O

Peptides	O
HR1	O
(	O
96	O
aa	O
)	O
and	O
HR2	O
(	O
39	O
aa	O
),	O
corresponding	O
to	O
the	O
HR1	O
and	O
HR2	O
regions	O
,	O
were	O
produced	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

Potato	B-SPEC
plants	B-SPEC
were	O
genetically	O
transformed	O
with	O
a	O
cDNA	O
construct	O
encoding	O
the	O
IBV	B-SPEC
S1	O
glycoprotein	O
with	O
the	O
Agrobacterium	B-SPEC
system	O
.	O

ABSTRACT	O
:	O
In	O
a	O
previous	O
study	O
,	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCV	B-SPEC
)	O
and	O
enteropathogenic	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
EPEC	O
)	O
were	O
shown	O
to	O
synergistically	O
interact	O
in	O
young	O
turkeys	B-SPEC
coinfected	O
with	O
these	O
agents	O
.	O

Only	O
mild	O
growth	O
depression	O
was	O
observed	O
in	O
turkeys	B-SPEC
inoculated	O
with	O
only	O
TCV	B-SPEC
;	O
however	O
,	O
turkeys	B-SPEC
inoculated	O
with	O
both	O
TCV	B-SPEC
and	O
10	O
(	O
4	O
)	O
CFU	O
EPEC	O
(	O
low	O
dose	O
exposure	O
)	O
developed	O
severe	O
disease	O
characterized	O
by	O
high	O
mortality	O
,	O
marked	O
growth	O
depression	O
,	O
and	O
AE	O
lesions	O
.	O

Coinfection	O
of	O
turkeys	B-SPEC
with	O
TCV	B-SPEC
and	O
EPEC	O
resulted	O
in	O
significantly	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
shedding	O
of	O
EPEC	O
,	O
but	O
not	O
TCV	B-SPEC
,	O
in	O
intestinal	O
contents	O
of	O
turkeys	B-SPEC
.	O

Both	O
Chlamydia	B-SPEC
-	O
like	O
and	O
coronavirus	B-SPEC
-	O
like	O
particles	O
were	O
found	O
in	O
EM	O
.	O

Since	O
the	O
novel	O
Chlamydia	B-SPEC
-	O
like	O
agent	O
was	O
found	O
co	O
-	O
existing	O
with	O
a	O
coronavirus	B-SPEC
-	O
like	O
agent	O
in	O
the	O
dead	O
cases	O
of	O
SARS	O
,	O
it	O
looks	O
most	O
likely	O
that	O
both	O
the	O
agents	O
play	O
some	O
roles	O
in	O
the	O
disease	O
.	O

RESULTS	O
:	O
Both	O
Chlamydia	B-SPEC
-	O
like	O
and	O
coronavirus	B-SPEC
-	O
like	O
particles	O
were	O
found	O
in	O
EM	O
.	O

Since	O
the	O
Chlamydia	B-SPEC
-	O
like	O
agents	O
visualized	O
in	O
both	O
organs	O
and	O
cell	O
cultures	O
could	O
not	O
react	O
with	O
the	O
genus	B-SPEC
specific	O
antibodies	O
against	O
Chlamydia	B-SPEC
and	O
monoclonal	O
antibodies	O
against	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
and	O
C	B-SPEC
.	I-SPEC
psittaci	I-SPEC
,	O
the	O
results	O
might	O
well	O
be	O
suggestive	O
of	O
a	O
novel	O
Chlamydia	B-SPEC
-	O
like	O
agent	O
.	O

This	O
raises	O
safety	O
concerns	O
about	O
the	O
SARS	O
virus	B-SPEC
being	O
carried	O
by	O
droplets	O
that	O
exit	O
from	O
the	O
exhalation	O
limb	O
of	O
the	O
ventilator	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
chest	O
X	O
-	O
ray	B-SPEC
manifestations	O
of	O
SARS	O
cases	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
scanning	O
was	O
performed	O
at	O
a	O
interval	O
of	O
1	O
-	O
3	O
days	O
according	O
to	O
the	O
requirements	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
a	O
fluorescent	O
polymerase	O
chain	O
reaction	O
(	O
F	O
-	O
PCR	O
)	O
method	O
for	O
detecting	O
the	O
coronavirus	B-SPEC
related	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
to	O
evaluate	O
its	O
value	O
for	O
clinical	O
application	O
.	O

The	O
primers	O
and	O
the	O
fluorescence	O
-	O
labeled	O
probe	O
were	O
designed	O
and	O
synthesized	O
according	O
to	O
the	O
published	O
sequence	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
genes	O
.	O

TITLE	O
:	O
Binding	O
mechanism	O
of	O
coronavirus	B-SPEC
main	O
proteinase	O
with	O
ligands	O
and	O
its	O
implication	O
to	O
drug	O
design	O
against	O
SARS	O
.	O

SARS	O
-	O
CoV	O
infection	O
was	O
diagnosed	O
in	O
329	O
(	O
75	O
%)	O
of	O
436	O
patients	O
fitting	O
the	O
case	O
definition	O
of	O
SARS	O
;	O
human	B-SPEC
metapneumovirus	I-SPEC
was	O
diagnosed	O
in	O
41	O
(	O
12	O
%)	O
of	O
335	O
,	O
and	O
other	O
respiratory	O
pathogens	O
were	O
diagnosed	O
only	O
sporadically	O
.	O

A	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
is	O
not	O
related	O
to	O
the	O
hitherto	O
known	O
coronaviruses	O
,	O
has	O
been	O
proven	O
to	O
be	O
associated	O
with	O
the	O
disease	O
.	O

RESULTS	O
:	O
Eight	O
patients	O
came	O
from	O
a	O
family	B-SPEC
,	O
and	O
15	O
patients	O
were	O
medical	O
staff	O
.	O

TITLE	O
:	O
[	O
Expression	O
and	O
purification	O
of	O
recombinant	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
].	O

Partial	O
spike	O
gene	O
fragments	O
(	O
751	O
-	O
1925	O
bp	O
,	O
2005	O
-	O
3410	O
bp	O
,	O
1	O
-	O
1925	O
bp	O
and	O
32	O
-	O
3659	O
bp	O
)	O
and	O
its	O
intact	O
gene	O
were	O
cloned	O
into	O
pET32	O
or	O
pGEX	O
vectors	O
,	O
and	O
transformed	O
into	O
competent	O
Escherichia	B-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
)	O
(	O
pLysS	O
),	O
respectively	O
.	O

The	O
sensitivity	O
,	O
specificity	O
,	O
positive	O
predictive	O
value	O
(	O
ppv	B-SPEC
),	O
negative	O
predictive	O
value	O
(	O
NPV	O
),	O
and	O
accuracy	O
were	O
used	O
to	O
evaluate	O
the	O
significance	O
of	O
the	O
antibodies	O
in	O
diagnosis	O
of	O
SARS	O
.	O

The	O
data	O
of	O
clinical	O
presentation	O
and	O
disease	O
progression	O
of	O
all	O
the	O
patients	O
including	O
index	O
subject	O
as	O
the	O
infectious	O
SARS	O
resource	O
patient	O
,	O
her	O
family	B-SPEC
infected	O
members	O
and	O
21	O
health	O
care	O
workers	O
were	O
abstracted	O
.	O

Micro	O
-	O
thrombus	B-SPEC
were	O
easily	O
found	O
in	O
these	O
lungs	O
.	O

Since	O
November	O
2002	O
the	O
virus	B-SPEC
has	O
spread	O
from	O
South	O
China	O
to	O
almost	O
30	O
other	O
countries	O
,	O
where	O
about	O
8500	O
infected	O
individuals	O
have	O
been	O
registered	O
;	O
about	O
800	O
people	O
have	O
already	O
died	O
from	O
the	O
disease	O
(	O
9	O
.	O
5	O
%).	O

The	O
characteristics	O
of	O
gender	O
,	O
age	O
,	O
occupation	O
,	O
contagious	O
history	O
and	O
previous	O
therapy	O
were	O
described	O
in	O
SARS	O
inpatients	O
when	O
they	O
visited	O
the	O
outpatient	O
department	O
for	O
SARS	O
in	O
the	O
first	O
time	O
;	O
the	O
clinical	O
symptoms	O
,	O
physical	O
signs	O
,	O
blood	O
WBC	O
counts	O
and	O
X	O
-	O
ray	B-SPEC
in	O
lungs	O
were	O
also	O
analyzed	O
.	O

The	O
clinical	O
symptoms	O
in	O
case	O
1	O
,	O
cases	O
2	O
,	O
case	O
4	O
and	O
case	O
5	O
weren	O
'	O
t	O
deteriorated	O
after	O
discontinuation	O
of	O
methylprednisolone	O
while	O
the	O
presentation	O
in	O
chest	O
X	O
ray	B-SPEC
was	O
progressed	O
3	O
-	O
6	O
days	O
later	O
.	O

The	O
temperature	O
in	O
case	O
3	O
was	O
elevated	O
again	O
and	O
the	O
shadow	O
in	O
chest	O
X	O
ray	B-SPEC
was	O
progressed	O
after	O
discontinuation	O
of	O
methylprednisolone	O
due	O
to	O
the	O
low	O
dosage	O
of	O
glucocorticosteroids	O
.	O

The	O
improvement	O
of	O
acute	O
stage	O
lesion	O
in	O
17	O
cases	O
is	O
related	O
to	O
the	O
usage	O
and	O
increased	O
dosage	O
of	O
corticosteroid	O
,	O
some	O
cases	O
showed	O
non	O
-	O
parallel	O
with	O
symptom	O
and	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

A	O
3D	O
structure	O
model	O
has	O
been	O
built	O
for	O
SARS	O
coronavirus	B-SPEC
3CL	O
proteinase	O
by	O
comparative	O
protein	O
modeling	O
.	O

Group	O
B	O
was	O
defined	O
as	O
the	O
stage	O
in	O
which	O
the	O
application	O
of	O
common	O
measures	O
of	O
the	O
prevention	O
and	O
protection	O
were	O
made	O
,	O
but	O
the	O
isolation	O
measure	O
was	O
not	O
taken	O
(	O
the	O
suspected	O
or	O
diagnosed	O
cases	O
had	O
the	O
chest	O
X	O
ray	B-SPEC
film	O
examination	O
in	O
the	O
department	O
of	O
radiology	O
).	O

In	O
addition	O
,	O
administration	O
of	O
limitin	O
to	O
mice	B-SPEC
suppressed	O
MHV	B-SPEC
-	O
induced	O
hepatitis	O
and	O
HSV	B-SPEC
-	O
induced	O
death	O
.	O

ABSTRACT	O
:	O
The	O
putative	O
NTPase	O
/	O
helicase	O
protein	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
postulated	O
to	O
play	O
a	O
number	O
of	O
crucial	O
roles	O
in	O
the	O
viral	O
life	O
cycle	O
,	O
making	O
it	O
an	O
attractive	O
target	O
for	O
anti	O
-	O
SARS	O
therapy	O
.	O

TITLE	O
:	O
Mechanisms	O
and	O
enzymes	O
involved	O
in	O
SARS	O
coronavirus	B-SPEC
genome	O
expression	O
.	O

Activities	O
of	O
three	O
SARS	O
coronavirus	B-SPEC
enzymes	O
,	O
the	O
helicase	O
and	O
two	O
cysteine	O
proteinases	O
,	O
which	O
are	O
known	O
to	O
be	O
critically	O
involved	O
in	O
replication	O
,	O
transcription	O
and	O
/	O
or	O
post	O
-	O
translational	O
polyprotein	O
processing	O
,	O
were	O
characterized	O
.	O

The	O
universality	O
of	O
this	O
primer	O
set	O
was	O
confirmed	O
by	O
testing	O
the	O
reference	O
strains	O
of	O
different	O
serotypes	O
or	O
variants	O
of	O
the	O
IBV	B-SPEC
present	O
in	O
the	O
United	O
States	O
.	O

Thus	O
,	O
both	O
recombinant	O
viruses	B-SPEC
were	O
highly	O
attenuated	O
and	O
expressed	O
viral	O
antigen	O
which	O
was	O
restricted	O
to	O
the	O
olfactory	O
bulbs	O
and	O
was	O
markedly	O
absent	O
from	O
other	O
regions	O
of	O
the	O
brains	O
at	O
5	O
days	O
postinfection	O
.	O

T	O
cells	O
participate	O
in	O
both	O
defense	O
and	O
disease	O
progression	O
following	O
MHV	B-SPEC
infection	O
.	O

Expression	O
of	O
chemokine	O
receptors	O
on	O
activated	O
T	O
cells	O
is	O
important	O
in	O
allowing	O
these	O
cells	O
to	O
traffic	O
into	O
and	O
accumulate	O
within	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

The	O
present	O
study	O
evaluated	O
the	O
contributions	O
of	O
CCR5	O
to	O
the	O
activation	O
and	O
trafficking	O
of	O
virus	B-SPEC
-	O
specific	O
CD8	O
(+)	O
T	O
cells	O
into	O
the	O
MHV	B-SPEC
-	O
infected	O
CNS	O
mice	B-SPEC
.	O

Comparable	O
numbers	O
of	O
virus	B-SPEC
-	O
specific	O
CD8	O
(+)	O
T	O
cells	O
derived	O
from	O
immunized	O
CCR5	O
(+/+)	O
or	O
CCR5	O
(-/-)	O
mice	B-SPEC
were	O
present	O
within	O
the	O
CNS	O
of	O
MHV	B-SPEC
-	O
infected	O
RAG1	O
(-/-)	O
mice	B-SPEC
following	O
adoptive	O
transfer	O
,	O
indicating	O
that	O
CCR5	O
is	O
not	O
required	O
for	O
trafficking	O
of	O
these	O
cells	O
into	O
the	O
CNS	O
.	O

This	O
study	O
was	O
designed	O
to	O
clarify	O
the	O
role	O
of	O
iNOS	O
in	O
mediating	O
extrapulmonary	O
comorbidity	O
in	O
sheep	B-SPEC
after	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
injuries	O
using	O
a	O
potent	O
and	O
highly	O
selective	O
iNOS	O
dimerization	O
inhibitor	O
,	O
BBS	O
-	O
2	O
.	O

3	O
.	O
1	O
)%	O
with	O
supplementary	O
oxygen	O
through	O
a	O
nasal	O
cannula	B-SPEC
.	O

A	O
phylogenetic	O
analysis	O
of	O
the	O
replicase	O
gene	O
,	O
using	O
a	O
distantly	O
related	O
torovirus	B-SPEC
as	O
an	O
outgroup	O
,	O
demonstrated	O
that	O
,	O
despite	O
a	O
number	O
of	O
unique	O
features	O
,	O
SARS	O
-	O
CoV	O
is	O
most	O
closely	O
related	O
to	O
group	O
2	O
coronaviruses	O
.	O

Intravenous	O
quinine	B-SPEC
and	O
quinidine	O
are	O
the	O
most	O
widely	O
used	O
drugs	O
in	O
the	O
initial	O
treatment	O
of	O
severe	O
falciparum	O
malaria	O
,	O
whereas	O
artemisinin	O
derivatives	O
are	O
currently	O
recommended	O
for	O
quinine	B-SPEC
-	O
resistant	O
cases	O
.	O

As	O
soon	O
as	O
the	O
patient	O
is	O
clinically	O
stable	O
and	O
able	O
to	O
swallow	B-SPEC
,	O
oral	O
treatment	O
should	O
be	O
given	O
.	O

Of	O
all	O
cases	O
,	O
health	O
care	O
workers	O
and	O
community	O
family	B-SPEC
cluster	O
cases	O
accounted	O
for	O
19	O
.	O
38	O
%	O
and	O
12	O
.	O
04	O
%.	O

Several	O
observations	O
support	O
the	O
hypothesis	O
of	O
an	O
animal	B-SPEC
origin	O
for	O
the	O
disease	O
.	O

One	O
patient	O
showed	O
no	O
clinical	O
symptoms	O
,	O
and	O
bilateral	O
infiltrates	O
was	O
found	O
in	O
his	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

The	O
microbial	O
findings	O
has	O
been	O
:	O
pathogenics	O
bacteria	B-SPEC
(	O
31	O
.	O
7	O
%),	O
fungus	B-SPEC
(	O
17	O
%),	O
parasites	O
(	O
1	O
.	O
2	O
%),	O
rotavirus	B-SPEC
(	O
16	O
.	O
4	O
%),	O
calicivirus	O
(	O
1	O
.	O
6	O
%),	O
adenovirus	B-SPEC
and	O
coronavirus	B-SPEC
(	O
1	O
.	O
6	O
%).	O

We	O
have	O
also	O
presented	O
information	O
on	O
porcine	B-SPEC
parvovirus	I-SPEC
,	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
,	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
,	O
herpesviruses	B-SPEC
(	O
pseudorabies	B-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
lymphotropic	O
herpesvirus	B-SPEC
,	O
porcine	B-SPEC
cytomegalovirus	I-SPEC
),	O
coronaviruses	O
(	O
TGEV	B-SPEC
,	O
PRCV	O
,	O
HEV	B-SPEC
,	O
PEDV	B-SPEC
)	O
and	O
adenovirus	B-SPEC
.	O

Thus	O
,	O
priming	O
piglets	O
with	O
PRCV	O
was	O
beneficial	O
in	O
providing	O
resistance	O
to	O
TGEV	B-SPEC
and	O
could	O
be	O
incorporated	O
into	O
a	O
vaccine	O
strategy	O
that	O
yields	O
better	O
protection	O
against	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
discovered	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
can	O
readily	O
spread	O
in	O
the	O
healthcare	O
setting	O
.	O

ABSTRACT	O
:	O
In	O
March	O
2003	O
,	O
SARS	O
-	O
CoV	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
which	O
has	O
been	O
proved	O
to	O
be	O
a	O
pathogen	O
causing	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
).	O

It	O
may	O
not	O
be	O
a	O
variant	O
of	O
other	O
coronaviruses	O
but	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
existed	O
independently	O
in	O
nature	O
and	O
was	O
not	O
recognized	O
by	O
human	B-SPEC
being	O
before	O
,	O
although	O
SARS	O
-	O
CoV	O
is	O
morphologically	O
similar	O
to	O
other	O
coronavirus	B-SPEC
and	O
belongs	O
to	O
coronavirus	B-SPEC
family	B-SPEC
.	O

We	O
initiated	O
MARS	O
therapy	O
(	O
extracorporeal	O
liver	O
support	O
utilizing	O
albumin	O
dialysis	B-SPEC
)	O
with	O
intention	O
to	O
positively	O
influence	O
the	O
organ	O
functions	O
in	O
his	O
MODS	O
on	O
the	O
basis	O
of	O
recently	O
published	O
studies	O
which	O
suggested	O
a	O
positive	O
impact	O
of	O
MARS	O
in	O
multiorgan	O
failure	O
secondary	O
to	O
respiratory	O
illnesses	O
and	O
the	O
possible	O
influence	O
on	O
inflammatory	O
mediators	O
and	O
cytokines	O
.	O

Immunohistochemical	O
examination	O
demonstrated	O
a	O
marked	O
increase	O
in	O
immunoreactivity	O
for	O
intracellular	O
adhesion	O
molecule	O
-	O
1	O
(	O
ICAM	O
-	O
1	O
),	O
P	O
-	O
selectin	O
and	O
E	O
-	O
selectin	O
in	O
the	O
pancreas	O
and	O
lung	O
of	O
cerulein	O
-	O
treated	O
mice	B-SPEC
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
some	O
immunological	O
patterns	O
involved	O
in	O
natural	O
and	O
acquired	O
resistance	O
against	O
MHV3	O
using	O
the	O
original	O
model	O
of	O
genetically	O
modified	O
lines	O
of	O
mice	B-SPEC
selected	O
for	O
high	O
(	O
HIII	O
)	O
and	O
low	O
(	O
LIII	O
)	O
antibody	O
responsiveness	O
.	O

As	O
previously	O
shown	O
,	O
a	O
lower	O
pre	O
-	O
existing	O
anti	O
-	O
MHV	B-SPEC
antibody	O
level	O
was	O
found	O
in	O
susceptible	O
HIII	O
mice	B-SPEC
as	O
compared	O
to	O
resistant	O
LIII	O
mice	B-SPEC
.	O

Mortality	O
rates	O
of	O
the	O
F1	O
(	O
H	O
x	O
L	O
)	O
hybrids	O
and	O
F2	O
and	O
backcross	O
segregants	O
reflected	O
co	O
-	O
dominance	O
of	O
both	O
characters	O
and	O
the	O
survivors	O
had	O
higher	O
preexisting	O
anti	O
-	O
MHV	B-SPEC
antibody	O
titers	O
.	O

The	O
present	O
data	O
show	O
that	O
both	O
lines	O
had	O
the	O
potential	O
to	O
synthesize	O
antibodies	O
and	O
that	O
the	O
resistance	O
acquired	O
by	O
the	O
susceptible	O
HIII	O
mice	B-SPEC
paralleled	O
the	O
antibody	O
synthesis	O
.	O

Evidence	O
of	O
virus	B-SPEC
infection	O
was	O
also	O
detected	O
in	O
other	O
animals	B-SPEC
(	O
including	O
a	O
raccoon	B-SPEC
dog	I-SPEC
,	O
Nyctereutes	B-SPEC
procyonoides	I-SPEC
)	O
and	O
in	O
humans	B-SPEC
working	O
at	O
the	O
same	O
market	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
role	O
of	O
HO	O
-	O
1	O
induction	O
in	O
a	O
rat	B-SPEC
model	O
of	O
CCl	O
(	O
4	O
)-	O
induced	O
acute	O
liver	O
injury	O
.	O

We	O
explore	O
the	O
situation	O
where	O
these	O
epidemics	O
may	O
be	O
caused	O
either	O
by	O
a	O
virus	B-SPEC
and	O
one	O
or	O
several	O
mutants	O
that	O
changed	O
its	O
tropism	O
,	O
or	O
by	O
two	O
unrelated	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHM	O
,	O
causes	O
acute	O
and	O
chronic	O
neurological	O
diseases	O
in	O
rodents	B-SPEC
.	O

These	O
proteins	O
displayed	O
MHV	B-SPEC
RNA	O
-	O
binding	O
affinity	O
and	O
specificity	O
similar	O
to	O
those	O
of	O
hnRNP	O
A1	O
.	O

We	O
systematically	O
searched	O
MEDLINE	O
and	O
CINAHL	O
(	O
cumulative	O
index	O
to	O
nursing	O
and	O
allied	O
health	O
),	O
EMBASE	O
,	O
and	O
the	O
Cochrane	O
Library	O
for	O
randomized	O
controlled	O
trials	O
and	O
meta	B-SPEC
-	O
analyses	O
of	O
randomized	O
controlled	O
trials	O
that	O
evaluated	O
any	O
form	O
of	O
nutrition	O
support	O
in	O
critically	O
ill	O
adults	O
.	O

Secondary	O
bacteria	B-SPEC
infection	O
is	O
one	O
of	O
important	O
reason	O
of	O
death	O
.	O

The	O
sensitive	O
rate	O
of	O
fluconazole	O
to	O
fungi	B-SPEC
was	O
92	O
.	O
4	O
percent	O
.	O

Invasive	O
ventilation	O
was	O
used	O
in	O
10	O
cases	O
and	O
death	O
rate	O
was	O
80	O
.	O
0	O
percent	O
,	O
among	O
them	O
5	O
patients	O
were	O
infected	O
with	O
bacteria	B-SPEC
.	O

If	O
the	O
three	O
factors	O
were	O
excluded	O
,	O
sepsis	B-SPEC
,	O
central	O
nerves	O
system	O
dysfunction	O
,	O
oliguria	O
became	O
the	O
risk	O
factors	O
of	O
mortality	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
first	O
imported	O
SARS	O
case	O
introduced	O
to	O
Beijing	O
had	O
infected	O
9	O
people	O
within	O
the	O
family	B-SPEC
and	O
at	O
the	O
hospital	O
,	O
with	O
two	O
of	O
whom	O
died	O
of	O
the	O
same	O
disease	O
.	O

In	O
addition	O
,	O
a	O
complete	O
screening	O
of	O
cytotoxicity	O
,	O
antiretroviral	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
antimicrobial	O
activity	O
has	O
been	O
carried	O
out	O
.	O

Cats	B-SPEC
that	O
were	O
transiently	O
infected	O
and	O
ceased	O
shedding	O
could	O
be	O
re	O
-	O
infected	O
with	O
either	O
the	O
same	O
,	O
or	O
a	O
different	O
,	O
strain	O
.	O

However	O
,	O
one	O
strain	O
was	O
unusual	O
in	O
that	O
it	O
infected	O
the	O
majority	O
of	O
cats	B-SPEC
in	O
the	O
household	O
simultaneously	O
and	O
was	O
still	O
being	O
shed	O
18	O
months	O
later	O
.	O

Based	O
on	O
the	O
correlation	O
of	O
the	O
overall	O
tetra	B-SPEC
-	O
nucleotide	O
usage	O
patterns	O
,	O
the	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
(	O
TGV	O
)	O
and	O
the	O
Feline	B-SPEC
CoronaVirus	B-SPEC
(	O
FCoV	O
)	O
are	O
closest	O
to	O
SARS	O
-	O
CoV	O
.	O
Surprisingly	O
also	O
,	O
the	O
RNA	O
viruses	B-SPEC
that	O
do	O
not	O
go	O
through	O
a	O
DNA	O
stage	O
displayed	O
a	O
remarkable	O
discrimination	O
against	O
the	O
CpG	O
and	O
UpA	O
di	O
-	O
nucleotide	O
(	O
z	O
=	O
-	O
77	O
.	O
31	O
,	O
-	O
52	O
.	O
48	O
respectively	O
)	O
and	O
selection	O
for	O
UpG	O
and	O
CpA	O
(	O
z	O
=	O
65	O
.	O
79	O
,	O
49	O
.	O
99	O
respectively	O
).	O

The	O
study	O
of	O
genomic	O
word	O
usage	O
is	O
a	O
powerful	O
method	O
to	O
classify	O
RNA	O
viruses	B-SPEC
.	O

TITLE	O
:	O
How	O
the	O
SARS	O
vaccine	O
effort	O
can	O
learn	O
from	O
HIV	B-SPEC
-	O
speeding	O
towards	O
the	O
future	O
,	O
learning	O
from	O
the	O
past	O
.	O

ABSTRACT	O
:	O
The	O
health	O
status	O
of	O
ring	B-SPEC
-	I-SPEC
necked	I-SPEC
pheasants	I-SPEC
in	O
view	O
of	O
the	O
prevalence	O
of	O
infectious	O
diseases	O
was	O
estimated	O
in	O
Polish	O
pheasantries	O
in	O
the	O
years	O
1997	O
-	O
2000	O
.	O

Anatomicopathological	O
,	O
microbiological	O
and	O
serological	O
examinations	O
were	O
carried	O
out	O
on	O
birds	B-SPEC
derived	O
from	O
26	O
pheasantries	O
,	O
including	O
birds	B-SPEC
randomly	O
selected	O
from	O
18	O
flocks	O
and	O
sick	O
or	O
dead	O
birds	B-SPEC
sent	O
from	O
8	O
pheasantries	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
artificial	O
genetic	O
information	O
systems	O
(	O
AEGIS	O
)	O
that	O
we	O
have	O
developed	O
have	O
been	O
used	O
in	O
FDA	O
-	O
approved	O
commercial	O
tests	O
for	O
managing	O
HIV	B-SPEC
and	O
hepatitis	B-SPEC
C	I-SPEC
infections	O
in	O
individual	O
patients	O
,	O
and	O
in	O
a	O
tool	O
that	O
seeks	O
the	O
virus	B-SPEC
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

TITLE	O
:	O
Molecular	O
modelling	O
of	O
S1	O
and	O
S2	O
subunits	O
of	O
SARS	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
.	O

Epidemiologic	O
findings	O
,	O
integral	O
to	O
defining	O
an	O
animal	B-SPEC
-	O
human	B-SPEC
linkage	O
,	O
may	O
be	O
confirmed	O
by	O
laboratory	O
studies	O
;	O
once	O
animal	B-SPEC
host	O
(	O
s	O
)	O
are	O
confirmed	O
,	O
interventions	O
may	O
be	O
needed	O
to	O
prevent	O
further	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

ABSTRACT	O
:	O
We	O
used	O
a	O
combination	O
approach	O
of	O
conventional	O
virus	B-SPEC
isolation	O
and	O
molecular	O
techniques	O
to	O
detect	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
HMPV	B-SPEC
)	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Using	O
this	O
combination	O
approach	O
,	O
we	O
found	O
that	O
human	B-SPEC
laryngeal	O
carcinoma	O
(	O
HEp	O
-	O
2	O
)	O
cells	O
were	O
superior	O
to	O
rhesus	B-SPEC
monkey	I-SPEC
kidney	O
(	O
LLC	O
-	O
MK2	O
)	O
cells	O
commonly	O
used	O
in	O
previous	O
studies	O
for	O
isolation	O
of	O
HMPV	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
coronavirus	B-SPEC
has	O
become	O
an	O
epidemic	O
affecting	O
many	O
regions	O
worldwide	O
.	O

ABSTRACT	O
:	O
Bicyclic	O
furano	O
pyrimidines	O
have	O
been	O
previously	O
reported	O
by	O
us	O
to	O
be	O
highly	O
potent	O
and	O
selective	O
inhibitors	O
of	O
varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
(	O
VZV	B-SPEC
).	O

p	O
-	O
Alkyl	O
phenyl	O
analogues	O
are	O
particularly	O
potent	O
with	O
EC50	O
values	O
below	O
1	O
nM	O
.	O
In	O
this	O
article	O
we	O
report	O
the	O
synthesis	O
and	O
anti	O
-	O
VZV	B-SPEC
activity	O
of	O
a	O
series	O
of	O
halophenyl	O
analogues	O
,	O
with	O
variation	O
in	O
the	O
nature	O
(	O
F	O
,	O
Cl	O
,	O
Br	O
)	O
and	O
location	O
(	O
o	O
,	O
m	O
,	O
p	O
)	O
of	O
the	O
halogen	O
substituent	O
.	O

The	O
p	O
-	O
fluorophenyl	O
compound	O
is	O
unique	O
amongst	O
compounds	O
of	O
this	O
class	B-SPEC
in	O
being	O
inactive	O
as	O
an	O
antiviral	O
.	O

Here	O
,	O
we	O
assess	O
phylogenetic	O
relationships	O
for	O
the	O
SARS	O
-	O
CoV	O
lineage	O
as	O
well	O
as	O
the	O
history	O
of	O
host	O
-	O
species	B-SPEC
shifts	O
for	O
SARS	O
-	O
CoV	O
and	O
other	O
coronaviruses	O
.	O

Mean	O
colibacillosis	O
lesion	O
scores	O
of	O
H52	O
-	O
infected	O
birds	B-SPEC
even	O
significantly	O
exceeded	O
those	O
of	O
birds	B-SPEC
infected	O
with	O
the	O
other	O
IB	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
nucleoprotein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
the	O
detection	O
of	O
antibodies	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Our	O
data	O
indicated	O
that	O
N	O
protein	O
purified	O
from	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
was	O
more	O
sensitive	O
to	O
anti	O
-	O
IBV	B-SPEC
serum	O
than	O
the	O
protein	O
from	O
Sf9	O
cells	O
.	O

In	O
addition	O
,	O
the	O
data	O
from	O
the	O
detection	O
of	O
field	O
samples	O
and	O
IBV	B-SPEC
strains	O
indicated	O
that	O
using	O
the	O
recombinant	O
protein	O
as	O
coating	O
antigen	O
could	O
achieve	O
an	O
equivalent	O
performance	O
to	O
an	O
ELISA	O
kit	O
based	O
on	O
infected	O
material	O
extracts	O
as	O
a	O
source	O
of	O
antigen	O
(	O
s	O
).	O

A	O
systematic	O
search	O
for	O
perinatal	O
transmission	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
,	O
including	O
serial	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
assays	O
,	O
viral	O
cultures	O
,	O
and	O
paired	O
serologic	O
titers	O
,	O
failed	O
to	O
detect	O
the	O
virus	B-SPEC
in	O
any	O
of	O
the	O
infants	O
.	O

Attention	O
should	O
be	O
paid	O
to	O
whether	O
these	O
genotype	O
and	O
mutation	O
patterns	O
are	O
related	O
to	O
the	O
virus	B-SPEC
'	O
s	O
biological	O
activities	O
,	O
epidemic	O
characteristics	O
and	O
host	O
clinical	O
symptoms	O
.	O

Regarding	O
possible	O
biological	O
activities	O
,	O
it	O
was	O
demonstrated	O
that	O
BN	O
acts	O
as	O
zinc	O
(	O
Zn2	O
+)	O
chelator	B-SPEC
.	O

Ninety	O
male	O
Wistar	B-SPEC
rats	I-SPEC
.	O

ABSTRACT	O
:	O
Pulmonary	O
gene	O
therapy	O
offers	O
the	O
hope	O
of	O
treatment	O
for	O
conditions	O
such	O
as	O
cystic	O
fibrosis	O
,	O
lung	O
cancer	B-SPEC
,	O
pulmonary	O
fibrosis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
for	O
which	O
current	O
therapy	O
is	O
inadequate	O
.	O

ABSTRACT	O
:	O
To	O
proceed	O
the	O
retrospective	O
analysis	O
of	O
the	O
dead	O
reasons	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
in	O
order	B-SPEC
to	O
provide	O
experience	O
for	O
decreasing	O
mortality	O
of	O
SARS	O
patients	O
in	O
clinic	O
.	O

TITLE	O
:	O
Binding	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
to	O
brush	O
border	O
membrane	O
sialoglycoproteins	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
a	O
porcine	B-SPEC
pathogen	O
causing	O
enteric	O
infections	O
that	O
are	O
lethal	O
for	O
suckling	O
piglets	O
.	O

Virus	B-SPEC
binding	O
assays	O
with	O
cryosections	O
of	O
the	O
small	O
intestine	O
from	O
a	O
suckling	O
piglet	O
revealed	O
the	O
binding	O
of	O
TGEV	B-SPEC
to	O
mucin	O
-	O
producing	O
goblet	O
cells	O
.	O

TITLE	O
:	O
[	O
Detection	O
and	O
analysis	O
of	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
antibodies	O
in	O
sera	O
from	O
non	O
-	O
SARS	O
children	O
].	O

TITLE	O
:	O
Prevalence	O
of	O
IgG	O
antibody	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
in	O
animal	B-SPEC
traders	O
--	O
Guangdong	O
Province	O
,	O
China	O
,	O
2003	O
.	O

Because	O
its	O
sequence	O
data	O
differ	O
from	O
that	O
of	O
known	O
human	B-SPEC
coronaviruses	O
,	O
SARS	O
-	O
CoV	O
is	O
suspected	O
to	O
have	O
crossed	O
the	O
species	B-SPEC
barrier	O
between	O
an	O
animal	B-SPEC
host	O
and	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
a	O
highly	O
contagious	O
and	O
economically	O
significant	O
disease	O
in	O
chickens	B-SPEC
.	O

In	O
the	O
first	O
of	O
two	O
experiments	O
,	O
intranasal	O
exposure	O
of	O
6	O
-	O
wk	O
-	O
old	O
antibody	O
-	O
free	O
chickens	B-SPEC
to	O
IBV	B-SPEC
vaccine	O
virus	B-SPEC
resulted	O
in	O
intermittent	O
shedding	O
of	O
the	O
virus	B-SPEC
from	O
both	O
trachea	B-SPEC
and	O
cloaca	B-SPEC
of	O
individual	O
birds	B-SPEC
for	O
up	O
to	O
63	O
days	O
.	O

When	O
the	O
lung	O
and	O
kidney	O
isolates	O
of	O
IBV	B-SPEC
from	O
the	O
latter	O
experiment	O
were	O
compared	O
with	O
the	O
parent	O
-	O
vaccine	O
virus	B-SPEC
,	O
no	O
changes	O
in	O
their	O
antigenicity	O
,	O
tissue	O
tropism	O
,	O
or	O
the	O
nucleotide	O
sequence	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
were	O
observed	O
.	O

Because	O
of	O
the	O
widespread	O
nature	O
of	O
the	O
GA98	O
virus	B-SPEC
in	O
the	O
southeastern	O
United	O
States	O
and	O
the	O
lack	O
of	O
adequate	O
protection	O
with	O
the	O
DE072	O
vaccine	O
,	O
we	O
developed	O
a	O
specific	O
vaccine	O
for	O
the	O
GA98	O
serotype	O
.	O

The	O
primers	O
were	O
specific	O
and	O
did	O
not	O
amplify	O
New	O
Castle	O
disease	O
virus	B-SPEC
,	O
Mycoplasma	B-SPEC
spp	O
.,	O
or	O
infectious	B-SPEC
laryngotracheitis	I-SPEC
virus	I-SPEC
.	O

When	O
the	O
Beaudette	O
strain	O
was	O
examined	O
,	O
two	O
melting	O
peaks	O
were	O
observed	O
at	O
44	O
C	O
and	O
51	O
C	O
,	O
indicating	O
a	O
quasispecies	O
in	O
that	O
laboratory	O
strain	O
of	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
While	O
the	O
risks	O
of	O
transfusion	O
-	O
transmitted	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
and	O
human	B-SPEC
T	O
-	O
cell	O
leukemia	O
virus	B-SPEC
I	O
/	O
II	O
continue	O
to	O
decrease	O
,	O
additional	O
threats	O
to	O
transfusion	O
safety	O
are	O
posed	O
by	O
emerging	O
""""	O
new	O
""""	O
infectious	O
diseases	O
.	O

The	O
isolated	O
infective	O
agent	O
,	O
identified	O
as	O
coronavirus	B-SPEC
strain	O
CoD	O
,	O
was	O
partly	O
characterized	O
and	O
deposited	O
to	O
the	O
virus	B-SPEC
collection	O
of	O
the	O
Center	O
of	O
Special	O
Laboratory	O
Diagnostics	O
and	O
Treatment	O
of	O
Quarantine	O
and	O
Exotic	O
Infectious	O
Diseases	O
.	O

Recombinant	O
viruses	B-SPEC
replicated	O
as	O
efficiently	O
as	O
WT	O
virus	B-SPEC
and	O
both	O
were	O
inhibited	O
by	O
treatment	O
with	O
the	O
cysteine	O
proteinase	O
inhibitor	O
(	O
2S	O
,	O
3S	O
)-	O
transepoxysuccinyl	O
-	O
L	O
-	O
leucylamido	O
-	O
3	O
-	O
methylbutane	O
ethyl	O
ester	O
.	O

The	O
purpose	O
of	O
this	O
article	O
is	O
to	O
describe	O
the	O
clinical	O
features	O
,	O
treatment	O
,	O
nursing	O
care	O
and	O
perceptions	O
of	O
the	O
illness	O
experience	O
of	O
patients	O
with	O
SARS	O
in	O
Hong	O
Kong	O
in	O
order	B-SPEC
to	O
better	O
inform	O
nurses	O
caring	O
for	O
patients	O
with	O
this	O
highly	O
contagious	O
and	O
potentially	O
lethal	O
disease	O
.	O

Recently	O
,	O
we	O
reported	O
several	O
rare	O
cases	O
that	O
indicate	O
that	O
ARDS	O
in	O
patients	O
with	O
Japanese	O
B	O
encephalitis	O
,	O
lymphangitis	O
with	O
breast	O
cancer	B-SPEC
and	O
fat	O
embolism	O
is	O
caused	O
by	O
different	O
mechanisms	O
.	O

ABSTRACT	O
:	O
The	O
Coronaviridae	B-SPEC
family	B-SPEC
,	O
comprising	O
the	O
Coronavirus	B-SPEC
and	O
Torovirus	B-SPEC
genera	O
,	O
is	O
part	O
of	O
the	O
Nidovirales	B-SPEC
order	B-SPEC
that	O
also	O
includes	O
two	O
other	O
families	O
,	O
Arteriviridae	B-SPEC
and	O
Roniviridae	B-SPEC
.	O

Apoptotic	O
oligodendrocytes	O
have	O
been	O
detected	O
in	O
the	O
vicinity	O
of	O
the	O
CNS	O
demyelinating	O
lesions	O
in	O
these	O
animals	B-SPEC
.	O

This	O
finding	O
provides	O
an	O
explanation	O
for	O
the	O
destruction	O
of	O
oligodendrocytes	O
and	O
the	O
damage	O
of	O
myelin	O
sheath	O
in	O
MHV	B-SPEC
-	O
infected	O
CNS	O
and	O
suggests	O
that	O
oligodendrocyte	O
apoptosis	O
may	O
be	O
one	O
of	O
the	O
underlying	O
mechanisms	O
for	O
the	O
pathogenesis	O
of	O
MHV	B-SPEC
-	O
induced	O
demyelinating	O
diseases	O
in	O
animals	B-SPEC
.	O

Of	O
these	O
4	O
dialysis	B-SPEC
patients	O
,	O
1	O
patient	O
was	O
receiving	O
hemodialysis	O
while	O
the	O
other	O
3	O
patients	O
were	O
on	O
continuous	O
ambulatory	O
peritoneal	O
dialysis	B-SPEC
.	O

TITLE	O
:	O
Beri	B-SPEC
-	O
beri	B-SPEC
:	O
the	O
major	O
cause	O
of	O
infant	O
mortality	O
in	O
Karen	O
refugees	O
.	O

Mortality	O
resulting	O
from	O
acute	O
respiratory	O
infections	O
did	O
not	O
change	O
(	O
15	O
and	O
11	O
per	O
1000	O
,	O
respectively	O
),	O
whereas	O
mortality	O
attributable	O
to	O
beri	B-SPEC
-	O
beri	B-SPEC
decreased	O
from	O
73	O
to	O
5	O
per	O
1000	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

Its	O
best	O
-	O
studied	O
effects	O
are	O
those	O
against	O
HIV	B-SPEC
replication	O
,	O
which	O
are	O
being	O
tested	O
in	O
clinical	O
trials	O
.	O

ABSTRACT	O
:	O
Cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
are	O
usually	O
lymphopenic	O
and	O
have	O
lymphoid	O
depletion	O
evident	O
in	O
spleen	O
and	O
lymph	O
nodes	O
.	O

ABSTRACT	O
:	O
Involvement	O
of	O
viruses	B-SPEC
in	O
human	B-SPEC
neurodegenerative	O
diseases	O
and	O
the	O
underlying	O
pathologic	O
mechanisms	O
remain	O
generally	O
unclear	O
.	O

Human	B-SPEC
respiratory	O
coronaviruses	O
(	O
HCoV	O
)	O
can	O
infect	O
neural	O
cells	O
,	O
persist	O
in	O
human	B-SPEC
brain	O
,	O
and	O
activate	O
myelin	O
-	O
reactive	O
T	O
cells	O
.	O

The	O
3	O
'	O
UTRs	O
of	O
BCoV	O
and	O
MHV	B-SPEC
have	O
been	O
previously	O
shown	O
to	O
be	O
interchangeable	O
.	O

Interestingly	O
,	O
infection	O
with	O
live	O
and	O
ultraviolet	O
light	O
-	O
inactivated	O
viruses	B-SPEC
equally	O
repressed	O
BNip3	O
expression	O
,	O
indicating	O
that	O
the	O
down	O
-	O
regulation	O
of	O
BNip3	O
expression	O
does	O
not	O
require	O
virus	B-SPEC
replication	O
and	O
is	O
mediated	O
during	O
cell	O
entry	O
.	O

Deletion	O
analysis	O
showed	O
that	O
the	O
sequence	O
between	O
nucleotides	O
262	O
and	O
550	O
of	O
the	O
588	O
-	O
base	O
-	O
pair	O
BNip3	O
promoter	O
is	O
necessary	O
and	O
sufficient	O
for	O
driving	O
the	O
BNip3	O
expression	O
and	O
that	O
it	O
contains	O
signals	O
that	O
are	O
responsible	O
for	O
MHV	B-SPEC
-	O
induced	O
down	O
-	O
regulation	O
of	O
BNip3	O
expression	O
in	O
DBT	O
cells	O
.	O

A	O
MEDLINE	O
search	O
was	O
performed	O
using	O
the	O
following	O
terms	O
:	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
SARS	O
virus	B-SPEC
.	O

Inflammatory	O
chemokines	O
play	O
both	O
beneficial	O
and	O
harmful	O
roles	O
in	O
infectious	O
diseases	O
caused	O
by	O
viruses	B-SPEC
.	O

Blocking	O
them	O
or	O
using	O
them	O
as	O
immunomodulators	O
,	O
depending	O
on	O
the	O
virus	B-SPEC
,	O
may	O
be	O
rational	O
approaches	O
to	O
treatment	O
or	O
prevention	O
of	O
disease	O
.	O

ABSTRACT	O
:	O
To	O
check	O
the	O
feasibility	O
of	O
expression	O
of	O
the	O
immunogenic	O
gene	O
of	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
plants	B-SPEC
,	O
the	O
transformation	O
of	O
S1	O
gene	O
of	O
IBV	B-SPEC
into	O
potato	B-SPEC
and	O
the	O
immunogenicity	O
of	O
its	O
expression	O
product	O
was	O
studied	O
.	O

The	O
S1	O
gene	O
of	O
IBV	B-SPEC
-	O
ZJ971	O
strain	O
was	O
inserted	O
into	O
plasmid	O
pBI121	O
under	O
the	O
control	O
of	O
35	O
S	O
promoter	O
.	O

TITLE	O
:	O
Changes	O
in	O
some	O
acute	O
phase	O
protein	O
and	O
immunoglobulin	O
concentrations	O
in	O
cats	B-SPEC
affected	O
by	O
feline	B-SPEC
infectious	O
peritonitis	O
or	O
exposed	O
to	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

Repeated	O
samplings	O
from	O
both	O
FIP	O
affected	O
and	O
FCoV	O
-	O
exposed	O
cats	B-SPEC
showed	O
that	O
when	O
FIP	O
appeared	O
in	O
the	O
group	O
,	O
all	O
the	O
cats	B-SPEC
had	O
increased	O
APP	O
levels	O
.	O

These	O
results	O
suggest	O
that	O
changes	O
in	O
the	O
electrophoretic	O
motility	O
of	O
APPs	O
or	O
APPs	O
other	O
than	O
Hp	O
,	O
SAA	O
and	O
AGP	O
might	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
FIP	O
or	O
in	O
protecting	O
cats	B-SPEC
from	O
the	O
disease	O
.	O

This	O
study	O
characterizes	O
inflammation	O
and	O
changes	O
in	O
cytokines	O
in	O
the	O
brain	O
tissue	O
of	O
FIP	O
-	O
affected	O
cats	B-SPEC
.	O

IL	O
-	O
1	O
beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
12	O
,	O
IL	O
-	O
18	O
,	O
TNF	O
-	O
alpha	O
,	O
macrophage	O
inhibitory	O
protein	O
(	O
MIP	O
)-	O
1	O
alpha	O
,	O
and	O
RANTES	O
showed	O
no	O
upregulation	O
in	O
the	O
brains	O
of	O
control	O
cats	B-SPEC
,	O
moderate	O
upregulation	O
in	O
neurological	O
FIP	O
cats	B-SPEC
,	O
and	O
very	O
high	O
upregulation	O
in	O
generalized	O
FIP	O
cats	B-SPEC
.	O

The	O
complete	O
genome	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
since	O
been	O
sequenced	O
.	O

We	O
describe	O
herein	O
a	O
DNA	O
microarray	O
-	O
based	O
platform	O
for	O
novel	O
virus	B-SPEC
identification	O
and	O
characterization	O
.	O

Central	O
to	O
this	O
approach	O
was	O
a	O
DNA	O
microarray	O
designed	O
to	O
detect	O
a	O
wide	O
range	O
of	O
known	O
viruses	B-SPEC
as	O
well	O
as	O
novel	O
members	O
of	O
existing	O
viral	O
families	O
;	O
this	O
microarray	O
contained	O
the	O
most	O
highly	O
conserved	O
70mer	O
sequences	O
from	O
every	O
fully	O
sequenced	O
reference	O
viral	O
genome	O
in	O
GenBank	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
caused	O
a	O
severe	O
outbreak	O
in	O
several	O
regions	O
of	O
the	O
world	O
in	O
2003	O
.	O

The	O
comparative	O
studies	O
of	O
other	O
coronaviruses	O
offer	O
insights	O
into	O
the	O
understanding	O
of	O
SARS	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
causal	O
agent	O
for	O
SARS	O
is	O
considered	O
as	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
has	O
never	O
been	O
described	O
both	O
in	O
human	B-SPEC
and	O
animals	B-SPEC
previously	O
.	O

A	O
total	O
of	O
10	O
(	O
6	O
)	O
TCID50	O
viruses	B-SPEC
were	O
placed	O
in	O
each	O
tested	O
condition	O
,	O
and	O
changes	O
of	O
the	O
viral	O
infectivity	O
in	O
samples	O
after	O
treatments	O
were	O
measured	O
by	O
evaluating	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
in	O
cell	O
line	O
Vero	O
-	O
E6	O
at	O
48	O
h	O
after	O
infection	O
.	O

RESULTS	O
:	O
The	O
results	O
showed	O
that	O
SARS	O
coronavirus	B-SPEC
in	O
the	O
testing	O
condition	O
could	O
survive	O
in	O
serum	O
,	O
1	O
:	O
20	O
diluted	O
sputum	O
and	O
feces	O
for	O
at	O
least	O
96	O
h	O
,	O
whereas	O
it	O
could	O
remain	O
alive	O
in	O
urine	O
for	O
at	O
least	O
72	O
h	O
with	O
a	O
low	O
level	O
of	O
infectivity	O
.	O

ABSTRACT	O
:	O
The	O
zoonotic	O
introduction	O
of	O
an	O
animal	B-SPEC
pathogen	O
into	O
the	O
human	B-SPEC
population	O
and	O
the	O
subsequent	O
extension	O
or	O
alteration	O
of	O
its	O
host	O
range	O
leading	O
to	O
the	O
successful	O
maintenance	O
of	O
the	O
corresponding	O
pathogen	O
by	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
pose	O
a	O
serious	O
risk	O
for	O
world	O
-	O
wide	O
health	O
care	O
.	O

In	O
this	O
review	O
,	O
the	O
potential	O
of	O
the	O
zoonotic	O
transmission	O
of	O
bovine	B-SPEC
,	O
feline	B-SPEC
and	O
equine	B-SPEC
foamy	O
retroviruses	B-SPEC
will	O
be	O
discussed	O
in	O
the	O
light	O
of	O
well	O
-	O
documented	O
cases	O
of	O
zoonotic	O
transmissions	O
of	O
different	O
simian	O
foamy	B-SPEC
viruses	I-SPEC
to	O
humans	B-SPEC
.	O

Close	O
contact	O
with	O
SARS	O
patients	O
can	O
cause	O
the	O
serum	O
anti	O
-	O
coronavirus	B-SPEC
antibody	O
titer	O
to	O
increase	O
significantly	O
in	O
medical	O
personnel	O
,	O
a	O
phenomenon	O
deserves	O
further	O
study	O
.	O

Peripheral	O
blood	O
from	O
162	O
cases	O
of	O
SARS	O
,	O
30	O
cases	O
of	O
mycoplasma	B-SPEC
pneumonia	O
and	O
30	O
healthy	O
adult	O
volunteers	O
were	O
measured	O
for	O
the	O
number	O
of	O
total	O
B	O
cells	O
(	O
CD19	O
+	O
B	O
cell	O
),	O
CD5	O
positive	O
B	O
cells	O
(	O
B1	O
cell	O
)	O
and	O
mean	O
fluorescent	O
intensity	O
of	O
CD40	O
on	O
B	O
cell	O
(	O
CD40MF	O
)	O
using	O
tri	O
-	O
color	O
flow	O
cytometry	O
to	O
analyze	O
the	O
distribution	O
of	O
the	O
above	O
parameters	O
in	O
SARS	O
,	O
mycoplasma	B-SPEC
pneumonia	O
and	O
healthy	O
adult	O
volunteers	O
and	O
their	O
relation	O
to	O
the	O
severity	O
of	O
SARS	O
.	O

TITLE	O
:	O
Assessment	O
of	O
immunoreactive	O
synthetic	O
peptides	O
from	O
the	O
structural	O
proteins	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Four	O
epitopic	O
sites	O
,	O
S599	O
,	O
M137	O
,	O
N66	O
,	O
and	O
N371	O
-	O
404	O
,	O
located	O
in	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
S	O
,	O
M	O
,	O
and	O
N	O
proteins	O
,	O
respectively	O
,	O
were	O
detected	O
by	O
screening	O
synthesized	O
peptides	O
.	O

TITLE	O
:	O
Vaccine	O
efficacy	O
of	O
a	O
cell	O
lysate	O
with	O
recombinant	O
baculovirus	B-SPEC
-	O
expressed	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
virus	B-SPEC
nucleocapsid	O
protein	O
against	O
progression	O
of	O
FIP	O
.	O

In	O
this	O
study	O
,	O
we	O
immunized	O
cats	B-SPEC
with	O
cell	O
lysate	O
with	O
recombinant	O
baculovirus	B-SPEC
-	O
expressed	O
N	O
protein	O
of	O
the	O
Type	O
I	O
FIPV	O
strain	O
KU	O
-	O
2	O
with	O
an	O
adjuvant	O
and	O
investigated	O
its	O
preventive	O
effect	O
on	O
the	O
progression	O
of	O
FIP	O
.	O

During	O
the	O
past	O
decade	O
,	O
evidence	O
has	O
accrued	O
on	O
the	O
protection	O
afforded	O
by	O
inactivated	O
vaccines	O
and	O
the	O
safety	O
and	O
efficacy	O
in	O
children	O
of	O
live	O
influenza	O
-	O
virus	B-SPEC
vaccines	O
.	O

ABSTRACT	O
:	O
We	O
report	O
here	O
that	O
fusions	O
of	O
single	O
-	O
chain	O
antibodies	O
(	O
scFvs	O
)	O
to	O
the	O
autotransporter	O
beta	O
domain	O
of	O
the	O
IgA	O
protease	O
of	O
Neisseria	B-SPEC
gonorrhoeae	I-SPEC
are	O
instrumental	O
in	O
locating	O
virus	B-SPEC
-	O
neutralizing	O
activity	O
on	O
the	O
cell	O
surface	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

Swollen	O
Golgi	O
sacs	O
contained	O
virus	B-SPEC
nucleocapsids	O
at	O
different	O
stages	O
of	O
maturation	O
.	O

Several	O
of	O
these	O
vacuoles	O
were	O
close	O
to	O
the	O
cell	O
periphery	O
,	O
ready	O
to	O
export	O
out	O
the	O
mature	O
progeny	O
virus	B-SPEC
particles	O
via	O
exocytosis	O
.	O

RESULTS	O
:	O
Prokaryoticly	O
expressed	O
and	O
purified	O
N	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
PUMC2	O
strain	O
was	O
obtained	O
.	O

Alterations	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
genome	O
are	O
unlikely	O
to	O
have	O
caused	O
the	O
distinctive	O
clinical	O
features	O
of	O
the	O
Amoy	O
Gardens	O
patients	O
,	O
and	O
these	O
results	O
highlight	O
the	O
importance	O
of	O
non	O
-	O
viral	O
genomic	O
factors	O
in	O
this	O
outbreak	O
.	O

It	O
emphasizes	O
on	O
the	O
fact	O
that	O
increasingly	O
combined	O
pollution	O
in	O
China	O
provides	O
a	O
substantial	O
basis	O
for	O
virus	B-SPEC
evolution	O
.	O

The	O
positive	O
and	O
negative	O
predictive	O
values	O
of	O
presence	O
of	O
anti	O
-	O
coronavirus	B-SPEC
antibodies	O
were	O
0	O
.	O
44	O
and	O
0	O
.	O
90	O
,	O
respectively	O
,	O
antibody	O
concentrations	O
(	O
1	O
:	O
1	O
,	O
600	O
)	O
were	O
0	O
.	O
94	O
and	O
0	O
.	O
88	O
.	O

TITLE	O
:	O
Characterization	O
of	O
N	O
protein	O
self	O
-	O
association	O
in	O
coronavirus	B-SPEC
ribonucleoprotein	O
complexes	O
.	O

In	O
situ	O
RT	O
-	O
PCR	O
detected	O
SARS	O
coronavirus	B-SPEC
RNA	O
in	O
type	O
II	O
alveolar	O
cells	O
,	O
interstitial	O
cells	O
and	O
bronchiolar	O
epithelial	O
cells	O
from	O
all	O
three	O
patients	O
.	O

The	O
closely	O
related	O
bovine	B-SPEC
coronavirus	B-SPEC
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
of	O
pigs	B-SPEC
were	O
differentiated	O
from	O
TCoV	O
using	O
the	O
same	O
RT	O
-	O
PCR	O
with	O
slight	O
modifications	O
.	O

The	O
surveillance	O
case	O
definition	O
changed	O
throughout	O
the	O
epidemic	O
as	O
understanding	O
of	O
the	O
clinical	O
,	O
laboratory	O
,	O
and	O
transmission	O
characteristics	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
increased	O
.	O

TITLE	O
:	O
A	O
193	O
-	O
amino	O
acid	O
fragment	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
S	O
protein	O
efficiently	O
binds	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

TITLE	O
:	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
receptor	O
CEACAM1	O
is	O
responsible	O
for	O
fusogenic	O
activation	O
and	O
conformational	O
changes	O
of	O
the	O
spike	O
protein	O
.	O

TITLE	O
:	O
Systematic	O
,	O
genome	O
-	O
wide	O
identification	O
of	O
host	O
genes	O
affecting	O
replication	O
of	O
a	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
.	O

Several	O
of	O
these	O
genes	O
were	O
shown	O
previously	O
to	O
function	O
in	O
BMV	B-SPEC
replication	O
,	O
validating	O
the	O
approach	O
.	O

Now	O
that	O
the	O
SARS	O
outbreak	O
is	O
under	O
control	O
,	O
hospitals	O
struggle	O
with	O
the	O
balance	O
between	O
adhering	O
to	O
patient	O
-	O
and	O
family	B-SPEC
-	O
centred	O
care	O
models	O
,	O
and	O
addressing	O
the	O
future	O
threat	O
of	O
infectious	O
diseases	O
.	O

Live	O
vaccines	O
are	O
usually	O
applied	O
to	O
meat	O
-	O
type	O
chickens	B-SPEC
at	O
1	O
day	O
of	O
age	O
.	O

In	O
experimental	O
situations	O
this	O
can	O
result	O
in	O
sterile	O
immunity	O
when	O
challenged	O
by	O
virulent	O
homologous	O
virus	B-SPEC
.	O

IBV	B-SPEC
exists	O
as	O
scores	O
of	O
serotypes	O
(	O
defined	O
by	O
the	O
neutralization	O
test	O
),	O
cross	O
-	O
protection	O
often	O
being	O
poor	O
.	O

Consequently	O
,	O
chickens	B-SPEC
may	O
be	O
re	O
-	O
vaccinated	O
,	O
with	O
the	O
same	O
or	O
another	O
serotype	O
,	O
two	O
or	O
three	O
weeks	O
later	O
.	O

Adoptive	O
transfer	O
of	O
IBV	B-SPEC
-	O
infection	O
-	O
induced	O
alphabeta	O
T	O
cells	O
bearing	O
CD8	O
antigen	O
protected	O
chicks	O
from	O
challenge	O
infection	O
.	O

Prevention	O
of	O
future	O
outbreaks	O
requires	O
strengthening	O
of	O
infection	O
control	O
practices	O
in	O
hospitals	O
,	O
development	O
of	O
a	O
rapid	O
diagnostic	O
test	O
and	O
a	O
vaccine	O
,	O
and	O
removal	O
of	O
any	O
animal	B-SPEC
reservoir	O
and	O
environmental	O
conditions	O
that	O
led	O
to	O
the	O
spread	O
of	O
the	O
disease	O
.	O

In	O
4	O
%	O
of	O
the	O
symptom	O
-	O
free	O
control	O
periods	O
a	O
virus	B-SPEC
was	O
detected	O
.	O

NCBI	O
resources	O
include	O
Entrez	O
,	O
PubMed	O
,	O
PubMed	O
Central	O
,	O
LocusLink	O
,	O
the	O
NCBI	O
Taxonomy	O
Browser	O
,	O
BLAST	O
,	O
BLAST	O
Link	O
(	O
BLink	O
),	O
Electronic	O
PCR	O
,	O
OrfFinder	O
,	O
Spidey	O
,	O
RefSeq	O
,	O
UniGene	O
,	O
HomoloGene	O
,	O
ProtEST	O
,	O
dbMHC	O
,	O
dbSNP	O
,	O
Cancer	B-SPEC
Chromosome	O
Aberration	O
Project	O
(	O
CCAP	O
),	O
Entrez	O
Genomes	O
and	O
related	O
tools	O
,	O
the	O
Map	O
Viewer	O
,	O
Model	O
Maker	O
,	O
Evidence	O
Viewer	O
,	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COGs	O
)	O
database	O
,	O
Retroviral	B-SPEC
Genotyping	O
Tools	O
,	O
SARS	O
Coronavirus	B-SPEC
Resource	O
,	O
SAGEmap	O
,	O
Gene	O
Expression	O
Omnibus	O
(	O
GEO	O
),	O
Online	O
Mendelian	O
Inheritance	O
in	O
Man	B-SPEC
(	O
OMIM	O
),	O
the	O
Molecular	O
Modeling	O
Database	O
(	O
MMDB	O
),	O
the	O
Conserved	O
Domain	O
Database	O
(	O
CDD	O
)	O
and	O
the	O
Conserved	O
Domain	O
Architecture	O
Retrieval	O
Tool	O
(	O
CDART	O
).	O

For	O
predicted	O
proteins	O
,	O
we	O
use	O
ProtParam	O
to	O
analyse	O
physical	O
and	O
chemical	O
features	O
;	O
SignalP	O
to	O
analyse	O
signal	O
peptide	O
;	O
BLAST	O
,	O
FASTA	O
to	O
search	O
similar	O
sequences	O
;	O
TMPred	O
,	O
TMHMM	O
,	O
PFAM	O
and	O
HMMTOP	O
to	O
analyse	O
domain	O
and	O
motif	O
in	O
order	B-SPEC
to	O
improve	O
reliability	O
of	O
gene	O
function	O
prediction	O
.	O

A	O
virus	B-SPEC
overlay	O
protein	O
binding	O
assay	O
(	O
VOPBA	O
)	O
was	O
used	O
to	O
identify	O
PEDV	B-SPEC
binding	O
protein	O
in	O
permissive	O
cells	O
.	O

VOPBA	O
identified	O
a	O
150	O
kDa	O
protein	O
,	O
as	O
a	O
putative	O
PEDV	B-SPEC
receptor	O
in	O
enterocytes	O
and	O
swine	B-SPEC
testicle	O
(	O
ST	O
)	O
cells	O
.	O

The	O
neuraminidase	O
inhibitors	O
(	O
NAIs	B-SPEC
)	O
are	O
a	O
new	O
class	B-SPEC
of	O
antiviral	O
drug	O
targeting	O
a	O
viral	O
influenza	O
enzyme	O
,	O
the	O
neuraminidase	O
,	O
which	O
acts	O
both	O
to	O
facilitate	O
virus	B-SPEC
infection	O
of	O
cells	O
by	O
clearing	O
a	O
passage	O
through	O
otherwise	O
protective	O
respiratory	O
fluids	O
and	O
also	O
by	O
helping	O
release	O
of	O
the	O
virus	B-SPEC
by	O
cutting	O
the	O
chemical	O
umbilical	O
cord	O
which	O
links	O
up	O
the	O
virus	B-SPEC
to	O
the	O
infected	O
cell	O
.	O

We	O
have	O
provided	O
evidence	O
for	O
the	O
interaction	O
of	O
these	O
four	O
proteins	O
with	O
the	O
3	O
'	O
end	O
region	O
of	O
MHV	B-SPEC
RNA	O
in	O
infected	O
cells	O
by	O
a	O
series	O
of	O
immunoprecipitation	O
RT	O
-	O
PCR	O
assays	O
.	O

Finally	O
,	O
lactam	O
12	O
induces	O
apoptosis	O
selectively	O
in	O
Jurkat	O
T	O
and	O
simian	B-SPEC
virus	I-SPEC
40	I-SPEC
-	O
transformed	O
,	O
but	O
not	O
in	O
nontransformed	O
NK	O
and	O
parental	O
normal	O
fibroblast	O
,	O
cells	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
mice	B-SPEC
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
A59	O
results	O
in	O
acute	O
encephalitis	O
,	O
hepatitis	O
,	O
and	O
chronic	O
demyelinating	O
disease	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
autophagy	O
is	O
required	O
for	O
formation	O
of	O
double	O
membrane	O
-	O
bound	O
MHV	B-SPEC
replication	O
complexes	O
and	O
that	O
DMV	O
formation	O
significantly	O
enhances	O
the	O
efficiency	O
of	O
replication	O
.	O

In	O
order	B-SPEC
to	O
analyze	O
the	O
antigenicity	O
and	O
receptor	O
-	O
binding	O
ability	O
of	O
SARS	O
-	O
CoV	O
S	O
protein	O
,	O
we	O
expressed	O
the	O
S	O
protein	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
using	O
a	O
pET	O
expression	O
vector	O
.	O

Based	O
on	O
these	O
results	O
,	O
all	O
chickens	B-SPEC
were	O
protected	O
against	O
the	O
California	B-SPEC
99	O
isolate	O
when	O
the	O
IBV	B-SPEC
Arkansas	O
type	O
was	O
used	O
as	O
a	O
vaccine	O
.	O

The	O
commonest	O
organisms	O
isolated	O
from	O
the	O
body	O
fluids	O
were	O
Pseudomonas	B-SPEC
and	O
Klebsiella	B-SPEC
.	O

TITLE	O
:	O
Mixed	O
cryoglobulinemia	O
due	O
to	O
chronic	O
hepatitis	B-SPEC
C	I-SPEC
with	O
severe	O
pulmonary	O
involvement	O
.	O

ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
described	O
infectious	O
disease	O
caused	O
by	O
a	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
Among	O
47	O
suspected	O
SARS	O
patients	O
with	O
normal	O
chest	O
radiographs	O
,	O
27	O
had	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
confirmed	O
by	O
RT	O
-	O
PCR	O
and	O
/	O
or	O
positive	O
serological	O
testing	O
.	O

Three	O
viruses	B-SPEC
found	O
in	O
Hong	O
Kong	O
in	O
February	O
were	O
phylogenetically	O
distinct	O
from	O
the	O
major	O
cluster	O
,	O
which	O
suggests	O
that	O
several	O
introductions	O
of	O
the	O
virus	B-SPEC
had	O
occurred	O
,	O
but	O
that	O
only	O
one	O
was	O
associated	O
with	O
the	O
subsequent	O
outbreak	O
in	O
Hong	O
Kong	O
,	O
which	O
in	O
turn	O
spread	O
globally	O
.	O

Clinical	O
manifestation	O
,	O
chest	O
X	O
-	O
ray	B-SPEC
,	O
computed	O
tomography	O
(	O
CT	O
)	O
and	O
pulmonary	O
function	O
of	O
4	O
cases	O
with	O
bronchiolitis	O
obliterans	O
were	O
retrospectively	O
analyzed	O
.	O

Therefore	O
,	O
instant	O
and	O
accurate	O
laboratory	O
confirmation	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
has	O
become	O
a	O
worldwide	O
interest	O
.	O

13	O
species	B-SPEC
of	O
SARS	O
virus	B-SPEC
have	O
been	O
sequenced	O
.	O

ABSTRACT	O
:	O
The	O
identification	O
of	O
a	O
new	O
coronavirus	B-SPEC
as	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
evoked	O
much	O
new	O
interest	O
in	O
the	O
molecular	O
biology	O
and	O
pathogenesis	O
of	O
coronaviruses	O
.	O

No	O
statistical	O
differences	O
were	O
found	O
in	O
modes	O
of	O
oxygen	O
therapy	O
and	O
sorts	O
of	O
antibiotics	O
prescribed	O
among	O
the	O
various	O
transmission	O
generations	O
(	O
P	O
>	O
0	O
.	O
05	O
);	O
however	O
,	O
as	O
with	O
the	O
advanced	O
transmission	O
generations	O
,	O
the	O
number	O
of	O
cases	O
prescribed	O
with	O
methylprednisolone	O
,	O
human	B-SPEC
gamma	O
-	O
globulin	O
,	O
interferon	O
-	O
alpha	O
,	O
antiviral	O
drugs	O
(	O
oral	O
ribavirin	O
or	O
oseltamivir	O
)	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
time	O
from	O
admission	O
to	O
starting	O
these	O
medication	O
shortened	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

There	O
were	O
188	O
point	O
mutations	O
in	O
the	O
33	O
virus	B-SPEC
full	O
genomes	O
with	O
the	O
counts	O
of	O
mutation	O
mounting	O
to	O
297	O
.	O

All	O
the	O
primers	O
derived	O
from	O
the	O
sequence	O
at	O
the	O
1b	O
frame	O
of	O
coronavirus	B-SPEC
replicase	O
gene	O
and	O
products	O
with	O
a	O
size	O
of	O
368	O
or	O
348	O
bp	O
were	O
expected	O
with	O
2	O
different	O
primer	O
pairs	O
.	O

The	O
data	O
mentioned	O
above	O
indicate	O
that	O
antigen	O
and	O
gene	O
detections	O
for	O
those	O
common	O
respiratory	O
viruses	B-SPEC
are	O
useful	O
methods	O
for	O
the	O
differentiation	O
to	O
avoid	O
the	O
spread	O
of	O
SARS	O
.	O

RESULTS	O
:	O
Amplicons	O
with	O
the	O
sizes	O
of	O
368	O
bp	O
and	O
348	O
bp	O
were	O
obtained	O
from	O
a	O
throat	O
swab	O
specimen	O
collected	O
from	O
a	O
17	O
years	O
old	O
girl	O
,	O
who	O
was	O
admitted	O
to	O
the	O
isolated	O
ward	O
because	O
of	O
high	O
fever	O
(	O
39	O
.	O
5	O
degrees	O
C	O
)	O
for	O
7	O
days	O
,	O
cough	O
for	O
2	O
days	O
,	O
low	O
WBC	O
count	O
,	O
and	O
pneumonia	O
shown	O
by	O
X	O
-	O
ray	B-SPEC
when	O
she	O
visited	O
the	O
""""	O
Fever	O
and	O
Cough	O
""""	O
Clinic	O
,	O
and	O
without	O
known	O
history	O
of	O
contact	O
with	O
probable	O
SARS	O
patient	O
.	O

Autopsy	O
tissue	O
was	O
submitted	O
to	O
the	O
Virology	O
Department	O
,	O
Singapore	O
General	O
Hospital	O
,	O
for	O
analysis	O
,	O
and	O
in	O
situ	O
hybridization	O
for	O
the	O
SARS	O
coronavirus	B-SPEC
was	O
carried	O
out	O
at	O
the	O
National	O
Institute	O
of	O
Infectious	O
Diseases	O
,	O
Tokyo	O
,	O
Japan	O
.	O

Despite	O
the	O
widespread	O
availability	O
of	O
affordable	O
refrigeration	O
,	O
many	O
Asian	O
people	O
prefer	O
live	O
animals	B-SPEC
for	O
fresh	O
produce	O
.	O

ABSTRACT	O
:	O
Purification	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
expressed	O
in	O
a	O
prokaryotic	O
expression	O
system	O
as	O
histidine	O
-	O
tagged	O
fusion	O
protein	O
is	O
demonstrated	O
in	O
the	O
present	O
study	O
.	O

Turkey	B-SPEC
coronavirus	B-SPEC
was	O
partially	O
purified	O
from	O
infected	O
intestine	O
of	O
turkey	B-SPEC
embryo	O
by	O
sucrose	O
gradient	O
ultracentrifugation	O
and	O
RNA	O
was	O
extracted	O
.	O

Increased	O
age	O
,	O
severity	O
of	O
illness	O
,	O
lymphocyte	O
count	O
,	O
decreased	O
steroid	O
dose	O
,	O
positive	O
fluid	O
balance	O
,	O
chronic	O
disease	O
or	O
immunosuppression	O
and	O
nosocomial	O
sepsis	B-SPEC
were	O
associated	O
with	O
poor	O
outcome	O
on	O
univariate	O
analysis	O
.	O

TITLE	O
:	O
The	O
protective	O
effects	O
of	O
early	O
treatment	O
with	O
propofol	O
on	O
endotoxin	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

Respondents	O
comprised	O
MBAs	O
(	O
Master	O
of	O
Business	O
Administration	O
students	O
)	O
and	O
human	B-SPEC
resource	O
managers	O
who	O
attended	O
classes	O
in	O
a	O
local	O
tertiary	O
institution	O
.	O

This	O
review	O
summarizes	O
recent	O
studies	O
that	O
demonstrate	O
the	O
critical	O
role	O
played	O
by	O
inflammatory	O
mediators	O
such	O
as	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
alpha	O
,	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
platelet	O
activating	O
factor	O
(	O
PAF	O
),	O
IL	O
-	O
10	O
,	O
granulocyte	O
macrophage	O
-	O
colony	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
),	O
C5a	O
,	O
intercellular	O
adhesion	O
molecule	O
(	O
ICAM	O
)-	O
1	O
,	O
substance	O
P	O
,	O
chemokines	O
,	O
VEGF	O
,	O
IGF	O
-	O
I	O
,	O
KGF	O
,	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
),	O
and	O
reactive	O
nitrogen	O
species	B-SPEC
(	O
RNS	O
)	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
.	O

TITLE	O
:	O
Tissue	O
and	O
cellular	O
tropism	O
of	O
the	O
coronavirus	B-SPEC
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
an	O
in	O
-	O
situ	O
hybridization	O
study	O
of	O
fatal	O
cases	O
.	O

These	O
results	O
provide	O
important	O
information	O
concerning	O
the	O
tissue	O
tropism	O
of	O
SARS	O
-	O
CoV	O
,	O
which	O
is	O
distinct	O
from	O
previously	O
identified	O
human	B-SPEC
coronaviruses	O
,	O
and	O
suggest	O
the	O
possible	O
involvement	O
of	O
novel	O
receptors	O
in	O
this	O
infection	O
.	O

The	O
same	O
virus	B-SPEC
was	O
detected	O
subsequently	O
in	O
86	O
humans	B-SPEC
who	O
handled	O
affected	O
poultry	O
and	O
in	O
three	O
of	O
their	O
family	B-SPEC
members	O
.	O

Untreated	O
SCID	O
mice	B-SPEC
exhibited	O
uncontrolled	O
virus	B-SPEC
replication	O
in	O
all	O
CNS	O
cell	O
types	O
but	O
had	O
little	O
or	O
no	O
demyelination	O
.	O

The	O
life	O
of	O
contemporary	O
man	B-SPEC
is	O
characterized	O
,	O
among	O
others	O
,	O
by	O
a	O
huge	O
thirst	O
for	O
traveling	O
,	O
for	O
varied	O
reasons	O
,	O
consequence	O
of	O
the	O
globalization	O
process	O
.	O

SARS	O
virus	B-SPEC
,	O
mutant	O
belonging	O
to	O
Coronaviridae	B-SPEC
,	O
occurred	O
in	O
one	O
of	O
the	O
most	O
densely	O
populated	O
areas	O
of	O
the	O
world	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
continues	O
to	O
be	O
a	O
major	O
source	O
of	O
viral	O
lower	O
respiratory	O
infection	O
illness	O
in	O
children	O
and	O
can	O
lead	O
to	O
childhood	O
asthma	O
.	O

However	O
,	O
concerns	O
about	O
the	O
possible	O
use	O
of	O
the	O
virus	B-SPEC
as	O
a	O
weapon	O
of	O
bioterrorism	O
have	O
increased	O
in	O
recent	O
years	O
.	O

At	O
first	O
,	O
Western	O
blotting	O
with	O
the	O
convalescent	O
sera	O
from	O
SARS	O
patients	O
demonstrated	O
that	O
there	O
were	O
various	O
structural	O
proteins	O
of	O
SARS	O
-	O
CoV	O
in	O
the	O
cultured	O
supernatant	O
of	O
virus	B-SPEC
infected	O
-	O
Vero	O
E6	O
cells	O
and	O
that	O
nucleocaspid	O
(	O
N	O
)	O
protein	O
had	O
a	O
prominent	O
immunogenicity	O
to	O
the	O
convalescent	O
sera	O
from	O
the	O
patients	O
with	O
SARS	O
,	O
while	O
the	O
immune	O
response	O
of	O
spike	O
(	O
S	O
)	O
protein	O
probably	O
binding	O
with	O
membrane	O
(	O
M	O
)	O
glycoprotein	O
was	O
much	O
weaker	O
.	O

Then	O
,	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
was	O
used	O
to	O
separate	O
the	O
complex	O
protein	O
constituents	O
,	O
and	O
the	O
strategy	O
of	O
continuous	O
slicing	O
from	O
loading	O
well	O
to	O
the	O
bottom	O
of	O
the	O
gels	O
was	O
utilized	O
to	O
search	O
thoroughly	O
the	O
structural	O
proteins	O
of	O
the	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Theiler	O
'	O
s	O
murine	B-SPEC
encephalomyelitis	O
virus	B-SPEC
(	O
TMEV	O
)	O
causes	O
demyelination	O
with	O
inflammation	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
in	O
mice	B-SPEC
and	O
is	O
used	O
as	O
an	O
animal	B-SPEC
model	O
for	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

This	O
likely	O
reflects	O
a	O
difference	O
in	O
the	O
pathogenesis	O
of	O
TMEV	O
infection	O
from	O
that	O
of	O
two	O
other	O
animal	B-SPEC
models	O
for	O
MS	O
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
and	O
experimental	O
allergic	O
encephalomyelitis	O
(	O
EAE	O
),	O
where	O
blocking	O
of	O
IP	O
-	O
10	O
resulted	O
in	O
clinical	O
and	O
histological	O
improvement	O
with	O
suppression	O
of	O
antigen	O
specific	O
lymphoproliferation	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
necessitated	O
an	O
in	O
-	O
depth	O
molecular	O
understanding	O
of	O
the	O
virus	B-SPEC
to	O
identify	O
new	O
drug	O
targets	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
as	O
an	O
enteric	O
pathogen	O
was	O
investigated	O
in	O
a	O
cohort	O
of	O
142	O
patients	O
with	O
SARS	O
who	O
were	O
treated	O
with	O
a	O
standard	O
treatment	O
protocol	O
.	O

A	O
higher	O
mean	O
virus	B-SPEC
load	O
in	O
nasopharyngeal	O
specimens	O
obtained	O
on	O
day	O
10	O
after	O
the	O
onset	O
of	O
symptoms	O
was	O
significantly	O
associated	O
with	O
the	O
occurrence	O
of	O
diarrhea	O
(	O
3	O
.	O
1	O
log10	O
vs	O
.	O
1	O
.	O
8	O
log10	O
copies	O
/	O
mL	O
;	O
P	O
=.	O
01	O
)	O
and	O
mortality	O
(	O
6	O
.	O
2	O
vs	O
.	O
1	O
.	O
7	O
log10	O
copies	O
/	O
mL	O
;	O
P	O
<.	O
01	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
viral	O
disease	O
that	O
may	O
be	O
contracted	O
by	O
exposure	O
to	O
a	O
newly	O
recognized	O
form	O
of	O
the	O
coronavirus	B-SPEC
.	O

Real	O
-	O
time	O
RT	O
-	O
PCR	O
provides	O
a	O
tool	O
for	O
large	O
-	O
scale	O
epidemiological	O
studies	O
to	O
further	O
clarify	O
the	O
role	O
that	O
coronavirus	B-SPEC
infection	O
plays	O
in	O
RTI	O
in	O
humans	B-SPEC
.	O

The	O
prominence	O
of	O
mitotic	O
activity	O
of	O
hepatocytes	O
is	O
unique	O
and	O
may	O
be	O
due	O
to	O
a	O
hyperproliferative	O
state	O
with	O
or	O
without	O
disruption	O
of	O
cell	O
cycle	O
by	O
the	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
three	O
-	O
color	O
flow	O
cytometry	O
assay	O
for	O
the	O
detection	O
of	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
in	O
the	O
cat	B-SPEC
.	O

By	O
using	O
the	O
anti	O
-	O
TNFalpha	O
mAb	O
in	O
combination	O
with	O
PE	O
-	O
and	O
FITC	O
-	O
conjugated	O
mAbs	O
against	O
feline	B-SPEC
CD4	O
and	O
CD8	O
,	O
respectively	O
,	O
antiviral	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
could	O
be	O
identified	O
in	O
the	O
peripheral	O
blood	O
and	O
in	O
the	O
spleens	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
-	O
infected	O
cats	B-SPEC
.	O

Furthermore	O
,	O
the	O
assay	O
will	O
add	O
to	O
the	O
value	O
of	O
those	O
systems	O
in	O
which	O
viral	O
infections	O
of	O
the	O
cat	B-SPEC
serve	O
as	O
models	O
for	O
human	B-SPEC
disease	O
.	O

ABSTRACT	O
:	O
As	O
part	O
of	O
a	O
high	O
-	O
throughput	O
structural	O
analysis	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
proteins	O
,	O
we	O
have	O
solved	O
the	O
structure	O
of	O
the	O
non	O
-	O
structural	O
protein	O
9	O
(	O
nsp9	O
).	O

TITLE	O
:	O
Molecular	O
cloning	O
,	O
expression	O
,	O
purification	O
,	O
and	O
mass	O
spectrometric	O
characterization	O
of	O
3C	O
-	O
like	O
protease	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

It	O
has	O
been	O
known	O
that	O
SARS	O
coronavirus	B-SPEC
(	O
SARS_CoV	O
)	O
is	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
and	O
is	O
responsible	O
for	O
SARS	O
infection	O
.	O

ABSTRACT	O
:	O
Nidoviruses	B-SPEC
produce	O
an	O
extensive	O
3	O
'-	O
coterminal	O
nested	O
set	O
of	O
subgenomic	O
mRNAs	O
,	O
which	O
are	O
used	O
to	O
express	O
their	O
structural	O
proteins	O
.	O

In	O
addition	O
,	O
arterivirus	B-SPEC
and	O
coronavirus	B-SPEC
mRNAs	O
contain	O
a	O
common	O
5	O
'	O
leader	O
sequence	O
,	O
derived	O
from	O
the	O
genomic	O
5	O
'	O
end	O
.	O

To	O
identify	O
RNA	O
structures	O
in	O
the	O
5	O
'-	O
proximal	O
region	O
of	O
the	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
genome	O
that	O
may	O
be	O
involved	O
in	O
subgenomic	O
mRNA	O
synthesis	O
,	O
a	O
detailed	O
secondary	O
RNA	O
structure	O
model	O
was	O
established	O
using	O
bioinformatics	O
,	O
phylogenetic	O
analysis	O
,	O
and	O
RNA	O
structure	O
probing	O
.	O

The	O
importance	O
of	O
the	O
LTH	O
was	O
supported	O
by	O
the	O
results	O
of	O
a	O
mutagenesis	O
study	O
using	O
an	O
EAV	B-SPEC
molecular	O
clone	O
.	O

CONCLUSIONS	O
:	O
It	O
is	O
essential	O
to	O
adhere	O
to	O
these	O
recommendations	O
in	O
order	B-SPEC
to	O
protect	O
the	O
health	O
and	O
safety	O
of	O
clinicians	O
,	O
colleagues	O
,	O
and	O
patients	O
.	O

It	O
appears	O
that	O
in	O
the	O
case	O
of	O
HIV	B-SPEC
,	O
the	O
increased	O
resistance	O
to	O
apoptosis	O
is	O
provided	O
by	O
expression	O
of	O
Bcl	O
-	O
2	O
and	O
suppression	O
of	O
p53	O
.	O

It	O
would	O
be	O
interesting	O
to	O
try	O
these	O
drugs	O
against	O
various	O
intracellular	O
parasites	O
including	O
HIV	B-SPEC
.	O

This	O
approach	O
to	O
prevent	O
or	O
eliminate	O
active	O
infections	O
might	O
be	O
particularly	O
attractive	O
against	O
a	O
range	O
of	O
parasites	O
(	O
virus	B-SPEC
,	O
bacteria	B-SPEC
,	O
protozoa	O
,	O
fungus	B-SPEC
)	O
when	O
safe	O
and	O
effective	O
vaccines	O
are	O
not	O
available	O
.	O

Twenty	O
-	O
eight	O
cases	O
were	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
infections	O
;	O
two	O
were	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
and	O
one	O
was	O
a	O
mixed	O
infection	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
and	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
.	O

ABSTRACT	O
:	O
We	O
measured	O
CD8	O
T	O
cell	O
clonotypic	O
diversity	O
to	O
three	O
epitopes	O
recognized	O
in	O
C57BL	O
/	O
6	O
mice	B-SPEC
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
strain	O
JHM	O
,	O
or	O
lymphocytic	B-SPEC
choriomeningitis	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Role	O
of	O
specific	O
CD8	O
+	O
T	O
cells	O
in	O
the	O
severity	O
of	O
a	O
fulminant	O
zoonotic	O
viral	O
hemorrhagic	O
fever	O
,	O
hantavirus	B-SPEC
pulmonary	O
syndrome	O
.	O

ABSTRACT	O
:	O
The	O
A59	O
strain	O
of	O
coronavirus	B-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
produces	O
acute	O
hepatitis	O
,	O
meningoencephalitis	O
,	O
and	O
chronic	O
demyelination	O
.	O

In	O
screening	O
for	O
anti	O
-	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
candidates	O
,	O
we	O
found	O
GA	O
active	O
against	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
.	O

TITLE	O
:	O
Potent	O
neutralization	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
by	O
a	O
human	B-SPEC
mAb	O
to	O
S1	O
protein	O
that	O
blocks	O
receptor	O
association	O
.	O

Another	O
interesting	O
finding	O
was	O
that	O
mouse	B-SPEC
antibodies	O
elicited	O
separately	O
by	O
plasmids	O
encoding	O
S1	O
and	O
S2	O
subunits	O
cooperatively	O
neutralized	O
SARS	O
-	O
CoV	O
but	O
neither	O
the	O
S1	O
nor	O
S2	O
specific	O
antibodies	O
did	O
,	O
suggesting	O
the	O
possible	O
role	O
of	O
both	O
S1	O
and	O
S2	O
subunits	O
in	O
host	O
cell	O
docking	O
and	O
entry	O
.	O

The	O
in	O
vitro	O
susceptibility	O
of	O
the	O
prototype	O
of	O
SARS	O
associated	O
coronavirus	B-SPEC
to	O
a	O
panel	O
of	O
nucleoside	O
analogues	O
and	O
protease	O
inhibitors	O
currently	O
licensed	O
for	O
clinical	O
use	O
was	O
studied	O
.	O

In	O
vitro	O
antiviral	O
activity	O
against	O
SARS	O
associated	O
coronavirus	B-SPEC
was	O
demonstrated	O
for	O
lopinavir	O
and	O
ribavirin	O
at	O
concentrations	O
of	O
4	O
micro	O
g	O
/	O
ml	O
and	O
50	O
micro	O
g	O
/	O
ml	O
,	O
respectively	O
,	O
only	O
at	O
48	O
hours	O
.	O

This	O
new	O
human	B-SPEC
emergent	O
infectious	O
disease	O
is	O
dominated	O
by	O
severe	O
lower	O
respiratory	O
illness	O
and	O
is	O
aetiologically	O
linked	O
to	O
a	O
new	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
defective	O
RNAs	O
(	O
D	O
-	O
RNAs	O
)	O
have	O
been	O
used	O
for	O
the	O
expression	O
of	O
heterologous	O
genes	O
in	O
a	O
helper	O
-	O
virus	B-SPEC
-	O
dependent	O
expression	O
system	O
.	O

The	O
use	O
of	O
the	O
picornavirus	B-SPEC
encephalomyocarditis	B-SPEC
virus	I-SPEC
(	O
EMCV	B-SPEC
)	O
internal	O
ribosome	O
entry	O
site	O
(	O
IRES	O
)	O
sequence	O
to	O
initiate	O
gene	O
translation	O
was	O
investigated	O
as	O
an	O
alternative	O
method	O
to	O
the	O
coronavirus	B-SPEC
-	O
mediated	O
TAS	O
-	O
controlled	O
heterologous	O
gene	O
expression	O
system	O
.	O

TITLE	O
:	O
Infectious	B-SPEC
salmon	I-SPEC
anemia	I-SPEC
virus	I-SPEC
specifically	O
binds	O
to	O
and	O
hydrolyzes	O
4	O
-	O
O	O
-	O
acetylated	O
sialic	O
acids	O
.	O

ABSTRACT	O
:	O
Infectious	B-SPEC
salmon	I-SPEC
anemia	I-SPEC
virus	I-SPEC
(	O
ISAV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
infections	O
in	O
farmed	O
Atlantic	B-SPEC
salmon	I-SPEC
.	O

We	O
have	O
analyzed	O
the	O
substrate	O
specificity	O
of	O
the	O
ISAV	B-SPEC
esterase	O
in	O
detail	O
.	O

Thus	O
,	O
the	O
enzymatic	O
activity	O
of	O
the	O
hemagglutinin	O
-	O
esterase	O
of	O
ISAV	B-SPEC
is	O
comparable	O
to	O
that	O
of	O
the	O
sialate	O
-	O
4	O
-	O
O	O
-	O
esterases	O
of	O
murine	B-SPEC
coronaviruses	O
and	O
related	O
group	O
2	O
coronaviruses	O
.	O

To	O
confirm	O
genetic	O
diversity	O
in	O
the	O
S1	O
genes	O
of	O
IBV	B-SPEC
isolates	O
,	O
viral	O
RNAs	O
of	O
representative	O
9	O
of	O
15	O
IBV	B-SPEC
isolates	O
were	O
amplified	O
,	O
cloned	O
,	O
sequenced	O
and	O
compared	O
with	O
published	O
sequences	O
for	O
non	O
-	O
Korean	O
IBV	B-SPEC
strains	O
.	O

A	O
comparative	O
study	O
of	O
a	O
matched	O
group	O
of	O
children	O
infected	O
by	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
found	O
no	O
significative	O
difference	O
for	O
hospitalisation	O
motive	O
,	O
clinical	O
criteria	O
and	O
treatment	O
.	O

ABSTRACT	O
:	O
Mutations	O
in	O
the	O
SARS	O
-	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
can	O
alter	O
its	O
clinical	O
presentation	O
,	O
and	O
the	O
study	O
of	O
its	O
mutation	O
patterns	O
in	O
human	B-SPEC
populations	O
can	O
facilitate	O
contact	O
tracing	O
.	O

Since	O
the	O
sequences	O
of	O
MHV	B-SPEC
-	O
RNA	O
that	O
were	O
extracted	O
from	O
the	O
intestine	O
of	O
a	O
serologically	O
MHV	B-SPEC
-	O
positive	O
mouse	B-SPEC
in	O
room	O
No	O
.	O
2	O
(	O
MS2	O
)	O
and	O
from	O
the	O
filter	O
dust	O
in	O
a	O
ventilation	O
duct	O
in	O
the	O
same	O
room	O
(	O
FD2	O
)	O
were	O
identical	O
,	O
amplified	O
product	O
from	O
filter	O
dust	O
was	O
demonstrated	O
to	O
come	O
from	O
the	O
MHV	B-SPEC
contaminated	O
room	O
.	O

The	O
role	O
of	O
molecular	O
biology	O
in	O
elucidating	O
structure	O
,	O
features	O
and	O
phylogenetic	O
aspects	O
of	O
SARS	O
coronavirus	B-SPEC
is	O
underlined	O
.	O

ABSTRACT	O
:	O
We	O
verified	O
the	O
analytical	O
performance	O
characteristics	O
of	O
a	O
previously	O
described	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
targeting	O
the	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
1b	O
region	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
with	O
RNA	O
transcripts	O
.	O

The	O
presence	O
of	O
this	O
type	O
of	O
protein	O
has	O
not	O
been	O
detected	O
in	O
the	O
replicative	O
complexes	O
of	O
RNA	O
viruses	B-SPEC
,	O
and	O
its	O
presence	O
may	O
reflect	O
the	O
unique	O
and	O
complex	O
CoV	O
viral	O
replication	O
/	O
transcription	O
machinery	O
.	O

Patients	O
awaiting	O
early	O
or	O
urgent	O
outpatient	O
appointments	O
rose	B-SPEC
by	O
200	O
%	O
with	O
waiting	O
times	O
for	O
colonoscopy	O
increased	O
by	O
a	O
median	O
3	O
,	O
5	O
or	O
9	O
weeks	O
for	O
outpatient	O
,	O
inpatient	O
or	O
non	O
-	O
urgent	O
cases	O
,	O
respectively	O
.	O

We	O
conclude	O
that	O
prolonged	O
dysregulated	O
cytokine	O
production	O
occurs	O
in	O
SARS	O
and	O
that	O
future	O
studies	O
should	O
be	O
directed	O
at	O
improving	O
anti	O
-	O
inflammatory	O
and	O
antiviral	O
therapies	O
in	O
order	B-SPEC
to	O
limit	O
cytokine	O
impairment	O
.	O

We	O
found	O
that	O
although	O
some	O
primate	B-SPEC
cell	O
lines	O
,	O
including	O
Vero	O
E6	O
,	O
293T	O
and	O
Huh	O
-	O
7	O
cells	O
,	O
could	O
be	O
efficiently	O
transduced	O
by	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
pseudoviruses	O
,	O
other	O
cells	O
lines	O
were	O
either	O
resistant	O
or	O
very	O
poorly	O
permissive	O
to	O
virus	B-SPEC
entry	O
.	O

The	O
concepts	O
of	O
clinical	O
uncertainty	O
and	O
the	O
flow	O
of	O
human	B-SPEC
contacts	O
provide	O
in	O
-	O
depth	O
insights	O
that	O
complement	O
the	O
findings	O
of	O
large	O
-	O
scale	O
epidemiological	O
studies	O
,	O
and	O
help	O
operationalize	O
their	O
general	O
calls	O
for	O
enhanced	O
control	O
measures	O
.	O

The	O
PPV	B-SPEC
and	O
NPV	O
for	O
the	O
rapid	O
test	O
thus	O
reached	O
95	O
.	O
3	O
and	O
100	O
%,	O
respectively	O
.	O

TITLE	O
:	O
Profiles	O
of	O
antibody	O
responses	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
recombinant	O
proteins	O
and	O
their	O
potential	O
use	O
as	O
diagnostic	O
markers	O
.	O

The	O
N195	O
protein	O
was	O
used	O
to	O
develop	O
a	O
Western	O
blot	O
assay	O
to	O
detect	O
antibodies	O
against	O
SARS	O
coronavirus	B-SPEC
in	O
274	O
clinically	O
blinded	O
samples	O
.	O

CONCLUSIONS	O
:	O
This	O
investigation	O
indicated	O
that	O
Chinese	O
herbal	O
medicine	O
will	O
be	O
an	O
important	O
source	O
for	O
ant	B-SPEC
-	O
SARS	O
new	O
drug	O
searching	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
has	O
been	O
identified	O
as	O
the	O
causal	O
agent	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
The	O
molecular	O
and	O
cellular	O
basis	O
of	O
coronavirus	B-SPEC
neurovirulence	O
is	O
poorly	O
understood	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
studied	O
the	O
interaction	O
between	O
coronaviruses	O
(	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
)	O
of	O
different	O
neurovirulences	O
with	O
primary	O
cell	O
cultures	O
of	O
brain	O
immune	O
cells	O
(	O
astrocytes	O
and	O
microglia	O
)	O
and	O
mouse	B-SPEC
tissues	O
.	O

These	O
findings	O
suggest	O
that	O
coronavirus	B-SPEC
neurovirulence	O
may	O
depend	O
on	O
a	O
novel	O
discriminatory	O
ability	O
of	O
astrocytes	O
and	O
microglia	O
to	O
induce	O
a	O
proinflammatory	O
response	O
in	O
the	O
CNS	O
.	O

Thus	O
,	O
antibodies	O
,	O
acting	O
alone	O
,	O
can	O
prevent	O
replication	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
in	O
the	O
lung	O
,	O
a	O
promising	O
observation	O
for	O
the	O
development	O
of	O
vaccines	O
,	O
immunotherapy	O
,	O
and	O
immunoprophylaxis	O
regimens	O
.	O

The	O
virus	B-SPEC
can	O
be	O
found	O
in	O
nasopharyngeal	O
aspirate	O
,	O
urine	O
and	O
stools	O
of	O
SARS	O
patients	O
.	O

Putative	O
sites	O
of	O
recombination	O
could	O
also	O
be	O
identified	O
in	O
both	O
the	O
E	O
and	O
M	O
ORFs	O
of	O
laboratory	O
strains	O
of	O
IBV	B-SPEC
.	O

It	O
is	O
noted	O
,	O
however	O
,	O
that	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
(	O
SARS	O
-	O
CoV	O
N	O
)	O
shares	O
little	O
homology	O
with	O
nucleocapsid	O
proteins	O
of	O
other	O
members	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
[	O
Science	O
300	O
(	O
2003	O
)	O
1399	O
;	O
Science	O
300	O
(	O
2003	O
)	O
1394	O
].	O

The	O
mammalian	B-SPEC
two	O
-	O
hybrid	O
assay	O
revealed	O
an	O
approximately	O
50	O
-	O
fold	O
increase	O
in	O
SEAP	O
activity	O
(	O
measurement	O
of	O
protein	O
-	O
protein	O
interaction	O
)	O
in	O
N	O
-	O
N	O
interaction	O
compared	O
to	O
that	O
observed	O
in	O
either	O
M	O
-	O
M	O
or	O
mock	O
transfection	O
.	O

Finally	O
,	O
the	O
full	O
-	O
length	O
nucleocapsid	O
protein	O
expressed	O
and	O
purified	O
from	O
baculovirus	B-SPEC
system	O
was	O
found	O
to	O
form	O
different	O
levels	O
of	O
higher	O
order	B-SPEC
structures	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
of	O
the	O
fractionated	O
proteins	O
.	O

S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
remains	O
the	O
most	O
important	O
cause	O
.	O

The	O
transmission	O
of	O
SARS	O
-	O
CoV	O
between	O
human	B-SPEC
beings	O
is	O
mainly	O
due	O
to	O
close	O
contact	O
.	O

Gene	O
-	O
based	O
vaccination	O
for	O
the	O
SARS	O
-	O
CoV	O
elicits	O
effective	O
immune	O
responses	O
that	O
generate	O
protective	O
immunity	O
in	O
an	O
animal	B-SPEC
model	O
.	O

TITLE	O
:	O
Transmission	O
of	O
enterotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
from	O
immunocompetent	O
and	O
immunodeficient	O
mice	B-SPEC
.	O

In	O
addition	O
,	O
constant	O
exposure	O
of	O
naive	O
mice	B-SPEC
to	O
infected	O
mice	B-SPEC
,	O
via	O
the	O
use	O
of	O
serial	O
sentinels	O
,	O
prolonged	O
viral	O
transmission	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
recently	O
emerged	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
but	O
its	O
immunopathological	O
mechanisms	O
have	O
not	O
yet	O
been	O
fully	O
elucidated	O
.	O

TITLE	O
:	O
Susceptibility	O
of	O
pigs	B-SPEC
and	O
chickens	B-SPEC
to	O
SARS	O
coronavirus	B-SPEC
.	O

To	O
address	O
speculations	O
that	O
the	O
virus	B-SPEC
originated	O
in	O
domesticated	O
animals	B-SPEC
,	O
or	O
that	O
domestic	O
species	B-SPEC
were	O
susceptible	O
to	O
the	O
virus	B-SPEC
,	O
we	O
inoculated	O
6	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
and	O
chickens	B-SPEC
intravenously	O
,	O
intranasally	O
,	O
ocularly	O
,	O
and	O
orally	O
with	O
106	O
PFU	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Laboratory	O
evaluation	O
of	O
clinical	O
specimens	O
showed	O
no	O
evidence	O
of	O
transmission	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
to	O
any	O
close	O
contact	O
of	O
this	O
patient	O
.	O

TITLE	O
:	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
transmission	O
,	O
United	O
States	O
.	O

ABSTRACT	O
:	O
To	O
better	O
assess	O
the	O
risk	O
for	O
transmission	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
we	O
obtained	O
serial	O
specimens	O
and	O
clinical	O
and	O
exposure	O
data	O
from	O
seven	O
confirmed	O
U	O
.	O
S	O
.	O
SARS	O
patients	O
and	O
their	O
10	O
household	O
contacts	O
.	O

Superspreading	O
appeared	O
to	O
be	O
associated	O
with	O
older	O
age	O
(	O
mean	O
56	O
vs	O
.	O
44	O
years	O
),	O
case	O
fatality	O
(	O
75	O
%	O
vs	O
.	O
16	O
%,	O
p	O
=	O
0	O
.	O
02	O
,	O
Fisher	B-SPEC
exact	O
test	O
),	O
number	O
of	O
close	O
contacts	O
(	O
36	O
vs	O
.	O
0	O
.	O
37	O
)	O
and	O
attack	O
rate	O
among	O
close	O
contacts	O
(	O
43	O
%	O
vs	O
.	O
18	O
.	O
5	O
%,	O
p	O
<	O
0	O
.	O
025	O
).	O

ABSTRACT	O
:	O
A	O
global	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
began	O
in	O
March	O
2003	O
.	O

We	O
show	O
that	O
infection	O
with	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
resulted	O
in	O
distinct	O
ultrastructural	O
features	O
:	O
double	O
-	O
membrane	O
vesicles	O
,	O
nucleocapsid	O
inclusions	O
,	O
and	O
large	O
granular	O
areas	O
of	O
cytoplasm	O
.	O

We	O
evaluated	O
the	O
susceptibility	O
of	O
the	O
SARS	O
-	O
related	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
to	O
ribavirin	O
and	O
interferon	O
(	O
IFN	O
)-	O
alpha	O
in	O
vitro	O
by	O
use	O
of	O
cytopathic	O
effect	O
,	O
plaque	O
assay	O
,	O
and	O
immunoblot	O
analysis	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
a	O
fourth	O
human	B-SPEC
coronavirus	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
using	O
a	O
new	O
method	O
of	O
virus	B-SPEC
discovery	O
.	O

Screening	O
of	O
clinical	O
specimens	O
from	O
individuals	O
suffering	O
from	O
respiratory	O
illness	O
identified	O
seven	O
additional	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
infected	O
individuals	O
,	O
indicating	O
that	O
the	O
virus	B-SPEC
was	O
widely	O
spread	O
within	O
the	O
human	B-SPEC
population	O
.	O

ABSTRACT	O
:	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
monkeypox	O
are	O
infectious	O
diseases	O
that	O
have	O
recently	O
been	O
introduced	O
into	O
areas	O
far	O
from	O
their	O
region	O
of	O
origin	O
.	O

The	O
challenge	O
for	O
policy	O
is	O
to	O
maintain	O
health	O
reform	O
whilst	O
tackling	O
the	O
problems	O
associated	O
with	O
rapid	O
urbanisation	O
,	O
widening	O
social	O
and	O
spatial	O
inequalities	O
and	O
the	O
emergence	O
of	O
HIV	B-SPEC
/	O
AIDS	O
and	O
other	O
infectious	O
diseases	O
.	O

ABSTRACT	O
:	O
Replicating	O
viruses	B-SPEC
generally	O
induce	O
type	O
1	O
immune	O
responses	O
,	O
with	O
high	O
interferon	O
(	O
IFN	O
)-	O
gamma	O
levels	O
and	O
antibodies	O
of	O
the	O
IgG2a	O
isotype	O
.	O

Because	O
disrupted	O
virions	O
also	O
induced	O
type	O
1	O
immune	O
responses	O
,	O
we	O
conclude	O
that	O
structural	O
elements	O
of	O
virions	O
inherently	O
contribute	O
to	O
IFN	O
-	O
gamma	O
-	O
dependent	O
isotype	O
switching	O
by	O
inactivated	O
viruses	B-SPEC
.	O

However	O
,	O
translational	O
selection	O
and	O
gene	O
length	O
have	O
no	O
effect	O
on	O
the	O
variations	O
of	O
synonymous	O
codon	O
usage	O
in	O
these	O
virus	B-SPEC
genes	O
.	O

Transmission	O
is	O
inter	O
-	O
human	B-SPEC
,	O
via	O
respiratory	O
particles	O
mainly	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
highly	O
infectious	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
),	O
predominantly	O
presents	O
with	O
severe	O
pneumonitis	O
leading	O
to	O
respiratory	O
failure	O
and	O
death	O
in	O
approximately	O
10	O
%	O
of	O
victims	O
.	O

We	O
used	O
a	O
similar	O
approach	O
to	O
study	O
the	O
fusogenic	O
mechanism	O
of	O
severe	O
-	O
acute	O
-	O
respiratory	O
-	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

With	O
this	O
objective	O
,	O
we	O
deleted	O
the	O
group	O
-	O
specific	O
gene	O
cluster	O
open	O
reading	O
frame	O
3abc	O
or	O
7ab	O
and	O
obtained	O
deletion	O
mutant	O
viruses	B-SPEC
that	O
not	O
only	O
multiplied	O
well	O
in	O
cell	O
culture	O
but	O
also	O
showed	O
an	O
attenuated	O
phenotype	O
in	O
the	O
cat	B-SPEC
.	O

The	O
passive	O
transfer	O
of	O
anti	O
-	O
human	B-SPEC
leukocyte	O
antigen	O
(	O
HLA	O
)	O
or	O
antineutrophil	O
antibodies	O
in	O
the	O
donated	O
blood	O
products	O
are	O
responsible	O
for	O
the	O
pathophysiological	O
process	O
in	O
TRALI	O
.	O

Age	O
was	O
found	O
to	O
be	O
an	O
independent	O
prognostic	O
indicator	B-SPEC
for	O
death	O
with	O
an	O
area	O
under	O
curve	O
(	O
AUC	O
)	O
of	O
0	O
.	O
96	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
0	O
.	O
90	O
-	O
0	O
.	O
99	O
]	O
but	O
not	O
for	O
admission	O
to	O
ICU	O
[	O
AUC	O
=	O
0	O
.	O
61	O
(	O
CI	O
=	O
0	O
.	O
51	O
-	O
0	O
.	O
70	O
)].	O

TITLE	O
:	O
Detection	O
of	O
human	B-SPEC
Coronavirus	I-SPEC
229E	I-SPEC
in	O
nasal	O
specimens	O
in	O
large	O
scale	O
studies	O
using	O
an	O
RT	O
-	O
PCR	O
hybridization	O
assay	O
.	O

Included	O
in	O
the	O
talks	O
were	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
presentations	O
about	O
infectious	O
clone	O
technology	O
and	O
recombinant	O
viruses	B-SPEC
,	O
pathogen	O
and	O
receptor	O
interactions	O
at	O
the	O
cellular	O
and	O
molecular	O
level	O
,	O
genomic	O
responses	O
to	O
infection	O
,	O
and	O
new	O
information	O
on	O
antiviral	O
mechanisms	O
of	O
action	O
.	O

The	O
most	O
common	O
complications	O
are	O
secondary	O
to	O
acute	O
liver	O
failure	O
and	O
include	O
severe	O
coagulopathy	O
,	O
encephalopathy	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
renal	O
failure	O
,	O
and	O
sepsis	B-SPEC
.	O

CONCLUSIONS	O
:	O
Inhaled	O
nitric	O
oxide	O
at	O
a	O
dose	O
of	O
5	O
ppm	O
in	O
patients	O
with	O
acute	O
lung	O
injury	O
not	O
due	O
to	O
sepsis	B-SPEC
and	O
without	O
evidence	O
of	O
nonpulmonary	O
organ	O
system	O
dysfunction	O
results	O
in	O
short	O
-	O
term	O
oxygenation	O
improvements	O
but	O
has	O
no	O
substantial	O
impact	O
on	O
the	O
duration	O
of	O
ventilatory	O
support	O
or	O
mortality	O
.	O

TITLE	O
:	O
Immunological	O
characterization	O
of	O
the	O
spike	O
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

We	O
conclude	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
smallpox	B-SPEC
are	O
easier	O
to	O
control	O
using	O
these	O
simple	O
public	O
health	O
measures	O
.	O

TITLE	O
:	O
Antiviral	O
chemotherapeutic	O
agents	O
against	O
respiratory	O
viruses	B-SPEC
:	O
where	O
are	O
we	O
now	O
and	O
what	O
'	O
s	O
in	O
the	O
pipeline	O
?	O

Compounds	O
with	O
activity	O
against	O
other	O
respiratory	O
viruses	B-SPEC
,	O
notably	O
rhinoviruses	B-SPEC
,	O
are	O
also	O
in	O
development	O
,	O
many	O
based	O
on	O
a	O
newer	O
knowledge	O
of	O
viral	O
protein	O
structure	O
and	O
function	O
(	O
rational	O
drug	O
design	O
).	O

TITLE	O
:	O
A	O
previously	O
undescribed	O
coronavirus	B-SPEC
associated	O
with	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

This	O
coronavirus	B-SPEC
replicated	O
efficiently	O
in	O
tertiary	O
monkey	B-SPEC
kidney	O
cells	O
and	O
Vero	O
cells	O
,	O
in	O
contrast	O
to	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
)	O
229E	O
and	O
OC43	O
.	O

The	O
edema	O
and	O
hypoxia	O
improved	O
,	O
but	O
respiratory	O
arrest	O
ensued	O
30	O
min	O
after	O
extubation	O
,	O
when	O
the	O
orangutan	B-SPEC
was	O
removed	O
from	O
mechanical	O
ventilation	O
.	O

The	O
codon	O
-	O
optimized	O
and	O
native	O
S	O
glycoproteins	O
exhibit	O
similar	O
molecular	O
weight	O
as	O
determined	O
by	O
Western	O
blot	O
analysis	O
,	O
indicating	O
that	O
synthetic	O
S	O
glycoprotein	O
is	O
modified	O
correctly	O
in	O
a	O
mammalian	B-SPEC
expression	O
system	O
.	O

TITLE	O
:	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
in	O
pneumocytes	O
of	O
the	O
lung	O
.	O

The	O
SARS	O
-	O
CoV	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
a	O
423	O
amino	O
-	O
acid	O
,	O
predicted	O
phospho	O
-	O
protein	O
of	O
46	O
kDa	O
that	O
shares	O
little	O
homology	O
with	O
other	O
members	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
.	O

In	O
order	B-SPEC
to	O
better	O
educate	O
the	O
public	O
about	O
this	O
emerging	O
infectious	O
disease	O
,	O
we	O
describe	O
the	O
characteristics	O
of	O
SARS	O
-	O
CoV	O
and	O
review	O
the	O
epidemiology	O
,	O
clinical	O
presentation	O
,	O
laboratory	O
,	O
radiographic	O
and	O
histopathological	O
features	O
,	O
diagnosis	O
,	O
treatment	O
,	O
prevention	O
and	O
infection	O
control	O
issues	O
pertaining	O
to	O
SARS	O
.	O

RESULTS	O
:	O
145	O
of	O
553	O
(	O
26	O
%)	O
patients	O
had	O
serologic	O
evidence	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
To	O
understand	O
the	O
time	O
-	O
course	O
of	O
viraemia	O
and	O
antibody	O
responses	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
RT	O
-	O
PCR	O
and	O
ELISA	O
were	O
used	O
to	O
assay	O
376	O
blood	O
samples	O
from	O
135	O
SARS	O
patients	O
at	O
various	O
stages	O
of	O
the	O
illness	O
,	O
including	O
samples	O
from	O
patients	O
who	O
were	O
in	O
their	O
early	O
convalescent	O
phase	O
.	O

Intranasal	O
or	O
intramuscular	O
inoculations	O
of	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
MVA	O
/	O
S	O
produced	O
serum	O
antibodies	O
that	O
recognized	O
the	O
SARS	O
S	O
in	O
ELISA	O
and	O
neutralized	O
SARS	O
-	O
CoV	O
in	O
vitro	O
.	O

Comparison	O
of	O
nasal	O
/	O
fecal	O
PRCV	O
pairs	O
from	O
individual	O
pigs	B-SPEC
revealed	O
different	O
deletions	O
in	O
the	O
spike	O
(	O
S	O
)	O
gene	O
(	O
648	O
or	O
681	O
nt	O
)	O
in	O
2	O
pairs	O
and	O
a	O
consistent	O
change	O
in	O
nt	O
790	O
/	O
791	O
(	O
aa	O
T	O
to	O
V	O
)	O
for	O
all	O
pairs	O
.	O

TITLE	O
:	O
Evidence	O
of	O
airborne	O
transmission	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
.	O

The	O
distribution	O
of	O
risk	O
in	O
buildings	O
B	O
,	O
C	O
,	O
and	O
D	O
corresponded	O
well	O
with	O
the	O
three	O
-	O
dimensional	O
spread	O
of	O
virus	B-SPEC
-	O
laden	O
aerosols	O
predicted	O
with	O
the	O
use	O
of	O
computational	O
fluid	O
-	O
dynamics	O
modeling	O
.	O

TITLE	O
:	O
Nosocomial	O
transmission	O
of	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
found	O
through	O
screening	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
--	O
Taipei	O
,	O
Taiwan	O
,	O
2003	O
.	O

HIV	B-SPEC
is	O
an	O
example	O
for	O
an	O
imported	O
pathogen	O
which	O
has	O
become	O
endemic	O
in	O
Germany	O
.	O

SARS	O
and	O
avian	B-SPEC
influenza	O
are	O
zoonoses	O
with	O
the	O
potential	O
to	O
spread	O
from	O
person	O
to	O
person	O
.	O

We	O
have	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
the	O
full	O
-	O
length	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
as	O
well	O
as	O
a	O
truncated	O
form	O
containing	O
only	O
the	O
catalytic	O
domains	O
.	O

Overall	O
,	O
the	O
molecular	O
and	O
biologic	O
characteristics	O
of	O
the	O
strain	O
HSR1	O
provide	O
evidence	O
that	O
SARS	O
-	O
CoV	O
forms	O
a	O
fourth	O
genetic	O
coronavirus	B-SPEC
group	I-SPEC
with	O
distinct	O
genomic	O
and	O
biologic	O
features	O
.	O

ABSTRACT	O
:	O
Acute	O
pneumonia	O
developed	O
in	O
a	O
previously	O
healthy	O
man	B-SPEC
during	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
southern	O
China	O
in	O
March	O
2003	O
.	O

Apart	O
from	O
frequently	O
causing	O
infections	O
in	O
the	O
general	O
community	O
,	O
many	O
types	O
of	O
viruses	B-SPEC
are	O
also	O
significant	O
nosocomial	O
pathogens	O
.	O

Indeed	O
,	O
the	O
relative	O
importance	O
of	O
viruses	B-SPEC
in	O
this	O
respect	O
is	O
increasing	O
due	O
to	O
a	O
number	O
of	O
societal	O
and	O
demographic	O
changes	O
as	O
well	O
as	O
alterations	O
in	O
healthcare	O
practices	O
.	O

TITLE	O
:	O
The	O
Internet	O
as	O
a	O
vehicle	O
to	O
communicate	O
health	O
information	O
during	O
a	O
public	O
health	O
emergency	O
:	O
a	O
survey	O
analysis	O
involving	O
the	O
anthrax	B-SPEC
scare	O
of	O
2001	O
.	O

In	O
order	B-SPEC
to	O
enhance	O
the	O
effectiveness	O
of	O
public	O
-	O
health	O
communication	O
,	O
physician	O
practices	O
could	O
use	O
this	O
technology	O
to	O
pro	O
-	O
actively	O
e	O
-	O
mail	O
their	O
patients	O
validated	O
information	O
.	O

RESULTS	O
:	O
Laboratory	O
confirmation	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
was	O
established	O
in	O
132	O
(	O
95	O
.	O
7	O
%).	O

In	O
suspension	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
gradually	O
lost	O
its	O
infectivity	O
completely	O
while	O
SARS	O
-	O
CoV	O
retained	O
its	O
infectivity	O
for	O
up	O
to	O
9	O
days	O
;	O
in	O
the	O
dried	O
state	O
,	O
survival	O
times	O
were	O
24	O
h	O
versus	O
6	O
days	O
.	O

These	O
are	O
:	O
Hendra	B-SPEC
virus	I-SPEC
,	O
formerly	O
named	O
equine	B-SPEC
morbillivirus	I-SPEC
,	O
which	O
was	O
responsible	O
for	O
an	O
outbreak	O
of	O
disease	O
in	O
horses	B-SPEC
and	O
humans	B-SPEC
in	O
Brisbane	O
,	O
Australia	O
,	O
in	O
1994	O
;	O
Australian	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
,	O
the	O
cause	O
of	O
a	O
severe	O
acute	O
encephalitis	O
,	O
in	O
1996	O
;	O
and	O
Nipah	B-SPEC
virus	I-SPEC
,	O
the	O
cause	O
of	O
a	O
major	O
outbreak	O
of	O
encephalitis	O
and	O
pulmonary	O
disease	O
in	O
domestic	B-SPEC
pigs	I-SPEC
and	O
people	O
in	O
peninsula	O
Malaysia	O
in	O
1999	O
.	O

This	O
will	O
be	O
very	O
important	O
if	O
diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
or	O
smallpox	B-SPEC
should	O
re	O
-	O
emerge	O
in	O
the	O
United	O
States	O
.	O

The	O
RT	O
-	O
PCR	O
successfully	O
typed	O
139	O
of	O
the	O
146	O
(	O
95	O
%)	O
rotavirus	B-SPEC
G	I-SPEC
types	O
and	O
124	O
(	O
85	O
%)	O
P	O
types	O
.	O

ABSTRACT	O
:	O
Two	O
thousand	O
,	O
two	O
hundred	O
and	O
seven	O
cats	B-SPEC
from	O
14	O
shelters	O
of	O
a	O
major	O
UK	O
cat	B-SPEC
charity	O
were	O
blood	O
tested	O
for	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
antibodies	O
.	O

There	O
are	O
four	O
outcomes	O
to	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infection	O
:	O
the	O
development	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
,	O
which	O
is	O
immune	O
-	O
mediated	O
),	O
subclinical	O
infection	O
,	O
development	O
of	O
healthy	O
lifelong	O
carriers	O
and	O
a	O
small	O
minority	O
of	O
cats	B-SPEC
who	O
resist	O
infection	O
(	O
Addie	O
and	O
Jarrett	O
,	O
Veterinary	O
Record	O
148	O
(	O
2001	O
)	O
649	O
).	O

FIP	O
is	O
most	O
prevalent	O
amongst	O
pedigree	O
cats	B-SPEC
,	O
although	O
how	O
much	O
of	O
this	O
is	O
due	O
to	O
them	O
living	O
in	O
large	O
groups	O
(	O
leading	O
to	O
higher	O
virus	B-SPEC
challenge	O
and	O
stress	O
which	O
predisposes	O
to	O
FIP	O
)	O
and	O
how	O
much	O
is	O
due	O
to	O
genetic	O
susceptibility	O
is	O
not	O
known	O
.	O

If	O
host	O
genetics	O
could	O
be	O
shown	O
to	O
play	O
a	O
role	O
in	O
disease	O
,	O
it	O
may	O
allow	O
the	O
detection	O
of	O
cats	B-SPEC
with	O
a	O
susceptibility	O
to	O
FIP	O
and	O
the	O
development	O
of	O
increased	O
population	O
resistance	O
through	O
selective	O
breeding	O
.	O

The	O
feline	B-SPEC
leucocyte	O
antigen	O
(	O
FLA	O
)	O
complex	O
contains	O
many	O
genes	O
that	O
are	O
central	O
to	O
the	O
control	O
of	O
the	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
Specified	O
pathogen	O
-	O
free	O
cats	B-SPEC
were	O
naturally	O
infected	O
with	O
FCoV	O
or	O
experimentally	O
infected	O
with	O
FCoV	O
type	O
I	O
.	O
Seroconversion	O
was	O
determined	O
and	O
the	O
course	O
of	O
infection	O
was	O
monitored	O
by	O
measuring	O
the	O
FCoV	O
loads	O
in	O
faeces	O
,	O
whole	O
blood	O
,	O
plasma	O
and	O
/	O
or	O
monocytes	O
.	O

TITLE	O
:	O
Common	O
virus	B-SPEC
infections	O
in	O
cats	B-SPEC
,	O
before	O
and	O
after	O
being	O
placed	O
in	O
shelters	O
,	O
with	O
emphasis	O
on	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
.	O

Fifteen	O
percent	O
of	O
cats	B-SPEC
were	O
shedding	O
FCV	B-SPEC
,	O
52	O
%	O
FHV	O
,	O
and	O
60	O
%	O
FECV	B-SPEC
after	O
1	O
week	O
.	O

Feline	B-SPEC
calicivirus	I-SPEC
infection	O
was	O
the	O
least	O
likely	O
to	O
spread	O
in	O
the	O
shelter	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
alpha	O
(	O
1	O
)-	O
acid	O
glycoprotein	O
(	O
fAGP	O
)	O
increases	O
during	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Those	O
that	O
survived	O
for	O
more	O
than	O
2	O
years	O
were	O
all	O
older	O
cats	B-SPEC
(	O
6	O
to	O
16	O
years	O
old	O
)	O
with	O
the	O
effusive	O
form	O
of	O
FIP	O
.	O

However	O
,	O
two	O
studies	O
have	O
shown	O
that	O
poxvirus	B-SPEC
vectors	O
(	O
vaccinia	O
WR	O
and	O
canarypox	O
)	O
expressing	O
only	O
the	O
FIPV	O
membrane	O
(	O
M	O
)	O
protein	O
can	O
elicit	O
a	O
partially	O
protective	O
immunity	O
which	O
is	O
supposed	O
to	O
be	O
cell	O
-	O
mediated	O
(	O
Virology	O
181	O
(	O
1991	O
)	O
327	O
;	O
International	O
patent	O
WO	O
97	O
/	O
20054	O
(	O
1997	O
)).	O

In	O
this	O
vector	O
,	O
the	O
M	O
gene	O
has	O
been	O
inserted	O
downstream	O
a	O
strong	O
early	O
/	O
late	O
promoter	O
,	O
whereas	O
the	O
two	O
previously	O
described	O
poxviruses	B-SPEC
expressed	O
the	O
M	O
protein	O
during	O
their	O
early	O
stage	O
only	O
.	O

ABSTRACT	O
:	O
In	O
August	O
2002	O
,	O
scientists	O
and	O
veterinarians	O
from	O
all	O
over	O
the	O
world	O
met	O
in	O
Scotland	O
to	O
discuss	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
and	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

TITLE	O
:	O
Structural	O
basis	O
for	O
coronavirus	B-SPEC
-	O
mediated	O
membrane	O
fusion	O
.	O

The	O
crystal	O
structure	O
of	O
the	O
fusion	O
core	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
S	O
protein	O
,	O
which	O
represents	O
the	O
first	O
fusion	O
core	O
structure	O
of	O
any	O
coronavirus	B-SPEC
,	O
reveals	O
a	O
central	O
hydrophobic	O
coiled	O
coil	O
trimer	O
surrounded	O
by	O
three	O
helices	B-SPEC
in	O
an	O
oblique	O
,	O
antiparallel	O
manner	O
.	O

We	O
have	O
proposed	O
the	O
binding	O
regions	O
of	O
HR1	O
and	O
HR2	O
of	O
other	O
coronaviruses	O
and	O
a	O
structure	O
model	O
of	O
their	O
fusion	O
core	O
based	O
on	O
our	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
fusion	O
core	O
structure	O
and	O
sequence	O
alignment	O
.	O

ABSTRACT	O
:	O
Postinfectious	O
proliferative	O
glomerulonephritis	O
may	O
occur	O
in	O
HIV	B-SPEC
-	O
infected	O
patients	O
,	O
although	O
it	O
is	O
not	O
a	O
common	O
cause	O
of	O
severe	O
acute	O
renal	O
failure	O
in	O
them	O
.	O

RESULTS	O
:	O
The	O
aetiological	O
diagnosis	O
by	O
infective	O
agent	O
is	O
as	O
follows	O
:	O
150	O
patients	O
(	O
25	O
.	O
2	O
%)	O
had	O
virus	B-SPEC
infections	O
,	O
of	O
which	O
90	O
.	O
7	O
%	O
(	O
136	O
/	O
150	O
)	O
were	O
by	O
rhinovirus	B-SPEC
.	O

TITLE	O
:	O
[	O
Comparative	O
study	O
of	O
clinical	O
characteristics	O
and	O
prognosis	O
of	O
clinically	O
diagnosed	O
SARS	O
patients	O
with	O
positive	O
and	O
negative	O
serum	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
antibodies	O
test	O
].	O

Culture	O
cells	O
initially	O
contained	O
five	O
times	O
more	O
N	O
-	O
than	O
R	O
-	O
gene	O
RNA	O
,	O
but	O
the	O
respective	O
levels	O
converged	O
during	O
4	O
days	O
of	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
The	O
new	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
),	O
described	O
in	O
February	O
2003	O
,	O
infected	O
a	O
total	O
of	O
8	O
,	O
439	O
people	O
.	O

The	O
linear	O
range	O
for	O
the	O
Artus	O
RealArt	O
HPA	O
-	O
Coronavirus	B-SPEC
assay	O
(	O
Artus	O
assay	O
)	O
was	O
1	O
x	O
10	O
(	O
2	O
)	O
to	O
1	O
x	O
10	O
(	O
7	O
)	O
copies	O
/	O
ml	O
,	O
and	O
that	O
for	O
the	O
Roche	O
LightCycler	O
SARS	O
CoV	O
Quantification	O
kit	O
(	O
Roche	O
assay	O
)	O
was	O
1	O
x	O
10	O
(	O
4	O
)	O
to	O
2	O
x	O
10	O
(	O
8	O
)	O
copies	O
/	O
ml	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
a	O
new	O
therapy	O
for	O
effectively	O
correcting	O
severe	O
hypoxemia	O
in	O
patients	O
with	O
infectious	O
diseases	O
by	O
infusion	O
of	O
oxygen	O
-	O
enriched	O
liquid	O
,	O
in	O
order	B-SPEC
to	O
raise	O
the	O
partial	O
pressure	O
of	O
blood	O
oxygen	O
without	O
passing	O
through	O
pathologically	O
damaged	O
alveoli	O
of	O
such	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
correlation	O
between	O
positive	O
rates	O
of	O
RNA	O
in	O
clinical	O
confirmed	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
and	O
its	O
appearance	O
in	O
relation	O
to	O
the	O
development	O
of	O
the	O
disease	O
in	O
order	B-SPEC
to	O
provide	O
scientific	O
basis	O
for	O
early	O
diagnosis	O
,	O
effective	O
prevention	O
and	O
treatment	O
of	O
the	O
disease	O
.	O

CONCLUSIONS	O
:	O
One	O
-	O
step	O
RT	O
-	O
PCR	O
proved	O
to	O
be	O
an	O
effective	O
method	O
for	O
the	O
detection	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
from	O
clinical	O
specimens	O
.	O

Detection	O
of	O
HEV	B-SPEC
viral	O
RNA	O
by	O
nested	O
PCR	O
was	O
more	O
sensitive	O
than	O
virus	B-SPEC
isolation	O
in	O
cell	O
cultures	O
.	O

TITLE	O
:	O
A	O
one	O
step	O
quantitative	O
RT	O
-	O
PCR	O
for	O
detection	O
of	O
SARS	O
coronavirus	B-SPEC
with	O
an	O
internal	O
control	O
for	O
PCR	O
inhibitors	O
.	O

To	O
detect	O
false	O
negative	O
results	O
due	O
to	O
PCR	O
inhibitors	O
or	O
faulty	O
RNA	O
extraction	O
,	O
we	O
have	O
further	O
modified	O
this	O
one	O
step	O
RT	O
-	O
PCR	O
assay	O
for	O
simultaneous	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
and	O
18S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
as	O
an	O
internal	O
positive	O
control	O
.	O

Hyenas	B-SPEC
also	O
have	O
a	O
unique	O
hierarchical	O
social	O
system	O
that	O
might	O
affect	O
the	O
flow	O
of	O
pathogens	O
.	O

The	O
lower	O
prevalence	O
of	O
CDV	B-SPEC
antibody	O
-	O
positive	O
hyenas	B-SPEC
near	O
human	B-SPEC
habitation	O
suggests	O
that	O
reservoirs	O
for	O
CDV	B-SPEC
other	O
than	O
domestic	O
dogs	B-SPEC
are	O
present	O
in	O
the	O
Serengeti	O
ecosystem	O
.	O

Testing	O
included	O
serology	O
for	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
),	O
canine	B-SPEC
adenovirus	I-SPEC
,	O
Leptospira	B-SPEC
interrogans	I-SPEC
,	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
),	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
herpesvirus	I-SPEC
,	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
),	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
,	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
and	O
Bartonella	B-SPEC
henselae	I-SPEC
.	O

High	O
seroprevalence	O
was	O
detected	O
for	O
B	B-SPEC
.	I-SPEC
henselae	I-SPEC
and	O
T	B-SPEC
.	I-SPEC
gondii	I-SPEC
in	O
both	O
zones	O
.	O

To	O
assess	O
the	O
extent	O
to	O
which	O
free	O
-	O
ranging	O
cheetahs	B-SPEC
are	O
exposed	O
to	O
feline	B-SPEC
and	O
canine	O
viruses	B-SPEC
,	O
sera	O
from	O
81	O
free	O
-	O
ranging	O
cheetahs	B-SPEC
sampled	O
between	O
1992	O
and	O
1998	O
were	O
evaluated	O
for	O
antibodies	O
against	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
;	O
FCoV	O
/	O
FIPV	O
),	O
feline	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
(	O
FHV1	O
),	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
(	O
FPV	B-SPEC
),	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
FIV	B-SPEC
),	O
and	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
)	O
and	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	O
)	O
antigens	O
.	O

Antibodies	O
against	O
CDV	B-SPEC
,	O
FCoV	O
/	O
FIPV	O
,	O
FHV1	O
,	O
FPV	B-SPEC
,	O
and	O
FCV	B-SPEC
were	O
detected	O
in	O
24	O
,	O
29	O
,	O
12	O
,	O
48	O
,	O
and	O
65	O
%	O
of	O
the	O
free	O
-	O
ranging	O
population	O
,	O
respectively	O
,	O
although	O
no	O
evidence	O
of	O
viral	O
disease	O
was	O
present	O
in	O
any	O
animal	B-SPEC
at	O
the	O
time	O
of	O
sample	O
collection	O
.	O

We	O
employed	O
online	O
database	O
analysis	O
to	O
compare	O
the	O
differences	O
in	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
homologous	O
T	O
epitopes	O
of	O
HCoV	B-SPEC
-	I-SPEC
229e	I-SPEC
and	O
SARS	O
-	O
CoV	O
.	O
The	O
identified	O
T	O
-	O
cell	O
epitope	O
peptides	O
were	O
synthesized	O
,	O
and	O
their	O
binding	O
affinities	O
for	O
HLA	O
-	O
A2	O
were	O
validated	O
and	O
compared	O
in	O
the	O
T2	O
cell	O
system	O
.	O

Among	O
the	O
peptides	O
used	O
in	O
the	O
study	O
,	O
the	O
affinity	O
of	O
peptides	O
from	O
HCoV	B-SPEC
-	I-SPEC
229e	I-SPEC
(	O
H77	O
and	O
H881	O
)	O
and	O
peptides	O
from	O
SARS	O
-	O
CoV	O
(	O
S978	O
and	O
S1203	O
)	O
for	O
binding	O
to	O
HLA	O
-	O
A2	O
was	O
higher	O
than	O
that	O
of	O
other	O
sequences	O
.	O

The	O
tropism	O
of	O
this	O
reporter	O
virus	B-SPEC
was	O
similar	O
to	O
that	O
of	O
wild	O
-	O
type	O
,	O
replication	O
-	O
competent	O
SARS	O
-	O
CoV	O
,	O
and	O
binding	O
of	O
purified	O
S	O
to	O
susceptible	O
target	O
cells	O
was	O
demonstrated	O
by	O
flow	O
cytometry	O
.	O

The	O
amounts	O
of	O
cyclin	O
D2	O
and	O
cyclin	O
E	O
were	O
not	O
increased	O
significantly	O
after	O
serum	O
stimulation	O
in	O
mock	O
-	O
infected	O
cells	O
,	O
whereas	O
they	O
were	O
decreased	O
in	O
MHV	B-SPEC
-	O
infected	O
cells	O
,	O
suggesting	O
the	O
possibility	O
that	O
MHV	B-SPEC
infection	O
may	O
induce	O
cyclin	O
D2	O
and	O
cyclin	O
E	O
degradation	O
.	O

TITLE	O
:	O
Antisense	O
morpholino	O
-	O
oligomers	O
directed	O
against	O
the	O
5	O
'	O
end	O
of	O
the	O
genome	O
inhibit	O
coronavirus	B-SPEC
proliferation	O
and	O
growth	O
.	O

Peptide	O
-	O
conjugated	O
morpholino	O
-	O
oligomers	O
exhibited	O
low	O
toxicity	O
in	O
DBT	O
astrocytoma	O
cells	O
used	O
for	O
culturing	O
MHV	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
budding	O
at	O
the	O
endoplasmic	O
reticulum	O
-	O
Golgi	O
intermediate	O
compartment	O
(	O
ERGIC	O
)	O
requires	O
accumulation	O
of	O
the	O
viral	O
envelope	O
proteins	O
at	O
this	O
point	O
in	O
the	O
secretory	O
pathway	O
.	O

This	O
dibasic	O
motif	O
also	O
retained	O
a	O
reporter	O
protein	O
in	O
the	O
ERGIC	O
,	O
similar	O
to	O
the	O
dilysine	O
motif	O
in	O
IBV	B-SPEC
S	O
.	O
The	O
cytoplasmic	O
tails	O
of	O
S	O
proteins	O
from	O
group	O
2	O
coronaviruses	O
lack	O
an	O
intracellular	O
localization	O
signal	O
.	O

While	O
cell	O
-	O
cell	O
fusion	O
was	O
clearly	O
affected	O
by	O
preventing	O
spike	O
protein	O
cleavage	O
,	O
virus	B-SPEC
-	O
cell	O
fusion	O
was	O
not	O
,	O
indicating	O
that	O
these	O
events	O
have	O
different	O
requirements	O
.	O

A	O
distinct	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
aetiological	O
agent	O
of	O
SARS	O
.	O

Transplantation	O
of	O
glial	O
-	O
committed	O
progenitor	O
cells	O
into	O
the	O
T8	O
spinal	O
cord	O
of	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
demonstrating	O
complete	O
hindlimb	O
paralysis	O
resulted	O
in	O
migration	O
of	O
cells	O
up	O
to	O
12	O
mm	O
from	O
the	O
implantation	O
site	O
and	O
remyelination	O
of	O
up	O
to	O
67	O
%	O
of	O
axons	O
.	O

Transplanted	O
-	O
remyelinated	O
animals	B-SPEC
contained	O
approximately	O
2x	O
the	O
number	O
of	O
axons	O
within	O
sampled	O
regions	O
of	O
the	O
ventral	O
and	O
lateral	O
columns	O
as	O
compared	O
to	O
non	O
-	O
transplanted	O
animals	B-SPEC
,	O
suggesting	O
that	O
remyelination	O
is	O
associated	O
with	O
axonal	O
sparing	O
.	O

Here	O
we	O
report	O
that	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
protease	O
inhibitor	O
,	O
nelfinavir	O
,	O
strongly	O
inhibited	O
replication	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Here	O
we	O
describe	O
the	O
three	O
-	O
dimensional	O
structure	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
nucleocapsid	O
protein	O
.	O

The	O
construction	O
of	O
engineered	O
virus	B-SPEC
-	O
like	O
particles	O
bearing	O
resemblance	O
to	O
the	O
authentic	O
one	O
is	O
an	O
important	O
step	O
towards	O
the	O
development	O
of	O
an	O
effective	O
vaccine	O
against	O
infection	O
of	O
SARS	O
CoV	O
.	O

Recently	O
,	O
the	O
enzyme	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
was	O
characterized	O
using	O
a	O
HPLC	O
assay	O
to	O
monitor	O
the	O
formation	O
of	O
products	O
from	O
11	O
peptide	O
substrates	O
covering	O
the	O
cleavage	O
sites	O
found	O
in	O
the	O
SARS	O
viral	O
genome	O
.	O

ABSTRACT	O
:	O
Transmission	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
related	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
appears	O
to	O
be	O
heterogeneous	O
.	O

To	O
examine	O
the	O
effect	O
of	O
storage	O
temperature	O
on	O
the	O
ability	O
to	O
detect	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
RNA	O
by	O
multiplex	O
RT	O
-	O
PCR	O
,	O
fecal	O
samples	O
were	O
stored	O
for	O
different	O
temperatures	O
(	O
4	O
,	O
21	O
,	O
36	O
,	O
and	O
45	O
C	O
)	O
before	O
extracting	O
viral	O
RNA	O
.	O

The	O
agent	O
causing	O
this	O
illness	O
has	O
been	O
identified	O
as	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

hCMV	O
/	O
beta	O
-	O
actin	O
-	O
eGFP	O
-	O
3	O
'	O
UTR	O
t	O
-	O
PA	O
transgenic	B-SPEC
mice	I-SPEC
express	O
eGFP	O
mRNA	O
in	O
all	O
brain	O
structures	O
analyzed	O
but	O
lack	O
eGFP	O
fluorescence	O
,	O
with	O
the	O
exception	O
of	O
blood	O
vessels	O
,	O
choroid	O
plexus	O
,	O
and	O
Purkinje	O
cells	O
.	O

Hantaviruses	B-SPEC
(	O
Puumala	O
,	O
Hantaan	O
,	O
Sin	O
Nombre	O
and	O
others	O
)	O
infecting	O
field	O
rodents	B-SPEC
may	O
be	O
a	O
cause	O
of	O
hemorrhagic	O
fever	O
with	O
renal	O
syndrome	O
(	O
HFRS	O
)	O
or	O
pulmonary	O
syndrome	O
(	O
HPS	O
)	O
in	O
farmers	O
and	O
laboratory	O
workers	O
.	O

Vaccinations	O
effectively	O
restricted	O
the	O
number	O
of	O
occupational	O
infections	O
with	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
),	O
and	O
work	O
-	O
related	O
infections	O
with	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
causing	O
acquired	O
immunodeficiency	O
syndrome	O
(	O
AIDS	O
)	O
are	O
very	O
rare	O
.	O

Droplet	O
aerosols	O
,	O
which	O
are	O
generated	O
from	O
water	O
,	O
oils	O
,	O
oil	O
-	O
water	O
emulsions	O
and	O
other	O
liquids	O
in	O
various	O
work	O
environments	O
,	O
may	O
contain	O
infectious	O
agents	O
(	O
Legionella	B-SPEC
spp	O
.)	O
as	O
well	O
as	O
allergic	O
and	O
/	O
or	O
toxic	O
agents	O
.	O

TITLE	O
:	O
Following	O
the	O
rule	O
:	O
formation	O
of	O
the	O
6	O
-	O
helix	O
bundle	O
of	O
the	O
fusion	O
core	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
identification	O
of	O
potent	O
peptide	O
inhibitors	O
.	O

ABSTRACT	O
:	O
A	O
protocol	O
for	O
obtaining	O
small	O
amounts	O
of	O
highly	O
pure	O
virus	B-SPEC
preparations	O
starting	O
from	O
reduced	O
volumes	O
(<	O
5	O
ml	O
)	O
of	O
infected	O
tissue	O
culture	O
supernatants	O
is	O
described	O
.	O

TITLE	O
:	O
Bioinformatics	O
analysis	O
of	O
SARS	O
coronavirus	B-SPEC
genome	O
polymorphism	O
.	O

Abnormal	O
liver	O
functions	O
were	O
common	O
in	O
patients	O
with	O
SARS	O
and	O
could	O
be	O
associated	O
with	O
virus	B-SPEC
replication	O
in	O
the	O
liver	O
.	O

The	O
excessive	O
life	O
response	O
to	O
serious	O
clinical	O
insults	O
,	O
such	O
as	O
sepsis	B-SPEC
,	O
severe	O
pancreatitis	O
,	O
trauma	O
and	O
shock	O
,	O
is	O
called	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
).	O

ABSTRACT	O
:	O
A	O
previously	O
unknown	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
is	O
the	O
aetiological	O
agent	O
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
for	O
which	O
an	O
effective	O
antiviral	O
treatment	O
is	O
urgently	O
needed	O
.	O

Interviews	O
were	O
conducted	O
with	O
key	O
informants	O
from	O
Telehealth	O
staff	O
,	O
the	O
public	O
health	O
services	O
of	O
Ontario	O
and	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
Atlanta	B-SPEC
,	O
GA	O
,	O
USA	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
prevalence	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
type	O
4	O
/	O
91	O
in	O
Iran	O
,	O
tracheal	O
swabs	O
from	O
77	O
broiler	O
flocks	O
in	O
16	O
provinces	O
were	O
collected	O
at	O
the	O
slaughterhouse	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
establish	O
the	O
life	O
cycle	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
in	O
host	O
cells	O
and	O
determine	O
the	O
pathogenesis	O
of	O
SARS	O
.	O

A	O
special	O
phenomenon	O
was	O
that	O
some	O
virus	B-SPEC
-	O
like	O
particles	O
appeared	O
in	O
the	O
nucleus	O
.	O

Recombinant	O
N	O
and	O
S	O
proteins	O
of	O
SARS	O
-	O
CoV	O
were	O
purified	O
from	O
transformed	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

68	O
virus	B-SPEC
and	O
bacterial	O
cultures	O
,	O
240	O
clinical	O
samples	O
from	O
people	O
without	O
SARS	O
symptoms	O
and	O
also	O
22	O
RNA	O
samples	O
from	O
patients	O
with	O
SARS	O
symptoms	O
received	O
during	O
the	O
epidemic	O
in	O
Beijing	O
were	O
used	O
.	O

Although	O
there	O
is	O
a	O
clear	O
and	O
pressing	O
need	O
for	O
vaccines	O
to	O
prevent	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
rhinoviruses	B-SPEC
,	O
coronaviruses	O
,	O
parainfluenza	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
progress	O
has	O
been	O
extremely	O
slow	O
.	O

Each	O
of	O
the	O
N	O
pairs	O
of	O
reagents	O
X	O
(	O
j	O
)	O
and	O
Y	O
(	O
j	O
)	O
defines	O
an	O
axis	B-SPEC
in	O
an	O
N	O
-	O
dimensional	O
shape	O
space	O
.	O

For	O
other	O
virus	B-SPEC
families	O
like	O
the	O
picornaviruses	B-SPEC
it	O
is	O
known	O
that	O
pathology	O
is	O
related	O
to	O
proteolytic	O
cleavage	O
of	O
host	O
proteins	O
by	O
viral	O
proteinases	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
emergent	O
disease	O
due	O
to	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
caused	O
outbreaks	O
worldwide	O
.	O

The	O
appearance	O
of	O
pan	B-SPEC
-	O
consolidation	O
in	O
the	O
lung	O
in	O
less	O
than	O
7	O
days	O
and	O
/	O
or	O
unable	O
to	O
recover	O
the	O
number	O
of	O
lymphocytes	O
and	O
T	O
lymphocyte	O
subset	O
will	O
be	O
associated	O
with	O
poor	O
prognosis	O
.	O

Here	O
,	O
we	O
provide	O
evidences	O
that	O
RNAi	O
targeting	O
at	O
coronavirus	B-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RDRP	O
)	O
using	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
expression	O
plasmids	O
can	O
specifically	O
inhibit	O
expression	O
of	O
extraneous	O
coronavirus	B-SPEC
RDRP	O
in	O
293	O
and	O
HeLa	O
cells	O
.	O

The	O
IBV	B-SPEC
M	O
(	O
pro	O
)	O
and	O
RdRp	O
domains	O
were	O
highly	O
conserved	O
with	O
82	O
.	O
7	O
%	O
and	O
92	O
.	O
7	O
%	O
conserved	O
residues	O
,	O
respectively	O
.	O

There	O
was	O
no	O
correlation	O
between	O
the	O
genotype	O
of	O
any	O
region	O
of	O
the	O
replicase	O
gene	O
and	O
pathotype	O
,	O
suggesting	O
that	O
the	O
replicase	O
is	O
not	O
the	O
sole	O
determinant	O
of	O
IBV	B-SPEC
pathogenicity	O
.	O

We	O
used	O
monoclonal	O
antibodies	O
specifically	O
directed	O
against	O
N	O
protein	O
to	O
establish	O
a	O
sensitive	O
antigen	O
capture	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
for	O
the	O
detection	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
assay	O
employed	O
a	O
mixture	O
of	O
three	O
monoclonal	O
antibodies	O
for	O
capture	O
and	O
rabbit	B-SPEC
polyclonal	O
antibodies	O
for	O
detection	O
of	O
serum	O
antigen	O
in	O
32	O
cases	O
of	O
clinically	O
probable	O
SARS	O
as	O
defined	O
by	O
the	O
World	O
Health	O
Organization	O
during	O
the	O
epidemic	O
in	O
Guangzhou	O
,	O
China	O
.	O

TITLE	O
:	O
Complete	O
nucleotide	O
sequences	O
of	O
S1	O
and	O
N	O
genes	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolated	O
in	O
Japan	O
and	O
Taiwan	O
.	O

ABSTRACT	O
:	O
Recombinant	O
plant	B-SPEC
expression	O
systems	O
offer	O
a	O
means	O
to	O
produce	O
large	O
quantities	O
of	O
selected	O
antigens	O
for	O
subunit	O
vaccines	O
.	O

The	O
downstream	O
targets	O
of	O
p38	O
MAPK	O
,	O
MAPKAPK	O
-	O
2	O
,	O
HSP	O
-	O
27	O
,	O
CREB	O
,	O
and	O
eIF4E	O
were	O
phosphorylated	O
in	O
virus	B-SPEC
-	O
infected	O
cells	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SCoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
is	O
the	O
major	O
surface	O
antigen	O
of	O
the	O
virus	B-SPEC
and	O
is	O
responsible	O
for	O
receptor	O
binding	O
and	O
the	O
generation	O
of	O
neutralizing	O
antibody	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
surfactant	O
(	O
Curosurf	O
)	O
for	O
acute	O
respiratory	O
failure	O
after	O
near	O
-	O
drowning	O
in	O
12	O
year	O
old	O
.	O

Eight	O
general	O
practitioners	O
had	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
SARS	O
)	O
in	O
Hong	O
Kong	O
during	O
the	O
epidemic	O
,	O
and	O
others	O
may	O
have	O
been	O
infected	O
by	O
the	O
SARS	O
coronavirus	B-SPEC
without	O
developing	O
the	O
full	O
syndrome	O
.	O

Gas	O
insufflation	O
through	O
the	O
trachea	B-SPEC
is	O
a	O
promising	O
therapeutic	O
option	O
for	O
correcting	O
hypercapnia	O
secondary	O
to	O
ventilation	O
for	O
lung	O
protection	O
in	O
such	O
patients	O
.	O

The	O
risks	O
and	O
complications	O
of	O
the	O
usual	O
method	O
of	O
monitoring	O
by	O
Swan	B-SPEC
-	O
Ganz	O
catheter	O
are	O
well	O
-	O
known	O
.	O

TITLE	O
:	O
Genetic	O
variation	O
of	O
SARS	O
coronavirus	B-SPEC
in	O
Beijing	O
Hospital	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
injected	O
intratracheally	O
into	O
chickens	B-SPEC
,	O
turkeys	B-SPEC
,	O
geese	B-SPEC
,	O
ducks	B-SPEC
,	O
and	O
quail	O
,	O
or	O
into	O
the	O
allantoic	O
sac	O
of	O
their	O
embryonating	O
eggs	O
,	O
failed	O
to	O
cause	O
disease	O
or	O
replicate	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
in	O
vitro	O
with	O
clinically	O
approved	O
antiviral	O
drugs	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
has	O
been	O
recently	O
identified	O
as	O
the	O
causative	O
agent	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreak	O
that	O
has	O
accounted	O
for	O
more	O
than	O
8000	O
infected	O
people	O
worldwide	O
.	O

Several	O
observations	O
support	O
the	O
hypothesis	O
of	O
a	O
wild	O
animal	B-SPEC
origin	O
for	O
SARS	O
.	O

TITLE	O
:	O
SARS	O
corona	B-SPEC
virus	B-SPEC
peptides	O
recognized	O
by	O
antibodies	O
in	O
the	O
sera	O
of	O
convalescent	O
cases	O
.	O

Thus	O
,	O
relatively	O
few	O
changes	O
in	O
the	O
N	O
-	O
terminal	O
region	O
of	O
S1	O
are	O
sufficient	O
to	O
permit	B-SPEC
MHV	B-SPEC
-	O
A59	O
to	O
interact	O
with	O
alternative	O
receptors	O
on	O
murine	B-SPEC
and	O
non	O
-	O
murine	B-SPEC
cells	O
.	O

Eight	O
were	O
on	O
peritoneal	O
dialysis	B-SPEC
(	O
PD	O
)	O
and	O
four	O
on	O
hemodialysis	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
replication	O
by	O
niclosamide	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
provided	O
an	O
opportunity	O
to	O
study	O
the	O
antibody	O
response	O
of	O
infected	O
individuals	O
to	O
the	O
causative	O
virus	B-SPEC
,	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
results	O
indicated	O
that	O
S	O
protein	O
expressed	O
in	O
transgenic	O
plants	B-SPEC
might	O
be	O
a	O
new	O
source	O
for	O
the	O
production	O
of	O
Coronaviridae	B-SPEC
IBV	B-SPEC
vaccine	O
.	O

Prophylactic	O
administration	O
of	O
the	O
monoclonal	O
antibody	O
at	O
10	O
mg	O
/	O
kg	O
reduced	O
replication	O
of	O
SARS	O
coronavirus	B-SPEC
in	O
the	O
lungs	O
of	O
infected	O
ferrets	B-SPEC
by	O
3	O
.	O
3	O
logs	O
(	O
95	O
%	O
CI	O
2	O
.	O
6	O
-	O
4	O
.	O
0	O
logs	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
completely	O
prevented	O
the	O
development	O
of	O
SARS	O
coronavirus	B-SPEC
-	O
induced	O
macroscopic	O
lung	O
pathology	O
(	O
p	O
=	O
0	O
.	O
013	O
),	O
and	O
abolished	O
shedding	O
of	O
virus	B-SPEC
in	O
pharyngeal	O
secretions	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

A	O
histidine	O
-	O
tagged	O
form	O
of	O
nsp13	O
,	O
which	O
was	O
expressed	O
in	O
insect	B-SPEC
cells	O
and	O
purified	O
,	O
is	O
reported	O
to	O
unwind	O
efficiently	O
both	O
partial	O
-	O
duplex	O
RNA	O
and	O
DNA	O
of	O
up	O
to	O
several	O
hundred	O
base	O
pairs	O
.	O

By	O
contrast	O
,	O
the	O
3	O
'	O
UTRs	O
of	O
representative	O
group	O
1	O
or	O
group	O
3	O
coronaviruses	O
cannot	O
operate	O
as	O
substitutes	O
for	O
the	O
MHV	B-SPEC
3	O
'	O
UTR	O
.	O

Furthermore	O
,	O
studies	O
in	O
a	O
new	O
human	B-SPEC
cell	O
culture	O
model	O
have	O
indicated	O
that	O
the	O
presence	O
of	O
ACE2	O
alone	O
is	O
not	O
sufficient	O
for	O
maintaining	O
viral	O
infection	O
.	O

TITLE	O
:	O
Moderate	O
mutation	O
rate	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
genome	O
and	O
its	O
implications	O
.	O

To	O
date	O
,	O
the	O
speed	O
at	O
which	O
the	O
deadly	O
virus	B-SPEC
evolved	O
in	O
nature	O
and	O
the	O
elapsed	O
time	O
before	O
it	O
was	O
transmitted	O
to	O
humans	B-SPEC
remains	O
poorly	O
understood	O
.	O

ABSTRACT	O
:	O
A	O
method	O
is	O
described	O
for	O
enabling	O
safe	O
transit	O
of	O
denatured	O
virus	B-SPEC
samples	O
for	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
identification	O
without	O
the	O
risk	O
of	O
unwanted	O
viable	O
viruses	B-SPEC
.	O

Double	O
microwave	O
treatment	O
of	O
IBV	B-SPEC
and	O
APV	O
with	O
an	O
interval	O
of	O
2	O
to	O
7	O
days	O
between	O
was	O
tested	O
.	O

Virulence	O
studies	O
indicated	O
that	O
the	O
five	O
Chinese	O
IBV	B-SPEC
isolates	O
caused	O
10	O
to	O
30	O
%	O
mortality	O
in	O
15	O
-	O
day	O
-	O
old	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
and	O
gross	O
lesions	O
were	O
mainly	O
confined	O
to	O
the	O
kidneys	O
in	O
all	O
of	O
the	O
dead	O
chickens	B-SPEC
.	O

This	O
clearly	O
showed	O
that	O
the	O
five	O
Chinese	O
IBV	B-SPEC
isolates	O
comprised	O
a	O
separate	O
genotype	O
.	O

In	O
addition	O
to	O
influenza	O
,	O
viruses	B-SPEC
known	O
to	O
cause	O
ILI	O
include	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
,	O
human	B-SPEC
coronaviruses	O
(	O
including	O
the	O
virus	B-SPEC
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
and	O
the	O
recently	O
recognised	O
human	B-SPEC
metapneumovirus	I-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
an	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
isolated	O
in	O
China	O
from	O
chickens	B-SPEC
with	O
nephritis	O
.	O

The	O
physiochemical	O
and	O
morphological	O
properties	O
of	O
the	O
isolate	O
SC021202	O
were	O
in	O
accordance	O
to	O
that	O
of	O
typical	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
inactivated	O
vaccine	O
was	O
prepared	O
by	O
SARS	O
-	O
CoV	O
virus	B-SPEC
propagation	O
in	O
Vero	O
cells	O
,	O
with	O
subsequent	O
beta	O
-	O
propiolactone	O
inactivation	O
and	O
Sepharose	O
4FF	O
column	O
chromatography	O
purification	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
possible	O
risk	O
factors	O
of	O
severe	O
acute	O
respiratory	O
syndromes	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
in	O
workers	O
from	O
animal	B-SPEC
markets	O
.	O

RESULTS	O
:	O
Results	O
from	O
simple	O
factor	O
logistic	O
regression	O
analysis	O
showed	O
that	O
jobs	O
which	O
dealing	O
with	O
domestic	O
livestock	O
,	O
wild	O
livestock	O
,	O
wild	O
animals	B-SPEC
,	O
aquatics	O
were	O
related	O
to	O
risk	O
factors	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
aminopeptidase	O
N	O
(	O
APN	O
/	O
CD13	O
/	O
ANPEP	O
)	O
has	O
been	O
identified	O
as	O
the	O
receptor	O
for	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
229E	O
.	O

These	O
results	O
demonstrate	O
that	O
there	O
is	O
a	O
relatively	O
broad	O
spectrum	O
of	O
variations	O
in	O
the	O
APN	O
domain	O
critical	O
for	O
coronavirus	B-SPEC
binding	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
demonstrate	O
that	O
there	O
is	O
a	O
relatively	O
broad	O
spectrum	O
of	O
variations	O
in	O
the	O
APN	O
domain	O
critical	O
for	O
coronavirus	B-SPEC
binding	O
.	O

Initial	O
screening	O
by	O
ELISA	O
,	O
using	O
highly	O
purified	O
virus	B-SPEC
as	O
the	O
coating	O
antigen	O
,	O
resulted	O
in	O
the	O
selection	O
of	O
103	O
mAbs	O
to	O
the	O
SARS	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
3	O
'	O
end	O
region	O
nucleotide	O
sequence	O
,	O
including	O
ORF7	O
,	O
of	O
nine	O
Japanese	O
and	O
two	O
U	O
.	O
S	O
.	O
A	O
.	O
isolates	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
were	O
determined	O
and	O
compared	O
.	O

Although	O
the	O
identity	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
was	O
confirmed	O
by	O
DNA	O
sequencing	O
,	O
it	O
is	O
impractical	O
to	O
sequence	O
the	O
entire	O
29	O
-	O
kb	O
SARS	O
-	O
CoV	O
genome	O
on	O
a	O
routine	O
basis	O
.	O

We	O
have	O
developed	O
an	O
improved	O
method	O
for	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
transformation	O
of	O
human	B-SPEC
B	O
cells	O
.	O

TITLE	O
:	O
Potent	O
and	O
selective	O
inhibition	O
of	O
SARS	O
coronavirus	B-SPEC
replication	O
by	O
aurintricarboxylic	O
acid	O
.	O

In	O
addition	O
,	O
when	O
compared	O
with	O
IFNs	O
alpha	O
and	O
beta	O
,	O
ATA	B-SPEC
was	O
approximately	O
10	O
times	O
more	O
potent	O
than	O
IFN	O
alpha	O
and	O
100	O
times	O
more	O
than	O
interferon	O
beta	O
at	O
their	O
highest	O
concentrations	O
reported	O
in	O
the	O
literature	O
previously	O
.	O

TITLE	O
:	O
SARS	O
:	O
responding	O
to	O
an	O
unknown	O
virus	B-SPEC
.	O

The	O
combination	O
of	O
these	O
gel	O
-	O
base	O
and	O
non	O
-	O
gel	O
methods	O
provides	O
fast	O
and	O
complimentary	O
approaches	O
to	O
SARS	O
-	O
CoV	O
proteome	O
and	O
can	O
be	O
widely	O
used	O
in	O
the	O
analysis	O
of	O
other	O
viruses	B-SPEC
.	O

TITLE	O
:	O
[	O
Immunological	O
reaction	O
between	O
the	O
peptides	O
from	O
S1	O
domain	O
of	O
SARS	O
coronavirus	B-SPEC
S	O
-	O
protein	O
and	O
the	O
serum	O
from	O
SARS	O
patients	O
].	O

ABSTRACT	O
:	O
To	O
identify	O
and	O
characterize	O
the	O
siRNA	O
duplexes	O
that	O
are	O
effective	O
for	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
infection	O
and	O
replication	O
in	O
the	O
non	O
-	O
human	B-SPEC
primate	B-SPEC
cells	O
.	O

RSV	B-SPEC
was	O
identified	O
in	O
20	O
(	O
11	O
.	O
7	O
%)	O
of	O
170	O
influenza	O
-	O
vaccinated	O
adults	O
suffering	O
from	O
flu	O
-	O
like	O
symptoms	O
.	O

TITLE	O
:	O
Prediction	O
of	O
class	B-SPEC
I	O
T	O
-	O
cell	O
epitopes	O
:	O
evidence	O
of	O
presence	O
of	O
immunological	O
hot	O
spots	B-SPEC
inside	O
antigens	O
.	O

The	O
analysis	O
of	O
proteins	O
E6	O
and	O
E7	O
showed	O
that	O
ANN	O
models	O
appear	O
to	O
be	O
more	O
accurate	O
for	O
prediction	O
of	O
HLA	O
-	O
A3	O
hot	O
spots	B-SPEC
and	O
HMM	O
models	O
for	O
HLA	O
-	O
A2	O
predictions	O
.	O

Knowledge	O
of	O
the	O
genomic	O
sequence	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
has	O
facilitated	O
the	O
development	O
of	O
rapid	O
diagnostic	O
tests	O
.	O

Although	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
has	O
been	O
identified	O
as	O
the	O
causative	O
agent	O
of	O
SARS	O
,	O
the	O
pathogenic	O
mechanisms	O
of	O
SARS	O
are	O
not	O
understood	O
.	O

Our	O
epitope	O
-	O
based	O
serologic	O
test	O
may	O
be	O
useful	O
in	O
laboratory	O
detection	O
of	O
the	O
virus	B-SPEC
and	O
in	O
further	O
study	O
of	O
the	O
pathogenesis	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
This	O
study	O
established	O
a	O
modified	O
alkaline	O
phosphatase	O
-	O
labelled	O
avidin	O
-	O
biotin	O
-	O
complex	O
(	O
ABC	O
-	O
AP	O
)	O
method	O
for	O
diagnosis	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
Mycoplasma	B-SPEC
pulmonis	I-SPEC
infection	O
from	O
formalin	O
-	O
fixed	O
,	O
paraffin	O
wax	O
-	O
embedded	O
sections	O
,	O
murine	B-SPEC
antibody	O
-	O
positive	O
serum	O
being	O
used	O
as	O
the	O
primary	O
reagent	O
.	O

With	O
this	O
method	O
,	O
MHV	B-SPEC
antigen	O
in	O
cAnNCrj	O
.	O

Blood	O
-	O
borne	O
contamination	O
may	O
be	O
achieved	O
only	O
by	O
adopting	O
a	O
high	O
level	O
,	O
between	O
-	O
patients	O
disinfection	O
protocol	O
of	O
the	O
DUWLs	O
based	O
on	O
the	O
use	O
of	O
chemical	O
agents	O
with	O
biocidal	O
activity	O
against	O
spores	O
,	O
viruses	B-SPEC
,	O
bacteria	B-SPEC
and	O
fungi	B-SPEC
(	O
Autosteril	O
method	O
).	O

Ten	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
SARS	O
,	O
and	O
virological	O
confirmation	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
were	O
identified	O
.	O

The	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
virus	B-SPEC
particle	O
showed	O
a	O
binding	O
and	O
redistribution	O
pattern	O
that	O
was	O
similar	O
to	O
that	O
caused	O
by	O
the	O
anti	O
-	O
CD13	O
antibody	O
:	O
the	O
virus	B-SPEC
bound	O
to	O
the	O
cell	O
evenly	O
when	O
incubated	O
on	O
ice	O
but	O
became	O
colocalized	O
with	O
caveolin	O
-	O
1	O
at	O
37	O
degrees	O
C	O
;	O
importantly	O
,	O
the	O
virus	B-SPEC
also	O
caused	O
sequestration	O
of	O
CD13	O
to	O
the	O
caveolin	O
-	O
1	O
-	O
positive	O
area	O
.	O

TITLE	O
:	O
Antibody	O
responses	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
and	O
its	O
nucleocaspid	O
in	O
SARS	O
patients	O
.	O

All	O
three	O
positive	O
fecal	O
samples	O
were	O
from	O
the	O
15	O
juvenile	O
animals	B-SPEC
(<	O
24	O
months	O
of	O
age	O
)	O
sampled	O
,	O
and	O
none	O
from	O
the	O
12	O
adults	O
sampled	O
.	O

Sequencing	O
of	O
two	O
amplified	O
products	O
from	O
the	O
S	O
protein	O
gene	O
of	O
a	O
positive	O
sample	O
revealed	O
the	O
presence	O
of	O
coronavirus	B-SPEC
specific	O
RNA	O
with	O
a	O
sequence	O
homology	O
to	O
canine	O
coronavirus	B-SPEC
of	O
76	O
and	O
78	O
%	O
and	O
to	O
feline	B-SPEC
coronavirus	B-SPEC
type	O
II	O
of	O
80	O
and	O
84	O
%,	O
respectively	O
.	O

In	O
this	O
report	O
,	O
the	O
sensitivity	O
of	O
the	O
viral	O
plaque	O
assay	O
,	O
mouse	B-SPEC
antibody	O
production	O
test	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
for	O
detection	O
of	O
MHV	B-SPEC
-	O
A59	O
and	O
MMVp	O
,	O
two	O
of	O
the	O
most	O
prevalent	O
pathogenic	O
viruses	B-SPEC
in	O
experimental	O
mouse	B-SPEC
facilities	O
,	O
was	O
compared	O
.	O

By	O
phylogenetic	O
analysis	O
based	O
on	O
the	O
S1	O
gene	O
including	O
the	O
sequence	O
of	O
the	O
hypervariable	O
regions	O
,	O
IBV	B-SPEC
isolates	O
in	O
Japan	O
were	O
classified	O
into	O
five	O
genetic	O
groups	O
,	O
which	O
included	O
two	O
already	O
-	O
known	O
groups	O
(	O
Mass	O
and	O
Gray	O
).	O

This	O
is	O
the	O
first	O
report	O
showing	O
the	O
ability	O
of	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
to	O
induce	O
apoptosis	O
and	O
actin	O
reorganization	O
in	O
mammalian	B-SPEC
cells	O
under	O
stressed	O
conditions	O
.	O

ALC	O
increased	O
by	O
approximately	O
63	O
.	O
7	O
%	O
and	O
EVLW	O
decreased	O
by	O
46	O
.	O
9	O
%	O
with	O
improved	O
hypoxemia	O
in	O
the	O
Terbutaline	O
(	O
10	O
(-	O
4	O
)	O
M	O
)	O
group	O
,	O
compared	O
those	O
in	O
injured	O
rats	B-SPEC
.	O

RESULTS	O
:	O
At	O
24	O
h	O
after	O
the	O
infusion	O
of	O
oleic	O
acid	O
,	O
the	O
rats	B-SPEC
developed	O
pulmonary	O
edema	O
and	O
severe	O
hypoxemia	O
,	O
with	O
EVLW	O
increased	O
by	O
47	O
.	O
9	O
%	O
and	O
ALC	O
decreased	O
by	O
49	O
.	O
2	O
%.	O

TITLE	O
:	O
Recombinant	O
scFv	O
antibodies	O
against	O
E	O
protein	O
and	O
N	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
sought	O
to	O
investigate	O
the	O
anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
(	O
SCoV	O
)	O
activities	O
of	O
type	O
I	O
(	O
alpha	O
and	O
beta	O
)	O
and	O
type	O
II	O
(	O
gamma	O
)	O
interferons	O
(	O
IFN	O
)	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
and	O
other	O
critical	O
illnesses	O
produce	O
a	O
biphasic	O
inflammatory	O
,	O
immune	O
,	O
hormonal	O
,	O
and	O
metabolic	O
response	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
rapidly	O
progressive	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
infection	O
.	O

TITLE	O
:	O
A	O
novel	O
sorting	O
signal	O
for	O
intracellular	O
localization	O
is	O
present	O
in	O
the	O
S	O
protein	O
of	O
a	O
porcine	B-SPEC
coronavirus	B-SPEC
but	O
absent	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Major	O
genetic	O
marker	O
of	O
nidoviruses	B-SPEC
encodes	O
a	O
replicative	O
endoribonuclease	O
.	O

I	O
discuss	O
what	O
we	O
have	O
learned	O
about	O
the	O
movement	O
of	O
viruses	B-SPEC
into	O
humans	B-SPEC
from	O
studies	O
of	O
influenza	O
A	O
,	O
both	O
how	O
it	O
crossed	O
from	O
birds	B-SPEC
to	O
humans	B-SPEC
and	O
how	O
it	O
subsequently	O
evolved	O
within	O
the	O
human	B-SPEC
population	O
.	O

ABSTRACT	O
:	O
Proof	O
that	O
a	O
newly	O
identified	O
coronavirus	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
primary	O
cause	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
came	O
from	O
a	O
series	O
of	O
studies	O
on	O
experimentally	O
infected	O
cynomolgus	O
macaques	B-SPEC
(	O
Macaca	B-SPEC
fascicularis	I-SPEC
).	O

To	O
address	O
these	O
dual	O
threats	O
to	O
the	O
long	O
-	O
term	O
future	O
of	O
biodiversity	O
,	O
including	O
man	B-SPEC
,	O
requires	O
a	O
less	O
anthropocentric	O
and	O
more	O
interdisciplinary	O
approach	O
to	O
problems	O
that	O
require	O
the	O
combined	O
research	O
expertise	O
of	O
ecologists	O
,	O
conservation	O
biologists	O
,	O
veterinarians	O
,	O
epidemiologists	O
,	O
virologists	O
,	O
as	O
well	O
as	O
human	B-SPEC
health	O
professionals	O
.	O

There	O
was	O
a	O
close	O
linkage	O
between	O
civet	B-SPEC
cats	I-SPEC
and	O
humans	B-SPEC
in	O
terms	O
of	O
transmission	O
of	O
SARS	O
.	O

We	O
were	O
,	O
and	O
are	O
,	O
expecting	O
a	O
new	O
influenza	O
A	O
pandemic	O
,	O
but	O
no	O
one	O
predicted	O
the	O
emergence	O
of	O
an	O
unknown	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
as	O
a	O
deadly	O
human	B-SPEC
pathogen	O
.	O

In	O
order	B-SPEC
to	O
control	O
and	O
prevent	O
SARS	O
,	O
strict	O
management	O
was	O
conducted	O
in	O
three	O
universities	O
which	O
providing	O
various	O
social	O
supports	O
.	O

ABSTRACT	O
:	O
The	O
worldwide	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
shown	O
to	O
be	O
associated	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
)	O
now	O
called	O
SARS	O
CoV	B-SPEC
.	O
We	O
report	O
here	O
the	O
generation	O
of	O
SARS	O
CoV	O
S	O
protein	O
-	O
pseudotyped	O
murine	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
MLV	O
)	O
vector	O
particles	O
.	O

A	O
cat	B-SPEC
cell	O
line	O
and	O
a	O
dog	B-SPEC
cell	O
line	O
were	O
not	O
susceptible	O
.	O

TITLE	O
:	O
The	O
N	O
-	O
terminal	O
region	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
spike	O
glycoprotein	O
is	O
associated	O
with	O
the	O
extended	O
host	O
range	O
of	O
viruses	B-SPEC
from	O
persistently	O
infected	O
murine	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Although	O
murine	B-SPEC
coronaviruses	O
naturally	O
infect	O
only	O
mice	B-SPEC
,	O
several	O
virus	B-SPEC
variants	O
derived	O
from	O
persistently	O
infected	O
murine	B-SPEC
cell	O
cultures	O
have	O
an	O
extended	O
host	O
range	O
.	O

The	O
gag	B-SPEC
,	O
cough	O
or	O
vomiting	O
reflexes	O
that	O
lead	O
to	O
the	O
generation	O
of	O
aerosols	O
should	O
also	O
be	O
prevented	O
.	O

ARDS	O
rabbit	B-SPEC
models	O
were	O
established	O
by	O
injecting	O
oleic	O
acid	O
through	O
central	O
vein	O
,	O
and	O
the	O
results	O
of	O
effective	O
local	O
blood	O
perfusion	O
in	O
different	O
areas	O
of	O
rabbit	B-SPEC
lung	O
(	O
upper	O
area	O
,	O
abdominal	O
area	O
,	O
and	O
dorsal	O
area	O
of	O
right	O
lung	O
)	O
with	O
PIM	O
-	O
II	O
laser	B-SPEC
perfusion	O
imager	O
and	O
arterial	O
blood	O
gas	O
under	O
different	O
ventilation	O
modes	O
[	O
large	O
tidal	O
volume	O
ventilation	O
,	O
low	O
tidal	O
volume	O
ventilation	O
+	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
),	O
prone	O
position	O
+	O
large	O
tidal	O
volume	O
ventilation	O
,	O
and	O
prone	O
position	O
+	O
low	O
tidal	O
volume	O
ventilation	O
+	O
PEEP	O
]	O
were	O
measured	O
.	O

A	O
novel	O
electropositive	O
filter	O
was	O
used	O
to	O
concentrate	O
the	O
SARS	O
-	O
CoV	O
from	O
the	O
sewage	O
of	O
two	O
hospitals	O
administered	O
SARS	O
patients	O
in	O
Beijing	O
,	O
including	O
twelve	O
2	O
,	O
500	O
ml	O
sewage	O
samples	O
from	O
the	O
hospitals	O
before	O
disinfection	O
,	O
and	O
ten	O
25	O
,	O
000	O
ml	O
samples	O
after	O
disinfection	O
;	O
as	O
well	O
as	O
cell	O
culture	O
,	O
RT	O
-	O
PCR	O
and	O
sequencing	O
of	O
gene	O
to	O
detect	O
and	O
identify	O
the	O
viruses	B-SPEC
from	O
sewage	O
.	O

This	O
article	O
evaluates	O
the	O
effectiveness	O
of	O
thermal	O
scanner	O
when	O
it	O
is	O
being	O
used	O
for	O
mass	O
blind	O
screening	O
of	O
potential	O
fever	O
subjects	O
such	O
as	O
SARS	O
or	O
bird	B-SPEC
flu	O
patients	O
.	O

277	O
(	O
2002	O
)	O
19727	O
]	O
that	O
the	O
SU	O
of	O
a	O
murine	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
forms	O
dimers	O
,	O
the	O
dimerization	O
domain	O
overlaps	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
and	O
that	O
this	O
dimeric	O
state	O
is	O
important	O
for	O
binding	O
to	O
receptor	O
molecules	O
that	O
initiates	O
entry	O
into	O
cells	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
SARS	O
-	O
CoV	O
.	O
It	O
spread	O
rapidly	O
to	O
many	O
countries	O
and	O
developing	O
a	O
SARS	O
vaccine	O
is	O
now	O
urgently	O
required	O
.	O

Immunocompromised	O
patients	O
without	O
AIDS	O
,	O
who	O
have	O
CMV	B-SPEC
pneumonia	O
,	O
generally	O
demonstrate	O
a	O
combination	O
of	O
ground	O
-	O
glass	O
attenuation	O
,	O
air	O
-	O
space	O
consolidation	O
,	O
and	O
small	O
nodules	O
on	O
HRCT	O
.	O

APC	O
inhibits	O
ET	O
-	O
induced	O
TNF	O
-	O
alpha	O
production	O
in	O
vitro	O
in	O
human	B-SPEC
monocytes	O
by	O
inhibiting	O
activation	O
of	O
NFkappaB	O
and	O
AP	O
-	O
1	O
by	O
inhibiting	O
degradation	O
of	O
IkappaB	O
and	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
pathways	O
,	O
respectively	O
.	O

Recombinant	O
APC	O
was	O
reported	O
to	O
reduce	O
the	O
mortality	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Furthermore	O
,	O
APC	O
reduced	O
the	O
spinal	O
cord	O
injury	O
induced	O
by	O
compression	O
-	O
trauma	O
or	O
ischemia	O
/	O
reperfusion	O
by	O
inhibiting	O
TNF	O
-	O
alpha	O
production	O
in	O
rats	B-SPEC
,	O
suggesting	O
that	O
APC	O
may	O
be	O
a	O
potential	O
therapeutic	O
agent	O
for	O
spinal	O
cord	O
injury	O
in	O
which	O
only	O
limited	O
therapeutic	O
measures	O
are	O
currently	O
available	O
.	O

TITLE	O
:	O
Low	O
stability	O
of	O
nucleocapsid	O
protein	O
in	O
SARS	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
protein	O
(	O
N	O
protein	O
)	O
is	O
one	O
of	O
the	O
major	O
virion	O
structural	O
proteins	O
of	O
a	O
newly	O
identified	O
coronavirus	B-SPEC
,	O
which	O
has	O
been	O
confirmed	O
as	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

We	O
describe	O
the	O
environmental	O
findings	O
and	O
observations	O
from	O
this	O
response	O
,	O
including	O
the	O
rapid	O
reconfiguration	O
of	O
medical	O
facilities	O
during	O
a	O
national	O
health	O
emergency	O
,	O
and	O
discuss	O
environmental	O
challenges	O
should	O
SARS	O
or	O
a	O
SARS	O
-	O
like	O
virus	B-SPEC
emerge	O
again	O
.	O

TITLE	O
:	O
Detection	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
in	O
throat	O
wash	O
and	O
saliva	O
in	O
early	O
diagnosis	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
detection	O
.	O

Such	O
differences	O
were	O
detected	O
in	O
individual	O
sera	O
from	O
various	O
mouse	B-SPEC
strains	O
,	O
and	O
were	O
ascribed	O
to	O
the	O
fact	O
that	O
proteins	O
insolubilized	O
on	O
solid	O
supports	O
expose	O
a	O
variety	O
of	O
conformational	O
and	O
cryptic	O
antigenic	O
determinants	O
.	O

A	O
72	O
-	O
year	O
-	O
old	O
African	O
American	O
man	B-SPEC
developed	O
an	O
acute	O
confusional	O
state	O
(	O
ACS	O
)	O
one	O
month	O
after	O
receiving	O
celecoxib	O
for	O
osteoarthritis	O
of	O
his	O
knee	O
joints	O
.	O

The	O
focus	O
of	O
the	O
17th	O
International	O
Conference	O
on	O
Antiviral	O
Research	O
was	O
the	O
discovery	O
and	O
development	O
of	O
antiviral	O
agents	O
(	O
chemistry	O
,	O
biology	O
,	O
animal	B-SPEC
models	O
and	O
clinical	O
trial	O
results	O
)	O
against	O
a	O
variety	O
of	O
human	B-SPEC
infectious	O
agents	O
including	O
HIV	B-SPEC
,	O
herpes	O
viruses	B-SPEC
,	O
hepatitis	O
viruses	B-SPEC
,	O
respiratory	O
viruses	B-SPEC
and	O
emerging	O
/	O
re	O
-	O
emerging	O
pathogens	O
.	O

TITLE	O
:	O
Identification	O
and	O
characterization	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
replicase	O
proteins	O
.	O

Antibodies	O
directed	O
against	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
virions	O
and	O
against	O
the	O
putative	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
Pol	O
)	O
detected	O
SARS	O
-	O
CoV	O
nucleocapsid	O
and	O
nsp12	O
(	O
Pol	O
),	O
respectively	O
,	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
cells	O
.	O

Various	O
hypotheses	O
have	O
been	O
proposed	O
,	O
all	O
involving	O
opportunities	O
for	O
virus	B-SPEC
spread	O
(	O
for	O
example	O
,	O
agricultural	O
practices	O
,	O
climate	O
changes	O
,	O
rainforest	O
clearing	O
or	O
air	O
travel	O
).	O

TITLE	O
:	O
Antibodies	O
to	O
selected	O
pathogens	O
in	O
free	O
-	O
ranging	O
terrestrial	O
carnivores	B-SPEC
and	O
marine	O
mammals	B-SPEC
in	O
Canada	O
.	O

Anti	O
-	O
SARS	O
virus	B-SPEC
activities	O
of	O
interferons	O
were	O
determined	O
by	O
using	O
CPE	O
inhibition	O
test	O
in	O
human	B-SPEC
skeletal	O
muscle	O
sarcoma	O
(	O
Rda	O
)	O
cell	O
culture	O
.	O

All	O
the	O
tested	O
recombinant	O
interferons	O
showed	O
anti	O
-	O
SARS	O
virus	B-SPEC
activities	O
on	O
the	O
Rda	O
cell	O
culture	O
with	O
different	O
sensitivities	O
.	O

SARS	O
virus	B-SPEC
cDNA	O
chip	O
was	O
prepared	O
by	O
comparing	O
the	O
published	O
SARS	O
virus	B-SPEC
genome	O
sequence	O
,	O
and	O
the	O
cDNA	O
chip	O
was	O
used	O
to	O
study	O
the	O
interferon	O
alpha2b	O
function	O
during	O
SARS	O
virus	B-SPEC
replication	O
.	O

SARS	O
virus	B-SPEC
cDNA	O
chip	O
was	O
successfully	O
prepared	O
by	O
using	O
PCR	O
method	O
.	O

A	O
SARS	O
virus	B-SPEC
whole	O
genome	O
cDNA	O
chip	O
was	O
established	O
.	O

It	O
could	O
be	O
used	O
to	O
study	O
the	O
virus	B-SPEC
molecular	O
biology	O
and	O
antiviral	O
drug	O
screening	O
.	O

The	O
results	O
also	O
showed	O
that	O
interferon	O
alpha2b	O
could	O
inhibit	O
almost	O
the	O
whole	O
virus	B-SPEC
gene	O
transcription	O
by	O
using	O
the	O
cDNA	O
chip	O
.	O

Indirect	O
immunofluorescence	O
test	O
showed	O
a	O
specific	O
antigen	O
-	O
antibody	O
reactivity	O
between	O
the	O
coronavirus	B-SPEC
and	O
convalescent	O
-	O
phase	O
sera	O
of	O
SARS	O
patients	O
.	O

Our	O
results	O
show	O
that	O
the	O
SARS	O
-	O
CoV	O
is	O
well	O
adapted	O
to	O
growth	O
in	O
culture	O
and	O
did	O
not	O
appear	O
to	O
undergo	O
specific	O
selection	O
in	O
human	B-SPEC
populations	O
.	O

Compared	O
with	O
the	O
general	O
population	O
,	O
EMS	O
providers	O
are	O
at	O
higher	O
risk	O
of	O
contracting	O
the	O
SARS	O
virus	B-SPEC
regardless	O
of	O
different	O
perceived	O
levels	O
of	O
risk	O
.	O

ABSTRACT	O
:	O
We	O
have	O
developed	O
a	O
new	O
experimental	O
system	O
based	O
on	O
a	O
microfluidic	O
chip	O
to	O
determine	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Our	O
findings	O
suggest	O
that	O
this	O
outbreak	O
of	O
acute	O
encephalitis	O
in	O
Andhra	O
Pradesh	O
was	O
associated	O
with	O
Chandipura	B-SPEC
virus	I-SPEC
,	O
adding	O
to	O
the	O
evidence	O
suggesting	O
that	O
this	O
virus	B-SPEC
should	O
be	O
considered	O
as	O
an	O
important	O
emerging	O
pathogen	O
.	O

Lung	O
wet	O
-	O
to	O
-	O
dry	O
weight	O
ratio	O
and	O
lung	O
vascular	O
permeability	O
were	O
also	O
measured	O
in	O
the	O
AQP1	O
knockout	O
mice	B-SPEC
(	O
n	O
=	O
9	O
)	O
that	O
received	O
IT	O
LPS	O
(	O
5	O
mg	O
/	O
kg	O
)	O
at	O
2	O
days	O
.	O

Sequence	O
analysis	O
of	O
the	O
virus	B-SPEC
indicates	O
that	O
there	O
is	O
only	O
20	O
%	O
amino	O
acid	O
(	O
aa	O
)	O
identity	O
with	O
known	O
coronaviruses	O
.	O

TITLE	O
:	O
In	O
vitro	O
inhibition	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
by	O
chloroquine	O
.	O

Influenza	O
A	O
(	O
H1N1	O
and	O
H3N2	O
)	O
and	O
B	O
viruses	B-SPEC
were	O
detected	O
at	O
all	O
sites	O
.	O

The	O
pattern	O
of	O
endemic	O
pathogenic	O
organisms	O
,	O
the	O
rates	O
of	O
acquisition	O
of	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
MRSA	O
),	O
and	O
the	O
rates	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
were	O
compared	O
with	O
those	O
of	O
the	O
pre	O
-	O
SARS	O
and	O
post	O
-	O
SARS	O
periods	O
.	O

The	O
trial	O
,	O
comprising	O
two	O
studies	O
,	O
REARMI	O
and	O
REARMII	O
(	O
Research	O
/	O
Evaluation	O
of	O
Ampligen	O
for	O
Retroviral	B-SPEC
Mutations	O
I	O
and	O
II	O
),	O
will	O
evaluate	O
the	O
ability	O
of	O
Ampligen	O
to	O
prevent	O
the	O
emergence	O
of	O
mutated	O
,	O
drug	O
-	O
resistant	O
strains	O
of	O
the	O
virus	B-SPEC
.	O
'	O

In	O
October	O
2003	O
,	O
Hemispherx	O
announced	O
that	O
,	O
based	O
on	O
these	O
promising	O
new	O
results	O
,	O
the	O
company	O
will	O
stockpile	O
injectible	O
and	O
/	O
or	O
oral	O
formats	O
of	O
Ampligen	O
and	O
Alferon	O
N	O
.	O
Independent	O
researchers	O
have	O
demonstrated	O
the	O
antiviral	O
activity	O
of	O
Ampligen	O
against	O
flaviviruses	B-SPEC
(	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
Equine	B-SPEC
Encephalitis	O
virus	B-SPEC
,	O
Dengue	O
fever	O
virus	B-SPEC
and	O
Japanese	B-SPEC
Encephalitis	I-SPEC
virus	I-SPEC
)	O
as	O
well	O
as	O
virus	B-SPEC
classes	O
associated	O
with	O
bioterrorism	O
.	O

ABSTRACT	O
:	O
The	O
molecular	O
basis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
induced	O
pathology	O
is	O
still	O
largely	O
unclear	O
.	O

ABSTRACT	O
:	O
The	O
worldwide	O
epidemic	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
2003	O
was	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
called	O
SARS	O
-	O
CoV	O
.	O
Coronaviruses	O
and	O
their	O
closest	O
relatives	O
possess	O
extremely	O
large	O
plus	O
-	O
strand	O
RNA	O
genomes	O
and	O
employ	O
unique	O
mechanisms	O
and	O
enzymes	O
in	O
RNA	O
synthesis	O
that	O
separate	O
them	O
from	O
all	O
other	O
RNA	O
viruses	B-SPEC
.	O

The	O
SARS	O
epidemic	O
prompted	O
a	O
variety	O
of	O
studies	O
on	O
multiple	O
aspects	O
of	O
the	O
coronavirus	B-SPEC
replication	O
cycle	O
,	O
yielding	O
both	O
rapid	O
identification	O
of	O
the	O
entry	O
mechanisms	O
of	O
SARS	O
-	O
CoV	O
into	O
host	O
cells	O
and	O
valuable	O
structural	O
and	O
functional	O
information	O
on	O
SARS	O
-	O
CoV	O
proteins	O
.	O

These	O
recent	O
advances	O
in	O
coronavirus	B-SPEC
research	O
have	O
important	O
implications	O
for	O
the	O
development	O
of	O
anti	O
-	O
SARS	O
drugs	O
and	O
vaccines	O
.	O

The	O
full	O
-	O
length	O
CKLF1	O
cDNA	O
contains	O
530	O
bp	O
encoding	O
99	O
amino	O
acid	O
residues	O
with	O
a	O
CC	O
motif	O
similar	O
to	O
that	O
of	O
other	O
CC	O
family	B-SPEC
chemokines	O
.	O

Chemical	O
cross	O
-	O
linking	O
,	O
thermal	O
denaturation	O
,	O
and	O
size	O
fractionation	O
analyses	O
suggested	O
that	O
the	O
full	O
-	O
length	O
S	O
glycoprotein	O
of	O
SARS	O
-	O
CoV	O
forms	O
a	O
higher	O
order	B-SPEC
structure	O
of	O
approximately	O
500	O
kDa	O
,	O
which	O
is	O
consistent	O
with	O
it	O
being	O
an	O
S	O
homotrimer	O
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
gene	O
1	O
encodes	O
several	O
nonstructural	O
proteins	O
.	O

The	O
functions	O
are	O
unknown	O
for	O
most	O
of	O
these	O
nonstructural	O
proteins	O
,	O
including	O
p28	O
,	O
which	O
is	O
encoded	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
MHV	B-SPEC
genome	O
.	O

There	O
are	O
many	O
contributing	O
factors	O
to	O
this	O
increased	O
demand	O
,	O
including	O
the	O
ever	O
-	O
increasing	O
prevalence	O
of	O
chronic	O
viral	O
infections	O
such	O
as	O
HIV	B-SPEC
and	O
hepatitis	O
B	O
and	O
C	O
,	O
and	O
the	O
emergence	O
of	O
new	O
viruses	B-SPEC
such	O
as	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
novel	O
small	O
-	O
molecule	O
inhibitors	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
by	O
chemical	O
genetics	O
.	O

To	O
create	O
a	O
novel	O
trial	O
vaccine	O
and	O
evaluate	O
its	O
potency	O
,	O
we	O
attempted	O
to	O
generate	O
a	O
SARS	O
inactivated	O
vaccine	O
using	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
strain	O
F69	O
treated	O
with	O
formaldehyde	O
and	O
mixed	O
with	O
Al	O
(	O
OH	O
)	O
3	O
.	O

TITLE	O
:	O
The	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
cleaved	O
in	O
virus	B-SPEC
infected	O
Vero	O
-	O
E6	O
cells	O
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
the	O
application	O
of	O
real	O
-	O
time	O
PCR	O
for	O
testing	O
antivirals	O
against	O
highly	O
pathogenic	O
viruses	B-SPEC
such	O
as	O
Lassa	B-SPEC
virus	I-SPEC
,	O
SARS	O
coronavirus	B-SPEC
and	O
Ebola	B-SPEC
virus	I-SPEC
.	O

Small	O
-	O
scale	O
screening	O
identified	O
a	O
class	B-SPEC
of	O
imidazole	O
nucleoside	O
/	O
nucleotide	O
analogues	O
with	O
antiviral	O
activity	O
against	O
Lassa	B-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Detecting	O
specific	O
cytotoxic	O
T	O
lymphocytes	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
with	O
DimerX	O
HLA	O
-	O
A2	O
:	O
Ig	O
fusion	O
protein	O
.	O

In	O
conclusion	O
,	O
DimerX	O
-	O
based	O
flow	O
cytometry	O
staining	O
may	O
prove	O
to	O
be	O
a	O
real	O
-	O
time	O
method	O
to	O
screen	O
for	O
CTL	O
directed	O
at	O
epitopes	O
from	O
a	O
newly	O
identified	O
virus	B-SPEC
.	O

The	O
two	O
-	O
step	O
screening	O
method	O
described	O
here	O
yielded	O
several	O
small	O
molecules	O
that	O
can	O
be	O
used	O
for	O
developing	O
new	O
classes	O
of	O
anti	O
-	O
SARS	O
-	O
CoV	O
drugs	O
and	O
is	O
potentially	O
useful	O
for	O
the	O
high	O
-	O
throughput	O
screening	O
of	O
drugs	O
inhibiting	O
the	O
entry	O
of	O
HIV	B-SPEC
,	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
and	O
other	O
insidious	O
viruses	B-SPEC
into	O
their	O
host	O
cells	O
.	O

The	O
coronavirus	B-SPEC
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
)	O
utilizes	O
the	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
to	O
infect	O
cells	O
.	O

Murine	B-SPEC
3T3	O
cells	O
expressing	O
human	B-SPEC
ACE2	O
supported	O
SARS	O
-	O
CoV	O
replication	O
,	O
whereas	O
replication	O
was	O
less	O
than	O
10	O
%	O
as	O
efficient	O
in	O
the	O
same	O
cells	O
expressing	O
murine	B-SPEC
ACE2	O
.	O

A	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
was	O
also	O
seen	O
in	O
systemic	O
inflammatory	O
response	O
syndrome	O
score	O
,	O
incidence	O
of	O
sepsis	B-SPEC
,	O
and	O
incidence	O
of	O
multiple	O
organ	O
failure	O
.	O

Intranasal	O
BCV	B-SPEC
antigen	O
concentration	O
and	O
antibody	O
titer	O
against	O
BCV	B-SPEC
were	O
measured	O
on	O
entry	O
to	O
a	O
feedlot	O
.	O

These	O
data	O
provide	O
further	O
evidence	O
of	O
an	O
association	O
between	O
BCV	B-SPEC
and	O
respiratory	O
tract	O
disease	O
in	O
feedlot	O
calves	O
.	O

Subsequent	O
investigation	O
demonstrated	O
persistent	O
shedding	O
of	O
MHV	B-SPEC
in	O
two	O
lines	O
of	O
mice	B-SPEC
for	O
at	O
least	O
7	O
weeks	O
.	O

To	O
the	O
author	O
'	O
s	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
documented	O
case	O
of	O
clinically	O
inapparent	O
persistent	O
shedding	O
of	O
MHV	B-SPEC
in	O
mice	B-SPEC
that	O
are	O
not	O
genetically	O
engineered	O
.	O

The	O
animal	B-SPEC
facility	O
we	O
describe	O
had	O
contained	O
an	O
enzootic	O
infection	O
of	O
mouse	B-SPEC
coronavirus	B-SPEC
for	O
more	O
than	O
a	O
decade	O
.	O

(	O
Acanthaceae	B-SPEC
),	O
popularly	O
known	O
as	O
Da	O
-	O
Ching	O
-	O
Yeh	O
,	O
has	O
been	O
commonly	O
used	O
in	O
traditional	O
Chinese	O
medicine	O
.	O

Mean	O
pressure	O
in	O
the	O
respiratory	O
paths	O
(	O
Pmean	O
,	O
C	O
,	O
PaO2	O
/	O
FiO2	O
and	O
rSO2	O
readings	O
by	O
the	O
Glasgow	O
coma	B-SPEC
scale	O
,	O
cerebral	O
perfusion	O
pressure	O
,	O
and	O
consumption	O
of	O
sedatives	O
,	O
muscle	O
relaxants	O
and	O
vasopressins	O
as	O
well	O
as	O
frequency	O
rate	O
of	O
acute	O
pulmonary	O
lesions	O
(	O
APL	O
)	O
were	O
registered	O
.	O

TITLE	O
:	O
[	O
Spread	O
of	O
viruses	B-SPEC
through	O
the	O
food	O
chain	O
].	O

The	O
three	O
most	O
important	O
viral	O
agents	O
are	O
noroviruses	B-SPEC
(	O
NV	O
)	O
(	O
formerly	O
known	O
as	O
Norwalk	B-SPEC
-	I-SPEC
like	I-SPEC
viruses	I-SPEC
),	O
Rotavirus	B-SPEC
(	O
RV	O
)	O
and	O
Hepatitis	O
A	O
-	O
Virus	B-SPEC
(	O
HAV	O
).	O

For	O
NV	O
,	O
one	O
of	O
the	O
most	O
important	O
foodborne	O
(	O
live	O
bivalve	B-SPEC
molluscs	B-SPEC
)	O
viral	O
pathogens	O
,	O
indicator	B-SPEC
organisms	O
are	O
in	O
use	O
.	O

The	O
development	O
of	O
PCR	O
assays	O
for	O
the	O
detection	O
of	O
CPIV	O
,	O
canine	B-SPEC
adenovirus	I-SPEC
types	O
1	O
and	O
2	O
,	O
and	O
canine	B-SPEC
herpesvirus	I-SPEC
(	O
CHV	O
)	O
is	O
described	O
.	O

Surprisingly	O
,	O
canine	B-SPEC
adenovirus	I-SPEC
was	O
not	O
detected	O
in	O
samples	O
from	O
this	O
population	O
,	O
whereas	O
19	O
.	O
4	O
%	O
of	O
tracheal	O
and	O
10	O
.	O
4	O
%	O
of	O
lung	O
samples	O
were	O
positive	O
for	O
CPIV	O
and	O
12	O
.	O
8	O
%	O
of	O
tracheal	O
and	O
9	O
.	O
6	O
%	O
of	O
lung	O
samples	O
were	O
positive	O
for	O
CHV	O
.	O

ABSTRACT	O
:	O
Virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
produced	O
by	O
recombinant	O
expression	O
of	O
the	O
major	O
viral	O
structural	O
proteins	O
could	O
be	O
an	O
attractive	O
method	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
control	O
.	O

The	O
high	O
level	O
expression	O
of	O
VLPs	O
with	O
correct	O
S	O
protein	O
conformation	O
by	O
a	O
single	O
recombinant	O
baculovirus	B-SPEC
offers	O
a	O
potential	O
candidate	O
vaccine	O
for	O
SARS	O
.	O

This	O
study	O
examines	O
how	O
this	O
novel	O
disease	O
threat	O
was	O
depicted	O
in	O
the	O
UK	O
newspapers	O
,	O
using	O
social	O
representations	O
theory	O
and	O
in	O
particular	O
existing	O
work	O
on	O
social	O
representations	O
of	O
HIV	B-SPEC
/	O
AIDS	O
and	O
Ebola	O
to	O
analyse	O
the	O
meanings	O
of	O
the	O
epidemic	O
.	O

TITLE	O
:	O
[	O
Seroepidemiological	O
study	O
of	O
coronavirus	B-SPEC
infection	O
in	O
children	O
and	O
adults	O
in	O
St	O
.	O
Petersburg	O
].	O

ABSTRACT	O
:	O
We	O
live	O
in	O
an	O
ever	O
more	O
connected	O
global	O
village	O
linked	O
through	O
international	O
travel	O
,	O
politics	O
,	O
economics	O
,	O
culture	O
and	O
human	B-SPEC
-	O
human	B-SPEC
and	O
human	B-SPEC
-	O
animal	B-SPEC
interactions	O
.	O

Novel	O
infectious	O
disease	O
microbes	O
continue	O
to	O
be	O
discovered	O
because	O
they	O
are	O
new	O
or	O
newly	O
recognized	O
,	O
have	O
expanded	O
their	O
geographic	O
range	O
,	O
have	O
been	O
shown	O
to	O
cause	O
a	O
new	O
disease	O
spectrum	O
,	O
have	O
jumped	O
the	O
species	B-SPEC
barrier	O
from	O
animals	B-SPEC
to	O
humans	B-SPEC
,	O
have	O
become	O
resistant	O
to	O
antimicrobial	O
agents	O
,	O
have	O
increased	O
in	O
incidence	O
or	O
have	O
become	O
more	O
virulent	O
.	O

Information	O
from	O
the	O
human	B-SPEC
genome	O
project	O
applied	O
to	O
microbial	O
organisms	O
and	O
their	O
hosts	O
will	O
provide	O
new	O
opportunities	O
for	O
detection	O
,	O
diagnosis	O
,	O
treatment	O
,	O
prevention	O
,	O
control	O
and	O
prognosis	O
.	O

All	O
but	O
metapneumovirus	B-SPEC
are	O
known	O
to	O
have	O
caused	O
epidemics	O
of	O
severe	O
disease	O
and	O
at	O
least	O
two	O
(	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
and	O
influenza	O
H5N1	O
)	O
have	O
the	O
potential	O
to	O
cause	O
global	O
pandemics	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
-	O
associated	O
human	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
HCoV	O
)	O
is	O
a	O
newly	O
described	O
,	O
emerging	O
virus	B-SPEC
conclusively	O
established	O
as	O
the	O
etiologic	O
agent	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Viral	O
RNA	O
from	O
different	O
TGEV	B-SPEC
isolates	O
and	O
clinical	O
specimens	O
was	O
detected	O
.	O

The	O
majority	O
of	O
the	O
heavy	O
chains	O
belong	O
to	O
a	O
single	O
Ig	O
germline	O
V	O
-	O
gene	O
family	B-SPEC
,	O
while	O
considerably	O
more	O
sequence	O
variation	O
is	O
evident	O
in	O
the	O
light	O
chain	O
sequences	O
.	O

The	O
patient	O
,	O
a	O
36	O
-	O
year	O
-	O
old	O
Indonesian	O
woman	O
,	O
was	O
a	O
caretaker	O
working	O
for	O
a	O
Taiwanese	O
family	B-SPEC
.	O

When	O
the	O
cDNA	O
encoding	O
CD209L	O
from	O
clone	O
2	O
.	O
27	O
was	O
cloned	O
and	O
transfected	O
into	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
cells	O
,	O
the	O
cells	O
expressed	O
human	B-SPEC
CD209L	O
glycoprotein	O
and	O
became	O
susceptible	O
to	O
infection	O
with	O
SARS	O
-	O
CoV	O
.	O
Immunohistochemistry	O
showed	O
that	O
CD209L	O
is	O
expressed	O
in	O
human	B-SPEC
lung	O
in	O
type	O
II	O
alveolar	O
cells	O
and	O
endothelial	O
cells	O
,	O
both	O
potential	O
targets	O
for	O
SARS	O
-	O
CoV	O
.	O
Several	O
other	O
enveloped	O
viruses	B-SPEC
including	O
Ebola	O
and	O
Sindbis	O
also	O
use	O
CD209L	O
as	O
a	O
portal	O
of	O
entry	O
,	O
and	O
HIV	B-SPEC
and	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
can	O
bind	O
to	O
CD209L	O
on	O
cell	O
membranes	O
but	O
do	O
not	O
use	O
it	O
to	O
mediate	O
virus	B-SPEC
entry	O
.	O

TITLE	O
:	O
Quantitation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
genome	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
assay	O
using	O
minor	O
groove	O
binder	O
DNA	O
probe	O
technology	O
.	O

In	O
a	O
longitudinal	O
cross	O
-	O
sectional	O
study	O
,	O
we	O
determined	O
the	O
prevalence	O
of	O
virus	B-SPEC
in	O
bodily	O
excretions	O
and	O
time	O
of	O
seroconversion	O
in	O
discharged	O
patients	O
with	O
SARS	O
.	O

TITLE	O
:	O
Programmed	O
-	O
1	O
ribosomal	O
frameshifting	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Although	O
much	O
research	O
has	O
been	O
performed	O
on	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
),	O
little	O
quantitative	O
information	O
is	O
available	O
on	O
the	O
relationships	O
between	O
virulence	O
and	O
in	O
vivo	O
virus	B-SPEC
replication	O
,	O
among	O
isolates	O
recovered	O
at	O
different	O
times	O
in	O
the	O
history	O
of	O
PRRS	O
,	O
or	O
the	O
relative	O
levels	O
of	O
virulence	O
associated	O
with	O
individual	O
virus	B-SPEC
isolates	O
.	O

Under	O
the	O
premise	O
that	O
HE	O
specificity	O
reflects	O
receptor	O
usage	O
,	O
we	O
propose	O
that	O
two	O
types	O
of	O
Sias	O
serve	O
as	O
initial	O
attachment	O
factors	O
for	O
coronaviruses	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Nonstructural	O
protein	O
15	O
(	O
Nsp15	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
produced	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
has	O
endoribonuclease	O
activity	O
that	O
preferentially	O
cleaved	O
5	O
'	O
of	O
uridylates	O
of	O
RNAs	O
.	O

These	O
findings	O
advance	O
the	O
understanding	O
of	O
the	O
morphogenesis	O
of	O
SARS	O
-	O
CoV	O
and	O
enable	O
the	O
generation	O
of	O
safe	O
,	O
conformational	O
mimetics	O
of	O
the	O
SARS	O
virus	B-SPEC
that	O
may	O
facilitate	O
the	O
development	O
of	O
vaccines	O
and	O
antiviral	O
drugs	O
.	O

To	O
facilitate	O
the	O
studies	O
on	O
the	O
function	O
and	O
structure	O
of	O
the	O
N	O
protein	O
,	O
this	O
report	O
describe	O
the	O
expression	O
and	O
purification	O
of	O
recombinant	O
SARS	O
-	O
CoV	O
N	O
protein	O
using	O
the	O
baculovirus	B-SPEC
expression	O
system	O
.	O

This	O
is	O
the	O
first	O
report	O
demonstrating	O
that	O
a	O
coronavirus	B-SPEC
-	O
encoded	O
protein	O
could	O
modify	O
membrane	O
permeability	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
cells	O
.	O

The	O
primers	O
were	O
derived	O
from	O
the	O
corresponding	O
sequences	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
consensus	O
transcription	O
-	O
regulating	O
sequence	O
(	O
TRS	O
)	O
of	O
IBV	B-SPEC
,	O
CT	O
(	O
T	O
/	O
G	O
)	O
AACAA	O
,	O
was	O
highly	O
conserved	O
in	O
TCoV	O
genome	O
at	O
the	O
levels	O
of	O
nucleotide	O
sequence	O
and	O
location	O
in	O
regarding	O
to	O
the	O
initiation	O
codon	O
of	O
individual	O
genes	O
.	O

There	O
were	O
substantial	O
differences	O
of	O
S	O
protein	O
sequence	O
between	O
TCoV	O
and	O
IBV	B-SPEC
with	O
only	O
33	O
.	O
8	O
-	O
33	O
.	O
9	O
%	O
of	O
similarity	O
.	O

It	O
is	O
true	O
that	O
most	O
established	O
respiratory	O
pathogens	O
of	O
human	B-SPEC
beings	O
recur	O
in	O
wintertime	O
,	O
but	O
a	O
new	O
appreciation	O
for	O
the	O
high	O
burden	O
of	O
disease	O
in	O
tropical	O
areas	O
reinforces	O
questions	O
about	O
explanations	O
resting	O
solely	O
on	O
cold	O
air	O
or	O
low	O
humidity	O
.	O

hMPV	B-SPEC
testing	O
has	O
clinical	O
utility	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
tract	O
infection	O
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
is	O
one	O
of	O
the	O
most	O
important	O
viral	O
agents	O
affecting	O
the	O
gastrointestinal	O
system	O
of	O
dogs	B-SPEC
.	O

In	O
this	O
study	O
virological	O
and	O
serological	O
investigations	O
were	O
performed	O
to	O
demonstrate	O
the	O
existence	O
and	O
prevalence	O
of	O
CCoV	O
infection	O
in	O
a	O
Turkish	O
dog	B-SPEC
population	O
.	O

RESULTS	O
:	O
Six	O
studies	O
(	O
n	O
=	O
366	O
)	O
fulfilling	O
the	O
inclusion	O
criteria	O
were	O
found	O
,	O
of	O
which	O
the	O
quality	O
of	O
one	O
study	O
was	O
graded	O
as	O
B	O
,	O
the	O
remaining	O
five	O
were	O
graded	O
as	O
C	O
.	O
Two	O
studies	O
were	O
performed	O
with	O
meta	B-SPEC
-	O
analysis	O
,	O
the	O
other	O
four	O
studies	O
existed	O
some	O
heterogeneity	O
for	O
which	O
meta	B-SPEC
-	O
analysis	O
could	O
not	O
be	O
performed	O
,	O
a	O
significant	O
effect	O
on	O
lung	O
infiltrate	O
absorption	O
was	O
found	O
in	O
the	O
treatment	O
groups	O
of	O
these	O
two	O
studies	O
(	O
RR	O
6	O
.	O
68	O
,	O
95	O
%	O
CI	O
(	O
2	O
.	O
93	O
,	O
15	O
.	O
24	O
),	O
P	O
<	O
0	O
.	O
01	O
),	O
there	O
was	O
no	O
significant	O
differences	O
between	O
the	O
mortality	O
(	O
RR	O
0	O
.	O
86	O
,	O
95	O
%	O
CI	O
(	O
0	O
.	O
22	O
,	O
3	O
.	O
29	O
),	O
P	O
=	O
0	O
.	O
82	O
)	O
and	O
the	O
average	O
dosage	O
of	O
corticosteroid	O
(	O
WMD	O
-	O
39	O
.	O
65	O
,	O
95	O
%	O
CI	O
(-	O
116	O
.	O
84	O
,	O
37	O
.	O
54	O
),	O
P	O
=	O
0	O
.	O
31	O
).	O

Here	O
,	O
we	O
try	O
to	O
provide	O
a	O
relational	O
insight	O
on	O
those	O
UC	O
-	O
ORFs	O
,	O
suggesting	O
that	O
a	O
number	O
of	O
them	O
are	O
remotely	O
related	O
to	O
structural	O
proteins	O
of	O
coronaviruses	O
and	O
other	O
viruses	B-SPEC
infecting	O
mammalian	B-SPEC
hosts	O
.	O

TITLE	O
:	O
Tyrosine	O
dephosphorylation	O
of	O
STAT3	O
in	O
SARS	O
coronavirus	B-SPEC
-	O
infected	O
Vero	O
E6	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
the	O
above	O
antigenic	O
sites	O
on	O
the	O
N	O
protein	O
are	O
important	O
in	O
eliciting	O
humoral	O
immune	O
response	O
against	O
SARS	O
-	O
CoV	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
and	O
can	O
be	O
used	O
as	O
antigens	O
for	O
developing	O
diagnostic	O
tests	O
.	O

ABSTRACT	O
:	O
The	O
disease	O
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
produces	O
great	O
economic	O
for	O
the	O
poultry	O
industry	O
.	O

Since	O
most	O
local	O
strains	O
are	O
in	O
Taiwanese	O
clusters	O
,	O
developing	O
vaccines	O
from	O
local	O
strains	O
is	O
necessary	O
for	O
IBV	B-SPEC
control	O
in	O
Taiwan	O
.	O

TITLE	O
:	O
Inactivated	O
SARS	O
-	O
CoV	O
vaccine	O
elicits	O
high	O
titers	O
of	O
spike	O
protein	O
-	O
specific	O
antibodies	O
that	O
block	O
receptor	O
binding	O
and	O
virus	B-SPEC
entry	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
a	O
new	O
human	B-SPEC
disease	O
in	O
the	O
autumn	O
of	O
2002	O
.	O

In	O
March	O
2003	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
found	O
to	O
be	O
the	O
causative	O
agent	O
.	O

The	O
causative	O
agent	O
is	O
a	O
new	O
strain	O
of	O
coronavirus	B-SPEC
most	O
likely	O
originating	O
from	O
wild	O
animals	B-SPEC
.	O

Associations	O
between	O
awareness	O
of	O
SARS	O
symptoms	O
and	O
(	O
i	O
)	O
first	O
action	O
to	O
be	O
taken	O
and	O
(	O
ii	O
)	O
mode	O
of	O
transportation	O
used	O
,	O
if	O
the	O
respondent	O
was	O
suspected	O
of	O
having	O
SARS	O
,	O
were	O
analysed	O
using	O
Chi	O
-	O
square	O
or	O
Fisher	B-SPEC
'	O
s	O
exact	O
tests	O
.	O

TITLE	O
:	O
Limited	O
transmission	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
in	O
young	O
turkeys	B-SPEC
by	O
adult	O
Alphitobius	B-SPEC
diaperinus	I-SPEC
(	O
Coleoptera	B-SPEC
:	O
Tenebrionidae	B-SPEC
).	O

Transmission	O
of	O
virus	B-SPEC
was	O
effectively	O
halted	O
by	O
surface	O
sterilization	O
of	O
the	O
beetles	B-SPEC
.	O

Whole	O
beetles	B-SPEC
were	O
also	O
examined	O
for	O
comparison	O
.	O

Special	O
RNA	O
fragment	O
of	O
SARS	O
virus	B-SPEC
has	O
not	O
been	O
detected	O
in	O
gargling	O
fluid	O
and	O
serum	O
of	O
SARS	O
convalescents	O
and	O
medical	O
staff	O
.	O

CONCLUSIONS	O
:	O
Special	O
RNA	O
fragment	O
of	O
SARS	O
virus	B-SPEC
has	O
not	O
been	O
detected	O
in	O
gargling	O
fluid	O
and	O
serum	O
of	O
SARS	O
convalescents	O
and	O
medical	O
staff	O
.	O

The	O
positions	O
of	O
bands	O
corresponding	O
to	O
some	O
of	O
the	O
structural	O
proteins	O
immobilized	O
on	O
the	O
membrane	O
were	O
then	O
located	O
and	O
verified	O
with	O
mouse	B-SPEC
or	O
rabbit	B-SPEC
antisera	O
specific	O
to	O
the	O
respective	O
proteins	O
.	O

The	O
overexpression	O
of	O
either	O
form	O
of	O
SYNCRIP	O
inhibited	O
syncytium	O
formation	O
induced	O
by	O
MHV	B-SPEC
infection	O
.	O

Furthermore	O
,	O
downregulation	O
of	O
the	O
endogenous	O
SYNCRIP	O
with	O
a	O
specific	O
short	O
interfering	O
RNA	O
delayed	O
MHV	B-SPEC
RNA	O
synthesis	O
;	O
in	O
contrast	O
,	O
overexpression	O
or	O
downregulation	O
of	O
SYNCRIP	O
did	O
not	O
affect	O
MHV	B-SPEC
translation	O
.	O

TITLE	O
:	O
Screening	O
for	O
fever	O
by	O
remote	O
-	O
sensing	O
infrared	O
thermographic	O
camera	B-SPEC
.	O

Other	O
viruses	B-SPEC
identified	O
included	O
influenza	B-SPEC
virus	I-SPEC
types	O
A	O
and	O
B	O
,	O
parainfluenzavirus	O
type	O
3	O
,	O
adenovirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
.	O

TITLE	O
:	O
Genome	O
structure	O
and	O
transcriptional	O
regulation	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
.	O

ABSTRACT	O
:	O
Two	O
human	B-SPEC
coronaviruses	O
are	O
known	O
since	O
the	O
1960s	O
:	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
.	O

SARS	O
-	O
CoV	O
was	O
discovered	O
in	O
the	O
early	O
spring	O
of	O
2003	O
,	O
followed	O
by	O
the	O
identification	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
the	O
fourth	O
member	O
of	O
the	O
coronaviridae	B-SPEC
family	B-SPEC
that	O
infects	O
humans	B-SPEC
.	O

It	O
may	O
also	O
contribute	O
to	O
the	O
development	O
of	O
additional	O
animal	B-SPEC
models	O
for	O
studying	O
SARS	O
pathogenesis	O
,	O
and	O
could	O
help	O
identify	O
the	O
animal	B-SPEC
reservoir	O
of	O
SARS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Topographic	O
changes	O
in	O
SARS	O
coronavirus	B-SPEC
-	O
infected	O
cells	O
at	O
late	O
stages	O
of	O
infection	O
.	O

High	O
magnification	O
of	O
the	O
maturing	O
virus	B-SPEC
particles	O
showed	O
a	O
rosette	O
appearance	O
with	O
short	O
knoblike	O
spikes	O
under	O
both	O
the	O
scanning	O
electron	O
and	O
atomic	O
force	O
microscopes	O
.	O

Thickening	O
of	O
the	O
actin	O
filaments	O
at	O
the	O
cell	O
edge	O
provided	O
the	O
bending	O
force	O
to	O
extrude	O
the	O
virus	B-SPEC
particles	O
.	O

Serum	O
samples	O
were	O
grouped	O
into	O
acute	O
SARS	O
(	O
n	O
=	O
74	O
;	O
<	O
7	O
days	O
after	O
onset	O
of	O
fever	O
)	O
and	O
non	O
-	O
SARS	O
[	O
n	O
=	O
1067	O
;	O
fever	O
and	O
influenza	O
A	O
(	O
n	O
=	O
203	O
),	O
pneumonia	O
(	O
n	O
=	O
176	O
);	O
lung	O
cancer	B-SPEC
(	O
n	O
=	O
29	O
);	O
and	O
healthy	O
controls	O
(	O
n	O
=	O
659	O
)]	O
cohorts	O
.	O

These	O
activities	O
have	O
a	O
re	O
-	O
emphasized	O
focus	O
as	O
a	O
result	O
of	O
the	O
events	O
of	O
September	O
11	O
,	O
2001	O
,	O
the	O
subsequent	O
anthrax	B-SPEC
events	O
,	O
and	O
the	O
continuing	O
importance	O
placed	O
on	O
bioterrorism	O
preparedness	O
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
and	O
emerging	O
infectious	O
diseases	O
(	O
eg	O
,	O
monkeypox	O
,	O
SARS	O
).	O

CVI	O
was	O
provoked	O
by	O
such	O
factors	O
as	O
the	O
course	O
of	O
the	O
main	O
disease	O
and	O
specific	O
treatment	O
,	O
previous	O
respiratory	O
infections	O
of	O
other	O
etiology	O
with	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
playing	O
the	O
leading	O
role	O
(	O
60	O
%).	O

This	O
feature	O
results	O
to	O
be	O
common	O
to	O
all	O
coronaviruses	O
,	O
suggesting	O
potential	O
targeting	O
for	O
drugs	O
preventing	O
coronavirus	B-SPEC
-	O
related	O
infections	O
.	O

Preliminary	O
data	O
suggest	O
that	O
a	O
high	O
viral	O
load	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
is	O
associated	O
with	O
adverse	O
outcomes	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
but	O
the	O
relation	O
of	O
viral	O
load	O
to	O
survival	O
is	O
unclear	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
microarrays	O
to	O
gain	O
a	O
global	O
view	O
of	O
the	O
transcriptional	O
responses	O
of	O
the	O
lung	O
to	O
LPS	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
ALI	O
that	O
mimics	O
ALI	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
[	O
Legionella	B-SPEC
pneumonia	O
which	O
occurred	O
in	O
a	O
private	O
whirlpool	O
bath	O
user	O
].	O

We	O
heard	O
from	O
her	O
family	B-SPEC
of	O
her	O
habit	O
she	O
had	O
taking	O
a	O
private	O
whirlpool	O
bath	O
2	O
or	O
3	O
times	O
everyday	O
.	O

TITLE	O
:	O
Overexpression	O
of	O
7a	O
,	O
a	O
protein	O
specifically	O
encoded	O
by	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
induces	O
apoptosis	O
via	O
a	O
caspase	O
-	O
dependent	O
pathway	O
.	O

TITLE	O
:	O
Genetic	O
screen	O
for	O
monitoring	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
.	O

We	O
studied	O
cardiovascular	O
stability	O
in	O
a	O
lamb	O
model	O
of	O
severe	O
ALI	O
,	O
comparing	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
with	O
AV	O
-	O
ECMO	O
therapy	O
.	O

Lambs	B-SPEC
in	O
the	O
AV	O
-	O
ECMO	O
group	O
were	O
able	O
to	O
maintain	O
normocapnia	O
with	O
a	O
maximum	O
of	O
30	O
%	O
reduction	O
in	O
the	O
minute	O
ventilation	O
,	O
as	O
compared	O
with	O
the	O
CMV	B-SPEC
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
virus	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
differs	O
from	O
the	O
previously	O
described	O
human	B-SPEC
coronaviruses	O
,	O
229E	O
and	O
OC43	O
.	O

TITLE	O
:	O
Humoral	O
immune	O
responses	O
in	O
rabbits	B-SPEC
induced	O
by	O
an	O
experimental	O
inactivated	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
vaccine	O
prepared	O
from	O
F69	O
strain	O
.	O

RESULTS	O
:	O
Rapid	O
and	O
potent	O
humoral	O
immune	O
responses	O
were	O
induced	O
by	O
the	O
inactivated	O
SARS	O
-	O
CoV	O
vaccine	O
in	O
all	O
the	O
eight	O
test	O
rabbits	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
2003	O
,	O
the	O
onset	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
worldwide	O
chaos	B-SPEC
.	O

ABSTRACT	O
:	O
--	O
Mortality	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
remains	O
at	O
unacceptable	O
levels	O
and	O
recent	O
new	O
strategies	O
are	O
not	O
being	O
widely	O
embraced	O
.	O

--	O
The	O
critical	O
care	O
nurse	O
plays	O
a	O
leading	O
role	O
in	O
the	O
detection	O
,	O
monitoring	O
and	O
treatment	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

The	O
history	O
of	O
coronavirus	B-SPEC
vaccines	O
and	O
the	O
occurrence	O
of	O
laboratory	O
-	O
associated	O
SARS	O
-	O
CoV	O
infections	O
underscore	O
the	O
need	O
for	O
stably	O
attenuated	O
strains	O
of	O
SARS	O
-	O
CoV	O
and	O
other	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
key	O
protein	O
for	O
the	O
formation	O
of	O
the	O
helical	O
nucleocapsid	O
during	O
virion	O
assembly	O
.	O

The	O
major	O
immunoglobulin	O
G	O
subclass	B-SPEC
recognizing	O
N	O
protein	O
was	O
immunoglobulin	O
G2a	O
,	O
and	O
stimulated	O
splenocytes	O
secreted	O
high	O
levels	O
of	O
gamma	O
interferon	O
and	O
IL	O
-	O
2	O
in	O
response	O
to	O
N	O
protein	O
.	O

More	O
importantly	O
,	O
the	O
immunized	O
mice	B-SPEC
produced	O
strong	O
delayed	O
-	O
type	O
hypersensitivity	O
(	O
DTH	O
)	O
and	O
CD8	O
(+)	O
CTL	O
responses	O
to	O
N	O
protein	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
a	O
life	O
-	O
threatening	O
disease	O
,	O
is	O
caused	O
by	O
the	O
newly	O
identified	O
virus	B-SPEC
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

This	O
interaction	O
could	O
be	O
blocked	O
by	O
either	O
the	O
serum	O
from	O
a	O
SARS	O
convalescent	O
patient	O
or	O
a	O
goat	B-SPEC
anti	O
-	O
ACE2	O
antibody	O
,	O
indicating	O
that	O
the	O
interaction	O
is	O
specific	O
.	O

ABSTRACT	O
:	O
We	O
built	O
a	O
system	O
to	O
guide	O
decisions	O
regarding	O
the	O
amount	O
of	O
genomic	O
sequencing	O
required	O
to	O
develop	O
diagnostic	O
DNA	O
signatures	O
,	O
which	O
are	O
short	O
sequences	O
that	O
are	O
sufficient	O
to	O
uniquely	O
identify	O
a	O
viral	O
species	B-SPEC
.	O

We	O
performed	O
simulations	O
,	O
based	O
on	O
existing	O
sequence	O
data	O
,	O
to	O
assess	O
the	O
number	O
of	O
genome	O
sequences	O
of	O
a	O
target	O
species	B-SPEC
and	O
of	O
close	O
phylogenetic	O
relatives	O
(	O
near	O
neighbors	O
)	O
that	O
are	O
required	O
to	O
predict	O
diagnostic	O
signature	O
regions	O
that	O
are	O
conserved	O
among	O
strains	O
of	O
the	O
target	O
species	B-SPEC
and	O
unique	O
relative	O
to	O
other	O
bacterial	O
and	O
viral	O
species	B-SPEC
.	O

For	O
DNA	O
viruses	B-SPEC
such	O
as	O
variola	B-SPEC
(	O
smallpox	B-SPEC
),	O
three	O
target	O
genomes	O
provide	O
sufficient	O
guidance	O
for	O
selecting	O
species	B-SPEC
-	O
wide	O
signatures	O
.	O

However	O
,	O
the	O
different	O
composition	O
of	O
the	O
tested	O
samples	O
affected	O
the	O
heat	O
sensitivity	O
of	O
the	O
virus	B-SPEC
strain	O
:	O
the	O
infectivity	O
of	O
the	O
virus	B-SPEC
in	O
Antithrombin	O
III	O
preparation	O
still	O
remained	O
after	O
heating	O
for	O
30	O
min	O
at	O
60	O
degrees	O
C	O
.	O
If	O
by	O
rare	O
chance	O
SARS	O
-	O
CoV	O
contaminates	O
source	O
plasma	O
,	O
there	O
should	O
be	O
no	O
or	O
only	O
minor	O
risk	O
of	O
this	O
virus	B-SPEC
infection	O
,	O
due	O
to	O
sufficient	O
inactivation	O
by	O
the	O
60	O
degrees	O
C	O
10	O
h	O
liquid	O
heating	O
step	O
,	O
although	O
we	O
must	O
pay	O
attention	O
to	O
the	O
composition	O
used	O
for	O
blood	O
product	O
preparation	O
.	O

However	O
,	O
the	O
different	O
composition	O
of	O
the	O
tested	O
samples	O
affected	O
the	O
heat	O
sensitivity	O
of	O
the	O
virus	B-SPEC
strain	O
:	O
the	O
infectivity	O
of	O
the	O
virus	B-SPEC
in	O
Antithrombin	O
III	O
preparation	O
still	O
remained	O
after	O
heating	O
for	O
30	O
min	O
at	O
60	O
degrees	O
C	O
.	O
CONCLUSIONS	O
:	O
If	O
by	O
rare	O
chance	O
SARS	O
-	O
CoV	O
contaminates	O
source	O
plasma	O
,	O
there	O
should	O
be	O
no	O
or	O
only	O
minor	O
risk	O
of	O
this	O
virus	B-SPEC
infection	O
,	O
due	O
to	O
sufficient	O
inactivation	O
by	O
the	O
60	O
degrees	O
C	O
10	O
h	O
liquid	O
heating	O
step	O
,	O
although	O
we	O
must	O
pay	O
attention	O
to	O
the	O
composition	O
used	O
for	O
blood	O
product	O
preparation	O
.	O

Comparing	O
these	O
data	O
to	O
the	O
mouse	B-SPEC
model	O
,	O
SARS	O
CoV	O
replicates	O
to	O
a	O
higher	O
titer	O
and	O
for	O
a	O
longer	O
duration	O
in	O
the	O
respiratory	O
tract	O
of	O
hamsters	B-SPEC
and	O
is	O
accompanied	O
by	O
significant	O
pathology	O
that	O
is	O
absent	O
in	O
mice	B-SPEC
.	O

Viremia	O
and	O
extrapulmonary	O
spread	O
of	O
SARS	O
CoV	O
to	O
liver	O
and	O
spleen	O
,	O
which	O
are	O
seen	O
in	O
hamsters	B-SPEC
,	O
were	O
not	O
detected	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
The	O
ubiquitin	O
-	O
proteasome	O
system	O
facilitates	O
the	O
transfer	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
from	O
endosome	O
to	O
cytoplasm	O
during	O
virus	B-SPEC
entry	O
.	O

In	O
the	O
presence	O
of	O
MG132	O
,	O
the	O
entering	O
viruses	B-SPEC
accumulated	O
in	O
both	O
the	O
endosome	O
and	O
denser	O
lysosome	O
,	O
suggesting	O
that	O
the	O
ubiquitin	O
-	O
proteasome	O
system	O
is	O
involved	O
in	O
the	O
release	O
of	O
virus	B-SPEC
from	O
the	O
endosome	O
to	O
the	O
cytosol	O
during	O
the	O
virus	B-SPEC
entry	O
step	O
.	O

TITLE	O
:	O
Monoclonal	O
antibodies	O
versus	O
reverse	O
transcription	O
-	O
PCR	O
for	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
in	O
a	O
patient	O
population	O
with	O
respiratory	O
tract	O
infections	O
admitted	O
to	O
hospital	O
.	O

Both	O
methods	O
detected	O
influenza	B-SPEC
viruses	I-SPEC
A	O
(	O
H1N1	O
and	O
H3N2	O
)	O
and	O
B	O
,	O
human	B-SPEC
parainfluenza	O
virus	B-SPEC
types	O
1	O
to	O
3	O
,	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
hRSV	B-SPEC
)	O
types	O
A	O
and	O
B	O
,	O
and	O
human	B-SPEC
adenoviruses	B-SPEC
.	O

TITLE	O
:	O
Structure	O
of	O
a	O
proteolytically	O
resistant	O
core	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
S2	O
fusion	O
protein	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
aetiological	O
agent	O
of	O
SARS	O
.	O

Vaccination	O
of	O
C57BL	O
/	O
6	O
mice	B-SPEC
with	O
Ad5	O
-	O
N	O
-	O
V	O
generated	O
potent	O
SARS	O
-	O
CoV	O
-	O
specific	O
humoral	O
and	O
T	O
cell	O
-	O
mediated	O
immune	O
responses	O
.	O

In	O
this	O
paper	O
,	O
we	O
highlight	O
three	O
examples	O
of	O
emerging	O
pathogens	O
:	O
Nipah	O
and	O
Hendra	B-SPEC
virus	I-SPEC
,	O
which	O
emerged	O
in	O
Malaysia	O
and	O
Australia	O
in	O
the	O
1990s	O
respectively	O
,	O
with	O
recent	O
outbreaks	O
caused	O
by	O
similar	O
viruses	B-SPEC
in	O
India	O
in	O
2000	O
and	O
Bangladesh	O
in	O
2004	O
;	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
which	O
emerged	O
in	O
the	O
New	O
World	O
in	O
1999	O
;	O
and	O
amphibian	B-SPEC
chytridiomycosis	O
,	O
which	O
has	O
emerged	O
globally	O
as	O
a	O
threat	O
to	O
amphibian	B-SPEC
populations	O
and	O
a	O
major	O
cause	O
of	O
amphibian	B-SPEC
population	O
declines	O
.	O

TITLE	O
:	O
Fatal	O
severe	O
acute	O
respiratory	O
syndrome	O
is	O
associated	O
with	O
multiorgan	O
involvement	O
by	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
reverse	O
genetics	O
and	O
development	O
of	O
vectors	O
for	O
gene	O
expression	O
.	O

A	O
new	O
family	B-SPEC
of	O
vectors	O
based	O
on	O
single	O
coronavirus	B-SPEC
genomes	O
,	O
in	O
which	O
essential	O
genes	O
have	O
been	O
deleted	O
,	O
has	O
emerged	O
including	O
replication	O
-	O
competent	O
,	O
propagation	O
-	O
deficient	O
vectors	O
.	O

TITLE	O
:	O
Reverse	O
genetics	O
of	O
coronaviruses	O
using	O
vaccinia	B-SPEC
virus	I-SPEC
vectors	O
.	O

We	O
describe	O
how	O
vaccinia	B-SPEC
virus	I-SPEC
-	O
mediated	O
homologous	O
recombination	O
can	O
be	O
used	O
to	O
introduce	O
specific	O
mutations	O
into	O
the	O
coronavirus	B-SPEC
genomic	O
cDNA	O
during	O
its	O
propagation	O
in	O
vaccinia	B-SPEC
virus	I-SPEC
and	O
how	O
recombinant	O
coronaviruses	O
can	O
be	O
isolated	O
.	O

Our	O
cloning	O
and	O
assembly	O
strategy	O
generated	O
an	O
infectious	O
clone	O
within	O
2	O
months	O
of	O
identification	O
of	O
the	O
causative	O
agent	O
of	O
SARS	O
,	O
providing	O
a	O
critical	O
tool	O
to	O
study	O
coronavirus	B-SPEC
pathogenesis	O
and	O
replication	O
.	O

The	O
main	O
impact	O
of	O
the	O
study	O
is	O
that	O
the	O
utilization	O
of	O
genetically	O
modified	O
(	O
GM	O
)	O
yeast	B-SPEC
produced	O
by	O
recombinant	O
DNA	O
technology	O
genomic	O
strategies	O
could	O
circumvent	O
the	O
bioprocessing	O
problems	O
that	O
otherwise	O
result	O
from	O
the	O
bioprocess	O
perturbations	O
:	O
this	O
is	O
as	O
a	O
result	O
of	O
oxidative	O
stress	O
caused	O
by	O
ROS	O
,	O
which	O
is	O
avoidable	O
by	O
deployment	O
of	O
appropriate	O
antioxidants	O
such	O
as	O
vitamins	O
E	O
,	O
C	O
and	O
D	O
(	O
and	O
antioxidant	O
proteins	O
and	O
enzymes	O
often	O
of	O
microbial	O
origin	O
via	O
recombinant	O
DNA	O
technology	O
).	O

Here	O
,	O
we	O
characterized	O
the	O
ATPase	O
and	O
helicase	O
activities	O
of	O
bacterially	O
expressed	O
mutant	O
forms	O
of	O
nsp10	O
and	O
its	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
ortholog	O
,	O
nsp13	O
,	O
and	O
correlated	O
these	O
in	O
vitro	O
activities	O
with	O
specific	O
virus	B-SPEC
phenotypes	O
.	O

Antibody	O
production	O
against	O
PEDV	B-SPEC
was	O
compared	O
among	O
groups	O
at	O
regular	O
intervals	O
.	O

ABSTRACT	O
:	O
This	O
review	O
reports	O
recent	O
findings	O
on	O
lipid	O
use	O
in	O
artificial	O
nutrition	O
in	O
patients	O
with	O
acute	O
respiratory	O
failure	O
or	O
severe	O
sepsis	B-SPEC
or	O
undergoing	O
major	O
surgery	O
.	O

Most	O
studies	O
focused	O
on	O
intravenous	O
fish	B-SPEC
oil	O
and	O
suggest	O
beneficial	O
effects	O
both	O
on	O
inflammatory	O
/	O
immune	O
parameters	O
and	O
patient	O
outcome	O
.	O

TITLE	O
:	O
[	O
Emergence	O
and	O
species	B-SPEC
barriers	O
].	O

In	O
humans	B-SPEC
,	O
emergent	O
viruses	B-SPEC
are	O
of	O
zoonotic	O
origin	O
and	O
often	O
due	O
to	O
crossing	O
of	O
species	B-SPEC
barrier	O
.	O

Screening	O
for	O
the	O
animal	B-SPEC
reservoir	O
is	O
extremely	O
important	O
to	O
prevent	O
re	O
-	O
emergence	O
and	O
to	O
eradicate	O
the	O
disease	O
.	O

The	O
emergential	O
success	O
of	O
some	O
viruses	B-SPEC
has	O
had	O
serious	O
consequences	O
on	O
human	B-SPEC
public	O
health	O
:	O
flu	O
pandemics	O
,	O
AIDS	O
pandemic	O
,	O
hemorrhagic	O
fever	O
,	O
and	O
more	O
recently	O
SARS	O
.	O

ABSTRACT	O
:	O
A	O
reverse	O
genetics	O
system	O
for	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
has	O
been	O
described	O
in	O
which	O
a	O
full	O
-	O
length	O
cDNA	O
,	O
corresponding	O
to	O
the	O
IBV	B-SPEC
(	O
Beaudette	O
-	O
CK	O
)	O
genome	O
,	O
was	O
inserted	O
into	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
genome	O
following	O
in	O
vitro	O
assembly	O
of	O
three	O
contiguous	O
cDNAs	O
[	O
Casais	O
,	O
R	O
.,	O
Thiel	O
,	O
V	O
.,	O
Siddell	O
,	O
S	O
.	O
G	O
.,	O
Cavanagh	O
,	O
D	O
.,	O
Britton	O
,	O
P	O
.,	O
2001	O
.	O

To	O
demonstrate	O
the	O
feasibility	O
of	O
the	O
method	O
we	O
exchanged	O
the	O
ectodomain	O
of	O
the	O
Beaudette	O
spike	O
gene	O
for	O
the	O
corresponding	O
region	O
from	O
IBV	B-SPEC
M41	O
and	O
generated	O
two	O
recombinant	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
rIBVs	O
)	O
expressing	O
the	O
chimaeric	O
S	O
protein	O
,	O
validating	O
the	O
method	O
as	O
an	O
alternative	O
way	O
for	O
generating	O
rIBVs	O
.	O

Control	O
measures	O
for	O
C	B-SPEC
.	I-SPEC
difficile	I-SPEC
Control	O
measures	O
include	O
paying	O
close	O
attention	O
to	O
the	O
hygiene	O
of	O
the	O
clinical	O
setting	O
,	O
disinfecting	O
using	O
bleach	O
and	O
the	O
isolation	O
of	O
infected	O
patients	O
.	O

TITLE	O
:	O
Comparison	O
of	O
the	O
clinical	O
manifestations	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
pneumonia	O
.	O

Respiratory	O
failure	O
developed	O
in	O
15	O
.	O
4	O
%	O
of	O
the	O
SARS	O
patients	O
and	O
in	O
none	O
of	O
the	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
patients	O
.	O

RESULTS	O
:	O
The	O
initial	O
clinical	O
manifestations	O
were	O
similar	O
in	O
patients	O
with	O
SARS	O
and	O
those	O
with	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
.	O

The	O
patient	O
was	O
previously	O
healthy	O
and	O
acquired	O
SARS	O
from	O
close	O
contact	O
with	O
an	O
infected	O
family	B-SPEC
member	O
.	O

Convalescent	O
serology	O
results	O
were	O
positive	O
for	O
antibodies	O
to	O
coronavirus	B-SPEC
.	O

However	O
,	O
since	O
sequencing	O
methods	O
can	O
read	O
fragments	O
of	O
up	O
to	O
1000	O
bp	O
only	O
,	O
methods	O
for	O
sequence	O
assembling	O
are	O
required	O
in	O
order	B-SPEC
to	O
read	O
whole	O
genomes	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
Bordetella	B-SPEC
pertussis	I-SPEC
can	O
cause	O
severe	O
illness	O
with	O
neurological	O
and	O
pulmonary	O
complications	O
in	O
children	O
.	O

Identification	O
of	O
antigenic	O
regions	O
in	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
may	O
be	O
important	O
for	O
the	O
functional	O
studies	O
of	O
this	O
virus	B-SPEC
or	O
the	O
development	O
of	O
clinical	O
diagnosis	O
.	O

Antibodies	O
against	O
SARS	O
virus	B-SPEC
were	O
screened	O
by	O
biopanning	O
with	O
immobilized	O
virus	B-SPEC
antigen	O
.	O

The	O
binding	O
specificity	O
of	O
phage	O
antibody	O
to	O
SARS	O
virus	B-SPEC
was	O
detected	O
by	O
ELISA	O
.	O

During	O
the	O
outbreak	O
of	O
SARS	O
in	O
the	O
first	O
half	O
of	O
2003	O
,	O
children	O
appeared	O
to	O
be	O
less	O
susceptible	O
to	O
the	O
SARS	O
coronavirus	B-SPEC
and	O
pediatric	O
patients	O
presented	O
with	O
a	O
less	O
aggressive	O
clinical	O
course	O
than	O
adult	O
patients	O
did	O
,	O
demonstrating	O
the	O
traits	O
which	O
were	O
rarely	O
observed	O
in	O
other	O
viral	O
contagious	O
disease	O
.	O

TITLE	O
:	O
[	O
Preparation	O
of	O
monoclonal	O
antibodies	O
against	O
SARS	O
coronavirus	B-SPEC
and	O
staining	O
usage	O
in	O
lung	O
autopsy	O
specimens	O
].	O

The	O
recommendations	O
in	O
the	O
CDC	O
document	O
were	O
based	O
on	O
some	O
of	O
the	O
important	O
lessons	O
learned	O
in	O
healthcare	O
settings	O
around	O
the	O
world	O
during	O
the	O
SARS	O
outbreak	O
of	O
2003	O
,	O
including	O
that	O
(	O
1	O
)	O
a	O
SARS	O
outbreak	O
requires	O
a	O
coordinated	O
and	O
dynamic	O
response	O
by	O
multiple	O
groups	O
;	O
(	O
2	O
)	O
unrecognized	O
cases	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
are	O
a	O
significant	O
source	O
of	O
transmission	O
;	O
(	O
3	O
)	O
restricting	O
access	O
to	O
the	O
healthcare	O
facility	O
can	O
minimize	O
transmission	O
;	O
(	O
4	O
)	O
airborne	O
infection	O
isolation	O
is	O
recommended	O
,	O
but	O
facilities	O
and	O
equipment	O
may	O
not	O
be	O
available	O
;	O
and	O
(	O
5	O
)	O
staffing	O
needs	O
and	O
support	O
will	O
pose	O
a	O
significant	O
challenge	O
.	O

Clinical	O
records	O
were	O
reviewed	O
,	O
and	O
age	O
,	O
duration	O
of	O
neurologic	O
illness	O
,	O
and	O
clinical	O
and	O
histopathologic	O
findings	O
in	O
cats	B-SPEC
with	O
spinal	O
cord	O
disease	O
were	O
abstracted	O
.	O

The	O
most	O
common	O
diseases	O
affecting	O
the	O
spinal	O
cord	O
of	O
cats	B-SPEC
were	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
lymphosarcoma	O
(	O
LSA	O
),	O
and	O
neoplasia	O
of	O
the	O
vertebral	O
column	O
secondarily	O
affecting	O
the	O
spinal	O
cord	O
.	O

Information	O
on	O
age	O
,	O
onset	O
and	O
duration	O
of	O
clinical	O
signs	O
,	O
and	O
lesion	O
localization	O
at	O
the	O
postmortem	O
examination	O
in	O
cats	B-SPEC
belonging	O
to	O
the	O
7	O
categories	O
of	O
disease	O
were	O
analyzed	O
to	O
create	O
a	O
practical	O
list	O
of	O
differential	O
diagnoses	O
.	O

From	O
the	O
host	O
distribution	O
of	O
different	O
groups	O
of	O
coronaviruses	O
and	O
the	O
phylogeny	O
of	O
s2m	O
,	O
we	O
can	O
deduce	O
that	O
avian	B-SPEC
is	O
the	O
probable	O
natural	O
host	O
of	O
SARS	O
-	O
CoV	O
.	O

ABSTRACT	O
:	O
To	O
develop	O
the	O
monoclonal	O
antibody	O
against	O
N	O
protein	O
of	O
SARS	O
virus	B-SPEC
and	O
study	O
its	O
applicability	O
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
recombinant	O
N	O
protein	O
.	O

CONCLUSIONS	O
:	O
The	O
monoclonal	O
antibody	O
has	O
good	O
specificity	O
and	O
may	O
be	O
used	O
to	O
detect	O
SARS	O
virus	B-SPEC
antigen	O
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
a	O
plasmid	O
bearing	O
codon	O
-	O
optimized	O
SARS	O
-	O
CoV	O
(	O
Tor2	O
strain	O
)	O
S1	O
domain	O
and	O
then	O
boosted	O
with	O
purified	O
S1	O
protein	O
;	O
the	O
SARS	O
-	O
CoV	O
specific	O
IgG	O
antibody	O
was	O
tested	O
by	O
ELISA	O
and	O
neutralization	O
antibody	O
was	O
determined	O
by	O
in	O
vitro	O
microneutralization	O
assay	O
.	O

S1	O
domain	O
of	O
SARS	O
-	O
CoV	O
spike	O
,	O
which	O
has	O
been	O
demonstrated	O
harboring	O
the	O
receptor	O
binding	O
domain	O
,	O
successfully	O
elicited	O
SARS	O
-	O
CoV	O
specific	O
IgG	O
antibody	O
in	O
mouse	B-SPEC
after	O
combined	O
immunization	O
with	O
DNA	O
and	O
purified	O
S1	O
protein	O
;	O
the	O
antibody	O
elicited	O
solely	O
by	O
S1	O
could	O
potently	O
neutralize	O
SARS	O
-	O
CoV	O
(	O
HKU	O
-	O
39849	O
)	O
in	O
vitro	O
,	O
50	O
%	O
of	O
1	O
000	O
TCID50	O
SARS	O
-	O
CoV	O
challenged	O
cells	O
were	O
protected	O
from	O
viral	O
infection	O
by	O
a	O
1	O
:	O
1499	O
.	O
68	O
dilution	O
of	O
mice	B-SPEC
sera	O
immunized	O
with	O
S1	O
protein	O
,	O
but	O
negative	O
control	O
sera	O
showed	O
no	O
protection	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
related	O
factors	O
of	O
the	O
X	O
-	O
ray	B-SPEC
outcomes	O
in	O
recovered	O
SARS	O
patients	O
.	O

TITLE	O
:	O
Expression	O
and	O
purification	O
of	O
SARS	O
coronavirus	B-SPEC
membrane	O
protein	O
.	O

ABSTRACT	O
:	O
To	O
construct	O
a	O
recombinant	O
plasmid	O
Pet23a	O
-	O
M	O
,	O
the	O
gene	O
encoding	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
membrane	O
protein	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
and	O
cloned	O
into	O
the	O
expression	O
plasmid	O
Pet23a	O
.	O

TITLE	O
:	O
Structure	O
and	O
intracellular	O
targeting	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
Orf7a	O
accessory	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
7a	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
a	O
unique	O
type	O
I	O
transmembrane	O
protein	O
of	O
unknown	O
function	O
.	O

TITLE	O
:	O
Prokaryotic	O
expression	O
,	O
refolding	O
,	O
and	O
purification	O
of	O
fragment	O
450	O
-	O
650	O
of	O
the	O
spike	O
protein	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

It	O
was	O
able	O
to	O
induce	O
strong	O
IgG	O
responses	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Here	O
,	O
we	O
investigated	O
the	O
influence	O
of	O
SARS	O
-	O
CoV	O
infection	O
on	O
CXCL8	O
(	O
interleukin	O
8	O
)	O
and	O
CXCL10	O
(	O
interferon	O
-	O
gamma	O
-	O
inducible	O
protein	O
10	O
)	O
in	O
human	B-SPEC
intestinal	O
epithelial	O
(	O
Caco2	O
)	O
cells	O
.	O

Three	O
(	O
2	O
.	O
5	O
%)	O
of	O
the	O
118	O
samples	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
tests	O
.	O

ABSTRACT	O
:	O
One	O
year	O
after	O
the	O
first	O
outbreak	O
infections	O
with	O
SARS	O
associated	O
coronavirus	B-SPEC
were	O
again	O
reported	O
and	O
the	O
clinical	O
picture	O
varied	O
.	O

Our	O
RT	O
-	O
PCR	O
for	O
SARS	O
associated	O
coronavirus	B-SPEC
is	O
a	O
valid	O
and	O
practicable	O
method	O
to	O
further	O
exclude	O
SARS	O
in	O
X	O
-	O
ray	B-SPEC
negative	O
patients	O
with	O
respiratory	O
symptoms	O
,	O
even	O
in	O
the	O
presence	O
of	O
other	O
respiratory	O
RNA	O
viruses	B-SPEC
.	O

The	O
highest	O
degree	O
of	O
similarity	O
is	O
demonstrated	O
between	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
BCoV	O
in	O
all	O
ORFs	O
with	O
the	O
exception	O
of	O
the	O
E	O
gene	O
.	O

TITLE	O
:	O
Identification	O
of	O
two	O
neutralizing	O
regions	O
on	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
produced	O
from	O
the	O
mammalian	B-SPEC
expression	O
system	O
.	O

ABSTRACT	O
:	O
Nitric	O
oxide	O
(	O
NO	O
)	O
is	O
an	O
important	O
signaling	O
molecule	O
between	O
cells	O
which	O
has	O
been	O
shown	O
to	O
have	O
an	O
inhibitory	O
effect	O
on	O
some	O
virus	B-SPEC
infections	O
.	O

The	O
levels	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
IgG	O
antibody	O
were	O
measured	O
by	O
ELISA	O
.	O

RESULTS	O
:	O
SARS	O
coronavirus	B-SPEC
IgG	O
antibody	O
was	O
detected	O
positive	O
in	O
6	O
of	O
the	O
9	O
patients	O
,	O
it	O
was	O
still	O
positive	O
in	O
the	O
sera	O
twelve	O
months	O
after	O
recovery	O
;	O
1	O
of	O
the	O
closely	O
contacted	O
persons	O
and	O
3	O
normal	O
subjects	O
were	O
found	O
positive	O
.	O

CONCLUSIONS	O
:	O
The	O
positive	O
rate	O
of	O
SARS	O
coronavirus	B-SPEC
IgG	O
antibody	O
of	O
patients	O
was	O
consistent	O
with	O
the	O
clinical	O
diagnosis	O
.	O

There	O
is	O
currently	O
an	O
urgent	O
need	O
to	O
identify	O
effective	O
antiviral	O
agents	O
that	O
will	O
prevent	O
and	O
treat	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
.	O

The	O
results	O
showed	O
that	O
SARS	O
-	O
CoV	O
grown	O
in	O
Vero	O
cells	O
is	O
moderately	O
sensitive	O
to	O
IFN	O
-	O
beta	O
and	O
only	O
weakly	O
sensitive	O
to	O
IFN	O
-	O
alpha	O
and	O
IFN	O
-	O
gamma	O
,	O
in	O
comparison	O
to	O
other	O
IFN	O
-	O
sensitive	O
viruses	B-SPEC
,	O
such	O
as	O
those	O
for	O
encephalomyocarditis	O
,	O
vesicular	O
stomatitis	O
and	O
Newcastle	O
disease	O
.	O

The	O
data	O
,	O
however	O
,	O
suggest	O
that	O
the	O
antiviral	O
activity	O
of	O
IFN	O
against	O
SARS	O
-	O
CoV	O
virus	B-SPEC
is	O
independent	O
of	O
MxA	O
expression	O
.	O

ABSTRACT	O
:	O
Serious	O
outbreaks	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
the	O
newly	O
discovered	O
coronavirus	B-SPEC
SARS	O
-	O
CoV	O
,	O
occurred	O
between	O
late	O
2002	O
and	O
early	O
2003	O
and	O
there	O
is	O
an	O
urgent	O
need	O
for	O
effective	O
antiviral	O
agents	O
.	O

RNA	O
interference	O
in	O
animals	B-SPEC
and	O
post	O
-	O
transcriptional	O
gene	O
silencing	O
plants	B-SPEC
is	O
mediated	O
by	O
small	O
double	O
-	O
stranded	O
RNA	O
molecules	O
named	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
).	O

The	O
findings	O
provide	O
possible	O
explanations	O
for	O
the	O
gastrointestinal	O
symptoms	O
and	O
the	O
presence	O
of	O
virus	B-SPEC
in	O
the	O
stool	O
of	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
emerged	O
in	O
later	O
February	O
2003	O
,	O
as	O
a	O
new	O
epidemic	O
form	O
of	O
life	O
-	O
threatening	O
infection	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

Using	O
these	O
probes	O
,	O
we	O
identified	O
genomic	O
sequences	O
of	O
a	O
novel	O
HCoV	O
,	O
designated	O
""""	O
New	O
Haven	O
coronavirus	B-SPEC
""""	O
(	O
HCoV	O
-	O
NH	O
).	O

We	O
identified	O
evidence	O
of	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
designated	O
""""	O
New	O
Haven	O
coronavirus	B-SPEC
""""	O
(	O
HCoV	O
-	O
NH	O
),	O
in	O
respiratory	O
secretions	O
from	O
a	O
6	O
-	O
month	O
-	O
old	O
infant	O
with	O
classic	O
Kawasaki	O
disease	O
.	O

TITLE	O
:	O
Development	O
and	O
characterization	O
of	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
neutralizing	O
human	B-SPEC
monoclonal	O
antibody	O
that	O
provides	O
effective	O
immunoprophylaxis	O
in	O
mice	B-SPEC
.	O

Antibodies	O
to	O
both	O
epitopes	O
protected	O
mice	B-SPEC
against	O
SARS	O
-	O
CoV	O
challenge	O
.	O

In	O
conclusion	O
,	O
our	O
work	O
provides	O
a	O
novel	O
strategy	O
to	O
produce	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
for	O
serodiagnosis	O
and	O
for	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
-	O
based	O
mucosal	O
vaccines	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
new	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
leads	O
to	O
deleterious	O
pulmonary	O
pathological	O
features	O
.	O

In	O
vitro	O
transcribed	O
RNA	O
from	O
a	O
cDNA	O
template	O
that	O
had	O
been	O
constructed	O
from	O
seven	O
cDNA	O
fragments	O
,	O
encompassing	O
the	O
entire	O
genome	O
of	O
IBV	B-SPEC
,	O
was	O
electroporated	O
into	O
BHK	O
-	O
21	O
cells	O
.	O

The	O
molecularly	O
cloned	O
IBV	B-SPEC
(	O
MIBV	O
)	O
demonstrated	O
growth	O
kinetics	O
,	O
and	O
plaque	O
size	O
and	O
morphology	O
that	O
resembled	O
the	O
parental	O
Beaudette	O
strain	O
IBV	B-SPEC
.	O

The	O
recombinant	O
virus	B-SPEC
was	O
further	O
manipulated	O
to	O
express	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
by	O
replacing	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
of	O
the	O
group	O
-	O
specific	O
gene	O
,	O
ORF	O
5a	O
,	O
with	O
the	O
EGFP	O
ORF	O
.	O

TITLE	O
:	O
Viral	O
and	O
bacterial	O
pathogens	O
in	O
bovine	B-SPEC
respiratory	O
disease	O
in	O
Finland	O
.	O

ABSTRACT	O
:	O
Pathogens	O
causing	O
bovine	B-SPEC
respiratory	O
tract	O
disease	O
in	O
Finland	O
were	O
investigated	O
.	O

Eighteen	O
cattle	B-SPEC
herds	O
with	O
bovine	B-SPEC
respiratory	O
disease	O
were	O
included	O
.	O

About	O
one	O
third	O
of	O
the	O
samples	O
were	O
also	O
tested	O
for	O
antibodies	O
to	O
bovine	B-SPEC
virus	B-SPEC
diarrhoea	O
virus	B-SPEC
(	O
BVDV	B-SPEC
)	O
with	O
negative	O
results	O
.	O

Mycoplasma	B-SPEC
bovis	I-SPEC
and	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
were	O
not	O
found	O
.	O

Of	O
58	O
participants	O
,	O
51	O
correctly	O
detected	O
virus	B-SPEC
in	O
all	O
samples	O
>	O
or	O
=	O
9	O
,	O
400	O
RNA	O
copies	O
per	O
milliliter	O
and	O
none	O
in	O
negative	O
samples	O
.	O

ABSTRACT	O
:	O
Using	O
three	O
different	O
assays	O
,	O
we	O
examined	O
103	O
serum	O
samples	O
collected	O
from	O
different	O
civet	B-SPEC
farms	O
and	O
a	O
market	O
in	O
China	O
in	O
June	O
2003	O
and	O
January	O
2004	O
.	O

The	O
assay	O
is	O
evaluated	O
as	O
a	O
diagnostic	O
test	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

The	O
assay	O
is	O
rapid	O
;	O
six	O
samples	O
can	O
be	O
tested	O
in	O
approximately	O
4	O
h	O
.	O
In	O
addition	O
,	O
the	O
primer	O
set	O
amplifies	O
all	O
IBV	B-SPEC
RNAs	O
tested	O
to	O
date	O
and	O
provides	O
a	O
built	O
in	O
control	O
for	O
detecting	O
IBV	B-SPEC
whether	O
it	O
is	O
typeable	O
or	O
not	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
emerged	O
infection	O
from	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

One	O
week	O
after	O
admission	O
,	O
she	O
became	O
suddenly	O
confused	O
and	O
had	O
a	O
convulsion	O
with	O
Glascow	O
Coma	B-SPEC
Score	O
10	O
(	O
3	O
+	O
3	O
+	O
4	O
).	O

Dialysis	B-SPEC
was	O
instituted	O
on	O
two	O
consecutive	O
days	O
from	O
the	O
eighth	O
day	O
.	O

Three	O
to	O
four	O
weeks	O
after	O
virus	B-SPEC
inoculation	O
,	O
T	O
cell	O
-	O
deficient	O
mice	B-SPEC
became	O
moribund	O
and	O
viral	O
RNA	O
was	O
detected	O
in	O
multiple	O
organ	O
systems	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
safe	O
and	O
sensitive	O
Spike	O
protein	O
-	O
based	O
immunofluorescence	O
assay	O
for	O
the	O
detection	O
of	O
antibody	O
responses	O
to	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Previously	O
,	O
we	O
have	O
identified	O
a	O
truncated	O
antigenic	O
fragment	O
named	O
protein	O
C	O
[	O
441	O
to	O
700	O
amino	O
acids	O
(	O
a	O
.	O
a	O
.)]	O
as	O
the	O
immunodominant	O
fragment	O
of	O
Spike	O
(	O
S	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

This	O
recombinant	O
baculovirus	B-SPEC
expressing	O
protein	O
C	O
was	O
first	O
characterized	O
using	O
five	O
SARS	O
convalescent	O
human	B-SPEC
sera	O
and	O
five	O
normal	O
human	B-SPEC
sera	O
.	O

All	O
of	O
the	O
21	O
SARS	O
-	O
positive	O
serum	O
samples	O
could	O
be	O
recognized	O
by	O
our	O
IFA	O
,	O
giving	O
a	O
specificity	O
and	O
sensitivity	O
of	O
100	O
%,	O
which	O
was	O
compatible	O
with	O
both	O
whole	O
virus	B-SPEC
-	O
based	O
IFA	O
assays	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
bats	B-SPEC
.	O

These	O
findings	O
suggest	O
that	O
this	O
virus	B-SPEC
might	O
be	O
commonly	O
circulating	O
in	O
M	B-SPEC
.	I-SPEC
pusillus	I-SPEC
in	O
Hong	O
Kong	O
.	O

TITLE	O
:	O
Role	O
of	O
nucleotides	O
immediately	O
flanking	O
the	O
transcription	O
-	O
regulating	O
sequence	O
core	O
in	O
coronavirus	B-SPEC
subgenomic	O
mRNA	O
synthesis	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
caused	O
by	O
a	O
novel	O
virus	B-SPEC
now	O
known	O
as	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Our	O
data	O
show	O
that	O
civets	B-SPEC
were	O
equally	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
isolates	O
GZ01	O
and	O
BJ01	O
.	O

TITLE	O
:	O
[	O
Prokaryotic	O
expression	O
of	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
construction	O
of	O
its	O
DNA	O
vaccine	O
].	O

Samples	O
from	O
children	O
hospitalized	O
with	O
respiratory	O
diseases	O
during	O
the	O
winter	O
seasons	O
of	O
2003	O
and	O
2004	O
were	O
evaluated	O
for	O
the	O
presence	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
using	O
a	O
optimized	O
pancoronavirus	O
RT	O
-	O
PCR	O
assay	O
.	O

TITLE	O
:	O
Function	O
of	O
HAb18G	O
/	O
CD147	O
in	O
invasion	O
of	O
host	O
cells	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Development	O
and	O
comparison	O
of	O
the	O
real	O
-	O
time	O
amplification	O
based	O
methods	O
--	O
NASBA	O
-	O
Beacon	O
,	O
RT	O
-	O
PCR	O
taqman	O
and	O
RT	O
-	O
PCR	O
hybridization	O
probe	O
assays	O
--	O
for	O
the	O
qualitative	O
detection	O
of	O
sars	O
coronavirus	B-SPEC
.	O

All	O
assays	O
yielded	O
results	O
by	O
detecting	O
SARS	O
coronavirus	B-SPEC
targeting	O
the	O
BNI	O
-	O
1	O
region	O
in	O
less	O
than	O
2	O
hours	O
.	O

RNA	O
detection	O
by	O
all	O
the	O
formats	O
was	O
unaffected	O
by	O
the	O
presence	O
of	O
human	B-SPEC
sputum	O
.	O

TITLE	O
:	O
Molecular	O
modeling	O
and	O
chemical	O
modification	O
for	O
finding	O
peptide	O
inhibitor	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
main	O
proteinase	O
.	O

In	O
this	O
study	O
,	O
the	O
cleavage	O
mechanism	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
(	O
Mpro	O
or	O
3CLpro	O
)	O
on	O
the	O
octapeptide	O
NH2	O
-	O
AVLQ	O
downward	O
arrowSGFR	O
-	O
COOH	O
was	O
investigated	O
using	O
molecular	O
mechanics	O
and	O
quantum	O
mechanics	O
simulations	O
based	O
on	O
the	O
experimental	O
structure	O
of	O
the	O
proteinase	O
.	O

Both	O
birds	B-SPEC
and	O
a	O
super	O
flu	O
could	O
bring	O
about	O
the	O
end	O
of	O
civilization	O
as	O
we	O
know	O
it	O
.	O

ABSTRACT	O
:	O
The	O
genomic	O
sequences	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronaviruses	O
from	O
human	B-SPEC
and	O
palm	O
civet	B-SPEC
of	O
the	O
2003	O
/	O
2004	O
outbreak	O
in	O
the	O
city	O
of	O
Guangzhou	O
,	O
China	O
,	O
were	O
nearly	O
identical	O
.	O

Phylogenetic	O
analysis	O
suggested	O
an	O
independent	O
viral	O
invasion	O
from	O
animal	B-SPEC
to	O
human	B-SPEC
in	O
this	O
new	O
episode	O
.	O

Although	O
many	O
parents	O
feared	O
transmitting	O
HIV	B-SPEC
to	O
their	O
children	O
or	O
catching	O
an	O
infection	O
from	O
their	O
children	O
,	O
few	O
were	O
avoiding	O
the	O
most	O
routine	O
forms	O
of	O
physical	O
affection	O
.	O

Clinicians	O
may	O
be	O
able	O
to	O
provide	O
education	O
to	O
HIV	B-SPEC
-	O
infected	O
parents	O
and	O
reassurance	O
about	O
HIV	B-SPEC
transmission	O
and	O
the	O
safety	O
of	O
various	O
activities	O
.	O

Previously	O
,	O
we	O
have	O
identified	O
two	O
immunodominant	O
epitopes	O
,	O
named	O
N195	O
and	O
Sc	O
,	O
in	O
the	O
two	O
major	O
structural	O
proteins	O
,	O
the	O
N	O
and	O
S	O
proteins	O
,	O
of	O
SARS	O
-	O
CoV	O
(	O
Q	O
.	O
He	O
,	O
K	O
.	O
H	O
.	O
Chong	O
,	O
H	O
.	O
H	O
.	O
Chng	O
,	O
B	O
.	O
Leung	O
,	O
A	O
.	O
E	O
.	O
Ling	B-SPEC
,	O
T	O
.	O
Wei	O
,	O
S	O
.	O
W	O
.	O
Chan	O
,	O
E	O
.	O
E	O
.	O
Ooi	O
,	O
and	O
J	O
.	O
Kwang	O
,	O
Clin	O
.	O

Evolution	O
towards	O
person	O
-	O
to	O
-	O
person	O
transmission	O
depends	O
on	O
the	O
biological	O
features	O
of	O
the	O
pathogen	O
,	O
but	O
may	O
well	O
be	O
triggered	O
or	O
facilitated	O
by	O
external	O
factors	O
such	O
as	O
changes	O
in	O
human	B-SPEC
exposure	O
.	O

Some	O
examples	O
of	O
pathogens	O
with	O
this	O
pattern	O
of	O
transmission	O
are	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
/	O
acquired	O
immune	O
deficiency	O
syndrome	O
,	O
influenza	O
A	O
,	O
Ebola	B-SPEC
virus	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

In	O
the	O
second	O
pattern	O
,	O
direct	O
or	O
vector	O
-	O
mediated	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
is	O
the	O
usual	O
source	O
of	O
human	B-SPEC
infection	O
.	O

The	O
disease	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
transmitted	O
from	O
human	B-SPEC
to	O
human	B-SPEC
by	O
droplets	O
or	O
by	O
direct	O
contact	O
.	O

Subsequent	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
analysis	O
,	O
using	O
the	O
enzymes	O
Acc	O
I	O
,	O
Alu	O
I	O
,	O
EcoR	O
I	O
and	O
Mbo	O
I	O
,	O
demonstrated	O
that	O
these	O
strains	O
could	O
be	O
divided	O
into	O
five	O
distinct	O
subgroups	O
and	O
that	O
the	O
same	O
MHV	B-SPEC
strains	O
were	O
detected	O
from	O
closely	O
related	O
mouse	B-SPEC
facilities	O
.	O

ABSTRACT	O
:	O
Ten	O
potential	O
reference	O
genes	O
were	O
compared	O
for	O
their	O
use	O
in	O
experiments	O
investigating	O
cellular	O
mRNA	O
expression	O
of	O
virus	B-SPEC
infected	O
cells	O
.	O

TITLE	O
:	O
Induction	O
of	O
Th1	O
type	O
response	O
by	O
DNA	O
vaccinations	O
with	O
N	O
,	O
M	O
,	O
and	O
E	O
genes	O
against	O
SARS	O
-	O
CoV	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Immunization	O
with	O
a	O
killed	O
or	O
inactivated	O
viral	O
vaccine	O
provides	O
significant	O
protection	O
in	O
animals	B-SPEC
against	O
challenge	O
with	O
certain	O
corresponding	O
pathogenic	O
coronaviruses	O
(	O
CoVs	O
).	O

TITLE	O
:	O
Recombinant	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
from	O
cloned	O
,	O
full	O
-	O
length	O
cDNA	O
replicates	O
to	O
high	O
titers	O
in	O
vitro	O
and	O
is	O
fully	O
pathogenic	O
in	O
vivo	O
.	O

Here	O
,	O
we	O
describe	O
a	O
reverse	O
genetic	O
system	O
for	O
MHV	B-SPEC
(	O
strain	O
A59	O
)	O
based	O
upon	O
the	O
cloning	O
of	O
a	O
full	O
-	O
length	O
genomic	O
cDNA	O
in	O
vaccinia	B-SPEC
virus	I-SPEC
.	O

The	O
system	O
monitors	B-SPEC
for	O
clusters	O
of	O
patients	O
with	O
syndromes	O
consistent	O
with	O
the	O
prodrome	O
of	O
a	O
terrorism	O
-	O
related	O
illness	O
(	O
e	O
.	O
g	O
.,	O
anthrax	B-SPEC
or	O
smallpox	B-SPEC
)	O
or	O
naturally	O
occurring	O
disease	O
(	O
e	O
.	O
g	O
.,	O
pandemic	O
influenza	O
or	O
food	O
and	O
waterborne	O
outbreaks	O
).	O

The	O
health	O
department	O
can	O
use	O
these	O
data	O
to	O
track	O
and	O
characterize	O
the	O
temporal	O
and	O
geographic	O
spread	O
of	O
a	O
known	O
outbreak	O
or	O
demonstrate	O
the	O
absence	O
of	O
cases	O
during	O
the	O
same	O
period	O
(	O
e	O
.	O
g	O
.,	O
severe	O
acute	O
respiratory	O
syndrome	O
[	O
SARS	O
]	O
or	O
anthrax	B-SPEC
).	O

Field	O
investigation	O
revealed	O
varying	O
chief	O
complaints	O
,	O
multiple	O
dates	O
of	O
ED	O
visits	O
,	O
and	O
a	O
coding	O
error	O
in	O
a	O
complementary	O
DOHMH	O
syndromic	O
system	O
,	O
and	O
confirmed	O
a	O
seasonal	O
norovirus	B-SPEC
outbreak	O
.	O

It	O
is	O
believed	O
that	O
IR	O
cameras	O
can	O
potentially	O
be	O
used	O
to	O
detect	O
subjects	O
with	O
fever	O
,	O
the	O
cardinal	B-SPEC
symptom	O
of	O
SARS	O
,	O
and	O
avian	B-SPEC
influenza	O
.	O

The	O
accuracy	O
of	O
the	O
infrared	O
system	O
can	O
,	O
however	O
,	O
be	O
affected	O
by	O
human	B-SPEC
,	O
environmental	O
,	O
and	O
equipment	O
variables	O
.	O

TITLE	O
:	O
Isolation	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
from	O
domestic	O
peafowl	B-SPEC
(	O
Pavo	B-SPEC
cristatus	I-SPEC
)	O
and	O
teal	O
(	O
Anas	B-SPEC
).	O

The	O
spike	O
,	O
membrane	O
and	O
nucleocapsid	O
protein	O
genes	O
of	O
pf	O
/	O
CH	O
/	O
LKQ3	O
/	O
03	O
had	O
>	O
99	O
%	O
identity	O
to	O
those	O
of	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
H120	O
vaccine	O
strain	O
(	O
Massachusetts	O
serotype	O
)	O
and	O
other	O
Massachusetts	O
serotype	O
isolates	O
.	O

Furthermore	O
,	O
when	O
pf	O
/	O
CH	O
/	O
LKQ3	O
/	O
03	O
was	O
inoculated	O
experimentally	O
into	O
chickens	B-SPEC
(	O
specific	O
-	O
pathogen	O
-	O
free	O
),	O
no	O
disease	O
signs	O
were	O
apparent	O
.	O

Cryptosporidial	O
oocysts	O
were	O
observed	O
in	O
the	O
gastric	O
pits	O
of	O
only	O
conventionally	O
-	O
housed	O
mice	B-SPEC
and	O
rats	B-SPEC
.	O

Helicobacter	B-SPEC
spp	O
.	O

This	O
paper	O
describes	O
bacteriological	O
,	O
parasitological	O
,	O
and	O
virological	O
examinations	O
of	O
the	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
lung	O
injury	O
(	O
ALI	O
)	O
induced	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
major	O
cause	O
of	O
mortality	O
among	O
humans	B-SPEC
.	O

TITLE	O
:	O
Object	O
-	O
oriented	O
biological	O
system	O
integration	O
:	O
a	O
SARS	O
coronavirus	B-SPEC
example	O
.	O

TITLE	O
:	O
Amino	O
acids	O
1055	O
to	O
1192	O
in	O
the	O
S2	O
region	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
S	O
protein	O
induce	O
neutralizing	O
antibodies	O
:	O
implications	O
for	O
the	O
development	O
of	O
vaccines	O
and	O
antiviral	O
agents	O
.	O

C57BL	O
/	O
6	O
mice	B-SPEC
were	O
infected	O
with	O
a	O
recombinant	O
A59	O
virus	B-SPEC
expressing	O
the	O
gp33	O
epitope	O
,	O
an	O
H	O
-	O
2Db	O
-	O
restricted	O
CD8	O
+	O
T	O
-	O
cell	O
epitope	O
encoded	O
in	O
the	O
glycoprotein	O
of	O
lymphocytic	B-SPEC
choriomeningitis	I-SPEC
virus	I-SPEC
,	O
as	O
a	O
fusion	O
with	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
RA59	O
-	O
gfp	O
/	O
gp33	O
).	O

Adoptive	O
transfer	O
of	O
P14	O
splenocytes	O
1	O
day	O
prior	O
to	O
infection	O
with	O
RA59	O
-	O
gfp	O
/	O
gp33	O
,	O
but	O
not	O
control	O
virus	B-SPEC
lacking	O
the	O
gp33	O
epitope	O
,	O
RA59	O
-	O
gfp	O
,	O
reduced	O
weight	O
loss	O
and	O
viral	O
replication	O
and	O
spread	O
in	O
the	O
brain	O
and	O
to	O
the	O
spinal	O
cord	O
.	O

Thus	O
,	O
an	O
early	O
robust	O
CD8	O
+	O
T	O
-	O
cell	O
response	O
was	O
necessary	O
to	O
reduce	O
virus	B-SPEC
replication	O
and	O
spread	O
,	O
specifically	O
to	O
the	O
spinal	O
cord	O
,	O
which	O
protected	O
against	O
demyelination	O
in	O
the	O
chronic	O
phase	O
of	O
the	O
disease	O
.	O

These	O
S2	O
-	O
targeting	O
antibodies	O
were	O
shown	O
to	O
effectively	O
neutralize	O
the	O
coronavirus	B-SPEC
,	O
indicating	O
that	O
they	O
provided	O
protective	O
immunity	O
to	O
help	O
the	O
patients	O
recover	O
from	O
the	O
viral	O
infection	O
.	O

TITLE	O
:	O
Exogenous	O
ACE2	O
expression	O
allows	O
refractory	O
cell	O
lines	O
to	O
support	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Of	O
30	O
cell	O
lines	O
and	O
primary	O
cells	O
examined	O
,	O
productive	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
Urbani	O
strain	O
)	O
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
after	O
low	O
-	O
multiplicity	O
inoculation	O
was	O
detected	O
in	O
only	O
six	O
:	O
three	O
African	B-SPEC
green	I-SPEC
monkey	I-SPEC
kidney	O
epithelial	O
cell	O
lines	O
(	O
Vero	O
,	O
Vero	O
E6	O
,	O
and	O
MA104	O
),	O
a	O
human	B-SPEC
colon	O
epithelial	O
line	O
(	O
CaCo	O
-	O
2	O
),	O
a	O
porcine	B-SPEC
kidney	O
epithelial	O
line	O
[	O
PK	O
(	O
15	O
)],	O
and	O
mink	B-SPEC
lung	O
epithelial	O
cells	O
(	O
Mv	O
1	O
Lu	O
).	O

TITLE	O
:	O
Newer	O
respiratory	O
virus	B-SPEC
infections	O
:	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
and	O
human	B-SPEC
coronaviruses	O
.	O

Two	O
previously	O
unrecognized	O
human	B-SPEC
coronaviruses	O
were	O
discovered	O
in	O
2004	O
in	O
The	O
Netherlands	O
and	O
Hong	O
Kong	O
.	O

TITLE	O
:	O
Multi	O
-	O
zone	O
modeling	O
of	O
probable	O
SARS	O
virus	B-SPEC
transmission	O
by	O
airflow	O
between	O
flats	O
in	O
Block	O
E	O
,	O
Amoy	O
Gardens	O
.	O

ABSTRACT	O
:	O
The	O
ability	O
of	O
the	O
avian	B-SPEC
pathogen	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
to	O
persist	O
despite	O
fluoroquinolone	O
treatment	O
was	O
investigated	O
in	O
chickens	B-SPEC
.	O

Mycoplasmas	B-SPEC
were	O
isolated	O
from	O
tracheal	O
rings	O
cultured	O
for	O
several	O
days	O
,	O
suggesting	O
that	O
M	B-SPEC
.	I-SPEC
gallisepticum	I-SPEC
persisted	O
in	O
the	O
trachea	B-SPEC
despite	O
the	O
enrofloxacin	O
treatment	O
.	O

SA59B	O
scFv	O
was	O
expressed	O
in	O
soluble	O
form	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
HB2151	O
and	O
purified	O
by	O
immobilized	O
metal	O
affinity	O
chromatography	O
.	O

Of	O
the	O
45	O
human	B-SPEC
SCoVs	O
,	O
one	O
isolate	O
from	O
Guangdong	O
province	O
,	O
China	O
,	O
exhibited	O
an	O
extra	O
29	O
-	O
nucleotide	O
fragment	O
between	O
Orf	O
10	O
and	O
Orf	O
11	O
--	O
similar	O
to	O
the	O
civet	B-SPEC
SCoV	O
genome	O
.	O

TITLE	O
:	O
New	O
antiviral	O
drugs	O
,	O
vaccines	O
and	O
classic	O
public	O
health	O
interventions	O
against	O
SARS	O
coronavirus	B-SPEC
.	O

We	O
have	O
isolated	O
a	O
SARS	O
-	O
CoV	O
in	O
China	O
and	O
analyzed	O
47	O
SARS	O
-	O
CoV	O
genomes	O
with	O
the	O
aims	O
to	O
reveal	O
the	O
evolution	O
trends	O
of	O
the	O
virus	B-SPEC
and	O
provide	O
insights	O
into	O
understanding	O
pathogenesis	O
and	O
SARS	O
epidemic	O
.	O

However	O
,	O
viruses	B-SPEC
with	O
Y162F	O
substitutions	O
had	O
wild	O
type	O
growth	O
,	O
suggesting	O
that	O
Y162	O
may	O
comprise	O
part	O
of	O
a	O
hydrophobic	O
domain	O
that	O
contacts	O
the	O
MHV	B-SPEC
-	O
binding	O
site	O
of	O
mCEACAM1a	O
.	O

TITLE	O
:	O
Epitope	O
mapping	O
and	O
biological	O
function	O
analysis	O
of	O
antibodies	O
produced	O
by	O
immunization	O
of	O
mice	B-SPEC
with	O
an	O
inactivated	O
Chinese	O
isolate	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

In	O
particular	O
,	O
inhibitors	O
of	O
viral	O
entry	O
,	O
comprising	O
therapeutic	O
peptides	O
,	O
were	O
based	O
on	O
the	O
recently	O
launched	O
anti	O
-	O
HIV	B-SPEC
drug	O
enfuvirtide	O
.	O

TITLE	O
:	O
Secondary	O
effects	O
of	O
femoral	O
instrumentation	O
on	O
pulmonary	O
physiology	O
in	O
a	O
standardised	O
sheep	B-SPEC
model	O
:	O
what	O
is	O
the	O
effect	O
of	O
lung	O
contusion	O
and	O
reaming	O
?	O

All	O
animals	B-SPEC
were	O
sacrificed	O
4	O
h	O
after	O
the	O
start	O
of	O
the	O
femoral	O
instrumentation	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
virus	B-SPEC
infections	O
such	O
as	O
SARS	O
and	O
pandemic	O
influenza	O
are	O
highly	O
contagious	O
diseases	O
that	O
cause	O
global	O
crisis	O
,	O
and	O
inflict	O
severe	O
human	B-SPEC
mortality	O
and	O
morbidity	O
.	O

ABSTRACT	O
:	O
We	O
have	O
investigated	O
to	O
develop	O
novel	O
vaccines	O
against	O
SARS	O
CoV	O
using	O
cDNA	O
constructs	O
encoding	O
the	O
structural	O
antigen	O
;	O
spike	O
protein	O
(	O
S	O
),	O
membrane	O
protein	O
(	O
M	O
),	O
envelope	O
protein	O
(	O
E	O
),	O
or	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
derived	O
from	O
SARS	O
CoV	O
.	O
Mice	B-SPEC
vaccinated	O
with	O
SARS	O
-	O
N	O
or	O
-	O
M	O
DNA	O
using	O
pcDNA	O
3	O
.	O
1	O
(+)	O
plasmid	O
vector	O
showed	O
T	O
cell	O
immune	O
responses	O
(	O
CTL	O
induction	O
and	O
proliferation	O
)	O
against	O
N	O
or	O
M	O
protein	O
,	O
respectively	O
.	O

This	O
is	O
amazing	O
since	O
the	O
number	O
of	O
human	B-SPEC
rabies	O
deaths	O
worldwide	O
is	O
greater	O
than	O
that	O
from	O
polio	O
,	O
meningococcal	O
meningitis	O
,	O
Japanese	B-SPEC
encephalitis	I-SPEC
,	O
yellow	O
fever	O
,	O
SARS	O
,	O
bird	B-SPEC
flue	O
and	O
other	O
scourges	O
that	O
attract	O
more	O
attention	O
.	O

TITLE	O
:	O
Rapid	O
identification	O
of	O
emerging	O
pathogens	O
:	O
coronavirus	B-SPEC
.	O

We	O
demonstrate	O
this	O
principle	O
by	O
using	O
14	O
isolates	O
of	O
9	O
diverse	O
Coronavirus	B-SPEC
spp	O
.,	O
including	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Most	O
respondents	O
believed	O
that	O
SARS	O
could	O
be	O
transmitted	O
through	O
droplets	O
,	O
fomites	O
,	O
sewage	O
,	O
and	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
3a	O
protein	O
was	O
a	O
unique	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
which	O
was	O
identified	O
in	O
SARS	O
-	O
CoV	O
infected	O
cells	O
and	O
SARS	O
patients	O
'	O
specimen	O
.	O

TITLE	O
:	O
Attenuation	O
of	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
by	O
oxymatrine	O
is	O
associated	O
with	O
inhibition	O
of	O
phosphorylated	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
.	O

Mycoplasma	B-SPEC
-	O
free	O
brown	O
layer	O
pullets	O
,	O
approximately	O
5	O
weeks	O
old	O
,	O
were	O
exposed	O
to	O
an	O
aerosol	O
dose	O
of	O
>	O
or	O
=	O
10	O
(	O
2	O
-	O
3	O
)	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
of	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
alone	O
or	O
3	O
days	O
after	O
inoculation	O
of	O
a	O
field	O
strain	O
of	O
IBV	B-SPEC
(	O
D1466	O
)	O
by	O
the	O
ocular	O
-	O
nasal	O
route	O
.	O

After	O
the	O
single	O
intravenous	O
,	O
low	O
-	O
dose	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
inoculation	O
11	O
%	O
of	O
birds	B-SPEC
developed	O
joint	O
lesions	O
,	O
whereas	O
70	O
%	O
of	O
those	O
receiving	O
the	O
second	O
inoculation	O
developed	O
lesions	O
.	O

ABSTRACT	O
:	O
Four	O
different	O
types	O
of	O
human	B-SPEC
interferon	O
,	O
interferon	O
-	O
beta	O
(	O
IFN	O
-	O
beta	O
),	O
recombinant	O
IFN	O
-	O
alpha2a	O
and	O
IFN	O
-	O
alpha2b	O
and	O
natural	O
IFN	O
-	O
alpha	O
were	O
tested	O
for	O
antiviral	O
activity	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Incidence	O
and	O
impact	O
of	O
organ	O
dysfunctions	O
associated	O
with	O
sepsis	B-SPEC
.	O

SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
was	O
demonstrated	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
in	O
all	O
4	O
patients	O
.	O

Since	O
the	O
outbreak	O
,	O
much	O
work	O
has	O
been	O
done	O
testing	O
new	O
agents	O
against	O
SARS	O
using	O
in	O
-	O
vitro	O
methods	O
and	O
animal	B-SPEC
models	O
.	O

*	O
Research	O
platforms	O
in	O
place	O
across	O
the	O
country	O
such	O
as	O
appropriately	O
secure	O
animal	B-SPEC
care	O
facilities	O
,	O
biobanks	O
,	O
and	O
other	O
technologies	O
necessary	O
to	O
immediately	O
address	O
research	O
issues	O
arising	O
from	O
such	O
a	O
crisis	O
.	O

TITLE	O
:	O
Inflammatory	O
cerebrospinal	O
fluid	O
analysis	O
in	O
cats	B-SPEC
:	O
clinical	O
diagnosis	O
and	O
outcome	O
.	O

CSF	O
analysis	O
alone	O
was	O
useful	O
only	O
in	O
the	O
diagnosis	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
,	O
Cryptococcus	B-SPEC
species	B-SPEC
infection	O
,	O
lymphoma	O
and	O
trauma	O
.	O

Cats	B-SPEC
with	O
URI	O
tended	O
to	O
be	O
housed	O
in	O
isolation	O
,	O
dehydrated	O
,	O
and	O
younger	O
than	O
cats	B-SPEC
without	O
URI	O
,	O
and	O
infected	O
with	O
FHV	O
,	O
Mycoplasma	B-SPEC
species	B-SPEC
,	O
FCV	B-SPEC
,	O
or	O
C	O
felis	B-SPEC
.	O

Shelters	O
differed	O
in	O
the	O
prevalence	O
of	O
pathogens	O
and	O
many	O
cats	B-SPEC
appeared	O
positive	O
for	O
infection	O
after	O
about	O
1	O
week	O
of	O
sheltering	O
.	O

It	O
is	O
helpful	O
for	O
shelters	O
to	O
understand	O
the	O
risk	O
factors	O
associated	O
with	O
URI	O
in	O
order	B-SPEC
to	O
evaluate	O
the	O
costs	O
and	O
benefits	O
of	O
treatment	O
and	O
improve	O
their	O
procedures	O
to	O
decrease	O
the	O
incidence	O
of	O
URI	O
within	O
their	O
facilities	O
.	O

TITLE	O
:	O
Extravascular	O
lung	O
water	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
:	O
a	O
prospective	O
cohort	O
study	O
.	O

TITLE	O
:	O
The	O
influence	O
of	O
iloprost	O
on	O
acute	O
lung	O
injury	O
induced	O
by	O
hind	O
limb	O
ischemia	O
-	O
reperfusion	O
in	O
rats	B-SPEC
.	O

We	O
employed	O
cDNA	O
microarray	O
analysis	O
to	O
characterize	O
the	O
cellular	O
transcriptional	O
responses	O
of	O
homologous	O
human	B-SPEC
genes	O
at	O
12	O
h	O
post	O
-	O
infection	O
.	O

Vero	O
cells	O
were	O
dually	O
infected	O
with	O
ca	O
-	O
PEDV	B-SPEC
and	O
one	O
of	O
the	O
three	O
chlamydial	O
strains	O
Chlamydia	B-SPEC
trachomatis	I-SPEC
S45	O
,	O
Chlamydophila	B-SPEC
abortus	I-SPEC
S26	O
/	O
3	O
or	O
Chlamydophila	B-SPEC
pecorum	I-SPEC
1710S	O
.	O

This	O
is	O
the	O
first	O
report	O
that	O
demonstrated	O
the	O
incorporation	O
of	O
3a	O
into	O
virion	O
and	O
showed	O
that	O
the	O
SARS	O
-	O
CoV	O
encodes	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
structural	O
protein	O
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
and	O
enteric	O
shedding	O
of	O
bovine	B-SPEC
coronaviruses	O
in	O
cattle	B-SPEC
in	O
Northwestern	O
Turkey	B-SPEC
.	O

TITLE	O
:	O
Evaluation	O
by	O
indirect	O
immunofluorescent	O
assay	O
and	O
enzyme	O
linked	O
immunosorbent	O
assay	O
of	O
the	O
dynamic	O
changes	O
of	O
serum	O
antibody	O
responses	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
newly	O
emerging	O
virus	B-SPEC
that	O
gives	O
rise	O
to	O
SARS	O
patients	O
with	O
high	O
rates	O
of	O
infectivity	O
and	O
fatality	O
.	O

We	O
also	O
compare	O
S	O
proteins	O
of	O
SARS	O
-	O
CoV	O
isolated	O
during	O
the	O
2002	O
-	O
2003	O
SARS	O
outbreak	O
and	O
during	O
the	O
much	O
less	O
severe	O
2003	O
-	O
2004	O
outbreak	O
,	O
and	O
from	O
palm	O
civets	B-SPEC
,	O
a	O
possible	O
source	O
of	O
SARS	O
-	O
CoV	O
found	O
in	O
humans	B-SPEC
.	O

All	O
three	O
S	O
proteins	O
bound	O
to	O
and	O
utilized	O
palm	O
-	O
civet	B-SPEC
ACE2	O
efficiently	O
,	O
but	O
the	O
latter	O
two	O
S	O
proteins	O
utilized	O
human	B-SPEC
ACE2	O
markedly	O
less	O
efficiently	O
than	O
did	O
the	O
S	O
protein	O
obtained	O
during	O
the	O
earlier	O
human	B-SPEC
outbreak	O
.	O

Collectively	O
,	O
these	O
data	O
describe	O
molecular	O
interactions	O
important	O
to	O
the	O
adaptation	O
of	O
SARS	O
-	O
CoV	O
to	O
human	B-SPEC
cells	O
,	O
and	O
provide	O
insight	O
into	O
the	O
severity	O
of	O
the	O
2002	O
-	O
2003	O
SARS	O
epidemic	O
.	O

ABSTRACT	O
:	O
Neurotropic	O
coronavirus	B-SPEC
-	O
induced	O
encephalitis	O
was	O
used	O
to	O
evaluate	O
recruitment	O
,	O
functional	O
activation	O
,	O
and	O
retention	O
of	O
peripheral	O
bystander	O
memory	O
CD8	O
+	O
T	O
cells	O
.	O

Mice	B-SPEC
were	O
first	O
infected	O
with	O
recombinant	O
vaccinia	B-SPEC
virus	I-SPEC
expressing	O
a	O
non	O
-	O
cross	O
-	O
reactive	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
epitope	O
,	O
designated	O
p18	O
.	O

Following	O
establishment	O
of	O
an	O
endogenous	O
p18	O
-	O
specific	O
memory	O
CD8	O
+	O
T	O
-	O
cell	O
population	O
,	O
mice	B-SPEC
were	O
challenged	O
with	O
coronavirus	B-SPEC
to	O
directly	O
compare	O
recruitment	O
,	O
longevity	O
,	O
and	O
activation	O
characteristics	O
of	O
both	O
primary	O
coronavirus	B-SPEC
-	O
specific	O
and	O
bystander	O
memory	O
populations	O
trafficking	O
into	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
).	O

Nevertheless	O
,	O
coronavirus	B-SPEC
-	O
specific	O
CD8	O
+	O
T	O
cells	O
were	O
preferentially	O
retained	O
.	O

These	O
data	O
suggest	O
that	O
in	O
contrast	O
to	O
the	O
results	O
seen	O
with	O
MMPs	O
,	O
inhibition	O
of	O
protease	O
activity	O
via	O
TIMP	O
-	O
1	O
expression	O
correlates	O
with	O
the	O
differential	O
tissue	O
distribution	O
of	O
T	O
-	O
cell	O
subsets	O
during	O
acute	O
coronavirus	B-SPEC
-	O
induced	O
encephalitis	O
.	O

Six	O
members	O
of	O
this	O
class	B-SPEC
of	O
compounds	O
:	O
bananin	O
,	O
iodobananin	O
,	O
vanillinbananin	O
,	O
ansabananin	O
,	O
eubananin	O
,	O
and	O
adeninobananin	O
were	O
synthesized	O
and	O
tested	O
as	O
inhibitors	O
of	O
the	O
SARS	O
Coronavirus	B-SPEC
(	O
SCV	B-SPEC
)	O
helicase	O
.	O

The	O
S450	O
-	O
650	O
-	O
based	O
ELISA	O
detected	O
IgG	O
Abs	O
in	O
41	O
out	O
of	O
51	O
serum	O
samples	O
from	O
22	O
hospitalized	O
patients	O
with	O
probable	O
SARS	O
,	O
a	O
result	O
closely	O
correlated	O
with	O
that	O
obtained	O
with	O
a	O
virus	B-SPEC
-	O
based	O
ELISA	O
(	O
r	O
=	O
0	O
.	O
75	O
,	O
k	O
=	O
0	O
.	O
8	O
).	O

RESULTS	O
:	O
The	O
S450	O
-	O
650	O
-	O
based	O
ELISA	O
detected	O
IgG	O
Abs	O
in	O
41	O
out	O
of	O
51	O
serum	O
samples	O
from	O
22	O
hospitalized	O
patients	O
with	O
probable	O
SARS	O
,	O
a	O
result	O
closely	O
correlated	O
with	O
that	O
obtained	O
with	O
a	O
virus	B-SPEC
-	O
based	O
ELISA	O
(	O
r	O
=	O
0	O
.	O
75	O
,	O
k	O
=	O
0	O
.	O
8	O
).	O

ABSTRACT	O
:	O
The	O
protocols	O
of	O
WHO	O
network	O
laboratories	O
facilitated	O
development	O
of	O
rapid	O
diagnosis	O
for	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
using	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
assays	O
.	O

Childhood	O
asthma	O
was	O
observed	O
in	O
40	O
,	O
4	O
%	O
of	O
children	O
without	O
any	O
associated	O
factor	O
wether	O
at	O
birth	O
or	O
in	O
PICU	B-SPEC
related	O
to	O
such	O
outcome	O
.	O

Here	O
we	O
describe	O
a	O
new	O
phylogenetic	O
analytical	O
method	O
to	O
study	O
the	O
sources	O
and	O
dissemination	O
paths	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infections	O
in	O
Taiwan	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
emerged	O
infection	O
that	O
is	O
caused	O
by	O
a	O
previously	O
unrecognized	O
virus	B-SPEC
-	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
designated	O
as	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

SARS	O
has	O
been	O
defined	O
using	O
clinical	O
and	O
epidemiological	O
criteria	O
and	O
cases	O
are	O
considered	O
laboratory	O
-	O
confirmed	O
if	O
SARS	O
coronavirus	B-SPEC
is	O
isolated	O
,	O
if	O
antibody	O
to	O
SARS	O
coronavirus	B-SPEC
is	O
detected	O
,	O
or	O
a	O
polymerase	O
chain	O
reaction	O
test	O
by	O
appropriate	O
criteria	O
is	O
positive	O
.	O

The	O
mouse	B-SPEC
antisera	O
effectively	O
neutralized	O
infection	O
by	O
both	O
SARS	O
-	O
CoV	O
and	O
SARS	O
pseudovirus	O
with	O
mean	O
50	O
%	O
neutralization	O
titers	O
of	O
1	O
/	O
15	O
,	O
360	O
and	O
1	O
/	O
24	O
,	O
737	O
,	O
respectively	O
.	O

Examples	O
are	O
emerging	O
infections	O
such	O
as	O
HIV	B-SPEC
/	O
AIDS	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
deliberate	O
release	O
of	O
microorganisms	O
,	O
such	O
as	O
the	O
anthrax	B-SPEC
episode	O
in	O
the	O
USA	O
,	O
the	O
increasing	O
problems	O
with	O
organisms	O
resistant	O
to	O
antimicrobial	O
treatment	O
,	O
such	O
as	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
and	O
the	O
threat	O
of	O
a	O
new	O
influenza	O
pandemic	O
with	O
a	O
case	O
fatality	O
rate	O
similar	O
to	O
that	O
in	O
the	O
1918	O
outbreak	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
OC43	O
causes	O
influenza	O
-	O
like	O
illness	O
in	O
residents	O
and	O
staff	O
of	O
aged	O
-	O
care	O
facilities	O
in	O
Melbourne	O
,	O
Australia	O
.	O

HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
was	O
detected	O
by	O
RT	O
-	O
PCR	O
in	O
16	O
out	O
of	O
27	O
(	O
59	O
%)	O
specimens	O
and	O
was	O
the	O
only	O
virus	B-SPEC
detected	O
at	O
the	O
time	O
of	O
sampling	O
.	O

ABSTRACT	O
:	O
A	O
method	O
for	O
the	O
isolation	O
of	O
genomic	O
fragments	O
of	O
RNA	O
virus	B-SPEC
based	O
on	O
cDNA	O
representational	O
difference	O
analysis	O
(	O
cDNA	O
RDA	O
)	O
was	O
developed	O
.	O

cDNA	O
RDA	O
has	O
been	O
applied	O
for	O
the	O
subtraction	O
of	O
poly	O
(	O
A	O
)(+)	O
RNAs	O
but	O
not	O
for	O
poly	O
(	O
A	O
)(-)	O
RNAs	O
,	O
such	O
as	O
RNA	O
virus	B-SPEC
genomes	O
,	O
owing	O
to	O
the	O
vast	O
quantity	O
of	O
ribosomal	O
RNAs	O
.	O

The	O
results	O
suggest	O
that	O
cDNA	O
RDA	O
with	O
non	O
-	O
ribosomal	O
primers	O
can	O
be	O
used	O
for	O
species	B-SPEC
-	O
independent	O
detection	O
of	O
viruses	B-SPEC
,	O
including	O
new	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
life	O
-	O
threatening	O
and	O
highly	O
contagious	O
disease	O
caused	O
by	O
the	O
novel	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
SARS	O
is	O
a	O
new	O
infection	O
in	O
human	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
been	O
identified	O
as	O
a	O
new	O
type	O
of	O
coronavirus	B-SPEC
,	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Overlapping	O
peptides	O
were	O
used	O
to	O
identify	O
major	O
histocompatibility	O
complex	O
class	B-SPEC
I	O
-	O
restricted	O
epitopes	O
in	O
mice	B-SPEC
immunized	O
with	O
vectors	O
encoding	O
codon	O
-	O
optimized	O
SARS	O
-	O
CoV	O
spike	O
protein	O
.	O

In	O
the	O
further	O
clinical	O
course	O
,	O
detection	O
of	O
Pseudomonas	B-SPEC
species	B-SPEC
in	O
bronchoalveolar	O
lavages	O
and	O
Staphylococci	O
as	O
well	O
as	O
Enterococci	O
in	O
a	O
number	O
of	O
positive	O
blood	O
cultures	O
.	O

Rhizopus	B-SPEC
infections	O
are	O
characterized	O
by	O
angioinvasive	O
growth	O
,	O
necroses	O
of	O
infected	O
tissue	O
and	O
perineural	O
invasion	O
.	O

The	O
thromboembolic	O
risk	O
of	O
radical	O
retropubic	O
prostatectomy	O
for	O
cancer	B-SPEC
parallels	O
lower	O
abdomen	O
oncologic	O
surgery	O
and	O
is	O
prolonged	O
.	O

TITLE	O
:	O
Aged	O
BALB	O
/	O
c	O
mice	B-SPEC
as	O
a	O
model	O
for	O
increased	O
severity	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
elderly	O
humans	B-SPEC
.	O

It	O
was	O
concluded	O
that	O
free	O
-	O
ranging	O
Swedish	O
lynx	B-SPEC
do	O
not	O
have	O
frequent	O
contact	O
with	O
the	O
infectious	O
agents	O
considered	O
in	O
this	O
study	O
.	O

TITLE	O
:	O
Hospital	O
preparedness	O
and	O
management	O
of	O
patients	O
affected	O
by	O
viral	O
haemorrhagic	O
fever	O
or	O
smallpox	B-SPEC
at	O
the	O
Lazzaro	O
Spallanzani	O
Institute	O
,	O
Italy	O
.	O

ABSTRACT	O
:	O
The	O
US	O
cases	O
of	O
anthrax	B-SPEC
in	O
2001	O
and	O
the	O
recent	O
severe	O
acute	O
respiratory	O
syndrome	O
outbreak	O
have	O
heightened	O
the	O
need	O
for	O
preparedness	O
and	O
response	O
to	O
naturally	O
emerging	O
and	O
re	O
-	O
emerging	O
infections	O
or	O
deliberately	O
released	O
biological	O
agents	O
.	O

Employing	O
RT	O
-	O
PCR	O
technique	O
to	O
amplify	O
ORF7	O
sequence	O
of	O
TGEV	B-SPEC
,	O
which	O
located	O
at	O
the	O
3	O
'	O
end	O
of	O
TGEV	B-SPEC
genome	O
and	O
is	O
poorly	O
understood	O
functionally	O
so	O
far	O
.	O

In	O
addition	O
,	O
a	O
phylogenetic	O
tree	O
based	O
on	O
these	O
ORF7	O
DNA	O
sequences	O
was	O
generated	O
,	O
and	O
the	O
tree	O
topology	O
suggests	O
that	O
possible	O
recombination	O
events	O
happened	O
in	O
the	O
evolutionary	O
history	O
of	O
TGEV	B-SPEC
.	O

TITLE	O
:	O
Differential	O
maturation	O
and	O
subcellular	O
localization	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
surface	O
proteins	O
S	O
,	O
M	O
and	O
E	O
.	O
ABSTRACT	O
:	O
Post	O
-	O
translational	O
modifications	O
and	O
correct	O
subcellular	O
localization	O
of	O
viral	O
structural	O
proteins	O
are	O
prerequisites	O
for	O
assembly	O
and	O
budding	O
of	O
enveloped	O
viruses	B-SPEC
.	O

The	O
primary	O
determinant	O
of	O
the	O
pantropism	O
is	O
the	O
enhanced	O
proteolytic	O
cleavability	O
of	O
the	O
fusion	O
(	O
F	O
)	O
protein	O
of	O
F1	O
-	O
R	O
,	O
which	O
allows	O
the	O
virus	B-SPEC
to	O
undergo	O
multiple	O
rounds	O
of	O
replication	O
in	O
many	O
different	O
organs	O
,	O
whereas	O
wild	O
-	O
type	O
virus	B-SPEC
can	O
only	O
undergo	O
multiple	O
rounds	O
of	O
replication	O
in	O
the	O
lungs	O
.	O

ABSTRACT	O
:	O
A	O
new	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
aetiological	O
agent	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

TITLE	O
:	O
Acute	O
inflammatory	O
sensorimotor	O
polyradiculoneuropathy	O
associated	O
with	O
immune	O
thrombocytopenic	O
purpura	B-SPEC
.	O

TITLE	O
:	O
Mannose	O
-	O
binding	O
lectin	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
the	O
innate	O
immune	O
response	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
.	O

Although	O
PEC	O
is	O
considered	O
to	O
be	O
a	O
polymicrobial	O
disease	O
,	O
numerous	O
viruses	B-SPEC
,	O
including	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCV	B-SPEC
),	O
turkey	B-SPEC
astrovirus	I-SPEC
type	O
2	O
(	O
TAstV	O
-	O
2	O
),	O
and	O
avian	B-SPEC
reoviruses	B-SPEC
(	O
ARVs	O
),	O
have	O
been	O
associated	O
with	O
PEC	O
-	O
like	O
disease	O
.	O

Virus	B-SPEC
detection	O
was	O
evaluated	O
with	O
samples	O
collected	O
from	O
poults	O
inoculated	O
at	O
1	O
day	O
of	O
age	O
with	O
each	O
of	O
the	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
SARS	O
coronavirus	B-SPEC
RNA	O
polymerase	O
.	O

ABSTRACT	O
:	O
The	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
essential	O
for	O
viral	O
replication	O
and	O
a	O
potential	O
target	O
for	O
anti	O
-	O
SARS	O
drugs	O
.	O

The	O
hAPN	O
expression	O
pattern	O
within	O
transgenic	O
mouse	B-SPEC
tissues	O
matched	O
that	O
of	O
mouse	B-SPEC
APN	O
and	O
was	O
similar	O
in	O
mice	B-SPEC
heterozygous	O
or	O
homozygous	O
for	O
the	O
transgene	O
.	O

The	O
HR1	O
helices	B-SPEC
form	O
an	O
exceptionally	O
long	O
(	O
120	O
A	O
)	O
internal	O
coiled	O
coil	O
stabilized	O
by	O
hydrophobic	O
and	O
polar	O
interactions	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
potential	O
of	O
using	O
non	O
-	O
human	B-SPEC
coronaviruses	O
for	O
cancer	B-SPEC
therapy	O
,	O
we	O
first	O
established	O
their	O
ability	O
to	O
kill	O
human	B-SPEC
tumor	O
cells	O
.	O

Furthermore	O
,	O
in	O
the	O
presence	O
of	O
the	O
targeting	O
antibody	O
,	O
infected	O
cancer	B-SPEC
cells	O
formed	O
syncytia	O
typical	O
of	O
productive	O
coronavirus	B-SPEC
infection	O
.	O

By	O
their	O
potent	O
cytotoxicity	O
,	O
the	O
selective	O
targeting	O
of	O
non	O
-	O
human	B-SPEC
coronaviruses	O
to	O
human	B-SPEC
cancer	B-SPEC
cells	O
provides	O
a	O
rationale	O
for	O
further	O
investigations	O
into	O
the	O
use	O
of	O
these	O
viruses	B-SPEC
as	O
anticancer	O
agents	O
.	O

Human	B-SPEC
mAbs	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
have	O
been	O
developed	O
by	O
several	O
research	O
groups	O
at	O
an	O
amazing	O
pace	O
.	O

These	O
antibodies	O
potently	O
neutralize	O
infectious	O
virus	B-SPEC
in	O
tissue	O
cultures	O
and	O
animal	B-SPEC
models	O
,	O
and	O
,	O
alone	O
or	O
in	O
combination	O
with	O
vaccines	O
and	O
other	O
drugs	O
,	O
may	O
have	O
potential	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
SARS	O
.	O

TITLE	O
:	O
Transcriptional	O
analysis	O
of	O
avian	B-SPEC
embryonic	O
tissues	O
following	O
infection	O
with	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Driven	O
by	O
economic	O
liberalization	O
and	O
changing	O
technologies	O
,	O
the	O
phenomenon	O
of	O
'	O
access	O
'	O
is	O
likely	O
to	O
dominate	O
to	O
an	O
increasing	O
extent	O
the	O
unfolding	O
experience	O
of	O
human	B-SPEC
disease	O
and	O
wellbeing	O
.	O

This	O
method	O
also	O
detected	O
an	O
additional	O
85	O
viruses	B-SPEC
and	O
33	O
co	O
-	O
infections	O
.	O

TITLE	O
:	O
Effects	O
of	O
cold	O
storage	O
on	O
detection	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
chicken	B-SPEC
carcasses	O
and	O
local	O
antibodies	O
in	O
tracheal	O
washes	O
.	O

Trachea	B-SPEC
,	O
lung	O
,	O
kidney	O
and	O
rectum	O
were	O
collected	O
for	O
virus	B-SPEC
isolation	O
by	O
tracheal	O
organ	O
culture	O
(	O
TOC	O
)	O
or	O
embryonated	O
chicken	B-SPEC
eggs	O
(	O
ECE	O
),	O
and	O
detection	O
by	O
nested	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

TITLE	O
:	O
Sumoylation	O
of	O
the	O
nucleocapsid	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
a	O
highly	O
basic	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
422	O
amino	O
acids	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
influence	O
of	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
on	O
SARS	O
-	O
CoV	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
expression	O
was	O
detected	O
in	O
cultured	O
cells	O
and	O
mouse	B-SPEC
muscles	O
.	O

TITLE	O
:	O
Prediction	O
of	O
smallpox	B-SPEC
outbreak	O
and	O
evaluation	O
of	O
control	O
-	O
measure	O
policy	O
in	O
Japan	O
,	O
using	O
a	O
mathematical	O
model	O
.	O

In	O
further	O
research	O
,	O
we	O
will	O
have	O
to	O
take	O
into	O
account	O
the	O
population	O
people	O
vaccinated	O
of	O
for	O
smallpox	B-SPEC
,	O
who	O
account	O
for	O
about	O
70	O
%	O
of	O
the	O
total	O
population	O
in	O
Japan	O
.	O

ABSTRACT	O
:	O
The	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
at	O
the	O
cellular	O
level	O
is	O
unclear	O
.	O

The	O
Puumala	B-SPEC
virus	I-SPEC
is	O
responsible	O
for	O
a	O
minor	O
form	O
of	O
the	O
disease	O
that	O
is	O
observed	O
in	O
areas	O
of	O
the	O
Occidental	O
sector	O
of	O
the	O
ex	O
-	O
URSS	O
,	O
in	O
Scandinavia	O
and	O
in	O
the	O
rest	O
of	O
Europe	O
,	O
notably	O
in	O
the	O
North	O
-	O
East	O
of	O
France	O
.	O

TITLE	O
:	O
The	O
nucleocapsid	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
has	O
a	O
high	O
binding	O
affinity	O
to	O
the	O
human	B-SPEC
cellular	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
A1	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
recombinant	O
plasmid	O
pET30a	O
(+)-	O
nsp13	O
was	O
confirmed	O
by	O
restriction	O
enzymes	O
and	O
sequencing	O
analysis	O
,	O
and	O
transformed	O
into	O
Escherichia	B-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
).	O

We	O
describe	O
here	O
a	O
rapid	O
,	O
sensitive	O
,	O
and	O
highly	O
efficient	O
assay	O
for	O
the	O
detection	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
cultured	O
material	O
and	O
a	O
small	O
number	O
(	O
n	O
=	O
7	O
)	O
of	O
clinical	O
samples	O
.	O

Full	O
recovery	O
of	O
the	O
syndrome	O
was	O
observed	O
in	O
6	O
days	O
,	O
while	O
chest	O
X	O
-	O
ray	B-SPEC
returned	O
to	O
normal	O
findings	O
within	O
4	O
days	O
.	O

Ninety	O
-	O
nine	O
porcine	B-SPEC
field	O
faecal	O
samples	O
obtained	O
from	O
37	O
herds	O
affected	O
with	O
diarrhoea	O
were	O
examined	O
,	O
and	O
various	O
TGEV	B-SPEC
levels	O
were	O
found	O
in	O
nine	O
samples	O
from	O
six	O
herds	O
.	O

SARS	O
is	O
one	O
of	O
the	O
many	O
viruses	B-SPEC
against	O
which	O
personnel	O
will	O
need	O
protecting	O
in	O
an	O
ophthalmic	O
setting	O
.	O

TITLE	O
:	O
Antibody	O
responses	O
to	O
individual	O
proteins	O
of	O
SARS	O
coronavirus	B-SPEC
and	O
their	O
neutralization	O
activities	O
.	O

ABSTRACT	O
:	O
A	O
new	O
disease	O
,	O
the	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
emerged	O
at	O
the	O
beginning	O
of	O
2003	O
and	O
rapidly	O
spread	O
throughout	O
the	O
world	O
.	O

TITLE	O
:	O
A	O
three	O
-	O
stemmed	O
mRNA	O
pseudoknot	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
frameshift	O
signal	O
.	O

For	O
the	O
ARIMA	O
model	O
parameters	O
,	O
we	O
considered	O
the	O
simplest	O
parsimonious	O
lowest	O
order	B-SPEC
model	O
.	O

We	O
found	O
that	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
vector	O
RNAs	O
that	O
lack	O
the	O
N	O
gene	O
were	O
greatly	O
impaired	O
in	O
their	O
ability	O
to	O
replicate	O
,	O
whereas	O
the	O
transcription	O
of	O
subgenomic	O
mRNA	O
from	O
these	O
vectors	O
was	O
easily	O
detectable	O
.	O

ABSTRACT	O
:	O
The	O
3C	O
-	O
like	O
proteinase	O
(	O
3CLpro	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
one	O
of	O
the	O
most	O
promising	O
targets	O
for	O
anti	O
-	O
SARS	O
-	O
CoV	O
drugs	O
due	O
to	O
its	O
crucial	O
role	O
in	O
the	O
viral	O
life	O
cycle	O
.	O

Cinanserin	O
(	O
SQ	O
10	O
,	O
643	O
),	O
a	O
well	O
-	O
characterized	O
serotonin	O
antagonist	O
that	O
has	O
undergone	O
preliminary	O
clinical	O
testing	O
in	O
humans	B-SPEC
in	O
the	O
1960s	O
,	O
showed	O
a	O
high	O
score	O
in	O
the	O
screening	O
and	O
was	O
chosen	O
for	O
further	O
experimental	O
evaluation	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
newly	O
identified	O
member	O
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
and	O
poses	O
a	O
serious	O
public	O
health	O
threat	O
.	O

Immunological	O
,	O
molecular	O
biological	O
,	O
and	O
pathological	O
studies	O
support	O
the	O
establishment	O
of	O
this	O
SARS	O
animal	B-SPEC
model	O
.	O

Finally	O
,	O
histopathological	O
changes	O
of	O
interstitial	O
pneumonia	O
were	O
found	O
in	O
the	O
lungs	O
during	O
the	O
60	O
days	O
after	O
viral	O
inoculation	O
:	O
these	O
changes	O
were	O
less	O
marked	O
at	O
later	O
time	O
points	O
,	O
indicating	O
that	O
an	O
active	O
healing	O
process	O
together	O
with	O
resolution	O
of	O
an	O
acute	O
inflammatory	O
response	O
was	O
taking	O
place	O
in	O
these	O
animals	B-SPEC
.	O

Compared	O
to	O
CDV	B-SPEC
(	O
cidofovir	O
),	O
CDV	B-SPEC
ether	O
lipid	O
esters	O
have	O
enhanced	O
activity	O
against	O
vaccinia	O
(	O
VV	O
)	O
and	O
cowpox	O
(	O
CV	O
)	O
viruses	B-SPEC
in	O
vitro	O
.	O

CDV	B-SPEC
,	O
may	O
be	O
useful	O
against	O
orthopoxvirus	B-SPEC
infections	O
in	O
humans	B-SPEC
.	O

No	O
false	O
positive	O
results	O
were	O
given	O
when	O
60	O
samples	O
from	O
healthy	O
individuals	O
were	O
tested	O
,	O
and	O
no	O
cross	O
-	O
reaction	O
occurred	O
when	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
chicken	B-SPEC
coronavirus	B-SPEC
,	O
was	O
tested	O
.	O

The	O
PR	O
assay	O
described	O
in	O
this	O
study	O
was	O
modified	O
from	O
the	O
traditional	O
viral	O
plaque	O
reduction	O
assay	O
by	O
using	O
an	O
improved	O
crystal	O
staining	O
method	O
to	O
achieve	O
better	O
plague	O
formation	O
in	O
SCV	B-SPEC
infected	O
Vero	O
E6	O
cells	O
.	O

TITLE	O
:	O
Physiologic	O
,	O
biochemical	O
,	O
and	O
imaging	O
characterization	O
of	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

Under	O
the	O
conditions	O
of	O
these	O
studies	O
,	O
only	O
mice	B-SPEC
exposed	O
to	O
oleic	O
acid	O
showed	O
both	O
structural	O
and	O
functional	O
characteristics	O
of	O
acute	O
lung	O
injury	O
.	O

We	O
thus	O
hypothesized	O
family	B-SPEC
physicians	O
between	O
the	O
two	O
places	O
would	O
be	O
different	O
in	O
how	O
they	O
protected	O
themselves	O
,	O
their	O
staff	O
and	O
families	O
during	O
the	O
epidemic	O
.	O

Potent	O
neutralizing	O
activity	O
directed	O
against	O
NL63	O
-	O
but	O
not	O
229E	O
-	O
S	O
protein	O
was	O
detected	O
in	O
virtually	O
all	O
sera	O
from	O
patients	O
8	O
years	O
of	O
age	O
or	O
older	O
,	O
suggesting	O
that	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
of	O
humans	B-SPEC
is	O
common	O
and	O
usually	O
acquired	O
during	O
childhood	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
associated	O
hemophagocytic	O
syndrome	O
in	O
an	O
international	O
traveler	O
as	O
a	O
differential	O
diagnosis	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
Despite	O
recent	O
advances	O
in	O
the	O
prospective	O
identification	O
of	O
the	O
patient	O
with	O
sepsis	B-SPEC
who	O
may	O
benefit	O
from	O
anti	O
-	O
inflammatory	O
or	O
antithrombotic	O
therapies	O
,	O
successful	O
treatment	O
regimens	O
have	O
been	O
fairly	O
modest	O
.	O

TITLE	O
:	O
Variation	O
analysis	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
putative	O
non	O
-	O
structural	O
protein	O
2	O
gene	O
and	O
construction	O
of	O
three	O
-	O
dimensional	O
model	O
.	O

Without	O
sufficient	O
knowledge	O
about	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
it	O
is	O
impossible	O
to	O
define	O
the	O
candidate	O
for	O
the	O
anti	O
-	O
SARS	O
targets	O
.	O

As	O
more	O
sequence	O
data	O
becomes	O
available	O
for	O
multiple	O
strains	O
and	O
isolates	O
of	O
a	O
species	B-SPEC
,	O
automated	O
,	O
computational	O
approaches	O
such	O
as	O
those	O
described	O
here	O
will	O
be	O
essential	O
to	O
make	O
sense	O
of	O
large	O
amounts	O
of	O
information	O
,	O
and	O
to	O
guide	O
and	O
optimize	O
efforts	O
in	O
the	O
laboratory	O
.	O

Phylogenetic	O
trees	O
created	O
based	O
on	O
SNPs	O
,	O
PCR	O
-	O
RFLPs	O
,	O
and	O
full	O
genomes	O
are	O
compared	O
for	O
SARS	O
virus	B-SPEC
,	O
illustrating	O
that	O
purported	O
phylogenies	O
based	O
only	O
on	O
SNP	O
or	O
PCR	O
-	O
RFLP	O
variations	O
do	O
not	O
match	O
those	O
based	O
on	O
multiple	O
sequence	O
alignment	O
of	O
the	O
full	O
genomes	O
.	O

RESULTS	O
:	O
Coronavirus	B-SPEC
infections	O
were	O
detected	O
in	O
26	O
(	O
4	O
.	O
4	O
%)	O
of	O
587	O
children	O
studied	O
;	O
15	O
(	O
2	O
.	O
6	O
%)	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
9	O
(	O
1	O
.	O
5	O
%)	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
and	O
2	O
(	O
0	O
.	O
3	O
%)	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

The	O
extract	O
potently	O
suppressed	O
acute	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
IIIB	O
)	O
infection	O
in	O
MT	O
-	O
4	O
cells	O
with	O
EC50	O
values	O
of	O
0	O
.	O
5	O
microg	O
/	O
ml	O
but	O
exhibited	O
low	O
cytotoxicity	O
to	O
MT	O
-	O
4	O
cells	O
even	O
at	O
a	O
high	O
concentration	O
(	O
CC50	O
>	O
1000	O
microg	O
/	O
ml	O
).	O

Physico	O
-	O
chemical	O
studies	O
revealed	O
that	O
the	O
anti	O
-	O
HIV	B-SPEC
activity	O
in	O
the	O
extract	O
was	O
essentially	O
maintained	O
after	O
boiling	O
at	O
100	O
degrees	O
C	O
in	O
1N	O
HCl	O
or	O
1N	O
NaOH	O
,	O
and	O
after	O
treatment	O
with	O
100	O
mM	O
NaIO4	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
aetiological	O
agent	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
In	O
2003	O
,	O
an	O
outbreak	O
of	O
a	O
novel	O
respiratory	O
virus	B-SPEC
exploded	O
from	O
mainland	O
China	O
into	O
an	O
international	O
issue	O
,	O
catching	O
the	O
world	O
by	O
surprise	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
transgenic	O
mouse	B-SPEC
model	O
susceptible	O
to	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

Immunohistochemical	O
studies	O
on	O
different	O
human	B-SPEC
tissues	O
,	O
including	O
a	O
cohort	O
of	O
nine	O
autopsies	O
,	O
two	O
liver	O
biopsies	O
and	O
intestinal	O
biopsies	O
of	O
SARS	O
patients	O
,	O
further	O
confirmed	O
the	O
existence	O
of	O
coronaviral	O
hypothetical	O
and	O
structural	O
proteins	O
in	O
the	O
cytoplasm	O
of	O
pneumocytes	O
and	O
small	O
intestinal	O
surface	O
enterocytes	O
in	O
SARS	O
patients	O
.	O

However	O
,	O
of	O
12	O
and	O
10	O
palm	O
civets	B-SPEC
sampled	O
in	O
November	O
and	O
December	O
including	O
five	O
of	O
which	O
had	O
been	O
at	O
the	O
live	O
animals	B-SPEC
market	O
for	O
2	O
days	O
,	O
none	O
of	O
them	O
was	O
tested	O
positive	O
.	O

TITLE	O
:	O
Efficacy	O
of	O
various	O
disinfectants	O
against	O
SARS	O
coronavirus	B-SPEC
.	O

However	O
,	O
only	O
limited	O
data	O
were	O
available	O
to	O
demonstrate	O
their	O
efficacy	O
against	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

We	O
further	O
investigated	O
the	O
3CL	O
(	O
Pro	O
)-	O
inhibitory	O
activity	O
of	O
extracts	O
from	O
several	O
different	O
types	O
of	O
teas	O
,	O
including	O
green	O
tea	O
,	O
oolong	O
tea	O
,	O
Puer	O
tea	O
and	O
black	B-SPEC
tea	I-SPEC
.	O

It	O
was	O
55	O
%	O
in	O
sepsis	B-SPEC
,	O
33	O
%	O
in	O
destructive	O
pancreatis	O
,	O
8	O
.	O
3	O
%	O
in	O
urosepsis	O
,	O
8	O
%	O
in	O
acute	O
interstitial	O
nephritis	O
,	O
64	O
.	O
7	O
%	O
in	O
rapidly	O
progressive	O
glomerulonephritis	O
.	O

TITLE	O
:	O
Expression	O
and	O
purification	O
of	O
SARS	O
coronavirus	B-SPEC
proteins	O
using	O
SUMO	O
-	O
fusions	O
.	O

The	O
work	O
reported	O
here	O
demonstrates	O
:	O
(	O
1	O
)	O
fusion	O
of	O
SUMO	O
(	O
small	O
ubiquitin	O
-	O
related	O
modifier	O
),	O
a	O
100	O
amino	O
acid	O
polypeptide	O
,	O
to	O
the	O
N	O
-	O
termini	O
of	O
SARS	O
-	O
CoV	O
proteins	O
dramatically	O
enhances	O
expression	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
cells	O
and	O
(	O
2	O
)	O
6x	O
His	O
-	O
tagged	O
SUMO	O
-	O
fusions	O
facilitate	O
rapid	O
purification	O
of	O
the	O
viral	O
proteins	O
on	O
a	O
large	O
scale	O
.	O

This	O
study	O
not	O
only	O
first	O
made	O
a	O
human	B-SPEC
neutralizing	O
antibody	O
,	O
which	O
recognized	O
an	O
epitope	O
on	O
S2	O
protein	O
like	O
natural	O
antibody	O
in	O
sera	O
,	O
but	O
also	O
may	O
help	O
us	O
to	O
better	O
understand	O
the	O
immunological	O
characteristics	O
of	O
SARS	O
protein	O
and	O
SARS	O
vaccine	O
design	O
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
purified	O
recombinant	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
for	O
producing	O
mAbs	O
,	O
and	O
New	O
Zealand	O
white	O
rabbits	B-SPEC
were	O
immunized	O
for	O
producing	O
polyclonal	O
antibodies	O
.	O

Capturing	O
and	O
detecting	O
antibodies	O
were	O
selected	O
by	O
pairing	O
the	O
mAbs	O
and	O
polyclonal	O
antibodies	O
one	O
by	O
one	O
and	O
an	O
antibodies	O
-	O
based	O
sandwich	O
antigen	O
capture	O
ELISA	O
was	O
used	O
for	O
detecting	O
N	O
antigen	O
of	O
SARS	O
-	O
CoV	O
.	O
Nine	O
mAbs	O
and	O
hyperimmune	O
rabbit	B-SPEC
polyclonal	O
antibodies	O
,	O
specifically	O
against	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
were	O
obtained	O
.	O

Specific	O
and	O
high	O
affinity	O
mAbs	O
and	O
rabbit	B-SPEC
polyclonal	O
antibodies	O
were	O
obtained	O
.	O

RESULTS	O
:	O
Nine	O
mAbs	O
and	O
hyperimmune	O
rabbit	B-SPEC
polyclonal	O
antibodies	O
,	O
specifically	O
against	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
were	O
obtained	O
.	O

In	O
contrast	O
,	O
both	O
types	O
of	O
recombinant	O
FeIFN	O
-	O
alpha	O
revealed	O
antiviral	O
activity	O
only	O
on	O
the	O
feline	B-SPEC
cells	O
.	O

To	O
address	O
the	O
significance	O
of	O
the	O
immunosuppression	O
associated	O
with	O
lung	O
contusion	O
,	O
we	O
investigated	O
how	O
the	O
consecutive	O
addition	O
of	O
moderate	O
or	O
severe	O
sepsis	B-SPEC
affected	O
survival	O
after	O
blunt	O
chest	O
trauma	O
.	O

Prospective	O
,	O
randomized	O
,	O
controlled	O
animal	B-SPEC
study	O
.	O

ABSTRACT	O
:	O
The	O
maturation	O
of	O
virus	B-SPEC
-	O
specific	O
immunoglobulin	O
G	O
avidity	O
during	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
was	O
examined	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
),	O
designated	O
SARS	O
-	O
CoV	B-SPEC
,	O
is	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
with	O
the	O
lungs	O
as	O
a	O
major	O
target	O
.	O

Recent	O
studies	O
indicate	O
that	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
spike	O
protein	O
(	O
S	O
protein	O
)	O
and	O
its	O
truncated	O
fragments	O
are	O
considered	O
the	O
best	O
candidates	O
for	O
generation	O
of	O
the	O
recombinant	O
vaccine	O
.	O

Plant	B-SPEC
-	O
derived	O
antigen	O
was	O
evaluated	O
to	O
induce	O
the	O
systemic	O
and	O
mucosal	O
immune	O
responses	O
in	O
mice	B-SPEC
.	O

Initially	O
,	O
the	O
MHV	B-SPEC
E	O
gene	O
was	O
inducibly	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
cells	O
,	O
leading	O
to	O
the	O
arrest	O
of	O
bacterial	O
growth	O
,	O
cell	O
lysis	O
and	O
permeabilization	O
to	O
different	O
compounds	O
.	O

ABSTRACT	O
:	O
The	O
transmission	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
associated	O
with	O
close	O
contact	O
to	O
SARS	O
patients	O
and	O
droplet	O
secretions	O
of	O
those	O
patients	O
.	O

TITLE	O
:	O
[	O
RNase	O
III	O
-	O
prepared	O
short	O
interfering	O
RNAs	O
induce	O
degradation	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
mRNAs	O
in	O
human	B-SPEC
cells	O
].	O

In	O
mammalian	B-SPEC
cells	O
,	O
RNAi	O
can	O
be	O
triggered	O
by	O
short	O
interfering	O
RNA	O
(	O
siRNA	O
).	O

ABSTRACT	O
:	O
Genes	O
encoding	O
nucleocaspid	O
(	O
N	O
)	O
and	O
membrane	O
(	O
M	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
were	O
obtained	O
by	O
RT	O
-	O
PCR	O
and	O
were	O
cloned	O
into	O
expression	O
vector	O
pET22b	O
and	O
pBV222	O
.	O

Intriguingly	O
,	O
heat	O
-	O
inactivated	O
SARS	O
-	O
CoV	O
elicited	O
recall	O
-	O
like	O
CTL	O
responses	O
to	O
SSp	O
-	O
1	O
but	O
not	O
to	O
S978	O
,	O
S1202	O
,	O
or	O
dominant	O
epitopes	O
from	O
several	O
other	O
human	B-SPEC
viruses	B-SPEC
in	O
5	O
of	O
36	O
(	O
13	O
.	O
8	O
%)	O
HLA	O
-	O
A	O
*	O
0201	O
(+)	O
healthy	O
donors	O
without	O
any	O
contact	O
history	O
with	O
SARS	O
-	O
CoV	O
.	O
SSp	O
-	O
1	O
-	O
specific	O
CTLs	O
expanded	O
from	O
memory	O
T	O
cells	O
of	O
both	O
recovered	O
SARS	O
patients	O
,	O
and	O
the	O
five	O
exceptional	O
healthy	O
donors	O
shared	O
a	O
differentiated	O
effector	O
CTL	O
phenotype	O
,	O
CD45RA	O
(+)	O
CCR7	O
(-)	O
CD62L	O
(-),	O
and	O
expressed	O
CCR5	O
and	O
CD44	O
.	O

We	O
identified	O
the	O
immunodominant	O
antigenic	O
sites	O
responsible	O
for	O
the	O
antibodies	O
in	O
sera	O
from	O
SARS	O
patients	O
and	O
antisera	O
from	O
small	O
animals	B-SPEC
and	O
differentiated	O
the	O
linear	O
from	O
the	O
conformational	O
antibody	O
-	O
combining	O
sites	O
comprising	O
the	O
natural	O
epitopes	O
by	O
use	O
of	O
yeast	B-SPEC
surface	O
display	O
.	O

The	O
antibody	O
responses	O
to	O
the	O
N	O
protein	O
fragments	O
in	O
mammalian	B-SPEC
sera	O
revealed	O
that	O
3	O
regions	O
of	O
the	O
N	O
protein	O
are	O
strong	O
antigenic	O
domains	O
.	O

TITLE	O
:	O
Recurrent	O
mutations	O
associated	O
with	O
isolation	O
and	O
passage	O
of	O
SARS	O
coronavirus	B-SPEC
in	O
cells	O
from	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
.	O

This	O
inhibition	O
suggested	O
that	O
ATA	B-SPEC
could	O
be	O
developed	O
as	O
potent	O
anti	O
-	O
viral	O
drug	O
.	O

ABSTRACT	O
:	O
Because	O
phosphorylation	O
of	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
nucleocapsid	O
protein	O
(	O
N	O
)	O
may	O
regulate	O
its	O
multiple	O
roles	O
in	O
viral	O
replication	O
,	O
the	O
dynamics	O
of	O
N	O
phosphorylation	O
were	O
examined	O
.	O

Pulse	O
-	O
chase	O
analyses	O
followed	O
by	O
immunoprecipitation	O
of	O
IBV	B-SPEC
N	O
proteins	O
using	O
rabbit	B-SPEC
anti	O
-	O
IBV	B-SPEC
N	O
polyclonal	O
antibody	O
demonstrated	O
that	O
the	O
phosphate	O
on	O
the	O
N	O
protein	O
was	O
stable	O
for	O
at	O
least	O
1	O
h	O
.	O
Simultaneous	O
labeling	O
with	O
32P	O
-	O
orthophosphate	O
and	O
3H	O
-	O
leucine	O
identified	O
a	O
3	O
.	O
5	O
-	O
fold	O
increase	O
in	O
the	O
32P	O
:	O
3H	O
counts	O
per	O
minute	O
(	O
cpm	O
)	O
ratio	O
of	O
N	O
in	O
the	O
virion	O
as	O
compared	O
to	O
the	O
32P	O
:	O
3H	O
cpm	O
ratio	O
of	O
N	O
in	O
the	O
cell	O
lysates	O
from	O
chicken	B-SPEC
embryo	O
kidney	O
cells	O
,	O
whereas	O
in	O
Vero	O
cells	O
the	O
32P	O
:	O
3H	O
cpm	O
ratio	O
of	O
N	O
from	O
the	O
virion	O
was	O
10	O
.	O
5	O
-	O
fold	O
greater	O
than	O
the	O
32P	O
:	O
3H	O
cpm	O
ratio	O
of	O
N	O
from	O
the	O
cell	O
lysates	O
.	O

In	O
all	O
sheep	B-SPEC
,	O
the	O
EVW	O
maintained	O
gas	O
exchange	O
during	O
and	O
after	O
bronchoconstriction	O
,	O
as	O
well	O
as	O
during	O
OA	O
injury	O
.	O

By	O
using	O
inhibitors	O
with	O
differing	O
potency	O
toward	O
different	O
members	O
of	O
the	O
ADAM	O
(	O
a	O
disintegrin	O
and	O
metalloproteinase	O
)	O
family	B-SPEC
of	O
proteases	O
,	O
we	O
identified	O
ADAM17	O
as	O
a	O
candidate	O
mediator	O
of	O
stimulated	O
ACE2	O
shedding	O
.	O

In	O
addition	O
,	O
a	O
discussion	O
of	O
the	O
zoonotic	O
implications	O
of	O
torovirus	B-SPEC
-	O
like	O
particles	O
detected	O
in	O
patients	O
with	O
gastroenteritis	O
that	O
resemble	O
and	O
cross	O
-	O
react	O
with	O
BoTV	O
is	O
presented	O
.	O

ABSTRACT	O
:	O
The	O
benefits	O
of	O
using	O
plant	B-SPEC
-	O
based	O
oral	O
vaccines	O
are	O
discussed	O
.	O

Twenty	O
-	O
four	O
rats	B-SPEC
underwent	O
one	O
of	O
three	O
'	O
first	O
-	O
hit	O
'	O
scenarios	O
:	O
(	O
1	O
)	O
severe	O
AP	O
induced	O
by	O
intraductal	O
glycodeoxycholic	O
acid	O
injection	O
and	O
intravenous	O
caerulein	O
infusion	O
,	O
(	O
2	O
)	O
sham	O
laparotomy	O
,	O
or	O
(	O
3	O
)	O
no	O
first	O
intervention	O
.	O

Eighteen	O
hours	O
later	O
,	O
all	O
animals	B-SPEC
received	O
a	O
'	O
second	O
hit	O
'	O
of	O
portal	O
LPS	O
in	O
an	O
isolated	O
liver	O
perfusion	O
system	O
.	O

Two	O
outbreaks	O
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
have	O
recently	O
provided	O
important	O
lessons	O
on	O
how	O
transplant	O
patients	O
are	O
affected	O
,	O
and	O
how	O
transplant	O
programmes	O
must	O
adapt	O
and	O
evolve	O
in	O
the	O
face	O
of	O
emerging	O
infections	O
.	O

With	O
subsequent	O
reduction	O
of	O
complications	O
and	O
improvement	O
of	O
biocompability	O
,	O
extracorporeal	O
membrane	O
oxygentation	O
(	O
ECMO	O
)	O
indications	O
may	O
be	O
extendend	O
to	O
treat	O
patients	O
earlier	O
and	O
not	O
only	O
in	O
rescue	O
situations	O
along	O
the	O
original	O
idea	B-SPEC
to	O
buy	O
the	O
lung	O
some	O
time	O
to	O
heal	O
by	O
avoiding	O
further	O
ventilator	O
associated	O
lung	O
injury	O
.	O

RESULTS	O
:	O
The	O
purified	O
hyperimmune	O
globulins	O
were	O
formulated	O
as	O
a	O
5	O
percent	O
solution	O
,	O
with	O
an	O
antibody	O
titer	O
specifically	O
against	O
the	O
SARS	O
virus	B-SPEC
of	O
1	O
:	O
83	O
,	O
1	O
:	O
1600	O
,	O
and	O
1	O
:	O
200	O
,	O
as	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
immunofluorescence	O
assay	O
,	O
and	O
neutralizing	O
antibody	O
test	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
61	O
fecal	O
samples	O
from	O
healthy	O
foxes	O
and	O
24	O
from	O
healthy	O
raccoon	B-SPEC
dogs	I-SPEC
were	O
examined	O
by	O
RT	O
-	O
nested	O
PCR	O
assays	O
for	O
the	O
presence	O
and	O
genotypic	O
identification	O
of	O
Canine	O
coronaviruses	O
(	O
CCVs	O
).	O

Sequence	O
analysis	O
showed	O
that	O
the	O
M	O
gene	O
of	O
CCV	O
type	O
I	O
had	O
a	O
high	O
similarity	O
of	O
96	O
.	O
7	O
%	O
-	O
98	O
.	O
1	O
%	O
between	O
the	O
fox	O
-	O
and	O
raccoon	B-SPEC
dog	I-SPEC
strains	O
and	O
the	O
reported	O
Italian	O
strain	O
from	O
diarrhea	O
dogs	B-SPEC
.	O

The	O
co	O
-	O
existence	O
and	O
popularity	O
of	O
the	O
two	O
CCV	O
genotypes	O
in	O
healthy	O
foxes	O
and	O
raccoon	B-SPEC
dogs	I-SPEC
were	O
first	O
confirmed	O
in	O
this	O
article	O
.	O

A	O
large	O
human	B-SPEC
scFv	O
library	O
against	O
SARS	O
virus	B-SPEC
with	O
good	O
diversity	O
was	O
constructed	O
,	O
which	O
may	O
be	O
used	O
for	O
screening	O
antibodies	O
to	O
SARS	O
virus	B-SPEC
antigens	O
.	O

CONCLUSIONS	O
:	O
A	O
large	O
human	B-SPEC
scFv	O
library	O
against	O
SARS	O
virus	B-SPEC
with	O
good	O
diversity	O
was	O
constructed	O
,	O
which	O
may	O
be	O
used	O
for	O
screening	O
antibodies	O
to	O
SARS	O
virus	B-SPEC
antigens	O
.	O

Here	O
,	O
we	O
examined	O
the	O
susceptibility	O
of	O
neural	O
cell	O
lines	O
of	O
human	B-SPEC
(	O
OL	O
)	O
and	O
rat	B-SPEC
(	O
C6	O
)	O
origins	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Nuclear	O
/	O
nucleolar	O
localization	O
properties	O
of	O
C	O
-	O
terminal	O
nucleocapsid	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

Nucleocapsid	O
(	O
N	O
)	O
proteins	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
have	O
no	O
discernable	O
homology	O
,	O
but	O
they	O
share	O
a	O
common	O
nucleolar	O
-	O
cytoplasmic	O
distribution	O
pattern	O
.	O

S	O
-	O
peptide	O
,	O
mice	B-SPEC
primed	O
with	O
i	O
.	O
m	O
.	O

S	O
-	O
peptide	O
,	O
mice	B-SPEC
primed	O
with	O
oral	O
live	O
-	O
attenuated	O
S	O
.	O
typhimurium	O
that	O
contained	O
tPA	O
-	O
optimize800	O
DNA	O
vaccine	O
(	O
Salmonella	B-SPEC
-	O
tPA	O
-	O
S	O
-	O
DNA	O
)	O
and	O
boosted	O
with	O
i	O
.	O
p	O
.	O

TITLE	O
:	O
Comparison	O
of	O
9	O
different	O
PCR	O
primers	O
for	O
the	O
rapid	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
using	O
2	O
RNA	O
extraction	O
methods	O
.	O

Although	O
additional	O
factors	O
doubtlessly	O
influence	O
the	O
relative	O
prevalence	O
of	O
FIP	O
,	O
this	O
study	O
provides	O
additional	O
guidance	O
when	O
prioritizing	O
differentials	O
in	O
ill	O
purebreed	O
cats	B-SPEC
.	O

TITLE	O
:	O
Contributions	O
of	O
the	O
viral	O
genetic	O
background	O
and	O
a	O
single	O
amino	O
acid	O
substitution	O
in	O
an	O
immunodominant	O
CD8	O
+	O
T	O
-	O
cell	O
epitope	O
to	O
murine	B-SPEC
coronavirus	I-SPEC
neurovirulence	O
.	O

72	O
:	O
5912	O
-	O
5918	O
,	O
1998	O
),	O
RJHM	O
(	O
N514S	O
)	O
was	O
not	O
more	O
virulent	O
than	O
the	O
parental	O
,	O
RJHM	O
,	O
in	O
4	O
-	O
week	O
-	O
old	O
C57BL	O
/	O
6	O
(	O
H	O
-	O
2b	O
)	O
mice	B-SPEC
after	O
intracranial	O
injection	O
.	O

Whereas	O
recombinants	O
expressing	O
the	O
wild	O
-	O
type	O
JHM	O
spike	O
(	O
SJHM	O
/	O
RA59	O
)	O
were	O
highly	O
neurovirulent	O
,	O
A59	O
recombinants	O
containing	O
the	O
N514S	O
mutation	O
(	O
SJHM	O
(	O
N514S	O
)/	O
RA59	O
)	O
were	O
attenuated	O
,	O
replicated	O
less	O
efficiently	O
,	O
and	O
exhibited	O
reduced	O
virus	B-SPEC
spread	O
in	O
the	O
brain	O
at	O
5	O
days	O
postinfection	O
(	O
peak	O
of	O
infectious	O
virus	B-SPEC
titers	O
in	O
the	O
central	O
nervous	O
system	O
)	O
compared	O
to	O
parental	O
virus	B-SPEC
encoding	O
wild	O
-	O
type	O
spike	O
.	O

All	O
patients	O
had	O
nasopharyngeal	O
and	O
throat	O
swabs	O
taken	O
for	O
respiratory	O
virus	B-SPEC
antigen	O
detection	O
,	O
culture	O
and	O
RT	O
-	O
PCR	O
.	O

Rates	O
of	O
rejection	O
,	O
decline	O
in	O
forced	O
expiratory	O
volume	O
(	O
L	O
)	O
in	O
1	O
s	O
(	O
FEV	B-SPEC
-	O
1	O
)	O
and	O
bacterial	O
and	O
fungal	O
superinfection	O
were	O
compared	O
at	O
the	O
3	O
-	O
month	O
primary	O
endpoint	O
.	O

In	O
the	O
50	O
patients	O
with	O
RTI	O
,	O
a	O
microbial	O
etiology	O
was	O
identified	O
in	O
33	O
of	O
50	O
(	O
66	O
%)	O
and	O
included	O
rhinovirus	B-SPEC
(	O
9	O
),	O
coronavirus	B-SPEC
(	O
8	O
),	O
RSV	B-SPEC
(	O
6	O
),	O
influenza	O
A	O
(	O
5	O
),	O
parainfluenza	O
(	O
4	O
)	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
1	O
).	O

Here	O
we	O
report	O
that	O
ACE2	O
and	O
the	O
angiotensin	O
II	O
type	O
2	O
receptor	O
(	O
AT2	O
)	O
protect	O
mice	B-SPEC
from	O
severe	O
acute	O
lung	O
injury	O
induced	O
by	O
acid	O
aspiration	O
or	O
sepsis	B-SPEC
.	O

To	O
develop	O
a	O
safe	O
,	O
simple	O
,	O
and	O
reliable	O
screening	O
method	O
for	O
SARS	O
diagnosis	O
and	O
epidemiological	O
study	O
,	O
two	O
recombinant	O
SARS	O
-	O
CoV	O
nucleocapsid	O
proteins	O
(	O
N	O
'	O
protein	O
and	O
(	O
N	O
)	O
Delta	O
(	O
121	O
)	O
protein	O
)	O
were	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
purified	O
by	O
affinity	O
chromatography	O
,	O
and	O
used	O
as	O
antigens	O
for	O
indirect	O
,	O
immunoglobulin	O
G	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISA	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbroke	O
in	O
2003	O
,	O
and	O
the	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
also	O
outbroke	O
in	O
2003	O
and	O
continued	O
to	O
2004	O
.	O

Bird	B-SPEC
faeces	O
are	O
also	O
key	O
carriers	O
of	O
the	O
viruses	B-SPEC
.	O

In	O
the	O
ponds	O
,	O
they	O
raise	O
ducks	B-SPEC
and	O
conduct	O
fish	B-SPEC
culture	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
associations	O
among	O
infectious	O
pathogens	O
and	O
diarrheal	O
disease	O
in	O
dogs	B-SPEC
in	O
an	O
animal	B-SPEC
shelter	O
and	O
demonstrate	O
the	O
use	O
of	O
geographic	O
information	O
systems	O
(	O
GISs	O
)	O
for	O
tracking	O
spatial	O
distributions	O
of	O
diarrheal	O
disease	O
within	O
shelters	O
.	O

Salmonella	B-SPEC
enterica	I-SPEC
and	O
Brachyspira	B-SPEC
spp	O
were	O
not	O
common	O
,	O
whereas	O
other	O
pathogens	O
such	O
as	O
canine	O
coronavirus	B-SPEC
and	O
Helicobacter	B-SPEC
spp	O
were	O
common	O
among	O
the	O
dogs	B-SPEC
that	O
were	O
surveyed	O
.	O

In	O
donors	O
,	O
the	O
presence	O
of	O
infectious	O
micro	O
-	O
organisms	O
,	O
like	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
and	O
human	B-SPEC
T	O
cell	O
lymphotrophic	O
virus	B-SPEC
,	O
should	O
be	O
evaluated	O
in	O
addition	O
to	O
the	O
possibility	O
of	O
other	O
new	O
infectious	O
agents	O
(	O
e	O
.	O
g	O
.	O
transmissible	O
spongiform	O
encephalopathies	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
).	O

Fastidious	O
micro	O
-	O
organisms	O
,	O
and	O
an	O
adventitious	O
or	O
endogenous	O
virus	B-SPEC
,	O
is	O
a	O
well	O
-	O
known	O
fact	O
that	O
will	O
also	O
have	O
to	O
be	O
considered	O
for	O
processes	O
involving	O
in	O
vitro	O
culture	O
of	O
stem	O
cells	O
.	O

Those	O
partially	O
resistant	O
viruses	B-SPEC
grew	O
more	O
slowly	O
and	O
formed	O
smaller	O
plaques	O
than	O
wild	O
-	O
type	O
SARS	O
-	O
CoV	O
.	O
These	O
results	O
suggest	O
PMO	O
compounds	O
have	O
powerful	O
therapeutic	O
and	O
investigative	O
potential	O
toward	O
coronavirus	B-SPEC
infection	O
.	O

However	O
,	O
the	O
MHV	B-SPEC
receptor	O
is	O
not	O
present	O
in	O
lipid	O
rafts	O
,	O
and	O
anchoring	O
of	O
the	O
MHV	B-SPEC
receptor	O
to	O
lipid	O
rafts	O
did	O
not	O
enhance	O
MHV	B-SPEC
infection	O
;	O
thus	O
,	O
the	O
mechanism	O
of	O
lipid	O
rafts	O
involvement	O
is	O
not	O
clear	O
.	O

We	O
showed	O
that	O
cholesterol	O
depletion	O
by	O
methyl	O
beta	O
-	O
cyclodextrin	O
or	O
filipin	O
did	O
not	O
affect	O
virus	B-SPEC
binding	O
but	O
reduced	O
virus	B-SPEC
entry	O
.	O

However	O
,	O
MHV	B-SPEC
spike	O
protein	O
has	O
an	O
inherent	O
ability	O
to	O
associate	O
with	O
lipid	O
rafts	O
.	O

TITLE	O
:	O
Asymptomatic	O
SARS	O
coronavirus	B-SPEC
infection	O
among	O
healthcare	O
workers	O
,	O
Singapore	O
.	O

Clinically	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
was	O
found	O
to	O
be	O
second	O
to	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
alone	O
,	O
as	O
a	O
cause	O
of	O
respiratory	O
tract	O
infections	O
,	O
while	O
duration	O
of	O
virus	B-SPEC
excretion	O
appeared	O
to	O
correlate	O
with	O
severity	O
of	O
infection	O
,	O
and	O
virus	B-SPEC
load	O
in	O
NPA	O
with	O
the	O
stage	O
of	O
respiratory	O
infection	O
.	O

TITLE	O
:	O
Viral	O
load	O
quantitation	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
RNA	O
using	O
a	O
one	O
-	O
step	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Genotype	O
-	O
specific	O
fluorogenic	O
RT	O
-	O
PCR	O
assays	O
for	O
the	O
detection	O
and	O
quantitation	O
of	O
canine	O
coronavirus	B-SPEC
type	O
I	O
and	O
type	O
II	O
RNA	O
in	O
faecal	O
samples	O
of	O
dogs	B-SPEC
.	O

At	O
the	O
same	O
time	O
,	O
dogs	B-SPEC
infected	O
experimentally	O
shed	O
type	O
I	O
RNA	O
with	O
higher	O
titres	O
with	O
respect	O
to	O
type	O
II	O
.	O

TITLE	O
:	O
Novel	O
rapid	O
immunochromatographic	O
test	O
based	O
on	O
an	O
enzyme	O
immunoassay	O
for	O
detecting	O
nucleocapsid	O
antigen	O
in	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

We	O
developed	O
a	O
novel	O
rapid	O
immunochromatographic	O
test	O
(	O
RICT	O
)	O
based	O
on	O
the	O
sandwich	O
format	O
enzyme	O
immunoassay	O
(	O
EIA	O
)	O
with	O
an	O
all	O
-	O
in	O
-	O
one	O
device	O
for	O
detecting	O
the	O
native	O
nucleocapsid	O
antigen	O
(	O
N	O
-	O
Ag	O
)	O
of	O
SARS	O
-	O
CoV	O
using	O
monoclonal	O
antibodies	O
(	O
MoAbs	O
),	O
which	O
we	O
produced	O
by	O
immunizing	O
recombinant	O
N	O
-	O
Ag	O
to	O
mice	B-SPEC
.	O

The	O
N	O
protein	O
gene	O
has	O
been	O
cloned	O
into	O
a	O
yeast	B-SPEC
expression	O
vector	O
pPIC9	O
,	O
transformed	O
into	O
Pichia	B-SPEC
pastoris	I-SPEC
strain	O
GS115	O
and	O
induced	O
for	O
expression	O
by	O
methanol	O
.	O

The	O
toxicity	O
of	O
beta	O
-	O
propiolactone	O
was	O
hydrolyzed	O
completely	O
when	O
the	O
inactivated	O
virus	B-SPEC
was	O
cultured	O
for	O
16	O
hours	O
at	O
2	O
degrees	O
C	O
,	O
8	O
degrees	O
C	O
and	O
in	O
water	O
bath	O
for	O
2	O
hours	O
at	O
37	O
degrees	O
C	O
.	O
CONCLUSIONS	O
:	O
The	O
titer	O
of	O
SARS	O
-	O
CoV	O
was	O
the	O
highest	O
when	O
it	O
was	O
cultured	O
in	O
Vero	O
or	O
Vero	O
-	O
E6	O
cells	O
for	O
72	O
hours	O
at	O
37	O
degrees	O
C	O
in	O
5	O
percent	O
CO2	O
incubator	O
.	O

Viruses	B-SPEC
were	O
detected	O
in	O
58	O
%	O
of	O
the	O
case	O
patients	O
,	O
beta	O
-	O
hemolytic	O
streptococci	O
group	O
A	O
were	O
detected	O
in	O
11	O
%,	O
and	O
mixed	O
infections	O
were	O
detected	O
in	O
3	O
%.	O

TITLE	O
:	O
An	O
update	O
on	O
aspects	O
of	O
viral	O
gastrointestinal	O
diseases	O
of	O
dogs	B-SPEC
and	O
cats	B-SPEC
.	O

It	O
is	O
concluded	O
that	O
some	O
autoantibodies	O
against	O
human	B-SPEC
epithelial	O
cells	O
and	O
endothelial	O
cells	O
would	O
be	O
developed	O
after	O
SARS	O
-	O
CoV	O
infection	O
and	O
this	O
phenomenon	O
may	O
indicate	O
post	O
-	O
infectious	O
cellular	O
injury	O
and	O
also	O
induce	O
SARS	O
-	O
induced	O
immunopathology	O
.	O

TITLE	O
:	O
Phosphorylation	O
and	O
subcellular	O
localization	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
nucleocapsid	O
protein	O
in	O
infected	O
cells	O
.	O

The	O
phosphorylation	O
state	O
and	O
intracellular	O
distribution	O
of	O
TGEV	B-SPEC
N	O
protein	O
in	O
infected	O
cells	O
were	O
characterized	O
by	O
a	O
combination	O
of	O
techniques	O
including	O
:	O
(	O
i	O
)	O
subcellular	O
fractionation	O
and	O
analysis	O
of	O
tryptic	O
peptides	O
by	O
two	O
-	O
dimensional	O
nano	O
-	O
liquid	O
chromatography	O
,	O
coupled	O
to	O
ion	O
-	O
trap	O
mass	O
spectrometry	O
;	O
(	O
ii	O
)	O
tandem	O
mass	O
-	O
spectrometry	O
analysis	O
of	O
N	O
protein	O
resolved	O
by	O
SDS	O
-	O
PAGE	O
;	O
(	O
iii	O
)	O
Western	O
blotting	O
using	O
two	O
specific	O
antisera	O
for	O
phosphoserine	O
-	O
containing	O
motifs	O
;	O
and	O
(	O
iv	O
)	O
confocal	O
microscopy	O
.	O

However	O
,	O
caution	O
should	O
be	O
taken	O
with	O
the	O
safety	O
of	O
whole	O
virus	B-SPEC
or	O
full	O
-	O
length	O
S	O
protein	O
-	O
based	O
immunogens	O
in	O
humans	B-SPEC
because	O
they	O
may	O
induce	O
harmful	O
immune	O
or	O
inflammatory	O
responses	O
.	O

TITLE	O
:	O
Papain	O
-	O
like	O
protease	O
2	O
(	O
PLP2	O
)	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
):	O
expression	O
,	O
purification	O
,	O
characterization	O
,	O
and	O
inhibition	O
.	O

Here	O
,	O
we	O
report	O
the	O
characterization	O
of	O
SARS	O
-	O
CoV	O
PLP2	O
(	O
from	O
residues	O
1414	O
to	O
1858	O
)	O
purified	O
from	O
baculovirus	B-SPEC
-	O
infected	O
insect	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Fever	O
greater	O
than	O
38	O
degrees	O
C	O
is	O
a	O
cardinal	B-SPEC
sign	O
of	O
patients	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndromes	O
(	O
SARS	O
).	O

The	O
following	O
variables	O
were	O
recorded	O
:	O
age	O
,	O
sex	O
,	O
personal	O
history	O
,	O
need	O
for	O
endotracheal	O
intubation	O
,	O
duration	O
of	O
intubation	O
,	O
isolated	O
bacteria	B-SPEC
,	O
antibiotic	O
treatment	O
,	O
steroid	O
administration	O
,	O
and	O
length	O
of	O
stay	O
in	O
the	O
PICU	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
open	O
reading	O
frame	O
3	O
(	O
ORF3	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
encodes	O
a	O
predicted	O
154	O
-	O
amino	O
acid	O
protein	O
,	O
which	O
lacks	O
similarities	O
to	O
any	O
known	O
protein	O
,	O
and	O
is	O
named	O
3b	O
.	O

SARS	O
-	O
CoV	O
(	O
SARS	O
coronavirus	B-SPEC
),	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
has	O
been	O
etiologically	O
associated	O
with	O
SARS	O
cases	O
,	O
is	O
homologous	O
with	O
MHV	B-SPEC
(	O
murine	B-SPEC
hepatitis	O
coronavirus	B-SPEC
),	O
and	O
MHV	B-SPEC
small	O
envelope	O
E	O
protein	O
is	O
capable	O
of	O
inducing	O
apoptosis	O
.	O

This	O
case	O
represents	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
case	O
of	O
Darier	O
disease	O
presenting	O
a	O
fatal	O
type	O
-	O
2	O
HSV	B-SPEC
infection	O
.	O

It	O
underlines	O
the	O
importance	O
of	O
rapidly	O
recognizing	O
HSV	B-SPEC
infection	O
in	O
Darier	O
disease	O
and	O
stresses	O
the	O
risk	O
of	O
lethal	O
outcome	O
.	O

We	O
inoculated	O
common	B-SPEC
marmosets	I-SPEC
(	O
Callithrix	B-SPEC
jacchus	I-SPEC
)	O
with	O
the	O
objective	O
of	O
developing	O
a	O
small	O
nonhuman	O
primate	B-SPEC
model	O
of	O
SARS	O
.	O

Today	O
a	O
variety	O
of	O
emerging	O
agents	O
are	O
of	O
concern	O
to	O
transfusion	O
safety	O
including	O
Trypanosoma	B-SPEC
cruzi	I-SPEC
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
and	O
Babesia	B-SPEC
microti	I-SPEC
to	O
name	B-SPEC
but	O
a	O
few	O
.	O

In	O
the	O
current	O
study	O
,	O
a	O
reverse	O
genetic	O
approach	O
was	O
used	O
to	O
define	O
the	O
role	O
of	O
the	O
28	O
-	O
kDa	O
amino	O
-	O
terminal	O
product	O
(	O
nsp1	O
)	O
of	O
the	O
gene	O
1	O
polyprotein	O
during	O
replication	O
of	O
the	O
coronavirus	B-SPEC
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
in	O
cell	O
culture	O
.	O

Furthermore	O
,	O
whereas	O
deletion	O
of	O
nsp1	O
residues	O
amino	O
-	O
terminal	O
to	O
K	O
(	O
124	O
)	O
failed	O
to	O
produce	O
infectious	O
virus	B-SPEC
,	O
point	O
mutagenesis	O
of	O
the	O
nsp1	O
amino	O
-	O
terminus	O
allowed	O
recovery	O
of	O
several	O
mutants	O
with	O
altered	O
replication	O
and	O
RNA	O
synthesis	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
associated	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
that	O
was	O
identified	O
and	O
molecularly	O
characterized	O
in	O
2003	O
.	O

TITLE	O
:	O
An	O
atypical	O
RNA	O
pseudoknot	O
stimulator	O
and	O
an	O
upstream	O
attenuation	O
signal	O
for	O
-	O
1	O
ribosomal	O
frameshifting	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
hypothalamic	O
-	O
pituitary	O
-	O
adrenal	O
(	O
HPA	O
)	O
axis	B-SPEC
dysfunction	O
of	O
the	O
majority	O
resolved	O
within	O
a	O
year	O
.	O

Recently	O
coronavirus	B-SPEC
infection	O
and	O
genetic	O
polymorphisms	O
have	O
been	O
implicated	O
.	O

We	O
showed	O
that	O
both	O
peptides	O
(	O
M1	O
-	O
31	O
and	O
M132	O
-	O
161	O
)	O
were	O
able	O
to	O
induce	O
high	O
titers	O
of	O
antibody	O
responses	O
in	O
the	O
immunized	O
rabbits	B-SPEC
,	O
highlighting	O
their	O
antigenicity	O
and	O
immunogenicity	O
.	O

TITLE	O
:	O
Expression	O
and	O
purification	O
of	O
N	O
and	O
E	O
proteins	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
:	O
a	O
comparative	O
study	O
.	O

SARS	O
-	O
CoV	O
virus	B-SPEC
is	O
able	O
to	O
induce	O
both	O
IFN	O
-	O
alpha	O
and	O
-	O
gamma	O
mRNA	O
accumulation	O
and	O
protein	O
release	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
MOI	O
10	O
being	O
the	O
most	O
effective	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
recently	O
emerged	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
has	O
been	O
designated	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
titer	O
of	O
neutralizing	O
antibodies	O
against	O
ReoV	O
and	O
SARS	O
-	O
CoV	O
ranged	O
from	O
80	O
to	O
160	O
when	O
the	O
animals	B-SPEC
were	O
inoculated	O
with	O
the	O
two	O
viruses	B-SPEC
,	O
respectively	O
,	O
while	O
the	O
titer	O
of	O
the	O
antibodies	O
was	O
just	O
below	O
10	O
in	O
coinfections	O
.	O

Four	O
macaque	B-SPEC
monkeys	B-SPEC
demonstrated	O
diffuse	O
alveolar	O
damage	O
,	O
characterized	O
by	O
hemorrhagic	O
pneumonia	O
,	O
serosanguineous	O
exudates	O
,	O
formation	O
of	O
hyaline	O
membranes	O
,	O
and	O
type	O
II	O
pneumocyte	O
hyperplasia	O
,	O
which	O
were	O
similar	O
to	O
those	O
that	O
have	O
been	O
noted	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
pathogenesis	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
a	O
newly	O
emerging	O
life	O
-	O
threatening	O
disease	O
in	O
humans	B-SPEC
,	O
remains	O
unknown	O
.	O

All	O
of	O
them	O
were	O
able	O
to	O
bind	O
to	O
the	O
surface	O
domain	O
of	O
the	O
whole	O
spike	O
protein	O
expressed	O
by	O
recombinant	O
baculovirus	B-SPEC
in	O
insect	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
The	O
S2	O
domain	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
is	O
responsible	O
for	O
fusion	O
between	O
virus	B-SPEC
and	O
target	O
cell	O
membranes	O
,	O
and	O
is	O
expected	O
to	O
be	O
immungenic	O
.	O

The	O
serum	O
IgG	O
level	O
of	O
the	O
vaccine	O
group	O
mice	B-SPEC
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
corresponding	O
control	O
group	O
at	O
day	O
14	O
after	O
vaccination	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

These	O
results	O
strongly	O
demonstrated	O
that	O
the	O
pVAX	O
-	O
S1	O
plasmid	O
could	O
induce	O
humoral	O
and	O
cellular	O
immune	O
responses	O
in	O
mice	B-SPEC
,	O
and	O
may	O
be	O
a	O
potential	O
candidate	O
for	O
a	O
DNA	O
vaccine	O
against	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
is	O
a	O
paramyxovirus	O
discovered	O
in	O
2001	O
in	O
the	O
Netherlands	O
,	O
with	O
a	O
seasonal	O
occurrence	O
and	O
spectrum	O
of	O
clinical	O
illness	O
most	O
similar	O
to	O
the	O
closely	O
related	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Most	O
animal	B-SPEC
species	B-SPEC
that	O
can	O
be	O
infected	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
do	O
not	O
reproducibly	O
develop	O
clinical	O
disease	O
,	O
hindering	O
studies	O
of	O
pathogenesis	O
.	O

TITLE	O
:	O
Intracellular	O
localization	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
:	O
absence	O
of	O
nucleolar	O
accumulation	O
during	O
infection	O
and	O
after	O
expression	O
as	O
a	O
recombinant	O
protein	O
in	O
vero	O
cells	O
.	O

Due	O
to	O
the	O
low	O
positive	O
rate	O
of	O
the	O
PCR	O
for	O
SARS	O
coronavirus	B-SPEC
,	O
and	O
the	O
low	O
positive	O
predictive	O
value	O
of	O
reported	O
cases	O
,	O
the	O
factuality	O
of	O
cases	O
with	O
unknown	O
sources	O
of	O
infection	O
should	O
be	O
further	O
verified	O
.	O

The	O
samples	O
had	O
been	O
collected	O
from	O
hospitalised	O
patients	O
and	O
outpatients	O
from	O
December	O
1999	O
to	O
October	O
2001	O
in	O
four	O
different	O
regions	O
in	O
Germany	O
as	O
part	O
of	O
the	O
prospective	O
population	O
-	O
based	O
PRI	O
.	O
DE	O
study	O
and	O
analysed	O
for	O
RNA	O
from	O
respiratory	O
viruses	B-SPEC
.	O

A	O
strong	O
association	O
with	O
croup	O
was	O
apparent	O
:	O
43	O
%	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
positive	O
patients	O
with	O
high	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
load	O
and	O
absence	O
of	O
co	O
-	O
infection	O
suffered	O
from	O
croup	O
,	O
compared	O
to	O
6	O
%	O
in	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
negative	O
group	O
,	O
p	O
<	O
0	O
.	O
0001	O
.	O

ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
cause	O
of	O
the	O
life	O
-	O
threatening	O
atypical	O
pneumonia	O
,	O
infects	O
many	O
organs	O
,	O
such	O
as	O
lung	O
,	O
liver	O
and	O
immune	O
organ	O
,	O
and	O
induces	O
parenchyma	O
cells	O
apoptosis	O
and	O
necrosis	O
.	O

The	O
genome	O
of	O
SARS	O
-	O
CoV	O
,	O
not	O
closely	O
related	O
to	O
any	O
of	O
the	O
previously	O
characterized	O
coronavirus	B-SPEC
,	O
encodes	O
replicase	O
and	O
four	O
major	O
structural	O
proteins	O
and	O
a	O
number	O
of	O
non	O
-	O
structural	O
proteins	O
.	O

The	O
use	O
of	O
a	O
shell	O
vial	O
assay	O
and	O
PCR	O
identified	O
a	O
pathogen	O
in	O
103	O
(	O
39	O
%)	O
of	O
the	O
patients	O
,	O
including	O
influenza	O
A	O
or	O
B	O
in	O
54	O
,	O
picornavirus	B-SPEC
in	O
28	O
(	O
including	O
rhinovirus	B-SPEC
in	O
24	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
in	O
12	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
in	O
4	O
,	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
in	O
2	O
,	O
adenovirus	B-SPEC
in	O
2	O
,	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
in	O
1	O
,	O
and	O
coinfection	O
with	O
influenza	O
and	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
in	O
2	O
.	O

On	O
the	O
basis	O
of	O
this	O
,	O
further	O
cynomolgus	O
and	O
rhesus	B-SPEC
macaques	I-SPEC
were	O
selected	O
and	O
experimentally	O
inoculated	O
SARS	O
-	O
CoV	O
,	O
the	O
quality	O
they	O
serve	O
as	O
animal	B-SPEC
model	O
for	O
SARS	O
was	O
evaluated	O
.	O

We	O
report	O
,	O
however	O
,	O
that	O
chloroquine	O
has	O
strong	O
antiviral	O
effects	O
on	O
SARS	O
-	O
CoV	O
infection	O
of	O
primate	B-SPEC
cells	O
.	O

Favorable	O
inhibition	O
of	O
virus	B-SPEC
spread	O
was	O
observed	O
when	O
the	O
cells	O
were	O
either	O
treated	O
with	O
chloroquine	O
prior	O
to	O
or	O
after	O
SARS	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
A	O
unique	O
coronavirus	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
revealed	O
to	O
be	O
a	O
causative	O
agent	O
of	O
a	O
life	O
-	O
threatening	O
SARS	O
.	O

ABSTRACT	O
:	O
Detection	O
of	O
viral	O
antigens	O
and	O
isolation	O
methods	O
has	O
long	O
been	O
used	O
for	O
the	O
diagnosis	O
of	O
respiratory	O
virus	B-SPEC
infections	O
.	O

Of	O
the	O
4	O
,	O
032	O
direct	O
fluorescent	O
assay	O
-	O
negative	O
nasal	O
aspirates	O
,	O
571	O
virus	B-SPEC
isolates	O
were	O
identified	O
by	O
using	O
HuH7	O
cell	O
culture	O
;	O
272	O
rhinoviruses	B-SPEC
,	O
100	O
influenza	B-SPEC
viruses	I-SPEC
A	O
and	O
B	O
,	O
85	O
enteroviruses	B-SPEC
,	O
40	O
adenoviruses	B-SPEC
,	O
35	O
coronaviruses	O
,	O
31	O
parainfluenza	O
viruses	B-SPEC
,	O
and	O
10	O
respiratory	O
syncytial	O
viruses	B-SPEC
.	O

Diffuse	O
bilateral	O
lung	O
infiltrates	O
were	O
present	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

ABSTRACT	O
:	O
Twenty	O
antiviral	O
drugs	O
,	O
that	O
is	O
about	O
half	O
of	O
those	O
that	O
are	O
currently	O
approved	O
,	O
are	O
formally	O
licensed	O
for	O
clinical	O
use	O
in	O
the	O
treatment	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
infections	O
(	O
acquired	O
immune	O
deficiency	O
syndrome	O
).	O

Recent	O
endeavours	O
have	O
focussed	O
on	O
the	O
development	O
of	O
improved	O
antiviral	O
therapies	O
for	O
virus	B-SPEC
infections	O
that	O
have	O
already	O
proved	O
amenable	O
to	O
antiviral	O
drug	O
treatment	O
,	O
as	O
well	O
as	O
for	O
virus	B-SPEC
infections	O
for	O
which	O
,	O
at	O
present	O
,	O
no	O
antiviral	O
drugs	O
have	O
been	O
formally	O
approved	O
(	O
i	O
.	O
e	O
.	O
human	B-SPEC
papilloma	O
viruses	B-SPEC
,	O
adenoviruses	B-SPEC
,	O
human	B-SPEC
herpesvirus	I-SPEC
type	I-SPEC
6	I-SPEC
,	O
poxviruses	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
hemorrhagic	O
fever	O
viruses	B-SPEC
).	O

In	O
this	O
study	O
,	O
a	O
recombinant	O
protein	O
(	O
rS268	O
,	O
corresponding	O
to	O
residues	O
268	O
-	O
1255	O
of	O
SARS	O
-	O
CoV	O
S	O
protein	O
)	O
was	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
was	O
purified	O
to	O
near	O
homogeneity	O
.	O

TITLE	O
:	O
Double	O
-	O
antigen	O
sandwich	O
ELISA	O
for	O
detection	O
of	O
antibodies	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
in	O
human	B-SPEC
serum	O
.	O

ABSTRACT	O
:	O
The	O
study	O
presented	O
here	O
was	O
conducted	O
to	O
evaluate	O
the	O
performance	O
of	O
a	O
double	O
-	O
antigen	O
sandwich	O
ELISA	O
to	O
detect	O
antibodies	O
in	O
human	B-SPEC
serum	O
against	O
the	O
coronavirus	B-SPEC
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

These	O
results	O
indicate	O
that	O
the	O
double	O
-	O
antigen	O
sandwich	O
ELISA	O
is	O
an	O
effective	O
screening	O
method	O
for	O
the	O
serodiagnosis	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Selection	O
of	O
and	O
recombination	O
between	O
minor	O
variants	O
lead	O
to	O
the	O
adaptation	O
of	O
an	O
avian	B-SPEC
coronavirus	I-SPEC
to	O
primate	B-SPEC
cells	O
.	O

Performance	O
of	O
the	O
assay	O
with	O
serially	O
diluted	O
RNA	O
demonstrated	O
that	O
the	O
multiplex	O
PCR	O
could	O
detect	O
4	O
.	O
8x10	O
(-	O
3	O
)	O
microg	O
of	O
TCoV	O
RNA	O
,	O
4	O
.	O
6x10	O
(-	O
4	O
)	O
microg	O
of	O
IBV	B-SPEC
RNA	O
,	O
and	O
8	O
.	O
0x10	O
(-	O
2	O
)	O
microg	O
of	O
BCoV	O
RNA	O
.	O

TITLE	O
:	O
Single	O
amino	O
acid	O
substitutions	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
determine	O
viral	O
entry	O
and	O
immunogenicity	O
of	O
a	O
major	O
neutralizing	O
domain	O
.	O

TITLE	O
:	O
Molecular	O
evolution	O
analysis	O
and	O
geographic	O
investigation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
-	O
like	O
virus	B-SPEC
in	O
palm	O
civets	B-SPEC
at	O
an	O
animal	B-SPEC
market	O
and	O
on	O
farms	O
.	O

Twenty	O
-	O
seven	O
novel	O
signature	O
variation	O
residues	O
(	O
SNVs	O
)	O
were	O
identified	O
on	O
the	O
spike	O
gene	O
and	O
were	O
analyzed	O
for	O
their	O
phylogenetic	O
relationships	O
,	O
based	O
on	O
17	O
sequences	O
obtained	O
from	O
animals	B-SPEC
in	O
our	O
study	O
and	O
from	O
other	O
published	O
studies	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL	I-SPEC
-	O
63	O
infections	O
in	O
children	O
:	O
a	O
1	O
-	O
year	O
study	O
.	O

Our	O
work	O
has	O
provided	O
experimental	O
support	O
for	O
testing	O
the	O
protective	O
equine	B-SPEC
immunoglobulin	O
in	O
future	O
large	O
primate	B-SPEC
or	O
human	B-SPEC
trials	O
.	O

TITLE	O
:	O
Screening	O
and	O
identification	O
of	O
linear	O
B	O
-	O
cell	O
epitopes	O
and	O
entry	O
-	O
blocking	O
peptide	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
using	O
synthetic	O
overlapping	O
peptide	O
library	O
.	O

The	O
gene	O
for	O
the	O
SARS	O
-	O
CoV	O
non	O
-	O
structural	O
protein	O
10	O
,	O
which	O
is	O
located	O
in	O
the	O
open	O
reading	O
frame	O
of	O
pp1a	O
/	O
pp1ab	O
gene	O
,	O
was	O
synthesized	O
and	O
used	O
to	O
screen	O
for	O
the	O
specific	O
cellular	O
gene	O
coding	O
for	O
the	O
protein	O
interacting	O
with	O
this	O
nsp10	O
protein	O
in	O
a	O
human	B-SPEC
embryo	O
lung	O
cDNA	O
library	O
using	O
a	O
yeast	B-SPEC
trap	O
method	O
.	O

Further	O
study	O
revealed	O
that	O
the	O
activity	O
of	O
the	O
NADH	O
-	O
cytochrome	O
was	O
altered	O
and	O
the	O
inner	O
mitochondrial	O
membrane	O
was	O
depolarized	O
in	O
the	O
transfected	O
human	B-SPEC
embryo	O
lung	O
fibroblast	O
by	O
the	O
nsp10	O
protein	O
gene	O
.	O

The	O
cytopathic	O
effect	O
of	O
the	O
Coronavirus	B-SPEC
229E	O
strain	O
appeared	O
more	O
extensive	O
in	O
these	O
cells	O
than	O
in	O
the	O
control	O
cells	O
.	O

These	O
results	O
together	O
indicate	O
that	O
stem	O
-	O
loop	O
IV	O
in	O
the	O
BCoV	O
5	O
'	O
UTR	O
is	O
a	O
cis	B-SPEC
-	O
acting	O
element	O
for	O
DI	O
RNA	O
replication	O
and	O
that	O
it	O
might	O
function	O
through	O
interactions	O
with	O
cellular	O
proteins	O
.	O

A	O
fragment	O
specific	O
for	O
SARS	O
human	B-SPEC
coronavirus	I-SPEC
was	O
amplified	O
from	O
cultures	O
of	O
the	O
brain	O
suspension	O
,	O
and	O
transmission	O
electronic	O
microscopy	O
revealed	O
the	O
presence	O
of	O
an	O
enveloped	O
virus	B-SPEC
morphologically	O
compatible	O
with	O
a	O
coronavirus	B-SPEC
isolated	O
in	O
the	O
cultures	O
.	O

ABSTRACT	O
:	O
Few	O
reports	O
exist	O
in	O
the	O
veterinary	O
medical	O
literature	O
describing	O
clinical	O
and	O
pathological	O
findings	O
resembling	O
conditions	O
described	O
as	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
man	B-SPEC
.	O

A	O
condition	O
closely	O
meeting	O
the	O
human	B-SPEC
criteria	O
for	O
ALI	O
/	O
ARDS	O
exists	O
in	O
foals	O
age	O
1	O
-	O
12	O
months	O
and	O
may	O
be	O
identical	O
to	O
previously	O
described	O
acute	O
bronchointerstitial	O
pneumonia	O
in	O
young	O
horses	B-SPEC
.	O

TITLE	O
:	O
T	O
-	O
Cell	O
response	O
profiling	O
to	O
biological	O
threat	O
agents	O
including	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
crystal	O
structure	O
at	O
2	O
.	O
9	O
angstrom	O
resolution	O
of	O
the	O
RBD	O
bound	O
with	O
the	O
peptidase	O
domain	O
of	O
human	B-SPEC
ACE2	O
shows	O
that	O
the	O
RBD	O
presents	O
a	O
gently	O
concave	O
surface	O
,	O
which	O
cradles	O
the	O
N	O
-	O
terminal	O
lobe	O
of	O
the	O
peptidase	O
.	O

The	O
atomic	O
details	O
at	O
the	O
interface	O
between	O
the	O
two	O
proteins	O
clarify	O
the	O
importance	O
of	O
residue	O
changes	O
that	O
facilitate	O
efficient	O
cross	O
-	O
species	B-SPEC
infection	O
and	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

In	O
addition	O
,	O
the	O
presence	O
of	O
a	O
29	O
-	O
bp	O
insertion	O
in	O
ORF	O
8	O
of	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
genome	O
,	O
not	O
in	O
most	O
human	B-SPEC
SARS	O
-	O
CoV	O
genomes	O
,	O
suggests	O
that	O
it	O
has	O
a	O
common	O
ancestor	O
with	O
civet	B-SPEC
SARS	O
-	O
CoV	O
.	O
Antibody	O
against	O
recombinant	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
was	O
detected	O
in	O
84	O
%	O
of	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
by	O
using	O
an	O
enzyme	O
immunoassay	O
.	O

TITLE	O
:	O
False	O
positive	O
antibody	O
results	O
against	O
human	B-SPEC
T	O
-	O
cell	O
lymphotropic	O
virus	B-SPEC
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Cross	O
-	O
reactivity	O
was	O
found	O
when	O
testing	O
for	O
antibody	O
against	O
human	B-SPEC
T	O
-	O
cell	O
lymphotropic	O
virus	B-SPEC
(	O
HTLV	O
)	O
in	O
one	O
patient	O
with	O
SARS	O
.	O

ABSTRACT	O
:	O
The	O
pentameric	O
B	O
subunit	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
heat	O
-	O
labile	O
enterotoxin	O
(	O
LTB	O
)	O
can	O
be	O
used	O
as	O
an	O
efficient	O
mucosal	O
carrier	O
of	O
either	O
immunogenic	O
or	O
tolerogenic	O
T	O
-	O
cell	O
epitopes	O
.	O

ABSTRACT	O
:	O
The	O
full	O
length	O
cDNA	O
of	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
was	O
amplified	O
by	O
PCR	O
and	O
cloned	O
into	O
yeast	B-SPEC
expression	O
vector	O
pPIC3	O
.	O
5K	O
to	O
generate	O
expression	O
vector	O
pPIC3	O
.	O
5K	O
-	O
SCoVN	O
.	O

ABSTRACT	O
:	O
Polymorphisms	O
of	O
human	B-SPEC
Fc	O
gamma	O
-	O
receptor	O
IIA	O
(	O
FcgammaRIIA	O
)	O
and	O
mannose	O
-	O
binding	O
lectin	O
(	O
MBL	O
)	O
genes	O
have	O
been	O
associated	O
with	O
susceptibility	O
to	O
or	O
severity	O
of	O
some	O
infectious	O
diseases	O
.	O

TITLE	O
:	O
A	O
comparison	O
of	O
methods	O
of	O
inducing	O
lachrymation	O
and	O
tear	O
collection	O
in	O
chickens	B-SPEC
for	O
detection	O
of	O
virus	B-SPEC
-	O
specific	O
immuoglobulins	O
after	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

This	O
report	O
is	O
the	O
first	O
description	O
of	O
IV	O
peppermint	B-SPEC
oil	O
injection	O
.	O

Lung	O
damage	O
due	O
to	O
OPP	O
ingestion	O
has	O
not	O
been	O
reported	O
in	O
humans	B-SPEC
.	O

We	O
report	O
a	O
suicidal	O
39	O
-	O
year	O
-	O
old	O
woman	O
with	O
stage	O
II	O
cervical	O
cancer	B-SPEC
who	O
drank	O
a	O
potentially	O
lethal	O
dose	O
of	O
OPP	O
in	O
the	O
form	O
of	O
a	O
commercial	O
antiseptic	O
,	O
which	O
led	O
to	O
the	O
complication	O
of	O
liver	O
and	O
renal	O
function	O
impairment	O
,	O
severe	O
lung	O
damage	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
subsequent	O
severe	O
lung	O
fibrosis	O
.	O

A	O
truncated	O
S	O
protein	O
of	O
the	O
TW1	O
strain	O
,	O
STR2	O
(	O
88	O
kDa	O
),	O
carrying	O
three	O
S	O
fragments	O
(	O
S74	O
-	O
253	O
,	O
S294	O
-	O
739	O
,	O
and	O
S1129	O
-	O
1255	O
)	O
was	O
investigated	O
to	O
study	O
the	O
influences	O
of	O
intron	O
and	O
exon	O
splicing	O
enhancers	O
to	O
improve	O
STR2	O
protein	O
expression	O
in	O
mammalian	B-SPEC
cells	O
.	O

Results	O
of	O
the	O
present	O
study	O
can	O
provide	O
an	O
optimal	O
strategy	O
to	O
enhance	O
SARS	O
-	O
CoV	O
S	O
protein	O
expression	O
in	O
mammalian	B-SPEC
cells	O
and	O
may	O
contribute	O
to	O
the	O
development	O
of	O
SARS	O
-	O
CoV	O
subunit	O
vaccine	O
.	O

It	O
is	O
concluded	O
that	O
MHV	B-SPEC
infection	O
of	O
mice	B-SPEC
with	O
transplantable	O
murine	B-SPEC
tumours	O
does	O
not	O
necessarily	O
cause	O
the	O
tumours	O
to	O
be	O
contaminated	O
.	O

RESULTS	O
:	O
The	O
recombinant	O
expression	O
vector	O
produced	O
high	O
level	O
of	O
the	O
N	O
fusion	O
protein	O
after	O
induction	O
,	O
and	O
that	O
protein	O
was	O
purified	O
successfully	O
by	O
affinity	O
chromatography	O
and	O
displayed	O
higher	O
antigenicity	O
and	O
specificity	O
as	O
compared	O
with	O
whole	O
virus	B-SPEC
lysates	O
.	O

ABSTRACT	O
:	O
In	O
response	O
to	O
recent	O
public	O
health	O
threats	O
and	O
disasters	O
,	O
greater	O
emphasis	O
has	O
been	O
placed	O
on	O
the	O
use	O
of	O
exercises	O
and	O
drills	B-SPEC
to	O
improve	O
individual	O
performance	O
and	O
enhance	O
capacity	O
of	O
the	O
public	O
health	O
workforce	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
membrane	O
protein	O
and	O
5	O
-	O
lipoxygenase	O
-	O
activating	O
protein	O
(	O
FLAP	O
)	O
are	O
among	O
a	O
large	O
number	O
of	O
membrane	O
proteins	O
that	O
are	O
poorly	O
expressed	O
when	O
traditional	O
expression	O
systems	O
and	O
methods	O
are	O
employed	O
.	O

The	O
Con	O
A	O
-	O
S	O
-	O
ELISA	O
was	O
also	O
used	O
to	O
measure	O
anti	O
-	O
IBV	B-SPEC
chicken	B-SPEC
antibodies	O
and	O
showed	O
a	O
high	O
coefficient	O
of	O
correlation	O
(	O
r	O
=	O
0	O
.	O
85	O
)	O
and	O
an	O
agreement	O
of	O
k	O
=	O
0	O
.	O
80	O
with	O
the	O
commercially	O
available	O
Indirect	O
-	O
ELISA	O
.	O

TITLE	O
:	O
Immunological	O
responses	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
in	O
humans	B-SPEC
.	O

Using	O
a	O
specific	O
monoclonal	O
antibody	O
,	O
we	O
demonstrated	O
that	O
the	O
3a	O
protein	O
displayed	O
a	O
punctate	O
cytoplasmic	O
localization	O
in	O
Drosophila	B-SPEC
as	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	O
.	O

Therefore	O
,	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
quantitatively	O
assess	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)	O
RNA	O
loads	O
in	O
haemolymphatic	O
tissues	O
of	O
healthy	O
,	O
long	O
-	O
term	O
FCoV	B-SPEC
-	O
infected	O
cats	B-SPEC
and	O
cats	B-SPEC
with	O
FIP	O
.	O

TITLE	O
:	O
The	O
dimer	O
interface	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
adapts	O
a	O
porcine	B-SPEC
respiratory	I-SPEC
and	I-SPEC
reproductive	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
-	O
like	O
structure	O
.	O

The	O
dimer	O
interface	O
consists	O
of	O
a	O
continuous	O
four	O
-	O
stranded	O
beta	O
-	O
sheet	O
superposed	O
by	O
two	O
long	O
alpha	O
helices	B-SPEC
,	O
reminiscent	O
of	O
that	O
found	O
in	O
the	O
nucleocapsid	O
protein	O
of	O
porcine	B-SPEC
respiratory	I-SPEC
and	I-SPEC
reproductive	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
.	O

Recent	O
research	O
has	O
demonstrated	O
the	O
potential	O
of	O
certain	O
dietary	O
oils	O
(	O
eg	O
,	O
fish	B-SPEC
oil	O
,	O
borage	B-SPEC
oil	O
)	O
to	O
modulate	O
pulmonary	O
inflammation	O
,	O
thereby	O
improving	O
lung	O
compliance	O
and	O
oxygenation	O
,	O
and	O
reducing	O
time	O
on	O
mechanical	O
ventilation	O
.	O

Genetically	O
inbred	O
mice	B-SPEC
.	O

Acute	O
lung	O
injury	O
caused	O
decreased	O
proliferation	O
and	O
increased	O
apoptosis	O
in	O
crypt	O
epithelial	O
cells	O
in	O
all	O
animals	B-SPEC
studied	O
.	O

Proliferation	O
and	O
apoptosis	O
were	O
not	O
correlated	O
to	O
severity	O
of	O
lung	O
injury	O
,	O
as	O
gut	O
alterations	O
were	O
lost	O
in	O
mice	B-SPEC
with	O
more	O
severe	O
acute	O
lung	O
injury	O
.	O

The	O
SARS	O
coronavirus	B-SPEC
epidemic	O
,	O
which	O
began	O
in	O
the	O
Fall	O
of	O
2002	O
,	O
was	O
related	O
to	O
the	O
exotic	O
food	O
industry	O
in	O
southern	O
China	O
,	O
initially	O
involving	O
disproportionate	O
numbers	O
of	O
animal	B-SPEC
handlers	O
,	O
chefs	O
,	O
and	O
caterers	O
.	O

After	O
induction	O
of	O
severe	O
lung	O
injury	O
by	O
repeated	O
saline	O
lung	O
lavage	O
,	O
19	O
adult	O
white	O
Japanese	O
rabbits	B-SPEC
were	O
randomized	O
into	O
two	O
groups	O
that	O
received	O
PLV	O
with	O
HFO	O
(	O
n	O
=	O
9	O
)	O
or	O
HFO	O
gas	O
ventilation	O
(	O
n	O
=	O
10	O
).	O

ABSTRACT	O
:	O
At	O
this	O
moment	O
,	O
public	O
health	O
authorities	O
,	O
physicians	O
and	O
scientists	O
around	O
the	O
world	O
are	O
struggling	O
to	O
cope	O
with	O
a	O
severe	O
and	O
rapidly	O
spreading	O
new	O
disease	O
in	O
humans	B-SPEC
called	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
or	O
SARS	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
significance	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
antibody	O
,	O
detected	O
by	O
ELISA	O
and	O
indirect	O
immunofluorescence	O
assays	O
(	O
IFA	O
)	O
for	O
the	O
SARS	O
-	O
CoV	O
Vero	O
E6	O
cell	O
lysates	O
,	O
in	O
non	O
-	O
SARS	O
subjects	O
,	O
114	O
serum	O
samples	O
from	O
healthy	O
controls	O
and	O
104	O
serum	O
specimens	O
from	O
autoimmune	O
disease	O
patients	O
were	O
collected	O
.	O

ABSTRACT	O
:	O
The	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
an	O
important	O
issue	O
for	O
treatment	O
and	O
prevention	O
of	O
SARS	O
.	O

TITLE	O
:	O
The	O
nsp2	O
replicase	O
proteins	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
are	O
dispensable	O
for	O
viral	O
replication	O
.	O

These	O
results	O
demonstrate	O
that	O
while	O
nsp2	O
of	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
is	O
dispensable	O
for	O
viral	O
replication	O
in	O
cell	O
culture	O
,	O
deletion	O
of	O
the	O
nsp2	O
coding	O
sequence	O
attenuates	O
viral	O
growth	O
and	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
fails	O
to	O
activate	O
cytokine	O
-	O
mediated	O
innate	O
immune	O
responses	O
in	O
cultured	O
human	B-SPEC
monocyte	O
-	O
derived	O
dendritic	O
cells	O
.	O

TITLE	O
:	O
A	O
simple	O
and	O
rapid	O
approach	O
for	O
screening	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
genotypes	O
:	O
an	O
evaluation	O
study	O
.	O

We	O
present	O
here	O
a	O
simple	O
and	O
rapid	O
assay	O
for	O
the	O
screening	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
genotypes	O
based	O
on	O
the	O
use	O
of	O
fluorogenic	O
oligonucleotide	O
probes	O
for	O
allelic	O
discrimination	O
.	O

CONCLUSIONS	O
:	O
We	O
have	O
developed	O
a	O
simple	O
and	O
accurate	O
method	O
for	O
the	O
characterization	O
and	O
screening	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
genotypes	O
.	O

The	O
clinical	O
manifestations	O
of	O
blast	O
injury	O
of	O
the	O
lungs	O
were	O
observed	O
7	O
-	O
10	O
days	O
after	O
the	O
injury	O
,	O
with	O
variable	O
manifestations	O
in	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

These	O
patients	O
often	O
have	O
delayed	O
onset	O
of	O
clinical	O
manifestation	O
,	O
severe	O
symptoms	O
of	O
long	O
duration	O
,	O
with	O
high	O
rate	O
of	O
pulmonary	O
infection	O
and	O
pleural	O
effusions	O
,	O
and	O
variable	O
manifestations	O
in	O
chest	O
X	O
-	O
ray	B-SPEC
easily	O
confused	O
with	O
pulmonary	O
infections	O
.	O

Here	O
,	O
we	O
report	O
that	O
TGEV	B-SPEC
fusion	O
core	O
(	O
HR1	O
-	O
SGGRGG	O
-	O
HR2	O
),	O
in	O
vitro	O
expressed	O
in	O
GST	O
prokaryotic	O
expression	O
system	O
,	O
shares	O
the	O
typical	O
properties	O
of	O
the	O
trimer	O
of	O
coiled	O
-	O
coil	O
heterodimer	O
(	O
six	O
alpha	O
-	O
helix	O
bundle	O
),	O
which	O
has	O
been	O
confirmed	O
by	O
a	O
combined	O
series	O
of	O
biochemical	O
and	O
biophysical	O
evidences	O
including	O
size	O
exclusion	O
chromatography	O
(	O
gel	O
-	O
filtration	O
),	O
chemical	O
crossing	O
,	O
and	O
circular	O
diagram	O
.	O

This	O
is	O
also	O
observed	O
in	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
,	O
except	O
for	O
one	O
site	O
at	O
the	O
junction	O
between	O
nsp10	O
(	O
helicase	O
)	O
and	O
nsp11	O
(	O
member	O
of	O
exonuclease	O
family	B-SPEC
),	O
where	O
the	O
P1	O
position	O
is	O
occupied	O
by	O
histidine	O
.	O

Results	O
suggest	O
that	O
a	O
wide	O
class	B-SPEC
of	O
models	O
for	O
incubation	O
times	O
should	O
be	O
considered	O
because	O
the	O
apparent	O
informativeness	O
of	O
a	O
likelihood	O
depends	O
on	O
the	O
choice	O
and	O
generalizability	O
of	O
a	O
model	O
.	O

The	O
attenuated	O
vaccine	O
was	O
not	O
pathogenic	O
in	O
1	O
-	O
week	O
-	O
old	O
chicks	O
,	O
had	O
a	O
neutralization	O
index	O
(	O
NI	O
)	O
of	O
greater	O
than	O
4	O
.	O
4	O
and	O
efficacy	O
of	O
90	O
%	O
when	O
inoculated	O
birds	B-SPEC
were	O
challenged	O
with	O
a	O
field	O
IBV	B-SPEC
strain	O
.	O

We	O
then	O
apply	O
the	O
method	O
to	O
study	O
the	O
origin	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Ribavirin	O
,	O
the	O
only	O
small	O
molecule	O
available	O
so	O
far	O
for	O
treating	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
infection	O
,	O
was	O
recently	O
used	O
in	O
an	O
emergency	O
context	O
to	O
treat	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
the	O
early	O
stages	O
of	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
main	O
protease	O
,	O
M	O
(	O
pro	O
),	O
is	O
considered	O
to	O
be	O
a	O
major	O
target	O
for	O
drugs	O
suitable	O
for	O
combating	O
coronavirus	B-SPEC
infections	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

In	O
a	O
fluorimetric	O
enzyme	O
assay	O
using	O
a	O
novel	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)	O
pair	O
labeled	O
substrate	O
,	O
compound	O
6b	O
showed	O
a	O
K	O
(	O
i	O
)	O
value	O
of	O
35	O
.	O
3	O
muM	B-SPEC
.	O
Since	O
the	O
novel	O
lead	O
compound	O
does	O
not	O
target	O
the	O
S1	O
',	O
S1	O
,	O
and	O
S2	O
subsites	O
of	O
the	O
enzyme	O
'	O
s	O
substrate	O
-	O
binding	O
pockets	O
,	O
there	O
is	O
room	O
for	O
improvement	O
that	O
underlines	O
the	O
lead	O
character	O
of	O
compound	O
6b	O
.	O

The	O
use	O
of	O
inactivated	O
SARS	O
virus	B-SPEC
with	O
MF59	O
enhanced	O
the	O
CD4	O
and	O
antibody	O
response	O
even	O
after	O
gene	O
-	O
based	O
vaccination	O
.	O

ABSTRACT	O
:	O
In	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
pathogenesis	O
,	O
the	O
ability	O
to	O
infect	O
macrophages	O
is	O
an	O
essential	O
virulence	O
factor	O
.	O

Molecular	O
tests	O
have	O
been	O
developed	O
to	O
detect	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
RNA	O
using	O
real	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
with	O
varying	O
levels	O
of	O
sensitivity	O
.	O

HIV	B-SPEC
-	O
NS	O
is	O
suggested	O
to	O
be	O
particularly	O
suitable	O
to	O
enhance	O
antigen	O
delivery	O
to	O
dendritic	O
cells	O
(	O
DCs	O
).	O

Since	O
studies	O
applying	O
molecular	O
diagnostic	O
assays	O
usually	O
report	O
reductions	O
in	O
the	O
number	O
of	O
undiagnosed	O
cases	O
of	O
infectious	O
disease	O
compared	O
to	O
traditional	O
techniques	O
,	O
we	O
applied	O
PCR	O
assays	O
to	O
investigate	O
the	O
role	O
of	O
two	O
recently	O
described	O
viruses	B-SPEC
,	O
namely	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
HKU1	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
HBoV	O
),	O
in	O
a	O
hospital	O
-	O
based	O
paediatric	O
population	O
.	O

Although	O
virus	B-SPEC
isolation	O
and	O
serology	O
were	O
useful	O
early	O
in	O
the	O
SARS	O
outbreak	O
for	O
diagnosing	O
new	O
cases	O
,	O
these	O
tests	O
are	O
not	O
generally	O
useful	O
because	O
virus	B-SPEC
culture	O
requires	O
a	O
BSL	O
-	O
3	O
laboratory	O
and	O
seroconversion	O
is	O
often	O
delayed	O
until	O
2	O
to	O
3	O
weeks	O
after	O
infection	O
.	O

TITLE	O
:	O
[	O
Preventive	O
and	O
therapeutic	O
effects	O
of	O
recombinant	O
IFN	O
-	O
alpha2b	O
nasal	O
spray	O
on	O
SARS	O
-	O
CoV	O
infection	O
in	O
Macaca	B-SPEC
mulata	O
].	O

Before	O
and	O
after	O
SARS	O
-	O
CoV	O
attack	O
,	O
the	O
virus	B-SPEC
was	O
detected	O
in	O
samples	O
such	O
as	O
pharyngeal	O
swab	O
in	O
all	O
the	O
two	O
groups	O
by	O
Real	O
-	O
time	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
virus	B-SPEC
isolation	O
was	O
performed	O
.	O

Hematology	O
items	O
showed	O
no	O
apparent	O
changes	O
after	O
virus	B-SPEC
attack	O
in	O
treated	O
group	O
.	O

Through	O
pathological	O
examination	O
,	O
the	O
morphology	O
of	O
the	O
lung	O
tissues	O
of	O
two	O
Macaques	B-SPEC
in	O
the	O
treated	O
group	O
was	O
normal	O
,	O
while	O
the	O
other	O
three	O
displayed	O
the	O
interstitial	O
pneumonia	O
with	O
the	O
thickened	O
septum	O
and	O
infiltration	O
with	O
mononuclear	O
cells	O
.	O

Among	O
which	O
,	O
one	O
monkey	B-SPEC
showed	O
part	O
of	O
thickened	O
septum	O
fused	O
with	O
each	O
other	O
.	O

These	O
lesions	O
in	O
the	O
interferon	O
treated	O
animals	B-SPEC
were	O
similar	O
to	O
those	O
seen	O
in	O
the	O
animals	B-SPEC
in	O
control	O
group	O
,	O
but	O
with	O
smaller	O
scope	O
of	O
pathological	O
changes	O
.	O

CONCLUSIONS	O
:	O
Recombinant	O
IFN	O
-	O
alpha2b	O
could	O
effectively	O
interdict	O
or	O
weaken	O
SARS	O
-	O
CoV	O
injury	O
in	O
monkeys	B-SPEC
.	O

On	O
the	O
other	O
hand	O
,	O
after	O
using	O
interferon	O
,	O
all	O
four	O
respiratory	O
viruses	B-SPEC
(	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
-	O
3	O
influenza	O
B	O
,	O
adenovirus	B-SPEC
types	O
3	O
,	O
7	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
)	O
in	O
interferon	O
group	O
had	O
lower	O
IgM	O
antibody	O
positive	O
rates	O
than	O
those	O
in	O
control	O
group	O
.	O

In	O
addition	O
,	O
although	O
diarrhea	O
is	O
rare	O
in	O
patients	O
with	O
early	O
Lyme	O
borreliosis	O
,	O
the	O
incidence	O
is	O
higher	O
in	O
those	O
with	O
other	O
tick	B-SPEC
-	O
borne	O
infections	O
,	O
such	O
as	O
ehrlichiosis	O
,	O
tick	B-SPEC
-	O
borne	O
relapsing	O
fever	O
and	O
Rocky	O
Mountain	O
spotted	O
fever	O
.	O

However	O
,	O
the	O
clinical	O
and	O
molecular	O
epidemiological	O
features	O
of	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
-	O
associated	O
pneumonia	O
are	O
unknown	O
.	O

Prospectively	O
collected	O
(	O
during	O
a	O
12	O
-	O
month	O
period	O
)	O
nasopharyngeal	O
aspirates	O
(	O
NPAs	O
)	O
from	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
from	O
4	O
hospitals	O
were	O
subjected	O
to	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
for	O
detection	O
of	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
.	O

The	O
epidemiological	O
,	O
clinical	O
,	O
and	O
laboratory	O
characteristics	O
of	O
patients	O
with	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
-	O
associated	O
pneumonia	O
were	O
analyzed	O
.	O

In	O
the	O
6	O
patients	O
from	O
whom	O
serum	O
samples	O
were	O
available	O
,	O
all	O
had	O
a	O
4	O
-	O
fold	O
change	O
in	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
titer	O
and	O
/	O
or	O
presence	O
of	O
IgM	O
against	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
.	O

The	O
trends	O
in	O
primate	B-SPEC
research	O
,	O
and	O
the	O
nature	O
and	O
effects	O
of	O
recent	O
and	O
proposed	O
changes	O
in	O
the	O
global	O
use	O
of	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
in	O
research	O
,	O
will	O
be	O
investigated	O
.	O

FRAME	O
continues	O
to	O
believe	O
that	O
we	O
have	O
a	O
duty	O
to	O
ensure	O
that	O
these	O
animals	B-SPEC
are	O
not	O
used	O
without	O
overwhelming	O
evidence	O
that	O
they	O
are	O
the	O
only	O
suitable	O
and	O
relevant	O
models	O
for	O
use	O
in	O
work	O
of	O
undeniable	O
significance	O
.	O

Anti	O
-	O
AGP	O
antiserum	O
,	O
as	O
confirmed	O
by	O
ELISA	O
and	O
Western	O
blot	O
techniques	O
,	O
and	O
a	O
pool	O
of	O
peritoneal	O
fluid	O
from	O
cats	B-SPEC
with	O
FIP	O
were	O
used	O
to	O
prepare	O
standards	O
.	O

Clinical	O
samples	O
of	O
feline	B-SPEC
peritoneal	O
fluid	O
(	O
n	O
=	O
55	O
)	O
and	O
serum	O
(	O
n	O
=	O
59	O
)	O
were	O
assayed	O
for	O
AGP	O
and	O
results	O
from	O
the	O
immunoturbidimetric	O
and	O
RID	O
methods	O
were	O
compared	O
.	O

Sequence	O
and	O
structure	O
comparison	O
of	O
all	O
known	O
macro	O
-	O
H2A	O
domains	O
combined	O
with	O
available	O
functional	O
data	O
suggests	O
that	O
proteins	O
of	O
this	O
superfamily	B-SPEC
form	O
an	O
emerging	O
group	O
of	O
nucleotide	O
phosphatases	O
that	O
dephosphorylate	O
Appr	O
-	O
1	O
''-	O
p	O
.	O

ABSTRACT	O
:	O
The	O
clinical	O
significance	O
of	O
human	B-SPEC
coronaviruses	O
in	O
more	O
severe	O
respiratory	O
illnesses	O
has	O
recently	O
been	O
shown	O
to	O
be	O
higher	O
than	O
was	O
previously	O
assumed	O
.	O

ABSTRACT	O
:	O
Spike	O
protein	O
of	O
coronavirus	B-SPEC
is	O
responsible	O
for	O
virus	B-SPEC
binding	O
,	O
fusion	O
and	O
entry	O
,	O
and	O
is	O
a	O
major	O
inducer	O
of	O
neutralizing	O
antibodies	O
.	O

And	O
the	O
recombinant	O
RBD	O
derived	O
from	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
can	O
be	O
used	O
to	O
developing	O
subunit	O
vaccine	O
to	O
block	O
S	O
protein	O
binding	O
with	O
receptor	O
and	O
to	O
neutralizing	O
SARS	O
-	O
Cov	O
infection	O
.	O

SARS	O
patients	O
might	O
need	O
anticoagulant	O
therapy	O
or	O
fibrinolytic	O
therapy	O
in	O
order	B-SPEC
to	O
reverse	O
intraalveolar	O
coagulation	O
,	O
microthrombi	O
formation	O
,	O
alveolar	O
and	O
interstitial	O
fibrin	O
deposition	O
.	O

The	O
rise	O
in	O
cefotaxime	O
-	O
resistant	O
or	O
ciprofloxacin	O
-	O
resistant	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
meropenem	O
-	O
resistant	O
P	B-SPEC
.	I-SPEC
aeruginosa	I-SPEC
was	O
significantly	O
correlated	O
with	O
increased	O
consumption	O
of	O
extended	O
-	O
spectrum	O
cephalosporins	O
,	O
beta	O
-	O
lactam	O
-	O
beta	O
-	O
lactamase	O
inhibitor	O
combinations	O
,	O
carbapenems	O
,	O
fluoroquinolones	O
and	O
aminoglycosides	O
(	O
for	O
ciprofloxacin	O
-	O
resistant	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
meropenem	O
-	O
resistant	O
P	B-SPEC
.	I-SPEC
aeruginosa	I-SPEC
only	O
)	O
in	O
the	O
hospital	O
(	O
Pearson	O
'	O
s	O
correlation	O
coefficient	O
,	O
r	O
>	O
0	O
.	O
72	O
(	O
or	O
<	O
-	O
0	O
.	O
72	O
)	O
and	O
P	O
-	O
value	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
The	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
genome	O
'	O
s	O
3	O
'	O
untranslated	O
region	O
contains	O
cis	B-SPEC
-	O
acting	O
sequences	O
necessary	O
for	O
replication	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
human	B-SPEC
ScFv	O
H12	O
against	O
SARS	O
-	O
CoV	O
has	O
been	O
selected	O
from	O
a	O
SARS	O
immune	O
library	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
reported	O
to	O
function	O
in	O
encapsidating	O
the	O
viral	O
genomic	O
RNA	O
into	O
helical	O
nucleocapsid	O
,	O
and	O
its	O
self	O
-	O
association	O
is	O
believed	O
to	O
be	O
vital	O
in	O
coating	O
the	O
viral	O
genomic	O
RNA	O
.	O

Characterization	O
of	O
SARS	O
-	O
CoV	O
N	O
multimerization	O
may	O
thereby	O
help	O
us	O
better	O
understand	O
the	O
coronavirus	B-SPEC
assembly	O
.	O

TITLE	O
:	O
Why	O
are	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
fusion	O
inhibitors	O
not	O
effective	O
against	O
SARS	O
-	O
CoV	O
?	O

This	O
study	O
demonstrates	O
that	O
the	O
PEDV	B-SPEC
ELISA	O
is	O
a	O
useful	O
serodiagnostic	O
screening	O
test	O
at	O
herd	O
level	O
for	O
detecting	O
swine	B-SPEC
antibodies	O
against	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
Preparation	O
and	O
development	O
of	O
equine	B-SPEC
hyperimmune	O
globulin	O
F	O
(	O
ab	O
')	O
2	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

CONCLUSIONS	O
:	O
This	O
research	O
provides	O
a	O
viable	O
strategy	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
with	O
equine	B-SPEC
hyperimmune	O
globulin	O
,	O
with	O
the	O
purpose	O
of	O
combating	O
any	O
resurgence	O
of	O
SARS	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
43	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
ITP	O
refractory	O
to	O
steroids	O
and	O
intravenous	O
immunoglobulin	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
after	O
a	O
single	O
infusion	O
of	O
rituximab	O
.	O

A	O
parent	O
field	O
PEDV	B-SPEC
and	O
a	O
cell	O
culture	O
adapted	O
PEDV	B-SPEC
DR13	O
were	O
inoculated	O
orally	O
to	O
colostrum	O
-	O
deprived	O
1	O
-	O
day	O
-	O
old	O
piglets	O
,	O
commercial	O
2	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
,	O
and	O
sows	O
(	O
1	O
-	O
5	O
ml	O
dose	O
,	O
10	O
(	O
5	O
.	O
8	O
)-	O
10	O
(	O
6	O
.	O
0	O
)	O
TCID	O
(	O
50	O
)/	O
0	O
.	O
1	O
ml	O
).	O

The	O
N	O
-	O
terminal	O
part	O
of	O
this	O
cellular	O
receptor	O
(	O
soR	O
)	O
is	O
sufficient	O
for	O
S	O
binding	O
and	O
for	O
subsequent	O
induction	O
of	O
the	O
conformational	O
changes	O
required	O
for	O
virus	B-SPEC
-	O
cell	O
membrane	O
fusion	O
.	O

The	O
soR	O
and	O
soR	O
-	O
425	O
proteins	O
,	O
both	O
produced	O
with	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
system	O
,	O
were	O
able	O
to	O
neutralize	O
MHV	B-SPEC
infection	O
of	O
murine	B-SPEC
LR7	O
cells	O
.	O

Furthermore	O
,	O
the	O
soR	O
-	O
425	O
-	O
mediated	O
infections	O
were	O
blocked	O
by	O
heptad	O
repeat	O
-	O
mimicking	O
peptides	O
,	O
indicating	O
that	O
virus	B-SPEC
entry	O
requires	O
the	O
regular	O
S	O
protein	O
fusion	O
process	O
.	O

Efficient	O
SARS	O
-	O
CoV	O
infection	O
of	O
ciliated	O
cells	O
in	O
HAE	O
provides	O
a	O
useful	O
in	O
vitro	O
model	O
of	O
human	B-SPEC
lung	O
origin	O
to	O
study	O
characteristics	O
of	O
SARS	O
-	O
CoV	O
replication	O
and	O
pathogenesis	O
.	O

The	O
caveolae	O
engulfed	O
SV40	B-SPEC
virions	O
begin	O
budding	O
from	O
plasma	O
membrane	O
depending	O
on	O
dynamin	O
.	O

A	O
corona	B-SPEC
of	O
large	O
,	O
distinctive	O
spikes	O
in	O
the	O
envelope	O
was	O
measured	O
after	O
treatment	O
with	O
hydroxyoctanoic	O
acid	O
.	O

However	O
,	O
a	O
dramatic	O
reduction	O
in	O
surfactant	O
protein	O
-	O
B	O
(	O
SP	O
-	O
B	O
)	O
expression	O
was	O
observed	O
in	O
the	O
lungs	O
of	O
LPS	O
-	O
treated	O
HO	O
-	O
1	O
(-/-)	O
mice	B-SPEC
compared	O
with	O
similarly	O
treated	O
WT	O
mice	B-SPEC
.	O

Using	O
reciprocal	O
bone	O
marrow	O
transplantation	O
(	O
BMT	O
)	O
to	O
generate	O
HO	O
-	O
1	O
-	O
chimeric	O
mice	B-SPEC
,	O
we	O
found	O
that	O
absence	O
of	O
HO	O
-	O
1	O
in	O
the	O
lung	O
parenchyma	O
,	O
not	O
in	O
bone	O
marrow	O
-	O
derived	O
inflammatory	O
cells	O
,	O
was	O
responsible	O
for	O
enhanced	O
SP	O
-	O
B	O
downregulation	O
and	O
severe	O
physiologic	O
lung	O
dysfunction	O
.	O

TITLE	O
:	O
The	O
putative	O
protein	O
6	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
:	O
expression	O
and	O
functional	O
characterization	O
.	O

Even	O
though	O
this	O
strain	O
is	O
not	O
able	O
yet	O
to	O
be	O
transmitted	O
among	O
humans	B-SPEC
,	O
evidence	O
has	O
accumulated	O
that	O
such	O
ability	O
could	O
be	O
reached	O
by	O
the	O
new	O
strain	O
,	O
since	O
it	O
was	O
already	O
detected	O
in	O
pigs	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
the	O
virus	B-SPEC
can	O
survive	O
for	O
14	O
days	O
in	O
sewage	O
at	O
4	O
degrees	O
C	O
,	O
2	O
days	O
at	O
20	O
degrees	O
C	O
,	O
and	O
its	O
RNA	O
can	O
be	O
detected	O
for	O
8	O
days	O
though	O
the	O
virus	B-SPEC
had	O
been	O
inactivated	O
.	O

TITLE	O
:	O
When	O
family	B-SPEC
-	O
centered	O
care	O
is	O
challenged	O
by	O
infectious	O
disease	O
:	O
pediatric	O
health	O
care	O
delivery	O
during	O
the	O
SARS	O
outbreaks	O
.	O

A	O
phylogenetic	O
tree	O
constructed	O
from	O
these	O
amplimers	O
,	O
that	O
spanned	O
the	O
HVR	O
of	O
the	O
S1	O
gene	O
,	O
revealed	O
the	O
IBV	B-SPEC
isolates	O
clustered	O
into	O
two	O
demarcated	O
groups	O
which	O
had	O
<	O
60	O
%	O
homology	O
.	O

TITLE	O
:	O
Immunopathogenesis	O
of	O
coronavirus	B-SPEC
infections	O
:	O
implications	O
for	O
SARS	O
.	O

On	O
the	O
basis	O
of	O
similarities	O
with	O
other	O
coronavirus	B-SPEC
infections	O
,	O
SARS	O
might	O
,	O
in	O
part	O
,	O
be	O
immune	O
mediated	O
.	O

ABSTRACT	O
:	O
Virtual	O
screening	O
,	O
a	O
fast	O
,	O
computational	O
approach	O
to	O
identify	O
drug	O
leads	O
[	O
Perola	B-SPEC
,	O
E	O
.;	O
Xu	O
,	O
K	O
.;	O
Kollmeyer	O
,	O
T	O
.	O
M	O
.;	O
Kaufmann	O
,	O
S	O
.	O
H	O
.;	O
Prendergast	O
,	O
F	O
.	O
G	O
.	O
J	O
.	O
Med	O
.	O

This	O
approach	O
has	O
not	O
been	O
able	O
to	O
identify	O
active	O
inhibitors	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
using	O
solely	O
the	O
crystal	O
structures	O
of	O
a	O
SARS	O
-	O
CoV	O
cysteine	O
proteinase	O
with	O
a	O
flexible	O
loop	O
in	O
the	O
active	O
site	O
[	O
Yang	O
,	O
H	O
.	O
T	O
.;	O
Yang	O
,	O
M	O
.	O
J	O
.;	O
Ding	O
,	O
Y	O
.;	O
Liu	O
,	O
Y	O
.	O
W	O
.;	O
Lou	O
,	O
Z	O
.	O
Y	O
.	O
Proc	O
.	O

A	O
strong	O
link	O
was	O
found	O
between	O
the	O
rate	O
of	O
influenza	B-SPEC
virus	I-SPEC
positivity	O
and	O
the	O
incidence	O
of	O
flu	O
-	O
like	O
illness	O
in	O
the	O
community	O
(	O
p	O
=	O
0	O
.	O
017	O
).	O

TITLE	O
:	O
Solution	O
structure	O
of	O
the	O
X4	O
protein	O
coded	O
by	O
the	O
SARS	O
related	O
coronavirus	B-SPEC
reveals	O
an	O
immunoglobulin	O
like	O
fold	O
and	O
suggests	O
a	O
binding	O
activity	O
to	O
integrin	O
I	O
domains	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
related	O
Coronavirus	B-SPEC
genome	O
contains	O
a	O
variety	O
of	O
novel	O
accessory	O
genes	O
.	O

Further	O
,	O
based	O
on	O
this	O
structure	O
based	O
prediction	O
,	O
potential	O
functions	O
of	O
X4	O
in	O
virus	B-SPEC
replication	O
and	O
pathogenesis	O
are	O
discussed	O
.	O

TITLE	O
:	O
The	O
N	O
-	O
terminal	O
octapeptide	O
acts	O
as	O
a	O
dimerization	O
inhibitor	O
of	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
proteinase	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Like	O
the	O
N	O
-	O
terminal	O
RNA	O
binding	O
domain	O
(	O
SARS	O
-	O
N45	O
-	O
181	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
N	O
protein	O
,	O
the	O
crystal	O
structure	O
of	O
the	O
IBV	B-SPEC
-	O
N29	O
-	O
160	O
fragment	O
at	O
1	O
.	O
85	O
A	O
resolution	O
reveals	O
a	O
protein	O
core	O
composed	O
of	O
a	O
five	O
-	O
stranded	O
antiparallel	O
beta	O
sheet	O
with	O
a	O
positively	O
charged	O
beta	O
hairpin	O
extension	O
and	O
a	O
hydrophobic	O
platform	O
that	O
are	O
probably	O
involved	O
in	O
RNA	O
binding	O
.	O

In	O
addition	O
to	O
hostcell	O
receptors	O
,	O
lysosomal	O
cysteine	O
proteases	O
are	O
required	O
for	O
productive	O
infection	O
by	O
some	O
viruses	B-SPEC
.	O

Inhibitors	O
of	O
cathepsin	O
L	O
blocked	O
infection	O
by	O
SARS	O
-	O
CoV	O
and	O
by	O
a	O
retrovirus	B-SPEC
pseudotyped	O
with	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
but	O
not	O
infection	O
by	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
or	O
a	O
retrovirus	B-SPEC
pseudotyped	O
with	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
S	O
protein	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
a	O
family	B-SPEC
of	O
enveloped	O
,	O
single	O
-	O
stranded	O
,	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
classified	O
within	O
the	O
Nidovirales	B-SPEC
order	B-SPEC
.	O

This	O
coronavirus	B-SPEC
family	B-SPEC
consists	O
of	O
pathogens	O
of	O
many	O
animal	B-SPEC
species	B-SPEC
and	O
of	O
humans	B-SPEC
,	O
including	O
the	O
recently	O
isolated	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Porcine	B-SPEC
pulmonary	O
artery	O
endothelial	O
cells	O
(	O
PAEC	O
)	O
were	O
treated	O
with	O
EtOH	O
(	O
0	O
.	O
04	O
-	O
0	O
.	O
16	O
%,	O
w	O
/	O
v	O
)	O
for	O
72	O
hr	O
in	O
sealed	O
chambers	O
to	O
prevent	O
evaporation	O
.	O

In	O
the	O
application	O
phase	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
diagnosis	O
based	O
on	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
microfluidic	O
chip	O
electrophoresis	O
(	O
MCE	O
)	O
with	O
18	O
cases	O
,	O
methylation	O
analysis	O
of	O
the	O
P16	O
gene	O
in	O
159	O
samples	O
of	O
patients	O
and	O
references	O
for	O
cancer	B-SPEC
diagnosis	O
and	O
polymorphism	O
analysis	O
of	O
angiotenigen	O
gene	O
in	O
226	O
patients	O
and	O
references	O
with	O
essential	O
hypertension	O
are	O
described	O
.	O

In	O
chicken	B-SPEC
tracheal	O
organ	O
cultures	O
(	O
TOCs	O
),	O
the	O
recombinant	O
rIBVs	O
reached	O
titers	O
similar	O
to	O
those	O
of	O
the	O
wild	O
-	O
type	O
virus	B-SPEC
,	O
but	O
in	O
the	O
case	O
of	O
viruses	B-SPEC
lacking	O
the	O
3a	O
protein	O
,	O
the	O
titer	O
declined	O
reproducibly	O
earlier	O
.	O

TITLE	O
:	O
How	O
the	O
SARS	O
coronavirus	B-SPEC
causes	O
disease	O
:	O
host	O
or	O
organism	O
?	O

The	O
pathogen	O
is	O
mainly	O
virus	B-SPEC
and	O
most	O
of	O
them	O
are	O
suspected	O
zoonotic	O
origin	O
.	O

Recently	O
,	O
many	O
outbreaks	O
of	O
virus	B-SPEC
zoonoses	O
are	O
reported	O
in	O
the	O
world	O
,	O
which	O
include	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
disease	O
,	O
avian	B-SPEC
influenza	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
surveillance	O
of	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
activity	O
has	O
been	O
effectively	O
conducted	O
by	O
using	O
seroprevalence	O
of	O
pigs	B-SPEC
for	O
more	O
than	O
20	O
years	O
in	O
Japan	O
.	O

TITLE	O
:	O
Homozygous	O
L	O
-	O
SIGN	O
(	O
CLEC4M	O
)	O
plays	O
a	O
protective	O
role	O
in	O
SARS	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Intestinal	O
invasion	O
and	O
disseminated	O
disease	O
associated	O
with	O
Penicillium	B-SPEC
chrysogenum	I-SPEC
.	O

ABSTRACT	O
:	O
Penicillium	B-SPEC
sp	O
.,	O
other	O
than	O
P	B-SPEC
.	I-SPEC
marneffei	I-SPEC
,	O
is	O
an	O
unusual	O
cause	O
of	O
invasive	O
disease	O
.	O

On	O
multivariate	O
analysis	O
,	O
severity	O
of	O
illness	O
,	O
clinical	O
grade	O
of	O
hemorrhage	O
,	O
packed	O
red	O
blood	O
cell	O
transfusions	O
,	O
and	O
severe	O
sepsis	B-SPEC
in	O
the	O
intensive	O
care	O
unit	O
were	O
independently	O
associated	O
with	O
development	O
of	O
acute	O
lung	O
injury	O
.	O

The	O
SARS	O
epidemic	O
put	O
the	O
animal	B-SPEC
coronaviruses	O
in	O
the	O
spotlight	O
.	O

TITLE	O
:	O
7a	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
inhibits	O
cellular	O
protein	O
synthesis	O
and	O
activates	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
.	O

ABSTRACT	O
:	O
It	O
was	O
recently	O
shown	O
that	O
the	O
7a	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
induces	O
biochemical	O
changes	O
associated	O
with	O
apoptosis	O
.	O

ABSTRACT	O
:	O
Cellular	O
localization	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
the	O
lungs	O
of	O
patients	O
with	O
SARS	O
is	O
important	O
in	O
confirming	O
the	O
etiological	O
association	O
of	O
the	O
virus	B-SPEC
with	O
disease	O
as	O
well	O
as	O
in	O
understanding	O
the	O
pathogenesis	O
of	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
Glycyrrhizin	O
,	O
the	O
major	O
bioactive	O
component	O
of	O
Glycyrrhiza	B-SPEC
uralensis	I-SPEC
,	O
is	O
widely	O
used	O
as	O
a	O
natural	O
sweetener	O
.	O

ABSTRACT	O
:	O
Enveloped	O
animal	B-SPEC
viruses	B-SPEC
such	O
as	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
papillomavirus	I-SPEC
,	O
Marburg	O
,	O
and	O
influenza	O
are	O
major	O
public	O
health	O
concerns	O
around	O
the	O
world	O
.	O

TITLE	O
:	O
Pyridine	O
N	O
-	O
oxide	O
derivatives	O
are	O
inhibitory	O
to	O
the	O
human	B-SPEC
SARS	O
and	O
feline	B-SPEC
infectious	O
peritonitis	O
coronavirus	B-SPEC
in	O
cell	O
culture	O
.	O

The	O
purified	O
SARS	O
vaccine	O
induced	O
high	O
levels	O
of	O
neutralizing	O
antibodies	O
and	O
prevented	O
the	O
replication	O
of	O
SARS	O
-	O
CoV	O
in	O
monkeys	B-SPEC
.	O

The	O
purified	O
inactivated	O
SARS	O
vaccine	O
could	O
induce	O
high	O
levels	O
of	O
neutralizing	O
antibody	O
,	O
and	O
protect	O
the	O
monkeys	B-SPEC
from	O
the	O
challenge	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
SARS	O
vaccine	O
prepared	O
in	O
the	O
study	O
appeared	O
to	O
be	O
safe	O
in	O
monkeys	B-SPEC
.	O

At	O
13	O
,	O
26	O
,	O
and	O
52	O
weeks	O
,	O
vector	O
and	O
phosphate	O
-	O
buffered	O
salineinjected	O
rats	B-SPEC
were	O
killed	O
(	O
n	O
=	O
6	O
per	O
time	O
point	O
),	O
and	O
blood	O
,	O
brain	O
,	O
and	O
distant	O
organs	O
were	O
assessed	O
.	O

Together	O
with	O
the	O
long	O
-	O
term	O
gene	O
expression	O
after	O
gene	O
transfer	O
,	O
these	O
findings	O
supported	O
the	O
initiation	O
of	O
clinical	O
trials	O
to	O
assess	O
the	O
safety	O
of	O
AAV2	B-SPEC
(	O
CU	O
)	O
hCLN2	O
administration	O
to	O
individuals	O
with	O
LINCL	O
.	O

Two	O
human	B-SPEC
SARS	O
-	O
CoV	O
strains	O
(	O
CDC	O
#	O
200301157	O
and	O
Urbani	O
)	O
were	O
resequenced	O
by	O
the	O
SARS	O
GeneChips	O
.	O

The	O
worst	O
-	O
case	O
scenario	O
would	O
be	O
the	O
emergence	O
of	O
a	O
transmissible	O
,	O
small	O
,	O
nonenveloped	O
virus	B-SPEC
in	O
the	O
blood	O
donor	O
population	O
.	O

Although	O
today	O
'	O
s	O
immunoglobulins	O
are	O
safer	O
than	O
ever	O
,	O
in	O
preparation	O
for	O
future	O
challenges	O
it	O
is	O
a	O
high	O
priority	O
for	O
the	O
plasma	O
industry	O
to	O
proactively	O
investigate	O
such	O
viruses	B-SPEC
on	O
a	O
molecular	O
and	O
cellular	O
level	O
to	O
identify	O
their	O
vulnerabilities	O
.	O

Multiple	O
animal	B-SPEC
groups	O
and	O
postaspiration	O
times	O
of	O
injury	O
were	O
analyzed	O
to	O
gauge	O
the	O
applicability	O
of	O
the	O
predictive	O
approach	O
:	O
rats	B-SPEC
(	O
6	O
and	O
24	O
h	O
),	O
C57	O
/	O
BL6	O
wild	O
-	O
type	O
mice	B-SPEC
(	O
5	O
and	O
24	O
h	O
),	O
and	O
transgenic	B-SPEC
mice	I-SPEC
on	O
the	O
same	O
background	O
deficient	O
in	O
the	O
gene	O
for	O
monocyte	O
chemoattractant	O
protein	O
1	O
(	O
MCP	O
-	O
1	O
[-/-]	O
mice	B-SPEC
;	O
5	O
and	O
24	O
h	O
).	O

Cytokines	O
and	O
chemokines	O
that	O
best	O
predicted	O
the	O
combination	O
of	O
acid	O
and	O
small	O
gastric	O
particles	O
were	O
cytokine	O
-	O
induced	O
neutrophil	O
chemoattractant	O
1	O
(	O
6	O
h	O
)	O
and	O
MCP	O
-	O
1	O
(	O
24	O
h	O
)	O
in	O
rats	B-SPEC
,	O
tumor	O
necrosis	O
factor	O
alpha	O
/	O
macrophage	O
inflammatory	O
protein	O
2	O
(	O
5	O
h	O
)	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
/	O
MCP	O
-	O
1	O
(	O
24	O
h	O
)	O
in	O
wild	O
-	O
type	O
mice	B-SPEC
,	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
/	O
macrophage	O
inflammatory	O
protein	O
2	O
(	O
5	O
h	O
)	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
/	O
keratinocyte	O
-	O
derived	O
cytokine	O
(	O
24	O
h	O
)	O
in	O
MCP	O
-	O
1	O
(-/-)	O
mice	B-SPEC
.	O

Fourteen	O
Chinese	O
IBV	B-SPEC
isolates	O
were	O
placed	O
in	O
genotype	O
I	O
,	O
having	O
small	O
evolutionary	O
distances	O
from	O
each	O
other	O
.	O

IBVs	O
in	O
same	O
genotypes	O
showed	O
more	O
than	O
90	O
%	O
amino	O
acid	O
sequence	O
similarities	O
,	O
whereas	O
most	O
of	O
the	O
viruses	B-SPEC
in	O
different	O
genotypes	O
showed	O
less	O
than	O
90	O
%.	O

TITLE	O
:	O
Ventilator	O
-	O
induced	O
lung	O
injury	O
is	O
reduced	O
in	O
transgenic	B-SPEC
mice	I-SPEC
that	O
overexpress	O
endothelial	O
nitric	O
oxide	O
synthase	O
.	O

Some	O
mice	B-SPEC
were	O
given	O
N	O
(	O
omega	O
)-	O
nitro	O
-	O
L	O
-	O
arginine	O
methyl	O
ester	O
(	O
L	O
-	O
NAME	B-SPEC
),	O
a	O
potent	O
NOS	O
inhibitor	O
,	O
via	O
drinking	O
water	O
(	O
1	O
mg	O
/	O
ml	O
)	O
for	O
1	O
wk	O
before	O
MV	O
.	O

A	O
digital	O
ring	O
fence	O
is	O
constructed	O
around	O
each	O
location	O
(	O
hot	O
-	O
spot	B-SPEC
)	O
using	O
Non	O
-	O
Homogeneous	O
Poisson	O
Process	O
(	O
NHPP	O
)	O
modeling	O
based	O
on	O
data	O
of	O
individuals	O
coming	O
into	O
contact	O
with	O
each	O
probable	O
case	O
.	O

Body	O
weight	O
uniformity	O
,	O
severity	O
of	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
airsacculitis	O
,	O
and	O
systemic	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
infection	O
at	O
7	O
days	O
following	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
inoculation	O
were	O
used	O
as	O
parameters	O
for	O
colibacillosis	O
.	O

ABSTRACT	O
:	O
In	O
1993	O
,	O
a	O
new	O
molecular	O
typing	O
method	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
introduced	O
.	O

In	O
addition	O
,	O
new	O
Ark	O
-	O
like	O
isolates	O
continued	O
to	O
emerge	O
each	O
year	O
(	O
except	O
in	O
the	O
year	O
2000	O
)	O
beginning	O
in	O
1997	O
,	O
reflecting	O
the	O
ability	O
of	O
that	O
IBV	B-SPEC
type	O
to	O
undergo	O
genetic	O
drift	O
.	O

Eighty	O
-	O
two	O
different	O
variant	O
viruses	B-SPEC
were	O
identified	O
although	O
only	O
two	O
(	O
GAV	O
and	O
GA98	O
)	O
became	O
persistent	O
and	O
caused	O
widespread	O
disease	O
.	O

Some	O
viruses	B-SPEC
tended	O
to	O
be	O
geographically	O
restricted	O
to	O
a	O
given	O
area	O
(	O
CAV	B-SPEC
in	O
California	B-SPEC
and	O
MX97	O
-	O
8147	O
in	O
Mexico	O
),	O
whereas	O
others	O
were	O
widespread	O
(	O
Ark	O
-	O
DPI	O
,	O
Conn	O
,	O
DE072	O
,	O
and	O
Mass	O
).	O

ABSTRACT	O
:	O
To	O
study	O
the	O
pulmonary	O
inflammatory	O
reaction	O
induced	O
by	O
N	O
-	O
protein	O
of	O
SARS	O
-	O
CoV	O
in	O
rat	B-SPEC
models	O
and	O
the	O
effects	O
of	O
glucocorticoids	O
on	O
the	O
inflammatory	O
reaction	O
.	O

How	O
the	O
virus	B-SPEC
has	O
successfully	O
jumped	O
the	O
species	B-SPEC
barrier	O
is	O
still	O
a	O
mystery	O
.	O

Herein	O
,	O
we	O
investigated	O
two	O
consequences	O
of	O
this	O
plasticity	O
in	O
species	B-SPEC
tropism	O
.	O

TITLE	O
:	O
Bidirectional	O
virus	B-SPEC
secretion	O
and	O
nonciliated	O
cell	O
tropism	O
following	O
Andes	B-SPEC
virus	I-SPEC
infection	O
of	O
primary	O
airway	O
epithelial	O
cell	O
cultures	O
.	O

TITLE	O
:	O
Redirecting	O
coronavirus	B-SPEC
to	O
a	O
nonnative	O
receptor	O
through	O
a	O
virus	B-SPEC
-	O
encoded	O
targeting	O
adapter	O
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)-	O
A59	O
infection	O
depends	O
on	O
the	O
interaction	O
of	O
its	O
spike	O
(	O
S	O
)	O
protein	O
with	O
the	O
cellular	O
receptor	O
mCEACAM1a	O
present	O
on	O
murine	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Several	O
viruses	B-SPEC
infect	O
the	O
mammalian	B-SPEC
central	O
nervous	O
system	O
(	O
CNS	O
),	O
some	O
with	O
devastating	O
consequences	O
,	O
others	O
resulting	O
in	O
chronic	O
or	O
persistent	O
infections	O
associated	O
with	O
little	O
or	O
no	O
overt	O
pathology	O
.	O

The	O
recombinant	O
proteins	O
S260	O
-	O
600	O
and	O
S397	O
-	O
796	O
were	O
efficiently	O
expressed	O
in	O
an	O
insoluble	O
form	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

Chemical	O
manipulation	O
of	O
their	O
redox	O
state	O
using	O
reducing	O
agents	O
or	O
free	O
sulfhydryl	O
reagents	O
affects	O
virus	B-SPEC
/	O
cell	O
interaction	O
.	O

We	O
examined	O
the	O
relationship	O
between	O
the	O
redox	O
state	O
of	O
the	O
20	O
cysteine	O
residues	O
of	O
the	O
SARS	O
-	O
CoV	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
)	O
Spike	O
glycoprotein	O
S1	O
subdomain	O
and	O
its	O
functional	O
properties	O
.	O

Thus	O
,	O
in	O
contrast	O
to	O
various	O
viruses	B-SPEC
including	O
HIV	B-SPEC
(	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
)	O
examined	O
in	O
parallel	O
,	O
the	O
functions	O
of	O
the	O
SARS	O
-	O
CoV	O
Spike	O
glycoprotein	O
exhibit	O
a	O
significant	O
and	O
surprising	O
independence	O
of	O
redox	O
state	O
,	O
which	O
may	O
contribute	O
to	O
the	O
wide	O
host	O
range	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Assessing	O
the	O
genetic	O
component	O
of	O
the	O
susceptibility	O
of	O
mice	B-SPEC
to	O
viral	O
infections	O
.	O

For	O
example	O
,	O
the	O
extraordinary	O
resistance	O
of	O
SJL	O
mice	B-SPEC
to	O
experimental	O
infections	O
with	O
hepatitis	O
virus	B-SPEC
strain	O
A59	O
is	O
the	O
consequence	O
of	O
a	O
structural	O
alteration	O
of	O
a	O
cell	O
adhesion	O
molecule	O
which	O
normally	O
binds	O
to	O
the	O
spikes	O
of	O
the	O
virus	B-SPEC
,	O
allowing	O
its	O
entry	O
into	O
the	O
cells	O
.	O

Wild	O
mice	B-SPEC
,	O
by	O
contrast	O
--	O
probably	O
because	O
they	O
are	O
constantly	O
exposed	O
to	O
natural	O
infections	O
--	O
are	O
resistant	O
.	O

Finally	O
,	O
some	O
mouse	B-SPEC
strains	O
resist	O
experimental	O
infections	O
by	O
the	O
mouse	B-SPEC
cytomegalovirus	I-SPEC
1	I-SPEC
(	O
MCMV	B-SPEC
-	O
1	O
)	O
because	O
,	O
once	O
infected	O
,	O
these	O
mice	B-SPEC
synthesise	O
a	O
molecule	O
at	O
the	O
surface	O
of	O
infected	O
cells	O
which	O
allows	O
immediate	O
recognition	O
and	O
killing	O
by	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
.	O

Influenza	B-SPEC
virus	I-SPEC
should	O
be	O
considered	O
as	O
a	O
cause	O
of	O
pneumonia	O
during	O
the	O
winter	O
months	O
,	O
especially	O
during	O
periods	O
of	O
peak	O
activity	O
.	O

TITLE	O
:	O
Longitudinal	O
profile	O
of	O
antibodies	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
in	O
SARS	O
patients	O
and	O
their	O
clinical	O
significance	O
.	O

ABSTRACT	O
:	O
Nucleocapsid	O
protein	O
plays	O
a	O
critical	O
role	O
in	O
SARS	O
-	O
CoV	O
pathogenesis	O
,	O
and	O
high	O
-	O
level	O
anti	O
-	O
nucleocapsid	O
antibodies	O
are	O
detected	O
in	O
the	O
patients	O
infected	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
ELISA	O
analysis	O
using	O
the	O
N	O
antigen	O
or	O
inactivated	O
SARS	O
-	O
CoV	O
particles	O
as	O
capture	O
antigen	O
showed	O
that	O
co	O
-	O
injection	O
of	O
SARS	O
-	O
M	O
could	O
enhance	O
N	O
-	O
induced	O
antibody	O
production	O
,	O
especially	O
IgG2a	O
subclass	B-SPEC
.	O

Using	O
surface	O
-	O
enhanced	O
laser	B-SPEC
desorption	O
/	O
ionization	O
(	O
SELDI	O
)	O
ProteinChip	O
technology	O
,	O
we	O
profiled	O
and	O
compared	O
serum	O
proteins	O
of	O
39	O
patients	O
with	O
early	O
-	O
stage	O
SARS	O
infection	O
and	O
39	O
non	O
-	O
SARS	O
patients	O
who	O
were	O
suspected	O
cases	O
during	O
the	O
SARS	O
outbreak	O
period	O
.	O

This	O
review	O
provides	O
an	O
overview	O
of	O
current	O
information	O
on	O
coronavirus	B-SPEC
and	O
the	O
application	O
of	O
small	O
interfering	O
RNA	O
in	O
viral	O
therapeutics	O
,	O
with	O
particular	O
reference	O
to	O
SARS	O
-	O
CoV	O
.	O

Nevertheless	O
,	O
virus	B-SPEC
-	O
specific	O
ASC	O
induced	O
by	O
peripheral	O
infection	O
localized	O
to	O
both	O
spleen	O
and	O
BM	O
.	O

Irrespective	O
of	O
Ag	O
deprivation	O
,	O
CNS	O
retention	O
of	O
ASC	O
coincided	O
with	O
elevated	O
BAFF	O
expression	O
and	O
ongoing	O
differentiation	O
of	O
class	B-SPEC
II	O
+	O
to	O
class	B-SPEC
II	O
-	O
CD138	O
+	O
CD19	O
+	O
plasmablasts	O
.	O

Balb	O
/	O
cJ	O
or	O
A	O
/	O
J	O
mice	B-SPEC
were	O
infected	O
intraperitoneally	O
(	O
ip	O
)	O
with	O
100	O
PFU	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
),	O
liver	O
and	O
serum	O
were	O
harvested	O
at	O
24	O
,	O
48	O
,	O
and	O
72	O
h	O
post	O
infection	O
for	O
further	O
use	O
.	O

ABSTRACT	O
:	O
Polyclonal	O
antibodies	O
have	O
a	O
century	O
-	O
old	O
history	O
of	O
being	O
effective	O
against	O
some	O
viruses	B-SPEC
;	O
recently	O
,	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
have	O
also	O
shown	O
success	O
.	O

A	O
major	O
problem	O
in	O
the	O
development	O
of	O
effective	O
therapeutic	O
agents	O
against	O
viruses	B-SPEC
,	O
including	O
therapeutic	O
antibodies	O
,	O
is	O
the	O
viruses	B-SPEC
'	O
heterogeneity	O
and	O
mutability	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
HCoV	O
-	O
HKU1	O
),	O
a	O
new	O
group	O
2	O
coronavirus	B-SPEC
,	O
was	O
first	O
characterized	O
in	O
2005	O
from	O
2	O
adults	O
with	O
pneumonia	O
in	O
Hong	O
Kong	O
,	O
China	O
.	O

Viral	O
RNA	O
was	O
extracted	O
either	O
directly	O
from	O
tissues	O
of	O
diseased	O
birds	B-SPEC
or	O
from	O
virus	B-SPEC
propagated	O
in	O
embryonated	O
eggs	O
,	O
and	O
was	O
subjected	O
to	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
disease	O
characterised	O
by	O
fever	O
and	O
atypical	O
pneumonia	O
and	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

No	O
CCVs	O
was	O
detected	O
from	O
healthy	O
mink	B-SPEC
feces	O
.	O

Our	O
study	O
confirmed	O
that	O
type	O
II	O
CCVs	O
infection	O
is	O
very	O
common	O
in	O
domestic	O
dog	B-SPEC
,	O
fox	O
,	O
and	O
raccoon	B-SPEC
dog	I-SPEC
populations	O
in	O
China	O
.	O

To	O
date	O
,	O
lucinactant	O
has	O
not	O
been	O
compared	O
with	O
an	O
animal	B-SPEC
-	O
derived	O
surfactant	O
in	O
a	O
premature	O
animal	B-SPEC
model	O
.	O

The	O
objective	O
was	O
to	O
compare	O
the	O
acute	O
and	O
sustained	O
effects	O
of	O
lucinactant	O
among	O
premature	O
lambs	B-SPEC
with	O
respiratory	O
distress	O
syndrome	O
(	O
RDS	O
)	O
with	O
the	O
effects	O
of	O
a	O
natural	O
porcine	B-SPEC
surfactant	O
(	O
poractant	O
-	O
alpha	O
).	O

Golden	O
Syrian	B-SPEC
hamsters	I-SPEC
that	O
were	O
intranasally	O
inoculated	O
with	O
SARS	O
-	O
CoV	O
were	O
treated	O
with	O
various	O
doses	O
of	O
MAb	O
201	O
or	O
an	O
irrelevant	O
MAb	O
24	O
h	O
after	O
inoculation	O
.	O

Postexposure	O
treatment	O
with	O
MAb	O
201	O
can	O
alleviate	O
the	O
viral	O
burden	O
and	O
associated	O
pathological	O
findings	O
in	O
a	O
golden	O
Syrian	B-SPEC
hamster	I-SPEC
model	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

After	O
a	O
hamster	B-SPEC
is	O
treated	O
with	O
MAb	O
201	O
,	O
its	O
viral	O
burden	O
is	O
reduced	O
by	O
102	O
.	O
4	O
-	O
103	O
.	O
9	O
50	O
%	O
tissue	O
-	O
culture	O
infectious	O
doses	O
per	O
gram	O
of	O
tissue	O
,	O
and	O
the	O
severity	O
of	O
associated	O
pathological	O
findings	O
,	O
including	O
interstitial	O
pneumonitis	O
and	O
consolidation	O
,	O
is	O
also	O
remarkably	O
reduced	O
.	O

TITLE	O
:	O
Epidemiological	O
and	O
genetic	O
correlates	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
the	O
hospital	O
with	O
the	O
highest	O
nosocomial	O
infection	O
rate	O
in	O
Taiwan	O
in	O
2003	O
.	O

ABSTRACT	O
:	O
The	O
90	O
kDa	O
ribosomal	O
S6	O
kinases	O
(	O
p90RSKs	O
)	O
are	O
a	O
family	B-SPEC
of	O
broadly	O
expressed	O
serine	O
/	O
threonine	O
kinases	O
with	O
two	O
kinase	O
domains	O
activated	O
by	O
extracellular	O
signal	O
-	O
regulated	O
protein	O
kinase	O
in	O
response	O
to	O
many	O
growth	O
factors	O
.	O

This	O
is	O
the	O
first	O
detailed	O
report	O
regarding	O
regulation	O
of	O
p90RSK	O
phosphorylation	O
by	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
has	O
been	O
reported	O
to	O
cause	O
acute	O
diarrhea	O
mainly	O
in	O
young	O
pups	O
.	O

However	O
,	O
it	O
has	O
recently	O
been	O
reported	O
in	O
the	O
United	O
Kingdom	B-SPEC
that	O
the	O
group	O
2	O
coronavirus	B-SPEC
gene	O
,	O
which	O
is	O
more	O
closely	O
related	O
to	O
the	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
and	O
human	B-SPEC
coronavirus	I-SPEC
strain	O
OC43	O
,	O
has	O
been	O
detected	O
in	O
respiratory	O
tract	O
tissue	O
samples	O
from	O
dogs	B-SPEC
with	O
respiratory	O
disease	O
.	O

No	O
correlation	O
was	O
found	O
between	O
the	O
titers	O
of	O
the	O
anti	O
-	O
BCoV	O
and	O
anti	O
-	O
CCoV	O
antibodies	O
in	O
the	O
198	O
serum	O
samples	O
of	O
dogs	B-SPEC
with	O
a	O
known	O
history	O
of	O
CCoV	O
vaccination	O
.	O

We	O
amplified	O
,	O
by	O
RT	O
-	O
PCR	O
,	O
group	O
2	O
coronavirus	B-SPEC
-	O
specific	O
hemagglutination	O
/	O
esterase	O
genes	O
in	O
the	O
oral	O
swabs	O
of	O
a	O
total	O
of	O
10	O
young	O
pups	O
presenting	O
with	O
or	O
having	O
recovered	O
from	O
respiratory	O
signs	O
,	O
or	O
having	O
anti	O
-	O
BCoV	O
antibodies	O
,	O
with	O
the	O
result	O
that	O
2	O
pups	O
were	O
positive	O
for	O
the	O
hemagglutination	O
/	O
esterase	O
genes	O
.	O

Of	O
the	O
protease	O
and	O
entry	O
inhibitors	O
approved	O
for	O
treating	O
HIV	B-SPEC
-	O
infected	O
patients	O
,	O
none	O
was	O
effective	O
against	O
SARS	O
-	O
CoV	O
,	O
although	O
in	O
vitro	O
activity	O
against	O
this	O
virus	B-SPEC
was	O
reported	O
for	O
the	O
protease	O
inhibitor	O
lopinavir	O
/	O
ritonavir	O
,	O
in	O
results	O
that	O
have	O
not	O
been	O
confirmed	O
in	O
the	O
most	O
recent	O
studies	O
.	O

Laboratory	O
tests	O
revealed	O
an	O
inflammation	O
probably	O
due	O
to	O
bacterial	O
infection	O
,	O
anemia	B-SPEC
,	O
acute	O
renal	O
failure	O
,	O
acute	O
hepatic	O
dysfunction	O
,	O
coagulopathy	O
and	O
lactic	O
acidosis	O
,	O
indicating	O
multi	O
-	O
organ	O
failure	O
and	O
septic	O
shock	O
.	O

The	O
usually	O
precise	O
switch	O
is	O
thought	O
to	O
occur	O
during	O
the	O
synthesis	O
of	O
negative	O
-	O
strand	O
templates	O
for	O
sgmRNA	O
production	O
and	O
to	O
be	O
directed	O
by	O
heptameric	O
core	O
donor	O
sequences	O
within	O
the	O
genome	O
that	O
match	O
an	O
acceptor	O
core	O
(	O
UCUAAAC	O
in	O
the	O
case	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
)	O
near	O
the	O
3	O
'	O
end	O
of	O
the	O
5	O
'-	O
terminal	O
genomic	O
leader	O
.	O

The	O
M	O
protein	O
plays	O
a	O
crucial	O
role	O
in	O
coronavirus	B-SPEC
assembly	O
and	O
is	O
glycosylated	O
in	O
all	O
coronaviruses	O
,	O
either	O
by	O
N	O
-	O
linked	O
or	O
by	O
O	O
-	O
linked	O
oligosaccharides	O
.	O

Thus	O
,	O
the	O
SARS	O
-	O
CoV	O
3a	O
protein	O
is	O
an	O
O	O
-	O
glycosylated	O
glycoprotein	O
,	O
like	O
the	O
group	O
2	O
coronavirus	B-SPEC
M	O
proteins	O
but	O
unlike	O
the	O
SARS	O
-	O
CoV	O
M	O
protein	O
,	O
which	O
is	O
N	O
glycosylated	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHM	O
(	O
MHV	B-SPEC
-	O
JHM	O
)	O
causes	O
acute	O
encephalitis	O
and	O
acute	O
and	O
chronic	O
demyelinating	O
diseases	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
Canine	O
coronavirus	B-SPEC
-	O
associated	O
puppy	O
mortality	O
without	O
evidence	O
of	O
concurrent	O
canine	O
parvovirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
This	O
report	O
presents	O
2	O
cases	O
in	O
which	O
puppy	O
fatalities	O
were	O
associated	O
with	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
),	O
but	O
no	O
evidence	O
of	O
concurrent	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
-	O
2	O
)	O
disease	O
was	O
observed	O
.	O

Gross	O
pathology	O
revealed	O
an	O
enteritis	O
suggestive	O
of	O
CPV	B-SPEC
-	O
2	O
.	O

Electron	O
microscopy	O
of	O
the	O
intestinal	O
contents	O
was	O
positive	O
for	O
coronavirus	B-SPEC
and	O
negative	O
for	O
parvovirus	B-SPEC
.	O

Immunohistochemistry	O
on	O
sections	O
of	O
affected	O
gut	O
were	O
positive	O
for	O
CCV	O
and	O
negative	O
for	O
CPV	B-SPEC
-	O
2	O
.	O

The	O
overall	O
prevalence	O
of	O
antibodies	O
against	O
FCoV	O
was	O
31	O
%,	O
significantly	O
higher	O
among	O
pure	O
breed	O
cats	B-SPEC
(	O
65	O
%)	O
than	O
among	O
mixed	O
breed	O
cats	B-SPEC
(	O
17	O
%).	O

ABSTRACT	O
:	O
Two	O
different	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
vaccine	O
strategies	O
were	O
evaluated	O
for	O
their	O
ability	O
to	O
protect	O
against	O
live	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
challenge	O
in	O
a	O
murine	B-SPEC
model	O
of	O
infection	O
.	O

A	O
whole	O
killed	O
(	O
inactivated	O
by	O
beta	O
-	O
propiolactone	O
)	O
SARS	O
-	O
CoV	O
vaccine	O
and	O
a	O
combination	O
of	O
two	O
adenovirus	B-SPEC
-	O
based	O
vectors	O
,	O
one	O
expressing	O
the	O
nucleocapsid	O
(	O
N	O
)	O
and	O
the	O
other	O
expressing	O
the	O
spike	O
(	O
S	O
)	O
protein	O
(	O
collectively	O
designated	O
Ad	O
S	O
/	O
N	O
),	O
were	O
evaluated	O
for	O
the	O
induction	O
of	O
serum	O
neutralizing	O
antibodies	O
and	O
cellular	O
immune	O
responses	O
and	O
their	O
ability	O
to	O
protect	O
against	O
pulmonary	O
SARS	O
-	O
CoV	O
replication	O
.	O

ABSTRACT	O
:	O
The	O
replicase	O
polyproteins	O
,	O
pp1a	O
and	O
pp1ab	O
,	O
of	O
porcine	B-SPEC
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
have	O
been	O
predicted	O
to	O
be	O
cleaved	O
by	O
viral	O
proteases	O
into	O
16	O
non	O
-	O
structural	O
proteins	O
(	O
nsp	O
).	O

Following	O
intracranial	O
(	O
i	O
.	O
c	O
.)	O
infection	O
of	O
susceptible	O
mice	B-SPEC
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
mice	B-SPEC
develop	O
an	O
acute	O
encephalomyelitis	O
followed	O
by	O
a	O
chronic	O
demyelinating	O
disease	O
.	O

Cellular	O
mRNA	O
transcription	O
,	O
which	O
was	O
reported	O
to	O
be	O
up	O
-	O
regulated	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Caco	O
-	O
2	O
cells	O
,	O
was	O
not	O
up	O
-	O
regulated	O
in	O
virus	B-SPEC
-	O
infected	O
Vero	O
E6	O
cells	O
,	O
partially	O
as	O
a	O
result	O
of	O
apoptosis	O
.	O

ABSTRACT	O
:	O
The	O
efficacy	O
of	O
several	O
povidone	O
-	O
iodine	O
(	O
PVP	O
-	O
I	O
)	O
products	O
,	O
a	O
number	O
of	O
other	O
chemical	O
agents	O
and	O
various	O
physical	O
conditions	O
were	O
evaluated	O
for	O
their	O
ability	O
to	O
inactivate	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Comparison	O
of	O
3	O
'-	O
end	O
encoding	O
regions	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
isolates	O
from	O
Indiana	O
,	O
North	O
Carolina	O
,	O
and	O
Minnesota	O
with	O
chicken	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
strains	O
.	O

The	O
sequence	O
similarity	O
between	O
TCoV	O
and	O
IBV	B-SPEC
was	O
lower	O
than	O
that	O
among	O
TCoV	O
isolates	O
or	O
that	O
among	O
IBV	B-SPEC
strains	O
.	O

ABSTRACT	O
:	O
The	O
threat	O
of	O
a	O
human	B-SPEC
influenza	O
pandemic	O
has	O
greatly	O
increased	O
over	O
the	O
past	O
several	O
years	O
with	O
the	O
emergence	O
of	O
highly	O
virulent	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
notably	O
H5N1	O
viruses	B-SPEC
,	O
which	O
have	O
infected	O
humans	B-SPEC
in	O
several	O
Asian	O
and	O
European	O
countries	O
.	O

The	O
US	O
Department	O
of	O
Health	O
and	O
Human	B-SPEC
Services	O
is	O
coordinating	O
a	O
national	O
strategy	O
to	O
respond	O
to	O
an	O
influenza	O
pandemic	O
that	O
involves	O
multiple	O
agencies	O
,	O
including	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
the	O
Food	O
and	O
Drug	O
Administration	O
,	O
and	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
NIH	O
).	O

In	O
contrast	O
,	O
survival	O
was	O
enhanced	O
in	O
both	O
ribavirin	O
-	O
and	O
HRC	O
203	O
-	O
treated	O
mice	B-SPEC
with	O
a	O
marked	O
reduction	O
in	O
biochemical	O
[	O
ALT	O
(	O
max	O
)	O
964	O
+/-	O

A	O
truncated	O
version	O
of	O
S	O
glycoprotein	O
,	O
containing	O
only	O
the	O
ecto	O
-	O
domain	O
,	O
as	O
well	O
as	O
a	O
His	O
-	O
tagged	O
full	O
-	O
length	O
version	O
were	O
cloned	O
and	O
expressed	O
in	O
a	O
serum	O
-	O
free	O
insect	B-SPEC
cell	O
line	O
,	O
ExpresSF	O
+.	O

ABSTRACT	O
:	O
Studies	O
of	O
programmed	O
-	O
1	O
ribosomal	O
frameshifting	O
(-	O
1	O
PRF	O
)	O
have	O
been	O
approached	O
over	O
the	O
past	O
two	O
decades	O
by	O
many	O
different	O
laboratories	O
using	O
a	O
diverse	O
array	O
of	O
virus	B-SPEC
-	O
derived	O
frameshift	O
signals	O
in	O
translational	O
assay	O
systems	O
derived	O
from	O
a	O
variety	O
of	O
sources	O
.	O

There	O
were	O
significant	O
differences	O
in	O
median	O
Coronase	O
antibody	O
titres	O
between	O
breeds	O
of	O
cats	B-SPEC
(	O
P	O
<	O
0	O
.	O
0005	O
).	O

There	O
was	O
no	O
statistical	O
relationship	O
between	O
the	O
Coronase	O
or	O
7B	O
FIP	O
antibody	O
titres	O
and	O
age	O
,	O
gender	O
or	O
overall	O
health	O
status	O
,	O
even	O
when	O
considering	O
only	O
those	O
cats	B-SPEC
in	O
which	O
clinical	O
signs	O
suggestive	O
of	O
FIP	O
were	O
present	O
.	O

ABSTRACT	O
:	O
Rapid	O
differentiation	O
of	O
vaccine	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
from	O
wild	O
type	O
strains	O
would	O
enhance	O
investigations	O
of	O
disease	O
outbreaks	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
associated	O
with	O
epizootic	O
catarrhal	O
enteritis	O
(	O
ECE	O
)	O
in	O
ferrets	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
designated	O
as	O
ferret	B-SPEC
enteric	I-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
),	O
was	O
identified	O
in	O
feces	O
of	O
domestic	B-SPEC
ferrets	I-SPEC
clinically	O
diagnosed	O
with	O
epizootic	O
catarrhal	O
enteritis	O
(	O
ECE	O
).	O

Serum	O
IgG	O
antibody	O
against	O
SARS	O
coronavirus	B-SPEC
is	O
positive	O
in	O
a	O
small	O
proportion	O
(	O
around	O
10	O
%)	O
of	O
the	O
medical	O
staff	O
members	O
exposed	O
to	O
the	O
virus	B-SPEC
in	O
our	O
hospital	O
,	O
but	O
may	O
not	O
cause	O
obvious	O
symptoms	O
,	O
suggesting	O
SARS	O
coronavirus	B-SPEC
infection	O
might	O
in	O
some	O
cases	O
have	O
mild	O
or	O
even	O
no	O
clinical	O
manifestations	O
.	O

METHODS	O
:	O
Enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
was	O
employed	O
to	O
detect	O
serum	O
antibody	O
against	O
SARS	O
coronavirus	B-SPEC
in	O
the	O
lysate	O
of	O
whole	O
SARS	O
coronavirus	B-SPEC
from	O
19	O
SARS	O
patients	O
and	O
200	O
medical	O
staff	O
members	O
without	O
obvious	O
SARS	O
symptoms	O
after	O
possible	O
exposure	O
to	O
the	O
virus	B-SPEC
during	O
routine	O
medical	O
practice	O
.	O

CONCLUSIONS	O
:	O
Serum	O
IgG	O
antibody	O
against	O
SARS	O
coronavirus	B-SPEC
is	O
positive	O
in	O
a	O
small	O
proportion	O
(	O
around	O
10	O
%)	O
of	O
the	O
medical	O
staff	O
members	O
exposed	O
to	O
the	O
virus	B-SPEC
in	O
our	O
hospital	O
,	O
but	O
may	O
not	O
cause	O
obvious	O
symptoms	O
,	O
suggesting	O
SARS	O
coronavirus	B-SPEC
infection	O
might	O
in	O
some	O
cases	O
have	O
mild	O
or	O
even	O
no	O
clinical	O
manifestations	O
.	O

Recently	O
,	O
the	O
structure	O
of	O
a	O
post	O
-	O
fusion	O
form	O
of	O
SARS	O
-	O
CoV	O
spike	O
,	O
which	O
consists	O
of	O
isolated	O
domains	O
of	O
heptad	O
repeats	O
1	O
and	O
2	O
(	O
HR1	O
and	O
HR2	O
),	O
has	O
been	O
determined	O
by	O
x	O
-	O
ray	B-SPEC
crystallography	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
SARS	O
-	O
CoV	O
.	O
Virus	B-SPEC
entry	O
into	O
cells	O
is	O
mediated	O
through	O
interactions	O
between	O
spike	O
(	O
S	O
)	O
glycoprotein	O
and	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
pathogenesis	O
in	O
the	O
central	O
nervous	O
system	O
is	O
independent	O
of	O
IL	O
-	O
15	O
and	O
natural	O
killer	O
cells	O
.	O

TITLE	O
:	O
Structure	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
as	O
an	O
active	O
C2	O
crystallographic	O
dimer	O
.	O

ABSTRACT	O
:	O
The	O
34	O
kDa	O
main	O
proteinase	O
(	O
Mpro	O
)	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
plays	O
an	O
important	O
role	O
in	O
the	O
virus	B-SPEC
life	O
cycle	O
through	O
the	O
specific	O
processing	O
of	O
viral	O
polyproteins	O
.	O

The	O
expanding	O
epizootic	O
of	O
avian	B-SPEC
A	O
/	O
H5N1	O
influenza	O
and	O
increasing	O
number	O
of	O
human	B-SPEC
cases	O
heighten	O
concern	O
regarding	O
the	O
threat	O
of	O
pandemic	O
influenza	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
:	O
application	O
of	O
monoclonal	O
antibodies	O
and	O
development	O
of	O
an	O
effective	O
vaccine	O
.	O

ABSTRACT	O
:	O
The	O
fusogenic	O
potential	O
of	O
Class	B-SPEC
I	O
viral	O
envelope	O
glycoproteins	O
is	O
activated	O
by	O
proteloytic	O
cleavage	O
of	O
the	O
precursor	O
glycoprotein	O
to	O
generate	O
the	O
mature	O
receptor	O
-	O
binding	O
and	O
transmembrane	O
fusion	O
subunits	O
.	O

Intracerebral	O
inoculation	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
into	O
BALB	O
/	O
c	O
mice	B-SPEC
led	O
to	O
an	O
acute	O
encephalitis	O
with	O
neuronal	O
cell	O
death	O
by	O
necrosis	O
and	O
apoptosis	O
.	O

In	O
case	O
of	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
inflammation	O
spill	O
over	O
from	O
the	O
lungs	O
,	O
particularly	O
there	O
is	O
a	O
persistent	O
increase	O
of	O
IL	O
-	O
6	O
and	O
CRP	O
in	O
serum	O
,	O
and	O
this	O
is	O
associated	O
with	O
a	O
worst	O
prognosis	O
and	O
possible	O
development	O
of	O
sepsis	B-SPEC
-	O
related	O
complications	O
.	O

The	O
correlation	O
of	O
preoperative	O
pulmonary	O
function	O
of	O
esophageal	O
cancer	B-SPEC
to	O
postoperative	O
ARDS	O
has	O
seldom	O
been	O
reported	O
.	O

Experiments	O
with	O
some	O
Group	O
1	O
coronaviruses	O
(	O
all	O
from	O
mammals	B-SPEC
,	O
to	O
date	O
)	O
have	O
shown	O
that	O
they	O
are	O
not	O
limited	O
to	O
replicating	O
or	O
causing	O
disease	O
in	O
a	O
single	O
host	O
.	O

Clearly	O
there	O
is	O
the	O
potential	O
for	O
the	O
emergence	O
of	O
new	O
coronavirus	B-SPEC
diseases	O
in	O
domestic	O
birds	B-SPEC
,	O
from	O
both	O
avian	B-SPEC
and	O
mammalian	B-SPEC
sources	O
.	O

Therefore	O
,	O
the	O
molecular	O
basis	O
of	O
coronavirus	B-SPEC
fusion	O
during	O
entry	O
into	O
host	O
cells	O
remains	O
incompletely	O
defined	O
.	O

TITLE	O
:	O
Functional	O
characterization	O
of	O
heptad	O
repeat	O
1	O
and	O
2	O
mutants	O
of	O
the	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Recovery	O
of	O
a	O
neurovirulent	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
from	O
an	O
infectious	O
cDNA	O
clone	O
.	O

The	O
second	O
step	O
consisted	O
in	O
the	O
insertion	O
of	O
the	O
whole	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
cDNA	O
genome	O
into	O
the	O
BAC	O
.	O

ABSTRACT	O
:	O
For	O
developing	O
efficient	O
vaccines	O
,	O
it	O
is	O
essential	O
to	O
identify	O
which	O
amino	O
acid	O
changes	O
are	O
most	O
important	O
to	O
the	O
survival	O
of	O
the	O
virus	B-SPEC
.	O

In	O
addition	O
,	O
the	O
SARS	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
also	O
analyzed	O
in	O
the	O
same	O
way	O
.	O

ABSTRACT	O
:	O
RNA	O
viruses	B-SPEC
are	O
notorious	O
for	O
their	O
genetic	O
plasticity	O
and	O
propensity	O
to	O
exploit	O
new	O
host	O
-	O
range	O
opportunities	O
,	O
which	O
can	O
lead	O
to	O
the	O
emergence	O
of	O
human	B-SPEC
disease	O
epidemics	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
AIDS	O
,	O
dengue	O
,	O
and	O
influenza	O
.	O

We	O
studied	O
the	O
emergence	O
of	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
(	O
VEEV	B-SPEC
),	O
an	O
alphavirus	B-SPEC
pathogen	O
of	O
people	O
and	O
equines	B-SPEC
that	O
has	O
had	O
severe	O
health	O
and	O
economic	O
effects	O
in	O
the	O
Americas	O
since	O
the	O
early	O
20th	O
century	O
.	O

This	O
mutation	O
allowed	O
an	O
enzootic	O
,	O
equine	B-SPEC
-	O
avirulent	O
VEEV	B-SPEC
strain	O
,	O
which	O
circulates	O
among	O
rodents	B-SPEC
in	O
nearby	O
forests	O
to	O
adapt	O
for	O
equine	B-SPEC
amplification	O
.	O

RNA	O
viruses	B-SPEC
including	O
alphaviruses	B-SPEC
exhibit	O
high	O
mutation	O
frequencies	O
.	O

Therefore	O
,	O
ecological	O
and	O
epidemiological	O
factors	O
probably	O
constrain	O
the	O
frequency	O
of	O
VEE	O
epidemics	O
more	O
than	O
the	O
generation	O
,	O
via	O
mutation	O
,	O
of	O
amplification	O
-	O
competent	O
(	O
high	O
equine	B-SPEC
viremia	O
)	O
virus	B-SPEC
strains	O
.	O

Besides	O
strongly	O
reduced	O
genome	O
replication	O
,	O
specific	O
defects	O
in	O
sg	O
RNA	O
synthesis	O
,	O
such	O
as	O
aberrant	O
sizes	O
of	O
specific	O
sg	O
RNAs	O
and	O
changes	O
in	O
the	O
molar	O
ratios	O
between	O
individual	O
sg	O
RNA	O
species	B-SPEC
,	O
were	O
observed	O
.	O

Detection	O
of	O
a	O
group	O
2	O
coronavirus	B-SPEC
in	O
dogs	B-SPEC
with	O
canine	O
infectious	O
respiratory	O
disease	O
.	O

The	O
overall	O
prevalence	O
of	O
this	O
virus	B-SPEC
in	O
both	O
North	O
America	O
and	O
the	O
UK	O
suggests	O
that	O
CRCoV	O
has	O
international	O
significance	O
and	O
that	O
further	O
epidemiological	O
studies	O
are	O
required	O
.	O

Novel	O
treatments	O
will	O
target	O
both	O
the	O
proinflammatory	O
and	O
procoagulation	O
cascades	O
of	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
High	O
expression	O
level	O
of	O
soluble	O
SARS	O
spike	O
protein	O
mediated	O
by	O
adenovirus	B-SPEC
in	O
HEK293	O
cells	O
.	O

The	O
number	O
of	O
cats	B-SPEC
per	O
household	O
at	O
the	O
time	O
of	O
blood	O
collection	O
had	O
a	O
strong	O
positive	O
association	O
with	O
Immunocomb	O
score	O
.	O

ABSTRACT	O
:	O
To	O
test	O
the	O
hypothesis	O
that	O
the	O
interaction	O
between	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
and	O
glucocorticoid	O
receptor	O
alpha	O
(	O
GRalpha	O
)	O
is	O
a	O
key	O
pathogenetic	O
mechanism	O
regulating	O
the	O
progression	O
of	O
systemic	O
and	O
pulmonary	O
inflammation	O
in	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
we	O
used	O
an	O
ex	O
vivo	O
model	O
of	O
systemic	O
inflammation	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
has	O
been	O
proposed	O
to	O
be	O
a	O
key	O
target	O
for	O
structurally	O
based	O
drug	O
design	O
against	O
SARS	O
.	O

TITLE	O
:	O
Avian	B-SPEC
influenza	O
(	O
H5N1	O
):	O
implications	O
for	O
intensive	O
care	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
the	O
first	O
potentially	O
lethal	O
complication	O
in	O
rabies	B-SPEC
virus	I-SPEC
infection	O
,	O
although	O
its	O
occurrence	O
is	O
rare	O
.	O

An	O
autopsy	O
proved	O
rabies	O
encephalitis	O
,	O
mainly	O
involving	O
the	O
medulla	O
oblongata	O
,	O
the	O
thalamus	O
,	O
part	O
of	O
the	O
pons	O
,	O
the	O
cerebellum	O
,	O
and	O
the	O
hippocampus	B-SPEC
.	O

Immunohistochemistry	O
stain	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
for	O
rabies	B-SPEC
virus	I-SPEC
failed	O
to	O
demonstrate	O
the	O
organism	O
in	O
the	O
lung	O
tissue	O
.	O

To	O
support	O
the	O
clinical	O
development	O
of	O
each	O
of	O
these	O
vaccine	O
candidates	O
,	O
preclinical	O
studies	O
have	O
been	O
performed	O
in	O
mice	B-SPEC
or	O
rabbits	B-SPEC
to	O
determine	O
where	O
in	O
the	O
body	O
these	O
plasmid	O
vaccines	O
would	O
biodistribute	O
and	O
how	O
rapidly	O
they	O
would	O
clear	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
cytokine	O
gene	O
expression	O
and	O
induction	O
of	O
chemokine	O
genes	O
in	O
non	O
-	O
lymphatic	O
cells	O
infected	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

Comparative	O
sequence	O
analysis	O
of	O
polyprotein	O
1a	O
of	O
equine	B-SPEC
torovirus	I-SPEC
(	O
EToV	O
)	O
strain	O
Berne	O
,	O
identified	O
a	O
serine	O
proteinase	O
domain	O
,	O
flanked	O
by	O
hydrophobic	O
regions	O
.	O

Apart	O
from	O
treatment	O
of	O
the	O
underlying	O
cause	O
(	O
e	O
.	O
g	O
sepsis	B-SPEC
),	O
there	O
is	O
no	O
specific	O
treatment	O
,	O
although	O
a	O
44	O
%	O
reduction	O
in	O
the	O
incidence	O
of	O
critical	O
illness	O
polyneuropathy	O
has	O
been	O
described	O
in	O
mechanically	O
ventilated	O
critically	O
ill	O
patients	O
who	O
received	O
intensive	O
insulin	O
therapy	O
to	O
maintain	O
the	O
blood	O
glucose	O
level	O
between	O
4	O
.	O
4	O
-	O
6	O
.	O
1	O
mmol	O
/	O
L	O
.	O
Recovery	O
usually	O
occurs	O
over	O
weeks	O
to	O
months	O
depending	O
on	O
the	O
severity	O
of	O
the	O
disease	O
.	O

For	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
and	O
related	O
viruses	B-SPEC
,	O
binding	O
to	O
cell	O
surface	O
components	O
containing	O
N	O
-	O
acetyl	O
-	O
9	O
-	O
O	O
-	O
acetylneuraminic	O
acid	O
is	O
essential	O
for	O
initiation	O
of	O
an	O
infection	O
.	O

These	O
enzymes	O
make	O
the	O
attachment	O
to	O
Sia	B-SPEC
reversible	O
,	O
thus	O
providing	O
the	O
virus	B-SPEC
with	O
an	O
escape	O
ticket	O
.	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
7a7b	O
genes	O
of	O
the	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
of	O
cheetahs	B-SPEC
,	O
which	O
are	O
believed	O
to	O
play	O
a	O
role	O
in	O
virulence	O
of	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
Tertiary	O
structure	O
prediction	O
of	O
SARS	O
coronavirus	B-SPEC
helicase	O
.	O

Angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)	O
plays	O
a	O
central	O
role	O
in	O
generating	O
angiotensin	O
II	O
from	O
angiotensin	O
I	O
,	O
and	O
capillary	O
blood	O
vessels	O
in	O
the	O
lung	O
are	O
one	O
of	O
the	O
major	O
sites	O
of	O
ACE	O
expression	O
and	O
angiotensin	O
II	O
production	O
in	O
the	O
human	B-SPEC
body	O
.	O

Macro	O
domains	O
are	O
also	O
present	O
in	O
a	O
number	O
of	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
,	O
but	O
their	O
precise	O
function	O
in	O
viral	O
replication	O
is	O
still	O
unknown	O
.	O

The	O
major	O
human	B-SPEC
pathogen	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
16	O
non	O
-	O
structural	O
proteins	O
(	O
nsps	O
),	O
one	O
of	O
which	O
(	O
nsp3	O
)	O
encompasses	O
a	O
macro	O
domain	O
.	O

Strains	O
from	O
cluster	O
2	O
showed	O
a	O
deletion	O
of	O
6	O
amino	O
acids	O
inside	O
domain	O
II	O
of	O
the	O
spike	O
protein	O
that	O
was	O
also	O
found	O
in	O
human	B-SPEC
coronavirus	I-SPEC
strain	O
OC43	O
,	O
supporting	O
the	O
recent	O
proposal	O
of	O
a	O
zoonotic	O
spill	O
-	O
over	O
of	O
BCoV	O
.	O
These	O
results	O
contribute	O
to	O
the	O
molecular	O
characterization	O
of	O
BCoV	O
,	O
to	O
the	O
prediction	O
of	O
the	O
efficiency	O
of	O
immunogens	O
,	O
and	O
to	O
the	O
definition	O
of	O
molecular	O
markers	O
useful	O
for	O
epidemiologic	O
surveys	O
on	O
coronavirus	B-SPEC
-	O
caused	O
diseases	O
.	O

TITLE	O
:	O
Anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
immune	O
responses	O
:	O
the	O
role	O
played	O
by	O
V	O
gamma	O
9V	O
delta	O
2	O
T	O
cells	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
strain	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
,	O
or	O
SCV	B-SPEC
),	O
which	O
caused	O
a	O
world	O
-	O
wide	O
epidemic	O
in	O
2002	O
and	O
2003	O
,	O
binds	O
to	O
a	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
through	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
its	O
envelope	O
(	O
spike	O
,	O
S	O
)	O
glycoprotein	O
.	O

By	O
mimicking	O
immune	O
responses	O
with	O
the	O
use	O
of	O
RBD	O
as	O
an	O
antigen	O
to	O
screen	O
a	O
large	O
human	B-SPEC
antibody	O
library	O
derived	O
from	O
healthy	O
volunteers	O
,	O
we	O
identified	O
a	O
novel	O
potent	O
cross	O
-	O
reactive	O
SCV	B-SPEC
-	O
neutralizing	O
monoclonal	O
antibody	O
,	O
m396	O
,	O
which	O
competes	O
with	O
ACE2	O
for	O
binding	O
to	O
RBD	O
,	O
and	O
determined	O
the	O
crystal	O
structure	O
of	O
the	O
RBD	O
-	O
antibody	O
complex	O
at	O
2	O
.	O
3	O
-	O
A	O
resolution	O
.	O

The	O
filtration	O
efficiency	O
of	O
high	O
efficiency	O
particulate	O
air	O
(	O
HEPA	O
)	O
filter	O
was	O
measured	O
with	O
the	O
biologic	O
aerosol	O
of	O
simulating	O
virus	B-SPEC
(	O
Escherichia	B-SPEC
coli	I-SPEC
bacteriophage	B-SPEC
f	O
(	O
2	O
)).	O

Susceptibility	O
of	O
each	O
peptide	O
substrate	O
to	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
cleavage	O
was	O
monitored	O
simultaneously	O
by	O
matrix	O
-	O
assisted	O
laser	B-SPEC
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
).	O

ABSTRACT	O
:	O
A	O
four	O
-	O
month	O
-	O
old	O
infant	O
was	O
hospitalized	O
because	O
of	O
RSV	B-SPEC
bronchiolitis	O
.	O

Sialic	O
acid	O
-	O
dependent	O
infection	O
was	O
also	O
observed	O
with	O
strain	O
M41	O
of	O
IBV	B-SPEC
,	O
which	O
infects	O
primary	O
chicken	B-SPEC
kidney	O
cells	O
but	O
not	O
cells	O
from	O
other	O
species	B-SPEC
.	O

In	O
previous	O
studies	O
,	O
with	O
respect	O
to	O
the	O
haemagglutinating	O
activity	O
of	O
IBV	B-SPEC
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
virus	B-SPEC
preferentially	O
recognizes	O
alpha2	O
,	O
3	O
-	O
linked	O
sialic	O
acid	O
.	O

In	O
agreement	O
with	O
this	O
finding	O
,	O
susceptibility	O
to	O
infection	O
by	O
IBV	B-SPEC
was	O
connected	O
to	O
the	O
expression	O
of	O
alpha2	O
,	O
3	O
-	O
linked	O
sialic	O
acid	O
as	O
indicated	O
by	O
the	O
reactivity	O
with	O
the	O
lectin	O
Maackia	B-SPEC
amurensis	I-SPEC
agglutinin	O
.	O

In	O
addition	O
,	O
BCoV	O
and	O
human	B-SPEC
coronavirus	I-SPEC
HCV	B-SPEC
-	O
OC43	O
contained	O
four	O
potential	O
O	O
-	O
glycosylation	O
sites	O
in	O
the	O
M	O
gene	O
.	O

SARS	O
-	O
CoV	O
infection	O
of	O
cynomolgus	O
macaques	B-SPEC
did	O
not	O
reproduce	O
the	O
severe	O
illness	O
seen	O
in	O
the	O
majority	O
of	O
adult	O
human	B-SPEC
cases	O
of	O
SARS	O
;	O
however	O
,	O
our	O
results	O
suggest	O
similarities	O
to	O
the	O
milder	O
syndrome	O
of	O
SARS	O
-	O
CoV	O
infection	O
characteristically	O
seen	O
in	O
young	O
children	O
.	O

TITLE	O
:	O
Nucleic	O
-	O
acid	O
-	O
based	O
antiviral	O
agents	O
against	O
positive	O
single	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
.	O

The	O
partial	O
1a	O
gene	O
sequences	O
from	O
two	O
positive	O
samples	O
(	O
BJ3140	O
and	O
BJ3787	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
showed	O
100	O
%	O
homology	O
between	O
each	O
other	O
and	O
high	O
homology	O
(	O
98	O
%-	O
99	O
%)	O
with	O
the	O
sequences	O
of	O
1a	O
gene	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
reported	O
from	O
different	O
countries	O
in	O
GenBank	O
.	O

These	O
data	O
suggest	O
that	O
some	O
of	O
acute	O
respiratory	O
infections	O
in	O
young	O
children	O
in	O
Beijing	O
area	O
are	O
related	O
to	O
the	O
newly	O
identified	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

RESULTS	O
:	O
Three	O
(	O
1	O
.	O
2	O
%)	O
out	O
of	O
the	O
245	O
samples	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
by	O
nested	O
-	O
PCR	O
using	O
primers	O
on	O
1b	O
gene	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
sequence	O
of	O
S2	O
gene	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
GD322	O
and	O
analyze	O
the	O
phyletic	O
evolution	O
of	O
S2	O
gene	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
dimerization	O
domain	O
reveals	O
evolutionary	O
linkage	O
between	O
corona	B-SPEC
-	O
and	O
arteriviridae	B-SPEC
.	O

Global	O
interconnectedness	O
continues	O
to	O
increase	O
with	O
international	O
travel	O
and	O
trade	O
;	O
economic	O
,	O
political	O
,	O
and	O
cultural	O
interactions	O
;	O
and	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
and	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
interactions	O
.	O

Torovirus	B-SPEC
-	O
specific	O
nucleic	O
acid	O
confirmed	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
was	O
found	O
in	O
12	O
of	O
230	O
calves	O
(	O
5	O
.	O
2	O
%).	O

Computer	O
assisted	O
analysis	O
of	O
two	O
nucleotide	O
sequences	O
obtained	O
from	O
Austrian	O
bovine	B-SPEC
samples	O
revealed	O
93	O
%	O
similarity	O
to	O
Breda	B-SPEC
strain	O
,	O
but	O
only	O
71	O
%	O
or	O
52	O
%	O
similarity	O
to	O
Equine	B-SPEC
Berne	O
or	O
Porcine	B-SPEC
Markelo	O
torovirus	B-SPEC
strains	O
respectively	O
.	O

Salmonella	B-SPEC
spp	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
defined	O
the	O
role	O
of	O
particular	O
cytokines	O
,	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
ligands	O
and	O
T	O
lymphocytes	O
in	O
the	O
porcine	B-SPEC
monocyte	O
-	O
derived	O
DC	O
(	O
MoDC	O
).	O

Natural	O
interferon	O
producing	O
cells	O
(	O
NIPC	O
,	O
or	O
plasmacytoid	O
DCs	O
)	O
represent	O
a	O
danger	O
-	O
recognition	O
system	O
of	O
the	O
immune	O
defences	O
,	O
and	O
can	O
respond	O
to	O
viruses	B-SPEC
not	O
otherwise	O
recognized	O
as	O
posing	O
a	O
danger	O
.	O

TITLE	O
:	O
Kinetics	O
and	O
synergistic	O
effects	O
of	O
siRNAs	O
targeting	O
structural	O
and	O
replicase	O
genes	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
was	O
identified	O
as	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
a	O
large	O
virus	B-SPEC
pool	O
was	O
identified	O
in	O
wild	O
animals	B-SPEC
.	O

ICE	O
provided	O
high	O
quality	O
2D	O
imaging	O
of	O
the	O
prosthesis	O
demonstrating	O
thrombus	B-SPEC
-	O
like	O
material	O
coating	O
the	O
inner	O
surfaces	O
of	O
the	O
prosthetic	O
valve	O
stents	O
effectively	O
forming	O
a	O
tunnel	O
-	O
like	O
obstruction	O
.	O

TITLE	O
:	O
Receptor	O
-	O
independent	O
infection	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
:	O
analysis	O
by	O
spinoculation	O
.	O

Avian	B-SPEC
influenza	O
was	O
more	O
severe	O
in	O
children	O
,	O
who	O
should	O
avoid	O
handling	O
dead	O
poultry	O
during	O
epizootics	O
.	O

By	O
integrating	O
these	O
different	O
data	O
sources	O
into	O
a	O
dynamic	O
model	O
,	O
we	O
identify	O
in	O
children	O
and	O
infants	O
presenting	O
to	O
the	O
pediatric	O
emergency	O
department	O
with	O
respiratory	O
syndromes	O
an	O
early	O
indicator	B-SPEC
of	O
impending	O
influenza	O
morbidity	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
The	O
enzymatic	O
activity	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
dimer	O
was	O
characterized	O
by	O
a	O
sensitive	O
,	O
quantitative	O
assay	O
.	O

ABSTRACT	O
:	O
The	O
existence	O
of	O
coronaviruses	O
in	O
bats	B-SPEC
is	O
unknown	O
until	O
the	O
recent	O
discovery	O
of	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
in	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
and	O
a	O
novel	O
group	O
1	O
coronavirus	B-SPEC
in	O
other	O
bat	B-SPEC
species	B-SPEC
.	O

Bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
infections	O
occurred	O
only	O
every	O
second	O
year	O
and	O
were	O
associated	O
with	O
a	O
treatment	O
peak	O
and	O
one	O
death	O
on	O
one	O
occasion	O
(	O
December	O
).	O

The	O
infection	O
patterns	O
for	O
PIV	O
-	O
3	O
and	O
BCoV	O
indicated	O
a	O
high	O
level	O
of	O
infectivity	O
amongst	O
bovine	B-SPEC
calves	O
,	O
whereas	O
the	O
incidence	O
for	O
BRSV	B-SPEC
was	O
observed	O
at	O
a	O
lower	O
level	O
.	O

ABSTRACT	O
:	O
This	O
study	O
used	O
a	O
sensitive	O
polymerase	O
chain	O
reaction	O
method	O
coupled	O
with	O
filter	O
sampling	O
to	O
detect	O
the	O
presence	O
of	O
airborne	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
in	O
an	O
isolation	O
patient	O
room	O
with	O
a	O
patient	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
receiving	O
mechanical	O
ventilatory	O
support	O
.	O

Treatment	O
of	O
picornavirus	B-SPEC
infections	O
.	O

Detection	O
of	O
rhinovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
coronavirus	B-SPEC
infections	O
in	O
acute	O
otitis	O
media	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
feline	B-SPEC
(	O
FIPV	O
)	O
and	O
human	B-SPEC
(	O
SARS	O
)	O
coronavirus	B-SPEC
by	O
semisynthetic	O
derivatives	O
of	O
glycopeptide	O
antibiotics	O
.	O

Nasal	O
airway	O
stenosis	B-SPEC
or	O
atresia	O
could	O
account	O
for	O
a	O
number	O
of	O
unexplained	O
deaths	O
in	O
the	O
delivery	O
room	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
clinical	O
manifestations	O
and	O
the	O
chest	O
imaging	O
characteristics	O
of	O
an	O
epidemic	O
outbreak	O
of	O
respiratory	O
infection	O
caused	O
by	O
Chlamydia	B-SPEC
pneumoniae	I-SPEC
(	O
CP	O
).	O

In	O
northern	O
China	O
,	O
these	O
conditions	O
are	O
most	O
likely	O
to	O
occur	O
in	O
the	O
spring	O
and	O
suggest	O
that	O
SARS	O
has	O
a	O
seasonal	O
nature	O
akin	O
to	O
viruses	B-SPEC
such	O
as	O
influenza	O
and	O
the	O
common	O
cold	O
.	O

The	O
library	O
was	O
screened	O
for	O
the	O
production	O
of	O
Fab	O
antibody	O
fragments	O
to	O
a	O
recombinant	O
spike	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

RESULTS	O
:	O
Two	O
(	O
0	O
.	O
57	O
%)	O
of	O
353	O
asymptomatic	O
children	O
from	O
the	O
high	O
-	O
risk	O
area	O
were	O
tested	O
positive	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
antibody	O
compared	O
with	O
0	O
of	O
361	O
in	O
the	O
low	O
-	O
risk	O
region	O
.	O

While	O
the	O
former	O
reflected	O
modified	O
team	O
and	O
functional	O
nursing	O
,	O
it	O
did	O
not	O
confine	O
patient	O
care	O
within	O
a	O
cubicle	O
as	O
suggested	O
by	O
its	O
name	B-SPEC
.	O

TITLE	O
:	O
Effects	O
of	O
high	O
-	O
volume	O
continuous	O
hemofiltration	O
on	O
experimental	O
pancreatitis	O
associated	O
lung	O
injury	O
in	O
pigs	B-SPEC
.	O

This	O
study	O
aims	O
to	O
characterize	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
chlorine	O
gas	O
(	O
Cl2	O
)	O
inhalation	O
in	O
a	O
large	O
-	O
animal	B-SPEC
model	O
.	O

An	O
IC	O
(	O
50	O
)	O
of	O
7	O
.	O
5	O
muM	B-SPEC
was	O
found	O
for	O
AcNSTSQ	O
-	O
H	O
and	O
AcESTLQ	O
-	O
H	O
.	O
Interestingly	O
,	O
the	O
most	O
potent	O
inhibitors	O
seem	O
to	O
bind	O
to	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
in	O
a	O
noncanonical	O
binding	O
mode	O
.	O

ABSTRACT	O
:	O
These	O
studies	O
attempt	O
to	O
understand	O
more	O
fully	O
the	O
host	O
response	O
and	O
pathogenesis	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
by	O
monitoring	O
gene	O
expression	O
using	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
(	O
FFPE	O
)	O
pulmonary	O
autopsy	O
tissues	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
a	O
structural	O
component	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
can	O
induce	O
antibody	O
responses	O
in	O
SARS	O
patients	O
during	O
infection	O
.	O

However	O
,	O
it	O
is	O
not	O
known	O
whether	O
SARS	O
-	O
CoV	O
N	O
protein	O
can	O
induce	O
a	O
long	O
persistence	O
of	O
memory	O
T	O
-	O
cell	O
response	O
in	O
human	B-SPEC
.	O

In	O
this	O
review	O
,	O
nidovirus	B-SPEC
transcription	O
mechanisms	O
are	O
compared	O
,	O
the	O
experimental	O
systems	O
used	O
are	O
critically	O
assessed	O
and	O
,	O
in	O
particular	O
,	O
the	O
impact	O
of	O
recently	O
developed	O
reverse	O
genetic	O
systems	O
is	O
discussed	O
.	O

The	O
classification	O
provides	O
a	O
new	O
perspective	O
on	O
functional	O
properties	O
across	O
a	O
protein	O
family	B-SPEC
and	O
is	O
able	O
to	O
highlight	O
features	O
important	O
for	O
potency	O
and	O
selectivity	O
.	O

The	O
major	O
infectious	O
organisms	O
in	O
endometritis	O
and	O
metritis	O
are	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
Streptococcus	B-SPEC
equi	I-SPEC
subspecies	O
zooepidemicus	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
potentiates	O
respiratory	O
disease	O
and	O
proinflammatory	O
cytokine	O
production	O
in	O
the	O
lungs	O
upon	O
intratracheal	O
inoculation	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
at	O
1	O
day	O
of	O
infection	O
.	O

ABSTRACT	O
:	O
Entry	O
of	O
SARS	O
coronavirus	B-SPEC
into	O
its	O
target	O
cell	O
requires	O
large	O
-	O
scale	O
structural	O
transitions	O
in	O
the	O
viral	O
spike	O
(	O
S	O
)	O
glycoprotein	O
in	O
order	B-SPEC
to	O
induce	O
fusion	O
of	O
the	O
virus	B-SPEC
and	O
cell	O
membranes	O
.	O

Our	O
results	O
provide	O
a	O
structural	O
framework	O
for	O
understanding	O
the	O
control	O
of	O
membrane	O
fusion	O
and	O
should	O
guide	O
efforts	O
to	O
intervene	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
entry	O
process	O
.	O

The	O
phages	O
specifically	O
inhibited	O
IBV	B-SPEC
infectivity	O
in	O
HeLa	O
cells	O
and	O
blocked	O
IBV	B-SPEC
haemagglutination	O
.	O

The	O
requirement	O
for	O
base	O
-	O
pairing	O
during	O
transcription	O
has	O
been	O
formally	O
demonstrated	O
in	O
arteriviruses	B-SPEC
and	O
CoVs	O
.	O

TITLE	O
:	O
Do	O
children	O
know	O
their	O
parent	O
'	O
s	O
HIV	B-SPEC
status	O
?	O

HIV	B-SPEC
-	O
infected	O
parents	O
reported	O
that	O
44	O
%	O
of	O
their	O
children	O
(	O
5	O
-	O
17	O
years	O
old	O
)	O
were	O
aware	O
of	O
their	O
parent	O
'	O
s	O
HIV	B-SPEC
status	O
,	O
and	O
parents	O
had	O
discussed	O
with	O
90	O
%	O
of	O
those	O
children	O
the	O
possibility	O
that	O
HIV	B-SPEC
or	O
acquired	O
immunodeficiency	O
syndrome	O
(	O
AIDS	O
)	O
might	O
lead	O
to	O
their	O
parent	O
'	O
s	O
death	O
.	O

HIV	B-SPEC
-	O
infected	O
parents	O
often	O
worry	O
about	O
the	O
emotional	O
consequences	O
of	O
disclosure	O
to	O
their	O
children	O
and	O
that	O
their	O
children	O
may	O
tell	O
others	O
.	O

Here	O
,	O
we	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
a	O
rationally	O
designed	O
fusion	O
core	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
HR1	O
-	O
SGGRGG	O
-	O
HR2	O
),	O
which	O
was	O
in	O
vitro	O
produced	O
in	O
GST	O
prokaryotic	O
expression	O
system	O
.	O

Multiple	O
lines	O
of	O
experimental	O
data	O
including	O
gel	O
-	O
filtration	O
,	O
chemical	O
cross	O
-	O
linking	O
,	O
and	O
circular	O
diagram	O
(	O
CD	O
)	O
demonstrated	O
that	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
fusion	O
core	O
possesses	O
the	O
typical	O
properties	O
of	O
the	O
trimer	O
of	O
coiled	O
-	O
coil	O
heterodimer	O
(	O
six	O
alpha	O
-	O
helix	O
bundle	O
).	O

The	O
study	O
involved	O
an	O
extended	O
12	O
-	O
month	O
thin	O
-	O
section	O
CT	O
follow	O
-	O
up	O
of	O
16	O
of	O
47	O
pediatrics	O
patients	O
with	O
SARS	O
coronavirus	B-SPEC
-	O
associated	O
pneumonia	O
proven	O
serologically	O
(	O
21	O
girls	O
and	O
26	O
boys	O
;	O
age	O
range	O
,	O
1	O
.	O
5	O
-	O
17	O
years	O
;	O
median	O
age	O
,	O
13	O
.	O
6	O
years	O
).	O

Avenues	O
for	O
research	O
are	O
also	O
suggested	O
in	O
order	B-SPEC
to	O
improve	O
survival	O
in	O
these	O
very	O
high	O
risk	O
patients	O
.	O

TITLE	O
:	O
Investigation	O
of	O
interaction	O
between	O
two	O
neutralizing	O
monoclonal	O
antibodies	O
and	O
SARS	O
virus	B-SPEC
using	O
biosensor	O
based	O
on	O
imaging	O
ellipsometry	O
.	O

In	O
addition	O
,	O
the	O
detection	O
of	O
still	O
untypeable	O
hCoV	O
strains	O
suggests	O
that	O
the	O
number	O
of	O
hCoVs	O
involved	O
in	O
human	B-SPEC
pathology	O
might	O
further	O
increase	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
infection	O
at	O
early	O
stages	O
of	O
the	O
replication	O
cycle	O
.	O

Of	O
the	O
28	O
compounds	O
that	O
we	O
tested	O
,	O
6	O
potently	O
inhibited	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
at	O
early	O
steps	O
of	O
the	O
replication	O
cycle	O
.	O

ABSTRACT	O
:	O
Tuberculosis	O
miliar	O
is	O
a	O
very	O
rare	O
complication	O
of	O
bacillus	B-SPEC
Calmette	O
-	O
Gurin	O
(	O
BCG	O
)	O
immunotherapy	O
that	O
is	O
associated	O
to	O
high	O
mortality	O
.	O

The	O
attenuated	O
DR13	O
virus	B-SPEC
remained	O
safe	O
,	O
even	O
after	O
three	O
backpassages	O
in	O
piglets	O
.	O

The	O
SV40	B-SPEC
polyA	O
sequence	O
was	O
then	O
inserted	O
into	O
the	O
downstream	O
of	O
S1	O
fragment	O
of	O
pHS	O
.	O

The	O
3	O
emerging	O
infectious	O
diseases	O
pose	O
very	O
different	O
threats	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
is	O
a	O
newly	O
identified	O
pathogen	O
that	O
caused	O
an	O
international	O
pandemic	O
;	O
the	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
investigation	O
involved	O
an	O
old	O
pathogen	O
that	O
was	O
identified	O
in	O
a	O
new	O
location	O
;	O
and	O
the	O
anthrax	B-SPEC
attacks	O
involved	O
the	O
intentional	O
introduction	O
of	O
a	O
pathogen	O
.	O

TITLE	O
:	O
Antigenic	O
and	O
immunogenic	O
characterization	O
of	O
recombinant	O
baculovirus	B-SPEC
-	O
expressed	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
:	O
implication	O
for	O
vaccine	O
design	O
.	O

TITLE	O
:	O
Ultrastructure	O
and	O
origin	O
of	O
membrane	O
vesicles	O
associated	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
replication	O
complex	O
.	O

ABSTRACT	O
:	O
The	O
RNA	O
replication	O
complexes	O
of	O
mammalian	B-SPEC
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
are	O
generally	O
associated	O
with	O
(	O
modified	O
)	O
intracellular	O
membranes	O
,	O
a	O
feature	O
thought	O
to	O
be	O
important	O
for	O
creating	O
an	O
environment	O
suitable	O
for	O
viral	O
RNA	O
synthesis	O
,	O
recruitment	O
of	O
host	O
components	O
,	O
and	O
possibly	O
evasion	O
of	O
host	O
defense	O
mechanisms	O
.	O

Here	O
,	O
using	O
a	O
panel	O
of	O
replicase	O
-	O
specific	O
antisera	O
,	O
we	O
have	O
analyzed	O
the	O
earlier	O
stages	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
in	O
Vero	O
E6	O
cells	O
,	O
in	O
particular	O
focusing	O
on	O
the	O
subcellular	O
localization	O
of	O
the	O
replicase	O
and	O
the	O
ultrastructure	O
of	O
the	O
associated	O
membranes	O
.	O

In	O
immunoelectron	O
microscopy	O
,	O
the	O
virus	B-SPEC
-	O
induced	O
vesicles	O
could	O
be	O
labeled	O
with	O
replicase	O
-	O
specific	O
antibodies	O
.	O

TITLE	O
:	O
Anti	O
-	O
RNA	O
virus	B-SPEC
activity	O
of	O
polyoxometalates	O
.	O

A	O
titanium	O
containing	O
polyoxotungstate	O
,	O
PM	O
-	O
523	O
exhibited	O
potent	O
anti	O
-	O
influenza	B-SPEC
virus	I-SPEC
(	O
FluV	O
)	O
A	O
and	O
anti	O
-	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
activities	O
in	O
vitro	O
.	O

TITLE	O
:	O
Reciprocal	O
antibody	O
and	O
complement	O
responses	O
of	O
two	O
chicken	B-SPEC
breeds	O
to	O
vaccine	O
strains	O
of	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
and	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Despite	O
a	O
shorter	O
duration	O
of	O
fever	O
(	O
mean	O
,	O
1	O
.	O
7	O
days	O
)	O
and	O
no	O
difference	O
in	O
maximum	O
temperature	O
in	O
children	O
with	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
infections	O
compared	O
to	O
patients	O
with	O
most	O
other	O
respiratory	O
virus	B-SPEC
infections	O
,	O
a	O
high	O
incidence	O
of	O
febrile	O
seizures	O
(	O
50	O
%)	O
was	O
noted	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
those	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
14	O
%),	O
adenovirus	B-SPEC
(	O
9	O
%),	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
1	I-SPEC
(	O
0	O
%),	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
8	O
%)	O
infections	O
.	O

ABSTRACT	O
:	O
A	O
cell	O
-	O
based	O
assay	O
was	O
developed	O
to	O
screen	O
small	O
interference	O
RNA	O
(	O
siRNA	O
)	O
to	O
block	O
the	O
expression	O
of	O
two	O
genes	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
.	O

These	O
siRNA	O
molecules	O
could	O
be	O
used	O
to	O
examine	O
the	O
function	O
of	O
these	O
genes	O
in	O
SARS	O
virus	B-SPEC
replication	O
and	O
assembly	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
viruses	B-SPEC
in	O
the	O
aetiology	O
of	O
community	O
-	O
acquired	O
pneumonia	O
in	O
adults	O
.	O

CONCLUSIONS	O
:	O
PCR	O
revealed	O
that	O
viruses	B-SPEC
represent	O
a	O
common	O
aetiology	O
of	O
CAP	O
.	O

Development	O
of	O
drug	O
resistance	O
against	O
clinical	O
anti	O
-	O
HBV	B-SPEC
drug	O
lamivudine	O
due	O
to	O
long	O
-	O
term	O
use	O
and	O
rebound	O
of	O
viral	O
DNA	O
after	O
cessation	O
of	O
treatment	O
has	O
been	O
a	O
major	O
setback	O
of	O
the	O
current	O
therapy	O
.	O

These	O
compounds	O
were	O
also	O
evaluated	O
for	O
their	O
antiviral	O
activity	O
for	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
SARS	O
-	O
coronavirus	B-SPEC
,	O
and	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
.	O

Taken	O
together	O
,	O
these	O
data	O
support	O
our	O
previous	O
observations	O
that	O
the	O
5	O
-	O
substituted	O
pyrimidine	O
nucleosides	O
containing	O
acyclic	O
glycosyl	O
moieties	O
have	O
potential	O
to	O
serve	O
as	O
a	O
new	O
generation	O
of	O
potent	O
,	O
selective	O
,	O
and	O
nontoxic	O
anti	O
-	O
HBV	B-SPEC
agents	O
for	O
wild	O
-	O
type	O
and	O
lamivudine	O
-	O
resistant	O
mutant	O
HBV	B-SPEC
.	O

TITLE	O
:	O
Is	O
there	O
an	O
ideal	O
animal	B-SPEC
model	O
for	O
SARS	O
?	O

None	O
of	O
the	O
remaining	O
93	O
participants	O
tested	O
positive	O
for	O
antibody	O
to	O
SARS	O
-	O
CoV	O
.	O
Based	O
on	O
the	O
chronological	O
order	B-SPEC
,	O
resident	O
A	O
might	O
have	O
transmitted	O
infection	O
to	O
resident	O
B	O
and	O
staff	O
C	O
.	O
Sitting	O
close	O
to	O
the	O
bathroom	O
doorway	O
while	O
resident	O
A	O
took	O
a	O
shower	O
was	O
the	O
only	O
contact	O
of	O
resident	O
B	O
with	O
resident	O
A	O
.	O
The	O
only	O
opportunity	O
for	O
staff	O
C	O
to	O
have	O
contact	O
with	O
body	O
fluids	O
/	O
excreta	O
of	O
resident	O
A	O
was	O
in	O
the	O
handling	O
of	O
rubbish	O
from	O
the	O
resident	O
'	O
s	O
room	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
preparedness	O
of	O
emergency	O
departments	O
(	O
EDs	O
)	O
in	O
the	O
United	O
Kingdom	B-SPEC
(	O
UK	O
)	O
for	O
the	O
management	O
of	O
potential	O
biological	O
incidents	O
.	O

Findings	O
showed	O
that	O
public	O
stigma	O
was	O
the	O
highest	O
towards	O
HIV	B-SPEC
/	O
AIDS	O
,	O
followed	O
by	O
TB	O
and	O
SARS	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
cause	O
a	O
variety	O
of	O
respiratory	O
and	O
enteric	O
diseases	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
including	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
A	O
synthetic	O
peptide	O
corresponding	O
to	O
amino	O
acids	O
(	O
aa	O
)	O
15	O
-	O
28	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
3a	O
protein	O
was	O
used	O
to	O
raise	O
polyclonal	O
antibodies	O
in	O
rabbits	B-SPEC
.	O

Rats	B-SPEC
were	O
treated	O
with	O
either	O
a	O
C5a	O
receptor	O
antagonist	O
(	O
C5aRA	O
,	O
AcF	O
-[	O
OP	O
(	O
d	O
-	O
Cha	O
)	O
WR	O
],	O
1	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.	O
or	O
10	O
mg	O
/	O
kg	O
p	O
.	O
o	O
.),	O
a	O
C3a	O
receptor	O
antagonist	O
(	O
C3aRA	O
,	O
N	O
(	O
2	O
)-[(	O
2	O
,	O
2	O
-	O
diphenylethoxy	O
)	O
acetyl	O
]-	O
l	O
-	O
arginine	O
,	O
0	O
.	O
1	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.)	O
or	O
a	O
convertase	O
inhibitor	O
,	O
rosmarinic	O
acid	O
(	O
RMA	O
,	O
10	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.),	O
prior	O
to	O
CVF	O
-	O
induced	O
complement	O
challenge	O
.	O

TITLE	O
:	O
[	O
Effects	O
of	O
different	O
modes	O
of	O
artificial	O
ventilation	O
on	O
lung	O
injury	O
in	O
dog	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
effects	O
of	O
different	O
modes	O
of	O
artificial	O
ventilation	O
on	O
lung	O
injury	O
in	O
a	O
dog	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
to	O
evaluate	O
the	O
protective	O
effect	O
of	O
various	O
parameters	O
in	O
mechanical	O
ventilation	O
on	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
The	O
mortality	O
rate	O
of	O
severe	O
sepsis	B-SPEC
is	O
still	O
high	O
(	O
20	O
to	O
65	O
%)	O
despite	O
the	O
advances	O
in	O
critical	O
care	O
.	O

In	O
view	O
of	O
this	O
,	O
the	O
softwares	O
,	O
ZCURVE_CoV	O
1	O
.	O
0	O
and	O
ZCURVE_CoV	O
2	O
.	O
0	O
(	O
http	O
://	O
tubic	O
.	O
tju	O
.	O
edu	O
.	O
cn	O
/	O
sars	O
/),	O
developed	O
recently	O
for	O
SARS	O
-	O
Coronavirus	B-SPEC
are	O
used	O
to	O
analyze	O
the	O
36	O
complete	O
SARS	O
-	O
Coronavirus	B-SPEC
RNA	O
sequences	O
in	O
the	O
gene	O
bank	O
NCBI	O
(	O
http	O
://	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/)	O
from	O
different	O
sources	O
for	O
protein	O
coding	O
genes	O
,	O
and	O
to	O
search	O
for	O
the	O
cleavage	O
sites	O
of	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
in	O
polyproteins	O
pp1a	O
and	O
pp1ab	O
.	O

TITLE	O
:	O
Multiplex	O
reverse	O
transcription	O
-	O
PCR	O
for	O
rapid	O
differential	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
and	O
porcine	B-SPEC
group	B-SPEC
A	I-SPEC
rotavirus	I-SPEC
.	O

A	O
mixture	O
of	O
3	O
pairs	O
of	O
published	O
primers	O
was	O
used	O
for	O
amplification	O
of	O
viral	O
nucleic	O
acids	O
,	O
yielding	O
3	O
different	O
amplicons	O
with	O
sizes	O
of	O
859	O
bp	O
,	O
651	O
bp	O
,	O
and	O
309	O
bp	O
for	O
TGEV	B-SPEC
,	O
PEDV	B-SPEC
,	O
and	O
porcine	B-SPEC
GAR	O
,	O
respectively	O
.	O

The	O
aim	O
of	O
this	O
tertiary	O
hospital	O
-	O
based	O
cohort	O
study	O
was	O
to	O
determine	O
and	O
compare	O
perinatal	O
outcome	O
and	O
neonatal	O
morbidities	O
of	O
pregnancies	O
with	O
twin	O
-	O
twin	O
transfusion	O
syndrome	O
(	O
TTTS	O
)	O
before	O
and	O
after	O
the	O
introduction	O
of	O
a	O
treatment	O
program	O
with	O
laser	B-SPEC
ablation	O
of	O
placental	O
communicating	O
vessels	O
.	O

The	O
data	O
were	O
compared	O
with	O
that	O
obtained	O
from	O
the	O
first	O
31	O
pregnancies	O
with	O
Stage	O
II	O
-	O
IV	O
TTTS	O
managed	O
with	O
laser	B-SPEC
ablation	O
of	O
placental	O
communicating	O
vessels	O
(	O
laser	B-SPEC
group	O
).	O

After	O
a	O
stabilisation	O
period	O
of	O
60	O
minutes	O
,	O
the	O
animals	B-SPEC
were	O
randomly	O
assigned	O
to	O
two	O
groups	O
:	O
Group	O
1	O
(	O
Pressure	O
controlled	O
ventilation	O
;	O
PCV	B-SPEC
):	O
FIO2	O
=	O
1	O
.	O
0	O
,	O
PEEP	O
=	O
5	O
cmH2O	O
,	O
V	O
(	O
T	O
)	O
=	O
6	O
ml	O
/	O
kg	O
,	O
respiratory	O
rate	O
=	O
30	O
/	O
min	O
,	O
I	O
:	O
E	O
=	O
1	O
:	O
1	O
;	O
group	O
2	O
(	O
High	O
-	O
frequency	O
oscillatory	O
ventilation	O
;	O
HFOV	O
):	O
FIO2	O
=	O
1	O
.	O
0	O
,	O
Bias	B-SPEC
flow	O
=	O
30	O
l	O
/	O
min	O
,	O
Amplitude	O
=	O
60	O
cmH2O	O
,	O
Frequency	O
=	O
6	O
Hz	O
,	O
I	O
:	O
E	O
=	O
1	O
:	O
1	O
.	O

9	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
during	O
HFOV	O
compared	O
to	O
lung	O
injury	O
and	O
PCV	B-SPEC
.	O

TITLE	O
:	O
Recombinant	O
adeno	B-SPEC
-	I-SPEC
associated	I-SPEC
virus	I-SPEC
expressing	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
S	O
protein	O
elicits	O
neutralizing	O
antibodies	O
:	O
Implication	O
for	O
developing	O
SARS	O
vaccines	O
.	O

This	O
is	O
the	O
first	O
report	O
describing	O
the	O
induction	O
of	O
apoptosis	O
by	O
SARS	O
-	O
CoV	O
M	O
protein	O
in	O
animal	B-SPEC
cells	O
and	O
possible	O
implications	O
are	O
discussed	O
.	O

All	O
10	O
CoV	O
HKU1	O
strains	O
with	O
incomplete	O
imperfect	O
repeats	O
(	O
1	O
.	O
4	O
and	O
4	O
.	O
4	O
)	O
belonged	O
to	O
genotype	O
A	O
.	O
The	O
present	O
study	O
represents	O
the	O
first	O
evidence	O
for	O
natural	O
recombination	O
in	O
coronavirus	B-SPEC
associated	O
with	O
human	B-SPEC
infection	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
E	O
protein	O
from	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
forms	O
cation	O
-	O
selective	O
ion	O
channels	O
in	O
planar	O
lipid	O
bilayers	O
(	O
Wilson	O
,	O
L	O
.,	O
McKinlay	O
,	O
C	O
.,	O
Gage	O
,	O
P	O
.,	O
Ewart	O
,	O
G	O
.,	O
2004	O
.	O

TITLE	O
:	O
Pathogenic	O
role	O
for	O
virus	B-SPEC
-	O
specific	O
CD4	O
T	O
cells	O
in	O
mice	B-SPEC
with	O
coronavirus	B-SPEC
-	O
induced	O
acute	O
encephalitis	O
.	O

ABSTRACT	O
:	O
Acute	O
viral	O
encephalitis	O
is	O
believed	O
to	O
result	O
from	O
direct	O
virus	B-SPEC
destruction	O
of	O
infected	O
cells	O
and	O
from	O
virus	B-SPEC
-	O
induced	O
host	O
immune	O
response	O
,	O
but	O
the	O
relative	O
contribution	O
of	O
each	O
remains	O
largely	O
unknown	O
.	O

SARS	O
-	O
CoV	O
,	O
reovirus	B-SPEC
and	O
poliovirus	B-SPEC
RNA	O
was	O
detected	O
by	O
using	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
;	O
IgG	O
antibody	O
to	O
the	O
poliovirus	B-SPEC
type	O
1	O
and	O
3	O
and	O
the	O
antibody	O
to	O
SARS	O
-	O
CoV	O
were	O
determined	O
using	O
enzyme	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
influence	O
of	O
ambroxol	O
on	O
paraquat	O
poisoning	O
induced	O
acute	O
lung	O
tissue	O
injury	O
and	O
the	O
change	O
of	O
pulmonary	O
surfactant	O
associated	O
protein	O
A	O
in	O
the	O
experimental	O
rats	B-SPEC
.	O

The	O
indexes	O
were	O
observed	O
among	O
the	O
three	O
groups	O
comprising	O
the	O
mortality	O
rate	O
,	O
the	O
change	O
of	O
arterial	O
blood	O
PaCO	O
(	O
2	O
)	O
and	O
PaO	O
(	O
2	O
),	O
the	O
ratio	O
of	O
wet	O
to	O
dry	O
lung	O
tissue	O
(	O
W	O
/	O
D	O
),	O
the	O
change	O
of	O
the	O
lung	O
tissue	O
under	O
light	O
and	O
electric	O
microscope	O
respectively	O
,	O
and	O
the	O
expression	O
of	O
pulmonary	O
surfactant	O
associated	O
protein	O
A	O
.	O
The	O
mortality	O
rate	O
of	O
rats	B-SPEC
in	O
the	O
PQ	O
group	O
was	O
50	O
.	O
0	O
%	O
on	O
the	O
seventh	O
day	O
while	O
the	O
mortality	O
rate	O
in	O
the	O
AT	O
group	O
was	O
25	O
.	O
0	O
%.	O

RESULTS	O
:	O
The	O
mortality	O
rate	O
of	O
rats	B-SPEC
in	O
the	O
PQ	O
group	O
was	O
50	O
.	O
0	O
%	O
on	O
the	O
seventh	O
day	O
while	O
the	O
mortality	O
rate	O
in	O
the	O
AT	O
group	O
was	O
25	O
.	O
0	O
%.	O

Two	O
dogs	B-SPEC
were	O
found	O
to	O
be	O
positive	O
.	O

Capacity	O
issues	O
should	O
be	O
addressed	O
as	O
part	O
of	O
a	O
larger	O
human	B-SPEC
resources	O
initiative	O
to	O
create	O
a	O
more	O
flexible	O
workforce	O
.	O

TITLE	O
:	O
The	O
non	O
-	O
structural	O
protein	O
Nsp10	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
binds	O
zinc	O
ions	O
and	O
nucleic	O
acids	O
.	O

At	O
the	O
same	O
time	O
,	O
however	O
,	O
countries	O
are	O
increasingly	O
seeking	O
to	O
collaborate	O
internationally	O
in	O
infectious	O
disease	O
surveillance	O
and	O
response	O
,	O
as	O
shown	O
in	O
the	O
current	O
situation	O
of	O
avian	B-SPEC
influenza	O
(	O
H5N1	O
),	O
and	O
in	O
the	O
formal	O
agreement	O
leading	O
to	O
the	O
revised	O
International	O
Health	O
Regulations	O
(	O
IHR	O
),	O
suggesting	O
that	O
a	O
new	O
world	O
order	B-SPEC
prevails	O
over	O
issues	O
that	O
once	O
had	O
been	O
considered	O
the	O
sole	O
domain	O
of	O
a	O
sovereign	O
nation	O
.	O

Finally	O
,	O
the	O
article	O
also	O
looks	O
at	O
some	O
of	O
the	O
post	O
-	O
SARS	O
enhancements	O
that	O
have	O
been	O
put	O
in	O
place	O
following	O
the	O
lessons	O
learnt	O
from	O
SARS	O
and	O
the	O
need	O
to	O
confront	O
new	O
infectious	O
outbreaks	O
like	O
avian	B-SPEC
flu	O
.	O

Subsequent	O
studies	O
in	O
animal	B-SPEC
models	O
demonstrated	O
the	O
efficacy	O
of	O
SARS	O
-	O
CoV	O
specific	O
monoclonal	O
antibodies	O
,	O
pegylated	O
-	O
interferon	O
-	O
alpha	O
and	O
siRNAs	O
against	O
SARS	O
-	O
CoV	O
.	O
Furthermore	O
,	O
several	O
antivirals	O
shown	O
to	O
be	O
effective	O
against	O
other	O
viruses	B-SPEC
were	O
tested	O
in	O
vitro	O
.	O

Full	O
genomes	O
of	O
four	O
coronavirues	O
from	O
bats	B-SPEC
were	O
sequenced	O
and	O
analyzed	O
.	O

Thus	O
,	O
the	O
findings	O
of	O
this	O
study	O
suggest	O
that	O
bats	B-SPEC
may	O
play	O
an	O
integral	O
role	O
in	O
the	O
ecology	O
and	O
evolution	O
of	O
coronaviruses	O
.	O

We	O
isolated	O
lungs	O
from	O
rats	B-SPEC
with	O
acute	O
pancreatitis	O
2	O
,	O
6	O
,	O
and	O
18h	O
after	O
taurocholic	O
acid	O
injection	O
in	O
the	O
biliopancreatic	O
duct	O
and	O
perfused	O
them	O
with	O
blood	O
collected	O
from	O
the	O
same	O
rats	B-SPEC
.	O

We	O
analyzed	O
pulmonary	O
surfactant	O
composition	O
and	O
function	O
in	O
bronchoalveolar	O
lavage	O
fluid	O
(	O
BALF	O
)	O
from	O
ventilated	O
and	O
spontaneously	O
breathing	O
HIV	B-SPEC
-	O
positive	O
patients	O
with	O
PCP	O
.	O

TITLE	O
:	O
Effects	O
of	O
enteral	O
feeding	O
with	O
eicosapentaenoic	O
acid	O
,	O
gamma	O
-	O
linolenic	O
acid	O
,	O
and	O
antioxidants	O
in	O
mechanically	O
ventilated	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
identify	O
respiratory	O
viruses	B-SPEC
that	O
affected	O
children	O
younger	O
than	O
five	O
years	O
old	O
in	O
Uberlndia	O
,	O
Midwestern	O
Brazil	O
.	O

Negative	O
samples	O
by	O
both	O
IFA	O
and	O
RT	O
-	O
PCR	O
might	O
reflect	O
the	O
presence	O
of	O
other	O
pathogens	O
,	O
such	O
as	O
hMPV	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
bacteria	B-SPEC
.	O

Laboratorial	O
diagnosis	O
constituted	O
an	O
essential	O
instrument	O
to	O
determine	O
the	O
incidence	O
of	O
the	O
most	O
common	O
viruses	B-SPEC
in	O
respiratory	O
infections	O
among	O
children	O
in	O
this	O
region	O
.	O

Seroprevalence	O
was	O
very	O
high	O
for	O
IBV	B-SPEC
(	O
84	O
%);	O
intermediate	O
for	O
reovirus	B-SPEC
(	O
41	O
%),	O
APV	O
(	O
40	O
%),	O
and	O
ILTV	B-SPEC
(	O
20	O
%);	O
and	O
very	O
low	O
for	O
ALV	B-SPEC
(<	O
5	O
%)	O
antibodies	O
.	O

By	O
in	O
situ	O
hybridization	O
,	O
the	O
IBV	B-SPEC
Nc	O
gene	O
was	O
more	O
consistently	O
detected	O
in	O
the	O
trachea	B-SPEC
at	O
early	O
stages	O
of	O
infection	O
(	O
7	O
,	O
14	O
,	O
and	O
21	O
days	O
)	O
and	O
in	O
the	O
cecal	O
tonsils	O
at	O
late	O
stages	O
of	O
infection	O
(	O
21	O
,	O
28	O
,	O
and	O
35	O
days	O
).	O

Only	O
5	O
cases	O
were	O
involved	O
in	O
SSEs	O
;	O
all	O
5	O
were	O
isolated	O
on	O
day	O
5	O
of	O
illness	O
or	O
later	O
,	O
and	O
spent	O
at	O
least	O
a	O
brief	O
period	O
in	O
a	O
non	O
-	O
isolation	O
ward	O
;	O
in	O
contrast	O
,	O
amongst	O
the	O
226	O
non	O
-	O
SSE	O
cases	O
,	O
only	O
40	O
.	O
7	O
%	O
and	O
4	O
.	O
0	O
%	O
were	O
isolated	O
late	O
and	O
admitted	O
to	O
non	O
-	O
isolation	O
wards	O
respectively	O
,	O
and	O
only	O
3	O
.	O
1	O
%	O
had	O
both	O
these	O
environmental	O
features	O
present	O
;	O
the	O
differences	O
were	O
highly	O
significant	O
(	O
P	O
=	O
0	O
.	O
012	O
,	O
P	O
<	O
0	O
.	O
001	O
and	O
P	O
<	O
0	O
.	O
001	O
by	O
Fisher	B-SPEC
'	O
s	O
Exact	O
test	O
).	O

Moreover	O
,	O
women	O
with	O
PMS	O
might	O
eliminate	O
sweet	O
-	O
tasting	O
food	O
and	O
caffeine	O
-	O
containing	O
beverages	O
,	O
particularly	O
coffee	B-SPEC
,	O
from	O
their	O
diet	O
.	O

Serum	O
samples	O
also	O
were	O
tested	O
,	O
by	O
Western	O
blot	O
and	O
ELISA	O
,	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	O
)	O
specific	O
antibodies	O
and	O
antigen	O
,	O
respectively	O
,	O
by	O
Western	O
blot	O
for	O
antibodies	O
to	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
FIV	B-SPEC
),	O
and	O
by	O
indirect	O
ELISA	O
for	O
antibodies	O
to	O
puma	B-SPEC
lentivirus	I-SPEC
(	O
PLV	O
).	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
isolated	O
from	O
humans	B-SPEC
infected	O
during	O
the	O
peak	O
of	O
epidemic	O
,	O
encodes	O
two	O
accessory	O
proteins	O
termed	O
as	O
8a	O
and	O
8b	O
.	O

Interestingly	O
,	O
the	O
SARS	O
-	O
CoV	O
isolated	O
from	O
animals	B-SPEC
contains	O
an	O
extra	O
29	O
-	O
nucleotide	O
in	O
this	O
region	O
such	O
that	O
these	O
proteins	O
are	O
fused	O
to	O
become	O
a	O
single	O
protein	O
,	O
8ab	O
.	O

Our	O
objective	O
was	O
to	O
investigate	O
the	O
plasma	O
levels	O
of	O
brain	O
and	O
atrial	O
natriuretic	O
peptides	O
(	O
BNP	O
and	O
ANP	O
,	O
respectively	O
)	O
in	O
patients	O
with	O
septic	O
shock	O
/	O
severe	O
sepsis	B-SPEC
and	O
to	O
study	O
the	O
association	O
of	O
BNP	O
and	O
ANP	O
levels	O
with	O
hemodynamic	O
parameters	O
,	O
severity	O
of	O
the	O
disease	O
,	O
and	O
prognosis	O
of	O
those	O
patients	O
.	O

NM	O
calves	O
had	O
a	O
high	O
geometric	O
mean	O
titer	O
for	O
BCV	B-SPEC
antibody	O
at	O
arrival	O
(	O
GMT	O
,	O
1	O
,	O
928	O
);	O
only	O
2	O
%	O
shed	O
BCV	B-SPEC
in	O
nasal	O
secretions	O
and	O
1	O
%	O
in	O
feces	O
.	O

Vaccination	O
of	O
calves	O
against	O
BCV	B-SPEC
before	O
shipping	O
to	O
feedlots	O
may	O
provide	O
protection	O
against	O
BCV	B-SPEC
infection	O
and	O
its	O
effects	O
with	O
other	O
pathogens	O
in	O
the	O
induction	O
of	O
respiratory	O
tract	O
disease	O
.	O

Bovine	B-SPEC
coronavirus	B-SPEC
infection	O
was	O
significantly	O
associated	O
with	O
respiratory	O
tract	O
disease	O
and	O
decreased	O
growth	O
performance	O
in	O
AR	O
calves	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	O
structure	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp15	O
at	O
2	O
.	O
6	O
-	O
A	O
resolution	O
.	O

The	O
possible	O
need	O
for	O
oxygen	O
supplementation	O
during	O
these	O
procedures	O
was	O
anticipated	O
because	O
of	O
the	O
size	O
of	O
the	O
animals	B-SPEC
relative	O
to	O
the	O
5	O
-	O
mm	O
bronchoscope	O
.	O

Predictors	O
of	O
influenza	B-SPEC
virus	I-SPEC
infection	O
during	O
the	O
influenza	O
season	O
have	O
previously	O
been	O
evaluated	O
in	O
adult	O
studies	O
of	O
the	O
antiviral	O
agent	O
zanamivir	O
;	O
cough	O
and	O
temperature	O
>	O
or	O
=	O
37	O
.	O
8	O
degrees	O
C	O
predicted	O
influenza	B-SPEC
virus	I-SPEC
positivity	O
in	O
79	O
%	O
of	O
those	O
evaluated	O
.	O

The	O
results	O
of	O
these	O
studies	O
suggest	O
that	O
,	O
during	O
the	O
influenza	O
season	O
,	O
symptomatic	O
predictors	O
of	O
influenza	B-SPEC
virus	I-SPEC
infection	O
are	O
applicable	O
to	O
identification	O
of	O
cases	O
in	O
children	O
,	O
although	O
confirmation	O
of	O
predictive	O
values	O
in	O
subjects	O
1	O
-	O
4	O
years	O
of	O
age	O
may	O
require	O
further	O
study	O
of	O
additional	O
signs	O
/	O
symptoms	O
.	O

These	O
two	O
protozoa	O
were	O
detected	O
together	O
in	O
4	O
animals	B-SPEC
upon	O
faeces	O
examination	O
.	O

Coronavirus	B-SPEC
was	O
detected	O
immunohistochemically	O
in	O
one	O
kid	O
with	O
neonatal	O
enteritis	O
.	O

Although	O
viable	O
viruses	B-SPEC
could	O
readily	O
be	O
isolated	O
from	O
WT	O
and	O
recombinant	O
genomes	O
containing	O
homogeneous	O
transcription	O
circuits	O
,	O
chimeras	O
that	O
contained	O
mixed	O
regulatory	O
networks	O
were	O
invariantly	O
lethal	O
,	O
because	O
viable	O
chimeric	O
viruses	B-SPEC
were	O
not	O
isolated	O
.	O

In	O
addition	O
,	O
the	O
samples	O
were	O
subjected	O
to	O
S	O
gene	O
typing	O
,	O
using	O
primers	O
that	O
differentiated	O
between	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
fcov	O
)	O
types	O
I	O
and	O
II	O
.	O

This	O
information	O
could	O
be	O
useful	O
for	O
the	O
extraction	O
of	O
other	O
RNA	O
viruses	B-SPEC
from	O
stool	O
samples	O
and	O
demonstrates	O
the	O
need	O
to	O
evaluate	O
extraction	O
methods	O
for	O
different	O
specimen	O
types	O
.	O

In	O
order	B-SPEC
to	O
determine	O
the	O
knowledge	O
of	O
these	O
clinicians	O
,	O
a	O
survey	O
of	O
their	O
understanding	O
of	O
SARS	O
and	O
their	O
use	O
of	O
educational	O
resources	O
was	O
administered	O
.	O

Review	O
of	O
the	O
timeline	O
that	O
has	O
been	O
created	O
for	O
the	O
evolution	O
of	O
HIV	B-SPEC
in	O
humans	B-SPEC
is	O
also	O
shown	O
to	O
be	O
qualitatively	O
and	O
quantitatively	O
consistent	O
with	O
this	O
hypothesis	O
(	O
and	O
not	O
with	O
either	O
version	O
of	O
the	O
conventional	O
hypothesis	O
).	O

TITLE	O
:	O
Recent	O
animal	B-SPEC
disease	O
outbreaks	O
and	O
their	O
impact	O
on	O
human	B-SPEC
populations	O
.	O

Recent	O
examples	O
include	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
avian	B-SPEC
influenza	O
,	O
and	O
monkeypox	O
.	O

The	O
putative	O
ion	O
channel	O
activity	O
of	O
this	O
protein	O
was	O
assessed	O
in	O
3a	O
-	O
complement	O
RNA	O
-	O
injected	O
Xenopus	B-SPEC
oocytes	O
by	O
two	O
-	O
electrode	O
voltage	O
clamp	O
.	O

TITLE	O
:	O
Coronaviruses	O
in	O
bent	O
-	O
winged	O
bats	B-SPEC
(	O
Miniopterus	B-SPEC
spp	O
.).	O

In	O
contrast	O
to	O
BS	O
-	O
IQFSs	O
,	O
the	O
RS	O
-	O
IQFS	O
was	O
not	O
susceptible	O
to	O
fluorescence	O
interference	O
from	O
coloured	O
samples	O
and	O
allowed	O
for	O
successful	O
screening	O
of	O
marine	O
natural	O
products	O
and	O
identification	O
of	O
a	O
coumarin	O
derivative	O
,	O
esculetin	O
-	O
4	O
-	O
carboxylic	O
acid	O
ethyl	O
ester	O
,	O
a	O
novel	O
3CLpro	O
inhibitor	O
(	O
IC50	O
=	O
46	O
microM	O
)	O
and	O
anti	O
-	O
SARS	O
agent	O
(	O
EC50	O
=	O
112	O
microM	O
;	O
median	O
toxic	O
concentration	O
>	O
800	O
microM	O
)	O
from	O
the	O
tropical	O
marine	O
sponge	B-SPEC
Axinella	B-SPEC
corrugata	I-SPEC
.	O

The	O
conserved	O
structural	O
determinants	O
of	O
this	O
site	O
may	O
provide	O
a	O
framework	O
for	O
attempting	O
to	O
design	O
antiviral	O
drugs	O
to	O
interfere	O
with	O
the	O
infectious	O
nidovirus	B-SPEC
life	O
cycle	O
.	O

TITLE	O
:	O
Adrenal	O
insufficiency	O
in	O
severe	O
West	B-SPEC
Nile	I-SPEC
Virus	I-SPEC
infection	O
.	O

Independent	O
of	O
line	O
of	O
chicken	B-SPEC
,	O
the	O
percentage	O
dam	O
-	O
to	O
-	O
chick	O
(	O
3	O
d	O
)	O
plasma	O
transfer	O
of	O
IgY	O
was	O
estimated	O
to	O
be	O
approximately	O
30	O
%,	O
with	O
that	O
for	O
IgM	O
and	O
IgA	O
less	O
than	O
1	O
%.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
protein	O
(	O
NP	O
)	O
is	O
one	O
of	O
the	O
predominant	O
antigenic	O
protein	O
and	O
the	O
most	O
abundant	O
shed	O
antigen	O
throughout	O
the	O
SARS	O
-	O
CoV	O
infection	O
.	O

We	O
found	O
that	O
the	O
expression	O
of	O
Egr	O
-	O
1	O
was	O
dramatically	O
increased	O
following	O
virus	B-SPEC
infection	O
.	O

However	O
,	O
therapies	O
aimed	O
at	O
the	O
inflammatory	O
cascade	O
in	O
sepsis	B-SPEC
have	O
been	O
unsuccessful	O
.	O

In	O
fact	O
,	O
the	O
first	O
therapy	O
to	O
reduce	O
mortality	O
in	O
sepsis	B-SPEC
modulates	O
the	O
coagulation	O
cascade	O
.	O

This	O
review	O
summarizes	O
the	O
current	O
understanding	O
of	O
the	O
role	O
of	O
coagulation	O
and	O
fibrinolytic	O
abnormalities	O
in	O
sepsis	B-SPEC
and	O
the	O
development	O
of	O
ALI	O
and	O
ARDS	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	O
studies	O
of	O
the	O
role	O
of	O
the	O
coagulation	O
cascade	O
in	O
sepsis	B-SPEC
and	O
lung	O
injury	O
will	O
be	O
discussed	O
,	O
including	O
initiation	O
of	O
coagulation	O
through	O
modulation	O
of	O
tissue	O
factor	O
and	O
tissue	O
factor	O
pathway	O
inhibitor	O
,	O
propagation	O
of	O
coagulation	O
via	O
protein	O
C	O
and	O
thrombomodulin	O
,	O
inhibition	O
of	O
thrombin	O
generation	O
and	O
resolution	O
through	O
thrombolysis	O
by	O
plasminogen	O
activator	O
,	O
and	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
.	O

Based	O
on	O
extensive	O
in	O
vitro	O
data	O
as	O
well	O
as	O
in	O
vivo	O
animal	B-SPEC
studies	O
demonstrating	O
the	O
anti	O
-	O
inflammatory	O
and	O
antibacterial	O
functions	O
of	O
various	O
surfactant	O
components	O
,	O
administration	O
of	O
surfactant	O
earlier	O
in	O
the	O
course	O
of	O
the	O
disease	O
,	O
when	O
lung	O
inflammation	O
is	O
present	O
but	O
before	O
severe	O
lung	O
dysfunction	O
occurs	O
,	O
may	O
prove	O
to	O
be	O
optimal	O
.	O

Here	O
,	O
we	O
characterized	O
the	O
macro	O
domains	O
from	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
,	O
Semliki	B-SPEC
Forest	I-SPEC
virus	I-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Highly	O
conserved	O
regions	O
within	O
the	O
spike	O
proteins	O
of	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
NL63	O
determine	O
recognition	O
of	O
their	O
respective	O
cellular	O
receptors	O
.	O

Moreover	O
,	O
we	O
observed	O
that	O
NL63	O
-	O
S	O
-	O
driven	O
entry	O
was	O
less	O
dependent	O
on	O
a	O
low	O
-	O
pH	O
environment	O
and	O
activity	O
of	O
endosomal	O
proteases	O
compared	O
to	O
infection	O
mediated	O
by	O
SARS	O
-	O
S	O
,	O
further	O
suggesting	O
differences	O
in	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
SARS	O
-	O
CoV	O
cellular	O
entry	O
.	O

(	O
including	O
VRE	O
),	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
including	O
MRSA	O
),	O
or	O
Streptococcus	B-SPEC
pyogenes	I-SPEC
,	O
survive	O
for	O
months	O
on	O
dry	O
surfaces	O
.	O

Mycobacteria	B-SPEC
,	O
including	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
,	O
and	O
spore	O
-	O
forming	O
bacteria	B-SPEC
,	O
including	O
Clostridium	B-SPEC
difficile	I-SPEC
,	O
can	O
also	O
survive	O
for	O
months	O
on	O
surfaces	O
.	O

During	O
the	O
epidemic	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
2003	O
,	O
PCR	O
not	O
only	O
offered	O
a	O
rapid	O
way	O
to	O
diagnose	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
,	O
but	O
also	O
made	O
the	O
molecular	O
analysis	O
of	O
its	O
genomic	O
sequence	O
possible	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
induced	O
by	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
virus	B-SPEC
in	O
mice	B-SPEC
.	O

A	O
chimera	O
containing	O
the	O
SCoV	O
5	O
'	O
UTR	O
in	O
which	O
the	O
SCoV	O
TRS	O
was	O
replaced	O
with	O
the	O
MHV	B-SPEC
TRS	O
was	O
also	O
not	O
viable	O
.	O

A	O
similar	O
phenotype	O
was	O
obtained	O
with	O
the	O
MHV	B-SPEC
/	O
SCoV	O
SL3	O
chimera	O
.	O

ABSTRACT	O
:	O
A	O
30	O
-	O
year	O
old	O
man	B-SPEC
was	O
admitted	O
to	O
our	O
hospital	O
with	O
cough	O
,	O
slight	O
fever	O
,	O
and	O
dyspnea	O
that	O
he	O
had	O
developed	O
several	O
hours	O
after	O
inhaling	O
the	O
fumes	O
produced	O
from	O
a	O
Teflon	O
-	O
coated	O
pan	B-SPEC
,	O
after	O
evaporation	O
of	O
the	O
water	O
in	O
the	O
pan	B-SPEC
.	O

Finally	O
,	O
we	O
performed	O
a	O
challenge	O
study	O
with	O
Cal99	O
and	O
demonstrated	O
that	O
the	O
virus	B-SPEC
causes	O
late	O
-	O
onset	O
respiratory	O
disease	O
,	O
with	O
a	O
severity	O
comparable	O
to	O
that	O
of	O
the	O
M41	O
IBV	B-SPEC
challenge	O
strain	O
.	O

Several	O
mechanisms	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
virus	B-SPEC
-	O
related	O
nephropathy	O
,	O
including	O
tropism	O
of	O
the	O
virus	B-SPEC
in	O
the	O
kidney	O
,	O
induction	O
of	O
abnormal	O
immune	O
complexes	O
,	O
direct	O
cytopathogenic	O
effects	O
,	O
and	O
multiorgan	O
failure	O
.	O

Infection	O
with	O
HIV	B-SPEC
is	O
associated	O
with	O
a	O
collapsing	O
focal	O
segmental	O
glomerulosclerosis	O
,	O
a	O
distinctive	O
disease	O
that	O
affects	O
mainly	O
Africans	O
and	O
African	O
Americans	O
.	O

The	O
assay	O
amplifies	O
a	O
143	O
-	O
bp	O
product	O
in	O
the	O
5	O
'-	O
UTR	O
of	O
the	O
IBV	B-SPEC
genome	O
and	O
has	O
a	O
limit	O
of	O
detection	O
and	O
quantification	O
of	O
100	O
template	O
copies	O
per	O
reaction	O
.	O

We	O
also	O
collected	O
a	O
total	O
of	O
120	O
tracheal	O
swabs	O
at	O
six	O
different	O
time	O
points	O
from	O
birds	B-SPEC
experimentally	O
infected	O
with	O
different	O
dosages	O
of	O
IBV	B-SPEC
and	O
found	O
that	O
,	O
independent	O
of	O
the	O
dose	O
given	O
,	O
the	O
viral	O
load	O
in	O
the	O
trachea	B-SPEC
plateau	O
at	O
5	O
days	O
post	O
-	O
inoculation	O
.	O

Finally	O
,	O
we	O
tested	O
300	O
total	O
tracheal	O
swab	O
samples	O
,	O
from	O
a	O
flock	O
of	O
commercial	O
broilers	O
spray	O
vaccinated	O
for	O
IBV	B-SPEC
in	O
the	O
field	O
.	O

Group	O
1	O
antibodies	O
recognized	O
epitopes	O
located	O
slightly	O
differently	O
in	O
N	O
from	O
those	O
of	O
group	O
2	O
antibodies	O
,	O
and	O
a	O
mouse	B-SPEC
hybridoma	O
antibody	O
resembling	O
the	O
former	O
type	O
was	O
generated	O
.	O

The	O
extremely	O
low	O
rate	O
(	O
0	O
.	O
008	O
%)	O
of	O
asymptomatic	O
SARS	O
infection	O
found	O
attests	O
to	O
the	O
high	O
virulence	O
of	O
the	O
SARS	O
-	O
CoV	O
virus	B-SPEC
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
uses	O
ER	O
as	O
a	O
site	O
for	O
synthesis	O
and	O
processing	O
of	O
viral	O
proteins	O
.	O

ABSTRACT	O
:	O
In	O
China	O
,	O
close	O
contacts	O
between	O
humans	B-SPEC
and	O
food	O
animals	B-SPEC
have	O
resulted	O
in	O
the	O
transmission	O
of	O
many	O
microbes	O
from	O
animals	B-SPEC
to	O
humans	B-SPEC
.	O

An	O
astonishing	O
diversity	O
of	O
coronaviruses	O
was	O
also	O
discovered	O
in	O
different	O
species	B-SPEC
of	O
bats	B-SPEC
.	O

In	O
addition	O
,	O
the	O
assay	O
exhibited	O
a	O
high	O
sensitivity	O
and	O
specificity	O
on	O
clinical	O
samples	O
from	O
different	O
animal	B-SPEC
species	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
SARS	O
-	O
CoV	O
N	O
)	O
protein	O
has	O
been	O
found	O
to	O
be	O
important	O
to	O
the	O
processes	O
related	O
to	O
viral	O
pathogenesis	O
,	O
such	O
as	O
virus	B-SPEC
replication	O
,	O
interference	O
of	O
the	O
cell	O
process	O
and	O
modulation	O
of	O
host	O
immune	O
response	O
;	O
detection	O
of	O
the	O
antigen	O
has	O
been	O
used	O
for	O
the	O
early	O
diagnosis	O
of	O
infection	O
.	O

These	O
mAbs	O
were	O
found	O
to	O
have	O
significant	O
reactivity	O
with	O
both	O
non	O
-	O
phosphorylated	O
and	O
phosphorylated	O
N	O
proteins	O
,	O
which	O
resulted	O
in	O
high	O
reactivity	O
with	O
native	O
N	O
protein	O
in	O
virus	B-SPEC
-	O
infected	O
cells	O
;	O
however	O
,	O
they	O
did	O
not	O
show	O
cross	O
-	O
reactivity	O
with	O
human	B-SPEC
coronavirus	I-SPEC
.	O

TITLE	O
:	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
stool	O
specimens	O
by	O
commercially	O
available	O
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
assays	O
.	O

This	O
is	O
particularly	O
true	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
(	O
WNV	B-SPEC
)	O
disease	O
,	O
Toscana	O
virus	B-SPEC
(	O
TOSV	O
)	O
disease	O
,	O
and	O
potentially	O
for	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
H5N1	O
).	O

The	O
residual	O
coliform	O
,	O
bacteria	B-SPEC
and	O
trihalomethanes	O
,	O
haloacetic	O
acids	O
were	O
determined	O
after	O
disinfection	O
.	O

Chlorine	O
disinfection	O
seems	O
to	O
be	O
the	O
best	O
available	O
technology	O
for	O
coliform	O
and	O
bacteria	B-SPEC
inactivation	O
.	O

Diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
or	O
avian	B-SPEC
influenza	O
have	O
not	O
been	O
reported	O
among	O
international	O
adoptees	O
,	O
but	O
transmission	O
is	O
possible	O
if	O
infection	O
is	O
present	O
.	O

Family	B-SPEC
members	O
may	O
be	O
infected	O
by	O
others	O
during	O
travel	O
or	O
by	O
their	O
adopted	O
child	O
after	O
returning	O
home	O
.	O

Following	O
agroinfiltration	O
of	O
tobacco	B-SPEC
leaves	O
,	O
analysis	O
by	O
laser	B-SPEC
confocal	O
scanning	O
microscopy	O
revealed	O
that	O
the	O
S1	O
:	O
GFP	O
fusion	O
protein	O
was	O
localized	O
to	O
the	O
cytosol	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
coronavirus	B-SPEC
from	O
pigeons	B-SPEC
with	O
pancreatitis	O
.	O

50	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
embryonated	O
chicken	B-SPEC
eggs	O
,	O
30	O
White	O
Leghorn	O
SPF	O
chickens	B-SPEC
,	O
and	O
12	O
clinically	O
normal	O
pigeons	B-SPEC
.	O

The	O
complete	O
S	O
protein	O
(	O
1	O
,	O
167	O
amino	O
acids	O
)	O
was	O
compared	O
with	O
published	O
S	O
protein	O
sequences	O
of	O
other	O
avian	B-SPEC
and	O
mammalian	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
Structural	O
basis	O
of	O
neutralization	O
by	O
a	O
human	B-SPEC
anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
spike	O
protein	O
antibody	O
,	O
80R	O
.	O

We	O
further	O
show	O
that	O
the	O
RBD	O
of	O
S1	O
forms	O
dimers	O
via	O
an	O
extensive	O
interface	O
that	O
is	O
disrupted	O
in	O
receptor	O
-	O
and	O
antibody	O
-	O
bound	O
crystal	O
structures	O
,	O
and	O
we	O
propose	O
a	O
role	O
for	O
the	O
dimer	O
in	O
virus	B-SPEC
stability	O
and	O
infectivity	O
.	O

Biological	O
comparisons	O
between	O
the	O
9	O
BCoV	O
strains	O
isolated	O
in	O
this	O
study	O
and	O
the	O
10	O
previously	O
isolated	O
WD	O
-	O
BCoV	O
strains	O
revealed	O
that	O
there	O
was	O
no	O
receptor	O
-	O
destroying	O
enzyme	O
(	O
RDE	O
)	O
activity	O
against	O
mouse	B-SPEC
erythrocytes	O
in	O
the	O
9	O
BCoV	O
strains	O
but	O
the	O
10	O
WD	O
-	O
BCoV	O
strains	O
had	O
high	O
RDE	O
activity	O
.	O

Extended	O
-	O
host	O
-	O
range	O
variants	O
of	O
MHV	B-SPEC
strain	O
A59	O
were	O
previously	O
obtained	O
from	O
persistently	O
infected	O
cells	O
(	O
J	O
.	O
H	O
.	O
Schickli	O
,	O
B	O
.	O
D	O
.	O
Zelus	B-SPEC
,	O
D	O
.	O
E	O
.	O
Wentworth	O
,	O
S	O
.	O
G	O
.	O
Sawicki	O
,	O
and	O
K	O
.	O
V	O
.	O
Holmes	O
,	O
J	O
.	O
Virol	O
.	O

However	O
,	O
when	O
the	O
mutations	O
in	O
both	O
parts	O
of	O
the	O
S	O
protein	O
were	O
combined	O
,	O
the	O
resulting	O
viruses	B-SPEC
became	O
independent	O
of	O
CEACAM1a	O
and	O
acquired	O
the	O
extended	O
host	O
range	O
.	O

In	O
addition	O
,	O
these	O
viruses	B-SPEC
showed	O
a	O
decreased	O
binding	O
to	O
and	O
inhibition	O
by	O
soluble	O
CEACAM1a	O
.	O

However	O
,	O
overall	O
there	O
is	O
a	O
paucity	O
of	O
CEA	B-SPEC
literature	O
on	O
the	O
management	O
of	O
the	O
critically	O
ill	O
,	O
and	O
further	O
high	O
-	O
quality	O
CEA	B-SPEC
is	O
needed	O
.	O

RESULTS	O
:	O
We	O
identified	O
19	O
CEAs	O
published	O
through	O
2003	O
with	O
48	O
cost	O
-	O
effectiveness	O
ratios	O
pertaining	O
to	O
treatment	O
of	O
severe	O
sepsis	B-SPEC
,	O
acute	O
respiratory	O
failure	O
,	O
and	O
general	O
critical	O
care	O
interventions	O
.	O

Injection	O
of	O
either	O
killed	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
or	O
killed	O
pneumococci	O
resulted	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
death	O
in	O
pigs	B-SPEC
.	O

About	O
57	O
%	O
of	O
the	O
nurse	O
participants	O
indicated	O
that	O
they	O
were	O
willing	O
to	O
care	O
for	O
patients	O
infected	O
with	O
avian	B-SPEC
influenza	O
.	O

ABSTRACT	O
:	O
Health	O
-	O
care	O
workers	O
are	O
concerned	O
about	O
the	O
risk	O
of	O
acquiring	O
contagious	O
diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
after	O
recent	O
outbreaks	O
.	O

To	O
assess	O
this	O
risk	O
,	O
a	O
human	B-SPEC
lung	O
model	O
(	O
respiration	O
rate	O
,	O
12	O
breaths	O
/	O
min	O
)	O
was	O
designed	O
to	O
test	O
the	O
potential	O
for	O
a	O
simple	O
oxygen	O
mask	O
at	O
a	O
common	O
setting	O
(	O
4	O
L	O
/	O
min	O
)	O
to	O
disperse	O
potentially	O
infectious	O
exhaled	O
air	O
into	O
the	O
surrounding	O
area	O
.	O

ABSTRACT	O
:	O
The	O
domestic	O
or	O
European	O
ferret	B-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
)	O
has	O
been	O
domesticated	O
for	O
thousands	O
of	O
years	O
.	O

Ferrets	B-SPEC
have	O
been	O
used	O
for	O
hunting	O
and	O
fur	O
production	O
,	O
as	O
pets	O
,	O
and	O
as	O
models	O
in	O
biomedical	O
research	O
.	O

Despite	O
the	O
relatively	O
small	O
numbers	O
used	O
in	O
the	O
laboratory	O
,	O
ferrets	B-SPEC
have	O
some	O
unique	O
applications	O
including	O
study	O
of	O
human	B-SPEC
influenza	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
corona	B-SPEC
virus	B-SPEC
.	O

Due	O
to	O
the	O
small	O
number	O
of	O
ferret	B-SPEC
suppliers	O
,	O
animals	B-SPEC
are	O
often	O
shipped	O
long	O
distances	O
,	O
requiring	O
air	O
transport	O
and	O
intermediate	O
handlers	O
.	O

The	O
animals	B-SPEC
have	O
specific	O
dietary	O
requirements	O
,	O
and	O
proper	O
nutrition	O
is	O
key	O
.	O

Successful	O
housing	O
requires	O
knowledge	O
of	O
ferret	B-SPEC
behaviors	O
including	O
social	O
behavior	O
,	O
eating	O
habits	O
,	O
a	O
general	O
inquisitive	O
nature	O
,	O
and	O
a	O
species	B-SPEC
-	O
typical	O
need	O
to	O
burrow	O
and	O
hide	O
.	O

ABSTRACT	O
:	O
The	O
genome	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
encodes	O
for	O
eight	O
accessory	O
viral	O
proteins	O
with	O
no	O
known	O
homologues	O
in	O
other	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
that	O
translate	O
their	O
genome	O
RNA	O
into	O
polyproteins	O
that	O
are	O
co	O
-	O
and	O
posttranslationally	O
processed	O
into	O
intermediate	O
and	O
mature	O
replicase	O
nonstructural	O
proteins	O
(	O
nsps	O
).	O

However	O
,	O
when	O
both	O
CS1	O
and	O
CS2	O
were	O
deleted	O
in	O
the	O
presence	O
of	O
inactivated	O
PLP1	O
,	O
the	O
growth	O
of	O
the	O
resulting	O
mutant	O
virus	B-SPEC
was	O
partially	O
compensated	O
,	O
comparable	O
to	O
that	O
of	O
the	O
CS1	O
and	O
CS2	O
deletion	O
mutant	O
.	O

After	O
challenge	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
no	O
diarrhea	O
or	O
virus	B-SPEC
shedding	O
was	O
detected	O
in	O
calves	O
inoculated	O
with	O
HECV	O
-	O
4408	O
,	O
but	O
a	O
mock	O
-	O
inoculated	O
calf	O
developed	O
diarrhea	O
and	O
fecal	O
and	O
nasal	O
shedding	O
.	O

Therefore	O
,	O
we	O
investigated	O
whether	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
N	O
protein	O
was	O
an	O
RNA	O
chaperone	O
.	O

The	O
recovered	O
mutant	O
virus	B-SPEC
showed	O
much	O
smaller	O
-	O
sized	O
plaques	O
.	O

The	O
current	O
work	O
evaluates	O
the	O
correlations	O
(	O
and	O
classifications	O
)	O
between	O
facial	O
skin	O
temperatures	O
,	O
including	O
eye	O
range	O
and	O
forehead	O
,	O
to	O
aural	O
temperature	O
using	O
a	O
neural	O
network	O
(	O
NN	O
)	O
approach	O
,	O
namely	O
training	O
backpropagation	O
(	O
BP	O
)	O
and	O
Kohonen	O
self	O
-	O
organizing	O
map	O
(	O
SOM	O
),	O
to	O
confirm	O
the	O
suitability	O
of	O
thermal	O
imagers	O
for	O
human	B-SPEC
temperature	O
screening	O
.	O

This	O
is	O
true	O
not	O
only	O
for	O
SARS	O
but	O
also	O
during	O
other	O
public	O
health	O
crises	O
where	O
widespread	O
transmission	O
of	O
infection	O
such	O
as	O
the	O
danger	O
of	O
avian	B-SPEC
flu	O
pandemic	O
is	O
a	O
concern	O
,	O
in	O
particular	O
at	O
places	O
like	O
hospitals	O
and	O
cross	O
-	O
border	O
checkpoints	O
.	O

The	O
recently	O
discovered	O
HCoVs	O
NL63	O
and	O
HKU1	O
contribute	O
significantly	O
to	O
the	O
overall	O
spectrum	O
of	O
coronavirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
This	O
study	O
demonstrates	O
a	O
unique	O
and	O
crucial	O
role	O
of	O
plasmacytoid	O
dendritic	O
cells	O
(	O
pDCs	O
)	O
and	O
pDC	O
-	O
derived	O
type	O
I	O
interferons	O
(	O
IFNs	O
)	O
in	O
the	O
pathogenesis	O
of	O
mouse	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

Recognition	O
of	O
MHV	B-SPEC
by	O
pDCs	O
was	O
mediated	O
via	O
TLR7	O
ensuring	O
a	O
swift	B-SPEC
IFN	O
-	O
alpha	O
production	O
following	O
encounter	O
with	O
this	O
cytopathic	O
RNA	O
virus	B-SPEC
.	O

IBV	B-SPEC
is	O
endemic	O
in	O
probably	O
all	O
countries	O
that	O
raise	O
chickens	B-SPEC
.	O

Only	O
a	O
few	O
amino	O
acid	O
differences	O
in	O
the	O
S1	O
protein	O
of	O
vaccine	O
and	O
challenge	O
strains	O
of	O
IBV	B-SPEC
may	O
result	O
in	O
poor	O
protection	O
.	O

CONCLUSIONS	O
:	O
Periodical	O
evaluation	O
of	O
cross	O
-	O
protective	O
capabilities	O
of	O
IBV	B-SPEC
vaccine	O
(	O
s	O
)	O
versus	O
recently	O
recovered	O
field	O
isolates	O
should	O
be	O
performed	O
to	O
ensure	O
optimum	O
control	O
of	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
Previous	O
reports	O
suggest	O
that	O
type	O
I	O
and	O
type	O
II	O
Interferon	O
can	O
co	O
-	O
operatively	O
inhibit	O
some	O
virus	B-SPEC
replication	O
,	O
e	O
.	O
g	O
.	O
HCV	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
order	B-SPEC
Nidovirales	I-SPEC
comprises	O
viruses	B-SPEC
from	O
the	O
families	O
Coronaviridae	B-SPEC
(	O
genera	O
Coronavirus	B-SPEC
and	O
Torovirus	B-SPEC
),	O
Roniviridae	B-SPEC
(	O
genus	B-SPEC
Okavirus	I-SPEC
),	O
and	O
Arteriviridae	B-SPEC
(	O
genus	B-SPEC
Arterivirus	I-SPEC
).	O

Studies	O
of	O
the	O
pathogenesis	O
of	O
anthrax	B-SPEC
and	O
of	O
the	O
immune	O
responses	O
following	O
infection	O
and	O
immunization	O
underscore	O
the	O
pivotal	O
role	O
that	O
antibodies	O
to	O
the	O
protective	O
antigen	O
play	O
in	O
protection	O
.	O

In	O
this	O
study	O
,	O
high	O
titered	O
mouse	B-SPEC
antisera	O
against	O
the	O
N	O
-	O
terminal	O
globular	O
(	O
S1	O
)	O
and	O
S2	O
subunits	O
of	O
the	O
S	O
protein	O
were	O
generated	O
and	O
total	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
was	O
purified	O
from	O
these	O
antisera	O
.	O

The	O
unexpected	O
blocking	O
ability	O
of	O
anti	O
-	O
S2	O
IgG	O
towards	O
the	O
receptor	O
binding	O
implied	O
a	O
possible	O
role	O
of	O
the	O
S2	O
subunit	O
in	O
virus	B-SPEC
docking	O
process	O
and	O
argues	O
against	O
the	O
current	O
hypothesis	O
of	O
viral	O
entry	O
.	O

ABSTRACT	O
:	O
The	O
entire	O
S1	O
protein	O
genes	O
of	O
eight	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
vaccine	O
strains	O
used	O
in	O
China	O
were	O
compared	O
with	O
those	O
of	O
the	O
IB	O
virus	B-SPEC
isolates	O
present	O
in	O
the	O
field	O
in	O
China	O
.	O

The	O
modified	O
gene	O
was	O
cloned	O
into	O
a	O
yeast	B-SPEC
expression	O
vector	O
pPIC9K	O
.	O

ABSTRACT	O
:	O
Recently	O
Simmons	O
et	O
al	O
.	O
reported	O
a	O
new	O
mechanism	O
for	O
SARS	O
virus	B-SPEC
entry	O
into	O
target	O
cells	O
,	O
where	O
MDL28170	O
was	O
identified	O
as	O
an	O
efficient	O
inhibitor	O
of	O
CTSL	O
-	O
meditated	O
substrate	O
cleavage	O
with	O
IC	O
(	O
50	O
)	O
of	O
2	O
.	O
5	O
nmol	O
/	O
l	O
.	O

The	O
m	O
-	O
PCR	O
detected	O
124	O
viruses	B-SPEC
which	O
were	O
not	O
found	O
by	O
conventional	O
methods	O
:	O
68	O
rhinovirus	B-SPEC
,	O
17	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
15	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
8	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
),	O
5	O
coronavirus	B-SPEC
229E	O
,	O
3	O
OC43	O
and	O
3	O
NL63	O
,	O
4	O
enterovirus	B-SPEC
,	O
2	O
influenza	B-SPEC
virus	I-SPEC
B	O
and	O
C	O
virus	B-SPEC
.	O

RSV	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
and	O
influenza	B-SPEC
virus	I-SPEC
were	O
the	O
most	O
frequent	O
viruses	B-SPEC
detected	O
in	O
this	O
population	O
,	O
representing	O
43	O
.	O
6	O
%,	O
31	O
.	O
8	O
%,	O
and	O
8	O
.	O
8	O
%	O
of	O
the	O
virus	B-SPEC
found	O
,	O
respectively	O
,	O
followed	O
by	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
4	O
.	O
4	O
%),	O
coronavirus	B-SPEC
(	O
3	O
.	O
4	O
%),	O
parainfluenza	O
virus	B-SPEC
(	O
3	O
.	O
2	O
%),	O
adenovirus	B-SPEC
(	O
2	O
.	O
3	O
%),	O
and	O
enterovirus	B-SPEC
(	O
2	O
.	O
1	O
%).	O

Moreover	O
,	O
the	O
use	O
of	O
m	O
-	O
PCR	O
pointed	O
out	O
the	O
frequency	O
of	O
rhinovirus	B-SPEC
and	O
mixed	O
viral	O
detections	O
in	O
these	O
patients	O
.	O

Biosensors	O
are	O
an	O
attractive	O
tool	O
which	O
have	O
the	O
potential	O
to	O
detect	O
the	O
outbreak	O
of	O
a	O
virus	B-SPEC
and	O
/	O
or	O
disease	O
.	O

TITLE	O
:	O
Use	O
of	O
virus	B-SPEC
vectors	O
for	O
the	O
expression	O
in	O
plants	B-SPEC
of	O
active	O
full	O
-	O
length	O
and	O
single	O
chain	O
anti	O
-	O
coronavirus	B-SPEC
antibodies	O
.	O

The	O
alphaSIP	O
molecule	O
consisted	O
of	O
a	O
single	O
chain	O
antibody	O
(	O
scFv	O
)	O
specific	O
for	O
the	O
porcine	B-SPEC
coronavirus	B-SPEC
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
linked	O
to	O
the	O
alpha	O
-	O
CH3	O
domain	O
from	O
human	B-SPEC
IgA	O
.	O
To	O
express	O
the	O
full	O
-	O
length	O
IgA	O
,	O
the	O
individual	O
light	O
and	O
heavy	O
chains	O
from	O
the	O
TGEV	B-SPEC
-	O
specific	O
mAb	O
6A	O
.	O
C3	O
were	O
inserted	O
into	O
separate	O
PVX	B-SPEC
constructs	O
and	O
plants	B-SPEC
were	O
co	O
-	O
infected	O
with	O
both	O
constructs	O
.	O

Oral	O
administration	O
of	O
crude	O
extracts	O
from	O
antibody	O
-	O
expressing	O
plant	B-SPEC
tissue	O
to	O
2	O
-	O
day	O
-	O
old	O
piglets	O
showed	O
that	O
both	O
the	O
alphaSIP	O
and	O
full	O
-	O
length	O
IgA	O
molecules	O
can	O
provide	O
in	O
vivo	O
protection	O
against	O
TGEV	B-SPEC
.	O

We	O
generated	O
a	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
-	O
expressing	O
recombinant	O
vaccinia	B-SPEC
virus	I-SPEC
(	O
RVV	O
-	O
S	O
)	O
using	O
highly	O
attenuated	O
strain	O
LC16m8	O
.	O

TITLE	O
:	O
Adaptive	O
evolution	O
of	O
the	O
spike	O
gene	O
of	O
SARS	O
coronavirus	B-SPEC
:	O
changes	O
in	O
positively	O
selected	O
sites	O
in	O
different	O
epidemic	O
groups	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
investigated	O
the	O
presence	O
and	O
location	O
of	O
fluorescent	O
microspheres	O
having	O
the	O
size	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
of	O
mouse	B-SPEC
minute	O
virus	B-SPEC
(	O
MMV	B-SPEC
)	O
in	O
the	O
zona	O
pellucida	O
(	O
ZP	O
)	O
of	O
in	O
vivo	O
-	O
produced	O
murine	B-SPEC
embryos	O
,	O
the	O
transmission	O
of	O
these	O
viruses	B-SPEC
by	O
embryos	O
during	O
embryo	O
transfer	O
,	O
and	O
the	O
time	O
of	O
seroconversion	O
of	O
recipients	O
and	O
pups	O
.	O

To	O
this	O
end	O
,	O
fertilized	O
oocytes	O
and	O
morulae	O
were	O
exposed	O
to	O
different	O
concentrations	O
of	O
MMVp	O
for	O
16	O
h	O
,	O
while	O
2	O
-	O
cell	O
embryos	O
and	O
blastocysts	O
were	O
coincubated	O
for	O
1	O
h	O
.	O
In	O
addition	O
,	O
morulae	O
were	O
exposed	O
to	O
MHV	B-SPEC
-	O
A59	O
for	O
16	O
h	O
.	O
One	O
group	O
of	O
embryos	O
was	O
washed	O
,	O
and	O
the	O
remaining	O
embryos	O
remained	O
unwashed	O
before	O
embryo	O
transfer	O
.	O

Emerging	O
infectious	O
diseases	O
are	O
almost	O
instantaneously	O
a	O
global	O
concern	O
because	O
of	O
the	O
speed	O
with	O
which	O
people	O
,	O
animals	B-SPEC
and	O
products	O
move	O
around	O
the	O
world	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
isolates	O
that	O
have	O
been	O
adapted	O
to	O
passage	O
in	O
cell	O
culture	O
maintain	O
their	O
infectivity	O
in	O
vitro	O
but	O
may	O
lose	O
their	O
pathogenicity	O
in	O
vivo	O
.	O

This	O
study	O
includes	O
seven	O
clinical	O
,	O
non	O
-	O
cell	O
culture	O
-	O
adapted	O
,	O
contemporary	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
strains	O
detected	O
in	O
France	O
in	O
2003	O
.	O

SARS	O
-	O
CoV	O
S	O
protein	O
and	O
its	O
RNA	O
were	O
only	O
detected	O
in	O
ACE2	O
+	O
cells	O
in	O
the	O
lungs	O
and	O
other	O
organs	O
,	O
indicating	O
that	O
ACE2	O
-	O
expressing	O
cells	O
are	O
the	O
primary	O
targets	O
for	O
SARS	O
-	O
CoV	O
infection	O
in	O
vivo	O
in	O
humans	B-SPEC
.	O

Reconstitution	O
experiments	O
,	O
in	O
which	O
uremic	O
neutrophils	O
were	O
injected	O
into	O
nonuremic	O
mice	B-SPEC
and	O
vice	O
versa	O
,	O
identified	O
uremic	O
neutrophils	O
as	O
the	O
primary	O
mediators	O
.	O

A	O
previous	O
study	O
from	O
our	O
laboratory	O
identified	O
a	O
coronavirus	B-SPEC
replicase	O
protein	O
that	O
plays	O
an	O
important	O
role	O
in	O
viral	O
pathogenesis	O
.	O

Mice	B-SPEC
vaccinated	O
with	O
SARS	O
CoV	O
(	O
N	O
)	O
DNA	O
or	O
(	O
M	O
)	O
DNA	O
using	O
pcDNA	O
3	O
.	O
1	O
(+)	O
plasmid	O
vector	O
showed	O
T	O
-	O
cell	O
immune	O
responses	O
(	O
CTL	O
induction	O
and	O
proliferation	O
)	O
against	O
type	O
II	O
alveolar	O
epithelial	O
cells	O
(	O
T7	O
)	O
transfected	O
with	O
SARS	O
(	O
N	O
)	O
or	O
(	O
M	O
)	O
DNA	O
,	O
respectively	O
.	O

into	O
IL	O
-	O
2	O
receptor	O
gamma	O
-	O
chain	O
-	O
disrupted	O
NOD	O
-	O
SCID	O
mice	B-SPEC
[	O
IL	O
-	O
2R	O
(-/-)	O
NOD	O
-	O
SCID	O
].	O

The	O
M	O
DNA	O
vaccine	O
enhanced	O
CTL	O
activity	O
and	O
proliferation	O
in	O
the	O
presence	O
of	O
M	O
peptide	O
in	O
SCID	O
-	O
PBL	O
/	O
hu	O
mice	B-SPEC
.	O

On	O
the	O
other	O
hand	O
,	O
we	O
have	O
developed	O
SARS	O
DNA	O
vaccines	O
that	O
induce	O
human	B-SPEC
neutralizing	O
antibodies	O
and	O
human	B-SPEC
monoclonal	O
antibodies	O
against	O
SARS	O
CoV	O
.	O
Transgenic	B-SPEC
mice	I-SPEC
expressing	O
SARS	O
-	O
CoV	O
receptor	O
(	O
angiotensin	O
converting	O
enzyme	O
2	O
)	O
are	O
also	O
under	O
development	O
.	O

Using	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
envelope	O
protein	O
(	O
SCVme	O
),	O
and	O
core	O
streptavidin	O
(	O
cSA	O
)	O
of	O
Streptomyces	B-SPEC
avidinii	I-SPEC
as	O
model	O
proteins	O
,	O
specific	O
immobilization	O
of	O
the	O
GBP	O
-	O
fusion	O
proteins	O
onto	O
the	O
gold	O
nanoparticles	O
and	O
generation	O
of	O
protein	O
nanopatterns	O
on	O
the	O
bare	O
gold	O
surface	O
were	O
demonstrated	O
.	O

TITLE	O
:	O
The	O
relationship	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
with	O
avian	B-SPEC
and	O
other	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
In	O
February	O
2003	O
,	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
humans	B-SPEC
in	O
Guangdong	O
Province	O
,	O
China	O
,	O
and	O
caused	O
an	O
epidemic	O
that	O
had	O
severe	O
impact	O
on	O
public	O
health	O
,	O
travel	O
,	O
and	O
economic	O
trade	O
.	O

Because	O
coronaviruses	O
have	O
been	O
shown	O
,	O
both	O
experimentally	O
and	O
in	O
nature	O
,	O
to	O
undergo	O
genetic	O
mutations	O
and	O
recombination	O
at	O
a	O
rate	O
similar	O
to	O
that	O
of	O
influenza	B-SPEC
viruses	I-SPEC
,	O
it	O
is	O
not	O
surprising	O
that	O
zoonosis	O
and	O
host	O
switching	O
that	O
leads	O
to	O
epidemic	O
diseases	O
have	O
occurred	O
among	O
coronaviruses	O
.	O

We	O
then	O
generated	O
nine	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
against	O
the	O
S	O
protein	O
to	O
map	O
the	O
DC	O
-	O
SIGN	O
-	O
binding	O
domain	O
using	O
capture	O
assays	O
with	O
pseudotyped	O
viruses	B-SPEC
and	O
observed	O
that	O
MAb	O
SIa5	O
significantly	O
blocked	O
S	O
protein	O
-	O
DC	O
-	O
SIGN	O
interaction	O
.	O

An	O
enhancement	O
assay	O
using	O
the	O
HKU39849	O
SARS	O
-	O
CoV	O
strain	O
and	O
human	B-SPEC
immature	O
dendritic	O
cells	O
confirmed	O
our	O
observation	O
.	O

TITLE	O
:	O
Murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
1	O
produces	O
a	O
clinically	O
relevant	O
model	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
A	O
/	O
J	O
mice	B-SPEC
.	O

These	O
animals	B-SPEC
developed	O
a	O
less	O
robust	O
type	O
I	O
interferon	O
response	O
to	O
MHV	B-SPEC
-	O
1	O
infection	O
than	O
resistant	O
C57BL	O
/	O
6J	O
mice	B-SPEC
,	O
and	O
treatment	O
with	O
recombinant	O
beta	O
interferon	O
improved	O
survival	O
.	O

The	O
simulation	O
results	O
show	O
that	O
the	O
physical	O
environment	O
and	O
the	O
dispersion	O
pattern	O
of	O
bacteria	B-SPEC
in	O
the	O
negative	O
pressure	O
theatre	O
were	O
as	O
good	O
as	O
,	O
if	O
not	O
better	O
than	O
,	O
those	O
in	O
the	O
original	O
positive	O
pressure	O
design	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
cats	B-SPEC
show	O
a	O
decrease	O
in	O
peripheral	O
blood	O
lymphocyte	O
counts	O
,	O
and	O
a	O
particularly	O
marked	O
decrease	O
in	O
T	O
cells	O
including	O
CD4	O
+	O
and	O
CD8	O
+	O
cells	O
.	O

The	O
SARS	O
3c	O
like	O
protease	O
,	O
namely	O
the	O
SARS	O
3CL	O
(	O
pro	O
)	O
is	O
the	O
key	O
function	O
protease	O
for	O
virus	B-SPEC
replication	O
as	O
well	O
as	O
transcription	O
and	O
thus	O
can	O
be	O
taken	O
as	O
one	O
of	O
the	O
key	O
targets	O
for	O
anti	O
-	O
SARS	O
drug	O
design	O
.	O

We	O
investigated	O
whether	O
a	O
recombinant	O
native	O
full	O
-	O
length	O
S	O
-	O
protein	O
trimer	O
(	O
triSpike	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
able	O
to	O
elicit	O
a	O
neutralizing	O
and	O
protective	O
immune	O
response	O
in	O
animals	B-SPEC
and	O
analyzed	O
the	O
capacity	O
of	O
anti	O
-	O
S	O
antibodies	O
to	O
mediate	O
antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
virus	B-SPEC
entry	O
in	O
vitro	O
and	O
enhancement	O
of	O
replication	O
in	O
vivo	O
.	O

SARS	O
-	O
CoV	O
-	O
specific	O
serum	O
and	O
mucosal	O
immunoglobulins	O
were	O
readily	O
detected	O
in	O
immunized	O
animals	B-SPEC
.	O

Here	O
proposes	O
a	O
strategy	O
--	O
sequence	O
the	O
whole	O
genome	O
(	O
chromosomal	O
as	O
well	O
as	O
other	O
genetic	O
systems	O
)	O
of	O
infected	O
human	B-SPEC
cells	O
obtained	O
from	O
diseased	O
patients	O
.	O

This	O
might	O
help	O
us	O
to	O
know	O
greatly	O
more	O
about	O
the	O
consequences	O
of	O
virus	B-SPEC
infection	O
and	O
achieve	O
biotherapy	O
of	O
specifically	O
targeted	O
in	O
future	O
.	O

Unlike	O
patient	O
sera	O
,	O
however	O
,	O
the	O
mouse	B-SPEC
antisera	O
were	O
unable	O
to	O
inhibit	O
the	O
infectivity	O
of	O
S	O
protein	O
-	O
expressing	O
(	O
SARS	O
-	O
CoV	O
-	O
S	O
)	O
pseudovirus	O
.	O

A	O
recent	O
screening	O
of	O
wild	O
birds	B-SPEC
for	O
the	O
presence	O
of	O
coronaviruses	O
,	O
using	O
a	O
pan	B-SPEC
-	O
coronavirus	B-SPEC
RT	O
-	O
PCR	O
,	O
led	O
to	O
the	O
identification	O
of	O
novel	O
coronaviruses	O
in	O
the	O
three	O
species	B-SPEC
studied	O
.	O

The	O
motif	O
is	O
inserted	O
at	O
a	O
homologous	O
place	O
in	O
avian	B-SPEC
and	O
SARS	O
coronavirus	B-SPEC
genomes	O
,	O
but	O
in	O
a	O
somewhat	O
different	O
context	O
for	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

If	O
the	O
presence	O
of	O
s2m	O
in	O
these	O
viruses	B-SPEC
is	O
a	O
result	O
of	O
two	O
separate	O
recombination	O
events	O
,	O
this	O
suggests	O
that	O
its	O
particular	O
position	O
in	O
these	O
genomes	O
is	O
the	O
only	O
one	O
that	O
would	O
not	O
be	O
deleterious	O
for	O
coronaviral	O
replication	O
,	O
or	O
that	O
it	O
is	O
the	O
result	O
of	O
a	O
copy	O
-	O
choice	O
recombination	O
between	O
coronaviruses	O
,	O
following	O
an	O
ancestral	O
introduction	O
in	O
the	O
coronavirus	B-SPEC
family	B-SPEC
by	O
an	O
unrelated	O
virus	B-SPEC
.	O

A	O
previously	O
unrecognized	O
coronavirus	B-SPEC
was	O
identified	O
as	O
the	O
causative	O
agent	O
,	O
and	O
health	O
officials	O
throughout	O
the	O
world	O
struggled	O
to	O
implement	O
measures	O
to	O
contain	O
its	O
spread	O
,	O
including	O
isolation	O
of	O
suspect	O
SARS	O
cases	O
and	O
quarantine	O
of	O
exposed	O
persons	O
.	O

The	O
sepsis	B-SPEC
-	O
derived	O
lesions	O
can	O
involve	O
many	O
organs	O
and	O
apparatus	O
leading	O
to	O
the	O
picture	O
of	O
sepsis	B-SPEC
syndrome	O
.	O

Sepsis	B-SPEC
syndrome	O
often	O
induces	O
severe	O
pulmonary	O
lesions	O
with	O
a	O
picture	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Notably	O
,	O
attenuated	O
PEDV	B-SPEC
DR13	O
has	O
previously	O
been	O
found	O
to	O
exhibit	O
reduced	O
pathogenicity	O
in	O
pigs	B-SPEC
.	O

The	O
attenuated	O
PEDV	B-SPEC
DR13	O
S	O
protein	O
contains	O
28	O
Asn	O
-	O
Xaa	O
-	O
Ser	O
/	O
Thr	O
sequons	O
,	O
21	O
asparagines	O
that	O
are	O
predicted	O
to	O
be	O
N	O
-	O
glycosylated	O
and	O
a	O
stretch	O
of	O
highly	O
hydrophobic	O
residues	O
at	O
positions	O
1	O
,	O
327	O
-	O
1	O
,	O
347	O
,	O
which	O
is	O
predicted	O
to	O
form	O
an	O
alpha	O
-	O
helix	O
and	O
to	O
function	O
as	O
a	O
membrane	O
anchor	O
.	O

Attenuated	O
PEDV	B-SPEC
DR13	O
has	O
96	O
.	O
5	O
,	O
96	O
.	O
4	O
,	O
96	O
.	O
1	O
,	O
93	O
.	O
9	O
,	O
93	O
.	O
5	O
and	O
96	O
.	O
6	O
%	O
DNA	O
sequence	O
identities	O
with	O
CV777	O
,	O
Br1	O
/	O
87	O
,	O
JS	O
-	O
2004	O
-	O
2	O
,	O
Spk1	O
,	O
Chinju99	O
and	O
parent	O
DR13	O
,	O
respectively	O
.	O

Phylogenetic	O
analysis	O
suggested	O
that	O
attenuated	O
PEDV	B-SPEC
DR13	O
is	O
closely	O
related	O
to	O
CV777	O
,	O
Br1	O
/	O
87	O
,	O
JS	O
-	O
2004	O
-	O
2	O
and	O
parent	O
DR13	O
,	O
rather	O
than	O
to	O
Spk1	O
and	O
Chinju99	O
and	O
is	O
especially	O
close	O
to	O
the	O
Chinese	O
PEDV	B-SPEC
strain	O
JS	O
-	O
2004	O
-	O
2	O
.	O

We	O
performed	O
autopsies	O
on	O
six	O
confirmed	O
SARS	O
cases	O
,	O
with	O
six	O
normal	O
subjects	O
as	O
controls	O
;	O
spleen	O
samples	O
from	O
these	O
autopsies	O
were	O
examined	O
with	O
hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
sections	O
,	O
in	O
situ	O
hybridization	O
for	O
SARS	O
virus	B-SPEC
genomic	O
sequences	O
,	O
and	O
immunohistochemistry	O
with	O
seven	O
monoclonal	O
antibodies	O
to	O
five	O
cell	O
types	O
.	O

Here	O
we	O
show	O
that	O
transgenic	B-SPEC
mice	I-SPEC
that	O
express	O
the	O
SARS	O
-	O
CoV	O
receptor	O
(	O
human	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
[	O
hACE2	O
])	O
in	O
airway	O
and	O
other	O
epithelia	O
develop	O
a	O
rapidly	O
lethal	O
infection	O
after	O
intranasal	O
inoculation	O
with	O
a	O
human	B-SPEC
strain	O
of	O
the	O
virus	B-SPEC
.	O

These	O
findings	O
indicate	O
that	O
the	O
Raf	O
/	O
MEK	O
/	O
ERK	O
signaling	O
pathway	O
is	O
involved	O
in	O
MHV	B-SPEC
RNA	O
synthesis	O
.	O

No	O
viral	O
infections	O
were	O
detected	O
in	O
six	O
herds	O
,	O
while	O
16	O
-	O
21	O
herds	O
had	O
RSV	B-SPEC
,	O
BCV	B-SPEC
,	O
BAV	O
or	O
PIV3	O
.	O

Humoral	O
immune	O
responses	O
of	O
vaccinated	O
mice	B-SPEC
were	O
investigated	O
for	O
up	O
to	O
12	O
months	O
at	O
a	O
1	O
-	O
month	O
interval	O
and	O
the	O
neutralizing	O
titers	O
of	O
produced	O
antibodies	O
were	O
reported	O
at	O
months	O
0	O
,	O
3	O
,	O
6	O
and	O
12	O
post	O
-	O
vaccination	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
),	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
),	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
),	O
and	O
human	B-SPEC
coronavirus	I-SPEC
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
which	O
belong	O
to	O
the	O
group	O
1	O
coronavirus	B-SPEC
,	O
use	O
aminopeptidase	O
N	O
(	O
APN	O
)	O
of	O
their	O
natural	O
host	O
and	O
feline	B-SPEC
APN	O
(	O
fAPN	O
)	O
as	O
receptors	O
.	O

HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
was	O
blocked	O
by	O
an	O
N	O
-	O
glycosylation	O
sequon	O
present	O
between	O
aa	O
288	O
to	O
290	O
in	O
murine	B-SPEC
APN	O
.	O

N740	O
and	O
T742	O
in	O
fAPN	O
and	O
the	O
homologous	O
R741	O
in	O
human	B-SPEC
APN	O
(	O
hAPN	O
)	O
were	O
key	O
determinants	O
of	O
host	O
range	O
for	O
FCoV	O
,	O
TGEV	B-SPEC
,	O
and	O
CCoV	O
.	O
Residue	O
N740	O
in	O
fAPN	O
was	O
essential	O
only	O
for	O
CCoV	O
receptor	O
activity	O
.	O

Thus	O
,	O
the	O
hydroxyl	O
on	O
T742	O
is	O
required	O
for	O
the	O
coronavirus	B-SPEC
receptor	O
activity	O
of	O
fAPN	O
.	O

ABSTRACT	O
:	O
The	O
3	O
'	O
cis	B-SPEC
-	O
acting	O
element	O
for	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
RNA	O
synthesis	O
resides	O
entirely	O
within	O
the	O
301	O
-	O
nucleotide	O
3	O
'	O
untranslated	O
region	O
(	O
3	O
'	O
UTR	O
)	O
of	O
the	O
viral	O
genome	O
and	O
consists	O
of	O
three	O
regions	O
.	O

Between	O
these	O
two	O
ends	O
is	O
a	O
hypervariable	O
region	O
(	O
HVR	O
)	O
that	O
is	O
only	O
poorly	O
conserved	O
between	O
MHV	B-SPEC
and	O
other	O
group	O
2	O
coronaviruses	O
.	O

Correspondingly	O
,	O
replication	O
of	O
the	O
HVR	O
deletion	O
mutant	O
in	O
the	O
brains	O
of	O
mice	B-SPEC
was	O
greatly	O
reduced	O
compared	O
to	O
that	O
of	O
the	O
wild	O
type	O
.	O

Preliminary	O
studies	O
with	O
mice	B-SPEC
of	O
a	O
second	O
lineage	O
,	O
AC63	O
,	O
in	O
which	O
the	O
transgene	O
expression	O
was	O
considerably	O
less	O
abundant	O
than	O
that	O
in	O
the	O
AC70	O
line	O
,	O
revealed	O
that	O
virus	B-SPEC
replication	O
was	O
largely	O
restricted	O
to	O
the	O
lungs	O
but	O
not	O
the	O
brain	O
.	O

Importantly	O
,	O
despite	O
significant	O
weight	O
loss	O
,	O
infected	O
Tg	O
+	O
AC63	O
mice	B-SPEC
eventually	O
recovered	O
from	O
the	O
illness	O
without	O
any	O
mortality	O
.	O

The	O
severity	O
of	O
the	O
disease	O
that	O
developed	O
in	O
these	O
transgenic	B-SPEC
mice	I-SPEC
--	O
AC70	O
in	O
particular	O
--	O
makes	O
these	O
mouse	B-SPEC
models	O
valuable	O
not	O
only	O
for	O
evaluating	O
the	O
efficacy	O
of	O
antivirals	O
and	O
vaccines	O
,	O
but	O
also	O
for	O
studying	O
SARS	O
coronavirus	B-SPEC
pathogenesis	O
.	O

The	O
recombinant	O
virus	B-SPEC
lacking	O
the	O
E	O
gene	O
(	O
rSARS	O
-	O
CoV	O
-	O
DeltaE	O
)	O
was	O
rescued	O
in	O
Vero	O
E6	O
cells	O
.	O

ABSTRACT	O
:	O
We	O
reported	O
the	O
analytical	O
interference	O
of	O
anti	O
-	O
Escherichia	B-SPEC
coli	I-SPEC
protein	O
(	O
EP	O
)	O
antibodies	O
in	O
human	B-SPEC
sera	O
and	O
residual	O
EP	O
in	O
a	O
recombinant	O
nucleocapsid	O
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
as	O
a	O
possible	O
source	O
of	O
false	O
positives	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
serodiagnosis	O
.	O

We	O
present	O
the	O
case	O
of	O
a	O
35	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
AIDS	O
,	O
who	O
was	O
admitted	O
to	O
our	O
medical	O
ICU	O
for	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
systemic	O
infection	O
that	O
clinically	O
manifests	O
as	O
progressive	O
pneumonia	O
.	O

Fifty	O
-	O
six	O
SARS	O
-	O
CoV	O
S	O
-	O
gene	O
sequences	O
,	O
obtained	O
from	O
patients	O
who	O
presented	O
with	O
SARS	O
to	O
the	O
Prince	O
of	O
Wales	O
Hospital	O
during	O
March	O
-	O
May	O
2003	O
,	O
were	O
analysed	O
using	O
a	O
maximum	O
likelihood	O
(	O
ML	O
)	O
approach	O
,	O
together	O
with	O
138	O
other	O
(	O
both	O
human	B-SPEC
and	O
animal	B-SPEC
)	O
S	O
-	O
gene	O
sequences	O
downloaded	O
from	O
GenBank	O
.	O

At	O
the	O
same	O
time	O
,	O
IBV	B-SPEC
RNA	O
concentrations	O
in	O
tracheas	O
and	O
lachrymal	O
fluids	O
were	O
higher	O
and	O
more	O
persistent	O
in	O
immunodeficient	O
chickens	B-SPEC
.	O

One	O
year	O
specific	O
immunotherapy	O
with	O
standardized	O
house	B-SPEC
dust	I-SPEC
mite	I-SPEC
(	O
HDM	O
)	O
vaccine	O
significantly	O
improved	O
symptoms	O
and	O
reduced	O
medication	O
use	O
in	O
mild	O
to	O
moderate	O
allergic	O
asthmatic	O
patients	O
.	O

CONCLUSIONS	O
:	O
One	O
year	O
specific	O
immunotherapy	O
with	O
standardized	O
house	B-SPEC
dust	I-SPEC
mite	I-SPEC
(	O
HDM	O
)	O
vaccine	O
significantly	O
improved	O
symptoms	O
and	O
reduced	O
medication	O
use	O
in	O
mild	O
to	O
moderate	O
allergic	O
asthmatic	O
patients	O
.	O

The	O
demographic	O
and	O
clinical	O
characteristics	O
associated	O
with	O
coronavirus	B-SPEC
infection	O
were	O
examined	O
retrospectively	O
.	O

Of	O
32	O
children	O
infected	O
with	O
a	O
coronavirus	B-SPEC
as	O
the	O
sole	O
respiratory	O
pathogen	O
,	O
13	O
had	O
lower	O
respiratory	O
tract	O
disease	O
.	O

Children	O
whose	O
only	O
detectable	O
respiratory	O
virus	B-SPEC
was	O
a	O
coronavirus	B-SPEC
were	O
more	O
likely	O
to	O
have	O
underlying	O
chronic	O
disease	O
than	O
were	O
children	O
coinfected	O
with	O
another	O
respiratory	O
virus	B-SPEC
.	O

Although	O
4	O
subtypes	O
of	O
coronavirus	B-SPEC
were	O
detected	O
,	O
the	O
recently	O
discovered	O
coronavirus	B-SPEC
subtypes	O
NL63	O
and	O
HKU1	O
accounted	O
for	O
the	O
majority	O
of	O
coronaviruses	O
detected	O
in	O
our	O
cohort	O
of	O
mostly	O
hospitalized	O
children	O
with	O
respiratory	O
symptoms	O
.	O

Pro	O
-	O
inflammatory	O
cytokines	O
,	O
including	O
type	O
I	O
interferon	O
(	O
IFN	O
),	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
),	O
and	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
were	O
found	O
in	O
lung	O
secretions	O
of	O
influenza	B-SPEC
virus	I-SPEC
infected	O
pigs	B-SPEC
,	O
and	O
correlated	O
with	O
the	O
intensity	O
of	O
clinical	O
signs	O
,	O
whereas	O
prior	O
vaccination	O
against	O
influenza	O
strongly	O
reduced	O
the	O
production	O
of	O
infectious	O
virus	B-SPEC
and	O
cytokines	O
in	O
the	O
lungs	O
upon	O
challenge	O
,	O
which	O
was	O
associated	O
with	O
clinical	O
protection	O
.	O

An	O
early	O
type	O
I	O
IFN	O
production	O
was	O
also	O
found	O
in	O
coronavirus	B-SPEC
infected	O
pigs	B-SPEC
,	O
including	O
at	O
mucosal	O
sites	O
.	O

ABSTRACT	O
:	O
We	O
generated	O
a	O
recombinant	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	B-SPEC
)	O
pseudotype	O
(	O
VSV	B-SPEC
Delta	O
G	O
*	O
SG	O
)	O
by	O
replacing	O
the	O
envelope	O
G	O
gene	O
with	O
the	O
GFP	O
gene	O
and	O
complementing	O
with	O
spike	O
glycoprotein	O
(	O
S	O
)	O
of	O
SARS	O
-	O
CoV	O
in	O
trans	O
.	O

To	O
detect	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
previously	O
described	O
nested	O
PCR	O
assays	O
for	O
1a	O
and	O
1b	O
were	O
used	O
.	O

We	O
constructed	O
recombinant	O
adenoviral	B-SPEC
vectors	O
that	O
can	O
express	O
shRNAs	O
,	O
which	O
inhibited	O
the	O
expression	O
of	O
SARS	O
-	O
CoV	O
genes	O
effectively	O
in	O
mammalian	B-SPEC
cells	O
.	O

The	O
levels	O
of	O
viral	O
mRNAs	O
and	O
viral	O
proteins	O
of	O
the	O
targets	O
were	O
significantly	O
decreased	O
or	O
completely	O
inhibited	O
in	O
cell	O
lines	O
after	O
being	O
infected	O
with	O
the	O
recombinant	O
adenoviruses	B-SPEC
that	O
expressed	O
specific	O
shRNA	O
molecules	O
.	O

Since	O
many	O
cell	O
types	O
can	O
be	O
efficiently	O
infected	O
by	O
adenovirus	B-SPEC
,	O
recombinant	O
adenoviruses	B-SPEC
could	O
serve	O
as	O
an	O
alternative	O
powerful	O
tool	O
for	O
shRNA	O
delivery	O
and	O
for	O
gene	O
suppression	O
,	O
especially	O
when	O
the	O
targeted	O
cells	O
are	O
resistant	O
to	O
transfection	O
by	O
DNA	O
or	O
RNA	O
.	O

RESULTS	O
:	O
The	O
levels	O
of	O
viral	O
mRNAs	O
and	O
viral	O
proteins	O
of	O
the	O
targets	O
were	O
significantly	O
decreased	O
or	O
completely	O
inhibited	O
in	O
cell	O
lines	O
after	O
being	O
infected	O
with	O
the	O
recombinant	O
adenoviruses	B-SPEC
that	O
expressed	O
specific	O
shRNA	O
molecules	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
infection	O
among	O
children	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
in	O
Thailand	O
.	O

In	O
addition	O
,	O
we	O
performed	O
this	O
study	O
in	O
order	B-SPEC
to	O
delineate	O
the	O
prevalence	O
,	O
the	O
potential	O
clinical	O
impacts	O
and	O
evaluation	O
of	O
the	O
genetic	O
characterization	O
of	O
this	O
pathogen	O
in	O
young	O
children	O
who	O
presented	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infections	O
(	O
ALRI	O
).	O

Of	O
the	O
226	O
NPs	O
samples	O
from	O
infants	O
and	O
young	O
children	O
presented	O
with	O
ALRI	O
,	O
8	O
(	O
3	O
.	O
54	O
%)	O
were	O
positive	O
for	O
hCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
2	O
(	O
0	O
.	O
88	O
%)	O
were	O
positive	O
for	O
hCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
and	O
1	O
(	O
0	O
.	O
44	O
%)	O
had	O
co	O
-	O
infection	O
.	O

Respiratory	O
specimens	O
from	O
children	O
aged	O
2	O
to	O
17	O
years	O
with	O
asthma	O
exacerbations	O
(	O
case	O
patients	O
,	O
n	O
=	O
65	O
)	O
and	O
with	O
well	O
-	O
controlled	O
asthma	O
(	O
control	O
subjects	O
,	O
n	O
=	O
77	O
),	O
frequency	O
matched	O
by	O
age	O
and	O
season	O
of	O
enrollment	O
,	O
were	O
tested	O
for	O
rhinoviruses	B-SPEC
,	O
enteroviruses	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
coronaviruses	O
229E	O
and	O
OC43	O
,	O
parainfluenza	O
viruses	B-SPEC
1	O
to	O
3	O
,	O
influenza	B-SPEC
viruses	I-SPEC
,	O
adenoviruses	B-SPEC
,	O
and	O
human	B-SPEC
bocavirus	I-SPEC
.	O

Other	O
viruses	B-SPEC
detected	O
included	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
4	O
.	O
6	O
%	O
in	O
patients	O
with	O
acute	O
asthma	O
vs	O
2	O
.	O
6	O
%	O
in	O
control	O
subjects	O
),	O
enteroviruses	B-SPEC
(	O
4	O
.	O
6	O
%	O
vs	O
0	O
%),	O
coronavirus	B-SPEC
229E	O
(	O
0	O
%	O
vs	O
1	O
.	O
3	O
%),	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
1	O
.	O
5	O
%	O
vs	O
0	O
%).	O

TITLE	O
:	O
Genetic	O
distance	O
of	O
SARS	O
coronavirus	B-SPEC
from	O
the	O
recent	O
natural	O
case	O
.	O

Pathogens	O
with	O
modified	O
antibiotic	O
susceptibility	O
patterns	O
have	O
emerged	O
,	O
which	O
display	O
an	O
increased	O
antibiotic	O
resistance	O
,	O
such	O
as	O
S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
,	O
H	B-SPEC
.	I-SPEC
influenzae	I-SPEC
.	O

After	O
10	O
serial	O
passages	O
,	O
replication	O
and	O
virulence	O
of	O
SARS	O
-	O
CoV	O
were	O
increased	O
in	O
the	O
respiratory	O
tract	O
of	O
young	O
rats	B-SPEC
without	O
clinical	O
signs	O
.	O

Malaria	O
must	O
be	O
treated	O
with	O
effective	O
drugs	O
,	O
but	O
current	O
choices	O
are	O
few	O
:	O
e	O
.	O
g	O
.	O
parenteral	O
artemisinins	O
,	O
intravenous	O
quinine	B-SPEC
or	O
quinidine	O
(	O
in	O
the	O
US	O
only	O
).	O

Both	O
treatments	O
blocked	O
virus	B-SPEC
infection	O
and	O
apoptosis	O
,	O
indicating	O
that	O
virus	B-SPEC
-	O
receptor	O
binding	O
is	O
necessary	O
but	O
not	O
sufficient	O
for	O
the	O
apoptosis	O
induction	O
.	O

Moreover	O
,	O
virus	B-SPEC
infection	O
did	O
not	O
alter	O
the	O
abundance	O
of	O
the	O
individual	O
proteins	O
of	O
the	O
complexes	O
,	O
suggesting	O
that	O
the	O
activation	O
of	O
the	O
Fas	O
signaling	O
pathway	O
was	O
at	O
the	O
post	O
-	O
translational	O
level	O
.	O

These	O
results	O
demonstrate	O
that	O
oligodendrocyte	O
apoptosis	O
is	O
triggered	O
by	O
MHV	B-SPEC
infection	O
during	O
cell	O
entry	O
through	O
the	O
activation	O
of	O
the	O
Fas	O
signaling	O
pathway	O
.	O

Demographics	O
,	O
mechanism	O
of	O
injury	O
(	O
MOI	O
),	O
ISS	O
,	O
revised	O
trauma	O
score	O
,	O
Glasgow	O
Coma	B-SPEC
score	O
,	O
hospital	O
course	O
,	O
morbidity	O
,	O
requirement	O
of	O
additional	O
procedures	O
,	O
mortality	O
,	O
and	O
cost	O
were	O
compared	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
respiratory	O
disease	O
in	O
chickens	B-SPEC
all	O
over	O
the	O
world	O
.	O

The	O
costly	O
treatment	O
of	O
infected	O
individuals	O
with	O
multiple	O
highly	O
efficient	O
anti	O
-	O
HIV	B-SPEC
drugs	O
is	O
only	O
affordable	O
in	O
industrialized	O
countries	O
.	O

First	O
,	O
the	O
receptor	O
of	O
HCoV	O
229E	O
,	O
human	B-SPEC
aminopeptidase	O
N	O
(	O
hAPN	O
or	O
CD13	O
)	O
is	O
expressed	O
mainly	O
on	O
human	B-SPEC
dendritic	O
cells	O
(	O
DCs	O
)	O
and	O
macrophages	O
indicating	O
that	O
targeting	O
of	O
HCoV	O
229E	O
-	O
based	O
vectors	O
to	O
professional	O
antigen	O
presenting	O
cells	O
can	O
be	O
achieved	O
by	O
receptor	O
-	O
mediated	O
transduction	O
.	O

TITLE	O
:	O
An	O
overall	O
picture	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
-	O
encoded	O
major	O
proteins	O
:	O
structures	O
,	O
functions	O
and	O
drug	O
development	O
.	O

TITLE	O
:	O
Bioinformatics	O
research	O
on	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS_CoV	O
)	O
in	O
China	O
.	O

As	O
its	O
pathogen	O
was	O
identified	O
as	O
a	O
new	O
kind	O
of	O
coronavirus	B-SPEC
(	O
SARS_CoV	O
),	O
its	O
genome	O
was	O
quickly	O
sequenced	O
on	O
several	O
isolates	O
.	O

Finally	O
,	O
a	O
brief	O
introduction	O
is	O
given	O
for	O
how	O
to	O
use	O
computer	O
-	O
generated	O
graphs	O
to	O
rapidly	O
diagnose	O
SARS	O
coronavirus	B-SPEC
.	O

Expression	O
of	O
both	O
the	O
MisL	O
-	O
and	O
987P	O
subunit	O
FasA	O
-	O
fusions	O
to	O
the	O
TGEV	B-SPEC
epitopes	O
were	O
under	O
the	O
control	O
of	O
in	O
vivo	O
-	O
induced	O
promoters	O
.	O

A	O
hybrid	O
interferon	O
,	O
interferon	O
alpha	O
(	O
IFN	O
-	O
alpha	O
)	O
B	O
/	O
D	O
,	O
and	O
a	O
mismatched	O
double	O
-	O
stranded	O
(	O
ds	O
)	O
RNA	O
interferon	O
(	O
IFN	O
)	O
inducer	O
,	O
Ampligen	O
(	O
poly	O
I	O
:	O
poly	O
C124	O
),	O
were	O
the	O
only	O
compounds	O
that	O
potently	O
inhibited	O
virus	B-SPEC
titres	O
in	O
the	O
lungs	O
of	O
infected	O
mice	B-SPEC
as	O
assessed	O
by	O
CPE	O
titration	O
assays	O
.	O

ABSTRACT	O
:	O
The	O
comparative	O
histopathology	O
of	O
2	O
different	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
T	O
and	O
N1	O
/	O
88	O
)	O
in	O
vaccinated	O
hens	O
was	O
studied	O
at	O
110	O
wk	O
of	O
age	O
.	O

This	O
was	O
initially	O
established	O
by	O
studies	O
demonstrating	O
that	O
cellular	O
expression	O
of	O
only	O
E	O
protein	O
and	O
the	O
membrane	O
protein	O
(	O
M	O
)	O
was	O
necessary	O
and	O
sufficient	O
for	O
the	O
generation	O
and	O
release	O
of	O
virus	B-SPEC
-	O
like	O
particles	O
.	O

We	O
obtain	O
general	O
results	O
for	O
special	O
cases	O
,	O
which	O
are	O
interpreted	O
with	O
respect	O
to	O
the	O
likely	O
success	O
of	O
tracing	O
for	O
influenza	O
,	O
smallpox	B-SPEC
,	O
SARS	O
,	O
and	O
foot	O
-	O
and	O
-	O
mouth	O
disease	O
epidemics	O
.	O

TITLE	O
:	O
Long	O
-	O
term	O
persistence	O
of	O
robust	O
antibody	O
and	O
cytotoxic	O
T	O
cell	O
responses	O
in	O
recovered	O
patients	O
infected	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
final	O
histological	O
examination	O
of	O
the	O
rectum	O
revealed	O
a	O
CMV	B-SPEC
infection	O
.	O

In	O
cases	O
of	O
this	O
kind	O
,	O
in	O
order	B-SPEC
to	O
quickly	O
detect	O
the	O
prevalence	O
of	O
such	O
infections	O
,	O
a	O
surveillance	O
system	O
that	O
includes	O
hospital	O
personnel	O
is	O
essential	O
.	O

Furthermore	O
,	O
some	O
insectivorous	O
bat	B-SPEC
species	B-SPEC
may	O
be	O
important	O
reservoirs	O
of	O
SARS	O
coronavirus	B-SPEC
,	O
whereas	O
Ebola	B-SPEC
virus	I-SPEC
has	O
been	O
detected	O
in	O
some	O
megachiropteran	O
fruit	O
bats	B-SPEC
.	O

Thus	O
far	O
,	O
European	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
(	O
EBLV	O
)	O
is	O
the	O
only	O
zoonotic	O
virus	B-SPEC
that	O
has	O
been	O
detected	O
in	O
bats	B-SPEC
in	O
Europe	O
.	O

With	O
the	O
knowledge	O
generated	O
from	O
this	O
kind	O
of	O
research	O
,	O
a	O
rapid	O
response	O
system	O
can	O
be	O
set	O
up	O
to	O
enhance	O
public	O
health	O
awareness	O
of	O
emerging	O
zoonotic	O
viruses	B-SPEC
of	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
positive	O
cells	O
are	O
present	O
in	O
pyogranulomas	O
and	O
exudates	O
from	O
cats	B-SPEC
with	O
FIP	O
.	O

How	O
these	O
cells	O
survive	O
in	O
immune	O
cats	B-SPEC
is	O
not	O
known	O
.	O

ABSTRACT	O
:	O
Interferon	O
(	O
IFN	O
)-	O
alpha	O
,	O
-	O
beta	O
and	O
-	O
gamma	O
have	O
been	O
shown	O
to	O
be	O
only	O
marginally	O
effective	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
replication	O
in	O
Vero	O
cell	O
lines	O
.	O

ABSTRACT	O
:	O
Aurintricarboxylic	O
acid	O
(	O
ATA	B-SPEC
)	O
has	O
been	O
shown	O
to	O
inhibit	O
the	O
replication	O
of	O
viruses	B-SPEC
from	O
several	O
different	O
families	O
,	O
including	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
,	O
and	O
the	O
coronavirus	B-SPEC
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

This	O
study	O
characterizes	O
the	O
inhibitory	O
effect	O
of	O
ATA	B-SPEC
on	O
vaccinia	B-SPEC
virus	I-SPEC
replication	O
in	O
HeLa	O
,	O
Huh7	O
,	O
and	O
AD293	O
cells	O
.	O

Vaccinia	B-SPEC
virus	I-SPEC
replication	O
is	O
significantly	O
abrogated	O
upon	O
ATA	B-SPEC
treatment	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
early	O
viral	O
gene	O
transcription	O
.	O

Thus	O
,	O
ATA	B-SPEC
inhibits	O
vaccinia	B-SPEC
virus	I-SPEC
replication	O
by	O
targeting	O
both	O
cellular	O
and	O
viral	O
factors	O
essential	O
for	O
the	O
early	O
stage	O
of	O
replication	O
.	O

A	O
SARS	O
-	O
CoV	O
vaccine	O
should	O
confer	O
long	O
-	O
term	O
protection	O
,	O
especially	O
in	O
vulnerable	O
senescent	O
populations	O
,	O
against	O
both	O
the	O
2003	O
epidemic	O
strains	O
and	O
zoonotic	O
strains	O
that	O
may	O
yet	O
emerge	O
from	O
animal	B-SPEC
reservoirs	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
encodes	O
a	O
single	O
ORF4	O
protein	O
between	O
the	O
spike	O
and	O
the	O
envelope	O
genes	O
.	O

To	O
determine	O
whether	O
primary	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
isolates	O
exhibit	O
this	O
unusual	O
genome	O
organization	O
,	O
we	O
analyzed	O
the	O
ORF4a	O
/	O
b	O
region	O
of	O
five	O
current	O
clinical	O
isolates	O
from	O
The	O
Netherlands	O
and	O
three	O
early	O
isolates	O
collected	O
at	O
the	O
Common	O
Cold	O
Unit	O
(	O
CCU	O
)	O
in	O
Salisbury	O
,	O
UK	O
.	O

ABSTRACT	O
:	O
Lipid	O
rafts	O
are	O
involved	O
in	O
the	O
life	O
cycle	O
of	O
many	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Crystal	O
structures	O
reveal	O
an	O
induced	O
-	O
fit	O
binding	O
of	O
a	O
substrate	O
-	O
like	O
Aza	O
-	O
peptide	O
epoxide	O
to	O
SARS	O
coronavirus	B-SPEC
main	O
peptidase	O
.	O

We	O
report	O
two	O
crystal	O
structures	O
of	O
M	O
(	O
pro	O
)	O
having	O
an	O
additional	O
Ala	O
at	O
the	O
N	O
terminus	O
of	O
each	O
protomer	O
(	O
M	O
(+	O
A	O
(-	O
1	O
))(	O
pro	O
)),	O
both	O
at	O
a	O
resolution	O
of	O
2	O
.	O
00	O
Angstroms	O
,	O
in	O
space	O
group	O
P4	O
(	O
3	O
)	O
2	O
(	O
1	O
)	O
2	O
:	O
one	O
unbound	O
and	O
one	O
bound	O
by	O
a	O
substrate	O
-	O
like	O
aza	O
-	O
peptide	O
epoxide	O
(	O
APE	B-SPEC
).	O

In	O
the	O
unbound	O
form	O
,	O
the	O
active	O
sites	O
and	O
the	O
S1	O
specificity	O
pockets	O
of	O
both	O
protomers	O
of	O
M	O
(+	O
A	O
(-	O
1	O
))(	O
pro	O
)	O
are	O
observed	O
in	O
a	O
collapsed	O
(	O
catalytically	O
incompetent	O
)	O
conformation	O
;	O
whereas	O
they	O
are	O
in	O
an	O
open	O
(	O
catalytically	O
competent	O
)	O
conformation	O
in	O
the	O
APE	B-SPEC
-	O
bound	O
form	O
.	O

The	O
structural	O
data	O
further	O
suggest	O
that	O
the	O
binding	O
of	O
APE	B-SPEC
to	O
M	O
(	O
pro	O
)	O
follows	O
an	O
induced	O
-	O
fit	O
model	O
.	O

Three	O
outbreaks	O
were	O
observed	O
in	O
animal	B-SPEC
shelters	O
of	O
southern	O
Italy	O
,	O
whereas	O
a	O
fourth	O
outbreak	O
involved	O
two	O
purebred	O
pups	O
imported	O
from	O
Hungary	O
few	O
days	O
before	O
the	O
onset	O
of	O
clinical	O
symptoms	O
.	O

All	O
patients	O
presented	O
with	O
nosocomial	O
respiratory	O
infection	O
related	O
to	O
Gram	O
-	O
negative	O
bacilli	B-SPEC
,	O
in	O
the	O
evolution	O
.	O

All	O
patients	O
received	O
quinine	B-SPEC
therapy	O
with	O
loading	O
dose	O
and	O
symptomatic	O
treatment	O
.	O

ABSTRACT	O
:	O
To	O
understand	O
the	O
mechanistic	O
basis	O
of	O
local	O
innate	O
and	O
adaptive	O
immunity	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
at	O
the	O
molecular	O
level	O
,	O
we	O
examined	O
the	O
gene	O
transcription	O
profile	O
of	O
tracheal	O
epithelial	O
layers	O
3	O
d	O
after	O
infection	O
of	O
chickens	B-SPEC
with	O
an	O
attenuated	O
IBV	B-SPEC
-	O
Massachusetts	O
strain	O
.	O

In	O
this	O
study	O
,	O
a	O
leucine	O
-	O
rich	O
nuclear	O
export	O
signal	O
(	O
NES	B-SPEC
)	O
(	O
291	O
-	O
LQLDGLHL	O
-	O
298	O
)	O
present	O
in	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
IBV	B-SPEC
N	O
protein	O
was	O
analyzed	O
by	O
using	O
alanine	O
substitution	O
and	O
deletion	O
mutagenesis	O
to	O
investigate	O
the	O
relative	O
contributions	O
that	O
leucine	O
residues	O
make	O
to	O
nuclear	O
export	O
and	O
where	O
these	O
residues	O
are	O
located	O
on	O
the	O
structure	O
of	O
the	O
IBV	B-SPEC
N	O
protein	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
development	O
of	O
an	O
immunoglobulin	O
M	O
(	O
IgM	O
)	O
antibody	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
MAC	B-SPEC
-	O
ELISA	O
)	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
by	O
using	O
recombinant	O
truncated	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
as	O
the	O
antigen	O
.	O

Our	O
newly	O
developed	O
MAC	B-SPEC
-	O
ELISA	O
system	O
offers	O
a	O
new	O
alternative	O
for	O
the	O
confirmation	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
have	O
evolved	O
a	O
myriad	O
of	O
strategies	O
for	O
promoting	O
viral	O
replication	O
,	O
survival	O
and	O
spread	O
.	O

The	O
treatment	O
of	O
choice	O
for	O
non	O
-	O
falciparum	O
malaria	O
is	O
a	O
3	O
-	O
day	O
course	O
of	O
oral	O
chloroquine	O
,	O
to	O
which	O
only	O
a	O
limited	O
proportion	O
of	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
strains	O
have	O
gained	O
resistance	O
.	O

ALL	O
patients	O
treated	O
for	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
malaria	O
should	O
be	O
admitted	O
to	O
hospital	O
for	O
at	O
least	O
24	O
h	O
,	O
since	O
patients	O
can	O
deteriorate	O
suddenly	O
,	O
especially	O
early	O
in	O
the	O
course	O
of	O
treatment	O
.	O

The	O
MA15	O
virus	B-SPEC
has	O
six	O
coding	O
mutations	O
associated	O
with	O
adaptation	O
and	O
increased	O
virulence	O
;	O
when	O
introduced	O
into	O
a	O
recombinant	O
SARS	O
-	O
CoV	O
,	O
these	O
mutations	O
result	O
in	O
a	O
highly	O
virulent	O
and	O
lethal	O
virus	B-SPEC
(	O
rMA15	O
),	O
duplicating	O
the	O
phenotype	O
of	O
the	O
biologically	O
derived	O
MA15	O
virus	B-SPEC
.	O

The	O
availability	O
of	O
the	O
MA15	O
virus	B-SPEC
will	O
enhance	O
the	O
use	O
of	O
the	O
mouse	B-SPEC
model	O
for	O
SARS	O
because	O
infection	O
with	O
MA15	O
causes	O
morbidity	O
,	O
mortality	O
,	O
and	O
pulmonary	O
pathology	O
.	O

TITLE	O
:	O
Membrane	O
topology	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
replicase	O
nonstructural	O
protein	O
3	O
.	O

The	O
spectrum	O
of	O
disseminated	O
infection	O
includes	O
acute	O
,	O
severe	O
,	O
life	O
-	O
threatening	O
sepsis	B-SPEC
and	O
chronic	O
,	O
slowly	O
progressive	O
infection	O
.	O

TITLE	O
:	O
Use	O
of	O
anti	O
-	O
coronavirus	B-SPEC
antibody	O
testing	O
of	O
cerebrospinal	O
fluid	O
for	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
involving	O
the	O
central	O
nervous	O
system	O
in	O
cats	B-SPEC
.	O

CSF	O
IgG	O
(	O
range	O
of	O
titers	O
,	O
1	O
:	O
32	O
to	O
1	O
:	O
4	O
,	O
096	O
)	O
was	O
detected	O
in	O
12	O
cats	B-SPEC
,	O
including	O
6	O
cats	B-SPEC
with	O
neurologic	O
manifestation	O
of	O
FIP	O
,	O
4	O
cats	B-SPEC
with	O
FIP	O
not	O
involving	O
the	O
CNS	O
,	O
and	O
2	O
cats	B-SPEC
with	O
brain	O
tumors	O
.	O

Blood	O
contamination	O
of	O
CSF	O
resulted	O
in	O
<	O
or	O
=	O
333	O
erythrocytes	O
/	O
microL	O
in	O
cats	B-SPEC
with	O
CSF	O
IgG	O
.	O

We	O
tested	O
a	O
prototype	O
of	O
computer	O
-	O
aided	O
differential	O
diagnosis	O
(	O
CADDY	O
)	O
on	O
simulated	O
data	O
and	O
on	O
more	O
than	O
100	O
real	O
cases	O
,	O
including	O
West	B-SPEC
Nile	I-SPEC
Virus	I-SPEC
,	O
Q	O
fever	O
,	O
SARS	O
,	O
anthrax	B-SPEC
,	O
plague	O
,	O
tularaemia	O
and	O
toxic	O
shock	O
cases	O
.	O

We	O
investigated	O
the	O
importance	O
of	O
the	O
hydrophobic	O
domain	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
A59	O
E	O
protein	O
.	O

TITLE	O
:	O
Ribonucleocapsid	O
formation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
through	O
molecular	O
action	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
N	O
protein	O
.	O

With	O
experimentally	O
placed	O
22	O
-	O
nt	O
-	O
long	O
donor	O
sequences	O
within	O
a	O
bovine	B-SPEC
coronavirus	B-SPEC
defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
we	O
have	O
shown	O
that	O
matching	O
sites	O
occurring	O
anywhere	O
within	O
a	O
65	O
-	O
nt	O
-	O
wide	O
5	O
'-	O
proximal	O
genomic	O
acceptor	O
hot	O
spot	B-SPEC
(	O
nt	O
33	O
through	O
97	O
)	O
can	O
be	O
used	O
for	O
production	O
of	O
templates	O
for	O
subgenomic	O
mRNA	O
synthesis	O
from	O
the	O
DI	O
RNA	O
.	O

Tests	O
for	O
detection	O
of	O
SARS	O
coronavirus	B-SPEC
antibody	O
were	O
performed	O
for	O
HCWs	O
at	O
these	O
2	O
time	O
points	O
and	O
for	O
control	O
subjects	O
during	O
the	O
SARS	O
epidemic	O
.	O

Cleavage	O
of	O
signal	O
peptide	O
at	O
the	O
C	O
-	O
terminus	O
of	O
HCV	B-SPEC
core	O
protein	O
by	O
SPP	O
was	O
characterized	O
in	O
this	O
study	O
.	O

niger	B-SPEC
was	O
chosen	O
as	O
a	O
surrogate	O
for	O
Bacillus	B-SPEC
anthracis	I-SPEC
.	O

Three	O
animal	B-SPEC
viruses	B-SPEC
;	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
avian	B-SPEC
pneumovirus	I-SPEC
(	O
APV	O
),	O
and	O
fowlpox	B-SPEC
virus	I-SPEC
were	O
chosen	O
as	O
surrogates	O
for	O
three	O
human	B-SPEC
viruses	B-SPEC
;	O
SARS	O
coronavirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
smallpox	B-SPEC
virus	I-SPEC
;	O
respectively	O
.	O

Although	O
the	O
virus	B-SPEC
infects	O
the	O
lungs	O
,	O
gastrointestinal	O
tract	O
,	O
liver	O
,	O
and	O
kidneys	O
,	O
the	O
disease	O
is	O
limited	O
to	O
the	O
lungs	O
,	O
where	O
diffuse	O
alveolar	O
damage	O
is	O
accompanied	O
by	O
a	O
disproportionately	O
sparse	O
inflammatory	O
infiltrate	O
.	O

ABSTRACT	O
:	O
Under	O
conditions	O
of	O
no	O
strand	O
bias	B-SPEC
the	O
number	O
of	O
Gs	O
is	O
equal	O
to	O
that	O
of	O
Cs	O
for	O
each	O
DNA	O
strand	O
;	O
similarly	O
,	O
the	O
total	O
number	O
of	O
Ts	O
is	O
equal	O
to	O
that	O
of	O
As	O
.	O

We	O
illustrate	O
the	O
use	O
of	O
DNA	O
skews	O
for	O
characterization	O
of	O
poxvirus	B-SPEC
and	O
coronavirus	B-SPEC
genomes	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
papain	O
-	O
like	O
proteases	O
have	O
overlapping	O
specificities	O
but	O
distinct	O
functions	O
in	O
viral	O
replication	O
.	O

Here	O
,	O
we	O
characterized	O
the	O
proteolytic	O
processing	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
amino	O
-	O
proximal	O
pp1a	O
/	O
pp1ab	O
region	O
by	O
two	O
paralogous	O
PLpro	O
activities	O
.	O

Commonly	O
to	O
other	O
animal	B-SPEC
coronavirus	B-SPEC
infection	O
caspase	O
-	O
3	O
is	O
likely	O
to	O
contribute	O
to	O
the	O
execution	O
phase	O
of	O
apoptosis	O
induced	O
by	O
CCoV	O
in	O
A	O
-	O
72	O
cells	O
since	O
we	O
found	O
activation	O
of	O
enzymatic	O
activity	O
as	O
well	O
as	O
procaspase	O
-	O
3	O
activating	O
cleavage	O
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
(	O
HUN	O
05	O
-	O
L20	O
)	O
clustered	O
into	O
the	O
subgroup	O
B1	O
has	O
the	O
closest	O
nucleotide	O
similarity	O
(	O
98	O
%)	O
to	O
JPS03	O
-	O
194	O
(	O
AY530094	O
)	O
detected	O
in	O
Japan	O
.	O

There	O
is	O
strong	O
and	O
sufficient	O
evidence	O
to	O
demonstrate	O
the	O
association	O
between	O
ventilation	O
,	O
air	O
movements	O
in	O
buildings	O
and	O
the	O
transmission	O
/	O
spread	O
of	O
infectious	O
diseases	O
such	O
as	O
measles	O
,	O
tuberculosis	O
,	O
chickenpox	O
,	O
influenza	O
,	O
smallpox	B-SPEC
and	O
SARS	O
.	O

From	O
each	O
calf	O
,	O
a	O
paired	O
blood	O
sample	O
was	O
obtained	O
for	O
serological	O
studies	O
of	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
-	O
3	O
,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
bovine	B-SPEC
adenovirus	B-SPEC
-	O
3	O
and	O
bovine	B-SPEC
adenovirus	B-SPEC
-	O
7	O
.	O

We	O
were	O
lucky	O
in	O
the	O
fight	O
against	O
SARS	O
,	O
the	O
virus	B-SPEC
was	O
in	O
fact	O
moderately	O
transmissible	O
and	O
then	O
only	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

We	O
therefore	O
explored	O
exosome	O
-	O
based	O
vaccines	O
containing	O
the	O
spike	O
S	O
proteins	O
of	O
SARS	O
-	O
CoV	O
.	O
S	O
-	O
containing	O
exosomes	O
were	O
obtained	O
by	O
replacing	O
the	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
of	O
the	O
S	O
protein	O
by	O
those	O
of	O
VSV	O
-	O
G	O
.	O
The	O
immunogenicity	O
and	O
efficacy	O
of	O
the	O
S	O
-	O
containing	O
exosomes	O
were	O
tested	O
in	O
mice	B-SPEC
and	O
compared	O
to	O
an	O
adenoviral	B-SPEC
vector	O
vaccine	O
expressing	O
the	O
S	O
protein	O
.	O

Human	B-SPEC
bocavirus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
Legionella	B-SPEC
,	O
Mycoplasma	B-SPEC
,	O
and	O
Chlamydophila	B-SPEC
species	B-SPEC
were	O
absent	O
or	O
appeared	O
at	O
frequencies	O
of	O
<	O
1	O
%.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
SARS	O
-	O
CoV	O
,	O
produced	O
a	O
scare	O
when	O
it	O
appeared	O
in	O
2003	O
in	O
China	O
and	O
later	O
quickly	O
spread	O
to	O
other	O
countries	O
around	O
the	O
world	O
.	O

TITLE	O
:	O
Selective	O
adaptation	O
and	O
human	B-SPEC
rights	O
to	O
health	O
in	O
China	O
.	O

For	O
experimentally	O
infected	O
samples	O
,	O
the	O
results	O
of	O
PCR	O
/	O
electrophoresis	O
were	O
in	O
complete	O
accord	O
with	O
those	O
of	O
this	O
system	O
when	O
anodic	O
currents	O
of	O
6	O
.	O
1	O
(	O
Cp	O
),	O
8	O
.	O
5	O
(	O
Hb	O
),	O
2	O
.	O
4	O
(	O
Hh	O
),	O
and	O
3	O
.	O
1	O
nA	O
(	O
MHV	B-SPEC
)	O
were	O
taken	O
as	O
the	O
cut	O
-	O
off	O
value	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
shown	O
that	O
the	O
nucleocapsid	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
activated	O
cyclooxygenase	O
-	O
2	O
(	O
COX	O
-	O
2	O
)	O
expression	O
.	O

Dating	O
of	O
different	O
coronavirus	B-SPEC
lineages	O
suggests	O
that	O
bat	B-SPEC
coronaviruses	O
are	O
older	O
than	O
those	O
recognized	O
in	O
other	O
animals	B-SPEC
and	O
that	O
the	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
was	O
directly	O
derived	O
from	O
viruses	B-SPEC
from	O
wild	O
animals	B-SPEC
in	O
wet	O
markets	O
of	O
southern	O
China	O
.	O

Further	O
surveillance	O
of	O
bat	B-SPEC
and	O
other	O
animal	B-SPEC
populations	O
is	O
needed	O
to	O
fully	O
describe	O
the	O
ecology	O
and	O
evolution	O
of	O
this	O
virus	B-SPEC
family	B-SPEC
.	O

Core	O
-	O
corona	B-SPEC
type	O
polymeric	O
nanospheres	O
have	O
applications	O
in	O
various	O
technological	O
and	O
biomedical	O
fields	O
,	O
because	O
their	O
chemical	O
structures	O
and	O
particle	O
size	O
can	O
be	O
easily	O
controlled	O
.	O

In	O
this	O
study	O
,	O
we	O
focused	O
on	O
the	O
development	O
of	O
a	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
vaccine	O
using	O
polymeric	O
nanoparticles	O
.	O

ABSTRACT	O
:	O
This	O
paper	O
characterises	O
a	O
virulent	O
strain	O
(	O
CB	O
/	O
05	O
)	O
of	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
isolated	O
from	O
the	O
internal	O
organs	O
of	O
pups	O
that	O
had	O
died	O
of	O
a	O
systemic	O
disease	O
without	O
evidence	O
of	O
other	O
common	O
canine	O
pathogens	O
.	O

CONCLUSIONS	O
:	O
Panic	O
and	O
interruption	O
of	O
daily	O
routines	O
may	O
occur	O
in	O
the	O
event	O
of	O
a	O
human	B-SPEC
avian	B-SPEC
influenza	O
outbreak	O
.	O

PTX3	O
plays	O
an	O
important	O
role	O
in	O
preventing	O
infection	O
of	O
certain	O
fungi	B-SPEC
,	O
bacteria	B-SPEC
,	O
and	O
viruses	B-SPEC
in	O
the	O
lung	O
.	O

Coronavirus	B-SPEC
and	O
parainfluenza	O
virus	B-SPEC
were	O
detected	O
in	O
one	O
patient	O
each	O
,	O
and	O
Epstein	O
-	O
Barr	O
viruses	B-SPEC
were	O
detected	O
in	O
three	O
patients	O
.	O

We	O
have	O
investigated	O
innate	O
immune	O
responses	O
to	O
both	O
viruses	B-SPEC
using	O
primary	O
human	B-SPEC
macrophages	O
and	O
respiratory	O
epithelial	O
cells	O
as	O
in	O
vitro	O
models	O
.	O

The	O
comprehensive	O
stochastic	O
spatio	O
-	O
temporal	O
models	O
have	O
considerably	O
reduced	O
the	O
complexity	O
plus	O
errors	O
as	O
compared	O
with	O
previous	O
works	O
and	O
will	O
be	O
able	O
to	O
characterize	O
other	O
various	O
epidemics	O
,	O
e	O
.	O
g	O
.	O
Avian	B-SPEC
Flu	O
.	O

ABSTRACT	O
:	O
The	O
investigation	O
of	O
interactions	O
between	O
two	O
kinds	O
of	O
monoclonal	O
antibodies	O
and	O
SARS	O
virus	B-SPEC
with	O
a	O
label	O
-	O
free	O
protein	O
array	O
technique	O
were	O
presented	O
in	O
this	O
paper	O
.	O

The	O
antiserum	O
from	O
the	O
animal	B-SPEC
immunized	O
by	O
Chap10	O
-	O
S2epi	O
recognized	O
full	O
length	O
of	O
SARS	O
coronavirus	B-SPEC
S2	O
spike	O
protein	O
.	O

CONCLUSIONS	O
:	O
The	O
predicted	O
B	O
cell	O
epitope	O
peptide	O
of	O
SARS	O
coronavirus	B-SPEC
S2	O
spike	O
protein	O
can	O
induce	O
the	O
antigenicity	O
of	O
S2	O
protein	O
,	O
which	O
provides	O
some	O
fundamental	O
data	O
for	O
developing	O
engineering	O
vaccine	O
against	O
SARS	O
coronavirus	B-SPEC
infection	O
.	O

Towards	O
this	O
,	O
we	O
cloned	O
ferret	B-SPEC
cytokines	O
and	O
established	O
semi	O
-	O
quantitative	O
real	O
-	O
time	O
PCR	O
assays	O
.	O

ABSTRACT	O
:	O
Between	O
2003	O
and	O
2005	O
,	O
four	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
isolated	O
from	O
the	O
vaccinated	O
chicken	B-SPEC
flocks	O
in	O
China	O
.	O

To	O
appreciate	O
the	O
studies	O
validity	O
,	O
we	O
scored	O
the	O
quality	O
evidence	O
of	O
the	O
studies	O
in	O
order	B-SPEC
to	O
grade	O
our	O
conclusions	O
.	O

Experimental	O
vector	O
IB	O
vaccines	O
and	O
genetically	O
manipulated	O
IBVs	O
--	O
with	O
heterologous	O
spike	O
protein	O
genes	O
--	O
have	O
produced	O
promising	O
results	O
,	O
including	O
in	O
the	O
context	O
of	O
in	O
ovo	B-SPEC
vaccination	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
is	O
a	O
global	O
respiratory	O
tract	O
pathogen	O
;	O
however	O
,	O
the	O
epidemiology	O
of	O
this	O
virus	B-SPEC
in	O
subtropical	O
area	O
is	O
not	O
well	O
known	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
was	O
used	O
to	O
detect	O
1b	O
gene	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

By	O
emphasizing	O
these	O
six	O
basic	O
concepts	O
,	O
a	O
rural	O
ED	O
passed	O
an	O
annual	O
state	O
-	O
run	O
bioterrorism	O
mass	O
-	O
casualty	O
drill	B-SPEC
.	O

TITLE	O
:	O
An	O
antibody	O
derivative	O
expressed	O
from	O
viral	O
vectors	O
passively	O
immunizes	O
pigs	B-SPEC
against	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
infection	O
when	O
supplied	O
orally	O
in	O
crude	O
plant	B-SPEC
extracts	O
.	O

A	O
1	O
-	O
year	O
study	O
was	O
undertaken	O
on	O
children	O
hospitalized	O
consecutively	O
for	O
acute	O
respiratory	O
infection	O
in	O
a	O
Pediatric	O
Department	O
in	O
Rome	O
to	O
characterize	O
the	O
viruses	B-SPEC
involved	O
.	O

Patients	O
in	O
this	O
group	O
developed	O
a	O
number	O
of	O
complications	O
,	O
inter	O
alia	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
acute	O
renal	O
failure	O
,	O
blackwater	O
fever	O
,	O
severe	O
anemia	B-SPEC
,	O
disseminated	O
intravascular	O
coagulation	O
,	O
myocarditis	O
,	O
consciousness	O
disorders	O
of	O
varied	O
degree	O
,	O
acute	O
transient	O
psychoses	O
,	O
and	O
exacerbation	O
of	O
ischemic	O
heart	O
disease	O
.	O

We	O
aim	O
to	O
characterize	O
the	O
impact	O
of	O
natural	O
mutations	O
within	O
the	O
RBDs	O
of	O
civet	B-SPEC
-	O
CoVs	O
on	O
viral	O
entry	O
and	O
cross	O
-	O
neutralization	O
.	O

Convalescence	O
-	O
phase	O
sera	O
from	O
humans	B-SPEC
were	O
similarly	O
ineffective	O
against	O
the	O
dominant	O
civet	B-SPEC
pseudovirus	O
.	O

Eight	O
of	O
the	O
cats	B-SPEC
had	O
been	O
vaccinated	O
previously	O
;	O
however	O
,	O
owners	O
were	O
unable	O
to	O
fully	O
describe	O
the	O
type	O
of	O
vaccine	O
and	O
date	O
of	O
administration	O
.	O

Furthermore	O
,	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
infection	O
could	O
not	O
prevent	O
IFN	O
induction	O
by	O
poly	O
(	O
I	O
:	O
C	O
)	O
or	O
Sendai	B-SPEC
virus	I-SPEC
,	O
suggesting	O
that	O
these	O
CoVs	O
do	O
not	O
inactivate	O
IRF3	O
-	O
mediated	O
transcription	O
regulation	O
,	O
but	O
apparently	O
prevent	O
detection	O
of	O
replicative	O
RNA	O
by	O
cellular	O
sensory	O
molecules	O
.	O

Results	O
from	O
this	O
study	O
show	O
that	O
free	O
-	O
ranging	O
maned	O
wolves	O
in	O
a	O
remote	O
area	O
of	O
Bolivia	O
have	O
been	O
exposed	O
to	O
multiple	O
infectious	O
and	O
parasitic	O
agents	O
of	O
domestic	O
carnivores	B-SPEC
,	O
including	O
CAV	B-SPEC
,	O
CDV	B-SPEC
,	O
CPV	B-SPEC
,	O
canine	O
coronavirus	B-SPEC
,	O
rabies	B-SPEC
virus	I-SPEC
,	O
Leptospira	B-SPEC
interrogans	I-SPEC
spp	O
.,	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
and	O
Dirofilaria	B-SPEC
immitis	I-SPEC
,	O
and	O
may	O
be	O
at	O
increased	O
risk	O
for	O
disease	O
due	O
to	O
these	O
agents	O
.	O

TITLE	O
:	O
Ranpirnase	O
:	O
amphibian	B-SPEC
ribonuclease	O
A	O
,	O
P	O
-	O
30	O
protein	O
-	O
alfacell	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
attenuates	O
acute	O
endotoxin	O
-	O
induced	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

However	O
,	O
a	O
notable	O
exception	O
is	O
the	O
receptor	O
utilization	O
by	O
group	O
3	O
coronaviruses	O
,	O
including	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

A	O
recent	O
report	O
has	O
also	O
suggested	O
a	O
role	O
for	O
fAPN	O
during	O
IBV	B-SPEC
entry	O
(	O
Miguel	O
B	O
,	O
Pharr	O
GT	O
,	O
Wang	O
C	O
:	O
The	O
role	O
of	O
feline	B-SPEC
aminopeptidase	O
N	O
as	O
a	O
receptor	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

We	O
also	O
show	O
that	O
BHK	O
-	O
21	O
cells	O
are	O
slightly	O
susceptible	O
to	O
certain	O
IBV	B-SPEC
strains	O
,	O
including	O
Ark99	O
,	O
Ark_DPI	O
,	O
CA99	O
,	O
and	O
Iowa97	O
(<	O
0	O
.	O
01	O
%	O
efficiency	O
),	O
but	O
this	O
level	O
of	O
infection	O
is	O
not	O
increased	O
by	O
fAPN	O
expression	O
.	O

In	O
addition	O
to	O
SARS	O
-	O
like	O
coronaviruses	O
,	O
many	O
other	O
novel	O
bat	B-SPEC
coronaviruses	O
,	O
which	O
belong	O
to	O
groups	O
1	O
and	O
2	O
of	O
the	O
3	O
existing	O
coronavirus	B-SPEC
groups	O
,	O
have	O
been	O
detected	O
by	O
PCR	O
.	O

The	O
substantial	O
scientific	O
contributions	O
made	O
by	O
the	O
Chinese	O
scientists	O
towards	O
understanding	O
the	O
virus	B-SPEC
and	O
the	O
disease	O
will	O
be	O
emphasized	O
.	O

Significantly	O
,	O
most	O
of	O
the	O
second	O
site	O
changes	O
in	O
the	O
R227E	O
mutant	O
viruses	B-SPEC
were	O
previously	O
shown	O
to	O
compensate	O
for	O
the	O
removal	O
of	O
negative	O
charges	O
in	O
the	O
N	O
protein	O
.	O

In	O
MHV	B-SPEC
lesions	O
,	O
Myt1	O
was	O
not	O
expressed	O
in	O
astrocytes	O
,	O
lymphocytes	O
,	O
or	O
macrophage	O
/	O
microglial	O
cells	O
.	O

A	O
third	O
patient	O
presented	O
with	O
an	O
upper	O
respiratory	O
tract	O
infection	O
but	O
coronavirus	B-SPEC
was	O
not	O
isolated	O
.	O

Both	O
patients	O
with	O
coronavirus	B-SPEC
required	O
prolonged	O
admission	O
to	O
hospital	O
and	O
extensive	O
investigations	O
because	O
they	O
were	O
HIV	B-SPEC
infected	O
.	O

TITLE	O
:	O
Heterologous	O
viral	O
RNA	O
export	O
elements	O
improve	O
expression	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
protective	O
efficacy	O
of	O
DNA	O
vaccines	O
against	O
SARS	O
.	O

Upon	O
immunization	O
of	O
mice	B-SPEC
with	O
low	O
doses	O
(	O
2	O
microg	O
)	O
of	O
naked	O
DNA	O
,	O
only	O
intron	O
and	O
WPRE	O
-	O
containing	O
vectors	O
could	O
induce	O
neutralizing	O
anti	O
-	O
S	O
antibodies	O
and	O
provide	O
protection	O
against	O
challenge	O
with	O
SARS	O
-	O
CoV	O
.	O
Our	O
observations	O
are	O
likely	O
to	O
be	O
useful	O
for	O
the	O
construction	O
of	O
plasmid	O
and	O
viral	O
vectors	O
designed	O
for	O
optimal	O
expression	O
of	O
intronless	O
genes	O
derived	O
from	O
cytoplasmic	O
RNA	O
viruses	B-SPEC
.	O

There	O
are	O
worldwide	O
concerns	O
of	O
an	O
impending	O
avian	B-SPEC
influenza	O
outbreak	O
,	O
with	O
nations	O
formulating	O
infection	O
control	O
strategies	O
to	O
prepare	O
for	O
such	O
an	O
event	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
have	O
demonstrated	O
that	O
the	O
concentration	O
of	O
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
transiently	O
increases	O
in	O
asymptomatic	O
cats	B-SPEC
infected	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
).	O

In	O
order	B-SPEC
to	O
establish	O
whether	O
these	O
fluctuations	O
depend	O
on	O
the	O
FCoV	O
status	O
,	O
the	O
serum	O
concentration	O
of	O
AGP	O
and	O
anti	O
-	O
FCoV	O
antibody	O
titres	O
and	O
/	O
or	O
faecal	O
shedding	O
of	O
FCoVs	O
in	O
clinically	O
healthy	O
cats	B-SPEC
from	O
catteries	O
with	O
different	O
levels	O
of	O
prevalence	O
of	O
FCoV	O
infection	O
were	O
monitored	O
over	O
time	O
.	O

In	O
uninfected	O
mice	B-SPEC
,	O
prolonged	O
P	O
-	O
PMO	O
treatment	O
did	O
not	O
result	O
in	O
weight	O
loss	O
or	O
detectable	O
histopathologic	O
changes	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
mid	O
60	O
'	O
s	O
the	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
),	O
represented	O
by	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
were	O
generally	O
considered	O
relatively	O
harmless	O
viruses	B-SPEC
.	O

Most	O
mice	B-SPEC
exposed	O
to	O
bedding	O
contaminated	O
with	O
MPV	B-SPEC
0	O
,	O
3	O
,	O
or	O
7	O
d	O
previously	O
seroconverted	O
,	O
whereas	O
only	O
mice	B-SPEC
exposed	O
to	O
bedding	O
contaminated	O
with	O
MHV	B-SPEC
4	O
h	O
previously	O
seroconverted	O
,	O
thus	O
confirming	O
the	O
differing	O
stabilities	O
of	O
these	O
viruses	B-SPEC
.	O

Index	O
mice	B-SPEC
were	O
inoculated	O
with	O
30	O
times	O
the	O
infectious	O
dose	O
50	O
(	O
ID50	O
)	O
of	O
MPV	B-SPEC
or	O
300	O
ID50	O
of	O
MHV	B-SPEC
.	O

ABSTRACT	O
:	O
Fragments	O
within	O
S1	O
genes	O
((	O
poly100	O
)	O
S1	O
)	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
ZJ971	O
,	O
M41	O
and	O
SC021202	O
(	O
SC	O
)	O
were	O
subcloned	O
into	O
a	O
prokaryotic	O
expression	O
vector	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	O
oxygenation	O
and	O
sepsis	B-SPEC
.	O

The	O
last	O
indication	O
is	O
generally	O
more	O
applicable	O
in	O
children	O
than	O
adults	O
,	O
because	O
of	O
differences	O
in	O
the	O
cardiovascular	O
response	O
to	O
severe	O
sepsis	B-SPEC
seen	O
across	O
age	O
groups	O
.	O

The	O
topics	O
covered	O
are	O
influenza	O
,	O
avian	B-SPEC
influenza	O
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Confocal	O
microscopy	O
revealed	O
that	O
cyclin	O
D1	O
decreased	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
as	O
infection	O
progressed	O
and	O
inhibition	O
studies	O
indicated	O
that	O
a	O
population	O
of	O
cyclin	O
D1	O
could	O
be	O
targeted	O
for	O
degradation	O
by	O
a	O
virus	B-SPEC
mediated	O
pathway	O
.	O

TITLE	O
:	O
A	O
dominant	O
antigenic	O
epitope	O
on	O
SARS	O
-	O
CoV	O
spike	O
protein	O
identified	O
by	O
an	O
avian	B-SPEC
single	O
-	O
chain	O
variable	O
fragment	O
(	O
scFv	O
)-	O
expressing	O
phage	O
.	O

In	O
this	O
paper	O
,	O
a	O
synthesis	O
of	O
the	O
information	O
available	O
on	O
selected	O
zoonoses	O
of	O
wildlife	O
origin	O
is	O
given	O
,	O
with	O
special	O
reference	O
to	O
sylvatic	O
tick	B-SPEC
-	O
borne	O
zoonoses	O
in	O
North	O
-	O
western	O
Italy	O
.	O

Thus	O
,	O
the	O
anti	O
-	O
cancer	B-SPEC
utility	O
of	O
suppressing	O
Bcl	O
-	O
2	O
in	O
cancer	B-SPEC
cells	O
is	O
limited	O
.	O

Specifically	O
,	O
the	O
unmethylated	O
CpG	O
ODN	O
(	O
and	O
/	O
or	O
the	O
phosphorothioate	O
group	O
)	O
activates	O
the	O
immune	O
system	O
,	O
but	O
this	O
potentially	O
important	O
anti	O
-	O
cancer	B-SPEC
effect	O
is	O
lost	O
when	O
the	O
immune	O
cells	O
undergo	O
premature	O
apoptosis	O
apparently	O
because	O
their	O
Bcl	O
-	O
2	O
levels	O
have	O
been	O
lowered	O
by	O
the	O
antisense	O
effect	O
of	O
G3139	O
.	O

These	O
results	O
demonstrate	O
that	O
DRAK2	O
signaling	O
is	O
dispensable	O
for	O
T	O
cell	O
recruitment	O
into	O
the	O
CNS	O
following	O
viral	O
infection	O
,	O
suggesting	O
that	O
the	O
resistance	O
of	O
Drak2	O
-	O
/	O
-	O
mice	B-SPEC
to	O
EAE	O
is	O
not	O
due	O
to	O
overt	O
T	O
cell	O
trafficking	O
defects	O
.	O

However	O
,	O
all	O
bursa	B-SPEC
of	O
Fabrcius	O
tissues	O
analysed	O
were	O
negative	O
.	O

ABSTRACT	O
:	O
Attenuated	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccines	O
are	O
available	O
but	O
the	O
relationship	O
between	O
sequence	O
and	O
virulence	O
is	O
not	O
clear	O
.	O

TITLE	O
:	O
Bioactive	O
coumarins	O
from	O
Boenninghausenia	B-SPEC
sessilicarpa	O
.	O

Viral	O
evasion	O
of	O
innate	O
immunity	O
,	O
hypercytokinemia	O
and	O
systemic	O
immunopathology	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
infected	O
host	O
have	O
been	O
suggested	O
as	O
possible	O
mechanisms	O
for	O
the	O
cause	O
of	O
severe	O
pathology	O
and	O
morbidity	O
in	O
SARS	O
patients	O
.	O

The	O
patient	O
had	O
suffered	O
severe	O
traumatic	O
brain	O
injury	O
,	O
the	O
Glasgow	O
coma	B-SPEC
score	O
(	O
GCS	O
)	O
was	O
four	O
and	O
there	O
were	O
signs	O
of	O
aspiration	O
of	O
gastric	O
contents	O
.	O

Residues	O
248	O
-	O
280	O
form	O
a	O
positively	O
charged	O
groove	O
similar	O
to	O
that	O
found	O
in	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
nucleocapsid	O
protein	O
.	O

TITLE	O
:	O
The	O
hypothalamic	O
pituitary	O
adrenal	O
axis	B-SPEC
in	O
sepsis	B-SPEC
.	O

Several	O
'	O
negative	O
'	O
randomized	O
controlled	O
trials	O
of	O
high	O
-	O
dose	O
of	O
glucocorticoids	O
given	O
for	O
a	O
short	O
period	O
of	O
time	O
in	O
the	O
early	O
course	O
of	O
severe	O
sepsis	B-SPEC
or	O
acute	O
respiratory	O
distress	O
syndrome	O
raised	O
serious	O
doubts	O
as	O
to	O
the	O
benefit	O
of	O
this	O
treatment	O
.	O

TITLE	O
:	O
TNF	O
-	O
alpha	O
,	O
produced	O
by	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)-	O
infected	O
macrophages	O
,	O
upregulates	O
expression	O
of	O
type	O
II	O
FIPV	B-SPEC
receptor	O
feline	B-SPEC
aminopeptidase	O
N	O
in	O
feline	B-SPEC
macrophages	O
.	O

It	O
was	O
demonstrated	O
that	O
a	O
heat	O
-	O
resistant	O
fAPN	O
-	O
inducing	O
factor	O
was	O
present	O
in	O
the	O
culture	O
supernatant	O
of	O
FIPV	O
-	O
infected	O
macrophages	O
,	O
and	O
this	O
factor	O
was	O
TNF	O
-	O
alpha	O
:	O
fAPN	O
expression	O
was	O
upregulated	O
in	O
recombinant	O
feline	B-SPEC
TNF	O
-	O
alpha	O
-	O
treated	O
macrophages	O
,	O
and	O
FIPV	O
infectivity	O
was	O
increased	O
in	O
these	O
macrophages	O
.	O

On	O
January	O
2004	O
the	O
disease	O
crossed	O
over	O
to	O
humans	B-SPEC
,	O
for	O
the	O
first	O
time	O
in	O
Vietnam	O
,	O
causing	O
74	O
deaths	O
to	O
date	O
(	O
mortality	O
rate	O
of	O
50	O
%)	O
in	O
southeastern	O
countries	O
.	O

The	O
SARS	O
coronavirus	B-SPEC
targets	O
the	O
epithelial	O
cells	O
of	O
the	O
respiratory	O
tract	O
,	O
resulting	O
in	O
diffuse	O
alveolar	O
damage	O
.	O

We	O
generated	O
polyclonal	O
antisera	O
directed	O
against	O
two	O
of	O
the	O
predicted	O
replicase	O
nonstructural	O
proteins	O
(	O
nsp3	O
and	O
nsp4	O
)	O
and	O
detected	O
replicase	O
proteins	O
from	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
infected	O
LLC	O
-	O
MK2	O
cells	O
by	O
immunofluorescence	O
,	O
immunoprecipitation	O
,	O
and	O
Western	O
blot	O
assays	O
.	O

The	O
identification	O
of	O
the	O
replicase	O
products	O
and	O
characterization	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
PLP	O
DUB	O
activity	O
will	O
facilitate	O
comparative	O
studies	O
of	O
CoV	O
proteases	O
and	O
aid	O
in	O
the	O
development	O
of	O
novel	O
antiviral	O
reagents	O
directed	O
against	O
human	B-SPEC
pathogens	O
such	O
as	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
SARS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Identification	O
and	O
characterization	O
of	O
dominant	O
helper	O
T	O
-	O
cell	O
epitopes	O
in	O
the	O
nucleocapsid	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
By	O
using	O
a	O
series	O
of	O
overlapping	O
synthetic	O
peptides	O
covering	O
98	O
%	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
nucleocapsid	O
protein	O
(	O
NP	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
four	O
helper	O
T	O
-	O
cell	O
(	O
Th	O
)	O
epitopes	O
(	O
NP11	O
,	O
residues	O
11	O
to	O
25	O
;	O
NP51	O
,	O
residues	O
51	O
to	O
65	O
;	O
NP61	O
,	O
residues	O
61	O
to	O
75	O
;	O
and	O
NP111	O
,	O
residues	O
111	O
to	O
125	O
)	O
in	O
C57BL	O
mice	B-SPEC
(	O
H	O
-	O
2	O
(	O
b	O
)),	O
four	O
(	O
NP21	O
,	O
residues	O
21	O
to	O
35	O
;	O
NP91	O
,	O
residues	O
91	O
to	O
105	O
;	O
NP331	O
,	O
residues	O
331	O
to	O
345	O
;	O
and	O
NP351	O
,	O
residues	O
351	O
to	O
365	O
)	O
in	O
C3H	O
mice	B-SPEC
(	O
H	O
-	O
2	O
(	O
k	O
)),	O
and	O
two	O
(	O
NP81	O
,	O
residues	O
81	O
to	O
95	O
;	O
and	O
NP351	O
,	O
residues	O
351	O
to	O
365	O
)	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
(	O
H	O
-	O
2	O
(	O
d	O
))	O
have	O
been	O
identified	O
.	O

Volunteers	O
from	O
employees	O
of	O
the	O
animal	B-SPEC
market	O
were	O
recruited	O
and	O
their	O
serum	O
specific	O
antibody	O
against	O
SARS	O
-	O
CoV	O
were	O
determined	O
by	O
enzyme	O
linked	O
immunesorbent	O
assay	O
(	O
ELISA	O
)	O
method	O
.	O

TITLE	O
:	O
Identification	O
of	O
new	O
human	B-SPEC
coronaviruses	O
.	O

In	O
the	O
mid	O
1960s	O
,	O
two	O
human	B-SPEC
coronaviruses	O
were	O
identified	O
that	O
cause	O
the	O
common	O
cold	O
:	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
)-	O
229E	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
.	O

The	O
human	B-SPEC
diphtheria	O
toxin	O
(	O
DT	O
)	O
receptor	O
(	O
DTR	O
),	O
heparin	O
-	O
binding	O
epidermal	O
growth	O
factor	O
-	O
like	O
growth	O
factor	O
(	O
HB	O
-	O
EGF	O
),	O
was	O
expressed	O
under	O
the	O
control	O
of	O
the	O
lysozyme	O
M	O
(	O
LysM	O
)	O
gene	O
promoter	O
in	O
the	O
mice	B-SPEC
.	O

When	O
DT	O
was	O
administrated	O
to	O
the	O
mice	B-SPEC
they	O
suffered	O
from	O
acute	O
lung	O
injury	O
and	O
died	O
within	O
4	O
days	O
.	O

Immunohistochemical	O
examination	O
revealed	O
that	O
AE2	O
cells	O
as	O
well	O
as	O
alveolar	O
macrophages	O
were	O
deleted	O
via	O
apoptosis	O
in	O
the	O
mice	B-SPEC
treated	O
with	O
DT	O
.	O

The	O
respiratory	O
syndrome	O
,	O
as	O
showed	O
by	O
chest	O
x	O
-	O
ray	B-SPEC
,	O
computed	O
tomography	O
scan	O
,	O
and	O
nuclear	O
magnetic	O
resonance	O
imaging	O
,	O
was	O
related	O
to	O
a	O
recurrent	O
giant	O
multiple	O
hemangioma	O
,	O
creating	O
a	O
prominent	O
compression	O
of	O
right	O
lung	O
with	O
left	O
mediastinal	O
shift	O
and	O
left	O
heart	O
dislocation	O
.	O

She	O
died	O
6	O
months	O
later	O
from	O
respiratory	O
insufficiency	O
and	O
hypercapnic	O
coma	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
review	O
examines	O
perspectives	O
of	O
human	B-SPEC
infection	O
with	O
avian	B-SPEC
influenza	O
A	O
H5N1	O
(	O
AI	O
H5N1	O
),	O
specifically	O
focusing	O
on	O
the	O
presentation	O
,	O
diagnosis	O
,	O
and	O
management	O
of	O
those	O
critically	O
ill	O
with	O
AI	O
H5N1	O
.	O

Because	O
of	O
the	O
nonspecific	O
clinical	O
,	O
laboratory	O
,	O
and	O
radiologic	O
features	O
,	O
it	O
is	O
critical	O
to	O
seek	O
a	O
history	O
of	O
exposure	O
to	O
poultry	O
or	O
wild	O
birds	B-SPEC
in	O
suspected	O
cases	O
.	O

TITLE	O
:	O
Vaccines	O
to	O
prevent	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
-	O
induced	O
disease	O
.	O

Several	O
types	O
of	O
vaccines	O
have	O
been	O
developed	O
including	O
inactivated	O
viruses	B-SPEC
,	O
subunit	O
vaccines	O
,	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
),	O
DNA	O
vaccines	O
,	O
heterologous	O
expression	O
systems	O
,	O
and	O
vaccines	O
derived	O
from	O
SARS	O
-	O
CoV	O
genome	O
by	O
reverse	O
genetics	O
.	O

Reverse	O
genetic	O
or	O
'	O
infectious	O
clone	O
'	O
systems	O
,	O
which	O
allow	O
the	O
manipulation	O
of	O
the	O
IBV	B-SPEC
genome	O
,	O
are	O
key	O
to	O
this	O
development	O
.	O

New	O
vaccines	O
would	O
ideally	O
be	O
:	O
genetically	O
stable	O
(	O
i	O
.	O
e	O
.	O
maintain	O
a	O
stable	O
attenuated	O
phenotype	O
);	O
administered	O
in	O
ovo	B-SPEC
;	O
and	O
be	O
flexible	O
with	O
respect	O
to	O
the	O
source	O
of	O
the	O
spike	O
protein	O
gene	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
by	O
equine	B-SPEC
neutralizing	O
antibody	O
in	O
golden	O
Syrian	B-SPEC
hamsters	I-SPEC
.	O

In	O
this	O
study	O
,	O
after	O
verification	O
by	O
various	O
methods	O
that	O
the	O
golden	O
Syrian	B-SPEC
hamster	I-SPEC
constitutes	O
a	O
model	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
infection	O
,	O
we	O
confirmed	O
that	O
the	O
antibody	O
could	O
protect	O
animals	B-SPEC
completely	O
from	O
SARS	O
-	O
CoV	O
infection	O
in	O
the	O
preventive	O
setting	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
antiviral	O
activity	O
of	O
plant	B-SPEC
lectins	O
with	O
specificity	O
for	O
different	O
glycan	O
structures	O
against	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
the	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
7a	O
protein	O
,	O
which	O
is	O
not	O
expressed	O
by	O
other	O
known	O
coronaviruses	O
,	O
can	O
induce	O
apoptosis	O
in	O
various	O
cell	O
lines	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
the	O
largest	O
RNA	O
viruses	B-SPEC
,	O
and	O
their	O
genomes	O
encode	O
replication	O
machinery	O
capable	O
of	O
efficient	O
replication	O
of	O
both	O
positive	O
-	O
and	O
negative	O
-	O
strand	O
viral	O
RNAs	O
as	O
well	O
as	O
enzymes	O
capable	O
of	O
processing	O
large	O
viral	O
polyproteins	O
into	O
putative	O
replication	O
intermediates	O
and	O
mature	O
proteins	O
.	O

ABSTRACT	O
:	O
Chicken	B-SPEC
nephropathogenic	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
was	O
prevalent	O
in	O
the	O
most	O
chicken	B-SPEC
farms	O
during	O
recent	O
years	O
,	O
although	O
the	O
IB	O
vaccination	O
program	O
has	O
been	O
widely	O
performed	O
in	O
China	O
.	O

The	O
results	O
reflect	O
the	O
social	O
workers	O
'	O
subjective	O
experience	O
of	O
their	O
interventions	O
with	O
patients	O
and	O
families	O
and	O
indicate	O
that	O
a	O
number	O
of	O
professional	O
tenets	O
,	O
such	O
as	O
advocacy	O
,	O
family	B-SPEC
-	O
centered	O
approach	O
,	O
knowledge	O
of	O
systems	O
,	O
open	O
communication	O
,	O
and	O
ethics	O
effectively	O
supported	O
social	O
work	O
practice	O
in	O
a	O
crisis	O
environment	O
.	O

TITLE	O
:	O
Quasispecies	O
of	O
bovine	B-SPEC
enteric	O
and	O
respiratory	O
coronaviruses	O
based	O
on	O
complete	O
genome	O
sequences	O
and	O
genetic	O
changes	O
after	O
tissue	O
culture	O
adaptation	O
.	O

ABSTRACT	O
:	O
The	O
genetic	O
diversity	O
of	O
2	O
pairs	O
(	O
AH65	O
and	O
AH187	O
)	O
of	O
wild	O
type	O
bovine	B-SPEC
coronaviruses	O
(	O
BCoV	O
)	O
sequenced	O
directly	O
from	O
nasal	O
(	O
respiratory	O
)	O
and	O
rectal	O
(	O
enteric	O
)	O
swabs	O
of	O
two	O
feedlot	O
calves	O
with	O
respiratory	O
and	O
enteric	O
symptoms	O
[	O
Hasoksuz	O
,	O
M	O
.,	O
Sreevatsan	O
,	O
S	O
.,	O
Cho	O
,	O
K	O
.	O
O	O
.,	O
Hoet	O
,	O
A	O
.	O
E	O
.,	O
Saif	O
,	O
L	O
.	O
J	O
.,	O
2002b	O
.	O

The	O
tissue	O
culture	O
(	O
TC	O
)	O
passaged	O
counterparts	O
of	O
AH65	O
respiratory	O
BCoV	O
(	O
AH65	O
-	O
R	O
-	O
TC	O
)	O
and	O
enteric	O
BCoV	O
(	O
AH65	O
-	O
E	O
-	O
TC	O
)	O
were	O
also	O
sequenced	O
after	O
14	O
and	O
15	O
passages	O
and	O
1	O
plaque	O
purification	O
in	O
human	B-SPEC
rectal	O
tumor	O
cells	O
(	O
HRT	O
-	O
18	O
),	O
respectively	O
.	O

The	O
immunized	O
mice	B-SPEC
showed	O
no	O
clinic	O
symptom	O
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
orally	O
with	O
SL7207	O
harboring	O
recombinant	O
plasmid	O
at	O
the	O
dosage	O
of	O
109	O
and	O
boosted	O
two	O
weeks	O
later	O
with	O
the	O
same	O
dose	O
,	O
for	O
a	O
total	O
of	O
three	O
times	O
.	O

This	O
report	O
is	O
noteworthy	O
because	O
it	O
is	O
the	O
first	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
demonstrating	O
the	O
presence	O
of	O
antibody	O
against	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
in	O
human	B-SPEC
milk	O
.	O

Our	O
data	O
also	O
suggest	O
that	O
the	O
46	O
-	O
LRLGSQLSL	O
-	O
54	O
amino	O
acid	O
sequence	O
of	O
9b	O
functions	O
as	O
a	O
nuclear	O
export	O
signal	O
(	O
NES	B-SPEC
).	O

Major	O
complications	O
during	O
ECMO	O
included	O
hemorrhage	O
(	O
52	O
%),	O
hemodialysis	O
(	O
42	O
%),	O
neurologic	O
(	O
12	O
%),	O
and	O
cardiac	O
(	O
28	O
%)	O
complications	O
,	O
inotropic	O
support	O
(	O
77	O
%),	O
and	O
sepsis	B-SPEC
(	O
15	O
%).	O

Two	O
calculation	O
examples	O
,	O
the	O
peptide	O
substrate	O
specificity	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
proteinase	O
and	O
the	O
affinity	O
prediction	O
for	O
epitope	O
-	O
peptides	O
with	O
Class	B-SPEC
I	O
MHC	O
molecules	O
are	O
studied	O
by	O
using	O
the	O
peptide	O
reagent	O
design	O
strategy	O
.	O

Alignment	O
of	O
10	O
complete	O
viral	O
genome	O
sequences	O
from	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
with	O
those	O
of	O
human	B-SPEC
SARS	O
-	O
CoVs	O
revealed	O
26	O
conserved	O
single	O
-	O
nucleotide	O
variations	O
(	O
SNVs	O
)	O
in	O
the	O
viruses	B-SPEC
from	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
.	O

Apart	O
from	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
and	O
bats	B-SPEC
,	O
29	O
other	O
animal	B-SPEC
species	B-SPEC
had	O
been	O
tested	O
for	O
the	O
SARS	O
-	O
CoV	O
,	O
and	O
the	O
results	O
are	O
summarized	O
in	O
this	O
paper	O
.	O

In	O
conclusion	O
,	O
SARS	O
coronavirus	B-SPEC
N	O
protein	O
can	O
induce	O
apoptosis	O
of	O
COS	O
-	O
1	O
cells	O
by	O
activating	O
mitochondrial	O
pathway	O
.	O

SARS	O
coronavirus	B-SPEC
M	O
,	O
S	O
protein	O
can	O
not	O
induce	O
apoptosis	O
in	O
COS	O
-	O
1	O
,	O
HepG2	O
and	O
Huh	O
-	O
7	O
and	O
SARS	O
coronavirus	B-SPEC
N	O
protein	O
can	O
not	O
induce	O
apoptosis	O
in	O
HepG2	O
and	O
Huh	O
-	O
7	O
by	O
methods	O
used	O
in	O
this	O
study	O
.	O

Aspiration	O
resulted	O
from	O
the	O
patient	O
'	O
s	O
father	O
inducing	O
emesis	B-SPEC
by	O
digital	O
stimulation	O
of	O
the	O
boy	O
'	O
s	O
throat	O
after	O
the	O
patient	O
had	O
ingested	O
an	O
unknown	O
amount	O
of	O
lamp	O
oil	O
.	O

ABSTRACT	O
:	O
Rhinoviruses	B-SPEC
and	O
coronaviruses	O
cause	O
the	O
majority	O
of	O
common	O
colds	O
and	O
play	O
a	O
part	O
in	O
more	O
serious	O
respiratory	O
illnesses	O
that	O
lead	O
to	O
increased	O
morbidity	O
and	O
mortality	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
viruses	I-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
,	O
and	O
adenoviruses	B-SPEC
cause	O
the	O
most	O
serious	O
disease	O
in	O
immunocompromised	O
hosts	O
,	O
but	O
other	O
respiratory	O
viruses	B-SPEC
are	O
becoming	O
increasingly	O
appreciated	O
as	O
a	O
cause	O
of	O
both	O
upper	O
and	O
lower	O
respiratory	O
tract	O
disease	O
.	O

TITLE	O
:	O
Analysis	O
of	O
the	O
genome	O
sequence	O
of	O
an	O
alpaca	B-SPEC
coronavirus	B-SPEC
.	O

In	O
order	B-SPEC
to	O
understand	O
this	O
infection	O
,	O
one	O
of	O
the	O
coronavirus	B-SPEC
isolates	O
was	O
sequenced	O
and	O
analyzed	O
.	O

This	O
virus	B-SPEC
designated	O
as	O
ACoV	O
-	O
00	O
-	O
1381	O
(	O
ACoV	O
)	O
encodes	O
all	O
10	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
characteristic	O
of	O
Group	O
2	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

The	O
Bayesian	O
approach	O
demonstrated	O
that	O
when	O
the	O
pretest	O
probability	O
of	O
FIP	O
is	O
high	O
,	O
based	O
on	O
history	O
and	O
clinical	O
signs	O
(	O
groups	O
1	O
or	O
2a	O
),	O
moderate	O
serum	O
AGP	O
levels	O
(	O
1	O
.	O
5	O
-	O
2	O
mg	O
/	O
ml	O
)	O
can	O
discriminate	O
cats	B-SPEC
with	O
FIP	O
from	O
others	O
,	O
while	O
only	O
high	O
serum	O
AGP	O
levels	O
(>	O
3	O
mg	O
/	O
ml	O
)	O
can	O
support	O
a	O
diagnosis	O
of	O
FIP	O
in	O
cats	B-SPEC
with	O
a	O
low	O
pretest	O
probability	O
of	O
disease	O
(	O
groups	O
2b	O
to	O
2e	O
).	O

These	O
findings	O
show	O
that	O
MHV	B-SPEC
employs	O
unique	O
strategies	O
to	O
circumvent	O
the	O
IFN	O
-	O
alpha	O
/	O
beta	O
response	O
at	O
multiple	O
steps	O
.	O

TITLE	O
:	O
Detection	O
of	O
a	O
novel	O
and	O
highly	O
divergent	O
coronavirus	B-SPEC
from	O
asian	O
leopard	B-SPEC
cats	I-SPEC
and	O
Chinese	O
ferret	B-SPEC
badgers	O
in	O
Southern	O
China	O
.	O

Bats	B-SPEC
have	O
provided	O
the	O
most	O
diverse	O
assemblages	O
of	O
coronaviruses	O
,	O
suggesting	O
that	O
they	O
may	O
be	O
the	O
natural	O
reservoir	O
.	O

This	O
study	O
demonstrates	O
the	O
importance	O
of	O
systematic	O
virological	O
surveillance	O
in	O
market	O
animals	B-SPEC
for	O
understanding	O
the	O
evolution	O
and	O
emergence	O
of	O
viruses	B-SPEC
with	O
infectious	O
potential	O
.	O

ABSTRACT	O
:	O
A	O
case	O
of	O
a	O
young	O
man	B-SPEC
with	O
community	O
-	O
acquired	O
pneumonia	O
,	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
sepsis	B-SPEC
is	O
reported	O
.	O

In	O
order	B-SPEC
to	O
understand	O
the	O
acquired	O
tropism	O
of	O
the	O
Beaudette	O
strain	O
,	O
we	O
compared	O
the	O
S	O
protein	O
sequences	O
of	O
several	O
IBV	B-SPEC
strains	O
.	O

TITLE	O
:	O
Serosurvey	O
of	O
infectious	O
disease	O
agents	O
of	O
carnivores	B-SPEC
in	O
captive	O
red	B-SPEC
pandas	I-SPEC
(	O
Ailurus	B-SPEC
fulgens	I-SPEC
)	O
in	O
China	O
.	O

The	O
present	O
study	O
is	O
a	O
first	O
step	O
toward	O
improved	O
understanding	O
of	O
infectious	O
diseases	O
in	O
the	O
species	B-SPEC
'	O
home	O
regions	O
.	O

In	O
the	O
seven	O
unvaccinated	O
groups	O
,	O
CDV	B-SPEC
titers	O
were	O
low	O
and	O
occurred	O
in	O
20	O
-	O
100	O
%	O
of	O
the	O
animals	B-SPEC
;	O
antibody	O
titers	O
against	O
CPV	B-SPEC
were	O
found	O
in	O
seven	O
of	O
eight	O
areas	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
found	O
infectious	O
disease	O
that	O
is	O
caused	O
by	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Two	O
conflicting	O
cellular	O
programs	O
,	O
apoptosis	O
to	O
eliminate	O
virus	B-SPEC
-	O
infected	O
cells	O
and	O
survival	O
to	O
delay	O
apoptosis	O
by	O
producing	O
antiviral	O
cytokines	O
,	O
occur	O
in	O
SARS	O
patients	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
showed	O
diffuse	O
lung	O
infiltration	O
.	O

The	O
prognosis	O
of	O
anti	O
-	O
GBM	O
glomerulonephritis	O
depends	O
on	O
serum	O
creatinine	O
and	O
the	O
need	O
of	O
dialysis	B-SPEC
at	O
initial	O
presentation	O
.	O

Cultures	O
grew	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
.	O

It	O
was	O
observed	O
that	O
the	O
positivity	O
rate	O
was	O
highest	O
in	O
cats	B-SPEC
aged	O
between	O
6	O
months	O
-	O
1	O
year	O
old	O
.	O

During	O
replication	O
of	O
the	O
RNA	O
genome	O
there	O
is	O
a	O
high	O
frequency	O
of	O
mutation	O
and	O
recombination	O
,	O
which	O
has	O
given	O
rise	O
to	O
many	O
strains	O
of	O
IBV	B-SPEC
and	O
results	O
in	O
the	O
potential	O
for	O
new	O
and	O
emerging	O
strains	O
.	O

The	O
importance	O
of	O
family	B-SPEC
support	O
and	O
'	O
significant	O
female	O
others	O
'	O
in	O
hand	O
hygiene	O
promotion	O
are	O
noted	O
.	O

TITLE	O
:	O
Type	O
I	O
feline	B-SPEC
coronavirus	B-SPEC
spike	O
glycoprotein	O
fails	O
to	O
recognize	O
aminopeptidase	O
N	O
as	O
a	O
functional	O
receptor	O
on	O
feline	B-SPEC
cell	O
lines	O
.	O

The	O
aim	O
of	O
the	O
studies	O
reported	O
here	O
was	O
to	O
provide	O
evidence	O
for	O
or	O
against	O
the	O
involvement	O
of	O
feline	B-SPEC
aminopeptidase	O
N	O
as	O
a	O
receptor	O
for	O
type	O
I	O
feline	B-SPEC
coronaviruses	O
.	O

This	O
suggests	O
that	O
feline	B-SPEC
aminopeptidase	O
N	O
is	O
not	O
a	O
receptor	O
for	O
type	O
I	O
feline	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
The	O
3a	O
accessory	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
specifically	O
interacts	O
with	O
the	O
5	O
'	O
UTR	O
of	O
its	O
genomic	O
RNA	O
,	O
Using	O
a	O
unique	O
75	O
amino	O
acid	O
interaction	O
domain	O
.	O

TITLE	O
:	O
Genetic	O
analysis	O
of	O
hyperoxic	O
acute	O
lung	O
injury	O
survival	O
in	O
reciprocal	O
intercross	O
mice	B-SPEC
.	O

Segregation	O
analysis	O
of	O
840	O
F2	O
mice	B-SPEC
generated	O
from	O
all	O
four	O
possible	O
intercrosses	O
between	O
C57BL	O
/	O
6J	O
and	O
129X1	O
/	O
SvJ	O
mice	B-SPEC
demonstrated	O
that	O
survival	O
time	O
is	O
a	O
quantitative	O
trait	O
with	O
decreased	O
penetrance	O
,	O
and	O
significant	O
sex	O
,	O
cross	O
,	O
and	O
parent	O
-	O
of	O
-	O
origin	O
effects	O
.	O

ABSTRACT	O
:	O
We	O
report	O
an	O
8	O
-	O
year	O
-	O
old	O
boy	O
with	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
respiratory	O
infection	O
complicated	O
by	O
pneumomediastinum	O
and	O
severe	O
oral	O
and	O
conjunctival	O
mucositis	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
replication	O
induces	O
host	O
translational	O
shutoff	O
and	O
mRNA	O
decay	O
,	O
with	O
concomitant	O
formation	O
of	O
stress	O
granules	O
and	O
processing	O
bodies	O
.	O

While	O
the	O
diagnostics	O
for	O
gastrointestinal	O
bacterial	O
and	O
parasitic	O
pathogens	O
and	O
their	O
etiological	O
role	O
in	O
disease	O
are	O
well	O
established	O
,	O
little	O
is	O
known	O
about	O
the	O
epidemiology	O
,	O
prevalence	O
and	O
role	O
of	O
viral	O
agents	O
in	O
diarrheal	O
illness	O
among	O
monkeys	B-SPEC
.	O

We	O
collected	O
fecal	O
specimens	O
from	O
monkeys	B-SPEC
with	O
diarrhea	O
that	O
were	O
housed	O
in	O
two	O
primate	B-SPEC
colonies	O
,	O
the	O
Institute	O
of	O
Laboratory	O
Animal	B-SPEC
Sciences	O
,	O
Beijing	O
,	O
China	O
and	O
the	O
Yerkes	O
National	O
Primate	B-SPEC
Research	O
Center	O
,	O
Georgia	O
,	O
USA	O
.	O

Our	O
findings	O
indicate	O
endemic	O
infections	O
with	O
enteric	O
viruses	B-SPEC
in	O
monkeys	B-SPEC
of	O
both	O
colonies	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
how	O
these	O
effects	O
are	O
brought	O
out	O
,	O
and	O
how	O
manipulation	O
of	O
the	O
functions	O
of	O
host	O
cells	O
would	O
influence	O
the	O
replication	O
cycle	O
of	O
coronavirus	B-SPEC
.	O

This	O
conclusion	O
was	O
drawn	O
based	O
on	O
the	O
observations	O
that	O
apoptosis	O
occurred	O
in	O
both	O
IBV	B-SPEC
-	O
infected	O
H1299	O
and	O
Vero	O
cells	O
,	O
and	O
that	O
IBV	B-SPEC
infection	O
did	O
not	O
affect	O
the	O
expression	O
of	O
p53	O
in	O
host	O
cells	O
.	O

TITLE	O
:	O
Induction	O
of	O
specific	O
immune	O
responses	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
DNA	O
vaccine	O
with	O
or	O
without	O
interleukin	O
-	O
2	O
immunization	O
using	O
different	O
vaccination	O
routes	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
was	O
attenuated	O
by	O
serial	O
passage	O
in	O
chicken	B-SPEC
embryos	O
.	O

Virus	B-SPEC
of	O
passage	O
115	O
was	O
attenuated	O
as	O
determined	O
by	O
clinical	O
response	O
to	O
inoculation	O
to	O
15	O
-	O
day	O
-	O
old	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
.	O

Mortality	O
occurred	O
particularly	O
in	O
young	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
involved	O
in	O
the	O
pathological	O
reaction	O
to	O
SARS	O
and	O
is	O
a	O
key	O
antigen	O
for	O
the	O
development	O
of	O
a	O
sensitive	O
diagnostic	O
assay	O
.	O

Finally	O
,	O
we	O
summarize	O
findings	O
of	O
a	O
variety	O
of	O
vaccine	O
approaches	O
and	O
discuss	O
the	O
available	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
addressing	O
the	O
potential	O
for	O
disease	O
enhancement	O
following	O
re	O
-	O
infection	O
in	O
animals	B-SPEC
previously	O
vaccinated	O
against	O
or	O
infected	O
with	O
SARS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Interaction	O
between	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
glycosaminoglycans	O
,	O
including	O
heparan	O
sulfate	O
.	O

Hence	O
,	O
in	O
recent	O
years	O
,	O
the	O
development	O
of	O
transgenic	O
animals	B-SPEC
has	O
allowed	O
us	O
to	O
determine	O
that	O
these	O
local	O
systems	O
are	O
implicated	O
in	O
the	O
roles	O
that	O
had	O
been	O
originally	O
attributed	O
exclusively	O
to	O
the	O
systemic	O
action	O
of	O
the	O
RAS	O
.	O

These	O
viruses	B-SPEC
may	O
cause	O
mild	O
to	O
life	O
-	O
threatening	O
infections	O
.	O

In	O
addition	O
,	O
the	O
capability	O
of	O
S	O
to	O
mediate	O
entry	O
of	O
SARS	O
S	O
-	O
pseudotyped	O
particles	O
overall	O
was	O
affected	O
moderately	O
in	O
the	O
mutant	O
proteins	O
,	O
also	O
arguing	O
for	O
a	O
nonvital	O
role	O
for	O
the	O
GxxxG	O
motif	O
in	O
SARS	O
coronavirus	B-SPEC
entry	O
.	O

The	O
molecular	O
mechanisms	O
that	O
govern	O
enhanced	O
susceptibility	O
of	O
elderly	O
populations	O
are	O
not	O
known	O
,	O
and	O
robust	O
animal	B-SPEC
models	O
are	O
needed	O
that	O
recapitulate	O
the	O
increased	O
pathogenic	O
phenotype	O
noted	O
with	O
increasing	O
age	O
.	O

All	O
viruses	B-SPEC
replicated	O
efficiently	O
,	O
but	O
none	O
produced	O
clinical	O
disease	O
or	O
death	O
in	O
young	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
is	O
responsible	O
for	O
mild	O
or	O
moderate	O
enteritis	O
in	O
puppies	O
.	O

TITLE	O
:	O
Formalin	O
-	O
treated	O
UV	O
-	O
inactivated	O
SARS	O
coronavirus	B-SPEC
vaccine	O
retains	O
its	O
immunogenicity	O
and	O
promotes	O
Th2	O
-	O
type	O
immune	O
responses	O
.	O

ABSTRACT	O
:	O
The	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
highly	O
infectious	O
virus	B-SPEC
that	O
causes	O
severe	O
respiratory	O
infections	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
the	O
immuno	O
-	O
competent	O
adult	O
Ebstein	O
-	O
Barr	O
virus	B-SPEC
(	O
EBV	O
)	O
infection	O
is	O
a	O
self	O
-	O
limiting	O
disease	O
that	O
resolves	O
spontaneously	O
.	O

About	O
38	O
%	O
of	O
interactions	O
were	O
subsequently	O
confirmed	O
by	O
CoIP	O
in	O
mammalian	B-SPEC
cells	O
.	O

Pretreatment	O
with	O
rupatadine	O
has	O
a	O
beneficial	O
effect	O
on	O
acute	O
lung	O
injury	O
induced	O
by	O
oleic	O
acid	O
in	O
rabbits	B-SPEC
.	O

The	O
pressor	O
response	O
was	O
reduced	O
in	O
lungs	O
of	O
PAF	O
receptor	O
-	O
deficient	O
mice	B-SPEC
and	O
after	O
PAF	O
receptor	O
blockade	O
by	O
BN	O
50730	O
.	O

N	O
protein	O
predominately	O
localises	O
in	O
the	O
cytoplasm	O
(	O
the	O
site	O
of	O
virus	B-SPEC
replication	O
and	O
assembly	O
)	O
but	O
also	O
in	O
the	O
nucleus	O
/	O
nucleolus	O
.	O

TITLE	O
:	O
Up	O
-	O
regulation	O
of	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
induced	O
by	O
SARS	O
-	O
coronavirus	B-SPEC
spike	O
protein	O
in	O
murine	B-SPEC
macrophages	O
via	O
NF	O
-	O
kappaB	O
pathway	O
.	O

African	B-SPEC
green	I-SPEC
monkeys	I-SPEC
immunized	O
through	O
the	O
respiratory	O
tract	O
with	O
two	O
doses	O
of	O
the	O
vaccine	O
developed	O
a	O
titer	O
of	O
SARS	O
-	O
CoV	O
-	O
neutralizing	O
antibodies	O
comparable	O
with	O
the	O
robust	O
secondary	O
response	O
observed	O
in	O
animals	B-SPEC
that	O
have	O
been	O
immunized	O
with	O
a	O
different	O
experimental	O
SARS	O
-	O
CoV	O
vaccine	O
and	O
challenged	O
with	O
SARS	O
-	O
CoV	O
.	O
When	O
animals	B-SPEC
immunized	O
with	O
NDV	B-SPEC
expressing	O
S	O
were	O
challenged	O
with	O
a	O
high	O
dose	O
of	O
SARS	O
-	O
CoV	O
,	O
direct	O
viral	O
assay	O
of	O
lung	O
tissues	O
taken	O
by	O
necropsy	O
at	O
the	O
peak	O
of	O
viral	O
replication	O
demonstrated	O
a	O
236	O
-	O
or	O
1	O
,	O
102	O
-	O
fold	O
(	O
depending	O
on	O
the	O
NDV	B-SPEC
vector	O
construct	O
)	O
mean	O
reduction	O
in	O
pulmonary	O
SARS	O
-	O
CoV	O
titer	O
compared	O
with	O
control	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Under	O
specific	O
pathogen	O
-	O
free	O
conditions	O
,	O
1	O
.	O
3	O
%	O
to	O
1	O
.	O
8	O
%	O
of	O
litters	O
born	O
in	O
our	O
inbred	O
101	O
/	O
H	O
and	O
C3HeB	O
/	O
FeJ	O
mouse	B-SPEC
colonies	O
had	O
pups	O
with	O
steatorrhea	O
and	O
runting	O
.	O

The	O
EAV	B-SPEC
nsp9	O
/	O
RdRp	O
initiates	O
RNA	O
synthesis	O
by	O
a	O
de	O
novo	O
mechanism	O
on	O
homopolymeric	O
templates	O
in	O
a	O
template	O
-	O
specific	O
manner	O
.	O

These	O
results	O
show	O
that	O
RMA	O
is	O
an	O
accurate	O
,	O
sensitive	O
,	O
and	O
practical	O
test	O
for	O
respiratory	O
-	O
virus	B-SPEC
infections	O
.	O

The	O
role	O
and	O
regulation	O
of	O
the	O
neprilysin	O
(	O
NEP	O
)	O
family	B-SPEC
of	O
metalloproteinases	O
is	O
highlighted	O
in	O
particular	O
in	O
the	O
context	O
of	O
proteolytic	O
events	O
underlying	O
the	O
pathology	O
of	O
Alzheimer	O
'	O
s	O
disease	O
.	O

A	O
total	O
of	O
79	O
cat	B-SPEC
sera	O
collected	O
in	O
the	O
years	O
between	O
2004	O
and	O
2005	O
were	O
examined	O
to	O
evaluate	O
seroprevalence	O
by	O
the	O
VN	O
test	O
,	O
showing	O
the	O
following	O
results	O
:	O
(	O
1	O
)	O
50	O
cats	B-SPEC
(	O
63	O
.	O
3	O
%)	O
were	O
sero	O
-	O
positive	O
to	O
FCoV	O
;	O
(	O
2	O
)	O
of	O
the	O
50	O
FCoV	O
positive	O
cat	B-SPEC
serum	O
samples	O
,	O
49	O
(	O
98	O
%)	O
showed	O
significantly	O
higher	O
titers	O
to	O
type	O
I	O
virus	B-SPEC
and	O
only	O
one	O
(	O
2	O
%)	O
for	O
type	O
II	O
virus	B-SPEC
.	O

These	O
results	O
indicate	O
that	O
the	O
VN	O
test	O
described	O
here	O
can	O
be	O
used	O
for	O
serological	O
differentiation	O
of	O
FCoV	O
infections	O
of	O
cats	B-SPEC
,	O
and	O
that	O
FCoV	O
type	O
I	O
is	O
a	O
dominant	O
type	O
in	O
recent	O
years	O
of	O
Japan	O
.	O

External	O
genital	O
samples	O
(	O
glans	O
/	O
corona	B-SPEC
,	O
shaft	O
,	O
and	O
scrotum	O
)	O
were	O
more	O
likely	O
than	O
anal	O
samples	O
to	O
contain	O
oncogenic	O
HPV	O
(	O
25	O
.	O
1	O
%	O
versus	O
5	O
.	O
0	O
%).	O

The	O
specimens	O
were	O
also	O
examined	O
for	O
the	O
presence	O
of	O
other	O
enteric	O
pathogens	O
,	O
bovine	B-SPEC
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
Cryptosporidium	B-SPEC
spp	O
.	O

Rotavirus	B-SPEC
was	O
confirmed	O
to	O
be	O
associated	O
with	O
calf	O
diarrhea	O
,	O
but	O
coronavirus	B-SPEC
and	O
Cryptosporidium	B-SPEC
spp	O
.	O

This	O
study	O
showed	O
that	O
BoTV	O
is	O
a	O
common	O
virus	B-SPEC
in	O
fecal	O
specimens	O
of	O
calves	O
with	O
diarrhea	O
in	O
Japan	O
and	O
may	O
be	O
an	O
important	O
pathogen	O
of	O
cattle	B-SPEC
,	O
principally	O
in	O
young	O
calves	O
less	O
than	O
2	O
weeks	O
of	O
age	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
is	O
an	O
enteropathogenic	O
coronavirus	B-SPEC
that	O
causes	O
a	O
highly	O
fatal	O
acute	O
diarrhea	O
in	O
newborn	O
pigs	B-SPEC
.	O

All	O
kinds	O
and	O
ages	O
of	O
pigs	B-SPEC
can	O
be	O
infected	O
.	O

The	O
result	O
indicated	O
that	O
the	O
expressed	O
product	O
maintain	O
the	O
antigenicity	O
of	O
TGEV	B-SPEC
as	O
expected	O
.	O

It	O
was	O
showed	O
that	O
the	O
mice	B-SPEC
immunized	O
with	O
pNZ8112	O
-	O
Sa	O
/	O
NZ9000	O
recombinant	O
strain	O
had	O
produced	O
clear	O
antibody	O
level	O
anti	O
TGEV	B-SPEC
,	O
and	O
which	O
had	O
provided	O
important	O
substance	O
foundation	O
and	O
explored	O
the	O
feasibility	O
of	O
Lactobacillus	B-SPEC
as	O
oral	O
vaccine	O
.	O

TITLE	O
:	O
Adrenomedullin	O
ameliorates	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

The	O
role	O
of	O
oral	O
corticosteroids	O
is	O
highly	O
debatable	O
in	O
young	O
children	O
with	O
virus	B-SPEC
-	O
associated	O
wheeze	O
.	O

The	O
WD	O
-	O
BCoV	O
antigen	O
was	O
detected	O
in	O
the	O
epithelium	O
of	O
the	O
small	O
and	O
large	O
intestines	O
,	O
nasal	O
turbinates	O
,	O
trachea	B-SPEC
and	O
lungs	O
.	O

RESULTS	O
:	O
Twenty	O
-	O
three	O
subjects	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
OSA	B-SPEC
and	O
23	O
subjects	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
OSA	B-SPEC
plus	O
OHS	O
underwent	O
a	O
1	O
-	O
night	O
trial	O
of	O
CPAP	O
.	O

The	O
expression	O
of	O
CD209L	O
was	O
relatively	O
higher	O
in	O
the	O
human	B-SPEC
lymphatic	O
endothelial	O
cells	O
.	O

Comparison	O
of	O
the	O
nucleotide	O
sequences	O
of	O
the	O
PCR	O
products	O
with	O
those	O
of	O
the	O
published	O
N	O
,	O
M	O
,	O
and	O
S	O
genes	O
(	O
476	O
to	O
497	O
,	O
672	O
,	O
and	O
687	O
to	O
690	O
nucleotides	O
,	O
respectively	O
)	O
of	O
toroviruses	B-SPEC
showed	O
high	O
sequence	O
identities	O
(	O
up	O
to	O
99	O
.	O
4	O
%,	O
98	O
.	O
7	O
%,	O
and	O
94	O
.	O
9	O
%	O
for	O
the	O
N	O
,	O
M	O
,	O
and	O
S	O
genes	O
,	O
respectively	O
)	O
between	O
the	O
isolate	O
and	O
BToVs	O
.	O

In	O
contrast	O
,	O
the	O
isolate	O
was	O
negative	O
for	O
BCV	B-SPEC
by	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Genetic	O
polymorphisms	O
have	O
been	O
demonstrated	O
to	O
be	O
associated	O
with	O
vulnerability	O
to	O
human	B-SPEC
infection	O
.	O

No	O
significant	O
association	O
to	O
susceptibility	O
to	O
SARS	O
infection	O
caused	O
by	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
found	O
for	O
the	O
FCER2	O
and	O
the	O
ICAM3	O
single	O
nucleotide	O
polymorphisms	O
.	O

The	O
first	O
outbreak	O
of	O
human	B-SPEC
cases	O
of	O
avian	B-SPEC
influenza	O
was	O
reported	O
in	O
1997	O
in	O
Hong	O
Kong	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effects	O
of	O
EGF	O
on	O
atrophic	O
enteritis	O
induced	O
in	O
piglets	O
by	O
experimental	O
infection	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strain	O
Dr13	O
.	O

PEDV	B-SPEC
+	I-SPEC
EGF	I-SPEC
piglets	O
had	O
less	O
severe	O
clinical	O
signs	O
than	O
PEDV	B-SPEC
only	O
piglets	O
at	O
48	O
and	O
60	O
h	O
post	O
-	O
infection	O
(	O
hpi	O
).	O

Immunohistochemistry	O
for	O
Ki67	O
demonstrated	O
increased	O
proliferation	O
in	O
intestinal	O
crypt	O
epithelial	O
cells	O
of	O
PEDV	O
+	O
EGF	O
piglets	O
compared	O
to	O
PEDV	B-SPEC
only	O
piglets	O
at	O
36	O
,	O
48	O
and	O
60	O
hpi	O
.	O

Comparative	O
analysis	O
between	O
FFA	O
and	O
plaque	O
assay	O
showed	O
no	O
significant	O
difference	O
in	O
estimating	O
the	O
titer	O
of	O
cell	O
adapted	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
A	O
rationale	O
for	O
using	O
steroids	O
in	O
the	O
treatment	O
of	O
severe	O
cases	O
of	O
H5N1	O
avian	B-SPEC
influenza	O
.	O

This	O
is	O
a	O
much	O
lower	O
dose	O
than	O
has	O
been	O
typically	O
used	O
to	O
treat	O
avian	B-SPEC
influenza	O
patients	O
.	O

Here	O
,	O
we	O
evaluate	O
various	O
vaccination	O
regimens	O
using	O
combinations	O
of	O
DNA	O
-	O
S	O
,	O
MVA	O
-	O
S	O
,	O
and	O
adenovirus	B-SPEC
type	O
5	O
(	O
Ad5	O
-	O
S	O
)	O
vaccines	O
.	O

We	O
detected	O
complexes	O
between	O
anti	O
-	O
KC	O
autoantibodies	O
and	O
KC	O
in	O
lung	O
lavages	O
and	O
tissues	O
of	O
mice	B-SPEC
treated	O
with	O
LPS	O
.	O

At	O
96	O
h	O
post	O
-	O
infection	O
(	O
p	O
.	O
i	O
.),	O
the	O
cytopathic	O
effect	O
was	O
graded	O
75	O
%	O
by	O
cell	O
fusion	O
,	O
rounding	O
up	O
of	O
cells	O
and	O
monolayer	O
detachment	O
,	O
and	O
the	O
electron	O
microscopy	O
image	O
characterized	O
by	O
coronavirus	B-SPEC
morphology	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCoV	O
)	O
M	O
protein	O
plays	O
a	O
key	O
role	O
in	O
viral	O
assembly	O
and	O
budding	O
.	O

All	O
of	O
the	O
chest	O
x	O
-	O
rays	B-SPEC
were	O
normal	O
on	O
the	O
day	O
of	O
the	O
chlorine	O
inhalation	O
.	O

Following	O
the	O
discovery	O
of	O
five	O
new	O
human	B-SPEC
respiratory	O
viruses	B-SPEC
since	O
2000	O
,	O
there	O
is	O
an	O
increasing	O
need	O
for	O
diagnostic	O
tests	O
to	O
detect	O
these	O
emerging	O
viruses	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
constructed	O
an	O
attenuated	O
S	B-SPEC
.	I-SPEC
enterica	I-SPEC
serovar	O
Typhi	O
strain	O
stably	O
expressing	O
conserved	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
by	O
integrating	O
the	O
N	O
gene	O
into	O
the	O
pilV	O
gene	O
,	O
which	O
was	O
under	O
the	O
control	O
of	O
the	O
type	O
IVB	O
pilus	O
operon	O
promoter	O
in	O
S	B-SPEC
.	I-SPEC
enterica	I-SPEC
serovar	O
Typhi	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
recently	O
identified	O
viruses	B-SPEC
,	O
including	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
),	O
and	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
hCoV	O
-	O
HKU1	O
)	O
in	O
children	O
with	O
acute	O
wheezing	O
.	O

Activation	O
of	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
adrenal	O
axis	B-SPEC
with	O
the	O
production	O
of	O
cortisol	O
is	O
a	O
fundamental	O
component	O
of	O
the	O
stress	O
response	O
and	O
is	O
essential	O
for	O
survival	O
of	O
the	O
host	O
.	O

Transgenic	B-SPEC
mice	I-SPEC
expressing	O
green	O
fluorescent	O
protein	O
under	O
control	O
of	O
the	O
astrocyte	O
-	O
specific	O
glial	O
fibrillary	O
acidic	O
protein	O
promoter	O
were	O
infected	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
to	O
facilitate	O
phenotypic	O
characterization	O
of	O
astrocytes	O
and	O
microglia	O
using	O
flow	O
cytometry	O
.	O

Samples	O
were	O
examined	O
for	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
oocysts	O
by	O
microscopy	O
,	O
and	O
a	O
subset	O
of	O
specimens	O
was	O
also	O
tested	O
for	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Salmonella	B-SPEC
,	O
bovine	B-SPEC
rotavirus	B-SPEC
and	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

Using	O
the	O
GLLAMM	O
function	O
in	O
Stata	O
9	O
.	O
0	O
,	O
multilevel	O
regression	O
techniques	O
were	O
employed	O
to	O
investigate	O
associations	O
between	O
management	O
practices	O
and	O
the	O
risk	O
of	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
shedding	O
or	O
diarrhea	O
.	O

Significant	O
predictors	O
of	O
the	O
calf	O
-	O
level	O
risk	O
of	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
shedding	O
included	O
the	O
use	O
of	O
calf	O
diarrhea	O
prophylaxis	O
in	O
pregnant	O
cows	B-SPEC
,	O
and	O
the	O
type	O
of	O
maternity	O
facilities	O
in	O
which	O
the	O
calves	O
were	O
born	O
.	O

ABSTRACT	O
:	O
Severe	O
sepsis	B-SPEC
is	O
the	O
leading	O
cause	O
of	O
death	O
for	O
patients	O
in	O
intensive	O
care	O
units	O
.	O

Mice	B-SPEC
pretreated	O
with	O
vehicle	O
and	O
receiving	O
endotoxin	O
exhibited	O
100	O
%	O
24	O
-	O
hour	O
lethality	O
,	O
a	O
dramatic	O
increase	O
in	O
all	O
parameters	O
of	O
systemic	O
and	O
pulmonary	O
inflammation	O
,	O
increased	O
capillary	O
leak	O
,	O
and	O
reduced	O
lung	O
function	O
.	O

Pathological	O
findings	O
and	O
immunohistochemical	O
identification	O
using	O
a	O
monoclonal	O
anti	O
-	O
canine	O
Coronavirus	B-SPEC
antibody	O
are	O
included	O
.	O

TITLE	O
:	O
Peripheral	O
infusion	O
of	O
rat	B-SPEC
bone	O
marrow	O
derived	O
endothelial	O
progenitor	O
cells	O
leads	O
to	O
homing	O
in	O
acute	O
lung	O
injury	O
.	O

The	O
virus	B-SPEC
titre	O
in	O
freshly	O
dispersed	O
HeLa	O
cells	O
was	O
1000	O
-	O
fold	O
higher	O
than	O
in	O
cell	O
monolayers	O
.	O

These	O
IBV	B-SPEC
strains	O
replicated	O
to	O
an	O
average	O
titre	O
of	O
10	O
(	O
3	O
.	O
4	O
+/-	O
0	O
.	O
2	O
)/	O
0	O
.	O
1	O
ml	O
median	O
tissue	O
culture	O
infectious	O
doses	O
in	O
freshly	O
dispersed	O
HeLa	O
cells	O
and	O
maintained	O
this	O
titre	O
for	O
the	O
first	O
12	O
passages	O
.	O

ABSTRACT	O
:	O
Infection	O
by	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
requires	O
the	O
release	O
of	O
the	O
viral	O
genome	O
by	O
fusion	O
with	O
the	O
respective	O
target	O
membrane	O
of	O
the	O
host	O
cell	O
.	O

TITLE	O
:	O
Molecular	O
and	O
serologic	O
characterization	O
,	O
pathogenicity	O
,	O
and	O
protection	O
studies	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
field	O
isolates	O
from	O
California	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
characterized	O
three	O
variant	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
isolated	O
in	O
2003	O
and	O
2004	O
from	O
broiler	O
chickens	B-SPEC
in	O
California	B-SPEC
and	O
compared	O
them	O
to	O
previously	O
isolated	O
California	B-SPEC
variant	O
viruses	B-SPEC
and	O
to	O
common	O
vaccine	O
serotypes	O
used	O
in	O
the	O
United	O
States	O
.	O

Cross	O
virus	B-SPEC
-	O
neutralization	O
testing	O
showed	O
that	O
none	O
of	O
the	O
2003	O
-	O
04	O
California	B-SPEC
IBV	B-SPEC
variant	O
viruses	B-SPEC
were	O
serologically	O
related	O
to	O
each	O
other	O
or	O
to	O
Ark	O
,	O
Conn	O
,	O
or	O
Mass	O
vaccine	O
strains	O
.	O

The	O
2003	O
-	O
04	O
California	B-SPEC
variant	O
viruses	B-SPEC
were	O
not	O
compared	O
with	O
variants	O
isolated	O
in	O
California	B-SPEC
during	O
1970s	O
and	O
1980s	O
because	O
,	O
to	O
our	O
knowledge	O
,	O
no	O
genetic	O
information	O
is	O
available	O
and	O
those	O
viruses	B-SPEC
are	O
no	O
longer	O
obtainable	O
.	O

Gross	O
pathology	O
,	O
histopathology	O
,	O
and	O
virus	B-SPEC
isolation	O
were	O
evaluated	O
.	O

Chickens	B-SPEC
vaccinated	O
with	O
Holland	O
/	O
Arkansas	O
had	O
marginally	O
better	O
protection	O
against	O
CA99	O
challenge	O
than	O
chickens	B-SPEC
vaccinated	O
with	O
Massachusetts	O
/	O
Arkansas	O
,	O
although	O
differences	O
were	O
not	O
statistically	O
significant	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
metapneumovirus	I-SPEC
(	O
aMPV	O
),	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
are	O
important	O
respiratory	O
pathogens	O
of	O
chickens	B-SPEC
.	O

However	O
,	O
previous	O
work	O
has	O
indicated	O
that	O
the	O
efficacy	O
of	O
aMPV	O
vaccines	O
may	O
be	O
affected	O
when	O
codelivered	O
with	O
IBV	B-SPEC
or	O
NDV	B-SPEC
vaccines	O
.	O

The	O
efficacy	O
of	O
an	O
aMPV	O
vaccine	O
when	O
codelivered	O
to	O
chickens	B-SPEC
in	O
a	O
trivalent	O
combination	O
with	O
an	O
NDV	B-SPEC
and	O
an	O
IBV	B-SPEC
vaccine	O
was	O
examined	O
.	O

The	O
serological	O
antibody	O
response	O
to	O
the	O
aMPV	O
vaccine	O
given	O
with	O
the	O
IBV	B-SPEC
and	O
NDV	B-SPEC
vaccine	O
was	O
significantly	O
lower	O
than	O
when	O
the	O
aMPV	O
vaccine	O
was	O
given	O
alone	O
.	O

No	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
had	O
been	O
isolated	O
but	O
a	O
novel	O
avian	B-SPEC
coronavirus	I-SPEC
strain	O
,	O
Peafowl	B-SPEC
/	O
GD	O
/	O
KQ6	O
/	O
2003	O
(	O
KQ6	O
),	O
was	O
identified	O
.	O

TITLE	O
:	O
The	O
S	O
proteins	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
bind	O
overlapping	O
regions	O
of	O
ACE2	O
.	O

Through	O
use	O
of	O
an	O
MHV	B-SPEC
reverse	O
genetics	O
system	O
,	O
in	O
-	O
frame	O
deletions	O
of	O
the	O
coding	O
sequences	O
for	O
nsp7	O
to	O
nsp10	O
,	O
or	O
ablation	O
of	O
their	O
flanking	O
Mpro	O
cleavage	O
sites	O
,	O
were	O
made	O
and	O
the	O
effects	O
upon	O
replication	O
were	O
determined	O
.	O

TITLE	O
:	O
Towards	O
our	O
understanding	O
of	O
SARS	O
-	O
CoV	O
,	O
an	O
emerging	O
and	O
devastating	O
but	O
quickly	O
conquered	O
virus	B-SPEC
.	O

Following	O
live	O
virus	B-SPEC
challenge	O
of	O
aged	O
mice	B-SPEC
,	O
no	O
virus	B-SPEC
was	O
detected	O
in	O
the	O
lungs	O
of	O
intranasally	O
immunized	O
mice	B-SPEC
,	O
in	O
contrast	O
to	O
intramuscularly	O
immunized	O
mice	B-SPEC
whose	O
lung	O
virus	B-SPEC
titers	O
were	O
comparable	O
to	O
those	O
observed	O
in	O
control	O
mice	B-SPEC
.	O

TITLE	O
:	O
Chicken	B-SPEC
single	O
-	O
chain	O
variable	O
fragments	O
against	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
.	O

In	O
the	O
absence	O
of	O
the	O
8a	O
region	O
,	O
protein	O
8b	O
undergoes	O
rapid	O
degradation	O
by	O
proteasomes	O
,	O
and	O
addition	O
of	O
proteasome	O
inhibitors	O
inhibits	O
the	O
degradation	O
of	O
protein	O
8b	O
as	O
well	O
as	O
the	O
protein	O
8b	O
-	O
induced	O
rapid	O
degradation	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
E	O
protein	O
.	O

TITLE	O
:	O
Expression	O
of	O
feline	B-SPEC
angiotensin	O
converting	O
enzyme	O
2	O
and	O
its	O
interaction	O
with	O
SARS	O
-	O
CoV	O
S1	O
protein	O
.	O

The	O
complete	O
coding	O
region	O
is	O
2418bp	O
in	O
length	O
and	O
is	O
the	O
closest	O
to	O
human	B-SPEC
ACE2	O
among	O
known	O
ACE2	O
homologs	O
of	O
non	O
-	O
primate	B-SPEC
animals	B-SPEC
.	O

The	O
derivation	O
depends	O
on	O
an	O
explicit	O
formula	O
for	O
the	O
basic	O
reproduction	O
number	O
of	O
a	O
general	O
class	B-SPEC
of	O
disease	O
transmission	O
models	O
,	O
which	O
is	O
extended	O
to	O
calculate	O
the	O
basic	O
reproduction	O
number	O
in	O
models	O
with	O
vertical	O
transmission	O
.	O

It	O
has	O
been	O
used	O
to	O
discover	O
serum	O
or	O
tissue	O
protein	O
signatures	O
and	O
biomarkers	O
for	O
infectious	O
diseases	O
in	O
the	O
fields	O
of	O
virology	O
(	O
hepatitis	O
B	O
and	O
C	O
viruses	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
human	B-SPEC
T	O
-	O
cell	O
leukemia	O
virus	B-SPEC
-	O
1	O
and	O
BK	B-SPEC
virus	I-SPEC
),	O
parasitology	O
(	O
trypanosomiasis	O
)	O
and	O
bacteriology	O
(	O
intra	O
-	O
amniotic	O
inflammation	O
,	O
tuberculosis	O
and	O
bacterial	O
endocarditis	O
).	O

TITLE	O
:	O
Specific	O
plant	B-SPEC
terpenoids	O
and	O
lignoids	O
possess	O
potent	O
antiviral	O
activities	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
221	O
phytocompounds	O
were	O
evaluated	O
for	O
activity	O
against	O
anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
activities	O
using	O
a	O
cell	O
-	O
based	O
assay	O
measuring	O
SARS	O
-	O
CoV	O
-	O
induced	O
cytopathogenic	O
effect	O
on	O
Vero	O
E6	O
cells	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
first	O
appeared	O
in	O
Southern	O
China	O
in	O
November	O
2002	O
,	O
and	O
then	O
quickly	O
spread	O
to	O
33	O
countries	O
on	O
five	O
continents	O
along	O
international	O
air	O
travel	O
routes	O
.	O

Analysis	O
of	O
humoral	O
and	O
cellular	O
immune	O
responses	O
in	O
immunized	O
mice	B-SPEC
demonstrated	O
that	O
pcDNA	O
-	O
SS	O
and	O
pcDNA	O
-	O
St	O
-	O
VP22C	O
are	O
the	O
most	O
immunogenic	O
SARS	O
vaccine	O
candidates	O
.	O

TITLE	O
:	O
Pseudomembranous	O
necrotizing	O
tracheobronchitis	O
caused	O
by	O
Aspergillus	B-SPEC
spp	O
--	O
contribution	O
of	O
one	O
case	O
with	O
acute	O
myeloid	O
leukemia	O
.	O

TITLE	O
:	O
Activation	O
of	O
human	B-SPEC
monocytes	O
after	O
infection	O
by	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

Moreover	O
,	O
productive	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
of	O
primary	O
monocytes	O
and	O
of	O
the	O
THP	O
-	O
1	O
monocytic	O
cell	O
line	O
led	O
to	O
their	O
activation	O
,	O
as	O
indicated	O
by	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
mediators	O
,	O
including	O
TNF	O
-	O
alpha	O
,	O
CCL5	O
,	O
CXCL10	O
and	O
CXCL11	O
and	O
MMP	O
-	O
9	O
.	O

TITLE	O
:	O
Enhancement	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
replication	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
protein	O
6	O
requires	O
the	O
N	O
-	O
terminal	O
hydrophobic	O
region	O
but	O
not	O
C	O
-	O
terminal	O
sorting	O
motifs	O
.	O

Despite	O
significant	O
increases	O
in	O
levels	O
of	O
Cxcl2	O
mRNA	O
and	O
functional	O
nucleus	O
-	O
to	O
-	O
cytoplasm	O
RNA	O
transport	O
,	O
no	O
CXCL2	O
protein	O
was	O
released	O
into	O
the	O
medium	O
from	O
MHV	B-SPEC
-	O
infected	O
cells	O
.	O

Imaging	O
with	O
chest	O
X	O
-	O
ray	B-SPEC
with	O
/	O
without	O
a	O
CT	O
scan	O
picked	O
up	O
the	O
lesion	O
in	O
all	O
cases	O
.	O

The	O
patient	O
'	O
s	O
medical	O
history	O
included	O
a	O
post	O
-	O
rheumatic	O
mitral	O
stenosis	B-SPEC
.	O

Here	O
we	O
report	O
the	O
generation	O
of	O
Apelin	O
gene	O
-	O
targeted	O
mice	B-SPEC
.	O

Importantly	O
,	O
in	O
pressure	O
overload	O
-	O
induced	O
heart	O
failure	O
,	O
loss	O
of	O
Apelin	O
did	O
not	O
significantly	O
affect	O
the	O
hypertrophy	O
response	O
,	O
but	O
Apelin	O
mutant	O
mice	B-SPEC
developed	O
progressive	O
heart	O
failure	O
.	O

TITLE	O
:	O
A	O
feline	B-SPEC
case	O
of	O
isolated	O
fourth	O
ventricle	O
with	O
syringomyelia	O
suspected	O
to	O
be	O
related	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

The	O
cat	B-SPEC
was	O
diagnosed	O
with	O
an	O
isolated	O
fourth	O
ventricle	O
(	O
IFV	B-SPEC
)	O
with	O
syringomyelia	O
.	O

The	O
serum	O
isoantibody	O
test	O
for	O
the	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
virus	B-SPEC
was	O
1	O
:	O
3	O
,	O
200	O
.	O

In	O
this	O
article	O
,	O
we	O
will	O
review	O
the	O
progress	O
of	O
structural	O
proteomics	O
initiatives	O
targeting	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
the	O
etiological	O
agent	O
of	O
the	O
2003	O
worldwide	O
epidemic	O
that	O
culminated	O
in	O
approximately	O
8	O
,	O
000	O
cases	O
and	O
800	O
deaths	O
.	O

AGP	O
plays	O
an	O
important	O
role	O
in	O
the	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
may	O
also	O
be	O
useful	O
also	O
in	O
studies	O
of	O
FIP	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
A	O
highly	O
neurovirulent	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
JHMV	O
strain	O
(	O
wt	O
)	O
with	O
receptor	O
(	O
MHVR	O
)-	O
independent	O
infection	O
activity	O
and	O
its	O
low	O
-	O
virulent	O
mutant	O
srr7	O
without	O
such	O
activity	O
were	O
found	O
to	O
attach	O
to	O
MHVR	O
-	O
negative	O
,	O
non	O
-	O
permissive	O
BHK	O
cells	O
.	O

The	O
present	O
study	O
indicates	O
that	O
HS	O
interacts	O
with	O
both	O
wt	O
JHMV	O
and	O
srr7	O
but	O
it	O
does	O
not	O
function	O
as	O
an	O
entry	O
receptor	O
as	O
it	O
apparently	O
does	O
for	O
MHV	B-SPEC
-	O
rec1	O
.	O

TITLE	O
:	O
Absence	O
of	O
E	O
protein	O
arrests	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
maturation	O
in	O
the	O
secretory	O
pathway	O
.	O

RNA	O
and	O
protein	O
composition	O
analysis	O
by	O
RNase	O
-	O
gold	O
and	O
immunoelectron	O
microscopy	O
showed	O
that	O
rTGEV	O
-	O
DeltaE	O
virions	O
contained	O
RNA	O
and	O
also	O
all	O
the	O
structural	O
TGEV	B-SPEC
proteins	O
,	O
except	O
the	O
deleted	O
E	O
protein	O
.	O

Importantly	O
,	O
replication	O
of	O
nsp1	O
mutant	O
virus	B-SPEC
in	O
professional	O
antigen	O
-	O
presenting	O
cells	O
such	O
as	O
conventional	O
dendritic	O
cells	O
and	O
macrophages	O
,	O
and	O
induction	O
of	O
type	O
I	O
IFN	O
in	O
plasmacytoid	O
dendritic	O
cells	O
,	O
was	O
not	O
impaired	O
.	O

Using	O
functional	O
genomics	O
,	O
we	O
analyzed	O
early	O
host	O
responses	O
to	O
SARS	O
-	O
CoV	O
infection	O
in	O
the	O
lungs	O
of	O
adolescent	O
cynomolgus	O
macaques	B-SPEC
(	O
Macaca	B-SPEC
fascicularis	I-SPEC
)	O
that	O
show	O
lung	O
pathology	O
similar	O
to	O
that	O
observed	O
in	O
human	B-SPEC
adults	O
with	O
SARS	O
.	O

TITLE	O
:	O
Multiplex	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
for	O
the	O
simultaneous	O
detection	O
and	O
quantification	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
To	O
examine	O
recent	O
literature	O
regarding	O
corticotherapy	O
in	O
critically	O
ill	O
patients	O
suffering	O
from	O
sepsis	B-SPEC
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
(	O
SCAP	O
).	O

It	O
is	O
logical	O
to	O
assume	O
that	O
increasing	O
the	O
dialysis	B-SPEC
dosage	O
would	O
minimize	O
uremic	O
complications	O
and	O
improve	O
outcomes	O
in	O
such	O
patients	O
.	O

Analytical	O
results	O
are	O
obtained	O
using	O
the	O
respective	O
ratios	O
of	O
susceptible	O
,	O
exposed	O
(	O
incubating	O
),	O
and	O
asymptomatic	O
classes	O
to	O
the	O
clinical	O
symptomatic	O
infective	O
class	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
pathogenesis	O
of	O
2	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
T	O
and	O
N1	O
/	O
88	O
strains	O
)	O
was	O
studied	O
in	O
the	O
eggshell	O
-	O
forming	O
regions	O
of	O
the	O
oviduct	O
of	O
commercial	O
laying	O
hens	O
.	O

TITLE	O
:	O
The	O
carbohydrate	O
-	O
binding	O
plant	B-SPEC
lectins	O
and	O
the	O
non	O
-	O
peptidic	O
antibiotic	O
pradimicin	O
A	O
target	O
the	O
glycans	O
of	O
the	O
coronavirus	B-SPEC
envelope	O
glycoproteins	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infects	O
many	O
organs	O
,	O
such	O
as	O
lung	O
,	O
liver	O
,	O
and	O
immune	O
organs	O
and	O
causes	O
life	O
-	O
threatening	O
atypical	O
pneumonia	O
,	O
SARS	O
causes	O
high	O
morbidity	O
and	O
mortality	O
rates	O
.	O

The	O
two	O
replicase	O
polyproteins	O
are	O
predicted	O
to	O
be	O
proteolytically	O
processed	O
by	O
three	O
virus	B-SPEC
-	O
encoded	O
proteases	O
into	O
16	O
non	O
-	O
structural	O
proteins	O
(	O
nsp1	O
-	O
16	O
).	O

In	O
present	O
study	O
,	O
mice	B-SPEC
were	O
immunized	O
with	O
SARS	O
CoV	O
S	O
DNA	O
vaccine	O
.	O

A	O
series	O
of	O
benzothiazolium	O
compounds	O
were	O
found	O
to	O
have	O
inhibitory	O
activity	O
against	O
TGEV	B-SPEC
3CL	O
(	O
pro	O
)	O
and	O
to	O
exert	O
anti	O
-	O
TGEV	B-SPEC
activities	O
in	O
terms	O
of	O
viral	O
protein	O
and	O
RNA	O
replication	O
in	O
TGEV	B-SPEC
-	O
infected	O
ST	O
cells	O
,	O
with	O
consequent	O
protection	O
of	O
TGEV	B-SPEC
-	O
infected	O
ST	O
cells	O
from	O
cytopathic	O
effect	O
by	O
blocking	O
the	O
activation	O
of	O
caspase	O
-	O
3	O
.	O

We	O
propose	O
that	O
,	O
in	O
the	O
disease	O
-	O
resistant	O
SIV	B-SPEC
-	O
infected	O
SMs	O
,	O
evolutionary	O
adaptation	O
to	O
both	O
preserve	O
immune	O
function	O
with	O
fewer	O
mucosal	O
CD4	O
+	O
T	O
cells	O
and	O
attenuate	O
the	O
immune	O
activation	O
that	O
follows	O
acute	O
viral	O
infection	O
protect	O
these	O
animals	B-SPEC
from	O
progressing	O
to	O
AIDS	O
.	O

Other	O
complications	O
such	O
as	O
severe	O
sepsis	B-SPEC
(	O
6	O
%),	O
renal	O
failure	O
(	O
1	O
.	O
5	O
%),	O
a	O
coagulation	O
disorder	O
(	O
6	O
%)	O
and	O
liver	O
failure	O
(	O
one	O
patient	O
)	O
were	O
infrequent	O
.	O

Here	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
could	O
inhibit	O
both	O
virus	B-SPEC
-	O
and	O
interferon	O
(	O
IFN	O
)-	O
dependent	O
signaling	O
,	O
two	O
key	O
steps	O
of	O
the	O
antiviral	O
response	O
.	O

We	O
mapped	O
a	O
strong	O
inhibitory	O
activity	O
to	O
SARS	O
-	O
CoV	O
nonstructural	O
protein	O
1	O
(	O
nsp1	O
)	O
and	O
show	O
that	O
expression	O
of	O
nsp1	O
significantly	O
inhibited	O
the	O
activation	O
of	O
all	O
three	O
virus	B-SPEC
-	O
dependent	O
signaling	O
pathways	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
analyses	O
have	O
identified	O
seven	O
glycosylation	O
sites	O
on	O
the	O
S	O
protein	O
critical	O
for	O
DC	O
/	O
L	O
-	O
SIGN	O
-	O
mediated	O
virus	B-SPEC
entry	O
.	O

ABSTRACT	O
:	O
Babesiosis	O
is	O
a	O
tick	B-SPEC
-	O
borne	O
illness	O
caused	O
by	O
the	O
protozoan	O
Babesia	B-SPEC
microti	I-SPEC
.	O

TITLE	O
:	O
[	O
Bovine	B-SPEC
coronavirus	B-SPEC
reproduction	O
in	O
the	O
continuous	O
cell	O
cultures	O
at	O
a	O
temperature	O
of	O
34	O
degrees	O
C	O
].	O

ABSTRACT	O
:	O
Cultivation	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
at	O
34	O
degrees	O
C	O
showed	O
the	O
relationship	O
of	O
the	O
degree	O
of	O
its	O
reproduction	O
to	O
the	O
cellular	O
system	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
impact	O
of	O
PGAR	O
co	O
-	O
infection	O
on	O
PEDV	B-SPEC
pathogenicity	O
in	O
piglets	O
.	O

The	O
piglets	O
were	O
euthanized	O
at	O
1	O
,	O
2	O
,	O
or	O
3	O
days	O
post	O
-	O
inoculation	O
(	O
DPI	O
)	O
to	O
measure	O
the	O
villous	O
height	O
:	O
crypt	O
depth	O
(	O
VH	O
:	O
CD	O
)	O
ratio	O
and	O
to	O
collect	O
fecal	O
samples	O
for	O
RT	O
-	O
PCR	O
and	O
virus	B-SPEC
isolation	O
.	O

We	O
propose	O
that	O
the	O
severe	O
diarrhea	O
exhibited	O
in	O
PEDV	B-SPEC
and	O
PGAR	O
co	O
-	O
infected	O
piglets	O
may	O
be	O
more	O
associated	O
with	O
the	O
immunity	O
level	O
of	O
the	O
host	O
rather	O
than	O
to	O
any	O
synergistic	O
effect	O
of	O
PGAR	O
on	O
PEDV	B-SPEC
enteritis	O
.	O

ABSTRACT	O
:	O
Cancer	B-SPEC
of	O
the	O
esophagus	O
has	O
a	O
poor	O
long	O
-	O
term	O
prognosis	O
and	O
a	O
high	O
peri	O
-	O
operative	O
morbidity	O
in	O
which	O
pulmonary	O
complications	O
play	O
a	O
major	O
role	O
.	O

TITLE	O
:	O
Regulation	O
of	O
IRF	O
-	O
3	O
-	O
dependent	O
innate	O
immunity	O
by	O
the	O
papain	O
-	O
like	O
protease	O
domain	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Most	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
develop	O
antibodies	O
against	O
the	O
SARS	O
coronavirus	B-SPEC
and	O
survive	O
the	O
infection	O
.	O

Fourteen	O
cats	B-SPEC
had	O
seizure	O
(	O
s	O
),	O
while	O
41	O
cats	B-SPEC
had	O
no	O
history	O
of	O
seizure	O
(	O
s	O
).	O

Generalised	O
tonic	O
-	O
clonic	O
seizures	O
were	O
seen	O
in	O
nine	O
cats	B-SPEC
;	O
and	O
complex	O
focal	O
seizures	O
were	O
observed	O
in	O
four	O
patients	O
.	O

However	O
,	O
seizures	O
were	O
significantly	O
more	O
frequent	O
in	O
animals	B-SPEC
with	O
marked	O
extension	O
of	O
the	O
inflammatory	O
lesions	O
to	O
the	O
forebrain	O
(	O
P	O
=	O
0	O
.	O
038	O
).	O

ABSTRACT	O
:	O
On	O
the	O
basis	O
of	O
our	O
previous	O
study	O
on	O
antiviral	O
agents	O
against	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
,	O
a	O
series	O
of	O
nucleoside	O
analogues	O
whose	O
5	O
'-	O
hydroxyl	O
groups	O
are	O
masked	O
by	O
various	O
protective	O
groups	O
such	O
as	O
carboxylate	O
,	O
sulfonate	O
,	O
and	O
ether	O
were	O
synthesized	O
and	O
evaluated	O
to	O
develop	O
novel	O
anti	O
-	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
agents	O
.	O

However	O
,	O
some	O
animal	B-SPEC
populations	O
are	O
reported	O
to	O
inbreed	O
without	O
incurring	O
inbreeding	O
depression	O
,	O
ostensibly	O
due	O
to	O
past	O
""""	O
purging	O
""""	O
of	O
deleterious	O
alleles	O
.	O

These	O
data	O
support	O
a	O
risk	O
factor	O
model	O
in	O
which	O
numerical	O
and	O
functional	O
deficits	O
in	O
PDC	O
-	O
mediated	O
innate	O
immune	O
responses	O
contribute	O
to	O
an	O
impaired	O
control	O
of	O
latent	O
herpes	B-SPEC
virus	I-SPEC
infections	O
and	O
subsequent	O
development	O
of	O
ARN	O
.	O

ABSTRACT	O
:	O
In	O
the	O
last	O
30	O
years	O
,	O
several	O
emerging	O
infections	O
due	O
to	O
novel	O
viruses	B-SPEC
have	O
been	O
identified	O
,	O
from	O
haemorrhagic	O
fever	O
viruses	B-SPEC
to	O
HIV	B-SPEC
,	O
from	O
the	O
SARS	O
-	O
Coronavirus	B-SPEC
to	O
Avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
.	O

ABSTRACT	O
:	O
We	O
analyzed	O
the	O
ability	O
of	O
two	O
rat	B-SPEC
coronavirus	B-SPEC
(	O
RCoV	B-SPEC
)	O
strains	O
,	O
sialodacryoadenitis	O
virus	B-SPEC
(	O
SDAV	O
)	O
and	O
Parker	O
'	O
s	O
RCoV	B-SPEC
(	O
RCoV	B-SPEC
-	O
P	O
),	O
to	O
infect	O
rat	B-SPEC
alveolar	O
type	O
I	O
cells	O
and	O
induce	O
chemokine	O
expression	O
.	O

ABSTRACT	O
:	O
Replication	O
fidelity	O
of	O
RNA	O
virus	B-SPEC
genomes	O
is	O
constrained	O
by	O
the	O
opposing	O
necessities	O
of	O
generating	O
sufficient	O
diversity	O
for	O
adaptation	O
and	O
maintaining	O
genetic	O
stability	O
,	O
but	O
it	O
is	O
unclear	O
how	O
the	O
largest	O
viral	O
RNA	O
genomes	O
have	O
evolved	O
and	O
are	O
maintained	O
under	O
these	O
constraints	O
.	O

Despite	O
the	O
recent	O
emergence	O
of	O
respiratory	O
viral	O
pathogens	O
such	O
as	O
SARS	O
and	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
UV	O
disinfection	O
of	O
pathogenic	O
viral	O
aerosols	O
has	O
not	O
been	O
examined	O
.	O

The	O
susceptibility	O
of	O
coronavirus	B-SPEC
aerosols	O
was	O
7	O
-	O
10	O
times	O
that	O
of	O
the	O
MS2	O
and	O
adenovirus	B-SPEC
aerosols	O
.	O

The	O
PCR	O
detection	O
results	O
obtained	O
for	O
other	O
viruses	B-SPEC
revealed	O
the	O
following	O
:	O
61	O
.	O
5	O
%	O
were	O
positive	O
for	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
,	O
30	O
.	O
8	O
%	O
for	O
swine	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
15	O
.	O
4	O
%	O
for	O
porcine	B-SPEC
parvovirus	I-SPEC
,	O
69	O
.	O
2	O
%	O
for	O
swine	B-SPEC
torque	B-SPEC
teno	I-SPEC
virus	I-SPEC
(	O
swTTV	O
),	O
38	O
.	O
5	O
%	O
for	O
swine	B-SPEC
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
swHEV	O
)	O
and	O
84	O
.	O
6	O
%	O
for	O
Mycoplasma	B-SPEC
hyorhinis	I-SPEC
;	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
and	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
/	O
PRCV	O
)	O
was	O
not	O
detected	O
.	O

Further	O
sequence	O
analyses	O
on	O
83	O
other	O
Canadian	O
PCV	B-SPEC
-	O
2	O
positive	O
cases	O
submitted	O
to	O
the	O
provincial	O
diagnostic	O
laboratory	O
during	O
years	O
2005	O
and	O
2006	O
showed	O
that	O
79	O
.	O
5	O
%	O
of	O
the	O
viral	O
sequences	O
obtained	O
clustered	O
in	O
the	O
PCV	B-SPEC
-	O
2b	O
genotype	O
.	O

During	O
in	O
vitro	O
translation	O
in	O
rabbit	B-SPEC
reticulocyte	O
lysate	O
,	O
we	O
observed	O
that	O
incorporation	O
of	O
the	O
pseudoknot	O
into	O
the	O
mRNA	O
resulted	O
in	O
production	O
of	O
a	O
translational	O
intermediate	O
that	O
corresponded	O
to	O
the	O
expected	O
size	O
for	O
ribosomal	O
arrest	O
at	O
the	O
pseudoknot	O
.	O

Thus	O
,	O
in	O
order	B-SPEC
to	O
improve	O
the	O
efficiency	O
of	O
selection	O
,	O
this	O
relatively	O
short	O
pseudoknot	O
sequence	O
could	O
be	O
incorporated	O
into	O
ribosome	O
display	O
.	O

Early	O
epidemiologic	O
investigations	O
suggested	O
an	O
animal	B-SPEC
origin	O
for	O
SARS	O
-	O
CoV	O
.	O
Virological	O
and	O
serological	O
studies	O
indicated	O
that	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
(	O
Paguma	B-SPEC
larvata	I-SPEC
),	O
together	O
with	O
two	O
other	O
wildlife	O
animals	B-SPEC
,	O
sampled	O
from	O
a	O
live	O
animal	B-SPEC
market	O
were	O
infected	O
with	O
SARS	O
-	O
CoV	O
or	O
a	O
closely	O
related	O
virus	B-SPEC
.	O

We	O
investigated	O
instances	O
of	O
radiographically	O
confirmed	O
lower	O
respiratory	O
tract	O
disease	O
among	O
symptomatic	O
children	O
with	O
coronavirus	B-SPEC
infection	O
.	O

Here	O
,	O
we	O
document	O
the	O
clinical	O
courses	O
of	O
2	O
previously	O
healthy	O
children	O
with	O
coronavirus	B-SPEC
-	O
associated	O
pneumonia	O
.	O

In	O
four	O
(	O
36	O
.	O
4	O
%)	O
patients	O
at	O
least	O
one	O
other	O
viral	O
pathogen	O
was	O
found	O
(	O
plus	O
RSV	B-SPEC
n	O
=	O
3	O
;	O
27	O
.	O
3	O
%;	O
Norovirus	B-SPEC
n	O
=	O
1	O
;	O
9	O
.	O
1	O
%).	O

TITLE	O
:	O
Cytomegalovirus	B-SPEC
and	O
Clostridium	B-SPEC
difficile	I-SPEC
ischemic	O
colitis	O
in	O
a	O
renal	O
transplant	O
recipient	O
:	O
a	O
lethal	O
complication	O
of	O
anti	O
-	O
rejection	O
therapy	O
?	O

The	O
sequences	O
of	O
six	O
bat	B-SPEC
GHV	O
were	O
similarly	O
related	O
to	O
members	O
of	O
the	O
gammaherpesvirus	O
genera	O
Percavirus	B-SPEC
and	O
Rhadinovirus	B-SPEC
.	O

The	O
seventh	O
GHV	O
was	O
related	O
to	O
the	O
porcine	B-SPEC
lymphotropic	O
herpesvirus	B-SPEC
1	O
(	O
genus	B-SPEC
Macavirus	B-SPEC
).	O

TITLE	O
:	O
Comparative	O
analysis	O
of	O
innate	O
immune	O
responses	O
following	O
infection	O
of	O
newborn	O
calves	O
with	O
bovine	B-SPEC
rotavirus	B-SPEC
and	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

To	O
address	O
this	O
hypothesis	O
,	O
gene	O
expression	O
following	O
BRV	O
and	O
BCV	B-SPEC
infection	O
was	O
analysed	O
in	O
surgically	O
prepared	O
intestinal	O
loops	O
from	O
1	O
-	O
day	O
-	O
old	O
colostrum	O
-	O
deprived	O
calves	O
.	O

Both	O
viruses	B-SPEC
also	O
downregulated	O
IFN	O
-	O
and	O
pro	O
-	O
inflammatory	O
cytokine	O
-	O
associated	O
pathways	O
.	O

The	O
purpose	O
of	O
this	O
work	O
was	O
to	O
assess	O
the	O
impact	O
of	O
recently	O
described	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
compared	O
with	O
other	O
respiratory	O
viruses	B-SPEC
by	O
using	O
sensitive	O
molecular	O
techniques	O
in	O
a	O
cohort	O
of	O
healthy	O
preschool	O
-	O
aged	O
children	O
.	O

Influenza	B-SPEC
virus	I-SPEC
and	O
adenovirus	B-SPEC
illnesses	O
had	O
the	O
greatest	O
impact	O
,	O
with	O
fever	O
in	O
more	O
than	O
three	O
quarters	O
and	O
requiring	O
,	O
on	O
average	O
,	O
>	O
1	O
local	O
doctor	O
visit	O
per	O
illness	O
.	O

To	O
date	O
,	O
RNAi	O
has	O
been	O
extensively	O
used	O
as	O
a	O
novel	O
and	O
effective	O
tool	O
for	O
functional	O
genomic	O
studies	O
,	O
and	O
has	O
displayed	O
great	O
potential	O
in	O
treating	O
human	B-SPEC
diseases	O
,	O
including	O
human	B-SPEC
genetic	O
and	O
acquired	O
disorders	O
such	O
as	O
cancer	B-SPEC
and	O
viral	O
infections	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
ability	O
of	O
a	O
high	O
-	O
cell	O
-	O
passage	O
canine	O
coronavirus	B-SPEC
vaccine	O
to	O
immunise	O
dogs	B-SPEC
against	O
challenge	O
with	O
a	O
field	O
isolate	O
of	O
the	O
virus	B-SPEC
.	O

,	O
numerous	O
researchers	O
around	O
the	O
world	O
have	O
been	O
working	O
relentlessly	O
to	O
understand	O
the	O
biology	O
of	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
Use	O
of	O
antibody	O
avidity	O
assays	O
for	O
diagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

In	O
two	O
of	O
these	O
patients	O
,	O
sequential	O
serum	O
samples	O
were	O
also	O
tested	O
for	O
IgG	O
avidity	O
against	O
human	B-SPEC
CoV	O
strains	O
OC43	O
and	O
229E	O
in	O
parallel	O
.	O

While	O
SARS	O
CoV	O
infections	O
induced	O
an	O
anamnestic	O
IgG	O
antibody	O
response	O
to	O
the	O
229E	O
and	O
OC43	O
viruses	B-SPEC
,	O
these	O
cross	O
-	O
reactive	O
antibodies	O
remained	O
of	O
high	O
avidity	O
from	O
early	O
(	O
the	O
first	O
month	O
)	O
postinfection	O
.	O

TITLE	O
:	O
Impact	O
of	O
SARS	O
on	O
avian	B-SPEC
influenza	O
preparedness	O
in	O
healthcare	O
workers	O
.	O

Animal	B-SPEC
studies	O
demonstrated	O
a	O
reduction	O
of	O
mortality	O
and	O
viral	O
activity	O
in	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
encephalitis	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
pneumonia	O
.	O

TITLE	O
:	O
[	O
Vertical	O
transmission	O
of	O
human	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoV	O
)	O
have	O
been	O
implicated	O
in	O
neonatal	O
nosocomial	O
respiratory	O
infection	O
.	O

Equally	O
indicated	O
is	O
the	O
inclusion	O
of	O
tests	O
to	O
detect	O
recently	O
identified	O
human	B-SPEC
coronaviruses	O
HCoV	O
NL63	O
and	O
HKU1	O
,	O
as	O
well	O
as	O
genomic	O
profile	O
analysis	O
of	O
HCoV	O
229	O
-	O
E	O
detected	O
in	O
the	O
3	O
positive	O
mother	O
-	O
child	O
couples	O
.	O

To	O
define	O
the	O
seroepidemiology	O
of	O
group	O
I	O
human	B-SPEC
coronaviruses	O
.	O

Infection	O
with	O
these	O
viruses	B-SPEC
is	O
common	O
in	O
childhood	O
though	O
the	O
prevalence	O
of	O
these	O
viruses	B-SPEC
may	O
vary	O
from	O
year	O
to	O
year	O
.	O

RESULTS	O
:	O
For	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
the	O
percentages	O
of	O
seropositive	O
individuals	O
were	O
57	O
.	O
1	O
%	O
for	O
infants	O
<	O
2	O
months	O
old	O
;	O
38	O
.	O
9	O
%	O
for	O
infants	O
2	O
-	O
3	O
months	O
old	O
;	O
4	O
.	O
7	O
%	O
for	O
infants	O
4	O
-	O
5	O
months	O
old	O
;	O
42	O
.	O
9	O
-	O
50	O
.	O
0	O
%	O
for	O
infants	O
6	O
-	O
12	O
months	O
old	O
;	O
34	O
.	O
8	O
-	O
62	O
.	O
5	O
%	O
for	O
individuals	O
1	O
-	O
20	O
years	O
old	O
.	O

The	O
data	O
suggested	O
that	O
the	O
region	O
of	O
amino	O
acids	O
78	O
-	O
85	O
within	O
N	O
protein	O
probably	O
was	O
the	O
conserved	O
region	O
for	O
all	O
coronaviruses	O
identified	O
so	O
far	O
including	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

In	O
conclusion	O
,	O
the	O
recombinant	O
plasmids	O
pCF	O
-	O
T	O
-	O
8081	O
N	O
and	O
pUCm	O
-	O
T	O
-	O
8081	O
E	O
were	O
successfully	O
constructed	O
and	O
sequenced	O
,	O
and	O
the	O
data	O
predicted	O
by	O
bioinformatics	O
are	O
helpful	O
for	O
the	O
further	O
analysis	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

Most	O
of	O
the	O
Chinese	O
IBV	B-SPEC
strains	O
were	O
included	O
in	O
clusters	O
II	O
and	O
IV	O
,	O
forming	O
distinct	O
groups	O
.	O

Molecular	O
modeling	O
demonstrated	O
that	O
the	O
catalytic	O
residues	O
of	O
mNsp15	O
are	O
superimposable	O
with	O
its	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
ortholog	O
.	O

The	O
secretion	O
level	O
of	O
IFN	O
-	O
gamma	O
was	O
much	O
higher	O
than	O
that	O
of	O
IL	O
-	O
4	O
in	O
vAc	O
-	O
N	O
or	O
vAc	O
-	O
S	O
immunized	O
groups	O
,	O
suggesting	O
a	O
strong	O
Th1	O
bias	B-SPEC
towards	O
cellular	O
immune	O
responses	O
.	O

TITLE	O
:	O
CoVDB	O
:	O
a	O
comprehensive	O
database	O
for	O
comparative	O
analysis	O
of	O
coronavirus	B-SPEC
genes	O
and	O
genomes	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
SARS	O
epidemic	O
has	O
boosted	O
interest	O
in	O
the	O
discovery	O
of	O
novel	O
human	B-SPEC
and	O
animal	B-SPEC
coronaviruses	O
.	O

By	O
July	O
2007	O
,	O
more	O
than	O
3000	O
coronavirus	B-SPEC
sequence	O
records	O
,	O
including	O
264	O
complete	O
genomes	O
,	O
are	O
available	O
in	O
GenBank	O
.	O

We	O
also	O
demonstrated	O
that	O
the	O
cross	O
-	O
reactivity	O
is	O
not	O
universal	O
for	O
all	O
group	O
1	O
CoVs	O
,	O
because	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
did	O
not	O
cross	O
-	O
react	O
with	O
SARS	O
-	O
CoV	O
.	O
One	O
-	O
way	O
cross	O
-	O
reactivity	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
with	O
group	O
1	O
CoVs	O
was	O
localized	O
to	O
aa	O
1	O
to	O
39	O
and	O
at	O
least	O
one	O
other	O
antigenic	O
site	O
in	O
the	O
N	O
-	O
protein	O
C	O
terminus	O
,	O
differing	O
from	O
the	O
cross	O
-	O
reactive	O
region	O
identified	O
in	O
SARS	O
-	O
CoV	O
N	O
protein	O
.	O

Herein	O
,	O
we	O
tested	O
whether	O
antiviral	O
antibody	O
-	O
mediated	O
suppression	O
of	O
virus	B-SPEC
replication	O
and	O
subsequent	O
virus	B-SPEC
clearance	O
were	O
necessary	O
for	O
preventing	O
CTL	O
escape	O
in	O
coronavirus	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
acute	O
and	O
chronic	O
central	O
nervous	O
system	O
infection	O
with	O
variants	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
strain	O
JHM	O
.	O

However	O
,	O
the	O
presence	O
of	O
T	O
lymphocytes	O
or	O
anti	O
-	O
viral	O
antibody	O
can	O
induce	O
disease	O
in	O
infected	O
immunodeficient	O
mice	B-SPEC
.	O

TITLE	O
:	O
Fatal	O
winter	O
dysentery	O
with	O
severe	O
anemia	B-SPEC
in	O
an	O
adult	O
cow	B-SPEC
.	O

Virus	B-SPEC
particles	O
were	O
found	O
in	O
the	O
necrotic	O
epithelial	O
cells	O
of	O
the	O
large	O
intestine	O
.	O

Virologically	O
,	O
BCV	B-SPEC
was	O
isolated	O
from	O
the	O
feces	O
of	O
the	O
dead	O
cow	B-SPEC
.	O

The	O
univariate	O
analysis	O
and	O
multivariate	O
analysis	O
demonstrated	O
that	O
the	O
clinical	O
conditions	O
such	O
as	O
elder	B-SPEC
age	O
,	O
shock	O
,	O
dyspnea	O
,	O
abnormal	O
arterial	O
blood	O
gas	O
,	O
hemopneumothorax	O
,	O
pulmonary	O
contusion	O
,	O
flail	O
chest	O
,	O
coexisting	O
pulmonary	O
diseases	O
,	O
multiple	O
abdominal	O
injury	O
and	O
high	O
ISS	O
score	O
were	O
the	O
independent	O
high	O
risk	O
factors	O
related	O
to	O
ARDS	O
.	O

There	O
were	O
no	O
differences	O
between	O
the	O
two	O
groups	O
with	O
respect	O
to	O
age	O
,	O
sex	O
,	O
ISS	O
,	O
Glasgow	O
coma	B-SPEC
score	O
(	O
GCS	O
),	O
head	O
,	O
abdomen	O
and	O
extremity	O
AIS	O
.	O

ABSTRACT	O
:	O
Development	O
of	O
vaccines	O
to	O
prevent	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
limited	O
by	O
the	O
lack	O
of	O
well	O
-	O
characterized	O
animal	B-SPEC
models	O
.	O

All	O
of	O
the	O
ferrets	B-SPEC
cleared	O
the	O
virus	B-SPEC
by	O
day	O
14	O
,	O
1	O
week	O
earlier	O
if	O
vaccinated	O
.	O

RESULTS	O
:	O
Humoral	O
responses	O
were	O
observed	O
in	O
ferrets	B-SPEC
that	O
received	O
an	O
inactivated	O
virus	B-SPEC
vaccine	O
.	O

Coding	O
included	O
news	O
frames	O
(	O
health	O
severity	O
,	O
human	B-SPEC
interest	O
,	O
economic	O
,	O
attribution	O
of	O
responsibility	O
,	O
denial	O
)	O
and	O
the	O
type	O
of	O
cited	O
sources	O
(	O
domestic	O
and	O
international	O
).	O

The	O
absence	O
of	O
IFN	O
-	O
I	O
signaling	O
did	O
not	O
impair	O
induction	O
or	O
recruitment	O
of	O
virus	B-SPEC
-	O
specific	O
CD8	O
T	O
cells	O
,	O
the	O
primary	O
adaptive	O
mediators	O
of	O
virus	B-SPEC
clearance	O
in	O
wt	O
mice	B-SPEC
.	O

These	O
data	O
demonstrate	O
a	O
critical	O
direct	O
antiviral	O
role	O
of	O
IFN	O
-	O
I	O
in	O
controlling	O
virus	B-SPEC
dissemination	O
within	O
the	O
CNS	O
,	O
even	O
in	O
the	O
presence	O
of	O
potent	O
cellular	O
immune	O
responses	O
.	O

The	O
intact	O
ORF8	O
present	O
in	O
animal	B-SPEC
and	O
some	O
early	O
human	B-SPEC
isolates	O
encodes	O
a	O
122	O
-	O
amino	O
-	O
acid	O
polypeptide	O
(	O
8ab	O
(+)),	O
which	O
we	O
expressed	O
in	O
cells	O
using	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
T7	O
expression	O
system	O
.	O

In	O
this	O
study	O
,	O
we	O
established	O
a	O
new	O
animal	B-SPEC
model	O
,	O
the	O
Chinese	B-SPEC
hamster	I-SPEC
,	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
an	O
RNA	O
binding	O
protein	O
which	O
is	O
phosphorylated	O
at	O
two	O
conserved	O
clusters	O
.	O

In	O
addition	O
,	O
all	O
PEDV	B-SPEC
vaccine	O
strains	O
were	O
used	O
as	O
live	O
virus	B-SPEC
vaccine	O
,	O
because	O
they	O
previously	O
exhibited	O
a	O
reduced	O
pathogenicity	O
in	O
pigs	B-SPEC
.	O

Therefore	O
,	O
large	O
deletion	O
region	O
,	O
which	O
is	O
comprise	O
17	O
amino	O
acid	O
deletions	O
caused	O
by	O
51	O
nucleotide	O
deletions	O
and	O
is	O
seen	O
in	O
all	O
PED	O
live	O
vaccine	O
strains	O
,	O
may	O
be	O
important	O
site	O
for	O
PEDV	B-SPEC
pathogenicity	O
,	O
and	O
we	O
can	O
use	O
it	O
for	O
differentiation	O
of	O
wild	O
-	O
and	O
attenuated	O
-	O
type	O
PEDVs	O
.	O

TITLE	O
:	O
Co	O
-	O
circulation	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
during	O
a	O
major	O
nosocomial	O
SARS	O
outbreak	O
in	O
Hong	O
Kong	O
.	O

All	O
available	O
nasopharyngeal	O
aspirate	O
(	O
NPA	O
)	O
collected	O
from	O
confirmed	O
patients	O
during	O
the	O
first	O
8	O
weeks	O
of	O
the	O
SARS	O
outbreak	O
in	O
2003	O
were	O
tested	O
for	O
hMPV	B-SPEC
by	O
a	O
nested	O
RT	O
-	O
PCR	O
assay	O
targeting	O
the	O
F	O
-	O
gene	O
.	O

TITLE	O
:	O
Altered	O
pathogenesis	O
of	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
in	O
pigs	B-SPEC
due	O
to	O
immunosuppressive	O
effects	O
of	O
dexamethasone	O
:	O
implications	O
for	O
corticosteroid	O
use	O
in	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Because	O
the	O
pulmonary	O
pathology	O
of	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	B-SPEC
)	O
in	O
pigs	B-SPEC
resembles	O
SARS	O
,	O
we	O
used	O
PRCV	B-SPEC
as	O
a	O
model	O
to	O
clarify	O
the	O
effects	O
of	O
the	O
corticosteroid	O
dexamethasone	O
(	O
DEX	O
)	O
on	O
coronavirus	B-SPEC
(	O
CoV	O
)-	O
induced	O
pneumonia	O
.	O

Conventional	O
weaned	O
pigs	B-SPEC
(	O
n	O
=	O
130	O
)	O
in	O
one	O
of	O
four	O
groups	O
(	O
PRCV	O
/	O
phosphate	O
-	O
buffered	O
saline	O
[	O
PBS	O
]	O
[	O
n	O
=	O
41	O
],	O
PRCV	O
/	O
DEX	O
[	O
n	O
=	O
41	O
],	O
mock	O
/	O
PBS	O
[	O
n	O
=	O
23	O
],	O
and	O
mock	O
/	O
DEX	O
[	O
n	O
=	O
25	O
])	O
were	O
inoculated	O
intranasally	O
and	O
intratracheally	O
with	O
the	O
ISU	O
-	O
1	O
strain	O
of	O
PRCV	O
(	O
1	O
x	O
10	O
(	O
7	O
)	O
PFU	O
)	O
or	O
cell	O
culture	O
medium	O
.	O

ABSTRACT	O
:	O
Several	O
studies	O
have	O
implicated	O
the	O
CXCL2	O
chemokine	O
as	O
a	O
mediator	O
in	O
the	O
development	O
of	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
,	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
and	O
HCoV	O
-	O
HKU1	O
were	O
first	O
described	O
in	O
2003	O
,	O
2004	O
and	O
2005	O
respectively	O
.	O

ABSTRACT	O
:	O
In	O
2003	O
,	O
European	O
critical	O
care	O
experts	O
have	O
drafted	O
surviving	O
sepsis	B-SPEC
campaign	O
(	O
SSC	O
)	O
guidelines	O
for	O
therapy	O
of	O
sepsis	B-SPEC
,	O
and	O
it	O
would	O
be	O
of	O
practical	O
use	O
for	O
the	O
clinician	O
,	O
but	O
case	O
mortality	O
of	O
severe	O
sepsis	B-SPEC
was	O
expected	O
to	O
lower	O
obviously	O
.	O

First	O
,	O
modulation	O
of	O
immunity	O
benefitted	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
;	O
second	O
,	O
early	O
anticoagulant	O
therapy	O
was	O
essential	O
to	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
,	O
because	O
disseminated	O
intravascular	O
coagulopathy	O
occurred	O
in	O
44	O
.	O
1	O
%	O
of	O
MODS	O
;	O
third	O
,	O
Chinese	O
herb	O
medicines	O
could	O
promote	O
and	O
protect	O
gastrointestinal	O
function	O
in	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
;	O
fourth	O
,	O
institution	O
of	O
mechanical	O
ventilation	O
with	O
low	O
tidal	O
volume	O
(	O
VT	O
)	O
was	O
effective	O
and	O
safe	O
in	O
ARDS	O
.	O

The	O
present	O
guidelines	O
supplements	O
some	O
pertinent	O
problems	O
which	O
were	O
neglected	O
in	O
SSC	O
guidelines	O
for	O
the	O
management	O
of	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
,	O
and	O
they	O
may	O
hopefully	O
improve	O
the	O
outcome	O
of	O
the	O
critically	O
ill	O
patient	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
Orf3a	O
protein	O
interacts	O
with	O
caveolin	O
.	O

ABSTRACT	O
:	O
The	O
orf3a	O
(	O
also	O
called	O
X1	O
or	O
U274	O
)	O
gene	O
is	O
the	O
largest	O
unique	O
open	O
reading	O
frame	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
genome	O
and	O
has	O
been	O
proposed	O
to	O
encode	O
a	O
protein	O
with	O
three	O
transmembrane	O
domains	O
and	O
a	O
large	O
cytoplasmic	O
domain	O
.	O

TITLE	O
:	O
Priapism	O
in	O
a	O
castrated	O
cat	B-SPEC
associated	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
a	O
case	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
a	O
castrated	O
cat	B-SPEC
which	O
first	O
presented	O
with	O
the	O
unusual	O
sign	O
of	O
priapism	O
.	O

One	O
month	O
after	O
the	O
first	O
examination	O
,	O
the	O
cat	B-SPEC
died	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
twofold	O
:	O
to	O
determine	O
if	O
reduced	O
fertility	O
following	O
vaccination	O
with	O
live	O
attenuated	O
virus	B-SPEC
was	O
the	O
result	O
of	O
reduced	O
sperm	O
concentration	O
or	O
reduced	O
sperm	O
quality	O
and	O
to	O
determine	O
if	O
vaccination	O
with	O
a	O
killed	O
strain	O
of	O
virus	B-SPEC
caused	O
a	O
similar	O
reduction	O
in	O
sperm	O
function	O
in	O
vivo	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
SARS	O
coronavirus	B-SPEC
helicase	O
by	O
bismuth	O
complexes	O
.	O

To	O
this	O
end	O
,	O
we	O
compared	O
a	O
productive	O
,	O
noncytopathic	O
infection	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
A59	O
in	O
the	O
fibroblastlike	O
cell	O
line	O
NIH	O
3T3	O
with	O
cytopathic	O
MHV	B-SPEC
infections	O
.	O

Using	O
flow	O
cytometry	O
,	O
we	O
demonstrated	O
that	O
NIH	O
3T3	O
cells	O
expressed	O
as	O
much	O
MHV	B-SPEC
receptor	O
CEACAM1	O
as	O
other	O
cell	O
lines	O
which	O
die	O
from	O
MHV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Clostridium	B-SPEC
difficile	I-SPEC
was	O
investigated	O
as	O
a	O
possible	O
cause	O
of	O
enteritis	O
in	O
calves	O
.	O

Prevalence	O
rates	O
for	O
coronavirus	B-SPEC
and	O
Cryptosporidium	B-SPEC
sp	O
.	O
were	O
substantially	O
higher	O
in	O
nondiarrheic	O
calves	O
than	O
in	O
diarrheic	O
,	O
but	O
rates	O
of	O
detection	O
of	O
rotavirus	B-SPEC
and	O
Giardia	B-SPEC
sp	O
.	O
were	O
more	O
nearly	O
equal	O
between	O
groups	O
.	O

Diagn	O
.,	O
St	O
.	O
Louis	O
,	O
MO	O
,	O
U	O
.	O
S	O
.	O
A	O
.]	O
and	O
add	O
strength	O
to	O
a	O
working	O
hypothesis	O
that	O
C	B-SPEC
.	I-SPEC
difficile	I-SPEC
infection	O
and	O
the	O
accompanying	O
intoxication	O
can	O
manifest	O
as	O
diarrhea	O
in	O
calves	O
.	O

TITLE	O
:	O
DRAK2	O
regulates	O
memory	O
T	O
cell	O
responses	O
following	O
murine	B-SPEC
coronavirus	I-SPEC
infection	O
.	O

TITLE	O
:	O
Continuous	O
negative	O
extrathoracic	O
pressure	O
combined	O
with	O
high	O
-	O
frequency	O
oscillation	O
improves	O
oxygenation	O
with	O
less	O
impact	O
on	O
blood	O
pressure	O
than	O
high	O
-	O
frequency	O
oscillation	O
alone	O
in	O
a	O
rabbit	B-SPEC
model	O
of	O
surfactant	O
depletion	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
a	O
small	O
animal	B-SPEC
model	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
we	O
developed	O
a	O
mouse	B-SPEC
model	O
of	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
by	O
introducing	O
the	O
human	B-SPEC
gene	O
for	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
hACE2	O
)	O
(	O
the	O
cellular	O
receptor	O
of	O
SARS	O
-	O
CoV	O
),	O
driven	O
by	O
the	O
mouse	B-SPEC
ACE2	O
promoter	O
,	O
into	O
the	O
mouse	B-SPEC
genome	O
.	O

In	O
an	O
effort	O
to	O
characterize	O
molecular	O
components	O
of	O
the	O
virus	B-SPEC
that	O
are	O
absent	O
in	O
other	O
coronaviruses	O
,	O
all	O
of	O
which	O
are	O
considerably	O
less	O
pathogenic	O
for	O
humans	B-SPEC
,	O
we	O
recombinantly	O
produced	O
the	O
SARS	O
-	O
unique	O
domain	O
(	O
SUD	O
)	O
within	O
non	O
-	O
structural	O
protein	O
3	O
(	O
Nsp3	O
)	O
of	O
SARS	O
-	O
CoV	O
and	O
characterized	O
its	O
nucleic	O
-	O
acid	O
binding	O
properties	O
.	O

ABSTRACT	O
:	O
A	O
phase	O
I	O
trial	O
was	O
initiated	O
to	O
establish	O
the	O
dose	O
-	O
limiting	O
toxicities	O
(	O
DLTs	O
)	O
and	O
the	O
maximum	O
tolerated	O
dose	O
(	O
MTD	O
)	O
of	O
chronomodulated	O
5	O
-	O
fluorouracil	O
and	O
cisplatin	O
given	O
concurrently	O
with	O
preoperative	O
radiotherapy	O
in	O
patients	O
with	O
esophageal	O
cancer	B-SPEC
.	O

Z	O
gene	O
was	O
successfully	O
designed	O
and	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
).	O

Rotavirus	B-SPEC
was	O
the	O
only	O
virus	B-SPEC
detected	O
prior	O
to	O
placement	O
(	O
7	O
of	O
16	O
samples	O
examined	O
).	O

TITLE	O
:	O
Pathogenesis	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
vaccinated	O
chickens	B-SPEC
of	O
two	O
different	O
major	O
histocompatibility	O
B	O
complex	O
genotypes	O
.	O

Additional	O
chickens	B-SPEC
of	O
both	O
genotypes	O
served	O
as	O
unvaccinated	O
/	O
challenged	O
and	O
unvaccinated	O
/	O
nonchallenged	O
controls	O
.	O

IBV	B-SPEC
genomes	O
were	O
present	O
in	O
the	O
tears	O
of	O
vaccinated	O
and	O
challenged	O
birds	B-SPEC
,	O
and	O
the	O
incidence	O
of	O
detectable	O
IBV	B-SPEC
genomes	O
did	O
not	O
vary	O
significantly	O
with	O
MHC	O
B	O
genotype	O
.	O

TITLE	O
:	O
Sequence	O
analysis	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
:	O
identification	O
of	O
a	O
novel	O
phylogenetic	O
group	O
in	O
Korea	O
.	O

The	O
S1	O
glycoprotein	O
genes	O
of	O
these	O
IBV	B-SPEC
isolates	O
were	O
amplified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RTPCR	O
)	O
and	O
analyzed	O
by	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
analysis	O
.	O

TITLE	O
:	O
Human	B-SPEC
(	O
non	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
coronavirus	B-SPEC
infections	O
in	O
hospitalised	O
children	O
in	O
France	O
.	O

To	O
evaluate	O
the	O
safety	O
and	O
immunogenicity	O
of	O
the	O
inactivated	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
vaccine	O
,	O
36	O
subjects	O
received	O
two	O
doses	O
of	O
16	O
SARS	O
-	O
CoV	O
units	O
(	O
SU	O
)	O
or	O
32	O
SU	O
inactivated	O
SARS	O
-	O
CoV	O
vaccine	O
,	O
or	O
placebo	O
control	O
.	O

In	O
the	O
scenario	O
of	O
the	O
cardiac	O
arrest	O
of	O
a	O
family	B-SPEC
member	O
,	O
more	O
would	O
perform	O
CCPR	O
than	O
SCPR	O
in	O
the	O
pre	O
-	O
SARS	O
era	O
(	O
92	O
.	O
8	O
%	O
vs	O
.	O
87	O
.	O
2	O
%,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
in	O
the	O
post	O
-	O
SARS	O
era	O
(	O
92	O
.	O
8	O
%	O
vs	O
.	O
84	O
.	O
9	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

As	O
it	O
has	O
been	O
already	O
suggested	O
for	O
other	O
viral	O
fusion	O
proteins	O
such	O
as	O
HIV	B-SPEC
gp41	O
,	O
the	O
region	O
of	O
the	O
SARS	O
-	O
CoV	O
protein	O
where	O
the	O
PTM	O
peptide	O
resides	O
could	O
be	O
involved	O
in	O
the	O
merging	O
of	O
the	O
viral	O
and	O
target	O
cell	O
membranes	O
working	O
synergistically	O
with	O
other	O
membrane	O
-	O
active	O
regions	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
to	O
heighten	O
the	O
fusion	O
process	O
and	O
therefore	O
might	O
be	O
essential	O
for	O
the	O
assistance	O
and	O
enhancement	O
of	O
the	O
viral	O
and	O
cell	O
fusion	O
process	O
.	O

The	O
presence	O
of	O
Mg	O
(	O
2	O
+)	O
significantly	O
increases	O
the	O
kinetic	O
barriers	O
to	O
unfolding	O
the	O
IBV	B-SPEC
pseudoknot	O
,	O
but	O
has	O
only	O
a	O
minor	O
effect	O
on	O
the	O
hairpin	O
unfolding	O
.	O

A	O
total	O
of	O
48	O
pigs	B-SPEC
were	O
divided	O
equally	O
into	O
groups	O
as	O
above	O
,	O
but	O
4	O
pigs	B-SPEC
from	O
each	O
group	O
were	O
euthanized	O
at	O
1	O
,	O
4	O
and	O
10	O
days	O
post	O
-	O
infection	O
.	O

In	O
this	O
report	O
,	O
recombinant	O
PPV	B-SPEC
(	O
plum	B-SPEC
pox	I-SPEC
virus	I-SPEC
)	O
NIa	B-SPEC
protease	O
was	O
employed	O
to	O
process	O
fusion	O
proteins	O
with	O
artificial	O
cleavage	O
site	O
in	O
vitro	O
.	O

Its	O
catalytic	O
capability	O
is	O
similar	O
to	O
those	O
of	O
TVMV	B-SPEC
and	O
TEV	B-SPEC
NIa	B-SPEC
protease	O
.	O

Recombinant	O
PPV	B-SPEC
NIa	B-SPEC
protease	O
was	O
resistant	O
to	O
self	O
-	O
lysis	O
for	O
at	O
least	O
five	O
days	O
.	O

Both	O
countries	O
are	O
experiencing	O
HIV	B-SPEC
epidemics	O
driven	O
by	O
injection	O
drug	O
use	O
and	O
have	O
maintained	O
generally	O
severe	O
policies	O
towards	O
injection	O
drug	O
users	O
(	O
IDUs	O
).	O

Excessive	O
reliance	O
on	O
law	O
enforcement	O
and	O
forced	O
detoxification	O
will	O
not	O
solve	O
the	O
problems	O
of	O
substance	O
abuse	O
or	O
of	O
HIV	B-SPEC
among	O
drug	O
users	O
.	O

A	O
total	O
of	O
450	O
chickens	B-SPEC
were	O
randomly	O
assigned	O
to	O
9	O
groups	O
at	O
14	O
d	O
of	O
age	O
and	O
vaccinated	O
first	O
with	O
live	O
Newcastle	O
disease	O
(	O
ND	O
)-	O
infectious	O
bronchitis	O
virus	B-SPEC
vaccine	O
,	O
and	O
second	O
with	O
ND	O
-	O
infectious	O
bronchitis	O
oil	O
adjuvant	O
vaccine	O
at	O
28	O
d	O
of	O
age	O
.	O

Collectively	O
,	O
these	O
findings	O
indicate	O
that	O
the	O
4	O
polysaccharides	O
possess	O
significant	O
immune	O
-	O
enhancing	O
properties	O
in	O
chickens	B-SPEC
.	O

Sequencing	O
of	O
the	O
V51	O
spike	O
gene	O
,	O
the	O
mediator	O
of	O
virus	B-SPEC
entry	O
,	O
revealed	O
13	O
amino	O
acid	O
substitutions	O
relative	O
to	O
the	O
originating	O
MHV	B-SPEC
A59	O
strain	O
.	O

The	O
second	O
class	B-SPEC
of	O
suppressor	O
was	O
mapped	O
to	O
the	O
extreme	O
3	O
'	O
end	O
of	O
the	O
genome	O
,	O
a	O
result	O
which	O
pointed	O
to	O
the	O
existence	O
of	O
a	O
direct	O
base	O
-	O
pairing	O
interaction	O
between	O
loop	O
1	O
of	O
the	O
pseudoknot	O
and	O
the	O
genomic	O
terminus	O
.	O

ABSTRACT	O
:	O
Here	O
we	O
report	O
the	O
development	O
of	O
a	O
more	O
-	O
sensitive	O
immunoassay	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
based	O
on	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
using	O
chemiluminescence	O
(	O
CLEIA	O
)	O
to	O
detect	O
the	O
viral	O
nucleocapsid	O
(	O
N	O
)	O
antigen	O
in	O
nasopharyngeal	O
aspirate	O
(	O
NPA	O
)	O
from	O
patients	O
infected	O
with	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

The	O
CLEIA	O
was	O
established	O
with	O
an	O
optical	O
combination	O
of	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
against	O
SARS	O
CoV	O
N	O
protein	O
prepared	O
from	O
mice	B-SPEC
immunized	O
with	O
recombinant	O
N	O
protein	O
without	O
cultivating	O
the	O
virus	B-SPEC
.	O

In	O
this	O
mini	O
-	O
review	O
,	O
we	O
will	O
summarize	O
the	O
so	O
far	O
limited	O
number	O
of	O
studies	O
that	O
have	O
demonstrated	O
that	O
double	O
-	O
membrane	O
vesicles	O
resembling	O
autophagosomes	O
are	O
the	O
sites	O
of	O
nidovirus	B-SPEC
replication	O
.	O

The	O
diagnosis	O
of	O
an	O
acute	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
was	O
confirmed	O
by	O
serology	O
and	O
PCR	O
.	O

Correlation	O
analysis	O
and	O
hierarchical	O
multiple	O
regression	O
analysis	O
were	O
used	O
to	O
examine	O
relationships	O
among	O
occupational	O
stress	O
,	O
psychological	O
stress	O
,	O
human	B-SPEC
resources	O
and	O
intent	O
to	O
stay	O
in	O
their	O
career	O
.	O

Results	O
indicate	O
that	O
human	B-SPEC
resources	O
play	O
an	O
important	O
role	O
in	O
this	O
issue	O
.	O

Infected	O
dogs	B-SPEC
generally	O
have	O
a	O
rapid	O
recovery	O
,	O
so	O
the	O
virus	B-SPEC
is	O
highly	O
contagious	O
and	O
the	O
spread	O
of	O
infection	O
is	O
difficult	O
to	O
control	O
.	O

In	O
general	O
,	O
virus	B-SPEC
inactivation	O
implies	O
a	O
permanent	O
loss	O
of	O
infectivity	O
which	O
can	O
be	O
evaluated	O
in	O
suspensions	O
and	O
hand	O
disinfection	O
tests	O
.	O

TITLE	O
:	O
In	O
vitro	O
inhibition	O
of	O
coronavirus	B-SPEC
replications	O
by	O
the	O
traditionally	O
used	O
medicinal	O
herbal	O
extracts	O
,	O
Cimicifuga	B-SPEC
rhizoma	O
,	O
Meliae	O
cortex	O
,	O
Coptidis	O
rhizoma	O
,	O
and	O
Phellodendron	B-SPEC
cortex	O
.	O

RESULTS	O
:	O
Cimicifuga	B-SPEC
rhizoma	O
,	O
Meliae	O
cortex	O
,	O
Coptidis	O
rhizoma	O
,	O
Phellodendron	B-SPEC
cortex	O
and	O
Sophora	B-SPEC
subprostrata	O
radix	B-SPEC
decreased	O
the	O
MHV	B-SPEC
production	O
and	O
the	O
intracellular	O
viral	O
RNA	O
and	O
protein	O
expression	O
with	O
EC50	O
values	O
ranging	O
from	O
2	O
.	O
0	O
to	O
27	O
.	O
5	O
microg	O
/	O
ml	O
.	O

Six	O
cynomolgus	B-SPEC
monkeys	I-SPEC
were	O
inoculated	O
with	O
the	O
HKU39849	O
isolate	O
of	O
SARS	O
-	O
CoV	O
via	O
four	O
routes	O
.	O

Analysis	O
of	O
135	O
HRSV	B-SPEC
-	O
positive	O
strains	O
using	O
restriction	O
fragment	O
length	O
polymorphism	O
showed	O
that	O
94	O
(	O
70	O
%)	O
belonged	O
to	O
subgroup	O
A	O
,	O
and	O
41	O
(	O
30	O
%)	O
to	O
subgroup	O
B	O
.	O
There	O
were	O
also	O
two	O
cases	O
of	O
mixed	O
genotypic	O
infection	O
.	O

Influenza	O
B	O
;	O
parainfluenza	O
viruses	B-SPEC
1	O
-	O
4	O
,	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
and	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
were	O
not	O
detected	O
.	O

The	O
remaining	O
two	O
agents	O
were	O
a	O
vaccine	O
for	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
infection	O
,	O
and	O
lipid	O
-	O
based	O
agent	O
for	O
septic	O
shock	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
encodes	O
several	O
RNA	O
-	O
processing	O
enzymes	O
that	O
are	O
unusual	O
for	O
RNA	O
viruses	B-SPEC
,	O
including	O
Nsp15	O
(	O
nonstructural	O
protein	O
15	O
),	O
a	O
hexameric	O
endoribonuclease	O
that	O
preferentially	O
cleaves	O
3	O
'	O
of	O
uridines	O
.	O

ABSTRACT	O
:	O
A	O
number	O
of	O
novel	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
were	O
previously	O
identified	O
in	O
commercial	O
poultry	O
in	O
Australia	O
,	O
where	O
they	O
caused	O
significant	O
economic	O
losses	O
.	O

This	O
data	O
is	O
fully	O
available	O
to	O
the	O
scientific	O
community	O
and	O
is	O
providing	O
an	O
unprecedented	O
level	O
of	O
insight	O
to	O
this	O
class	B-SPEC
of	O
RNA	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Inhibition	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
infection	O
in	O
human	B-SPEC
epithelial	O
lung	O
cells	O
(	O
L132	O
)	O
by	O
chloroquine	O
:	O
involvement	O
of	O
p38	O
MAPK	O
and	O
ERK	O
.	O

ABSTRACT	O
:	O
Tissues	O
from	O
nine	O
ferrets	B-SPEC
with	O
granulomatous	O
lesions	O
similar	O
to	O
those	O
seen	O
in	O
feline	B-SPEC
infectious	O
peritonitis	O
were	O
examined	O
histopathologically	O
and	O
immunohistochemically	O
.	O

carboxy	O
-	O
terminal	O
portion	O
of	O
the	O
spike	O
protein	O
(	O
S	O
-	O
CT24	O
)	O
elicited	O
a	O
strong	O
antibody	O
response	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
that	O
had	O
specific	O
reactivity	O
against	O
the	O
S	O
-	O
CT24	O
and	O
PEDV	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
previous	O
studies	O
a	O
variety	O
of	O
novel	O
accessory	O
genes	O
has	O
been	O
identified	O
that	O
were	O
interspersed	O
among	O
the	O
structural	O
genes	O
of	O
the	O
SARS	O
-	O
CoV	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
)	O
genome	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
heterologous	O
expression	O
of	O
ORF10	O
and	O
X5	O
genes	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
S	B-SPEC
.	I-SPEC
lividans	I-SPEC
TK24	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
aerosolized	O
anticoagulants	O
will	O
reduce	O
the	O
degree	O
of	O
airway	O
obstruction	O
and	O
improve	O
pulmonary	O
function	O
in	O
sheep	B-SPEC
with	O
severe	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
by	O
preventing	O
the	O
formation	O
of	O
airway	O
fibrin	O
clots	O
.	O

Prospective	O
,	O
randomized	O
,	O
controlled	O
,	O
experimental	O
animal	B-SPEC
study	O
.	O

Sheep	B-SPEC
were	O
randomly	O
divided	O
into	O
five	O
groups	O
:	O
sham	O
,	O
noninjured	O
and	O
nontreated	O
(	O
n	O
=	O
6	O
);	O
control	O
,	O
injured	O
and	O
aerosolized	O
with	O
saline	O
(	O
n	O
=	O
6	O
);	O
recombinant	O
human	B-SPEC
antithrombin	O
(	O
rhAT	O
)	O
+	O
heparin	O
,	O
injured	O
and	O
aerosolized	O
with	O
rhAT	O
(	O
290	O
units	O
for	O
each	O
)	O
and	O
heparin	O
(	O
10	O
,	O
000	O
units	O
for	O
each	O
)	O
(	O
n	O
=	O
6	O
);	O
rhAT	O
,	O
injured	O
and	O
aerosolized	O
with	O
rhAT	O
alone	O
(	O
290	O
units	O
for	O
each	O
;	O
n	O
=	O
5	O
);	O
and	O
heparin	O
,	O
injured	O
and	O
aerosolized	O
with	O
heparin	O
alone	O
(	O
10	O
,	O
000	O
units	O
for	O
each	O
;	O
n	O
=	O
5	O
).	O

ABSTRACT	O
:	O
In	O
this	O
study	O
we	O
report	O
the	O
complete	O
sequence	O
and	O
genome	O
organization	O
of	O
the	O
serotype	O
I	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
strain	O
Black	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
which	O
uses	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
its	O
receptor	O
for	O
cell	O
entry	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
receptor	O
usage	O
of	O
the	O
SL	O
-	O
CoV	O
S	O
by	O
combining	O
a	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
-	O
based	O
pseudovirus	O
system	O
with	O
cell	O
lines	O
expressing	O
the	O
ACE2	O
molecules	O
of	O
human	B-SPEC
,	O
civet	B-SPEC
,	O
or	O
horseshoe	B-SPEC
bat	I-SPEC
.	O

Prevention	O
includes	O
epidemiological	O
control	O
of	O
donor	O
populations	O
;	O
checks	O
on	O
each	O
donor	O
'	O
s	O
health	O
condition	O
;	O
analysis	O
of	O
each	O
donation	O
for	O
the	O
main	O
pathogens	O
using	O
serological	O
methods	O
;	O
additional	O
analysis	O
of	O
all	O
plasma	O
for	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
),	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
),	O
hepatitis	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
HAV	O
)	O
and	O
the	O
B19	B-SPEC
virus	I-SPEC
,	O
using	O
nucleic	O
acid	O
amplification	O
techniques	O
(	O
NAT	O
).	O

ABSTRACT	O
:	O
Immunocompetent	O
,	O
but	O
not	O
RAG1	O
(-/-)	O
mice	B-SPEC
infected	O
with	O
MHV	B-SPEC
-	O
JHM	O
develop	O
demyelination	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
1980s	O
,	O
a	O
number	O
of	O
key	O
events	O
have	O
significantly	O
altered	O
our	O
ideas	O
on	O
biosecurity	O
and	O
the	O
role	O
of	O
biocontainment	O
laboratories	O
,	O
such	O
as	O
the	O
bovine	B-SPEC
spongiform	O
encephalopathy	O
(	O
BSE	O
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreaks	O
and	O
the	O
anthrax	B-SPEC
episode	O
of	O
2001	O
in	O
the	O
USA	O
.	O

Parvovirus	B-SPEC
was	O
only	O
detected	O
in	O
one	O
healthy	O
dog	B-SPEC
(	O
0	O
.	O
5	O
per	O
cent	O
),	O
thus	O
with	O
a	O
prevalence	O
that	O
was	O
significantly	O
lower	O
than	O
16	O
.	O
0	O
per	O
cent	O
detected	O
in	O
the	O
dogs	B-SPEC
with	O
acute	O
haemorrhagic	O
diarrhoea	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

2	O
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
gag	B-SPEC
/	O
pol	O
construct	O
)	O
and	O
pHR	B-SPEC
'	I-SPEC
CMV	I-SPEC
EGFP	O
(	O
the	O
green	O
fluorescent	O
protein	O
reporter	O
construct	O
).	O

TITLE	O
:	O
Structures	O
of	O
two	O
coronavirus	B-SPEC
main	O
proteases	O
:	O
implications	O
for	O
substrate	O
binding	O
and	O
antiviral	O
drug	O
design	O
.	O

Furthermore	O
,	O
a	O
Michael	O
acceptor	O
inhibitor	O
(	O
named	O
N3	O
)	O
was	O
cocrystallized	O
with	O
IBV	B-SPEC
M	O
(	O
pro	O
)	O
and	O
was	O
found	O
to	O
demonstrate	O
in	O
vitro	O
inactivation	O
of	O
IBV	B-SPEC
M	O
(	O
pro	O
)	O
and	O
potent	O
antiviral	O
activity	O
against	O
IBV	B-SPEC
in	O
chicken	B-SPEC
embryos	O
.	O

To	O
explore	O
the	O
underlying	O
mechanisms	O
associated	O
with	O
protection	O
from	O
disease	O
in	O
MHV	B-SPEC
-	O
CXCL10	O
-	O
infected	O
mice	B-SPEC
,	O
the	O
functional	O
contributions	O
of	O
the	O
NK	O
cell	O
-	O
activating	O
receptor	O
NKG2D	O
in	O
host	O
defense	O
were	O
examined	O
.	O

TITLE	O
:	O
CD4	O
T	O
cells	O
contribute	O
to	O
virus	B-SPEC
control	O
and	O
pathology	O
following	O
central	O
nervous	O
system	O
infection	O
with	O
neurotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

These	O
data	O
suggest	O
that	O
the	O
human	B-SPEC
adaptation	O
of	O
zoonotic	O
SARS	O
-	O
CoV	O
strains	O
may	O
select	O
for	O
some	O
variants	O
that	O
are	O
highly	O
susceptible	O
to	O
select	O
MAbs	O
that	O
bind	O
to	O
RBDs	O
.	O

Blocking	O
studies	O
on	O
human	B-SPEC
lung	O
fibroblasts	O
indicate	O
that	O
IL	O
-	O
1beta	O
is	O
the	O
major	O
cyclooxygenase	O
-	O
2	O
mRNA	O
and	O
PGE2	O
-	O
inducing	O
factor	O
in	O
pulmonary	O
edema	O
fluid	O
and	O
accounts	O
for	O
the	O
differential	O
PGE2	O
induction	O
noted	O
in	O
samples	O
from	O
ALI	O
patients	O
.	O

This	O
study	O
examines	O
the	O
inhibitory	O
effects	O
of	O
lipids	O
extracted	O
and	O
purified	O
chromatographically	O
from	O
TB	O
on	O
the	O
surface	O
-	O
active	O
function	O
of	O
lavaged	O
bovine	B-SPEC
lung	O
surfactant	O
(	O
LS	O
)	O
and	O
a	O
clinically	O
relevant	O
calf	O
lung	O
surfactant	O
extract	O
(	O
CLSE	O
).	O

Since	O
the	O
next	O
epidemic	O
may	O
be	O
more	O
like	O
SARS	O
than	O
HIV	B-SPEC
,	O
it	O
is	O
important	O
to	O
illuminate	O
these	O
issues	O
.	O

To	O
date	O
,	O
12	O
structures	O
have	O
been	O
determined	O
by	O
X	O
-	O
ray	B-SPEC
crystallography	O
or	O
NMR	O
from	O
the	O
28	O
proteins	O
encoded	O
by	O
SARS	O
-	O
CoV	O
.	O
One	O
key	O
protein	O
,	O
the	O
SARS	O
-	O
CoV	O
main	O
protease	O
(	O
M	O
(	O
pro	O
)),	O
has	O
been	O
the	O
focus	O
of	O
considerable	O
structure	O
-	O
based	O
drug	O
discovery	O
efforts	O
.	O

Recommendations	O
specific	O
to	O
pediatric	O
severe	O
sepsis	B-SPEC
include	O
greater	O
use	O
of	O
physical	O
examination	O
therapeutic	O
end	O
points	O
(	O
2C	O
);	O
dopamine	O
as	O
the	O
first	O
drug	O
of	O
choice	O
for	O
hypotension	O
(	O
2C	O
);	O
steroids	O
only	O
in	O
children	O
with	O
suspected	O
or	O
proven	O
adrenal	O
insufficiency	O
(	O
2C	O
);	O
and	O
a	O
recommendation	O
against	O
the	O
use	O
of	O
recombinant	O
activated	O
protein	O
C	O
in	O
children	O
(	O
1B	O
).	O

Offspring	O
from	O
the	O
two	O
sub	O
-	O
lines	O
were	O
subjected	O
to	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
order	B-SPEC
to	O
determine	O
their	O
genetic	O
susceptibility	O
to	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
CCR1	O
deficiency	O
increases	O
susceptibility	O
to	O
fatal	O
coronavirus	B-SPEC
infection	O
of	O
the	O
central	O
nervous	O
system	O
.	O

Despite	O
the	O
reduction	O
in	O
T	O
-	O
cell	O
trafficking	O
into	O
the	O
CNS	O
of	O
CCR1	O
-/-	O
mice	B-SPEC
during	O
acute	O
disease	O
,	O
components	O
of	O
host	O
defense	O
remained	O
unaltered	O
;	O
T	O
-	O
cell	O
effector	O
functions	O
including	O
cytolytic	O
activity	O
and	O
proliferation	O
and	O
the	O
expression	O
of	O
IFN	O
-	O
gamma	O
within	O
the	O
CNS	O
were	O
not	O
significantly	O
different	O
between	O
CCR1	O
+/+	O
and	O
CCR1	O
-/-	O
infected	O
mice	B-SPEC
.	O

Furthermore	O
,	O
assessment	O
of	O
neuropathology	O
revealed	O
no	O
difference	O
in	O
the	O
severity	O
of	O
demyelination	O
between	O
CCR1	O
-	O
deficient	O
and	O
wild	O
-	O
type	O
mice	B-SPEC
.	O

Together	O
,	O
these	O
findings	O
reveal	O
that	O
T	O
-	O
cell	O
and	O
macrophage	O
trafficking	O
are	O
not	O
dependent	O
on	O
CCR1	O
and	O
highlight	O
an	O
important	O
role	O
for	O
CCR1	O
signaling	O
in	O
promoting	O
survival	O
during	O
chronic	O
MHV	B-SPEC
infection	O
.	O

We	O
report	O
a	O
case	O
of	O
gemcitabine	O
-	O
induced	O
ARDS	O
in	O
a	O
72	O
-	O
year	O
old	O
patient	O
treated	O
with	O
gemcitabine	O
and	O
cisplatin	O
for	O
a	O
bladder	O
cancer	B-SPEC
without	O
lung	O
metastasis	O
.	O

Sera	O
of	O
SARS	O
convalescent	O
-	O
phase	O
patients	O
,	O
normal	O
human	B-SPEC
sera	O
,	O
sera	O
of	O
patients	O
with	O
other	O
respiratory	O
diseases	O
,	O
and	O
swine	B-SPEC
sera	O
were	O
screened	O
by	O
ELISA	O
,	O
with	O
whole	O
SARS	O
-	O
CoV	O
F69	O
,	O
N	O
and	O
N199	O
proteins	O
as	O
antigens	O
.	O

RESULTS	O
:	O
The	O
sensitivity	O
and	O
specificity	O
of	O
N	O
and	O
N199	O
proteins	O
in	O
human	B-SPEC
sera	O
diagnosis	O
were	O
approximate	O
(	O
P	O
=	O
0	O
.	O
743	O
),	O
which	O
was	O
higher	O
than	O
whole	O
viral	O
protein	O
but	O
the	O
difference	O
was	O
not	O
significant	O
(	O
P	O
=	O
0	O
.	O
234	O
).	O

Differences	O
in	O
replication	O
and	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
between	O
the	O
KT2	O
-	O
L	O
and	O
KT2	O
-	O
H	O
strains	O
in	O
swine	B-SPEC
testicular	O
cells	O
were	O
investigated	O
.	O

ABSTRACT	O
:	O
3C	O
-	O
like	O
protease	O
(	O
3CL	O
pro	O
)	O
plays	O
pivotal	O
roles	O
in	O
the	O
life	O
cycle	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
only	O
the	O
dimeric	O
protease	O
is	O
proposed	O
as	O
the	O
functional	O
form	O
.	O

ABSTRACT	O
:	O
Four	O
outbreaks	O
of	O
bovine	B-SPEC
respiratory	O
disease	O
(	O
BRD	O
)	O
associated	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
infection	O
in	O
Italian	O
cattle	B-SPEC
herds	O
were	O
reported	O
.	O

By	O
using	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
BCoV	O
RNA	O
was	O
detected	O
in	O
all	O
outbreaks	O
without	O
evidence	O
of	O
concurrent	O
viral	O
pathogens	O
(	O
i	O
.	O
e	O
.,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
herpesvirus	I-SPEC
type	I-SPEC
1	I-SPEC
,	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
).	O

One	O
hundred	O
twenty	O
sera	O
collected	O
from	O
cats	B-SPEC
belonging	O
to	O
catteries	O
or	O
community	O
shelters	O
and	O
to	O
households	O
were	O
tested	O
for	O
FCoV	O
type	O
I	O
and	O
II	O
antibodies	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
envelope	O
(	O
E	O
)	O
proteins	O
play	O
an	O
important	O
,	O
not	O
fully	O
understood	O
role	O
(	O
s	O
)	O
in	O
the	O
virus	B-SPEC
life	O
cycle	O
.	O

In	O
this	O
study	O
,	O
we	O
confirmed	O
that	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
A59	O
E	O
protein	O
is	O
palmitoylated	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
assembly	O
process	O
encloses	O
a	O
ribonucleoprotein	O
genome	O
into	O
vesicles	O
containing	O
the	O
lipid	O
-	O
embedded	O
proteins	O
S	O
(	O
spike	O
),	O
E	O
(	O
envelope	O
),	O
and	O
M	O
(	O
membrane	O
).	O

Studies	O
in	O
the	O
populations	O
of	O
Hong	O
Kong	O
and	O
Taiwan	O
showed	O
an	O
association	O
of	O
human	B-SPEC
leucocyte	O
antigen	O
(	O
HLA	O
)	O
polymorphisms	O
with	O
the	O
development	O
and	O
/	O
or	O
severity	O
of	O
SARS	O
,	O
respectively	O
.	O

TITLE	O
:	O
Determination	O
and	O
application	O
of	O
immunodominant	O
regions	O
of	O
SARS	O
coronavirus	B-SPEC
spike	O
and	O
nucleocapsid	O
proteins	O
recognized	O
by	O
sera	O
from	O
different	O
animal	B-SPEC
species	B-SPEC
.	O

Using	O
a	O
membrane	O
-	O
strip	O
based	O
Western	O
blot	O
approach	O
,	O
the	O
reactivity	O
of	O
each	O
antigen	O
fragment	O
against	O
a	O
panel	O
of	O
animal	B-SPEC
sera	O
was	O
determined	O
.	O

Based	O
on	O
these	O
findings	O
,	O
one	O
-	O
step	O
competition	O
ELISAs	O
were	O
established	O
which	O
were	O
able	O
to	O
detect	O
SARS	O
-	O
CoV	O
antibodies	O
from	O
human	B-SPEC
and	O
at	O
least	O
seven	O
different	O
animal	B-SPEC
species	B-SPEC
.	O

TITLE	O
:	O
A	O
line	O
immunoassay	O
utilizing	O
recombinant	O
nucleocapsid	O
proteins	O
for	O
detection	O
of	O
antibodies	O
to	O
human	B-SPEC
coronaviruses	O
.	O

The	O
cats	B-SPEC
were	O
randomly	O
selected	O
for	O
treatment	O
with	O
either	O
FeIFN	O
-	O
omega	O
or	O
a	O
placebo	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
fourteen	O
small	O
interfering	O
RNAs	O
(	O
siRNAs	O
)	O
were	O
synthesized	O
for	O
targeting	O
of	O
coding	O
gene	O
sequences	O
,	O
specific	O
5	O
'-	O
leader	O
sequence	O
of	O
mRNA	O
and	O
3	O
'-	O
end	O
sequence	O
of	O
the	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
genome	O
.	O

These	O
three	O
MAbs	O
(	O
S109	O
.	O
8	O
,	O
S227	O
.	O
14	O
,	O
and	O
S230	O
.	O
15	O
)	O
were	O
tested	O
for	O
use	O
in	O
passive	O
vaccination	O
studies	O
using	O
lethal	O
SARS	O
-	O
CoV	O
challenge	O
models	O
for	O
young	O
and	O
senescent	O
mice	B-SPEC
with	O
four	O
different	O
homologous	O
and	O
heterologous	O
SARS	O
-	O
CoV	O
S	O
variants	O
.	O

Both	O
S227	O
.	O
14	O
and	O
S230	O
.	O
15	O
completely	O
protected	O
young	O
and	O
old	O
mice	B-SPEC
from	O
weight	O
loss	O
and	O
virus	B-SPEC
replication	O
in	O
the	O
lungs	O
for	O
all	O
viruses	B-SPEC
tested	O
,	O
while	O
S109	O
.	O
8	O
completely	O
protected	O
mice	B-SPEC
from	O
weight	O
loss	O
and	O
clinical	O
signs	O
in	O
the	O
presence	O
of	O
viral	O
titers	O
.	O

Each	O
genomic	O
segment	O
is	O
flanked	O
by	O
authentic	O
NDV	B-SPEC
3	O
'	O
and	O
5	O
'	O
noncoding	O
termini	O
allowing	O
for	O
efficient	O
replication	O
and	O
transcription	O
.	O

A	O
reporter	O
gene	O
encoding	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
was	O
inserted	O
into	O
one	O
segment	O
,	O
and	O
a	O
red	O
fluorescent	O
protein	O
dsRed	O
gene	O
was	O
inserted	O
into	O
the	O
other	O
segment	O
in	O
order	B-SPEC
to	O
easily	O
detect	O
the	O
replication	O
and	O
transcription	O
of	O
segments	O
in	O
infected	O
cells	O
.	O

TITLE	O
:	O
Aromatic	O
amino	O
acids	O
in	O
the	O
juxtamembrane	O
domain	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
are	O
important	O
for	O
receptor	O
-	O
dependent	O
virus	B-SPEC
entry	O
and	O
cell	O
-	O
cell	O
fusion	O
.	O

The	O
aromatic	O
amino	O
acids	O
in	O
the	O
JMD	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
play	O
critical	O
roles	O
in	O
receptor	O
-	O
dependent	O
virus	B-SPEC
-	O
cell	O
and	O
cell	O
-	O
cell	O
fusion	O
.	O

Distinct	O
kinetics	O
of	O
Class	B-SPEC
I	O
protein	O
upregulation	O
correlated	O
with	O
cell	O
type	O
specific	O
transcription	O
patterns	O
of	O
genes	O
encoding	O
Class	B-SPEC
I	O
heavy	O
chains	O
and	O
antigen	O
processing	O
components	O
.	O

Ultimately	O
mRNAs	O
reached	O
similar	O
levels	O
in	O
both	O
cell	O
types	O
at	O
their	O
respective	O
time	O
points	O
of	O
maximal	O
Class	B-SPEC
I	O
expression	O
.	O

Concern	O
about	O
contracting	O
avian	B-SPEC
influenza	O
was	O
a	O
predictor	O
of	O
the	O
vaccination	O
rate	O
in	O
2006	O
but	O
not	O
in	O
2007	O
(	O
OR	O
,	O
1	O
.	O
47	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
03	O
-	O
2	O
.	O
09	O
];	O
P	O
<.	O
05	O
),	O
as	O
was	O
the	O
perceived	O
lack	O
of	O
control	O
over	O
avian	B-SPEC
influenza	O
infection	O
(	O
OR	O
,	O
1	O
.	O
52	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
06	O
-	O
2	O
.	O
18	O
];	O
P	O
<.	O
05	O
).	O

Ions	O
were	O
generated	O
by	O
laser	B-SPEC
shots	O
and	O
flied	O
in	O
a	O
time	O
of	O
flight	O
mode	O
to	O
the	O
ion	O
detector	O
according	O
to	O
their	O
mass	O
over	O
charge	O
(	O
m	O
/	O
z	O
)	O
ratio	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
anti	O
-	O
infectives	O
.	O

Clinical	O
manifestation	O
,	O
direct	O
laryngoscope	O
,	O
CT	O
,	O
X	O
-	O
ray	B-SPEC
barium	O
meal	O
examination	O
results	O
and	O
the	O
treatment	O
process	O
were	O
recorded	O
.	O

Serologic	O
antibody	O
titers	O
against	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
),	O
canine	B-SPEC
adenovirus	I-SPEC
(	O
CAV	B-SPEC
),	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
),	O
canine	B-SPEC
herpesvirus	I-SPEC
,	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
),	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
Neospora	B-SPEC
caninum	I-SPEC
,	O
and	O
Leptospira	B-SPEC
interrogans	I-SPEC
were	O
measured	O
in	O
44	O
samples	O
taken	O
from	O
19	O
giant	B-SPEC
pandas	I-SPEC
between	O
1998	O
and	O
2003	O
at	O
the	O
Chengdu	O
Research	O
Base	O
of	O
Giant	B-SPEC
Panda	I-SPEC
Breeding	O
in	O
Sichuan	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Phase	O
I	O
human	B-SPEC
clinical	O
studies	O
involving	O
therapeutics	O
for	O
emerging	O
and	O
biodefense	O
pathogens	O
with	O
low	O
incidence	O
,	O
such	O
as	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
requires	O
at	O
a	O
minimum	O
preclinical	O
evaluation	O
of	O
efficacy	O
in	O
two	O
well	O
-	O
characterized	O
and	O
robust	O
animal	B-SPEC
models	O
.	O

TITLE	O
:	O
Steady	O
-	O
state	O
and	O
pre	O
-	O
steady	O
-	O
state	O
kinetic	O
evaluation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
3CLpro	O
cysteine	O
protease	O
:	O
development	O
of	O
an	O
ion	O
-	O
pair	O
model	O
for	O
catalysis	O
.	O

Presented	O
here	O
is	O
a	O
review	O
of	O
recently	O
reported	O
agents	O
present	O
in	O
pomegranate	O
juice	O
(	O
polyphenols	O
,	O
beta	O
-	O
sitosterol	O
,	O
sugars	O
and	O
ellagic	O
acid	O
)	O
and	O
fulvic	O
acid	O
,	O
described	O
here	O
as	O
the	O
envelope	O
virus	B-SPEC
neutralising	O
compounds	O
(	O
EVNCs	O
)	O
and	O
complex	O
molecules	O
like	O
lectins	O
and	O
mucins	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
SARS	O
infection	O
.	O

Nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
encapsidates	O
the	O
viral	O
RNA	O
and	O
plays	O
an	O
important	O
role	O
in	O
virus	B-SPEC
particle	O
assembly	O
and	O
release	O
.	O

TITLE	O
:	O
Equine	B-SPEC
coronavirus	B-SPEC
induces	O
apoptosis	O
in	O
cultured	O
cells	O
.	O

Moreover	O
,	O
as	O
is	O
commonly	O
observed	O
in	O
coronavirus	B-SPEC
infection	O
in	O
other	O
animals	B-SPEC
,	O
the	O
activities	O
of	O
effecter	O
caspases	O
-	O
caspase	O
-	O
3	O
/	O
7	O
-	O
and	O
initiator	O
caspases	O
-	O
caspase	O
-	O
8	O
and	O
caspase	O
-	O
9	O
-	O
that	O
are	O
representative	O
factors	O
in	O
the	O
death	O
receptor	O
-	O
mediated	O
apoptotic	O
pathway	O
and	O
mitochondrial	O
apoptotic	O
pathway	O
,	O
respectively	O
,	O
were	O
increased	O
in	O
ECoV	O
-	O
infected	O
MDBK	O
cells	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
for	O
the	O
quantification	O
of	O
FCoV	O
shedding	O
in	O
the	O
faeces	O
of	O
domestic	B-SPEC
cats	I-SPEC
.	O

We	O
designed	O
a	O
retrospective	O
study	O
examining	O
the	O
experience	O
with	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
in	O
pediatric	O
patients	O
with	O
underlying	O
malignancies	O
and	O
hematopoietic	O
stem	O
cell	O
transplant	O
recipients	O
seen	O
between	O
1997	O
and	O
2005	O
.	O

Commercial	O
NDV	B-SPEC
vaccine	O
strains	O
used	O
were	O
B1	O
,	O
VG	O
/	O
GA	O
,	O
and	O
C2	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
strains	O
isolated	O
from	O
the	O
enteric	O
contents	O
of	O
Brazilian	O
laying	O
hens	O
and	O
broilers	O
.	O

Eleven	O
IBV	B-SPEC
samples	O
were	O
isolated	O
in	O
embryonated	O
eggs	O
and	O
resulted	O
in	O
S1	O
sequences	O
.	O

TITLE	O
:	O
Detection	O
of	O
group	O
1	O
coronaviruses	O
in	O
bats	B-SPEC
in	O
North	O
America	O
.	O

The	O
prevalence	O
of	O
viral	O
RNA	O
shedding	O
was	O
high	O
:	O
17	O
%	O
in	O
Eptesicus	B-SPEC
fuscus	I-SPEC
and	O
50	O
%	O
in	O
Myotis	B-SPEC
occultus	I-SPEC
.	O

Sequence	O
analysis	O
of	O
a	O
440	O
-	O
bp	O
amplicon	O
in	O
gene	O
1b	O
showed	O
that	O
these	O
Rocky	O
Mountain	O
bat	B-SPEC
coronaviruses	O
formed	O
3	O
clusters	O
in	O
phylogenetic	O
group	O
1	O
that	O
were	O
distinct	O
from	O
group	O
1	O
coronaviruses	O
of	O
Asian	O
bats	B-SPEC
.	O

TITLE	O
:	O
Detecting	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
of	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
).	O

Given	O
that	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
occurs	O
,	O
we	O
estimate	O
the	O
infection	O
secondary	O
attack	O
rates	O
(	O
SARs	O
)	O
and	O
the	O
local	O
basic	O
reproductive	O
number	O
,	O
R0	O
.	O

ABSTRACT	O
:	O
Many	O
genetic	O
and	O
mechanistic	O
features	O
distinguish	O
the	O
coronavirus	B-SPEC
replication	O
machinery	O
from	O
that	O
encoded	O
by	O
most	O
other	O
RNA	O
viruses	B-SPEC
.	O

The	O
coronavirus	B-SPEC
replication	O
/	O
transcription	O
complex	O
is	O
an	O
assembly	O
of	O
viral	O
and	O
,	O
most	O
probably	O
,	O
cellular	O
proteins	O
that	O
mediate	O
the	O
synthesis	O
of	O
both	O
the	O
unusually	O
large	O
(	O
approximately	O
30	O
kb	O
)	O
RNA	O
genome	O
and	O
an	O
extensive	O
set	O
of	O
subgenomic	O
mRNAs	O
.	O

Phylogenetic	O
analyses	O
showed	O
multiple	O
incongruent	O
associations	O
between	O
the	O
phylogenies	O
of	O
rhinolophid	O
bats	B-SPEC
and	O
their	O
CoVs	O
,	O
which	O
suggested	O
that	O
host	O
shifts	O
have	O
occurred	O
in	O
the	O
recent	O
evolutionary	O
history	O
of	O
this	O
group	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
how	O
the	O
capsid	O
proteins	O
from	O
medically	O
relevant	O
RNA	O
viruses	B-SPEC
interact	O
with	O
host	O
cell	O
signaling	O
pathways	O
.	O

Autoantibodies	O
to	O
several	O
cytokines	O
,	O
including	O
IL	O
-	O
8	O
,	O
have	O
been	O
found	O
in	O
human	B-SPEC
plasma	O
and	O
other	O
tissues	O
.	O

These	O
complexes	O
are	O
present	O
in	O
various	O
human	B-SPEC
tissues	O
,	O
including	O
the	O
lung	O
,	O
as	O
they	O
have	O
been	O
detected	O
in	O
lung	O
fluids	O
from	O
patients	O
with	O
ALI	O
/	O
ARDS	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
were	O
interested	O
in	O
determining	O
if	O
high	O
titered	O
egg	O
adapted	O
modified	O
live	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccines	O
contain	O
spike	O
gene	O
related	O
quasispecies	O
that	O
undergo	O
selection	O
in	O
chickens	B-SPEC
,	O
following	O
vaccination	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
showing	O
selection	O
of	O
a	O
more	O
fit	O
virus	B-SPEC
subpopulation	O
as	O
well	O
as	O
mutations	O
associated	O
with	O
replication	O
of	O
modified	O
live	O
IBV	B-SPEC
vaccine	O
viruses	B-SPEC
in	O
chickens	B-SPEC
.	O

Severity	O
of	O
lymphocytic	O
bronchiolitis	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
BOS	B-SPEC
and	O
death	O
after	O
lung	O
transplantation	O
independent	O
of	O
acute	O
vascular	O
rejection	O
.	O

Although	O
our	O
current	O
understanding	O
of	O
these	O
processes	O
is	O
limited	O
by	O
the	O
inability	O
to	O
accurately	O
replicate	O
the	O
complex	O
human	B-SPEC
physiology	O
in	O
laboratory	O
settings	O
,	O
it	O
has	O
recently	O
become	O
apparent	O
that	O
the	O
process	O
of	O
repair	O
and	O
remodelling	O
begins	O
early	O
in	O
the	O
course	O
of	O
ARDS	O
/	O
ALI	O
and	O
may	O
be	O
determined	O
by	O
the	O
type	O
of	O
pulmonary	O
injury	O
.	O

Consequently	O
,	O
China	O
may	O
be	O
one	O
of	O
the	O
weak	O
links	O
in	O
global	O
preparedness	O
for	O
avian	B-SPEC
influenza	O
.	O

Inadequate	O
compensation	O
to	O
farmers	O
for	O
culled	O
birds	B-SPEC
leads	O
to	O
nonreporting	O
,	O
and	O
local	O
officials	O
may	O
be	O
complicit	O
if	O
they	O
suspect	O
that	O
reporting	O
might	O
lead	O
to	O
economic	O
losses	O
for	O
their	O
communities	O
.	O

Two	O
weeks	O
after	O
boosting	O
,	O
chickens	B-SPEC
were	O
challenged	O
by	O
virulent	O
IBV	B-SPEC
strain	O
.	O

The	O
hypothesis	O
may	O
be	O
confirmed	O
by	O
:	O
(	O
1	O
)	O
demonstrating	O
an	O
improvement	O
in	O
physiologic	O
parameters	O
,	O
intracranial	O
pressure	O
,	O
and	O
brain	O
oxygenation	O
with	O
inhaled	O
nitric	O
oxide	O
use	O
in	O
severely	O
head	O
injured	O
patients	O
,	O
and	O
(	O
2	O
)	O
demonstrating	O
a	O
decrease	O
in	O
biochemical	O
serum	O
markers	O
in	O
such	O
patients	O
;	O
specifically	O
,	O
glial	O
fibrillary	O
acidic	O
protein	O
,	O
inflammatory	O
cytokines	O
,	O
and	O
biomarkers	O
of	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
adrenal	O
axis	B-SPEC
,	O
and	O
(	O
3	O
)	O
documentation	O
of	O
outcomes	O
.	O

The	O
incidence	O
and	O
characteristics	O
of	O
OM	O
complicating	O
URI	O
due	O
to	O
specific	O
viruses	B-SPEC
have	O
not	O
been	O
well	O
studied	O
.	O

AOM	O
occurred	O
in	O
approximately	O
one	O
-	O
half	O
of	O
children	O
with	O
URI	O
due	O
to	O
adenovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
or	O
coronavirus	B-SPEC
and	O
in	O
approximately	O
one	O
-	O
third	O
of	O
those	O
with	O
URI	O
due	O
to	O
influenza	B-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
or	O
rhinovirus	B-SPEC
.	O

Recently	O
,	O
the	O
Acute	O
Dialysis	B-SPEC
Quality	O
Initiative	O
proposed	O
the	O
RIFLE	O
consensus	O
classification	O
for	O
AKI	O
.	O

ABSTRACT	O
:	O
Lack	O
of	O
circumcision	O
has	O
been	O
identified	O
as	O
a	O
risk	O
factor	O
for	O
male	O
genital	O
human	B-SPEC
papillomavirus	I-SPEC
(	O
HPV	O
)	O
infection	O
,	O
although	O
this	O
association	O
has	O
not	O
been	O
consistently	O
supported	O
.	O

Feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
antigen	O
,	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
antibody	O
,	O
or	O
coronavirus	B-SPEC
antibodies	O
were	O
not	O
detected	O
.	O

Bartonella	B-SPEC
sp	O
.	O
(	O
44	O
%)	O
infections	O
were	O
common	O
in	O
cats	B-SPEC
,	O
but	O
only	O
one	O
was	O
infected	O
with	O
M	B-SPEC
.	I-SPEC
haemofelis	I-SPEC
.	O

Despite	O
their	O
relative	O
seclusion	O
from	O
the	O
rest	O
of	O
the	O
world	O
,	O
cats	B-SPEC
and	O
dogs	B-SPEC
of	O
Isabela	O
were	O
exposed	O
to	O
many	O
pathogens	O
found	O
in	O
mainland	O
South	O
America	O
.	O

No	O
significant	O
immune	O
responses	O
and	O
protective	O
effects	O
were	O
detected	O
in	O
mice	B-SPEC
vaccinated	O
with	O
RBD	O
-	O
Pep	O
or	O
blank	O
AAV	O
alone	O
.	O

TITLE	O
:	O
Serological	O
evidence	O
of	O
coronavirus	B-SPEC
infection	O
in	O
mithuns	O
(	O
Bos	B-SPEC
frontalis	I-SPEC
)	O
from	O
India	O
.	O

ABSTRACT	O
:	O
Studies	O
conducted	O
on	O
mithuns	O
at	O
the	O
National	O
Research	O
Centre	O
on	O
Mithun	O
,	O
and	O
mithuns	O
found	O
in	O
free	O
-	O
ranging	O
conditions	O
in	O
Nagaland	O
,	O
India	O
,	O
revealed	O
that	O
the	O
overall	O
prevalence	O
of	O
antibodies	O
to	O
coronavirus	B-SPEC
was	O
80	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
77	O
-	O
83	O
)	O
when	O
detected	O
by	O
a	O
commercially	O
available	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
that	O
replicate	O
in	O
the	O
cytoplasm	O
of	O
infected	O
cells	O
by	O
generating	O
a	O
membrane	O
-	O
associated	O
replicase	O
complex	O
.	O

We	O
used	O
reverse	O
genetics	O
to	O
generate	O
infectious	O
clone	O
viruses	B-SPEC
(	O
icv	O
)	O
with	O
an	O
alanine	O
substitution	O
at	O
nsp4	O
glycosylation	O
site	O
N176	O
or	O
N237	O
,	O
or	O
an	O
asparagine	O
to	O
threonine	O
substitution	O
(	O
nsp4	O
-	O
N258T	O
),	O
which	O
is	O
proposed	O
to	O
confer	O
a	O
temperature	O
sensitive	O
phenotype	O
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
coronaviruses	O
with	O
mutations	O
in	O
gene	O
3	O
.	O

However	O
,	O
the	O
sizes	O
of	O
the	O
corresponding	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
of	O
some	O
genes	O
varied	O
among	O
the	O
virus	B-SPEC
strains	O
.	O

To	O
determine	O
if	O
chemokine	O
expression	O
corresponds	O
with	O
the	O
cellular	O
infiltrate	O
,	O
chemokine	O
protein	O
and	O
RNA	O
levels	O
from	O
the	O
brains	O
of	O
infected	O
mice	B-SPEC
were	O
quantified	O
.	O

Recent	O
studies	O
have	O
attempted	O
to	O
better	O
characterize	O
the	O
epidemiology	O
of	O
viral	O
infections	O
in	O
chronic	O
obstructive	O
pulmonary	O
disease	O
,	O
identify	O
unique	O
clinical	O
manifestations	O
of	O
virus	B-SPEC
-	O
associated	O
exacerbations	O
,	O
and	O
develop	O
new	O
diagnostic	O
tools	O
and	O
treatments	O
.	O

Rhinovirus	B-SPEC
,	O
the	O
organism	O
most	O
often	O
responsible	O
for	O
causing	O
the	O
common	O
cold	O
,	O
is	O
also	O
the	O
most	O
common	O
infectious	O
cause	O
of	O
chronic	O
obstructive	O
pulmonary	O
disease	O
exacerbations	O
.	O

The	O
role	O
of	O
this	O
modified	O
response	O
and	O
its	O
potential	O
relevance	O
to	O
viral	O
mechanisms	O
for	O
the	O
evasion	O
of	O
innate	O
defense	O
signaling	O
pathways	O
during	O
coronavirus	B-SPEC
replication	O
are	O
discussed	O
.	O

Here	O
we	O
report	O
that	O
the	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
C	O
-	O
terminal	O
domain	O
alone	O
(	O
residues	O
187	O
to	O
306	O
;	O
M	O
(	O
pro	O
)-	O
C	O
)	O
is	O
produced	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
in	O
both	O
monomeric	O
and	O
dimeric	O
forms	O
,	O
and	O
no	O
exchange	O
could	O
be	O
observed	O
between	O
them	O
at	O
room	O
temperature	O
.	O

Both	O
a	O
SARS	O
-	O
CoV	O
mutant	O
virus	B-SPEC
,	O
encoding	O
the	O
nsp1	O
-	O
mt	O
protein	O
(	O
SARS	O
-	O
CoV	O
-	O
mt	O
),	O
and	O
a	O
wild	O
-	O
type	O
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
-	O
WT	O
)	O
replicated	O
efficiently	O
and	O
exhibited	O
similar	O
one	O
-	O
step	O
growth	O
kinetics	O
in	O
susceptible	O
cells	O
.	O

However	O
,	O
the	O
length	O
of	O
RNA	O
packaged	O
in	O
the	O
virus	B-SPEC
-	O
like	O
particles	O
with	O
high	O
efficiency	O
is	O
usually	O
less	O
than	O
500	O
bases	O
.	O

We	O
used	O
the	O
WHO	O
International	O
Standard	O
for	O
HCV	B-SPEC
RNA	O
(	O
NIBSC	O
96	O
/	O
790	O
)	O
to	O
calibrate	O
the	O
chimeric	O
armored	O
L	O
-	O
RNA	O
,	O
which	O
was	O
diluted	O
by	O
10	O
-	O
fold	O
serial	O
dilutions	O
to	O
obtain	O
samples	O
containing	O
10	O
(	O
6	O
)	O
to	O
10	O
(	O
2	O
)	O
copies	O
.	O

We	O
found	O
that	O
(	O
1	O
)	O
amiodarone	O
associates	O
with	O
different	O
cell	O
membranes	O
and	O
accumulates	O
in	O
acidic	O
organelles	O
;	O
(	O
2	O
)	O
the	O
diethylamino	O
-	O
beta	O
-	O
ethoxy	O
group	O
is	O
an	O
important	O
determinant	O
of	O
uptake	O
;	O
(	O
3	O
)	O
vacuoles	O
forming	O
upon	O
exposure	O
to	O
amiodarone	O
are	O
enlarged	O
late	O
endosomes	O
;	O
(	O
4	O
)	O
amiodarone	O
inhibits	O
the	O
spreading	O
in	O
vitro	O
of	O
SARS	O
coronavirus	B-SPEC
;	O
and	O
(	O
5	O
)	O
trypsin	O
cleavage	O
of	O
the	O
viral	O
spike	O
protein	O
before	O
infection	O
,	O
which	O
permits	B-SPEC
virus	B-SPEC
entry	O
through	O
the	O
plasma	O
membrane	O
,	O
does	O
not	O
impair	O
amiodarone	O
antiviral	O
activity	O
.	O

In	O
this	O
study	O
,	O
eleven	O
synthetic	O
peptides	O
from	O
the	O
S	O
protein	O
were	O
selected	O
based	O
on	O
its	O
sequence	O
homology	O
with	O
human	B-SPEC
proteins	O
.	O

However	O
,	O
other	O
mutations	O
at	O
this	O
residue	O
,	O
which	O
also	O
abrogate	O
the	O
CTL	O
response	O
,	O
are	O
never	O
selected	O
in	O
vivo	O
even	O
though	O
they	O
do	O
not	O
compromise	O
virus	B-SPEC
fitness	O
in	O
acutely	O
infected	O
animals	B-SPEC
or	O
induce	O
a	O
significant	O
de	O
novo	O
CTL	O
response	O
.	O

TITLE	O
:	O
Epidemic	O
of	O
diarrhoea	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
in	O
Italy	O
.	O

To	O
characterize	O
each	O
locus	O
,	O
two	O
farmed	O
masked	B-SPEC
palm	I-SPEC
civet	I-SPEC
populations	O
from	O
Shanxi	O
and	O
Guangxi	O
provinces	O
in	O
China	O
were	O
genotyped	O
.	O

TITLE	O
:	O
Enhancement	O
of	O
the	O
immunogenicity	O
of	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
DNA	O
vaccine	O
by	O
a	O
bicistronic	O
plasmid	O
encoding	O
nucleocapsid	O
protein	O
and	O
interleukin	O
-	O
2	O
.	O

When	O
chickens	B-SPEC
were	O
challenged	O
with	O
a	O
virulent	O
strain	O
of	O
IBV	B-SPEC
,	O
the	O
protective	O
efficacy	O
could	O
be	O
enhanced	O
significantly	O
after	O
immunization	O
with	O
bicistronic	O
DNA	O
vaccine	O
.	O

TITLE	O
:	O
Outbreaks	O
of	O
human	B-SPEC
coronavirus	I-SPEC
in	O
a	O
pediatric	O
and	O
neonatal	O
intensive	O
care	O
unit	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	O
)	O
has	O
been	O
recently	O
recognized	O
as	O
a	O
potential	O
agent	O
of	O
nosocomial	O
viral	O
respiratory	O
infections	O
(	O
NRVI	O
)	O
in	O
high	O
-	O
risk	O
infants	O
.	O

However	O
,	O
both	O
alcohol	O
-	O
fed	O
animals	B-SPEC
and	O
otherwise	O
healthy	O
alcoholic	O
humans	B-SPEC
do	O
not	O
have	O
pulmonary	O
edema	O
at	O
baseline	O
,	O
even	O
though	O
their	O
lungs	O
are	O
highly	O
susceptible	O
to	O
acute	O
edematous	O
injury	O
in	O
response	O
to	O
inflammatory	O
stresses	O
.	O

Thus	O
,	O
this	O
study	O
suggests	O
that	O
cyclophilins	O
,	O
whether	O
recruited	O
from	O
host	O
cells	O
(	O
i	O
.	O
e	O
.	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
SARS	O
)	O
or	O
virally	O
encoded	O
(	O
i	O
.	O
e	O
.	O
Mimivirus	B-SPEC
),	O
are	O
localized	O
on	O
viral	O
surfaces	O
for	O
at	O
least	O
a	O
subset	O
of	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Pathological	O
changes	O
in	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
experimentally	O
infected	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
residues	O
in	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
spike	O
protein	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
that	O
are	O
critical	O
for	O
the	O
RBD	O
-	O
ACE2	O
receptor	O
interaction	O
.	O

Both	O
recombinant	O
viruses	B-SPEC
stably	O
expressed	O
the	O
corresponding	O
SARS	O
-	O
CoV	O
proteins	O
,	O
grew	O
to	O
similar	O
end	O
titres	O
as	O
the	O
parental	O
strain	O
and	O
induced	O
high	O
antibody	O
titres	O
against	O
MV	O
and	O
the	O
vectored	O
SARS	O
-	O
CoV	O
antigens	O
(	O
S	O
and	O
N	O
)	O
in	O
transgenic	B-SPEC
mice	I-SPEC
susceptible	O
to	O
measles	O
infection	O
.	O

The	O
source	O
of	O
contamination	O
often	O
is	O
unknown	O
,	O
but	O
may	O
be	O
introduced	O
by	O
wild	O
rats	B-SPEC
from	O
surrounding	O
environments	O
.	O

Here	O
,	O
we	O
used	O
a	O
panviral	O
DNA	O
microarray	O
to	O
investigate	O
the	O
death	O
of	O
a	O
captive	O
beluga	B-SPEC
whale	I-SPEC
in	O
an	O
aquatic	O
park	O
.	O

Parainfluenza	O
virus	B-SPEC
(	O
PIV	B-SPEC
)	O
2	O
,	O
PIV	B-SPEC
3	O
,	O
PIV	B-SPEC
4	O
,	O
bocavirus	B-SPEC
,	O
human	B-SPEC
rhinovirus	I-SPEC
A	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
were	O
each	O
identified	O
in	O
one	O
case	O
(	O
9	O
%).	O

ABSTRACT	O
:	O
The	O
chemical	O
composition	O
of	O
the	O
essential	O
oils	O
of	O
Laurus	B-SPEC
nobilis	I-SPEC
,	O
Juniperus	B-SPEC
oxycedrus	I-SPEC
ssp	O
.	O

oxycedrus	O
,	O
Thuja	B-SPEC
orientalis	I-SPEC
,	O
Cupressus	B-SPEC
sempervirens	I-SPEC
ssp	O
.	O

Essential	O
oils	O
have	O
been	O
evaluated	O
for	O
their	O
inhibitory	O
activity	O
against	O
SARS	O
-	O
CoV	O
and	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
in	O
vitro	O
by	O
visually	O
scoring	O
of	O
the	O
virus	B-SPEC
-	O
induced	O
cytopathogenic	O
effect	O
post	O
-	O
infection	O
.	O

L	B-SPEC
.	I-SPEC
nobilis	I-SPEC
oil	O
exerted	O
an	O
interesting	O
activity	O
against	O
SARS	O
-	O
CoV	O
with	O
an	O
IC	O
(	O
50	O
)	O
value	O
of	O
120	O
microg	O
/	O
ml	O
and	O
a	O
selectivity	O
index	O
(	O
SI	O
)	O
of	O
4	O
.	O
16	O
.	O

Using	O
the	O
RDV	B-SPEC
system	O
,	O
it	O
is	O
possible	O
to	O
obtain	O
viral	O
nucleic	O
acid	O
sequences	O
within	O
2	O
days	O
.	O

The	O
nucleic	O
acid	O
sequences	O
of	O
SARS	O
-	O
CoV	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
which	O
represent	O
emerging	O
and	O
re	O
-	O
emerging	O
infectious	O
viruses	B-SPEC
,	O
were	O
determined	O
from	O
infectious	O
viral	O
culture	O
supernatant	O
by	O
the	O
RDV	B-SPEC
method	O
.	O

We	O
investigated	O
whether	O
IBV	B-SPEC
affects	O
recruitment	O
and	O
function	O
of	O
phagocytic	O
cells	O
and	O
examined	O
NO	O
production	O
,	O
phagocytic	O
and	O
bactericidal	O
activity	O
,	O
and	O
kinetics	O
of	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
and	O
splenocytes	O
.	O

Inoculation	O
with	O
IBV	B-SPEC
induced	O
extended	O
and	O
more	O
severe	O
colibacillosis	O
than	O
with	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
alone	O
.	O

From	O
1	O
to	O
4dpi	O
,	O
NO	O
production	O
by	O
PBMC	O
from	O
all	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
-	O
inoculated	O
animals	B-SPEC
was	O
elevated	O
compared	O
to	O
PBS	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
mRNA	O
expression	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
COV	O
)	O
functional	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
in	O
human	B-SPEC
femoral	O
head	O
and	O
conjunctiva	O
,	O
and	O
explore	O
the	O
possible	O
entry	O
route	O
of	O
SARS	O
-	O
COV	O
in	O
human	B-SPEC
femoral	O
head	O
.	O

ACE2	O
mRNA	O
in	O
human	B-SPEC
femoral	O
head	O
was	O
detected	O
by	O
nested	O
RT	O
-	O
PCR	O
with	O
human	B-SPEC
beta	O
actin	O
gene	O
as	O
the	O
positive	O
control	O
.	O

The	O
mRNA	O
of	O
human	B-SPEC
ACE2	O
was	O
expressed	O
efficiently	O
in	O
the	O
normal	O
lung	O
tissue	O
,	O
but	O
not	O
in	O
the	O
cartilage	O
and	O
cancellous	O
bone	O
under	O
the	O
weight	O
-	O
bearing	O
area	O
of	O
the	O
femoral	O
head	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
hMPV	B-SPEC
,	O
HCoV	O
NL63	O
and	O
HBoV	O
in	O
South	O
African	O
children	O
with	O
acute	O
wheezing	O
.	O

Fifteen	O
of	O
59	O
(	O
25	O
%)	O
samples	O
were	O
positive	O
for	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Phylogenetic	O
analysis	O
showed	O
co	O
-	O
circulation	O
of	O
hMPV	B-SPEC
and	O
HCoV	O
NL63	O
A	O
and	O
B	O
lineages	O
,	O
although	O
only	O
HBoV	O
genotype	O
st2	O
was	O
found	O
.	O

Viruses	B-SPEC
are	O
an	O
important	O
cause	O
of	O
wheezing	O
in	O
preschool	O
children	O
;	O
hMPV	B-SPEC
,	O
HCoV	O
NL63	O
,	O
and	O
HBoV	O
are	O
less	O
common	O
than	O
the	O
usual	O
respiratory	O
pathogens	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
was	O
implicated	O
as	O
a	O
direct	O
cause	O
of	O
respiratory	O
failure	O
.	O

Lemierre	O
'	O
s	O
syndrome	O
is	O
characterized	O
by	O
severe	O
infection	O
,	O
with	O
pharyngitis	O
,	O
sepsis	B-SPEC
and	O
thrombosis	O
of	O
the	O
internal	O
jugular	O
vein	O
,	O
and	O
is	O
most	O
frequently	O
associated	O
with	O
upper	O
airway	O
infection	O
with	O
Fusobacterium	B-SPEC
necrophorum	I-SPEC
,	O
often	O
preceded	O
by	O
infection	O
with	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
which	O
enables	O
bacteria	B-SPEC
growing	O
in	O
the	O
oral	O
cavity	O
to	O
invade	O
.	O

As	O
few	O
as	O
10	O
arthroconidia	O
are	O
capable	O
of	O
causing	O
an	O
infection	O
in	O
animal	B-SPEC
models	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
systemic	O
disease	O
characterized	O
by	O
both	O
lung	O
pathology	O
and	O
widespread	O
extrapulmonary	O
virus	B-SPEC
dissemination	O
causing	O
multiple	O
organ	O
injuries	O
.	O

ABSTRACT	O
:	O
Many	O
retroviruses	B-SPEC
use	O
-	O
1	O
ribosomal	O
frameshifting	O
as	O
part	O
of	O
the	O
mechanism	O
in	O
translational	O
control	O
of	O
viral	O
protein	O
synthesis	O
.	O

TITLE	O
:	O
Application	O
of	O
siRNA	O
against	O
SARS	O
in	O
the	O
rhesus	B-SPEC
macaque	I-SPEC
model	O
.	O

Observations	O
of	O
SCV	B-SPEC
-	O
induced	O
SARS	O
-	O
like	O
symptoms	O
,	O
measurements	O
of	O
SCV	B-SPEC
RNA	O
presence	O
in	O
the	O
respiratory	O
tract	O
,	O
microscopic	O
inspections	O
of	O
lung	O
histopathology	O
,	O
and	O
immunohistochemistry	O
sections	O
from	O
21	O
tested	O
macaques	B-SPEC
consistently	O
demonstrated	O
siRNA	O
-	O
mediated	O
anti	O
-	O
SCV	B-SPEC
activity	O
.	O

The	O
GFP	O
spots	B-SPEC
expanded	O
as	O
rings	O
from	O
5	O
dpi	O
,	O
then	O
fused	O
to	O
each	O
other	O
,	O
and	O
most	O
fluorescence	O
faded	O
out	O
at	O
10	O
-	O
12	O
dpi	O
.	O

TITLE	O
:	O
Characterization	O
and	O
epitope	O
mapping	O
of	O
monoclonal	O
antibodies	O
to	O
the	O
nucleocapsid	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
An	O
Outbreak	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
Infection	O
and	O
Serological	O
Cross	O
-	O
reactivity	O
with	O
SARS	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
summer	O
2003	O
,	O
a	O
respiratory	O
outbreak	O
was	O
investigated	O
in	O
British	O
Columbia	O
,	O
during	O
which	O
nucleic	O
acid	O
tests	O
and	O
serology	O
unexpectedly	O
indicated	O
reactivity	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
results	O
were	O
that	O
the	O
majority	O
(	O
53	O
%)	O
of	O
bronchiolites	O
in	O
children	O
had	O
like	O
etiology	O
RSV	B-SPEC
and	O
a	O
lot	O
of	O
these	O
infections	O
had	O
double	O
viral	O
etiology	O
(	O
26	O
%	O
RSV	O
+	O
Rhinovirus	B-SPEC
;	O
2	O
,	O
7	O
%	O
RSV	B-SPEC
+	I-SPEC
HMPV	I-SPEC
and	O
1	O
%	O
RSV	B-SPEC
+	I-SPEC
Coronavirus	I-SPEC
229E	O
).	O

ABSTRACT	O
:	O
A	O
SARS	O
vaccine	O
based	O
on	O
a	O
live	O
-	O
attenuated	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	B-SPEC
)	O
recombinant	O
expressing	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
provides	O
long	O
-	O
term	O
protection	O
of	O
immunized	O
mice	B-SPEC
from	O
SARS	O
-	O
CoV	O
infection	O
(	O
Kapadia	O
,	O
S	O
.	O
U	O
.,	O
Rose	B-SPEC
,	O
J	O
.	O
K	O
.,	O
Lamirande	O
,	O
E	O
.,	O
Vogel	O
,	O
L	O
.,	O
Subbarao	O
,	O
K	O
.,	O
Roberts	O
,	O
A	O
.,	O
2005	O
.	O

TITLE	O
:	O
Infection	O
of	O
the	O
tracheal	O
epithelium	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
is	O
sialic	O
acid	O
dependent	O
.	O

TITLE	O
:	O
Impact	O
of	O
extravascular	O
lung	O
water	O
index	O
on	O
outcomes	O
of	O
severe	O
sepsis	B-SPEC
patients	O
in	O
a	O
medical	O
intensive	O
care	O
unit	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
designated	O
to	O
investigate	O
whether	O
extravascular	O
lung	O
water	O
index	O
(	O
EVLI	O
)	O
is	O
an	O
independent	O
predictor	O
for	O
mortality	O
outcome	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

This	O
study	O
prospectively	O
recruited	O
patients	O
with	O
severe	O
sepsis	B-SPEC
from	O
a	O
medical	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
at	O
a	O
university	O
affiliated	O
hospital	O
.	O

ABSTRACT	O
:	O
We	O
tested	O
315	O
bats	B-SPEC
from	O
7	O
different	O
bat	B-SPEC
species	B-SPEC
in	O
northern	O
Germany	O
for	O
coronaviruses	O
by	O
reverse	O
transcription	O
-	O
PCR	O
.	O

Nine	O
flavonoids	O
(	O
2	O
,	O
3	O
,	O
6	O
,	O
8	O
,	O
10	O
-	O
13	O
,	O
15	O
)	O
were	O
found	O
to	O
show	O
inhibitory	O
effects	O
towards	O
the	O
CP	O
and	O
AP	O
of	O
complement	O
system	O
,	O
luteolin	O
(	O
10	O
)	O
was	O
the	O
most	O
potent	O
with	O
the	O
CH50	O
and	O
AP50	O
values	O
of	O
0	O
.	O
19	O
and	O
0	O
.	O
17	O
mM	O
.	O
The	O
bioactive	O
flavonoids	O
were	O
mainly	O
derived	O
from	O
Herba	O
Houttuyniae	O
,	O
Flos	B-SPEC
Chrysanthemi	O
Indici	O
and	O
Herba	O
Artemisiae	O
Scopariae	O
.	O

Interestingly	O
,	O
this	O
feature	O
can	O
be	O
lost	O
during	O
cell	O
culture	O
adaptation	O
by	O
a	O
single	O
mutation	O
in	O
the	O
cleavage	O
motif	O
;	O
this	O
,	O
however	O
,	O
preserves	O
a	O
heparan	O
sulfate	O
binding	O
motif	O
and	O
renders	O
infection	O
by	O
the	O
virus	B-SPEC
heparan	O
sulfate	O
dependent	O
.	O

Proliferative	O
and	O
necrotising	O
pneumonia	O
(	O
PNP	O
)	O
was	O
diagnosed	O
in	O
two	O
animals	B-SPEC
,	O
while	O
severe	O
acute	O
interstitial	O
pneumonia	O
characterised	O
by	O
the	O
presence	O
of	O
abundant	O
hyaline	O
membrane	O
in	O
the	O
alveoli	O
and	O
fibrin	O
in	O
the	O
bronchioles	O
was	O
found	O
in	O
one	O
pig	B-SPEC
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
quantify	O
and	O
compare	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
concentrations	O
in	O
the	O
serum	O
of	O
clinically	O
normal	O
cats	B-SPEC
infected	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)	O
with	O
its	O
concentration	O
in	O
the	O
sera	O
and	O
effusions	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
disease	O
associated	O
with	O
infection	O
with	O
a	O
mutated	O
form	O
of	O
FCoV	B-SPEC
.	O
Clinically	O
normal	O
FCoV	O
-	O
infected	O
cats	B-SPEC
living	O
in	O
catteries	O
with	O
a	O
high	O
prevalence	O
of	O
FIP	O
had	O
the	O
highest	O
serum	O
IFN	O
-	O
gamma	O
concentrations	O
.	O

These	O
findings	O
support	O
the	O
hypothesis	O
that	O
there	O
is	O
a	O
strong	O
,	O
'	O
systemic	O
'	O
cell	O
mediated	O
immune	O
response	O
in	O
clinically	O
normal	O
,	O
FCoV	O
-	O
infected	O
cats	B-SPEC
and	O
that	O
a	O
similar	O
process	O
,	O
albeit	O
at	O
a	O
tissue	O
level	O
,	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
FIP	O
.	O

RNA	O
viruses	B-SPEC
are	O
responsible	O
for	O
most	O
of	O
the	O
emerging	O
diseases	O
.	O

Workers	O
at	O
risk	O
include	O
those	O
who	O
are	O
in	O
contact	O
with	O
live	O
or	O
dead	O
infected	O
animals	B-SPEC
,	O
with	O
aerosols	O
,	O
dust	O
or	O
surfaces	O
contaminated	O
by	O
animal	B-SPEC
secretions	O
,	O
persons	O
engaged	O
in	O
animal	B-SPEC
breeding	O
and	O
trade	O
,	O
veterinaries	O
,	O
and	O
others	O
.	O

Few	O
subjects	O
with	O
adenovirus	B-SPEC
or	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
were	O
detected	O
.	O

Acute	O
laryngeal	O
croup	O
is	O
most	O
often	O
associated	O
with	O
PIV	O
,	O
RSV	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
and	O
enterovirus	B-SPEC
.	O

CONCLUSIONS	O
:	O
Acute	O
laryngeal	O
croup	O
is	O
most	O
often	O
associated	O
with	O
PIV	O
,	O
RSV	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
and	O
enterovirus	B-SPEC
.	O

A	O
73	O
-	O
year	O
-	O
old	O
man	B-SPEC
developed	O
severe	O
hypoxemia	O
after	O
transfusion	O
of	O
platelet	O
concentrate	O
just	O
before	O
completion	O
of	O
surgery	O
.	O

Our	O
results	O
suggest	O
that	O
coronavirus	B-SPEC
mRNA	O
carries	O
a	O
cap	O
-	O
1	O
,	O
onto	O
which	O
2	O
'	O
O	O
methylation	O
follows	O
an	O
order	B-SPEC
of	O
events	O
in	O
which	O
2	O
'	O
O	O
-	O
methyl	O
transfer	O
must	O
be	O
preceded	O
by	O
guanine	O
N7	O
methylation	O
,	O
with	O
the	O
latter	O
step	O
being	O
performed	O
by	O
a	O
yet	O
-	O
unknown	O
N7	O
-	O
specific	O
MTase	O
.	O

RJHM	O
was	O
unable	O
to	O
suppress	O
the	O
CD8	O
(+)	O
T	O
-	O
cell	O
response	O
elicited	O
by	O
RA59	O
in	O
mice	B-SPEC
simultaneously	O
infected	O
with	O
both	O
strains	O
,	O
suggesting	O
that	O
RJHM	O
does	O
not	O
cause	O
generalized	O
immunosuppression	O
.	O

Here	O
we	O
report	O
that	O
Toll	O
-	O
like	O
receptor	O
4	O
(	O
TLR4	O
)	O
mutant	O
mice	B-SPEC
display	O
natural	O
resistance	O
to	O
acid	O
-	O
induced	O
acute	O
lung	O
injury	O
(	O
ALI	O
).	O

Intraperitoneal	O
treatment	O
with	O
promazine	O
using	O
a	O
prophylactic	O
(-	O
4h	O
)/	O
therapeutic	O
regimen	O
of	O
1	O
,	O
10	O
,	O
or	O
50mg	O
/(	O
kg	O
day	O
)	O
did	O
not	O
reduce	O
virus	B-SPEC
lung	O
titers	O
at	O
day	O
3	O
,	O
yet	O
prolonged	O
virus	B-SPEC
replication	O
to	O
14	O
days	O
.	O

Bats	B-SPEC
are	O
natural	O
reservoirs	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
like	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Scrub	O
typhus	O
is	O
a	O
zoonotic	O
disease	O
caused	O
by	O
Orientia	B-SPEC
tsutsugamushi	I-SPEC
.	O

RESULTS	O
:	O
Fever	O
and	O
chigger	B-SPEC
bite	O
history	O
were	O
presented	O
in	O
all	O
15	O
cases	O
,	O
and	O
eschar	O
lesion	O
was	O
identified	O
in	O
12	O
patients	O
(	O
80	O
%).	O

Acute	O
lung	O
injury	O
was	O
induced	O
successfully	O
by	O
intratracheal	O
administration	O
of	O
LPS	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
in	O
male	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

CoPPIX	O
or	O
ZnPPIX	O
(	O
an	O
HO	O
-	O
1	O
inhibitor	O
)	O
was	O
administered	O
to	O
mice	B-SPEC
24	O
h	O
prior	O
to	O
LPS	O
exposure	O
.	O

Ethyl	O
pyruvate	O
was	O
shown	O
to	O
ameliorate	O
some	O
of	O
the	O
structural	O
and	O
functional	O
changes	O
associated	O
with	O
mesenteric	O
ischemia	O
and	O
reperfusion	O
in	O
rats	B-SPEC
.	O

It	O
remains	O
to	O
be	O
determined	O
whether	O
this	O
ester	O
can	O
be	O
used	O
successfully	O
to	O
treat	O
human	B-SPEC
diseases	O
.	O

Patients	O
were	O
considered	O
to	O
have	O
probable	O
cases	O
of	O
Nipah	B-SPEC
virus	I-SPEC
infection	O
if	O
they	O
had	O
symptoms	O
consistent	O
with	O
Nipah	B-SPEC
virus	I-SPEC
infection	O
during	O
the	O
same	O
time	O
and	O
in	O
the	O
same	O
community	O
as	O
patients	O
with	O
confirmed	O
cases	O
.	O

Clinical	O
characteristics	O
of	O
Nipah	B-SPEC
virus	I-SPEC
infection	O
in	O
Bangladesh	O
,	O
including	O
a	O
severe	O
respiratory	O
component	O
,	O
appear	O
distinct	O
from	O
clinical	O
characteristics	O
reported	O
during	O
earlier	O
outbreaks	O
in	O
other	O
countries	O
.	O

Among	O
patients	O
with	O
Nipah	B-SPEC
virus	I-SPEC
infection	O
who	O
had	O
well	O
-	O
defined	O
exposure	O
to	O
another	O
patient	O
infected	O
with	O
Nipah	B-SPEC
virus	I-SPEC
,	O
the	O
median	O
incubation	O
period	O
was	O
9	O
days	O
(	O
range	O
,	O
6	O
-	O
11	O
days	O
).	O

ABSTRACT	O
:	O
Experimental	O
studies	O
were	O
conducted	O
to	O
evaluate	O
two	O
species	B-SPEC
of	O
cotton	B-SPEC
rats	I-SPEC
,	O
Sigmodon	B-SPEC
hispidus	I-SPEC
and	O
Sigmodon	B-SPEC
fulviventer	I-SPEC
,	O
as	O
a	O
model	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Blood	O
and	O
turbinate	O
wash	O
samples	O
,	O
and	O
lung	O
tissue	O
were	O
collected	O
from	O
each	O
animal	B-SPEC
at	O
different	O
time	O
points	O
after	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
for	O
determining	O
the	O
growth	O
curve	O
of	O
virus	B-SPEC
,	O
if	O
any	O
,	O
by	O
the	O
standard	O
infectivity	O
assay	O
in	O
Vero	O
E6	O
cells	O
.	O

Further	O
studies	O
are	O
warranted	O
to	O
consider	O
other	O
animal	B-SPEC
species	B-SPEC
in	O
efforts	O
to	O
find	O
better	O
animal	B-SPEC
models	O
for	O
the	O
evaluation	O
of	O
SARS	O
-	O
CoV	O
vaccines	O
and	O
antiviral	O
drugs	O
.	O

Lymphopenia	O
along	O
with	O
neutrophilia	O
was	O
a	O
feature	O
of	O
SARS	O
,	O
as	O
it	O
is	O
in	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
Ebola	O
infections	O
,	O
to	O
name	B-SPEC
a	O
few	O
.	O

TITLE	O
:	O
The	O
nucleocapsid	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
inhibits	O
cell	O
cytokinesis	O
and	O
proliferation	O
by	O
interacting	O
with	O
translation	O
elongation	O
factor	O
1alpha	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
numerous	O
accessory	O
proteins	O
whose	O
importance	O
in	O
the	O
natural	O
infection	O
process	O
is	O
currently	O
unclear	O
.	O

TITLE	O
:	O
The	O
discovery	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
and	O
its	O
role	O
in	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

The	O
RTC	O
is	O
believed	O
to	O
be	O
associated	O
with	O
characteristic	O
virus	B-SPEC
-	O
induced	O
double	O
-	O
membrane	O
structures	O
in	O
the	O
cytoplasm	O
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	O
.	O

TITLE	O
:	O
Pathogenicity	O
of	O
severe	O
acute	O
respiratory	O
coronavirus	B-SPEC
deletion	O
mutants	O
in	O
hACE	O
-	O
2	O
transgenic	B-SPEC
mice	I-SPEC
.	O

These	O
data	O
indicate	O
that	O
E	O
gene	O
might	O
be	O
a	O
virulence	O
factor	O
influencing	O
replication	O
level	O
,	O
tissue	O
tropism	O
and	O
pathogenicity	O
of	O
SARS	O
-	O
CoV	O
,	O
suggesting	O
that	O
DeltaE	O
attenuated	O
viruses	B-SPEC
are	O
promising	O
vaccine	O
candidates	O
.	O

ABSTRACT	O
:	O
Direct	O
antigen	O
test	O
(	O
DAT	O
)	O
and	O
culture	O
are	O
primary	O
tests	O
to	O
diagnose	O
infections	O
by	O
respiratory	O
viruses	B-SPEC
,	O
but	O
are	O
mainly	O
available	O
for	O
the	O
traditional	O
viral	O
pathogens	O
such	O
as	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
),	O
and	O
adenovirus	B-SPEC
in	O
clinical	O
laboratories	O
.	O

Emerging	O
viral	O
infectious	O
diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
present	O
with	O
acute	O
FRIs	O
progressing	O
to	O
respiratory	O
failure	O
and	O
ARDS	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
-	O
passaged	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
leads	O
to	O
lethal	O
pulmonary	O
edema	O
and	O
diffuse	O
alveolar	O
damage	O
in	O
adult	O
but	O
not	O
young	O
mice	B-SPEC
.	O

In	O
this	O
method	O
,	O
the	O
target	O
cDNA	O
of	O
SARS	O
associated	O
coronavirus	B-SPEC
was	O
firstly	O
captured	O
and	O
enriched	O
from	O
the	O
mixture	O
of	O
target	O
cDNA	O
and	O
non	O
-	O
target	O
cDNA	O
by	O
the	O
use	O
of	O
the	O
functionalized	O
silica	O
coated	O
superparamagnetic	O
nanoparticles	O
.	O

Each	O
year	O
our	O
country	O
is	O
stricken	O
by	O
flu	O
epidemics	O
,	O
but	O
at	O
some	O
points	O
of	O
time	O
unexpected	O
new	O
flu	O
viruses	B-SPEC
may	O
cause	O
a	O
worldwide	O
pandemic	O
.	O

Many	O
factors	O
,	O
some	O
changing	O
others	O
more	O
persistent	O
,	O
may	O
explain	O
the	O
high	O
appearance	O
rate	O
of	O
new	O
viral	O
infections	O
:	O
increasing	O
intercontinental	O
travel	O
,	O
globalization	O
of	O
transportation	O
,	O
increased	O
contacts	O
of	O
man	B-SPEC
with	O
new	O
ecological	O
niches	O
,	O
great	O
variability	O
and	O
adaptability	O
of	O
viruses	B-SPEC
,	O
climate	O
changes	O
,	O
increasing	O
density	O
of	O
populations	O
and	O
urbanisation	O
,	O
changing	O
human	B-SPEC
behaviour	O
(	O
more	O
sexual	O
freedom	O
,	O
use	O
of	O
intravenous	O
drugs	O
,	O
etc	O
...),	O
changing	O
social	O
and	O
economic	O
conditions	O
,	O
which	O
influence	O
housing	O
,	O
nutrition	O
,	O
access	O
to	O
water	O
,	O
etc	O
...).	O

Yet	O
,	O
this	O
effect	O
has	O
not	O
been	O
investigated	O
despite	O
the	O
many	O
reports	O
that	O
describe	O
gene	O
expression	O
profiling	O
of	O
virus	B-SPEC
-	O
infected	O
cells	O
using	O
microarrays	O
.	O

(	O
Saururaceae	B-SPEC
)(	O
HC	O
)	O
was	O
shortlisted	O
by	O
Chinese	O
scientists	O
to	O
tackle	O
SARS	O
problem	O
as	O
it	O
is	O
conventionally	O
used	O
to	O
treat	O
pneumonia	O
.	O

On	O
the	O
other	O
hand	O
,	O
oral	O
acute	O
toxicity	O
test	O
demonstrated	O
that	O
HC	O
was	O
non	O
-	O
toxic	O
to	O
laboratory	O
animals	B-SPEC
following	O
oral	O
administration	O
at	O
16	O
g	O
/	O
kg	O
.	O

Cd36	O
(-/-)	O
mice	B-SPEC
,	O
which	O
have	O
decreased	O
parasite	O
lung	O
sequestration	O
,	O
were	O
relatively	O
protected	O
from	O
ALI	O
.	O

In	O
the	O
first	O
case	O
,	O
acute	O
respiratory	O
failure	O
and	O
coma	B-SPEC
occurred	O
after	O
a	O
single	O
normal	O
oral	O
dose	O
of	O
quetiapine	O
in	O
combination	O
with	O
lorazepam	O
(	O
although	O
even	O
higher	O
doses	O
of	O
lorazepam	O
alone	O
were	O
tolerated	O
)	O
in	O
a	O
patient	O
with	O
previously	O
unknown	O
SAS	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
have	O
shown	O
that	O
the	O
brain	O
is	O
a	O
target	O
of	O
persistent	O
infection	O
with	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
)	O
and	O
have	O
demonstrated	O
viral	O
tropism	O
for	O
neurons	O
as	O
well	O
as	O
other	O
endogenous	O
cell	O
types	O
in	O
diverse	O
brain	O
areas	O
.	O

Coronavirus	B-SPEC
phylogenomics	O
based	O
on	O
BBC	O
is	O
well	O
consistent	O
with	O
that	O
of	O
previous	O
studies	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
high	O
-	O
risk	O
infectious	O
pathogen	O
.	O

Herein	O
,	O
we	O
use	O
these	O
mice	B-SPEC
to	O
show	O
that	O
virus	B-SPEC
enters	O
the	O
brain	O
primarily	O
via	O
the	O
olfactory	O
bulb	O
,	O
and	O
infection	O
results	O
in	O
rapid	O
,	O
transneuronal	O
spread	O
to	O
connected	O
areas	O
of	O
the	O
brain	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
229E	O
seroconversion	O
in	O
children	O
.	O

Children	O
infected	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
often	O
develop	O
croup	O
,	O
with	O
obstruction	O
of	O
the	O
airway	O
.	O

In	O
this	O
study	O
we	O
investigated	O
at	O
which	O
age	O
children	O
are	O
confronted	O
for	O
the	O
first	O
time	O
with	O
an	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
and	O
,	O
thus	O
,	O
at	O
which	O
age	O
they	O
seroconvert	O
to	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
positivity	O
.	O

ABSTRACT	O
:	O
Infectious	O
respiratory	O
disease	O
in	O
dogs	B-SPEC
is	O
a	O
constant	O
challenge	O
because	O
of	O
the	O
involvement	O
of	O
several	O
pathogens	O
and	O
environmental	O
factors	O
.	O

TITLE	O
:	O
H5N1	O
influenza	O
marker	O
vaccine	O
for	O
serological	O
differentiation	O
between	O
vaccinated	O
and	O
infected	O
chickens	B-SPEC
.	O

H5N1	O
/	O
PR8	O
-	O
5B19	O
is	O
not	O
lethal	O
to	O
embryonated	O
eggs	O
or	O
chickens	B-SPEC
.	O

Immunohistochemistry	O
identified	O
intensified	O
AQP	O
-	O
4	O
expression	O
in	O
rat	B-SPEC
lung	O
tissues	O
and	O
RT	O
-	O
PCR	O
also	O
demonstrated	O
increased	O
AQP	O
-	O
4	O
mRNA	O
expression	O
as	O
compared	O
with	O
the	O
control	O
group	O
.	O

TITLE	O
:	O
[	O
Development	O
of	O
a	O
SPA	O
-	O
ELISA	O
method	O
for	O
detecting	O
anti	O
-	O
coronavirus	B-SPEC
IgG	O
antibodies	O
in	O
serum	O
samples	O
from	O
fulvous	O
fruit	O
bats	B-SPEC
].	O

Rotavirus	B-SPEC
also	O
has	O
marked	O
environmental	O
resistance	O
,	O
but	O
periodic	O
reintroduction	O
into	O
facilities	O
,	O
possibly	O
on	O
bags	O
of	O
feed	O
,	O
bedding	O
,	O
or	O
other	O
supplies	O
or	O
equipment	O
,	O
also	O
seems	O
likely	O
.	O

ABSTRACT	O
:	O
The	O
most	O
important	O
political	O
and	O
organizational	O
events	O
considerably	O
affecting	O
the	O
strategy	O
and	O
tactics	O
of	O
prevention	O
of	O
infectious	O
diseases	O
may	O
be	O
called	O
at	O
the	O
Summit	O
of	O
Eight	O
(	O
Saint	O
Petersburg	O
)	O
that	O
has	O
considered	O
the	O
problem	O
of	O
consolidation	O
of	O
the	O
world	O
community	O
'	O
s	O
efforts	O
in	O
counteracting	O
the	O
prevalence	O
of	O
infectious	O
diseases	O
,	O
as	O
well	O
as	O
the	O
adopted	O
specific	O
decisions	O
on	O
this	O
matter	O
;	O
development	O
of	O
a	O
concept	O
of	O
financial	O
provision	O
of	O
Russian	O
initiatives	O
in	O
the	O
control	O
of	O
infectious	O
diseases	O
and	O
its	O
realization	O
by	O
the	O
Government	O
of	O
the	O
Russian	O
Federation	O
;	O
implementation	O
of	O
the	O
national	O
priority	O
health	O
project	O
on	O
the	O
additional	O
mass	O
immunization	O
against	O
rubella	O
,	O
influenza	O
,	O
poliomyelitis	O
,	O
prevention	O
and	O
treatment	O
of	O
HIV	B-SPEC
/	O
AIDS	O
and	O
viral	O
hepatitis	O
B	O
and	O
C	O
;	O
implementation	O
of	O
regional	O
and	O
federal	O
programs	O
on	O
the	O
population	O
'	O
s	O
sanitary	O
-	O
and	O
-	O
epidemiological	O
well	O
-	O
being	O
;	O
further	O
improvement	O
and	O
development	O
of	O
a	O
legal	O
and	O
standard	O
basis	O
in	O
the	O
control	O
of	O
infectious	O
diseases	O
;	O
reorganization	O
of	O
a	O
state	O
sanitary	O
-	O
and	O
-	O
epidemiological	O
service	O
on	O
a	O
large	O
scale	O
;	O
conferment	O
of	O
the	O
status	O
of	O
a	O
poliomyelitis	O
-	O
free	O
country	O
and	O
a	O
WHO	O
certificate	O
to	O
the	O
Russian	O
Federation	O
;	O
development	O
and	O
implementation	O
of	O
the	O
national	O
action	O
plan	O
to	O
maintain	O
the	O
achieved	O
results	O
;	O
implementation	O
of	O
the	O
national	O
program	O
in	O
eradicating	O
measles	O
in	O
the	O
Russian	O
Federation	O
;	O
implementation	O
of	O
complex	O
measures	O
against	O
the	O
importation	O
and	O
spread	O
of	O
revived	O
particularly	O
dangerous	O
infections	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
and	O
preparation	O
of	O
the	O
population	O
for	O
a	O
possible	O
influenza	O
pandemic	O
;	O
establishment	O
of	O
an	O
executive	O
headquarters	O
to	O
coordinate	O
activities	O
against	O
the	O
prevalence	O
of	O
avian	B-SPEC
influenza	O
in	O
the	O
Russian	O
Federation	O
;	O
making	O
decisions	O
,	O
with	O
the	O
results	O
of	O
a	O
meeting	O
of	O
the	O
Russian	O
Federation	O
'	O
s	O
State	O
Council	O
being	O
kept	O
in	O
mind	O
,	O
on	O
the	O
intensification	O
and	O
coordination	O
of	O
activities	O
aimed	O
at	O
counteracting	O
the	O
epidemic	O
of	O
HIV	B-SPEC
/	O
AIDS	O
in	O
the	O
Russian	O
Federation	O
,	O
by	O
setting	O
up	O
a	O
governmental	O
commission	O
;	O
involvement	O
in	O
the	O
solution	O
of	O
biological	O
safety	O
problems	O
in	O
accordance	O
with	O
the	O
""""	O
Foundations	O
of	O
public	O
chemical	O
and	O
biological	O
safety	O
policy	O
of	O
the	O
Russian	O
Federation	O
for	O
the	O
period	O
till	O
2000	O
and	O
further	O
prospects	O
""""	O
approved	O
by	O
the	O
President	O
of	O
the	O
Russian	O
Federation	O
;	O
implementation	O
of	O
measures	O
for	O
sanitary	O
area	O
control	O
within	O
the	O
framework	O
of	O
the	O
goal	O
-	O
oriented	O
federal	O
program	O
""""	O
The	O
State	O
Boundary	O
of	O
the	O
Russian	O
Federation	O
""""	O
(	O
2003	O
-	O
2010	O
).	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
leflunomide	O
,	O
an	O
immunomodulatory	O
agent	O
,	O
on	O
oxidant	O
/	O
antioxidant	O
status	O
with	O
nitric	O
oxide	O
(	O
NO	O
)	O
level	O
and	O
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
in	O
rats	B-SPEC
with	O
sepsis	B-SPEC
-	O
induced	O
ALI	O
.	O

Fifty	O
male	O
Wistar	O
albino	O
rats	B-SPEC
were	O
divided	O
into	O
five	O
groups	O
:	O
control	O
,	O
sham	O
,	O
sepsis	B-SPEC
,	O
leflunomide	O
(	O
10	O
mg	O
/	O
kg	O
,	O
intragastrically	O
for	O
two	O
doses	O
with	O
an	O
8	O
h	O
interval	O
prior	O
to	O
the	O
experiment	O
)	O
and	O
sepsis	B-SPEC
+	O
leflunomide	O
.	O

The	O
light	O
microscopic	O
evaluation	O
showed	O
that	O
pulmonary	O
architecture	O
was	O
preserved	O
,	O
and	O
infiltration	O
of	O
neutrophil	O
and	O
edema	O
decreased	O
in	O
sepsis	B-SPEC
+	O
leflunomide	O
group	O
.	O

The	O
grade	O
of	O
alveolar	O
damage	O
was	O
significantly	O
decreased	O
in	O
sepsis	B-SPEC
+	O
leflunomide	O
group	O
in	O
comparison	O
with	O
sepsis	B-SPEC
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
A	O
chimeric	O
multi	O
-	O
epitope	O
DNA	O
vaccine	O
elicited	O
specific	O
antibody	O
response	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
which	O
attenuated	O
the	O
virulence	O
of	O
SARS	O
-	O
CoV	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Epitope	O
-	O
based	O
vaccines	O
designed	O
to	O
induce	O
antibody	O
responses	O
specific	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
are	O
being	O
developed	O
as	O
a	O
means	O
for	O
increasing	O
vaccine	O
potency	O
.	O

TITLE	O
:	O
[	O
Genetic	O
variation	O
of	O
S1	O
gene	O
hypervariable	O
region	O
I	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
isolated	O
in	O
different	O
periods	O
in	O
Guangxi	O
].	O

CONCLUSIONS	O
:	O
Nephelometry	O
is	O
a	O
reliable	O
method	O
for	O
measurement	O
of	O
CSF	O
protein	O
,	O
albumin	O
,	O
and	O
IgG	O
in	O
cats	B-SPEC
.	O

The	O
live	O
attenuated	O
vaccines	O
only	O
provided	O
partial	O
protection	O
to	O
the	O
vaccinated	O
chickens	B-SPEC
against	O
heterologous	O
IBV	B-SPEC
infection	O
,	O
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97	O
I	O
.	O

Twenty	O
-	O
nine	O
of	O
these	O
cats	B-SPEC
were	O
FECV	B-SPEC
nave	O
before	O
infection	O
and	O
followed	O
sequentially	O
for	O
fecal	O
virus	B-SPEC
shedding	O
and	O
antibody	O
responses	O
over	O
a	O
period	O
of	O
8	O
-	O
48	O
months	O
.	O

Four	O
cats	B-SPEC
,	O
which	O
had	O
ceased	O
shedding	O
,	O
re	O
-	O
manifested	O
a	O
primary	O
type	O
infection	O
when	O
secondarily	O
infected	O
.	O

About	O
85	O
%	O
of	O
RSV	B-SPEC
,	O
influenza	O
A	O
and	O
adenovirus	B-SPEC
detections	O
were	O
associated	O
with	O
a	O
CFLI	O
,	O
whereas	O
less	O
than	O
62	O
%	O
of	O
other	O
virus	B-SPEC
detections	O
were	O
associated	O
with	O
CFLI	O
.	O

The	O
frequency	O
of	O
PCR	O
virus	B-SPEC
detection	O
without	O
CFLI	O
was	O
different	O
among	O
viruses	B-SPEC
.	O

About	O
85	O
%	O
of	O
RSV	B-SPEC
,	O
influenza	O
A	O
and	O
adenovirus	B-SPEC
detections	O
were	O
associated	O
with	O
a	O
CFLI	O
,	O
whereas	O
less	O
than	O
62	O
%	O
of	O
other	O
virus	B-SPEC
detections	O
were	O
associated	O
with	O
CFLI	O
.	O

Here	O
,	O
the	O
crystal	O
structure	O
of	O
HLA	O
-	O
B	O
*	O
1501	O
in	O
complex	O
with	O
a	O
SARS	O
coronavirus	B-SPEC
-	O
derived	O
nonapeptide	O
(	O
VQQESSFVM	O
)	O
has	O
been	O
determined	O
at	O
high	O
resolution	O
(	O
1	O
.	O
87	O
A	O
).	O

After	O
the	O
animals	B-SPEC
were	O
euthanized	O
at	O
4	O
hours	O
treatment	O
time	O
point	O
,	O
the	O
right	O
middle	O
lobe	O
of	O
rabbit	B-SPEC
lung	O
was	O
harvested	O
for	O
the	O
examination	O
of	O
caspase	O
-	O
3	O
and	O
p73	O
contents	O
and	O
relative	O
values	O
,	O
as	O
well	O
as	O
mRNA	O
expression	O
of	O
caspase	O
-	O
3	O
and	O
p73	O
.	O

(	O
2	O
)	O
Caspase	O
-	O
3	O
,	O
p73	O
mRNA	O
expressions	O
in	O
lung	O
tissue	O
in	O
HFOV	O
group	O
and	O
HFOV	O
+	O
PS	O
group	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
CMV	B-SPEC
group	O
and	O
CMV	O
+	O
PS	O
group	O
(	O
all	O
P	O
<	O
0	O
.	O
01	O
).	O

Virus	B-SPEC
detection	O
rates	O
of	O
36	O
%	O
to	O
100	O
%	O
and	O
50	O
%	O
to	O
70	O
%	O
were	O
found	O
in	O
Miniopterus	B-SPEC
magnater	I-SPEC
and	O
Miniopterus	B-SPEC
pusillus	I-SPEC
bats	B-SPEC
,	O
respectively	O
,	O
captured	O
within	O
a	O
single	O
bat	B-SPEC
habitat	O
during	O
four	O
consecutive	O
visits	O
spanning	O
1	O
year	O
.	O

There	O
was	O
high	O
genetic	O
diversity	O
of	O
viruses	B-SPEC
in	O
bats	B-SPEC
found	O
within	O
this	O
single	O
habitat	O
.	O

These	O
findings	O
are	O
likely	O
to	O
provide	O
new	O
insights	O
into	O
the	O
ecology	O
and	O
evolution	O
of	O
astroviruses	O
and	O
reinforce	O
the	O
role	O
of	O
bats	B-SPEC
as	O
a	O
reservoir	O
of	O
viruses	B-SPEC
with	O
potential	O
to	O
pose	O
a	O
zoonotic	O
threat	O
to	O
human	B-SPEC
health	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	O
structure	O
of	O
a	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
HE	O
in	O
complex	O
with	O
its	O
receptor	O
.	O

Collectively	O
,	O
our	O
results	O
demonstrate	O
that	O
GBF1	O
-	O
mediated	O
ARF1	O
activation	O
is	O
required	O
for	O
efficient	O
MHV	B-SPEC
RNA	O
replication	O
and	O
reveal	O
that	O
the	O
early	O
secretory	O
pathway	O
and	O
MHV	B-SPEC
replication	O
complex	O
formation	O
are	O
closely	O
connected	O
.	O

In	O
this	O
study	O
,	O
we	O
expressed	O
a	O
fusion	O
protein	O
containing	O
the	O
human	B-SPEC
codon	O
-	O
optimized	O
RBD	O
of	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
linked	O
to	O
the	O
Fc	O
portion	O
of	O
human	B-SPEC
IgG1	O
(	O
named	O
RBD	O
-	O
Fc	O
)	O
in	O
HEK293	O
cells	O
.	O

TITLE	O
:	O
[	O
Detection	O
of	O
coronavirus	B-SPEC
in	O
experimental	O
pneumocystic	O
pneumonia	O
].	O

ABSTRACT	O
:	O
Transmission	O
electron	O
microscopy	O
(	O
of	O
ultrathin	O
sections	O
)	O
was	O
used	O
to	O
examine	O
the	O
biomass	O
of	O
lung	O
tissue	O
in	O
the	O
immunodeficiency	O
minipigs	O
experimentally	O
infected	O
with	O
Pneumocystis	B-SPEC
carinii	I-SPEC
.	O

A	O
wide	O
range	O
of	O
respiratory	O
viruses	B-SPEC
cocirculates	O
in	O
LTCFs	O
and	O
contributes	O
to	O
respiratory	O
illness	O
morbidity	O
in	O
these	O
populations	O
.	O

Albumin	O
-	O
INF	O
-	O
alpha	O
and	O
albumin	O
-	O
INF	O
-	O
beta	O
are	O
novel	O
recombinant	O
proteins	O
consisting	O
of	O
IFN	O
-	O
alpha	O
or	O
IFN	O
-	O
beta	O
genetically	O
fused	O
to	O
human	B-SPEC
albumin	O
.	O

Identification	O
of	O
IBV	B-SPEC
was	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
of	O
RNA	O
extracted	O
from	O
oropharyngeal	O
swabs	O
taken	O
from	O
poultry	O
flocks	O
exhibiting	O
signs	O
of	O
clinical	O
disease	O
thought	O
to	O
be	O
attributable	O
to	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
examined	O
spike	O
(	O
S	O
)	O
gene	O
sequences	O
of	O
the	O
virus	B-SPEC
populations	O
of	O
four	O
different	O
commercial	O
ArkDPI	O
-	O
derived	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
vaccines	O
before	O
and	O
during	O
a	O
single	O
passage	O
in	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
.	O

We	O
found	O
different	O
degrees	O
of	O
genetic	O
heterogeneity	O
among	O
the	O
four	O
vaccines	O
before	O
passage	O
in	O
chickens	B-SPEC
,	O
ranging	O
from	O
no	O
apparent	O
heterogeneity	O
to	O
heterogeneity	O
in	O
20	O
positions	O
in	O
the	O
S	O
gene	O
.	O

Instillation	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
,	O
a	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
)	O
into	O
the	O
CNS	O
of	O
mice	B-SPEC
results	O
in	O
acute	O
encephalitis	O
followed	O
by	O
a	O
chronic	O
immune	O
-	O
mediated	O
demyelinating	O
disease	O
.	O

In	O
vivo	O
,	O
whereas	O
A	O
/	O
J	O
mice	B-SPEC
are	O
highly	O
permissive	O
for	O
both	O
MHV	B-SPEC
-	O
1	O
and	O
CVB3	O
infections	O
and	O
mount	O
a	O
poor	O
IFN	O
response	O
,	O
C57B1	O
/	O
6	O
mice	B-SPEC
are	O
relatively	O
resistant	O
to	O
both	O
virus	B-SPEC
infections	O
and	O
mount	O
a	O
vigorous	O
IFN	O
response	O
.	O

In	O
addition	O
,	O
a	O
total	O
of	O
100	O
field	O
samples	O
from	O
ileum	O
,	O
ileum	O
-	O
cecal	O
junction	O
,	O
and	O
ceca	O
,	O
collected	O
from	O
30	O
to	O
45	O
-	O
d	O
-	O
old	O
turkeys	B-SPEC
poults	O
experiencing	O
an	O
outbreak	O
of	O
acute	O
enteritis	O
,	O
were	O
used	O
to	O
search	O
for	O
TCoV	O
by	O
the	O
same	O
D	O
-	O
IHC	O
.	O

TITLE	O
:	O
Experimental	O
optic	O
neuritis	O
induced	O
by	O
a	O
demyelinating	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

The	O
SZ16	O
-	O
S	O
mutant	O
viruses	B-SPEC
adapted	O
to	O
human	B-SPEC
airway	O
epithelial	O
cells	O
and	O
displayed	O
enhanced	O
affinity	O
for	O
hACE2	O
but	O
exhibited	O
severe	O
growth	O
defects	O
in	O
the	O
DBT	O
-	O
cACE2	O
cells	O
,	O
suggesting	O
that	O
the	O
evolutionary	O
pathway	O
that	O
promoted	O
efficient	O
hACE2	O
interactions	O
simultaneously	O
abolished	O
efficient	O
cACE2	O
interactions	O
.	O

Complement	O
activation	O
,	O
as	O
judged	O
by	O
lung	O
allograft	O
deposition	O
of	O
C3d	O
/	O
C4d	O
,	O
is	O
common	O
early	O
post	O
-	O
lung	O
transplant	O
and	O
may	O
be	O
triggered	O
by	O
primary	O
graft	O
dysfunction	O
and	O
/	O
or	O
airway	O
infection	O
,	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
early	O
BOS	B-SPEC
.	O

However	O
,	O
in	O
a	O
multivariate	O
analysis	O
MBL	O
insufficiency	O
was	O
associated	O
with	O
the	O
development	O
of	O
the	O
most	O
severe	O
forms	O
of	O
sepsis	B-SPEC
(	O
P	O
=	O
.	O
007	O
),	O
acute	O
respiratory	O
failure	O
(	O
P	O
=	O
.	O
009	O
),	O
multiorgan	O
dysfunction	O
syndrome	O
(	O
P	O
=	O
.	O
036	O
),	O
intensive	O
care	O
unit	O
admission	O
(	O
P	O
=	O
.	O
020	O
),	O
and	O
death	O
(	O
P	O
=	O
.	O
003	O
).	O

CONCLUSIONS	O
:	O
Our	O
large	O
study	O
suggests	O
that	O
MBL	O
plays	O
a	O
redundant	O
role	O
in	O
human	B-SPEC
defenses	O
against	O
primary	O
infection	O
,	O
at	O
least	O
in	O
adults	O
with	O
CAP	O
,	O
and	O
provides	O
,	O
for	O
the	O
first	O
time	O
,	O
evidence	O
that	O
MBL	O
insufficiency	O
predisposes	O
to	O
higher	O
severity	O
and	O
fatal	O
outcome	O
in	O
patients	O
with	O
CAP	O
,	O
irrespective	O
of	O
the	O
causal	O
microorganisms	O
.	O

In	O
conclusion	O
,	O
the	O
pathology	O
of	O
SARS	O
-	O
CoV	O
infection	O
in	O
cats	B-SPEC
and	O
ferrets	B-SPEC
resembles	O
that	O
in	O
humans	B-SPEC
except	O
that	O
syncytia	O
and	O
hyaline	O
membranes	O
were	O
not	O
observed	O
.	O

ABSTRACT	O
:	O
We	O
replaced	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
nucleocapsid	O
(	O
NC	O
)	O
domain	O
with	O
different	O
N	O
-	O
coding	O
sequences	O
to	O
test	O
SARS	O
-	O
CoV	O
nucleocapsid	O
(	O
N	O
)	O
self	O
-	O
interaction	O
capacity	O
,	O
and	O
determined	O
the	O
capabilities	O
of	O
each	O
chimera	O
to	O
direct	O
virus	B-SPEC
-	O
like	O
particle	O
(	O
VLP	O
)	O
assembly	O
.	O

In	O
summary	O
,	O
(	O
a	O
)	O
DC	O
-	O
SIGN	O
acts	O
as	O
a	O
capture	O
or	O
attachment	O
molecule	O
for	O
avian	B-SPEC
H5N1	O
virus	B-SPEC
,	O
and	O
(	O
b	O
)	O
DC	O
-	O
SIGN	O
mediates	O
infections	O
in	O
cis	B-SPEC
and	O
in	O
trans	O
.	O

DNA	O
was	O
isolated	O
from	O
67	O
consecutive	O
patients	O
who	O
fulfilled	O
international	O
criteria	O
for	O
severe	O
sepsis	B-SPEC
and	O
for	O
ALI	O
and	O
96	O
population	O
-	O
based	O
controls	O
drawn	O
from	O
the	O
general	O
population	O
.	O

To	O
gain	O
insight	O
into	O
the	O
C	O
-	O
terminal	O
recognition	O
region	O
of	O
ubiquitin	O
by	O
DUBs	O
,	O
we	O
synthesized	O
positional	O
scanning	O
libraries	O
of	O
fluorigenic	O
tetrapeptides	O
and	O
tested	O
them	O
on	O
three	O
examples	O
of	O
human	B-SPEC
DUBs	O
[	O
OTU	O
-	O
1	O
(	O
ovarian	O
tumour	O
1	O
),	O
Iso	B-SPEC
-	O
T	O
(	O
isopeptidase	O
T	O
)	O
and	O
UCH	O
-	O
L3	O
(	O
ubiquitin	O
C	O
-	O
terminal	O
hydrolase	O
L3	O
)]	O
and	O
one	O
viral	O
ubiquitin	O
-	O
specific	O
protease	O
,	O
namely	O
PLpro	O
(	O
papain	O
-	O
like	O
protease	O
)	O
from	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
and	O
acute	O
lung	O
injury	O
for	O
a	O
part	O
of	O
a	O
devastating	O
syndrome	O
characterized	O
by	O
acute	O
onset	O
,	O
hypoxemia	O
and	O
bilateral	O
infiltrates	O
in	O
the	O
chest	O
x	O
-	O
ray	B-SPEC
with	O
absence	O
of	O
heart	O
failure	O
signs	O
.	O

ABSTRACT	O
:	O
Five	O
known	O
human	B-SPEC
coronaviruses	O
infect	O
the	O
human	B-SPEC
respiratory	O
tract	O
:	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	O
-	O
HKU1	O
.	O

Antigenically	O
similar	O
to	O
their	O
virulent	O
counterparts	O
are	O
FCoV	O
biotypes	O
designated	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
),	O
which	O
usually	O
cause	O
only	O
mild	O
enteritis	O
and	O
are	O
unable	O
to	O
efficiently	O
infect	O
macrophages	O
and	O
monocytes	O
.	O

Here	O
we	O
show	O
that	O
the	O
FECV	B-SPEC
strain	O
WSU	O
79	O
-	O
1683	O
(	O
FECV	B-SPEC
-	O
1683	O
)	O
is	O
highly	O
dependent	O
on	O
host	O
cell	O
cathepsin	O
B	O
and	O
cathepsin	O
L	O
activity	O
for	O
entry	O
into	O
the	O
host	O
cell	O
,	O
as	O
well	O
as	O
on	O
the	O
low	O
pH	O
of	O
endocytic	O
compartments	O
.	O

Here	O
we	O
report	O
the	O
case	O
of	O
a	O
67	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
PD	O
who	O
rapidly	O
developed	O
a	O
severe	O
akinetic	O
state	O
with	O
rise	O
of	O
temperature	O
(	O
39	O
degrees	O
C	O
)	O
and	O
creatine	O
phosphokinase	O
concentration	O
(	O
up	O
to	O
5000	O
mg	O
/	O
dL	O
).	O

Other	O
pathogens	O
included	O
in	O
the	O
order	B-SPEC
of	O
frequency	O
group	O
1	O
canine	O
coronavirus	B-SPEC
(	O
4	O
.	O
4	O
%),	O
canine	B-SPEC
adenovirus	I-SPEC
type	O
2	O
(	O
2	O
.	O
9	O
%),	O
group	O
2	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
1	O
.	O
5	O
%),	O
and	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
1	O
.	O
5	O
%).	O

TITLE	O
:	O
Virus	B-SPEC
-	O
like	O
particles	O
of	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
formed	O
by	O
membrane	O
proteins	O
from	O
different	O
origins	O
demonstrate	O
stimulating	O
activity	O
in	O
human	B-SPEC
dendritic	O
cells	O
.	O

Co	O
-	O
infection	O
of	O
insect	B-SPEC
cells	O
with	O
these	O
two	O
recombinant	O
baculoviruses	O
led	O
to	O
self	O
-	O
assembly	O
of	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
BVLPs	O
)	O
as	O
demonstrated	O
by	O
electron	O
microscopy	O
.	O

In	O
agreement	O
,	O
SL	O
-	O
CoV	O
S	O
DNA	O
vaccine	O
evoked	O
a	O
more	O
vigorous	O
antibody	O
response	O
and	O
a	O
stronger	O
T	O
cell	O
response	O
than	O
SARS	O
-	O
CoV	O
S	O
DNA	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
Genomic	O
analysis	O
reveals	O
age	O
-	O
dependent	O
innate	O
immune	O
responses	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

In	O
contrast	O
,	O
aged	O
mice	B-SPEC
had	O
a	O
greater	O
number	O
of	O
upregulated	O
immune	O
response	O
and	O
cell	O
-	O
to	O
-	O
cell	O
signaling	O
genes	O
,	O
and	O
the	O
expression	O
of	O
many	O
genes	O
was	O
sustained	O
even	O
after	O
viral	O
clearance	O
,	O
suggesting	O
an	O
exacerbated	O
host	O
response	O
to	O
virus	B-SPEC
.	O

Since	O
1993	O
,	O
more	O
than	O
1800	O
cases	O
of	O
suspected	O
PE	O
have	O
been	O
submitted	O
for	O
examination	O
by	O
negative	O
stain	O
electron	O
microscopy	O
;	O
this	O
has	O
involved	O
more	O
than	O
2400	O
individual	O
results	O
,	O
because	O
in	O
many	O
cases	O
more	O
than	O
one	O
virus	B-SPEC
was	O
identified	O
;	O
at	O
least	O
1500	O
individual	O
results	O
were	O
positive	O
for	O
viruses	B-SPEC
.	O

Based	O
upon	O
the	O
rotavirus	B-SPEC
NSP4	O
gene	O
sequence	O
,	O
the	O
chicken	B-SPEC
and	O
turkey	B-SPEC
origin	O
rotaviruses	B-SPEC
assorted	O
in	O
a	O
species	B-SPEC
-	O
specific	O
manner	O
.	O

ABSTRACT	O
:	O
Nosocomial	O
infection	O
(	O
i	O
.	O
e	O
.	O
infection	O
in	O
healthcare	O
facilities	O
)	O
raises	O
a	O
serious	O
public	O
health	O
problem	O
,	O
as	O
implied	O
by	O
the	O
existence	O
of	O
pathogens	O
characteristic	O
to	O
healthcare	O
facilities	O
such	O
as	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
and	O
hospital	O
-	O
mediated	O
outbreaks	O
of	O
influenza	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Initial	O
in	O
vitro	O
studies	O
demonstrated	O
recombinant	O
human	B-SPEC
PBEF	O
(	O
rhPBEF	O
)	O
as	O
a	O
direct	O
rat	B-SPEC
neutrophil	O
chemotactic	O
factor	O
with	O
in	O
vivo	O
studies	O
demonstrating	O
marked	O
increases	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
leukocytes	O
(	O
PMNs	O
)	O
after	O
intratracheal	O
injection	O
in	O
C57BL	O
/	O
6J	O
mice	B-SPEC
.	O

In	O
a	O
computational	O
study	O
,	O
we	O
proposed	O
that	O
ion	O
channel	O
activity	O
can	O
be	O
explained	O
by	O
either	O
of	O
two	O
similar	O
ETM	O
homopentameric	O
transmembrane	O
alpha	O
-	O
helical	O
bundles	O
,	O
related	O
by	O
a	O
approximately	O
50	O
degrees	O
rotation	O
of	O
the	O
helices	B-SPEC
.	O

Smallpox	B-SPEC
probably	O
reached	O
Europe	O
from	O
Asia	O
in	O
the	O
5th	O
century	O
,	O
and	O
yellow	O
fever	O
emerged	O
in	O
the	O
Americas	O
during	O
the	O
16th	O
century	O
as	O
a	O
consequence	O
of	O
the	O
African	O
slave	O
trade	O
.	O

Thus	O
,	O
MHV	B-SPEC
induces	O
type	O
I	O
IFN	O
in	O
macrophages	O
and	O
microglia	O
in	O
the	O
brains	O
of	O
infected	O
animals	B-SPEC
and	O
is	O
recognized	O
by	O
an	O
MDA5	O
-	O
dependent	O
pathway	O
in	O
macrophages	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
of	O
extraordinary	O
genetic	O
complexity	O
and	O
diversity	O
.	O

After	O
exposure	O
to	O
the	O
plasmid	O
,	O
human	B-SPEC
spermatozoa	O
were	O
used	O
to	O
fertilize	O
with	O
zona	O
-	O
free	O
hamster	B-SPEC
ova	O
.	O

Routine	O
testing	O
for	O
respiratory	O
viruses	B-SPEC
may	O
be	O
warranted	O
for	O
adults	O
who	O
have	O
been	O
hospitalized	O
with	O
pneumonia	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
new	O
5	O
-	O
alkyl	O
-	O
2	O
-	O
benzylsulfanylpyrimidin	O
-	O
4	O
(	O
3H	O
)-	O
ones	O
(	O
5a	O
-	O
y	O
)	O
bearing	O
different	O
substituted	O
arylmethyl	O
moieties	O
at	O
the	O
C	O
-	O
6	O
position	O
of	O
the	O
pyrimidine	O
core	O
have	O
been	O
synthesized	O
and	O
evaluated	O
for	O
their	O
in	O
vitro	O
activities	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
HIV	B-SPEC
-	I-SPEC
2	I-SPEC
in	O
MT	O
-	O
4	O
cell	O
cultures	O
.	O

Rats	B-SPEC
were	O
pretreated	O
with	O
empty	O
liposomes	O
,	O
NAC	O
,	O
or	O
L	O
-	O
NAC	O
(	O
25mg	O
/	O
kg	O
body	O
weight	O
,	O
iv	O
);	O
4h	O
later	O
were	O
challenged	O
with	O
LPS	O
(	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
LPS	O
0111	O
:	O
B4	O
)	O
and	O
sacrificed	O
20h	O
later	O
.	O

Challenge	O
of	O
saline	O
(	O
SAL	O
)-	O
pretreated	O
animals	B-SPEC
with	O
LPS	O
resulted	O
in	O
lung	O
injury	O
as	O
evidenced	O
by	O
increases	O
in	O
wet	O
lung	O
weight	O
(	O
edema	O
),	O
increases	O
in	O
lipid	O
peroxidation	O
(	O
marker	O
of	O
oxidative	O
stress	O
),	O
decreases	O
of	O
lung	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)	O
(	O
injury	O
marker	O
for	O
pulmonary	O
endothelial	O
cells	O
)	O
and	O
increases	O
in	O
the	O
pro	O
-	O
inflammatory	O
eicosanoids	O
,	O
thromboxane	O
B	O
(	O
2	O
)	O
and	O
leukotriene	O
B	O
(	O
4	O
).	O

ABSTRACT	O
:	O
The	O
sialylation	O
pattern	O
of	O
serum	O
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
in	O
non	O
-	O
symptomatic	O
cats	B-SPEC
infected	O
by	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
and	O
its	O
possible	O
relationship	O
with	O
the	O
amount	O
of	O
FCoVs	O
shed	O
in	O
faeces	O
were	O
investigated	O
.	O

These	O
results	O
suggest	O
that	O
hypersialylation	O
of	O
AGP	O
may	O
be	O
involved	O
in	O
host	O
-	O
virus	B-SPEC
interactions	O
.	O

The	O
unadjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
of	O
mortality	O
were	O
associated	O
with	O
six	O
risk	O
factors	O
out	O
of	O
23	O
:	O
APACHE	O
II	O
score	O
,	O
duration	O
of	O
trauma	O
factor	O
,	O
pulmonary	O
contusion	O
,	O
aspiration	O
of	O
gastric	O
contents	O
,	O
sepsis	B-SPEC
and	O
duration	O
of	O
mechanical	O
ventilation	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
spread	O
from	O
China	O
to	O
more	O
than	O
30	O
countries	O
,	O
causing	O
severe	O
outbreaks	O
of	O
atypical	O
pneumonia	O
and	O
over	O
800	O
deaths	O
worldwide	O
.	O

TITLE	O
:	O
Expression	O
and	O
functional	O
characterisation	O
of	O
the	O
putative	O
SARS	O
coronavirus	B-SPEC
non	O
-	O
structural	O
proteins	O
X1	O
-	O
X5	O
.	O

The	O
adenovirus	B-SPEC
-	O
mediated	O
overexpression	O
of	O
SARS	O
-	O
CoV	O
N	O
-	O
terminal	O
domain	O
(	O
S1	O
)	O
and	O
other	O
structural	O
proteins	O
,	O
including	O
E	O
,	O
M	O
and	O
N	O
protein	O
,	O
do	O
not	O
induce	O
apoptosis	O
.	O

Subclinical	O
SARS	O
coronavirus	B-SPEC
infection	O
is	O
rare	O
in	O
children	O
.	O

Direct	O
infection	O
/	O
interaction	O
between	O
viruses	B-SPEC
and	O
lymphocytes	O
/	O
monocytes	O
is	O
unlikely	O
to	O
be	O
the	O
cause	O
of	O
lymphopaenia	O
in	O
SARS	O
patients	O
.	O

A	O
novel	O
HLA	O
-	O
A2	O
.	O
1	O
-	O
specific	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
epitope	O
(	O
N220	O
-	O
N228	O
LALLLLDRL	O
)	O
able	O
to	O
activate	O
cytotoxic	O
T	O
cells	O
in	O
vitro	O
has	O
been	O
identified	O
.	O

Primers	O
of	O
hantaviruses	B-SPEC
,	O
Crimea	O
-	O
and	O
-	O
Congo	O
hemorrhage	O
fever	O
,	O
coronaviruses	O
,	O
SARS	O
,	O
Leptospirosis	O
and	O
virus	B-SPEC
hepatitis	O
.	O

DFA	O
and	O
RT	O
-	O
PCR	O
for	O
influenza	O
,	O
parainfluenza	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
adenovirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
and	O
metapneumovirus	B-SPEC
were	O
performed	O
on	O
nasal	O
washes	O
and	O
61	O
.	O
8	O
%	O
resulted	O
positive	O
.	O

These	O
findings	O
highlight	O
the	O
implications	O
of	O
other	O
viruses	B-SPEC
in	O
ILI	O
etiology	O
and	O
suggest	O
that	O
during	O
the	O
influenza	O
season	O
,	O
this	O
clinical	O
overlap	O
must	O
be	O
considered	O
in	O
the	O
diagnosis	O
and	O
clinical	O
management	O
of	O
patients	O
.	O

Parvovirus	B-SPEC
B19	I-SPEC
infection	O
is	O
associated	O
sometimes	O
with	O
myocarditis	O
.	O

Evidence	O
was	O
for	O
the	O
presence	O
of	O
the	O
adenovirus	B-SPEC
genome	O
in	O
6	O
(	O
75	O
%)	O
of	O
the	O
children	O
.	O

TITLE	O
:	O
RNA	O
viruses	B-SPEC
and	O
the	O
mitogenic	O
Raf	O
/	O
MEK	O
/	O
ERK	O
signal	O
transduction	O
cascade	O
.	O

In	O
contrast	O
,	O
the	O
consequences	O
of	O
RNA	O
virus	B-SPEC
-	O
induced	O
Raf	O
/	O
MEK	O
/	O
ERK	O
signaling	O
were	O
less	O
clear	O
for	O
a	O
long	O
time	O
,	O
but	O
since	O
the	O
turn	O
of	O
the	O
century	O
the	O
number	O
of	O
publications	O
on	O
this	O
topic	O
has	O
rapidly	O
increased	O
.	O

Research	O
on	O
this	O
virus	B-SPEC
/	O
host	O
-	O
interaction	O
will	O
broaden	O
our	O
understanding	O
of	O
its	O
relevance	O
in	O
viral	O
replication	O
.	O

Serological	O
tests	O
and	O
bone	O
marrow	O
examination	O
with	O
in	O
-	O
situ	O
hybridisation	O
revealed	O
severe	O
acquired	O
haemophagocytic	O
lymphohistiocytosis	O
secondary	O
to	O
acute	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
infection	O
.	O

TITLE	O
:	O
Post	O
-	O
mortem	O
histological	O
pulmonary	O
analysis	O
in	O
patients	O
with	O
HIV	B-SPEC
/	O
AIDS	O
.	O

ABSTRACT	O
:	O
Certain	O
aspects	O
of	O
pulmonary	O
pathology	O
observed	O
in	O
autopsies	O
of	O
HIV	B-SPEC
/	O
AIDS	O
patients	O
are	O
still	O
unknown	O
.	O

This	O
study	O
considers	O
250	O
autopsies	O
of	O
HIV	B-SPEC
/	O
AIDS	O
patients	O
who	O
died	O
of	O
acute	O
respiratory	O
failure	O
and	O
describes	O
the	O
demographic	O
data	O
,	O
etiology	O
,	O
and	O
histological	O
pulmonary	O
findings	O
of	O
the	O
various	O
pathologies	O
.	O

Odds	O
ratio	O
of	O
the	O
HIV	B-SPEC
/	O
AIDS	O
-	O
associated	O
diseases	O
developing	O
a	O
specific	O
histopathological	O
pattern	O
was	O
determined	O
by	O
logistic	O
regression	O
.	O

Multivariate	O
analysis	O
showed	O
a	O
significant	O
and	O
positive	O
association	O
between	O
Pneumocystis	B-SPEC
jiroveci	I-SPEC
pneumonia	O
and	O
acute	O
interstitial	O
pneumonia	O
(	O
Odds	O
ratio	O
,	O
4	O
.	O
51	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
46	O
-	O
8	O
.	O
24	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
severe	O
sepsis	B-SPEC
and	O
/	O
or	O
septic	O
shock	O
and	O
diffuse	O
alveolar	O
damage	O
(	O
Odds	O
ratio	O
,	O
3	O
.	O
60	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
78	O
-	O
7	O
.	O
27	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
cytomegalovirus	B-SPEC
and	O
acute	O
interstitial	O
pneumonia	O
(	O
Odds	O
ratio	O
,	O
2	O
.	O
22	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
-	O
4	O
.	O
93	O
;	O
p	O
=	O
0	O
.	O
05	O
).	O

This	O
report	O
is	O
the	O
first	O
autopsy	O
study	O
to	O
include	O
demographic	O
data	O
,	O
etiologic	O
diagnosis	O
,	O
and	O
respective	O
histopathological	O
findings	O
in	O
patients	O
with	O
HIV	B-SPEC
/	O
AIDS	O
and	O
acute	O
respiratory	O
failure	O
.	O

Analysis	O
of	O
the	O
molecular	O
structure	O
of	O
the	O
cluster	O
in	O
different	O
mammalian	B-SPEC
species	B-SPEC
including	O
human	B-SPEC
indicates	O
that	O
the	O
cluster	O
is	O
extremely	O
polymorphic	O
with	O
a	O
highly	O
variable	O
number	O
of	O
genes	O
and	O
pseudogenes	O
whose	O
functions	O
are	O
not	O
yet	O
completely	O
established	O
.	O

Although	O
still	O
preliminary	O
,	O
a	O
few	O
recent	O
observations	O
also	O
substantiate	O
a	O
possible	O
role	O
for	O
OAS1	O
in	O
human	B-SPEC
susceptibility	O
to	O
viral	O
infections	O
(	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
SARS	O
,	O
etc	O
.)	O
and	O
its	O
possible	O
involvement	O
in	O
some	O
other	O
diseases	O
such	O
as	O
type	O
1	O
diabetes	O
and	O
multiple	O
sclerosis	O
.	O

TITLE	O
:	O
Importance	O
of	O
cholesterol	O
for	O
infection	O
of	O
cells	O
by	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

Both	O
the	O
whole	O
killed	O
SARS	O
-	O
CoV	O
vaccine	O
(	O
with	O
and	O
without	O
alum	O
)	O
and	O
adenovirus	B-SPEC
-	O
based	O
vectors	O
encoding	O
the	O
nucleocapsid	O
(	O
N	O
)	O
and	O
spike	O
(	O
S	O
)	O
protein	O
induced	O
neutralizing	O
antibody	O
responses	O
and	O
reduced	O
viral	O
replication	O
and	O
shedding	O
in	O
the	O
upper	O
respiratory	O
tract	O
and	O
progression	O
of	O
virus	B-SPEC
to	O
the	O
lower	O
respiratory	O
tract	O
.	O

Dynamin	O
inhibitory	O
peptide	O
and	O
DN	O
dynamin	O
effectively	O
inhibited	O
virus	B-SPEC
internalization	O
.	O

Syrian	B-SPEC
golden	I-SPEC
hamsters	I-SPEC
are	O
among	O
the	O
best	O
small	O
animal	B-SPEC
models	O
,	O
though	O
little	O
clinical	O
illness	O
and	O
no	O
mortality	O
are	O
observed	O
after	O
virus	B-SPEC
infection	O
.	O

Cyclophosphamide	O
was	O
used	O
to	O
immunosuppress	O
hamsters	B-SPEC
leading	O
to	O
a	O
prolonged	O
disease	O
course	O
and	O
higher	O
mortality	O
after	O
SARS	O
-	O
CoV	O
infection	O
.	O

Infection	O
with	O
recombinant	O
SARS	O
-	O
CoV	O
viruses	B-SPEC
bearing	O
disruptions	O
in	O
the	O
gene	O
7	O
coding	O
region	O
showed	O
no	O
significant	O
change	O
in	O
replication	O
kinetics	O
,	O
tissue	O
tropism	O
,	O
morbidity	O
,	O
or	O
mortality	O
suggesting	O
that	O
the	O
ORF7a	O
(	O
7a	O
)	O
and	O
ORF7b	O
(	O
7b	O
)	O
proteins	O
are	O
not	O
required	O
for	O
virus	B-SPEC
replication	O
in	O
immunosuppressed	O
hamsters	B-SPEC
.	O

Applications	O
of	O
the	O
proposed	O
approach	O
to	O
modeling	O
the	O
effects	O
of	O
immunological	O
heterogeneity	O
on	O
the	O
dynamics	O
of	O
bat	B-SPEC
rabies	O
are	O
presented	O
.	O

Thererfore	O
,	O
the	O
tender	O
leaf	O
of	O
Toona	B-SPEC
sinensis	I-SPEC
Roem	O
may	O
be	O
an	O
important	O
resource	O
agninst	O
SARS	O
-	O
CoV	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
whether	O
expression	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
7b	O
protein	O
,	O
as	O
indicated	O
by	O
the	O
presence	O
of	O
specific	O
serum	O
antibodies	O
,	O
consistently	O
correlated	O
with	O
occurrence	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
cats	B-SPEC
.	O

Overall	O
,	O
the	O
prevalence	O
of	O
detected	O
respiratory	O
viruses	B-SPEC
was	O
:	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
55	O
(	O
43	O
%);	O
Rhinovirus	B-SPEC
30	O
(	O
23	O
%);	O
Metapneumovirus	B-SPEC
13	O
(	O
10	O
%);	O
Influenza	O
A	O
8	O
(	O
6	O
%);	O
Enterovirus	B-SPEC
6	O
(	O
5	O
%);	O
Bocavirus	B-SPEC
6	O
(	O
5	O
%);	O
Adenovirus	B-SPEC
4	O
(	O
3	O
%);	O
Coronavirus	B-SPEC
3	O
(	O
2	O
%);	O
Parainfluenza	O
1	O
:	O
2	O
(	O
1	O
%);	O
Influenza	O
B	O
,	O
1	O
(	O
1	O
%)	O
and	O
Parainfluenza	O
3	O
:	O
1	O
(	O
1	O
%).	O

Antigen	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
performed	O
to	O
detect	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
in	O
faeces	O
of	O
all	O
the	O
calves	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
rapid	O
assays	O
for	O
the	O
detection	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
rotavirus	B-SPEC
A	I-SPEC
and	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
in	O
faecal	O
samples	O
of	O
calves	O
.	O

ABSTRACT	O
:	O
Rapid	O
immunochromatographic	O
assays	O
for	O
detecting	O
infections	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
),	O
rotavirus	B-SPEC
A	I-SPEC
and	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
in	O
calf	O
faeces	O
were	O
evaluated	O
using	O
as	O
gold	O
standards	O
a	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
BCV	B-SPEC
and	O
rotavirus	B-SPEC
)	O
and	O
a	O
sedimentation	O
-	O
flotation	O
technique	O
(	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
).	O

Here	O
we	O
describe	O
a	O
discovery	O
platform	O
that	O
utilizes	O
self	O
-	O
inactivating	O
(	O
SIN	O
)	O
lentiviral	O
vectors	O
for	O
the	O
surface	O
display	O
of	O
high	O
-	O
affinity	O
single	O
-	O
chain	O
variable	O
region	O
(	O
scFv	O
)	O
antibody	O
fragments	O
on	O
human	B-SPEC
cells	O
and	O
lentivirus	B-SPEC
particles	O
.	O

Both	O
antibody	O
-	O
displaying	O
human	B-SPEC
cells	O
and	O
virus	B-SPEC
particles	O
bound	O
antigen	O
specifically	O
.	O

High	O
level	O
scFvFc	O
expression	O
and	O
stable	O
integration	O
was	O
achieved	O
in	O
human	B-SPEC
cells	O
following	O
transduction	O
with	O
IRES	O
containing	O
bicistronic	O
SIN	O
lentivectors	O
encoding	O
ZsGreen	O
when	O
scFvFc	O
fusion	O
proteins	O
were	O
expressed	O
from	O
the	O
first	O
cassette	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
(	O
77	O
%),	O
followed	O
by	O
adenovirus	B-SPEC
(	O
15	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
11	O
%),	O
coronavirus	B-SPEC
(	O
8	O
%),	O
parainfluenza	O
(	O
6	O
%)	O
and	O
influenza	O
(	O
1	O
%).	O

Of	O
the	O
139	O
samples	O
with	O
RSV	B-SPEC
detected	O
,	O
34	O
(	O
24	O
%)	O
were	O
co	O
-	O
infected	O
with	O
another	O
viral	O
pathogen	O
.	O

TITLE	O
:	O
Entry	O
from	O
the	O
cell	O
surface	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
with	O
cleaved	O
S	O
protein	O
as	O
revealed	O
by	O
pseudotype	O
virus	B-SPEC
bearing	O
cleaved	O
S	O
protein	O
.	O

These	O
data	O
demonstrated	O
the	O
up	O
-	O
regulation	O
of	O
37	O
genes	O
and	O
down	O
-	O
regulation	O
of	O
nine	O
genes	O
,	O
including	O
those	O
involved	O
in	O
cell	O
signaling	O
,	O
inflammation	O
,	O
and	O
gene	O
transcription	O
in	O
SOD3	O
-/-	O
mice	B-SPEC
compared	O
with	O
either	O
mice	B-SPEC
with	O
acute	O
SOD3	O
reduction	O
or	O
wild	O
-	O
type	O
controls	O
.	O

However	O
,	O
having	O
had	O
family	B-SPEC
members	O
or	O
friends	O
contract	O
,	O
SARS	O
was	O
not	O
related	O
to	O
alcohol	O
abuse	O
/	O
dependence	O
symptom	O
count	O
.	O

Furthermore	O
,	O
a	O
phylogenetic	O
tree	O
based	O
on	O
these	O
M	O
DNA	O
sequences	O
was	O
generated	O
,	O
and	O
the	O
tree	O
topology	O
suggests	O
that	O
some	O
Chinese	O
IBV	B-SPEC
strains	O
may	O
have	O
a	O
common	O
ancestor	O
;	O
however	O
,	O
HH06	O
is	O
a	O
new	O
local	O
IBV	B-SPEC
isolate	O
that	O
is	O
responsible	O
for	O
the	O
field	O
outbreak	O
of	O
nephritis	O
.	O

These	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
M	O
protein	O
,	O
similar	O
to	O
the	O
M	O
proteins	O
of	O
other	O
coronaviruses	O
,	O
plays	O
a	O
pivotal	O
role	O
in	O
virus	B-SPEC
assembly	O
.	O

TITLE	O
:	O
Perceptions	O
related	O
to	O
bird	B-SPEC
-	O
to	O
-	O
human	B-SPEC
avian	B-SPEC
influenza	O
,	O
influenza	O
vaccination	O
,	O
and	O
use	O
of	O
face	O
mask	O
.	O

ABSTRACT	O
:	O
The	O
aims	O
of	O
this	O
study	O
were	O
firstly	O
to	O
evaluate	O
the	O
pathogenicity	O
of	O
an	O
Italian	O
isolate	O
of	O
the	O
QX	O
strain	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
virus	B-SPEC
using	O
1	O
-	O
day	O
-	O
old	O
female	O
specific	O
pathogen	O
free	O
chicks	O
(	O
layer	O
type	O
)	O
and	O
1	O
-	O
day	O
-	O
old	O
female	O
commercial	O
broiler	O
type	O
chickens	B-SPEC
,	O
and	O
secondly	O
to	O
assess	O
the	O
level	O
of	O
protection	O
induced	O
in	O
these	O
birds	B-SPEC
by	O
a	O
vaccination	O
programme	O
including	O
the	O
IB	O
Massachusetts	O
and	O
4	O
/	O
91	O
serotype	O
live	O
attenuated	O
vaccines	O
.	O

In	O
broilers	O
,	O
replication	O
of	O
the	O
challenge	O
virus	B-SPEC
was	O
not	O
prevented	O
but	O
was	O
significantly	O
reduced	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
,	O
a	O
large	O
group	O
including	O
human	B-SPEC
pathogens	O
such	O
as	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
replicate	O
in	O
the	O
cytoplasm	O
of	O
infected	O
host	O
cells	O
.	O

We	O
have	O
now	O
applied	O
electron	O
tomography	O
of	O
cryofixed	O
infected	O
cells	O
for	O
the	O
three	O
-	O
dimensional	O
imaging	O
of	O
coronavirus	B-SPEC
-	O
induced	O
membrane	O
alterations	O
at	O
high	O
resolution	O
.	O

Our	O
data	O
document	O
the	O
extensive	O
virus	B-SPEC
-	O
induced	O
reorganization	O
of	O
host	O
cell	O
membranes	O
into	O
a	O
network	O
that	O
is	O
used	O
to	O
organize	O
viral	O
replication	O
and	O
possibly	O
hide	O
replicating	O
RNA	O
from	O
antiviral	O
defense	O
mechanisms	O
.	O

TITLE	O
:	O
Utilization	O
of	O
DC	O
-	O
SIGN	O
for	O
entry	O
of	O
feline	B-SPEC
coronaviruses	O
into	O
host	O
cells	O
.	O

ABSTRACT	O
:	O
The	O
prevalences	O
of	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
,	O
rotavirus	B-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
),	O
and	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
E	O
coli	O
K99	O
)	O
were	O
determined	O
in	O
diarrhoeic	O
dairy	O
calves	O
aged	O
one	O
to	O
21	O
days	O
on	O
71	O
dairy	O
farms	O
in	O
western	O
Switzerland	O
during	O
the	O
winter	O
of	O
2005	O
to	O
2006	O
.	O

Currently	O
,	O
specific	O
treatment	O
choices	O
for	O
malaria	O
include	O
parenteral	O
artemisinins	O
or	O
intravenous	O
quinine	B-SPEC
along	O
with	O
doxycycline	O
.	O

Typically	O
,	O
it	O
follows	O
group	O
A	O
beta	O
-	O
hemolytic	O
streptococcus	B-SPEC
skin	O
or	O
upper	O
respiratory	O
tract	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
described	O
isolation	O
of	O
a	O
potentially	O
new	O
mammalian	B-SPEC
reovirus	B-SPEC
,	O
designated	O
BYD1	O
,	O
which	O
can	O
cause	O
clinical	O
symptoms	O
similar	O
to	O
that	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
guinea	B-SPEC
pigs	I-SPEC
and	O
macaques	B-SPEC
,	O
from	O
throat	O
swabs	O
of	O
one	O
SARS	O
patient	O
of	O
Beijing	O
,	O
in	O
2003	O
.	O

TITLE	O
:	O
Importance	O
of	O
cholesterol	O
-	O
rich	O
membrane	O
microdomains	O
in	O
the	O
interaction	O
of	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
with	O
the	O
cellular	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

ABSTRACT	O
:	O
Historically	O
,	O
coronaviruses	O
were	O
predominantly	O
associated	O
with	O
mild	O
upper	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
viruses	B-SPEC
and	O
Legionella	B-SPEC
spp	O
.	O

The	O
most	O
frequently	O
detected	O
pathogens	O
were	O
coronavirus	B-SPEC
(	O
17	O
%),	O
parainfluenza	O
virus	B-SPEC
(	O
6	O
%)	O
and	O
influenza	B-SPEC
virus	I-SPEC
(	O
4	O
%).	O

This	O
study	O
demonstrates	O
that	O
real	O
-	O
time	O
PCR	O
can	O
increase	O
the	O
number	O
of	O
microbiological	O
detections	O
of	O
respiratory	O
pathogens	O
,	O
mainly	O
as	O
a	O
result	O
of	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Length	O
of	O
stay	O
was	O
longer	O
in	O
patients	O
with	O
HCV	B-SPEC
(	O
4	O
.	O
0	O
versus	O
2	O
.	O
6	O
days	O
,	O
P	O
<	O
0	O
.	O
0001	O
).	O

Our	O
retrospective	O
analysis	O
suggests	O
that	O
patients	O
with	O
HCV	B-SPEC
may	O
be	O
at	O
increased	O
risk	O
of	O
ALI	O
following	O
AO	O
.	O

TITLE	O
:	O
[	O
The	O
functions	O
of	O
liver	O
natural	O
killer	O
cells	O
in	O
murine	B-SPEC
fulminant	O
hepatitis	O
induced	O
by	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
3	O
].	O

ABSTRACT	O
:	O
To	O
examine	O
trajectories	O
of	O
psychological	O
functioning	O
using	O
latent	O
class	B-SPEC
analysis	O
on	O
a	O
sample	O
of	O
hospitalized	O
survivors	O
of	O
the	O
2003	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
in	O
Hong	O
Kong	O
.	O

CONCLUSIONS	O
:	O
This	O
study	O
demonstrated	O
that	O
longitudinal	O
outcome	O
trajectories	O
following	O
a	O
major	O
health	O
-	O
threat	O
event	O
in	O
an	O
Asian	O
sample	O
bear	B-SPEC
close	O
resemblance	O
to	O
prototypical	O
trajectories	O
observed	O
in	O
trauma	O
studies	O
using	O
Western	O
samples	O
.	O

We	O
report	O
the	O
safety	O
and	O
immunogenicity	O
of	O
a	O
SARS	O
DNA	O
vaccine	O
in	O
a	O
Phase	O
I	O
human	B-SPEC
study	O
.	O

A	O
paradigm	O
is	O
emerging	O
that	O
the	O
genetic	O
risk	O
for	O
ALI	O
can	O
be	O
best	O
understood	O
in	O
terms	O
of	O
factors	O
that	O
control	O
3	O
overlapping	O
stages	O
of	O
ALI	O
pathogenesis	O
:	O
risk	O
for	O
the	O
acquisition	O
of	O
a	O
predisposing	O
condition	O
(	O
such	O
as	O
a	O
severe	O
pneumonia	O
),	O
risk	O
for	O
progression	O
to	O
lung	O
injury	O
during	O
systemic	O
inflammatory	O
states	O
(	O
such	O
as	O
severe	O
sepsis	B-SPEC
),	O
and	O
risk	O
for	O
failure	O
of	O
endogenous	O
mechanisms	O
to	O
resolve	O
the	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
Effective	O
vaccines	O
should	O
confer	O
long	O
-	O
term	O
protection	O
against	O
future	O
outbreaks	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
a	O
novel	O
zoonotic	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
with	O
unknown	O
animal	B-SPEC
reservoirs	O
.	O

Our	O
study	O
provides	O
a	O
roadmap	O
for	O
the	O
immunogenicity	O
of	O
SARS	O
-	O
CoV	O
and	O
types	O
of	O
immune	O
responses	O
that	O
may	O
be	O
responsible	O
for	O
the	O
virus	B-SPEC
clearance	O
,	O
and	O
should	O
serve	O
as	O
a	O
benchmark	O
for	O
SARS	O
-	O
CoV	O
vaccine	O
design	O
and	O
evaluation	O
.	O

These	O
mechanisms	O
were	O
tested	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
2003	O
,	O
and	O
a	O
series	O
of	O
practical	O
and	O
conceptual	O
blind	O
spots	B-SPEC
in	O
preparedness	O
were	O
revealed	O
.	O

TITLE	O
:	O
The	O
immunoreactivity	O
of	O
a	O
chimeric	O
multi	O
-	O
epitope	O
DNA	O
vaccine	O
against	O
IBV	B-SPEC
in	O
chickens	B-SPEC
.	O

From	O
these	O
results	O
,	O
PRCVs	O
with	O
different	O
origins	O
from	O
the	O
exotic	O
PRCVs	O
might	O
be	O
prevalent	O
in	O
pig	B-SPEC
farms	O
in	O
Japan	O
.	O

ABSTRACT	O
:	O
The	O
antiviral	O
role	O
of	O
CD4	O
(+)	O
T	O
cells	O
in	O
virus	B-SPEC
-	O
induced	O
pathologies	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
has	O
not	O
been	O
explored	O
extensively	O
.	O

Control	O
of	O
neurotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
requires	O
the	O
collaboration	O
of	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	O
cells	O
,	O
with	O
CD8	O
(+)	O
T	O
cells	O
providing	O
direct	O
perforin	O
and	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)-	O
mediated	O
antiviral	O
activity	O
.	O

To	O
distinguish	O
bystander	O
from	O
direct	O
antiviral	O
contributions	O
of	O
CD4	O
(+)	O
T	O
cells	O
in	O
virus	B-SPEC
clearance	O
and	O
pathology	O
,	O
memory	O
CD4	O
(+)	O
T	O
cells	O
purified	O
from	O
wild	O
type	O
(	O
wt	O
),	O
perforin	O
-	O
deficient	O
(	O
PKO	O
),	O
and	O
IFN	O
-	O
gamma	O
-	O
deficient	O
(	O
GKO	O
)	O
immune	O
donors	O
were	O
transferred	O
to	O
immunodeficient	O
SCID	O
mice	B-SPEC
prior	O
to	O
CNS	O
challenge	O
.	O

The	O
fecal	O
samples	O
from	O
the	O
sambar	B-SPEC
deer	I-SPEC
,	O
the	O
waterbuck	B-SPEC
,	O
and	O
the	O
white	B-SPEC
-	I-SPEC
tailed	I-SPEC
deer	I-SPEC
were	O
collected	O
during	O
winter	O
dysentery	O
outbreaks	O
and	O
sporadic	O
diarrhea	O
cases	O
in	O
1993	O
and	O
1994	O
(	O
H	O
.	O
Tsunemitsu	O
,	O
Z	O
.	O
R	O
.	O
el	O
-	O
Kanawati	O
,	O
D	O
.	O
R	O
.	O
Smith	O
,	O
H	O
.	O
H	O
.	O
Reed	O
,	O
and	O
L	O
.	O
J	O
.	O
Saif	O
,	O
J	O
.	O
Clin	O
.	O

High	O
nucleotide	O
identities	O
(	O
99	O
.	O
4	O
to	O
99	O
.	O
6	O
%)	O
among	O
the	O
wild	O
-	O
ruminant	B-SPEC
strains	O
and	O
recent	O
BCoV	O
strains	O
(	O
BCoV	O
-	O
LUN	O
and	O
BCoV	O
-	O
ENT	O
,	O
isolated	O
in	O
1998	O
)	O
further	O
confirm	O
the	O
close	O
relatedness	O
.	O

Here	O
,	O
we	O
further	O
investigated	O
the	O
biological	O
function	O
of	O
apoD	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
acute	O
encephalitis	O
.	O

Our	O
results	O
show	O
that	O
apoD	O
transcript	O
and	O
protein	O
are	O
upregulated	O
during	O
acute	O
encephalitis	O
induced	O
by	O
the	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
infection	O
.	O

The	O
apoD	O
upregulation	O
coincides	O
with	O
glial	O
activation	O
,	O
and	O
its	O
expression	O
returns	O
to	O
normal	O
levels	O
when	O
the	O
virus	B-SPEC
is	O
cleared	O
,	O
concomitantly	O
to	O
a	O
resolved	O
glial	O
reactivity	O
.	O

During	O
the	O
period	O
of	O
coma	B-SPEC
,	O
due	O
to	O
lying	O
in	O
particular	O
position	O
over	O
a	O
long	O
period	O
of	O
time	O
,	O
pressure	O
upon	O
the	O
certain	O
part	O
of	O
the	O
body	O
caused	O
muscle	O
compression	O
and	O
capillary	O
occlusion	O
in	O
fascial	O
compartments	O
,	O
which	O
led	O
to	O
ischemia	O
.	O

We	O
report	O
here	O
a	O
severe	O
case	O
of	O
AEFCSE	O
following	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
,	O
with	O
emphasis	O
on	O
the	O
cranial	O
MRI	O
findings	O
.	O

The	O
model	O
demonstrated	O
that	O
the	O
physical	O
form	O
of	O
heartworm	O
Ag	O
used	O
for	O
IV	O
challenge	O
in	O
D	B-SPEC
.	I-SPEC
immitis	I-SPEC
-	O
sensitized	O
cats	B-SPEC
is	O
an	O
important	O
factor	O
for	O
determining	O
the	O
characteristics	O
of	O
the	O
post	O
-	O
challenge	O
reaction	O
,	O
and	O
the	O
amount	O
of	O
exposed	O
internal	O
filarial	B-SPEC
Ag	O
presented	O
to	O
the	O
feline	B-SPEC
immune	O
system	O
may	O
influence	O
the	O
severity	O
of	O
the	O
response	O
to	O
challenge	O
.	O

TITLE	O
:	O
[	O
Influence	O
of	O
combining	O
positive	O
end	O
-	O
expiratory	O
pressure	O
with	O
prone	O
position	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
pig	B-SPEC
].	O

In	O
pigs	B-SPEC
with	O
ARDS	O
,	O
prone	O
position	O
improves	O
PaO2	O
/	O
FiO2	O
significantly	O
without	O
influence	O
on	O
respiratory	O
mechanics	O
and	O
hemodynamics	O
.	O

Definitive	O
diagnosis	O
of	O
FIP	O
was	O
made	O
by	O
histopathology	O
and	O
by	O
immunohistochemical	O
demonstration	O
of	O
coronavirus	B-SPEC
antigen	O
in	O
macrophages	O
within	O
kidney	O
and	O
skin	O
lesions	O
.	O

ABSTRACT	O
:	O
Although	O
in	O
different	O
groups	O
,	O
the	O
coronaviruses	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
NL63	O
use	O
the	O
same	O
receptor	O
,	O
angiotensin	O
converting	O
enzyme	O
(	O
ACE	O
)-	O
2	O
,	O
for	O
entry	O
into	O
the	O
host	O
cell	O
.	O

Here	O
we	O
show	O
that	O
the	O
bacterially	O
expressed	O
human	B-SPEC
PP11	O
displays	O
RNA	O
binding	O
capability	O
and	O
cleaves	O
single	O
stranded	O
RNA	O
in	O
a	O
Mn	O
(	O
2	O
+)-	O
dependent	O
manner	O
at	O
uridylates	O
,	O
to	O
produce	O
molecules	O
with	O
2	O
',	O
3	O
'-	O
cyclic	O
phosphate	O
ends	O
.	O

A	O
number	O
of	O
different	O
types	O
of	O
vaccines	O
,	O
such	O
as	O
inactivated	O
virus	B-SPEC
vaccine	O
,	O
subunit	O
vaccine	O
,	O
DNA	O
vaccine	O
and	O
vaccine	O
using	O
viral	O
expression	O
vector	O
as	O
well	O
as	O
attenuated	O
live	O
vaccine	O
so	O
far	O
reported	O
indicate	O
that	O
neutralizing	O
antibodies	O
play	O
an	O
important	O
role	O
for	O
protection	O
.	O

The	O
lower	O
limits	O
of	O
the	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
of	O
the	O
R	O
of	O
IBV	B-SPEC
H120	O
vaccine	O
,	O
and	O
of	O
IBV	B-SPEC
M41	O
,	O
were	O
significantly	O
<	O
1	O
.	O

The	O
LC16m8rVV	O
-	O
NMES	O
-	O
immunized	O
group	O
exhibited	O
as	O
severe	O
pneumonia	O
as	O
the	O
control	O
groups	O
,	O
although	O
LC16m8rVV	O
-	O
NMES	O
significantly	O
decreased	O
the	O
pulmonary	O
SARS	O
-	O
CoV	O
titer	O
to	O
the	O
same	O
extent	O
as	O
LC16m8rVV	O
-	O
S	O
.	O
To	O
identify	O
the	O
cause	O
of	O
the	O
exacerbated	O
pneumonia	O
,	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
recombinant	O
VV	O
that	O
expressed	O
the	O
individual	O
structural	O
proteins	O
of	O
SARS	O
-	O
CoV	O
(	O
LC16mOrVV	O
-	O
N	O
,	O
-	O
M	O
,	O
-	O
E	O
,	O
-	O
S	O
)	O
with	O
or	O
without	O
LC16mOrVV	O
-	O
S	O
(	O
i	O
.	O
e	O
.,	O
LC16mOrVV	O
-	O
N	O
,	O
LC16mOrVV	O
-	O
M	O
,	O
LC16mOrVV	O
-	O
E	O
,	O
or	O
LC16mOrVV	O
-	O
S	O
alone	O
or	O
LC16mOrVV	O
-	O
N	O
+	O
LC16mOrVV	O
-	O
S	O
,	O
LC16mOrVV	O
-	O
M	O
+	O
LC16mOrVV	O
-	O
S	O
,	O
or	O
LC16mOrVV	O
-	O
E	O
+	O
LC16mOrVV	O
-	O
S	O
),	O
and	O
infected	O
with	O
SARS	O
-	O
CoV	O
more	O
than	O
4	O
wk	O
later	O
.	O

Both	O
LC16mOrVV	O
-	O
N	O
-	O
immunized	O
mice	B-SPEC
and	O
LC16mOrVV	O
-	O
N	O
+	O
LC16mOrVV	O
-	O
S	O
-	O
immunized	O
mice	B-SPEC
exhibited	O
severe	O
pneumonia	O
.	O

The	O
high	O
-	O
level	O
immunoreactivity	O
of	O
each	O
coronavirus	B-SPEC
was	O
significantly	O
associated	O
with	O
the	O
summer	O
season	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
01	O
to	O
0	O
.	O
0001	O
).	O

During	O
this	O
period	O
,	O
the	O
trachea	B-SPEC
can	O
also	O
be	O
obstructed	O
by	O
pseudomembranes	O
.	O

RESULTS	O
:	O
History	O
of	O
varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
(	O
VZV	B-SPEC
)	O
infection	O
was	O
positive	O
in	O
42	O
%	O
of	O
controls	O
and	O
66	O
%	O
of	O
MS	O
cases	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
001	O
).	O

A	O
designed	O
ssDNA	O
fragment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
at	O
a	O
much	O
lower	O
concentration	O
than	O
the	O
target	O
ssDNA	O
(	O
I	O
)	O
was	O
also	O
recovered	O
with	O
high	O
efficiency	O
and	O
good	O
selectivity	O
.	O

ABSTRACT	O
:	O
In	O
this	O
territory	O
-	O
wide	O
molecular	O
epidemiology	O
study	O
of	O
coronaviruses	O
(	O
CoVs	O
)	O
in	O
Hong	O
Kong	O
involving	O
1	O
,	O
541	O
dead	O
wild	O
birds	B-SPEC
,	O
three	O
novel	O
CoVs	O
were	O
identified	O
in	O
three	O
different	O
bird	B-SPEC
families	O
(	O
bulbul	B-SPEC
CoV	O
HKU11	O
[	O
BuCoV	O
HKU11	O
],	O
thrush	B-SPEC
CoV	O
HKU12	O
[	O
ThCoV	O
HKU12	O
],	O
and	O
munia	O
CoV	O
HKU13	O
[	O
MuCoV	O
HKU13	O
]).	O

TITLE	O
:	O
Insertion	O
of	O
the	O
CXC	O
chemokine	O
ligand	O
9	O
(	O
CXCL9	O
)	O
into	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
genome	O
results	O
in	O
protection	O
from	O
viral	O
-	O
induced	O
encephalitis	O
and	O
hepatitis	O
.	O

Inoculation	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
CXCL9	O
-/-	O
mice	B-SPEC
with	O
MHV	B-SPEC
resulted	O
in	O
accelerated	O
and	O
increased	O
mortality	O
compared	O
to	O
wild	O
type	O
mice	B-SPEC
supporting	O
an	O
important	O
role	O
for	O
CXCL9	O
in	O
anti	O
-	O
viral	O
defense	O
.	O

The	O
presence	O
of	O
high	O
numbers	O
of	O
T	O
cells	O
and	O
macrophages	O
in	O
IBV	B-SPEC
infected	O
birds	B-SPEC
most	O
likely	O
induced	O
an	O
altered	O
immune	O
response	O
,	O
which	O
is	O
responsible	O
for	O
the	O
enhanced	O
clinical	O
signs	O
of	O
colibacillosis	O
.	O

Canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
has	O
previously	O
been	O
shown	O
to	O
have	O
a	O
widespread	O
international	O
presence	O
and	O
has	O
been	O
implicated	O
in	O
outbreaks	O
of	O
canine	O
infectious	O
respiratory	O
disease	O
(	O
CIRD	O
).	O

ABSTRACT	O
:	O
Macro	O
domain	O
is	O
a	O
highly	O
conserved	O
protein	O
domain	O
found	O
in	O
both	O
eukaryotes	B-SPEC
and	O
prokaryotes	B-SPEC
.	O

Moreover	O
,	O
combination	O
of	O
an	O
HR	O
-	O
1	O
peptide	O
,	O
N46	O
,	O
and	O
its	O
mutated	O
version	O
,	O
N46eg	O
,	O
shows	O
synergistic	O
inhibition	O
with	O
an	O
IC	O
(	O
50	O
)	O
of	O
1	O
.	O
39	O
+/-	O
0	O
.	O
05	O
microM	O
and	O
combination	O
index	O
of	O
0	O
.	O
75	O
+/-	O
0	O
.	O
15	O
,	O
suggesting	O
a	O
common	O
strategy	O
to	O
achieve	O
promising	O
inhibition	O
by	O
HR1	O
peptide	O
for	O
other	O
class	B-SPEC
I	O
envelope	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
HCoV	O
-	O
HKU1	O
)	O
is	O
a	O
recently	O
discovered	O
human	B-SPEC
coronavirus	I-SPEC
associated	O
with	O
respiratory	O
tract	O
infections	O
worldwide	O
.	O

ABSTRACT	O
:	O
The	O
coronaviruses	O
are	O
a	O
large	O
family	B-SPEC
of	O
plus	O
-	O
strand	O
RNA	O
viruses	B-SPEC
that	O
cause	O
a	O
wide	O
variety	O
of	O
diseases	O
both	O
in	O
humans	B-SPEC
and	O
in	O
other	O
organisms	O
.	O

In	O
vitro	O
immune	O
pressure	O
on	O
this	O
epitope	O
using	O
2002	O
/	O
03	O
strain	O
-	O
specific	O
nAb	O
80R	O
recapitulated	O
a	O
dominant	O
escape	O
mutation	O
that	O
was	O
present	O
in	O
all	O
2003	O
/	O
04	O
animal	B-SPEC
and	O
human	B-SPEC
viruses	B-SPEC
.	O

The	O
measurements	O
demonstrated	O
a	O
significant	O
dependency	O
of	O
blood	O
flow	O
via	O
the	O
iLA	O
device	O
on	O
cannula	B-SPEC
size	O
(	O
mean	O
+/-	O
sd	O
1	O
.	O
59	O
+/-	O
0	O
.	O
52	O
L	O
x	O
min	O
(-	O
1	O
)	O
for	O
15	O
French	O
(	O
Fr	O
),	O
1	O
.	O
94	O
+/-	O
0	O
.	O
35	O
L	O
x	O
min	O
(-	O
1	O
)	O
for	O
17	O
Fr	O
,	O
and	O
2	O
.	O
22	O
+/-	O
0	O
.	O
45	O
L	O
x	O
min	O
(-	O
1	O
)	O
for	O
19	O
Fr	O
)	O
and	O
on	O
mean	O
arterial	O
pressure	O
.	O

TITLE	O
:	O
Field	O
strain	O
feline	B-SPEC
coronaviruses	O
with	O
small	O
deletions	O
in	O
ORF7b	O
associated	O
with	O
both	O
enteric	O
infection	O
and	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

12	O
different	O
cell	O
cultures	O
were	O
tested	O
for	O
susceptibility	O
to	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

The	O
utility	O
of	O
plaque	O
assays	O
with	O
agrose	O
overlay	O
was	O
demonstrated	O
for	O
purifying	O
virus	B-SPEC
,	O
thereby	O
increasing	O
viral	O
infectivity	O
by	O
1	O
log	O
10	O
PFU	O
/	O
mL	O
.	O
CONCLUSIONS	O
:	O
CaCo	O
-	O
2	O
cells	O
support	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
better	O
than	O
LLC	O
-	O
MK2	O
cells	O
and	O
enable	O
cytopathogenic	O
plaque	O
assays	O
.	O

For	O
vaccine	O
-	O
induced	O
enhanced	O
susceptibility	O
to	O
infection	O
with	O
certain	O
viruses	B-SPEC
like	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
Dengue	B-SPEC
virus	I-SPEC
,	O
and	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
it	O
has	O
been	O
shown	O
that	O
antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
plays	O
an	O
important	O
role	O
.	O

Also	O
recent	O
failures	O
in	O
the	O
development	O
of	O
a	O
vaccine	O
against	O
HIV	B-SPEC
may	O
at	O
least	O
in	O
part	O
be	O
attributed	O
to	O
induction	O
of	O
enhanced	O
susceptibility	O
to	O
infection	O
.	O

These	O
cleavage	O
products	O
are	O
believed	O
to	O
play	O
essential	O
roles	O
in	O
replication	O
of	O
the	O
giant	O
RNA	O
genome	O
of	O
approximately	O
30	O
kb	O
and	O
transcription	O
of	O
a	O
nested	O
set	O
of	O
5	O
to	O
9	O
subgenomic	O
RNA	O
species	B-SPEC
by	O
a	O
unique	O
discontinuous	O
transcription	O
mechanism	O
.	O

TITLE	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
non	O
-	O
structure	O
protein	O
NSP15	O
--	O
an	O
endoribonuclease	O
.	O

To	O
establish	O
proof	O
-	O
of	O
-	O
principle	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
was	O
evaluated	O
,	O
and	O
the	O
first	O
visualization	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
virus	B-SPEC
by	O
transmission	O
electron	O
microscopy	O
(	O
TEM	O
)	O
is	O
reported	O
.	O

TITLE	O
:	O
Differential	O
inhibitory	O
activities	O
and	O
stabilisation	O
of	O
DNA	O
aptamers	O
against	O
the	O
SARS	O
coronavirus	B-SPEC
helicase	O
.	O

Influenza	O
A	O
,	O
parainfluenza	O
and	O
RSV	B-SPEC
accounted	O
for	O
51	O
%,	O
and	O
non	O
-	O
cultivable	O
viruses	B-SPEC
accounted	O
for	O
30	O
%	O
of	O
positive	O
cases	O
.	O

Experimental	O
infection	O
of	O
dogs	B-SPEC
with	O
a	O
TGEV	B-SPEC
-	O
like	O
isolate	O
induced	O
mild	O
gastroenteritis	O
without	O
any	O
systemic	O
involvement	O
.	O

Our	O
data	O
support	O
the	O
potential	O
recombinant	O
origin	O
of	O
the	O
TGEV	B-SPEC
-	O
like	O
CCoVs	O
.	O

However	O
,	O
predicting	O
tenable	O
pathways	O
of	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
movement	O
has	O
been	O
hindered	O
by	O
challenges	O
in	O
identifying	O
reservoir	O
species	B-SPEC
,	O
cultivating	O
zoonotic	O
organisms	O
in	O
culture	O
,	O
and	O
isolating	O
full	O
-	O
length	O
genomes	O
for	O
cloning	O
and	O
genetic	O
studies	O
.	O

RESULTS	O
:	O
Genes	O
encoding	O
truncated	O
nucleocapsid	O
(	O
N	O
)	O
and	O
spike	O
(	O
S	O
)	O
proteins	O
of	O
SARSCoV	O
were	O
cloned	O
into	O
the	O
expression	O
vector	O
pQE30	O
and	O
fusionally	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
M15	O
.	O

Fluorescent	O
quantitative	O
RT	O
-	O
PCR	O
showed	O
that	O
BALB	O
/	O
c	O
mice	B-SPEC
challenged	O
intranasally	O
with	O
SARSCoV	O
at	O
day	O
33	O
post	O
injection	O
were	O
completely	O
protected	O
from	O
virus	B-SPEC
replication	O
.	O

TITLE	O
:	O
Development	O
of	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
-	O
based	O
test	O
with	O
a	O
cocktail	O
of	O
nucleocapsid	O
and	O
spike	O
proteins	O
for	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
specific	O
antibody	O
.	O

During	O
their	O
hospitalization	O
,	O
40	O
(	O
57	O
%)	O
developed	O
abnormal	O
x	O
-	O
ray	B-SPEC
findings	O
,	O
74	O
%	O
of	O
those	O
within	O
the	O
first	O
day	O
.	O

These	O
data	O
suggest	O
that	O
virus	B-SPEC
-	O
infected	O
macrophages	O
overproduce	O
B	O
-	O
cell	O
differentiation	O
/	O
survival	O
factors	O
,	O
and	O
these	O
factors	O
act	O
on	O
B	O
-	O
cells	O
and	O
promote	O
B	O
-	O
cell	O
differentiation	O
into	O
plasma	O
cells	O
in	O
FIPV	O
-	O
infected	O
cats	B-SPEC
.	O

In	O
pneumonia	O
severity	O
score	O
,	O
chest	O
X	O
-	O
ray	B-SPEC
film	O
score	O
was	O
higher	O
in	O
the	O
group	O
of	O
fatalities	O
than	O
in	O
the	O
survival	O
group	O
.	O

ABSTRACT	O
:	O
Over	O
10	O
mo	O
,	O
287	O
mouse	B-SPEC
litters	O
were	O
cross	O
-	O
fostered	O
by	O
using	O
1	O
of	O
2	O
paradigms	O
to	O
eliminate	O
murine	B-SPEC
norovirus	I-SPEC
(	O
MNV	O
),	O
Helicobacter	B-SPEC
spp	O
.,	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
and	O
Syphacia	B-SPEC
obvelata	I-SPEC
.	O

The	O
use	O
of	O
cross	O
-	O
foster	O
rederivation	O
alone	O
was	O
unsuccessful	O
for	O
the	O
elimination	O
of	O
Syphacia	B-SPEC
obvelata	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
innate	O
immune	O
system	O
guards	O
against	O
virus	B-SPEC
infection	O
through	O
a	O
variety	O
of	O
mechanisms	O
including	O
mobilization	O
of	O
the	O
host	O
interferon	O
system	O
,	O
which	O
attacks	O
viral	O
products	O
mainly	O
at	O
a	O
posttranscriptional	O
level	O
.	O

The	O
influenza	B-SPEC
virus	I-SPEC
NS1	O
protein	O
is	O
a	O
multifunctional	O
facilitator	O
of	O
virus	B-SPEC
replication	O
,	O
one	O
of	O
whose	O
actions	O
is	O
to	O
antagonize	O
the	O
interferon	O
response	O
.	O

Since	O
NS1	O
is	O
required	O
for	O
efficient	O
virus	B-SPEC
replication	O
,	O
it	O
was	O
reasoned	O
that	O
chemical	O
inhibitors	O
of	O
this	O
protein	O
could	O
be	O
used	O
to	O
further	O
understand	O
virus	B-SPEC
-	O
host	O
interactions	O
and	O
also	O
serve	O
as	O
potential	O
new	O
antiviral	O
agents	O
.	O

A	O
yeast	B-SPEC
-	O
based	O
assay	O
was	O
developed	O
to	O
identify	O
compounds	O
that	O
phenotypically	O
suppress	O
NS1	O
function	O
.	O

The	O
effects	O
of	O
the	O
compounds	O
were	O
specific	O
to	O
NS1	O
,	O
because	O
they	O
had	O
no	O
effect	O
on	O
the	O
ability	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
papainlike	O
protease	O
protein	O
to	O
block	O
beta	O
interferon	O
promoter	O
activation	O
.	O

ABSTRACT	O
:	O
The	O
modulation	O
of	O
the	O
immune	O
response	O
is	O
a	O
common	O
practice	O
of	O
many	O
highly	O
pathogenic	O
viruses	B-SPEC
.	O

These	O
viruses	B-SPEC
have	O
broad	O
or	O
specific	O
host	O
ranges	O
,	O
suggesting	O
the	O
possibility	O
of	O
novel	O
strategies	O
for	O
targeting	O
and	O
regulating	O
host	O
innate	O
immune	O
responses	O
following	O
virus	B-SPEC
infection	O
.	O

These	O
studies	O
are	O
revealing	O
a	O
rich	O
set	O
of	O
novel	O
viral	O
proteins	O
that	O
engage	O
,	O
modify	O
,	O
and	O
/	O
or	O
disrupt	O
host	O
cell	O
signaling	O
and	O
nuclear	O
import	O
machinery	O
for	O
the	O
benefit	O
of	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Chicken	B-SPEC
tracheal	O
organ	O
cultures	O
(	O
TOCs	O
),	O
comprising	O
transverse	O
sections	O
of	O
chick	O
embryo	O
trachea	B-SPEC
with	O
beating	O
cilia	O
,	O
have	O
proved	O
useful	O
in	O
the	O
isolation	O
of	O
several	O
respiratory	O
viruses	B-SPEC
and	O
as	O
a	O
viral	O
assay	O
system	O
,	O
using	O
ciliostasis	O
as	O
the	O
criterion	O
for	O
infection	O
.	O

An	O
alternative	O
indirect	O
immunoperoxidase	O
assay	O
(	O
IPA	O
)	O
is	O
herein	O
described	O
for	O
the	O
detection	O
and	O
titration	O
of	O
these	O
viruses	B-SPEC
.	O

Virus	B-SPEC
discovery	O
based	O
on	O
cDNA	O
-	O
amplified	O
fragment	O
length	O
polymorphism	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
is	O
a	O
novel	O
human	B-SPEC
disease	O
caused	O
by	O
a	O
coronavirus	B-SPEC
of	O
animal	B-SPEC
origin	O
.	O

Soon	O
after	O
the	O
discovery	O
SARS	O
-	O
CoV	O
,	O
several	O
molecular	O
assays	O
were	O
described	O
for	O
the	O
detection	O
of	O
this	O
virus	B-SPEC
.	O

Virus	B-SPEC
isolation	O
and	O
detection	O
of	O
antibody	O
,	O
antigen	O
,	O
and	O
nucleic	O
acid	O
.	O

ABSTRACT	O
:	O
Group	O
2a	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
contains	O
human	B-SPEC
and	O
animal	B-SPEC
pathogens	O
that	O
include	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
rat	B-SPEC
coronavirus	B-SPEC
,	O
human	B-SPEC
respiratory	O
coronaviruses	O
OC43	O
and	O
the	O
recently	O
identified	O
HKU1	O
strain	O
,	O
a	O
newly	O
recognized	O
canine	O
respiratory	O
coronavirus	B-SPEC
,	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
,	O
equine	B-SPEC
coronavirus	B-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
and	O
wild	O
-	O
ruminant	B-SPEC
coronaviruses	O
.	O

BCoV	O
is	O
ubiquitous	O
in	O
cattle	B-SPEC
worldwide	O
and	O
is	O
an	O
economically	O
significant	O
cause	O
of	O
calf	O
diarrhea	O
,	O
winter	O
dysentery	O
of	O
adult	O
cattle	B-SPEC
,	O
and	O
respiratory	O
disease	O
in	O
calves	O
and	O
feedlot	O
cattle	B-SPEC
.	O

The	O
primer	O
combinations	O
were	O
:	O
oligonucleotide	O
pair	O
2Bp	O
/	O
4Bm	O
,	O
which	O
is	O
in	O
a	O
region	O
of	O
gene	O
1	O
that	O
is	O
moderately	O
conserved	O
among	O
all	O
species	B-SPEC
of	O
coronavirus	B-SPEC
(	O
1	O
);	O
and	O
UTR11	O
-/	O
UTR41	O
+,	O
which	O
are	O
in	O
a	O
highly	O
conserved	O
part	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
avian	B-SPEC
coronaviruses	O
related	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
2	O
).	O

This	O
strategy	O
allows	O
the	O
sequencing	O
of	O
some	O
50	O
-	O
100	O
nucleotides	O
from	O
the	O
3	O
'-	O
end	O
of	O
the	O
virus	B-SPEC
genome	O
,	O
representing	O
sufficient	O
sequence	O
information	O
for	O
initiation	O
of	O
further	O
genomic	O
characterization	O
in	O
a	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
(	O
5	O
'-	O
RACE	O
)	O
and	O
primer	O
walking	O
strategy	O
.	O

TITLE	O
:	O
Pseudotyped	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
for	O
analysis	O
of	O
virus	B-SPEC
entry	O
mediated	O
by	O
SARS	O
coronavirus	B-SPEC
spike	O
proteins	O
.	O

TITLE	O
:	O
Identification	O
of	O
sugar	O
residues	O
involved	O
in	O
the	O
binding	O
of	O
TGEV	B-SPEC
to	O
porcine	B-SPEC
brush	O
border	O
membranes	O
.	O

ABSTRACT	O
:	O
We	O
have	O
developed	O
a	O
DNA	O
assembly	O
platform	O
that	O
utilizes	O
the	O
nonspecific	O
,	O
highly	O
variable	O
sequence	O
signatures	O
of	O
type	O
IIs	O
restriction	O
enzymes	O
to	O
assemble	O
a	O
full	O
-	O
length	O
molecular	O
clone	O
of	O
murine	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
A59	O
.	O

The	O
procedure	O
is	O
illustrated	O
by	O
the	O
cloning	O
of	O
the	O
genome	O
of	O
SARS	O
coronavirus	B-SPEC
,	O
Urbani	O
strain	O
.	O

Using	O
classical	O
RT	O
-	O
PCR	O
assays	O
that	O
target	O
a	O
highly	O
conserved	O
sequence	O
among	O
coronaviruses	O
,	O
we	O
identified	O
the	O
first	O
coronaviruses	O
in	O
bats	B-SPEC
.	O

Here	O
we	O
describe	O
procedures	O
for	O
the	O
generation	O
of	O
recombinant	O
and	O
mutant	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
and	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
.	O

TITLE	O
:	O
Establishment	O
and	O
characterization	O
of	O
monoclonal	O
antibodies	O
against	O
SARS	O
coronavirus	B-SPEC
.	O

IBV	B-SPEC
E	O
,	O
a	O
viral	O
envelope	O
protein	O
,	O
plays	O
a	O
role	O
in	O
virus	B-SPEC
budding	O
,	O
possibly	O
by	O
altering	O
membrane	O
morphology	O
at	O
the	O
virus	B-SPEC
assembly	O
site	O
.	O

Conversely	O
,	O
the	O
IBV	B-SPEC
3a	O
and	O
IBV	B-SPEC
3b	O
proteins	O
are	O
nonstructural	O
proteins	O
.	O

Antibodies	O
were	O
raised	O
in	O
rabbits	B-SPEC
following	O
inoculation	O
with	O
IBV	B-SPEC
-	O
specific	O
peptides	O
and	O
GST	O
fusion	O
proteins	O
,	O
and	O
were	O
screened	O
by	O
immunofluorescence	O
,	O
radioimmunoprecipitation	O
,	O
and	O
immunoblotting	O
.	O

The	O
developing	O
embryo	O
and	O
its	O
membranes	O
provide	O
the	O
diversity	O
of	O
cell	O
types	O
that	O
are	O
needed	O
for	O
successful	O
replication	O
of	O
a	O
wide	O
variety	O
of	O
different	O
viruses	B-SPEC
.	O

All	O
human	B-SPEC
coronaviruses	O
characterized	O
at	O
present	O
are	O
associated	O
with	O
respiratory	O
illnesses	O
,	O
ranging	O
from	O
mild	O
common	O
colds	O
to	O
more	O
severe	O
lower	O
respiratory	O
tract	O
infections	O
.	O

ABSTRACT	O
:	O
The	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
replicates	O
primarily	O
within	O
glial	O
cells	O
following	O
intracranial	O
inoculation	O
of	O
susceptible	O
mice	B-SPEC
,	O
with	O
relative	O
sparing	O
of	O
neurons	O
.	O

A	O
60	O
-	O
y	O
-	O
old	O
obese	O
man	B-SPEC
,	O
with	O
a	O
diagnosis	O
of	O
esophageal	O
carcinoma	O
with	O
local	O
metastases	O
,	O
underwent	O
feeding	O
jejunostomy	O
tube	O
insertion	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
and	O
identification	O
of	O
12	O
respiratory	O
viruses	B-SPEC
using	O
a	O
dual	O
priming	O
oligonucleotide	O
system	O
-	O
based	O
multiplex	O
PCR	O
assay	O
.	O

ABSTRACT	O
:	O
Acute	O
viral	O
respiratory	O
infections	O
are	O
among	O
the	O
most	O
common	O
causes	O
of	O
human	B-SPEC
disease	O
.	O

Further	O
,	O
assuming	O
that	O
the	O
general	O
principles	O
underlying	O
MIRR	O
-	O
mediated	O
transmembrane	O
signaling	O
mechanisms	O
are	O
similar	O
,	O
the	O
SCHOOL	O
model	O
can	O
be	O
applied	O
to	O
any	O
particular	O
receptor	O
of	O
the	O
MIRR	O
family	B-SPEC
.	O

TITLE	O
:	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
induces	O
acute	O
interferon	O
-	O
gamma	O
production	O
through	O
polyclonal	O
stimulation	O
of	O
chicken	B-SPEC
leukocytes	O
.	O

We	O
found	O
that	O
in	O
vitro	O
stimulation	O
with	O
IBV	B-SPEC
resulted	O
in	O
ChIFN	O
-	O
gamma	O
production	O
in	O
splenocytes	O
of	O
both	O
infected	O
birds	B-SPEC
and	O
uninfected	O
birds	B-SPEC
.	O

Recently	O
,	O
our	O
laboratory	O
and	O
others	O
developed	O
a	O
recombinant	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
rMA15	O
)	O
that	O
was	O
lethal	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Despite	O
increased	O
viral	O
loads	O
,	O
the	O
expression	O
of	O
multiple	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
within	O
lung	O
tissue	O
and	O
recruitment	O
of	O
inflammatory	O
monocytes	O
/	O
macrophages	O
to	O
the	O
lung	O
was	O
severely	O
impaired	O
in	O
MyD88	O
(-/-)	O
mice	B-SPEC
compared	O
to	O
wild	O
-	O
type	O
mice	B-SPEC
.	O

The	O
relatively	O
short	O
travel	O
times	O
offered	O
by	O
modern	O
aviation	O
can	O
result	O
in	O
the	O
rapid	O
spread	O
of	O
blood	O
-	O
borne	O
pathogens	O
before	O
measures	O
to	O
counteract	O
transmission	O
can	O
be	O
put	O
in	O
place	O
;	O
this	O
would	O
have	O
happened	O
with	O
SARS	O
if	O
the	O
basic	O
life	O
cycle	O
of	O
the	O
SARS	O
virus	B-SPEC
included	O
an	O
asymptomatic	O
viraemia	O
.	O

TITLE	O
:	O
Pathogenicity	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
from	O
Ontario	O
chickens	B-SPEC
.	O

Men	O
were	O
eligible	O
if	O
they	O
reported	O
sex	O
with	O
a	O
woman	O
within	O
the	O
past	O
year	O
,	O
no	O
history	O
of	O
genital	O
warts	O
or	O
penile	O
or	O
anal	O
cancer	B-SPEC
,	O
and	O
no	O
current	O
diagnosis	O
of	O
a	O
sexually	O
transmitted	O
infection	O
.	O

Of	O
all	O
the	O
patients	O
,	O
32	O
.	O
5	O
%	O
were	O
suspected	O
to	O
have	O
single	O
bacterial	O
infections	O
;	O
1	O
.	O
9	O
%,	O
multiple	O
bacterial	O
infections	O
;	O
15	O
.	O
2	O
%,	O
coinfections	O
of	O
bacteria	B-SPEC
and	O
viruses	B-SPEC
;	O
25	O
.	O
8	O
%,	O
single	O
viral	O
infections	O
;	O
and	O
2	O
.	O
1	O
%,	O
multiple	O
viral	O
infections	O
.	O

The	O
breakdown	O
of	O
suspected	O
causative	O
pathogens	O
was	O
as	O
follows	O
:	O
24	O
.	O
4	O
%	O
were	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
,	O
14	O
.	O
8	O
%	O
were	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
,	O
11	O
.	O
3	O
%	O
were	O
Haemophilus	B-SPEC
influenzae	I-SPEC
,	O
and	O
1	O
.	O
4	O
%	O
were	O
Chlamydophila	B-SPEC
pneumoniae	I-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
several	O
accessory	O
proteins	O
of	O
unknown	O
function	O
.	O

Here	O
,	O
we	O
reconcile	O
these	O
apparently	O
conflicting	O
results	O
by	O
showing	O
that	O
p6	O
enhances	O
SARS	O
-	O
CoV	O
replication	O
to	O
nearly	O
the	O
same	O
extent	O
as	O
when	O
expressed	O
in	O
the	O
context	O
of	O
MHV	B-SPEC
if	O
cells	O
are	O
infected	O
at	O
a	O
low	O
MOI	O
and	O
accelerates	O
disease	O
in	O
mice	B-SPEC
transgenic	O
for	O
the	O
human	B-SPEC
SARS	O
-	O
CoV	O
receptor	O
.	O

TITLE	O
:	O
Real	O
-	O
time	O
MR	O
imaging	O
of	O
adeno	O
-	O
associated	O
viral	O
vector	O
delivery	O
to	O
the	O
primate	B-SPEC
brain	O
.	O

ABSTRACT	O
:	O
We	O
are	O
developing	O
a	O
method	O
for	O
real	O
-	O
time	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
visualization	O
of	O
convection	O
-	O
enhanced	O
delivery	O
(	O
CED	O
)	O
of	O
adeno	O
-	O
associated	O
viral	O
vectors	O
(	O
AAV	O
)	O
to	O
the	O
primate	B-SPEC
brain	O
.	O

The	O
procedure	O
was	O
tolerated	O
well	O
by	O
all	O
three	O
animals	B-SPEC
in	O
the	O
study	O
.	O

All	O
of	O
the	O
recombinants	O
showed	O
chimeric	O
IBV	B-SPEC
genome	O
arrangements	O
originated	O
from	O
Taiwan	O
and	O
China	O
-	O
like	O
parental	O
strains	O
.	O

ABSTRACT	O
:	O
An	O
infectious	O
bronchitis	O
virus	B-SPEC
Arkansas	O
DPI	O
(	O
Ark	O
DPI	O
)	O
virulent	O
strain	O
was	O
sequenced	O
,	O
analyzed	O
and	O
compared	O
with	O
many	O
different	O
IBV	B-SPEC
strains	O
and	O
coronaviruses	O
.	O

Comparative	O
sequence	O
analysis	O
of	O
Ark	O
DPI	O
with	O
other	O
IBV	B-SPEC
strains	O
shows	O
striking	O
similarity	O
to	O
the	O
Conn	O
,	O
Gray	O
,	O
JMK	O
,	O
and	O
Ark	O
99	O
,	O
which	O
were	O
circulating	O
during	O
that	O
time	O
period	O
.	O

Independent	O
recombination	O
events	O
may	O
have	O
occurred	O
in	O
the	O
entire	O
genome	O
of	O
Ark	O
DPI	O
,	O
involving	O
four	O
different	O
IBV	B-SPEC
strains	O
,	O
suggesting	O
that	O
genomic	O
RNA	O
recombination	O
may	O
occur	O
in	O
any	O
part	O
of	O
the	O
genome	O
at	O
number	O
of	O
sites	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
IL	O
-	O
15	O
in	O
T	O
cell	O
survival	O
was	O
examined	O
during	O
chronic	O
CNS	O
coronavirus	B-SPEC
infection	O
.	O

The	O
effect	O
of	O
GSK	O
-	O
3	O
inhibitor	O
was	O
reproduced	O
in	O
another	O
coronavirus	B-SPEC
,	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

We	O
report	O
the	O
case	O
of	O
a	O
1	O
month	O
infant	O
who	O
was	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
for	O
a	O
severe	O
pertussis	O
.	O

Weaning	O
from	O
mechanical	O
ventilation	O
was	O
possible	O
on	O
D15	O
and	O
the	O
total	O
length	O
of	O
stay	O
in	O
PICU	B-SPEC
was	O
20days	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
and	O
correlation	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
type	O
I	O
and	O
II	O
:	O
a	O
5	O
-	O
year	O
study	O
in	O
Taiwan	O
.	O

Among	O
them	O
,	O
197	O
(	O
88	O
.	O
7	O
%)	O
cats	B-SPEC
were	O
type	O
I	O
-	O
positive	O
,	O
13	O
(	O
5	O
.	O
9	O
%)	O
were	O
type	O
II	O
-	O
positive	O
,	O
and	O
12	O
(	O
5	O
.	O
4	O
%)	O
were	O
positive	O
for	O
both	O
types	O
.	O

Accordingly	O
,	O
a	O
preliminary	O
report	O
of	O
our	O
experience	O
of	O
suspected	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infections	O
in	O
children	O
was	O
published	O
without	O
microbiological	O
findings	O
.	O

A	O
proven	O
case	O
was	O
defined	O
as	O
one	O
that	O
fulfilled	O
the	O
clinical	O
criteria	O
for	O
suspect	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
and	O
demonstrated	O
a	O
serologic	O
response	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

In	O
3	O
of	O
these	O
8	O
children	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
was	O
also	O
detected	O
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
in	O
the	O
stool	O
.	O

All	O
8	O
had	O
documented	O
exposure	O
to	O
>	O
or	O
=	O
1	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
infected	O
adults	O
residing	O
in	O
the	O
same	O
household	O
.	O

IRF3	O
translocation	O
was	O
independent	O
of	O
p38	O
kinase	O
activity	O
,	O
indicating	O
that	O
IRF3	O
and	O
p38	O
kinase	O
are	O
distinct	O
pathways	O
leading	O
to	O
cytokine	O
production	O
by	O
H5N1	O
virus	B-SPEC
.	O

Plasmacytoid	O
dendritic	O
cell	O
-	O
derived	O
type	O
I	O
IFNs	O
are	O
of	O
prime	O
importance	O
for	O
the	O
initial	O
control	O
of	O
highly	O
cytopathic	O
viruses	B-SPEC
such	O
as	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

This	O
study	O
identifies	O
type	O
I	O
IFN	O
-	O
mediated	O
cross	O
-	O
talk	O
between	O
plasmacytoid	O
dendritic	O
cells	O
on	O
one	O
side	O
and	O
macrophages	O
and	O
conventional	O
dendritic	O
cells	O
on	O
the	O
other	O
,	O
as	O
an	O
essential	O
cellular	O
pathway	O
for	O
the	O
control	O
of	O
fatal	O
cytopathic	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
C57BL	O
/	O
6	O
mice	B-SPEC
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
strain	O
JHM	O
(	O
JHMV	O
)	O
develop	O
a	O
rapidly	O
fatal	O
acute	O
encephalitis	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp9	O
dimerization	O
is	O
essential	O
for	O
efficient	O
viral	O
growth	O
.	O

ABSTRACT	O
:	O
To	O
estimate	O
the	O
coincidence	O
of	O
new	O
otitis	O
media	O
(	O
OM	O
)	O
for	O
first	O
nasopharyngeal	O
detections	O
of	O
the	O
more	O
common	O
viruses	B-SPEC
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O

New	O
OM	O
episodes	O
are	O
usually	O
coincident	O
with	O
a	O
viral	O
upper	O
respiratory	O
tract	O
infection	O
(	O
vURTI	O
),	O
but	O
there	O
are	O
conflicting	O
data	O
regarding	O
the	O
association	O
between	O
specific	O
viruses	B-SPEC
and	O
OM	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
major	O
pathogen	O
in	O
commercial	O
poultry	O
flocks	O
.	O

We	O
recently	O
demonstrated	O
that	O
sialic	O
acid	O
serves	O
as	O
a	O
receptor	O
determinant	O
for	O
IBV	B-SPEC
on	O
the	O
tracheal	O
epithelium	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
canine	O
respiratory	O
coronavirus	B-SPEC
strain	O
detected	O
in	O
Italy	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
are	O
positive	O
-	O
stranded	O
,	O
non	O
-	O
segmented	O
RNA	O
viruses	B-SPEC
generally	O
responsible	O
for	O
the	O
emergence	O
of	O
respiratory	O
and	O
enteric	O
disease	O
in	O
humans	B-SPEC
,	O
companion	O
animals	B-SPEC
and	O
livestock	O
.	O

All	O
strains	O
contained	O
an	O
open	O
reading	O
frame	O
for	O
the	O
nonstructural	O
protein	O
7b	O
,	O
which	O
is	O
not	O
present	O
in	O
TGEV	B-SPEC
,	O
indicating	O
that	O
the	O
strains	O
were	O
related	O
to	O
the	O
previously	O
described	O
CCoV	O
strain	O
UCD	O
-	O
1	O
.	O

These	O
4	O
/	O
91	O
isolates	O
were	O
neutralized	O
with	O
serum	O
from	O
birds	B-SPEC
immunized	O
with	O
4	O
/	O
91	O
vaccine	O
.	O

While	O
delivery	O
of	O
an	O
NDV	B-SPEC
-	O
vectored	O
vaccine	O
by	O
the	O
combined	O
intranasal	O
/	O
intratracheal	O
route	O
elicited	O
protective	O
immune	O
responses	O
,	O
delivery	O
by	O
the	O
subcutaneous	O
route	O
or	O
the	O
intranasal	O
route	O
alone	O
elicited	O
limited	O
or	O
no	O
protective	O
immune	O
responses	O
,	O
suggesting	O
the	O
necessity	O
for	O
vaccine	O
delivery	O
to	O
the	O
lower	O
respiratory	O
tract	O
.	O

Interestingly	O
,	O
none	O
of	O
the	O
mutant	O
viruses	B-SPEC
were	O
attenuated	O
for	O
replication	O
in	O
mouse	B-SPEC
brain	O
following	O
intracranial	O
inoculation	O
.	O

CONCLUSIONS	O
:	O
In	O
case	O
of	O
new	O
outbreaks	O
of	O
SARS	O
/	O
avian	B-SPEC
flu	O
in	O
China	O
,	O
local	O
authorities	O
in	O
the	O
UK	O
and	O
The	O
Netherlands	O
can	O
best	O
reach	O
Chinese	O
people	O
through	O
informal	O
networks	O
and	O
British	O
/	O
Dutch	O
TV	O
,	O
while	O
trying	O
to	O
improve	O
confidence	O
in	O
information	O
from	O
the	O
government	O
.	O

TITLE	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
is	O
more	O
closely	O
related	O
to	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
than	O
to	O
mammalian	B-SPEC
coronaviruses	O
:	O
a	O
review	O
.	O

Should	O
the	O
avian	B-SPEC
coronaviruses	O
from	O
turkeys	B-SPEC
,	O
pheasants	O
and	O
other	O
birds	B-SPEC
each	O
be	O
considered	O
as	O
distinct	O
coronavirus	B-SPEC
species	B-SPEC
?	O

Negative	O
contrast	O
electron	O
microscopy	O
of	O
caecal	O
contents	O
revealed	O
virus	B-SPEC
particles	O
,	O
which	O
in	O
size	O
and	O
morphology	O
had	O
the	O
appearance	O
of	O
a	O
coronavirus	B-SPEC
.	O

The	O
turkey	B-SPEC
/	O
UK	O
/	O
412	O
/	O
00	O
also	O
resembled	O
IBV	B-SPEC
,	O
but	O
not	O
mammalian	B-SPEC
coronaviruses	O
,	O
in	O
having	O
three	O
open	O
reading	O
frames	O
in	O
the	O
gene	O
encoding	O
E	O
protein	O
(	O
gene	O
3	O
).	O

All	O
90	O
aspirations	O
were	O
also	O
analyzed	O
for	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
),	O
parainfluenza	O
-	O
3	O
virus	B-SPEC
,	O
and	O
bovine	B-SPEC
corona	B-SPEC
virus	B-SPEC
by	O
antigen	O
ELISA	O
.	O

M	B-SPEC
.	I-SPEC
bovis	I-SPEC
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
samples	O
.	O

After	O
a	O
tracheotomy	O
had	O
been	O
performed	O
,	O
ALI	O
was	O
produced	O
in	O
the	O
control	O
and	O
APC	O
groups	O
by	O
infusion	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
endotoxin	O
100	O
microg	O
/	O
kg	O
per	O
hour	O
intravenously	O
for	O
1	O
hour	O
.	O

APC	O
-	O
treated	O
rabbits	B-SPEC
showed	O
no	O
significant	O
difference	O
in	O
platelet	O
count	O
and	O
antithrombin	O
but	O
exhibited	O
less	O
D	O
-	O
dimer	O
production	O
than	O
did	O
the	O
controls	O
.	O

ABSTRACT	O
:	O
Epidemiologic	O
studies	O
and	O
clinical	O
description	O
of	O
severe	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
in	O
adults	O
living	O
in	O
malaria	O
-	O
endemic	O
areas	O
are	O
rare	O
and	O
more	O
attention	O
is	O
needed	O
to	O
understand	O
the	O
dynamics	O
and	O
its	O
interaction	O
with	O
the	O
immune	O
system	O
.	O

TITLE	O
:	O
The	O
impact	O
of	O
social	O
amplification	O
and	O
attenuation	O
of	O
risk	O
and	O
the	O
public	O
reaction	O
to	O
mad	O
cow	B-SPEC
disease	O
in	O
Canada	O
.	O

Consumers	O
actually	O
increased	O
their	O
consumption	O
of	O
beef	O
slightly	O
after	O
the	O
news	O
of	O
an	O
increased	O
risk	O
from	O
mad	O
cow	B-SPEC
disease	O
,	O
which	O
has	O
been	O
interpreted	O
as	O
public	O
support	O
for	O
beef	O
farmers	O
and	O
confidence	O
in	O
government	O
regulators	O
.	O

The	O
widespread	O
incorporation	O
of	O
molecular	O
methods	O
into	O
clinical	O
microbiology	O
laboratories	O
has	O
not	O
only	O
led	O
to	O
notable	O
advances	O
in	O
the	O
etiological	O
diagnosis	O
of	O
viral	O
respiratory	O
infections	O
but	O
has	O
also	O
increased	O
insight	O
into	O
the	O
pathology	O
and	O
epidemiological	O
profiles	O
of	O
the	O
causative	O
viruses	B-SPEC
.	O

However	O
,	O
there	O
are	O
also	O
some	O
disadvantages	O
in	O
the	O
use	O
of	O
these	O
new	O
technologies	O
such	O
as	O
detection	O
of	O
viruses	B-SPEC
that	O
merely	O
colonize	O
the	O
respiratory	O
tract	O
of	O
healthy	O
people	O
,	O
or	O
those	O
found	O
in	O
the	O
nasopharyngeal	O
secretions	O
of	O
patients	O
who	O
have	O
recovered	O
from	O
respiratory	O
infections	O
,	O
due	O
to	O
longterm	O
viral	O
shedding	O
,	O
when	O
the	O
viruses	B-SPEC
are	O
unlikely	O
to	O
act	O
as	O
pathogens	O
.	O

Additionally	O
,	O
sequencing	O
of	O
the	O
amplification	O
products	O
allows	O
further	O
characterization	O
of	O
detected	O
viruses	B-SPEC
,	O
including	O
molecular	O
epidemiology	O
,	O
genotyping	O
,	O
or	O
detection	O
of	O
antiviral	O
resistance	O
,	O
to	O
cite	O
only	O
a	O
few	O
examples	O
.	O

Proventriculitis	O
was	O
also	O
associated	O
with	O
some	O
new	O
IBV	B-SPEC
strains	O
.	O

ABSTRACT	O
:	O
The	O
large	O
number	O
of	O
deaths	O
in	O
a	O
short	O
period	O
of	O
time	O
due	O
to	O
the	O
spread	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infection	O
led	O
to	O
the	O
unparalleled	O
collaborative	O
efforts	O
world	O
wide	O
to	O
determine	O
and	O
characterize	O
the	O
new	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Novel	O
respiratory	O
viruses	B-SPEC
were	O
discovered	O
in	O
the	O
last	O
years	O
predominantly	O
in	O
children	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
2003	O
and	O
the	O
subsequent	O
emergence	O
of	O
the	O
H5N1	O
virus	B-SPEC
have	O
highlighted	O
the	O
threat	O
of	O
a	O
global	O
pandemic	O
influenza	O
outbreak	O
.	O

BLI	O
thus	O
elucidated	O
new	O
anatomic	O
locations	O
of	O
virus	B-SPEC
replication	O
.	O

Furthermore	O
,	O
MHV	B-SPEC
dissemination	O
was	O
shown	O
to	O
be	O
critically	O
depended	O
on	O
the	O
viral	O
spike	O
protein	O
,	O
but	O
also	O
on	O
the	O
mouse	B-SPEC
strain	O
used	O
.	O

Sensitivity	O
varied	O
from	O
4	O
.	O
0	O
%	O
to	O
89	O
.	O
6	O
%,	O
specificity	O
from	O
75	O
.	O
4	O
%	O
to	O
99	O
.	O
6	O
%,	O
positive	O
predictive	O
value	O
(	O
PPV	B-SPEC
)	O
from	O
0	O
.	O
9	O
%	O
to	O
76	O
.	O
0	O
%	O
and	O
negative	O
predictive	O
value	O
(	O
NPV	O
)	O
from	O
86	O
.	O
1	O
%	O
to	O
99	O
.	O
7	O
%.	O

Structural	O
,	O
functional	O
and	O
biochemical	O
analyses	O
[	O
corrected	O
]	O
have	O
provided	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
of	O
receptor	O
recognition	O
and	O
antibody	O
neutralization	O
,	O
and	O
suggested	O
that	O
these	O
antibodies	O
alone	O
or	O
in	O
combination	O
could	O
fight	O
the	O
viruses	B-SPEC
'	O
heterogeneity	O
and	O
mutability	O
,	O
which	O
is	O
a	O
major	O
problem	O
in	O
the	O
development	O
of	O
effective	O
therapeutic	O
agents	O
against	O
viruses	B-SPEC
,	O
including	O
therapeutic	O
antibodies	O
.	O

Comparison	O
of	O
the	O
genome	O
sequences	O
of	O
the	O
virulent	O
and	O
attenuated	O
Ark	O
DPI	O
viruses	B-SPEC
reveals	O
that	O
these	O
viruses	B-SPEC
are	O
similar	O
and	O
differ	O
only	O
by	O
21	O
nucleotides	O
,	O
resulting	O
in	O
17	O
amino	O
acids	O
changes	O
.	O

By	O
comparing	O
the	O
deduced	O
amino	O
acid	O
sequences	O
of	O
virulent	O
and	O
attenuated	O
viruses	B-SPEC
,	O
we	O
identified	O
sequence	O
changes	O
responsible	O
for	O
the	O
adaptation	O
and	O
attenuation	O
of	O
the	O
IBV	B-SPEC
-	O
Ark	O
DPI	O
strain	O
.	O

Since	O
Ddx5	O
is	O
a	O
multifunctional	O
protein	O
that	O
plays	O
important	O
roles	O
in	O
transcriptional	O
regulation	O
,	O
its	O
interaction	O
with	O
SARS	O
coronavirus	B-SPEC
helicase	O
provides	O
interesting	O
clues	O
for	O
studying	O
virus	B-SPEC
-	O
host	O
cell	O
interactions	O
in	O
SARS	O
-	O
CoV	O
infections	O
.	O

We	O
studied	O
the	O
impact	O
of	O
recently	O
discovered	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
human	B-SPEC
bocavirus	I-SPEC
(	O
HBoV	O
),	O
and	O
new	O
coronaviruses	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HKU1	O
)	O
on	O
the	O
global	O
epidemiology	O
of	O
ARTI	O
.	O

One	O
hundred	O
twenty	O
-	O
four	O
out	O
of	O
237	O
samples	O
(	O
52	O
.	O
3	O
%)	O
were	O
positive	O
for	O
one	O
or	O
more	O
viruses	B-SPEC
.	O

Viruses	B-SPEC
were	O
identified	O
in	O
more	O
than	O
50	O
%	O
of	O
the	O
studied	O
ARTI	O
,	O
providing	O
useful	O
information	O
on	O
clinical	O
features	O
and	O
epidemiology	O
of	O
specific	O
agents	O
affecting	O
children	O
in	O
cold	O
months	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
and	O
acute	O
respiratory	O
illness	O
in	O
older	O
adults	O
with	O
chronic	O
obstructive	O
pulmonary	O
disease	O
.	O

ABSTRACT	O
:	O
Two	O
Malaysian	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
,	O
MH5365	O
/	O
95	O
and	O
V9	O
/	O
04	O
were	O
characterized	O
based	O
on	O
sequence	O
and	O
phylogenetic	O
analyses	O
of	O
S1	O
,	O
S2	O
,	O
M	O
,	O
and	O
N	O
genes	O
.	O

Nucleotide	O
sequence	O
alignments	O
revealed	O
many	O
point	O
mutations	O
,	O
short	O
deletions	O
,	O
and	O
insertions	O
in	O
S1	O
region	O
of	O
both	O
IBV	B-SPEC
isolates	O
.	O

Meanwhile	O
,	O
V9	O
/	O
04	O
showed	O
only	O
67	O
-	O
77	O
%	O
identity	O
to	O
all	O
the	O
previously	O
studied	O
IBV	B-SPEC
strains	O
included	O
in	O
this	O
study	O
suggesting	O
it	O
is	O
a	O
variant	O
of	O
IBV	B-SPEC
isolate	O
that	O
is	O
unique	O
to	O
Malaysia	O
.	O

Coronaviruses	O
can	O
remain	O
infectious	O
for	O
long	O
periods	O
in	O
water	O
and	O
pasteurized	O
settled	O
sewage	O
,	O
suggesting	O
contaminated	O
water	O
is	O
a	O
potential	O
vehicle	O
for	O
human	B-SPEC
exposure	O
if	O
aerosols	O
are	O
generated	O
.	O

ABSTRACT	O
:	O
Application	O
of	O
glucocorticoids	O
in	O
sepsis	B-SPEC
or	O
severe	O
infection	O
is	O
disputable	O
in	O
clinic	O
.	O

ABSTRACT	O
:	O
Interest	O
in	O
the	O
potential	O
of	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
to	O
serve	O
as	O
therapeutic	O
agents	O
has	O
surged	O
in	O
the	O
past	O
decade	O
with	O
a	O
major	O
emphasis	O
on	O
human	B-SPEC
viral	O
diseases	O
.	O

Rats	B-SPEC
were	O
intravenously	O
injected	O
with	O
oleic	O
acid	O
(	O
OA	O
)	O
to	O
induce	O
ALI	O
and	O
30	O
minutes	O
later	O
they	O
were	O
divided	O
into	O
five	O
groups	O
:	O
model	O
(	O
injury	O
only	O
),	O
PPS	O
aerosol	O
(	O
PPS	O
-	O
aer	O
),	O
saline	O
aerosol	O
(	O
saline	O
-	O
aer	O
),	O
PPS	O
instillation	O
(	O
PPS	O
-	O
inst	O
),	O
and	O
saline	O
instillation	O
(	O
Saline	O
-	O
Inst	O
).	O

The	O
PPS	O
aerosol	O
particles	O
were	O
less	O
than	O
2	O
.	O
0	O
mum	B-SPEC
in	O
size	O
as	O
determined	O
by	O
a	O
laser	B-SPEC
aerosol	O
particle	O
counter	O
.	O

TITLE	O
:	O
The	O
autoimmune	O
response	O
induced	O
by	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
is	O
expanded	O
by	O
a	O
hepatotoxic	O
agent	O
.	O

Carbon	O
tetrachloride	O
(	O
CCl	O
(	O
4	O
))	O
was	O
injected	O
into	O
mice	B-SPEC
30	O
days	O
after	O
MHV	B-SPEC
infection	O
,	O
and	O
serum	O
was	O
assayed	O
for	O
autoAb	O
and	O
total	O
IgG	O
20	O
days	O
later	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
studies	O
of	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
immune	O
responses	O
to	O
recombinant	O
replication	O
-	O
defective	O
adenovirus	B-SPEC
expressing	O
SARS	O
coronavirus	B-SPEC
N	O
protein	O
.	O

This	O
observation	O
may	O
have	O
major	O
practical	O
value	O
for	O
field	O
studies	O
,	O
such	O
as	O
the	O
immunisation	O
of	O
civet	B-SPEC
cats	I-SPEC
,	O
as	O
the	O
cost	O
of	O
recombinant	O
proteins	O
produced	O
by	O
E	O
coli	O
is	O
much	O
lower	O
than	O
those	O
produced	O
by	O
eukaryotic	O
systems	O
.	O
3	O
.	O

ABSTRACT	O
:	O
The	O
surface	O
proteins	O
S	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
were	O
compared	O
for	O
their	O
ability	O
to	O
mediate	O
infection	O
of	O
viral	O
pseudotypes	O
based	O
on	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	O
).	O

Extended	O
PPV	B-SPEC
is	O
emerging	O
as	O
an	O
effective	O
therapy	O
in	O
the	O
rescue	O
of	O
patients	O
from	O
severe	O
ARDS	O
.	O

Key	O
facts	O
to	O
ameliorate	O
in	O
order	B-SPEC
to	O
improve	O
prognosis	O
and	O
length	O
of	O
hospital	O
admission	O
could	O
be	O
a	O
swifter	O
diagnosis	O
and	O
consensus	O
on	O
the	O
AB	O
treatment	O
.	O

Baylisascariasis	O
,	O
a	O
raccoon	B-SPEC
zoonosis	O
,	O
caused	O
by	O
the	O
raccoon	B-SPEC
roundworm	B-SPEC
,	O
Baylisascaris	B-SPEC
procyonis	I-SPEC
,	O
has	O
extended	O
its	O
US	O
distribution	O
range	O
from	O
suburban	O
neighborhoods	O
in	O
the	O
northern	O
US	O
to	O
the	O
Southeast	O
and	O
West	O
Coast	O
since	O
the	O
1980s	O
.	O

This	O
review	O
analyzes	O
scientific	O
articles	O
selected	O
by	O
MEDLINE	O
search	O
,	O
1966	O
-	O
2008	O
,	O
in	O
order	B-SPEC
to	O
assess	O
the	O
evolving	O
epidemiology	O
of	O
EoM	O
in	O
the	O
US	O
,	O
and	O
specifically	O
in	O
Louisiana	O
;	O
and	O
to	O
alert	O
Louisiana	O
clinicians	O
to	O
populations	O
at	O
increased	O
risk	O
of	O
helminthic	O
EoM	O
as	O
a	O
result	O
of	O
age	O
,	O
ethnicity	O
,	O
lifestyle	O
,	O
food	O
choices	O
,	O
location	O
of	O
permanent	O
residence	O
,	O
or	O
recent	O
travel	O
in	O
the	O
Americas	O
or	O
Caribbean	O
.	O

ABSTRACT	O
:	O
The	O
sepsis	B-SPEC
syndrome	O
is	O
defined	O
as	O
a	O
clinically	O
suspected	O
infection	O
accompanied	O
by	O
systemic	O
manifestations	O
.	O

ADEM	O
following	O
mixed	O
infection	O
with	O
measles	O
and	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
is	O
rare	O
,	O
and	O
it	O
is	O
not	O
clear	O
whether	O
an	O
additional	O
infection	O
with	O
measles	O
influenced	O
the	O
onset	O
of	O
ADEM	O
after	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
.	O

TITLE	O
:	O
Differential	O
virological	O
and	O
immunological	O
outcome	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
susceptible	O
and	O
resistant	O
transgenic	B-SPEC
mice	I-SPEC
expressing	O
human	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

We	O
also	O
found	O
that	O
CD8	O
(+)	O
T	O
cells	O
were	O
partially	O
effective	O
in	O
attenuating	O
the	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
infection	O
in	O
lethality	O
-	O
resistant	O
AC22	O
mice	B-SPEC
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
bacterially	O
expressed	O
nsp11	O
proteins	O
of	O
two	O
arteriviruses	B-SPEC
,	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
and	O
porcine	B-SPEC
respiratory	I-SPEC
and	I-SPEC
reproductive	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
,	O
possess	O
pyrimidine	O
-	O
specific	O
endoribonuclease	O
activity	O
.	O

TITLE	O
:	O
[	O
Successful	O
treatment	O
of	O
life	O
-	O
threatening	O
Panton	O
-	O
Valentine	O
leucocidin	O
positive	O
Staphylococcus	B-SPEC
aureus	I-SPEC
pneumonia	O
with	O
antibiotics	O
and	O
immunoglobulins	O
targeting	O
the	O
toxin	O
production	O
].	O

TITLE	O
:	O
Recombinant	O
Ov	O
-	O
ASP	O
-	O
1	O
,	O
a	O
Th1	O
-	O
biased	O
protein	O
adjuvant	O
derived	O
from	O
the	O
helminth	O
Onchocerca	B-SPEC
volvulus	I-SPEC
,	O
can	O
directly	O
bind	O
and	O
activate	O
antigen	O
-	O
presenting	O
cells	O
.	O

It	O
appears	O
that	O
rOv	O
-	O
ASP	O
-	O
1	O
primarily	O
bound	O
to	O
the	O
APCs	O
among	O
human	B-SPEC
PBMCs	O
and	O
triggered	O
Th1	O
-	O
biased	O
proinflammatory	O
cytokine	O
production	O
probably	O
via	O
the	O
activation	O
of	O
monocyte	O
-	O
derived	O
dendritic	O
cells	O
and	O
the	O
TLR	O
,	O
TLR2	O
,	O
and	O
TLR4	O
,	O
thus	O
suggesting	O
that	O
rOv	O
-	O
ASP	O
-	O
1	O
is	O
a	O
novel	O
potent	O
innate	O
adjuvant	O
.	O

Currently	O
,	O
the	O
lengthy	O
process	O
of	O
sequence	O
analysis	O
of	O
the	O
IBV	B-SPEC
S1	O
gene	O
is	O
considered	O
the	O
gold	O
standard	O
for	O
IBV	B-SPEC
strain	O
identification	O
,	O
with	O
a	O
high	O
nucleotide	O
identity	O
(	O
e	O
.	O
g	O
.	O
>	O
or	O
=	O
95	O
%)	O
indicating	O
related	O
strains	O
.	O

When	O
ectopically	O
expressed	O
in	O
mammalian	B-SPEC
cells	O
,	O
8ab	O
induced	O
the	O
proteolysis	O
of	O
ATF6	O
and	O
the	O
translocation	O
of	O
its	O
cleaved	O
DNA	O
-	O
binding	O
and	O
transcription	O
-	O
activation	O
domains	O
from	O
the	O
ER	O
to	O
the	O
nucleus	O
.	O

The	O
RT	O
-	O
PCR	O
tests	O
were	O
negative	O
to	O
influenza	B-SPEC
virus	I-SPEC
A	O
/	O
B	O
,	O
adenovirus	B-SPEC
,	O
RSV	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
Nipah	B-SPEC
virus	I-SPEC
and	O
Legionella	B-SPEC
.	O

Interestingly	O
,	O
the	O
M	O
(	O
pro	O
)-	O
C	O
dimer	O
structure	O
is	O
characterized	O
by	O
3D	O
domain	O
-	O
swapping	O
,	O
in	O
which	O
the	O
first	O
helices	B-SPEC
of	O
the	O
two	O
protomers	O
are	O
interchanged	O
and	O
each	O
is	O
enwrapped	O
by	O
four	O
other	O
helices	B-SPEC
from	O
the	O
other	O
protomer	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
spike	O
protein	O
(	O
S	O
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
early	O
steps	O
of	O
viral	O
infection	O
,	O
with	O
the	O
S1	O
domain	O
responsible	O
for	O
receptor	O
binding	O
and	O
the	O
S2	O
domain	O
mediating	O
membrane	O
fusion	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
strains	O
from	O
outbreaks	O
in	O
Argentina	B-SPEC
(	O
2001	O
-	O
2008	O
).	O

TITLE	O
:	O
Structural	O
insights	O
into	O
immune	O
recognition	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
S	O
protein	O
receptor	O
binding	O
domain	O
.	O

Reported	O
here	O
is	O
the	O
X	O
-	O
ray	B-SPEC
crystal	O
structure	O
of	O
the	O
RBD	O
in	O
complex	O
with	O
the	O
Fab	O
of	O
a	O
neutralizing	O
mouse	B-SPEC
monoclonal	O
antibody	O
,	O
F26G19	O
,	O
elicited	O
by	O
immunization	O
with	O
chemically	O
inactivated	O
SARS	O
-	O
CoV	O
.	O
The	O
RBD	O
-	O
F26G19	O
Fab	O
complex	O
represents	O
the	O
first	O
example	O
of	O
the	O
structural	O
characterization	O
of	O
an	O
antibody	O
elicited	O
by	O
an	O
immune	O
response	O
to	O
SARS	O
-	O
CoV	O
or	O
any	O
fragment	O
of	O
it	O
.	O

TITLE	O
:	O
Binding	O
of	O
SARS	O
coronavirus	B-SPEC
to	O
its	O
receptor	O
damages	O
islets	O
and	O
causes	O
acute	O
diabetes	O
.	O

The	O
localization	O
of	O
ACE2	O
expression	O
in	O
the	O
endocrine	O
part	O
of	O
the	O
pancreas	O
suggests	O
that	O
SARS	O
coronavirus	B-SPEC
enters	O
islets	O
using	O
ACE2	O
as	O
its	O
receptor	O
and	O
damages	O
islets	O
causing	O
acute	O
diabetes	O
.	O

In	O
addition	O
,	O
51	O
commercial	O
chicken	B-SPEC
flocks	O
(	O
25	O
broilers	O
,	O
15	O
layers	O
,	O
and	O
11	O
broiler	O
breeders	O
)	O
suffering	O
from	O
respiratory	O
disease	O
were	O
tested	O
for	O
the	O
presence	O
of	O
IBV	B-SPEC
,	O
using	O
the	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

Transcription	O
of	O
the	O
proinflammatory	O
cytokines	O
IL	O
-	O
1beta	O
and	O
IL	O
-	O
6	O
,	O
but	O
not	O
tumor	O
necrosis	O
factor	O
,	O
were	O
initially	O
reduced	O
in	O
infected	O
p35	O
(-/-)	O
mice	B-SPEC
but	O
increased	O
to	O
wild	O
-	O
type	O
levels	O
during	O
peak	O
inflammation	O
.	O

Type	O
II	O
was	O
only	O
detected	O
in	O
3	O
.	O
5	O
%	O
in	O
animals	B-SPEC
with	O
Feline	B-SPEC
Infectious	O
Peritonitis	O
.	O

ABSTRACT	O
:	O
Ethyl	O
pyruvate	O
(	O
EtP	O
)	O
may	O
prolong	O
survival	O
and	O
ameliorate	O
organ	O
dysfunction	O
in	O
a	O
variety	O
of	O
models	O
of	O
critical	O
illness	O
,	O
e	O
.	O
g	O
.	O
severe	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
syndrome	O
,	O
by	O
modulation	O
of	O
the	O
expression	O
of	O
inflammatory	O
mediators	O
.	O

This	O
review	O
examines	O
dsRNA	O
including	O
Poly	O
ICLC	O
and	O
liposome	O
-	O
encapsulated	O
Poly	O
ICLC	O
(	O
LE	O
Poly	O
ICLC	O
)	O
as	O
TLR	O
-	O
3	O
agonists	O
for	O
their	O
antiviral	O
activity	O
against	O
seasonal	O
and	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	O
(	O
HPAI	O
)	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Nonstructural	O
protein	O
1	O
(	O
nsp1	O
),	O
a	O
28	O
-	O
kDa	O
protein	O
in	O
the	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
and	O
closely	O
related	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
,	O
is	O
the	O
first	O
protein	O
cleaved	O
from	O
the	O
open	O
reading	O
frame	O
1	O
(	O
ORF	O
1	O
)	O
polyprotein	O
product	O
of	O
genome	O
translation	O
.	O

Recently	O
,	O
a	O
30	O
-	O
nucleotide	O
(	O
nt	O
)	O
cis	B-SPEC
-	O
replication	O
stem	O
-	O
loop	O
VI	O
(	O
SLVI	O
)	O
has	O
been	O
mapped	O
at	O
nt	O
101	O
to	O
130	O
within	O
a	O
288	O
-	O
nt	O
5	O
'-	O
terminal	O
segment	O
of	O
the	O
738	O
-	O
nt	O
nsp1	O
cistron	O
in	O
a	O
BCoV	O
defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
.	O

Notably	O
,	O
nsp1	O
specifically	O
binds	O
SLIII	O
and	O
its	O
flanking	O
sequences	O
in	O
the	O
5	O
'	O
UTR	O
with	O
approximately	O
2	O
.	O
5	O
muM	B-SPEC
affinity	O
.	O

We	O
detected	O
RNA	O
of	O
a	O
group	O
1	O
coronavirus	B-SPEC
from	O
M	B-SPEC
.	I-SPEC
lucifugus	I-SPEC
(	O
3	O
of	O
31	O
animals	B-SPEC
)	O
and	O
DNA	O
from	O
an	O
as	O
-	O
yet	O
undescribed	O
polyomavirus	B-SPEC
from	O
female	O
M	B-SPEC
.	I-SPEC
lucifugus	I-SPEC
(	O
4	O
of	O
31	O
animals	B-SPEC
)	O
and	O
M	B-SPEC
.	I-SPEC
californicus	I-SPEC
(	O
pooled	O
tissues	O
from	O
two	O
females	O
).	O

Seven	O
of	O
the	O
selected	O
intrabodies	O
tested	O
do	O
not	O
perturb	O
cellular	O
function	O
when	O
expressed	O
singly	O
in	O
vivo	O
and	O
inhibit	O
virus	B-SPEC
replication	O
from	O
11	O
-	O
to	O
5900	O
-	O
fold	O
when	O
expressed	O
in	O
cells	O
prior	O
to	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
outcome	O
of	O
a	O
viral	O
infection	O
is	O
regulated	O
in	O
part	O
by	O
the	O
complex	O
coordination	O
of	O
viral	O
and	O
host	O
interactions	O
that	O
compete	O
for	O
the	O
control	O
and	O
optimization	O
of	O
virus	B-SPEC
replication	O
.	O

Several	O
diagnostic	O
assays	O
have	O
been	O
employed	O
to	O
detect	O
the	O
presence	O
of	O
the	O
virus	B-SPEC
in	O
stool	O
samples	O
from	O
calves	O
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
viruses	B-SPEC
with	O
a	O
multiplex	O
polymerase	O
chain	O
reaction	O
assay	O
(	O
MultiCode	O
-	O
PLx	O
Respiratory	O
Virus	B-SPEC
Panel	O
)	O
in	O
patients	O
with	O
hematologic	O
malignancies	O
.	O

Sensitive	O
molecular	O
assays	O
have	O
increased	O
the	O
detection	O
of	O
common	O
respiratory	O
viruses	B-SPEC
and	O
expanded	O
the	O
panel	O
of	O
detectable	O
viruses	B-SPEC
.	O

Improved	O
diagnostics	O
for	O
respiratory	O
viruses	B-SPEC
may	O
lead	O
to	O
more	O
effective	O
management	O
and	O
better	O
outcomes	O
in	O
this	O
patient	O
population	O
.	O

M	O
protein	O
potently	O
antagonizes	O
the	O
activation	O
of	O
interferon	O
-	O
stimulated	O
response	O
element	O
-	O
dependent	O
transcription	O
by	O
double	O
-	O
stranded	O
RNA	O
,	O
RIG	O
-	O
I	O
,	O
MDA5	O
,	O
TBK1	O
,	O
IKKepsilon	O
,	O
and	O
virus	B-SPEC
-	O
induced	O
signaling	O
adaptor	O
(	O
VISA	O
)	O
but	O
has	O
no	O
influence	O
on	O
the	O
transcriptional	O
activity	O
of	O
this	O
element	O
when	O
IRF3	O
or	O
IRF7	O
is	O
overexpressed	O
.	O

Moreover	O
,	O
despite	O
control	O
of	O
infectious	O
virus	B-SPEC
,	O
CD8	O
T	O
cells	O
within	O
the	O
CNS	O
of	O
persistently	O
infected	O
mice	B-SPEC
maintained	O
high	O
PD	O
-	O
1	O
expression	O
.	O

Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
replicase	O
products	O
nsp3	O
,	O
nsp4	O
,	O
and	O
nsp6	O
are	O
predicted	O
to	O
act	O
as	O
membrane	O
anchors	O
during	O
assembly	O
of	O
the	O
viral	O
replication	O
complexes	O
.	O

We	O
report	O
the	O
first	O
antibody	O
-	O
mediated	O
Western	O
blot	O
detection	O
of	O
nsp6	O
from	O
MHV	B-SPEC
-	O
infected	O
cells	O
.	O

Unfortunately	O
,	O
very	O
few	O
references	O
provide	O
detailed	O
descriptions	O
of	O
large	O
cohorts	O
of	O
affected	O
cats	B-SPEC
.	O

We	O
fitted	O
a	O
log	O
-	O
normal	O
distribution	O
to	O
pooled	O
data	O
and	O
found	O
the	O
median	O
incubation	O
period	O
to	O
be	O
5	O
.	O
6	O
days	O
(	O
95	O
%	O
CI	O
4	O
.	O
8	O
-	O
6	O
.	O
3	O
)	O
for	O
adenovirus	B-SPEC
,	O
3	O
.	O
2	O
days	O
(	O
95	O
%	O
CI	O
2	O
.	O
8	O
-	O
3	O
.	O
7	O
)	O
for	O
human	B-SPEC
coronavirus	I-SPEC
,	O
4	O
.	O
0	O
days	O
(	O
95	O
%	O
CI	O
3	O
.	O
6	O
-	O
4	O
.	O
4	O
)	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
1	O
.	O
4	O
days	O
(	O
95	O
%	O
CI	O
1	O
.	O
3	O
-	O
1	O
.	O
5	O
)	O
for	O
influenza	O
A	O
,	O
0	O
.	O
6	O
days	O
(	O
95	O
%	O
CI	O
0	O
.	O
5	O
-	O
0	O
.	O
6	O
)	O
for	O
influenza	O
B	O
,	O
12	O
.	O
5	O
days	O
(	O
95	O
%	O
CI	O
11	O
.	O
8	O
-	O
13	O
.	O
3	O
)	O
for	O
measles	O
,	O
2	O
.	O
6	O
days	O
(	O
95	O
%	O
CI	O
2	O
.	O
1	O
-	O
3	O
.	O
1	O
)	O
for	O
parainfluenza	O
,	O
4	O
.	O
4	O
days	O
(	O
95	O
%	O
CI	O
3	O
.	O
9	O
-	O
4	O
.	O
9	O
)	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
1	O
.	O
9	O
days	O
(	O
95	O
%	O
CI	O
1	O
.	O
4	O
-	O
2	O
.	O
4	O
)	O
for	O
rhinovirus	B-SPEC
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
accessory	O
protein	O
9b	O
is	O
a	O
virion	O
-	O
associated	O
protein	O
.	O

Various	O
pre	O
-	O
and	O
postnatal	O
factors	O
,	O
such	O
as	O
exposure	O
to	O
chorioamnionitis	O
,	O
pneumonia	O
,	O
sepsis	B-SPEC
and	O
asphyxia	O
,	O
induce	O
an	O
injurious	O
inflammatory	O
response	O
in	O
the	O
lungs	O
of	O
preterm	O
infants	O
,	O
which	O
may	O
subsequently	O
affect	O
surfactant	O
function	O
,	O
synthesis	O
and	O
alveolar	O
stability	O
.	O

TITLE	O
:	O
Plant	B-SPEC
production	O
of	O
veterinary	O
vaccines	O
and	O
therapeutics	O
.	O

Unfortunately	O
,	O
no	O
single	O
animal	B-SPEC
model	O
of	O
ARDS	O
replicates	O
the	O
complex	O
pathophysiological	O
changes	O
seen	O
in	O
patients	O
.	O

The	O
gene	O
that	O
encodes	O
HCoV	O
-	O
HKU1	O
nsp9	O
was	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
the	O
protein	O
was	O
subjected	O
to	O
crystallization	O
trials	O
.	O

TITLE	O
:	O
Towards	O
construction	O
of	O
viral	O
vectors	O
based	O
on	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
for	O
gene	O
delivery	O
and	O
vaccine	O
development	O
.	O

TITLE	O
:	O
Ectodomain	O
shedding	O
of	O
angiotensin	O
converting	O
enzyme	O
2	O
in	O
human	B-SPEC
airway	O
epithelia	O
.	O

The	O
regulation	O
of	O
ACE2	O
release	O
was	O
investigated	O
in	O
polarized	O
human	B-SPEC
airway	O
epithelia	O
.	O

In	O
the	O
case	O
of	O
the	O
S2	O
domain	O
of	O
protein	O
S	O
,	O
it	O
has	O
been	O
found	O
a	O
highly	O
hydrophobic	O
and	O
interfacial	O
domain	O
flanked	O
by	O
the	O
heptad	O
repeat	O
1	O
and	O
2	O
regions	O
;	O
significantly	O
,	O
different	O
peptides	O
pertaining	O
to	O
this	O
domain	O
have	O
shown	O
a	O
significant	O
leakage	O
effect	O
and	O
an	O
important	O
plaque	O
formation	O
inhibition	O
,	O
which	O
,	O
similarly	O
to	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
gp41	O
,	O
support	O
the	O
role	O
of	O
this	O
region	O
in	O
the	O
fusion	O
process	O
.	O

This	O
protein	O
was	O
purified	O
and	O
used	O
to	O
develop	O
an	O
indirect	O
ELISA	O
for	O
detection	O
of	O
antibodies	O
against	O
TCoV	O
.	O
Using	O
experimentally	O
derived	O
positive	O
and	O
negative	O
turkey	B-SPEC
serum	O
samples	O
this	O
ELISA	O
showed	O
high	O
sensitivity	O
(	O
95	O
%)	O
and	O
specificity	O
(	O
92	O
%)	O
for	O
TCoV	O
.	O
To	O
further	O
evaluate	O
the	O
potential	O
of	O
the	O
ELISA	O
,	O
360	O
serum	O
samples	O
from	O
commercial	O
turkey	B-SPEC
farms	O
in	O
Ontario	O
were	O
tested	O
for	O
TCoV	O
-	O
specific	O
antibodies	O
using	O
the	O
recombinant	O
TCoV	O
ELISA	O
.	O

ABSTRACT	O
:	O
Several	O
respiratory	O
viruses	B-SPEC
,	O
including	O
influenza	B-SPEC
virus	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
produce	O
more	O
severe	O
disease	O
in	O
the	O
elderly	O
,	O
yet	O
the	O
molecular	O
mechanisms	O
governing	O
age	O
-	O
related	O
susceptibility	O
remain	O
poorly	O
studied	O
.	O

The	O
clinical	O
course	O
of	O
ALI	O
/	O
ARDS	O
is	O
variable	O
with	O
the	O
likely	O
pathophysiologic	O
complexity	O
of	O
human	B-SPEC
ALI	O
/	O
ARDS	O
.	O

TITLE	O
:	O
Analysis	O
of	O
the	O
properties	O
of	O
neutralizing	O
monoclonal	O
antibodies	O
against	O
the	O
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
and	O
inhibition	O
of	O
HEV	B-SPEC
infection	O
by	O
specific	O
MAb	O
.	O

The	O
1	O
:	O
800	O
-	O
diluted	O
MAb120	O
inhibited	O
the	O
viral	O
infection	O
in	O
mice	B-SPEC
pups	O
,	O
though	O
the	O
1	O
:	O
1	O
,	O
000	O
-	O
diluted	O
MAb120	O
failed	O
to	O
inhibit	O
the	O
viral	O
infectivity	O
.	O

TITLE	O
:	O
Label	O
-	O
free	O
,	O
electrical	O
detection	O
of	O
the	O
SARS	O
virus	B-SPEC
N	O
-	O
protein	O
with	O
nanowire	O
biosensors	O
utilizing	O
antibody	O
mimics	O
as	O
capture	O
probes	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
does	O
not	O
modulate	O
transcription	O
of	O
the	O
human	B-SPEC
FGL2	O
gene	O
.	O

Here	O
,	O
we	O
showed	O
that	O
N	O
protein	O
expressed	O
in	O
cultured	O
human	B-SPEC
cells	O
was	O
predominantly	O
found	O
in	O
the	O
cytoplasm	O
and	O
was	O
competent	O
in	O
repressing	O
the	O
transcriptional	O
activity	O
driven	O
by	O
interferon	O
-	O
stimulated	O
response	O
elements	O
.	O

The	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
)	O
harboring	O
the	O
recombinant	O
construct	O
was	O
efficiently	O
induced	O
to	O
express	O
the	O
pAPN	O
protein	O
at	O
a	O
high	O
level	O
.	O

Indirubin	O
,	O
one	O
of	O
the	O
biological	O
active	O
compounds	O
of	O
Isatis	B-SPEC
indigotica	I-SPEC
,	O
had	O
the	O
most	O
significant	O
cytotoxicity	O
on	O
HL	O
-	O
60	O
cells	O
and	O
inhibitory	O
effect	O
on	O
PrV	B-SPEC
replication	O
.	O

RESULTS	O
:	O
Indirubin	O
,	O
one	O
of	O
the	O
biological	O
active	O
compounds	O
of	O
Isatis	B-SPEC
indigotica	I-SPEC
,	O
had	O
the	O
most	O
significant	O
cytotoxicity	O
on	O
HL	O
-	O
60	O
cells	O
and	O
inhibitory	O
effect	O
on	O
PrV	B-SPEC
replication	O
.	O

TITLE	O
:	O
Massachusetts	O
live	O
vaccination	O
protects	O
against	O
a	O
novel	O
infectious	O
bronchitis	O
virus	B-SPEC
S1	O
genotype	O
DMV	O
/	O
5642	O
/	O
06	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
non	O
-	O
contact	O
screening	O
system	O
for	O
rapid	O
medical	O
inspection	O
at	O
a	O
quarantine	O
depot	O
using	O
a	O
laser	B-SPEC
Doppler	O
blood	O
-	O
flow	O
meter	O
,	O
microwave	O
radar	O
and	O
infrared	O
thermography	O
.	O

In	O
order	B-SPEC
to	O
achieve	O
a	O
pseudo	O
-	O
infection	O
condition	O
,	O
the	O
subjects	O
maintained	O
an	O
ergo	O
-	O
meter	O
exercise	O
load	O
(	O
100	O
W	O
,	O
10	O
minutes	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
emerged	O
fleetingly	O
in	O
the	O
winter	O
of	O
2002	O
and	O
again	O
in	O
the	O
winter	O
of	O
2003	O
,	O
resulting	O
in	O
the	O
infection	O
of	O
~	O
8	O
,	O
000	O
people	O
and	O
the	O
death	O
of	O
~	O
800	O
.	O

The	O
approaches	O
to	O
combating	O
coronaviral	O
infections	O
are	O
built	O
on	O
the	O
foundation	O
of	O
antivirals	O
against	O
other	O
viruses	B-SPEC
and	O
the	O
fundamental	O
insights	O
gained	O
by	O
dissection	O
of	O
the	O
coronaviral	O
lifecycle	O
.	O

These	O
approaches	O
include	O
the	O
prevention	O
of	O
viral	O
entry	O
,	O
reviewed	O
here	O
,	O
and	O
interference	O
with	O
the	O
intracellular	O
lifecycle	O
of	O
the	O
virus	B-SPEC
in	O
the	O
infected	O
cell	O
,	O
reviewed	O
next	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
modulation	O
of	O
myocardial	O
ACE2	O
expression	O
and	O
inflammation	O
in	O
patients	O
with	O
SARS	O
.	O

ABSTRACT	O
:	O
The	O
case	O
fatality	O
rate	O
is	O
an	O
important	O
indicator	B-SPEC
of	O
the	O
severity	O
of	O
a	O
disease	O
,	O
and	O
unbiased	O
and	O
accurate	O
estimates	O
of	O
it	O
during	O
an	O
outbreak	O
are	O
important	O
in	O
the	O
study	O
of	O
epidemic	O
diseases	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
Development	O
of	O
cancer	B-SPEC
after	O
transplantation	O
has	O
rapidly	O
became	O
one	O
of	O
the	O
leading	O
causes	O
of	O
death	O
in	O
kidney	O
transplant	O
recipients	O
with	O
functioning	O
grafts	O
.	O

Infection	O
with	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
is	O
associated	O
with	O
progressive	O
neurological	O
disease	O
and	O
subclinical	O
infections	O
in	O
dogs	B-SPEC
.	O

Infection	O
with	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
can	O
cause	O
disease	O
and	O
mortality	O
in	O
cats	B-SPEC
and	O
is	O
mostly	O
subclinical	O
in	O
dogs	B-SPEC
.	O

Administration	O
of	O
recombinant	O
human	B-SPEC
APC	O
to	O
correct	O
the	O
dysregulated	O
protein	O
C	O
system	O
reduced	O
mortality	O
in	O
severe	O
sepsis	B-SPEC
patients	O
(	O
PROWESS	O
trial	O
),	O
which	O
stimulated	O
further	O
research	O
into	O
its	O
mechanisms	O
of	O
action	O
.	O

The	O
anti	O
-	O
viral	O
effect	O
of	O
GD	O
and	O
LiCl	O
on	O
virus	B-SPEC
,	O
on	O
virus	B-SPEC
-	O
infected	O
cells	O
or	O
on	O
cells	O
pre	O
-	O
treated	O
by	O
both	O
drugs	O
was	O
analysed	O
,	O
respectively	O
.	O

As	O
emerging	O
'	O
new	O
'	O
respiratory	O
viruses	B-SPEC
are	O
identified	O
in	O
many	O
wild	O
and	O
domestic	O
animals	B-SPEC
,	O
issues	O
of	O
interspecies	O
transmission	O
have	O
become	O
of	O
increasing	O
concern	O
.	O

An	O
updated	O
veterinary	O
curriculum	O
is	O
essential	O
to	O
empower	O
future	O
graduates	O
to	O
work	O
in	O
an	O
international	O
environment	O
,	O
applying	O
international	O
standards	O
for	O
disease	O
surveillance	O
,	O
veterinary	O
public	O
health	O
,	O
food	O
safety	O
and	O
animal	B-SPEC
welfare	O
.	O

RESULTS	O
:	O
Corticosteroid	O
was	O
administered	O
systemically	O
in	O
all	O
cases	O
except	O
one	O
case	O
of	O
TEN	O
which	O
developed	O
methicillin	O
resistant	O
staphylococcus	B-SPEC
aureus	I-SPEC
(	O
MRSA	O
)	O
pneumoniae	O
before	O
the	O
onset	O
of	O
the	O
eruption	O
.	O

The	O
viral	O
model	O
used	O
was	O
the	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
229E	O
chosen	O
for	O
(	O
i	O
)	O
its	O
increasing	O
medical	O
interest	O
,	O
(	O
ii	O
)	O
its	O
potential	O
resistance	O
and	O
(	O
iii	O
)	O
its	O
representing	O
enveloped	O
viruses	B-SPEC
mentioned	O
in	O
the	O
European	O
Standard	O
.	O

TITLE	O
:	O
Synthetic	O
peptides	O
coupled	O
to	O
the	O
surface	O
of	O
liposomes	O
effectively	O
induce	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
cytotoxic	O
T	O
lymphocytes	O
and	O
viral	O
clearance	O
in	O
HLA	O
-	O
A	O
*	O
0201	O
transgenic	B-SPEC
mice	I-SPEC
.	O

Two	O
of	O
the	O
liposomal	O
peptides	O
were	O
effective	O
for	O
peptide	O
-	O
specific	O
CTL	O
induction	O
,	O
and	O
one	O
of	O
them	O
was	O
efficient	O
for	O
the	O
clearance	O
of	O
vaccinia	B-SPEC
virus	I-SPEC
expressing	O
epitopes	O
of	O
SARS	O
-	O
CoV	O
,	O
suggesting	O
that	O
the	O
surface	O
-	O
linked	O
liposomal	O
peptide	O
might	O
offer	O
an	O
effective	O
CTL	O
-	O
based	O
vaccine	O
against	O
SARS	O
.	O

Future	O
studies	O
should	O
explore	O
links	O
between	O
the	O
timing	O
of	O
coronavirus	B-SPEC
infections	O
and	O
subsequent	O
development	O
of	O
schizophrenia	O
and	O
other	O
disorders	O
with	O
psychotic	O
symptoms	O
.	O

TITLE	O
:	O
Bats	B-SPEC
and	O
emerging	O
zoonoses	O
:	O
henipaviruses	B-SPEC
and	O
SARS	O
.	O

The	O
majority	O
have	O
spilled	O
from	O
wildlife	O
reservoirs	O
,	O
either	O
directly	O
to	O
humans	B-SPEC
or	O
via	O
domestic	O
animals	B-SPEC
.	O

The	O
epidemiological	O
investigation	O
of	O
EIDs	O
associated	O
with	O
wildlife	O
requires	O
a	O
trans	O
-	O
disciplinary	O
approach	O
that	O
includes	O
an	O
understanding	O
of	O
the	O
ecology	O
of	O
the	O
wildlife	O
species	B-SPEC
,	O
and	O
an	O
understanding	O
of	O
human	B-SPEC
behaviours	O
that	O
increase	O
risk	O
of	O
exposure	O
.	O

Mitigating	O
and	O
managing	O
the	O
risk	O
requires	O
an	O
appreciation	O
of	O
the	O
connectedness	O
between	O
human	B-SPEC
,	O
livestock	O
and	O
wildlife	O
health	O
,	O
and	O
of	O
the	O
factors	O
and	O
processes	O
that	O
disrupt	O
the	O
balance	O
.	O

The	O
complications	O
in	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
were	O
thrombocytopenia	O
,	O
biochemical	O
evidence	O
of	O
hepatic	O
dysfunction	O
,	O
renal	O
damage	O
,	O
positive	O
DCT	O
and	O
death	O
due	O
to	O
ARDS	O
.	O

One	O
patient	O
went	O
into	O
acute	O
renal	O
failure	O
following	O
quinine	B-SPEC
therapy	O
and	O
showed	O
red	O
cell	O
fragments	O
in	O
the	O
peripheral	O
blood	O
.	O

ABSTRACT	O
:	O
Respiratory	O
virus	B-SPEC
infections	O
are	O
the	O
most	O
important	O
trigger	O
of	O
respiratory	O
illnesses	O
in	O
childhood	O
.	O

HRV	O
infections	O
were	O
associated	O
with	O
a	O
prolonged	O
period	O
of	O
symptoms	O
compared	O
with	O
RSV	B-SPEC
(	O
P	O
=	O
0	O
.	O
03	O
).	O

This	O
knowledge	O
may	O
be	O
important	O
for	O
the	O
control	O
of	O
re	O
-	O
emerging	O
SARS	O
,	O
or	O
other	O
future	O
emerging	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmittable	O
infections	O
.	O

Patients	O
with	O
LC	O
are	O
at	O
risk	O
for	O
gastric	O
aspiration	O
at	O
the	O
time	O
of	O
trauma	O
,	O
but	O
the	O
combined	O
insults	O
have	O
not	O
been	O
well	O
-	O
studied	O
in	O
animal	B-SPEC
models	O
.	O

Lung	O
injury	O
and	O
inflammation	O
were	O
assessed	O
by	O
arterial	O
blood	O
gases	O
and	O
levels	O
of	O
albumin	O
,	O
cells	O
,	O
and	O
cytokines	O
/	O
chemokines	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
at	O
5	O
and	O
24	O
h	O
.	O
Rats	B-SPEC
with	O
LC	O
+	O
CASP	O
had	O
lower	O
mean	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
ratios	O
compared	O
with	O
LC	O
alone	O
at	O
24	O
h	O
,	O
and	O
higher	O
BAL	O
albumin	O
concentrations	O
compared	O
with	O
either	O
LC	O
or	O
CASP	O
alone	O
.	O

RESULTS	O
:	O
Rats	B-SPEC
with	O
LC	O
+	O
CASP	O
had	O
lower	O
mean	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
ratios	O
compared	O
with	O
LC	O
alone	O
at	O
24	O
h	O
,	O
and	O
higher	O
BAL	O
albumin	O
concentrations	O
compared	O
with	O
either	O
LC	O
or	O
CASP	O
alone	O
.	O

The	O
virus	B-SPEC
was	O
partially	O
attenuated	O
at	O
passage	O
40	O
(	O
P40	O
)	O
and	O
P70	O
,	O
and	O
was	O
fully	O
attenuated	O
at	O
P110	O
.	O

Substitutions	O
in	O
the	O
S1	O
subunit	O
occurred	O
between	O
P3	O
and	O
P40	O
and	O
all	O
subpopulations	O
in	O
a	O
virus	B-SPEC
passage	O
showed	O
the	O
same	O
substitutions	O
.	O

Here	O
,	O
we	O
demonstrated	O
that	O
the	O
post	O
-	O
transcriptional	O
gene	O
silencing	O
suppressor	O
p19	O
protein	O
from	O
tomato	B-SPEC
bushy	I-SPEC
stunt	I-SPEC
virus	I-SPEC
substantially	O
enhanced	O
the	O
transient	O
expression	O
of	O
recombinant	O
SARS	O
-	O
CoV	O
nucleocapsid	O
(	O
rN	O
)	O
protein	O
in	O
Nicotiana	B-SPEC
benthamiana	I-SPEC
.	O

The	O
5	O
-	O
Acetyl	O
-	O
2	O
-(	O
4	O
'-	O
nitrobiphenyl	O
-	O
4	O
-	O
yl	O
)-	O
1H	O
-	O
benzimidazole	O
(	O
24	O
)	O
emerged	O
as	O
potent	O
active	O
lead	O
compound	O
against	O
Yellow	B-SPEC
Fever	I-SPEC
Virus	I-SPEC
(	O
a	O
Flavivirus	B-SPEC
)	O
(	O
EC	O
(	O
50	O
)	O
=	O
0	O
.	O
5	O
microM	O
)	O
and	O
CVB	O
-	O
2	O
at	O
1	O
microM	O
and	O
was	O
not	O
cytotoxic	O
,	O
whereas	O
the	O
other	O
title	O
benzimidazoles	O
showed	O
no	O
antiviral	O
activity	O
at	O
concentrations	O
not	O
cytotoxic	O
for	O
the	O
resting	O
cell	O
monolayers	O
.	O

ABSTRACT	O
:	O
In	O
this	O
review	O
,	O
the	O
current	O
state	O
of	O
vaccine	O
development	O
against	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
,	O
focusing	O
on	O
recently	O
published	O
data	O
is	O
assessed	O
.	O

While	O
there	O
is	O
much	O
evidence	O
that	O
various	O
vaccine	O
strategies	O
against	O
SARS	O
are	O
safe	O
and	O
immunogenic	O
,	O
vaccinated	O
animals	B-SPEC
still	O
display	O
significant	O
disease	O
upon	O
challenge	O
.	O

Current	O
data	O
suggest	O
that	O
intranasal	O
vaccination	O
may	O
be	O
crucial	O
and	O
that	O
new	O
or	O
combination	O
strategies	O
may	O
be	O
required	O
for	O
good	O
protective	O
efficacy	O
against	O
SARS	O
in	O
humans	B-SPEC
.	O

Plasmids	O
carrying	O
the	O
S1	O
gene	O
of	O
IBV	B-SPEC
(	O
pVAX	O
-	O
S1	O
)	O
and	O
the	O
chicken	B-SPEC
GM	O
-	O
CSF	O
gene	O
(	O
pVAX	O
-	O
chGM	O
-	O
CSF	O
)	O
were	O
constructed	O
.	O

Chickens	B-SPEC
were	O
challenged	O
with	O
virulent	O
IBV	B-SPEC
at	O
3	O
weeks	O
after	O
the	O
booster	O
immunization	O
and	O
observed	O
for	O
2	O
weeks	O
.	O

In	O
addition	O
,	O
vaccination	O
with	O
pVAX	O
-	O
chGM	O
-	O
CSF	O
and	O
pVAX	O
-	O
S1	O
provided	O
86	O
.	O
7	O
%	O
protection	O
(	O
13	O
/	O
15	O
)	O
against	O
IBV	B-SPEC
challenge	O
.	O

TITLE	O
:	O
[	O
Effect	O
on	O
mRNA	O
and	O
secretion	O
levels	O
of	O
proinflammatory	O
cytokines	O
in	O
DC	O
infected	O
by	O
SARS	O
-	O
CoV	O
N	O
gene	O
recombinant	O
adenovirus	B-SPEC
].	O

These	O
include	O
two	O
human	B-SPEC
coronaviruses	O
(	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
),	O
10	O
other	O
mammalian	B-SPEC
coronaviruses	O
[	O
bat	B-SPEC
SARS	O
coronavirus	B-SPEC
,	O
bat	B-SPEC
coronavirus	B-SPEC
(	O
bat	B-SPEC
-	O
CoV	O
)	O
HKU2	O
,	O
bat	B-SPEC
-	O
CoV	O
HKU4	O
,	O
bat	B-SPEC
-	O
CoV	O
HKU5	O
,	O
bat	B-SPEC
-	O
CoV	O
HKU8	O
,	O
bat	B-SPEC
-	O
CoV	O
HKU9	O
,	O
bat	B-SPEC
-	O
CoV	O
512	O
/	O
2005	O
,	O
bat	B-SPEC
-	O
CoV	O
1A	O
,	O
equine	B-SPEC
coronavirus	B-SPEC
,	O
and	O
beluga	B-SPEC
whale	I-SPEC
coronavirus	B-SPEC
]	O
and	O
four	O
avian	B-SPEC
coronaviruses	O
(	O
turkey	B-SPEC
coronavirus	B-SPEC
,	O
bulbul	B-SPEC
coronavirus	B-SPEC
HKU11	O
,	O
thrush	B-SPEC
coronavirus	B-SPEC
HKU12	O
,	O
and	O
munia	O
coronavirus	B-SPEC
HKU13	O
).	O

Virus	B-SPEC
replication	O
and	O
distribution	O
did	O
not	O
correlate	O
with	O
the	O
relative	O
susceptibilities	O
of	O
A	O
/	O
J	O
,	O
BALB	O
/	O
c	O
,	O
C3H	O
/	O
HeJ	O
,	O
and	O
C57BL	O
/	O
6	O
mice	B-SPEC
.	O

In	O
order	B-SPEC
to	O
further	O
define	O
the	O
role	O
of	O
the	O
host	O
genetic	O
background	O
in	O
influencing	O
susceptibility	O
to	O
MHV	B-SPEC
-	O
1	O
-	O
induced	O
disease	O
,	O
we	O
examined	O
14	O
different	O
inbred	O
mouse	B-SPEC
strains	O
.	O

A	O
multitarget	O
,	O
sensitive	O
,	O
specific	O
high	O
-	O
throughput	O
Respiratory	O
MultiCode	O
assay	O
tested	O
for	O
respiratory	O
-	O
virus	B-SPEC
sequences	O
for	O
eight	O
distinct	O
groups	O
:	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
metapneumovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
enterovirus	B-SPEC
.	O

Acute	O
asthmatics	O
were	O
thrice	O
as	O
likely	O
to	O
be	O
infected	O
with	O
a	O
respiratory	O
virus	B-SPEC
(	O
OR	O
=	O
2	O
.	O
5	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
2	O
-	O
5	O
.	O
3	O
).	O

Further	O
clinical	O
and	O
virology	O
investigations	O
are	O
recommended	O
on	O
the	O
role	O
of	O
infections	O
with	O
the	O
rhinovirus	B-SPEC
in	O
Caribbean	O
childhood	O
wheeze	O
.	O

The	O
positive	O
predictive	O
value	O
(	O
PPV	B-SPEC
)	O
was	O
0	O
.	O
8	O
,	O
and	O
the	O
negative	O
predictive	O
value	O
(	O
NPV	O
)	O
was	O
0	O
.	O
93	O
.	O

Bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
IHC	O
testing	O
was	O
positive	O
in	O
5	O
.	O
3	O
%	O
of	O
the	O
animals	B-SPEC
.	O

Statistically	O
significant	O
relationships	O
were	O
present	O
among	O
the	O
agents	O
,	O
lesions	O
,	O
and	O
the	O
animal	B-SPEC
treatment	O
,	O
disease	O
onset	O
,	O
and	O
mortality	O
data	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	O
oxygenation	O
support	O
for	O
59	O
days	O
without	O
changing	O
the	O
ECMO	O
circuit	O
:	O
a	O
case	O
of	O
Legionella	B-SPEC
pneumonia	O
.	O

Feces	O
samples	O
were	O
available	O
for	O
44	O
animals	B-SPEC
,	O
including	O
one	O
L	B-SPEC
.	I-SPEC
geoffroyi	I-SPEC
,	O
eight	O
L	B-SPEC
.	I-SPEC
pardalis	I-SPEC
,	O
14	O
L	B-SPEC
.	I-SPEC
wiedii	I-SPEC
,	O
20	O
L	B-SPEC
.	I-SPEC
tigrinus	I-SPEC
,	O
and	O
one	O
P	O
.	O
yagouaroundi	O
.	O

Blood	O
DNA	O
samples	O
were	O
evaluated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	O
)	O
proviral	O
DNA	O
,	O
whereas	O
reverse	O
transcriptase	O
-	O
PCR	O
was	O
run	O
on	O
fecal	O
samples	O
for	O
detection	O
of	O
coronavirus	B-SPEC
RNA	O
.	O

Interestingly	O
,	O
when	O
the	O
genomic	O
RNAs	O
were	O
delivered	O
directly	O
into	O
the	O
cells	O
via	O
transfection	O
,	O
the	O
levels	O
of	O
gene	O
expression	O
for	O
these	O
viruses	B-SPEC
were	O
similar	O
.	O

In	O
A	O
/	O
J	O
and	O
C3H	O
/	O
HeJ	O
mice	B-SPEC
,	O
which	O
are	O
highly	O
susceptible	O
to	O
MHV	B-SPEC
-	O
1	O
-	O
induced	O
disease	O
,	O
we	O
demonstrate	O
that	O
both	O
CD4	O
and	O
CD8	O
T	O
cells	O
contribute	O
to	O
morbidity	O
during	O
primary	O
infection	O
,	O
and	O
memory	O
responses	O
can	O
enhance	O
morbidity	O
and	O
mortality	O
during	O
subsequent	O
reexposure	O
to	O
MHV	B-SPEC
-	O
1	O
.	O

TITLE	O
:	O
Intragastric	O
administration	O
of	O
attenuated	O
Salmonella	B-SPEC
typhimurium	O
harbouring	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
DNA	O
vaccine	O
induced	O
specific	O
antibody	O
production	O
.	O

A	O
2	O
.	O
2kb	O
DNA	O
fragment	O
,	O
encoding	O
for	O
N	O
-	O
terminal	O
domain	O
glycoprotein	O
S	O
of	O
TGEV	B-SPEC
,	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
and	O
cloned	O
into	O
eukaryotic	O
expression	O
vector	O
pVAX1	O
.	O

The	O
results	O
indicated	O
that	O
attenuated	O
S	O
.	O
typhimurium	O
could	O
be	O
used	O
as	O
a	O
delivery	O
vector	O
for	O
oral	O
immunization	O
of	O
TGEV	B-SPEC
DNA	O
vaccine	O
.	O

Our	O
finding	O
provides	O
a	O
new	O
way	O
to	O
develop	O
multi	O
-	O
epitope	O
based	O
peptide	O
vaccine	O
against	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
monitor	O
and	O
study	O
the	O
molecular	O
epidemiology	O
,	O
evolution	O
and	O
pathogenicity	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	B-SPEC
)	O
in	O
China	O
in	O
recent	O
years	O
and	O
further	O
our	O
knowledge	O
of	O
the	O
evolution	O
of	O
IBVs	B-SPEC
.	O

Thirty	O
-	O
seven	O
IBV	B-SPEC
isolates	O
were	O
isolated	O
from	O
commercial	O
chickens	B-SPEC
in	O
China	O
.	O

CONCLUSIONS	O
:	O
Mutations	O
,	O
insertions	O
,	O
deletions	O
and	O
recombination	O
of	O
the	O
S1	O
protein	O
gene	O
contribute	O
to	O
the	O
genetic	O
diversity	O
of	O
IBV	B-SPEC
in	O
China	O
.	O

ABSTRACT	O
:	O
Assuming	O
that	O
no	O
human	B-SPEC
had	O
any	O
previously	O
acquired	O
immunoprotection	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
during	O
the	O
2003	O
SARS	O
outbreak	O
,	O
the	O
biological	O
bases	O
for	O
possible	O
difference	O
in	O
individual	O
susceptibility	O
are	O
intriguing	O
.	O

TITLE	O
:	O
Structure	O
and	O
inhibition	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
envelope	O
protein	O
ion	O
channel	O
.	O

Further	O
,	O
the	O
drug	O
hexamethylene	O
amiloride	O
(	O
HMA	O
),	O
but	O
not	O
amiloride	O
,	O
inhibited	O
in	O
vitro	O
ion	O
channel	O
activity	O
of	O
some	O
synthetic	O
coronavirus	B-SPEC
E	O
proteins	O
,	O
and	O
also	O
viral	O
replication	O
.	O

HIV	B-SPEC
seropositivity	O
was	O
associated	O
with	O
worse	O
outcomes	O
overall	O
,	O
but	O
did	O
not	O
modify	O
or	O
confound	O
the	O
negative	O
results	O
.	O

TITLE	O
:	O
Immunogenicity	O
difference	O
between	O
the	O
SARS	O
coronavirus	B-SPEC
and	O
the	O
bat	B-SPEC
SARS	O
-	O
like	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
proteins	O
.	O

Sepsis	B-SPEC
was	O
controlled	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
a	O
family	B-SPEC
of	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
that	O
includes	O
important	O
pathogens	O
of	O
humans	B-SPEC
and	O
other	O
animals	B-SPEC
.	O

TITLE	O
:	O
Experimental	O
infection	O
of	O
Mongolian	B-SPEC
gerbils	I-SPEC
by	O
a	O
genotype	O
4	O
strain	O
of	O
swine	B-SPEC
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
.	O

Distribution	O
of	O
the	O
virus	B-SPEC
antigens	O
was	O
determined	O
by	O
immunohistochemical	O
staining	O
.	O

Viremia	O
and	O
fecal	O
virus	B-SPEC
shedding	O
lasted	O
nearly	O
4	O
weeks	O
,	O
while	O
the	O
virus	B-SPEC
could	O
be	O
detected	O
constantly	O
in	O
the	O
liver	O
,	O
and	O
occasionally	O
in	O
the	O
kidneys	O
and	O
spleen	O
as	O
well	O
as	O
the	O
small	O
intestine	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
a	O
costly	O
respiratory	O
viral	O
disease	O
of	O
chickens	B-SPEC
.	O

Sequence	O
analysis	O
showed	O
some	O
viruses	B-SPEC
to	O
be	O
related	O
to	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Chinese	O
-	O
like	O
strain	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
Thailand	O
.	O

In	O
order	B-SPEC
to	O
search	O
for	O
the	O
pharmacophore	O
space	O
around	O
the	O
diketoacid	O
core	O
,	O
three	O
classes	O
of	O
dihydroxychromone	O
derivatives	O
were	O
prepared	O
.	O

TITLE	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
from	O
raccoon	B-SPEC
dog	I-SPEC
can	O
serve	O
as	O
an	O
efficient	O
receptor	O
for	O
the	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
-	O
backboned	O
pseudoviruses	O
expressing	O
spike	O
proteins	O
derived	O
from	O
human	B-SPEC
SARS	O
-	O
CoV	O
or	O
SARS	O
-	O
CoV	O
-	O
like	O
viruses	B-SPEC
of	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
and	O
raccoon	B-SPEC
dogs	I-SPEC
were	O
tested	O
for	O
their	O
entry	O
efficiency	O
into	O
these	O
cell	O
lines	O
.	O

As	O
IBV	B-SPEC
S1	O
plays	O
a	O
major	O
role	O
in	O
antigenicity	O
,	O
the	O
antigenic	O
relatedness	O
of	O
NGA	O
/	O
A116E7	O
/	O
2006	O
was	O
compared	O
with	O
strains	O
of	O
other	O
serotypes	O
.	O

CXCL10	O
neutralization	O
selectively	O
reduced	O
accumulation	O
and	O
/	O
or	O
retention	O
of	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
T	O
cells	O
,	O
yet	O
exhibited	O
limited	O
effect	O
on	O
virus	B-SPEC
-	O
specific	O
CD8	O
+	O
T	O
cells	O
.	O

The	O
response	O
of	O
CXCL10	O
neutralization	O
on	O
virus	B-SPEC
-	O
specific	O
T	O
cell	O
subsets	O
is	O
not	O
due	O
to	O
differential	O
expression	O
of	O
the	O
CXCL10	O
receptor	O
CXCR3	O
on	O
T	O
cells	O
as	O
there	O
was	O
no	O
appreciable	O
difference	O
in	O
receptor	O
expression	O
on	O
virus	B-SPEC
-	O
specific	O
T	O
cells	O
during	O
either	O
acute	O
or	O
chronic	O
disease	O
.	O

In	O
addition	O
,	O
differential	O
signals	O
are	O
required	O
for	O
trafficking	O
and	O
retention	O
of	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
during	O
chronic	O
demyelination	O
in	O
JHMV	O
-	O
infected	O
mice	B-SPEC
.	O

Pediatric	O
respiratory	O
specimens	O
(	O
1	O
,	O
683	O
)	O
submitted	O
to	O
a	O
diagnostic	O
virology	O
laboratory	O
over	O
a	O
1	O
-	O
year	O
period	O
(	O
December	O
2004	O
-	O
November	O
2005	O
)	O
that	O
were	O
negative	O
for	O
seven	O
respiratory	O
viruses	B-SPEC
by	O
conventional	O
methods	O
were	O
tested	O
for	O
RNA	O
of	O
four	O
HCoVs	O
using	O
sensitive	O
RT	O
-	O
PCR	O
assays	O
.	O

These	O
data	O
indicated	O
that	O
the	O
recombinant	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
could	O
be	O
a	O
valuable	O
tool	O
in	O
the	O
development	O
of	O
future	O
vaccines	O
against	O
TGEV	B-SPEC
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
field	O
vaccination	O
coverage	O
and	O
persistence	O
of	O
Arkansas	O
-	O
type	O
viruses	B-SPEC
in	O
commercial	O
broilers	O
.	O

Protection	O
studies	O
conducted	O
on	O
birds	B-SPEC
vaccinated	O
with	O
Arkansas	O
-	O
and	O
Delaware	O
-	O
type	O
vaccines	O
and	O
removed	O
from	O
the	O
field	O
at	O
21	O
days	O
postvaccination	O
showed	O
complete	O
protection	O
against	O
challenge	O
with	O
Delaware	O
(	O
except	O
for	O
one	O
bird	B-SPEC
),	O
whereas	O
protection	O
against	O
Arkansas	O
challenge	O
was	O
between	O
37	O
.	O
5	O
%	O
and	O
62	O
.	O
5	O
%.	O

In	O
the	O
present	O
study	O
,	O
we	O
analyzed	O
the	O
kinetics	O
of	O
interferon	O
(	O
IFN	O
),	O
cytokine	O
,	O
and	O
chemokine	O
mRNA	O
expression	O
in	O
chicken	B-SPEC
embryonic	O
spleen	O
at	O
6	O
hr	O
,	O
24	O
hr	O
,	O
48	O
hr	O
,	O
and	O
72	O
hr	O
after	O
administration	O
of	O
CpG	O
ODN	O
2007	O
(	O
B	O
-	O
class	B-SPEC
)	O
in	O
18	O
-	O
day	O
-	O
old	O
chicken	B-SPEC
embryos	O
.	O

Alveolar	O
epithelial	O
cells	O
are	O
an	O
important	O
target	O
for	O
coronavirus	B-SPEC
infection	O
in	O
the	O
lung	O
,	O
and	O
infected	O
cells	O
can	O
initiate	O
innate	O
immune	O
responses	O
to	O
viral	O
infection	O
.	O

All	O
animals	B-SPEC
were	O
ventilated	O
in	O
the	O
pressure	O
-	O
controlled	O
ventilation	O
mode	O
(	O
PCV	B-SPEC
)	O
with	O
VTs	O
ranging	O
from	O
0	O
-	O
8	O
ml	O
/	O
kg	O
.	O

Phylogenetic	O
analysis	O
of	O
partial	O
M	O
gene	O
sequences	O
revealed	O
that	O
all	O
seven	O
positive	O
samples	O
grouped	O
with	O
type	O
I	O
CECoV	O
,	O
the	O
first	O
report	O
of	O
this	O
virus	B-SPEC
in	O
the	O
UK	O
.	O

The	O
protective	O
effectors	O
against	O
MHV	B-SPEC
infection	O
are	O
,	O
however	O
,	O
still	O
unknown	O
.	O

129SvEv	O
mice	B-SPEC
lacking	O
the	O
type	O
I	O
interferon	O
receptor	O
(	O
IFNAR	O
-/-),	O
however	O
,	O
were	O
not	O
able	O
to	O
control	O
the	O
infection	O
.	O

As	O
the	O
BALB	O
/	O
c	O
and	O
the	O
IFNAR	O
-/-	O
129SvEv	O
mice	B-SPEC
demonstrated	O
very	O
similar	O
viral	O
loads	O
in	O
their	O
brains	O
,	O
we	O
also	O
compared	O
their	O
gene	O
expression	O
profiles	O
upon	O
infection	O
with	O
MHV	B-SPEC
in	O
order	B-SPEC
to	O
identify	O
type	O
I	O
IFN	O
-	O
dependent	O
transcriptional	O
responses	O
.	O

Profiling	O
of	O
IFNAR	O
-/-	O
mice	B-SPEC
allowed	O
us	O
to	O
identify	O
type	O
I	O
IFN	O
-	O
independent	O
and	O
-	O
dependent	O
responses	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
the	O
Cepheid	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
influenza	B-SPEC
virus	I-SPEC
A	O
/	O
B	O
real	O
-	O
time	O
PCR	O
analyte	O
specific	O
reagent	O
.	O

ABSTRACT	O
:	O
Two	O
rapid	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assays	O
,	O
specific	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
influenza	O
A	O
and	O
B	O
,	O
were	O
evaluated	O
for	O
the	O
detection	O
of	O
these	O
viruses	B-SPEC
in	O
clinical	O
respiratory	O
samples	O
.	O

Studies	O
have	O
highlighted	O
various	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
to	O
be	O
significantly	O
associated	O
with	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
hospitalisation	O
,	O
and	O
a	O
candidate	O
gene	O
approach	O
demonstrated	O
that	O
innate	O
immune	O
gene	O
SNPs	O
had	O
the	O
strongest	O
association	O
with	O
bronchiolitis	O
.	O

The	O
nsp2	O
protein	O
from	O
IBV	B-SPEC
has	O
a	O
unique	O
and	O
novel	O
sequence	O
and	O
has	O
no	O
experimentally	O
confirmed	O
function	O
in	O
replication	O
,	O
whereas	O
it	O
has	O
been	O
proposed	O
to	O
be	O
crucial	O
for	O
early	O
viral	O
infection	O
and	O
may	O
inhibit	O
the	O
early	O
host	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
The	O
threat	O
of	O
outbreak	O
of	O
infectious	O
disease	O
such	O
as	O
non	O
-	O
seasonal	O
influenza	O
A	O
(	O
H1N1	O
),	O
commonly	O
referred	O
to	O
as	O
Swine	B-SPEC
Flu	O
,	O
can	O
provoke	O
the	O
implementation	O
of	O
public	O
health	O
control	O
measures	O
such	O
as	O
quarantine	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
modifies	O
innate	O
immunity	O
and	O
alters	O
disease	O
outcome	O
in	O
pigs	B-SPEC
subsequently	O
infected	O
with	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
:	O
implications	O
for	O
respiratory	O
viral	O
co	O
-	O
infections	O
.	O

This	O
study	O
provides	O
new	O
insights	O
into	O
host	O
-	O
pathogen	O
interactions	O
related	O
to	O
co	O
-	O
infection	O
by	O
CoVs	O
and	O
other	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
in	O
human	B-SPEC
serum	O
using	O
a	O
localized	O
surface	O
plasmon	O
coupled	O
fluorescence	O
fiber	O
-	O
optic	O
biosensor	O
.	O

This	O
review	O
is	O
focused	O
on	O
members	O
of	O
the	O
GBF	O
/	O
Gea	B-SPEC
and	O
BIG	O
/	O
Sec7	O
subfamilies	O
of	O
Arf	O
GEFs	O
,	O
all	O
of	O
which	O
use	O
the	O
class	B-SPEC
I	O
Arf	O
proteins	O
(	O
Arf1	O
-	O
3	O
)	O
as	O
substrates	O
,	O
and	O
play	O
a	O
fundamental	O
role	O
in	O
trafficking	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)-	O
Golgi	O
and	O
endosomal	O
membrane	O
systems	O
.	O

The	O
patient	O
developed	O
deep	O
coma	B-SPEC
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
hepatic	O
and	O
renal	O
dysfunction	O
,	O
and	O
shock	O
in	O
the	O
first	O
24	O
hours	O
after	O
admission	O
.	O

Preference	O
will	O
be	O
given	O
to	O
rRBD	O
expressed	O
in	O
mammalian	B-SPEC
cells	O
for	O
future	O
evaluation	O
of	O
the	O
vaccine	O
efficacy	O
in	O
a	O
non	O
-	O
human	B-SPEC
primate	B-SPEC
model	O
of	O
SARS	O
because	O
of	O
its	O
ability	O
to	O
refold	O
into	O
a	O
native	O
conformation	O
more	O
readily	O
and	O
to	O
induce	O
higher	O
level	O
of	O
neutralizing	O
antibody	O
responses	O
than	O
those	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
insect	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
a	O
lung	O
disease	O
with	O
high	O
mortality	O
.	O

The	O
sputum	O
examinations	O
of	O
Gram	O
stain	O
both	O
yielded	O
larvae	O
of	O
Strongyloides	B-SPEC
stercoralis	I-SPEC
precipitously	O
.	O

In	O
addition	O
to	O
SARS	O
,	O
the	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AIV	B-SPEC
),	O
H5N1	O
,	O
and	O
the	O
lower	O
pathogenicity	O
H9N2	O
AIV	B-SPEC
have	O
expanded	O
their	O
host	O
ranges	O
to	O
infect	O
human	B-SPEC
beings	O
and	O
other	O
mammalian	B-SPEC
species	B-SPEC
as	O
well	O
as	O
birds	B-SPEC
.	O

A	O
new	O
highly	O
pathogenic	O
variant	O
of	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
has	O
been	O
isolated	O
in	O
both	O
China	O
and	O
Vietnam	O
recently	O
;	O
although	O
PRRSV	B-SPEC
is	O
not	O
a	O
zoonotic	O
human	B-SPEC
pathogen	O
,	O
its	O
severe	O
outbreaks	O
have	O
implications	O
for	O
food	O
safety	O
.	O

TITLE	O
:	O
Detection	O
and	O
molecular	O
characterization	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolated	O
from	O
recent	O
outbreaks	O
in	O
broiler	O
flocks	O
in	O
Thailand	O
.	O

TITLE	O
:	O
Elucidation	O
of	O
the	O
stability	O
and	O
functional	O
regions	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
nucleocapsid	O
protein	O
.	O

Here	O
,	O
we	O
characterized	O
the	O
stability	O
and	O
identified	O
the	O
functional	O
regions	O
of	O
the	O
recombinant	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
N	O
protein	O
.	O

SPR	O
experiments	O
demonstrated	O
that	O
the	O
C	O
-	O
terminal	O
region	O
(	O
residues	O
301	O
-	O
448	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
N	O
protein	O
lacks	O
RNA	O
-	O
binding	O
activity	O
,	O
while	O
crosslinking	O
and	O
gel	O
filtration	O
analyses	O
revealed	O
that	O
the	O
C	O
-	O
terminal	O
region	O
is	O
mainly	O
involved	O
in	O
the	O
oligomerization	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
N	O
protein	O
.	O

In	O
this	O
study	O
,	O
the	O
antiviral	O
activity	O
of	O
standard	O
household	O
products	O
was	O
assayed	O
against	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
as	O
a	O
potential	O
surrogate	O
for	O
SARS	O
-	O
CoV	O
.	O
A	O
surface	O
test	O
method	O
,	O
which	O
involves	O
drying	O
an	O
amount	O
of	O
virus	B-SPEC
on	O
a	O
surface	O
and	O
then	O
applying	O
the	O
product	O
for	O
a	O
specific	O
contact	O
time	O
,	O
was	O
used	O
to	O
determine	O
the	O
virucidal	O
activity	O
.	O

CONCLUSIONS	O
:	O
Common	O
household	O
disinfectants	O
and	O
antiseptics	O
were	O
effective	O
at	O
inactivating	O
MHV	B-SPEC
,	O
a	O
possible	O
surrogate	O
for	O
SARS	O
-	O
CoV	O
,	O
from	O
surfaces	O
when	O
used	O
as	O
directed	O
.	O

Occult	O
aggressive	O
fungal	O
sepsis	B-SPEC
resulting	O
in	O
early	O
multiple	O
organ	O
failure	O
should	O
be	O
kept	O
in	O
mind	O
.	O

Compared	O
to	O
traditional	O
in	O
-	O
class	B-SPEC
continuing	O
education	O
,	O
a	O
web	O
-	O
based	O
learning	O
system	O
is	O
efficient	O
for	O
nurses	O
with	O
a	O
three	O
shift	O
-	O
working	O
schedule	O
and	O
is	O
timely	O
to	O
deliver	O
knowledge	O
about	O
newly	O
emerging	O
epidemics	O
such	O
as	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
.	O

Although	O
A	B-SPEC
.	I-SPEC
baumannii	I-SPEC
is	O
considered	O
the	O
causative	O
agent	O
in	O
nosocomical	O
pneumonia	O
,	O
community	O
-	O
acquired	O
pneumonia	O
due	O
to	O
A	B-SPEC
.	I-SPEC
baumannii	I-SPEC
is	O
very	O
rare	O
.	O

Transfection	O
of	O
capped	O
RNA	O
transcribed	O
from	O
this	O
construct	O
yielded	O
infectious	O
virus	B-SPEC
that	O
was	O
indistinguishable	O
from	O
the	O
original	O
virus	B-SPEC
isolate	O
.	O

This	O
difference	O
could	O
explain	O
earlier	O
observations	O
of	O
enhanced	O
virulence	O
of	O
Frankfurt	O
-	O
1	O
in	O
Hamsters	B-SPEC
as	O
compared	O
to	O
other	O
SARS	O
-	O
Coronavirus	B-SPEC
reference	O
strains	O
and	O
identifies	O
the	O
SARS	O
-	O
CoV	O
7b	O
protein	O
as	O
an	O
attenuating	O
factor	O
with	O
the	O
SARS	O
-	O
Coronavirus	B-SPEC
genome	O
.	O

In	O
contrast	O
,	O
in	O
the	O
absence	O
of	O
extracellular	O
proteases	O
,	O
these	O
viruses	B-SPEC
can	O
enter	O
cells	O
via	O
an	O
endosomal	O
pathway	O
and	O
utilize	O
endosomal	O
cathepsins	O
for	O
S	O
protein	O
activation	O
.	O

Although	O
trypsin	O
treatment	O
enabled	O
receptor	O
-	O
bound	O
MHV	B-SPEC
-	O
2	O
to	O
enter	O
from	O
the	O
cell	O
surface	O
,	O
CPL	O
failed	O
to	O
do	O
so	O
.	O

Dental	O
monitoring	O
during	O
cancer	B-SPEC
treatment	O
is	O
imperative	O
in	O
order	B-SPEC
to	O
emphasize	O
the	O
importance	O
of	O
dental	O
plaque	O
control	O
and	O
the	O
maintenance	O
of	O
a	O
healthy	O
periodontal	O
condition	O
throughout	O
medical	O
treatment	O
.	O

Thirty	O
-	O
two	O
months	O
after	O
presentation	O
of	O
the	O
initial	O
symptoms	O
,	O
the	O
patient	O
died	O
due	O
to	O
complications	O
related	O
to	O
leukaemia	O
recurrence	O
(	O
haemorrhage	O
,	O
sepsis	B-SPEC
and	O
respiratory	O
distress	O
syndrome	O
).	O

TITLE	O
:	O
Rhesus	O
theta	O
-	O
defensin	O
prevents	O
death	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
pulmonary	O
disease	O
.	O

TITLE	O
:	O
Severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
at	O
the	O
Hajj	O
:	O
etiologies	O
and	O
outcomes	O
.	O

ABSTRACT	O
:	O
The	O
S2	O
domain	O
of	O
the	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
is	O
known	O
to	O
be	O
responsible	O
for	O
mediating	O
membrane	O
fusion	O
.	O

We	O
first	O
examine	O
the	O
approach	O
by	O
analyzing	O
an	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
Hong	O
Kong	O
(	O
2003	O
)	O
with	O
known	O
unbiased	O
cCFR	O
estimate	O
,	O
and	O
then	O
investigate	O
published	O
epidemiological	O
datasets	O
of	O
novel	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
infection	O
in	O
the	O
USA	O
and	O
Canada	O
(	O
2009	O
).	O

While	O
comparing	O
the	O
interactions	O
that	O
humans	B-SPEC
and	O
bats	B-SPEC
establish	O
with	O
Lyssavirus	B-SPEC
,	O
scientists	O
try	O
to	O
understand	O
the	O
molecular	O
basis	O
ofpathogenicity	O
in	O
man	B-SPEC
,	O
a	O
indispensable	O
prerequisite	O
to	O
identify	O
antiviral	O
targets	O
in	O
a	O
perspective	O
of	O
therapy	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
sensitivity	O
of	O
FIP	O
-	O
virus	B-SPEC
(	O
FIPV	O
)	O
infected	O
cells	O
towards	O
ADCML	O
and	O
to	O
examine	O
the	O
role	O
of	O
the	O
accessory	O
proteins	O
3abc	O
and	O
7ab	O
in	O
this	O
process	O
.	O

CONCLUSIONS	O
:	O
CMV	B-SPEC
pneumonia	O
is	O
associated	O
with	O
lower	O
CD4	O
(+)	O
T	O
cell	O
level	O
in	O
kidney	O
transplant	O
recipients	O
.	O

The	O
immune	O
responses	O
of	O
mice	B-SPEC
to	O
these	O
four	O
constructs	O
were	O
evaluated	O
.	O

Beyond	O
corona	B-SPEC
inception	O
(	O
i	O
.	O
e	O
.,	O
at	O
applied	O
voltages	O
of	O
-	O
10	O
,	O
-	O
8	O
,	O
+	O
8	O
,	O
and	O
+	O
10	O
kV	O
),	O
log	O
reduction	O
values	O
obtained	O
with	O
the	O
plaque	O
assay	O
were	O
much	O
higher	O
compared	O
to	O
those	O
of	O
the	O
qPCR	O
assay	O
because	O
nonviable	O
particles	O
,	O
while	O
present	O
in	O
the	O
effluent	O
were	O
unaccounted	O
for	O
in	O
the	O
plaque	O
assay	O
.	O

The	O
AIV	O
matrix	O
protein	O
(	O
M	O
),	O
and	O
HA	O
and	O
NA	O
genes	O
,	O
IBV	B-SPEC
nucleoprotein	O
(	O
NP	O
)	O
gene	O
,	O
NDV	B-SPEC
NP	O
gene	O
,	O
and	O
IBDV	B-SPEC
A	O
fragment	O
gene	O
were	O
cloned	O
into	O
plasmids	O
.	O

Results	O
demonstrated	O
that	O
microarray	O
based	O
on	O
asymmetric	O
RT	O
-	O
PCR	O
is	O
an	O
effective	O
way	O
to	O
distinguish	O
AIV	O
,	O
IBV	B-SPEC
,	O
NDV	B-SPEC
,	O
and	O
IBDV	B-SPEC
simultaneously	O
.	O

ABSTRACT	O
:	O
The	O
production	O
of	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
by	O
infiltrating	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
in	O
liver	O
is	O
involved	O
in	O
the	O
control	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
.	O

Virus	B-SPEC
infection	O
induced	O
an	O
increase	O
in	O
surfactant	O
protein	O
SP	O
-	O
D	O
levels	O
in	O
BALF	O
of	O
infected	O
rats	B-SPEC
on	O
days	O
4	O
and	O
8	O
p	O
.	O
i	O
.	O

TITLE	O
:	O
Epidemiology	O
and	O
clinical	O
presentations	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
infections	O
in	O
hong	O
kong	O
children	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
infected	O
patients	O
were	O
younger	O
and	O
more	O
likely	O
to	O
have	O
croup	O
,	O
febrile	O
convulsions	O
,	O
and	O
acute	O
gastroenteritis	O
.	O

Diarrheic	O
samples	O
(	O
n	O
=	O
191	O
)	O
were	O
assayed	O
for	O
rotavirus	B-SPEC
group	I-SPEC
A	I-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
Cryptosporidium	B-SPEC
,	O
and	O
Escherichia	B-SPEC
coli	I-SPEC
F5	O
by	O
antigen	O
ELISA	O
.	O

Blood	O
samples	O
from	O
calves	O
of	O
>	O
150	O
d	O
of	O
age	O
(	O
n	O
=	O
1	O
,	O
348	O
)	O
were	O
analyzed	O
for	O
antibodies	O
against	O
parainfluenza	O
virus	B-SPEC
3	O
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
),	O
and	O
Mycoplasma	B-SPEC
bovis	I-SPEC
.	O

Other	O
factors	O
found	O
to	O
increase	O
the	O
risk	O
of	O
respiratory	O
disease	O
in	O
calves	O
were	O
shared	O
housing	O
with	O
cows	B-SPEC
during	O
the	O
first	O
week	O
of	O
life	O
compared	O
with	O
separate	O
housing	O
(	O
HR	O
=	O
16	O
.	O
7	O
),	O
a	O
larger	O
herd	O
size	O
(>	O
50	O
cow	B-SPEC
years	O
)	O
compared	O
with	O
smaller	O
herds	O
(	O
HR	O
=	O
8	O
.	O
2	O
),	O
more	O
than	O
an	O
8	O
-	O
wk	O
age	O
difference	O
between	O
calves	O
housed	O
together	O
in	O
the	O
same	O
group	O
pen	O
compared	O
with	O
having	O
pen	O
mates	B-SPEC
of	O
a	O
more	O
similar	O
age	O
(	O
HR	O
=	O
3	O
.	O
9	O
),	O
previous	O
recordings	O
of	O
diarrhea	O
compared	O
with	O
no	O
recorded	O
diarrhea	O
(	O
HR	O
=	O
3	O
.	O
9	O
),	O
and	O
leaving	O
calves	O
with	O
dams	O
for	O
>	O
24	O
h	O
after	O
birth	O
compared	O
with	O
earlier	O
separation	O
(	O
HR	O
=	O
3	O
.	O
5	O
).	O

Risk	O
of	O
bias	B-SPEC
of	O
randomised	O
studies	O
was	O
assessed	O
for	O
generation	O
of	O
the	O
allocation	O
sequence	O
,	O
allocation	O
concealment	O
,	O
blinding	O
,	O
and	O
follow	O
-	O
up	O
.	O

However	O
,	O
many	O
simple	O
and	O
low	O
cost	O
interventions	O
reduce	O
the	O
transmission	O
of	O
epidemic	O
respiratory	O
viruses	B-SPEC
.	O

A	O
rapid	O
and	O
sensitive	O
microarray	O
approach	O
for	O
detection	O
of	O
these	O
viruses	B-SPEC
and	O
a	O
panel	O
of	O
specific	O
probes	O
covering	O
nine	O
genera	O
and	O
16	O
virus	B-SPEC
species	B-SPEC
were	O
designed	O
.	O

TITLE	O
:	O
Regulation	O
of	O
proinflammatory	O
cytokine	O
expression	O
in	O
primary	O
mouse	B-SPEC
astrocytes	O
by	O
coronavirus	B-SPEC
infection	O
.	O

In	O
this	O
study	O
the	O
development	O
of	O
a	O
real	O
-	O
time	O
TaqMan	O
RT	O
-	O
PCR	O
targeting	O
the	O
highly	O
conserved	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
of	O
IBV	B-SPEC
and	O
including	O
an	O
internal	O
PCR	O
control	O
is	O
described	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
N	O
protein	O
N	O
-	O
terminal	O
domain	O
(	O
NTD	O
)	O
specifically	O
binds	O
the	O
transcriptional	O
regulatory	O
sequence	O
(	O
TRS	O
)	O
and	O
melts	O
TRS	O
-	O
cTRS	O
RNA	O
duplexes	O
.	O

Viruses	B-SPEC
harboring	O
Y127A	O
N	O
mutation	O
are	O
strongly	O
selected	O
against	O
and	O
Y127A	O
N	O
does	O
not	O
support	O
an	O
accessory	O
function	O
in	O
MHV	B-SPEC
replication	O
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
maintenance	O
of	O
T	O
cell	O
responses	O
in	O
the	O
virus	B-SPEC
-	O
infected	O
CNS	O
is	O
a	O
dynamic	O
process	O
.	O

The	O
virus	B-SPEC
prevalence	O
in	O
insectivorous	O
bats	B-SPEC
(	O
n	O
=	O
123	O
)	O
was	O
9	O
.	O
76	O
%.	O

To	O
resolve	O
these	O
alternative	O
hypotheses	O
,	O
we	O
isolated	O
viral	O
sequences	O
from	O
FCoV	O
-	O
infected	O
clinically	O
healthy	O
and	O
sick	O
cats	B-SPEC
(	O
8	O
FIP	O
cases	O
and	O
48	O
FECV	B-SPEC
-	O
asymptomatic	O
animals	B-SPEC
);	O
735	O
sequences	O
from	O
4	O
gene	O
segments	O
were	O
generated	O
and	O
subjected	O
to	O
phylogenetic	O
analyses	O
.	O

ABSTRACT	O
:	O
Here	O
we	O
introduce	O
a	O
culture	O
system	O
for	O
the	O
isolation	O
,	O
passaging	O
and	O
amplification	O
of	O
avian	B-SPEC
tracheal	O
epithelial	O
(	O
ATE	O
)	O
cells	O
.	O

The	O
ATE	O
medium	O
,	O
which	O
contains	O
chicken	B-SPEC
embryo	O
extract	O
and	O
fetal	O
bovine	B-SPEC
serum	O
,	O
supports	O
the	O
growth	O
of	O
ciliated	O
cells	O
,	O
goblet	O
cells	O
and	O
basal	O
cells	O
from	O
chicken	B-SPEC
tracheas	O
on	O
fibronectin	O
-	O
or	O
matrigel	O
-	O
coated	O
dishes	O
.	O

TITLE	O
:	O
Role	O
of	O
spike	O
protein	O
endodomains	O
in	O
regulating	O
coronavirus	B-SPEC
entry	O
.	O

Seventy	O
-	O
three	O
of	O
the	O
251	O
samples	O
(	O
29	O
%)	O
were	O
seropositive	O
for	O
CRCoV	O
.	O
Dogs	B-SPEC
<	O
2	O
years	O
old	O
were	O
less	O
likely	O
to	O
be	O
seropositive	O
for	O
CRCoV	O
than	O
older	O
dogs	B-SPEC
.	O

RESULTS	O
:	O
Seventy	O
-	O
three	O
of	O
the	O
251	O
samples	O
(	O
29	O
%)	O
were	O
seropositive	O
for	O
CRCoV	O
.	O
Dogs	B-SPEC
<	O
2	O
years	O
old	O
were	O
less	O
likely	O
to	O
be	O
seropositive	O
for	O
CRCoV	O
than	O
older	O
dogs	B-SPEC
.	O

Although	O
infection	O
with	O
A	B-SPEC
.	I-SPEC
lumbricoides	I-SPEC
is	O
rare	O
in	O
the	O
United	O
States	O
,	O
it	O
may	O
become	O
manifest	O
with	O
severe	O
consequences	O
in	O
the	O
postoperative	O
period	O
.	O

RESULTS	O
:	O
Four	O
emergent	O
themes	O
included	O
:	O
(	O
1	O
)	O
substantial	O
personal	O
/	O
professional	O
dilemmas	O
;	O
(	O
2	O
)	O
assistance	O
with	O
child	O
,	O
elder	B-SPEC
,	O
and	O
/	O
or	O
pet	O
care	O
;	O
(	O
3	O
)	O
adequate	O
resources	O
and	O
vaccinations	O
to	O
protect	O
families	O
;	O
and	O
(	O
4	O
)	O
appropriate	O
mechanisms	O
to	O
enable	O
two	O
-	O
way	O
communication	O
between	O
employees	O
and	O
their	O
families	O
under	O
conditions	O
of	O
quarantine	O
or	O
long	O
work	O
hours	O
.	O

Data	O
indicated	O
that	O
neither	O
the	O
FAH	O
minimal	O
epitopes	O
nor	O
the	O
key	O
residues	O
important	O
for	O
binding	O
to	O
Ab	O
from	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
have	O
their	O
counterparts	O
in	O
the	O
viral	O
proteins	O
.	O

Differences	O
in	O
clinical	O
symptoms	O
between	O
probable	O
and	O
suspected	O
SARS	O
cases	O
were	O
tested	O
by	O
Fisher	B-SPEC
'	O
s	O
exact	O
test	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
demonstrated	O
that	O
the	O
replacement	O
of	O
the	O
S	O
gene	O
from	O
an	O
avirulent	O
strain	O
(	O
Beaudette	O
)	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
with	O
an	O
S	O
gene	O
from	O
a	O
virulent	O
strain	O
(	O
M41	O
)	O
resulted	O
in	O
a	O
recombinant	O
virus	B-SPEC
(	O
BeauR	O
-	O
M41	O
(	O
S	O
))	O
with	O
the	O
in	O
vitro	O
cell	O
tropism	O
of	O
the	O
virulent	O
virus	B-SPEC
but	O
that	O
was	O
still	O
avirulent	O
.	O

The	O
recombinant	O
IBV	B-SPEC
was	O
in	O
effect	O
a	O
chimaeric	O
virus	B-SPEC
with	O
the	O
replicase	O
gene	O
derived	O
from	O
Beaudette	O
and	O
the	O
rest	O
of	O
the	O
genome	O
from	O
M41	O
.	O

The	O
overall	O
prevalence	O
of	O
FCoV	O
infection	O
was	O
84	O
%	O
and	O
the	O
infection	O
rate	O
was	O
higher	O
in	O
Persian	O
purebred	O
cats	B-SPEC
(	O
96	O
%)	O
than	O
mix	O
-	O
breed	O
cats	B-SPEC
(	O
70	O
%).	O

TITLE	O
:	O
Genetic	O
analysis	O
of	O
canine	O
group	O
2	O
coronavirus	B-SPEC
in	O
Korean	O
dogs	B-SPEC
.	O

In	O
addition	O
,	O
information	O
was	O
collected	O
on	O
animal	B-SPEC
characteristics	O
and	O
herd	O
-	O
management	O
practices	O
.	O

Putative	O
risk	O
factors	O
for	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
Coronavirus	B-SPEC
and	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
included	O
the	O
presence	O
of	O
peer	O
-	O
calves	O
shedding	O
Coronavirus	B-SPEC
,	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
or	O
Rotavirus	B-SPEC
,	O
respectively	O
.	O

Main	O
outcome	O
measurements	O
were	O
age	O
,	O
breastfeeding	O
history	O
,	O
family	B-SPEC
smoking	O
habits	O
,	O
family	B-SPEC
history	O
for	O
asthma	O
and	O
atopy	O
,	O
blood	O
eosinophil	O
count	O
,	O
chest	O
radiological	O
findings	O
,	O
clinical	O
severity	O
score	O
and	O
number	O
of	O
days	O
of	O
hospitalisation	O
.	O

Thirty	O
-	O
two	O
primary	O
studies	O
on	O
term	O
infant	O
health	O
outcomes	O
,	O
43	O
primary	O
studies	O
on	O
maternal	O
health	O
outcomes	O
,	O
and	O
28	O
systematic	O
reviews	O
or	O
meta	B-SPEC
-	O
analyses	O
that	O
covered	O
approximately	O
400	O
individual	O
studies	O
were	O
included	O
in	O
this	O
review	O
.	O

TITLE	O
:	O
Virologic	O
survey	O
of	O
dogs	B-SPEC
with	O
naturally	O
acquired	O
idiopathic	O
conjunctivitis	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
frequency	O
of	O
viral	O
detection	O
in	O
conjunctival	O
samples	O
from	O
client	O
-	O
owned	O
domestic	O
dogs	B-SPEC
with	O
naturally	O
acquired	O
idiopathic	O
conjunctivitis	O
and	O
to	O
identify	O
signalment	O
,	O
historical	O
,	O
and	O
clinical	O
findings	O
positively	O
associated	O
with	O
viral	O
detection	O
.	O

Conjunctival	O
swab	O
specimens	O
were	O
analyzed	O
by	O
use	O
of	O
virus	B-SPEC
isolation	O
and	O
PCR	O
assays	O
for	O
the	O
following	O
viruses	B-SPEC
:	O
canine	B-SPEC
adenovirus	I-SPEC
-	O
2	O
(	O
CAV	B-SPEC
-	O
2	O
),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	B-SPEC
herpesvirus	I-SPEC
-	O
1	O
(	O
CHV	O
-	O
1	O
),	O
canine	O
parainfuenza	O
virus	B-SPEC
,	O
canine	O
respiratory	O
coronavirus	B-SPEC
,	O
infuenza	O
A	O
virus	B-SPEC
,	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
.	O

Therapeutic	O
strategies	O
can	O
target	O
either	O
the	O
viral	O
trigger	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
if	O
present	O
,	O
or	O
pathogenic	O
events	O
downstream	O
the	O
triggering	O
infection	O
,	O
e	O
.	O
g	O
,	O
the	O
proliferation	O
B	O
-	O
cells	O
directly	O
.	O

Antiviral	O
therapy	O
should	O
be	O
considered	O
as	O
a	O
first	O
-	O
line	O
treatment	O
in	O
many	O
HCV	B-SPEC
-	O
positive	O
patients	O
.	O

ABSTRACT	O
:	O
Autoimmune	O
hemolytic	O
anemia	B-SPEC
in	O
children	O
younger	O
than	O
2	O
years	O
of	O
age	O
is	O
usually	O
characterized	O
by	O
a	O
severe	O
course	O
,	O
with	O
a	O
mortality	O
rate	O
of	O
approximately	O
10	O
%.	O

We	O
describe	O
the	O
case	O
of	O
an	O
8	O
-	O
month	O
-	O
old	O
Caucasian	O
girl	O
affected	O
by	O
a	O
severe	O
form	O
of	O
autoimmune	O
hemolytic	O
anemia	B-SPEC
,	O
which	O
required	O
continuous	O
steroid	O
treatment	O
for	O
16	O
months	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
benign	O
acute	O
childhood	O
myositis	O
associated	O
with	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
infection	O
.	O

The	O
detection	O
limits	O
for	O
the	O
IBV	B-SPEC
RT	O
-	O
LAMP	O
assay	O
were	O
10	O
(	O
1	O
)	O
50	O
%	O
egg	O
infection	O
dose	O
(	O
EID	O
(	O
50	O
))	O
per	O
50	O
microl	O
of	O
titrated	O
viruses	B-SPEC
and	O
no	O
cross	O
-	O
reaction	O
of	O
IBV	B-SPEC
RT	O
-	O
LAMP	O
was	O
found	O
when	O
tested	O
with	O
other	O
viruses	B-SPEC
including	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
avian	B-SPEC
reovirus	I-SPEC
(	O
ARV	O
),	O
and	O
infectious	O
laryngotrachietis	O
virus	B-SPEC
(	O
ILTV	B-SPEC
)	O
due	O
to	O
their	O
mismatch	O
with	O
IBV	B-SPEC
RT	O
-	O
LAMP	O
primers	O
.	O

TITLE	O
:	O
A	O
two	O
-	O
pronged	O
strategy	O
to	O
suppress	O
host	O
protein	O
synthesis	O
by	O
SARS	O
coronavirus	B-SPEC
Nsp1	O
protein	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp1	O
protein	O
suppresses	O
host	O
gene	O
expression	O
,	O
including	O
type	O
I	O
interferon	O
production	O
,	O
by	O
promoting	O
host	O
mRNA	O
degradation	O
and	O
inhibiting	O
host	O
translation	O
,	O
in	O
infected	O
cells	O
.	O

TITLE	O
:	O
Morphogenesis	O
of	O
Coronavirus	B-SPEC
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
in	O
Cell	O
Culture	O
:	O
A	O
Transmission	O
Electron	O
Microscopic	O
Study	O
.	O

TITLE	O
:	O
Detection	O
and	O
molecular	O
characterization	O
of	O
gene	O
3	O
and	O
5	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
from	O
turkeys	B-SPEC
with	O
severe	O
enteritis	O
in	O
Brazil	O
.	O

Reverse	O
transcription	O
-	O
PCR	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
,	O
nucleotide	O
sequencing	O
,	O
and	O
GenBank	O
BLAST	O
database	O
analyses	O
of	O
the	O
hypervariable	O
region	O
of	O
the	O
S1	O
subunit	O
of	O
the	O
virus	B-SPEC
spike	O
gene	O
showed	O
that	O
the	O
three	O
isolates	O
,	O
designated	O
TN20	O
/	O
00	O
,	O
TN200	O
/	O
01	O
,	O
and	O
TN335	O
/	O
01	O
,	O
share	O
from	O
64	O
%	O
to	O
82	O
%	O
homologies	O
between	O
each	O
other	O
but	O
are	O
very	O
different	O
from	O
the	O
H120	O
strain	O
,	O
the	O
only	O
infectious	O
bronchitis	O
vaccine	O
used	O
in	O
Tunisia	O
.	O

Recently	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
,	O
which	O
inactivates	O
angiotensin	O
II	O
,	O
has	O
been	O
shown	O
to	O
ameliorate	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

Animals	B-SPEC
treated	O
with	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
maintained	O
significantly	O
higher	O
PaO2	O
than	O
the	O
control	O
group	O
,	O
and	O
pulmonary	O
hypertension	O
was	O
less	O
pronounced	O
.	O

Further	O
,	O
adoptive	O
transfer	O
of	O
activated	O
but	O
not	O
resting	O
bone	O
marrow	O
-	O
derived	O
dendritic	O
cells	O
(	O
BMDC	O
)	O
protect	O
mice	B-SPEC
from	O
lethal	O
MA15	O
infection	O
.	O

We	O
adapted	O
and	O
characterized	O
a	O
new	O
strain	O
of	O
SARS	O
-	O
CoV	O
(	O
strain	O
v2163	O
)	O
that	O
was	O
highly	O
lethal	O
in	O
5	O
-	O
to	O
6	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Strain	O
v2163	O
increased	O
IL	O
-	O
1alpha	O
,	O
IL	O
-	O
6	O
,	O
MIP	O
-	O
1alpha	O
,	O
MCP	O
-	O
1	O
,	O
and	O
RANTES	O
in	O
mice	B-SPEC
,	O
and	O
high	O
IL	O
-	O
6	O
expression	O
correlated	O
with	O
mortality	O
.	O

The	O
new	O
influenza	O
A	O
pandemia	O
was	O
transmitted	O
from	O
swine	B-SPEC
to	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Interspecies	O
transmission	O
of	O
pathogens	O
may	O
result	O
in	O
the	O
emergence	O
of	O
new	O
infectious	O
diseases	O
in	O
humans	B-SPEC
as	O
well	O
as	O
in	O
domestic	O
and	O
wild	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
causes	O
a	O
prolonged	O
,	O
economically	O
devastating	O
infection	O
in	O
pigs	B-SPEC
,	O
and	O
immune	O
resistance	O
to	O
infection	O
appears	O
variable	O
.	O

Thus	O
,	O
young	O
piglets	O
,	O
growing	O
16	O
-	O
20	O
-	O
week	O
-	O
old	O
finisher	O
pigs	B-SPEC
,	O
and	O
mature	O
third	O
parity	O
sows	O
were	O
infected	O
with	O
virulent	O
or	O
attenuated	O
PRRSV	B-SPEC
,	O
and	O
the	O
dynamics	O
of	O
viral	O
infection	O
,	O
disease	O
,	O
and	O
immune	O
response	O
were	O
monitored	O
over	O
time	O
.	O

ABSTRACT	O
:	O
An	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
is	O
the	O
central	O
catalytic	O
subunit	O
of	O
the	O
RNA	O
-	O
synthesizing	O
machinery	O
of	O
all	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
.	O

However	O
,	O
female	O
and	O
male	O
mice	B-SPEC
that	O
received	O
the	O
high	O
dose	O
experienced	O
a	O
16	O
%	O
and	O
8	O
%	O
incidence	O
,	O
respectively	O
,	O
of	O
fatal	O
pulmonary	O
hemorrhage	O
.	O

On	O
the	O
other	O
hand	O
,	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
seldom	O
results	O
in	O
pulmonary	O
damage	O
,	O
and	O
pulmonary	O
complications	O
are	O
exceedingly	O
rare	O
.	O

TITLE	O
:	O
Otitis	O
media	O
:	O
viruses	B-SPEC
,	O
bacteria	B-SPEC
,	O
biofilms	O
and	O
vaccines	O
.	O

Predominant	O
bacteria	B-SPEC
that	O
cause	O
otitis	O
media	O
are	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
,	O
Moraxella	B-SPEC
catarrhalis	I-SPEC
,	O
and	O
non	O
-	O
typeable	O
Haemophilus	B-SPEC
influenzae	I-SPEC
.	O

TITLE	O
:	O
Immunity	O
after	O
natural	O
exposure	O
to	O
enteric	O
canine	O
coronavirus	B-SPEC
does	O
not	O
provide	O
complete	O
protection	O
against	O
infection	O
with	O
the	O
new	O
pantropic	O
CB	O
/	O
05	O
strain	O
.	O

Twenty	O
-	O
two	O
,	O
10	O
-	O
week	O
-	O
old	O
beagles	O
with	O
a	O
recent	O
natural	O
infection	O
by	O
enteric	O
CCoV	O
were	O
randomly	O
distributed	O
in	O
two	O
experimental	O
groups	O
of	O
eight	O
(	O
groups	O
A	O
and	O
B	O
)	O
and	O
one	O
control	O
group	O
of	O
six	O
(	O
group	O
C	O
)	O
dogs	B-SPEC
.	O

Our	O
findings	O
suggest	O
that	O
functional	O
3c	O
protein	O
expression	O
is	O
crucial	O
for	O
FECV	B-SPEC
replication	O
in	O
the	O
gut	O
,	O
but	O
dispensable	O
for	O
systemic	O
FIPV	O
replication	O
.	O

Most	O
cats	B-SPEC
with	O
FIP	O
had	O
no	O
detectable	O
intestinal	O
feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
)	O
and	O
had	O
seemingly	O
cleared	O
the	O
primary	O
FECV	B-SPEC
infection	O
.	O

Other	O
medical	O
concerns	O
include	O
recurrent	O
oral	O
staphylococcal	O
infections	O
,	O
otitis	O
media	O
,	O
ocular	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
keratitis	O
,	O
asthma	O
,	O
steroid	O
-	O
induced	O
gastritis	O
,	O
steroid	O
-	O
induced	O
cataracts	O
,	O
recurrent	O
upper	O
respiratory	O
infections	O
,	O
and	O
acute	O
pharyngitis	O
.	O

Blocking	O
CXCR2	O
signaling	O
did	O
not	O
impair	O
the	O
generation	O
of	O
virus	B-SPEC
-	O
specific	O
T	O
cells	O
,	O
indicating	O
that	O
CXCR2	O
is	O
not	O
required	O
to	O
tailor	O
anti	O
-	O
JHMV	O
T	O
cell	O
responses	O
.	O

ABSTRACT	O
:	O
NL63	O
coronavirus	B-SPEC
(	O
NL63	O
-	O
CoV	O
),	O
a	O
prevalent	O
human	B-SPEC
respiratory	O
virus	B-SPEC
,	O
is	O
the	O
only	O
group	O
I	O
coronavirus	B-SPEC
known	O
to	O
use	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
its	O
receptor	O
.	O

Type	O
II	O
FCoVs	O
can	O
be	O
propagated	O
to	O
high	O
titers	O
by	O
employing	O
feline	B-SPEC
aminopeptidase	O
N	O
(	O
fAPN	O
)	O
as	O
a	O
cellular	O
receptor	O
,	O
whereas	O
the	O
propagation	O
of	O
type	O
I	O
FCoVs	O
is	O
usually	O
difficult	O
,	O
and	O
the	O
involvement	O
of	O
fAPN	O
as	O
a	O
receptor	O
is	O
controversial	O
.	O

Following	O
intranasal	O
administration	O
,	O
the	O
virus	B-SPEC
replicated	O
in	O
the	O
lungs	O
,	O
with	O
peak	O
titers	O
on	O
day	O
2	O
postinfection	O
.	O

TITLE	O
:	O
Recombination	O
,	O
reservoirs	O
,	O
and	O
the	O
modular	O
spike	O
:	O
mechanisms	O
of	O
coronavirus	B-SPEC
cross	O
-	O
species	B-SPEC
transmission	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
past	O
30	O
years	O
,	O
several	O
cross	O
-	O
species	B-SPEC
transmission	O
events	O
,	O
as	O
well	O
as	O
changes	O
in	O
virus	B-SPEC
tropism	O
,	O
have	O
mediated	O
significant	O
animal	B-SPEC
and	O
human	B-SPEC
diseases	O
.	O

Eight	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
inoculated	O
intranasally	O
with	O
1	O
x	O
101	O
MID50	O
of	O
A	O
/	O
Chicken	B-SPEC
/	O
Hebei	O
/	O
108	O
/	O
2002	O
(	O
H5N1	O
)	O
viruses	B-SPEC
.	O

The	O
dramatically	O
elevated	O
hydroxyproline	O
levels	O
in	O
H5N1	O
-	O
infected	O
mice	B-SPEC
showed	O
deposition	O
of	O
collagen	O
in	O
lungs	O
,	O
and	O
confirmed	O
fibrosis	O
of	O
lungs	O
.	O

Three	O
animal	B-SPEC
trials	O
were	O
conducted	O
to	O
further	O
validate	O
the	O
assay	O
.	O

Ten	O
-	O
day	O
-	O
old	O
turkey	B-SPEC
poults	O
were	O
inoculated	O
orally	O
with	O
100	O
EID	O
(	O
50	O
)	O
of	O
TCoV	O
.	O
Intestinal	O
tissues	O
(	O
duodenum	O
,	O
jejunum	O
,	O
ileum	O
,	O
cecum	O
),	O
feces	O
from	O
the	O
cloacal	O
swabs	O
,	O
or	O
feces	O
from	O
the	O
floor	O
were	O
collected	O
at	O
12	O
h	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
/	O
or	O
14	O
days	O
post	O
-	O
inoculation	O
(	O
DPI	O
).	O

Taken	O
together	O
,	O
the	O
results	O
indicated	O
that	O
the	O
developed	O
RRT	O
-	O
PCR	O
assay	O
is	O
rapid	O
,	O
sensitive	O
,	O
and	O
specific	O
for	O
detection	O
,	O
differentiation	O
,	O
and	O
quantitation	O
of	O
TCoV	O
in	O
the	O
turkey	B-SPEC
tissues	O
and	O
should	O
be	O
helpful	O
in	O
monitoring	O
the	O
progression	O
of	O
TCoV	O
induced	O
acute	O
enteritis	O
in	O
the	O
turkey	B-SPEC
flocks	O
.	O

The	O
R667A	O
SARS	O
-	O
CoVpp	O
mutant	O
exhibited	O
a	O
lack	O
of	O
virus	B-SPEC
entry	O
enhancement	O
following	O
protease	O
treatment	O
.	O

These	O
results	O
suggest	O
that	O
SARS	O
S	O
-	O
protein	O
is	O
susceptible	O
to	O
airway	O
protease	O
cleavage	O
and	O
,	O
furthermore	O
,	O
that	O
protease	O
mediated	O
enhancement	O
of	O
virus	B-SPEC
entry	O
depends	O
on	O
specific	O
conformation	O
of	O
SARS	O
S	O
-	O
protein	O
upon	O
ACE2	O
binding	O
.	O

ABSTRACT	O
:	O
We	O
report	O
two	O
cases	O
of	O
severe	O
late	O
-	O
onset	O
nosocomial	O
pneumonia	O
caused	O
by	O
Chlamydophila	B-SPEC
pneumaniae	O
.	O

TITLE	O
:	O
Expression	O
of	O
beta	O
-	O
defensins	O
in	O
the	O
canine	O
respiratory	O
tract	O
and	O
antimicrobial	O
activity	O
against	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
.	O

Recent	O
epidemics	O
of	O
measles	O
,	O
avian	B-SPEC
flu	O
,	O
and	O
SARS	O
demonstrated	O
how	O
an	O
organism	O
can	O
rapidly	O
spread	O
worldwide	O
because	O
of	O
airline	O
travel	O
.	O

Specific	O
pathogen	O
free	O
1	O
-	O
week	O
-	O
old	O
chickens	B-SPEC
exhibited	O
severe	O
respiratory	O
symptoms	O
(	O
dyspnea	O
)	O
and	O
nephropathogenic	O
lesions	O
(	O
swollen	O
kidneys	O
with	O
nephritis	O
and	O
urate	O
deposits	O
)	O
following	O
challenge	O
with	O
the	O
recent	O
IBV	B-SPEC
field	O
strain	O
.	O

This	O
report	O
is	O
the	O
first	O
to	O
document	O
the	O
emergence	O
of	O
a	O
new	O
antigenic	O
variant	O
of	O
nephropathogenic	O
IBV	B-SPEC
in	O
chicken	B-SPEC
from	O
Korea	O
.	O

An	O
increasing	O
body	O
of	O
evidence	O
suggests	O
that	O
kidney	O
and	O
lung	O
interact	O
(	O
crosstalk	O
)	O
during	O
severe	O
insults	O
,	O
such	O
as	O
shock	O
,	O
trauma	O
,	O
and	O
sepsis	B-SPEC
,	O
due	O
to	O
a	O
loss	O
of	O
the	O
normal	O
balance	O
of	O
immune	O
,	O
inflammatory	O
and	O
soluble	O
mediators	O
.	O

Mean	O
body	O
weights	O
of	O
birds	B-SPEC
infected	O
at	O
2	O
or	O
28	O
days	O
of	O
age	O
were	O
significantly	O
reduced	O
compared	O
with	O
uninfected	O
birds	B-SPEC
by	O
7	O
d	O
.	O
p	O
.	O
i	O
.	O
and	O
remained	O
significantly	O
lower	O
for	O
the	O
duration	O
of	O
the	O
study	O
.	O

All	O
groups	O
were	O
inoculated	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
D1466	O
at	O
18	O
weeks	O
of	O
age	O
.	O

Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
is	O
a	O
positive	O
strand	O
RNA	O
virus	B-SPEC
that	O
,	O
following	O
intracranial	O
infection	O
of	O
susceptible	O
mice	B-SPEC
,	O
induces	O
an	O
acute	O
encephalomyelitis	O
that	O
later	O
resolves	O
into	O
a	O
chronic	O
fulminating	O
demyelinating	O
disease	O
.	O

ABSTRACT	O
:	O
Purified	O
nucleocapsid	O
protein	O
(	O
N	O
protein	O
)	O
from	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
enhanced	O
hammerhead	O
ribozyme	O
self	O
-	O
cleavage	O
and	O
favored	O
nucleic	O
acid	O
annealing	O
,	O
properties	O
that	O
define	O
RNA	O
chaperones	O
,	O
as	O
previously	O
reported	O
.	O

ABSTRACT	O
:	O
Cheetah	B-SPEC
populations	O
are	O
diminishing	O
rapidly	O
in	O
their	O
natural	O
habitat	O
.	O

There	O
was	O
no	O
clinical	O
or	O
pathological	O
evidence	O
of	O
infectious	O
diseases	O
in	O
living	O
or	O
dead	O
cheetahs	B-SPEC
.	O

TITLE	O
:	O
Comprehensive	O
detection	O
and	O
identification	O
of	O
seven	O
animal	B-SPEC
coronaviruses	O
and	O
human	B-SPEC
respiratory	O
coronavirus	B-SPEC
229E	O
with	O
a	O
microarray	O
hybridization	O
assay	O
.	O

The	O
results	O
showed	O
that	O
extensive	O
cross	O
-	O
reaction	O
existed	O
between	O
CCoV	O
,	O
FCoV	O
,	O
FIPV	O
,	O
TGEV	B-SPEC
and	O
PRCoV	O
,	O
while	O
there	O
was	O
no	O
cross	O
-	O
reaction	O
between	O
BCoV	O
,	O
TCoV	O
and	O
HRCoV	O
.	O
The	O
ultimate	O
specific	O
gene	O
chip	O
was	O
developed	O
with	O
DNA	O
fragments	O
reamplified	O
from	O
the	O
chosen	O
recombinant	O
plasmids	O
without	O
cross	O
-	O
reaction	O
between	O
different	O
coronaviruses	O
.	O

TITLE	O
:	O
[	O
Evaluation	O
of	O
clinical	O
effects	O
on	O
low	O
-	O
dose	O
heparin	O
therapy	O
for	O
sepsis	B-SPEC
].	O

The	O
prevalence	O
rates	O
for	O
Bartonella	B-SPEC
species	B-SPEC
antibodies	O
and	O
DNA	O
in	O
the	O
blood	O
and	O
the	O
tissues	O
did	O
not	O
differ	O
between	O
the	O
two	O
groups	O
.	O

ABSTRACT	O
:	O
Few	O
infectious	O
diseases	O
are	O
entirely	O
human	B-SPEC
-	O
specific	O
:	O
Most	O
human	B-SPEC
pathogens	O
also	O
circulate	O
in	O
animals	B-SPEC
or	O
else	O
originated	O
in	O
nonhuman	O
hosts	O
.	O

Influenza	O
,	O
plague	O
,	O
and	O
trypanosomiasis	O
are	O
classic	O
examples	O
of	O
zoonotic	O
infections	O
that	O
transmit	O
from	O
animals	B-SPEC
to	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
structure	O
of	O
the	O
X	O
(	O
or	O
ADRP	O
)	O
domain	O
of	O
a	O
pathogenic	O
variant	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
has	O
been	O
determined	O
in	O
tetragonal	O
and	O
cubic	O
crystal	O
forms	O
to	O
3	O
.	O
1	O
and	O
2	O
.	O
2	O
A	O
resolution	O
,	O
respectively	O
.	O

Our	O
data	O
show	O
a	O
remarkable	O
resemblance	O
to	O
results	O
obtained	O
recently	O
by	O
others	O
with	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
.	O

The	O
observations	O
point	O
to	O
intriguing	O
and	O
as	O
yet	O
unrecognized	O
similarities	O
between	O
the	O
RTC	O
dynamics	O
of	O
different	O
plus	O
-	O
strand	O
RNA	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Predictive	O
modeling	O
and	O
inflammatory	O
biomarkers	O
in	O
rats	B-SPEC
with	O
lung	O
contusion	O
and	O
gastric	O
aspiration	O
.	O

We	O
previously	O
showed	O
that	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
spike	O
domain	O
2	O
(	O
S2	O
)	O
in	O
the	O
patient	O
sera	O
can	O
cross	O
-	O
react	O
with	O
human	B-SPEC
lung	O
epithelial	O
cells	O
;	O
however	O
,	O
the	O
autoantigen	O
is	O
not	O
yet	O
identified	O
.	O

Both	O
types	O
of	O
viruses	B-SPEC
translate	O
their	O
genetic	O
information	O
into	O
polyprotein	O
precursors	O
that	O
are	O
processed	O
by	O
virally	O
encoded	O
3C	O
proteases	O
(	O
3C	O
(	O
pro	O
))	O
and	O
3C	O
-	O
like	O
proteases	O
(	O
3CL	O
(	O
pro	O
)),	O
respectively	O
,	O
to	O
generate	O
functional	O
viral	O
proteins	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
S1	O
gene	O
sequences	O
of	O
the	O
isolated	O
27	O
strains	O
together	O
with	O
29	O
strains	O
published	O
in	O
Genbank	O
revealed	O
that	O
all	O
IBV	B-SPEC
strains	O
except	O
for	O
one	O
isolated	O
and	O
one	O
published	O
were	O
clustered	O
into	O
six	O
distinct	O
genotypes	O
I	O
-	O
VI	O
.	O

If	O
the	O
aircraft	O
is	O
only	O
partially	O
loaded	O
,	O
under	O
certain	O
conditions	O
more	O
infections	O
could	O
occur	O
in	O
First	O
Class	B-SPEC
than	O
in	O
Economy	O
Class	B-SPEC
.	O

Two	O
vectors	O
for	O
expressing	O
fusion	O
proteins	O
with	O
the	O
T25G	O
recognition	O
site	O
(	O
Ala	O
-	O
Val	O
-	O
Leu	O
-	O
Gln	O
[	O
downward	O
arrow	O
]	O
Met	O
)	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
yeast	B-SPEC
were	O
constructed	O
.	O

TITLE	O
:	O
Human	B-SPEC
rhinovirus	I-SPEC
and	O
coronavirus	B-SPEC
detection	O
among	O
allogeneic	O
hematopoietic	O
stem	O
cell	O
transplantation	O
recipients	O
.	O

TITLE	O
:	O
Novel	O
2009	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
infection	O
requiring	O
extracorporeal	O
membrane	O
oxygenation	O
in	O
a	O
pediatric	O
heart	O
transplant	O
recipient	O
.	O

In	O
October	O
2009	O
,	O
it	O
was	O
found	O
that	O
he	O
had	O
developed	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
secondary	O
to	O
novel	O
2009	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
.	O

Importantly	O
,	O
the	O
initial	O
specimen	O
evaluated	O
by	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
was	O
negative	O
for	O
novel	O
2009	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
.	O

Early	O
suspicion	O
for	O
infection	O
and	O
initiation	O
of	O
treatment	O
,	O
even	O
with	O
negative	O
testing	O
,	O
is	O
essential	O
for	O
cardiothoracic	O
transplant	O
recipients	O
during	O
the	O
current	O
pandemic	O
of	O
novel	O
2009	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
.	O

Furthermore	O
,	O
the	O
observation	O
indicates	O
that	O
viral	O
infection	O
has	O
cytopathic	O
effects	O
on	O
the	O
monocyte	O
lineage	O
,	O
which	O
plays	O
a	O
critical	O
role	O
in	O
innate	O
immunity	O
,	O
leading	O
to	O
the	O
rapid	O
spread	O
of	O
viruses	B-SPEC
during	O
the	O
early	O
stage	O
of	O
infection	O
.	O

The	O
FCoV	O
positive	O
cases	O
included	O
56	O
%	O
domestic	O
short	O
hair	O
(	O
DSH	O
),	O
40	O
%	O
Persian	O
,	O
and	O
4	O
%	O
Siamese	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
case	O
of	O
a	O
previously	O
healthy	O
lady	O
with	O
community	O
-	O
acquired	O
pneumonia	O
who	O
progressed	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
renal	O
failure	O
,	O
disseminated	O
intravascular	O
coagulation	O
and	O
sepsis	B-SPEC
is	O
reported	O
.	O

More	O
than	O
half	O
of	O
patients	O
had	O
patchy	O
alveolar	O
infiltrates	O
on	O
chest	O
X	O
ray	B-SPEC
.	O

Bats	B-SPEC
carrying	O
SARSr	O
-	O
Rh	O
-	O
BatCoV	O
appeared	O
healthy	O
,	O
with	O
viral	O
clearance	O
occurring	O
between	O
2	O
weeks	O
and	O
4	O
months	O
.	O

TITLE	O
:	O
Contribution	O
of	O
the	O
porcine	B-SPEC
aminopeptidase	O
N	O
(	O
CD13	O
)	O
receptor	O
density	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
.	O

Thus	O
,	O
8	O
(	O
19	O
%)	O
cases	O
were	O
positive	O
for	O
a	O
single	O
virus	B-SPEC
,	O
whereas	O
a	O
combination	O
of	O
viruses	B-SPEC
was	O
detected	O
in	O
the	O
remaining	O
35	O
(	O
81	O
%)	O
cases	O
.	O

The	O
presence	O
of	O
more	O
than	O
one	O
virus	B-SPEC
and	O
changes	O
at	O
the	O
genetic	O
level	O
in	O
a	O
virus	B-SPEC
may	O
affect	O
the	O
severity	O
of	O
PES	O
in	O
turkey	B-SPEC
flocks	O
.	O

TITLE	O
:	O
A	O
prospective	O
molecular	O
surveillance	O
study	O
evaluating	O
the	O
clinical	O
impact	O
of	O
community	O
-	O
acquired	O
respiratory	O
viruses	B-SPEC
in	O
lung	O
transplant	O
recipients	O
.	O

A	O
respiratory	O
virus	B-SPEC
was	O
isolated	O
in	O
48	O
of	O
93	O
(	O
51	O
.	O
6	O
%)	O
patients	O
on	O
at	O
least	O
one	O
BAL	O
sample	O
.	O

Of	O
81	O
positive	O
samples	O
,	O
the	O
viruses	B-SPEC
isolated	O
included	O
rhinovirus	B-SPEC
(	O
n	O
=	O
46	O
),	O
parainfluenza	O
1	O
to	O
4	O
(	O
n	O
=	O
17	O
),	O
coronavirus	B-SPEC
(	O
n	O
=	O
11	O
),	O
influenza	O
(	O
n	O
=	O
4	O
),	O
metapneumovirus	B-SPEC
(	O
n	O
=	O
4	O
),	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
n	O
=	O
2	O
).	O

Using	O
N	O
-	O
terminally	O
FLAG	B-SPEC
-	O
tagged	O
ORF	O
3	O
protein	O
and	O
an	O
antiserum	O
specific	O
to	O
the	O
C	O
-	O
terminus	O
we	O
verified	O
the	O
proposed	O
topology	O
of	O
an	O
extracellular	O
N	O
-	O
terminus	O
and	O
a	O
cytosolic	O
C	O
-	O
terminus	O
.	O

Comparative	O
sequence	O
analysis	O
of	O
the	O
distal	O
one	O
-	O
third	O
of	O
the	O
genomes	O
of	O
one	O
FRSCV	O
and	O
one	O
FRECV	O
strain	O
showed	O
that	O
these	O
two	O
ferret	B-SPEC
coronaviruses	O
share	O
>	O
96	O
%	O
nucleotide	O
sequence	O
identities	O
in	O
the	O
membrane	O
(	O
M	O
),	O
nucleocapsid	O
(	O
N	O
)	O
and	O
non	O
-	O
structural	O
protein	O
genes	O
(	O
partial	O
polymerase	O
,	O
open	O
reading	O
frames	O
[	O
ORFs	O
]	O
3	O
and	O
7b	O
).	O

These	O
findings	O
illustrate	O
the	O
prospect	O
for	O
TGEV	B-SPEC
-	O
specific	O
shRNAs	O
to	O
be	O
new	O
anti	O
-	O
TGEV	B-SPEC
agents	O
.	O

The	O
specificity	O
of	O
these	O
pandemic	O
strains	O
to	O
infect	O
lower	O
respiratory	O
tract	O
is	O
of	O
immunological	O
origin	O
:	O
only	O
patients	O
with	O
little	O
or	O
no	O
immunity	O
to	O
the	O
virus	B-SPEC
can	O
develop	O
viral	O
pneumonia	O
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
)	O
are	O
enveloped	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
that	O
induce	O
different	O
membrane	O
rearrangements	O
in	O
infected	O
cells	O
in	O
order	B-SPEC
to	O
efficiently	O
replicate	O
and	O
assemble	O
.	O

We	O
included	O
any	O
physical	O
interventions	O
(	O
isolation	O
,	O
quarantine	O
,	O
social	O
distancing	O
,	O
barriers	O
,	O
personal	O
protection	O
and	O
hygiene	O
)	O
to	O
prevent	O
transmission	O
of	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
attempted	O
to	O
establish	O
a	O
simple	O
detection	O
method	O
for	O
classification	O
of	O
IBV	B-SPEC
S1	O
genotypes	O
by	O
direct	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

The	O
present	O
study	O
indicates	O
that	O
genotype	O
-	O
specific	O
RT	O
-	O
PCR	O
could	O
be	O
a	O
convenient	O
and	O
useful	O
tool	O
for	O
determining	O
IBV	B-SPEC
serotypes	O
and	O
could	O
contribute	O
to	O
the	O
control	O
of	O
IBV	B-SPEC
outbreaks	O
in	O
Japan	O
.	O

Four	O
scientific	O
search	O
engines	O
using	O
12	O
search	O
sequences	O
identified	O
21	O
mask	O
studies	O
in	O
healthcare	O
settings	O
for	O
the	O
prevention	O
of	O
transmission	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
Bordetella	B-SPEC
pertussis	I-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

The	O
effect	O
of	O
QR448	O
(	O
a	O
)	O
on	O
IBV	B-SPEC
in	O
chickens	B-SPEC
was	O
also	O
investigated	O
.	O

Anti	O
-	O
IBV	B-SPEC
activity	O
of	O
QR448	O
(	O
a	O
)	O
was	O
greater	O
prior	O
to	O
virus	B-SPEC
attachment	O
and	O
entry	O
indicating	O
that	O
the	O
effect	O
is	O
virucidal	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
on	O
the	O
in	O
vivo	O
use	O
of	O
a	O
virucidal	O
mixture	O
of	O
compounds	O
effective	O
against	O
the	O
coronavirus	B-SPEC
IBV	B-SPEC
.	O

The	O
SARS	O
-	O
CoV	O
3CL	O
protease	O
was	O
purified	O
from	O
a	O
colon	O
bacillus	B-SPEC
recombinant	O
.	O

Various	O
strains	O
were	O
found	O
to	O
exhibit	O
moderate	O
to	O
complete	O
monolayer	O
protection	O
against	O
viral	O
RV	O
or	O
TGEV	B-SPEC
disruption	O
.	O

In	O
the	O
rest	O
of	O
the	O
cases	O
,	O
each	O
interaction	O
was	O
LAB	O
-	O
cell	O
line	O
-	O
virus	B-SPEC
specific	O
,	O
barring	O
general	O
conclusions	O
.	O

Consistent	O
with	O
a	O
role	O
in	O
virus	B-SPEC
replication	O
,	O
p6	O
partially	O
colocalized	O
with	O
nonstructural	O
protein	O
3	O
(	O
nsp3	O
),	O
a	O
marker	O
for	O
virus	B-SPEC
replication	O
complexes	O
.	O

Ticks	B-SPEC
are	O
among	O
the	O
most	O
competent	O
and	O
versatile	O
arthropod	B-SPEC
vectors	O
of	O
infectious	O
diseases	O
because	O
ticks	B-SPEC
of	O
all	O
ages	O
and	O
both	O
sexes	O
remain	O
infectious	O
for	O
generations	O
without	O
having	O
to	O
reacquire	O
infections	O
from	O
reservoir	O
hosts	O
.	O

The	O
passaged	O
virus	B-SPEC
remained	O
avirulent	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
isolation	O
of	O
the	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
identified	O
as	O
the	O
cause	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
the	O
detection	O
of	O
2	O
new	O
human	B-SPEC
CoVs	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	O
-	O
HKU1	O
)	O
have	O
led	O
to	O
studies	O
of	O
the	O
epidemiology	O
and	O
clinical	O
and	O
socioeconomic	O
effects	O
of	O
infections	O
caused	O
by	O
all	O
HCoVs	O
,	O
including	O
those	O
known	O
since	O
the	O
late	O
1960s	O
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
).	O

Furthermore	O
,	O
unlike	O
other	O
RNA	O
viruses	B-SPEC
,	O
HCoVs	O
can	O
easily	O
mutate	O
and	O
recombine	O
when	O
different	O
strains	O
infect	O
the	O
same	O
cells	O
and	O
give	O
rise	O
to	O
a	O
novel	O
virus	B-SPEC
with	O
unpredictable	O
host	O
ranges	O
and	O
pathogenicity	O
.	O

Major	O
glycans	O
were	O
high	O
-	O
mannose	O
(	O
Man	B-SPEC
(	O
5	O
-	O
9	O
)	O
GlcNAc	O
(	O
2	O
)),	O
hybrid	O
and	O
bi	O
-,	O
tri	O
-	O
and	O
tetra	B-SPEC
-	O
antennary	O
complex	O
with	O
and	O
without	O
bisecting	O
GlcNAc	O
and	O
core	O
fucose	O
.	O

Treatment	O
with	O
the	O
glucosidase	O
inhibitor	O
N	O
-	O
butyl	O
-	O
deoxynojirimycin	O
(	O
NB	O
-	O
DNJ	O
)	O
inhibited	O
N	O
-	O
glycan	O
processing	O
as	O
evidenced	O
by	O
the	O
appearance	O
of	O
glycans	O
of	O
composition	O
Glc	O
(	O
3	O
)	O
Man	B-SPEC
(	O
7	O
-	O
9	O
)	O
GlcNAc	O
(	O
2	O
).	O

TITLE	O
:	O
Heterogeneity	O
in	O
spike	O
protein	O
genes	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
viruses	B-SPEC
isolated	O
in	O
Korea	O
.	O

The	O
entire	O
S	O
genes	O
of	O
all	O
isolates	O
were	O
found	O
to	O
be	O
nine	O
nucleotides	O
longer	O
in	O
length	O
than	O
other	O
PEDV	B-SPEC
reference	O
strains	O
.	O

Reactive	O
hemophagocytosis	O
,	O
thrombotic	O
phenomena	O
,	O
lymphoid	O
atrophy	O
,	O
diffuse	O
alveolar	O
damage	O
,	O
and	O
multiorgan	O
dysfunction	O
similar	O
to	O
fatal	O
avian	B-SPEC
influenza	O
A	O
H5N1	O
infection	O
were	O
found	O
at	O
postmortem	O
examinations	O
.	O

Reactive	O
hemophagocytosis	O
,	O
thrombotic	O
phenomena	O
,	O
lymphoid	O
atrophy	O
,	O
diffuse	O
alveolar	O
damage	O
,	O
and	O
multiorgan	O
dysfunction	O
similar	O
to	O
fatal	O
avian	B-SPEC
influenza	O
A	O
H5N1	O
infection	O
were	O
found	O
at	O
postmortem	O
examinations	O
.	O

We	O
have	O
tested	O
the	O
performance	O
of	O
the	O
EpiSearch	O
algorithm	O
for	O
six	O
experimental	O
data	O
sets	O
of	O
phage	O
display	O
experiments	O
,	O
the	O
human	B-SPEC
epidermal	O
growth	O
factor	O
receptor	O
-	O
2	O
(	O
HER	O
-	O
2	O
/	O
neu	O
),	O
the	O
antibody	O
mAb	O
Bo2C11	O
targeting	O
the	O
C	O
(	O
2	O
)	O
domain	O
of	O
FVIII	O
,	O
antibodies	O
mAb	O
17b	O
and	O
mAb	O
b12	O
of	O
the	O
HIV	B-SPEC
envelope	O
protein	O
gp120	O
,	O
mAb	O
13b5	O
targeting	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
capsid	O
protein	O
and	O
80R	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

These	O
nuclei	O
and	O
their	O
telomere	O
content	O
strongly	O
contrasted	O
with	O
the	O
corona	B-SPEC
of	O
surrounding	O
lymphocytes	O
showing	O
numerous	O
midsized	O
telomere	O
hybridization	O
signals	O
.	O

Detailed	O
phylogenetic	O
analysis	O
and	O
epidemiologic	O
studies	O
have	O
suggested	O
that	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
originated	O
from	O
animals	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
generated	O
neutralization	O
escape	O
mutants	O
and	O
studied	O
the	O
effect	O
of	O
these	O
neutralization	O
escape	O
mutations	O
on	O
human	B-SPEC
and	O
animal	B-SPEC
receptor	O
usage	O
as	O
well	O
as	O
on	O
in	O
vitro	O
and	O
in	O
vivo	O
fitness	O
.	O

TITLE	O
:	O
Self	O
-	O
assembly	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
membrane	O
protein	O
.	O

ABSTRACT	O
:	O
Campylobacter	B-SPEC
jejuni	I-SPEC
enteritis	O
is	O
the	O
predominant	O
bacterial	O
infection	O
preceding	O
Guillain	O
-	O
Barr	O
syndrome	O
(	O
GBS	O
),	O
an	O
acute	O
postinfectious	O
immune	O
-	O
mediated	O
polyradiculoneuropathy	O
.	O

We	O
report	O
an	O
unusually	O
high	O
frequency	O
of	O
the	O
axonal	O
variant	O
of	O
Guillain	O
-	O
Barr	O
syndrome	O
in	O
Bangladesh	O
,	O
associated	O
with	O
preceding	O
Campylobacter	B-SPEC
jejuni	I-SPEC
infection	O
,	O
severe	O
residual	O
disability	O
,	O
and	O
high	O
mortality	O
.	O

The	O
apparent	O
simplicity	O
of	O
the	O
mechanism	O
of	O
SARS	O
-	O
CoV	O
neutralization	O
is	O
in	O
stark	O
contrast	O
to	O
the	O
complexity	O
shown	O
by	O
other	O
enveloped	O
viruses	B-SPEC
.	O

The	O
lung	O
samples	O
were	O
cultured	O
for	O
bacteria	B-SPEC
and	O
tested	O
by	O
multiplex	O
polymerase	O
chain	O
reaction	O
for	O
presence	O
of	O
swine	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
type	O
A	O
),	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
both	O
European	O
and	O
US	O
type	O
),	O
porcine	B-SPEC
circovirus	I-SPEC
type	I-SPEC
2	I-SPEC
(	O
PCV2	O
),	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
,	O
porcine	B-SPEC
cytomegalovirus	I-SPEC
,	O
Mycoplasma	B-SPEC
hyopneumoniae	I-SPEC
and	O
Mycoplasma	B-SPEC
hyorhinis	I-SPEC
.	O

Furthermore	O
,	O
addition	O
of	O
an	O
inhibitor	O
that	O
blocks	O
coronavirus	B-SPEC
protease	O
/	O
DUB	O
activity	O
did	O
not	O
abrogate	O
interferon	O
antagonism	O
.	O

TITLE	O
:	O
Identification	O
of	O
intertypic	O
recombinant	O
infectious	O
bronchitis	O
viruses	B-SPEC
from	O
slaughtered	O
chickens	B-SPEC
.	O

New	O
IBV	B-SPEC
geno	O
-	O
and	O
serotypes	O
are	O
continually	O
reported	O
.	O

Based	O
on	O
the	O
phylogenetic	O
analysis	O
of	O
the	O
S1	O
gene	O
,	O
11	O
of	O
13	O
isolates	O
(	O
84	O
.	O
6	O
%)	O
clustered	O
with	O
Taiwan	O
group	O
I	O
.	O
One	O
IBV	B-SPEC
isolate	O
showed	O
evidence	O
of	O
frequent	O
recombination	O
events	O
with	O
China	O
-	O
like	O
IBV	B-SPEC
in	O
the	O
spike	O
glycoprotein	O
(	O
S	O
)	O
gene	O
.	O

Based	O
on	O
our	O
work	O
,	O
we	O
suggest	O
that	O
sampling	O
chickens	B-SPEC
in	O
poultry	O
slaughterhouses	O
is	O
an	O
effective	O
and	O
valuable	O
means	O
of	O
compiling	O
viral	O
prevalence	O
data	O
,	O
particularly	O
in	O
situations	O
where	O
there	O
is	O
subclinical	O
infection	O
.	O

Furthermore	O
,	O
the	O
hemagglutination	O
titer	O
in	O
the	O
SIAMP	O
-	O
IBV	B-SPEC
group	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
the	O
IBV	B-SPEC
-	O
infected	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Based	O
on	O
structural	O
equation	O
modeling	O
,	O
findings	O
showed	O
that	O
self	O
-	O
care	O
self	O
-	O
efficacy	O
completely	O
mediated	O
the	O
effects	O
of	O
perceived	O
medical	O
staff	O
support	O
and	O
perceived	O
family	B-SPEC
/	O
friends	O
support	O
on	O
mental	O
health	O
status	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
resulting	O
from	O
novel	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
H1N1	O
)	O
infection	O
remains	O
uncommon	O
.	O

The	O
results	O
indicated	O
that	O
ZJ971	O
could	O
be	O
a	O
variant	O
of	O
IBV	B-SPEC
strain	O
H120	O
.	O

Quantum	O
dots	O
(	O
QDs	O
)	O
posses	O
unique	O
fluorescence	O
properties	O
that	O
have	O
also	O
been	O
explored	O
for	O
their	O
application	O
to	O
virus	B-SPEC
detection	O
when	O
combined	O
with	O
direct	O
antibody	O
conjugation	O
or	O
streptavidin	O
-	O
biotin	O
binding	O
systems	O
.	O

The	O
development	O
of	O
these	O
nanoparticle	O
-	O
based	O
detection	O
strategies	O
holds	O
the	O
potential	O
to	O
be	O
a	O
powerful	O
method	O
to	O
quickly	O
and	O
easily	O
confirm	O
respiratory	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Analysis	O
of	O
the	O
gene	O
3	O
region	O
sequences	O
of	O
Chinese	O
field	O
strains	O
of	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

Late	O
reactions	O
due	O
to	O
cow	B-SPEC
'	O
s	O
milk	O
allergy	O
are	O
atopic	O
dermatitis	O
,	O
chronic	O
diarrhoea	O
,	O
blood	O
in	O
the	O
stools	O
,	O
iron	O
deficiency	O
anaemia	O
,	O
gastroesophageal	O
reflux	O
disease	O
,	O
constipation	O
,	O
chronic	O
vomiting	O
,	O
colic	O
,	O
poor	O
growth	O
(	O
food	O
refusal	O
),	O
enterocolitis	O
syndrome	O
,	O
protein	O
-	O
losing	O
enteropathy	O
with	O
hypoalbuminemia	O
,	O
eosinophilic	O
oesophagogastroenteropathy	O
.	O

ABSTRACT	O
:	O
Mice	B-SPEC
infected	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
develop	O
acute	O
and	O
chronic	O
demyelinating	O
diseases	O
with	O
histopathological	O
similarities	O
to	O
multiple	O
sclerosis	O
.	O

Given	O
that	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
have	O
potent	O
anti	O
-	O
inflammatory	O
effects	O
,	O
we	O
adoptively	O
transferred	O
Tregs	O
into	O
infected	O
C57BL	O
/	O
6	O
and	O
RAG1	O
(-/-)	O
mice	B-SPEC
.	O

TITLE	O
:	O
A	O
simple	O
and	O
rapid	O
strip	O
test	O
for	O
detection	O
of	O
antibodies	O
to	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

The	O
GICA	O
test	O
strip	O
is	O
a	O
reliable	O
and	O
useful	O
tool	O
for	O
the	O
on	O
-	O
site	O
surveillance	O
of	O
anti	O
-	O
IBV	B-SPEC
antibodies	O
.	O

TITLE	O
:	O
Trypsin	O
-	O
induced	O
hemagglutination	O
activity	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

Both	O
strains	O
showed	O
HA	O
activity	O
with	O
rabbit	B-SPEC
erythrocytes	O
only	O
after	O
treatment	O
with	O
trypsin	O
or	O
neuraminidase	O
.	O

Recently	O
,	O
a	O
large	O
number	O
of	O
viruses	B-SPEC
closely	O
related	O
to	O
members	O
of	O
the	O
genus	B-SPEC
Coronavirus	B-SPEC
have	O
been	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
detected	O
in	O
bat	B-SPEC
species	B-SPEC
.	O

The	O
use	O
of	O
mathematical	O
models	O
is	O
illustrated	O
,	O
using	O
the	O
2001	O
UK	O
foot	O
-	O
and	O
-	O
mouth	O
disease	O
(	O
FMD	O
)	O
epidemic	O
,	O
the	O
2003	O
global	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
,	O
and	O
human	B-SPEC
influenza	O
pandemics	O
,	O
as	O
examples	O
.	O

The	O
construction	O
of	O
non	O
-	O
replicating	O
human	B-SPEC
adenovirus	B-SPEC
vector	O
encoding	O
S1	O
gene	O
of	O
IBV	B-SPEC
and	O
its	O
in	O
ovo	B-SPEC
delivery	O
demonstrated	O
the	O
potential	O
of	O
an	O
alternative	O
vaccination	O
strategy	O
against	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
affected	O
South	O
Africa	O
late	O
during	O
the	O
2009	O
Southern	O
hemisphere	O
winter	O
and	O
placed	O
an	O
extra	O
burden	O
on	O
a	O
health	O
care	O
system	O
already	O
dealing	O
with	O
a	O
high	O
prevalence	O
of	O
chronic	O
lung	O
diseases	O
and	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
infection	O
.	O

MHV	B-SPEC
can	O
,	O
under	O
some	O
circumstances	O
,	O
compromise	O
the	O
antiviral	O
effects	O
of	O
IFN	O
signaling	O
.	O

The	O
nucleocapsid	O
protein	O
as	O
well	O
as	O
the	O
nsp1	O
and	O
nsp3	O
proteins	O
of	O
MHV	B-SPEC
has	O
been	O
reported	O
to	O
have	O
IFN	O
antagonist	O
activity	O
.	O

However	O
,	O
in	O
primary	O
cell	O
types	O
such	O
as	O
plasmacytoid	O
dendritic	O
cells	O
(	O
pDC	O
)	O
and	O
macrophages	O
,	O
IFN	O
is	O
induced	O
by	O
MHV	B-SPEC
infection	O
and	O
an	O
antiviral	O
state	O
is	O
established	O
.	O

Other	O
primary	O
cell	O
types	O
such	O
as	O
neurons	O
,	O
astrocytes	O
and	O
hepatocytes	O
fail	O
to	O
produce	O
IFN	O
following	O
infection	O
and	O
,	O
in	O
vivo	O
,	O
likely	O
depend	O
on	O
IFN	O
produced	O
by	O
pDCs	O
and	O
macrophages	O
for	O
protection	O
from	O
MHV	B-SPEC
.	O

TITLE	O
:	O
An	O
outbreak	O
of	O
canine	O
coronavirus	B-SPEC
in	O
puppies	O
in	O
a	O
Greek	O
kennel	O
.	O

We	O
also	O
used	O
this	O
ELISA	O
system	O
to	O
evaluate	O
77	O
murine	B-SPEC
serum	O
samples	O
obtained	O
from	O
15	O
conventional	O
mouse	B-SPEC
rooms	O
in	O
research	O
facilities	O
in	O
Japan	O
and	O
found	O
that	O
approximately	O
half	O
of	O
the	O
serum	O
samples	O
contained	O
antibody	O
to	O
MNV	O
-	O
S7	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
known	O
respiratory	O
pathogens	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
belongs	O
to	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
and	O
causes	O
significant	O
economic	O
loss	O
in	O
Taiwan	O
(	O
TW	O
),	O
even	O
in	O
flocks	O
that	O
have	O
been	O
extensively	O
immunised	O
with	O
Massachusetts	O
(	O
Mass	O
)-	O
serotype	O
vaccines	O
.	O

The	O
best	O
awareness	O
within	O
both	O
groups	O
was	O
regarding	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
and	O
fair	O
knowledge	O
was	O
found	O
regarding	O
anthrax	B-SPEC
,	O
plague	O
,	O
Ebola	O
,	O
and	O
smallpox	B-SPEC
.	O

In	O
critically	O
ill	O
patients	O
with	O
pandemic	O
H1N1	O
,	O
kidney	O
injury	O
,	O
kidney	O
failure	O
,	O
and	O
the	O
need	O
for	O
dialysis	B-SPEC
are	O
common	O
and	O
associated	O
with	O
an	O
increase	O
in	O
mortality	O
and	O
length	O
of	O
intensive	O
care	O
unit	O
stay	O
.	O

Kidney	O
failure	O
was	O
associated	O
with	O
increased	O
death	O
(	O
OR	O
,	O
11	O
.	O
29	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
29	O
-	O
98	O
.	O
9	O
),	O
whereas	O
the	O
need	O
for	O
dialysis	B-SPEC
was	O
associated	O
with	O
an	O
increase	O
in	O
length	O
of	O
stay	O
(	O
RR	O
,	O
2	O
.	O
38	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
13	O
-	O
25	O
.	O
75	O
).	O

Viroporins	O
E	O
from	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
6K	O
from	O
Sindbis	B-SPEC
virus	I-SPEC
and	O
NS4A	O
protein	O
from	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
were	O
also	O
able	O
to	O
permeabilize	O
neighbouring	O
cells	O
to	O
different	O
extents	O
.	O

These	O
viruses	B-SPEC
were	O
more	O
pathogenic	O
and	O
replicated	O
to	O
higher	O
titers	O
in	O
the	O
lungs	O
of	O
mice	B-SPEC
lacking	O
both	O
IFN	O
receptors	O
than	O
in	O
mice	B-SPEC
with	O
single	O
IFN	O
receptor	O
defects	O
.	O

In	O
total	O
1756	O
respiratory	O
samples	O
,	O
from	O
hospitalized	O
children	O
or	O
children	O
who	O
visited	O
the	O
outpatient	O
clinic	O
,	O
were	O
tested	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

RESULTS	O
:	O
Sixty	O
-	O
nine	O
samples	O
were	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
positive	O
,	O
35	O
were	O
with	O
high	O
loads	O
,	O
and	O
of	O
these	O
25	O
were	O
single	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infections	O
.	O

In	O
85	O
BAL	O
samples	O
from	O
82	O
patients	O
,	O
median	O
viral	O
loads	O
were	O
as	O
follows	O
:	O
for	O
RSV	B-SPEC
(	O
n	O
=	O
35	O
),	O
2	O
.	O
6	O
x	O
10	O
(	O
6	O
)	O
copies	O
/	O
mL	O
;	O
for	O
parainfluenza	O
virus	B-SPEC
(	O
n	O
=	O
35	O
),	O
4	O
.	O
9	O
x	O
10	O
(	O
7	O
)	O
copies	O
/	O
mL	O
;	O
for	O
influenza	B-SPEC
virus	I-SPEC
(	O
n	O
=	O
9	O
),	O
6	O
.	O
8	O
x	O
10	O
(	O
5	O
)	O
copies	O
/	O
mL	O
;	O
for	O
MPV	B-SPEC
(	O
n	O
=	O
7	O
),	O
3	O
.	O
9	O
x	O
10	O
(	O
7	O
)	O
copies	O
/	O
mL	O
;	O
and	O
for	O
CoV	O
(	O
n	O
=	O
4	O
),	O
1	O
.	O
8	O
x	O
10	O
(	O
5	O
)	O
copies	O
/	O
mL	O
.	O
Quantitative	O
viral	O
load	O
was	O
not	O
associated	O
with	O
mechanical	O
ventilation	O
or	O
death	O
.	O

RESULTS	O
:	O
In	O
85	O
BAL	O
samples	O
from	O
82	O
patients	O
,	O
median	O
viral	O
loads	O
were	O
as	O
follows	O
:	O
for	O
RSV	B-SPEC
(	O
n	O
=	O
35	O
),	O
2	O
.	O
6	O
x	O
10	O
(	O
6	O
)	O
copies	O
/	O
mL	O
;	O
for	O
parainfluenza	O
virus	B-SPEC
(	O
n	O
=	O
35	O
),	O
4	O
.	O
9	O
x	O
10	O
(	O
7	O
)	O
copies	O
/	O
mL	O
;	O
for	O
influenza	B-SPEC
virus	I-SPEC
(	O
n	O
=	O
9	O
),	O
6	O
.	O
8	O
x	O
10	O
(	O
5	O
)	O
copies	O
/	O
mL	O
;	O
for	O
MPV	B-SPEC
(	O
n	O
=	O
7	O
),	O
3	O
.	O
9	O
x	O
10	O
(	O
7	O
)	O
copies	O
/	O
mL	O
;	O
and	O
for	O
CoV	O
(	O
n	O
=	O
4	O
),	O
1	O
.	O
8	O
x	O
10	O
(	O
5	O
)	O
copies	O
/	O
mL	O
.	O
Quantitative	O
viral	O
load	O
was	O
not	O
associated	O
with	O
mechanical	O
ventilation	O
or	O
death	O
.	O

ABSTRACT	O
:	O
To	O
verify	O
if	O
secretory	O
phospholipase	O
A2	O
(	O
sPLA2	O
)	O
is	O
increased	O
in	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
triggered	O
or	O
not	O
by	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
and	O
to	O
clarify	O
how	O
the	O
enzyme	O
may	O
influence	O
the	O
disease	O
severity	O
and	O
the	O
degree	O
of	O
ventilatory	O
support	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
how	O
children	O
requiring	O
endotracheal	O
intubation	O
are	O
mechanically	O
ventilated	O
in	O
Italian	O
pediatric	O
intensive	O
care	O
units	O
(	O
PICUs	B-SPEC
).	O

Mechanical	O
ventilation	O
is	O
frequently	O
used	O
in	O
Italian	O
PICUs	B-SPEC
with	O
almost	O
one	O
child	O
of	O
two	O
requiring	O
endotracheal	O
intubation	O
.	O

To	O
confront	O
emerging	O
viral	O
threats	O
,	O
nations	O
have	O
implemented	O
strategies	O
to	O
prepare	O
for	O
pandemics	O
and	O
to	O
control	O
virus	B-SPEC
spread	O
.	O

1	O
.	O
1	O
to	O
0	O
.	O
45	O
+/-	O
0	O
.	O
06	O
.	O
We	O
have	O
developed	O
a	O
reproducible	O
large	O
animal	B-SPEC
model	O
of	O
acetaminophen	O
-	O
induced	O
liver	O
failure	O
,	O
which	O
allows	O
in	O
-	O
depth	O
investigation	O
of	O
the	O
pathophysiological	O
basis	O
of	O
this	O
condition	O
.	O

TITLE	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
delays	O
expression	O
of	O
a	O
subset	O
of	O
interferon	O
-	O
stimulated	O
genes	O
.	O

This	O
review	O
attempts	O
to	O
bridge	O
this	O
gap	O
by	O
presenting	O
conceptual	O
,	O
technical	O
,	O
and	O
practical	O
aspects	O
of	O
applying	O
phylogenetic	O
methods	O
in	O
studies	O
of	O
influenza	O
,	O
HIV	B-SPEC
,	O
and	O
SCoV	O
.	O
It	O
aims	O
to	O
provide	O
,	O
with	O
minimal	O
mathematics	O
and	O
statistics	O
,	O
a	O
practical	O
overview	O
of	O
how	O
phylogenetic	O
methods	O
can	O
be	O
incorporated	O
into	O
virological	O
studies	O
by	O
clinical	O
and	O
laboratory	O
specialists	O
.	O

ABSTRACT	O
:	O
Guillain	O
-	O
Barr	O
syndrome	O
includes	O
acute	O
inflammatory	O
demyelinating	O
polyradiculoneuropathy	O
,	O
acute	O
motor	O
axonal	O
neuropathy	O
,	O
acute	O
motor	O
and	O
sensory	O
axonal	O
neuropathy	O
,	O
Miller	O
Fisher	B-SPEC
syndrome	O
and	O
acute	O
pandysautonomia	O
.	O

The	O
present	O
review	O
highlights	O
the	O
drug	O
design	O
approaches	O
utilized	O
to	O
understand	O
the	O
mechanism	O
of	O
inhibition	O
and	O
discovery	O
of	O
inhibitors	O
against	O
protozoal	O
cysteine	O
protease	O
,	O
falcipain	O
(	O
a	O
cysteine	O
protease	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
which	O
causes	O
malaria	O
),	O
and	O
viral	O
cysteine	O
protease	O
,	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
(	O
a	O
cysteine	O
protease	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
).	O

A	O
monoclonal	O
antibody	O
designated	O
2D2	O
was	O
prepared	O
against	O
the	O
IBV	B-SPEC
N	O
protein	O
,	O
and	O
a	O
series	O
of	O
23	O
partially	O
overlapping	O
,	O
tagged	O
fragments	O
of	O
the	O
IBV	B-SPEC
N	O
gene	O
were	O
expressed	O
.	O

These	O
peptides	O
and	O
five	O
heterogeneous	O
IBV	B-SPEC
strains	O
were	O
used	O
to	O
identify	O
the	O
epitope	O
recognized	O
by	O
2D2	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
and	O
Western	O
blotting	O
analysis	O
.	O

RBD219	O
-	O
CHO	O
protein	O
elicited	O
potent	O
protective	O
immunity	O
that	O
protected	O
all	O
vaccinated	O
mice	B-SPEC
from	O
SARS	O
-	O
CoV	O
challenge	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
spread	O
during	O
the	O
winter	O
of	O
2003	O
,	O
and	O
attempts	O
have	O
been	O
made	O
to	O
develop	O
vaccines	O
against	O
SARS	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
present	O
report	O
is	O
,	O
to	O
our	O
knowledge	O
,	O
the	O
first	O
on	O
a	O
heart	O
transplant	O
patient	O
who	O
developed	O
H1N1	O
virus	B-SPEC
infection	O
and	O
had	O
a	O
favorable	O
outcome	O
,	O
thus	O
generating	O
discussion	O
on	O
the	O
real	O
role	O
of	O
immunosuppressive	O
therapy	O
as	O
a	O
risk	O
factor	O
for	O
the	O
severe	O
form	O
of	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
4	O
-[(	O
1	O
,	O
2	O
-	O
dihydro	O
-	O
2	O
-	O
oxo	O
-	O
3H	O
-	O
indol	O
-	O
3	O
-	O
ylidene	O
)	O
amino	O
]-	O
N	O
(	O
4	O
,	O
6	O
-	O
dimethyl	O
-	O
2	O
-	O
pyrimidiny	O
)	O
benzene	O
sulphonamide	O
and	O
its	O
derivatives	O
were	O
evaluated	O
for	O
antiviral	O
activity	O
against	O
Pathogenic	O
viruses	B-SPEC
such	O
as	O
Hepatitis	B-SPEC
C	I-SPEC
Virus	I-SPEC
and	O
SARS	O
-	O
CoV	O
in	O
Vero	O
and	O
Huh	O
5	O
-	O
2	O
cells	O
,	O
respectively	O
.	O

The	O
presence	O
of	O
two	O
or	O
three	O
different	O
viruses	B-SPEC
in	O
combination	O
may	O
affect	O
the	O
dynamics	O
of	O
turkey	B-SPEC
health	O
and	O
disease	O
.	O

In	O
this	O
study	O
the	O
susceptibility	O
of	O
specified	O
pathogen	O
free	O
(	O
SPF	O
)	O
broiler	O
breeder	O
hens	O
to	O
produce	O
eggs	O
with	O
EAA	O
after	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
infection	O
was	O
assessed	O
.	O

with	O
this	O
strain	O
at	O
19	O
and	O
26	O
weeks	O
of	O
age	O
,	O
a	O
group	O
inoculated	O
with	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
i	O
.	O
t	O
.	O

at	O
19	O
weeks	O
of	O
age	O
and	O
infected	O
5	O
days	O
earlier	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
D1466	O
(	O
IBV	B-SPEC
),	O
and	O
a	O
fifth	O
group	O
similar	O
to	O
the	O
former	O
but	O
inoculated	O
i	O
.	O
t	O
.	O

Avian	B-SPEC
metapneumoviruses	B-SPEC
,	O
the	O
cause	O
of	O
turkey	B-SPEC
rhinotracheitis	O
and	O
respiratory	O
disease	O
in	O
chickens	B-SPEC
exists	O
as	O
4	O
subtypes	O
,	O
A	O
,	O
B	O
,	O
C	O
and	O
D	O
.	O
A	O
and	O
B	O
are	O
widespread	O
and	O
vaccines	O
work	O
well	O
provided	O
that	O
accurate	O
doses	O
are	O
given	O
.	O

The	O
virus	B-SPEC
surface	O
glycoprotein	O
hemagglutinin	O
-	O
esterase	O
(	O
HE	O
)	O
is	O
responsible	O
for	O
both	O
viral	O
attachment	O
and	O
release	O
.	O

In	O
contrast	O
,	O
the	O
Ser	O
(	O
32	O
)	O
amino	O
acid	O
substitution	O
totally	O
abolished	O
enzymatic	O
activity	O
while	O
receptor	O
binding	O
increased	O
,	O
as	O
observed	O
by	O
agglutination	O
of	O
Atlantic	B-SPEC
salmon	I-SPEC
red	O
blood	O
cells	O
.	O

TITLE	O
:	O
Effect	O
of	O
mucosal	O
and	O
systemic	O
immunization	O
with	O
virus	B-SPEC
-	O
like	O
particles	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
mice	B-SPEC
.	O

Here	O
,	O
we	O
investigated	O
mucosal	O
immune	O
responses	O
to	O
SARS	O
-	O
CoV	O
VLPs	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

Mice	B-SPEC
were	O
immunized	O
in	O
parallel	O
,	O
intraperitoneally	O
or	O
intranasally	O
,	O
with	O
VLPs	O
alone	O
or	O
with	O
VLPs	O
plus	O
cytosine	O
-	O
phosphate	O
-	O
guanosine	O
(	O
CpG	O
).	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
proteins	O
interacting	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
envelope	O
(	O
E	O
)	O
protein	O
,	O
a	O
SARS	O
-	O
CoV	O
was	O
engineered	O
including	O
two	O
tags	O
associated	O
to	O
the	O
E	O
protein	O
.	O

Our	O
study	O
suggests	O
that	O
unlike	O
PRRSV	B-SPEC
which	O
induces	O
apoptosis	O
in	O
AMs	O
,	O
respiratory	O
CoVs	O
such	O
as	O
PRCV	O
that	O
infect	O
pulmonary	O
epithelial	O
cells	O
and	O
cause	O
cytolysis	O
,	O
induce	O
NO	O
production	O
in	O
the	O
respiratory	O
tract	O
.	O

The	O
principal	O
receptor	O
for	O
MHV	B-SPEC
is	O
murine	B-SPEC
CEACAM1	O
(	O
mCEACAM1	O
).	O

We	O
compared	O
the	O
MHV	B-SPEC
susceptibility	O
of	O
these	O
chimeric	O
mice	B-SPEC
to	O
that	O
of	O
SJL	O
and	O
B6	O
mice	B-SPEC
.	O

TITLE	O
:	O
A	O
serological	O
survey	O
of	O
canine	O
respiratory	O
coronavirus	B-SPEC
and	O
canine	O
influenza	B-SPEC
virus	I-SPEC
in	O
Korean	O
dogs	B-SPEC
.	O

Serum	O
antibodies	O
for	O
both	O
viruses	B-SPEC
were	O
detected	O
in	O
6	O
of	O
the	O
483	O
dogs	B-SPEC
sampled	O
,	O
suggesting	O
that	O
these	O
viruses	B-SPEC
are	O
present	O
in	O
dogs	B-SPEC
in	O
Korea	O
.	O

ATF3	O
protein	O
expression	O
and	O
nuclear	O
translocation	O
is	O
increased	O
in	O
the	O
lung	O
after	O
mechanical	O
ventilation	O
in	O
wild	O
-	O
type	O
mice	B-SPEC
.	O

We	O
propose	O
ATF3	O
acts	O
to	O
counterbalance	O
CS	O
and	O
high	O
volume	O
-	O
induced	O
inflammation	O
,	O
dampening	O
its	O
ability	O
to	O
cause	O
injury	O
and	O
consequently	O
protecting	O
animals	B-SPEC
from	O
injurious	O
CS	O
.	O

picornavirus	B-SPEC
was	O
the	O
most	O
commonly	O
detected	O
virus	B-SPEC
with	O
WMP	O
17	O
.	O
3	O
%	O
(	O
95	O
%	O
CI	O
:	O
7	O
.	O
2	O
-	O
27	O
.	O
3	O
),	O
followed	O
by	O
influenza	O
;	O
7	O
.	O
4	O
%	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
-	O
12	O
.	O
0	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
;	O
5	O
.	O
3	O
%	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
6	O
-	O
9	O
.	O
0	O
),	O
corona	B-SPEC
viruses	B-SPEC
;	O
3	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
4	O
-	O
5	O
.	O
8	O
),	O
parainfluenza	O
;	O
2	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
4	O
-	O
4	O
.	O
8	O
),	O
adenovirus	B-SPEC
;	O
1	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
:	O
-	O
1	O
.	O
1	O
to	O
3	O
.	O
3	O
),	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
;	O
0	O
.	O
7	O
%	O
(	O
95	O
%	O
CI	O
:	O
-	O
0	O
.	O
3	O
to	O
1	O
.	O
8	O
).	O

TITLE	O
:	O
Detection	O
of	O
novel	O
respiratory	O
viruses	B-SPEC
from	O
influenza	O
-	O
like	O
illness	O
in	O
the	O
Philippines	O
.	O

However	O
,	O
the	O
epidemiology	O
of	O
these	O
viruses	B-SPEC
in	O
tropical	O
countries	O
remains	O
unclear	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
provide	O
an	O
overview	O
of	O
the	O
epidemiology	O
of	O
novel	O
respiratory	O
viruses	B-SPEC
,	O
including	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
human	B-SPEC
bocavirus	I-SPEC
,	O
new	O
subtypes	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
NL63	O
and	O
HKU1	O
),	O
KI	O
virus	B-SPEC
,	O
WU	O
virus	B-SPEC
,	O
and	O
Melaka	O
virus	B-SPEC
in	O
the	O
Philippines	O
,	O
a	O
tropical	O
country	O
.	O

The	O
coronavirus	B-SPEC
main	O
protease	O
,	O
3CL	O
(	O
pro	O
),	O
is	O
a	O
key	O
target	O
for	O
broad	O
-	O
spectrum	O
antiviral	O
development	O
because	O
of	O
its	O
critical	O
role	O
in	O
viral	O
maturation	O
and	O
high	O
degree	O
of	O
structural	O
conservation	O
among	O
coronaviruses	O
.	O

Characterization	O
of	O
these	O
dimerization	O
mechanisms	O
is	O
important	O
for	O
the	O
structure	O
-	O
based	O
design	O
of	O
new	O
treatments	O
targeting	O
coronavirus	B-SPEC
-	O
based	O
infections	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
nonstructural	O
proteins	O
1	O
to	O
3	O
are	O
processed	O
by	O
one	O
or	O
two	O
papain	O
-	O
like	O
proteases	O
(	O
PLP1	O
and	O
PLP2	O
)	O
at	O
specific	O
cleavage	O
sites	O
(	O
CS1	O
to	O
-	O
3	O
).	O

Examples	O
of	O
these	O
emerging	O
zoonotic	O
diseases	O
are	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	O
,	O
bovine	B-SPEC
spongiform	O
encephalopathy	O
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
the	O
clinical	O
features	O
of	O
patients	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
(	O
LRTI	O
)	O
attributable	O
to	O
influenza	O
A	O
pH1N1	O
virus	B-SPEC
and	O
compare	O
them	O
with	O
those	O
admitted	O
with	O
LRTI	O
due	O
to	O
other	O
viral	O
pathogens	O
.	O

PICU	B-SPEC
in	O
a	O
university	O
-	O
affiliated	O
,	O
tertiary	O
-	O
care	O
,	O
pediatric	O
hospital	O
.	O

A	O
pair	O
of	O
primers	O
(	O
P1	O
and	O
P4	O
)	O
specific	O
for	O
CDV	B-SPEC
corresponding	O
to	O
the	O
highly	O
conserved	O
region	O
of	O
the	O
CDV	B-SPEC
genome	O
were	O
used	O
as	O
a	O
common	O
primer	O
pair	O
in	O
the	O
first	O
-	O
round	O
PCR	O
of	O
the	O
nested	O
PCR	O
.	O

No	O
amplification	O
was	O
achieved	O
for	O
uninfected	O
cells	O
,	O
or	O
cells	O
infected	O
with	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
),	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
),	O
rabies	B-SPEC
virus	I-SPEC
(	O
RV	O
),	O
or	O
canine	B-SPEC
adenovirus	I-SPEC
(	O
CAV	B-SPEC
).	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
frequently	O
are	O
recovered	O
in	O
the	O
upper	O
-	O
respiratory	O
tract	O
during	O
acute	O
exacerbations	O
of	O
COPD	O
(	O
AECOPD	O
),	O
but	O
their	O
role	O
as	O
contributing	O
pathogens	O
remains	O
unclear	O
.	O

The	O
spleen	O
was	O
normal	O
in	O
echogenicity	O
in	O
14	O
cats	B-SPEC
and	O
was	O
hypoechoic	O
in	O
two	O
.	O

One	O
alternative	O
to	O
the	O
use	O
of	O
soyabean	O
oil	O
is	O
its	O
partial	O
replacement	O
by	O
fish	B-SPEC
oil	O
,	O
which	O
contains	O
n	O
-	O
3	O
fatty	O
acids	O
.	O

In	O
contrast	O
,	O
a	O
P1	O
-	O
Asn	O
substitution	O
at	O
the	O
nsp6	O
-	O
7	O
/	O
Q3379	O
,	O
nsp12	O
-	O
13	O
/	O
Q4868	O
,	O
nsp13	O
-	O
14	O
/	O
Q5468	O
,	O
and	O
nsp14	O
-	O
15	O
/	O
Q5989	O
sites	O
,	O
as	O
well	O
as	O
a	O
P1	O
-	O
Pro	O
substitution	O
at	O
the	O
nsp15	O
-	O
16	O
/	O
Q6327	O
site	O
,	O
abolished	O
3CLpro	O
-	O
mediated	O
cleavage	O
at	O
the	O
corresponding	O
position	O
and	O
blocked	O
the	O
recovery	O
of	O
infectious	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Immune	O
response	O
of	O
AA	O
broilers	O
to	O
IBV	B-SPEC
H120	O
vaccine	O
and	O
sodium	O
new	O
houttuyfonate	O
.	O

Three	O
children	O
,	O
aged	O
8	O
,	O
11	O
,	O
and	O
17	O
yrs	O
,	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
hemodynamic	O
compromise	O
related	O
to	O
the	O
2009	O
pH1N1	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
documented	O
by	O
polymerase	O
chair	O
reaction	O
.	O

Furthermore	O
,	O
none	O
of	O
the	O
antisera	O
used	O
in	O
this	O
study	O
neutralized	O
the	O
index	O
isolate	O
(	O
JP	O
/	O
Ibaraki	O
/	O
168	O
-	O
1	O
/	O
2009	O
)	O
in	O
virus	B-SPEC
neutralization	O
tests	O
.	O

ABSTRACT	O
:	O
Diseases	O
transmitted	O
from	O
animals	B-SPEC
have	O
assumed	O
substantial	O
public	O
health	O
importance	O
.	O

ABSTRACT	O
:	O
Most	O
RNA	O
viruses	B-SPEC
lack	O
the	O
mechanisms	O
to	O
recognize	O
and	O
correct	O
mutations	O
that	O
arise	O
during	O
genome	O
replication	O
,	O
resulting	O
in	O
quasispecies	O
diversity	O
that	O
is	O
required	O
for	O
pathogenesis	O
and	O
adaptation	O
.	O

However	O
,	O
it	O
is	O
not	O
known	O
how	O
viruses	B-SPEC
encoding	O
large	O
viral	O
RNA	O
genomes	O
such	O
as	O
the	O
Coronaviridae	B-SPEC
(	O
26	O
to	O
32	O
kb	O
)	O
balance	O
the	O
requirements	O
for	O
genome	O
stability	O
and	O
quasispecies	O
diversity	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
elucidate	O
the	O
role	O
of	O
TNF	O
-	O
alpha	O
in	O
the	O
development	O
of	O
virus	B-SPEC
-	O
endotoxin	O
-	O
induced	O
respiratory	O
disease	O
.	O

The	O
main	O
objective	O
was	O
to	O
investigate	O
the	O
potential	O
threat	O
of	O
stray	O
cats	B-SPEC
for	O
animal	B-SPEC
and	O
public	O
health	O
.	O

Our	O
results	O
revealed	O
that	O
zoonotic	O
agents	O
,	O
namely	O
dermatophyte	B-SPEC
fungi	B-SPEC
and	O
Toxocara	B-SPEC
cati	I-SPEC
were	O
present	O
in	O
stray	O
cat	B-SPEC
colonies	O
in	O
the	O
investigated	O
counties	O
.	O

The	O
compound	O
also	O
displayed	O
cathepsin	O
L	O
/	O
B	O
selectivity	O
of	O
>	O
700	O
-	O
fold	O
and	O
was	O
nontoxic	O
to	O
human	B-SPEC
aortic	O
endothelial	O
cells	O
at	O
100	O
muM	B-SPEC
.	O
The	O
oxocarbazate	O
and	O
a	O
related	O
thiocarbazate	O
(	O
PubChem	O
CID	O
16725315	O
)	O
were	O
tested	O
in	O
a	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
and	O
Ebola	B-SPEC
virus	I-SPEC
-	O
pseudotype	O
infection	O
assay	O
with	O
the	O
oxocarbazate	O
but	O
not	O
the	O
thiocarbazate	O
,	O
demonstrating	O
activity	O
in	O
blocking	O
both	O
SARS	O
-	O
CoV	B-SPEC
(	O
IC	O
(	O
50	O
)	O
=	O
273	O
+/-	O

RESULTS	O
:	O
Using	O
surface	O
plasmon	O
resonance	O
biomolecular	O
interaction	O
analysis	O
(	O
SPR	O
/	O
BIA	B-SPEC
)	O
and	O
matrix	O
-	O
assisted	O
laser	B-SPEC
desorption	O
/	O
ionization	O
time	O
of	O
flight	O
(	O
MALDI	O
-	O
TOF	O
)	O
mass	O
spectrometry	O
,	O
we	O
found	O
that	O
only	O
the	O
proteasome	O
subunit	O
p42	O
from	O
human	B-SPEC
fetal	O
lung	O
diploid	O
fibroblast	O
(	O
2BS	O
)	O
cells	O
bound	O
to	O
SARS	O
-	O
CoV	O
NP	O
.	O

ABSTRACT	O
:	O
The	O
association	O
between	O
coronaviruses	O
and	O
bats	B-SPEC
is	O
a	O
worldwide	O
phenomenon	O
and	O
bats	B-SPEC
belonging	O
to	O
genus	B-SPEC
Rhinolophus	I-SPEC
are	O
the	O
reservoir	O
host	O
for	O
several	O
coronaviruses	O
,	O
including	O
a	O
large	O
number	O
of	O
viruses	B-SPEC
closely	O
related	O
genetically	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Cytomegalovirus	B-SPEC
antigenemia	O
was	O
also	O
not	O
detected	O
.	O

TITLE	O
:	O
Varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
in	O
progressive	O
forms	O
of	O
multiple	O
sclerosis	O
.	O

Similar	O
to	O
findings	O
in	O
patients	O
with	O
R	O
/	O
R	O
MS	O
,	O
VZV	B-SPEC
might	O
be	O
associated	O
to	O
progressive	O
MS	O
,	O
but	O
in	O
minor	O
quantity	O
.	O

Inhibition	O
of	O
the	O
proteasome	O
by	O
different	O
chemical	O
compounds	O
(	O
i	O
.	O
e	O
.,	O
MG132	O
,	O
epoxomicin	O
,	O
and	O
Velcade	O
)	O
appeared	O
to	O
not	O
only	O
impair	O
entry	O
but	O
also	O
RNA	O
synthesis	O
and	O
subsequent	O
protein	O
expression	O
of	O
different	O
CoVs	O
(	O
i	O
.	O
e	O
.,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
[	O
MHV	B-SPEC
],	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
).	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
is	O
a	O
lethal	O
disease	O
of	O
felids	B-SPEC
caused	O
by	O
systemic	O
infection	O
with	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Many	O
viruses	B-SPEC
,	O
including	O
coronaviruses	O
(	O
CoVs	O
),	O
depend	O
on	O
a	O
functional	O
cellular	O
proteasome	O
for	O
efficient	O
infection	O
in	O
vitro	O
.	O

Among	O
them	O
,	O
13	O
received	O
ECMO	O
for	O
ARDS	O
(	O
5	O
H1N1	O
-	O
virus	B-SPEC
related	O
),	O
with	O
a	O
62	O
%	O
survival	O
.	O

Attenuated	O
Salmonella	B-SPEC
vaccine	O
(	O
chi8501	O
)	O
containing	O
swIFN	O
-	O
alpha	O
-	O
encoding	O
pYA3560	O
vector	O
(	O
chi8501	O
/	O
swIFN	O
-	O
alpha	O
)	O
successfully	O
induced	O
the	O
secretion	O
of	O
swIFN	O
-	O
alpha	O
protein	O
into	O
the	O
culture	O
supernatants	O
,	O
as	O
confirmed	O
by	O
SDS	O
-	O
PAGE	O
and	O
Western	O
blot	O
.	O

A	O
cross	O
-	O
sectional	O
serological	O
survey	O
for	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
was	O
carried	O
out	O
in	O
Swedish	O
beef	O
cattle	B-SPEC
to	O
explore	O
any	O
geographical	O
patterns	O
of	O
these	O
infections	O
.	O

An	O
area	O
in	O
south	O
-	O
east	O
Sweden	O
(	O
Kronoberg	O
-	O
Blekinge	O
)	O
had	O
lower	O
prevalences	O
for	O
both	O
infections	O
than	O
expected	O
(	O
23	O
.	O
8	O
and	O
20	O
.	O
7	O
%	O
for	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
respectively	O
).	O

TITLE	O
:	O
Synthesis	O
and	O
evaluation	O
of	O
novel	O
alpha	O
-	O
amino	O
cyclic	O
boronates	O
as	O
inhibitors	O
of	O
HCV	B-SPEC
NS3	O
protease	O
.	O

ABSTRACT	O
:	O
The	O
aim	O
of	O
this	O
paper	O
was	O
the	O
evaluation	O
of	O
clinical	O
characteristics	O
,	O
demographics	O
and	O
therapeutic	O
response	O
for	O
oseltamivir	O
,	O
among	O
patients	O
with	O
swine	B-SPEC
flu	O
confirmed	O
,	O
hospitalized	O
in	O
the	O
Hospital	O
For	O
Infectious	O
Diseases	O
in	O
Warsaw	O
,	O
Poland	O
.	O

We	O
observed	O
bacterial	O
superinfections	O
associated	O
with	O
swine	B-SPEC
flu	O
,	O
ARDS	O
and	O
shock	O
syndrome	O
,	O
secondary	O
bacterial	O
pneumonia	O
and	O
neurological	O
complications	O
.	O

CONCLUSIONS	O
:	O
In	O
a	O
sample	O
of	O
Kenyan	O
infants	O
and	O
children	O
admitted	O
with	O
severe	O
pneumonia	O
to	O
a	O
rural	O
hospital	O
,	O
RSV	B-SPEC
was	O
the	O
predominant	O
viral	O
pathogen	O
.	O

Here	O
,	O
we	O
show	O
that	O
DBA	O
/	O
2	O
mice	B-SPEC
infected	O
with	O
P	B-SPEC
.	I-SPEC
berghei	I-SPEC
ANKA	O
constitute	O
a	O
new	O
model	O
for	O
malaria	O
-	O
associated	O
ALI	O
.	O

Up	O
to	O
60	O
%	O
of	O
the	O
mice	B-SPEC
showed	O
dyspnea	O
,	O
airway	O
obstruction	O
and	O
hypoxemia	O
and	O
died	O
between	O
days	O
7	O
and	O
12	O
post	O
-	O
infection	O
.	O

TITLE	O
:	O
Severe	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
infection	O
in	O
cancer	B-SPEC
patients	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
90	O
%	O
(	O
395	O
)	O
of	O
hospitalized	O
children	O
:	O
194	O
(	O
44	O
%)	O
rhinovirus	B-SPEC
,	O
131	O
(	O
30	O
%)	O
adenovirus	B-SPEC
,	O
102	O
(	O
23	O
%)	O
RSV	B-SPEC
,	O
77	O
(	O
18	O
%)	O
para	O
influenza	B-SPEC
viruses	I-SPEC
(	O
PIV	O
),	O
66	O
(	O
15	O
%)	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
23	O
(	O
5	O
%)	O
influenza	O
,	O
and	O
25	O
(	O
6	O
%)	O
coronavirus	B-SPEC
.	O

Fifty	O
-	O
two	O
percent	O
(	O
221	O
)	O
of	O
control	O
children	O
had	O
a	O
virus	B-SPEC
detected	O
,	O
most	O
commonly	O
rhinovirus	B-SPEC
(	O
33	O
%),	O
and	O
adenovirus	B-SPEC
(	O
16	O
%).	O

RSV	B-SPEC
,	O
PIV	O
,	O
hMPV	B-SPEC
,	O
and	O
influenza	O
were	O
significantly	O
more	O
common	O
in	O
hospitalized	O
cases	O
than	O
control	O
children	O
,	O
but	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
were	O
not	O
.	O

TITLE	O
:	O
Crystallization	O
and	O
preliminary	O
X	O
-	O
ray	B-SPEC
diffraction	O
studies	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
nonstructural	O
protein	O
9	O
.	O

The	O
gene	O
segment	O
encoding	O
IBV	B-SPEC
nsp9	O
has	O
been	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

The	O
protein	O
has	O
been	O
crystallized	O
and	O
the	O
crystals	O
diffracted	O
X	O
-	O
rays	B-SPEC
to	O
2	O
.	O
44	O
A	O
resolution	O
.	O

TITLE	O
:	O
Accessory	O
protein	O
5a	O
is	O
a	O
major	O
antagonist	O
of	O
the	O
antiviral	O
action	O
of	O
interferon	O
against	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

A	O
particular	O
strain	O
of	O
MHV	B-SPEC
,	O
MHV	B-SPEC
-	O
S	O
,	O
exhibited	O
orders	O
-	O
of	O
-	O
magnitude	O
higher	O
sensitivity	O
to	O
IFN	O
than	O
prototype	O
strain	O
MHV	B-SPEC
-	O
A59	O
.	O

RESULTS	O
:	O
Ten	O
herds	O
were	O
antibody	O
negative	O
to	O
both	O
viruses	B-SPEC
and	O
were	O
compared	O
with	O
69	O
herds	O
positive	O
to	O
BCV	B-SPEC
or	O
BRSV	B-SPEC
or	O
both	O
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
of	O
purified	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
particles	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
coronavirus	B-SPEC
of	O
domestic	O
chickens	B-SPEC
causing	O
major	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
.	O

Apart	O
from	O
the	O
virus	B-SPEC
-	O
encoded	O
structural	O
proteins	O
,	O
we	O
detected	O
60	O
host	O
proteins	O
in	O
the	O
purified	O
virions	O
which	O
can	O
be	O
grouped	O
into	O
several	O
functional	O
categories	O
including	O
intracellular	O
trafficking	O
proteins	O
(	O
20	O
%),	O
molecular	O
chaperone	O
(	O
18	O
%),	O
macromolcular	O
biosynthesis	O
proteins	O
(	O
17	O
%),	O
cytoskeletal	O
proteins	O
(	O
15	O
%),	O
signal	O
transport	O
proteins	O
(	O
15	O
%),	O
protein	O
degradation	O
(	O
8	O
%),	O
chromosome	O
associated	O
proteins	O
(	O
2	O
%),	O
ribosomal	O
proteins	O
(	O
2	O
%),	O
and	O
other	O
function	O
proteins	O
(	O
3	O
%).	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
an	O
avian	B-SPEC
coronavirus	I-SPEC
affecting	O
the	O
respiratory	O
tract	O
of	O
chickens	B-SPEC
.	O

This	O
is	O
the	O
first	O
study	O
,	O
using	O
PCLSs	O
of	O
chicken	B-SPEC
origin	O
,	O
to	O
analyze	O
virus	B-SPEC
infection	O
.	O

Apparently	O
,	O
expansion	O
of	O
group	O
A	O
betacoronaviruses	O
into	O
new	O
hosts	O
and	O
niches	O
was	O
accompanied	O
by	O
changes	O
in	O
HE	O
ligand	O
and	O
substrate	O
preference	O
and	O
in	O
the	O
roles	O
of	O
HE	O
and	O
S	O
in	O
Sia	B-SPEC
receptor	O
usage	O
.	O

We	O
show	O
that	O
MHV	B-SPEC
co	O
-	O
opts	O
the	O
host	O
cell	O
machinery	O
for	O
COPII	O
-	O
independent	O
vesicular	O
ER	O
export	O
of	O
a	O
short	O
-	O
living	O
regulator	O
of	O
ER	O
-	O
associated	O
degradation	O
(	O
ERAD	O
),	O
EDEM1	O
,	O
to	O
derive	O
cellular	O
membranes	O
for	O
replication	O
.	O

Open	O
reading	O
frame	O
3	O
(	O
ORF3	O
)	O
is	O
the	O
only	O
accessory	O
gene	O
in	O
the	O
PEDV	B-SPEC
genome	O
.	O

The	O
entire	O
ORF3	O
genes	O
of	O
12	O
PEDV	B-SPEC
field	O
strains	O
and	O
one	O
vaccine	O
strain	O
were	O
sequenced	O
.	O

TITLE	O
:	O
Rapid	O
heat	O
-	O
treatment	O
attenuation	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Virus	B-SPEC
with	O
the	O
longest	O
incubation	O
time	O
that	O
produced	O
lesions	O
in	O
the	O
embryos	O
was	O
harvested	O
,	O
again	O
incubated	O
at	O
56	O
degrees	O
C	O
as	O
described	O
and	O
passaged	O
in	O
embryonated	O
eggs	O
.	O

The	O
attenuation	O
process	O
took	O
10	O
weeks	O
to	O
complete	O
,	O
which	O
is	O
a	O
substantially	O
shorter	O
time	O
than	O
required	O
to	O
attenuate	O
infectious	O
bronchitis	O
virus	B-SPEC
by	O
serial	O
passage	O
in	O
embryonated	O
eggs	O
without	O
heat	O
treatment	O
(	O
38	O
weeks	O
or	O
more	O
).	O

Generally	O
,	O
coronaviruses	O
displayed	O
marked	O
winter	O
seasonality	O
between	O
the	O
months	O
of	O
December	O
and	O
April	O
and	O
were	O
not	O
detected	O
in	O
summer	O
months	O
,	O
which	O
is	O
comparable	O
to	O
the	O
pattern	O
seen	O
with	O
influenza	B-SPEC
viruses	I-SPEC
.	O

HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
was	O
the	O
exception	O
;	O
detection	O
was	O
confined	O
to	O
the	O
winter	O
of	O
2008	O
and	O
was	O
sporadic	O
in	O
the	O
following	O
year	O
.	O

Susceptible	O
C3H	O
/	O
HeJ	O
mice	B-SPEC
mount	O
robust	O
and	O
broad	O
MHV	B-SPEC
-	O
1	O
-	O
specific	O
CD4	O
T	O
cell	O
responses	O
,	O
whereas	O
in	O
resistant	O
B6	O
mice	B-SPEC
,	O
Ag	O
-	O
specific	O
CD8	O
T	O
cell	O
responses	O
dominate	O
.	O

The	O
viruses	B-SPEC
causing	O
acute	O
bronchiolitis	O
in	O
the	O
community	O
were	O
hRSV	B-SPEC
(	O
42	O
%),	O
rhinovirus	B-SPEC
(	O
19	O
.	O
5	O
%),	O
coronavirus	B-SPEC
(	O
8	O
%),	O
PIV	O
(	O
3	O
.	O
5	O
%),	O
and	O
hMPV	B-SPEC
(	O
2	O
.	O
5	O
%).	O

Of	O
the	O
hRSV	B-SPEC
cases	O
,	O
48	O
.	O
2	O
%	O
were	O
detected	O
in	O
November	O
and	O
December	O
and	O
44	O
.	O
5	O
%	O
in	O
January	O
and	O
February	O
.	O

The	O
hRSV	B-SPEC
epidemic	O
started	O
the	O
1st	O
or	O
2nd	O
week	O
of	O
October	O
but	O
it	O
varied	O
from	O
one	O
year	O
to	O
another	O
and	O
from	O
one	O
region	O
to	O
another	O
.	O

A	O
rate	O
of	O
54	O
.	O
6	O
%	O
of	O
viruses	B-SPEC
was	O
detected	O
in	O
September	O
and	O
October	O
and	O
38	O
.	O
5	O
%	O
in	O
March	O
and	O
April	O
.	O

The	O
results	O
show	O
that	O
ACE2s	O
of	O
Myotis	B-SPEC
daubentoni	I-SPEC
and	O
Rhinolophus	B-SPEC
sinicus	I-SPEC
support	O
viral	O
entry	O
mediated	O
by	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
,	O
albeit	O
with	O
different	O
efficiency	O
in	O
comparison	O
to	O
that	O
of	O
the	O
human	B-SPEC
ACE2	O
.	O

This	O
calls	O
for	O
continuation	O
and	O
expansion	O
of	O
field	O
surveillance	O
studies	O
among	O
different	O
bat	B-SPEC
populations	O
to	O
eventually	O
identify	O
the	O
true	O
natural	O
reservoir	O
of	O
SARS	O
-	O
CoV	O
.	O

RESULTS	O
:	O
If	O
the	O
risks	O
of	O
hospital	O
and	O
community	O
infection	O
are	O
equal	O
,	O
95	O
%	O
of	O
patients	O
who	O
develop	O
symptoms	O
of	O
adenovirus	B-SPEC
infection	O
within	O
5	O
days	O
of	O
hospital	O
admission	O
will	O
have	O
been	O
infected	O
in	O
the	O
community	O
,	O
as	O
will	O
95	O
%	O
of	O
patients	O
who	O
develop	O
symptoms	O
within	O
3	O
days	O
for	O
human	B-SPEC
-	O
coronavirus	B-SPEC
infection	O
,	O
2	O
.	O
5	O
days	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
1	O
day	O
for	O
influenza	O
A	O
,	O
0	O
.	O
5	O
day	O
for	O
influenza	O
B	O
,	O
12	O
days	O
for	O
measles	O
,	O
2	O
days	O
for	O
parainfluenza	O
,	O
4	O
days	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
,	O
and	O
1	O
.	O
5	O
days	O
for	O
rhinovirus	B-SPEC
infection	O
.	O

Histopathological	O
and	O
immunohistochemical	O
methods	O
were	O
employed	O
to	O
define	O
the	O
main	O
sites	O
of	O
virus	B-SPEC
replication	O
.	O

To	O
search	O
for	O
such	O
cellular	O
proteins	O
,	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screening	O
was	O
carried	O
out	O
by	O
using	O
the	O
nonstructural	O
protein	O
14	O
(	O
nsp14	O
)	O
from	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
as	O
a	O
bait	O
protein	O
,	O
leading	O
to	O
the	O
identification	O
of	O
DDX1	O
,	O
a	O
cellular	O
RNA	O
helicase	O
in	O
the	O
DExD	O
/	O
H	O
helicase	O
family	B-SPEC
,	O
as	O
a	O
potential	O
interacting	O
partner	O
.	O

ABSTRACT	O
:	O
New	O
variants	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
have	O
emerged	O
in	O
Australia	O
despite	O
its	O
geographical	O
isolation	O
and	O
intensive	O
vaccination	O
programs	O
.	O

It	O
was	O
concluded	O
that	O
novel	O
IBVs	O
,	O
which	O
have	O
not	O
been	O
detected	O
since	O
1993	O
,	O
and	O
which	O
are	O
phylogenically	O
more	O
distant	O
from	O
classical	O
IBVs	O
than	O
turkey	B-SPEC
coronaviruses	O
,	O
might	O
still	O
be	O
circulating	O
and	O
contributing	O
to	O
the	O
evolution	O
of	O
IBV	B-SPEC
in	O
Australia	O
.	O

As	O
demonstrated	O
by	O
the	O
international	O
response	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
influenza	O
A	O
,	O
rapid	O
genomic	O
sequencing	O
is	O
a	O
crucial	O
tool	O
to	O
understand	O
diseases	O
that	O
occur	O
at	O
the	O
interface	O
of	O
human	B-SPEC
and	O
animal	B-SPEC
populations	O
.	O

We	O
found	O
that	O
the	O
higher	O
the	O
isolation	O
rate	O
of	O
A	O
(	O
H3N2	O
)	O
and	O
vaccine	O
-	O
mismatched	O
influenza	B-SPEC
viruses	I-SPEC
,	O
the	O
greater	O
the	O
monthly	O
P	O
&	O
I	O
mortality	O
.	O

Mice	B-SPEC
were	O
randomly	O
assigned	O
to	O
one	O
of	O
the	O
following	O
groups	O
:	O
(	O
1	O
)	O
sham	O
-	O
operated	O
;	O
(	O
2	O
)	O
sham	O
+	O
HB	O
-	O
EGF	O
(	O
1200	O
microg	O
/	O
kg	O
in	O
0	O
.	O
6	O
mL	O
administered	O
by	O
intra	O
-	O
luminal	O
injection	O
at	O
the	O
jejuno	O
-	O
ileal	O
junction	O
immediately	O
after	O
identification	O
of	O
the	O
superior	O
mesenteric	O
artery	O
);	O
(	O
3	O
)	O
superior	O
mesenteric	O
artery	O
occlusion	O
for	O
45	O
min	O
followed	O
by	O
reperfusion	O
for	O
6	O
h	O
(	O
I	O
/	O
R	O
);	O
or	O
(	O
4	O
)	O
I	O
/	O
R	O
+	O
HB	O
-	O
EGF	O
(	O
1200	O
microg	O
/	O
kg	O
in	O
0	O
.	O
6	O
mL	O
)	O
administered	O
15	O
min	O
after	O
vascular	O
occlusion	O
.	O

TITLE	O
:	O
Vectored	O
vaccines	O
to	O
protect	O
against	O
PRRSV	B-SPEC
.	O

A	O
TGEV	B-SPEC
derived	O
vector	O
(	O
rTGEV	O
)	O
was	O
generated	O
,	O
expressing	O
PRRSV	B-SPEC
wild	O
type	O
or	O
modified	O
GP5	O
and	O
M	O
proteins	O
,	O
described	O
as	O
the	O
main	O
inducers	O
of	O
neutralizing	O
antibodies	O
and	O
cellular	O
immune	O
response	O
,	O
respectively	O
.	O

Since	O
the	O
ratios	O
of	O
these	O
sequences	O
generally	O
remained	O
constant	O
in	O
the	O
quasispecies	O
population	O
during	O
replication	O
,	O
factors	O
that	O
could	O
affect	O
the	O
balance	O
of	O
virulent	O
to	O
avirulent	O
sequences	O
during	O
viral	O
infection	O
of	O
birds	B-SPEC
were	O
investigated	O
.	O

We	O
hypothesized	O
that	O
during	O
host	O
invasion	O
,	O
the	O
replicating	O
IBV	B-SPEC
population	O
further	O
changes	O
as	O
it	O
confronts	O
the	O
distinct	O
environments	O
of	O
different	O
tissues	O
,	O
leading	O
to	O
selection	O
of	O
the	O
most	O
fit	O
population	O
.	O

However	O
,	O
synthesis	O
of	O
host	O
immune	O
and	O
non	O
-	O
immune	O
proteins	O
was	O
inhibited	O
by	O
nsp1	O
proteins	O
at	O
both	O
transcriptional	O
and	O
translational	O
levels	O
,	O
similar	O
to	O
SARS	O
coronavirus	B-SPEC
nsp1	O
.	O

TITLE	O
:	O
T	O
cell	O
responses	O
are	O
required	O
for	O
protection	O
from	O
clinical	O
disease	O
and	O
for	O
virus	B-SPEC
clearance	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

However	O
,	O
we	O
recently	O
showed	O
that	O
inefficient	O
immune	O
activation	O
and	O
a	O
poor	O
virus	B-SPEC
-	O
specific	O
T	O
cell	O
response	O
underlie	O
severe	O
disease	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
mice	B-SPEC
.	O

In	O
an	O
effort	O
to	O
survey	O
for	O
the	O
presence	O
of	O
other	O
infectious	O
agents	O
,	O
known	O
and	O
unknown	O
,	O
we	O
screened	O
sera	O
from	O
16	O
Pteropus	B-SPEC
giganteus	I-SPEC
bats	B-SPEC
from	O
Faridpur	O
,	O
Bangladesh	O
,	O
using	O
high	O
-	O
throughput	O
pyrosequencing	O
.	O

At	O
present	O
,	O
there	O
are	O
no	O
BCoV	O
vaccines	O
to	O
prevent	O
respiratory	O
BCoV	O
infections	O
in	O
cattle	B-SPEC
,	O
and	O
the	O
correlates	O
of	O
immunity	O
to	O
respiratory	O
BCoV	O
infections	O
are	O
unknown	O
.	O

Glasgow	O
Coma	B-SPEC
Scale	O
(	O
GCS	O
)	O
scores	O
and	O
the	O
need	O
for	O
cardiopulmonary	O
resuscitation	O
(	O
CPR	O
)	O
at	O
the	O
scene	O
of	O
injury	O
were	O
associated	O
with	O
eventual	O
patient	O
mortality	O
(	O
100	O
%	O
mortality	O
for	O
an	O
initial	O
GCS	O
score	O
of	O
3	O
and	O
75	O
%	O
mortality	O
for	O
on	O
-	O
scene	O
CPR	O
).	O

We	O
present	O
the	O
results	O
of	O
laboratory	O
tests	O
and	O
the	O
imaging	O
findings	O
(	O
chest	O
X	O
-	O
ray	B-SPEC
and	O
CT	O
scans	O
).	O

This	O
concept	O
is	O
further	O
highlighted	O
as	O
the	O
etiology	O
of	O
MS	O
remains	O
enigmatic	O
,	O
but	O
viruses	B-SPEC
have	O
long	O
been	O
considered	O
as	O
potential	O
triggering	O
agents	O
in	O
initiating	O
and	O
/	O
or	O
maintaining	O
MS	O
symptoms	O
.	O

Sequential	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	O
from	O
all	O
patients	O
hospitalised	O
with	O
acute	O
respiratory	O
illness	O
over	O
12	O
months	O
(	O
n	O
=	O
283	O
)	O
were	O
tested	O
for	O
the	O
presence	O
of	O
17	O
respiratory	O
viruses	B-SPEC
by	O
multiplex	O
PCR	O
assay	O
and	O
for	O
newly	O
discovered	O
respiratory	O
viruses	B-SPEC
(	O
bocavirus	B-SPEC
,	O
WU	O
and	O
KI	O
polyomaviruses	B-SPEC
)	O
by	O
single	O
-	O
target	O
PCR	O
.	O

39	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
37	O
(	O
13	O
.	O
1	O
%	O
of	O
total	O
)	O
patients	O
by	O
molecular	O
testing	O
,	O
including	O
rhinovirus	B-SPEC
(	O
n	O
=	O
13	O
),	O
influenza	B-SPEC
virus	I-SPEC
(	O
n	O
=	O
8	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
n	O
=	O
6	O
),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
n	O
=	O
3	O
),	O
coronavirus	B-SPEC
NL63	O
(	O
n	O
=	O
2	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
n	O
=	O
2	O
),	O
adenovirus	B-SPEC
(	O
n	O
=	O
1	O
)	O
and	O
newly	O
discovered	O
viruses	B-SPEC
(	O
n	O
=	O
4	O
).	O

Respiratory	O
viruses	B-SPEC
can	O
be	O
found	O
in	O
patients	O
with	O
serious	O
acute	O
respiratory	O
illness	O
by	O
use	O
of	O
PCR	O
assays	O
more	O
frequently	O
than	O
previously	O
appreciated	O
.	O

The	O
viral	O
7a	O
accessory	O
protein	O
suppressed	O
both	O
transgene	O
and	O
virus	B-SPEC
-	O
induced	O
gene	O
silencing	O
by	O
reducing	O
the	O
levels	O
of	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
).	O

ABSTRACT	O
:	O
We	O
report	O
here	O
investigation	O
into	O
the	O
genetic	O
basis	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
1	O
(	O
MHV	B-SPEC
-	O
1	O
)	O
pneumovirulence	O
.	O

This	O
finding	O
and	O
results	O
from	O
modified	O
substructures	O
suggest	O
that	O
also	O
the	O
surface	O
properties	O
seem	O
robust	O
enough	O
to	O
provide	O
stable	O
information	O
about	O
the	O
recognition	O
of	O
interacting	O
biomolecular	O
species	B-SPEC
although	O
they	O
are	O
obtained	O
from	O
medium	O
molecular	O
weighted	O
subfragments	O
of	O
macromolecular	O
complexes	O
,	O
which	O
consist	O
of	O
no	O
more	O
than	O
approximately	O
40	O
residues	O
.	O

ABSTRACT	O
:	O
Hens	O
were	O
vaccinated	O
during	O
the	O
rearing	O
phase	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccines	O
commercially	O
available	O
in	O
Australia	O
(	O
Vic	O
S	O
and	O
A3	O
)	O
or	O
left	O
unvaccinated	O
and	O
then	O
challenged	O
with	O
the	O
N1	O
/	O
88	O
strain	O
of	O
IBV	B-SPEC
at	O
30	O
wk	O
of	O
age	O
.	O

This	O
new	O
test	O
will	O
be	O
useful	O
for	O
the	O
rapid	O
identification	O
of	O
the	O
N1	O
/	O
88	O
strain	O
of	O
IBV	B-SPEC
from	O
oviduct	O
and	O
fecal	O
samples	O
.	O

Studies	O
using	O
POMxp	O
showed	O
that	O
5min	O
treatment	O
at	O
room	O
temperature	O
with	O
800g	O
/	O
ml	O
PPs	O
resulted	O
in	O
at	O
least	O
a	O
3log	O
reduction	O
in	O
the	O
titers	O
of	O
influenza	B-SPEC
viruses	I-SPEC
PR8	O
(	O
H1N1	O
),	O
X31	O
(	O
H3N2	O
),	O
and	O
a	O
reassortant	O
H5N1	O
virus	B-SPEC
derived	O
from	O
a	O
human	B-SPEC
isolate	O
.	O

However	O
,	O
the	O
antiviral	O
activity	O
was	O
less	O
against	O
a	O
coronavirus	B-SPEC
and	O
reassortant	O
H5N1	O
influenza	B-SPEC
viruses	I-SPEC
derived	O
from	O
avian	B-SPEC
isolates	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
induced	O
indirect	O
lung	O
injury	O
by	O
intraperitoneal	O
injection	O
of	O
LPS	O
and	O
direct	O
lung	O
injury	O
by	O
intratracheal	O
injection	O
of	O
LPS	O
in	O
wild	O
-	O
type	O
and	O
Sftpd	O
(-/-)	O
mice	B-SPEC
to	O
elucidate	O
the	O
role	O
of	O
SP	O
-	O
D	O
during	O
ALI	O
/	O
ARDS	O
.	O

The	O
complications	O
observed	O
were	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
eight	O
patients	O
,	O
severe	O
sepsis	B-SPEC
in	O
four	O
,	O
catheter	O
-	O
related	O
bacteremia	O
in	O
one	O
,	O
iatrogenic	O
pneumothorax	O
in	O
one	O
,	O
and	O
rhabdomyolysis	O
in	O
two	O
,	O
while	O
four	O
among	O
them	O
died	O
due	O
to	O
severe	O
sepsis	B-SPEC
.	O

Given	O
that	O
exposure	O
to	O
numerous	O
infectious	O
pathogens	O
occurs	O
during	O
childhood	O
,	O
and	O
that	O
some	O
viral	O
infections	O
can	O
lead	O
to	O
neurodegeneration	O
and	O
demyelination	O
,	O
it	O
is	O
conceivable	O
that	O
some	O
viruses	B-SPEC
may	O
act	O
as	O
triggering	O
factors	O
in	O
neuropathogenesis	O
.	O

The	O
role	O
of	O
APN	O
is	O
discussed	O
in	O
the	O
context	O
of	O
virus	B-SPEC
receptor	O
usage	O
.	O

ABSTRACT	O
:	O
It	O
is	O
known	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
a	O
severe	O
infectious	O
illness	O
,	O
which	O
caused	O
an	O
epidemic	O
in	O
Asia	O
in	O
2003	O
,	O
has	O
extensive	O
and	O
complex	O
effects	O
on	O
human	B-SPEC
organ	O
systems	O
.	O

To	O
investigate	O
the	O
genomic	O
feature	O
of	O
H120	O
and	O
further	O
understand	O
its	O
role	O
in	O
the	O
epidemiology	O
of	O
IBV	B-SPEC
,	O
complete	O
genome	O
of	O
H120	O
was	O
sequenced	O
and	O
compared	O
with	O
sequences	O
of	O
other	O
IBV	B-SPEC
strains	O
by	O
phylogenetic	O
and	O
recombination	O
analysis	O
.	O

TITLE	O
:	O
Serum	O
protein	O
electrophoresis	O
in	O
155	O
cats	B-SPEC
.	O

The	O
most	O
common	O
DAMNITV	O
classification	O
associated	O
with	O
SPE	O
abnormalities	O
was	O
infectious	O
/	O
inflammatory	O
disease	O
(	O
80	O
/	O
136	O
;	O
58	O
.	O
8	O
%),	O
including	O
39	O
cats	B-SPEC
diagnosed	O
with	O
FIP	O
.	O

Enteritis	O
first	O
appeared	O
in	O
one	O
shed	O
of	O
post	O
-	O
parturient	O
cows	B-SPEC
;	O
it	O
spread	O
for	O
6	O
weeks	O
,	O
until	O
at	O
least	O
30	O
%	O
of	O
the	O
lactating	O
stock	O
contracted	O
enteritis	O
or	O
dysentery	O
.	O

ABSTRACT	O
:	O
In	O
July	O
2009	O
,	O
a	O
pandemic	O
influenza	O
(	O
H1N1	O
)	O
(	O
pdm	O
H1N1	O
)	O
virus	B-SPEC
epidemic	O
emerged	O
rapidly	O
in	O
Phitsanulok	O
,	O
Thailand	O
.	O

TITLE	O
:	O
An	O
interaction	O
between	O
the	O
nucleocapsid	O
protein	O
and	O
a	O
component	O
of	O
the	O
replicase	O
-	O
transcriptase	O
complex	O
is	O
crucial	O
for	O
the	O
infectivity	O
of	O
coronavirus	B-SPEC
genomic	O
RNA	O
.	O

The	O
resulting	O
viral	O
mutant	O
was	O
severely	O
defective	O
,	O
even	O
though	O
individual	O
domains	O
of	O
the	O
N	O
protein	O
responsible	O
for	O
N	O
-	O
RNA	O
,	O
N	O
-	O
M	O
,	O
or	O
N	O
-	O
N	O
interactions	O
were	O
completely	O
interchangeable	O
between	O
BCoV	O
and	O
MHV	B-SPEC
.	O

TITLE	O
:	O
Studies	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
pathology	O
in	O
human	B-SPEC
cases	O
and	O
animal	B-SPEC
models	O
.	O

The	O
proteases	O
produced	O
in	O
the	O
lung	O
during	O
inflammation	O
could	O
also	O
play	O
an	O
important	O
role	O
for	O
exacerbation	O
of	O
SARS	O
in	O
animals	B-SPEC
.	O

TITLE	O
:	O
SARS	O
spike	O
protein	O
induces	O
phenotypic	O
conversion	O
of	O
human	B-SPEC
B	O
cells	O
to	O
macrophage	O
-	O
like	O
cells	O
.	O

Transmission	O
electron	O
microscopy	O
showed	O
that	O
,	O
compared	O
to	O
revertant	O
virus	B-SPEC
,	O
the	O
number	O
of	O
double	O
-	O
membrane	O
vesicles	O
in	O
MHV	B-SPEC
-	O
Brts31	O
-	O
infected	O
cells	O
is	O
reduced	O
at	O
the	O
nonpermissive	O
temperature	O
.	O

The	O
purified	O
recombinant	O
TGEV	B-SPEC
PL1	O
(	O
pro	O
)	O
was	O
shown	O
to	O
cleave	O
a	O
peptide	O
mimicking	O
the	O
cognate	O
nsp2	O
|	O
nsp3	O
cleavage	O
site	O
.	O

In	O
combination	O
with	O
the	O
prior	O
characterization	O
of	O
PL2	O
(	O
pro	O
)	O
from	O
other	O
alphacoronaviruses	O
,	O
e	O
.	O
g	O
.,	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
NL63	O
,	O
our	O
results	O
unequivocally	O
establish	O
that	O
these	O
viruses	B-SPEC
employ	O
two	O
PL	O
(	O
pro	O
)	O
s	O
with	O
overlapping	O
specificities	O
toward	O
both	O
viral	O
and	O
cellular	O
substrates	O
.	O

The	O
need	O
for	O
new	O
antimicrobial	O
therapeutics	O
is	O
acute	O
because	O
of	O
growing	O
resistance	O
to	O
available	O
antibiotics	O
,	O
the	O
emergence	O
of	O
new	O
infectious	O
diseases	O
like	O
SARS	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
and	O
the	O
risk	O
of	O
bioterrorist	O
attacks	O
using	O
infectious	O
agents	O
that	O
may	O
not	O
be	O
immediately	O
identifiable	O
.	O

TITLE	O
:	O
[	O
Clinical	O
aspects	O
of	O
human	B-SPEC
infection	O
by	O
the	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
].	O

ABSTRACT	O
:	O
Influenza	B-SPEC
viruses	I-SPEC
continue	O
to	O
cause	O
yearly	O
epidemics	O
and	O
occasional	O
pandemics	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Occupational	O
pulmonary	O
infectious	O
diseases	O
include	O
tuberculosis	O
(	O
TB	O
)	O
and	O
many	O
viral	O
pathogens	O
,	O
including	O
influenza	O
,	O
coronavirus	B-SPEC
(	O
severe	O
acute	O
respiratory	O
syndrome	O
or	O
SARS	O
),	O
varicella	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
hantavirus	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
novel	O
conformationally	O
-	O
restricted	O
thiourea	O
analogs	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	O
for	O
their	O
anti	O
-	O
HCV	B-SPEC
activity	O
.	O

TITLE	O
:	O
Forsythoside	O
a	O
inhibits	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
cell	O
culture	O
.	O

The	O
overall	O
prevalence	O
of	O
virus	B-SPEC
RNA	O
was	O
55	O
.	O
8	O
%.	O

This	O
new	O
systemic	O
disease	O
resembles	O
the	O
dry	O
form	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
has	O
been	O
reported	O
in	O
the	O
United	O
States	O
and	O
Europe	O
.	O

TITLE	O
:	O
Genomic	O
characterization	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
-	I-SPEC
related	I-SPEC
coronavirus	I-SPEC
in	O
European	O
bats	B-SPEC
and	O
classification	O
of	O
coronaviruses	O
based	O
on	O
partial	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
sequences	O
.	O

Criteria	O
for	O
defining	O
separate	O
RGU	O
in	O
mammalian	B-SPEC
CoV	O
were	O
a	O
>	O
4	O
.	O
8	O
%	O
amino	O
acid	O
distance	O
for	O
alphacoronaviruses	O
and	O
a	O
>	O
6	O
.	O
3	O
%	O
distance	O
for	O
betacoronaviruses	O
.	O

ABSTRACT	O
:	O
Canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
)	O
and	O
canine	O
enteric	B-SPEC
coronavirus	I-SPEC
(	O
CECoV	O
)	O
are	O
often	O
cited	O
as	O
causes	O
of	O
diarrhoea	O
in	O
dogs	B-SPEC
.	O

CPV	B-SPEC
-	O
positive	O
animals	B-SPEC
were	O
more	O
likely	O
to	O
present	O
with	O
depression	O
/	O
lethargy	O
than	O
CPV	B-SPEC
-	O
negative	O
cases	O
.	O

For	O
each	O
herd	O
,	O
a	O
pooled	O
milk	O
sample	O
from	O
five	O
primiparous	O
cows	B-SPEC
was	O
analysed	O
for	O
the	O
presence	O
of	O
antibodies	O
to	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
.	O

Logistic	O
regression	O
was	O
used	O
to	O
evaluate	O
the	O
association	O
between	O
predictors	O
and	O
antibody	O
status	O
to	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
.	O

Positive	O
herds	O
were	O
not	O
spatially	O
autocorrelated	O
when	O
compared	O
with	O
negative	O
herds	O
as	O
estimated	O
by	O
the	O
K	O
-	O
function	O
regarding	O
both	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
.	O

Prospective	O
,	O
observational	O
animal	B-SPEC
study	O
in	O
a	O
Laboratory	O
Investigation	O
Unit	O
.	O

ARDS	O
-	O
like	O
syndrome	O
was	O
produced	O
by	O
lung	O
lavage	O
in	O
eight	O
pigs	B-SPEC
(	O
ARDS	O
group	O
).	O

In	O
contrast	O
,	O
in	O
pigs	B-SPEC
with	O
ARDS	O
-	O
like	O
syndrome	O
ventilated	O
with	O
small	O
VT	O
,	O
DeltaPP	O
is	O
not	O
a	O
good	O
indicator	B-SPEC
of	O
severe	O
hemorrhage	O
.	O

Electrophoretic	O
separation	O
of	O
serum	O
CK	O
isoenzymes	O
and	O
macroenzymes	O
was	O
performed	O
on	O
freeze	O
-	O
thawed	O
serum	O
samples	O
from	O
20	O
healthy	O
dogs	B-SPEC
and	O
3	O
dogs	B-SPEC
with	O
central	O
neurologic	O
disease	O
and	O
from	O
14	O
healthy	O
cats	B-SPEC
and	O
6	O
cats	B-SPEC
with	O
neurologic	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

CK	O
-	O
BB	O
increased	O
in	O
dogs	B-SPEC
with	O
neurologic	O
disease	O
.	O

RESULTS	O
:	O
CK	O
-	O
MM	O
was	O
the	O
predominant	O
isoenzyme	O
in	O
the	O
serum	O
of	O
healthy	O
dogs	B-SPEC
and	O
cats	B-SPEC
,	O
followed	O
by	O
macro	O
-	O
CK2	O
and	O
CK	O
-	O
BB	O
in	O
dogs	B-SPEC
and	O
by	O
both	O
macroenzymes	O
in	O
cats	B-SPEC
.	O

TITLE	O
:	O
A	O
fulminant	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
associated	O
with	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
infection	O
.	O

TITLE	O
:	O
Transcriptomic	O
analysis	O
reveals	O
a	O
mechanism	O
for	O
a	O
prefibrotic	O
phenotype	O
in	O
STAT1	O
knockout	O
mice	B-SPEC
during	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

Western	O
blot	O
assays	O
using	O
recombinant	O
N	O
proteins	O
of	O
Ro	O
-	O
BatCoV	O
HKU9	O
,	O
Betacoronavirus	B-SPEC
subgroup	O
A	O
(	O
HCoV	O
-	O
HKU1	O
),	O
subgroup	O
B	O
(	O
SARSr	O
-	O
Rh	O
-	O
BatCoV	O
),	O
and	O
subgroup	O
C	O
(	O
Ty	O
-	O
BatCoV	O
HKU4	O
and	O
Pi	O
-	O
BatCoV	O
HKU5	O
)	O
coronaviruses	O
were	O
subgroup	O
specific	O
,	O
supporting	O
their	O
classification	O
as	O
separate	O
subgroups	O
under	O
Betacoronavirus	B-SPEC
.	O

Antibodies	O
were	O
detected	O
in	O
75	O
(	O
43	O
%)	O
of	O
175	O
and	O
224	O
(	O
64	O
%)	O
of	O
350	O
tested	O
serum	O
samples	O
from	O
Leschenault	B-SPEC
'	I-SPEC
s	I-SPEC
rousette	I-SPEC
bats	B-SPEC
by	O
Ro	O
-	O
BatCoV	O
HKU9	O
N	O
-	O
protein	O
-	O
based	O
Western	O
blot	O
and	O
enzyme	O
immunoassays	O
,	O
respectively	O
.	O

TITLE	O
:	O
Medicinal	O
herbal	O
extracts	O
of	O
Sophorae	O
radix	B-SPEC
,	O
Acanthopanacis	O
cortex	O
,	O
Sanguisorbae	O
radix	B-SPEC
and	O
Torilis	B-SPEC
fructus	O
inhibit	O
coronavirus	B-SPEC
replication	O
in	O
vitro	O
.	O

RESULTS	O
:	O
Sophorae	O
radix	B-SPEC
,	O
Acanthopanacis	O
cortex	O
and	O
Torilis	B-SPEC
fructus	O
reduced	O
intracellular	O
viral	O
RNA	O
levels	O
with	O
comparable	O
reductions	O
in	O
viral	O
proteins	O
and	O
MHV	B-SPEC
-	O
A59	O
production	O
.	O

ABSTRACT	O
:	O
Previously	O
,	O
we	O
showed	O
that	O
intraperitoneal	O
infection	O
with	O
murine	B-SPEC
coronavirus	I-SPEC
strain	O
JHM	O
(	O
JHMV	O
)	O
established	O
a	O
persistent	O
infection	O
with	O
subacute	O
granulomatous	O
serositis	O
in	O
interferon	O
-	O
gamma	O
-	O
deficient	O
C57BL	O
/	O
6	O
(	O
B6	O
-	O
GKO	O
)	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
case	O
-	O
control	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
role	O
of	O
different	O
Cryptosporidium	B-SPEC
spp	O
.	O

C	B-SPEC
.	I-SPEC
ryanae	I-SPEC
and	O
C	B-SPEC
.	I-SPEC
andersoni	I-SPEC
were	O
only	O
detected	O
in	O
non	O
-	O
diarrhoeal	O
samples	O
,	O
whereas	O
the	O
other	O
pathogens	O
were	O
detected	O
in	O
both	O
diarrhoeal	O
and	O
non	O
-	O
diarrhoeal	O
samples	O
.	O

Moreover	O
,	O
immunofluorescence	O
assays	O
showed	O
that	O
the	O
MAb	O
is	O
able	O
to	O
detect	O
cell	O
infection	O
by	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
membrane	O
(	O
M	O
)	O
proteins	O
play	O
key	O
roles	O
in	O
virus	B-SPEC
assembly	O
,	O
through	O
M	O
-	O
M	O
,	O
M	O
-	O
spike	O
(	O
S	O
),	O
and	O
M	O
-	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
interactions	O
.	O

All	O
recovered	O
viruses	B-SPEC
with	O
alanine	O
substitutions	O
in	O
place	O
of	O
SWWS	O
residues	O
had	O
second	O
-	O
site	O
,	O
partially	O
compensating	O
,	O
changes	O
in	O
the	O
first	O
TM	O
of	O
M	O
.	O
Alanine	O
substitution	O
for	O
proline	O
had	O
little	O
impact	O
on	O
the	O
virus	B-SPEC
.	O

High	O
virus	B-SPEC
yields	O
were	O
found	O
for	O
several	O
days	O
postinoculation	O
and	O
electron	O
micrograph	O
,	O
Northern	O
blot	O
,	O
and	O
immunofluorescence	O
data	O
confirmed	O
that	O
HCoV	O
-	O
HKU1	O
replicated	O
efficiently	O
within	O
ciliated	O
cells	O
,	O
demonstrating	O
that	O
this	O
cell	O
type	O
is	O
infected	O
by	O
all	O
human	B-SPEC
coronaviruses	O
identified	O
to	O
date	O
.	O

This	O
study	O
aimed	O
at	O
developing	O
a	O
multiplex	O
semi	O
-	O
nested	O
RT	O
-	O
PCR	O
for	O
simultaneous	O
detection	O
of	O
BCoV	O
(	O
N	O
gene	O
)	O
and	O
group	B-SPEC
A	I-SPEC
rotavirus	I-SPEC
(	O
VP1	O
gene	O
)	O
with	O
the	O
addition	O
of	O
an	O
internal	O
control	O
(	O
mRNA	O
ND5	O
).	O

The	O
pregnant	O
females	O
infected	O
with	O
PEDV	B-SPEC
during	O
the	O
first	O
30	O
days	O
of	O
pregnancy	O
had	O
a	O
12	O
.	O
6	O
percentage	O
point	O
decrease	O
of	O
FR	O
(	O
91	O
.	O
1	O
%	O
vs	O
.	O
78	O
.	O
5	O
%,	O
P	O
=	O
0	O
.	O
003	O
),	O
a	O
5	O
.	O
7	O
percentage	O
point	O
increase	O
of	O
RR	O
(	O
3	O
.	O
5	O
%	O
vs	O
.	O
9	O
.	O
2	O
%,	O
P	O
=	O
0	O
.	O
01	O
),	O
a	O
1	O
.	O
3	O
percentage	O
point	O
increase	O
of	O
AR	O
(	O
2	O
.	O
1	O
%	O
vs	O
.	O
3	O
.	O
4	O
%,	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
a	O
2	O
.	O
0	O
percentage	O
point	O
increase	O
of	O
MM	O
(	O
3	O
.	O
5	O
%	O
vs	O
.	O
5	O
.	O
6	O
%,	O
P	O
<	O
0	O
.	O
001	O
).	O

Furthermore	O
,	O
the	O
potent	O
tylophorine	O
compounds	O
exerted	O
profound	O
anti	O
-	O
TGEV	B-SPEC
replication	O
activity	O
and	O
thereby	O
blocked	O
the	O
TGEV	B-SPEC
-	O
induced	O
apoptosis	O
and	O
subsequent	O
cytopathic	O
effect	O
in	O
ST	O
cells	O
.	O

In	O
rescue	O
experiments	O
,	O
ANP	O
injection	O
significantly	O
reduced	O
lung	O
injury	O
in	O
Nppa	O
(-/-)	O
mice	B-SPEC
caused	O
by	O
LPS	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
N	O
-	O
aryl	O
-	O
2	O
-	O
arylthioacetamide	O
derivatives	O
(	O
2	O
-	O
4	O
)	O
designed	O
as	O
non	O
-	O
nucleoside	O
reverse	O
transcriptase	O
inhibitors	O
was	O
synthesized	O
and	O
evaluated	O
for	O
their	O
inhibitory	O
activity	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
IIIB	O
)	O
replication	O
in	O
MT	O
-	O
4	O
cell	O
cultures	O
.	O

EID	O
(	O
50	O
/	O
50	O
l	O
)	O
TCoV	O
genome	O
,	O
and	O
no	O
cross	O
-	O
reaction	O
with	O
other	O
avian	B-SPEC
viruses	B-SPEC
was	O
observed	O
.	O

For	O
this	O
reason	O
a	O
search	O
in	O
PubMed	O
and	O
Scopus	B-SPEC
was	O
performed	O
for	O
the	O
time	O
period	O
from	O
1982	O
to	O
2009	O
.	O

Specifically	O
21	O
patients	O
with	O
CNS	O
involvement	O
(	O
meningoencephalitis	O
,	O
cerebellitis	O
),	O
4	O
with	O
peripheral	O
nervous	O
system	O
involvement	O
(	O
Guillain	O
-	O
Barr	O
,	O
myeloradiculitis	O
,	O
facial	O
nerve	O
palsy	O
),	O
5	O
with	O
hepatitis	O
and	O
15	O
with	O
other	O
afflictions	O
(	O
including	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
thrombocytopenia	O
,	O
aplastic	O
anemia	B-SPEC
,	O
acute	O
renal	O
failure	O
,	O
ulcerations	O
,	O
myocarditis	O
,	O
and	O
frosted	O
branch	O
vasculitis	O
)	O
received	O
antiviral	O
medications	O
.	O

Of	O
the	O
95	O
respiratory	O
samples	O
tested	O
,	O
30	O
(	O
31	O
%)	O
were	O
positive	O
for	O
the	O
detection	O
of	O
influenza	O
A	O
/	O
H1N1v	O
virus	B-SPEC
infection	O
by	O
both	O
RT	O
-	O
PCR	O
DNA	O
microarray	O
and	O
classical	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
detection	O
assays	O
.	O

Here	O
we	O
investigated	O
,	O
using	O
recombinant	O
murine	B-SPEC
coronaviruses	O
expressing	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)-	O
tagged	O
versions	O
of	O
the	O
N	O
protein	O
,	O
the	O
dynamics	O
of	O
its	O
interactions	O
with	O
the	O
RTCs	O
and	O
the	O
domain	O
(	O
s	O
)	O
involved	O
.	O

The	O
currently	O
available	O
serological	O
tests	O
have	O
low	O
specificity	O
and	O
sensitivity	O
for	O
detection	O
of	O
active	O
infection	O
and	O
cross	O
-	O
react	O
with	O
FCoV	O
strains	O
of	O
low	O
pathogenicity	O
,	O
the	O
feline	B-SPEC
enteric	O
coronaviruses	O
(	O
FECV	B-SPEC
).	O

Studies	O
since	O
the	O
SARS	O
outbreak	O
suggest	O
that	O
many	O
novel	O
viruses	B-SPEC
exist	O
in	O
animals	B-SPEC
and	O
some	O
,	O
but	O
probably	O
not	O
many	O
,	O
will	O
present	O
a	O
risk	O
to	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Certain	O
emerging	O
infections	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
,	O
represent	O
a	O
great	O
risk	O
to	O
healthcare	O
workers	O
(	O
HCWs	O
).	O

TITLE	O
:	O
Growth	O
hormone	O
releasing	O
peptide	O
-	O
2	O
,	O
a	O
ghrelin	O
agonist	O
,	O
attenuates	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
lung	O
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
the	O
most	O
common	O
complications	O
of	O
sepsis	B-SPEC
,	O
and	O
the	O
mortality	O
of	O
sepsis	B-SPEC
-	O
induced	O
ALI	O
remains	O
high	O
in	O
critically	O
ill	O
patients	O
.	O

TITLE	O
:	O
Generating	O
stable	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
cell	O
clones	O
to	O
produce	O
a	O
truncated	O
SARS	O
-	O
CoV	O
spike	O
protein	O
for	O
vaccine	O
development	O
.	O

Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
and	O
avian	B-SPEC
influenza	O
H5N1	O
prompted	O
development	O
of	O
pandemic	O
preparedness	O
plans	O
.	O

Some	O
states	O
propose	O
use	O
of	O
emergency	O
powers	O
that	O
might	O
potentially	O
override	O
human	B-SPEC
rights	O
protections	O
while	O
other	O
states	O
propose	O
to	O
limit	O
interventions	O
to	O
those	O
authorized	O
by	O
public	O
health	O
laws	O
.	O

In	O
addition	O
,	O
antiviral	O
activity	O
was	O
determined	O
by	O
inhibition	O
studies	O
on	O
the	O
infection	O
cycle	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
measured	O
as	O
minimum	O
concentration	O
of	O
cherry	O
extracts	O
that	O
inhibited	O
50	O
%	O
of	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
on	O
PEDV	B-SPEC
.	O

In	O
particular	O
,	O
P	B-SPEC
.	I-SPEC
cerasus	I-SPEC
contains	O
higher	O
antioxidants	O
and	O
antiviral	O
activities	O
as	O
well	O
as	O
polyphenolic	O
content	O
than	O
other	O
varieties	O
.	O

ABSTRACT	O
:	O
After	O
renovation	O
of	O
the	O
adult	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
with	O
installation	O
of	O
ten	O
single	O
rooms	O
,	O
an	O
enhanced	O
infection	O
control	O
program	O
was	O
conducted	O
to	O
control	O
the	O
spread	O
of	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
MRSA	O
)	O
in	O
our	O
hospital	O
.	O

This	O
is	O
the	O
first	O
gene	O
prediction	O
program	O
for	O
rotavirus	B-SPEC
and	O
rhinovirus	B-SPEC
for	O
public	O
access	O
.	O

A	O
dual	O
fluorescence	O
reporter	O
was	O
employed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
to	O
empirically	O
test	O
the	O
model	O
.	O

This	O
study	O
raises	O
questions	O
about	O
the	O
significance	O
of	O
the	O
detection	O
of	O
some	O
respiratory	O
viruses	B-SPEC
,	O
especially	O
using	O
highly	O
sensitive	O
methods	O
,	O
given	O
their	O
presence	O
in	O
apparently	O
healthy	O
individuals	O
.	O

TITLE	O
:	O
The	O
membrane	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
acts	O
as	O
a	O
dominant	O
immunogen	O
revealed	O
by	O
a	O
clustering	O
region	O
of	O
novel	O
functionally	O
and	O
structurally	O
defined	O
cytotoxic	O
T	O
-	O
lymphocyte	O
epitopes	O
.	O

Female	O
C57BL	O
/	O
6	O
mice	B-SPEC
received	O
complete	O
crush	O
injuries	O
at	O
either	O
thoracic	O
level	O
3	O
(	O
T3	O
)	O
or	O
9	O
(	O
T9	O
),	O
and	O
1	O
week	O
post	O
-	O
injury	O
,	O
injured	O
mice	B-SPEC
and	O
un	O
-	O
injured	O
controls	O
were	O
infected	O
with	O
different	O
dosages	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
,	O
a	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
).	O

Infection	O
at	O
all	O
dosages	O
resulted	O
in	O
significantly	O
higher	O
viral	O
titer	O
in	O
both	O
T3	O
-	O
and	O
T9	O
-	O
injured	O
mice	B-SPEC
compared	O
to	O
un	O
-	O
injured	O
controls	O
.	O

TITLE	O
:	O
Muscarinic	O
receptor	O
antagonist	O
therapy	O
improves	O
acute	O
pulmonary	O
dysfunction	O
after	O
smoke	O
inhalation	O
injury	O
in	O
sheep	B-SPEC
.	O

The	O
worst	O
reductions	O
in	O
quality	O
of	O
life	O
were	O
seen	O
in	O
cases	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
prolonged	O
mechanical	O
ventilation	O
,	O
severe	O
trauma	O
,	O
and	O
severe	O
sepsis	B-SPEC
.	O

Here	O
we	O
report	O
that	O
the	O
carboxy	O
-	O
terminal	O
domain	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
small	O
envelope	O
protein	O
(	O
E	O
)	O
binds	O
to	O
human	B-SPEC
PALS1	O
.	O

TITLE	O
:	O
Severe	O
ventilator	O
-	O
associated	O
pneumonia	O
caused	O
by	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
and	O
other	O
pathogens	O
:	O
report	O
of	O
a	O
case	O
successfully	O
managed	O
by	O
serial	O
surveillance	O
cultures	O
of	O
endotracheal	O
aspirates	O
.	O

This	O
ubiquitous	O
trimethylxanthine	O
,	O
pervasively	O
used	O
in	O
the	O
human	B-SPEC
diet	O
and	O
beverages	O
,	O
significantly	O
impacts	O
on	O
major	O
acute	O
neonatal	O
morbidities	O
including	O
apnea	O
of	O
prematurity	O
,	O
bronchopulmonary	O
dysplasia	O
,	O
patent	O
ductus	O
arteriousus	O
with	O
or	O
without	O
surgical	O
ligation	O
and	O
post	O
-	O
operative	O
apnea	O
.	O

Although	O
enhanced	O
T	O
cell	O
activity	O
accelerated	O
virus	B-SPEC
control	O
,	O
50	O
%	O
of	O
mice	B-SPEC
succumbed	O
to	O
infection	O
.	O

We	O
sequenced	O
and	O
analyzed	O
the	O
spike	O
(	O
S	O
)	O
and	O
hemagglutinin	O
/	O
esterase	O
(	O
HE	O
)	O
genes	O
of	O
these	O
viruses	B-SPEC
and	O
compared	O
the	O
nucleotide	O
(	O
nt	O
)	O
and	O
deduced	O
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
with	O
those	O
of	O
other	O
bovine	B-SPEC
CoV	O
(	O
BcoV	O
)	O
strains	O
.	O

Phylogenetically	O
,	O
bovine	B-SPEC
-	O
like	O
CoVs	O
belong	O
to	O
group	O
2a	O
CoVs	O
,	O
which	O
are	O
related	O
most	O
closely	O
to	O
the	O
BcoV	O
strains	O
recently	O
isolated	O
in	O
Korea	O
.	O

These	O
emerging	O
sublineages	O
display	O
varying	O
levels	O
of	O
drug	O
resistance	O
and	O
in	O
some	O
cases	O
an	O
increased	O
preference	O
for	O
binding	O
to	O
human	B-SPEC
2	O
,	O
6	O
-	O
linked	O
sialic	O
acid	O
cellular	O
receptors	O
.	O

All	O
patients	O
had	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
complicating	O
severe	O
H1N1	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
M	O
protein	O
-	O
based	O
ELISA	O
for	O
virus	B-SPEC
detection	O
.	O

Pandemic	O
H1N1	O
,	O
influenza	O
and	O
parainfluenza	O
viruses	B-SPEC
may	O
be	O
associated	O
with	O
significant	O
childhood	O
morbidity	O
and	O
PICU	B-SPEC
admissions	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
-	O
induced	O
immunosuppression	O
exacerbates	O
the	O
inflammatory	O
response	O
to	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
in	O
pigs	B-SPEC
.	O

We	O
evaluated	O
the	O
effect	O
of	O
vaccine	O
dose	O
and	O
each	O
adjuvant	O
on	O
immunogenicity	O
and	O
efficacy	O
in	O
mice	B-SPEC
,	O
and	O
the	O
effect	O
of	O
vaccine	O
dose	O
with	O
or	O
without	O
the	O
AS01	O
(	O
B	O
)	O
adjuvant	O
on	O
the	O
immunogenicity	O
and	O
efficacy	O
in	O
hamsters	B-SPEC
.	O

Efficacy	O
was	O
evaluated	O
by	O
challenge	O
with	O
wild	O
-	O
type	O
virus	B-SPEC
at	O
early	O
and	O
late	O
time	O
points	O
(	O
4	O
and	O
18	O
wk	O
post	O
-	O
vaccination	O
).	O

TITLE	O
:	O
Household	O
transmission	O
of	O
the	O
2009	O
pandemic	O
A	O
/	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
:	O
elevated	O
laboratory	O
	O
confirmed	O
secondary	O
attack	O
rates	O
and	O
evidence	O
of	O
asymptomatic	O
infections	O
.	O

TITLE	O
:	O
Evolved	O
variants	O
of	O
the	O
membrane	O
protein	O
can	O
partially	O
replace	O
the	O
envelope	O
protein	O
in	O
murine	B-SPEC
coronavirus	I-SPEC
assembly	O
.	O

Results	O
indicate	O
that	O
TMPRSS2	O
needs	O
to	O
be	O
expressed	O
in	O
the	O
opposing	O
(	O
target	O
)	O
cell	O
membrane	O
to	O
activate	O
S	O
protein	O
rather	O
than	O
in	O
the	O
producer	O
cell	O
,	O
as	O
found	O
for	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
and	O
metapneumoviruses	B-SPEC
.	O

Here	O
,	O
we	O
present	O
preliminary	O
characterization	O
of	O
the	O
virome	O
of	O
three	O
common	O
North	O
American	O
bat	B-SPEC
species	B-SPEC
,	O
including	O
big	B-SPEC
brown	I-SPEC
bats	I-SPEC
(	O
Eptesicus	B-SPEC
fuscus	I-SPEC
),	O
tricolored	B-SPEC
bats	I-SPEC
(	O
Perimyotis	B-SPEC
subflavus	I-SPEC
),	O
and	O
little	O
brown	O
myotis	B-SPEC
(	O
Myotis	B-SPEC
lucifugus	I-SPEC
).	O

TITLE	O
:	O
Biflavonoids	O
from	O
Torreya	B-SPEC
nucifera	I-SPEC
displaying	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
inhibition	O
.	O

ABSTRACT	O
:	O
As	O
part	O
of	O
our	O
search	O
for	O
botanical	O
sources	O
of	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
inhibitors	O
,	O
we	O
selected	O
Torreya	B-SPEC
nucifera	I-SPEC
,	O
which	O
is	O
traditionally	O
used	O
as	O
a	O
medicinal	O
plant	B-SPEC
in	O
Asia	O
.	O

ABSTRACT	O
:	O
Adaptation	O
is	O
often	O
thought	O
to	O
affect	O
the	O
likelihood	O
that	O
a	O
virus	B-SPEC
will	O
be	O
able	O
to	O
successfully	O
emerge	O
in	O
a	O
new	O
host	O
species	B-SPEC
.	O

ABSTRACT	O
:	O
Perioperative	O
red	O
blood	O
cell	O
transfusion	O
is	O
commonly	O
used	O
to	O
address	O
anemia	B-SPEC
,	O
an	O
independent	O
risk	O
factor	O
for	O
morbidity	O
and	O
mortality	O
after	O
cardiac	O
operations	O
;	O
however	O
,	O
evidence	O
regarding	O
optimal	O
blood	O
transfusion	O
practice	O
in	O
patients	O
undergoing	O
cardiac	O
surgery	O
is	O
lacking	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
antibodies	O
to	O
four	O
human	B-SPEC
coronaviruses	O
is	O
lower	O
in	O
nasal	O
secretions	O
than	O
in	O
serum	O
.	O

TITLE	O
:	O
Genetic	O
analysis	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
non	O
-	O
structural	O
protein	O
16	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
the	O
induction	O
of	O
humoral	O
responses	O
directed	O
against	O
human	B-SPEC
autoantigens	O
during	O
acute	O
inflammation	O
.	O

Using	O
Luciferase	O
Immunoprecipitation	O
Systems	O
(	O
LIPS	O
),	O
a	O
cohort	O
of	O
control	O
,	O
ARDS	O
and	O
sepsis	B-SPEC
patients	O
were	O
tested	O
for	O
antibodies	O
to	O
a	O
panel	O
of	O
autoantigens	O
.	O

Analysis	O
of	O
serial	O
samples	O
revealed	O
that	O
several	O
seropositive	O
patients	O
had	O
low	O
autoantibodies	O
at	O
early	O
time	O
points	O
that	O
often	O
rose	B-SPEC
precipitously	O
and	O
peaked	O
between	O
days	O
7	O
-	O
14	O
.	O

ABSTRACT	O
:	O
Smallpox	B-SPEC
is	O
an	O
acute	O
disease	O
caused	O
by	O
infection	O
with	O
variola	B-SPEC
virus	I-SPEC
that	O
has	O
had	O
historic	O
effects	O
on	O
the	O
human	B-SPEC
population	O
due	O
to	O
its	O
virulence	O
and	O
infectivity	O
.	O

As	O
variola	B-SPEC
is	O
a	O
uniquely	O
human	B-SPEC
virus	B-SPEC
lacking	O
a	O
robust	O
animal	B-SPEC
model	O
,	O
the	O
development	O
of	O
rational	O
therapeutic	O
or	O
vaccine	O
approaches	O
for	O
variola	B-SPEC
requires	O
the	O
use	O
of	O
model	O
systems	O
that	O
reflect	O
the	O
clinical	O
aspects	O
of	O
human	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
The	O
complete	O
genome	O
sequence	O
of	O
transmissible	O
Gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
strain	O
TS	O
,	O
previously	O
isolated	O
from	O
Gansu	O
province	O
,	O
was	O
cloned	O
and	O
compared	O
with	O
published	O
sequence	O
data	O
from	O
other	O
TGEV	B-SPEC
strains	O
.	O

The	O
second	O
section	O
examines	O
securitizing	O
and	O
desecuritizing	O
moves	O
in	O
Chinese	O
responses	O
to	O
SARS	O
and	O
avian	B-SPEC
influenza	O
.	O

TITLE	O
:	O
Transfusion	O
-	O
related	O
Plasmodium	B-SPEC
ovale	I-SPEC
malaria	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
a	O
non	O
-	O
endemic	O
country	O
.	O

The	O
patient	O
remained	O
intubated	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
for	O
16	O
days	O
,	O
and	O
was	O
later	O
extubated	O
successfully	O
with	O
a	O
clear	O
chest	O
x	O
-	O
ray	B-SPEC
after	O
a	O
total	O
of	O
one	O
month	O
hospitalization	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
secondary	O
to	O
blood	O
transfusion	O
related	O
P	B-SPEC
.	I-SPEC
ovale	I-SPEC
malaria	O
infection	O
in	O
a	O
non	O
-	O
endemic	O
country	O
.	O

To	O
begin	O
to	O
understand	O
why	O
IFN	O
is	O
produced	O
in	O
infected	O
macrophages	O
,	O
we	O
infected	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMM	O
)	O
and	O
as	O
a	O
control	O
,	O
bone	O
marrow	O
-	O
derived	O
DC	O
(	O
BMDC	O
)	O
with	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

Further	O
,	O
our	O
results	O
also	O
show	O
that	O
BMM	O
are	O
generally	O
more	O
responsive	O
to	O
MHV	B-SPEC
infection	O
,	O
since	O
MyD88	O
-	O
dependent	O
pathways	O
are	O
also	O
activated	O
to	O
a	O
greater	O
extent	O
in	O
these	O
cells	O
than	O
in	O
BMDC	O
.	O

These	O
findings	O
represent	O
the	O
first	O
discovery	O
of	O
the	O
widespread	O
differential	O
expression	O
of	O
long	O
ncRNAs	O
in	O
response	O
to	O
virus	B-SPEC
infection	O
and	O
suggest	O
that	O
ncRNAs	O
are	O
involved	O
in	O
regulating	O
the	O
host	O
response	O
,	O
including	O
innate	O
immunity	O
.	O

From	O
initial	O
studies	O
,	O
we	O
hypothesized	O
that	O
attenuated	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
(	O
VEE	O
)	O
replicon	O
particle	O
(	O
VRP	O
)	O
vaccine	O
glycoproteins	O
mediated	O
vaccine	O
failure	O
in	O
the	O
aged	O
.	O

We	O
then	O
compared	O
the	O
efficacies	O
of	O
vaccines	O
bearing	O
attenuated	O
(	O
VRP	O
(	O
3014	O
))	O
or	O
wild	O
-	O
type	O
VEE	O
glycoproteins	O
(	O
VRP	O
(	O
3000	O
))	O
in	O
young	O
and	O
aged	O
mice	B-SPEC
within	O
novel	O
models	O
of	O
severe	O
SARS	O
-	O
CoV	O
pathogenesis	O
.	O

Aged	O
animals	B-SPEC
receiving	O
VRP	O
(	O
3000	O
)-	O
based	O
vaccines	O
were	O
protected	O
from	O
SARS	O
-	O
CoV	O
disease	O
,	O
while	O
animals	B-SPEC
receiving	O
the	O
VRP	O
(	O
3014	O
)-	O
based	O
vaccines	O
were	O
not	O
.	O

Our	O
results	O
show	O
that	O
it	O
is	O
critical	O
to	O
carefully	O
tune	O
the	O
nanotube	O
density	O
in	O
order	B-SPEC
to	O
fabricate	O
sensitive	O
and	O
reliable	O
devices	O
.	O

TITLE	O
:	O
Investigation	O
of	O
the	O
influence	O
of	O
EPs	O
	O
7630	O
,	O
a	O
herbal	O
drug	O
preparation	O
from	O
Pelargonium	B-SPEC
sidoides	O
,	O
on	O
replication	O
of	O
a	O
broad	O
panel	O
of	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Pelargonium	B-SPEC
sidoides	O
extract	O
EPs	O
	O
7630	O
is	O
an	O
approved	O
drug	O
for	O
the	O
treatment	O
of	O
acute	O
bronchitis	O
in	O
Germany	O
.	O

ABSTRACT	O
:	O
Severe	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
in	O
adults	O
has	O
been	O
reported	O
from	O
Bikaner	O
(	O
northwestern	O
India	O
)	O
but	O
the	O
reports	O
on	O
children	O
are	O
scanty	O
.	O

Basic	O
hygienic	O
measures	O
such	O
as	O
wearing	O
face	O
masks	O
and	O
the	O
hygienic	O
practice	O
of	O
hand	O
washing	O
could	O
reduce	O
the	O
spread	O
of	O
the	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Comparison	O
of	O
immunohistochemistry	O
and	O
polymerase	O
chain	O
reaction	O
for	O
detection	O
of	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
in	O
naturally	O
infected	O
dead	O
birds	B-SPEC
.	O

Based	O
on	O
WNv	B-SPEC
screening	O
of	O
kidney	O
tissue	O
,	O
IHC	O
and	O
RT	O
-	O
PCR	O
were	O
in	O
agreement	O
with	O
95	O
.	O
45	O
%	O
(	O
21	O
/	O
22	O
)	O
for	O
positive	O
dead	O
birds	B-SPEC
and	O
were	O
in	O
100	O
%	O
(	O
22	O
/	O
22	O
)	O
agreement	O
when	O
multi	O
-	O
organ	O
screening	O
by	O
IHC	O
was	O
performed	O
.	O

The	O
RBD	O
of	O
SARS	O
-	O
CoV	O
is	O
highly	O
immunogenic	O
in	O
humans	B-SPEC
and	O
mediates	O
protective	O
responses	O
and	O
RBD	O
-	O
based	O
vaccines	O
and	O
diagnostic	O
approaches	O
can	O
be	O
further	O
developed	O
.	O

TITLE	O
:	O
Alphacoronavirus	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
nsp1	O
protein	O
suppresses	O
protein	O
translation	O
in	O
mammalian	B-SPEC
cells	O
and	O
in	O
cell	O
-	O
free	O
HeLa	O
cell	O
extracts	O
but	O
not	O
in	O
rabbit	B-SPEC
reticulocyte	O
lysate	O
.	O

Unlike	O
the	O
nsp1	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
a	O
betacoronavirus	B-SPEC
,	O
the	O
TGEV	B-SPEC
nsp1	O
protein	O
was	O
unable	O
to	O
bind	O
40S	O
ribosomal	O
subunits	O
or	O
promote	O
host	O
mRNA	O
degradation	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
E	O
protein	O
plays	O
an	O
important	O
role	O
in	O
virus	B-SPEC
assembly	O
.	O

The	O
genomic	O
variations	O
present	O
in	O
Australian	O
IBVs	O
were	O
investigated	O
and	O
compared	O
to	O
those	O
of	O
another	O
group	O
III	O
coronavirus	B-SPEC
,	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
).	O

The	O
ResPlex	O
II	O
additionally	O
detects	O
coronavirus	B-SPEC
(	O
229E	O
,	O
OC43	O
,	O
NL63	O
,	O
HKU1	O
),	O
coxsackie	O
/	O
echo	B-SPEC
virus	B-SPEC
,	O
bocavirus	B-SPEC
and	O
differentiates	O
adenoviruses	B-SPEC
(	O
B	O
,	O
E	O
).	O

RESULTS	O
:	O
The	O
PRV	B-SPEC
assays	O
detected	O
more	O
viruses	B-SPEC
than	O
culture	O
.	O

After	O
adjusting	O
for	O
age	O
,	O
chronic	O
disease	O
,	O
LRTI	O
,	O
and	O
co	O
-	O
detection	O
of	O
other	O
viruses	B-SPEC
in	O
a	O
multiple	O
logistic	O
regression	O
analysis	O
,	O
HCoV	O
was	O
associated	O
with	O
a	O
shorter	O
fever	O
period	O
and	O
shorter	O
hospitalization	O
time	O
than	O
RSV	B-SPEC
.	O

We	O
detected	O
diverse	O
CoVs	O
by	O
RT	O
-	O
PCR	O
in	O
wild	O
birds	B-SPEC
in	O
the	O
Beringia	B-SPEC
area	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
reservoirs	O
for	O
emerging	O
zoonotic	O
viruses	B-SPEC
that	O
can	O
have	O
a	O
profound	O
impact	O
on	O
human	B-SPEC
and	O
animal	B-SPEC
health	O
,	O
including	O
lyssaviruses	B-SPEC
,	O
filoviruses	O
,	O
paramyxoviruses	O
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronaviruses	O
(	O
SARS	O
-	O
CoVs	O
).	O

Coronavirus	B-SPEC
consensus	O
PCR	O
and	O
unbiased	O
high	O
-	O
throughput	O
pyrosequencing	O
revealed	O
the	O
presence	O
of	O
coronavirus	B-SPEC
sequences	O
related	O
to	O
those	O
of	O
SARS	O
-	O
CoV	O
in	O
a	O
Commerson	O
'	O
s	O
leaf	B-SPEC
-	I-SPEC
nosed	I-SPEC
bat	I-SPEC
(	O
Hipposideros	B-SPEC
commersoni	I-SPEC
).	O

Inactivated	O
vaccines	O
,	O
viral	O
and	O
bacterial	O
vector	O
vaccines	O
,	O
recombinant	O
protein	O
vaccines	O
,	O
subunit	O
vaccines	O
,	O
DNA	O
vaccines	O
,	O
and	O
live	O
-	O
attenuated	O
virus	B-SPEC
vaccines	O
have	O
been	O
studied	O
in	O
different	O
animal	B-SPEC
models	O
.	O

Although	O
all	O
the	O
cubicles	O
were	O
in	O
'	O
positive	O
pressure	O
'	O
towards	O
the	O
corridor	O
,	O
the	O
virus	B-SPEC
-	O
containing	O
bioaerosols	O
generated	O
from	O
the	O
index	O
patient	O
'	O
s	O
cubicle	O
were	O
still	O
transmitted	O
to	O
other	O
cubicles	O
,	O
which	O
cannot	O
be	O
explained	O
in	O
a	O
traditional	O
manner	O
.	O

TITLE	O
:	O
Eosinophilic	O
infiltrate	O
in	O
a	O
patient	O
with	O
severe	O
Legionella	B-SPEC
pneumonia	O
as	O
a	O
levofloxacin	O
-	O
related	O
complication	O
:	O
a	O
case	O
report	O
.	O

LPS	O
instillation	O
induced	O
ALI	O
in	O
both	O
PTX3	O
-	O
KO	O
and	O
WT	O
mice	B-SPEC
.	O

TITLE	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
neuropathogenesis	O
:	O
determinants	O
of	O
virulence	O
.	O

JHM	O
.	O
SD	O
spreads	O
more	O
quickly	O
among	O
neurons	O
than	O
less	O
neurovirulent	O
MHVs	O
,	O
and	O
is	O
able	O
to	O
spread	O
in	O
the	O
absence	O
of	O
the	O
canonical	O
MHV	B-SPEC
receptor	O
,	O
CEACAM1a	O
.	O

The	O
RNA	O
synthesis	O
of	O
these	O
two	O
distantly	O
related	O
nidoviruses	B-SPEC
is	O
catalyzed	O
by	O
an	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
),	O
which	O
is	O
the	O
core	O
enzyme	O
of	O
their	O
multiprotein	O
replication	O
and	O
transcription	O
complex	O
(	O
RTC	O
).	O

TITLE	O
:	O
Differentiation	O
between	O
human	B-SPEC
coronaviruses	O
NL63	O
and	O
229E	O
using	O
a	O
novel	O
double	O
-	O
antibody	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
based	O
on	O
specific	O
monoclonal	O
antibodies	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
are	O
two	O
of	O
the	O
four	O
HCoVs	O
that	O
circulate	O
worldwide	O
and	O
are	O
close	O
phylogenetic	O
relatives	O
.	O

Three	O
specific	O
MAbs	O
to	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
one	O
MAb	O
specific	O
to	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
and	O
four	O
MAbs	O
that	O
recognized	O
both	O
viruses	B-SPEC
were	O
obtained	O
.	O

Sheep	B-SPEC
treated	O
with	O
TLV	O
maintained	O
normal	O
blood	O
gases	O
with	O
statistically	O
greater	O
PO2	O
(	O
p	O
<	O
10	O
(-	O
9	O
))	O
and	O
lower	O
PCO2	O
(	O
p	O
<	O
10	O
(-	O
3	O
))	O
than	O
the	O
CMV	B-SPEC
group	O
.	O

2	O
'-	O
O	O
methylation	O
of	O
viral	O
RNA	O
did	O
not	O
affect	O
IFN	O
induction	O
in	O
WNV	B-SPEC
-	O
infected	O
fibroblasts	O
but	O
instead	O
modulated	O
the	O
antiviral	O
effects	O
of	O
IFN	O
-	O
induced	O
proteins	O
with	O
tetratricopeptide	O
repeats	O
(	O
IFIT	O
),	O
which	O
are	O
interferon	O
-	O
stimulated	O
genes	O
(	O
ISGs	O
)	O
implicated	O
in	O
regulation	O
of	O
protein	O
translation	O
.	O

ABSTRACT	O
:	O
A	O
truncated	O
gene	O
(	O
designated	O
S1	O
)	O
encoding	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
in	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
amplified	O
by	O
PCR	O
.	O

ELISA	O
indicated	O
that	O
the	O
antibody	O
against	O
SARS	O
-	O
CoV	O
S1	O
protein	O
had	O
no	O
cross	O
reaction	O
with	O
S1	O
proteins	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
a	O
porcine	B-SPEC
coronavirus	B-SPEC
,	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
an	O
avian	B-SPEC
coronavirus	I-SPEC
.	O

Furthermore	O
,	O
age	O
65	O
years	O
and	O
cough	O
were	O
independent	O
predictors	O
for	O
pandemic	O
(	O
H1N1	O
)	O
2009	O
virus	B-SPEC
positivity	O
in	O
a	O
multivariate	O
regression	O
analysis	O
.	O

TITLE	O
:	O
Characterization	O
of	O
T	O
helper	O
(	O
Th	O
)	O
1	O
-	O
and	O
Th2	O
-	O
type	O
immune	O
responses	O
caused	O
by	O
baculovirus	B-SPEC
-	O
expressed	O
protein	O
derived	O
from	O
the	O
S2	O
domain	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
,	O
and	O
exploration	O
of	O
the	O
Th1	O
and	O
Th2	O
epitopes	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

The	O
ability	O
of	O
three	O
baculovirus	B-SPEC
-	O
expressed	O
proteins	O
to	O
induce	O
Th1	O
-	O
and	O
Th2	O
-	O
type	O
immune	O
responses	O
was	O
investigated	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

TITLE	O
:	O
Single	O
-	O
dose	O
intranasal	O
administration	O
with	O
mDEF201	O
(	O
adenovirus	B-SPEC
vectored	O
mouse	B-SPEC
interferon	O
-	O
alpha	O
)	O
confers	O
protection	O
from	O
mortality	O
in	O
a	O
lethal	O
SARS	O
-	O
CoV	O
BALB	O
/	O
c	O
mouse	B-SPEC
model	O
.	O

Complete	O
survival	O
protection	O
was	O
observed	O
in	O
mice	B-SPEC
given	O
a	O
single	O
dose	O
of	O
mDEF201	O
administered	O
intranasally	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
,	O
or	O
14	O
days	O
prior	O
to	O
lethal	O
SARS	O
-	O
CoV	O
challenge	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
body	O
weights	O
of	O
these	O
treated	O
mice	B-SPEC
were	O
unaffected	O
by	O
the	O
challenge	O
.	O

Intranasal	O
treatment	O
with	O
mDEF201	O
ranging	O
from	O
10	O
(	O
6	O
)	O
to	O
10	O
(	O
8	O
)	O
PFU	O
significantly	O
protected	O
mice	B-SPEC
against	O
a	O
lethal	O
SARS	O
-	O
CoV	O
infection	O
in	O
a	O
dose	O
dependent	O
manner	O
up	O
to	O
12h	O
post	O
infection	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

When	O
status	O
epileptics	O
or	O
prolonged	O
coma	B-SPEC
manifests	O
even	O
in	O
patients	O
with	O
severe	O
brain	O
disorders	O
,	O
we	O
must	O
consider	O
encephalopathy	O
in	O
the	O
differential	O
diagnosis	O
.	O

BALB	O
/	O
c	O
and	O
STAT1	O
-	O
deficient	O
mice	B-SPEC
were	O
inoculated	O
with	O
the	O
recombinant	O
viral	O
vector	O
rTGEV	O
(	O
S	O
-	O
MHV	B-SPEC
)-	O
VP7	O
,	O
which	O
replicates	O
in	O
the	O
intestine	O
and	O
spreads	O
to	O
other	O
organs	O
such	O
as	O
liver	O
,	O
spleen	O
and	O
lungs	O
.	O

Twenty	O
-	O
four	O
mice	B-SPEC
were	O
randomly	O
divided	O
into	O
control	O
group	O
,	O
virus	B-SPEC
group	O
,	O
damp	O
-	O
heat	O
group	O
and	O
model	O
group	O
.	O

The	O
mouse	B-SPEC
model	O
established	O
using	O
MHV	B-SPEC
-	O
A59	O
virus	B-SPEC
and	O
the	O
damp	O
-	O
heat	O
factors	O
can	O
mimic	O
damp	O
-	O
heat	O
syndrome	O
described	O
in	O
traditional	O
Chinese	O
medicine	O
theory	O
.	O

TITLE	O
:	O
Positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
prone	O
positioning	O
,	O
and	O
activated	O
protein	O
C	O
:	O
a	O
critical	O
review	O
of	O
meta	B-SPEC
-	O
analyses	O
.	O

Meta	B-SPEC
-	O
analysis	O
models	O
can	O
be	O
very	O
useful	O
for	O
clinical	O
decisions	O
if	O
they	O
include	O
all	O
of	O
the	O
similar	O
papers	O
on	O
a	O
medical	O
topic	O
and	O
are	O
correct	O
from	O
the	O
methodological	O
point	O
of	O
view	O
;	O
however	O
,	O
these	O
results	O
must	O
be	O
checked	O
by	O
a	O
careful	O
and	O
well	O
-	O
informed	O
reader	O
.	O

Although	O
several	O
reports	O
have	O
suggested	O
the	O
possible	O
efficacy	O
of	O
immunotherapies	O
such	O
as	O
plasmapheresis	O
and	O
intravenous	O
immunoglobulins	O
(	O
IVIg	O
)	O
in	O
treating	O
Fisher	B-SPEC
syndrome	O
,	O
there	O
have	O
been	O
no	O
randomized	O
controlled	O
studies	O
.	O

Therefore	O
,	O
Fisher	B-SPEC
syndrome	O
alone	O
does	O
not	O
necessarily	O
require	O
immunotherapy	O
.	O

There	O
have	O
been	O
no	O
prospective	O
,	O
controlled	O
studies	O
(	O
randomized	O
or	O
nonrandomized	O
)	O
of	O
the	O
use	O
of	O
immunotherapy	O
to	O
treat	O
Fisher	B-SPEC
syndrome	O
.	O

To	O
evaluate	O
the	O
efficacy	O
of	O
immunotherapies	O
used	O
to	O
treat	O
Fisher	B-SPEC
syndrome	O
,	O
large	O
prospective	O
studies	O
are	O
required	O
.	O

Samples	O
were	O
screened	O
for	O
the	O
viruses	B-SPEC
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
typed	O
via	O
DNA	O
sequence	O
analysis	O
.	O

ABSTRACT	O
:	O
We	O
developed	O
a	O
two	O
-	O
layer	O
,	O
four	O
-	O
channel	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)-	O
capillary	O
electrophoresis	O
microdevice	O
that	O
integrates	O
nucleic	O
acid	O
amplification	O
,	O
sample	O
cleanup	O
and	O
concentration	O
,	O
capillary	O
electrophoretic	O
separation	O
,	O
and	O
detection	O
for	O
multiplex	O
analysis	O
of	O
four	O
human	B-SPEC
respiratory	O
viral	O
pathogens	O
,	O
influenza	O
A	O
,	O
influenza	O
B	O
,	O
coronavirus	B-SPEC
OC43	O
,	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
.	O

Five	O
non	O
-	O
traumatic	O
patients	O
acquired	O
SC	O
-	O
CIP	O
during	O
long	O
-	O
term	O
intensive	O
-	O
care	O
-	O
unit	O
stays	O
due	O
to	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

Ten	O
had	O
positive	O
results	O
for	O
IgM	O
against	O
leptospira	B-SPEC
while	O
2	O
had	O
borderline	O
positive	O
result	O
.	O

ABSTRACT	O
:	O
The	O
M	O
protein	O
of	O
coronavirus	B-SPEC
plays	O
a	O
central	O
role	O
in	O
virus	B-SPEC
assembly	O
,	O
turning	O
cellular	O
membranes	O
into	O
workshops	O
where	O
virus	B-SPEC
and	O
host	O
factors	O
come	O
together	O
to	O
make	O
new	O
virus	B-SPEC
particles	O
.	O

We	O
investigated	O
how	O
M	O
structure	O
and	O
organization	O
is	O
related	O
to	O
virus	B-SPEC
shape	O
and	O
size	O
using	O
cryo	O
-	O
electron	O
microscopy	O
,	O
tomography	O
and	O
statistical	O
analysis	O
.	O

A	O
total	O
of	O
25	O
(	O
n	O
=	O
25	O
)	O
different	O
species	B-SPEC
were	O
tested	O
for	O
viral	O
RNA	O
using	O
individual	O
fecal	O
samples	O
collected	O
from	O
healthy	O
birds	B-SPEC
.	O

Community	O
restriction	O
strategies	O
such	O
as	O
school	O
and	O
workplace	O
closures	O
and	O
cancellation	O
of	O
group	O
events	O
were	O
not	O
utilized	O
as	O
public	O
health	O
measures	O
to	O
delay	O
the	O
spread	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Inactivation	O
of	O
MS2	O
bacteriophage	B-SPEC
by	O
streamer	O
corona	B-SPEC
discharge	O
in	O
water	O
.	O

This	O
study	O
demonstrates	O
the	O
inactivation	O
of	O
a	O
virus	B-SPEC
using	O
the	O
streamer	O
corona	B-SPEC
discharge	O
process	O
(	O
SCDP	O
)	O
with	O
MS2	O
phage	O
as	O
a	O
surrogate	O
.	O

Most	O
of	O
the	O
synthesized	O
compounds	O
possessed	O
potent	O
anti	O
-	O
HBV	B-SPEC
activity	O
,	O
of	O
which	O
the	O
promising	O
compound	O
44	O
exhibited	O
significantly	O
inhibitory	O
potency	O
against	O
the	O
secretion	O
of	O
hepatitis	O
surface	O
antigen	O
(	O
HBsAg	O
)	O
(	O
IC	O
(	O
50	O
)	O
=	O
0	O
.	O
010	O
mM	O
,	O
SI	O
>	O
135	O
),	O
hepatitis	O
e	O
antigen	O
(	O
HBeAg	O
)	O
(	O
IC	O
(	O
50	O
)	O
=	O
0	O
.	O
026	O
mM	O
,	O
SI	O
>	O
51	O
)	O
and	O
the	O
replication	O
of	O
HBV	B-SPEC
DNA	O
(	O
IC	O
(	O
50	O
)	O
=	O
0	O
.	O
045	O
mM	O
).	O

This	O
plant	B-SPEC
expression	O
vector	O
was	O
transformed	O
into	O
lettuce	O
(	O
Lactuca	B-SPEC
sativa	I-SPEC
L	O
.)	O
using	O
the	O
Agrobacterium	B-SPEC
-	O
mediated	O
transformation	O
method	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
literature	O
on	O
novel	O
swine	B-SPEC
origin	O
influenza	O
A	O
(	O
H1N1	O
2009	O
)	O
as	O
a	O
cause	O
of	O
respiratory	O
failure	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
During	O
the	O
2009	O
-	O
2010	O
winter	O
season	O
,	O
the	O
new	O
pandemic	O
influenza	O
A	O
/	O
H1N1	O
virus	B-SPEC
(	O
S	O
-	O
OIV	O
)	O
was	O
responsible	O
for	O
1	O
,	O
334	O
hospitalized	O
severe	O
infection	O
cases	O
including	O
312	O
(	O
23	O
.	O
4	O
%)	O
deaths	O
in	O
metropolitan	O
France	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
change	O
of	O
special	O
antibodies	O
titer	O
IgG	O
,	O
IgM	O
and	O
nucleocapsid	O
to	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
and	O
observing	O
the	O
expression	O
of	O
stomach	O
and	O
enteric	O
involvement	O
on	O
SARS	O
-	O
CoV	B-SPEC
infection	O
by	O
monoclonal	O
antibody	O
against	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	B-SPEC
in	O
the	O
7	O
-	O
year	O
recovery	O
period	O
among	O
family	B-SPEC
clustering	O
cases	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

The	O
cats	B-SPEC
presented	O
with	O
signs	O
of	O
CHF	O
including	O
acute	O
collapse	O
,	O
tachypnea	O
,	O
increased	O
respiratory	O
effort	O
,	O
and	O
pulmonary	O
crackles	O
.	O

All	O
cats	B-SPEC
had	O
heart	O
murmurs	O
and	O
echocardiographic	O
signs	O
consistent	O
with	O
hypertrophic	O
cardiomyopathy	O
.	O

Coronavirus	B-SPEC
particles	O
were	O
observed	O
in	O
the	O
feces	O
via	O
electron	O
microscopy	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
of	O
Type	O
1	O
diabetes	O
in	O
this	O
age	O
group	O
and	O
the	O
first	O
report	O
of	O
transient	O
neonatal	O
diabetes	O
mellitus	O
in	O
horses	B-SPEC
.	O

However	O
,	O
frequent	O
changes	O
in	O
the	O
surface	O
antigens	O
of	O
influenza	B-SPEC
viruses	I-SPEC
allow	O
them	O
to	O
avoid	O
antibody	O
-	O
mediated	O
immunity	O
.	O

The	O
present	O
authors	O
have	O
previously	O
demonstrated	O
that	O
antigens	O
chemically	O
coupled	O
to	O
the	O
surface	O
of	O
liposomes	O
made	O
using	O
unsaturated	O
fatty	O
acids	O
are	O
cross	O
-	O
presented	O
by	O
APCs	O
via	O
MHC	O
class	B-SPEC
I	O
to	O
CD8	O
(+)	O
T	O
cells	O
and	O
induce	O
antigen	O
-	O
specific	O
CTLs	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)-	O
HKU1	O
(	O
HCoV	O
-	O
HKU1	O
)	O
was	O
first	O
isolated	O
by	O
Woo	O
et	O
al	O
in	O
Hong	O
Kong	O
.	O

Several	O
successive	O
reports	O
confirmed	O
retrospectively	O
that	O
this	O
new	O
human	B-SPEC
coronavirus	I-SPEC
was	O
circulating	O
in	O
different	O
countries	O
worldwide	O
.	O

Moreover	O
,	O
the	O
excellent	O
immune	O
responses	O
in	O
mice	B-SPEC
induced	O
by	O
the	O
identified	O
phages	O
provided	O
the	O
possibility	O
to	O
develop	O
novel	O
phage	O
-	O
based	O
vaccines	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
is	O
a	O
versatile	O
pathogen	O
armed	O
with	O
a	O
host	O
of	O
factors	O
countering	O
the	O
antiviral	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
system	O
.	O

This	O
inactivity	O
is	O
likely	O
due	O
to	O
virus	B-SPEC
-	O
mediated	O
interference	O
since	O
the	O
typical	O
IFN	O
-	O
	O
response	O
by	O
either	O
purified	O
or	O
nonsorted	O
porcine	B-SPEC
pDC	O
to	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
or	O
the	O
Toll	O
-	O
like	O
receptor	O
9	O
agonist	O
,	O
oligodeoxynucleotide	O
(	O
ODN	O
)	O
D19	O
,	O
was	O
markedly	O
reduced	O
in	O
the	O
presence	O
of	O
PRRSV	B-SPEC
.	O

Suppression	O
occurred	O
independently	O
of	O
virus	B-SPEC
viability	O
and	O
acidification	O
of	O
pDC	O
early	O
endosomes	O
but	O
correlated	O
with	O
diminished	O
levels	O
of	O
IFN	O
-	O
	O
mRNA	O
.	O

Likewise	O
,	O
PRRSV	B-SPEC
did	O
not	O
impact	O
a	O
specific	O
TGEV	B-SPEC
-	O
associated	O
enhancement	O
of	O
IL	O
-	O
8	O
expression	O
.	O

TITLE	O
:	O
Interferon	O
-	O
gamma	O
negatively	O
regulates	O
Th17	O
-	O
mediated	O
immunopathology	O
during	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
.	O

We	O
show	O
that	O
IL	O
-	O
17	O
levels	O
in	O
serum	O
are	O
rapidly	O
elevated	O
and	O
positively	O
correlated	O
to	O
liver	O
damage	O
and	O
death	O
of	O
the	O
mice	B-SPEC
.	O

As	O
a	O
prototype	O
coronavirus	B-SPEC
,	O
MHV	B-SPEC
has	O
been	O
explored	O
extensively	O
and	O
is	O
often	O
used	O
to	O
express	O
foreign	O
proteins	O
.	O

These	O
results	O
suggest	O
that	O
the	O
partial	O
deletion	O
in	O
the	O
S	O
endodomain	O
may	O
increase	O
the	O
usefulness	O
of	O
MHV	B-SPEC
as	O
a	O
viral	O
vector	O
by	O
attenuation	O
and	O
maintaining	O
foreign	O
protein	O
expression	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
immune	O
responses	O
of	O
BALB	O
/	O
c	O
mice	B-SPEC
immunized	O
via	O
intranasal	O
(	O
i	O
.	O
n	O
.)	O
route	O
with	O
SARS	O
DNA	O
vaccine	O
(	O
pci	O
-	O
S	O
)	O
in	O
a	O
PEI	O
/	O
pci	O
-	O
S	O
complex	O
form	O
have	O
been	O
examined	O
.	O

We	O
studied	O
the	O
spatial	O
distributions	O
of	O
simulated	O
virus	B-SPEC
-	O
laden	O
respiratory	O
droplets	O
when	O
human	B-SPEC
subjects	O
wore	O
facemasks	O
and	O
were	O
exposed	O
to	O
regulatory	O
viral	O
droplets	O
by	O
conducting	O
in	O
vivo	O
experiments	O
in	O
facemask	O
use	O
.	O

Here	O
we	O
report	O
the	O
crystal	O
structures	O
of	O
the	O
two	O
proteolytically	O
resistant	O
N	O
-	O
(	O
NTD	O
)	O
and	O
C	O
-	O
terminal	O
(	O
CTD	O
)	O
domains	O
of	O
the	O
N	O
protein	O
from	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

The	O
structure	O
of	O
NTD	O
in	O
two	O
different	O
crystal	O
forms	O
was	O
solved	O
to	O
1	O
.	O
5	O
	O
.	O
The	O
higher	O
resolution	O
provides	O
more	O
detailed	O
structural	O
information	O
than	O
previous	O
reports	O
,	O
showing	O
that	O
the	O
NTD	O
structure	O
from	O
MHV	B-SPEC
shares	O
a	O
similar	O
overall	O
and	O
topology	O
structure	O
with	O
that	O
of	O
SARS	O
-	O
CoV	O
and	O
IBV	B-SPEC
,	O
but	O
varies	O
in	O
its	O
potential	O
surface	O
,	O
which	O
indicates	O
a	O
possible	O
difference	O
in	O
RNA	O
-	O
binding	O
module	O
.	O

The	O
similarity	O
between	O
the	O
structures	O
of	O
these	O
two	O
domains	O
from	O
SARS	O
-	O
CoV	O
,	O
IBV	B-SPEC
and	O
MHV	B-SPEC
corroborates	O
a	O
conserved	O
mechanism	O
of	O
nucleocapsid	O
formation	O
for	O
coronaviruses	O
.	O

Regarding	O
the	O
nsp8	O
as	O
the	O
primase	O
in	O
RNA	O
synthesis	O
,	O
we	O
confirmed	O
that	O
the	O
proteolysis	O
product	O
of	O
the	O
primase	O
(	O
nsp8	O
)	O
contains	O
the	O
globular	O
domain	O
(	O
nsp8C	O
),	O
and	O
indentified	O
the	O
resectioning	O
site	O
that	O
is	O
notably	O
conserved	O
in	O
all	O
the	O
three	O
groups	O
of	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Gaps	O
remain	O
in	O
China	O
'	O
s	O
ability	O
to	O
detect	O
emerging	O
infectious	O
diseases	O
despite	O
advances	O
since	O
the	O
onset	O
of	O
SARS	O
and	O
avian	B-SPEC
flu	O
.	O

Sequence	O
analysis	O
and	O
BLAST	O
homology	O
search	O
in	O
GenBank	O
data	O
base	O
indicate	O
that	O
two	O
of	O
the	O
farms	O
were	O
infected	O
with	O
the	O
4	O
/	O
91	O
strain	O
,	O
one	O
with	O
an	O
unidentified	O
IBV	B-SPEC
and	O
five	O
were	O
infected	O
with	O
Sul	O
/	O
01	O
/	O
09	O
.	O

Antibodies	O
against	O
IBV	B-SPEC
were	O
detected	O
in	O
vaccinated	O
chickens	B-SPEC
1	O
-	O
week	O
post	O
inoculation	O
.	O

These	O
results	O
indicate	O
that	O
the	O
rFPV	O
-	O
IFNS1	O
protected	O
chickens	B-SPEC
against	O
challenge	O
with	O
homotypic	O
IBV	B-SPEC
strain	O
LX4	O
and	O
heterotypic	O
strains	O
LHLJ04XI	O
and	O
LHB	O
.	O

A	O
total	O
of	O
64	O
consecutive	O
subjects	O
,	O
divided	O
into	O
four	O
groups	O
:	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
15	O
);	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
plus	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
(	O
n	O
=	O
18	O
);	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
(	O
n	O
=	O
16	O
);	O
and	O
mechanically	O
ventilated	O
controls	O
(	O
n	O
=	O
15	O
).	O

The	O
rapidly	O
mutating	O
nature	O
of	O
viruses	B-SPEC
presents	O
a	O
major	O
difficulty	O
,	O
highlighting	O
the	O
need	O
for	O
specific	O
detection	O
of	O
genetically	O
diverse	O
strains	O
.	O

Four	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
against	O
the	O
N	O
-	O
terminal	O
half	O
of	O
spike	O
protein	O
(	O
S1	O
protein	O
)	O
of	O
TGEV	B-SPEC
were	O
identified	O
.	O

These	O
mAbs	O
were	O
capable	O
of	O
reacting	O
with	O
the	O
TGEV	B-SPEC
S1	O
protein	O
analysed	O
by	O
ELISA	O
and	O
Western	O
blot	O
.	O

Investigation	O
on	O
the	O
neutralizing	O
ability	O
of	O
these	O
mAbs	O
indicated	O
that	O
two	O
of	O
these	O
mAbs	O
completely	O
neutralized	O
TGEV	B-SPEC
at	O
an	O
appropriate	O
concentration	O
.	O

The	O
most	O
N	O
-	O
terminal	O
portion	O
of	O
the	O
S1	O
region	O
,	O
which	O
comprises	O
antigenic	O
sites	O
C	O
and	O
B	O
,	O
is	O
needed	O
for	O
the	O
enteric	O
tropism	O
of	O
TGEV	B-SPEC
,	O
whereas	O
the	O
major	O
antigenic	O
site	O
A	O
at	O
the	O
C	O
-	O
terminal	O
moiety	O
is	O
required	O
for	O
both	O
respiratory	O
and	O
enteric	O
cell	O
tropism	O
,	O
and	O
is	O
engaged	O
in	O
recognition	O
of	O
the	O
aminopeptidase	O
N	O
(	O
APN	O
)	O
receptor	O
.	O

ABSTRACT	O
:	O
Diagnosis	O
of	O
respiratory	O
viruses	B-SPEC
traditionally	O
relies	O
on	O
culture	O
or	O
antigen	O
detection	O
.	O

In	O
38	O
healthy	O
individuals	O
,	O
nasal	O
inoculation	O
with	O
human	B-SPEC
rhinovirus	I-SPEC
-	O
16	O
(	O
HRV	O
-	O
16	O
)	O
was	O
performed	O
.	O

CONCLUSIONS	O
:	O
With	O
the	O
expectation	O
that	O
2009	O
H1N1	O
will	O
continue	O
to	O
cause	O
disease	O
in	O
the	O
immediate	O
future	O
,	O
the	O
virus	B-SPEC
has	O
been	O
included	O
as	O
a	O
component	O
of	O
the	O
2010	O
-	O
2011	O
seasonal	O
influenza	O
vaccine	O
.	O

The	O
injury	O
was	O
induced	O
by	O
48	O
breaths	O
of	O
cotton	B-SPEC
smoke	O
and	O
a	O
third	O
-	O
degree	O
burn	O
of	O
40	O
%	O
total	O
body	O
surface	O
area	O
.	O

In	O
this	O
report	O
,	O
we	O
investigate	O
the	O
utility	O
and	O
sensitivity	O
of	O
the	O
Virochip	O
to	O
positively	O
detect	O
swine	B-SPEC
viruses	B-SPEC
in	O
both	O
cell	O
culture	O
-	O
derived	O
samples	O
and	O
clinical	O
swine	B-SPEC
samples	O
.	O

Results	O
from	O
the	O
in	O
silico	O
study	O
indicated	O
that	O
<	O
1	O
%	O
errors	O
in	O
virus	B-SPEC
identification	O
could	O
be	O
achieved	O
when	O
nucleotide	O
-	O
based	O
search	O
programs	O
(	O
BLASTn	O
or	O
tBLASTx	O
),	O
viral	O
genome	O
only	O
databases	O
and	O
sequence	O
reads	O
>	O
200	O
nt	O
were	O
considered	O
.	O

Within	O
the	O
51	O
,	O
925	O
annotated	O
sequences	O
,	O
94	O
DNA	O
and	O
19	O
RNA	O
sequences	O
were	O
identified	O
as	O
human	B-SPEC
viruses	B-SPEC
.	O

This	O
study	O
provided	O
a	O
bioinformatic	O
approach	O
for	O
identifying	O
pathogens	O
in	O
a	O
virome	O
data	O
set	O
and	O
demonstrated	O
the	O
human	B-SPEC
virus	B-SPEC
diversity	O
in	O
a	O
relevant	O
environmental	O
sample	O
.	O

TITLE	O
:	O
Immunogenicity	O
and	O
protective	O
efficacy	O
in	O
dogs	B-SPEC
of	O
an	O
MF59	O
-	O
adjuvanted	O
vaccine	O
against	O
recombinant	O
canine	O
/	O
porcine	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Recently	O
,	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
strains	O
with	O
putative	O
recombinant	O
origin	O
with	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
were	O
shown	O
to	O
be	O
widespread	O
in	O
Europe	O
.	O

ABSTRACT	O
:	O
A	O
new	O
equine	B-SPEC
coronavirus	B-SPEC
was	O
isolated	O
from	O
the	O
feces	O
of	O
adult	O
horses	B-SPEC
with	O
pyrogenic	O
and	O
enteric	O
disease	O
.	O

This	O
is	O
the	O
first	O
equine	B-SPEC
coronavirus	B-SPEC
to	O
be	O
isolated	O
from	O
adult	O
horses	B-SPEC
with	O
pyrogenic	O
and	O
enteric	O
disease	O
.	O

Hospitalization	O
for	O
LRTI	O
induced	O
or	O
not	O
by	O
RSV	B-SPEC
during	O
the	O
first	O
year	O
of	O
life	O
was	O
assessed	O
through	O
phone	O
interview	O
at	O
the	O
end	O
of	O
the	O
RSV	B-SPEC
season	O
(	O
November	O
-	O
March	O
)	O
and	O
at	O
the	O
completion	O
of	O
the	O
first	O
year	O
of	O
life	O
.	O

ABSTRACT	O
:	O
Individuals	O
infected	O
with	O
HIV	B-SPEC
are	O
at	O
higher	O
risk	O
for	O
severe	O
cases	O
of	O
seasonal	O
influenza	O
infection	O
and	O
should	O
receive	O
annual	O
doses	O
of	O
vaccine	O
.	O

Our	O
objectives	O
were	O
to	O
evaluate	O
the	O
immunogenicity	O
of	O
an	O
influenza	O
vaccine	O
in	O
37	O
HIV	B-SPEC
-	O
infected	O
patients	O
(	O
HIV	B-SPEC
group	O
)	O
compared	O
to	O
29	O
uninfected	O
individuals	O
(	O
control	O
group	O
)	O
and	O
to	O
carry	O
out	O
a	O
clinical	O
and	O
virological	O
surveillance	O
of	O
influenza	O
during	O
a	O
6	O
-	O
month	O
follow	O
-	O
up	O
.	O

ABSTRACT	O
:	O
The	O
shedding	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
into	O
saliva	O
droplets	O
plays	O
a	O
critical	O
role	O
in	O
viral	O
transmission	O
.	O

ABSTRACT	O
:	O
The	O
past	O
decade	O
saw	O
emerging	O
infections	O
such	O
as	O
SARS	O
,	O
avian	B-SPEC
and	O
pandemic	O
influenza	O
,	O
food	O
-	O
borne	O
infections	O
and	O
the	O
bioterror	O
threat	O
.	O

The	O
most	O
obvious	O
example	O
is	O
anti	O
-	O
AIDS	O
research	O
,	O
where	O
HIV	B-SPEC
protease	O
and	O
reverse	O
transcriptase	O
have	O
triggered	O
enormous	O
efforts	O
in	O
developing	O
and	O
improving	O
computational	O
methods	O
.	O

ABSTRACT	O
:	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
retrospectively	O
evaluate	O
whether	O
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
have	O
prognostic	O
value	O
for	O
the	O
prediction	O
of	O
mortality	O
and	O
severity	O
of	O
the	O
clinical	O
course	O
in	O
patients	O
presenting	O
with	O
early	O
stage	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
due	O
to	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
S	O
-	O
OIV	O
).	O

Two	O
weeks	O
after	O
vaccination	O
(	O
28	O
days	O
of	O
age	O
),	O
the	O
chickens	B-SPEC
were	O
challenged	O
with	O
a	O
virulent	O
ILTV	B-SPEC
field	O
strain	O
(	O
63140	O
isolate	O
,	O
group	O
V	O
genotype	O
).	O

The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
the	O
NDV	B-SPEC
(	O
B1	B-SPEC
)	O
and	O
IBV	B-SPEC
(	O
ARK	B-SPEC
)	O
vaccines	O
and	O
a	O
multivalent	O
vaccine	O
constituted	O
by	O
NDV	B-SPEC
(	O
B1	B-SPEC
)	O
and	O
IBV	B-SPEC
(	O
ARK	B-SPEC
and	O
MASS	O
)	O
did	O
not	O
interfere	O
with	O
the	O
protection	O
induced	O
by	O
the	O
CEO	O
ILTV	B-SPEC
vaccine	O
.	O

For	O
the	O
first	O
time	O
,	O
we	O
showed	O
that	O
Midazolam	O
abolished	O
,	O
although	O
transiently	O
,	O
the	O
breathing	O
defects	O
of	O
Mecp2	O
(-/	O
y	O
)	O
mice	B-SPEC
,	O
confirming	O
a	O
crucial	O
role	O
of	O
GABA	O
deficits	O
in	O
their	O
breathing	O
defects	O
.	O

In	O
this	O
article	O
,	O
we	O
show	O
that	O
IL	O
-	O
10	O
,	O
a	O
potent	O
anti	O
-	O
inflammatory	O
cytokine	O
,	O
is	O
produced	O
transiently	O
at	O
the	O
peak	O
of	O
infection	O
by	O
CD8	O
T	O
cells	O
in	O
the	O
brains	O
of	O
coronavirus	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

Furthermore	O
,	O
IL	O
-	O
10	O
produced	O
by	O
CD8	O
T	O
cells	O
diminished	O
disease	O
severity	O
in	O
mice	B-SPEC
with	O
coronavirus	B-SPEC
-	O
induced	O
acute	O
encephalitis	O
,	O
suggesting	O
a	O
self	O
-	O
regulatory	O
mechanism	O
that	O
minimizes	O
immunopathological	O
changes	O
.	O

ABSTRACT	O
:	O
Recently	O
emerged	O
viral	O
infectious	O
diseases	O
(	O
VIDs	O
)	O
include	O
HIV	B-SPEC
/	O
AIDS	O
,	O
influenzas	O
H5N1	O
and	O
2009	O
H1N1	O
,	O
SARS	O
,	O
and	O
Ebola	O
hemorrhagic	O
fevers	O
.	O

Inflammatory	O
cytokines	O
that	O
play	O
a	O
major	O
role	O
in	O
mediating	O
and	O
amplifying	O
ALI	O
/	O
ARDS	O
or	O
have	O
neutrophil	O
chemoattractant	O
activity	O
,	O
such	O
as	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
CXCL1	O
,	O
and	O
CXCL2	O
,	O
were	O
,	O
however	O
,	O
induced	O
only	O
in	O
macaques	B-SPEC
.	O

Western	O
blot	O
analysis	O
revealed	O
that	O
SARS	O
S	O
was	O
cleaved	O
into	O
several	O
fragments	O
upon	O
coexpression	O
of	O
TMPRSS2	O
(	O
cis	B-SPEC
-	O
cleavage	O
)	O
and	O
upon	O
contact	O
between	O
SARS	O
S	O
-	O
expressing	O
cells	O
and	O
TMPRSS2	O
-	O
positive	O
cells	O
(	O
trans	O
-	O
cleavage	O
).	O

TITLE	O
:	O
Infection	O
with	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
enhances	O
streptococcal	O
adherence	O
to	O
epithelial	O
cells	O
.	O

The	O
enhanced	O
binding	O
of	O
bacteria	B-SPEC
correlated	O
with	O
an	O
increased	O
expression	O
level	O
of	O
the	O
platelet	O
-	O
activating	O
factor	O
receptor	O
(	O
PAF	O
-	O
R	O
),	O
but	O
detailed	O
evaluation	O
of	O
the	O
bacterium	B-SPEC
-	O
PAF	O
-	O
R	O
interaction	O
revealed	O
a	O
limited	O
relevance	O
of	O
this	O
process	O
.	O

The	O
result	O
showed	O
a	O
high	O
diversity	O
of	O
the	O
transcripts	O
,	O
covering	O
much	O
of	O
the	O
human	B-SPEC
genome	O
,	O
including	O
loci	O
which	O
do	O
not	O
contain	O
protein	O
coding	O
sequences	O
.	O

In	O
this	O
study	O
,	O
we	O
created	O
a	O
MHV	B-SPEC
-	O
A59	O
temperature	O
sensitive	O
(	O
ts	O
)	O
mutant	O
Wu	O
"""-"	O
ts18	O
(	O
cd	O
)	O
using	O
the	O
recombinant	O
vaccinia	O
reverse	O
genetics	O
system	O
.	O

ABSTRACT	O
:	O
Seventy	O
-	O
eight	O
isolates	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
obtained	O
from	O
different	O
field	O
outbreaks	O
in	O
China	O
in	O
2009	O
and	O
genotyped	O
with	O
34	O
reference	O
strains	O
.	O

TITLE	O
:	O
Efficacy	O
and	O
safety	O
of	O
an	O
attenuated	O
live	O
QX	O
-	O
like	O
infectious	O
bronchitis	O
virus	B-SPEC
strain	O
as	O
a	O
vaccine	O
for	O
chickens	B-SPEC
.	O

In	O
both	O
SPF	O
chickens	B-SPEC
and	O
chickens	B-SPEC
with	O
MDA	O
,	O
the	O
vaccines	O
based	O
on	O
strain	O
IB	O
L1148	O
were	O
efficacious	O
against	O
challenge	O
.	O

TITLE	O
:	O
Successful	O
extracorporeal	O
membrane	O
oxygenation	O
for	O
respiratory	O
failure	O
in	O
an	O
infant	O
with	O
DiGeorge	O
anomaly	O
,	O
following	O
thymus	B-SPEC
transplantation	O
.	O

A	O
23	O
-	O
month	O
-	O
old	O
female	O
with	O
complete	O
immune	O
-	O
incompetent	O
DiGeorge	O
anomaly	O
65	O
days	O
after	O
allogenic	O
thymus	B-SPEC
transplantation	O
was	O
treated	O
in	O
our	O
pediatric	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
failure	O
secondary	O
to	O
bacterial	O
sepsis	B-SPEC
.	O

A	O
lack	O
of	O
suitable	O
reagents	O
and	O
specific	O
assays	O
for	O
monitoring	O
host	O
responses	O
has	O
limited	O
the	O
use	O
of	O
this	O
animal	B-SPEC
model	O
to	O
clinical	O
observations	O
,	O
pathology	O
and	O
humoral	O
immune	O
responses	O
.	O

Multivariate	O
predictors	O
for	O
use	O
of	O
rescue	O
therapy	O
included	O
age	O
(	O
odds	O
ratio	O
per	O
10	O
yrs	O
and	O
95	O
%	O
confidence	O
interval	O
:	O
0	O
.	O
88	O
;	O
0	O
.	O
78	O
-	O
0	O
.	O
99	O
;	O
p	O
=	O
.	O
049	O
),	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
1	O
.	O
33	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
05	O
-	O
1	O
.	O
69	O
;	O
p	O
=	O
.	O
019	O
),	O
Pao2	O
/	O
Fio2	O
;	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
0	O
.	O
98	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
96	O
-	O
0	O
.	O
99	O
;	O
p	O
=	O
.	O
017	O
),	O
peak	O
airway	O
pressure	O
(	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
1	O
.	O
11	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
001	O
-	O
1	O
.	O
237	O
;	O
p	O
=	O
.	O
047	O
),	O
and	O
study	O
order	B-SPEC
(	O
odds	O
ratio	O
per	O
subsequent	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Clinical	O
Trials	O
Network	O
study	O
:	O
1	O
.	O
21	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
03	O
-	O
1	O
.	O
41	O
;	O
p	O
=	O
.	O
02	O
).	O

A	O
multivariable	O
analysis	O
including	O
age	O
,	O
gender	O
,	O
current	O
tobacco	B-SPEC
use	O
,	O
prehospital	O
aspirin	O
use	O
,	O
race	O
,	O
and	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
revealed	O
that	O
patients	O
on	O
statin	O
therapy	O
before	O
hospitalization	O
were	O
less	O
likely	O
to	O
have	O
or	O
develop	O
severe	O
sepsis	B-SPEC
(	O
odds	O
ratio	O
0	O
.	O
62	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
40	O
-	O
0	O
.	O
96	O
)	O
or	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
odds	O
ratio	O
0	O
.	O
60	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
36	O
-	O
0	O
.	O
99	O
)	O
during	O
the	O
first	O
four	O
intensive	O
care	O
unit	O
days	O
.	O

Patients	O
who	O
had	O
prehospital	O
use	O
of	O
both	O
statins	O
and	O
aspirin	O
had	O
the	O
lowest	O
rates	O
of	O
severe	O
sepsis	B-SPEC
,	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
mortality	O
.	O

In	O
order	B-SPEC
to	O
establish	O
the	O
polarity	O
of	O
entry	O
and	O
release	O
of	O
CCoV	O
from	O
epithelial	O
cells	O
,	O
the	O
interactions	O
of	O
the	O
virus	B-SPEC
with	O
A72	O
and	O
CrFK	O
cells	O
grown	O
on	O
permeable	O
supports	O
was	O
evaluated	O
,	O
and	O
the	O
amount	O
of	O
infective	O
virus	B-SPEC
in	O
the	O
apical	O
and	O
in	O
the	O
basolateral	O
media	O
was	O
determined	O
and	O
compared	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
LJB	O
/	O
03	O
strain	O
was	O
isolated	O
from	O
the	O
feces	O
of	O
piglets	O
suspected	O
to	O
be	O
suffering	O
from	O
a	O
severe	O
diarrhea	O
in	O
Heilongjiang	O
Province	O
,	O
and	O
was	O
identified	O
by	O
immunofluorescence	O
test	O
,	O
immunelectronmicroscopy	O
,	O
RT	O
-	O
PCR	O
and	O
indirect	O
ELISA	O
assay	O
.	O

ABSTRACT	O
:	O
A	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
previously	O
shown	O
to	O
be	O
associated	O
with	O
catarrhal	O
gastroenteritis	O
in	O
mink	B-SPEC
(	O
Mustela	B-SPEC
vison	I-SPEC
)	O
was	O
identified	O
by	O
electron	O
microscopy	O
in	O
mink	B-SPEC
faeces	O
from	O
two	O
fur	O
farms	O
in	O
Wisconsin	O
and	O
Minnesota	O
in	O
1998	O
.	O

Additionally	O
,	O
the	O
new	O
MCoVs	O
appeared	O
to	O
be	O
phylogenetically	O
distant	O
from	O
human	B-SPEC
(	O
229E	O
and	O
NL63	O
)	O
and	O
other	O
alphacoronaviruses	O
and	O
did	O
not	O
belong	O
to	O
the	O
species	B-SPEC
Alphacoronavirus	B-SPEC
1	I-SPEC
.	O

Following	O
administration	O
of	O
MG	O
ts	O
-	O
11	O
C3	O
(+	O
CS	O
)	O
to	O
chickens	B-SPEC
by	O
eye	O
-	O
drop	O
,	O
an	O
antibody	O
response	O
to	O
MG	O
and	O
IBV	B-SPEC
-	O
S1	O
,	O
as	O
determined	O
by	O
the	O
rapid	O
serum	O
agglutination	O
test	O
(	O
RSA	O
)	O
and	O
Western	O
blotting	O
,	O
respectively	O
,	O
could	O
be	O
detected	O
.	O

Birds	B-SPEC
inoculated	O
with	O
the	O
recombinant	O
vaccine	O
had	O
significantly	O
enhanced	O
weight	O
gain	O
and	O
were	O
partially	O
protected	O
against	O
damage	O
by	O
pathogenic	O
IBV	B-SPEC
.	O

TITLE	O
:	O
PLP2	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
targets	O
TBK1	O
to	O
negatively	O
regulate	O
cellular	O
type	O
I	O
interferon	O
signaling	O
pathway	O
.	O

We	O
have	O
previously	O
shown	O
that	O
papain	O
-	O
like	O
protease	O
domain	O
2	O
(	O
PLP2	O
),	O
a	O
catalytic	O
domain	O
of	O
the	O
nonstructural	O
protein	O
3	O
(	O
nsp3	O
)	O
of	O
MHV	B-SPEC
-	O
A59	O
,	O
encodes	O
a	O
deubiquitinase	O
(	O
DUB	O
)	O
and	O
inactivates	O
IFN	O
regulatory	O
factor	O
3	O
(	O
IRF3	O
)	O
thereby	O
the	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
response	O
.	O

Intriguing	O
enough	O
,	O
results	O
of	O
PLP2	O
overexpression	O
system	O
and	O
MHV	B-SPEC
-	O
A59	O
infection	O
system	O
proved	O
that	O
PLP2	O
formed	O
an	O
inactive	O
complex	O
with	O
TBK1	O
and	O
IRF3	O
in	O
the	O
cytoplasm	O
and	O
the	O
presence	O
of	O
PLP2	O
stabilized	O
the	O
hypo	O
-	O
phosphorylated	O
IRF3	O
-	O
TBK1	O
complex	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

For	O
IgG	O
antibodies	O
in	O
the	O
3rd	O
y	O
,	O
the	O
positive	O
rate	O
of	O
whole	O
-	O
virus	B-SPEC
-	O
specific	O
antibodies	O
was	O
42	O
%,	O
which	O
was	O
tested	O
with	O
commercial	O
kits	O
at	O
1	O
/	O
10	O
dilution	O
of	O
the	O
sera	O
.	O

To	O
date	O
,	O
five	O
coronaviruses	O
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	O
HKU	O
-	O
1	O
)	O
that	O
infect	O
humans	B-SPEC
have	O
been	O
identified	O
,	O
four	O
of	O
which	O
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	O
-	O
HKU	O
-	O
1	O
)	O
circulate	O
continuously	O
in	O
the	O
human	B-SPEC
population	O
.	O

TITLE	O
:	O
In	O
vitro	O
inhibition	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
replication	O
by	O
small	O
interfering	O
RNAs	O
.	O

Efficacy	O
was	O
determined	O
by	O
qRT	O
-	O
PCR	O
of	O
intracellular	O
viral	O
genomic	O
and	O
messenger	O
RNA	O
,	O
TCID50	O
infectivity	O
assay	O
of	O
extracellular	O
virus	B-SPEC
,	O
and	O
direct	O
IFA	O
for	O
viral	O
protein	O
expression	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
suggested	O
that	O
the	O
four	O
species	B-SPEC
of	O
siRNAs	O
can	O
efficiently	O
inhibit	O
PHE	O
-	O
CoV	O
genome	O
replication	O
and	O
infectious	O
virus	B-SPEC
production	O
.	O

TITLE	O
:	O
[	O
Encephalomyelitis	O
caused	O
by	O
enterovirus	B-SPEC
type	O
71	O
in	O
children	O
].	O

Moreover	O
,	O
western	O
blotting	O
analysis	O
further	O
confirmed	O
the	O
changes	O
of	O
annexin	O
A5	O
and	O
HSPB1	O
during	O
IBV	B-SPEC
infection	O
.	O

The	O
Collaborative	O
H1N1	O
Adjuvant	O
Treatment	O
(	O
CHAT	B-SPEC
)	O
Pilot	O
Trial	O
sought	O
to	O
investigate	O
the	O
feasibility	O
of	O
conducting	O
a	O
trial	O
during	O
a	O
global	O
pandemic	O
in	O
critically	O
ill	O
patients	O
with	O
H1N1	O
with	O
the	O
goal	O
of	O
informing	O
the	O
design	O
of	O
a	O
larger	O
trial	O
powered	O
to	O
determine	O
impact	O
of	O
statins	O
on	O
important	O
outcomes	O
.	O

TITLE	O
:	O
Structure	O
and	O
functional	O
relevance	O
of	O
a	O
transcription	O
-	O
regulating	O
sequence	O
involved	O
in	O
coronavirus	B-SPEC
discontinuous	O
RNA	O
synthesis	O
.	O

Co	O
-	O
infections	O
occurred	O
in	O
29	O
.	O
4	O
%	O
(	O
69	O
/	O
235	O
)	O
of	O
infected	O
patients	O
and	O
rhinovirus	B-SPEC
was	O
the	O
most	O
detected	O
virus	B-SPEC
(	O
27	O
.	O
5	O
%).	O

While	O
rhinovirus	B-SPEC
and	O
adenovirus	B-SPEC
infections	O
occurred	O
year	O
round	O
,	O
RSV	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
A	O
and	O
coronavirus	B-SPEC
OC43	O
had	O
defined	O
period	O
of	O
circulation	O
.	O

One	O
coronavirus	B-SPEC
,	O
6	O
astroviruses	O
,	O
and	O
1	O
novel	O
adenovirus	B-SPEC
were	O
identified	O
and	O
monitored	O
quantitatively	O
.	O

The	O
breeding	O
success	O
of	O
the	O
colony	O
was	O
significantly	O
better	O
in	O
2010	O
than	O
in	O
2008	O
,	O
in	O
spite	O
of	O
stronger	O
amplification	O
of	O
coronaviruses	O
and	O
astroviruses	O
in	O
2010	O
,	O
suggesting	O
that	O
these	O
viruses	B-SPEC
had	O
little	O
pathogenic	O
influence	O
on	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
Fecal	O
samples	O
(	O
n	O
=	O
107	O
)	O
were	O
collected	O
from	O
cattle	B-SPEC
with	O
ascertained	O
or	O
suspected	O
diarrheal	O
disease	O
on	O
Korean	O
farms	O
during	O
2008	O
-	O
2010	O
.	O

A	O
general	O
shell	O
vial	O
culture	O
using	O
a	O
pool	O
of	O
monoclonal	O
antibodies	O
was	O
used	O
to	O
detect	O
other	O
common	O
respiratory	O
viruses	B-SPEC
on	O
26	O
%	O
of	O
samples	O
.	O

The	O
main	O
clinical	O
manifestations	O
can	O
be	O
divided	O
into	O
infectious	O
disease	O
,	O
hemolytic	O
anemia	B-SPEC
and	O
vaso	O
-	O
occlusive	O
events	O
.	O

Studying	O
RVP	O
FAST	O
efficacy	O
in	O
detecting	O
respiratory	O
viruses	B-SPEC
in	O
67	O
aspirate	O
samples	O
from	O
the	O
nasal	O
cavities	O
of	O
children	O
with	O
acute	O
respiratory	O
infection	O
,	O
we	O
compared	O
RVP	O
FAST	O
results	O
to	O
those	O
of	O
conventional	O
nucleic	O
acid	O
amplification	O
tests	O
(	O
NAT	O
),	O
e	O
.	O
g	O
.,	O
real	O
-	O
time	O
PCR	O
,	O
targeting	O
8	O
strains	O
.	O

Partial	O
exchange	O
transfusion	O
should	O
be	O
reserved	O
for	O
children	O
with	O
only	O
mild	O
anemia	B-SPEC
(	O
Hb	O
>	O
9	O
g	O
/	O
dL	O
)	O
but	O
deteriorating	O
respiratory	O
status	O
.	O

Polypyrimidine	O
tract	O
-	O
binding	O
protein	O
(	O
PTB	O
)	O
was	O
reproducibly	O
identified	O
in	O
association	O
with	O
positive	O
-	O
sense	O
RNAs	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
TRS	O
-	O
L	O
and	O
TRS	O
-	O
B	O
by	O
affinity	O
chromatography	O
and	O
mass	O
spectrometry	O
.	O

TITLE	O
:	O
Spongiform	O
degeneration	O
induced	O
by	O
neuropathogenic	O
murine	B-SPEC
coronavirus	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Soluble	O
receptor	O
-	O
resistant	O
mutant	O
7	O
(	O
ssr7	O
)	O
is	O
isolated	O
from	O
a	O
highly	O
neurovirulent	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
JHMV	O
cl	O
-	O
2	O
strain	O
(	O
cl	O
-	O
2	O
).	O

From	O
this	O
restricted	O
site	O
of	O
infection	O
in	O
the	O
SVZ	O
,	O
a	O
large	O
area	O
of	O
gliosis	O
extended	O
deep	O
into	O
the	O
brain	O
parenchyma	O
where	O
no	O
viral	O
antigens	O
were	O
detected	O
but	O
vacuolar	O
degeneration	O
started	O
at	O
48	O
h	O
pi	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Vomiting	O
and	O
wasting	O
disease	O
associated	O
with	O
hemagglutinating	O
encephalomyelitis	O
viruses	B-SPEC
infection	O
in	O
piglets	O
in	O
Jilin	O
,	O
China	O
.	O

ABSTRACT	O
:	O
One	O
coronavirus	B-SPEC
strain	O
was	O
isolated	O
from	O
brain	O
tissues	O
of	O
ten	O
piglets	O
with	O
evident	O
clinical	O
manifestations	O
of	O
vomiting	O
,	O
diarrhea	O
and	O
dyskinesia	O
in	O
Jilin	O
province	O
in	O
China	O
.	O

MicroRNAs	O
(	O
miRNAs	O
)	O
have	O
emerged	O
as	O
a	O
novel	O
class	B-SPEC
of	O
gene	O
regulators	O
that	O
play	O
critical	O
roles	O
in	O
complex	O
diseases	O
including	O
ALI	O
.	O

The	O
SLIV	O
domain	O
(	O
nt	O
174	O
to	O
210	O
)	O
required	O
a	O
16	O
-	O
nt	O
extension	O
into	O
BCoV	O
open	O
reading	O
frame	O
1	O
(	O
ORF1	O
)	O
for	O
apparent	O
stabilization	O
of	O
a	O
longer	O
BCoV	O
SLIV	O
(	O
nt	O
174	O
to	O
226	O
)	O
and	O
optimal	O
virus	B-SPEC
replication	O
.	O

The	O
main	O
tools	O
were	O
the	O
Tutte	O
polynomials	O
and	O
Maple	B-SPEC
package	O
Graph	O
-	O
Theory	O
.	O

We	O
suggest	O
that	O
the	O
technique	O
may	O
mitigate	O
the	O
risk	O
of	O
guidewire	O
looping	O
during	O
insertion	O
of	O
the	O
dilators	O
/	O
cannula	B-SPEC
and	O
thereby	O
reduce	O
the	O
risk	O
of	O
perforation	O
of	O
the	O
right	O
ventricle	O
.	O

CONCLUSIONS	O
:	O
We	O
suggest	O
that	O
the	O
technique	O
may	O
mitigate	O
the	O
risk	O
of	O
guidewire	O
looping	O
during	O
insertion	O
of	O
the	O
dilators	O
/	O
cannula	B-SPEC
and	O
thereby	O
reduce	O
the	O
risk	O
of	O
perforation	O
of	O
the	O
right	O
ventricle	O
.	O

We	O
found	O
that	O
R667	O
was	O
dispensable	O
for	O
SARS	O
-	O
S	O
-	O
driven	O
virus	B-SPEC
-	O
cell	O
fusion	O
and	O
for	O
SARS	O
-	O
S	O
-	O
activation	O
by	O
trypsin	O
and	O
cathepsin	O
L	O
in	O
a	O
virus	B-SPEC
-	O
virus	B-SPEC
fusion	O
assay	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
61	O
of	O
166	O
episodes	O
(	O
36	O
.	O
7	O
%).	O

Although	O
newly	O
discovered	O
respiratory	O
viruses	B-SPEC
were	O
identified	O
in	O
these	O
episodes	O
,	O
rhinovirus	B-SPEC
was	O
the	O
commonest	O
organism	O
associated	O
with	O
both	O
asthma	O
exacerbations	O
and	O
non	O
-	O
asthma	O
related	O
episodes	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
Golgi	O
complex	O
-	O
targeting	O
signal	O
in	O
the	O
cytoplasmic	O
tail	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
envelope	O
protein	O
.	O

Co	O
-	O
infections	O
with	O
multiple	O
viruses	B-SPEC
were	O
detected	O
in	O
20	O
%	O
(	O
62	O
/	O
309	O
)	O
of	O
patients	O
.	O

Similar	O
to	O
other	O
parts	O
in	O
the	O
world	O
,	O
RSV	B-SPEC
and	O
influenza	O
were	O
the	O
predominant	O
viral	O
pathogens	O
detected	O
in	O
Vietnamese	O
hospitalized	O
children	O
.	O

ABSTRACT	O
:	O
The	O
influenza	B-SPEC
virus	I-SPEC
infection	O
may	O
be	O
severe	O
in	O
non	O
-	O
immune	O
people	O
.	O

However	O
,	O
several	O
threats	O
exist	O
for	O
transfer	O
of	O
diseases	O
among	O
unvaccinated	O
dogs	B-SPEC
and	O
wolves	O
.	O

TITLE	O
:	O
PIKA	B-SPEC
provides	O
an	O
adjuvant	O
effect	O
to	O
induce	O
strong	O
mucosal	O
and	O
systemic	O
humoral	O
immunity	O
against	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
a	O
deadly	O
infectious	O
disease	O
caused	O
by	O
SARS	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

When	O
intranasal	O
immunization	O
was	O
used	O
,	O
PIKA	B-SPEC
was	O
obligatorily	O
for	O
inducing	O
neutralizing	O
activity	O
in	O
serum	O
as	O
well	O
as	O
in	O
mucosal	O
sites	O
and	O
was	O
correlated	O
with	O
both	O
mucosal	O
IgA	O
and	O
mucosal	O
IgG	O
response	O
.	O

In	O
an	O
airtight	O
environment	O
,	O
rabbit	B-SPEC
ARDS	O
model	O
can	O
be	O
reproduced	O
successfully	O
by	O
blast	O
injury	O
with	O
1	O
917	O
.	O
3	O
mm	O
Hg	O
explosion	O
pressure	O
;	O
TNF	O
-	O
	O
and	O
IL	O
-	O
6	O
are	O
involved	O
in	O
the	O
pathogenesis	O
and	O
development	O
of	O
ARDS	O
in	O
blast	O
injury	O
.	O

TITLE	O
:	O
Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
),	O
produced	O
by	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
virus	B-SPEC
-	O
infected	O
monocytes	O
and	O
macrophages	O
,	O
induces	O
vascular	O
permeability	O
and	O
effusion	O
in	O
cats	B-SPEC
with	O
FIP	O
.	O

We	O
investigated	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
to	O
examine	O
the	O
relationship	O
between	O
VEGF	O
levels	O
and	O
the	O
amounts	O
of	O
effusion	O
in	O
cats	B-SPEC
with	O
FIP	O
.	O

The	O
performance	O
of	O
the	O
test	O
was	O
evaluated	O
using	O
laboratory	O
isolates	O
of	O
IBV	B-SPEC
and	O
field	O
samples	O
.	O

Puppies	O
were	O
also	O
infected	O
by	O
canine	O
parvovirus	B-SPEC
type	O
2	O
(	O
CPV	B-SPEC
-	O
2	O
).	O

ABSTRACT	O
:	O
During	O
the	O
co	O
-	O
evolution	O
of	O
viruses	B-SPEC
and	O
their	O
hosts	O
,	O
the	O
latter	O
have	O
equipped	O
themselves	O
with	O
an	O
elaborate	O
immune	O
system	O
to	O
defend	O
themselves	O
from	O
the	O
invading	O
viruses	B-SPEC
.	O

In	O
this	O
work	O
,	O
based	O
on	O
a	O
novel	O
platform	O
of	O
receptor	O
signaling	O
,	O
the	O
Signaling	O
Chain	O
HOmoOLigomerization	O
(	O
SCHOOL	O
)	O
platform	O
,	O
I	O
suggest	O
specific	O
mechanisms	O
used	O
by	O
different	O
viruses	B-SPEC
such	O
as	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
cytomegalovirus	B-SPEC
(	O
CMV	B-SPEC
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
human	B-SPEC
herpesvirus	I-SPEC
6	I-SPEC
and	O
others	O
,	O
to	O
modulate	O
receptor	O
signaling	O
.	O

To	O
develop	O
gene	O
therapy	O
strategies	O
for	O
Friedreich	O
'	O
s	O
ataxia	O
(	O
FRDA	O
),	O
we	O
have	O
examined	O
the	O
persistence	O
of	O
transgene	O
expression	O
in	O
the	O
brain	O
in	O
vivo	O
provided	O
by	O
the	O
entire	O
135	O
kb	O
FXN	O
genomic	O
DNA	O
locus	O
delivered	O
as	O
an	O
infectious	O
bacterial	O
artificial	O
chromosome	O
(	O
iBAC	O
)	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
)-	O
based	O
vector	O
injected	O
in	O
the	O
adult	O
mouse	B-SPEC
cerebellum	O
.	O

SHSY5Y	O
human	B-SPEC
neuroblastoma	O
cells	O
transduced	O
by	O
iBAC	O
-	O
FXN	O
-	O
lacZ	O
showed	O
high	O
efficiency	O
of	O
vector	O
delivery	O
and	O
LacZ	O
expression	O
.	O

Green	O
fluorescent	O
protein	O
expression	O
driven	O
from	O
the	O
same	O
vector	O
but	O
by	O
the	O
strong	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
IE4	O
/	O
5	O
promoter	O
was	O
transient	O
.	O

Current	O
standard	O
precaution	O
practices	O
are	O
insufficient	O
to	O
prevent	O
most	O
of	O
the	O
unconventional	O
infections	O
in	O
hospitals	O
analyzed	O
in	O
this	O
study	O
;	O
it	O
is	O
recommended	O
that	O
special	O
attention	O
be	O
given	O
to	O
flaviviruses	B-SPEC
in	O
these	O
settings	O
.	O

ABSTRACT	O
:	O
As	O
part	O
of	O
an	O
epidemiological	O
study	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
Brazil	O
,	O
252	O
samples	O
from	O
IBV	B-SPEC
-	O
suspect	O
flocks	O
were	O
tested	O
and	O
the	O
IBV	B-SPEC
-	O
positive	O
samples	O
were	O
analysed	O
by	O
sequencing	O
of	O
hypervariable	O
regions	O
1	O
and	O
2	O
of	O
the	O
S1	O
gene	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
may	O
persist	O
in	O
the	O
airways	O
of	O
asthmatics	O
between	O
episodes	O
of	O
clinical	O
worsening	O
.	O

Thirty	O
-	O
two	O
of	O
525	O
patient	O
assessments	O
(	O
6	O
%)	O
showed	O
a	O
virus	B-SPEC
-	O
positive	O
sample	O
.	O

ABSTRACT	O
:	O
Certain	O
Staphylococcus	B-SPEC
aureus	I-SPEC
strains	O
produce	O
Panton	O
-	O
Valentine	O
leukocidin	O
,	O
a	O
toxin	O
that	O
lyses	O
white	O
blood	O
cells	O
causing	O
extensive	O
tissue	O
necrosis	O
and	O
chronic	O
,	O
recurrent	O
or	O
severe	O
infection	O
.	O

Bacterial	O
isolates	O
from	O
specimens	O
recovered	O
from	O
our	O
patient	O
before	O
and	O
after	O
his	O
death	O
were	O
analyzed	O
using	O
microarray	O
DNA	O
analysis	O
and	O
spa	O
typing	O
,	O
and	O
the	O
results	O
revealed	O
that	O
the	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
isolates	O
belonged	O
to	O
clonal	O
complex	O
8	O
,	O
were	O
methicillin	O
-	O
susceptible	O
and	O
positive	O
for	O
Panton	O
-	O
Valentine	O
leukocidin	O
.	O

CONCLUSIONS	O
:	O
Rapid	O
identification	O
of	O
Panton	O
-	O
Valentine	O
leukocidin	O
in	O
methicillin	O
-	O
sensitive	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
isolates	O
causing	O
severe	O
infections	O
is	O
necessary	O
so	O
as	O
not	O
to	O
miss	O
their	O
potentially	O
devastating	O
consequences	O
.	O

RESULTS	O
:	O
Among	O
843	O
cases	O
,	O
90	O
were	O
HboV	O
positive	O
(	O
10	O
.	O
7	O
%),	O
131	O
were	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
positive	O
(	O
15	O
.	O
5	O
%),	O
117	O
were	O
influenza	B-SPEC
virus	I-SPEC
positive	O
(	O
13	O
.	O
9	O
%),	O
84	O
were	O
parainfluenza	O
virus	B-SPEC
positive	O
(	O
10	O
.	O
0	O
%),	O
55	O
were	O
rhinovirus	B-SPEC
positive	O
(	O
6	O
.	O
5	O
%),	O
48	O
were	O
coronavirus	B-SPEC
positive	O
(	O
5	O
.	O
7	O
%),	O
and	O
33	O
were	O
human	B-SPEC
metapneumovirus	I-SPEC
positive	O
(	O
3	O
.	O
7	O
%).	O

This	O
inhibitor	O
significantly	O
decreased	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
replication	O
,	O
reducing	O
the	O
percentage	O
of	O
infected	O
cells	O
and	O
intra	O
-	O
and	O
extracellular	O
infectious	O
virus	B-SPEC
titers	O
.	O

Impaired	O
ASC	O
recruitment	O
into	O
the	O
CNS	O
of	O
infected	O
CXCR3	O
(-/-)	O
mice	B-SPEC
coincided	O
with	O
elevated	O
levels	O
of	O
persisting	O
viral	O
RNA	O
,	O
sustained	O
infectious	O
virus	B-SPEC
,	O
increased	O
clinical	O
disease	O
,	O
and	O
mortality	O
.	O

Chest	O
radiographs	O
are	O
usually	O
appropriate	O
in	O
(	O
1	O
)	O
patients	O
with	O
positive	O
physical	O
examination	O
or	O
risk	O
factors	O
for	O
pneumonia	O
,	O
(	O
2	O
)	O
for	O
the	O
assessment	O
of	O
complicated	O
pneumonia	O
,	O
or	O
(	O
3	O
)	O
in	O
cases	O
of	O
emerging	O
infections	O
and	O
biological	O
warfare	O
agents	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
H1N1	O
,	O
and	O
anthrax	B-SPEC
.	O

Main	O
diagnosis	O
for	O
ICU	O
admission	O
was	O
virus	B-SPEC
-	O
related	O
pneumonia	O
.	O

CONCLUSIONS	O
:	O
This	O
is	O
the	O
first	O
case	O
,	O
to	O
our	O
knowledge	O
,	O
of	O
the	O
use	O
of	O
ECMO	O
in	O
a	O
trauma	O
patient	O
with	O
severe	O
fulminant	O
A	B-SPEC
.	I-SPEC
hydrophila	I-SPEC
pneumonia	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
recent	O
field	O
isolates	O
of	O
IBV	B-SPEC
in	O
China	O
were	O
mostly	O
belonged	O
to	O
A2	O
-	O
branch	O
(	O
QXIBV	O
-	O
branch	O
)	O
and	O
HN08	O
-	O
branch	O
,	O
only	O
one	O
isolate	O
was	O
belonged	O
to	O
Gray	O
-	O
branch	O
and	O
M41	O
-	O
branch	O
respectively	O
.	O

Bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
,	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
and	O
feline	B-SPEC
calicivirus	I-SPEC
were	O
used	O
as	O
models	O
for	O
other	O
important	O
avian	B-SPEC
pathogens	O
,	O
such	O
as	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
and	O
avian	B-SPEC
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
.	O

Examples	O
include	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
or	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
H3N2	O
.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
in	O
lung	O
transplant	O
recipients	O
:	O
a	O
critical	O
review	O
and	O
pooled	O
analysis	O
of	O
clinical	O
studies	O
.	O

Fourteen	O
children	O
had	O
no	O
identifiable	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Subcellular	O
location	O
and	O
topology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
envelope	O
protein	O
.	O

TITLE	O
:	O
The	O
ADP	O
-	O
ribose	O
-	O
1	O
''-	O
monophosphatase	O
domains	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
mediate	O
resistance	O
to	O
antiviral	O
interferon	O
responses	O
.	O

Here	O
,	O
we	O
report	O
that	O
genetically	O
engineered	O
mutants	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
expressing	O
ADRP	O
-	O
deficient	O
macrodomains	O
displayed	O
an	O
increased	O
sensitivity	O
to	O
the	O
antiviral	O
effect	O
of	O
alpha	O
interferon	O
compared	O
with	O
their	O
wild	O
-	O
type	O
counterparts	O
.	O

Infection	O
of	O
transgenic	O
IL	O
-	O
10	O
/	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
reporter	O
mice	B-SPEC
revealed	O
that	O
CNS	O
-	O
infiltrating	O
T	O
cells	O
were	O
the	O
major	O
source	O
of	O
IL	O
-	O
10	O
,	O
with	O
minimal	O
IL	O
-	O
10	O
production	O
by	O
macrophages	O
and	O
resident	O
microglia	O
.	O

ABSTRACT	O
:	O
This	O
study	O
explored	O
the	O
feasibility	O
of	O
Lactobacillus	B-SPEC
pentosus	I-SPEC
as	O
a	O
live	O
vehicle	O
to	O
deliver	O
and	O
express	O
antigen	O
.	O

ABSTRACT	O
:	O
The	O
bacterially	O
expressed	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
porcine	B-SPEC
respiratory	I-SPEC
and	I-SPEC
reproductive	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
was	O
used	O
as	O
immunogen	O
to	O
generate	O
a	O
rabbit	B-SPEC
-	O
derived	O
polyclonal	O
antibody	O
.	O

The	O
polyclonal	O
antibody	O
against	O
PRRSV	B-SPEC
N	O
protein	O
used	O
as	O
a	O
diagnostic	O
agent	O
was	O
capable	O
of	O
differentiating	O
PRRSV	B-SPEC
from	O
the	O
other	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Inflammation	O
induced	O
by	O
infection	O
potentiates	O
tau	O
pathological	O
features	O
in	O
transgenic	B-SPEC
mice	I-SPEC
.	O

Researchers	O
have	O
recently	O
demonstrated	O
that	O
triggering	O
inflammation	O
in	O
the	O
brain	O
exacerbates	O
tau	O
pathological	O
characteristics	O
in	O
animal	B-SPEC
models	O
.	O

SARS	O
-	O
CoV	O
is	O
a	O
zoonotic	O
pathogen	O
that	O
entered	O
the	O
human	B-SPEC
population	O
through	O
an	O
intermediate	O
host	O
like	O
the	O
palm	O
civet	B-SPEC
.	O

TITLE	O
:	O
Attenuated	O
live	O
vaccine	O
usage	O
affects	O
accurate	O
measures	O
of	O
virus	B-SPEC
diversity	O
and	O
mutation	O
rates	O
in	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Positive	O
selection	O
was	O
not	O
detected	O
and	O
mutation	O
rates	O
ranged	O
from	O
10	O
(-	O
4	O
)	O
to	O
10	O
(-	O
6	O
)	O
substitutions	O
/	O
site	O
/	O
year	O
for	O
Mass	O
and	O
Conn	O
IBV	B-SPEC
types	O
where	O
attenuated	O
live	O
vaccines	O
are	O
routinely	O
used	O
to	O
control	O
the	O
disease	O
.	O

The	O
genetic	O
data	O
also	O
identified	O
a	O
recombinant	O
IBV	B-SPEC
isolate	O
with	O
7	O
breakpoints	O
distributed	O
across	O
the	O
entire	O
genome	O
suggesting	O
that	O
viruses	B-SPEC
within	O
the	O
same	O
serotype	O
can	O
have	O
a	O
high	O
degree	O
of	O
genetic	O
variability	O
outside	O
of	O
the	O
spike	O
gene	O
.	O

TITLE	O
:	O
[	O
The	O
specific	O
features	O
of	O
the	O
reproduction	O
of	O
the	O
bovine	B-SPEC
coronavirus	B-SPEC
strain	O
ARRIAH	O
in	O
the	O
continuous	O
RBT	O
cell	O
culture	O
].	O

ABSTRACT	O
:	O
Viral	O
and	O
bacterial	O
pathogens	O
may	O
be	O
present	O
in	O
the	O
air	O
after	O
being	O
released	O
from	O
infected	O
individuals	O
and	O
animals	B-SPEC
.	O

This	O
study	O
was	O
undertaken	O
to	O
determine	O
the	O
utility	O
of	O
sampling	O
used	O
ventilation	O
filters	O
to	O
assess	O
the	O
types	O
and	O
concentrations	O
of	O
virus	B-SPEC
aerosols	O
present	O
in	O
buildings	O
.	O

RESULTS	O
:	O
Attempts	O
were	O
made	O
to	O
detect	O
viruses	B-SPEC
by	O
inoculation	O
of	O
these	O
eluates	O
in	O
cell	O
cultures	O
(	O
Vero	O
,	O
MDCK	O
,	O
and	O
RK	O
-	O
13	O
)	O
and	O
specific	O
pathogen	O
-	O
free	O
embryonated	O
chicken	B-SPEC
eggs	O
.	O

Nine	O
of	O
the	O
64	O
filters	O
tested	O
were	O
positive	O
for	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
2	O
filters	O
were	O
positive	O
for	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
and	O
1	O
filter	O
was	O
positive	O
for	O
parainfluenza	O
virus	B-SPEC
1	O
.	O

Interestingly	O
,	O
S	O
protein	O
of	O
the	O
attenuated	O
100th	O
-	O
passaged	O
83P	O
-	O
5	O
showed	O
a	O
remarkable	O
sequence	O
similarity	O
to	O
that	O
of	O
previously	O
reported	O
DR	O
-	O
13	O
strain	O
of	O
attenuated	O
PEDV	B-SPEC
that	O
also	O
had	O
been	O
established	O
by	O
serial	O
passage	O
in	O
Vero	O
cells	O
.	O

In	O
the	O
current	O
study	O
,	O
the	O
action	O
mechanism	O
of	O
LiCl	O
on	O
cell	O
infection	O
by	O
TGEV	B-SPEC
was	O
investigated	O
.	O

Our	O
data	O
indicate	O
that	O
LiCl	O
inhibits	O
TGEV	B-SPEC
infection	O
by	O
exerting	O
an	O
anti	O
-	O
apoptotic	O
effect	O
.	O

Together	O
with	O
other	O
reports	O
concerning	O
the	O
inhibitory	O
effect	O
of	O
lithium	O
salts	O
on	O
IBV	B-SPEC
in	O
cell	O
culture	O
,	O
our	O
results	O
indicate	O
that	O
LiCl	O
may	O
be	O
a	O
potent	O
agent	O
against	O
porcine	B-SPEC
and	O
avian	B-SPEC
coronaviruses	O
.	O

Here	O
we	O
report	O
three	O
patients	O
with	O
severe	O
influenza	O
pneumonia	O
who	O
recovered	O
following	O
treatment	O
with	O
porcine	B-SPEC
surfactant	O
(	O
Tab	O
.	O

5H10	O
,	O
which	O
recognized	O
the	O
same	O
epitope	O
that	O
is	O
also	O
a	O
cleavage	O
site	O
critical	O
for	O
the	O
entry	O
of	O
SARS	O
-	O
CoV	O
into	O
host	O
cells	O
,	O
inhibited	O
propagation	O
of	O
the	O
virus	B-SPEC
and	O
pathological	O
changes	O
found	O
in	O
Rhesus	B-SPEC
macaques	I-SPEC
infected	O
with	O
the	O
virus	B-SPEC
through	O
the	O
nasal	O
route	O
.	O

In	O
addition	O
,	O
we	O
analyzed	O
the	O
mode	O
of	O
action	O
of	O
5H10	O
,	O
and	O
the	O
results	O
suggested	O
that	O
5H10	O
inhibited	O
fusion	O
between	O
the	O
virus	B-SPEC
envelope	O
and	O
host	O
cell	O
membrane	O
.	O

RESULTS	O
:	O
5H10	O
,	O
which	O
recognized	O
the	O
same	O
epitope	O
that	O
is	O
also	O
a	O
cleavage	O
site	O
critical	O
for	O
the	O
entry	O
of	O
SARS	O
-	O
CoV	O
into	O
host	O
cells	O
,	O
inhibited	O
propagation	O
of	O
the	O
virus	B-SPEC
and	O
pathological	O
changes	O
found	O
in	O
Rhesus	B-SPEC
macaques	I-SPEC
infected	O
with	O
the	O
virus	B-SPEC
through	O
the	O
nasal	O
route	O
.	O

Virus	B-SPEC
multiplication	O
in	O
cell	O
culture	O
was	O
monitored	O
and	O
examined	O
under	O
the	O
transmission	O
electron	O
microscope	O
.	O

Here	O
,	O
we	O
examined	O
the	O
therapeutic	O
effects	O
of	O
increased	O
levels	O
of	O
IL	O
-	O
10	O
at	O
early	O
times	O
after	O
infection	O
by	O
engineering	O
a	O
recombinant	O
J2	O
.	O
2	O
virus	B-SPEC
to	O
produce	O
IL	O
-	O
10	O
.	O

ABSTRACT	O
:	O
Several	O
studies	O
have	O
reported	O
that	O
intramuscular	O
injection	O
of	O
DNA	O
vaccines	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
induces	O
protective	O
immune	O
responses	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
oral	O
and	O
nasal	O
DNA	O
vaccines	O
that	O
carried	O
the	O
S1	O
gene	O
and	O
N	O
gene	O
of	O
IBV	B-SPEC
delivered	O
by	O
attenuated	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
strains	O
SL	O
/	O
pV	O
-	O
S1	O
and	O
SL	O
/	O
pV	O
-	O
N	O
,	O
respectively	O
.	O

Several	O
virus	B-SPEC
families	O
in	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
,	O
such	O
as	O
the	O
coronaviruses	O
(	O
CoVs	O
)	O
must	O
achieve	O
these	O
objectives	O
with	O
the	O
largest	O
and	O
most	O
complex	O
replicating	O
RNA	O
genomes	O
known	O
,	O
up	O
to	O
32	O
kb	O
of	O
positive	O
-	O
sense	O
RNA	O
.	O

The	O
CoVs	O
,	O
including	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
SARS	O
-	O
CoV	O
,	O
encode	O
a	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
activity	O
(	O
ExoN	O
)	O
in	O
nsp14	O
.	O

The	O
results	O
of	O
a	O
virus	B-SPEC
neutralization	O
assay	O
indicated	O
that	O
the	O
carboxyl	O
terminal	O
region	O
of	O
the	O
S1	O
protein	O
(	O
Mod4F	O
/	O
Epi4R	O
)	O
or	O
the	O
combined	O
carboxyl	O
terminal	O
S1	O
and	O
amino	O
terminal	O
S2	O
protein	O
(	O
4F	O
/	O
4R	O
)	O
possesses	O
the	O
neutralizing	O
epitopes	O
,	O
while	O
the	O
S2	O
fragment	O
(	O
6F	O
/	O
6R	O
)	O
contains	O
antigenic	O
epitopes	O
but	O
not	O
neutralizing	O
epitopes	O
.	O

TITLE	O
:	O
Effect	O
of	O
Da	O
-	O
Cheng	O
-	O
Qi	O
decoction	O
on	O
pancreatitis	O
-	O
associated	O
lung	O
injury	O
in	O
patients	O
and	O
anti	O
-	O
inflammatory	O
responses	O
in	O
rat	B-SPEC
models	O
.	O

Rats	B-SPEC
treated	O
with	O
DCQD	O
had	O
lower	O
mean	O
pathological	O
lung	O
lesion	O
scores	O
than	O
those	O
in	O
SAP	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
Two	O
potential	O
receptors	O
have	O
been	O
described	O
for	O
the	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
):	O
feline	B-SPEC
aminopeptidase	O
N	O
(	O
fAPN	O
)	O
and	O
feline	B-SPEC
dendritic	O
cell	O
-	O
specific	O
intercellular	O
adhesion	O
molecule	O
grabbing	O
non	O
-	O
integrin	O
(	O
fDC	O
-	O
SIGN	O
).	O

TITLE	O
:	O
Pyogranulomatous	O
pleuropneumonia	B-SPEC
and	O
mediastinitis	O
in	O
ferrets	B-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
)	O
associated	O
with	O
Pseudomonas	B-SPEC
luteola	I-SPEC
Infection	O
.	O

This	O
review	O
will	O
mainly	O
focus	O
on	O
the	O
rhinovirus	B-SPEC
,	O
where	O
significant	O
advances	O
have	O
been	O
made	O
in	O
understanding	O
the	O
epidemiology	O
,	O
natural	O
history	O
and	O
relationship	O
with	O
other	O
pathogens	O
.	O

Because	O
it	O
has	O
been	O
proposed	O
that	O
the	O
immune	O
system	O
is	O
stimulated	O
by	O
alarm	O
signals	O
called	O
damage	O
-	O
associated	O
molecular	O
patterns	O
or	O
alarmins	O
,	O
we	O
investigated	O
the	O
participation	O
of	O
uric	O
acid	O
and	O
high	O
-	O
mobility	O
group	O
box	O
protein	O
1	O
(	O
HMGB1	O
)	O
in	O
the	O
autoimmune	O
response	O
elicited	O
by	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
causative	O
agent	O
of	O
pig	B-SPEC
diarrhea	O
,	O
requires	O
a	O
protease	O
(	O
s	O
)	O
for	O
multicycle	O
replication	O
in	O
cultured	O
cells	O
.	O

In	O
addition	O
,	O
treatment	O
of	O
infected	O
Vero	O
/	O
TMPRSS2	O
cells	O
with	O
the	O
protease	O
inhibitor	O
leupeptin	O
strongly	O
blocked	O
the	O
release	O
of	O
virus	B-SPEC
into	O
the	O
culture	O
fluid	O
.	O

This	O
case	O
suggests	O
that	O
ECMO	O
permits	B-SPEC
large	O
reductions	O
in	O
lung	O
inflation	O
and	O
ventilation	O
to	O
rest	O
the	O
lungs	O
,	O
while	O
maintaining	O
acceptable	O
oxygenation	O
.	O

Among	O
the	O
other	O
42	O
patients	O
,	O
5	O
(	O
11	O
.	O
9	O
%)	O
seroconverted	O
from	O
HBcAb	O
-	O
negative	O
to	O
HBcAb	O
-	O
positive	O
,	O
whereas	O
one	O
HBcAb	O
-	O
positive	O
recipient	O
became	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
surface	O
antigen	O
-	O
positive	O
with	O
clinical	O
signs	O
of	O
active	O
hepatitis	O
6	O
years	O
after	O
transplantation	O
.	O

TITLE	O
:	O
Virucidal	O
activity	O
of	O
a	O
scorpion	B-SPEC
venom	O
peptide	O
variant	O
mucroporin	O
-	O
M1	O
against	O
measles	O
,	O
SARS	O
-	O
CoV	O
and	O
influenza	O
H5N1	O
viruses	B-SPEC
.	O

Surprisingly	O
,	O
we	O
found	O
that	O
the	O
antiviral	O
activities	O
of	O
mucroporin	O
-	O
M1	O
against	O
measles	O
,	O
SARS	O
-	O
CoV	O
and	O
influenza	O
H5N1	O
viruses	B-SPEC
were	O
notably	O
increased	O
with	O
an	O
EC	O
of	O
7	O
.	O
15	O
g	O
/	O
ml	O
(	O
3	O
.	O
52	O
M	O
)	O
and	O
a	O
CC	O
of	O
70	O
.	O
46	O
g	O
/	O
ml	O
(	O
34	O
.	O
70	O
M	O
)	O
against	O
measles	B-SPEC
virus	I-SPEC
,	O
an	O
EC	O
of	O
14	O
.	O
46	O
g	O
/	O
ml	O
(	O
7	O
.	O
12	O
M	O
)	O
against	O
SARS	O
-	O
CoV	O
and	O
an	O
EC	O
of	O
2	O
.	O
10	O
g	O
/	O
ml	O
(	O
1	O
.	O
03	O
M	O
)	O
against	O
H5N1	O
,	O
while	O
the	O
original	O
peptide	O
mucroporin	O
showed	O
no	O
antiviral	O
activity	O
against	O
any	O
of	O
these	O
three	O
viruses	B-SPEC
.	O

This	O
report	O
provides	O
evidence	O
that	O
host	O
defense	O
peptides	O
from	O
scorpion	B-SPEC
venom	O
can	O
be	O
modified	O
for	O
antiviral	O
activity	O
by	O
rational	O
design	O
and	O
represents	O
a	O
practical	O
approach	O
for	O
developing	O
broad	O
-	O
spectrum	O
antiviral	O
agents	O
,	O
especially	O
against	O
RNA	O
viruses	B-SPEC
.	O

Additionally	O
,	O
since	O
plasmatic	O
uric	O
acid	O
and	O
high	O
-	O
mobility	O
group	O
box	O
protein	O
1	O
(	O
HGMB1	O
)	O
concentrations	O
augmented	O
in	O
MHV	B-SPEC
-	O
and	O
/	O
or	O
PADRE	O
-	O
treated	O
mice	B-SPEC
,	O
it	O
is	O
suggested	O
that	O
both	O
alarmins	O
were	O
probably	O
involved	O
in	O
the	O
spreading	O
of	O
the	O
immune	O
response	O
induced	O
by	O
the	O
viral	O
infection	O
and	O
the	O
adjuvant	O
administration	O
.	O

Widespread	O
vaccination	O
against	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
may	O
have	O
resulted	O
in	O
changes	O
in	O
bacterial	O
epidemiology	O
and	O
clinicians	O
should	O
be	O
continuously	O
aware	O
of	O
this	O
severe	O
disease	O
.	O

Further	O
,	O
we	O
found	O
that	O
9b	O
interacts	O
with	O
the	O
cellular	O
protein	O
Crm1	O
and	O
gets	O
exported	O
out	O
of	O
the	O
nucleus	O
using	O
an	O
active	O
NES	B-SPEC
.	O

In	O
contrast	O
,	O
all	O
8	O
ferrets	B-SPEC
had	O
moderate	O
or	O
severe	O
CNS	O
lesions	O
,	O
characterized	O
by	O
meningoencephalitis	O
,	O
choroiditis	O
,	O
and	O
ependymitis	O
,	O
and	O
centered	O
on	O
tissues	O
adjoining	O
the	O
cerebrospinal	O
fluid	O
.	O

Most	O
rabies	O
modeling	O
has	O
focused	O
on	O
disease	O
dynamics	O
and	O
control	O
within	O
terrestrial	O
mammals	B-SPEC
(	O
e	O
.	O
g	O
.,	O
raccoons	B-SPEC
and	O
foxes	O
).	O

Because	O
bats	B-SPEC
have	O
been	O
implicated	O
as	O
natural	O
reservoirs	O
for	O
several	O
emerging	O
zoonotic	O
viruses	B-SPEC
,	O
including	O
SARS	O
-	O
like	O
corona	B-SPEC
viruses	B-SPEC
,	O
henipaviruses	B-SPEC
,	O
and	O
lyssaviruses	B-SPEC
,	O
understanding	O
how	O
pathogens	O
are	O
maintained	O
within	O
a	O
population	O
becomes	O
vital	O
.	O

We	O
propose	O
that	O
life	O
history	O
patterns	O
of	O
many	O
species	B-SPEC
of	O
temperate	O
-	O
zone	O
bats	B-SPEC
,	O
coupled	O
with	O
sufficiently	O
long	O
incubation	O
periods	O
,	O
allows	O
for	O
rabies	B-SPEC
virus	I-SPEC
maintenance	O
.	O

Within	O
viable	O
bat	B-SPEC
populations	O
,	O
sufficiently	O
long	O
incubation	O
periods	O
allow	O
enough	O
infected	O
individuals	O
to	O
enter	O
hibernation	O
and	O
survive	O
until	O
the	O
following	O
year	O
,	O
and	O
hence	O
avoid	O
an	O
epizootic	O
fadeout	O
of	O
rabies	B-SPEC
virus	I-SPEC
.	O

A	O
panel	O
of	O
17	O
respiratory	O
viruses	B-SPEC
was	O
screened	O
by	O
PCR	O
,	O
and	O
densities	O
of	O
S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
H	B-SPEC
.	I-SPEC
influenzae	I-SPEC
and	O
M	B-SPEC
.	I-SPEC
catarrhalis	I-SPEC
were	O
estimated	O
by	O
quantitative	O
real	O
time	O
PCR	O
.	O

TITLE	O
:	O
Detection	O
of	O
feline	B-SPEC
herpes	B-SPEC
virus	I-SPEC
1	O
via	O
polymerase	O
chain	O
reaction	O
and	O
immunohistochemistry	O
in	O
cats	B-SPEC
with	O
ulcerative	O
facial	O
dermatitis	O
,	O
eosinophilic	O
granuloma	O
complex	O
reaction	O
patterns	O
and	O
mosquito	B-SPEC
bite	O
hypersensitivity	O
.	O

A	O
recently	O
introduced	O
dual	O
-	O
lumen	O
cannula	B-SPEC
for	O
VV	O
-	O
ECMO	O
promises	O
single	O
vessel	O
access	O
through	O
the	O
right	O
internal	O
jugular	O
vein	O
and	O
patient	O
ambulation	O
.	O

We	O
present	O
a	O
new	O
ultrasound	O
-	O
guided	O
technique	O
for	O
the	O
placement	O
of	O
a	O
dual	O
-	O
lumen	O
VV	O
-	O
ECMO	O
cannula	B-SPEC
in	O
a	O
patient	O
with	O
ARDS	O
and	O
extreme	O
obesity	O
.	O

A	O
total	O
of	O
115	O
patients	O
in	O
the	O
early	O
stages	O
of	O
sepsis	B-SPEC
requiring	O
EN	O
were	O
included	O
,	O
among	O
whom	O
106	O
were	O
considered	O
evaluable	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
have	O
evolved	O
diverse	O
mechanisms	O
to	O
recognize	O
different	O
receptors	O
for	O
their	O
cross	O
-	O
species	B-SPEC
transmission	O
and	O
host	O
-	O
range	O
expansion	O
.	O

Here	O
we	O
present	O
the	O
crystal	O
structure	O
of	O
MHV	B-SPEC
NTD	O
complexed	O
with	O
its	O
receptor	O
murine	B-SPEC
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecule	O
1a	O
(	O
mCEACAM1a	O
).	O

Sugar	O
-	O
binding	O
assays	O
reveal	O
that	O
galectin	O
-	O
like	O
NTDs	O
of	O
some	O
coronaviruses	O
such	O
as	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
bind	O
sugars	O
.	O

Structural	O
analysis	O
and	O
mutagenesis	O
localize	O
the	O
sugar	O
-	O
binding	O
site	O
in	O
coronavirus	B-SPEC
NTDs	O
to	O
be	O
above	O
the	O
	O
-	O
sandwich	O
core	O
.	O

We	O
propose	O
that	O
coronavirus	B-SPEC
NTDs	O
originated	O
from	O
a	O
host	O
galectin	O
and	O
retained	O
sugar	O
-	O
binding	O
functions	O
in	O
some	O
contemporary	O
coronaviruses	O
,	O
but	O
evolved	O
new	O
structural	O
features	O
in	O
MHV	B-SPEC
for	O
mCEACAM1a	O
binding	O
.	O

An	O
increase	O
of	O
eukaryotic	O
translation	O
initiation	O
factor	O
2	O
(	O
eIF2	O
)	O
phosphorylation	O
and	O
an	O
enhanced	O
nuclease	O
,	O
most	O
likely	O
RNase	O
L	O
,	O
activity	O
were	O
observed	O
in	O
rTGEV	O
-	O
7	O
virus	B-SPEC
infected	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
the	O
FLK	O
-	O
N3	O
cell	O
line	O
could	O
be	O
useful	O
for	O
isolation	O
and	O
propagation	O
of	O
viruses	B-SPEC
that	O
affect	O
cloven	O
-	O
hoofed	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
binding	O
of	O
viruses	B-SPEC
to	O
host	O
cells	O
is	O
the	O
first	O
step	O
in	O
determining	O
tropism	O
and	O
pathogenicity	O
.	O

While	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
infection	O
and	O
avian	B-SPEC
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	B-SPEC
)	O
infection	O
both	O
depend	O
on	O
2	O
,	O
3	O
-	O
linked	O
sialic	O
acids	O
,	O
the	O
host	O
tropism	O
of	O
IBV	B-SPEC
is	O
restricted	O
compared	O
to	O
that	O
of	O
IAV	B-SPEC
.	O

We	O
examined	O
serial	O
pathological	O
changes	O
in	O
the	O
lungs	O
of	O
mice	B-SPEC
infected	O
with	O
influenza	B-SPEC
virus	I-SPEC
to	O
determine	O
the	O
progress	O
from	O
viral	O
pneumonia	O
to	O
ARDS	O
/	O
DAD	O
.	O

Furthermore	O
,	O
the	O
truncated	O
rS	O
-	O
AD	O
peptide	O
was	O
able	O
to	O
bind	O
to	O
the	O
surface	O
of	O
cells	O
from	O
swine	B-SPEC
testes	O
in	O
a	O
competitive	O
manner	O
and	O
completely	O
inhibit	O
viral	O
infection	O
.	O

We	O
compared	O
the	O
effects	O
of	O
airway	O
pressure	O
release	O
ventilation	O
and	O
conventional	O
mechanical	O
ventilation	O
on	O
oxygenation	O
in	O
a	O
porcine	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
induced	O
by	O
wood	O
smoke	O
inhalation	O
.	O

Before	O
injury	O
,	O
the	O
pigs	B-SPEC
were	O
randomized	O
to	O
receive	O
conventional	O
mechanical	O
ventilation	O
(	O
n	O
=	O
15	O
)	O
or	O
airway	O
pressure	O
release	O
ventilation	O
(	O
n	O
=	O
12	O
)	O
for	O
48	O
hrs	O
after	O
smoke	O
inhalation	O
.	O

ABSTRACT	O
:	O
During	O
2008	O
-	O
2009	O
,	O
fifteen	O
field	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
were	O
isolated	O
from	O
commercial	O
chicken	B-SPEC
farms	O
in	O
Thailand	O
.	O

These	O
results	O
show	O
that	O
TNFR1	O
,	O
not	O
TNFR2	O
,	O
mediates	O
TNF	O
-	O
	O
stimulation	O
of	O
DC	O
maturation	O
and	O
T	O
cell	O
response	O
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
in	O
vivo	O
.	O

However	O
,	O
future	O
research	O
should	O
focus	O
on	O
the	O
intracellular	O
signaling	O
pathways	O
that	O
mediate	O
ALI	O
development	O
,	O
potentially	O
focusing	O
on	O
the	O
role	O
of	O
reactive	O
biological	O
species	B-SPEC
in	O
ALI	O
pathogenesis	O
.	O

Ventilation	O
was	O
more	O
homogeneously	O
distributed	O
during	O
HFOV	O
than	O
during	O
initial	O
CMV	B-SPEC
.	O

Higher	O
respiratory	O
system	O
compliance	O
and	O
tidal	O
volume	O
were	O
found	O
during	O
CMV	B-SPEC
after	O
24	O
hours	O
of	O
HFOV	O
.	O

Higher	O
respiratory	O
system	O
compliance	O
and	O
tidal	O
volume	O
were	O
found	O
during	O
CMV	B-SPEC
after	O
24	O
hours	O
of	O
HFOV	O
.	O

TITLE	O
:	O
Gene	O
N	O
proximal	O
and	O
distal	O
RNA	O
motifs	O
regulate	O
coronavirus	B-SPEC
nucleocapsid	O
mRNA	O
transcription	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
stem	O
-	O
loop	O
4	O
functions	O
as	O
a	O
spacer	O
element	O
required	O
to	O
drive	O
subgenomic	O
RNA	O
synthesis	O
.	O

Antibodies	O
to	O
feline	B-SPEC
herpesvirus	I-SPEC
,	O
feline	B-SPEC
calicivirus	I-SPEC
,	O
feline	B-SPEC
parvovirus	I-SPEC
,	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
were	O
present	O
in	O
the	O
lion	B-SPEC
population	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
in	O
antibody	O
prevalence	O
between	O
native	O
and	O
translocated	O
lions	B-SPEC
and	O
their	O
offspring	O
,	O
and	O
these	O
feline	B-SPEC
viruses	B-SPEC
did	O
not	O
appear	O
to	O
have	O
an	O
effect	O
on	O
the	O
clinical	O
health	O
of	O
HiP	O
lions	B-SPEC
.	O

The	O
admission	O
diagnoses	O
were	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
(	O
70	O
%),	O
severe	O
pneumonia	O
(	O
38	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
21	O
%).	O

TITLE	O
:	O
The	O
invasion	O
of	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
RNA	O
induces	O
endoplasmic	O
reticulum	O
stress	O
-	O
related	O
autophagy	O
in	O
HeLa	O
cells	O
.	O

WNv	B-SPEC
antigen	O
was	O
detected	O
in	O
brain	O
,	O
spleen	O
,	O
heart	O
,	O
kidney	O
,	O
liver	O
,	O
gonads	O
,	O
intestine	O
,	O
lung	O
,	O
and	O
pancreas	O
.	O

Heart	O
and	O
pancreas	O
were	O
positive	O
in	O
63	O
%	O
while	O
brain	O
was	O
positive	O
in	O
36	O
.	O
5	O
%	O
of	O
the	O
infected	O
crows	B-SPEC
.	O

These	O
PAbs	O
contained	O
the	O
IgG2a	O
subclass	B-SPEC
,	O
which	O
cross	O
-	O
reacted	O
with	O
the	O
virion	O
-	O
associated	O
envelope	O
(	O
E	O
)	O
glycoprotein	O
of	O
the	O
DENV	O
-	O
2	O
NSx	O
strain	O
,	O
suggesting	O
that	O
they	O
could	O
generate	O
its	O
AER	O
via	O
all	O
mouse	B-SPEC
Fc	O
-	O
receptor	O
classes	O
.	O

The	O
earliest	O
steps	O
in	O
retrovirus	B-SPEC
assembly	O
-	O
those	O
immediately	O
following	O
synthesis	O
of	O
Gag	B-SPEC
on	O
cytosolic	O
ribosomes	O
-	O
are	O
poorly	O
understood	O
.	O

These	O
patients	O
illustrate	O
that	O
severe	O
neurologic	O
complications	O
,	O
including	O
malignant	O
cerebral	O
edema	O
,	O
can	O
occur	O
in	O
adults	O
infected	O
with	O
H1N1	O
virus	B-SPEC
,	O
and	O
illustrate	O
the	O
need	O
for	O
close	O
neurological	O
monitoring	O
of	O
potential	O
neurological	O
morbidities	O
in	O
future	O
pandemics	O
.	O

TITLE	O
:	O
Programmed	O
death	O
(	O
PD	O
)-	O
1	O
-	O
deficient	O
mice	B-SPEC
are	O
extremely	O
sensitive	O
to	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
-	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
)	O
infection	O
.	O

TITLE	O
:	O
Cell	O
-	O
type	O
-	O
specific	O
type	O
I	O
interferon	O
antagonism	O
influences	O
organ	O
tropism	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

In	O
addition	O
,	O
ns2	O
mutants	O
are	O
more	O
sensitive	O
than	O
wt	O
virus	B-SPEC
to	O
pretreatment	O
of	O
BMM	O
,	O
but	O
not	O
L2	O
fibroblasts	O
or	O
primary	O
astrocytes	O
,	O
with	O
alpha	O
/	O
beta	O
interferon	O
(	O
IFN	O
-	O
	O
/	O
	O
).	O

TITLE	O
:	O
New	O
respiratory	O
viruses	B-SPEC
and	O
the	O
elderly	O
.	O

Patients	O
with	O
uncomplicated	O
disease	O
received	O
chloroquine	O
,	O
quinine	B-SPEC
,	O
or	O
artemether	O
-	O
lumefantrine	O
,	O
and	O
those	O
with	O
severe	O
disease	O
received	O
intravenous	O
quinine	B-SPEC
or	O
artesunate	O
.	O

TITLE	O
:	O
Chimeric	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
S	O
glycoprotein	O
and	O
influenza	O
matrix	O
1	O
efficiently	O
form	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
that	O
protect	O
mice	B-SPEC
against	O
challenge	O
with	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
was	O
the	O
cause	O
of	O
the	O
global	O
pandemic	O
in	O
2003	O
that	O
infected	O
over	O
8000	O
people	O
in	O
8	O
months	O
.	O

These	O
chimeric	O
SARS	O
VLPs	O
have	O
a	O
similar	O
size	O
and	O
morphology	O
to	O
the	O
wild	O
type	O
SARS	O
-	O
CoV	O
.	O
We	O
tested	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
purified	O
chimeric	O
SARS	O
VLPs	O
and	O
full	O
length	O
SARS	O
S	O
protein	O
vaccines	O
in	O
a	O
mouse	B-SPEC
lethal	O
challenge	O
model	O
.	O

To	O
this	O
end	O
,	O
RdRp	O
sequence	O
of	O
Coronavirinae	B-SPEC
was	O
targeted	O
by	O
RT	O
-	O
PCR	O
in	O
non	O
-	O
invasive	O
samples	O
from	O
bats	B-SPEC
collected	O
in	O
Thailand	O
.	O

Two	O
new	O
coronaviruses	O
were	O
detected	O
in	O
two	O
bat	B-SPEC
species	B-SPEC
:	O
one	O
Betacoronavirus	B-SPEC
in	O
Hipposideros	B-SPEC
larvatus	I-SPEC
and	O
one	O
Alphacoronavirus	B-SPEC
in	O
Hipposiderosarmiger	O
.	O

Moreover	O
,	O
despite	O
its	O
probable	O
pathogenicity	O
,	O
we	O
found	O
that	O
a	O
Betacoronavirus	B-SPEC
-	O
b	O
can	O
persistently	O
infect	O
a	O
medium	O
-	O
sized	O
hipposiderid	O
bat	B-SPEC
colony	O
.	O

TITLE	O
:	O
Recent	O
developments	O
in	O
anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
chemotherapy	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
early	O
2003	O
to	O
cause	O
a	O
very	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
which	O
eventually	O
resulted	O
in	O
a	O
10	O
%	O
case	O
-	O
fatality	O
rate	O
.	O

TITLE	O
:	O
Detection	O
of	O
alpha	O
and	O
betacoronaviruses	O
in	O
multiple	O
Iberian	O
bat	B-SPEC
species	B-SPEC
.	O

To	O
determine	O
the	O
presence	O
and	O
distribution	O
of	O
CoV	O
in	O
Iberian	O
bats	B-SPEC
,	O
576	O
individuals	O
of	O
26	O
different	O
bat	B-SPEC
species	B-SPEC
were	O
captured	O
in	O
13	O
locations	O
in	O
Spain	O
.	O

Our	O
study	O
provides	O
the	O
foundation	O
for	O
development	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
serological	O
detection	O
reagents	O
and	O
an	O
experimental	O
tool	O
for	O
immunological	O
research	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
many	O
other	O
viruses	B-SPEC
also	O
encode	O
PBM	O
-	O
containing	O
proteins	O
that	O
bind	O
to	O
cellular	O
PDZ	O
proteins	O
.	O

ABSTRACT	O
:	O
Public	O
health	O
measures	O
successfully	O
contained	O
outbreaks	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
.	O

However	O
,	O
the	O
precursor	O
of	O
the	O
SARS	O
-	O
CoV	O
remains	O
in	O
its	O
natural	O
bat	B-SPEC
reservoir	O
,	O
and	O
reemergence	O
of	O
a	O
human	B-SPEC
-	O
adapted	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
remains	O
a	O
plausible	O
public	O
health	O
concern	O
.	O

Here	O
,	O
we	O
developed	O
a	O
real	O
-	O
time	O
monitoring	O
system	O
for	O
airborne	O
influenza	O
H3N2	O
viruses	B-SPEC
by	O
integrating	O
electronically	O
addressable	O
silicon	O
nanowire	O
(	O
SiNW	O
)	O
sensor	O
devices	O
,	O
microfluidics	O
and	O
bioaerosol	O
-	O
to	O
-	O
hydrosol	O
air	O
sampling	O
techniques	O
.	O

TITLE	O
:	O
Discovering	O
novel	O
zoonotic	O
viruses	B-SPEC
.	O

While	O
molecular	O
approaches	O
will	O
continue	O
to	O
lead	O
the	O
way	O
in	O
virus	B-SPEC
discovery	O
,	O
other	O
technological	O
platforms	O
are	O
required	O
to	O
increase	O
the	O
chance	O
of	O
success	O
.	O

Similarity	O
of	O
coronavirus	B-SPEC
HKU1	O
with	O
those	O
published	O
in	O
the	O
GenBank	O
at	O
nucleotide	O
levels	O
was	O
98	O
.	O
18	O
%	O
-	O
100	O
%.	O

Coronavirus	B-SPEC
HKU1	O
may	O
be	O
important	O
pathogens	O
in	O
children	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
.	O

CONCLUSIONS	O
:	O
Coronavirus	B-SPEC
HKU1	O
may	O
be	O
important	O
pathogens	O
in	O
children	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
in	O
testicles	O
and	O
venereal	O
transmission	O
.	O

A	O
screen	O
of	O
individual	O
IBV	B-SPEC
non	O
-	O
structural	O
proteins	O
(	O
nsps	O
)	O
showed	O
that	O
autophagy	O
was	O
activated	O
by	O
IBV	B-SPEC
nsp6	O
.	O

This	O
property	O
was	O
shared	O
with	O
nsp6	O
of	O
mammalian	B-SPEC
coronaviruses	O
Mouse	B-SPEC
Hepatitis	O
Virus	B-SPEC
,	O
and	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Virus	B-SPEC
,	O
and	O
the	O
equivalent	O
nsp5	O
-	O
7	O
of	O
the	O
arterivirus	B-SPEC
Porcine	B-SPEC
Reproductive	I-SPEC
and	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Virus	I-SPEC
.	O

MMP3	O
expression	O
remained	O
largely	O
confined	O
to	O
astrocytes	O
,	O
similar	O
to	O
WT	O
mice	B-SPEC
.	O

The	O
PEDV	B-SPEC
N	O
gene	O
and	O
B23	O
.	O
1	O
gene	O
were	O
amplified	O
by	O
RT	O
-	O
PCR	O
from	O
PEDV	B-SPEC
strain	O
CV777	O
and	O
Vero	O
E6	O
cells	O
,	O
respectively	O
;	O
then	O
cloned	O
into	O
eukaryotic	O
expression	O
vector	O
pAcGFP1	O
-	O
C1	O
and	O
pDsRed2	O
-	O
N1	O
,	O
to	O
generate	O
the	O
recombinant	O
plasmids	O
pAcGFP1	O
-	O
C1	O
/	O
N	O
and	O
pDsRed2	O
-	O
N1	O
/	O
B23	O
.	O
1	O
,	O
respectively	O
.	O

Notably	O
,	O
XendoU	O
family	B-SPEC
members	O
have	O
been	O
implicated	O
in	O
human	B-SPEC
pathologies	O
such	O
as	O
cancer	B-SPEC
and	O
respiratory	O
diseases	O
:	O
PP11	O
is	O
aberrantly	O
expressed	O
in	O
various	O
tumors	O
,	O
while	O
NendoU	O
activity	O
has	O
been	O
associated	O
with	O
respiratory	O
infections	O
by	O
pathogenic	O
coronaviruses	O
.	O

TITLE	O
:	O
Identification	O
of	O
antigenic	O
peptides	O
derived	O
from	O
B	O
-	O
cell	O
epitopes	O
of	O
nucleocapsid	O
protein	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
for	O
serological	O
diagnosis	O
.	O

Sixteen	O
antigenic	O
linear	O
sequences	O
in	O
the	O
N	O
protein	O
were	O
found	O
using	O
antisera	O
obtained	O
from	O
mice	B-SPEC
infected	O
naturally	O
with	O
MHV	B-SPEC
and	O
a	O
peptide	O
array	O
containing	O
overlapping	O
10	O
-	O
mer	O
peptides	O
covering	O
the	O
entire	O
N	O
protein	O
.	O

TITLE	O
:	O
Engineering	O
T	O
cells	O
specific	O
for	O
a	O
dominant	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
CD8	O
T	O
cell	O
epitope	O
.	O

Therefore	O
,	O
this	O
study	O
aimed	O
to	O
investigate	O
whether	O
17	O
-	O
estradiol	O
(	O
E2	O
)	O
treatment	O
can	O
attenuate	O
seawater	O
aspiration	O
-	O
induced	O
ALI	O
in	O
rats	B-SPEC
.	O

As	O
an	O
example	O
of	O
the	O
power	O
of	O
this	O
assay	O
a	O
class	B-SPEC
of	O
inhibitors	O
is	O
reported	O
with	O
the	O
potential	O
to	O
inhibit	O
SARS	O
-	O
CoV	O
at	O
two	O
steps	O
of	O
the	O
replication	O
cycle	O
,	O
viral	O
entry	O
and	O
particle	O
assembly	O
.	O

TITLE	O
:	O
Extracorporeal	O
liver	O
support	O
with	O
multipass	O
albumin	O
dialysis	B-SPEC
or	O
plasmapheresis	O
and	O
filtering	O
systems	O
in	O
acute	O
liver	O
failure	O
.	O

We	O
use	O
four	O
case	O
studies	O
to	O
demonstrate	O
that	O
advances	O
in	O
disease	O
forecasting	O
require	O
better	O
understanding	O
of	O
zoonotic	O
host	O
and	O
vector	O
populations	O
,	O
as	O
well	O
of	O
the	O
dynamics	O
that	O
facilitate	O
pathogen	O
amplification	O
and	O
disease	O
spillover	O
into	O
humans	B-SPEC
.	O

TITLE	O
:	O
Induction	O
of	O
cystic	O
oviducts	O
and	O
protection	O
against	O
early	O
challenge	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
serotype	O
D388	O
(	O
genotype	O
QX	O
)	O
by	O
maternally	O
derived	O
antibodies	O
and	O
by	O
early	O
vaccination	O
.	O

Vaccination	O
programmes	O
using	O
different	O
combinations	O
of	O
heterologous	O
live	O
vaccines	O
at	O
day	O
0	O
or	O
at	O
days	O
0	O
and	O
14	O
induced	O
a	O
reasonable	O
to	O
high	O
level	O
of	O
protection	O
in	O
the	O
trachea	B-SPEC
,	O
kidney	O
,	O
oviduct	O
and	O
air	O
sacs	O
against	O
challenge	O
with	O
the	O
D388	O
strain	O
at	O
28	O
days	O
of	O
age	O
.	O

Titres	O
of	O
9	O
to	O
10	O
log	O
(	O
2	O
)	O
maternally	O
-	O
derived	O
D388	O
virus	B-SPEC
-	O
neutralizing	O
antibodies	O
,	O
which	O
provided	O
partial	O
protection	O
against	O
tracheal	O
damage	O
and	O
a	O
high	O
protection	O
against	O
replication	O
of	O
D388	O
in	O
the	O
kidney	O
after	O
challenge	O
at	O
6	O
or	O
10	O
days	O
of	O
age	O
,	O
could	O
be	O
achieved	O
using	O
a	O
broad	O
heterologous	O
live	O
priming	O
and	O
subsequent	O
boosting	O
using	O
inactivated	O
IBV	B-SPEC
vaccines	O
containing	O
two	O
or	O
three	O
heterologous	O
IBV	B-SPEC
antigens	O
.	O

Our	O
results	O
show	O
that	O
13	O
.	O
8	O
%	O
(	O
39	O
/	O
283	O
)	O
samples	O
were	O
reactive	O
for	O
NDV	B-SPEC
,	O
and	O
the	O
prevalence	O
of	O
IBV	B-SPEC
was	O
3	O
.	O
9	O
%	O
(	O
11	O
/	O
283	O
).	O

The	O
prevalence	O
of	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
was	O
3	O
.	O
2	O
%	O
(	O
95	O
%	O
CI	O
:	O
0	O
-	O
6	O
.	O
6	O
)	O
with	O
a	O
1	O
.	O
7	O
%	O
(	O
95	O
%	O
CI	O
:	O
0	O
-	O
3	O
.	O
2	O
)	O
prevalence	O
of	O
H5N1	O
being	O
detected	O
.	O

TITLE	O
:	O
Phylogenetic	O
analysis	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
isolated	O
in	O
China	O
during	O
2009	O
-	O
2010	O
.	O

Meanwhile	O
,	O
Chinese	O
IBV	B-SPEC
strains	O
isolated	O
in	O
this	O
study	O
,	O
which	O
were	O
mainly	O
nephropathogenic	O
,	O
could	O
be	O
separated	O
into	O
six	O
variant	O
lineages	O
(	O
CH	O
I	O
-	O
CH	O
VI	O
),	O
and	O
current	O
vaccine	O
strains	O
used	O
in	O
China	O
formed	O
Mass	O
variant	O
lineage	O
that	O
is	O
evolutionarily	O
distant	O
from	O
Chinese	O
isolates	O
.	O

TITLE	O
:	O
Report	O
of	O
the	O
'	O
mechanisms	O
of	O
lung	O
injury	O
and	O
immunomodulator	O
interventions	O
in	O
influenza	O
'	O
workshop	O
,	O
21	O
March	O
2010	O
,	O
Ventura	O
,	O
California	B-SPEC
,	O
USA	O
.	O

ABSTRACT	O
:	O
Ferret	B-SPEC
systemic	I-SPEC
coronavirus	I-SPEC
infection	O
(	O
FSCV	O
)	O
is	O
a	O
systemic	O
disease	O
in	O
ferrets	B-SPEC
that	O
clinically	O
and	O
pathologically	O
resembles	O
the	O
dry	O
form	O
of	O
FIP	O
.	O

Abdominal	O
survey	O
radiographs	O
were	O
available	O
for	O
eight	O
ferrets	B-SPEC
and	O
ultrasound	O
examination	O
for	O
all	O
cases	O
.	O

ABSTRACT	O
:	O
The	O
ssRNA	O
+	O
family	B-SPEC
Coronaviridae	I-SPEC
includes	O
two	O
subfamilies	O
prototyped	O
by	O
coronaviruses	O
and	O
toroviruses	B-SPEC
that	O
cause	O
respiratory	O
and	O
enteric	O
infections	O
.	O

To	O
facilitate	O
the	O
identification	O
of	O
new	O
distantly	O
related	O
members	O
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
,	O
we	O
have	O
developed	O
a	O
molecular	O
assay	O
with	O
broad	O
specificity	O
.	O

It	O
detected	O
57	O
%	O
(	O
32	O
of	O
56	O
)	O
of	O
the	O
respiratory	O
specimens	O
positive	O
for	O
4	O
human	B-SPEC
coronaviruses	O
,	O
as	O
well	O
as	O
stool	O
specimens	O
positive	O
for	O
a	O
bovine	B-SPEC
torovirus	I-SPEC
.	O

The	O
high	O
sensitivity	O
and	O
broad	O
virus	B-SPEC
range	O
of	O
this	O
assay	O
makes	O
it	O
suitable	O
for	O
screening	O
biological	O
specimens	O
in	O
search	O
for	O
new	O
viruses	B-SPEC
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
.	O

Total	O
fiber	O
counts	O
,	O
nerve	O
density	O
,	O
and	O
percent	O
neural	O
tissue	O
were	O
all	O
significantly	O
reduced	O
in	O
infected	O
animals	B-SPEC
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Seven	O
thousand	O
eight	O
hundred	O
and	O
fifty	O
-	O
three	O
nasopharyngeal	O
samples	O
from	O
7220	O
patients	O
(	O
age	O
range	O
0	O
-	O
98	O
y	O
,	O
median	O
22	O
y	O
)	O
obtained	O
during	O
36	O
consecutive	O
months	O
(	O
November	O
2006	O
-	O
October	O
2009	O
),	O
were	O
analyzed	O
with	O
a	O
multiplex	O
PCR	O
panel	O
including	O
influenza	O
A	O
(	O
IfA	O
)	O
and	O
B	O
(	O
IfB	O
)	O
virus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
)	O
1	O
-	O
3	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
OC43	O
,	O
NL63	O
,	O
and	O
229E	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
HMPV	B-SPEC
),	O
adenovirus	B-SPEC
(	O
AdV	O
),	O
enterovirus	B-SPEC
(	O
EV	O
),	O
and	O
2	O
bacteria	B-SPEC
--	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
and	O
Chlamydophila	B-SPEC
pneumoniae	I-SPEC
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
cause	O
a	O
high	O
percentage	O
of	O
community	O
-	O
acquired	O
pneumonias	O
.	O

Such	O
increased	O
ammonia	B-SPEC
levels	O
are	O
suggested	O
to	O
alter	O
neurotransmission	O
signals	O
and	O
impair	O
cerebral	O
energy	O
metabolism	O
due	O
to	O
mitochondrial	O
dysfunctions	O
.	O

Disease	O
burden	O
caused	O
by	O
respiratory	O
viruses	B-SPEC
in	O
hospitalized	O
patients	O
was	O
quantified	O
using	O
the	O
World	O
Health	O
Organization	O
endorsed	O
DALY	O
model	O
.	O

Survival	O
to	O
hospital	O
discharge	O
was	O
higher	O
in	O
the	O
HFO	O
-	O
TGI	O
group	O
versus	O
the	O
CMV	B-SPEC
group	O
(	O
38	O
(	O
62	O
.	O
3	O
%)	O
out	O
of	O
61	O
versus	O
23	O
(	O
35	O
.	O
9	O
%)	O
out	O
of	O
64	O
subjects	O
;	O
p	O
=	O
0	O
.	O
004	O
).	O

RESULTS	O
:	O
Occupational	O
health	O
and	O
safety	O
issues	O
anticipated	O
by	O
Canadian	O
nurses	O
for	O
future	O
infectious	O
respiratory	O
disease	O
outbreaks	O
were	O
grouped	O
into	O
four	O
major	O
themes	O
:	O
(	O
1	O
)	O
apprehension	O
about	O
occupational	O
risks	O
to	O
pregnant	O
nurses	O
;	O
(	O
2	O
)	O
unknown	O
pregnancy	O
risks	O
of	O
anti	O
-	O
infective	O
therapy	O
/	O
prophylaxis	O
;	O
(	O
3	O
)	O
occupational	O
risk	O
communication	O
for	O
pregnant	O
nurses	O
;	O
and	O
(	O
4	O
)	O
human	B-SPEC
resource	O
strategies	O
required	O
for	O
pregnant	O
nurses	O
during	O
outbreaks	O
.	O

TITLE	O
:	O
Treatment	O
of	O
severe	O
neurological	O
deficits	O
with	O
IgG	O
depletion	O
through	O
immunoadsorption	O
in	O
patients	O
with	O
Escherichia	B-SPEC
coli	I-SPEC
O104	O
:	O
H4	O
-	O
associated	O
haemolytic	O
uraemic	O
syndrome	O
:	O
a	O
prospective	O
trial	O
.	O

The	O
draft	O
chicken	B-SPEC
genome	O
was	O
first	O
scanned	O
using	O
human	B-SPEC
sPLA2	O
sequences	O
to	O
identify	O
chicken	B-SPEC
sPLA2s	O
(	O
ChPLA2	O
),	O
chicken	B-SPEC
total	O
mRNA	O
were	O
isolated	O
and	O
RT	O
-	O
PCR	O
experiments	O
were	O
performed	O
to	O
amplify	O
and	O
then	O
sequence	O
orthologous	O
cDNAs	O
.	O

Cytochrome	O
P450	O
Family	B-SPEC
3A	O
(	O
CYP4F3A	O
)	O
is	O
an	O
	O
-	O
oxidase	O
that	O
inactivates	O
Leukotriene	O
B4	O
(	O
LTB4	O
)	O
in	O
human	B-SPEC
neutrophils	O
and	O
the	O
liver	O
.	O

TITLE	O
:	O
Neutralizing	O
human	B-SPEC
monoclonal	O
antibodies	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
target	O
,	O
mechanism	O
of	O
action	O
,	O
and	O
therapeutic	O
potential	O
.	O

hmAbs	O
may	O
be	O
used	O
therapeutically	O
without	O
the	O
drawbacks	O
of	O
chimeric	O
or	O
animal	B-SPEC
Abs	O
.	O

TITLE	O
:	O
Non	O
-	O
cancer	B-SPEC
effects	O
of	O
chemical	O
agents	O
on	O
children	O
'	O
s	O
health	O
.	O

The	O
meta	B-SPEC
-	O
analytic	O
pooled	O
risk	O
estimate	O
for	O
SIDS	O
based	O
on	O
15	O
studies	O
is	O
2	O
.	O
94	O
(	O
95	O
%	O
confidence	O
interval	O
:	O
2	O
.	O
43	O
-	O
3	O
.	O
57	O
).	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
exposure	O
of	O
captive	O
wild	O
felids	B-SPEC
to	O
various	O
infectious	O
pathogens	O
using	O
serological	O
and	O
molecular	O
methods	O
.	O

Results	O
suggest	O
that	O
testing	O
is	O
appropriate	O
prior	O
to	O
relocation	O
of	O
felids	B-SPEC
.	O

In	O
a	O
second	O
approach	O
,	O
pre	O
-	O
treatment	O
of	O
the	O
virus	B-SPEC
with	O
porcine	B-SPEC
intestinal	O
mucin	O
was	O
performed	O
,	O
followed	O
by	O
the	O
plaque	O
assay	O
after	O
a	O
5	O
min	O
adsorption	O
time	O
.	O

Another	O
TGEV	B-SPEC
strain	O
,	O
TGEV	B-SPEC
Miller	O
,	O
and	O
IBV	B-SPEC
Beaudette	O
showed	O
a	O
reduction	O
in	O
infectivity	O
after	O
neuraminidase	O
treatment	O
of	O
the	O
cultured	O
cells	O
irrespective	O
of	O
the	O
virion	O
adsorption	O
time	O
.	O

Another	O
TGEV	B-SPEC
strain	O
,	O
TGEV	B-SPEC
Miller	O
,	O
and	O
IBV	B-SPEC
Beaudette	O
showed	O
a	O
reduction	O
in	O
infectivity	O
after	O
neuraminidase	O
treatment	O
of	O
the	O
cultured	O
cells	O
irrespective	O
of	O
the	O
virion	O
adsorption	O
time	O
.	O

TITLE	O
:	O
Human	B-SPEC
metapneumovirus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
infection	O
and	O
pathogenicity	O
in	O
Saudi	O
children	O
hospitalized	O
with	O
acute	O
respiratory	O
illness	O
.	O

Our	O
results	O
confirm	O
and	O
extend	O
our	O
previous	O
findings	O
and	O
conclusions	O
that	O
swapping	O
of	O
the	O
ectodomain	O
of	O
the	O
S	O
protein	O
is	O
a	O
precise	O
and	O
effective	O
way	O
of	O
generating	O
genetically	O
defined	O
candidate	O
IBV	B-SPEC
vaccines	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
activation	O
of	O
cellular	O
DNA	O
damage	O
response	O
is	O
one	O
of	O
the	O
mechanisms	O
exploited	O
by	O
Coronavirus	B-SPEC
to	O
induce	O
cell	O
cycle	O
arrest	O
.	O

Furthermore	O
,	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screens	O
and	O
subsequent	O
biochemical	O
and	O
functional	O
studies	O
demonstrated	O
that	O
interaction	O
between	O
Coronavirus	B-SPEC
nsp13	O
and	O
DNA	O
polymerase	O
	O
induced	O
DNA	O
replication	O
stress	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
.	O

TITLE	O
:	O
2009	O
Influenza	O
A	O
(	O
H1N1	O
)	O
in	O
Panama	B-SPEC
:	O
a	O
disease	O
affecting	O
children	O
with	O
a	O
benign	O
course	O
.	O

We	O
included	O
patients	O
with	O
severe	O
acute	O
respiratory	O
infection	O
in	O
whom	O
a	O
nasopharyngeal	O
swab	O
was	O
positive	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
for	O
2009	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
virus	B-SPEC
and	O
negative	O
for	O
seasonal	O
influenza	O
A	O
H1	O
and	O
H3	O
.	O

Here	O
,	O
we	O
identified	O
ANXA2	O
as	O
a	O
RNA	O
binding	O
protein	O
(	O
RBP	O
)	O
that	O
binds	O
IBV	B-SPEC
(	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
)	O
pseudoknot	O
RNA	O
.	O

The	O
structure	O
of	O
HR2	O
,	O
as	O
determined	O
by	O
NMR	O
spectroscopy	O
in	O
the	O
presence	O
of	O
the	O
co	O
-	O
solvent	O
trifluoroethanol	O
(	O
TFE	O
),	O
is	O
a	O
trimer	O
of	O
parallel	O
helices	B-SPEC
,	O
whereas	O
the	O
structure	O
of	O
HR2	O
,	O
as	O
determined	O
by	O
X	O
-	O
ray	B-SPEC
crystallography	O
,	O
is	O
a	O
tetramer	O
of	O
anti	O
-	O
parallel	O
helices	B-SPEC
.	O

We	O
find	O
that	O
the	O
relaxation	O
effects	O
are	O
consistent	O
with	O
an	O
orientation	O
corresponding	O
to	O
a	O
trimer	O
of	O
parallel	O
helices	B-SPEC
in	O
both	O
the	O
presence	O
and	O
absence	O
of	O
TFE	O
.	O

TITLE	O
:	O
2	O
,	O
6	O
-	O
Bis	O
-	O
arylmethyloxy	O
-	O
5	O
-	O
hydroxychromones	O
with	O
antiviral	O
activity	O
against	O
both	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
and	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
).	O

TITLE	O
:	O
A	O
double	O
-	O
inactivated	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
vaccine	O
provides	O
incomplete	O
protection	O
in	O
mice	B-SPEC
and	O
induces	O
increased	O
eosinophilic	O
proinflammatory	O
pulmonary	O
response	O
upon	O
challenge	O
.	O

The	O
death	O
of	O
two	O
children	O
even	O
when	O
on	O
treatment	O
and	O
the	O
family	B-SPEC
histories	O
of	O
sibling	O
deaths	O
re	O
-	O
inforces	O
the	O
need	O
for	O
accurate	O
genetic	O
diagnosis	O
,	O
optimised	O
pharmacological	O
treatment	O
and	O
additional	O
supportive	O
measures	O
to	O
manage	O
acute	O
respiratory	O
crises	O
.	O

Investigations	O
for	O
infection	O
and	O
immunological	O
disorder	O
were	O
negative	O
and	O
toxicology	O
was	O
negative	O
except	O
for	O
cannabis	B-SPEC
.	O

Death	O
occurred	O
15	O
days	O
later	O
due	O
to	O
alveolar	O
haemorrhage	O
following	O
a	O
further	O
""""	O
bang	O
""""	O
of	O
cannabis	B-SPEC
.	O

Fifty	O
-	O
two	O
percent	O
(	O
615	O
/	O
1192	O
)	O
of	O
patients	O
from	O
October	O
,	O
2009	O
to	O
December	O
,	O
2009	O
had	O
a	O
single	O
respiratory	O
virus	B-SPEC
(	O
291	O
pH1N1	O
;	O
207	O
rhinovirus	B-SPEC
;	O
45	O
RSV	B-SPEC
A	O
/	O
B	O
;	O
37	O
parainfluenza	O
;	O
27	O
adenovirus	B-SPEC
;	O
6	O
coronavirus	B-SPEC
;	O
and	O
2	O
metapneumovirus	B-SPEC
).	O

Individuals	O
with	O
pH1N1	O
,	O
compared	O
to	O
other	O
viruses	B-SPEC
,	O
were	O
more	O
likely	O
to	O
present	O
with	O
fever	O
(	O
92	O
%	O
&	O
70	O
%),	O
cough	O
(	O
92	O
%	O
&	O
86	O
%),	O
sore	O
throat	O
(	O
32	O
%	O
&	O
16	O
%),	O
nausea	O
(	O
31	O
%	O
&	O
8	O
%),	O
vomiting	O
(	O
39	O
%	O
&	O
30	O
%),	O
abdominal	O
pain	O
(	O
14	O
%	O
&	O
7	O
%),	O
and	O
a	O
lower	O
white	O
blood	O
count	O
(	O
8	O
,	O
500	O
/	O
L	O
&	O
13	O
,	O
600	O
/	O
L	O
,	O
all	O
p	O
-	O
values	O
<	O
0	O
.	O
05	O
).	O

Previous	O
studies	O
have	O
demonstrated	O
absolute	O
requirement	O
of	O
NF	O
-	O
B	O
activation	O
for	O
efficient	O
replication	O
of	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
HSV	B-SPEC
-	O
2	O
and	O
inhibition	O
of	O
NF	O
-	O
B	O
activation	O
has	O
been	O
shown	O
to	O
suppress	O
HSV	B-SPEC
infection	O
.	O

Gammacoronaviruses	O
were	O
found	O
predominantly	O
in	O
Anseriformes	B-SPEC
birds	B-SPEC
,	O
whereas	O
deltacoronaviruses	O
could	O
be	O
detected	O
in	O
Ciconiiformes	B-SPEC
,	O
Pelecaniformes	B-SPEC
,	O
and	O
Anseriformes	B-SPEC
birds	B-SPEC
in	O
this	O
study	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoV	O
)	O
are	O
recognized	O
respiratory	O
pathogens	O
,	O
and	O
some	O
strains	O
,	O
including	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
can	O
infect	O
human	B-SPEC
neuronal	O
and	O
glial	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
and	O
activate	O
neuroinflammatory	O
mechanisms	O
.	O

Herein	O
,	O
we	O
show	O
that	O
a	O
single	O
point	O
mutation	O
in	O
the	O
viral	O
spike	O
(	O
S	O
)	O
glycoprotein	O
(	O
Y241H	O
),	O
acquired	O
during	O
viral	O
persistence	O
in	O
human	B-SPEC
neural	O
cells	O
,	O
led	O
to	O
a	O
hind	O
-	O
limb	O
paralytic	O
disease	O
in	O
infected	O
mice	B-SPEC
.	O

Taken	O
together	O
,	O
our	O
results	O
strongly	O
suggest	O
an	O
involvement	O
of	O
excitotoxicity	O
in	O
the	O
paralysis	O
-	O
associated	O
neuropathology	O
induced	O
by	O
an	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
mutant	O
which	O
harbors	O
a	O
single	O
point	O
mutation	O
in	O
its	O
spike	O
protein	O
that	O
is	O
acquired	O
upon	O
persistent	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Induction	O
of	O
pro	O
-	O
inflammatory	O
response	O
is	O
a	O
crucial	O
cellular	O
process	O
that	O
detects	O
and	O
controls	O
the	O
invading	O
viruses	B-SPEC
at	O
early	O
stages	O
of	O
the	O
infection	O
.	O

Along	O
with	O
other	O
innate	O
immunity	O
,	O
this	O
nonspecific	O
response	O
would	O
either	O
clear	O
the	O
invading	O
viruses	B-SPEC
or	O
allow	O
the	O
adaptive	O
immune	O
system	O
to	O
establish	O
an	O
effective	O
antiviral	O
response	O
at	O
late	O
stages	O
of	O
the	O
infection	O
.	O

TITLE	O
:	O
Identifying	O
public	O
health	O
competencies	O
relevant	O
to	O
family	B-SPEC
medicine	O
.	O

Costimulation	O
of	O
primary	O
human	B-SPEC
fibroblasts	O
with	O
IL	O
-	O
17	O
greatly	O
enhanced	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
-	O
induced	O
or	O
synthetic	O
dsRNA	O
-	O
based	O
viral	O
mimic	O
polyinosinic	O
:	O
polycytidylic	O
acid	O
-	O
induced	O
expression	O
of	O
proinflammatory	O
genes	O
without	O
affecting	O
expression	O
of	O
IFN	O
-	O
	O
-	O
stimulated	O
or	O
IFN	O
-	O
stimulated	O
genes	O
.	O

In	O
the	O
course	O
of	O
this	O
study	O
it	O
was	O
discovered	O
that	O
Q7R	O
is	O
an	O
extremely	O
potent	O
compound	O
against	O
PEDV	B-SPEC
.	O

CONCLUSIONS	O
:	O
The	O
presence	O
of	O
gross	O
vulva	O
oedema	O
in	O
pre	O
-	O
eclampsia	O
may	O
be	O
an	O
indicator	B-SPEC
of	O
severity	O
of	O
disease	O
and	O
or	O
deteriorating	O
fetomaternal	O
condition	O
.	O

In	O
influenza	B-SPEC
virus	I-SPEC
,	O
the	O
protease	O
makes	O
a	O
simple	O
cut	O
in	O
the	O
GP	O
during	O
maturation	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
may	O
be	O
a	O
causative	O
agent	O
of	O
previously	O
unexplained	O
respiratory	O
illnesses	O
.	O

TITLE	O
:	O
Scientific	O
report	O
:	O
highlights	O
of	O
24th	O
ICAR	O
,	O
8	O
-	O
11	O
May	O
2011	O
,	O
Sofia	O
,	O
Bulgaria	B-SPEC
.	O

This	O
report	O
aims	O
to	O
reflect	O
the	O
diversity	O
of	O
topics	O
across	O
different	O
disciplines	O
(	O
chemistry	O
to	O
biology	O
)	O
discussed	O
at	O
ICAR	O
:	O
old	O
viruses	B-SPEC
(	O
smallpox	B-SPEC
),	O
emerging	O
viruses	B-SPEC
(	O
SARS	O
,	O
new	O
strains	O
of	O
influenza	O
and	O
flaviviruses	B-SPEC
),	O
problematic	O
viruses	B-SPEC
(	O
HIV	B-SPEC
and	O
HCV	B-SPEC
),	O
sporadic	O
viruses	B-SPEC
(	O
arenaviruses	B-SPEC
),	O
neglected	O
viruses	B-SPEC
(	O
enteroviruses	B-SPEC
),	O
new	O
research	O
targets	O
(	O
for	O
HCV	B-SPEC
)	O
and	O
new	O
approaches	O
(	O
lethal	O
mutagenesis	O
).	O

There	O
were	O
timely	O
reports	O
on	O
promising	O
compounds	O
against	O
adenoviruses	B-SPEC
,	O
cytomegalovirus	B-SPEC
,	O
HCV	B-SPEC
and	O
HIV	B-SPEC
in	O
clinical	O
trials	O
.	O

In	O
this	O
trial	O
,	O
the	O
cytokine	O
levels	O
of	O
IL6	O
,	O
IL8	O
and	O
IL10	O
were	O
measured	O
and	O
compared	O
in	O
30	O
patients	O
who	O
had	O
undergone	O
an	O
extended	O
radical	O
thoracoabdominal	O
esophagectomy	O
for	O
esophageal	O
cancer	B-SPEC
,	O
via	O
anterolateral	O
thoracotomy	O
(	O
n	O
=	O
17	O
)	O
or	O
posterolateral	O
thoracotomy	O
(	O
n	O
=	O
13	O
).	O

Here	O
,	O
we	O
analyzed	O
the	O
role	O
of	O
the	O
type	O
II	O
transmembrane	O
serine	O
proteases	O
(	O
TTSPs	O
)	O
human	B-SPEC
airway	O
trypsin	O
-	O
like	O
protease	O
(	O
HAT	O
)	O
and	O
transmembrane	O
protease	O
,	O
serine	O
2	O
(	O
TMPRSS2	O
),	O
in	O
SARS	O
-	O
S	O
activation	O
.	O

HCoV	O
-	O
HKU1	O
is	O
a	O
group	O
2a	O
coronavirus	B-SPEC
that	O
is	O
still	O
not	O
cultivable	O
.	O

There	O
was	O
a	O
high	O
rate	O
of	O
mutability	O
in	O
all	O
structural	O
and	O
accessory	O
genes	O
both	O
within	O
and	O
between	O
cats	B-SPEC
,	O
leading	O
to	O
minor	O
genetic	O
variants	O
.	O

Coronaviruses	O
possess	O
the	O
largest	O
genomes	O
(	O
26	O
.	O
4	O
to	O
31	O
.	O
7	O
kb	O
)	O
among	O
all	O
known	O
RNA	O
viruses	B-SPEC
,	O
with	O
G	O
+	O
C	O
contents	O
varying	O
from	O
32	O
%	O
to	O
43	O
%.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
canine	O
coronavirus	B-SPEC
NA	O
/	O
09	O
strain	O
detected	O
in	O
a	O
dog	B-SPEC
'	O
s	O
organs	O
.	O

The	O
papain	O
-	O
like	O
cysteine	O
proteases	O
encoded	O
by	O
the	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
:	O
PLpro	O
;	O
NL63	O
:	O
PLP1	O
and	O
PLP2	O
)	O
represent	O
potential	O
targets	O
for	O
antiviral	O
drug	O
development	O
.	O

Nucleotide	O
and	O
amino	O
acid	O
sequence	O
comparisons	O
have	O
shown	O
that	O
the	O
recent	O
isolates	O
bear	B-SPEC
98	O
.	O
97	O
%	O
genetic	O
similarity	O
with	O
strains	O
of	O
the	O
QX	O
-	O
like	O
genotype	O
.	O

The	O
C	O
subunit	O
of	O
pAPN	O
(	O
pAPN	O
-	O
C	O
)	O
produced	O
by	O
PCR	O
from	O
the	O
plasmid	O
pMD18	O
-	O
T	O
-	O
pAPN	O
was	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
using	O
vector	O
pET	O
-	O
32a	O
with	O
His	O
tag	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
monoclonal	O
antibodies	O
developed	O
using	O
a	O
prokaryotic	O
expressed	O
protein	O
.	O

The	O
primary	O
IBV	B-SPEC
infection	O
induced	O
changes	O
in	O
circulating	O
T	O
-	O
cell	O
populations	O
and	O
in	O
the	O
specific	O
antibody	O
responses	O
.	O

Serum	O
MBL	O
levels	O
also	O
influenced	O
IBV	B-SPEC
vaccine	O
-	O
induced	O
changes	O
in	O
circulating	O
T	O
-	O
cell	O
populations	O
.	O

Further	O
treatment	O
was	O
complicated	O
by	O
septic	O
shock	O
due	O
to	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
infection	O
of	O
the	O
vagina	O
,	O
treated	O
with	O
piperacillin	O
/	O
tazobactam	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
-	O
induced	O
neuronal	O
programmed	O
cell	O
death	O
is	O
cyclophilin	O
d	O
dependent	O
and	O
potentially	O
caspase	O
dispensable	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
proapoptotic	O
proteins	O
BAX	O
,	O
cytochrome	O
c	O
(	O
CytC	O
),	O
and	O
apoptosis	O
-	O
inducing	O
factor	O
(	O
AIF	O
)	O
were	O
relocalized	O
toward	O
the	O
mitochondria	O
,	O
cytosol	O
,	O
and	O
nucleus	O
,	O
respectively	O
,	O
after	O
infection	O
by	O
both	O
virus	B-SPEC
variants	O
.	O

TITLE	O
:	O
Respiratory	O
support	O
by	O
neurally	O
adjusted	O
ventilatory	O
assist	O
(	O
NAVA	O
)	O
in	O
severe	O
RSV	B-SPEC
-	O
related	O
bronchiolitis	O
:	O
a	O
case	O
series	O
report	O
.	O

We	O
report	O
here	O
a	O
series	O
of	O
3	O
children	O
(	O
1	O
month	O
,	O
3	O
years	O
,	O
and	O
28	O
days	O
old	O
)	O
with	O
severe	O
respiratory	O
distress	O
due	O
to	O
RSV	B-SPEC
-	O
related	O
bronchiolitis	O
requiring	O
invasive	O
mechanical	O
ventilation	O
with	O
a	O
high	O
level	O
of	O
oxygen	O
(	O
FiO2	O
	O
50	O
%)	O
for	O
whom	O
NAVA	O
facilitated	O
respiratory	O
support	O
.	O

Repetitive	O
freeze	O
-	O
thawing	O
also	O
produced	O
a	O
significant	O
effect	O
on	O
ELISA	O
results	O
for	O
IBV	B-SPEC
(	O
less	O
positive	O
)	O
and	O
AEV	O
(	O
more	O
positive	O
).	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
Cal99	O
variant	O
was	O
isolated	O
from	O
the	O
kidneys	O
of	O
seven	O
2	O
-	O
5	O
-	O
mo	O
-	O
old	O
game	O
chickens	B-SPEC
with	O
nephritis	O
and	O
respiratory	O
disease	O
.	O

Macroscopically	O
,	O
the	O
majority	O
of	O
the	O
birds	B-SPEC
had	O
moderately	O
to	O
severely	O
enlarged	O
and	O
mottled	O
pale	O
kidneys	O
,	O
with	O
increased	O
urates	O
in	O
the	O
ureters	O
.	O

TITLE	O
:	O
Phylogenetic	O
analysis	O
of	O
S1	O
gene	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
from	O
China	O
.	O

SPECIAL	O
ARTICLE	O
:	O
Five	O
case	O
scenarios	O
that	O
we	O
confronted	O
at	O
the	O
pediatric	O
ward	O
of	O
the	O
field	O
hospital	O
are	O
presented	O
:	O
two	O
children	O
with	O
respiratory	O
compromise	O
due	O
to	O
pulmonary	O
infection	O
,	O
one	O
premature	O
baby	O
with	O
respiratory	O
distress	O
syndrome	O
,	O
an	O
asphyxiated	O
neonate	O
,	O
and	O
a	O
baby	O
with	O
severe	O
sepsis	B-SPEC
of	O
a	O
probable	O
abdominal	O
origin	O
.	O

ABSTRACT	O
:	O
We	O
explored	O
the	O
diagnostic	O
value	O
of	O
a	O
urine	O
soluble	O
triggering	O
receptor	O
expressed	O
on	O
myeloid	O
cells	O
-	O
1	O
(	O
sTREM	O
-	O
1	O
)	O
for	O
early	O
sepsis	B-SPEC
identification	O
,	O
severity	O
and	O
prognosis	O
assessment	O
,	O
and	O
for	O
secondary	O
acute	O
kidney	O
injury	O
(	O
AKI	O
).	O

In	O
addition	O
to	O
re	O
-	O
analyzing	O
data	O
from	O
the	O
ARMA	B-SPEC
trial	O
,	O
we	O
also	O
apply	O
our	O
methodology	O
to	O
data	O
from	O
a	O
subsequent	O
trial	O
(	O
ALVEOLI	O
),	O
which	O
implemented	O
the	O
LTVV	O
regime	O
in	O
both	O
of	O
its	O
study	O
arms	O
and	O
also	O
suffered	O
from	O
non	O
-	O
adherence	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
envelope	O
protein	O
regulates	O
cell	O
stress	O
response	O
and	O
apoptosis	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
that	O
lacks	O
the	O
envelope	O
(	O
E	O
)	O
gene	O
(	O
rSARS	O
-	O
CoV	O
-	O
E	O
)	O
is	O
attenuated	O
in	O
vivo	O
.	O

TITLE	O
:	O
Epidemiology	O
and	O
immunoprotection	O
of	O
nephropathogenic	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
southern	O
China	O
.	O

By	O
virus	B-SPEC
recovery	O
trials	O
,	O
187	O
of	O
the	O
isolates	O
caused	O
the	O
birds	B-SPEC
died	O
or	O
distressed	O
from	O
nephritis	O
,	O
which	O
was	O
accordant	O
with	O
the	O
clinical	O
record	O
.	O

ABSTRACT	O
:	O
This	O
article	O
reviews	O
the	O
currently	O
available	O
literature	O
on	O
pantropic	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
),	O
providing	O
a	O
meaningful	O
update	O
on	O
the	O
virologic	O
,	O
epidemiologic	O
,	O
clinical	O
,	O
diagnostic	O
,	O
and	O
prophylactic	O
aspects	O
of	O
the	O
infections	O
caused	O
by	O
this	O
emerging	O
pathogen	O
of	O
dogs	B-SPEC
.	O

TITLE	O
:	O
Clinical	O
presentations	O
of	O
pandemic	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
infection	O
in	O
hospitalized	O
Thai	O
children	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
of	O
swine	B-SPEC
origin	O
caused	O
human	B-SPEC
infection	O
and	O
acute	O
respiratory	O
illness	O
in	O
Mexico	O
during	O
the	O
spring	O
of	O
2009	O
.	O

The	O
authors	O
describe	O
3	O
challenging	O
cases	O
of	O
the	O
abrupt	O
onset	O
of	O
CM	O
-	O
I	O
/	O
syringomyelia	O
to	O
reveal	O
more	O
information	O
on	O
the	O
clinical	O
presentation	O
and	O
pathogenetic	O
mechanisms	O
of	O
this	O
sudden	O
and	O
potentially	O
severe	O
clinical	O
phenomenon	O
:	O
a	O
38	O
-	O
year	O
-	O
old	O
man	B-SPEC
experienced	O
acute	O
respiratory	O
failure	O
requiring	O
intubation	O
following	O
acute	O
decompensation	O
of	O
hydrocephalus	O
associated	O
with	O
Noonan	O
syndrome	O
,	O
a	O
1	O
-	O
year	O
-	O
old	O
boy	O
had	O
sudden	O
hemiparesis	O
and	O
Horner	O
syndrome	O
after	O
a	O
minor	O
head	O
/	O
neck	O
injury	O
,	O
and	O
a	O
2	O
.	O
5	O
-	O
year	O
-	O
old	O
boy	O
presented	O
with	O
quickly	O
progressing	O
tetraplegia	O
and	O
dyspnea	O
after	O
a	O
mild	O
flexion	O
and	O
extension	O
neck	O
injury	O
a	O
few	O
hours	O
before	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
systems	O
biology	O
approach	O
employing	O
a	O
genome	O
-	O
wide	O
yeast	B-SPEC
-	O
two	O
hybrid	O
interaction	O
screen	O
to	O
identify	O
immunopilins	O
(	O
PPIA	O
,	O
PPIB	O
,	O
PPIH	O
,	O
PPIG	O
,	O
FKBP1A	O
,	O
FKBP1B	O
)	O
as	O
interaction	O
partners	O
of	O
the	O
CoV	O
non	O
-	O
structural	O
protein	O
1	O
(	O
Nsp1	O
).	O

Aerosolized	O
EC	O
-	O
SOD	O
protected	O
mice	B-SPEC
against	O
oxygen	O
toxicity	O
and	O
reduced	O
mortality	O
in	O
a	O
hyperoxic	O
model	O
.	O

The	O
advent	O
of	O
electron	O
microscopy	O
and	O
molecular	O
biology	O
showed	O
that	O
diarrhea	O
could	O
also	O
be	O
caused	O
by	O
viruses	B-SPEC
,	O
both	O
in	O
humans	B-SPEC
and	O
in	O
other	O
animals	B-SPEC
.	O

This	O
""""	O
reo	O
-	O
like	O
virus	B-SPEC
""""	O
was	O
subsequently	O
identified	O
as	O
a	O
rotavirus	B-SPEC
,	O
and	O
was	O
shown	O
only	O
four	O
years	O
later	O
to	O
be	O
responsible	O
for	O
severe	O
diarrhea	O
in	O
young	O
children	O
.	O

TITLE	O
:	O
Flow	O
cytometric	O
immune	O
profiling	O
of	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
before	O
and	O
after	O
infectious	O
challenges	O
.	O

Treatment	O
requires	O
prompt	O
administration	O
of	O
safe	O
and	O
fast	O
-	O
acting	O
antimalarials	O
,	O
which	O
in	O
severe	O
malaria	O
is	O
treatment	O
with	O
quinine	B-SPEC
or	O
artesunate	O
.	O

Since	O
young	O
and	O
aged	O
(	O
1	O
-	O
year	O
-	O
old	O
)	O
mice	B-SPEC
do	O
not	O
develop	O
severe	O
clinical	O
disease	O
following	O
infection	O
with	O
wild	O
-	O
type	O
SARS	O
-	O
CoV	O
,	O
a	O
mouse	B-SPEC
-	O
adapted	O
strain	O
of	O
SARS	O
-	O
CoV	O
(	O
called	O
MA15	O
)	O
was	O
developed	O
and	O
was	O
shown	O
to	O
cause	O
lethal	O
infection	O
in	O
these	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
a	O
severe	O
form	O
of	O
respiratory	O
failure	O
characterized	O
by	O
acute	O
onset	O
of	O
significant	O
hypoxaemia	O
(	O
PaO2	O
:	O
FiO2	O
<	O
200mmHg	O
)	O
with	O
diffuse	O
bilateral	O
pulmonary	O
air	O
-	O
space	O
shadowing	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
,	O
without	O
clinical	O
signs	O
of	O
heart	O
failure	O
(	O
Bernard	O
et	O
al	O
,	O
1994	O
).	O

ABSTRACT	O
:	O
We	O
previously	O
reported	O
widespread	O
differential	O
expression	O
of	O
long	O
non	O
-	O
protein	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
in	O
response	O
to	O
virus	B-SPEC
infection	O
.	O

A	O
majority	O
of	O
identified	O
microRNAs	O
(	O
miRNAs	O
)	O
showed	O
divergent	O
changes	O
in	O
expression	O
across	O
mouse	B-SPEC
strains	O
with	O
respect	O
to	O
SARS	O
-	O
CoV	O
and	O
influenza	B-SPEC
virus	I-SPEC
infections	O
and	O
responded	O
differently	O
to	O
a	O
highly	O
pathogenic	O
reconstructed	O
1918	O
virus	B-SPEC
compared	O
to	O
a	O
minimally	O
pathogenic	O
seasonal	O
influenza	B-SPEC
virus	I-SPEC
isolate	O
.	O

These	O
findings	O
represent	O
the	O
first	O
integrated	O
sequencing	O
analysis	O
of	O
the	O
response	O
of	O
host	O
small	O
RNAs	O
to	O
virus	B-SPEC
infection	O
and	O
show	O
that	O
small	O
RNAs	O
are	O
an	O
integrated	O
component	O
of	O
complex	O
networks	O
involved	O
in	O
regulating	O
the	O
host	O
response	O
to	O
infection	O
.	O

However	O
,	O
mammalian	B-SPEC
genomes	O
transcribe	O
many	O
short	O
and	O
long	O
non	O
-	O
protein	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
).	O

ABSTRACT	O
:	O
This	O
experimental	O
animal	B-SPEC
study	O
investigates	O
the	O
effects	O
of	O
combined	O
recombinant	O
human	B-SPEC
activated	O
protein	O
C	O
(	O
rhAPC	O
)	O
and	O
ceftazidime	O
on	O
cardiopulmonary	O
function	O
in	O
acute	O
lung	O
injury	O
and	O
severe	O
sepsis	B-SPEC
.	O

Fluorescent	O
antibody	O
staining	O
indicated	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
could	O
readily	O
infect	O
AMs	O
,	O
but	O
no	O
evidence	O
was	O
found	O
for	O
infection	O
in	O
differentiated	O
alveolar	O
epithelial	O
type	O
II	O
cells	O
and	O
only	O
a	O
very	O
low	O
level	O
of	O
infection	O
in	O
type	O
II	O
cells	O
transitioning	O
to	O
the	O
type	O
I	O
-	O
like	O
cell	O
phenotype	O
.	O

ABSTRACT	O
:	O
Pandemic	O
2009	O
H1N1	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
arrived	O
at	O
Isfahan	O
in	O
August	O
2009	O
.	O

Out	O
of	O
216	O
patients	O
with	O
confirmed	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
,	O
26	O
cases	O
with	O
abnormal	O
CT	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

FIP	O
was	O
confirmed	O
by	O
histology	O
or	O
immunostaining	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
antigen	O
in	O
effusion	O
or	O
tissue	O
macrophages	O
or	O
both	O
.	O

All	O
cats	B-SPEC
received	O
additional	O
treatment	O
with	O
glucocorticoids	O
,	O
antibiotics	O
,	O
and	O
low	O
molecular	O
weight	O
heparin	O
according	O
to	O
methods	O
.	O

The	O
identified	O
studies	O
were	O
evaluated	O
using	O
the	O
Meta	B-SPEC
-	O
Analysis	O
of	O
Statistics	O
,	O
Assessment	O
and	O
Review	O
Instrument	O
and	O
the	O
Qualitative	O
Assessment	O
and	O
Review	O
Instrument	O
from	O
the	O
Joanna	B-SPEC
Briggs	O
Institute	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
pathogenesis	O
.	O

SARS	O
-	O
CoV	O
emerged	O
in	O
the	O
human	B-SPEC
population	O
in	O
China	O
in	O
2002	O
,	O
causing	O
a	O
worldwide	O
epidemic	O
with	O
severe	O
morbidity	O
and	O
high	O
mortality	O
rates	O
,	O
particularly	O
in	O
older	O
individuals	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
in	O
young	O
children	O
hospitalized	O
for	O
acute	O
respiratory	O
illness	O
and	O
asymptomatic	O
controls	O
.	O

In	O
order	B-SPEC
to	O
illustrate	O
that	O
the	O
diversity	O
of	O
CDR3	O
was	O
increased	O
by	O
the	O
fsPCR	O
step	O
,	O
a	O
second	O
scFv	O
library	O
was	O
constructed	O
using	O
a	O
single	O
scFv	O
clone	O
L3G7C	O
as	O
a	O
template	O
.	O

To	O
determine	O
whether	O
germline	O
library	O
represented	O
the	O
endogenous	O
immune	O
status	O
,	O
specific	O
scFv	O
clones	O
for	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCoV	O
)	O
were	O
obtained	O
both	O
from	O
nave	O
and	O
immunized	O
germline	O
scFv	O
libraries	O
.	O

Serum	O
CRP	O
concentration	O
was	O
significantly	O
lower	O
in	O
pigs	B-SPEC
with	O
PRDC	O
than	O
in	O
PMWS	O
affected	O
pigs	B-SPEC
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Decreased	O
rDC	O
migration	O
resulted	O
in	O
diminished	O
T	O
cell	O
responses	O
and	O
more	O
severe	O
clinical	O
disease	O
in	O
older	O
mice	B-SPEC
infected	O
with	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Development	O
of	O
a	O
combined	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
specific	O
RT	O
-	O
PCR	O
protocol	O
for	O
the	O
differentiation	O
of	O
infected	O
and	O
vaccinated	O
animals	B-SPEC
(	O
DIVA	O
)	O
and	O
genetic	O
characterization	O
of	O
the	O
hemagglutinin	O
gene	O
of	O
seven	O
Chinese	O
strains	O
demonstrated	O
in	O
dogs	B-SPEC
.	O

A	O
pair	O
of	O
primers	O
(	O
P1	O
/	O
P2	O
)	O
was	O
used	O
to	O
detect	O
both	O
CDV	B-SPEC
wild	O
-	O
type	O
strains	O
and	O
vaccines	O
.	O

Another	O
pair	O
(	O
P3	O
/	O
P4	O
)	O
was	O
used	O
to	O
detect	O
only	O
CDV	B-SPEC
wild	O
-	O
type	O
strains	O
.	O

The	O
combined	O
RT	O
-	O
PCR	O
method	O
detected	O
effectively	O
and	O
differentiated	O
the	O
CDV	B-SPEC
wild	O
-	O
type	O
and	O
vaccine	O
strains	O
by	O
two	O
separate	O
RT	O
-	O
PCRs	O
.	O

Pneumonia	O
caused	O
by	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
is	O
uncommon	O
and	O
has	O
been	O
reported	O
in	O
pediatric	O
patients	O
and	O
previously	O
healthy	O
adults	O
.	O

This	O
paper	O
emphasizes	O
the	O
need	O
to	O
suspect	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
infection	O
in	O
critically	O
ill	O
immunocompromised	O
patients	O
with	O
progressive	O
deterioration	O
of	O
cardiopulmonary	O
function	O
despite	O
treatment	O
with	O
antibiotics	O
.	O

We	O
used	O
a	O
stratified	O
,	O
two	O
-	O
stage	O
cluster	O
survey	O
sample	O
to	O
select	O
1200	O
households	O
from	O
the	O
Department	O
of	O
Santa	O
Rosa	B-SPEC
.	O

Using	O
this	O
technique	O
,	O
we	O
found	O
that	O
the	O
unique	O
neuropathologies	O
caused	O
by	O
infection	O
with	O
the	O
mutant	O
viruses	B-SPEC
result	O
from	O
infecting	O
neurons	O
,	O
which	O
do	O
not	O
express	O
MHVR	O
.	O

After	O
nine	O
days	O
of	O
ECMO	O
and	O
further	O
two	O
days	O
of	O
conventional	O
ventilatory	O
treatment	O
he	O
was	O
extubated	O
,	O
and	O
four	O
months	O
later	O
the	O
child	O
presented	O
with	O
normal	O
X	O
-	O
ray	B-SPEC
of	O
the	O
lungs	O
and	O
without	O
any	O
signs	O
of	O
disease	O
.	O

TITLE	O
:	O
Isolation	O
of	O
influenza	B-SPEC
viruses	I-SPEC
in	O
MDCK	O
33016PF	O
cells	O
and	O
clearance	O
of	O
contaminating	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
In	O
vitro	O
anti	O
-	O
hepatitis	O
B	O
and	O
SARS	O
virus	B-SPEC
activities	O
of	O
a	O
titanium	O
-	O
substituted	O
-	O
heteropolytungstate	O
.	O

ABSTRACT	O
:	O
A	O
structural	O
determined	O
heteropolytungstate	O
,	O
[	O
K	O
(	O
4	O
)(	O
H	O
(	O
2	O
)	O
O	O
)(	O
8	O
)	O
Cl	O
][	O
K	O
(	O
4	O
)(	O
H	O
(	O
2	O
)	O
O	O
)(	O
4	O
)	O
PTi	O
(	O
2	O
)	O
W	O
(	O
10	O
)	O
O	O
(	O
40	O
)]	O
NH	O
(	O
2	O
)	O
OH	O
1	O
,	O
has	O
been	O
synthesized	O
and	O
evaluated	O
for	O
in	O
vitro	O
antiviral	O
activities	O
against	O
hepatitis	O
B	O
(	O
HBV	B-SPEC
)	O
and	O
SARS	O
virus	B-SPEC
.	O

MassTag	O
polymerase	O
chain	O
reaction	O
for	O
influenza	O
A	O
and	O
B	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
groups	O
A	O
and	O
B	O
,	O
human	B-SPEC
coronavirus	I-SPEC
-	O
229E	O
and	O
human	B-SPEC
coronavirus	I-SPEC
-	O
OC43	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
enterovirus	B-SPEC
,	O
human	B-SPEC
parainfluenza	O
viruses	B-SPEC
2	O
,	O
3	O
,	O
and	O
4a	O
,	O
human	B-SPEC
adenovirus	B-SPEC
,	O
Haemophilus	B-SPEC
influenzae	I-SPEC
,	O
Neisseria	B-SPEC
meningitidis	I-SPEC
,	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
,	O
Legionella	B-SPEC
pneumonia	O
,	O
and	O
Mycoplasma	B-SPEC
pneumonia	O
was	O
done	O
on	O
respiratory	O
specimens	O
.	O

Out	O
of	O
6	O
samples	O
,	O
3	O
tested	O
positive	O
for	O
H	B-SPEC
.	I-SPEC
influenzae	I-SPEC
;	O
1	O
tested	O
positive	O
for	O
both	O
H	B-SPEC
.	I-SPEC
influenzae	I-SPEC
and	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
3	I-SPEC
;	O
and	O
2	O
tested	O
negative	O
.	O

On	O
49th	O
day	O
after	O
the	O
last	O
immunization	O
,	O
splenocytes	O
were	O
prepared	O
from	O
mice	B-SPEC
immunized	O
with	O
surface	O
-	O
displayed	O
mixture	O
,	O
secretory	O
mixture	O
and	O
negative	O
control	O
to	O
be	O
stimulated	O
by	O
purified	O
N	O
and	O
S	O
protein	O
,	O
respectively	O
.	O

Here	O
,	O
we	O
report	O
a	O
protective	O
role	O
of	O
FXR	O
in	O
a	O
lipopolysaccharide	O
-	O
induced	O
mouse	B-SPEC
model	O
of	O
acute	O
lung	O
injury	O
.	O

These	O
investigations	O
have	O
contributed	O
to	O
detecting	O
and	O
characterizing	O
new	O
pathogens	O
(	O
e	O
.	O
g	O
.,	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
)	O
and	O
conditions	O
,	O
provided	O
insights	O
regarding	O
factors	O
that	O
cause	O
or	O
contribute	O
to	O
disease	O
acquisition	O
(	O
e	O
.	O
g	O
.,	O
Ebola	O
hemorrhagic	O
fever	O
),	O
led	O
to	O
development	O
of	O
new	O
diagnostics	O
and	O
surveillance	O
technologies	O
,	O
and	O
provided	O
information	O
upon	O
which	O
global	O
health	O
policies	O
and	O
regulations	O
can	O
be	O
based	O
.	O

The	O
shRNAs	O
were	O
transiently	O
transfected	O
into	O
a	O
porcine	B-SPEC
kidney	O
cell	O
line	O
,	O
PK	O
-	O
15	O
,	O
to	O
determine	O
whether	O
these	O
constructs	O
inhibited	O
PHEV	O
production	O
.	O

TITLE	O
:	O
Novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
-	O
induced	O
hemophagocytosis	O
:	O
first	O
case	O
reported	O
in	O
Saudi	O
Arabia	O
.	O

The	O
animal	B-SPEC
reservoirs	O
for	O
SARS	O
-	O
CoV	O
precursors	O
still	O
exist	O
and	O
the	O
likelihood	O
of	O
future	O
outbreaks	O
in	O
the	O
human	B-SPEC
population	O
is	O
high	O
.	O

Furthermore	O
the	O
data	O
with	O
NSC158362	O
suggest	O
a	O
novel	O
mechanism	O
for	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
replication	O
that	O
may	O
involve	O
an	O
unknown	O
activity	O
of	O
PLP	O
,	O
or	O
alternatively	O
a	O
direct	O
effect	O
on	O
a	O
cellular	O
target	O
that	O
modifies	O
or	O
bypasses	O
PLP	O
function	O
in	O
yeast	B-SPEC
and	O
mammalian	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
torovirus	I-SPEC
(	O
BToV	O
)	O
is	O
recognized	O
as	O
an	O
enteric	O
pathogen	O
of	O
calves	O
,	O
but	O
its	O
etiological	O
role	O
in	O
diarrhea	O
and	O
epidemiological	O
characterization	O
in	O
adult	O
cows	B-SPEC
remain	O
unclear	O
.	O

The	O
short	O
projections	O
that	O
are	O
believed	O
to	O
be	O
formed	O
by	O
the	O
HE	O
protein	O
on	O
virus	B-SPEC
particles	O
were	O
not	O
observed	O
in	O
these	O
cultured	O
strains	O
by	O
electron	O
microscopy	O
.	O

The	O
use	O
of	O
ISH	O
technique	O
demonstrated	O
the	O
presence	O
of	O
viral	O
RNA	O
in	O
nasal	O
turbinates	O
prior	O
to	O
trachea	B-SPEC
,	O
but	O
more	O
consistent	O
and	O
longer	O
replication	O
periods	O
in	O
enterocytes	O
of	O
lower	O
gastrointestinal	O
tract	O
.	O

MPV	B-SPEC
,	O
RSV	B-SPEC
and	O
HRV	O
were	O
the	O
main	O
pathogens	O
caused	O
infection	O
among	O
children	O
under	O
4	O
years	O
old	O
,	O
accounting	O
for	O
9	O
.	O
7	O
%	O
(	O
49	O
/	O
503	O
),	O
21	O
.	O
7	O
%	O
(	O
109	O
/	O
503	O
)	O
and	O
18	O
.	O
9	O
%	O
(	O
95	O
/	O
503	O
).	O

A	O
new	O
generation	O
of	O
vaccines	O
is	O
called	O
for	O
and	O
one	O
means	O
of	O
controlling	O
IBV	B-SPEC
involves	O
the	O
development	O
of	O
new	O
and	O
safer	O
vaccines	O
by	O
precisely	O
modifying	O
the	O
IBV	B-SPEC
genome	O
using	O
reverse	O
genetics	O
for	O
the	O
production	O
of	O
rationally	O
attenuated	O
IBVs	O
in	O
order	B-SPEC
to	O
obtain	O
an	O
optimum	O
balance	O
between	O
loss	O
of	O
virulence	O
and	O
capacity	O
to	O
induce	O
immunity	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infections	O
cause	O
great	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
worldwide	O
,	O
and	O
the	O
emergence	O
of	O
new	O
variant	O
strains	O
complicates	O
disease	O
control	O
.	O

TITLE	O
:	O
Molecular	O
diagnosis	O
of	O
respiratory	O
virus	B-SPEC
infections	O
.	O

Again	O
we	O
observed	O
most	O
infection	O
by	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
n	O
=	O
85	O
)	O
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
(	O
n	O
=	O
60	O
),	O
followed	O
by	O
HCoV	O
-	O
HKU1	O
(	O
n	O
=	O
47	O
)	O
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
n	O
=	O
15	O
).	O

Virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
tests	O
were	O
performed	O
in	O
tracheal	O
organ	O
cultures	O
(	O
TOCs	O
)	O
using	O
these	O
10	O
strains	O
with	O
the	O
antisera	O
,	O
and	O
a	O
one	O
-	O
way	O
VN	O
test	O
was	O
then	O
used	O
to	O
compare	O
the	O
relationship	O
of	O
10	O
monovalent	O
antisera	O
to	O
the	O
other	O
19	O
field	O
isolates	O
.	O

Recently	O
,	O
these	O
issues	O
were	O
addressed	O
by	O
showing	O
a	O
very	O
good	O
response	O
to	O
inducing	O
neutralizing	O
antibodies	O
by	O
plant	B-SPEC
-	O
derived	O
dengue	O
vaccine	O
antigens	O
.	O

Nevertheless	O
,	O
the	O
absence	O
of	O
CNS	O
CD4	O
T	O
cells	O
was	O
associated	O
with	O
reduced	O
gamma	O
interferon	O
(	O
IFN	O
-	O
	O
)	O
and	O
granzyme	O
B	O
expression	O
by	O
infiltrating	O
CD8	O
T	O
cells	O
,	O
increased	O
CD8	O
T	O
cell	O
apoptosis	O
,	O
and	O
impaired	O
control	O
of	O
infectious	O
virus	B-SPEC
.	O

This	O
study	O
identified	O
shared	O
structural	O
topologies	O
(	O
connectivity	O
of	O
secondary	O
structural	O
elements	O
)	O
in	O
S1	O
domains	O
of	O
different	O
coronavirus	B-SPEC
genera	O
.	O

In	O
addition	O
,	O
farms	O
positive	O
for	O
H1N2	O
and	O
porcine	B-SPEC
reproductive	O
and	O
respiratory	O
disease	O
virus	B-SPEC
(	O
PRRSV	B-SPEC
)	O
were	O
more	O
likely	O
to	O
have	O
higher	O
levels	O
of	O
severe	O
and	O
mild	O
pleurisy	O
reported	O
by	O
the	O
BPHS	O
,	O
respectively	O
.	O

RESULTS	O
:	O
BPHS	O
reports	O
were	O
obtained	O
from	O
a	O
subset	O
of	O
70	O
pig	B-SPEC
farms	O
involved	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
conducted	O
in	O
2008	O
-	O
09	O
investigating	O
the	O
epidemiology	O
of	O
post	O
-	O
weaning	O
multi	O
-	O
systemic	O
wasting	O
syndrome	O
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
in	O
both	O
beef	O
calves	O
direct	O
from	O
the	O
ranch	O
and	O
commingled	O
,	O
mixed	O
-	O
source	O
calves	O
obtained	O
from	O
an	O
auction	O
market	O
.	O

EVLW	O
was	O
associated	O
with	O
degree	O
of	O
lung	O
injury	O
and	O
mortality	O
,	O
regardless	O
of	O
the	O
index	O
used	O
,	O
confirming	O
that	O
it	O
may	O
be	O
used	O
as	O
a	O
bedside	O
indicator	B-SPEC
of	O
disease	O
severity	O
.	O

To	O
study	O
the	O
function	O
of	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
,	O
we	O
have	O
conducted	O
a	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screening	O
experiment	O
to	O
identify	O
cellular	O
proteins	O
that	O
may	O
interact	O
with	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
.	O

The	O
binding	O
domains	O
of	O
these	O
two	O
proteins	O
were	O
also	O
determined	O
using	O
the	O
yeast	B-SPEC
two	O
-	O
hybrid	O
system	O
.	O

They	O
were	O
panned	O
against	O
different	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
envelope	O
glycoproteins	O
(	O
Envs	O
),	O
SARS	O
CoV	O
protein	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
and	O
soluble	O
Hendra	B-SPEC
virus	I-SPEC
G	O
protein	O
(	O
sG	O
).	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
role	O
of	O
virus	B-SPEC
and	O
bacteria	B-SPEC
in	O
CD4	O
(+)	O
T	O
cell	O
-	O
derived	O
cytokine	O
production	O
in	O
newborns	O
.	O

We	O
compared	O
the	O
effects	O
of	O
five	O
bacteria	B-SPEC
(	O
Staphlococcus	O
aureus	O
,	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Clostridium	B-SPEC
difficile	I-SPEC
,	O
Lactobacillus	B-SPEC
rhamnosus	I-SPEC
and	O
Bifidobacterium	B-SPEC
bifidus	O
)	O
and	O
seven	O
virus	B-SPEC
(	O
adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
cytomegalovirus	B-SPEC
,	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
morbillivirus	B-SPEC
and	O
poliovirus	B-SPEC
)	O
on	O
the	O
Th1	O
/	O
Th2	O
cytokine	O
production	O
in	O
mixed	O
lymphocyte	O
reactions	O
using	O
CD4	O
(+)	O
T	O
cells	O
from	O
cord	O
blood	O
cocultured	O
with	O
allogenic	O
myeloid	O
or	O
plasmacytoid	O
dendritic	O
cells	O
.	O

TITLE	O
:	O
T	O
helper	O
cell	O
-	O
and	O
CD40	O
-	O
dependent	O
germline	O
IgM	O
prevents	O
chronic	O
virus	B-SPEC
-	O
induced	O
demyelinating	O
disease	O
.	O

Infection	O
of	O
the	O
CNS	O
with	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
provides	O
a	O
unique	O
model	O
situation	O
in	O
which	O
the	O
extent	O
of	O
inflammatory	O
CNS	O
disease	O
is	O
determined	O
by	O
the	O
balance	O
between	O
antiviral	O
immune	O
control	O
,	O
viral	O
replication	O
,	O
and	O
immune	O
-	O
mediated	O
damage	O
.	O

Here	O
,	O
we	O
present	O
a	O
mouse	B-SPEC
model	O
of	O
ARDS	O
induced	O
by	O
2009	O
H1N1	O
virus	B-SPEC
.	O

TITLE	O
:	O
Two	O
palmitylated	O
cysteine	O
residues	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
are	O
critical	O
for	O
S	O
incorporation	O
into	O
virus	B-SPEC
-	O
like	O
particles	O
,	O
but	O
not	O
for	O
M	O
-	O
S	O
co	O
-	O
localization	O
.	O

TITLE	O
:	O
Contact	O
with	O
domestic	O
dogs	B-SPEC
increases	O
pathogen	O
exposure	O
in	O
endangered	O
African	B-SPEC
wild	I-SPEC
dogs	I-SPEC
(	O
Lycaon	B-SPEC
pictus	I-SPEC
).	O

These	O
findings	O
,	O
combined	O
with	O
other	O
data	O
,	O
suggest	O
that	O
management	O
directed	O
at	O
domestic	O
dogs	B-SPEC
might	O
help	O
to	O
protect	O
wild	O
dog	B-SPEC
populations	O
from	O
rabies	B-SPEC
virus	I-SPEC
,	O
but	O
not	O
from	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
.	O

Characterization	O
of	O
CoV	O
N	O
NTDs	O
from	O
infectious	O
bronchitis	O
virus	B-SPEC
and	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
revealed	O
that	O
,	O
although	O
detailed	O
NTD	O
-	O
TRS	O
determinants	O
are	O
distinct	O
from	O
those	O
of	O
MHV	B-SPEC
NTD	O
,	O
rapid	O
helix	O
destabilization	O
activity	O
of	O
CoV	O
N	O
NTDs	O
is	O
most	O
strongly	O
correlated	O
with	O
CoV	O
function	O
and	O
virus	B-SPEC
viability	O
.	O

A	O
total	O
of	O
57	O
patients	O
with	O
osteolysis	O
of	O
lymphatic	O
origin	O
had	O
been	O
studied	O
at	O
our	O
institution	O
,	O
of	O
whom	O
three	O
died	O
,	O
two	O
from	O
sepsis	B-SPEC
,	O
and	O
one	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Male	O
ACE2	O
(-/	O
y	O
)	O
BLM	O
injured	O
mice	B-SPEC
exhibited	O
poorer	O
exercise	O
capacity	O
,	O
worse	O
lung	O
function	O
and	O
exacerbated	O
lung	O
fibrosis	O
and	O
collagen	O
deposition	O
compared	O
with	O
WT	O
.	O

These	O
counties	O
account	O
for	O
an	O
important	O
part	O
of	O
the	O
Croatian	O
commercial	O
pig	B-SPEC
production	O
and	O
have	O
a	O
high	O
density	O
of	O
wild	B-SPEC
boars	I-SPEC
.	O

ABSTRACT	O
:	O
Wild	O
Amur	B-SPEC
tigers	I-SPEC
(	O
Panthera	B-SPEC
tigris	I-SPEC
altaica	I-SPEC
,	O
n	O
=	O
44	O
)	O
from	O
the	O
Russian	O
Far	O
East	O
were	O
tested	O
for	O
antibodies	O
to	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
corona	B-SPEC
virus	B-SPEC
(	O
FCoV	O
),	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
parvovirus	I-SPEC
(	O
FPV	B-SPEC
),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
and	O
Bartonella	B-SPEC
henselae	I-SPEC
.	O

By	O
ultrastructurally	O
examining	O
HEV	B-SPEC
-	O
infected	O
rat	B-SPEC
dorsal	O
root	O
ganglia	O
,	O
we	O
found	O
that	O
HEV	B-SPEC
in	O
the	O
cell	O
bodies	O
of	O
infected	O
neurons	O
budded	O
from	O
endoplasmic	O
reticulum	O
-	O
Golgi	O
intermediate	O
compartments	O
,	O
and	O
were	O
assembled	O
either	O
individually	O
within	O
small	O
vesicles	O
or	O
in	O
groups	O
within	O
large	O
vesicles	O
.	O

ABSTRACT	O
:	O
The	O
pandemic	O
of	O
the	O
swine	B-SPEC
-	O
origin	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
S	O
-	O
OIV	O
)	O
in	O
2009	O
demonstrated	O
severe	O
viral	O
pneumonia	O
followed	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Like	O
many	O
other	O
human	B-SPEC
and	O
animal	B-SPEC
viruses	B-SPEC
,	O
coronavirus	B-SPEC
infection	O
of	O
mammalian	B-SPEC
cells	O
induces	O
apoptosis	O
.	O

Treatment	O
of	O
sepsis	B-SPEC
patients	O
with	O
CMT	O
-	O
3	O
could	O
significantly	O
reduce	O
progression	O
from	O
sepsis	B-SPEC
into	O
ARDS	O
.	O

Pandemic	O
(	O
swine	B-SPEC
)	O
influenza	O
was	O
readily	O
transmitted	O
between	O
people	O
,	O
including	O
young	O
adults	O
,	O
and	O
caused	O
severe	O
illness	O
in	O
high	O
-	O
risk	O
groups	O
including	O
pregnant	O
women	O
,	O
children	O
,	O
and	O
those	O
with	O
co	O
-	O
morbidities	O
and	O
obesity	O
.	O

Based	O
on	O
that	O
event	O
,	O
the	O
World	O
Health	O
Organization	O
recommended	O
that	O
research	O
be	O
implemented	O
to	O
define	O
modes	O
of	O
transmission	O
of	O
SARS	O
coronavirus	B-SPEC
through	O
sewage	O
,	O
feces	O
,	O
food	O
and	O
water	O
.	O

Environmental	O
studies	O
have	O
shown	O
that	O
animal	B-SPEC
coronaviruses	O
remain	O
infectious	O
in	O
water	O
and	O
sewage	O
for	O
up	O
to	O
a	O
year	O
depending	O
on	O
the	O
temperature	O
and	O
humidity	O
.	O

For	O
BCV	B-SPEC
,	O
this	O
association	O
was	O
significant	O
also	O
when	O
accounting	O
for	O
herd	O
size	O
and	O
regional	O
cattle	B-SPEC
density	O
,	O
but	O
not	O
for	O
BRSV	B-SPEC
.	O

Then	O
we	O
discuss	O
its	O
molecular	O
epidemiology	O
and	O
diagnosis	O
,	O
what	O
vaccines	O
are	O
available	O
,	O
and	O
how	O
PEDV	B-SPEC
can	O
be	O
treated	O
.	O

TITLE	O
:	O
Discovery	O
of	O
seven	O
novel	O
Mammalian	B-SPEC
and	O
avian	B-SPEC
coronaviruses	O
in	O
the	O
genus	B-SPEC
deltacoronavirus	O
supports	O
bat	B-SPEC
coronaviruses	O
as	O
the	O
gene	O
source	O
of	O
alphacoronavirus	B-SPEC
and	O
betacoronavirus	B-SPEC
and	O
avian	B-SPEC
coronaviruses	O
as	O
the	O
gene	O
source	O
of	O
gammacoronavirus	B-SPEC
and	O
deltacoronavirus	O
.	O

Clinically	O
,	O
ARDS	O
can	O
be	O
divided	O
into	O
ARDS	O
due	O
to	O
direct	O
causes	O
such	O
as	O
pneumonia	O
,	O
aspiration	O
or	O
injurious	O
ventilation	O
,	O
and	O
due	O
to	O
extrapulmonary	O
indirect	O
causes	O
such	O
as	O
sepsis	B-SPEC
,	O
severe	O
burns	O
or	O
pancreatitis	O
.	O

PCR	O
was	O
used	O
to	O
look	O
for	O
common	O
respiratory	O
viruses	B-SPEC
(	O
parainfluenza	O
1	O
,	O
2	O
,	O
and	O
3	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
[	O
RSV	B-SPEC
];	O
human	B-SPEC
metapneumovirus	I-SPEC
[	O
hMPV	B-SPEC
];	O
adenovirus	B-SPEC
[	O
ADV	O
];	O
rhinovirus	B-SPEC
;	O
coronavirus	B-SPEC
;	O
bocavirus	B-SPEC
[	O
BoV	O
];	O
cytomegalovirus	B-SPEC
[	O
CMV	B-SPEC
];	O
and	O
influenza	O
A	O
and	O
B	O
).	O

No	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
any	O
of	O
the	O
samples	O
.	O

RESULTS	O
:	O
No	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
any	O
of	O
the	O
samples	O
.	O

TITLE	O
:	O
Eculizumab	O
safely	O
reverses	O
neurologic	O
impairment	O
and	O
eliminates	O
need	O
for	O
dialysis	B-SPEC
in	O
severe	O
atypical	O
hemolytic	O
uremic	O
syndrome	O
.	O

TITLE	O
:	O
Mechanisms	O
of	O
host	O
receptor	O
adaptation	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Numerous	O
mutations	O
have	O
been	O
identified	O
in	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
different	O
SARS	O
-	O
CoV	O
strains	O
isolated	O
from	O
humans	B-SPEC
or	O
civets	B-SPEC
.	O

The	O
human	B-SPEC
-	O
optimized	O
RBD	O
contains	O
all	O
of	O
the	O
hACE2	O
-	O
adapted	O
residues	O
(	O
Phe	O
-	O
442	O
,	O
Phe	O
-	O
472	O
,	O
Asn	O
-	O
479	O
,	O
Asp	O
-	O
480	O
,	O
and	O
Thr	O
-	O
487	O
)	O
and	O
possesses	O
exceptionally	O
high	O
affinity	O
for	O
hACE2	O
but	O
relative	O
low	O
affinity	O
for	O
cACE2	O
.	O

ABSTRACT	O
:	O
This	O
prospective	O
study	O
evaluated	O
seroepidemiologic	O
features	O
of	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
),	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
),	O
and	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
infections	O
in	O
dogs	B-SPEC
in	O
an	O
urban	O
humane	O
shelter	O
and	O
in	O
rural	O
/	O
small	O
community	O
dog	B-SPEC
populations	O
in	O
western	O
Canada	O
.	O

TITLE	O
:	O
Synthesis	O
and	O
antiviral	O
evaluation	O
of	O
7	O
-	O
O	O
-	O
arylmethylquercetin	O
derivatives	O
against	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
)	O
and	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
).	O

TITLE	O
:	O
A	O
novel	O
full	O
-	O
length	O
isoform	O
of	O
murine	B-SPEC
pregnancy	O
-	O
specific	O
glycoprotein	O
16	O
(	O
psg16	O
)	O
is	O
expressed	O
in	O
the	O
brain	O
but	O
does	O
not	O
mediate	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
MHV	B-SPEC
)	O
entry	O
.	O

ABSTRACT	O
:	O
The	O
mouse	B-SPEC
pregnancy	O
-	O
specific	O
glycoprotein	O
16	O
(	O
PSG16	O
)	O
has	O
been	O
reported	O
to	O
be	O
an	O
alternative	O
receptor	O
for	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
some	O
strains	O
of	O
which	O
cause	O
encephalitis	O
in	O
mice	B-SPEC
lacking	O
the	O
canonical	O
receptor	O
CEACAM1a	O
.	O

TITLE	O
:	O
Enhancement	O
of	O
anti	O
-	O
murine	B-SPEC
colon	O
cancer	B-SPEC
immunity	O
by	O
fusion	O
of	O
a	O
SARS	O
fragment	O
to	O
a	O
low	O
-	O
immunogenic	O
carcinoembryonic	O
antigen	O
.	O

RESULTS	O
:	O
To	O
enhance	O
the	O
immune	O
efficiency	O
of	O
CEA	B-SPEC
in	O
mice	B-SPEC
that	O
received	O
,	O
we	O
fused	O
a	O
partial	O
CEA	B-SPEC
gene	O
with	O
exogenous	O
SARS	O
-	O
CoV	O
fragments	O
.	O

In	O
young	O
children	O
,	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
infection	O
is	O
associated	O
with	O
a	O
high	O
rate	O
of	O
febrile	O
seizures	O
(	O
50	O
%).	O

Although	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
was	O
not	O
identified	O
in	O
any	O
of	O
the	O
studied	O
animals	B-SPEC
,	O
a	O
coronavirus	B-SPEC
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
(	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
)	O
was	O
identified	O
in	O
23	O
(	O
19	O
%)	O
of	O
118	O
wild	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

TITLE	O
:	O
Virus	B-SPEC
-	O
infected	O
alveolar	O
epithelial	O
cells	O
direct	O
neutrophil	O
chemotaxis	O
and	O
inhibit	O
their	O
apoptosis	O
.	O

ABSTRACT	O
:	O
A	O
new	O
human	B-SPEC
coronavirus	I-SPEC
responsible	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
identified	O
in	O
2003	O
,	O
which	O
raised	O
concern	O
about	O
coronaviruses	O
as	O
agents	O
of	O
serious	O
infectious	O
disease	O
.	O

The	O
better	O
stability	O
of	O
SARS	O
coronavirus	B-SPEC
at	O
low	O
temperature	O
and	O
low	O
humidity	O
environment	O
may	O
facilitate	O
its	O
transmission	O
in	O
community	O
in	O
subtropical	O
area	O
(	O
such	O
as	O
Hong	O
Kong	O
)	O
during	O
the	O
spring	O
and	O
in	O
air	O
-	O
conditioned	O
environments	O
.	O

Here	O
we	O
show	O
that	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
NL63	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
CoV	O
papain	O
-	O
like	O
proteases	O
(	O
PLP	O
)	O
antagonize	O
innate	O
immune	O
signaling	O
mediated	O
by	O
STING	O
(	O
stimulator	O
of	O
interferon	O
genes	O
,	O
also	O
known	O
as	O
MITA	O
/	O
ERIS	B-SPEC
/	O
MYPS	O
).	O

Since	O
2002	O
,	O
when	O
20	O
cats	B-SPEC
on	O
the	O
Falkland	O
Islands	O
were	O
found	O
to	O
be	O
FCoV	O
seronegative	O
,	O
only	O
seronegative	O
cats	B-SPEC
could	O
be	O
imported	O
.	O

Between	O
2005	O
-	O
2007	O
,	O
95	O
pet	O
and	O
10	O
feral	O
cats	B-SPEC
tested	O
negative	O
by	O
indirect	O
immunofluorescence	O
antibody	O
(	O
IFA	O
)	O
analysis	O
using	O
two	O
strains	O
of	O
type	O
II	O
FCoV	O
,	O
two	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
assays	O
,	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
and	O
rapid	O
immunomigration	O
test	O
.	O

This	O
failure	O
was	O
associated	O
with	O
reduced	O
numbers	O
and	O
functionality	O
of	O
LCMV	B-SPEC
-	O
specific	O
CD4	O
(+)	O
helper	O
T	O
cells	O
and	O
impaired	O
antiviral	O
CD8	O
(+)	O
T	O
-	O
cell	O
responses	O
.	O

In	O
contrast	O
,	O
mice	B-SPEC
with	O
pDC	O
-	O
specific	O
loss	O
of	O
MHC	O
class	B-SPEC
II	O
expression	O
supported	O
normal	O
CD4	O
(+)	O
T	O
-	O
cell	O
response	O
to	O
LCMV	B-SPEC
.	O

To	O
the	O
knowledge	O
of	O
the	O
authors	O
,	O
this	O
is	O
the	O
first	O
reported	O
case	O
in	O
the	O
veterinary	O
literature	O
of	O
an	O
ascending	O
flaccid	O
paralysis	O
,	O
consistent	O
with	O
Mojave	O
toxin	O
,	O
developing	O
after	O
an	O
envenomation	O
by	O
a	O
Southern	B-SPEC
Pacific	I-SPEC
rattlesnake	I-SPEC
.	O

Two	O
patients	O
were	O
treated	O
with	O
veno	O
-	O
arterial	O
(	O
V	O
-	O
A	O
)	O
ECMO	O
for	O
severe	O
heart	O
failure	O
,	O
and	O
7	O
with	O
veno	O
-	O
venous	O
(	O
V	O
-	O
V	O
)	O
ECMO	O
due	O
to	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
ARDS	O
caused	O
by	O
2009	O
novel	O
H1N1	O
virus	B-SPEC
infection	O
.	O

We	O
present	O
here	O
the	O
2	O
.	O
6	O
-	O
	O
crystal	O
structure	O
of	O
the	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
Nsp7	O
:	O
Nsp8	O
complex	O
,	O
which	O
is	O
a	O
2	O
:	O
1	O
heterotrimer	O
containing	O
two	O
copies	O
of	O
the	O
	O
-	O
helical	O
Nsp7	O
with	O
conformational	O
differences	O
between	O
them	O
,	O
and	O
one	O
copy	O
of	O
Nsp8	O
that	O
consists	O
of	O
an	O
	O
/	O
	O
domain	O
and	O
a	O
long	O
-	O
	O
-	O
helix	O
domain	O
.	O

ABSTRACT	O
:	O
A	O
male	O
ferret	B-SPEC
,	O
which	O
was	O
purchased	O
from	O
abroad	O
at	O
9	O
months	O
of	O
age	O
,	O
had	O
shown	O
significant	O
weight	O
loss	O
starting	O
at	O
13	O
months	O
of	O
age	O
.	O

The	O
ferret	B-SPEC
subsequently	O
showed	O
decreasing	O
motor	O
activity	O
and	O
recumbency	O
and	O
was	O
euthanized	O
at	O
14	O
months	O
of	O
age	O
.	O

Parvovirus	B-SPEC
-	O
infected	O
patients	O
also	O
showed	O
significantly	O
lower	O
leukocyte	O
and	O
erythrocyte	O
counts	O
as	O
well	O
as	O
hematocrit	O
,	O
total	O
protein	O
,	O
and	O
albumin	O
levels	O
compared	O
to	O
all	O
other	O
groups	O
.	O

All	O
ECMO	O
cases	O
with	O
severe	O
ARDS	O
associated	O
with	O
novel	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
were	O
analyzed	O
in	O
5	O
intensive	O
care	O
units	O
(	O
ICUs	O
)	O
from	O
5	O
different	O
hospitals	O
in	O
Beijing	O
and	O
Tianjin	O
.	O

TITLE	O
:	O
Diagnostics	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
antigen	O
using	O
chicken	B-SPEC
immunoglobulin	O
Y	O
.	O
ABSTRACT	O
:	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
develop	O
a	O
quantitative	O
detection	O
system	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
targeting	O
the	O
nucleocapsid	O
protein	O
(	O
NP	O
),	O
to	O
determine	O
the	O
presence	O
and	O
degree	O
of	O
infection	O
in	O
suspected	O
individuals	O
.	O

In	O
SARS	O
-	O
CoV	O
homologous	O
rechallenge	O
studies	O
,	O
11	O
of	O
the	O
12	O
animals	B-SPEC
were	O
free	O
of	O
replicating	O
virus	B-SPEC
at	O
day	O
5	O
after	O
rechallenge	O
.	O

ABSTRACT	O
:	O
Increasing	O
data	O
indicate	O
that	O
bats	B-SPEC
harbor	O
diverse	O
viruses	B-SPEC
,	O
some	O
of	O
which	O
cause	O
severe	O
human	B-SPEC
diseases	O
.	O

ABSTRACT	O
:	O
	O
-	O
Defensins	O
are	O
cyclic	O
octadecapeptides	O
found	O
in	O
nonhuman	O
primates	B-SPEC
whose	O
broad	O
antiviral	O
spectrum	O
includes	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	O
).	O

ABSTRACT	O
:	O
Recent	O
research	O
has	O
shown	O
that	O
Coronavirus	B-SPEC
(	O
CoV	O
)	O
replication	O
depends	O
on	O
active	O
immunophilin	O
pathways	O
.	O

Examination	O
of	O
faecal	O
samples	O
of	O
healthy	O
young	O
cats	B-SPEC
,	O
organ	O
samples	O
of	O
perished	O
animals	B-SPEC
,	O
which	O
suffered	O
from	O
feline	B-SPEC
infectious	O
peritonitis	O
,	O
and	O
cat	B-SPEC
leukocytes	O
from	O
uncertain	O
clinical	O
cases	O
were	O
also	O
subjected	O
to	O
the	O
assay	O
.	O

ABSTRACT	O
:	O
This	O
work	O
investigates	O
the	O
formulation	O
and	O
in	O
vivo	O
efficacy	O
of	O
dendritic	O
cell	O
(	O
DC	O
)	O
targeted	O
plasmid	O
DNA	O
loaded	O
biotinylated	O
chitosan	O
nanoparticles	O
for	O
nasal	O
immunization	O
against	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
as	O
antigen	O
.	O

ABSTRACT	O
:	O
Foreign	O
experience	O
with	O
empirical	O
management	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
due	O
to	O
coronavirus	B-SPEC
,	O
genotype	O
IV	O
is	O
described	O
.	O

TITLE	O
:	O
Binding	O
of	O
the	O
5	O
'-	O
untranslated	O
region	O
of	O
coronavirus	B-SPEC
RNA	O
to	O
zinc	O
finger	O
CCHC	O
-	O
type	O
and	O
RNA	O
-	O
binding	O
motif	O
1	O
enhances	O
viral	O
replication	O
and	O
transcription	O
.	O

MADP1	O
was	O
found	O
to	O
be	O
translocated	O
to	O
the	O
cytoplasm	O
and	O
partially	O
co	O
-	O
localized	O
with	O
the	O
viral	O
replicase	O
/	O
transcriptase	O
complexes	O
(	O
RTCs	O
)	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
,	O
deviating	O
from	O
its	O
usual	O
nuclear	O
localization	O
in	O
a	O
normal	O
cell	O
using	O
indirect	O
immunofluorescence	O
.	O

This	O
article	O
briefly	O
reviews	O
the	O
clinical	O
significance	O
of	O
newly	O
discovered	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Treatment	O
of	O
sepsis	B-SPEC
and	O
ARDS	O
with	O
extracorporeal	O
membrane	O
oxygenation	O
and	O
interventional	O
lung	O
assist	O
membrane	O
ventilator	O
in	O
a	O
patient	O
with	O
acute	O
lymphoblastic	O
leukemia	O
.	O

She	O
developed	O
Staphylococcus	B-SPEC
epidermidis	I-SPEC
bacteremia	O
,	O
severe	O
sepsis	B-SPEC
,	O
septic	O
shock	O
,	O
and	O
ARDS	O
following	O
chemotherapy	O
-	O
induced	O
severe	O
bone	O
marrow	O
failure	O
.	O

Host	O
proteins	O
that	O
are	O
strongly	O
targeted	O
by	O
a	O
virus	B-SPEC
seem	O
to	O
be	O
particularly	O
attractive	O
for	O
other	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
bocavirus	I-SPEC
infections	O
in	O
hospitalized	O
Greek	O
children	O
.	O

ABSTRACT	O
:	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
(	O
MP	O
),	O
the	O
smallest	O
self	O
-	O
replicating	O
biological	O
system	O
,	O
is	O
a	O
common	O
cause	O
of	O
upper	O
and	O
lower	O
respiratory	O
tract	O
infections	O
,	O
leading	O
to	O
a	O
wide	O
range	O
of	O
pulmonary	O
and	O
extra	O
-	O
pulmonary	O
manifestations	O
.	O

TITLE	O
:	O
The	O
SARS	O
-	O
like	O
coronaviruses	O
:	O
the	O
role	O
of	O
bats	B-SPEC
and	O
evolutionary	O
relationships	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

In	O
the	O
last	O
few	O
years	O
,	O
it	O
has	O
been	O
discovered	O
that	O
the	O
association	O
between	O
coronaviruses	O
and	O
bats	B-SPEC
is	O
a	O
worldwide	O
phenomenon	O
,	O
and	O
it	O
has	O
been	O
hypothesised	O
that	O
all	O
mammalian	B-SPEC
coronaviruses	O
were	O
derived	O
from	O
ancestral	O
viruses	B-SPEC
residing	O
in	O
bats	B-SPEC
.	O

However	O
,	O
one	O
patient	O
died	O
of	O
adenovirus	B-SPEC
(	O
AdV	O
)	O
pneumonia	O
with	O
pulmonary	O
hemorrhage	O
;	O
the	O
mortality	O
rate	O
of	O
RV	O
infection	O
within	O
28	O
d	O
after	O
HSCT	O
was	O
0	O
.	O
57	O
%.	O

TITLE	O
:	O
Differential	O
domain	O
structure	O
stability	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
.	O

ABSTRACT	O
:	O
Papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
is	O
one	O
of	O
the	O
two	O
proteases	O
involved	O
in	O
the	O
proteolytic	O
processing	O
of	O
the	O
virion	O
polyproteins	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
novel	O
Betacoronavirus	B-SPEC
subgroup	O
A	O
coronavirus	B-SPEC
,	O
rabbit	B-SPEC
coronavirus	B-SPEC
HKU14	O
,	O
from	O
domestic	B-SPEC
rabbits	I-SPEC
.	O

RbCoV	O
HKU14	O
also	O
possessed	O
genomic	O
features	O
distinct	O
from	O
those	O
of	O
other	O
Betacoronavirus	B-SPEC
subgroup	O
A	O
coronaviruses	O
,	O
including	O
a	O
unique	O
NS2a	O
region	O
with	O
a	O
variable	O
number	O
of	O
small	O
open	O
reading	O
frames	O
(	O
ORFs	O
).	O

Antibody	O
against	O
RbCoV	O
was	O
detected	O
in	O
20	O
(	O
67	O
%)	O
of	O
30	O
rabbit	B-SPEC
sera	O
tested	O
by	O
an	O
N	O
-	O
protein	O
-	O
based	O
Western	O
blot	O
assay	O
,	O
whereas	O
neutralizing	O
antibody	O
was	O
detected	O
in	O
1	O
of	O
these	O
20	O
rabbits	B-SPEC
.	O

The	O
patient	O
signalment	O
of	O
382	O
FIP	O
confirmed	O
cases	O
were	O
compared	O
with	O
the	O
Companion	O
Animal	B-SPEC
Register	O
of	O
NSW	O
and	O
the	O
general	O
cat	B-SPEC
population	O
of	O
Sydney	O
.	O

Younger	O
cats	B-SPEC
were	O
significantly	O
over	O
-	O
represented	O
among	O
FIP	O
cases	O
.	O

Domestic	O
crossbred	O
,	O
Persian	O
and	O
Himalayan	O
cats	B-SPEC
were	O
significantly	O
under	O
-	O
represented	O
in	O
the	O
FIP	O
cohort	O
,	O
while	O
several	O
breeds	O
were	O
over	O
-	O
represented	O
,	O
including	O
British	O
Shorthair	O
,	O
Devon	O
Rex	O
and	O
Abyssinian	O
.	O

TITLE	O
:	O
Ameliorative	O
effect	O
of	O
a	O
microbial	O
feed	O
additive	O
on	O
infectious	O
bronchitis	O
virus	B-SPEC
antibody	O
titer	O
and	O
stress	O
index	O
in	O
broiler	O
chicks	O
fed	O
deoxynivalenol	O
.	O

Deoxynivalenol	O
affected	O
the	O
blood	O
biochemistry	O
,	O
whereas	O
plasma	O
total	O
protein	O
and	O
uric	O
acid	O
concentrations	O
in	O
birds	B-SPEC
fed	O
contaminated	O
grains	O
were	O
decreased	O
compared	O
with	O
those	O
of	O
the	O
controls	O
.	O

It	O
was	O
concluded	O
that	O
broiler	O
performance	O
and	O
some	O
blood	O
and	O
immunological	O
parameters	O
were	O
adversely	O
affected	O
by	O
feeding	O
diets	O
contaminated	O
with	O
the	O
Fusarium	B-SPEC
mycotoxin	O
DON	O
.	O

TITLE	O
:	O
Development	O
and	O
application	O
of	O
one	O
-	O
step	O
multiplex	O
reverse	O
transcription	O
PCR	O
for	O
simultaneous	O
detection	O
of	O
five	O
diarrheal	O
viruses	B-SPEC
in	O
adult	O
cattle	B-SPEC
.	O

The	O
detection	O
limit	O
of	O
the	O
one	O
-	O
step	O
multiplex	O
RT	O
-	O
PCR	O
for	O
GAR	O
,	O
GCR	O
,	O
BCV	B-SPEC
,	O
and	O
BToV	O
was	O
10	O
(	O
2	O
),	O
10	O
(	O
0	O
),	O
10	O
(	O
1	O
),	O
and	O
10	O
(	O
2	O
)	O
TCID	O
(	O
50	O
)/	O
ml	O
,	O
respectively	O
,	O
and	O
that	O
for	O
GBR	O
was	O
10	O
(	O
6	O
)	O
copies	O
/	O
ml	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
find	O
new	O
molecules	O
for	O
antiviral	O
drug	O
design	O
,	O
we	O
screened	O
102	O
ethyl	O
acetate	O
extracts	O
from	O
New	O
-	O
Caledonian	O
flora	O
for	O
antiviral	O
activity	O
against	O
the	O
dengue	O
2	O
virus	B-SPEC
RNA	O
-	O
dependant	O
RNA	O
polymerase	O
(	O
DV	O
-	O
NS5	O
RdRp	O
).	O

The	O
leaf	O
extract	O
of	O
Dacrydium	B-SPEC
balansae	I-SPEC
,	O
which	O
strongly	O
inhibited	O
the	O
DV	O
-	O
NS5	O
,	O
was	O
submitted	O
to	O
bioguided	O
fractionation	O
.	O

Although	O
the	O
original	O
outbreak	O
was	O
controlled	O
by	O
classical	O
public	O
health	O
measures	O
,	O
there	O
is	O
a	O
real	O
risk	O
that	O
another	O
SARS	O
-	O
CoV	O
could	O
re	O
-	O
emerge	O
from	O
its	O
natural	O
reservoir	O
,	O
either	O
in	O
its	O
original	O
form	O
or	O
as	O
a	O
more	O
virulent	O
or	O
pathogenic	O
strain	O
;	O
in	O
which	O
case	O
,	O
the	O
virus	B-SPEC
would	O
be	O
difficult	O
to	O
control	O
in	O
the	O
absence	O
of	O
any	O
effective	O
antiviral	O
drugs	O
or	O
vaccines	O
.	O

The	O
SARS	O
-	O
CoV	O
genome	O
was	O
cloned	O
in	O
separate	O
vaccinia	B-SPEC
virus	I-SPEC
vectors	O
,	O
(	O
vSARS	O
-	O
CoV	O
-	O
5prime	O
and	O
vSARS	O
-	O
CoV	O
-	O
3prime	O
)	O
as	O
two	O
cDNAs	O
that	O
were	O
subsequently	O
ligated	O
to	O
create	O
a	O
genome	O
-	O
length	O
SARS	O
-	O
CoV	O
cDNA	O
template	O
for	O
in	O
vitro	O
transcription	O
of	O
SARS	O
-	O
CoV	O
infectious	O
RNA	O
transcripts	O
.	O

Using	O
this	O
approach	O
,	O
we	O
demonstrate	O
that	O
,	O
in	O
contrast	O
to	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
SARS	O
-	O
CoV	O
is	O
not	O
able	O
to	O
mediate	O
efficient	O
heterologous	O
gene	O
expression	O
in	O
hDCs	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
presence	O
of	O
viral	O
pathogens	O
in	O
natural	O
areas	O
a	O
survey	O
was	O
conducted	O
on	O
an	O
opportunistic	O
sample	O
of	O
fifty	O
eight	O
wild	O
(	O
Felis	B-SPEC
silvestris	I-SPEC
silvestris	I-SPEC
)	O
and	O
feral	O
cats	B-SPEC
(	O
F	O
.	O
s	B-SPEC
.	I-SPEC
catus	I-SPEC
).	O

A	O
total	O
of	O
67	O
common	O
biological	O
pathways	O
were	O
identified	O
among	O
the	O
seven	O
different	O
respiratory	O
viruses	B-SPEC
analyzed	O
,	O
representing	O
fifteen	O
laboratories	O
,	O
nine	O
different	O
cell	O
types	O
,	O
and	O
seven	O
different	O
array	O
platforms	O
.	O

Our	O
study	O
suggests	O
that	O
multiple	O
and	O
diverse	O
respiratory	O
viruses	B-SPEC
invoke	O
several	O
common	O
host	O
response	O
pathways	O
.	O

RESULTS	O
:	O
Increased	O
expressions	O
of	O
KCTD9	O
mRNA	O
was	O
observed	O
in	O
livers	O
of	O
both	O
model	O
mice	B-SPEC
of	O
fulminant	O
viral	O
hepatitis	O
and	O
chronic	O
hepatitis	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
virulent	O
respiratory	O
infectious	O
diseases	O
such	O
as	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
and	O
Influenza	O
A	O
/	O
H1N1	O
viruses	B-SPEC
predisposes	O
nurses	O
to	O
occupational	O
risks	O
.	O

Compared	O
with	O
256	O
patients	O
without	O
pneumonia	O
,	O
these	O
195	O
patients	O
with	O
pneumonia	O
were	O
more	O
likely	O
to	O
be	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
52	O
%	O
vs	O
16	O
%),	O
have	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
;	O
26	O
%	O
vs	O
2	O
%),	O
have	O
sepsis	B-SPEC
(	O
18	O
%	O
vs	O
3	O
%),	O
and	O
die	O
(	O
17	O
%	O
vs	O
2	O
%;	O
P	O
<	O
.	O
0001	O
).	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
strain	O
DF	O
-	O
2	O
and	O
studies	O
of	O
the	O
role	O
of	O
ORF3abc	O
in	O
viral	O
cell	O
tropism	O
.	O

TITLE	O
:	O
Emerging	O
zoonotic	O
viruses	B-SPEC
:	O
new	O
lessons	O
on	O
receptor	O
and	O
entry	O
mechanisms	O
.	O

TITLE	O
:	O
Mass	O
extinctions	O
,	O
biodiversity	O
and	O
mitochondrial	O
function	O
:	O
are	O
bats	B-SPEC
'	O
special	O
'	O
as	O
reservoirs	O
for	O
emerging	O
viruses	B-SPEC
?	O

ABSTRACT	O
:	O
For	O
the	O
past	O
10	O
-	O
15	O
years	O
,	O
bats	B-SPEC
have	O
attracted	O
growing	O
attention	O
as	O
reservoirs	O
of	O
emerging	O
zoonotic	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Comparison	O
of	O
three	O
diagnostic	O
techniques	O
for	O
detection	O
of	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
in	O
calf	O
faeces	O
in	O
Australia	O
.	O

ABSTRACT	O
:	O
Compare	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
),	O
a	O
commercially	O
available	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
and	O
lateral	O
flow	O
immunochromatography	O
assay	O
(	O
LAT	O
)	O
for	O
the	O
detection	O
of	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
in	O
faecal	O
samples	O
collected	O
from	O
diarrhoeic	O
calves	O
.	O

A	O
subset	O
of	O
samples	O
was	O
screened	O
using	O
qRT	O
-	O
PCR	O
,	O
ELISA	O
and	O
a	O
commercial	O
LAT	O
dipstick	O
(	O
132	O
faecal	O
samples	O
were	O
tested	O
for	O
coronavirus	B-SPEC
and	O
122	O
samples	O
for	O
rotavirus	B-SPEC
).	O

ABSTRACT	O
:	O
We	O
investigated	O
the	O
clinical	O
impact	O
of	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
)	O
OC43	O
,	O
229E	O
,	O
HKU1	O
and	O
NL63	O
in	O
pediatric	O
patients	O
with	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
during	O
routine	O
and	O
exacerbation	O
visits	O
.	O

The	O
proteomic	O
alterations	O
described	O
here	O
may	O
suggest	O
that	O
these	O
changes	O
to	O
protein	O
expression	O
correlate	O
with	O
IBV	B-SPEC
virus	B-SPEC
'	O
virulence	O
in	O
chicken	B-SPEC
,	O
hence	O
provides	O
valuable	O
insights	O
into	O
the	O
interactions	O
of	O
IBV	B-SPEC
with	O
its	O
host	O
and	O
may	O
also	O
assist	O
with	O
investigations	O
of	O
the	O
pathogenesis	O
of	O
IBV	B-SPEC
and	O
other	O
coronavirus	B-SPEC
infections	O
.	O

Here	O
we	O
review	O
recent	O
genetic	O
advances	O
that	O
have	O
questioned	O
traditional	O
wisdom	O
regarding	O
the	O
origins	O
of	O
virulent	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
diseases	O
,	O
the	O
pathogenic	O
potential	O
of	O
Feline	B-SPEC
Immunodeficiency	I-SPEC
Virus	I-SPEC
(	O
FIV	B-SPEC
)	O
in	O
wild	O
non	O
-	O
domestic	O
Felidae	B-SPEC
species	B-SPEC
,	O
and	O
the	O
restriction	O
of	O
Feline	B-SPEC
Leukemia	I-SPEC
Virus	I-SPEC
(	O
FeLV	O
)	O
mediated	O
immune	O
impairment	O
to	O
domestic	B-SPEC
cats	I-SPEC
rather	O
than	O
other	O
Felidae	B-SPEC
species	B-SPEC
.	O

The	O
mean	O
HI	O
titres	O
to	O
ND	O
vaccine	O
was	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
lower	O
in	O
the	O
toxin	O
groups	O
at	O
all	O
the	O
intervals	O
,	O
and	O
the	O
antibody	O
titres	O
in	O
IBV	B-SPEC
infected	O
group	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
higher	O
than	O
that	O
of	O
T	O
-	O
2	O
toxin	O
fed	O
and	O
co	O
-	O
infected	O
with	O
IBV	B-SPEC
group	O
but	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
lower	O
than	O
the	O
control	O
at	O
21	O
(	O
3	O
)	O
and	O
28	O
(	O
10	O
)	O
days	O
of	O
toxin	O
feeding	O
(	O
DTF	O
)	O
(	O
days	O
post	O
infection	O
(	O
DPI	O
)).	O

Because	O
of	O
the	O
persistent	O
threat	O
from	O
the	O
A	O
/	O
H5N1	O
virus	B-SPEC
since	O
1997	O
and	O
the	O
outbreak	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
in	O
2003	O
,	O
medical	O
and	O
scientific	O
communities	O
have	O
been	O
more	O
prepared	O
in	O
mindset	O
and	O
infrastructure	O
.	O

A	O
PubMed	O
search	O
using	O
the	O
keywords	O
""""	O
pandemic	O
influenza	B-SPEC
virus	I-SPEC
H1N1	O
2009	O
""""	O
yielded	O
over	O
2	O
,	O
500	O
publications	O
,	O
which	O
markedly	O
exceeded	O
the	O
number	O
published	O
on	O
previous	O
pandemics	O
.	O

Nine	O
compounds	O
showed	O
activity	O
against	O
BVDV	B-SPEC
(	O
EC	O
(	O
50	O
)	O
=	O
0	O
.	O
8	O
-	O
8	O
.	O
0	O
M	O
),	O
compound	O
31	O
being	O
the	O
most	O
potent	O
(	O
EC	O
(	O
50	O
)	O
=	O
0	O
.	O
80	O
M	O
)	O
and	O
selective	O
(	O
SI	O
=	O
CC	O
(	O
50	O
)/	O
EC	O
(	O
50	O
)	O
=	O
>	O
100	O
).	O

Further	O
studies	O
are	O
needed	O
to	O
determine	O
why	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
malaria	O
is	O
becoming	O
more	O
severe	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
(	O
PHE	O
)	O
is	O
caused	O
by	O
the	O
coronavirus	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHE	O
-	O
CoV	O
),	O
and	O
the	O
recent	O
,	O
rapid	O
spread	O
of	O
PHE	O
-	O
CoV	O
in	O
piglets	O
from	O
many	O
countries	O
emphasizes	O
the	O
urgent	O
need	O
for	O
a	O
PHE	O
-	O
CoV	O
vaccine	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
define	O
a	O
pathological	O
fecal	O
score	O
for	O
weaning	O
puppies	O
,	O
and	O
to	O
study	O
the	O
impact	O
on	O
that	O
score	O
of	O
two	O
intestinal	O
viruses	B-SPEC
(	O
canine	O
parvovirus	B-SPEC
type	O
2	O
and	O
canine	O
coronavirus	B-SPEC
).	O

The	O
partial	O
S	O
gene	O
and	O
complete	O
M	O
gene	O
were	O
amplified	O
from	O
PEDV	B-SPEC
-	O
positive	O
strains	O
by	O
RT	O
-	O
PCR	O
,	O
cloned	O
,	O
sequenced	O
and	O
compared	O
with	O
each	O
other	O
,	O
as	O
well	O
as	O
with	O
the	O
reference	O
strains	O
in	O
GenBank	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
commercial	O
rapid	O
test	O
kit	O
for	O
detecting	O
bovine	B-SPEC
enteric	O
pathogens	O
in	O
feces	O
.	O

In	O
comparison	O
to	O
mrtPCR	O
,	O
the	O
diagnostic	O
sensitivity	O
of	O
Bovine	B-SPEC
Enterichek	O
was	O
60	O
.	O
0	O
%,	O
42	O
.	O
3	O
%,	O
71	O
.	O
4	O
%,	O
and	O
81	O
.	O
5	O
%,	O
and	O
the	O
diagnostic	O
specificity	O
was	O
51	O
.	O
4	O
%,	O
100	O
%,	O
100	O
%,	O
and	O
98	O
.	O
6	O
%	O
for	O
BCV	B-SPEC
-	O
1	O
,	O
RV	O
-	O
A	O
,	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
(	O
+	O
),	O
and	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
,	O
respectively	O
.	O

Vaccination	O
of	O
mice	B-SPEC
with	O
recombinant	O
S450	O
-	O
650	O
(	O
rS450	O
-	O
650	O
)	O
can	O
induce	O
Abs	O
against	O
SARS	O
-	O
CoV	O
,	O
although	O
the	O
titer	O
is	O
relatively	O
low	O
.	O

In	O
the	O
present	O
study	O
,	O
a	O
fusion	O
protein	O
linking	O
a	O
fragment	O
(	O
residues	O
39	O
-	O
272	O
)	O
of	O
murine	B-SPEC
calreticulin	O
(	O
CRT	O
)	O
to	O
S450	O
-	O
650	O
in	O
a	O
prokaryotic	O
expression	O
system	O
was	O
created	O
.	O

Moreover	O
,	O
the	O
serum	O
of	O
mice	B-SPEC
immunized	O
with	O
LAB	O
displaying	O
divalent	O
antigens	O
had	O
much	O
stronger	O
immune	O
reactivity	O
against	O
ARV	O
C	O
protein	O
compared	O
to	O
IBV	B-SPEC
-	O
S1	O
.	O

A	O
new	O
scorpion	B-SPEC
venom	O
peptide	O
derivative	O
Kn2	O
-	O
7	O
was	O
identified	O
as	O
the	O
most	O
potent	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
peptide	O
by	O
screening	O
assays	O
with	O
an	O
EC	O
(	O
50	O
)	O
value	O
of	O
2	O
.	O
76	O
g	O
/	O
ml	O
(	O
1	O
.	O
65	O
M	O
)	O
and	O
showed	O
low	O
cytotoxicity	O
to	O
host	O
cells	O
with	O
a	O
selective	O
index	O
(	O
SI	O
)	O
of	O
13	O
.	O
93	O
.	O

TITLE	O
:	O
Immunization	O
with	O
SARS	O
coronavirus	B-SPEC
vaccines	O
leads	O
to	O
pulmonary	O
immunopathology	O
on	O
challenge	O
with	O
the	O
SARS	O
virus	B-SPEC
.	O

Caution	O
in	O
proceeding	O
to	O
application	O
of	O
a	O
SARS	O
-	O
CoV	O
vaccine	O
in	O
humans	B-SPEC
is	O
indicated	O
.	O

Here	O
we	O
review	O
a	O
number	O
of	O
association	O
studies	O
,	O
compare	O
inflammatory	O
shock	O
data	O
from	O
gene	O
knockout	O
studies	O
in	O
mice	B-SPEC
and	O
provide	O
some	O
insights	O
from	O
recent	O
investigations	O
with	O
inhibitors	O
of	O
MMPs	O
.	O

Gross	O
lesions	O
and	O
histological	O
changes	O
were	O
mainly	O
evident	O
in	O
the	O
gut	O
and	O
lymphoid	O
tissues	O
,	O
although	O
some	O
animals	B-SPEC
showed	O
remarkable	O
changed	O
also	O
in	O
parenchymatous	O
organs	O
.	O

There	O
are	O
currently	O
four	O
commercially	O
available	O
vaccines	O
in	O
Australia	O
to	O
protect	O
chickens	B-SPEC
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

An	O
in	O
vivo	O
investigation	O
involved	O
5	O
groups	O
of	O
20	O
chickens	B-SPEC
each	O
and	O
found	O
that	O
VicS	O
-	O
del	O
grew	O
to	O
a	O
significantly	O
lesser	O
extent	O
in	O
the	O
chicken	B-SPEC
tissues	O
collected	O
than	O
did	O
VicS	O
-	O
v	O
.	O

These	O
results	O
indicate	O
the	O
potential	O
for	O
a	O
cooperative	O
,	O
instead	O
of	O
an	O
expected	O
competitive	O
,	O
relationship	O
between	O
VicS	O
-	O
v	O
and	O
VicS	O
-	O
del	O
to	O
infect	O
a	O
host	O
,	O
which	O
is	O
reminiscent	O
of	O
RNA	O
viral	O
quasi	O
-	O
species	B-SPEC
.	O

Common	O
causes	O
of	O
RV	O
failure	O
include	O
left	O
ventricular	O
(	O
LV	O
)	O
failure	O
,	O
RV	O
infarction	O
,	O
sepsis	B-SPEC
,	O
cor	O
pulmonale	O
due	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pulmonary	O
emboli	O
,	O
or	O
pulmonary	O
hypertension	O
.	O

TITLE	O
:	O
Palmitoylation	O
of	O
virus	B-SPEC
proteins	O
.	O

TITLE	O
:	O
A	O
human	B-SPEC
coronavirus	I-SPEC
responsible	O
for	O
the	O
common	O
cold	O
massively	O
kills	O
dendritic	O
cells	O
but	O
not	O
monocytes	O
.	O

Here	O
,	O
we	O
show	O
that	O
both	O
HAT	O
and	O
TMPRSS2	O
are	O
coexpressed	O
with	O
2	O
,	O
6	O
-	O
linked	O
sialic	O
acids	O
,	O
the	O
major	O
receptor	O
determinant	O
of	O
human	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
throughout	O
the	O
human	B-SPEC
respiratory	O
tract	O
.	O

The	O
present	O
results	O
confirm	O
a	O
significant	O
diversity	O
of	O
CoVs	O
circulating	O
in	O
Kenya	O
bats	B-SPEC
.	O

We	O
searched	O
PubMed	O
,	O
EMBASE	O
,	O
MEDLINE	O
,	O
CINAHL	O
,	O
the	O
Cochrane	O
Library	O
,	O
University	O
of	O
York	O
CRD	O
databases	O
,	O
EuroScan	O
,	O
LILACS	B-SPEC
,	O
Indian	O
Medlars	B-SPEC
,	O
Index	O
Medicus	O
for	O
SE	O
Asia	O
,	O
international	O
health	O
technology	O
agencies	O
and	O
the	O
Internet	O
in	O
all	O
languages	O
for	O
articles	O
from	O
01	O
/	O
01	O
/	O
1990	O
to	O
22	O
/	O
10	O
/	O
2010	O
.	O

Chickens	B-SPEC
exhibited	O
mild	O
respiratory	O
signs	O
and	O
depression	O
.	O

We	O
also	O
examined	O
how	O
the	O
membrane	O
topology	O
of	O
IBV	B-SPEC
E	O
affected	O
its	O
function	O
by	O
generating	O
mutant	O
versions	O
that	O
adopted	O
either	O
a	O
transmembrane	O
or	O
membrane	O
hairpin	O
topology	O
.	O

We	O
found	O
that	O
a	O
transmembrane	O
topology	O
was	O
required	O
for	O
disrupting	O
the	O
secretory	O
pathway	O
,	O
but	O
was	O
less	O
efficient	O
for	O
virus	B-SPEC
-	O
like	O
particle	O
production	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
pathogenesis	O
:	O
host	O
innate	O
immune	O
responses	O
and	O
viral	O
antagonism	O
of	O
interferon	O
.	O

While	O
none	O
of	O
the	O
compounds	O
,	O
examined	O
in	O
our	O
study	O
inhibited	O
the	O
DNA	O
unwinding	O
activity	O
or	O
ATPase	O
activity	O
of	O
human	B-SPEC
HCV	B-SPEC
helicase	O
protein	O
,	O
we	O
found	O
that	O
myricetin	O
and	O
scutellarein	O
potently	O
inhibit	O
the	O
SARS	O
-	O
CoV	O
helicase	O
protein	O
in	O
vitro	O
by	O
affecting	O
the	O
ATPase	O
activity	O
,	O
but	O
not	O
the	O
unwinding	O
activity	O
,	O
nsP13	O
.	O

ABSTRACT	O
:	O
Acylguanidines	O
are	O
a	O
new	O
class	B-SPEC
of	O
antiviral	O
compounds	O
with	O
the	O
unique	O
ability	O
to	O
target	O
both	O
RNA	O
polymerase	O
and	O
transmembrane	O
proteins	O
of	O
viruses	B-SPEC
from	O
different	O
families	O
.	O

BIT225	O
,	O
developed	O
by	O
Biotron	O
Limited	O
,	O
is	O
the	O
first	O
acylguanidine	O
in	O
clinical	O
trials	O
against	O
HIV	B-SPEC
type	O
1	O
and	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Many	O
viruses	B-SPEC
are	O
known	O
to	O
cause	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
);	O
however	O
,	O
in	O
nearly	O
50	O
%	O
of	O
patients	O
,	O
the	O
etiologic	O
agent	O
remains	O
unknown	O
.	O

All	O
patient	O
samples	O
were	O
tested	O
for	O
influenza	B-SPEC
virus	I-SPEC
,	O
and	O
286	O
negative	O
nasal	O
swabs	O
were	O
tested	O
further	O
for	O
18	O
other	O
respiratory	O
viruses	B-SPEC
using	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

This	O
study	O
found	O
that	O
many	O
respiratory	O
viruses	B-SPEC
circulated	O
during	O
this	O
period	O
and	O
that	O
the	O
A	O
/	O
H1N1p	O
did	O
not	O
impact	O
on	O
the	O
kinetics	O
of	O
other	O
respiratory	O
viruses	B-SPEC
.	O

The	O
danger	O
of	O
TOPC	O
virus	B-SPEC
latent	O
circulation	O
among	O
wild	O
animals	B-SPEC
in	O
China	O
requires	O
research	O
of	O
new	O
efficient	O
medical	O
agents	O
for	O
protection	O
of	O
the	O
people	O
from	O
the	O
pathogen	O
in	O
the	O
Russian	O
Federation	O
.	O

We	O
focus	O
on	O
receptors	O
and	O
proteases	O
in	O
prompting	O
entry	O
and	O
highlight	O
the	O
type	O
II	O
transmembrane	O
serine	O
proteases	O
(	O
TTSPs	O
)	O
known	O
to	O
activate	O
several	O
virus	B-SPEC
fusion	O
proteins	O
.	O

An	O
etiological	O
study	O
of	O
adult	O
community	O
-	O
acquired	O
pneumonia	O
was	O
carried	O
out	O
prospectively	O
at	O
Beijing	O
Chao	B-SPEC
-	O
Yang	O
Hospital	O
.	O

Efficient	O
replication	O
of	O
CCoV	O
-	O
A76	O
is	O
restricted	O
to	O
canine	O
cell	O
lines	O
,	O
in	O
contrast	O
to	O
the	O
prototypical	O
type	O
II	O
strain	O
CCoV	O
-	O
1	O
-	O
71	O
that	O
more	O
efficiently	O
replicates	O
in	O
feline	B-SPEC
cells	O
.	O

Moreover	O
,	O
the	O
adjuvanticity	O
of	O
rOv	O
-	O
ASP	O
-	O
1	O
was	O
retained	O
with	O
an	O
efficacy	O
similar	O
to	O
that	O
obtained	O
when	O
it	O
was	O
used	O
for	O
a	O
first	O
vaccination	O
,	O
even	O
though	O
a	O
high	O
level	O
of	O
anti	O
-	O
rOv	O
-	O
ASP	O
-	O
1	O
antibodies	O
was	O
present	O
in	O
the	O
sera	O
of	O
mice	B-SPEC
before	O
the	O
administration	O
of	O
the	O
second	O
vaccine	O
.	O

In	O
virus	B-SPEC
-	O
infected	O
cells	O
,	O
MHV	B-SPEC
nsp15	O
distributed	O
unevenly	O
throughout	O
the	O
cytoplasm	O
but	O
predominantly	O
in	O
the	O
perinuclear	O
region	O
.	O

Collectively	O
these	O
results	O
thus	O
underscore	O
the	O
differential	O
biochemical	O
and	O
biological	O
functions	O
among	O
the	O
nsp15s	O
of	O
MHV	B-SPEC
,	O
TGEV	B-SPEC
and	O
SARS	O
-	O
CoV	O
in	O
host	O
cells	O
.	O

BTLA	O
-	O
deficient	O
(	O
BTLA	O
-/-)	O
mice	B-SPEC
and	O
their	O
wild	O
-	O
type	O
littermates	O
were	O
infected	O
with	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
-	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
),	O
and	O
the	O
levels	O
of	O
tissue	O
damage	O
,	O
cell	O
apoptosis	O
,	O
serum	O
liver	O
enzymes	O
,	O
fibrinogen	O
-	O
like	O
protein	O
2	O
(	O
FGL2	O
)	O
and	O
cytokine	O
production	O
were	O
measured	O
and	O
compared	O
.	O

Transfer	O
of	O
GKO	O
memory	O
CD4	O
+	O
T	O
cells	O
into	O
infected	O
SCID	O
mice	B-SPEC
induced	O
rapid	O
mortality	O
compared	O
to	O
recipients	O
of	O
WT	O
memory	O
CD4	O
+	O
T	O
cells	O
,	O
despite	O
similar	O
virus	B-SPEC
control	O
and	O
demyelination	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
,	O
a	O
highly	O
contagious	O
enteric	O
disease	O
of	O
swine	B-SPEC
.	O

Animals	B-SPEC
were	O
examined	O
for	O
T	O
lymphocyte	O
proliferation	O
,	O
anti	O
-	O
PEDV	B-SPEC
antibodies	O
,	O
IFN	O
-	O
	O
and	O
IL	O
-	O
4	O
protein	O
levels	O
,	O
and	O
cytotoxic	O
T	O
cell	O
function	O
in	O
mouse	B-SPEC
peripheral	O
blood	O
and	O
spleen	O
.	O

This	O
was	O
further	O
complicated	O
by	O
a	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
.	O

TITLE	O
:	O
A	O
real	O
-	O
time	O
PCR	O
assay	O
for	O
bat	B-SPEC
SARS	O
-	O
like	O
coronavirus	B-SPEC
detection	O
and	O
its	O
application	O
to	O
Italian	O
greater	B-SPEC
horseshoe	I-SPEC
bat	I-SPEC
faecal	O
sample	O
surveys	O
.	O

TITLE	O
:	O
Short	O
peptides	O
derived	O
from	O
the	O
interaction	O
domain	O
of	O
SARS	O
coronavirus	B-SPEC
nonstructural	O
protein	O
nsp10	O
can	O
suppress	O
the	O
2	O
'-	O
O	O
-	O
methyltransferase	O
activity	O
of	O
nsp10	O
/	O
nsp16	O
complex	O
.	O

Parenteral	O
nutrition	O
,	O
respiratory	O
support	O
with	O
a	O
ventilator	O
,	O
antibiotics	O
for	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
steroid	O
therapeutics	O
for	O
nephropathy	O
,	O
deeper	O
debridement	O
for	O
wounds	O
,	O
and	O
skin	O
grafting	O
were	O
applied	O
for	O
treatment	O
of	O
this	O
patient	O
.	O

This	O
different	O
antigenic	O
phenotype	O
was	O
also	O
confirmed	O
by	O
a	O
neutralizing	O
test	O
with	O
clinically	O
isolated	O
human	B-SPEC
sera	O
.	O

TITLE	O
:	O
Purification	O
,	O
crystallization	O
and	O
preliminary	O
X	O
-	O
ray	B-SPEC
analysis	O
of	O
nonstructural	O
protein	O
2	O
(	O
nsp2	O
)	O
from	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

DIC	O
is	O
also	O
seen	O
in	O
association	O
with	O
toxic	O
exposures	O
,	O
including	O
snake	B-SPEC
bites	O
.	O

TITLE	O
:	O
Neurotropic	O
virus	B-SPEC
tracing	O
suggests	O
a	O
membranous	O
-	O
coating	O
-	O
mediated	O
mechanism	O
for	O
transsynaptic	O
communication	O
.	O

ABSTRACT	O
:	O
	O
-	O
Defensins	O
,	O
the	O
only	O
cyclic	O
peptides	O
of	O
animal	B-SPEC
origin	O
,	O
have	O
been	O
isolated	O
from	O
the	O
leukocytes	O
of	O
rhesus	B-SPEC
macaques	I-SPEC
and	O
baboons	B-SPEC
.	O

To	O
fill	O
this	O
gap	O
,	O
we	O
analysed	O
entire	O
proteomes	O
of	O
3484	O
species	B-SPEC
from	O
three	O
domains	O
of	O
life	O
(	O
archaea	B-SPEC
,	O
bacteria	B-SPEC
and	O
eukaryotes	B-SPEC
)	O
and	O
from	O
viruses	B-SPEC
.	O

For	O
both	O
the	O
prokaryotes	B-SPEC
and	O
eukaryotes	B-SPEC
,	O
the	O
disorder	O
content	O
is	O
generally	O
independent	O
of	O
the	O
proteome	O
size	O
.	O

TITLE	O
:	O
Antagonism	O
of	O
the	O
interferon	O
-	O
induced	O
OAS	O
-	O
RNase	O
L	O
pathway	O
by	O
murine	B-SPEC
coronavirus	I-SPEC
ns2	O
protein	O
is	O
required	O
for	O
virus	B-SPEC
replication	O
and	O
liver	O
pathology	O
.	O

ABSTRACT	O
:	O
Many	O
viruses	B-SPEC
induce	O
hepatitis	O
in	O
humans	B-SPEC
,	O
highlighting	O
the	O
need	O
to	O
understand	O
the	O
underlying	O
mechanisms	O
of	O
virus	B-SPEC
-	O
induced	O
liver	O
pathology	O
.	O

Feline	B-SPEC
coronaviruses	O
occur	O
as	O
2	O
pathotypes	O
:	O
nonvirulent	O
feline	B-SPEC
enteric	O
coronaviruses	O
(	O
FECVs	O
),	O
which	O
replicate	O
in	O
intestinal	O
epithelium	O
cells	O
,	O
and	O
lethal	O
feline	B-SPEC
infectious	O
peritonitis	O
viruses	B-SPEC
(	O
FIPVs	O
),	O
which	O
replicate	O
in	O
macrophages	O
.	O

Evidence	O
indicates	O
that	O
FIPV	O
originates	O
from	O
FECV	B-SPEC
by	O
mutation	O
,	O
but	O
consistent	O
distinguishing	O
differences	O
have	O
not	O
been	O
established	O
.	O

We	O
investigated	O
whether	O
cellular	O
ACE2	O
downregulation	O
occurs	O
at	O
optimal	O
replication	O
conditions	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

In	O
this	O
study	O
,	O
we	O
detected	O
4	O
non	O
-	O
SARS	O
related	O
HCoV	O
species	B-SPEC
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
in	O
981	O
nasopharyngeal	O
swabs	O
collected	O
from	O
March	O
2009	O
to	O
February	O
2011	O
.	O

Undifferentiated	O
human	B-SPEC
rhinoviruses	B-SPEC
and	O
influenza	O
(	O
Flu	O
)	O
A	O
were	O
the	O
most	O
common	O
viruses	B-SPEC
detected	O
(	O
more	O
than	O
35	O
%)	O
in	O
HCoV	O
co	O
-	O
infections	O
.	O

All	O
4	O
non	O
-	O
SARS	O
-	O
associated	O
HCoVs	O
were	O
more	O
frequently	O
detected	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
in	O
adults	O
with	O
URTI	O
in	O
Beijing	O
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
led	O
to	O
the	O
most	O
prevalent	O
infection	O
.	O

ABSTRACT	O
:	O
Ebolavirus	B-SPEC
causes	O
severe	O
hemorrhagic	O
fever	O
in	O
humans	B-SPEC
and	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
.	O

PTX3	O
-	O
deficient	O
mice	B-SPEC
(	O
129	O
/	O
SvEv	O
/	O
C57BL6	O
/	O
J	O
)	O
and	O
their	O
wild	O
-	O
type	O
(	O
WT	O
)	O
littermates	O
were	O
intranasally	O
infected	O
MHV	B-SPEC
-	O
1	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
,	O
caused	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
for	O
which	O
there	O
are	O
no	O
approved	O
treatments	O
.	O

TITLE	O
:	O
Liver	O
TCR	O
(+)	O
CD3	O
(+)	O
CD4	O
(-)	O
CD8	O
(-)	O
T	O
cells	O
contribute	O
to	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
3	O
-	O
induced	O
hepatic	O
injury	O
through	O
a	O
TNF	O
-	O
	O
-	O
dependent	O
pathway	O
.	O

We	O
demonstrate	O
that	O
predominant	O
population	O
of	O
DN	O
T	O
cells	O
in	O
the	O
liver	O
of	O
healthy	O
or	O
MHV	B-SPEC
-	O
3	O
-	O
infected	O
mice	B-SPEC
express	O
TCR	O
(+).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
is	O
not	O
only	O
a	O
poor	O
inducer	O
of	O
type	O
I	O
interferon	O
but	O
also	O
inhibits	O
the	O
efficient	O
induction	O
of	O
type	O
I	O
interferon	O
by	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
synthetic	O
dsRNA	O
molecules	O
,	O
Poly	O
I	O
:	O
C	O
.	O
However	O
,	O
the	O
mechanistic	O
basis	O
by	O
which	O
PRRSV	B-SPEC
interferes	O
with	O
the	O
induction	O
of	O
type	O
I	O
interferon	O
in	O
its	O
natural	O
host	O
cells	O
remains	O
less	O
well	O
defined	O
.	O

The	O
purposes	O
of	O
this	O
review	O
are	O
to	O
summarize	O
the	O
key	O
findings	O
in	O
supporting	O
the	O
post	O
-	O
transcriptional	O
control	O
of	O
type	O
I	O
interferon	O
in	O
its	O
natural	O
host	O
cells	O
and	O
to	O
propose	O
the	O
possible	O
role	O
of	O
translational	O
control	O
in	O
the	O
regulation	O
of	O
type	O
I	O
interferon	O
induction	O
by	O
PRRSV	B-SPEC
.	O

nTregs	O
develop	O
in	O
the	O
thymus	B-SPEC
and	O
function	O
in	O
maintaining	O
peripheral	O
immune	O
tolerance	O
.	O

Coronaviruses	O
(	O
CoVs	O
)	O
are	O
single	O
-	O
stranded	O
,	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
that	O
cause	O
acute	O
and	O
chronic	O
infections	O
and	O
can	O
productively	O
infect	O
macrophages	O
.	O

Nineteen	O
deaths	O
occurred	O
,	O
13	O
of	O
which	O
had	O
a	O
cytomegalovirus	B-SPEC
viral	O
load	O
	O
log	O
4	O
.	O

High	O
-	O
flow	O
nasal	O
cannula	B-SPEC
O	O
(	O
2	O
)	O
therapy	O
appears	O
to	O
be	O
an	O
innovative	O
and	O
effective	O
modality	O
for	O
early	O
treatment	O
of	O
adults	O
with	O
SARI	O
.	O

While	O
parasites	O
often	O
relate	O
to	O
very	O
specific	O
animal	B-SPEC
hosts	O
and	O
contribute	O
significantly	O
to	O
the	O
human	B-SPEC
disease	O
burden	O
,	O
virus	B-SPEC
have	O
often	O
been	O
related	O
to	O
major	O
,	O
well	O
-	O
published	O
global	O
outbreaks	O
,	O
e	O
.	O
g	O
.	O
SARS	O
and	O
avian	B-SPEC
-	O
and	O
swine	B-SPEC
-	O
influenza	O
.	O

ABSTRACT	O
:	O
Clinical	O
information	O
regarding	O
murine	B-SPEC
typhus	O
in	O
Taiwan	O
is	O
limited	O
.	O

ABSTRACT	O
:	O
Severe	O
disease	O
attributable	O
to	O
Plasmodium	B-SPEC
vivax	I-SPEC
infection	O
is	O
already	O
well	O
described	O
worldwide	O
;	O
however	O
,	O
autopsies	O
in	O
these	O
patients	O
are	O
scarce	O
.	O

In	O
13	O
of	O
17	O
deceased	O
patients	O
,	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
was	O
the	O
plausible	O
cause	O
of	O
death	O
.	O

Since	O
replication	O
of	O
the	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
is	O
impaired	O
upon	O
proteasomal	O
inhibition	O
,	O
the	O
relevance	O
of	O
the	O
UPS	O
for	O
the	O
replication	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
investigated	O
in	O
this	O
study	O
.	O

TITLE	O
:	O
Cleistanthus	B-SPEC
collinus	O
poisoning	O
.	O

MEDLINE	O
(	O
PUBMED	O
)	O
and	O
Google	O
were	O
searched	O
for	O
published	O
papers	O
using	O
the	O
search	O
/	O
MeSH	O
terms	O
""""	O
Cleistanthus	B-SPEC
collinus	O
","""	O
""""	O
Euphorbiaceae	B-SPEC
","""	O
""""	O
Diphyllin	O
","""	O
""""	O
Cleistanthin	O
A	O
","""	O
Cleistanthin	O
B	O
""""	O
and	O
""""	O
Oduvanthalai	O
.	O

Consumption	O
of	O
decoctions	O
of	O
C	B-SPEC
.	I-SPEC
collinus	I-SPEC
leaves	O
,	O
hypokalemia	O
,	O
renal	O
failure	O
,	O
severe	O
metabolic	O
acidosis	O
,	O
ARDS	O
and	O
cardiac	O
arrhythmias	O
occur	O
in	O
severe	O
poisonings	O
and	O
predict	O
mortality	O
.	O

We	O
hypothesize	O
that	O
Cordyceps	B-SPEC
has	O
beneficial	O
effects	O
on	O
lung	O
fibrosis	O
and	O
the	O
objective	O
of	O
this	O
study	O
is	O
to	O
explore	O
the	O
target	O
(	O
s	O
)	O
of	O
Cordyceps	B-SPEC
in	O
the	O
relief	O
of	O
lung	O
fibrosis	O
in	O
animal	B-SPEC
and	O
cell	O
models	O
and	O
to	O
gain	O
insight	O
into	O
its	O
underlying	O
mechanisms	O
.	O

This	O
epithelial	O
-	O
mesenchymal	O
transition	O
could	O
be	O
partially	O
reverted	O
by	O
cordycepin	O
,	O
a	O
major	O
component	O
of	O
Cordyceps	B-SPEC
.	O

RESULTS	O
:	O
Reduction	O
of	O
infiltration	O
of	O
inflammatory	O
cells	O
,	O
deposition	O
of	O
fibroblastic	O
loci	O
and	O
collagen	O
,	O
formation	O
of	O
reactive	O
oxygen	O
species	B-SPEC
,	O
and	O
production	O
of	O
cytokines	O
,	O
as	O
well	O
as	O
recovery	O
from	O
imbalance	O
of	O
MMP	O
-	O
9	O
/	O
TIMP	O
-	O
1	O
,	O
were	O
observed	O
in	O
fibrotic	O
rats	B-SPEC
after	O
treatment	O
with	O
Cordyceps	B-SPEC
in	O
preventive	O
(	O
from	O
the	O
day	O
of	O
BLM	O
administration	O
)	O
and	O
therapeutic	O
(	O
from	O
14	O
days	O
after	O
BLM	O
)	O
regimens	O
.	O

The	O
clinical	O
outcome	O
measures	O
included	O
the	O
mortality	O
rate	O
at	O
28th	O
day	O
,	O
respiratory	O
index	O
(	O
FiO2	O
/	O
PO2	O
),	O
dynamic	O
lung	O
compliance	O
(	O
Cdyn	O
),	O
arterial	O
partial	O
pressure	O
of	O
oxygen	O
(	O
PaO2	O
),	O
arterial	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
(	O
PaCO2	O
),	O
mechanical	O
ventilation	O
parameters	O
,	O
vasoactive	O
drug	O
dose	O
and	O
lung	O
X	O
-	O
ray	B-SPEC
changes	O
.	O

TITLE	O
:	O
Positive	O
predictive	O
value	O
of	O
albumin	O
:	O
globulin	O
ratio	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
in	O
a	O
mid	O
-	O
western	O
referral	O
hospital	O
population	O
.	O

Other	O
enteropathogens	O
identified	O
in	O
cats	B-SPEC
with	O
and	O
without	O
diarrhea	O
included	O
Clostridium	B-SPEC
perfringens	I-SPEC
enterotoxin	O
A	O
(	O
42	O
%	O
and	O
50	O
%,	O
respectively	O
),	O
Cryptosporidium	B-SPEC
spp	O
(	O
10	O
%	O
and	O
20	O
%,	O
respectively	O
),	O
Giardia	B-SPEC
spp	O
(	O
20	O
%	O
and	O
8	O
%,	O
respectively	O
),	O
Cystoisospora	B-SPEC
spp	O
(	O
14	O
%	O
and	O
10	O
%,	O
respectively	O
),	O
hookworms	B-SPEC
(	O
10	O
%	O
and	O
18	O
%,	O
respectively	O
),	O
ascarids	O
(	O
6	O
%	O
and	O
16	O
%,	O
respectively	O
),	O
Salmonella	B-SPEC
spp	O
(	O
6	O
%	O
and	O
4	O
%,	O
respectively	O
),	O
astrovirus	O
(	O
8	O
%	O
and	O
2	O
%,	O
respectively	O
),	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
(	O
4	O
%	O
and	O
4	O
%,	O
respectively	O
),	O
calicivirus	O
(	O
0	O
%	O
and	O
2	O
%,	O
respectively	O
),	O
and	O
Spirometra	B-SPEC
spp	O
(	O
0	O
%	O
and	O
2	O
%,	O
respectively	O
).	O

Only	O
Clostridium	B-SPEC
perfringens	I-SPEC
enterotoxin	O
A	O
gene	O
was	O
significantly	O
more	O
common	O
in	O
dogs	B-SPEC
with	O
diarrhea	O
(	O
64	O
%)	O
than	O
in	O
dogs	B-SPEC
with	O
normal	O
feces	O
(	O
40	O
%).	O

Other	O
enteropathogens	O
identified	O
in	O
dogs	B-SPEC
with	O
and	O
without	O
diarrhea	O
included	O
hookworms	B-SPEC
(	O
58	O
%	O
and	O
48	O
%,	O
respectively	O
),	O
Giardia	B-SPEC
spp	O
(	O
22	O
%	O
and	O
16	O
%,	O
respectively	O
),	O
canine	O
enteric	B-SPEC
coronavirus	I-SPEC
(	O
2	O
%	O
and	O
18	O
%,	O
respectively	O
),	O
whipworms	O
(	O
12	O
%	O
and	O
8	O
%,	O
respectively	O
),	O
Cryptosporidium	B-SPEC
spp	O
(	O
12	O
%	O
and	O
2	O
%,	O
respectively	O
),	O
ascarids	O
(	O
8	O
%	O
and	O
8	O
%,	O
respectively	O
),	O
Salmonella	B-SPEC
spp	O
(	O
2	O
%	O
and	O
6	O
%,	O
respectively	O
),	O
Cystoisospora	B-SPEC
spp	O
(	O
2	O
%	O
and	O
4	O
%,	O
respectively	O
),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
8	O
%	O
and	O
0	O
%,	O
respectively	O
),	O
Dipylidium	B-SPEC
caninum	I-SPEC
(	O
2	O
%	O
and	O
2	O
%,	O
respectively	O
),	O
canine	O
parvovirus	B-SPEC
(	O
2	O
%	O
and	O
2	O
%,	O
respectively	O
),	O
and	O
rotavirus	B-SPEC
(	O
2	O
%	O
and	O
0	O
%,	O
respectively	O
).	O

TITLE	O
:	O
Clinical	O
features	O
of	O
the	O
hospitalized	O
patients	O
with	O
2009	O
pandemic	O
influenza	O
A	O
(	O
H1N1	O
)	O
in	O
Santa	O
Fe	O
,	O
Argentina	B-SPEC
.	O

TITLE	O
:	O
Antiviral	O
activity	O
of	O
zinc	O
salts	O
against	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Zinc	O
has	O
been	O
shown	O
to	O
mediate	O
antiviral	O
effects	O
against	O
certain	O
viruses	B-SPEC
.	O

The	O
results	O
of	O
the	O
study	O
suggest	O
that	O
zinc	O
salts	O
do	O
not	O
interfere	O
with	O
TGEV	B-SPEC
-	O
cell	O
binding	O
but	O
that	O
they	O
mediate	O
antiviral	O
effects	O
through	O
inhibition	O
of	O
viral	O
penetration	O
or	O
egress	O
or	O
the	O
intracellular	O
phase	O
of	O
the	O
viral	O
life	O
-	O
cycle	O
.	O

Although	O
an	O
NMR	O
-	O
based	O
model	O
for	O
the	O
TM	O
domain	O
of	O
the	O
E	O
protein	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
E	O
)	O
has	O
been	O
reported	O
,	O
structural	O
data	O
and	O
biophysical	O
studies	O
of	O
full	O
length	O
E	O
proteins	O
are	O
not	O
available	O
because	O
efficient	O
expression	O
and	O
purification	O
methods	O
for	O
these	O
proteins	O
are	O
lacking	O
.	O

ABSTRACT	O
:	O
The	O
3	O
'	O
proximal	O
one	O
-	O
third	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
encodes	O
the	O
structural	O
proteins	O
and	O
eight	O
accessory	O
proteins	O
,	O
including	O
3a	O
,	O
3b	O
,	O
6	O
,	O
7a	O
,	O
7b	O
,	O
8a	O
,	O
8b	O
and	O
9b	O
,	O
varying	O
in	O
length	O
from	O
39	O
to	O
274aa	O
which	O
do	O
not	O
share	O
significant	O
homology	O
with	O
viral	O
proteins	O
of	O
known	O
coronaviruses	O
.	O

The	O
mortality	O
rate	O
of	O
around	O
20	O
%	O
was	O
similar	O
in	O
severe	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
and	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
mono	O
-	O
infection	O
.	O

AGP	O
-	O
positive	O
leucocytes	O
were	O
found	O
in	O
23	O
%	O
of	O
cats	B-SPEC
.	O

Therefore	O
,	O
the	O
identification	O
of	O
the	O
causative	O
viruses	B-SPEC
and	O
bacteria	B-SPEC
is	O
only	O
feasible	O
using	O
multiplex	O
PCR	O
or	O
several	O
monoplex	B-SPEC
PCR	O
tests	O
in	O
parallel	O
.	O

In	O
winter	O
,	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
32	O
TS	O
samples	O
(	O
64	O
%)	O
by	O
RespiFinder	O
-	O
19	O
,	O
whereas	O
the	O
detection	O
rate	O
with	O
RVP	O
was	O
only	O
22	O
%.	O

The	O
most	O
frequent	O
viruses	B-SPEC
were	O
adenovirus	B-SPEC
(	O
32	O
%)	O
and	O
PIV	O
-	O
2	O
(	O
20	O
%).	O

Analysis	O
of	O
clinical	O
samples	O
showed	O
a	O
high	O
concordance	O
of	O
detected	O
viruses	B-SPEC
by	O
the	O
RespiFinder	O
-	O
19	O
compared	O
to	O
monoplex	B-SPEC
tests	O
.	O

RESULTS	O
:	O
To	O
compare	O
the	O
analytical	O
sensitivity	O
of	O
the	O
multiplex	O
assays	O
,	O
samples	O
were	O
inoculated	O
with	O
13	O
different	O
quantified	O
viruses	B-SPEC
in	O
the	O
range	O
of	O
10	O
(	O
1	O
)	O
to	O
10	O
(	O
5	O
)	O
copies	O
/	O
ml	O
.	O

Western	O
blotting	O
revealed	O
that	O
66	O
.	O
5	O
%	O
of	O
bat	B-SPEC
sera	O
had	O
antibodies	O
to	O
BtCoV	O
.	O
These	O
surveys	O
suggested	O
the	O
endemic	O
presence	O
of	O
BtCoVs	O
in	O
the	O
Philippines	O
.	O

Chickens	B-SPEC
were	O
sacrificed	O
every	O
3	O
days	O
to	O
monitor	O
antigen	O
specific	O
serum	O
IgG	O
and	O
IBV	B-SPEC
nucleoprotein	O
-	O
specific	O
immune	O
responses	O
using	O
a	O
chicken	B-SPEC
MHC	O
I	O
tetramer	O
developed	O
in	O
our	O
laboratory	O
.	O

These	O
data	O
facilitates	O
the	O
design	O
of	O
a	O
new	O
generation	O
of	O
IBV	B-SPEC
vaccine	O
.	O

North	O
Queensland	O
is	O
a	O
high	O
risk	O
area	O
(	O
a	O
health	O
security	O
hot	O
spot	B-SPEC
)	O
for	O
Australia	O
,	O
due	O
in	O
part	O
to	O
its	O
connection	O
to	O
neighbouring	O
countries	O
via	O
the	O
Torres	O
Strait	O
and	O
the	O
Indo	O
-	O
Papuan	O
conduit	O
,	O
its	O
high	O
diversity	O
of	O
wildlife	O
reservoirs	O
and	O
its	O
environmental	O
characteristics	O
.	O

Although	O
biosecurity	O
threats	O
may	O
initially	O
have	O
regional	O
impacts	O
(	O
e	O
.	O
g	O
.	O
Hendra	B-SPEC
virus	I-SPEC
),	O
a	O
break	O
down	O
in	O
security	O
in	O
health	O
security	O
hot	O
spots	B-SPEC
can	O
have	O
national	O
and	O
international	O
consequences	O
,	O
as	O
has	O
been	O
seen	O
recently	O
in	O
other	O
regions	O
with	O
the	O
emergence	O
of	O
SARS	O
and	O
pandemic	O
avian	B-SPEC
influenza	O
.	O

In	O
the	O
present	O
study	O
we	O
reported	O
five	O
cases	O
of	O
multiple	O
respiratory	O
infection	O
in	O
hospitalized	O
immunosuppressed	O
patients	O
:	O
two	O
double	O
infections	O
with	O
influenza	B-SPEC
virus	I-SPEC
(	O
IV	B-SPEC
)	O
type	O
A	O
/	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
type	O
A	O
and	O
IV	B-SPEC
type	O
A	O
/	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
OC43	O
,	O
one	O
infection	O
with	O
four	O
viruses	B-SPEC
-	O
IV	B-SPEC
type	O
A	O
/	O
RSV	B-SPEC
type	O
A	O
and	O
B	O
/	O
CoV	B-SPEC
OC43	O
,	O
and	O
two	O
cases	O
of	O
mixed	O
infections	O
caused	O
by	O
five	O
viral	O
agents	O
-	O
IV	B-SPEC
type	O
A	O
and	O
B	O
/	O
RSV	B-SPEC
type	O
A	O
and	O
B	O
/	O
parainfluenza	O
type	O
3	O
or	O
CoV	B-SPEC
OC43	O
.	O

Several	O
clinical	O
disorders	O
can	O
precipitate	O
ARDS	O
,	O
including	O
pneumonia	O
,	O
sepsis	B-SPEC
,	O
aspiration	O
of	O
gastric	O
contents	O
,	O
and	O
major	O
trauma	O
.	O

CONCLUSIONS	O
:	O
Despite	O
scientific	O
advances	O
,	O
breast	O
milk	O
continues	O
to	O
demonstrate	O
clear	O
advantages	O
for	O
human	B-SPEC
health	O
in	O
the	O
short	O
and	O
long	O
term	O
.	O

ABSTRACT	O
:	O
To	O
prepare	O
and	O
characterize	O
the	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
against	O
N	O
protein	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

TITLE	O
:	O
Nearly	O
constant	O
shedding	O
of	O
diverse	O
enteric	O
viruses	B-SPEC
by	O
two	O
healthy	O
infants	O
.	O

Adenovirus	B-SPEC
,	O
Aichi	B-SPEC
virus	I-SPEC
,	O
Anellovirus	B-SPEC
,	O
Astrovirus	O
,	O
Bocavirus	B-SPEC
,	O
Enterovirus	B-SPEC
,	O
Parechovirus	B-SPEC
,	O
Picobirnavirus	B-SPEC
,	O
and	O
Rotavirus	B-SPEC
were	O
detected	O
.	O

ABSTRACT	O
:	O
The	O
coronaviruses	O
(	O
CoVs	O
)	O
are	O
enveloped	O
viruses	B-SPEC
of	O
animals	B-SPEC
and	O
humans	B-SPEC
associated	O
mostly	O
with	O
enteric	O
and	O
respiratory	O
diseases	O
,	O
such	O
as	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
10	O
-	O
20	O
%	O
of	O
all	O
common	O
colds	O
.	O

We	O
here	O
report	O
the	O
first	O
complete	O
genome	O
sequence	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
strain	O
CBJ	O
037	O
isolated	O
in	O
2008	O
from	O
a	O
patient	O
with	O
bronchitis	O
in	O
Beijing	O
,	O
China	O
.	O

However	O
,	O
monotherapy	O
with	O
NAIs	B-SPEC
is	O
insufficient	O
for	O
severe	O
pneumonia	O
secondary	O
to	O
influenza	B-SPEC
virus	I-SPEC
infection	O
.	O

Therefore	O
,	O
the	O
present	O
study	O
examined	O
whether	O
combination	O
therapy	O
of	O
NAI	O
with	O
exogenous	O
artificial	O
surfactant	O
affects	O
mortality	O
of	O
influenza	B-SPEC
virus	I-SPEC
-	O
infected	O
mice	B-SPEC
.	O

Infected	O
mice	B-SPEC
treated	O
with	O
combination	O
therapy	O
of	O
laninamivir	O
octanoate	O
with	O
artificial	O
surfactant	O
showed	O
a	O
significantly	O
higher	O
survival	O
rate	O
compared	O
with	O
those	O
that	O
received	O
laninamivir	O
octanoate	O
monotherapy	O
(	O
p	O
=	O
0	O
.	O
003	O
).	O

Additionally	O
,	O
the	O
inhibition	O
is	O
selective	O
because	O
these	O
compounds	O
do	O
not	O
exert	O
significant	O
inhibitory	O
effects	O
against	O
other	O
proteases	O
including	O
chymotrysin	O
,	O
papain	O
,	O
and	O
HIV	B-SPEC
protease	O
.	O

TITLE	O
:	O
Contribution	O
of	O
IL	O
-	O
17	O
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
3	O
-	O
induced	O
acute	O
liver	O
failure	O
.	O

ABSTRACT	O
:	O
Unique	O
disorders	O
appear	O
episodically	O
in	O
human	B-SPEC
populations	O
and	O
cause	O
life	O
-	O
threatening	O
systemic	O
or	O
neurological	O
disease	O
.	O

ABSTRACT	O
:	O
We	O
followed	O
changes	O
in	O
a	O
portion	O
of	O
the	O
S1	O
gene	O
sequence	O
of	O
the	O
dominant	O
populations	O
of	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
Arkansas	O
(	O
Ark	O
)	O
vaccine	O
strain	O
during	O
serial	O
passage	O
in	O
chickens	B-SPEC
infected	O
with	O
the	O
immunosuppressive	O
chicken	B-SPEC
anaemia	I-SPEC
virus	I-SPEC
(	O
CAV	B-SPEC
)	O
and	O
/	O
or	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
IBDV	B-SPEC
)	O
as	O
well	O
as	O
in	O
immunocompetent	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Colonisation	O
of	O
conventional	O
weaned	O
pigs	B-SPEC
by	O
enteropathogenic	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
EPEC	O
)	O
and	O
its	O
hazard	O
potential	O
for	O
human	B-SPEC
health	O
.	O

Their	O
pathogenicity	O
for	O
pigs	B-SPEC
has	O
been	O
tested	O
by	O
oral	O
infection	O
of	O
colostrum	O
-	O
deprived	O
newborn	O
,	O
and	O
of	O
severely	O
immunosuppressed	O
weaned	O
pigs	B-SPEC
,	O
but	O
colonisation	O
of	O
conventional	O
weaned	O
pigs	B-SPEC
by	O
porcine	B-SPEC
EPEC	O
has	O
not	O
been	O
experimentally	O
studied	O
.	O

EPEC	O
show	O
similarities	O
to	O
enterohaemorrhagic	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
(	O
EHEC	O
)	O
additionally	O
carrying	O
shiga	O
toxin	O
genes	O
integrated	O
into	O
the	O
chromosome	O
by	O
lambdoid	O
phages	O
.	O

We	O
have	O
demonstrated	O
earlier	O
that	O
the	O
porcine	B-SPEC
EPEC	O
prototype	O
strain	O
P86	O
-	O
1390	O
(	O
O45	O
)	O
could	O
be	O
transduced	O
in	O
vivo	O
(	O
in	O
ligated	O
loops	O
of	O
weaned	O
pigs	B-SPEC
),	O
by	O
Stx2	O
phage	O
derived	O
from	O
a	O
human	B-SPEC
EHEC	O
.	O

To	O
clarify	O
this	O
question	O
,	O
four	O
intragastric	O
infection	O
experiments	O
were	O
performed	O
on	O
a	O
total	O
of	O
95	O
conventional	O
weaned	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
Five	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
were	O
isolated	O
from	O
broiler	O
chickens	B-SPEC
showing	O
respiratory	O
and	O
renal	O
lesions	O
.	O

Surveillance	O
of	O
influenza	O
in	O
swine	B-SPEC
has	O
provided	O
insights	O
into	O
the	O
emergence	O
of	O
the	O
2009	O
pandemic	O
,	O
to	O
the	O
reverse	O
zoonosis	O
of	O
the	O
pandemic	O
virus	B-SPEC
from	O
humans	B-SPEC
to	O
swine	B-SPEC
and	O
to	O
the	O
emergence	O
of	O
novel	O
reassortant	O
viruses	B-SPEC
within	O
swine	B-SPEC
.	O

TITLE	O
:	O
Avian	B-SPEC
coronavirus	I-SPEC
spike	O
glycoprotein	O
ectodomain	O
shows	O
a	O
low	O
codon	O
adaptation	O
to	O
Gallus	B-SPEC
gallus	I-SPEC
with	O
virus	B-SPEC
-	O
exclusive	O
codons	O
in	O
strategic	O
amino	O
acids	O
positions	O
.	O

ABSTRACT	O
:	O
This	O
is	O
a	O
study	O
on	O
the	O
Avian	B-SPEC
coronavirus	I-SPEC
IBV	B-SPEC
and	O
chicken	B-SPEC
host	O
-	O
relationship	O
from	O
the	O
codon	O
usage	O
point	O
of	O
view	O
based	O
on	O
fifty	O
-	O
nine	O
non	O
-	O
redundant	O
IBV	B-SPEC
S1	O
sequences	O
(	O
nt	O
1	O
-	O
507	O
)	O
from	O
strains	O
detected	O
worldwide	O
and	O
chicken	B-SPEC
tissue	O
-	O
specific	O
protein	O
genes	O
sequences	O
from	O
IBV	B-SPEC
-	O
replicating	O
sites	O
.	O

TITLE	O
:	O
Diagnostic	O
accuracy	O
of	O
the	O
Rivalta	O
test	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
calculate	O
sensitivity	O
,	O
specificity	O
,	O
and	O
positive	O
(	O
PPV	B-SPEC
)	O
and	O
negative	O
(	O
NPV	O
)	O
predictive	O
values	O
of	O
the	O
Rivalta	O
test	O
for	O
FIP	O
and	O
to	O
identify	O
correlations	O
between	O
a	O
positive	O
Rivalta	O
test	O
and	O
variables	O
measured	O
in	O
effusion	O
fluid	O
and	O
peripheral	O
blood	O
.	O

Of	O
851	O
cats	B-SPEC
with	O
effusions	O
,	O
782	O
had	O
conclusively	O
positive	O
or	O
negative	O
results	O
for	O
the	O
Rivalta	O
test	O
.	O

A	O
workflow	O
was	O
developed	O
consisting	O
of	O
an	O
optimized	O
fecal	O
nucleic	O
acid	O
purification	O
and	O
multiplex	O
reverse	O
transcription	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
qPCR	O
)	O
for	O
single	O
tube	O
concurrent	O
detection	O
of	O
BCV	B-SPEC
,	O
BRV	O
,	O
and	O
Cryptosporidium	B-SPEC
spp	O
.,	O
and	O
an	O
internal	O
control	O
to	O
monitor	O
nucleic	O
acid	O
purification	O
efficacy	O
and	O
PCR	O
reagent	O
functionality	O
.	O

TITLE	O
:	O
Broad	O
-	O
spectrum	O
antivirals	O
against	O
3C	O
or	O
3C	O
-	O
like	O
proteases	O
of	O
picornaviruses	B-SPEC
,	O
noroviruses	B-SPEC
,	O
and	O
coronaviruses	O
.	O

These	O
viruses	B-SPEC
possess	O
3C	O
or	O
3C	O
-	O
like	O
proteases	O
(	O
3Cpro	O
or	O
3CLpro	O
,	O
respectively	O
),	O
which	O
contain	O
a	O
typical	O
chymotrypsin	O
-	O
like	O
fold	O
and	O
a	O
catalytic	O
triad	O
(	O
or	O
dyad	O
)	O
with	O
a	O
Cys	O
residue	O
as	O
a	O
nucleophile	O
.	O

We	O
report	O
herein	O
the	O
broad	O
-	O
spectrum	O
antiviral	O
activities	O
of	O
three	O
compounds	O
possessing	O
a	O
common	O
dipeptidyl	O
residue	O
with	O
different	O
warheads	O
,	O
i	O
.	O
e	O
.,	O
an	O
aldehyde	O
(	O
GC373	O
),	O
a	O
bisulfite	O
adduct	O
(	O
GC376	O
),	O
and	O
an	O
	O
-	O
ketoamide	O
(	O
GC375	O
),	O
against	O
viruses	B-SPEC
that	O
belong	O
to	O
the	O
supercluster	O
.	O

We	O
also	O
report	O
the	O
high	O
-	O
resolution	O
X	O
-	O
ray	B-SPEC
cocrystal	O
structures	O
of	O
NV	O
3CLpro	O
-,	O
poliovirus	B-SPEC
3Cpro	O
-,	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
3CLpro	O
-	O
GC376	O
inhibitor	O
complexes	O
,	O
which	O
show	O
the	O
compound	O
covalently	O
bound	O
to	O
a	O
nucleophilic	O
Cys	O
residue	O
in	O
the	O
catalytic	O
site	O
of	O
the	O
corresponding	O
protease	O
.	O

To	O
address	O
this	O
age	O
-	O
related	O
susceptibility	O
to	O
SARS	O
-	O
CoV	O
and	O
IAV	O
,	O
we	O
infected	O
C57BL	O
/	O
6	O
(	O
B6	O
)	O
mice	B-SPEC
with	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
MA15	O
)	O
or	O
IAV	O
(	O
PR8	O
),	O
both	O
of	O
which	O
cause	O
severe	O
disease	O
in	O
aged	O
mice	B-SPEC
.	O

Intranasal	O
pretreatment	O
of	O
aged	O
mice	B-SPEC
with	O
poly	O
(	O
I	O
	O
C	O
)	O
(	O
a	O
TLR3	O
agonist	O
)	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
CpG	O
,	O
R848	O
,	O
or	O
lipopolysaccharide	O
(	O
TLR9	O
,	O
TLR7	O
/	O
8	O
,	O
or	O
TLR4	O
agonists	O
),	O
provided	O
a	O
high	O
level	O
of	O
protection	O
[	O
90	O
%	O
to	O
100	O
%	O
survival	O
rate	O
after	O
poly	O
(	O
I	O
	O
C	O
)	O
treatment	O
]	O
against	O
lethal	O
MA15	O
or	O
IAV	O
challenge	O
and	O
reduced	O
pathological	O
changes	O
and	O
virus	B-SPEC
loads	O
in	O
the	O
lungs	O
at	O
early	O
times	O
after	O
infection	O
.	O

30	O
kb	O
as	O
a	O
genome	O
,	O
which	O
is	O
wrapped	O
by	O
the	O
envelope	O
,	O
and	O
constitute	O
Nidovirales	B-SPEC
together	O
with	O
Arteriviridae	B-SPEC
.	O

Coronaviruses	O
have	O
several	O
to	O
more	O
than	O
10	O
different	O
species	B-SPEC
of	O
subgenomic	O
mRNA	O
and	O
generally	O
only	O
the	O
OFR	O
located	O
in	O
the	O
5	O
'	O
end	O
of	O
each	O
mRNA	O
is	O
translated	O
.	O

MCR	O
was	O
orally	O
administered	O
before	O
and	O
after	O
LPS	O
was	O
introduced	O
into	O
rats	B-SPEC
(	O
MCR	O
-	O
LPS	O
group	O
and	O
LPS	O
-	O
MCR	O
group	O
,	O
respectively	O
).	O

Similar	O
to	O
other	O
tropical	O
countries	O
,	O
rhinovirus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
were	O
the	O
principal	O
viral	O
pathogens	O
detected	O
among	O
children	O
hospitalized	O
for	O
lower	O
tract	O
respiratory	O
infection	O
in	O
Cambodia	O
.	O

Four	O
theoretically	O
effective	O
sequences	O
of	O
TGEV	B-SPEC
ORF	O
7	O
gene	O
were	O
designed	O
and	O
selected	O
for	O
construction	O
of	O
shRNA	O
expression	O
plasmids	O
.	O

RESULTS	O
:	O
Four	O
theoretically	O
effective	O
sequences	O
of	O
TGEV	B-SPEC
ORF	O
7	O
gene	O
were	O
designed	O
and	O
selected	O
for	O
construction	O
of	O
shRNA	O
expression	O
plasmids	O
.	O

The	O
purpose	O
of	O
this	O
investigation	O
was	O
to	O
characterize	O
the	O
management	O
and	O
prognosis	O
of	O
severe	O
Pneumocystis	B-SPEC
jirovecii	I-SPEC
pneumonia	O
(	O
PJP	O
)	O
in	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)-	O
negative	O
patients	O
.	O

To	O
investigate	O
possible	O
interspecies	O
transmission	O
between	O
the	O
two	O
bat	B-SPEC
species	B-SPEC
,	O
the	O
complete	O
genomes	O
of	O
two	O
Ro	O
-	O
BatCoV	O
HKU10	O
and	O
six	O
Hi	O
-	O
BatCoV	O
HKU10	O
strains	O
were	O
sequenced	O
.	O

syndrome	O
-	O
related	O
Rhinolophus	B-SPEC
bat	B-SPEC
coronavirus	B-SPEC
(	O
SARSr	O
-	O
CoV	O
)	O
in	O
bats	B-SPEC
and	O
civets	B-SPEC
.	O

This	O
study	O
investigates	O
cytokine	O
expression	O
and	O
proteomic	O
change	O
induced	O
by	O
SARS	O
-	O
CoV	O
PLpro	O
in	O
human	B-SPEC
promonocyte	O
cells	O
.	O

Accordingly	O
,	O
a	O
global	O
movement	O
of	O
'	O
One	O
-	O
Health	O
/	O
One	O
-	O
Medicine	O
'	O
has	O
been	O
launched	O
to	O
foster	O
collaborative	O
efforts	O
amongst	O
animal	B-SPEC
and	O
human	B-SPEC
health	O
officials	O
and	O
researchers	O
to	O
address	O
these	O
problems	O
.	O

Although	O
swine	B-SPEC
are	O
widely	O
recognized	O
as	O
a	O
potential	O
host	O
for	O
generating	O
novel	O
influenza	B-SPEC
viruses	I-SPEC
,	O
and	O
that	O
some	O
of	O
these	O
viruses	B-SPEC
,	O
including	O
pandemic	O
influenza	O
A	O
/	O
H1N1	O
2009	O
,	O
have	O
been	O
shown	O
to	O
be	O
readily	O
transmissible	O
between	O
humans	B-SPEC
and	O
swine	B-SPEC
,	O
only	O
one	O
study	O
was	O
found	O
related	O
to	O
the	O
modelling	O
of	O
influenza	O
spread	O
at	O
the	O
swine	B-SPEC
-	O
human	B-SPEC
interface	O
.	O

The	O
emergence	O
or	O
re	O
-	O
emergence	O
of	O
bacterial	O
(	O
Mycobacterium	B-SPEC
bovis	I-SPEC
and	O
Brucella	B-SPEC
spp	O
)	O
or	O
viral	O
(	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
)	O
infections	O
shows	O
that	O
zoonoses	O
should	O
be	O
considered	O
as	O
emerging	O
risks	O
in	O
agricultural	O
and	O
animal	B-SPEC
breeding	O
and	O
should	O
be	O
addressed	O
by	O
specific	O
preventive	O
interventions	O
.	O

We	O
used	O
mice	B-SPEC
lacking	O
functional	O
receptors	O
for	O
both	O
type	O
I	O
and	O
type	O
III	O
IFN	O
(	O
double	O
knockout	O
,	O
dKO	O
)	O
to	O
evaluate	O
the	O
possibility	O
that	O
type	O
III	O
IFN	O
plays	O
a	O
decisive	O
role	O
in	O
SARS	O
-	O
CoV	O
protection	O
.	O

Using	O
ps20	O
knockout	O
mice	B-SPEC
we	O
provide	O
evidence	O
that	O
intranasal	O
MHV	B-SPEC
-	O
1	O
infection	O
results	O
in	O
increased	O
lung	O
viral	O
titers	O
in	O
ps20	O
(-/-)	O
compared	O
to	O
ps20	O
(+/+)	O
mice	B-SPEC
.	O

No	O
notable	O
differences	O
in	O
other	O
immune	O
cell	O
profiles	O
were	O
observed	O
between	O
the	O
ps20	O
(+/+)	O
and	O
ps20	O
(-/-)	O
mice	B-SPEC
.	O

Accordingly	O
,	O
we	O
examined	O
MHV	B-SPEC
-	O
1	O
infection	O
of	O
neutrophils	O
and	O
provide	O
evidence	O
that	O
neutrophils	O
isolated	O
from	O
ps20	O
(-/-)	O
mice	B-SPEC
are	O
more	O
susceptible	O
to	O
MHV	B-SPEC
-	O
1	O
infection	O
than	O
neutrophils	O
isolated	O
from	O
ps20	O
(+/+)	O
mice	B-SPEC
.	O

RESULTS	O
:	O
The	O
overall	O
rate	O
of	O
DAIs	B-SPEC
was	O
3	O
.	O
03	O
episodes	O
per	O
1000	O
device	O
-	O
days	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
epidemiological	O
and	O
clinical	O
profile	O
of	O
children	O
with	O
Henoch	O
-	O
Schonlein	O
purpura	B-SPEC
(	O
HSP	O
)	O
in	O
eastern	O
Saudi	O
Arabia	O
during	O
a	O
15	O
-	O
year	O
period	O
.	O

TITLE	O
:	O
A	O
framework	O
for	O
the	O
study	O
of	O
zoonotic	O
disease	O
emergence	O
and	O
its	O
drivers	O
:	O
spillover	O
of	O
bat	B-SPEC
pathogens	O
as	O
a	O
case	O
study	O
.	O

ABSTRACT	O
:	O
An	O
outbreak	O
of	O
diarrhea	O
in	O
pigs	B-SPEC
started	O
in	O
Guangdong	O
,	O
South	O
China	O
in	O
January	O
2011	O
.	O

We	O
have	O
used	O
the	O
JHMV	O
-	O
induced	O
demyelination	O
model	O
to	O
evaluate	O
the	O
antigenicity	O
of	O
transplanted	O
allogeneic	O
NPCs	O
within	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
mice	B-SPEC
with	O
established	O
immune	O
-	O
mediated	O
demyelination	O
.	O

Cultured	O
NPCs	O
constitutively	O
expressed	O
the	O
costimulatory	O
molecules	O
CD80	O
/	O
CD86	O
,	O
and	O
IFN	O
-	O
	O
treatment	O
induced	O
expression	O
of	O
MHC	O
class	B-SPEC
I	O
and	O
II	O
antigens	O
.	O

We	O
reported	O
that	O
administration	O
of	O
PGRN	O
maintained	O
the	O
body	O
weight	O
and	O
survival	O
of	O
ALI	O
mice	B-SPEC
.	O

A	O
VRDAL	O
multiplex	O
PCR	O
for	O
10	O
common	O
respiratory	O
viruses	B-SPEC
was	O
performed	O
on	O
collected	O
specimens	O
compared	O
with	O
the	O
Seeplex	O
	O
RV15	O
ACE	O
Detection	O
kit	O
for	O
15	O
respiratory	O
viruses	B-SPEC
.	O

Viruses	B-SPEC
were	O
detected	O
in	O
84	O
(	O
51	O
.	O
2	O
%)	O
patients	O
by	O
VRDAL	O
multiplex	O
PCR	O
,	O
and	O
8	O
(	O
4	O
.	O
9	O
%)	O
of	O
cases	O
were	O
mixed	O
infections	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
mRT	O
-	O
PCR	O
were	O
determined	O
by	O
comparing	O
it	O
to	O
a	O
rapid	O
antigen	O
test	O
(	O
RAT	B-SPEC
)	O
or	O
immuno	O
-	O
chromatography	O
test	O
kit	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
in	O
the	O
detection	O
of	O
CDV	B-SPEC
,	O
CRCoV	O
and	O
CIV	B-SPEC
antigens	O
present	O
in	O
100	O
clinical	O
samples	O
(	O
nasal	O
swabs	O
and	O
whole	O
blood	O
samples	O
)	O
from	O
50	O
dogs	B-SPEC
with	O
respiratory	O
disease	O
symptoms	O
.	O

TITLE	O
:	O
Therapeutic	O
effects	O
of	O
inhaling	O
aerosolized	O
surfactant	O
alone	O
or	O
with	O
dexamethasone	O
generated	O
by	O
a	O
novel	O
noninvasive	O
apparatus	O
on	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

RESULTS	O
:	O
Animals	B-SPEC
treated	O
with	O
air	O
-	O
PS	O
for	O
20	O
minutes	O
had	O
significantly	O
improved	O
lung	O
function	O
,	O
reduced	O
pulmonary	O
edema	O
,	O
decreased	O
concentration	O
of	O
total	O
protein	O
and	O
proinflammatory	O
cytokines	O
in	O
BALF	O
,	O
ameliorated	O
lung	O
injury	O
,	O
and	O
improved	O
animal	B-SPEC
survival	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
the	O
utility	O
of	O
animal	B-SPEC
models	O
for	O
studies	O
of	O
influenza	O
A	O
viruses	B-SPEC
,	O
HIV	B-SPEC
and	O
SARS	O
-	O
CoV	O
in	O
light	O
of	O
viral	O
emergence	O
,	O
assessment	O
of	O
infection	O
and	O
transmission	O
risks	O
,	O
and	O
regulatory	O
decision	O
making	O
.	O

The	O
susceptibility	O
,	O
immune	O
responses	O
,	O
pathogenesis	O
,	O
and	O
pharmacokinetics	O
may	O
differ	O
between	O
the	O
various	O
animal	B-SPEC
models	O
.	O

TITLE	O
:	O
Potential	O
cross	O
-	O
reactivity	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)-	O
based	O
IgG	O
ELISA	O
assay	O
for	O
plasma	O
samples	O
from	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
positive	O
intravenous	O
drug	O
users	O
(	O
IDUs	O
).	O

ABSTRACT	O
:	O
to	O
evaluate	O
the	O
specificity	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
-	O
based	O
IgG	O
ELISA	O
assay	O
for	O
detection	O
of	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
in	O
plasma	O
samples	O
obtained	O
from	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
positive	O
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
negative	O
intravenous	O
drug	O
users	O
(	O
IDUs	O
).	O

CONCLUSIONS	O
:	O
the	O
specificity	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
-	O
based	O
IgG	O
ELISA	O
assay	O
for	O
the	O
detection	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
specific	O
IgG	O
in	O
plasma	O
samples	O
from	O
IDUs	O
with	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
positive	O
is	O
,	O
therefore	O
,	O
questionable	O
.	O

ABSTRACT	O
:	O
The	O
prevalence	O
of	O
various	O
viral	O
infections	O
was	O
examined	O
in	O
primary	O
accession	O
cases	O
of	O
feline	B-SPEC
lower	O
urinary	O
tract	O
disease	O
(	O
FLUTD	O
)	O
and	O
healthy	O
control	O
cats	B-SPEC
in	O
Norway	O
.	O

All	O
urinary	O
samples	O
were	O
negative	O
for	O
FCV	B-SPEC
and	O
FCoV	O
.	O
One	O
(	O
1	O
%)	O
of	O
the	O
FLUTD	O
cats	B-SPEC
was	O
found	O
to	O
be	O
positive	O
for	O
FHV	O
-	O
1	O
.	O

ABSTRACT	O
:	O
Programmed	O
-	O
1	O
frameshifting	O
,	O
whereby	O
the	O
reading	O
frame	O
of	O
a	O
ribosome	O
on	O
messenger	O
RNA	O
is	O
shifted	O
in	O
order	B-SPEC
to	O
generate	O
an	O
alternate	O
gene	O
product	O
,	O
is	O
often	O
triggered	O
by	O
a	O
pseudoknot	O
structure	O
in	O
the	O
mRNA	O
in	O
combination	O
with	O
an	O
upstream	O
slippery	O
sequence	O
.	O

ABSTRACT	O
:	O
Respiratory	O
infections	O
caused	O
by	O
respiratory	O
viruses	B-SPEC
are	O
common	O
in	O
paediatric	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
patients	O
and	O
are	O
associated	O
with	O
increased	O
morbidity	O
.	O

Newly	O
identified	O
viruses	B-SPEC
such	O
as	O
pandemic	O
influenza	O
A	O
/	O
H1N1	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
human	B-SPEC
bocavirus	I-SPEC
,	O
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
were	O
not	O
detected	O
in	O
our	O
population	O
,	O
except	O
for	O
1	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
.	O

The	O
spike	O
glycoprotein	O
of	O
IBV	B-SPEC
is	O
essential	O
for	O
host	O
cell	O
attachment	O
,	O
neutralization	O
,	O
and	O
is	O
involved	O
in	O
the	O
induction	O
of	O
protective	O
immunity	O
.	O

TITLE	O
:	O
Evidence	O
supporting	O
a	O
zoonotic	O
origin	O
of	O
human	B-SPEC
coronavirus	I-SPEC
strain	O
NL63	O
.	O

Interestingly	O
,	O
cellular	O
furin	O
abundance	O
in	O
five	O
human	B-SPEC
cell	O
lines	O
was	O
shown	O
to	O
be	O
strongly	O
correlated	O
with	O
productive	O
IBV	B-SPEC
infection	O
.	O

Because	O
of	O
the	O
expanding	O
size	O
and	O
density	O
of	O
its	O
population	O
and	O
the	O
frequent	O
interaction	O
of	O
people	O
with	O
animals	B-SPEC
,	O
China	O
is	O
a	O
hotspot	O
for	O
the	O
emergence	O
and	O
spread	O
of	O
new	O
microbial	O
threats	O
and	O
is	O
a	O
major	O
contributor	O
to	O
the	O
worldwide	O
infectious	O
disease	O
burden	O
.	O

Drug	O
resistance	O
amongst	O
nosocomial	O
bacteria	B-SPEC
has	O
been	O
on	O
a	O
rapid	O
upward	O
trend	O
with	O
a	O
strong	O
inclination	O
towards	O
multidrug	O
resistance	O
.	O

The	O
overall	O
frequency	O
of	O
coronavirus	B-SPEC
NL63	O
infection	O
was	O
0	O
.	O
8	O
%,	O
6	O
(	O
60	O
%)	O
out	O
of	O
the	O
coronavirus	B-SPEC
NL63	O
positive	O
patients	O
were	O
detected	O
in	O
summer	O
,	O
2	O
in	O
autumn	O
,	O
1	O
in	O
spring	O
and	O
winter	O
,	O
respectively	O
.	O

RESULTS	O
:	O
The	O
overall	O
frequency	O
of	O
coronavirus	B-SPEC
NL63	O
infection	O
was	O
0	O
.	O
8	O
%,	O
6	O
(	O
60	O
%)	O
out	O
of	O
the	O
coronavirus	B-SPEC
NL63	O
positive	O
patients	O
were	O
detected	O
in	O
summer	O
,	O
2	O
in	O
autumn	O
,	O
1	O
in	O
spring	O
and	O
winter	O
,	O
respectively	O
.	O

There	O
was	O
serological	O
evidence	O
of	O
previous	O
exposure	O
to	O
bovine	B-SPEC
viral	O
diarrhoea	O
virus	B-SPEC
,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
,	O
but	O
not	O
to	O
bovine	B-SPEC
herpesvirus	I-SPEC
type	I-SPEC
1	I-SPEC
.	O

None	O
of	O
these	O
viral	O
pathogens	O
or	O
Mycoplasma	B-SPEC
bovis	I-SPEC
was	O
identified	O
by	O
qRT	O
-	O
PCR	O
.	O

RESULTS	O
:	O
BCoV	O
was	O
detected	O
in	O
nasal	O
swabs	O
and	O
pulmonary	O
lesions	O
using	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
assay	O
and	O
virus	B-SPEC
isolation	O
.	O

A	O
mouse	B-SPEC
model	O
of	O
acute	O
SARS	O
-	O
CoV	O
infection	O
has	O
been	O
helpful	O
in	O
understanding	O
the	O
host	O
response	O
to	O
infection	O
;	O
however	O
,	O
there	O
are	O
still	O
unanswered	O
questions	O
concerning	O
SARS	O
-	O
CoV	O
pathogenesis	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
conserved	O
linear	O
B	O
-	O
cell	O
epitope	O
in	O
the	O
M	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

The	O
McAb	O
could	O
serve	O
as	O
a	O
candidate	O
for	O
development	O
of	O
a	O
McAb	O
-	O
based	O
antigen	O
capture	O
ELISA	O
for	O
detection	O
of	O
PEDV	B-SPEC
.	O

We	O
identified	O
gene	O
expression	O
signatures	O
in	O
the	O
lungs	O
of	O
ferrets	B-SPEC
associated	O
with	O
primary	O
immune	O
responses	O
to	O
SARS	O
-	O
CoV	O
infection	O
and	O
in	O
ferrets	B-SPEC
that	O
received	O
an	O
identical	O
second	O
inoculum	O
.	O

nsp1	O
inhibited	O
different	O
steps	O
of	O
translation	O
initiation	O
on	O
CrPV	B-SPEC
and	O
HCV	B-SPEC
IRES	O
,	O
both	O
of	O
which	O
initiate	O
translation	O
via	O
an	O
IRES	O
-	O
40S	O
binary	O
complex	O
intermediate	O
;	O
nsp1	O
inhibited	O
binary	O
complex	O
formation	O
on	O
CrPV	B-SPEC
IRES	O
and	O
48S	O
complex	O
formation	O
on	O
HCV	B-SPEC
IRES	O
.	O

Human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
)	O
was	O
the	O
second	O
most	O
common	O
identified	O
virus	B-SPEC
(	O
in	O
19	O
.	O
5	O
%),	O
followed	O
by	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
rhinovirus	B-SPEC
,	O
influenza	B-SPEC
viruses	I-SPEC
,	O
and	O
coronavirus	B-SPEC
OC43	O
.	O

RSV	B-SPEC
was	O
the	O
most	O
common	O
etiologic	O
agent	O
for	O
children	O
with	O
bronchiolitis	O
in	O
Taiwan	O
.	O

ABSTRACT	O
:	O
We	O
present	O
two	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
assays	O
for	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
),	O
targeting	O
regions	O
upstream	O
of	O
the	O
E	O
gene	O
(	O
upE	O
)	O
or	O
within	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
1b	O
,	O
respectively	O
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
associated	O
with	O
severe	O
respiratory	O
disease	O
:	O
case	O
definition	O
and	O
public	O
health	O
measures	O
.	O

TITLE	O
:	O
Expression	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
multi	O
-	O
epitope	O
based	O
peptide	O
EpiC	O
in	O
Lactococcus	B-SPEC
lactis	I-SPEC
for	O
oral	O
immunization	O
of	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Conventional	O
and	O
molecular	O
epidemiologic	O
studies	O
have	O
confirmed	O
the	O
ability	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
to	O
rapidly	O
evolve	O
and	O
successfully	O
circumvent	O
extensive	O
vaccination	O
programs	O
implemented	O
since	O
the	O
early	O
1950s	O
.	O

From	O
a	O
broad	O
perspective	O
,	O
these	O
results	O
indicate	O
that	O
selection	O
is	O
an	O
important	O
force	O
driving	O
IBV	B-SPEC
evolution	O
.	O

This	O
single	O
-	O
tube	O
mRT	O
-	O
PCR	O
assay	O
has	O
the	O
potential	O
to	O
serve	O
as	O
a	O
rapid	O
diagnostic	O
method	O
for	O
the	O
simultaneous	O
detection	O
of	O
the	O
three	O
enteric	O
viruses	B-SPEC
in	O
turkeys	B-SPEC
.	O

The	O
first	O
patient	O
,	O
a	O
man	B-SPEC
aged	O
60	O
years	O
from	O
Saudi	O
Arabia	O
,	O
was	O
hospitalized	O
in	O
June	O
2012	O
and	O
died	O
;	O
the	O
second	O
patient	O
,	O
a	O
man	B-SPEC
aged	O
49	O
years	O
from	O
Qatar	O
with	O
onset	O
of	O
symptoms	O
in	O
September	O
2012	O
was	O
transported	O
to	O
the	O
United	O
Kingdom	B-SPEC
for	O
intensive	O
care	O
.	O

Most	O
often	O
the	O
viruses	B-SPEC
isolated	O
include	O
rhinovirus	B-SPEC
(	O
RV	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
picornavirus	B-SPEC
.	O

Influenza	B-SPEC
viruses	I-SPEC
and	O
RSV	B-SPEC
were	O
common	O
.	O

Specificity	O
of	O
the	O
PCR	O
and	O
DFA	O
methods	O
for	O
RSV	B-SPEC
infections	O
were	O
detected	O
as	O
96	O
%	O
and	O
100	O
%	O
respectively	O
.	O

TITLE	O
:	O
Long	O
-	O
distance	O
RNA	O
-	O
RNA	O
interactions	O
in	O
the	O
coronavirus	B-SPEC
genome	O
form	O
high	O
-	O
order	B-SPEC
structures	O
promoting	O
discontinuous	O
RNA	O
synthesis	O
during	O
transcription	O
.	O

Evidence	O
of	O
high	O
exposure	O
to	O
these	O
viral	O
agents	O
was	O
also	O
observed	O
in	O
unvaccinated	O
domestic	O
dogs	B-SPEC
from	O
neighboring	O
farms	O
.	O

ABSTRACT	O
:	O
Fouchier	O
et	O
al	O
.	O
reported	O
the	O
isolation	O
and	O
genome	O
sequencing	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
tentatively	O
named	O
""""	O
human	B-SPEC
betacoronavirus	B-SPEC
2c	O
EMC	O
/	O
2012	O
(	O
HCoV	O
-	O
EMC	O
")"""	O
from	O
a	O
Saudi	O
patient	O
presenting	O
with	O
pneumonia	O
and	O
renal	O
failure	O
in	O
June	O
2012	O
.	O

A	O
meta	B-SPEC
-	O
analysis	O
was	O
conducted	O
if	O
adequate	O
data	O
was	O
available	O
from	O
2	O
or	O
more	O
studies	O
and	O
where	O
statistical	O
and	O
clinical	O
heterogeneity	O
among	O
studies	O
was	O
not	O
an	O
issue	O
.	O

TITLE	O
:	O
Isolation	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
from	O
a	O
man	B-SPEC
with	O
pneumonia	O
in	O
Saudi	O
Arabia	O
.	O

Pyelonephritis	O
was	O
the	O
most	O
common	O
etiology	O
overall	O
(	O
37	O
%)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
was	O
the	O
most	O
common	O
organ	O
injury	O
in	O
both	O
severe	O
sepsis	B-SPEC
(	O
50	O
%)	O
and	O
septic	O
shock	O
(	O
80	O
%).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
acute	O
respiratory	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
first	O
appeared	O
in	O
Foshan	O
City	O
,	O
China	O
on	O
22	O
December	O
2002	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
have	O
the	O
potential	O
to	O
cause	O
severe	O
transmissible	O
human	B-SPEC
disease	O
,	O
as	O
demonstrated	O
by	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreak	O
of	O
2003	O
.	O

Recent	O
outbreaks	O
of	O
Ebola	O
haemorrhagic	O
fever	O
in	O
Uganda	O
and	O
the	O
Democratic	O
Republic	O
of	O
the	O
Congo	O
,	O
cholera	O
in	O
Sierra	O
Leone	O
,	O
and	O
infections	O
associated	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
Saudi	O
Arabia	O
and	O
Qatar	O
required	O
review	O
of	O
the	O
health	O
recommendations	O
of	O
the	O
2012	O
Hajj	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
protein	O
N	O
-	O
terminal	O
domains	O
(	O
NTDs	O
)	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
and	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
recognize	O
sugar	O
and	O
protein	O
receptors	O
,	O
respectively	O
,	O
despite	O
their	O
significant	O
sequence	O
homology	O
.	O

One	O
critical	O
factor	O
that	O
has	O
helped	O
the	O
country	O
overcome	O
these	O
innate	O
and	O
man	B-SPEC
-	O
made	O
public	O
health	O
vulnerabilities	O
is	O
the	O
development	O
of	O
a	O
resilient	O
field	O
epidemiology	O
service	O
,	O
which	O
includes	O
our	O
enhancement	O
of	O
surveillance	O
and	O
response	O
capacities	O
for	O
outbreak	O
management	O
,	O
and	O
investment	O
in	O
public	O
health	O
leadership	O
.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
from	O
hospitalized	O
children	O
with	O
severe	O
pneumonia	O
in	O
the	O
Philippines	O
.	O

The	O
viruses	B-SPEC
in	O
severe	O
pneumonia	O
remain	O
poorly	O
defined	O
.	O

Novel	O
viruses	B-SPEC
such	O
as	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
,	O
human	B-SPEC
bocavirus	I-SPEC
,	O
and	O
human	B-SPEC
polyomaviruses	B-SPEC
WU	O
and	O
KI	O
were	O
also	O
detected	O
.	O

It	O
analyses	O
the	O
trends	O
in	O
consultations	O
for	O
respiratory	O
causes	O
in	O
three	O
primary	O
care	O
centers	O
and	O
hospital	O
discharges	O
by	O
comparing	O
data	O
from	O
years	O
2008	O
and	O
2009	O
until	O
epidemiological	O
week	O
37	O
.	O
It	O
also	O
includes	O
a	O
study	O
of	O
cases	O
of	O
ILI	O
/	O
SARI	O
(	O
influenza	O
like	O
disease	O
/	O
severe	O
acute	O
respiratory	O
disease	O
)	O
in	O
which	O
viruses	B-SPEC
were	O
detected	O
by	O
direct	O
immunofluorescence	O
(	O
DIF	O
)	O
of	O
nasopharyngeal	O
aspirates	O
and	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
in	O
the	O
case	O
of	O
influenza	O
A	O
(	O
H1N1	O
)	O
2009	O
.	O

TITLE	O
:	O
Murine	B-SPEC
hepatitis	O
virus	B-SPEC
nsp4	O
N258T	O
mutants	O
are	O
not	O
temperature	O
-	O
sensitive	O
.	O

In	O
humans	B-SPEC
the	O
number	O
of	O
cases	O
infected	O
with	O
this	O
virus	B-SPEC
is	O
few	O
but	O
the	O
mortality	O
has	O
been	O
about	O
60	O
%.	O

The	O
symptoms	O
of	O
infection	O
with	O
this	O
virus	B-SPEC
are	O
similar	O
to	O
seasonal	O
influenza	O
but	O
it	O
currently	O
affecting	O
younger	O
individuals	O
more	O
often	O
.	O

ABSTRACT	O
:	O
Care	O
of	O
patients	O
with	O
sepsis	B-SPEC
has	O
improved	O
over	O
the	O
last	O
decade	O
.	O

This	O
review	O
will	O
present	O
an	O
overview	O
of	O
newly	O
recognized	O
as	O
well	O
as	O
the	O
main	O
emerging	O
respiratory	O
viruses	B-SPEC
and	O
seek	O
to	O
focus	O
on	O
the	O
their	O
contribution	O
to	O
infection	O
and	O
co	O
-	O
infection	O
in	O
LRTIs	O
in	O
childhood	O
.	O

TITLE	O
:	O
The	O
heptide	O
repeat	O
2	O
and	O
upstream	O
region	O
of	O
TGEV	B-SPEC
induces	O
potent	O
cross	O
-	O
neutralizing	O
antibodies	O
against	O
group	O
I	O
coronaviruses	O
.	O

This	O
study	O
provides	O
new	O
insight	O
for	O
designing	O
vaccine	O
and	O
therapeutic	O
reagents	O
against	O
coronavirus	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
infection	O
was	O
associated	O
with	O
significant	O
morbidity	O
,	O
mainly	O
among	O
children	O
and	O
young	O
adults	O
.	O

In	O
experimentally	O
infected	O
animals	B-SPEC
,	O
the	O
level	O
of	O
pulmonary	O
replication	O
of	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
was	O
higher	O
than	O
that	O
of	O
seasonal	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Pathological	O
studies	O
in	O
autopsy	O
specimens	O
indicated	O
that	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
mainly	O
targeted	O
the	O
lower	O
respiratory	O
tract	O
,	O
resulting	O
in	O
diffuse	O
alveolar	O
damage	O
(	O
edema	O
,	O
hyaline	O
membranes	O
,	O
inflammation	O
,	O
and	O
fibrosis	O
),	O
manifested	O
clinically	O
by	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
refractory	O
hypoxemia	O
.	O

Recombinant	O
feline	B-SPEC
interferon	O
-	O
	O
(	O
rFeIFN	O
)	O
has	O
shown	O
an	O
antiviral	O
action	O
not	O
only	O
against	O
FIV	B-SPEC
and	O
FeLV	O
but	O
also	O
against	O
herpesvirus	B-SPEC
(	O
FHV	O
-	O
1	O
)	O
and	O
calicivirus	O
(	O
FCV	B-SPEC
).	O

Cats	B-SPEC
were	O
submitted	O
to	O
clinical	O
evaluations	O
and	O
concomitant	O
virus	B-SPEC
excretion	O
assessement	O
.	O

Four	O
horses	B-SPEC
from	O
3	O
different	O
outbreaks	O
were	O
euthanized	O
or	O
died	O
due	O
to	O
rapid	O
progression	O
of	O
clinical	O
signs	O
.	O

We	O
have	O
assayed	O
new	O
AQ	O
derivatives	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RNase	O
H	O
activities	O
in	O
biochemical	O
assays	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
multiplex	O
real	O
-	O
time	O
PCR	O
assay	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
in	O
clinical	O
specimens	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
analytical	O
performance	O
and	O
clinical	O
potential	O
of	O
a	O
one	O
-	O
step	O
multiplex	O
real	O
-	O
time	O
PCR	O
assay	O
for	O
the	O
simultaneous	O
detection	O
of	O
14	O
types	O
of	O
respiratory	O
viruses	B-SPEC
using	O
the	O
AdvanSure	O
RV	O
real	O
-	O
time	O
PCR	O
Kit	O
(	O
LG	O
Life	O
Sciences	O
,	O
Korea	O
).	O

We	O
present	O
the	O
case	O
of	O
a	O
fit	O
52	O
-	O
year	O
-	O
old	O
experienced	O
female	O
diver	O
who	O
developed	O
TP	O
and	O
shock	O
following	O
a	O
routine	O
training	O
dive	B-SPEC
to	O
27m	O
.	O

ABSTRACT	O
:	O
Vaccinia	B-SPEC
virus	I-SPEC
membrane	O
biogenesis	O
requires	O
the	O
A14	O
and	O
A17	O
proteins	O
.	O

The	O
N	O
-	O
terminal	O
most	O
domain	O
of	O
nsp3	O
,	O
nsp3a	O
,	O
has	O
been	O
identified	O
by	O
reverse	O
genetics	O
as	O
a	O
likely	O
binding	O
partner	O
of	O
MHV	B-SPEC
nucleocapsid	O
protein	O
.	O

Among	O
RNA	O
viruses	B-SPEC
,	O
replication	O
fidelity	O
is	O
recognized	O
as	O
a	O
key	O
determinant	O
of	O
virulence	O
and	O
escape	O
from	O
antiviral	O
therapy	O
;	O
increased	O
fidelity	O
is	O
attenuating	O
for	O
some	O
viruses	B-SPEC
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
engineered	O
inactivation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
ExoN	O
activity	O
results	O
in	O
a	O
stable	O
mutator	O
phenotype	O
with	O
profoundly	O
decreased	O
fidelity	O
in	O
vivo	O
and	O
attenuation	O
of	O
pathogenesis	O
in	O
young	O
,	O
aged	O
and	O
immunocompromised	O
mice	B-SPEC
.	O

CXCL10	O
may	O
not	O
be	O
a	O
bystander	O
to	O
the	O
severe	O
virus	B-SPEC
infection	O
but	O
may	O
directly	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
neutrophil	O
-	O
mediated	O
,	O
excessive	O
pulmonary	O
inflammation	O
.	O

We	O
induced	O
nonviral	O
ARDS	O
by	O
acid	O
aspiration	O
and	O
viral	O
ARDS	O
by	O
intratracheal	O
influenza	B-SPEC
virus	I-SPEC
infection	O
in	O
wild	O
-	O
type	O
mice	B-SPEC
and	O
mice	B-SPEC
deficient	O
in	O
CXCL10	O
,	O
CXCR3	O
,	O
IFNAR1	O
(	O
IFN	O
-	O
	O
/	O
	O
receptor	O
1	O
),	O
or	O
TIR	O
domain	O
-	O
containing	O
adaptor	O
inducing	O
IFN	O
-	O
	O
(	O
TRIF	O
).	O

TITLE	O
:	O
Construction	O
of	O
recombinant	O
lactobacilli	O
expressing	O
the	O
core	O
neutralizing	O
epitope	O
(	O
COE	O
)	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
a	O
fusion	O
protein	O
consisting	O
of	O
COE	O
and	O
Escherichia	B-SPEC
coli	I-SPEC
heat	O
-	O
labile	O
enterotoxin	O
B	O
,	O
and	O
comparison	O
of	O
the	O
immune	O
responses	O
by	O
orogastric	O
immunization	O
.	O

To	O
enhance	O
the	O
vaccine	O
'	O
s	O
immunogenicity	O
,	O
Escherichia	B-SPEC
coli	I-SPEC
heat	O
-	O
labile	O
enterotoxin	O
B	O
(	O
LTB	O
)	O
has	O
usually	O
been	O
adopted	O
as	O
a	O
molecular	O
adjuvant	O
.	O

PEDV	B-SPEC
was	O
detected	O
in	O
92	O
.	O
7	O
%	O
of	O
the	O
samples	O
(	O
267	O
/	O
288	O
).	O

TITLE	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
and	O
deep	O
pectoral	O
myopathy	O
-	O
a	O
case	O
control	O
study	O
.	O

Human	B-SPEC
	O
-	O
actin	O
DNA	O
concentration	O
was	O
determined	O
in	O
the	O
swabs	O
as	O
a	O
quality	O
control	O
.	O

We	O
presented	O
a	O
male	O
patient	O
,	O
aged	O
50	O
,	O
hospitalized	O
in	O
the	O
Emergency	O
Center	O
Kragujevac	O
due	O
to	O
altered	O
mental	O
status	O
(	O
Glasgow	O
Coma	B-SPEC
Score	O
11	O
),	O
partial	O
respiratory	O
insufficiency	O
(	O
pO2	O
7	O
.	O
5	O
kPa	O
,	O
pCO2	O
4	O
.	O
3	O
kPa	O
,	O
SpO2	O
89	O
%),	O
weakness	O
of	O
lower	O
extremities	O
and	O
atypical	O
electrocardiographic	O
changes	O
.	O

We	O
have	O
demonstrated	O
that	O
RNA	O
recombination	O
can	O
give	O
rise	O
to	O
a	O
new	O
viral	O
population	O
,	O
supported	O
by	O
the	O
finding	O
that	O
most	O
isolated	O
Taiwanese	O
(	O
TW	O
)	O
IBVs	O
,	O
similar	O
to	O
Chinese	O
(	O
CH	O
)	O
IBVs	O
,	O
exhibit	O
a	O
genetic	O
rearrangement	O
with	O
the	O
American	O
(	O
US	O
)	O
IBV	B-SPEC
at	O
the	O
5	O
'	O
end	O
of	O
the	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
.	O

Forty	O
patients	O
after	O
the	O
resuscitation	O
phase	O
of	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
who	O
were	O
mechanically	O
ventilated	O
with	O
6	O
ml	O
kg	O
(-	O
1	O
)	O
were	O
included	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
molecular	O
epidemiology	O
of	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
in	O
patients	O
with	O
acute	O
respiratory	O
illness	O
.	O

ABSTRACT	O
:	O
In	O
2005	O
,	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
HCoV	O
-	O
HKU1	O
)	O
was	O
isolated	O
and	O
identified	O
from	O
a	O
71	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
pneumonia	O
in	O
Hong	O
Kong	O
.	O

These	O
findings	O
will	O
contribute	O
additional	O
insights	O
into	O
the	O
molecular	O
characteristics	O
of	O
evolving	O
IBV	B-SPEC
genomes	O
and	O
the	O
need	O
for	O
effective	O
control	O
of	O
IBV	B-SPEC
in	O
China	O
.	O

TITLE	O
:	O
Complete	O
genome	O
sequence	O
of	O
a	O
Vero	O
cell	O
-	O
adapted	O
isolate	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
eastern	O
China	O
.	O

TITLE	O
:	O
Complete	O
genome	O
sequence	O
of	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
chimera	O
between	O
cocirculating	O
heterotypic	O
strains	O
.	O

Influenza	B-SPEC
virus	I-SPEC
circulation	O
peaked	O
during	O
June	O
-	O
August	O
in	O
both	O
years	O
and	O
A	O
(	O
H1N1	O
)	O
pdm09	O
occurred	O
at	O
the	O
end	O
of	O
the	O
influenza	O
season	O
in	O
2009	O
.	O

The	O
specimens	O
were	O
tested	O
using	O
real	O
-	O
time	O
and	O
multiplex	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
methods	O
for	O
the	O
detection	O
of	O
15	O
RNA	O
respiratory	O
viruses	B-SPEC
.	O

We	O
detected	O
at	O
least	O
1	O
respiratory	O
virus	B-SPEC
in	O
365	O
of	O
561	O
specimens	O
(	O
65	O
.	O
1	O
%).	O

HCoV	O
-	O
EMC	O
/	O
2012	O
is	O
the	O
sixth	O
coronavirus	B-SPEC
known	O
to	O
infect	O
humans	B-SPEC
and	O
the	O
first	O
human	B-SPEC
virus	B-SPEC
within	O
betacoronavirus	B-SPEC
lineage	O
C	O
.	O
Coronaviruses	O
are	O
capable	O
of	O
infecting	O
humans	B-SPEC
and	O
many	O
animal	B-SPEC
species	B-SPEC
.	O

Most	O
infections	O
caused	O
by	O
human	B-SPEC
coronaviruses	O
are	O
relatively	O
mild	O
.	O

TITLE	O
:	O
Virulent	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
,	O
People	O
'	O
s	O
Republic	O
of	O
China	O
.	O

Tracheal	O
and	O
severe	O
kidney	O
lesions	O
developed	O
in	O
all	O
infected	O
birds	B-SPEC
,	O
confirming	O
the	O
ability	O
of	O
YN	O
strain	O
to	O
induce	O
both	O
respiratory	O
and	O
renal	O
disease	O
.	O

IBV	B-SPEC
antigens	O
were	O
detected	O
by	O
immunohistochemical	O
analysis	O
in	O
the	O
trachea	B-SPEC
,	O
lung	O
,	O
kidney	O
,	O
and	O
bursa	B-SPEC
,	O
consistent	O
with	O
histopathologic	O
observations	O
,	O
virus	B-SPEC
isolation	O
,	O
and	O
reverse	O
transcription	O
PCR	O
detection	O
.	O

TITLE	O
:	O
Isolation	O
and	O
molecular	O
characterization	O
of	O
type	O
I	O
and	O
type	O
II	O
feline	B-SPEC
coronavirus	B-SPEC
in	O
Malaysia	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
and	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
are	O
two	O
important	O
coronaviruses	O
of	O
domestic	B-SPEC
cat	I-SPEC
worldwide	O
.	O

Of	O
the	O
total	O
number	O
of	O
cats	B-SPEC
sampled	O
,	O
95	O
%	O
(	O
40	O
/	O
42	O
)	O
were	O
RT	O
-	O
PCR	O
positive	O
for	O
FCoV	O
.	O
Inoculation	O
of	O
clinical	O
samples	O
into	O
Crandell	O
feline	B-SPEC
kidney	O
cells	O
(	O
CrFK	O
),	O
and	O
Feline	B-SPEC
catus	O
whole	O
fetus	O
-	O
4	O
cells	O
(	O
Fcwf	O
-	O
4	O
),	O
show	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
characterized	O
by	O
syncytial	O
cells	O
formation	O
and	O
later	O
cell	O
detachment	O
.	O

The	O
rabbit	B-SPEC
polyclonal	O
antibody	O
demonstrated	O
greater	O
immunoreactivity	O
to	O
the	O
central	O
-	O
linker	O
region	O
and	O
the	O
C	O
-	O
terminal	O
domain	O
than	O
to	O
the	O
N	O
-	O
terminal	O
domain	O
.	O

Three	O
different	O
patterns	O
for	O
the	O
immunoreactivities	O
of	O
the	O
three	O
structural	O
regions	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
NP	O
were	O
observed	O
in	O
human	B-SPEC
serum	O
,	O
suggesting	O
variability	O
in	O
the	O
immune	O
responses	O
that	O
occur	O
during	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
in	O
humans	B-SPEC
.	O

We	O
report	O
a	O
case	O
of	O
EC	O
in	O
a	O
70	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
recently	O
underwent	O
transrectal	O
ultrasound	O
needle	O
-	O
guided	O
prostate	O
biopsy	O
,	O
after	O
which	O
he	O
underwent	O
pylorogastrectomy	O
.	O

In	O
addition	O
,	O
molecular	O
markers	O
have	O
been	O
identified	O
that	O
distinguish	O
between	O
field	O
and	O
vaccine	O
(	O
or	O
vaccine	O
-	O
like	O
)	O
Mass	O
-	O
type	O
viruses	B-SPEC
,	O
which	O
may	O
be	O
able	O
to	O
differentiate	O
between	O
field	O
and	O
vaccine	O
strains	O
for	O
diagnostic	O
purposes	O
.	O

TITLE	O
:	O
Association	O
of	O
the	O
chicken	B-SPEC
MHC	O
B	O
haplotypes	O
with	O
resistance	O
to	O
avian	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
N	O
protein	O
oligomerizes	O
via	O
its	O
carboxyl	O
terminus	O
.	O

Based	O
on	O
the	O
protein	O
disorder	O
prediction	O
system	O
,	O
a	O
comprehensive	O
series	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
N	O
protein	O
mutants	O
with	O
truncated	O
CTD	O
was	O
generated	O
and	O
systematically	O
investigated	O
by	O
biophysical	O
and	O
biochemical	O
analyses	O
to	O
clarify	O
the	O
role	O
of	O
the	O
C	O
-	O
terminal	O
tail	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
N	O
protein	O
in	O
oligomerization	O
.	O

ABSTRACT	O
:	O
Immune	O
sera	O
from	O
convalescent	O
patients	O
have	O
been	O
shown	O
to	O
be	O
effective	O
in	O
the	O
treatment	O
of	O
patients	O
infected	O
with	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
making	O
passive	O
immune	O
therapy	O
with	O
human	B-SPEC
monoclonal	O
antibodies	O
an	O
attractive	O
treatment	O
strategy	O
for	O
SARS	O
.	O

Coinfection	O
with	O
>	O
1	O
virus	B-SPEC
was	O
present	O
in	O
47	O
(	O
24	O
%)	O
patients	O
,	O
and	O
did	O
not	O
increase	O
the	O
risk	O
for	O
LRTI	O
.	O

ABSTRACT	O
:	O
Most	O
pandemics	O
--	O
eg	O
,	O
HIV	B-SPEC
/	O
AIDS	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
pandemic	O
influenza	O
--	O
originate	O
in	O
animals	B-SPEC
,	O
are	O
caused	O
by	O
viruses	B-SPEC
,	O
and	O
are	O
driven	O
to	O
emerge	O
by	O
ecological	O
,	O
behavioural	O
,	O
or	O
socioeconomic	O
changes	O
.	O

A	O
recombination	O
analysis	O
revealed	O
that	O
SNU8067	O
was	O
a	O
recombinant	O
virus	B-SPEC
with	O
a	O
KM91	O
-	O
like	O
backbone	O
except	O
S1	O
,	O
3a	O
,	O
and	O
3b	O
genes	O
which	O
might	O
be	O
from	O
an	O
unknown	O
virus	B-SPEC
.	O

TITLE	O
:	O
The	O
role	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	B-SPEC
accessory	O
proteins	O
in	O
virus	B-SPEC
pathogenesis	O
.	O

This	O
review	O
will	O
summarize	O
current	O
knowledge	O
on	O
the	O
capacity	O
of	O
human	B-SPEC
coronaviruses	O
to	O
survive	O
in	O
the	O
environment	O
and	O
the	O
efficacy	O
of	O
well	O
-	O
known	O
antiseptic	O
-	O
disinfectants	O
against	O
them	O
,	O
with	O
particular	O
focus	O
on	O
the	O
development	O
of	O
new	O
methodologies	O
to	O
evaluate	O
the	O
activity	O
of	O
new	O
antiseptic	O
-	O
disinfectants	O
on	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Virus	B-SPEC
pathogen	O
database	O
and	O
analysis	O
resource	O
(	O
ViPR	O
):	O
a	O
comprehensive	O
bioinformatics	O
database	O
and	O
analysis	O
resource	O
for	O
the	O
coronavirus	B-SPEC
research	O
community	O
.	O

Little	O
is	O
known	O
about	O
the	O
different	O
phenotypes	O
of	O
patients	O
with	O
BOS	B-SPEC
and	O
their	O
outcomes	O
.	O

Control	O
of	O
viral	O
replication	O
during	O
acute	O
disease	O
is	O
mediated	O
by	O
infiltrating	O
virus	B-SPEC
-	O
specific	O
T	O
cells	O
via	O
cytokine	O
secretion	O
and	O
cytolytic	O
activity	O
,	O
however	O
sterile	O
immunity	O
is	O
not	O
achieved	O
and	O
virus	B-SPEC
persists	O
resulting	O
in	O
chronic	O
neuroinflammation	O
associated	O
with	O
demyelination	O
.	O

CXCR2	O
is	O
a	O
chemokine	O
receptor	O
that	O
upon	O
binding	O
to	O
specific	O
ligands	O
promotes	O
host	O
defense	O
through	O
recruitment	O
of	O
myeloid	O
cells	O
to	O
the	O
CNS	O
as	O
well	O
as	O
protecting	O
oligodendroglia	O
from	O
cytokine	O
-	O
mediated	O
death	O
in	O
response	O
to	O
MHV	B-SPEC
infection	O
.	O

Currently	O
,	O
there	O
is	O
no	O
specific	O
treatment	O
approved	O
for	O
FIP	O
despite	O
the	O
importance	O
of	O
FIP	O
as	O
the	O
leading	O
infectious	O
cause	O
of	O
death	O
in	O
young	O
cats	B-SPEC
.	O

Previously	O
,	O
we	O
reported	O
the	O
generation	O
of	O
broad	O
-	O
spectrum	O
peptidyl	O
inhibitors	O
against	O
viruses	B-SPEC
that	O
possess	O
a	O
3C	O
or	O
3CL	O
protease	O
.	O

TITLE	O
:	O
Samples	O
with	O
high	O
virus	B-SPEC
load	O
cause	O
a	O
trend	O
toward	O
lower	O
signal	O
in	O
feline	B-SPEC
coronavirus	B-SPEC
antibody	O
tests	O
.	O

However	O
,	O
five	O
samples	O
were	O
negative	O
by	O
RT	O
-	O
PCR	O
,	O
so	O
the	O
presence	O
of	O
virus	B-SPEC
alone	O
may	O
not	O
explain	O
all	O
cases	O
of	O
false	O
-	O
negative	O
FCoV	O
antibody	O
tests	O
,	O
although	O
it	O
is	O
a	O
possible	O
explanation	O
in	O
71	O
%	O
of	O
discordant	O
samples	O
.	O

We	O
conclude	O
that	O
falsely	O
low	O
or	O
negative	O
FCoV	O
antibody	O
tests	O
can	O
occur	O
in	O
samples	O
rich	O
in	O
virus	B-SPEC
.	O

TITLE	O
:	O
[	O
Protocol	O
of	O
the	O
management	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
].	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
is	O
an	O
acute	O
,	O
highly	O
contagious	O
disease	O
of	O
chickens	B-SPEC
.	O

To	O
study	O
the	O
differences	O
of	O
dynamic	O
distribution	O
between	O
nephropathogenic	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
such	O
as	O
SAIBK	O
and	O
other	O
strains	O
(	O
the	O
M41	O
and	O
H120	O
strains	O
),	O
relative	O
quantitative	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
was	O
developed	O
by	O
housekeeping	O
gene	O
selection	O
.	O

TITLE	O
:	O
The	O
survey	O
of	O
porcine	B-SPEC
teschoviruses	B-SPEC
,	O
porcine	B-SPEC
circovirus	I-SPEC
and	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
infecting	O
piglets	O
in	O
clinical	O
specimens	O
in	O
China	O
.	O

HCoV	O
-	O
EMC	O
is	O
a	O
member	O
of	O
the	O
same	O
virus	B-SPEC
genus	B-SPEC
as	O
SARS	O
-	O
CoV	O
but	O
constitutes	O
a	O
sister	O
species	B-SPEC
.	O

As	O
human	B-SPEC
CoV	O
normally	O
cannot	O
replicate	O
in	O
bat	B-SPEC
cells	O
from	O
different	O
families	O
,	O
this	O
suggests	O
that	O
hCoV	O
-	O
EMC	O
might	O
use	O
a	O
receptor	O
molecule	O
that	O
is	O
conserved	O
in	O
bats	B-SPEC
,	O
pigs	B-SPEC
,	O
and	O
humans	B-SPEC
,	O
implicating	O
a	O
low	O
barrier	O
against	O
cross	O
-	O
host	O
transmission	O
.	O

ADV	O
is	O
one	O
of	O
the	O
most	O
important	O
pathogens	O
of	O
acute	O
respiratory	O
tract	O
infection	O
in	O
children	O
in	O
Nanjing	O
area	O
,	O
and	O
adenovirus	B-SPEC
type	O
3	O
was	O
the	O
most	O
prevalent	O
serotype	O
.	O

One	O
N	O
-	O
phenacyl	O
amantadine	O
derivative	O
was	O
investigated	O
for	O
inhibiting	O
the	O
in	O
vitro	O
replication	O
of	O
respiratory	O
viruses	B-SPEC
(	O
influenza	O
A	O
viruses	B-SPEC
,	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
).	O

An	O
amantadine	O
-	O
folate	O
conjugate	O
was	O
inhibitory	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
in	O
primary	O
human	B-SPEC
lymphocytes	O
,	O
and	O
one	O
N	O
-	O
phenacyl	O
amantadine	O
derivative	O
was	O
inhibitory	O
towards	O
low	O
pathogenic	O
avian	B-SPEC
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
H5N1	O
)	O
replication	O
in	O
vitro	O
.	O

The	O
ACoV	O
was	O
genetically	O
most	O
similar	O
to	O
the	O
common	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
229E	O
with	O
92	O
.	O
2	O
%	O
nucleotide	O
identity	O
over	O
the	O
entire	O
genome	O
.	O

The	O
results	O
highlight	O
the	O
need	O
to	O
strengthen	O
,	O
amongst	O
the	O
health	O
staff	O
,	O
the	O
knowledge	O
of	O
the	O
guidelines	O
for	O
the	O
clinical	O
care	O
of	O
malaria	O
patients	O
,	O
in	O
order	B-SPEC
to	O
make	O
a	O
correct	O
clinical	O
diagnosis	O
and	O
provide	O
appropriate	O
treatment	O
.	O

TITLE	O
:	O
Three	O
-	O
dimensional	O
architecture	O
and	O
biogenesis	O
of	O
membrane	O
structures	O
associated	O
with	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
replication	O
.	O

TITLE	O
:	O
Enhanced	O
CD8	O
T	O
-	O
cell	O
anti	O
-	O
viral	O
function	O
and	O
clinical	O
disease	O
in	O
B7	O
-	O
H1	O
-	O
deficient	O
mice	B-SPEC
requires	O
CD4	O
T	O
cells	O
during	O
encephalomyelitis	O
.	O

With	O
an	O
exchange	O
of	O
nearly	O
one	O
-	O
third	O
of	O
the	O
genome	O
with	O
other	O
members	O
of	O
alphacoronaviruses	O
,	O
the	O
new	O
emerging	O
virus	B-SPEC
could	O
gain	O
new	O
antigenicity	O
,	O
posing	O
a	O
threat	O
to	O
cats	B-SPEC
that	O
either	O
have	O
been	O
infected	O
with	O
a	O
type	O
I	O
virus	B-SPEC
before	O
or	O
never	O
have	O
been	O
infected	O
with	O
FCoV	O
.	O

In	O
nasopharyngeal	O
aspirates	O
the	O
following	O
viruses	B-SPEC
were	O
analyzed	O
by	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
:	O
cytomegalovirus	B-SPEC
,	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
,	O
parvovirus	B-SPEC
B19	I-SPEC
,	O
influenza	O
A	O
and	O
B	O
,	O
parainfluenza	O
viruses	B-SPEC
,	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
and	O
B	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
rhinovirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
,	O
229E	O
,	O
NL63	O
and	O
human	B-SPEC
bocavirus	I-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
viral	O
respiratory	O
infections	O
are	O
an	O
important	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
humans	B-SPEC
worldwide	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
of	O
human	B-SPEC
coronavirus	I-SPEC
infections	O
in	O
a	O
series	O
of	O
children	O
hospitalized	O
with	O
symptoms	O
of	O
acute	O
respiratory	O
tract	O
disease	O
in	O
a	O
one	O
-	O
year	O
period	O
in	O
Slovenia	O
.	O

Comparison	O
of	O
bat	B-SPEC
genomes	O
with	O
other	O
mammalian	B-SPEC
species	B-SPEC
has	O
provided	O
new	O
insights	O
into	O
bat	B-SPEC
biology	O
and	O
evolution	O
.	O

TITLE	O
:	O
Epimedium	B-SPEC
koreanum	I-SPEC
Nakai	I-SPEC
Water	O
Extract	O
Exhibits	O
Antiviral	O
Activity	O
against	O
Porcine	B-SPEC
Epidermic	O
Diarrhea	O
Virus	B-SPEC
In	O
Vitro	O
and	O
In	O
Vivo	O
.	O

We	O
have	O
screened	O
333	O
natural	O
oriental	O
herbal	O
medicines	O
to	O
search	O
for	O
new	O
antiviral	O
candidates	O
against	O
PEDV	B-SPEC
.	O

As	O
a	O
result	O
,	O
it	O
is	O
recommended	O
the	O
multiplex	O
nested	O
PCR	O
as	O
an	O
effective	O
tool	O
for	O
detecting	O
and	O
studying	O
the	O
molecular	O
epidemiology	O
of	O
various	O
mixed	O
infections	O
of	O
one	O
or	O
more	O
of	O
these	O
viruses	B-SPEC
in	O
poultry	O
.	O

The	O
delicate	O
balance	O
of	O
multiple	O
effects	O
of	O
DN	O
T	O
cells	O
may	O
lead	O
to	O
viral	O
persistence	O
in	O
MHV	B-SPEC
-	O
3	O
induced	O
hepatitis	O
.	O

ABSTRACT	O
:	O
Protection	O
of	O
the	O
human	B-SPEC
lung	O
from	O
infectious	O
agents	O
,	O
allergens	O
,	O
and	O
ultrafine	O
particles	O
is	O
difficult	O
with	O
current	O
technologies	O
.	O

Several	O
recent	O
studies	O
hypothesized	O
that	O
bats	B-SPEC
,	O
an	O
ancient	O
group	O
of	O
flying	O
mammals	B-SPEC
,	O
are	O
the	O
major	O
reservoir	O
of	O
several	O
important	O
RNA	O
virus	B-SPEC
families	O
from	O
which	O
other	O
mammalian	B-SPEC
viruses	B-SPEC
of	O
livestock	O
and	O
humans	B-SPEC
were	O
derived	O
.	O

Compared	O
with	O
the	O
control	O
group	O
,	O
the	O
mice	B-SPEC
in	O
high	O
-	O
fat	O
diet	O
group	O
and	O
the	O
two	O
virus	B-SPEC
infection	O
groups	O
had	O
significantly	O
increased	O
AST	O
and	O
ALT	O
levels	O
with	O
also	O
elevated	O
TC	O
and	O
LDL	O
-	O
C	O
levels	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
has	O
re	O
-	O
emerged	O
with	O
devastating	O
impact	O
in	O
central	O
China	O
since	O
October	O
2010	O
.	O

Proinflammatory	O
innate	O
and	O
adaptive	O
immune	O
responses	O
mediate	O
virus	B-SPEC
clearance	O
.	O

The	O
only	O
available	O
structural	O
information	O
on	O
coronavirus	B-SPEC
nsp1	O
is	O
the	O
nuclear	O
magnetic	O
resonance	O
(	O
NMR	O
)	O
structure	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
nsp1	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
from	O
the	O
betacoronavirus	B-SPEC
genus	B-SPEC
.	O

Here	O
we	O
present	O
the	O
first	O
nsp1	O
structure	O
from	O
an	O
alphacoronavirus	B-SPEC
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
nsp1	O
.	O

Fecal	O
RT	O
-	O
nPCR	O
results	O
were	O
used	O
to	O
calculate	O
the	O
probability	O
of	O
correctly	O
identifying	O
a	O
cheetah	B-SPEC
known	O
to	O
shed	O
virus	B-SPEC
given	O
multiple	O
hypothetical	O
fecal	O
collection	O
schedules	O
.	O

Because	O
some	O
cheetahs	B-SPEC
shed	O
virus	B-SPEC
intermittently	O
to	O
rarely	O
,	O
fecal	O
sampling	O
schedules	O
meant	O
to	O
identify	O
all	O
known	O
shedders	O
would	O
be	O
impractical	O
with	O
current	O
tests	O
and	O
eradication	O
of	O
virus	B-SPEC
from	O
the	O
population	O
unreasonable	O
.	O

We	O
previously	O
described	O
an	O
unusual	O
three	O
-	O
stemmed	O
pseudoknot	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
that	O
stimulated	O
-	O
1	O
PRF	O
.	O

ABSTRACT	O
:	O
Canine	O
infectious	O
respiratory	O
disease	O
(	O
CIRD	O
)	O
occurs	O
frequently	O
in	O
densely	O
housed	O
dog	B-SPEC
populations	O
.	O

By	O
study	O
day	O
14	O
dogs	B-SPEC
had	O
seroconverted	O
to	O
CRCoV	O
and	O
the	O
antibodies	O
raised	O
were	O
neutralising	O
against	O
both	O
homologous	O
and	O
heterologous	O
strains	O
of	O
CRCoV	O
in	O
vitro	O
,	O
thus	O
demonstrating	O
antigenic	O
homogeneity	O
among	O
CRCoV	O
strains	O
from	O
the	O
two	O
continents	O
.	O

HLA	O
tetramers	O
with	O
redirected	O
specificity	O
could	O
detect	O
antigen	O
-	O
specific	O
CD8	O
(+)	O
T	O
-	O
cell	O
responses	O
against	O
human	B-SPEC
cytomegalovirus	I-SPEC
,	O
hepatitis	O
B	O
(	O
HBV	B-SPEC
),	O
dengue	B-SPEC
virus	I-SPEC
(	O
DENV	O
),	O
and	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	O
)	O
infections	O
.	O

Even	O
though	O
the	O
S	O
protein	O
is	O
the	O
main	O
viral	O
factor	O
influencing	O
coronavirus	B-SPEC
infection	O
of	O
susceptible	O
cells	O
,	O
our	O
results	O
taken	O
together	O
indicate	O
that	O
a	O
functionally	O
active	O
HE	O
protein	O
enhances	O
the	O
infectious	O
properties	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
contributes	O
to	O
efficient	O
virus	B-SPEC
dissemination	O
in	O
cell	O
culture	O
.	O

TITLE	O
:	O
Anti	O
-	O
human	B-SPEC
coronavirus	I-SPEC
(	O
anti	O
-	O
HCoV	O
)	O
triterpenoids	O
from	O
the	O
leaves	O
of	O
Euphorbia	B-SPEC
neriifolia	I-SPEC
.	O

At	O
least	O
1	O
virus	B-SPEC
was	O
detected	O
in	O
382	O
(	O
84	O
%)	O
of	O
455	O
new	O
-	O
onset	O
illnesses	O
with	O
multiple	O
viruses	B-SPEC
identified	O
in	O
212	O
(	O
46	O
%).	O

Children	O
with	O
multiple	O
viruses	B-SPEC
detected	O
at	O
the	O
time	O
of	O
illness	O
onset	O
had	O
less	O
frequent	O
fever	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
0	O
.	O
56	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
0	O
.	O
35	O
,	O
0	O
.	O
90	O
),	O
however	O
,	O
these	O
children	O
more	O
often	O
had	O
illness	O
symptoms	O
lasting	O
over	O
7	O
days	O
(	O
OR	O
,	O
1	O
.	O
94	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
20	O
,	O
3	O
.	O
14	O
).	O

In	O
a	O
recent	O
article	O
,	O
van	O
Boheemen	O
et	O
al	O
.	O
demonstrated	O
how	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
sequencing	O
technology	O
and	O
bioinformatic	O
analysis	O
can	O
quickly	O
provide	O
critical	O
insight	O
into	O
the	O
viral	O
genome	O
sequence	O
,	O
phylogeny	O
,	O
replication	O
strategy	O
,	O
and	O
potential	O
drug	O
and	O
vaccine	O
targets	O
and	O
generate	O
tools	O
to	O
evaluate	O
the	O
possible	O
epidemic	O
risk	O
associated	O
with	O
this	O
novel	O
human	B-SPEC
virus	B-SPEC
.	O

Virus	B-SPEC
detection	O
rates	O
in	O
KD	O
patients	O
and	O
control	O
subjects	O
were	O
32	O
.	O
7	O
%	O
and	O
30	O
.	O
8	O
%,	O
respectively	O
(	O
P	O
=	O
0	O
.	O
811	O
).	O

Moreover	O
,	O
the	O
few	O
ASC	O
recruited	O
to	O
the	O
CNS	O
in	O
CXCL10	O
(-/-)	O
mice	B-SPEC
were	O
confined	O
to	O
the	O
vasculature	O
,	O
distinct	O
from	O
the	O
parenchymal	O
localization	O
in	O
wild	O
-	O
type	O
and	O
CXCL9	O
(-/-)	O
mice	B-SPEC
.	O

These	O
studies	O
reveal	O
that	O
the	O
SR	O
-	O
rich	O
linker	O
of	O
MHV	B-SPEC
N	O
is	O
necessary	O
but	O
not	O
sufficient	O
to	O
maintain	O
this	O
high	O
-	O
affinity	O
binding	O
to	O
N	O
.	O

Compression	O
of	O
trachea	B-SPEC
,	O
oesophagus	O
,	O
vascular	O
and	O
neural	O
structures	O
may	O
cause	O
dyspnoea	O
,	O
dysphagia	O
,	O
superior	O
vena	O
cava	O
syndrome	O
,	O
subclavian	O
vein	O
thrombosis	O
,	O
hoarseness	O
,	O
and	O
Horner	O
'	O
s	O
syndrome	O
.	O

TITLE	O
:	O
One	O
step	O
closer	O
to	O
an	O
experimental	O
infection	O
system	O
for	O
Hepatitis	B-SPEC
B	I-SPEC
Virus	I-SPEC
?	O

Acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
is	O
rare	O
but	O
must	O
be	O
considered	O
when	O
the	O
appropriate	O
clinical	O
and	O
radiological	O
pattern	O
occurs	O
.	O

ARDS	O
and	O
presence	O
of	O
severe	O
sepsis	B-SPEC
were	O
determined	O
daily	O
during	O
intensive	O
care	O
.	O

As	O
important	O
,	O
HCoV	O
-	O
EMC	O
does	O
not	O
enter	O
cells	O
using	O
the	O
SARS	O
-	O
CoV	O
receptor	O
,	O
human	B-SPEC
angiotensin	O
-	O
converting	O
receptor	O
-	O
2	O
(	O
hACE2	O
).	O

TITLE	O
:	O
Phenolic	O
phytochemical	O
displaying	O
SARS	O
-	O
CoV	O
papain	O
-	O
like	O
protease	O
inhibition	O
from	O
the	O
seeds	O
of	O
Psoralea	B-SPEC
corylifolia	I-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
is	O
a	O
key	O
enzyme	O
that	O
plays	O
an	O
important	O
role	O
in	O
SARS	O
virus	B-SPEC
replication	O
.	O

Adenovirus	B-SPEC
serotype	O
7	O
and	O
3	O
can	O
cause	O
severe	O
disease	O
-	O
even	O
death	O
-	O
in	O
children	O
,	O
especially	O
those	O
with	O
underlying	O
neurological	O
diseases	O
.	O

In	O
severe	O
sepsis	B-SPEC
,	O
levels	O
of	O
the	O
NOS	O
substrate	O
citrulline	O
are	O
low	O
and	O
are	O
associated	O
with	O
ARDS	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
determine	O
whether	O
citrulline	O
supplementation	O
could	O
prevent	O
the	O
development	O
of	O
ARDS	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
to	O
determine	O
its	O
role	O
in	O
NOS	O
coupling	O
and	O
function	O
.	O

These	O
vectors	O
can	O
be	O
used	O
as	O
tools	O
to	O
visualize	O
autophagosome	O
formation	O
and	O
fusion	O
with	O
endosomes	O
/	O
lysosomes	O
in	O
avian	B-SPEC
cells	O
and	O
provide	O
a	O
valuable	O
resource	O
for	O
studying	O
autophagy	O
in	O
avian	B-SPEC
cells	O
.	O

However	O
,	O
expression	O
of	O
IBV	B-SPEC
nonstructural	O
protein	O
6	O
alone	O
did	O
induce	O
autophagic	O
signaling	O
in	O
avian	B-SPEC
cells	O
,	O
as	O
seen	O
previously	O
in	O
mammalian	B-SPEC
cells	O
.	O

Further	O
studies	O
show	O
that	O
PEDV	B-SPEC
E	O
protein	O
induced	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
activated	O
NF	O
-	O
B	O
which	O
is	O
responsible	O
for	O
the	O
up	O
-	O
regulation	O
of	O
IL	O
-	O
8	O
and	O
Bcl	O
-	O
2	O
expression	O
.	O

We	O
report	O
the	O
spontaneous	O
formation	O
of	O
a	O
stable	O
nanoparticle	O
-	O
IFN	O
protein	O
corona	B-SPEC
,	O
which	O
was	O
exploited	O
to	O
generate	O
IFN	O
-	O
loaded	O
spheres	O
,	O
obviating	O
the	O
need	O
to	O
specifically	O
couple	O
the	O
cytokine	O
to	O
the	O
nanoparticles	O
(	O
NPs	O
).	O

In	O
comparison	O
with	O
free	O
IFN	O
,	O
IFN	O
-	O
loaded	O
spheres	O
resulted	O
in	O
a	O
more	O
sustained	O
biologically	O
relevant	O
STAT1	O
activation	O
,	O
demonstrated	O
also	O
by	O
conferring	O
innate	O
cellular	O
immunity	O
against	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	O
)	O
infection	O
.	O

TITLE	O
:	O
Altering	O
SARS	O
coronavirus	B-SPEC
frameshift	O
efficiency	O
affects	O
genomic	O
and	O
subgenomic	O
RNA	O
production	O
.	O

Here	O
,	O
viruses	B-SPEC
with	O
synonymous	O
codon	O
changes	O
are	O
shown	O
to	O
produce	O
different	O
ratios	O
of	O
genomic	O
and	O
subgenomic	O
RNA	O
.	O

Recent	O
studies	O
have	O
suggested	O
these	O
viruses	B-SPEC
can	O
cause	O
severe	O
lower	O
respiratory	O
tract	O
illnesses	O
in	O
children	O
.	O

We	O
retrospectively	O
identified	O
patients	O
with	O
positive	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
respiratory	O
specimens	O
between	O
December	O
2009	O
and	O
December	O
2010	O
in	O
a	O
pediatric	O
hospital	O
in	O
Montreal	O
.	O

Each	O
case	O
was	O
compared	O
with	O
2	O
controls	O
(	O
tested	O
negative	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
).	O

In	O
summary	O
the	O
Puumala	O
infection	O
bears	B-SPEC
the	O
potential	O
for	O
a	O
severe	O
multi	O
-	O
organ	O
failure	O
,	O
which	O
is	O
not	O
typical	O
for	O
this	O
usually	O
benign	O
infection	O
.	O

TITLE	O
:	O
Adjuvant	O
activity	O
of	O
Sargassum	B-SPEC
pallidum	I-SPEC
polysaccharides	O
against	O
combined	O
Newcastle	O
disease	O
,	O
infectious	O
bronchitis	O
and	O
avian	B-SPEC
influenza	O
inactivated	O
vaccines	O
.	O

The	O
adjuvanticity	O
of	O
Sargassum	B-SPEC
pallidum	I-SPEC
polysaccharides	O
in	O
Newcastle	O
disease	O
(	O
ND	O
),	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
and	O
avian	B-SPEC
influenza	O
(	O
AI	O
)	O
was	O
investigated	O
by	O
examining	O
the	O
antibody	O
titers	O
and	O
lymphocyte	O
proliferation	O
following	O
immunization	O
in	O
chickens	B-SPEC
.	O

Data	O
from	O
193	O
patients	O
(	O
44	O
	O
18	O
y	O
;	O
77	O
%	O
male	O
;	O
admission	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
4	O
	O
2	O
)	O
were	O
reviewed	O
.	O

ABSTRACT	O
:	O
The	O
large	O
diversity	O
of	O
viruses	B-SPEC
that	O
exist	O
in	O
human	B-SPEC
populations	O
are	O
potentially	O
excreted	O
into	O
sewage	O
collection	O
systems	O
and	O
concentrated	O
in	O
sewage	O
sludge	O
.	O

TITLE	O
:	O
[	O
A	O
case	O
of	O
miliary	O
tuberculosis	O
complicated	O
by	O
disseminated	O
intravascular	O
coagulation	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
successfully	O
treated	O
with	O
recombinant	O
human	B-SPEC
soluble	O
thrombomodulin	O
].	O

ABSTRACT	O
:	O
To	O
provide	O
an	O
update	O
to	O
the	O
""""	O
Surviving	O
Sepsis	B-SPEC
Campaign	O
Guidelines	O
for	O
Management	O
of	O
Severe	O
Sepsis	B-SPEC
and	O
Septic	O
Shock	O
","""	O
last	O
published	O
in	O
2008	O
.	O

The	O
genome	O
contains	O
27	O
,	O
695	O
nucleotides	O
(	O
nt	O
),	O
and	O
possesses	O
a	O
genomic	O
structure	O
similar	O
to	O
other	O
IBV	B-SPEC
strains	O
.	O

TITLE	O
:	O
Surviving	O
Sepsis	B-SPEC
Campaign	O
:	O
international	O
guidelines	O
for	O
management	O
of	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
2012	O
.	O

RESULTS	O
:	O
Key	O
recommendations	O
and	O
suggestions	O
,	O
listed	O
by	O
category	O
,	O
include	O
:	O
early	O
quantitative	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
h	O
after	O
recognition	O
(	O
1C	O
);	O
blood	O
cultures	O
before	O
antibiotic	O
therapy	O
(	O
1C	O
);	O
imaging	O
studies	O
performed	O
promptly	O
to	O
confirm	O
a	O
potential	O
source	O
of	O
infection	O
(	O
UG	O
);	O
administration	O
of	O
broad	O
-	O
spectrum	O
antimicrobials	O
therapy	O
within	O
1	O
h	O
of	O
the	O
recognition	O
of	O
septic	O
shock	O
(	O
1B	O
)	O
and	O
severe	O
sepsis	B-SPEC
without	O
septic	O
shock	O
(	O
1C	O
)	O
as	O
the	O
goal	O
of	O
therapy	O
;	O
reassessment	O
of	O
antimicrobial	O
therapy	O
daily	O
for	O
de	O
-	O
escalation	O
,	O
when	O
appropriate	O
(	O
1B	O
);	O
infection	O
source	O
control	O
with	O
attention	O
to	O
the	O
balance	O
of	O
risks	O
and	O
benefits	O
of	O
the	O
chosen	O
method	O
within	O
12	O
h	O
of	O
diagnosis	O
(	O
1C	O
);	O
initial	O
fluid	O
resuscitation	O
with	O
crystalloid	O
(	O
1B	O
)	O
and	O
consideration	O
of	O
the	O
addition	O
of	O
albumin	O
in	O
patients	O
who	O
continue	O
to	O
require	O
substantial	O
amounts	O
of	O
crystalloid	O
to	O
maintain	O
adequate	O
mean	O
arterial	O
pressure	O
(	O
2C	O
)	O
and	O
the	O
avoidance	O
of	O
hetastarch	O
formulations	O
(	O
1B	O
);	O
initial	O
fluid	O
challenge	O
in	O
patients	O
with	O
sepsis	B-SPEC
-	O
induced	O
tissue	O
hypoperfusion	O
and	O
suspicion	O
of	O
hypovolemia	O
to	O
achieve	O
a	O
minimum	O
of	O
30	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
more	O
rapid	O
administration	O
and	O
greater	O
amounts	O
of	O
fluid	O
may	O
be	O
needed	O
in	O
some	O
patients	O
(	O
1C	O
);	O
fluid	O
challenge	O
technique	O
continued	O
as	O
long	O
as	O
hemodynamic	O
improvement	O
is	O
based	O
on	O
either	O
dynamic	O
or	O
static	O
variables	O
(	O
UG	O
);	O
norepinephrine	O
as	O
the	O
first	O
-	O
choice	O
vasopressor	O
to	O
maintain	O
mean	O
arterial	O
pressure	O
	O
65	O
mmHg	O
(	O
1B	O
);	O
epinephrine	O
when	O
an	O
additional	O
agent	O
is	O
needed	O
to	O
maintain	O
adequate	O
blood	O
pressure	O
(	O
2B	O
);	O
vasopressin	O
(	O
0	O
.	O
03	O
U	O
/	O
min	O
)	O
can	O
be	O
added	O
to	O
norepinephrine	O
to	O
either	O
raise	O
mean	O
arterial	O
pressure	O
to	O
target	O
or	O
to	O
decrease	O
norepinephrine	O
dose	O
but	O
should	O
not	O
be	O
used	O
as	O
the	O
initial	O
vasopressor	O
(	O
UG	O
);	O
dopamine	O
is	O
not	O
recommended	O
except	O
in	O
highly	O
selected	O
circumstances	O
(	O
2C	O
);	O
dobutamine	O
infusion	O
administered	O
or	O
added	O
to	O
vasopressor	O
in	O
the	O
presence	O
of	O
(	O
a	O
)	O
myocardial	O
dysfunction	O
as	O
suggested	O
by	O
elevated	O
cardiac	O
filling	O
pressures	O
and	O
low	O
cardiac	O
output	O
,	O
or	O
(	O
b	O
)	O
ongoing	O
signs	O
of	O
hypoperfusion	O
despite	O
achieving	O
adequate	O
intravascular	O
volume	O
and	O
adequate	O
mean	O
arterial	O
pressure	O
(	O
1C	O
);	O
avoiding	O
use	O
of	O
intravenous	O
hydrocortisone	O
in	O
adult	O
septic	O
shock	O
patients	O
if	O
adequate	O
fluid	O
resuscitation	O
and	O
vasopressor	O
therapy	O
are	O
able	O
to	O
restore	O
hemodynamic	O
stability	O
(	O
2C	O
);	O
hemoglobin	O
target	O
of	O
7	O
-	O
9	O
g	O
/	O
dL	O
in	O
the	O
absence	O
of	O
tissue	O
hypoperfusion	O
,	O
ischemic	O
coronary	O
artery	O
disease	O
,	O
or	O
acute	O
hemorrhage	O
(	O
1B	O
);	O
low	O
tidal	O
volume	O
(	O
1A	O
)	O
and	O
limitation	O
of	O
inspiratory	O
plateau	O
pressure	O
(	O
1B	O
)	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
application	O
of	O
at	O
least	O
a	O
minimal	O
amount	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
in	O
ARDS	O
(	O
1B	O
);	O
higher	O
rather	O
than	O
lower	O
level	O
of	O
PEEP	O
for	O
patients	O
with	O
sepsis	B-SPEC
-	O
induced	O
moderate	O
or	O
severe	O
ARDS	O
(	O
2C	O
);	O
recruitment	O
maneuvers	O
in	O
sepsis	B-SPEC
patients	O
with	O
severe	O
refractory	O
hypoxemia	O
due	O
to	O
ARDS	O
(	O
2C	O
);	O
prone	O
positioning	O
in	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
patients	O
with	O
a	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
ratio	O
of	O
	O
100	O
mm	O
Hg	O
in	O
facilities	O
that	O
have	O
experience	O
with	O
such	O
practices	O
(	O
2C	O
);	O
head	O
-	O
of	O
-	O
bed	O
elevation	O
in	O
mechanically	O
ventilated	O
patients	O
unless	O
contraindicated	O
(	O
1B	O
);	O
a	O
conservative	O
fluid	O
strategy	O
for	O
patients	O
with	O
established	O
ARDS	O
who	O
do	O
not	O
have	O
evidence	O
of	O
tissue	O
hypoperfusion	O
(	O
1C	O
);	O
protocols	O
for	O
weaning	O
and	O
sedation	O
(	O
1A	O
);	O
minimizing	O
use	O
of	O
either	O
intermittent	O
bolus	O
sedation	O
or	O
continuous	O
infusion	O
sedation	O
targeting	O
specific	O
titration	O
endpoints	O
(	O
1B	O
);	O
avoidance	O
of	O
neuromuscular	O
blockers	O
if	O
possible	O
in	O
the	O
septic	O
patient	O
without	O
ARDS	O
(	O
1C	O
);	O
a	O
short	O
course	O
of	O
neuromuscular	O
blocker	O
(	O
no	O
longer	O
than	O
48	O
h	O
)	O
for	O
patients	O
with	O
early	O
ARDS	O
and	O
a	O
PaO	O
(	O
2	O
)/	O
FI	O
O	O
(	O
2	O
)	O
<	O
150	O
mm	O
Hg	O
(	O
2C	O
);	O
a	O
protocolized	O
approach	O
to	O
blood	O
glucose	O
management	O
commencing	O
insulin	O
dosing	O
when	O
two	O
consecutive	O
blood	O
glucose	O
levels	O
are	O
>	O
180	O
mg	O
/	O
dL	O
,	O
targeting	O
an	O
upper	O
blood	O
glucose	O
	O
180	O
mg	O
/	O
dL	O
(	O
1A	O
);	O
equivalency	O
of	O
continuous	O
veno	O
-	O
venous	O
hemofiltration	O
or	O
intermittent	O
hemodialysis	O
(	O
2B	O
);	O
prophylaxis	O
for	O
deep	O
vein	O
thrombosis	O
(	O
1B	O
);	O
use	O
of	O
stress	O
ulcer	O
prophylaxis	O
to	O
prevent	O
upper	O
gastrointestinal	O
bleeding	O
in	O
patients	O
with	O
bleeding	O
risk	O
factors	O
(	O
1B	O
);	O
oral	O
or	O
enteral	O
(	O
if	O
necessary	O
)	O
feedings	O
,	O
as	O
tolerated	O
,	O
rather	O
than	O
either	O
complete	O
fasting	O
or	O
provision	O
of	O
only	O
intravenous	O
glucose	O
within	O
the	O
first	O
48	O
h	O
after	O
a	O
diagnosis	O
of	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
(	O
2C	O
);	O
and	O
addressing	O
goals	O
of	O
care	O
,	O
including	O
treatment	O
plans	O
and	O
end	O
-	O
of	O
-	O
life	O
planning	O
(	O
as	O
appropriate	O
)	O
(	O
1B	O
),	O
as	O
early	O
as	O
feasible	O
,	O
but	O
within	O
72	O
h	O
of	O
intensive	O
care	O
unit	O
admission	O
(	O
2C	O
).	O

TITLE	O
:	O
Comparison	O
of	O
Anyplex	O
II	O
RV16	O
with	O
the	O
xTAG	O
respiratory	O
viral	O
panel	O
and	O
Seeplex	O
RV15	O
for	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
.	O

For	O
specimens	O
with	O
discrepant	O
results	O
,	O
monoplex	B-SPEC
PCR	O
and	O
sequencing	O
of	O
the	O
target	O
viruses	B-SPEC
were	O
performed	O
.	O

The	O
recent	O
implication	O
of	O
a	O
novel	O
beta	O
(	O
	O
)-	O
CoV	O
as	O
the	O
cause	O
of	O
fatal	O
respiratory	O
disease	O
in	O
the	O
Middle	O
East	O
emphasizes	O
the	O
importance	O
of	O
surveillance	O
for	O
CoVs	O
that	O
have	O
potential	O
to	O
move	O
from	O
bats	B-SPEC
into	O
the	O
human	B-SPEC
population	O
.	O

Analyses	O
of	O
these	O
viruses	B-SPEC
in	O
the	O
context	O
of	O
their	O
hosts	O
and	O
ecological	O
habitat	O
indicated	O
that	O
host	O
species	B-SPEC
is	O
a	O
strong	O
selective	O
driver	O
in	O
CoV	O
evolution	O
,	O
even	O
in	O
allopatric	O
populations	O
separated	O
by	O
significant	O
geographical	O
distance	O
;	O
and	O
that	O
a	O
single	O
species	B-SPEC
/	O
genus	B-SPEC
of	O
bat	B-SPEC
can	O
contain	O
multiple	O
CoVs	O
.	O

While	O
it	O
is	O
important	O
to	O
investigate	O
unknown	O
viral	O
diversity	O
in	O
bats	B-SPEC
,	O
it	O
is	O
also	O
important	O
to	O
remember	O
that	O
the	O
majority	O
of	O
viruses	B-SPEC
they	O
carry	O
will	O
not	O
pose	O
any	O
clinical	O
risk	O
,	O
and	O
bats	B-SPEC
should	O
not	O
be	O
stigmatized	O
ubiquitously	O
as	O
significant	O
threats	O
to	O
public	O
health	O
.	O

CONCLUSIONS	O
:	O
The	O
presence	O
of	O
the	O
allele	O
D	O
of	O
the	O
ACE	O
gene	O
is	O
associated	O
with	O
ARDS	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

By	O
bioinformatic	O
and	O
systems	O
biology	O
approaches	O
,	O
we	O
evaluated	O
the	O
impact	O
of	O
nuclear	O
import	O
antagonism	O
on	O
host	O
expression	O
networks	O
by	O
using	O
human	B-SPEC
lung	O
epithelial	O
cells	O
infected	O
with	O
either	O
wild	O
-	O
type	O
virus	B-SPEC
or	O
a	O
mutant	O
that	O
does	O
not	O
express	O
ORF6	O
protein	O
.	O

The	O
American	O
Academy	O
of	O
Pediatrics	O
,	O
Elk	B-SPEC
Grove	O
Village	O
,	O
Ill	O
.,	O
recommends	O
that	O
breastfeeding	O
should	O
be	O
exclusive	O
for	O
about	O
the	O
first	O
six	O
months	O
of	O
life	O
and	O
should	O
continue	O
,	O
with	O
the	O
introduction	O
of	O
appropriate	O
complementary	O
foods	O
,	O
to	O
at	O
least	O
age	O
12	O
months	O
or	O
beyond	O
,	O
as	O
desired	O
by	O
mother	O
and	O
child	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
a	O
well	O
-	O
known	O
cause	O
of	O
respiratory	O
infections	O
but	O
their	O
role	O
in	O
gastrointestinal	O
infections	O
is	O
unclear	O
.	O

All	O
four	O
HCoVs	O
species	B-SPEC
were	O
detected	O
in	O
stool	O
and	O
NP	O
samples	O
.	O

TITLE	O
:	O
Genetic	O
variation	O
of	O
nucleocapsid	O
genes	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
field	O
strains	O
in	O
China	O
.	O

ABSTRACT	O
:	O
The	O
protective	O
efficacy	O
of	O
DNA	O
plasmids	O
encoding	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
S1	O
,	O
N	O
,	O
or	O
M	O
protein	O
was	O
investigated	O
in	O
chickens	B-SPEC
.	O

Antibody	O
titers	O
of	O
the	O
chickens	B-SPEC
immunized	O
with	O
pVAX1	O
-	O
16S1	O
/	O
M	O
/	O
N	O
were	O
much	O
higher	O
than	O
those	O
of	O
the	O
monovalent	O
groups	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
acute	O
diarrhea	O
and	O
dehydration	O
with	O
high	O
mortality	O
rates	O
in	O
swine	B-SPEC
.	O

In	O
this	O
study	O
,	O
the	O
N	O
genes	O
of	O
15	O
PEDV	B-SPEC
strains	O
were	O
amplified	O
by	O
RT	O
-	O
PCR	O
and	O
cloned	O
into	O
the	O
pMT	O
-	O
19T	O
vector	O
,	O
sequenced	O
,	O
and	O
compared	O
to	O
each	O
other	O
as	O
well	O
as	O
to	O
PEDV	B-SPEC
reference	O
strains	O
.	O

TITLE	O
:	O
The	O
required	O
sample	O
size	O
in	O
vaccination	O
-	O
challenge	O
experiments	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
a	O
meta	B-SPEC
-	O
analysis	O
.	O

ABSTRACT	O
:	O
For	O
statistical	O
,	O
animal	B-SPEC
welfare	O
and	O
financial	O
reasons	O
the	O
choice	O
of	O
the	O
number	O
of	O
chickens	B-SPEC
per	O
group	O
in	O
experiments	O
is	O
important	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
the	O
relationship	O
between	O
angiogenic	O
factors	O
,	O
their	O
soluble	O
receptors	O
and	O
ALI	O
/	O
ARDS	O
associated	O
with	O
critically	O
ill	O
patients	O
,	O
including	O
sepsis	B-SPEC
,	O
severe	O
trauma	O
,	O
and	O
post	O
-	O
cardiac	O
arrest	O
syndrome	O
(	O
PCAS	O
).	O

The	O
cause	O
of	O
bronchiolitis	O
was	O
a	O
coronavirus	B-SPEC
NL63	O
viral	O
infection	O
,	O
confirmed	O
in	O
nasopharyngeal	O
aspirations	O
.	O

Genetic	O
typing	O
of	O
IBV	B-SPEC
,	O
which	O
involves	O
reverse	O
transcription	O
-	O
PCR	O
amplification	O
and	O
sequence	O
analysis	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
,	O
has	O
revolutionized	O
diagnosis	O
and	O
identification	O
of	O
this	O
virus	B-SPEC
by	O
making	O
it	O
possible	O
to	O
type	O
and	O
compare	O
the	O
relatedness	O
of	O
a	O
large	O
number	O
of	O
virus	B-SPEC
isolates	O
in	O
a	O
short	O
period	O
of	O
time	O
.	O

Two	O
ArkDPI	O
-	O
derived	O
vaccines	O
that	O
contain	O
a	O
higher	O
proportion	O
of	O
viruses	B-SPEC
with	O
S1	O
genes	O
that	O
become	O
selected	O
during	O
replication	O
in	O
chickens	B-SPEC
exhibited	O
more	O
rapid	O
establishment	O
of	O
those	O
selected	O
subpopulations	O
in	O
chickens	B-SPEC
,	O
produced	O
significantly	O
higher	O
viral	O
loads	O
in	O
tears	O
,	O
and	O
induced	O
higher	O
antibody	O
responses	O
compared	O
with	O
two	O
other	O
ArkDPI	O
vaccines	O
with	O
lower	O
proportions	O
of	O
viruses	B-SPEC
that	O
become	O
selected	O
in	O
chickens	B-SPEC
.	O

We	O
observed	O
lower	O
antibody	O
responses	O
to	O
the	O
vaccines	O
that	O
produced	O
lower	O
viral	O
loads	O
,	O
which	O
might	O
contribute	O
to	O
the	O
persistence	O
of	O
Ark	O
serotype	O
IBV	B-SPEC
vaccines	O
observed	O
in	O
commercial	O
flocks	O
.	O

Viruses	B-SPEC
harboring	O
such	O
mutations	O
exhibited	O
WT	O
replication	O
kinetics	O
,	O
confirming	O
that	O
PLP2	O
-	O
mediated	O
polyprotein	O
cleavage	O
was	O
intact	O
,	O
but	O
the	O
loss	O
of	O
DUB	O
activity	O
strikingly	O
enhanced	O
innate	O
immune	O
signaling	O
.	O

Our	O
objective	O
is	O
to	O
describe	O
prediction	O
models	O
for	O
surgical	O
patients	O
who	O
have	O
suspected	O
obstructive	O
sleep	O
apnea	O
(	O
OSA	B-SPEC
)	O
at	O
risk	O
for	O
postoperative	O
respiratory	O
complications	O
and	O
for	O
surgical	O
patients	O
at	O
risk	O
for	O
postoperative	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Furthermore	O
,	O
IFN	O
-	O
	O
production	O
in	O
the	O
lungs	O
was	O
significantly	O
reduced	O
in	O
IFN	O
-	O
	O
-	O
treated	O
mice	B-SPEC
,	O
compared	O
with	O
control	O
mice	B-SPEC
,	O
but	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
	O
production	O
was	O
almost	O
equivalent	O
for	O
both	O
groups	O
.	O

CCoV	O
type	O
II	O
is	O
divided	O
in	O
two	O
subtypes	O
,	O
CCoV	O
-	O
IIa	O
(	O
classical	O
strains	O
)	O
and	O
CCoV	O
-	O
IIb	O
,	O
with	O
CCoV	O
-	O
IIb	O
emerging	O
as	O
a	O
result	O
of	O
a	O
putative	O
recombination	O
between	O
CCoV	O
-	O
IIa	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Multiple	O
respiratory	O
viruses	B-SPEC
beyond	O
influenza	O
are	O
associated	O
with	O
significant	O
morbidity	O
and	O
mortality	O
among	O
adults	O
and	O
children	O
in	O
Mexico	O
City	O
.	O

All	O
63	O
patients	O
with	O
AKI	O
received	O
artesunate	O
and	O
12	O
(	O
19	O
%)	O
received	O
quinine	B-SPEC
after	O
failure	O
of	O
response	O
to	O
artesunate	O
.	O

More	O
patients	O
ever	O
experienced	O
acute	O
and	O
severe	O
acute	O
rejections	O
(	O
A	O
	O
2	O
;	O
both	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
lymphocytic	O
bronchiolitis	O
(	O
P	O
=	O
0	O
.	O
0006	O
)	O
in	O
BOS	B-SPEC
and	O
RAS	O
versus	O
control	O
.	O

To	O
expand	O
the	O
knowledge	O
on	O
fundamental	O
virus	B-SPEC
-	O
host	O
interactions	O
for	O
all	O
four	O
HCoVs	O
at	O
the	O
site	O
of	O
primary	O
infection	O
,	O
we	O
used	O
pseudostratified	O
HAE	O
cell	O
cultures	O
to	O
isolate	O
and	O
characterize	O
representative	O
clinical	O
HCoV	O
strains	O
directly	O
from	O
nasopharyngeal	O
material	O
.	O

TITLE	O
:	O
A	O
DNA	O
prime	O
-	O
protein	O
boost	O
vaccination	O
strategy	O
targeting	O
turkey	B-SPEC
coronavirus	B-SPEC
spike	O
protein	O
fragment	O
containing	O
neutralizing	O
epitope	O
against	O
infectious	O
challenge	O
.	O

TCoV	O
viral	O
RNA	O
loads	O
measured	O
by	O
quantitative	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
PCR	O
were	O
lower	O
in	O
vaccinated	O
turkeys	B-SPEC
than	O
those	O
in	O
challenge	O
control	O
turkeys	B-SPEC
.	O

The	O
turkeys	B-SPEC
in	O
G3	O
-	O
750DDP	O
produced	O
the	O
highest	O
level	O
of	O
TCoV	O
S	O
protein	O
-	O
specific	O
antibody	O
and	O
virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
titer	O
.	O

ABSTRACT	O
:	O
A	O
strong	O
cell	O
-	O
mediated	O
immunity	O
(	O
CMI	O
)	O
is	O
thought	O
to	O
be	O
indispensable	O
for	O
protection	O
against	O
infection	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
in	O
cats	B-SPEC
.	O

When	O
quantified	O
,	O
both	O
NK	O
cells	O
and	O
Tregs	O
were	O
drastically	O
depleted	O
from	O
the	O
peripheral	O
blood	O
,	O
mesenteric	O
lymph	O
node	O
(	O
LN	O
)	O
and	O
spleen	O
in	O
FIP	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
nucleotide	O
sequences	O
of	O
a	O
region	O
including	O
S1	O
,	O
S2	O
,	O
3a	O
,	O
3b	O
and	O
E	O
genes	O
of	O
twenty	O
-	O
seven	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
in	O
Korea	O
between	O
1990	O
-	O
2011	O
were	O
determined	O
and	O
phylogenetic	O
and	O
computational	O
recombination	O
analyses	O
were	O
conducted	O
.	O

ABSTRACT	O
:	O
In	O
September	O
2012	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
was	O
isolated	O
from	O
a	O
patient	O
in	O
Saudi	O
Arabia	O
who	O
had	O
died	O
of	O
an	O
acute	O
respiratory	O
illness	O
and	O
renal	O
failure	O
.	O

The	O
first	O
9	O
cases	O
were	O
in	O
individuals	O
resident	O
in	O
the	O
Middle	O
East	O
,	O
while	O
the	O
most	O
recent	O
3	O
cases	O
were	O
in	O
family	B-SPEC
members	O
resident	O
in	O
the	O
UK	O
.	O

The	O
index	O
case	O
in	O
the	O
UK	O
family	B-SPEC
cluster	O
had	O
travel	O
history	O
to	O
Pakistan	O
and	O
Saudi	O
Arabia	O
.	O

However	O
,	O
the	O
PS	O
was	O
found	O
to	O
provide	O
a	O
distinct	O
selective	O
advantage	O
to	O
MHV	B-SPEC
.	O

Thus	O
,	O
HCoV	O
-	O
EMC	O
can	O
utilize	O
a	O
broad	O
range	O
of	O
human	B-SPEC
cell	O
substrates	O
and	O
suppress	O
IFN	O
induction	O
,	O
but	O
it	O
does	O
not	O
reach	O
the	O
IFN	O
resistance	O
of	O
SARS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Autoprocessing	O
mechanism	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
(	O
SARS	O
-	O
CoV	O
3CLpro	O
)	O
from	O
its	O
polyproteins	O
.	O

The	O
stimulation	O
by	O
N	O
-	O
terminal	O
pro	O
-	O
sequence	O
removal	O
is	O
due	O
to	O
the	O
cis	B-SPEC
(	O
intra	O
-	O
dimer	O
and	O
inter	O
-	O
protomer	O
)	O
effect	O
of	O
formation	O
of	O
the	O
new	O
N	O
-	O
terminus	O
,	O
whereas	O
that	O
by	O
C	O
-	O
terminal	O
cleavage	O
is	O
due	O
to	O
removal	O
of	O
its	O
trans	O
(	O
inter	O
-	O
dimer	O
)	O
inhibitory	O
effect	O
.	O

The	O
main	O
target	O
damage	O
during	O
severe	O
sepsis	B-SPEC
is	O
the	O
endothelium	O
.	O

Phylogenetic	O
analysis	O
showed	O
that	O
recent	O
prevalent	O
Korean	O
PEDV	B-SPEC
field	O
isolates	O
are	O
closely	O
related	O
to	O
the	O
Chinese	O
field	O
strains	O
and	O
differ	O
genetically	O
from	O
the	O
European	O
strains	O
and	O
the	O
vaccine	O
strains	O
used	O
in	O
Korea	O
,	O
which	O
raises	O
questions	O
of	O
whether	O
a	O
new	O
-	O
type	O
PEDV	B-SPEC
vaccine	O
may	O
be	O
necessary	O
for	O
preventing	O
PEDV	B-SPEC
infection	O
more	O
effectively	O
in	O
Korea	O
.	O

In	O
August	O
2011	O
,	O
a	O
severe	O
infectious	O
disease	O
affecting	O
rabbits	B-SPEC
,	O
which	O
caused	O
42	O
%	O
mortality	O
,	O
occurred	O
in	O
Mianyang	O
,	O
Sichuan	O
Province	O
,	O
China	O
.	O

Expression	O
of	O
the	O
known	O
coronavirus	B-SPEC
receptors	O
ACE2	O
,	O
CD13	O
,	O
and	O
CEACAM1	O
did	O
not	O
facilitate	O
EMC	O
-	O
S	O
-	O
driven	O
transduction	O
,	O
suggesting	O
that	O
hCoV	O
-	O
EMC	O
uses	O
a	O
novel	O
receptor	O
for	O
entry	O
.	O

All	O
major	O
respiratory	O
viruses	B-SPEC
and	O
their	O
association	O
with	O
human	B-SPEC
ocular	O
disease	O
are	O
discussed	O
.	O

ABSTRACT	O
:	O
Poult	O
enteritis	O
complex	O
has	O
been	O
associated	O
with	O
enteritis	O
and	O
reduction	O
in	O
growth	O
rates	O
in	O
commercial	O
turkeys	B-SPEC
worldwide	O
.	O

We	O
illustrate	O
this	O
by	O
deriving	O
transmissibility	O
estimates	O
for	O
the	O
H3N2v	O
-	O
M	O
virus	B-SPEC
,	O
an	O
important	O
step	O
in	O
evaluating	O
the	O
possible	O
pandemic	O
threat	O
posed	O
by	O
this	O
virus	B-SPEC
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
dynamics	O
of	O
bovine	B-SPEC
corona	B-SPEC
virus	B-SPEC
(	O
BCV	B-SPEC
)	O
and	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
infections	O
in	O
dairy	O
herds	O
over	O
a	O
3	O
-	O
year	O
period	O
.	O

In	O
the	O
Southern	O
Regions	O
the	O
percentage	O
of	O
antibody	O
-	O
positive	O
herds	O
remained	O
persistently	O
high	O
(	O
75	O
-	O
100	O
%),	O
whereas	O
in	O
herds	O
based	O
in	O
the	O
Northern	O
Region	O
,	O
the	O
percentage	O
of	O
positive	O
herds	O
for	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
was	O
38	O
-	O
80	O
%	O
and	O
0	O
-	O
80	O
%,	O
respectively	O
,	O
with	O
antibody	O
levels	O
to	O
BRSV	B-SPEC
decreasing	O
over	O
time	O
.	O

ABSTRACT	O
:	O
A	O
27	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
with	O
acute	O
dyspnea	O
and	O
a	O
previous	O
respiratory	O
tract	O
infection	O
with	O
progressive	O
dyspnoea	O
and	O
chest	O
pain	O
over	O
2	O
weeks	O
.	O

Events	O
such	O
as	O
the	O
anthrax	B-SPEC
letters	O
of	O
2001	O
,	O
Hurricanes	O
Katrina	O
,	O
Irene	O
,	O
and	O
Sandy	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
outbreaks	O
,	O
and	O
the	O
2009	O
H1N1	O
influenza	O
pandemic	O
have	O
demonstrated	O
that	O
public	O
health	O
,	O
emergency	O
management	O
,	O
and	O
national	O
security	O
efforts	O
are	O
interconnected	O
.	O

Overall	O
case	O
fatality	O
rate	O
of	O
complicated	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
malaria	O
was	O
10	O
.	O
63	O
%.	O

The	O
incidences	O
of	O
pancreatic	O
sepsis	B-SPEC
,	O
multiple	O
organ	O
dysfunction	O
syndrome	O
and	O
mortality	O
were	O
lower	O
in	O
the	O
somatostatin	O
,	O
somatostatin	O
+	O
ulinastatin	O
,	O
somatostatin	O
+	O
S	O
miltiorrhiza	O
and	O
somatostatin	O
+	O
ulinastatin	O
+	O
S	O
miltiorrhiza	O
subgroups	O
compared	O
with	O
the	O
basic	O
treatment	O
subgroup	O
.	O

FCoV	O
RNA	O
was	O
detected	O
in	O
all	O
4	O
FIP	O
cat	B-SPEC
postmortem	O
samples	O
and	O
in	O
9	O
of	O
the	O
16	O
fecal	O
samples	O
from	O
contemporary	O
-	O
asymptomatic	O
cats	B-SPEC
.	O

Phylogenetic	O
analysis	O
showed	O
that	O
the	O
FIP	O
-	O
associated	O
strains	O
of	O
FCoV	O
from	O
the	O
outbreak	O
were	O
very	O
closely	O
related	O
to	O
the	O
fecally	O
derived	O
strains	O
of	O
FCoV	O
from	O
contemporary	O
-	O
asymptomatic	O
cats	B-SPEC
.	O

RESULTS	O
:	O
FCoV	O
RNA	O
was	O
detected	O
in	O
all	O
4	O
FIP	O
cat	B-SPEC
postmortem	O
samples	O
and	O
in	O
9	O
of	O
the	O
16	O
fecal	O
samples	O
from	O
contemporary	O
-	O
asymptomatic	O
cats	B-SPEC
.	O

The	O
primers	O
were	O
designed	O
on	O
the	O
basis	O
of	O
highly	O
conserved	O
regions	O
of	O
several	O
TGEV	B-SPEC
sequences	O
included	O
in	O
the	O
analysis	O
.	O

Secondary	O
bacterial	O
infections	O
were	O
common	O
after	O
hospitalization	O
and	O
included	O
sepsis	B-SPEC
(	O
33	O
.	O
3	O
%),	O
pneumonia	O
(	O
33	O
.	O
3	O
%),	O
and	O
urinary	O
tract	O
infection	O
(	O
50	O
.	O
0	O
%).	O

TITLE	O
:	O
Differential	O
cell	O
line	O
susceptibility	O
to	O
the	O
emerging	O
novel	O
human	B-SPEC
betacoronavirus	B-SPEC
2c	O
EMC	O
/	O
2012	O
:	O
implications	O
for	O
disease	O
pathogenesis	O
and	O
clinical	O
manifestation	O
.	O

TITLE	O
:	O
TMPRSS2	O
activates	O
the	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
for	O
cathepsin	O
-	O
independent	O
host	O
cell	O
entry	O
and	O
is	O
expressed	O
in	O
viral	O
target	O
cells	O
in	O
the	O
respiratory	O
epithelium	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
is	O
associated	O
with	O
the	O
common	O
cold	O
and	O
may	O
result	O
in	O
pneumonia	O
in	O
immunocompromised	O
patients	O
.	O

In	O
sum	O
,	O
our	O
results	O
indicate	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
can	O
employ	O
redundant	O
proteolytic	O
pathways	O
to	O
ensure	O
its	O
activation	O
in	O
host	O
cells	O
.	O

In	O
addition	O
,	O
our	O
observations	O
and	O
previous	O
work	O
suggest	O
that	O
diverse	O
human	B-SPEC
respiratory	O
viruses	B-SPEC
are	O
activated	O
by	O
TMPRSS2	O
,	O
which	O
may	O
constitute	O
a	O
target	O
for	O
antiviral	O
intervention	O
.	O

The	O
results	O
showed	O
that	O
the	O
ExoN	O
domain	O
is	O
closely	O
involved	O
in	O
the	O
activity	O
of	O
the	O
N7	O
-	O
MTase	O
,	O
suggesting	O
that	O
coronavirus	B-SPEC
N7	O
-	O
MTase	O
is	O
different	O
from	O
all	O
other	O
viral	O
N7	O
-	O
MTases	O
,	O
which	O
are	O
separable	O
from	O
other	O
structural	O
domains	O
located	O
in	O
the	O
same	O
polypeptide	O
.	O

Multiplex	O
reverse	O
-	O
transcription	O
PCR	O
was	O
performed	O
for	O
the	O
detection	O
of	O
viruses	B-SPEC
in	O
nasopharyngeal	O
aspirat	O
.	O

Polymyxin	O
B	O
-	O
immobilized	O
fiber	O
column	O
direct	O
hemoperfusion	O
(	O
PMX	O
-	O
DHP	O
)	O
is	O
a	O
medical	O
device	O
that	O
reduces	O
blood	O
endotoxin	O
levels	O
in	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
acalculous	O
cholecystitis	O
(	O
AAC	O
)	O
is	O
an	O
uncommon	O
condition	O
related	O
to	O
serious	O
clinical	O
conditions	O
,	O
such	O
as	O
surgery	O
,	O
trauma	O
,	O
burn	O
injuries	O
and	O
sepsis	B-SPEC
.	O

This	O
minireview	O
summarized	O
major	O
advances	O
of	O
recently	O
identified	O
coronaviruses	O
,	O
focusing	O
on	O
the	O
genome	O
structures	O
and	O
interspecies	O
jumping	O
mechanism	O
of	O
coronavirus	B-SPEC
.	O

The	O
transmissibility	O
and	O
pathogenesis	O
of	O
HCoV	O
-	O
EMC	O
remain	O
poorly	O
understood	O
,	O
and	O
elucidating	O
its	O
cellular	O
tropism	O
in	O
human	B-SPEC
respiratory	O
tissues	O
will	O
provide	O
mechanistic	O
insights	O
into	O
the	O
key	O
cellular	O
targets	O
for	O
virus	B-SPEC
propagation	O
and	O
spread	O
.	O

While	O
SARS	O
-	O
CoV	O
productively	O
replicated	O
in	O
lung	O
tissue	O
,	O
replication	O
in	O
human	B-SPEC
bronchial	O
tissue	O
was	O
limited	O
.	O

In	O
contrast	O
,	O
there	O
was	O
minimal	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
in	O
these	O
tissues	O
.	O

Here	O
we	O
show	O
that	O
TIM1	O
promotes	O
infection	O
of	O
retroviruses	B-SPEC
and	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
pseudotyped	O
with	O
a	O
range	O
of	O
viral	O
entry	O
proteins	O
,	O
in	O
particular	O
those	O
from	O
the	O
filovirus	B-SPEC
,	O
flavivirus	B-SPEC
,	O
New	O
World	O
arenavirus	B-SPEC
and	O
alphavirus	B-SPEC
families	O
.	O

TITLE	O
:	O
Mast	O
cells	O
in	O
Canine	O
parvovirus	B-SPEC
-	O
2	O
-	O
associated	O
enteritis	O
with	O
crypt	O
abscess	O
.	O

We	O
found	O
that	O
in	O
the	O
body	O
of	O
corpus	O
callosum	O
the	O
fractional	O
anisotropy	O
(	O
FA	O
)	O
was	O
significantly	O
reduced	O
,	O
whereas	O
mean	O
diffusivity	O
(	O
MD	O
)	O
and	O
radial	O
diffusivity	O
(	O
RD	O
)	O
were	O
increased	O
in	O
HIV	B-SPEC
patients	O
.	O

Analyzing	O
the	O
corona	B-SPEC
radiata	O
,	O
axial	O
diffusivity	O
(	O
AD	O
)	O
and	O
MD	O
were	O
significantly	O
increased	O
in	O
the	O
left	O
superior	O
region	O
,	O
MD	O
and	O
RD	O
were	O
increased	O
in	O
the	O
left	O
posterior	O
area	O
,	O
and	O
,	O
furthermore	O
,	O
MD	O
was	O
also	O
increased	O
in	O
the	O
right	O
posterior	O
region	O
.	O

We	O
also	O
investigate	O
the	O
subcellular	O
localization	O
and	O
function	O
of	O
PEDV	B-SPEC
N	O
protein	O
by	O
examining	O
its	O
effects	O
on	O
cell	O
growth	O
,	O
cycle	O
progression	O
,	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
expression	O
,	O
and	O
survival	O
.	O

TITLE	O
:	O
Metagenomic	O
study	O
of	O
the	O
viruses	B-SPEC
of	O
African	O
straw	O
-	O
coloured	O
fruit	O
bats	B-SPEC
:	O
detection	O
of	O
a	O
chiropteran	O
poxvirus	B-SPEC
and	O
isolation	O
of	O
a	O
novel	O
adenovirus	B-SPEC
.	O

In	O
sum	O
,	O
E	B-SPEC
.	I-SPEC
helvum	I-SPEC
display	O
a	O
wide	O
variety	O
of	O
mammalian	B-SPEC
viruses	B-SPEC
,	O
some	O
of	O
them	O
genetically	O
similar	O
to	O
known	O
human	B-SPEC
pathogens	O
,	O
highlighting	O
the	O
possibility	O
of	O
zoonotic	O
transmission	O
.	O

The	O
main	O
underlying	O
causes	O
of	O
ARDS	O
are	O
trauma	O
,	O
pancreatitis	O
,	O
and	O
pulmonary	O
manifestation	O
of	O
systemic	O
inflammatory	O
response	O
syndrome	O
/	O
sepsis	B-SPEC
.	O

Most	O
mountain	O
lions	B-SPEC
sampled	O
were	O
killed	O
because	O
of	O
depredation	O
or	O
public	O
safety	O
concerns	O
and	O
75	O
%	O
were	O
adults	O
.	O

Pathogens	O
detected	O
by	O
serosurvey	O
in	O
sampled	O
mountain	O
lions	B-SPEC
included	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
(	O
39	O
.	O
0	O
%),	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
33	O
.	O
0	O
%),	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
,	O
15	O
.	O
1	O
%),	O
feline	B-SPEC
herpesvirus	I-SPEC
(	O
13	O
.	O
0	O
%),	O
heartworm	O
(	O
12	O
.	O
4	O
%),	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
5	O
.	O
4	O
%),	O
and	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
3	O
%).	O

An	O
outbreak	O
of	O
heartworm	O
exposure	O
occurred	O
from	O
1995	O
to	O
2003	O
and	O
higher	O
than	O
expected	O
levels	O
of	O
FCoV	O
-	O
antibody	O
-	O
positive	O
mountain	O
lions	B-SPEC
were	O
observed	O
from	O
2005	O
to	O
2008	O
,	O
with	O
foci	O
in	O
southern	O
Mendocino	O
and	O
eastern	O
Lake	B-SPEC
counties	O
.	O

The	O
virus	B-SPEC
can	O
attack	O
many	O
organ	O
systems	O
and	O
causes	O
a	O
broad	O
range	O
of	O
signs	O
,	O
commonly	O
including	O
weight	O
loss	O
and	O
fever	O
.	O

Feline	B-SPEC
coronavirus	B-SPEC
antigen	O
was	O
detected	O
in	O
both	O
the	O
heart	O
and	O
intestinal	O
tissue	O
by	O
immunohistochemistry	O
.	O

To	O
review	O
the	O
epidemiological	O
,	O
pathogenetic	O
,	O
clinical	O
and	O
therapeutic	O
features	O
of	O
prenatal	O
and	O
perinatal	O
CMV	B-SPEC
lung	O
diseases	O
.	O

CMV	B-SPEC
is	O
frequent	O
and	O
severe	O
in	O
immunosuppressed	O
infants	O
but	O
infrequent	O
in	O
full	O
-	O
term	O
neonates	O
and	O
occurs	O
more	O
frequently	O
after	O
perinatal	O
than	O
after	O
congenital	O
infection	O
,	O
particularly	O
in	O
premature	O
infants	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
betacoronavirus	B-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
-	O
EMC	O
),	O
has	O
recently	O
been	O
detected	O
in	O
humans	B-SPEC
with	O
severe	O
respiratory	O
disease	O
.	O

In	O
this	O
study	O
,	O
we	O
compared	O
the	O
immunogenicity	O
and	O
protection	O
efficacy	O
of	O
recombinant	O
proteins	O
corresponding	O
to	O
different	O
domains	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

Trimeric	O
recombinant	O
proteins	O
were	O
created	O
by	O
fusing	O
the	O
foldon	O
domain	O
derived	O
from	O
T4	O
bacteriophage	B-SPEC
to	O
the	O
carboxy	O
-	O
termini	O
of	O
individual	O
domains	O
of	O
the	O
spike	O
protein	O
.	O

TITLE	O
:	O
Human	B-SPEC
monoclonal	O
antibodies	O
as	O
candidate	O
therapeutics	O
against	O
emerging	O
viruses	B-SPEC
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
.	O

However	O
,	O
in	O
the	O
last	O
decade	O
novel	O
potent	O
mAbs	O
have	O
been	O
discovered	O
and	O
characterized	O
with	O
potential	O
as	O
therapeutics	O
against	O
viruses	B-SPEC
of	O
major	O
importance	O
for	O
public	O
health	O
and	O
biosecurity	O
including	O
Hendra	B-SPEC
virus	I-SPEC
(	O
HeV	B-SPEC
),	O
Nipah	B-SPEC
virus	I-SPEC
(	O
NiV	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Ebola	B-SPEC
virus	I-SPEC
(	O
EBOV	O
),	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
(	O
WNV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
(	O
IFV	B-SPEC
)	O
and	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
).	O

No	O
specific	O
therapy	O
for	O
any	O
human	B-SPEC
coronavirus	I-SPEC
is	O
available	O
,	O
making	O
vaccine	O
development	O
critical	O
for	O
protection	O
against	O
these	O
viruses	B-SPEC
.	O

Immunization	O
with	O
this	O
virus	B-SPEC
completely	O
protected	O
mice	B-SPEC
of	O
three	O
ages	O
from	O
lethal	O
disease	O
and	O
effected	O
more	O
-	O
rapid	O
virus	B-SPEC
clearance	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
poultry	O
with	O
influenza	O
A	O
subtype	O
H7	O
viruses	B-SPEC
occurs	O
worldwide	O
,	O
but	O
the	O
introduction	O
of	O
this	O
subtype	O
to	O
humans	B-SPEC
in	O
Asia	O
has	O
not	O
been	O
observed	O
previously	O
.	O

A	O
novel	O
reassortant	O
avian	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
was	O
isolated	O
from	O
respiratory	O
specimens	O
obtained	O
from	O
all	O
three	O
patients	O
and	O
was	O
identified	O
as	O
H7N9	O
.	O

Novel	O
reassortant	O
H7N9	O
viruses	B-SPEC
were	O
associated	O
with	O
severe	O
and	O
fatal	O
respiratory	O
disease	O
in	O
three	O
patients	O
.	O

TITLE	O
:	O
Demonstration	O
of	O
Ornithobacterium	B-SPEC
rhinotracheale	I-SPEC
in	O
pheasants	O
(	O
Phasianus	B-SPEC
colchicus	I-SPEC
)	O
with	O
pneumonia	O
and	O
airsacculitis	O
.	O

TITLE	O
:	O
[	O
Diffuse	O
infiltrative	O
lung	O
disease	O
in	O
scleroderma	B-SPEC
.	O

ABSTRACT	O
:	O
Scleroderma	B-SPEC
(	O
SD	O
)	O
is	O
a	O
systemic	O
disease	O
that	O
predominantly	O
affects	O
the	O
skin	O
.	O

ABSTRACT	O
:	O
The	O
study	O
investigates	O
the	O
ability	O
of	O
subtype	O
A	O
Avian	B-SPEC
metapneumovirus	I-SPEC
(	O
AMPV	O
)	O
to	O
accept	O
foreign	O
genes	O
and	O
be	O
used	O
as	O
a	O
vector	O
for	O
delivery	O
of	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
QX	O
genes	O
to	O
chickens	B-SPEC
.	O

After	O
recombinant	O
virus	B-SPEC
had	O
been	O
recovered	O
by	O
reverse	O
genetics	O
,	O
GFP	O
positions	O
supporting	O
gene	O
expression	O
while	O
maintaining	O
virus	B-SPEC
viability	O
in	O
vitro	O
,	O
were	O
determined	O
.	O

Nonetheless	O
evidence	O
of	O
AMPV	O
/	O
IBV	B-SPEC
seroconversion	O
,	O
or	O
major	O
recombinant	O
tracheal	O
replication	O
,	O
were	O
largely	O
absent	O
.	O

The	O
mutant	O
virus	B-SPEC
had	O
similar	O
growth	O
kinetics	O
to	O
MHV	B-SPEC
-	O
A59	O
wild	O
-	O
type	O
virus	B-SPEC
in	O
17CI	O
-	O
1	O
cells	O
,	O
but	O
was	O
highly	O
attenuated	O
in	O
vivo	O
.	O

TITLE	O
:	O
Specific	O
serology	O
for	O
emerging	O
human	B-SPEC
coronaviruses	O
by	O
protein	O
microarray	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
PEDV	B-SPEC
infection	O
blocked	O
synthetic	O
dsRNA	O
-	O
induced	O
IFN	O
-	O
	O
production	O
by	O
interfering	O
with	O
the	O
activation	O
of	O
interferon	O
regulatory	O
factor	O
3	O
(	O
IRF3	O
).	O

These	O
results	O
show	O
that	O
PEDV	B-SPEC
infection	O
suppresses	O
production	O
of	O
IFN	O
-	O
	O
and	O
provides	O
evidence	O
indicating	O
that	O
the	O
PEDV	B-SPEC
papain	O
-	O
like	O
protease	O
2	O
acts	O
as	O
a	O
viral	O
DUB	O
to	O
interfere	O
with	O
the	O
RIG	O
-	O
I	O
-	O
and	O
STING	O
-	O
mediated	O
signalling	O
pathway	O
.	O

Molecular	O
clock	O
dating	O
analyses	O
of	O
coronaviruses	O
suggest	O
that	O
the	O
most	O
recent	O
common	O
ancestor	O
of	O
these	O
viruses	B-SPEC
existed	O
around	O
10	O
,	O
000	O
years	O
ago	O
.	O

The	O
amplified	O
product	O
of	O
the	O
FIP	O
virus	B-SPEC
(	O
223	O
-	O
bp	O
)	O
was	O
analyzed	O
within	O
10s	O
by	O
single	O
-	O
channel	O
ME	O
under	O
a	O
sieving	O
gel	O
of	O
0	O
.	O
3	O
%	O
poly	O
(	O
ethylene	O
oxide	O
)	O
(	O
Mr	O
=	O
8	O
,	O
000	O
,	O
000	O
)	O
in	O
1x	O
TBE	O
buffer	O
(	O
pH	O
8	O
.	O
33	O
)	O
and	O
a	O
short	O
effective	O
channel	O
length	O
of	O
1	O
.	O
3	O
cm	O
with	O
a	O
programmed	O
step	O
electric	O
field	O
strength	O
(	O
PSEFS	O
)	O
condition	O
as	O
follows	O
:	O
470	O
.	O
6	O
V	O
/	O
cm	O
for	O
9	O
s	O
,	O
294	O
.	O
1	O
V	O
/	O
cm	O
1	O
.	O
5	O
s	O
,	O
and	O
470	O
.	O
6	O
V	O
/	O
cm	O
for	O
9	O
.	O
5	O
s	O
.	O
The	O
single	O
-	O
channel	O
ME	O
/	O
PSEFS	O
method	O
was	O
50	O
times	O
faster	O
than	O
that	O
obtained	O
with	O
conventional	O
slab	O
gel	O
electrophoresis	O
.	O

Complications	O
and	O
outcomes	O
including	O
respiratory	O
and	O
abdominal	O
infection	O
,	O
sepsis	B-SPEC
,	O
abdominal	O
hemorrhage	O
,	O
intra	O
-	O
abdominal	O
hypertension	O
,	O
abdominal	O
compartment	O
syndrome	O
(	O
ACS	O
),	O
renal	O
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
multiple	O
organ	O
dysfunction	O
syndrome	O
(	O
MODS	O
),	O
operation	O
intervention	O
,	O
length	O
of	O
intensive	O
care	O
unit	O
stay	O
,	O
length	O
of	O
hospital	O
stay	O
,	O
and	O
mortality	O
at	O
60	O
d	O
were	O
compared	O
.	O

TITLE	O
:	O
Expression	O
and	O
Purification	O
of	O
the	O
scFv	O
from	O
hybridoma	O
cells	O
secreting	O
a	O
monoclonal	O
antibody	O
against	O
S	O
PROTEIN	O
of	O
PEDV	B-SPEC
.	O

The	O
recombinant	O
scFv	O
/	O
6E6	O
protein	O
was	O
successfully	O
expressed	O
in	O
recombinant	O
Escherichia	B-SPEC
coli	I-SPEC
by	O
IPTG	O
induction	O
.	O

Immunofluorescence	O
assays	O
showed	O
that	O
MAb	O
1H4	O
was	O
able	O
to	O
detect	O
infection	O
of	O
cells	O
with	O
TGEV	B-SPEC
.	O

TCoV	O
has	O
been	O
associated	O
with	O
poult	O
enteritis	O
complex	O
,	O
a	O
syndrome	O
that	O
severely	O
affects	O
turkey	B-SPEC
production	O
.	O

As	O
TCoV	O
does	O
not	O
grow	O
in	O
cell	O
culture	O
,	O
the	O
presence	O
of	O
residual	O
infectious	O
TCoV	O
in	O
the	O
stored	O
samples	O
was	O
tested	O
by	O
inoculating	O
embryonated	O
specific	O
pathogen	O
free	O
turkey	B-SPEC
eggs	O
.	O

C57BL	O
/	O
6	O
mice	B-SPEC
received	O
sequential	O
intratracheal	O
administration	O
of	O
	O
-	O
galactosylceramide	O
(	O
	O
-	O
GalCer	O
)	O
and	O
lipopolysaccharide	O
(	O
LPS	O
),	O
which	O
resulted	O
in	O
the	O
development	O
of	O
severe	O
ARDS	O
.	O

TITLE	O
:	O
Positive	O
immunostaining	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
a	O
Sphinx	B-SPEC
cat	B-SPEC
with	O
cutaneous	O
lesions	O
and	O
bilateral	O
panuveitis	O
.	O

Despite	O
the	O
improvements	O
in	O
surgical	O
techniques	O
and	O
perioperative	O
patient	O
management	O
,	O
postoperative	O
cardiopulmonary	O
complications	O
still	O
occur	O
in	O
20	O
%-	O
30	O
%	O
of	O
lung	O
cancer	B-SPEC
surgical	O
patients	O
.	O

Carriers	O
are	O
indeed	O
reported	O
to	O
have	O
various	O
advantageous	O
phenotypes	O
related	O
to	O
haemostasis	O
,	O
inflammation	O
and	O
fertility	O
:	O
less	O
acute	O
blood	O
loss	O
;	O
less	O
menstrual	O
blood	O
loss	O
;	O
decreased	O
risk	O
of	O
intracranial	O
haemorrhage	O
;	O
milder	O
phenotypes	O
of	O
haemophilia	O
;	O
higher	O
survival	O
in	O
and	O
lower	O
susceptibility	O
to	O
severe	O
sepsis	B-SPEC
;	O
higher	O
survival	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
less	O
severe	O
diabetic	O
nephropathy	O
and	O
higher	O
fecundity	O
in	O
both	O
men	O
and	O
women	O
.	O

Therefore	O
,	O
we	O
sought	O
evidence	O
for	O
genetic	O
susceptibility	O
to	O
FIP	O
using	O
feline	B-SPEC
high	O
density	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
arrays	O
in	O
a	O
genome	O
-	O
wide	O
association	O
study	O
(	O
GWAS	O
).	O

TITLE	O
:	O
MERS	O
-	O
coronavirus	B-SPEC
replication	O
induces	O
severe	O
in	O
vitro	O
cytopathology	O
and	O
is	O
strongly	O
inhibited	O
by	O
cyclosporin	O
A	O
or	O
interferon	O
-	O
	O
treatment	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
(	O
CoV	O
)	O
infections	O
are	O
commonly	O
associated	O
with	O
respiratory	O
and	O
enteric	O
disease	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
MERS	O
-	O
CoV	O
replication	O
and	O
cytotoxicity	O
in	O
human	B-SPEC
and	O
monkey	B-SPEC
cell	O
lines	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
is	O
an	O
important	O
antiviral	O
target	O
due	O
to	O
its	O
key	O
roles	O
in	O
SARS	O
virus	B-SPEC
replication	O
.	O

The	O
MeOH	O
extracts	O
of	O
the	O
fruits	O
of	O
the	O
Paulownia	B-SPEC
tree	O
yielded	O
many	O
small	O
molecules	O
capable	O
of	O
targeting	O
PLpro	O
.	O

The	O
RT	O
-	O
PCR	O
or	O
real	O
time	O
RT	O
-	O
PCR	O
assays	O
for	O
novel	O
HCoV	O
were	O
developed	O
without	O
cross	O
-	O
reactivity	O
with	O
other	O
HCoV	O
and	O
several	O
common	O
respiratory	O
viruses	B-SPEC
using	O
clinical	O
specimen	O
panel	O
.	O

There	O
were	O
annual	O
differences	O
in	O
the	O
prevalence	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

Interestingly	O
,	O
in	O
TGEV	B-SPEC
endodomain	O
chimeras	O
the	O
reverting	O
mutations	O
resulted	O
in	O
stronger	O
S	O
incorporation	O
into	O
virions	O
,	O
and	O
a	O
net	O
gain	O
of	O
negatively	O
charged	O
residues	O
in	O
the	O
charge	O
-	O
rich	O
motif	O
accounted	O
for	O
the	O
improvement	O
.	O

TITLE	O
:	O
Risk	O
factors	O
for	O
severe	O
acute	O
lower	O
respiratory	O
infections	O
in	O
children	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

We	O
conducted	O
a	O
quality	O
assessment	O
of	O
all	O
eligible	O
studies	O
according	O
to	O
GRADE	O
criteria	O
and	O
performed	O
a	O
meta	B-SPEC
-	O
analysis	O
to	O
report	O
the	O
odds	O
ratios	O
for	O
all	O
risk	O
factors	O
identified	O
in	O
these	O
studies	O
.	O

These	O
data	O
will	O
help	O
to	O
generate	O
hypotheses	O
and	O
make	O
rapid	O
advancements	O
in	O
characterizing	O
this	O
new	O
virus	B-SPEC
.	O

The	O
association	O
of	O
selected	O
cellular	O
proteins	O
with	O
IBV	B-SPEC
N	O
protein	O
was	O
confirmed	O
by	O
immunoblotting	O
,	O
cosedimentation	O
,	O
and	O
confocal	O
microscopy	O
.	O

Further	O
,	O
the	O
localization	O
of	O
selected	O
proteins	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
as	O
well	O
as	O
their	O
activity	O
during	O
virus	B-SPEC
infection	O
was	O
assessed	O
by	O
small	O
interfering	O
RNA	O
-	O
mediated	O
depletion	O
,	O
demonstrating	O
the	O
functional	O
importance	O
of	O
cellular	O
proteins	O
in	O
the	O
biology	O
of	O
IBV	B-SPEC
.	O

Additionally	O
,	O
using	O
a	O
dual	O
luciferase	O
assay	O
,	O
it	O
can	O
be	O
shown	O
that	O
a	O
hairpin	O
stimulated	O
+	O
1	O
frameshifting	O
when	O
placed	O
upstream	O
of	O
a	O
+	O
1	O
shifty	O
site	O
in	O
yeast	B-SPEC
.	O

The	O
situation	O
is	O
different	O
in	O
Europe	O
and	O
Australia	O
,	O
where	O
myxomatosis	O
and	O
rabbit	B-SPEC
hemorrhagic	O
disease	O
are	O
endemic	O
.	O

This	O
review	O
considers	O
viruses	B-SPEC
affecting	O
rabbits	B-SPEC
by	O
their	O
clinical	O
significance	O
.	O

ABSTRACT	O
:	O
Legionella	B-SPEC
-	O
associated	O
respiratory	O
failure	O
has	O
a	O
high	O
mortality	O
,	O
despite	O
modern	O
ventilation	O
modalities	O
.	O

TITLE	O
:	O
Dieckol	O
,	O
a	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
inhibitor	O
,	O
isolated	O
from	O
the	O
edible	O
brown	B-SPEC
algae	I-SPEC
Ecklonia	B-SPEC
cava	I-SPEC
.	O

Each	O
class	B-SPEC
of	O
mutants	O
clustered	O
on	O
SARS	O
-	O
CoV	O
nsp1	O
surface	O
and	O
suggested	O
nsp1	O
interacts	O
with	O
distinct	O
host	O
factors	O
to	O
exert	O
its	O
inhibitory	O
activities	O
.	O

ABSTRACT	O
:	O
Dengue	O
is	O
a	O
mosquito	B-SPEC
-	O
borne	O
viral	O
disease	O
endemic	O
in	O
many	O
countries	O
in	O
the	O
tropics	O
and	O
sub	O
-	O
tropics	O
.	O

Both	O
PEDV	B-SPEC
N	O
protein	O
and	O
the	O
polyclonal	O
antibody	O
generated	O
in	O
this	O
study	O
are	O
valuable	O
diagnostic	O
reagents	O
for	O
PEDV	B-SPEC
surveillance	O
.	O

TITLE	O
:	O
Phages	O
bearing	O
affinity	O
peptides	O
to	O
severe	O
acute	O
respiratory	O
syndromes	O
-	O
associated	O
coronavirus	B-SPEC
differentiate	O
this	O
virus	B-SPEC
from	O
other	O
viruses	B-SPEC
.	O

HFRS	O
is	O
considered	O
to	O
be	O
distinct	O
from	O
hantavirus	B-SPEC
(	O
cardio	O
-)	O
pulmonary	O
syndrome	O
(	O
HPS	O
or	O
HCPS	O
),	O
described	O
in	O
the	O
New	O
World	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
infection	O
induced	O
apoptosis	O
in	O
several	O
cell	O
lines	O
in	O
vitro	O
.	O

We	O
observed	O
that	O
TGEV	B-SPEC
infection	O
decreased	O
p300	O
/	O
CBP	O
,	O
downregulated	O
MDM2	O
and	O
promoted	O
p53	O
phosphorylation	O
at	O
serines	O
15	O
,	O
20	O
and	O
46	O
,	O
resulting	O
in	O
accumulation	O
and	O
activation	O
of	O
p53	O
in	O
PK	O
-	O
15	O
cells	O
.	O

TITLE	O
:	O
Upregulation	O
of	O
CHOP	O
/	O
GADD153	O
during	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
modulates	O
apoptosis	O
by	O
restricting	O
activation	O
of	O
the	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
pathway	O
.	O

Knockdown	O
of	O
PERK	O
by	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
suppressed	O
the	O
activation	O
of	O
GADD153	O
and	O
the	O
IBV	B-SPEC
-	O
induced	O
apoptosis	O
.	O

Analysis	O
of	O
the	O
pathways	O
downstream	O
of	O
GADD153	O
revealed	O
much	O
more	O
activation	O
of	O
the	O
extracellular	O
signal	O
-	O
related	O
kinase	O
(	O
ERK	O
)	O
pathway	O
in	O
GADD153	O
-	O
knockdown	O
cells	O
during	O
IBV	B-SPEC
infection	O
,	O
indicating	O
that	O
GADD153	O
may	O
modulate	O
apoptosis	O
through	O
suppression	O
of	O
the	O
pathway	O
.	O

In	O
a	O
controlled	O
laboratory	O
study	O
,	O
40	O
%	O
of	O
chickens	B-SPEC
vaccinated	O
with	O
a	O
combination	O
live	O
vaccine	O
containing	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
Massachusetts	O
(	O
Mass	O
)	O
+	O
Connecticut	O
(	O
Conn	O
)	O
were	O
positive	O
on	O
virus	B-SPEC
isolation	O
attempts	O
after	O
challenge	O
with	O
DMV	O
/	O
1639	O
/	O
11	O
,	O
compared	O
with	O
only	O
13	O
%	O
of	O
Mass	O
+	O
Arkansas	O
(	O
Ark	O
)	O
vaccinates	O
.	O

TITLE	O
:	O
Survival	O
of	O
Respiratory	O
Viruses	B-SPEC
on	O
Fresh	O
Produce	O
.	O

TITLE	O
:	O
A	O
Simulation	O
Framework	O
to	O
Investigate	O
ABSTRACT	O
:	O
Virus	B-SPEC
infection	O
is	O
a	O
complex	O
biological	O
phenomenon	O
for	O
which	O

We	O
describe	O
a	O
number	O
of	O
experimental	O
therapies	O
that	O
have	O
shown	O
promise	O
in	O
preventing	O
or	O
reversing	O
increased	O
vascular	O
leak	O
in	O
animal	B-SPEC
models	O
of	O
sepsis	B-SPEC
or	O
influenza	O
.	O

However	O
,	O
ARDS	O
is	O
less	O
often	O
described	O
with	O
other	O
Plasmodium	B-SPEC
species	B-SPEC
.	O

Compared	O
with	O
quinine	B-SPEC
,	O
intravenous	O
artemisinin	O
compounds	O
(	O
artesunate	O
,	O
arteether	O
,	O
artemether	O
)	O
are	O
well	O
tolerated	O
by	O
patients	O
and	O
have	O
fewer	O
side	O
effects	O
.	O

Among	O
infants	O
with	O
croup	O
,	O
39	O
%	O
had	O
HRV	O
,	O
28	O
%	O
parainfluenza	O
virus	B-SPEC
,	O
28	O
%	O
RSV	B-SPEC
,	O
11	O
%	O
influenza	O
,	O
6	O
%	O
coronavirus	B-SPEC
and	O
none	O
human	B-SPEC
metapneumovirus	I-SPEC
.	O

Relative	O
contraindications	O
to	O
ECMO	O
include	O
advanced	O
age	O
,	O
severe	O
irreversible	O
brain	O
injury	O
,	O
untreatable	O
metastatic	O
cancer	B-SPEC
,	O
severe	O
organ	O
dysfunction	O
(	O
some	O
suggest	O
a	O
Sequential	O
Organ	O
Failure	O
Assessment	O
(	O
SOFA	O
)	O
score	O
>	O
15	O
),	O
and	O
high	O
pressure	O
positive	O
pressure	O
ventilation	O
for	O
more	O
than	O
7	O
days	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
have	O
demonstrated	O
that	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nonstructural	O
protein	O
2	O
(	O
ns2	O
)	O
is	O
a	O
2	O
',	O
5	O
'-	O
phosphodiesterase	O
that	O
inhibits	O
activation	O
of	O
the	O
interferon	O
-	O
induced	O
oligoadenylate	O
synthetase	O
(	O
OAS	O
)-	O
RNase	O
L	O
pathway	O
.	O

In	O
our	O
previous	O
work	O
,	O
the	O
nonstructural	O
protein	O
(	O
nsp	O
)	O
14	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
identified	O
as	O
a	O
cap	O
(	O
guanine	O
-	O
N7	O
)-	O
methyltransferase	O
(	O
N7	O
-	O
MTase	O
).	O

Topics	O
that	O
are	O
covered	O
include	O
severe	O
sepsis	B-SPEC
and	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
status	O
asthmaticus	O
,	O
diabetic	O
ketoacidosis	O
,	O
poisoning	O
(	O
acetaminophen	O
,	O
decongestants	O
,	O
prescription	O
medications	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
),	O
and	O
trauma	O
.	O

Human	B-SPEC
ApoE	O
consists	O
of	O
three	O
isoforms	O
(	O
E2	O
,	O
E3	O
,	O
and	O
E4	O
)	O
with	O
the	O
E4	O
and	O
E2	O
alleles	O
representing	O
a	O
greater	O
and	O
a	O
lower	O
risk	O
for	O
developping	O
AD	O
,	O
respectively	O
.	O

TITLE	O
:	O
Transient	O
oligomerization	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
--	O
implication	O
for	O
virus	B-SPEC
ribonucleoprotein	O
packaging	O
.	O

The	O
IBV	B-SPEC
virus	B-SPEC
was	O
detected	O
in	O
the	O
caecal	O
tonsils	O
and	O
cloaca	B-SPEC
from	O
the	O
2nd	O
to	O
the	O
12th	O
day	O
PI	O
.	O

The	O
virus	B-SPEC
was	O
detected	O
in	O
the	O
trachea	B-SPEC
,	O
lungs	O
and	O
thymus	B-SPEC
.	O

The	O
most	O
obvious	O
histopathological	O
lesions	O
were	O
found	O
in	O
the	O
trachea	B-SPEC
,	O
kidney	O
,	O
lungs	O
and	O
bursa	B-SPEC
of	O
Fabricius	O
.	O

TITLE	O
:	O
Fatal	O
disseminated	O
toxoplasmosis	O
in	O
an	O
immunocompetent	O
cat	B-SPEC
.	O

Conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
via	O
endotracheal	O
intubation	O
(	O
ETI	O
)	O
has	O
been	O
usually	O
considered	O
as	O
the	O
""""	O
golden	O
standard	O
""""	O
ventilator	O
treatment	O
in	O
ACS	O
.	O

Although	O
both	O
viruses	B-SPEC
were	O
under	O
purifying	O
selection	O
,	O
the	O
S	O
of	O
Pi	O
-	O
BatCoV	O
HKU5	O
displayed	O
marked	O
sequence	O
polymorphisms	O
and	O
more	O
positively	O
selected	O
sites	O
than	O
that	O
of	O
Ty	O
-	O
BatCoV	O
HKU4	O
,	O
suggesting	O
that	O
Pi	O
-	O
BatCoV	O
HKU5	O
may	O
generate	O
variants	O
to	O
occupy	O
new	O
ecological	O
niches	O
along	O
with	O
its	O
host	O
in	O
diverse	O
habitats	O
.	O

Although	O
MERS	O
-	O
CoV	O
may	O
have	O
diverged	O
from	O
potential	O
lineage	O
C	O
betacoronaviruses	O
in	O
European	O
bats	B-SPEC
more	O
recently	O
,	O
these	O
bat	B-SPEC
viruses	B-SPEC
were	O
unlikely	O
to	O
be	O
the	O
direct	O
ancestor	O
of	O
MERS	O
-	O
CoV	O
.	O
Intensive	O
surveillance	O
for	O
lineage	O
C	O
betaCoVs	O
in	O
Pipistrellus	B-SPEC
and	O
related	O
bats	B-SPEC
with	O
diverse	O
habitats	O
and	O
other	O
animals	B-SPEC
in	O
the	O
Middle	O
East	O
may	O
fill	O
the	O
evolutionary	O
gap	O
.	O

TITLE	O
:	O
Hyposialylated	O
1	O
-	O
acid	O
glycoprotein	O
inhibits	O
phagocytosis	O
of	O
feline	B-SPEC
neutrophils	O
.	O

This	O
study	O
demonstrated	O
that	O
hyposialylated	O
fAGP	O
down	O
-	O
regulates	O
the	O
phagocytic	O
activity	O
of	O
feline	B-SPEC
neutrophils	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
infection	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
named	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
first	O
identified	O
in	O
Saudi	O
Arabia	O
and	O
the	O
Middle	O
East	O
in	O
September	O
,	O
2012	O
,	O
with	O
44	O
laboratory	O
-	O
confirmed	O
cases	O
as	O
of	O
May	O
23	O
,	O
2013	O
.	O

This	O
report	O
describes	O
several	O
events	O
in	O
which	O
virus	B-SPEC
isolation	O
and	O
identification	O
by	O
electron	O
microscopy	O
were	O
critical	O
to	O
initial	O
recognition	O
of	O
the	O
etiologic	O
agent	O
,	O
which	O
was	O
further	O
analyzed	O
by	O
additional	O
laboratory	O
diagnostic	O
assays	O
.	O

The	O
region	O
is	O
certainly	O
a	O
hot	O
spot	B-SPEC
of	O
socioeconomic	O
and	O
environmental	O
change	O
,	O
and	O
although	O
some	O
changes	O
(	O
e	O
.	O
g	O
.,	O
urbanization	O
and	O
agricultural	O
intensification	O
)	O
may	O
reduce	O
the	O
probability	O
of	O
emerging	O
infectious	O
diseases	O
,	O
the	O
effect	O
of	O
any	O
individual	O
emergence	O
event	O
may	O
be	O
increased	O
by	O
the	O
greater	O
concentration	O
and	O
connectivity	O
of	O
livestock	O
,	O
persons	O
,	O
and	O
products	O
.	O

We	O
discuss	O
and	O
compare	O
the	O
pathogenesis	O
of	O
MA	O
-	O
ARDS	O
in	O
patients	O
and	O
in	O
different	O
murine	B-SPEC
models	O
,	O
including	O
recent	O
models	O
without	O
cerebral	O
involvement	O
,	O
and	O
summarize	O
the	O
roles	O
of	O
different	O
leukocyte	O
subclasses	O
,	O
adhesion	O
molecules	O
,	O
cytokines	O
,	O
and	O
chemokines	O
.	O

Experimental	O
anti	O
-	O
inflammatory	O
interventions	O
are	O
successful	O
in	O
mice	B-SPEC
and	O
remain	O
to	O
be	O
validated	O
in	O
patients	O
.	O

Anyplex	O
	O
II	O
RV16	O
[	O
RV16	O
]	O
was	O
designed	O
for	O
simultaneous	O
detection	O
of	O
16	O
respiratory	O
viruses	B-SPEC
using	O
multiplex	O
PCR	O
coupled	O
with	O
TOCE	O
	O
technology	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
prepdominat	O
agent	O
causing	O
severe	O
entero	O
-	O
pathogenic	O
diarrhea	O
in	O
swine	B-SPEC
,	O
there	O
are	O
no	O
effective	O
therapeutical	O
treatment	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

A	O
21	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
severe	O
head	O
injury	O
after	O
a	O
car	B-SPEC
accident	O
was	O
endotracheally	O
intubated	O
,	O
mechanically	O
ventilated	O
,	O
and	O
hemodynamically	O
stabilized	O
before	O
transfer	O
to	O
our	O
university	O
hospital	O
.	O

We	O
found	O
that	O
the	O
N	O
-	O
nsp3	O
interaction	O
maps	O
to	O
the	O
amino	O
-	O
terminal	O
ubiquitin	O
-	O
like	O
domain	O
of	O
nsp3	O
,	O
which	O
is	O
essential	O
for	O
the	O
virus	B-SPEC
.	O

Closely	O
related	O
alphacoronaviruses	O
were	O
detected	O
in	O
Carollia	B-SPEC
perspicillata	I-SPEC
and	O
C	B-SPEC
.	I-SPEC
brevicauda	I-SPEC
across	O
a	O
geographical	O
distance	O
exceeding	O
5600	O
km	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronaviruses	O
(	O
FCoV	O
)	O
exist	O
as	O
2	O
biotypes	O
:	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
and	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
).	O

It	O
is	O
thought	O
that	O
mutations	O
in	O
FECV	B-SPEC
enable	O
infection	O
of	O
macrophages	O
,	O
causing	O
FIP	O
.	O

We	O
document	O
a	O
functionally	O
relevant	O
S1	O
/	O
S2	O
mutation	O
that	O
arises	O
when	O
FIP	O
develops	O
in	O
a	O
cat	B-SPEC
.	O

Replication	O
of	O
PHEV	O
in	O
a	O
porcine	B-SPEC
kidney	O
-	O
derived	O
cell	O
line	O
(	O
PK	O
-	O
15	O
cells	O
)	O
caused	O
an	O
extensive	O
CPE	O
,	O
leading	O
to	O
the	O
destruction	O
of	O
the	O
entire	O
monolayer	O
and	O
the	O
death	O
of	O
the	O
infected	O
cells	O
.	O

Moreover	O
,	O
as	O
is	O
commonly	O
observed	O
for	O
coronavirus	B-SPEC
infections	O
of	O
other	O
animals	B-SPEC
,	O
the	O
activities	O
of	O
the	O
effecter	O
caspase	O
,	O
caspase	O
-	O
3	O
,	O
and	O
the	O
initiator	O
caspases	O
,	O
caspase	O
-	O
8	O
and	O
caspase	O
-	O
9	O
,	O
which	O
are	O
representative	O
factors	O
in	O
the	O
death	O
receptor	O
-	O
mediated	O
apoptotic	O
pathway	O
and	O
the	O
mitochondrial	O
apoptotic	O
pathway	O
,	O
respectively	O
,	O
were	O
increased	O
in	O
PHEV	O
-	O
infected	O
PK	O
-	O
15	O
cells	O
.	O

TITLE	O
:	O
Interspecies	O
transmission	O
and	O
emergence	O
of	O
novel	O
viruses	B-SPEC
:	O
lessons	O
from	O
bats	B-SPEC
and	O
birds	B-SPEC
.	O

The	O
lack	O
of	O
regulations	O
,	O
threshold	O
values	O
and	O
standardized	O
detection	O
methods	O
for	O
viruses	B-SPEC
in	O
indoor	O
environments	O
,	O
make	O
both	O
research	O
and	O
interpretation	O
of	O
results	O
difficult	O
in	O
this	O
field	O
,	O
hampering	O
infection	O
control	O
efforts	O
.	O

RESULTS	O
:	O
The	O
vast	O
majority	O
of	O
studies	O
reviewed	O
here	O
concern	O
hospital	O
and	O
other	O
health	O
facilities	O
where	O
viruses	B-SPEC
are	O
a	O
well	O
-	O
known	O
cause	O
of	O
occupational	O
and	O
nosocomial	O
infections	O
.	O

ABSTRACT	O
:	O
Severe	O
malaria	O
due	O
to	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
is	O
increasingly	O
observed	O
now	O
a	O
days	O
.	O

All	O
adult	O
indoor	O
patients	O
positive	O
for	O
malarial	O
infection	O
based	O
on	O
peripheral	O
smear	O
or	O
malarial	O
antigen	O
(	O
LDH	O
)	O
spot	B-SPEC
test	O
were	O
included	O
in	O
the	O
study	O
.	O

ABSTRACT	O
:	O
In	O
September	O
2012	O
,	O
the	O
World	O
Health	O
Organization	O
reported	O
the	O
first	O
cases	O
of	O
pneumonia	O
caused	O
by	O
the	O
novel	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Among	O
217	O
household	O
contacts	O
and	O
more	O
than	O
200	O
health	O
care	O
worker	O
contacts	O
whom	O
we	O
identified	O
,	O
MERS	O
-	O
CoV	O
infection	O
developed	O
in	O
5	O
family	B-SPEC
members	O
(	O
3	O
with	O
laboratory	O
-	O
confirmed	O
cases	O
)	O
and	O
in	O
2	O
health	O
care	O
workers	O
(	O
both	O
with	O
laboratory	O
-	O
confirmed	O
cases	O
).	O

Stool	O
samples	O
obtained	O
on	O
days	O
12	O
and	O
16	O
contained	O
the	O
virus	B-SPEC
,	O
with	O
up	O
to	O
1031	O
RNA	O
copies	O
per	O
g	O
(	O
close	O
to	O
the	O
lowest	O
detection	O
limit	O
of	O
the	O
assay	O
).	O

ABSTRACT	O
:	O
Detection	O
of	O
human	B-SPEC
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
internationally	O
is	O
a	O
global	O
public	O
health	O
concern	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
that	O
caused	O
outbreaks	O
of	O
a	O
SARS	O
-	O
like	O
illness	O
in	O
the	O
Middle	O
East	O
,	O
is	O
now	O
considered	O
a	O
threat	O
to	O
global	O
public	O
health	O
.	O

As	O
of	O
14	O
June	O
2013	O
,	O
58	O
human	B-SPEC
cases	O
of	O
MERS	O
CoV	O
infection	O
have	O
been	O
confirmed	O
,	O
including	O
33	O
deaths	O
(	O
case	O
fatality	O
rate	O
of	O
57	O
%).	O

MERS	O
CoV	O
is	O
a	O
beta	O
-	O
coronavirus	B-SPEC
,	O
in	O
the	O
same	O
family	B-SPEC
as	O
SARS	O
-	O
CoV	O
,	O
and	O
shares	O
a	O
probable	O
origin	O
from	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
sudden	O
increase	O
in	O
the	O
number	O
of	O
novel	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
pH1N1	O
-	O
2009	O
)	O
infection	O
prompted	O
us	O
to	O
compare	O
the	O
clinical	O
presentation	O
and	O
outcomes	O
of	O
patients	O
infected	O
with	O
pH1N1	O
-	O
2009	O
and	O
seasonal	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
during	O
the	O
post	O
-	O
pandemic	O
phase	O
.	O

TITLE	O
:	O
Evolutionary	O
dynamics	O
of	O
bovine	B-SPEC
coronaviruses	O
:	O
natural	O
selection	O
pattern	O
of	O
the	O
spike	O
gene	O
implies	O
adaptive	O
evolution	O
of	O
the	O
strains	O
.	O

Since	O
SV40	B-SPEC
induces	O
the	O
formation	O
of	O
cytoplasmic	O
vacuoles	O
,	O
this	O
batch	O
of	O
RPTEC	O
was	O
rejected	O
for	O
the	O
SV40	B-SPEC
study	O
.	O

By	O
molecular	O
analysis	O
of	O
the	O
whole	O
genome	O
,	O
CaKV	O
that	O
appeared	O
genetically	O
closest	O
to	O
the	O
murine	B-SPEC
kobuvirus	B-SPEC
(	O
MuKV	O
)	O
and	O
to	O
the	O
human	B-SPEC
Aichi	B-SPEC
virus	I-SPEC
(	O
AiV	O
),	O
may	O
be	O
classified	O
in	O
the	O
Kobuvirus	B-SPEC
genus	B-SPEC
as	O
new	O
genotype	O
(	O
CaKV	O
type	O
1	O
)	O
within	O
the	O
species	B-SPEC
Aichivirus	O
A	O
.	O
To	O
date	O
,	O
there	O
are	O
no	O
information	O
on	O
the	O
epidemiology	O
of	O
these	O
novel	O
viruses	B-SPEC
in	O
other	O
continents	O
.	O

All	O
the	O
positive	O
dogs	B-SPEC
presented	O
diarrhea	O
and	O
were	O
found	O
to	O
be	O
infected	O
by	O
CaKV	O
alone	O
or	O
in	O
mixed	O
infections	O
with	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
and	O
/	O
or	O
canine	O
parvovirus	B-SPEC
type	O
2	O
(	O
CPV	B-SPEC
-	O
2	O
).	O

Those	O
with	O
histologic	O
evidence	O
of	O
ALI	O
/	O
ARDS	O
(	O
diffuse	O
alveolar	O
damage	O
)	O
and	O
with	O
a	O
more	O
severe	O
chest	O
x	O
-	O
ray	B-SPEC
pattern	O
or	O
who	O
satisfied	O
the	O
criteria	O
for	O
a	O
number	O
of	O
consecutive	O
days	O
were	O
no	O
more	O
likely	O
to	O
have	O
a	O
clinical	O
diagnosis	O
of	O
ALI	O
/	O
ARDS	O
recorded	O
.	O

TITLE	O
:	O
A	O
report	O
from	O
the	O
26th	O
International	O
Conference	O
on	O
Antiviral	O
Research	O
(	O
May	O
11	O
-	O
15	O
,	O
San	O
Francisco	O
,	O
California	B-SPEC
,	O
USA	O
).	O

Two	O
children	O
[	O
2	O
/	O
18	O
(	O
11	O
	O
1	O
%)]	O
infected	O
with	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
had	O
died	O
of	O
cerebral	O
malaria	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
shock	O
,	O
and	O
metabolic	O
acidosis	O
.	O

The	O
clinical	O
presentation	O
and	O
outcome	O
of	O
severe	O
vivax	O
malaria	O
was	O
found	O
to	O
be	O
similar	O
to	O
severe	O
malaria	O
caused	O
by	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
and	O
mixed	O
infection	O
,	O
except	O
for	O
higher	O
chances	O
of	O
severe	O
anaemia	O
among	O
the	O
children	O
infected	O
with	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
(	O
P	O
=	O
0	O
	O
04	O
).	O

We	O
diagnosed	O
Legionella	B-SPEC
pneumonia	O
from	O
his	O
chest	O
X	O
-	O
ray	B-SPEC
imaging	O
which	O
showed	O
bilateral	O
lobe	O
consolidation	O
excluding	O
the	O
left	O
upper	O
lobe	O
,	O
and	O
his	O
sputum	O
culture	O
yielded	O
Legionella	B-SPEC
pneumophilla	O
serogroup	O
1	O
.	O

TITLE	O
:	O
[	O
A	O
case	O
of	O
Legionella	B-SPEC
pneumophila	I-SPEC
pneumonia	O
accompanied	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
epilepsy	O
].	O

We	O
emphasize	O
the	O
importance	O
of	O
aggressive	O
workup	O
and	O
empirical	O
therapy	O
for	O
patients	O
with	O
Legionella	B-SPEC
pneumonia	O
with	O
rapidly	O
worsening	O
symptoms	O
and	O
clinical	O
features	O
such	O
as	O
unconsciousness	O
,	O
epilepsy	O
,	O
and	O
hyponatremia	O
and	O
in	O
whom	O
fluoroquinolone	O
and	O
corticosteroid	O
therapy	O
are	O
effective	O
despite	O
the	O
presence	O
of	O
epilepsy	O
.	O

Betulinic	O
acid	O
and	O
5	O
,	O
7	O
,	O
3	O
',	O
5	O
'-	O
tetrahydroxyflavanone	O
7	O
-	O
O	O
-	O
glucoside	O
were	O
active	O
on	O
both	O
RT	O
-	O
associated	O
activities	O
,	O
and	O
betulinic	O
acid	O
was	O
also	O
active	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
mutant	O
RTs	O
resistant	O
to	O
efavirenz	O
.	O

TITLE	O
:	O
Biological	O
features	O
of	O
novel	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
.	O

Using	O
the	O
H5N1	O
influenza	B-SPEC
virus	I-SPEC
as	O
a	O
model	O
,	O
we	O
first	O
immunized	O
rhesus	B-SPEC
macaques	I-SPEC
with	O
recombinant	O
adenoviruses	B-SPEC
carrying	O
a	O
synthetic	O
gene	O
encoding	O
hemagglutinin	O
(	O
HA	O
).	O

Selected	O
mAbs	O
demonstrated	O
potent	O
neutralizing	O
activities	O
against	O
three	O
clades	O
(	O
0	O
,	O
1	O
,	O
2	O
)	O
of	O
the	O
H5N1	O
influenza	B-SPEC
viruses	I-SPEC
.	O

TITLE	O
:	O
Comparison	O
of	O
the	O
FilmArray	O
RP	O
,	O
Verigene	O
RV	O
+,	O
and	O
Prodesse	O
ProFLU	O
+/	O
FAST	O
+	O
multiplex	O
platforms	O
for	O
detection	O
of	O
influenza	B-SPEC
viruses	I-SPEC
in	O
clinical	O
samples	O
from	O
the	O
2011	O
-	O
2012	O
influenza	O
season	O
in	O
Belgium	O
.	O

In	O
the	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
as	O
a	O
model	O
,	O
we	O
previously	O
reported	O
that	O
accessory	O
gene	O
7	O
counteracts	O
the	O
host	O
antiviral	O
response	O
by	O
associating	O
with	O
the	O
catalytic	O
subunit	O
of	O
protein	O
phosphatase	O
1	O
(	O
PP1c	O
).	O

An	O
exacerbated	O
innate	O
immune	O
response	O
during	O
infection	O
with	O
rTGEV	O
-	O
7	O
virus	B-SPEC
was	O
observed	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Parent	O
-	O
collected	O
respiratory	O
specimens	O
were	O
tested	O
for	O
respiratory	O
viruses	B-SPEC
using	O
real	O
-	O
time	O
PCR	O
(	O
RT	O
-	O
PCR	O
).	O

Healthcare	O
visits	O
were	O
increased	O
if	O
the	O
child	O
was	O
non	O
-	O
Caucasian	O
,	O
lived	O
in	O
a	O
detached	O
house	O
,	O
had	O
working	O
parents	O
or	O
had	O
a	O
virus	B-SPEC
-	O
positive	O
ILI	O
.	O

Severe	O
pneumonitis	O
caused	O
by	O
influenza	B-SPEC
virus	I-SPEC
and	O
varicella	O
zoster	O
infection	O
may	O
occur	O
.	O

A	O
chemically	O
synthesized	O
,	O
TGEV	B-SPEC
-	O
M7	O
peptide	O
(	O
pepTGEV	O
-	O
M7	O
;	O
HALTPIKYIPPG	O
)	O
was	O
evaluated	O
for	O
antiviral	O
activity	O
.	O

TITLE	O
:	O
Interhuman	O
transmissibility	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
estimation	O
of	O
pandemic	O
risk	O
.	O

Oral	O
and	O
nasal	O
inoculation	O
with	O
the	O
recombinant	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
of	O
chickens	B-SPEC
elicited	O
significantly	O
high	O
humoral	O
and	O
mucosal	O
immune	O
responses	O
,	O
especially	O
in	O
the	O
nasally	O
immunized	O
group	O
.	O

HV	O
infection	O
caused	O
by	O
Choclo	B-SPEC
virus	I-SPEC
in	O
Panama	B-SPEC
presents	O
often	O
as	O
HF	O
,	O
which	O
contrasts	O
with	O
HV	O
in	O
the	O
Americas	O
but	O
is	O
consistent	O
with	O
the	O
high	O
seroprevalence	O
in	O
endemic	O
regions	O
.	O

This	O
study	O
has	O
demonstrated	O
that	O
heterologous	O
genes	O
can	O
be	O
incorporated	O
into	O
,	O
and	O
expressed	O
from	O
a	O
range	O
of	O
IBV	B-SPEC
genome	O
locations	O
and	O
that	O
replacement	O
of	O
accessory	O
Gene	O
5	O
offers	O
a	O
promising	O
target	O
for	O
realising	O
the	O
potential	O
of	O
IBV	B-SPEC
as	O
a	O
vaccine	O
vector	O
for	O
other	O
avian	B-SPEC
pathogens	O
.	O

ABSTRACT	O
:	O
On	O
June	O
11	O
,	O
2013	O
,	O
CDC	O
issued	O
interim	O
infection	O
prevention	O
and	O
control	O
recommendations	O
for	O
hospitalized	O
patients	O
with	O
known	O
or	O
suspected	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
U	O
.	O
S	O
.	O
hospitals	O
.	O

In	O
this	O
study	O
we	O
explored	O
the	O
use	O
of	O
Syrian	B-SPEC
hamsters	I-SPEC
as	O
a	O
small	O
animal	B-SPEC
disease	O
model	O
,	O
using	O
intratracheal	O
inoculation	O
and	O
inoculation	O
via	O
aerosol	O
.	O

Pre	O
-	O
HFO	O
-	O
TGI	O
CMV	B-SPEC
plateau	O
pressure	O
(	O
30	O
.	O
4	O
	O
4	O
.	O
5	O
cm	O
H2O	O
)	O
and	O
respiratory	O
compliance	O
(	O
37	O
.	O
8	O
	O
9	O
.	O
2	O
ml	O
/	O
cm	O
H2O	O
),	O
respectively	O
,	O
improved	O
on	O
average	O
by	O
approximately	O
7	O
.	O
5	O
%	O
and	O
20	O
%	O
after	O
HFO	O
-	O
TGI	O
(	O
P	O
<	O
0	O
.	O
01	O
for	O
both	O
).	O

TITLE	O
:	O
Simultaneous	O
detection	O
of	O
five	O
major	O
serotypes	O
of	O
Avian	B-SPEC
coronavirus	I-SPEC
by	O
a	O
multiplex	O
microsphere	O
-	O
based	O
assay	O
.	O

In	O
an	O
effort	O
to	O
improve	O
conventional	O
diagnostic	O
tests	O
,	O
a	O
microsphere	O
-	O
based	O
assay	O
was	O
developed	O
and	O
evaluated	O
for	O
simultaneous	O
detection	O
of	O
the	O
most	O
common	O
IBV	B-SPEC
vaccine	O
serotypes	O
in	O
the	O
United	O
States	O
:	O
Arkansas	O
(	O
Ark	O
),	O
Connecticut	O
(	O
Conn	O
),	O
Massachusetts	O
(	O
Mass	O
),	O
Delaware	O
(	O
DE072	O
),	O
and	O
Georgia	O
98	O
(	O
GA98	O
).	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
distribution	O
and	O
seasonal	O
occurrences	O
of	O
respiratory	O
viruses	B-SPEC
detected	O
by	O
multiplex	O
molecular	O
assay	O
in	O
6	O
,	O
014	O
samples	O
from	O
2008	O
to	O
2011	O
in	O
a	O
French	O
hospital	O
.	O

Since	O
the	O
distributions	O
of	O
respiratory	O
viruses	B-SPEC
in	O
multiply	O
infected	O
patients	O
were	O
subject	O
to	O
preferential	O
association	O
patterns	O
between	O
viruses	B-SPEC
,	O
we	O
propose	O
complex	O
interactions	O
between	O
different	O
respiratory	O
viruses	B-SPEC
and	O
host	O
factors	O
.	O

Information	O
remains	O
limited	O
about	O
the	O
comparative	O
protein	O
expression	O
of	O
host	O
cells	O
in	O
response	O
to	O
TGEV	B-SPEC
infection	O
.	O

The	O
present	O
study	O
provides	O
protein	O
-	O
related	O
information	O
that	O
should	O
be	O
useful	O
for	O
understanding	O
the	O
host	O
cell	O
response	O
to	O
TGEV	B-SPEC
infection	O
and	O
the	O
underlying	O
mechanism	O
of	O
TGEV	B-SPEC
replication	O
and	O
pathogenicity	O
.	O

Western	O
blot	O
analysis	O
was	O
used	O
to	O
validate	O
the	O
changes	O
of	O
alpha	O
tubulin	O
,	O
keratin	O
19	O
,	O
and	O
prohibitin	O
during	O
TGEV	B-SPEC
infection	O
.	O

We	O
report	O
a	O
case	O
series	O
of	O
patients	O
with	O
severe	O
Legionella	B-SPEC
pneumonia	O
who	O
developed	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
failed	O
to	O
improve	O
with	O
mechanical	O
ventilation	O
alone	O
and	O
required	O
extracorporeal	O
life	O
support	O
(	O
ECLS	O
).	O

Among	O
them	O
,	O
seven	O
cats	B-SPEC
were	O
confirmed	O
by	O
necropsy	O
and	O
/	O
or	O
histopathological	O
examinations	O
.	O

Moreover	O
,	O
birds	B-SPEC
of	O
vaccinated	O
groups	O
,	O
especially	O
with	O
full	O
dose	O
,	O
developed	O
higher	O
levels	O
of	O
lachrymal	O
IBV	B-SPEC
-	O
specific	O
IgG	O
and	O
IgA	O
and	O
increased	O
the	O
expression	O
of	O
cell	O
-	O
mediated	O
immunity	O
(	O
CMI	O
)	O
genes	O
,	O
such	O
as	O
gamma	O
interferon	O
(	O
IFN	O
),	O
CD8	O
+	O
T	O
cell	O
marker	O
,	O
and	O
granzyme	O
homolog	O
A	O
more	O
rapidly	O
.	O

There	O
was	O
no	O
mitogenic	O
activity	O
toward	O
mouse	B-SPEC
splenocytes	O
.	O

XILP	O
reduced	O
the	O
activity	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
with	O
an	O
IC50	O
of	O
11	O
.	O
1M	O
,	O
but	O
lacked	O
inhibitory	O
activity	O
toward	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
integrase	O
and	O
SARS	O
coronavirus	B-SPEC
proteinase	O
.	O

TITLE	O
:	O
Sialic	O
Acid	O
Receptors	O
of	O
Viruses	B-SPEC
.	O

On	O
d	O
1	O
,	O
7	O
,	O
and	O
11	O
postinoculation	O
4	O
chickens	B-SPEC
from	O
the	O
experimental	O
group	O
and	O
2	O
chickens	B-SPEC
from	O
the	O
control	O
group	O
were	O
randomly	O
selected	O
.	O

TITLE	O
:	O
Homologous	O
2	O
',	O
5	O
'-	O
phosphodiesterases	O
from	O
disparate	O
RNA	O
viruses	B-SPEC
antagonize	O
antiviral	O
innate	O
immunity	O
.	O

Rhinoviruses	B-SPEC
/	O
enteroviruses	B-SPEC
(	O
Rhino	O
/	O
Entero	O
)	O
were	O
the	O
most	O
prevalent	O
(	O
34	O
.	O
3	O
%)	O
followed	O
by	O
RSV	B-SPEC
(	O
19	O
.	O
2	O
%)	O
and	O
hMPV	B-SPEC
(	O
6	O
.	O
2	O
%).	O

The	O
first	O
laboratory	O
-	O
confirmed	O
case	O
,	O
which	O
involved	O
a	O
60	O
-	O
year	O
-	O
old	O
man	B-SPEC
from	O
Bisha	O
,	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
),	O
who	O
died	O
of	O
rapidly	O
progressive	O
community	O
-	O
acquired	O
pneumonia	O
and	O
acute	O
renal	O
failure	O
,	O
was	O
announced	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
on	O
September	O
23	O
,	O
2012	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causing	O
severe	O
,	O
life	O
-	O
threatening	O
respiratory	O
disease	O
has	O
emerged	O
in	O
the	O
Middle	O
East	O
at	O
a	O
time	O
when	O
two	O
international	O
mass	O
gatherings	O
in	O
Saudi	O
Arabia	O
are	O
imminent	O
.	O

16	O
.	O
8	O
million	O
travelers	O
flew	O
on	O
commercial	O
flights	O
out	O
of	O
Saudi	O
Arabia	O
,	O
Jordan	O
,	O
Qatar	O
,	O
and	O
the	O
United	O
Arab	O
Emirates	O
between	O
June	O
and	O
November	O
2012	O
,	O
of	O
which	O
51	O
.	O
6	O
%	O
were	O
destined	O
for	O
India	O
(	O
16	O
.	O
3	O
%),	O
Egypt	O
(	O
10	O
.	O
4	O
%),	O
Pakistan	O
(	O
7	O
.	O
8	O
%),	O
the	O
United	O
Kingdom	B-SPEC
(	O
4	O
.	O
3	O
%),	O
Kuwait	O
(	O
3	O
.	O
6	O
%),	O
Bangladesh	O
(	O
3	O
.	O
1	O
%),	O
Iran	O
(	O
3	O
.	O
1	O
%)	O
and	O
Bahrain	O
(	O
2	O
.	O
9	O
%).	O

Statistically	O
,	O
BRV	O
-	O
A	O
,	O
BCoV	O
,	O
BNoV	O
,	O
Nebovirus	B-SPEC
,	O
Salmonella	B-SPEC
,	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
(+),	O
and	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
were	O
significantly	O
associated	O
with	O
calf	O
diarrhea	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Unexpectedly	O
BNoV	O
(	O
OR	O
=	O
2	O
.	O
0	O
)	O
and	O
Nebovirus	B-SPEC
(	O
OR	O
=	O
16	O
.	O
7	O
)	O
were	O
identified	O
with	O
high	O
frequency	O
in	O
diarrheic	O
calves	O
,	O
suggesting	O
these	O
viruses	B-SPEC
may	O
have	O
a	O
significant	O
contribution	O
to	O
calf	O
diarrhea	O
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
infections	O
in	O
Jordan	O
,	O
April	O
2012	O
:	O
epidemiological	O
findings	O
from	O
a	O
retrospective	O
investigation	O
.	O

In	O
view	O
of	O
this	O
new	O
virus	B-SPEC
,	O
there	O
is	O
now	O
an	O
urgent	O
need	O
for	O
strong	O
public	O
health	O
vigilance	O
and	O
monitoring	O
of	O
the	O
evolution	O
of	O
the	O
virus	B-SPEC
in	O
the	O
Region	O
.	O

The	O
most	O
commonly	O
encountered	O
viruses	B-SPEC
,	O
in	O
order	B-SPEC
of	O
frequency	O
,	O
include	O
influenza	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
and	O
adenovirus	B-SPEC
.	O

TITLE	O
:	O
Emerging	O
respiratory	O
and	O
novel	B-SPEC
coronavirus	I-SPEC
2012	O
infections	O
and	O
mass	O
gatherings	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
a	O
novel	O
strain	O
of	O
coronavirus	B-SPEC
in	O
the	O
Arabian	O
Peninsula	O
raised	O
a	O
global	O
health	O
concern	O
in	O
2012	O
,	O
partly	O
because	O
the	O
majority	O
of	O
human	B-SPEC
infections	O
were	O
fatal	O
and	O
partly	O
due	O
to	O
its	O
presumed	O
animal	B-SPEC
origin	O
.	O

An	O
urgent	O
meeting	O
of	O
scientific	O
and	O
public	O
health	O
experts	O
was	O
convened	O
by	O
WHO	O
in	O
January	O
2013	O
in	O
view	O
of	O
the	O
limited	O
knowledge	O
available	O
on	O
the	O
epidemiological	O
and	O
natural	O
history	O
of	O
infection	O
with	O
this	O
novel	O
virus	B-SPEC
.	O

Through	O
summarizing	O
the	O
available	O
information	O
and	O
progress	O
in	O
coronavirus	B-SPEC
research	O
,	O
this	O
review	O
provides	O
a	O
systematic	O
assessment	O
of	O
the	O
potential	O
wide	O
-	O
spectrum	O
features	O
on	O
the	O
most	O
popular	O
drug	O
targets	O
including	O
viral	O
proteases	O
,	O
spike	O
protein	O
,	O
RNA	O
polymerases	O
and	O
editing	O
enzymes	O
as	O
well	O
as	O
host	O
-	O
virus	B-SPEC
interaction	O
pathways	O
associated	O
with	O
coronaviruses	O
.	O

Elevated	O
serum	O
lactate	O
levels	O
in	O
the	O
ED	O
and	O
a	O
recently	O
validated	O
clinical	O
prediction	O
score	O
were	O
independently	O
associated	O
with	O
the	O
development	O
of	O
ARDS	O
in	O
severe	O
sepsis	B-SPEC
.	O

To	O
combat	O
SARS	O
,	O
scientists	O
applied	O
for	O
patents	O
on	O
various	O
therapeutic	O
agents	O
,	O
including	O
small	O
-	O
molecule	O
inhibitors	O
targeting	O
the	O
essential	O
proteases	O
,	O
helicase	O
and	O
other	O
proteins	O
of	O
the	O
virus	B-SPEC
,	O
natural	O
products	O
,	O
approved	O
drugs	O
,	O
molecules	O
binding	O
to	O
the	O
virus	B-SPEC
,	O
neutralizing	O
antibodies	O
,	O
vaccines	O
,	O
anti	O
-	O
sense	O
RNA	O
,	O
siRNA	O
and	O
ribozyme	O
against	O
SARS	O
-	O
CoV	O
.	O
In	O
this	O
article	O
,	O
the	O
patents	O
published	O
from	O
2008	O
to	O
the	O
present	O
for	O
the	O
new	O
therapeutics	O
that	O
could	O
potentially	O
be	O
used	O
in	O
the	O
prophylaxis	O
and	O
treatment	O
of	O
SARS	O
are	O
reviewed	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
explored	O
whether	O
the	O
ORF4a	O
protein	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
has	O
similar	O
functions	O
.	O

Collectively	O
,	O
this	O
evidence	O
indicates	O
that	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
ORF4a	O
protein	O
is	O
functionally	O
analogous	O
to	O
the	O
SARS	O
-	O
CoV	O
3a	O
protein	O
,	O
which	O
also	O
acts	O
as	O
a	O
viroporin	O
that	O
regulates	O
virus	B-SPEC
production	O
.	O

Same	O
-	O
day	O
PCR	O
testing	O
and	O
result	O
reporting	O
for	O
13	O
respiratory	O
viruses	B-SPEC
were	O
carried	O
out	O
by	O
locally	O
trained	O
scientists	O
.	O

Because	O
recombinant	O
human	B-SPEC
aPC	O
has	O
been	O
withdrawn	O
from	O
the	O
market	O
,	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
interactions	O
between	O
coagulation	O
and	O
inflammation	O
is	O
needed	O
before	O
considering	O
the	O
development	O
of	O
new	O
drugs	O
that	O
modulate	O
both	O
coagulation	O
and	O
acute	O
inflammation	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
A	O
family	B-SPEC
cluster	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
infections	O
related	O
to	O
a	O
likely	O
unrecognized	O
asymptomatic	O
or	O
mild	O
case	O
.	O

We	O
report	O
the	O
details	O
of	O
a	O
second	O
family	B-SPEC
cluster	O
of	O
MERS	O
-	O
CoV	O
infections	O
from	O
Riyadh	O
,	O
Saudi	O
Arabia	O
.	O

All	O
3	O
patients	O
had	O
fever	O
,	O
cough	O
,	O
shortness	O
of	O
breath	O
,	O
bilateral	O
infiltrates	O
on	O
chest	O
x	O
-	O
ray	B-SPEC
,	O
thrombocytopenia	O
,	O
lymphopenia	O
and	O
rises	O
in	O
serum	O
creatinine	O
kinase	O
and	O
alanine	O
transaminase	O
.	O

In	O
addition	O
,	O
increasing	O
levels	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
systematically	O
increased	O
strain	O
along	O
the	O
sternovertebral	O
axis	B-SPEC
.	O

This	O
novel	B-SPEC
coronavirus	I-SPEC
is	O
culturable	O
and	O
two	O
complete	O
genome	O
sequences	O
are	O
now	O
available	O
.	O

TITLE	O
:	O
New	O
strategy	O
for	O
virus	B-SPEC
discovery	O
:	O
viruses	B-SPEC
identified	O
in	O
human	B-SPEC
feces	O
in	O
the	O
last	O
decade	O
.	O

Some	O
of	O
these	O
viruses	B-SPEC
have	O
the	O
potential	O
for	O
rapid	O
and	O
global	O
spread	O
with	O
high	O
morbidity	O
and	O
mortality	O
,	O
such	O
as	O
the	O
SARS	O
coronavirus	B-SPEC
outbreak	O
.	O

This	O
review	O
explains	O
the	O
viral	O
metagenomics	O
strategy	O
for	O
virus	B-SPEC
discovery	O
and	O
describes	O
viruses	B-SPEC
discovered	O
in	O
human	B-SPEC
feces	O
in	O
the	O
past	O
10	O
years	O
using	O
this	O
approach	O
.	O

To	O
assess	O
the	O
contribution	O
of	O
HA	O
-	O
RBS	O
variability	O
in	O
critically	O
ill	O
patients	O
,	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
from	O
adult	O
patients	O
with	O
severe	O
infection	O
admitted	O
to	O
ICU	O
for	O
extracorporeal	O
membrane	O
oxygenation	O
support	O
(	O
ECMO	O
)	O
during	O
influenza	O
season	O
2009	O
-	O
2011	O
in	O
Piemonte	O
(	O
4	O
	O
2	O
million	O
inhabitants	O
),	O
northwestern	O
Italy	O
,	O
was	O
studied	O
.	O

By	O
HA	O
-	O
RBS	O
direct	O
sequencing	O
of	O
respiratory	O
specimens	O
,	O
D222G	O
and	O
D222N	O
viral	O
variants	O
were	O
identified	O
in	O
a	O
higher	O
proportion	O
in	O
ICU	O
patients	O
(	O
n	O
=	O
8	O
/	O
24	O
,	O
33	O
	O
3	O
%)	O
than	O
in	O
patients	O
with	O
mild	O
disease	O
(	O
n	O
=	O
2	O
/	O
34	O
,	O
6	O
%)	O
or	O
in	O
outpatients	O
(	O
n	O
=	O
0	O
/	O
44	O
)	O
(	O
Fisher	B-SPEC
'	O
s	O
exact	O
test	O
P	O
<	O
0	O
	O
0001	O
;	O
OR	O
38	O
	O
5	O
;	O
CI	O
95	O
%	O
4	O
	O
494	O
-	O
329	O
	O
9	O
).	O

Simultaneous	O
detection	O
of	O
two	O
or	O
more	O
viruses	B-SPEC
was	O
found	O
in	O
377	O
cases	O
.	O

This	O
TCR	O
-	O
	O
chain	O
was	O
introduced	O
into	O
bone	O
marrow	O
cells	O
with	O
a	O
lentivirus	B-SPEC
vector	O
,	O
generating	O
TCR	O
-	O
	O
retrogenic	O
mice	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
neutralising	O
serum	O
antibodies	O
in	O
dromedary	B-SPEC
camels	B-SPEC
:	O
a	O
comparative	O
serological	O
study	O
.	O

ABSTRACT	O
:	O
A	O
new	O
betacoronavirus	B-SPEC
-	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)-	O
has	O
been	O
identified	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
infection	O
.	O

We	O
took	O
sera	O
from	O
animals	B-SPEC
in	O
the	O
Middle	O
East	O
(	O
Oman	O
)	O
and	O
from	O
elsewhere	O
(	O
Spain	O
,	O
Netherlands	O
,	O
Chile	O
).	O

We	O
demonstrated	O
the	O
expression	O
of	O
both	O
GFP	O
and	O
Renilla	B-SPEC
luciferase	O
as	O
well	O
as	O
the	O
application	O
of	O
these	O
viruses	B-SPEC
by	O
establishing	O
a	O
convenient	O
and	O
rapid	O
virus	B-SPEC
neutralization	O
assay	O
.	O

TITLE	O
:	O
Spiking	O
the	O
MERS	O
-	O
coronavirus	B-SPEC
receptor	O
.	O

ABSTRACT	O
:	O
Humoral	O
immunity	O
is	O
important	O
for	O
controlling	O
viral	O
diseases	O
of	O
poultry	O
,	O
but	O
recent	O
studies	O
have	O
indicated	O
that	O
cytotoxic	O
T	O
cells	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
immune	O
response	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

A	O
series	O
of	O
insertions	O
,	O
deletions	O
,	O
and	O
mutations	O
in	O
the	O
S	O
gene	O
was	O
found	O
in	O
five	O
PEDV	B-SPEC
variants	O
compared	O
with	O
classical	O
and	O
vaccine	O
strains	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
chickens	B-SPEC
infected	O
with	O
the	O
ChVI	O
genotype	O
(	O
Kr	O
/	O
ADL120003	O
/	O
2012	O
)	O
did	O
not	O
show	O
a	O
response	O
other	O
than	O
a	O
mild	O
upregulation	O
of	O
cytokines	O
at	O
1	O
d	O
postinoculation	O
,	O
which	O
appears	O
to	O
indicate	O
the	O
invasion	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
ACE2	O
-	O
from	O
the	O
renin	O
-	O
angiotensin	O
system	O
to	O
gut	O
microbiota	B-SPEC
and	O
malnutrition	O
.	O

Histology	O
revealed	O
severe	O
atrophy	O
of	O
villi	O
in	O
all	O
segments	O
of	O
the	O
small	O
intestines	O
with	O
occasional	O
villus	O
-	O
epithelial	O
syncytial	O
cells	O
,	O
but	O
testing	O
for	O
rotaviruses	B-SPEC
and	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
Alphacoronavirus	B-SPEC
1	I-SPEC
)	O
were	O
negative	O
.	O

Over	O
the	O
past	O
9	O
months	O
,	O
since	O
the	O
virus	B-SPEC
was	O
first	O
isolated	O
,	O
much	O
has	O
been	O
learned	O
about	O
the	O
biology	O
of	O
the	O
virus	B-SPEC
.	O

Infection	O
with	O
the	O
virus	B-SPEC
has	O
so	O
far	O
resulted	O
in	O
only	O
91	O
cases	O
and	O
46	O
deaths	O
(	O
as	O
of	O
29	O
July	O
2013	O
),	O
but	O
it	O
is	O
nonetheless	O
setting	O
off	O
alarm	O
bells	O
among	O
public	O
health	O
officials	O
,	O
including	O
Margaret	O
Chan	O
,	O
Director	O
-	O
General	O
of	O
the	O
World	O
Health	O
Organization	O
,	O
who	O
called	O
MERS	O
-	O
CoV	O
""""	O
a	O
threat	O
to	O
the	O
entire	O
world	O
.	O

To	O
date	O
,	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
research	O
has	O
been	O
hampered	O
by	O
the	O
lack	O
of	O
susceptible	O
cell	O
lines	O
for	O
the	O
propagation	O
of	O
serotype	O
I	O
FCoVs	O
.	O

In	O
this	O
study	O
,	O
long	O
-	O
term	O
feline	B-SPEC
intestinal	O
epithelial	O
cell	O
cultures	O
were	O
established	O
from	O
primary	O
ileocytes	O
and	O
colonocytes	O
by	O
simian	B-SPEC
virus	I-SPEC
40	I-SPEC
(	O
SV40	B-SPEC
)	O
T	O
-	O
antigen	O
-	O
and	O
human	B-SPEC
Telomerase	O
Reverse	O
Transcriptase	O
(	O
hTERT	O
)-	O
induced	O
immortalization	O
.	O

These	O
results	O
indicated	O
that	O
TGEV	B-SPEC
genome	O
packaging	O
is	O
a	O
complex	O
process	O
involving	O
many	O
factors	O
in	O
addition	O
to	O
the	O
identified	O
RNA	O
packaging	O
signal	O
.	O

The	O
integrity	O
of	O
epithelial	O
and	O
endothelial	O
barriers	O
in	O
the	O
lower	O
airspaces	O
of	O
the	O
lungs	O
has	O
to	O
be	O
tightly	O
regulated	O
,	O
in	O
order	B-SPEC
to	O
prevent	O
leakage	O
and	O
to	O
assure	O
efficient	O
gas	O
exchange	O
between	O
the	O
alveoli	O
and	O
capillaries	O
.	O

Upon	O
activation	O
,	O
arginase	O
competes	O
with	O
eNOS	O
for	O
the	O
substrate	O
l	O
-	O
arginine	O
,	O
as	O
such	O
impairing	O
eNOS	O
-	O
dependent	O
NO	O
generation	O
and	O
promoting	O
reactive	O
oxygen	O
species	B-SPEC
generation	O
by	O
the	O
enzyme	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
(	O
TGE	O
)	O
is	O
a	O
coronavirus	B-SPEC
-	O
induced	O
disease	O
of	O
pigs	B-SPEC
,	O
characterised	O
by	O
diarrhoea	O
and	O
vomiting	O
.	O

Analysis	O
of	O
the	O
amplified	O
partial	O
gene	O
sequences	O
showed	O
that	O
TGEV	B-SPEC
was	O
present	O
in	O
herds	O
with	O
TGE	O
clinical	O
signs	O
together	O
with	O
PRCoV	O
.	O
The	O
sequences	O
,	O
apart	O
from	O
the	O
deletions	O
in	O
PRCoV	O
,	O
were	O
identical	O
and	O
at	O
least	O
two	O
types	O
of	O
PRCoV	O
spike	O
proteins	O
could	O
be	O
identified	O
based	O
on	O
the	O
length	O
of	O
the	O
deleted	O
sequence	O
.	O

Two	O
human	B-SPEC
coronaviruses	O
,	O
HCoV	O
-	O
HKU1	O
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
were	O
identified	O
shortly	O
after	O
the	O
SARS	O
-	O
CoV	O
epidemic	O
as	O
common	O
causes	O
of	O
human	B-SPEC
respiratory	O
tract	O
infections	O
.	O

Source	O
identification	O
requires	O
detailed	O
epidemiological	O
studies	O
of	O
the	O
infected	O
patients	O
and	O
enhanced	O
surveillance	O
of	O
MERS	O
-	O
CoV	O
or	O
similar	O
coronaviruses	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

TITLE	O
:	O
Tracing	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

While	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
are	O
genetically	O
closely	O
related	O
to	O
bat	B-SPEC
coronaviruses	O
,	O
intermediate	O
host	O
(	O
s	O
)	O
is	O
(	O
are	O
)	O
likely	O
to	O
be	O
involved	O
in	O
the	O
emergence	O
and	O
cross	O
-	O
species	B-SPEC
transmission	O
of	O
these	O
novel	O
human	B-SPEC
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
coronavirus	B-SPEC
is	O
causing	O
alarm	O
among	O
researchers	O
and	O
international	O
health	O
officials	O
.	O

TITLE	O
:	O
A	O
safe	O
and	O
convenient	O
pseudovirus	O
-	O
based	O
inhibition	O
assay	O
to	O
detect	O
neutralizing	O
antibodies	O
and	O
screen	O
for	O
viral	O
entry	O
inhibitors	O
against	O
the	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Evidence	O
points	O
to	O
the	O
emergence	O
of	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
which	O
causes	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
disease	O
.	O

Furthermore	O
,	O
one	O
small	O
molecule	O
HIV	B-SPEC
entry	O
inhibitor	O
targeting	O
gp41	O
(	O
ADS	O
-	O
J1	B-SPEC
)	O
and	O
the	O
3	O
-	O
hydroxyphthalic	O
anhydride	O
-	O
modified	O
human	B-SPEC
serum	O
albumin	O
(	O
HP	O
-	O
HSA	O
)	O
could	O
significantly	O
inhibit	O
MERS	O
-	O
CoV	O
pseudovirus	O
infection	O
.	O

Microglia	O
can	O
be	O
persistently	O
infected	O
by	O
MHV	B-SPEC
.	O

TITLE	O
:	O
Treatment	O
with	O
neuromuscular	O
blocking	O
agents	O
and	O
the	O
risk	O
of	O
in	O
-	O
hospital	O
mortality	O
among	O
mechanically	O
ventilated	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

A	O
pharmacoepidemiologic	O
cohort	O
study	O
of	O
patients	O
with	O
sepsis	B-SPEC
and	O
a	O
respiratory	O
infection	O
who	O
had	O
been	O
admitted	O
to	O
intensive	O
care	O
and	O
placed	O
on	O
mechanical	O
ventilation	O
within	O
the	O
first	O
2	O
days	O
of	O
hospitalization	O
.	O

TITLE	O
:	O
Prevalence	O
,	O
risk	O
factors	O
of	O
infection	O
and	O
molecular	O
characterization	O
of	O
trichomonads	B-SPEC
in	O
puppies	O
from	O
French	O
breeding	O
kennels	O
.	O

Moreover	O
,	O
puppies	O
from	O
large	O
breeding	O
kennels	O
,	O
excreting	O
a	O
high	O
level	O
of	O
G	B-SPEC
.	I-SPEC
intestinalis	I-SPEC
and	O
/	O
or	O
excreting	O
a	O
high	O
level	O
of	O
C	B-SPEC
.	I-SPEC
canis	I-SPEC
oocysts	O
showed	O
a	O
higher	O
probability	O
of	O
being	O
positive	O
for	O
P	B-SPEC
.	I-SPEC
hominis	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
detected	O
in	O
a	O
number	O
of	O
countries	O
in	O
the	O
Middle	O
East	O
and	O
Europe	O
with	O
an	O
apparently	O
high	O
mortality	O
rate	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
reported	O
from	O
a	O
number	O
of	O
countries	O
in	O
the	O
Middle	O
East	O
and	O
Europe	O
with	O
a	O
reported	O
high	O
mortality	O
rate	O
.	O

Research	O
during	O
the	O
past	O
ten	O
years	O
has	O
revealed	O
the	O
existence	O
of	O
a	O
diverse	O
pool	O
of	O
coronaviruses	O
circulating	O
among	O
various	O
bat	B-SPEC
species	B-SPEC
and	O
other	O
animals	B-SPEC
,	O
suggesting	O
that	O
further	O
introductions	O
of	O
highly	O
pathogenic	O
coronaviruses	O
into	O
the	O
human	B-SPEC
population	O
are	O
not	O
merely	O
probable	O
,	O
but	O
inevitable	O
.	O

In	O
this	O
series	O
,	O
experts	O
in	O
many	O
different	O
aspects	O
of	O
coronavirus	B-SPEC
replication	O
and	O
disease	O
will	O
provide	O
authoritative	O
,	O
up	O
-	O
to	O
-	O
date	O
reviews	O
of	O
the	O
following	O
topics	O
:	O
-	O
clinical	O
management	O
and	O
infection	O
control	O
of	O
SARS	O
;	O
-	O
reservoir	O
hosts	O
of	O
coronaviruses	O
;	O
-	O
receptor	O
recognition	O
and	O
cross	O
-	O
species	B-SPEC
transmission	O
of	O
SARS	O
-	O
CoV	O
;	O
-	O
SARS	O
-	O
CoV	O
evasion	O
of	O
innate	O
immune	O
responses	O
;	O
-	O
structures	O
and	O
functions	O
of	O
individual	O
coronaviral	O
proteins	O
;	O
-	O
anti	O
-	O
coronavirus	B-SPEC
drug	O
discovery	O
and	O
development	O
;	O
and	O
-	O
the	O
public	O
health	O
legacy	O
of	O
the	O
SARS	O
outbreak	O
.	O

TITLE	O
:	O
Treatment	O
with	O
interferon	O
-	O
2b	O
and	O
ribavirin	O
improves	O
outcome	O
in	O
MERS	O
-	O
CoV	O
-	O
infected	O
rhesus	B-SPEC
macaques	I-SPEC
.	O

The	O
rhesus	B-SPEC
macaque	I-SPEC
is	O
the	O
only	O
known	O
model	O
organism	O
for	O
MERS	O
-	O
CoV	O
infection	O
,	O
developing	O
an	O
acute	O
localized	O
to	O
widespread	O
pneumonia	O
with	O
transient	O
clinical	O
disease	O
that	O
recapitulates	O
mild	O
to	O
moderate	O
human	B-SPEC
MERS	O
-	O
CoV	O
cases	O
.	O

TITLE	O
:	O
The	O
antiviral	O
activity	O
of	O
poly	O
-	O
	O
-	O
glutamic	O
acid	O
,	O
a	O
polypeptide	O
secreted	O
by	O
Bacillus	B-SPEC
sp	I-SPEC
.,	O
through	O
induction	O
of	O
CD14	O
-	O
dependent	O
type	O
I	O
interferon	O
responses	O
.	O

Therefore	O
,	O
the	O
rMERS	O
-	O
CoV	O
-	O
E	O
mutant	O
virus	B-SPEC
is	O
potentially	O
a	O
safe	O
and	O
promising	O
vaccine	O
candidate	O
to	O
prevent	O
MERS	O
-	O
CoV	O
infection	O
.	O

We	O
analyzed	O
six	O
different	O
cell	O
lines	O
from	O
either	O
Yinpterochiroptera	O
(	O
including	O
African	O
flying	B-SPEC
foxes	I-SPEC
and	O
a	O
rhinolophid	O
bat	B-SPEC
)	O
or	O
Yangochiroptera	O
(	O
genera	O
Carollia	B-SPEC
and	O
Tadarida	B-SPEC
)	O
for	O
susceptibility	O
to	O
infection	O
by	O
different	O
enveloped	O
RNA	O
viruses	B-SPEC
.	O

Asymptomatic	O
viral	O
carriage	O
,	O
mainly	O
of	O
picornaviruses	B-SPEC
,	O
was	O
found	O
at	O
10	O
%	O
of	O
screening	O
visits	O
.	O

The	O
hospitalisation	O
rate	O
was	O
50	O
%	O
(	O
95	O
%	O
CI	O
30	O
%	O
to	O
70	O
.	O
9	O
%)	O
for	O
influenza	O
and	O
parainfluenza	O
and	O
16	O
.	O
9	O
%	O
(	O
95	O
%	O
CI	O
11	O
.	O
2	O
%	O
to	O
23	O
.	O
9	O
%)	O
for	O
other	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
utilizes	O
host	O
proteases	O
for	O
virus	B-SPEC
entry	O
into	O
lung	O
cells	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
CoVs	O
)	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)	O
cause	O
epidemics	O
of	O
severe	O
human	B-SPEC
respiratory	O
disease	O
.	O

Exchange	O
of	O
nsp5	O
proteases	O
from	O
HCoV	O
-	O
HKU1	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
which	O
share	O
the	O
same	O
genogroup	O
,	O
genogroup	O
2a	O
,	O
with	O
MHV	B-SPEC
,	O
allowed	O
for	O
immediate	O
viral	O
recovery	O
with	O
efficient	O
replication	O
albeit	O
with	O
impaired	O
fitness	O
in	O
direct	O
competition	O
with	O
wild	O
-	O
type	O
MHV	B-SPEC
.	O

TITLE	O
:	O
Induced	O
expression	O
and	O
functional	O
effects	O
of	O
aquaporin	O
-	O
1	O
in	O
human	B-SPEC
leukocytes	O
in	O
sepsis	B-SPEC
.	O

To	O
asses	O
the	O
risk	O
factor	O
related	O
to	O
clinical	O
material	O
,	O
climatic	O
condition	O
and	O
type	O
of	O
RT	O
-	O
PCR	O
applied	O
,	O
cloacal	O
swabs	O
(	O
CS	O
),	O
faeces	O
,	O
sera	O
,	O
bursa	B-SPEC
of	O
Fabricius	O
(	O
BF	O
),	O
thymus	B-SPEC
(	O
TH	O
)	O
and	O
spleen	O
(	O
SP	O
)	O
and	O
ileum	O
-	O
caeca	O
region	O
were	O
collected	O
from	O
30	O
-	O
day	O
-	O
old	O
poults	O
suffering	O
of	O
enteritis	O
episode	O
characterized	O
as	O
poult	O
enteritis	O
mortality	O
syndrome	O
(	O
PEMS	O
).	O

TITLE	O
:	O
Differentiation	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
bcov	O
)	O
genotypes	O
by	O
a	O
restriction	O
enzyme	O
assay	O
.	O

Adenovirus	B-SPEC
and	O
norovirus	B-SPEC
were	O
the	O
most	O
common	O
viruses	B-SPEC
in	O
this	O
cohort	O
,	O
while	O
aichi	B-SPEC
virus	I-SPEC
was	O
the	O
only	O
gastrointestinal	O
agent	O
not	O
detected	O
.	O

Surprisingly	O
,	O
rhinovirus	B-SPEC
was	O
one	O
of	O
the	O
most	O
frequently	O
detected	O
viruses	B-SPEC
.	O

CONCLUSIONS	O
:	O
the	O
severity	O
of	O
AVB	O
by	O
RSV	B-SPEC
is	O
a	O
phenomenon	O
that	O
depends	O
on	O
the	O
varying	O
degrees	O
of	O
interaction	O
among	O
epidemiological	O
,	O
environmental	O
,	O
and	O
genetic	O
variables	O
.	O

Additionally	O
,	O
the	O
results	O
show	O
the	O
applicability	O
of	O
the	O
real	O
-	O
time	O
PCR	O
assay	O
in	O
laboratory	O
practice	O
for	O
the	O
identification	O
and	O
differentiation	O
of	O
Newcastle	O
disease	O
and	O
influenza	O
A	O
viruses	B-SPEC
in	O
birds	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrated	O
that	O
the	O
lack	O
of	O
binding	O
of	O
Beaudette	O
S1	O
was	O
not	O
due	O
to	O
absence	O
of	O
virus	B-SPEC
receptors	O
on	O
this	O
tissue	O
nor	O
due	O
to	O
the	O
production	O
of	O
S1	O
from	O
mammalian	B-SPEC
cells	O
,	O
as	O
S1	O
proteins	O
expressed	O
from	O
chicken	B-SPEC
cells	O
also	O
lacked	O
the	O
ability	O
to	O
bind	O
IBV	B-SPEC
-	O
susceptible	O
embryonic	O
tissue	O
.	O

In	O
contrast	O
,	O
Beaudette	O
spike	O
ectodomain	O
had	O
relatively	O
weak	O
ability	O
to	O
bind	O
to	O
chicken	B-SPEC
trachea	B-SPEC
,	O
but	O
displayed	O
marked	O
extended	O
host	O
range	O
to	O
mammalian	B-SPEC
cells	O
.	O

Rather	O
,	O
the	O
interplay	O
between	O
S1	O
and	O
S2	O
subunits	O
of	O
spikes	O
from	O
the	O
same	O
viral	O
origin	O
might	O
finally	O
determine	O
the	O
avidity	O
and	O
specificity	O
of	O
virus	B-SPEC
attachment	O
and	O
thus	O
viral	O
host	O
range	O
.	O

TITLE	O
:	O
Reverse	O
genetics	O
with	O
a	O
full	O
-	O
length	O
infectious	O
cDNA	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Following	O
contig	O
assembly	O
into	O
genome	O
-	O
length	O
cDNA	O
,	O
transfected	O
full	O
-	O
length	O
transcripts	O
recovered	O
several	O
recombinant	O
viruses	B-SPEC
(	O
rMERS	O
-	O
CoV	O
)	O
that	O
contained	O
the	O
expected	O
marker	O
mutations	O
inserted	O
into	O
the	O
component	O
clones	O
.	O

Because	O
the	O
wild	O
-	O
type	O
MERS	O
-	O
CoV	O
contains	O
a	O
tissue	O
culture	O
-	O
adapted	O
T1015N	O
mutation	O
in	O
the	O
S	O
glycoprotein	O
,	O
rMERS	O
-	O
CoV	O
replicated	O
~	O
0	O
.	O
5	O
log	O
less	O
efficiently	O
than	O
wild	O
-	O
type	O
virus	B-SPEC
.	O

The	O
availability	O
of	O
a	O
MERS	O
-	O
CoV	O
molecular	O
clone	O
,	O
as	O
well	O
as	O
recombinant	O
viruses	B-SPEC
expressing	O
indicator	B-SPEC
proteins	O
,	O
will	O
allow	O
for	O
high	O
-	O
throughput	O
testing	O
of	O
therapeutic	O
compounds	O
and	O
provide	O
a	O
genetic	O
platform	O
for	O
studying	O
gene	O
function	O
and	O
the	O
rational	O
design	O
of	O
live	O
virus	B-SPEC
vaccines	O
.	O

LOH	O
is	O
frequently	O
associated	O
with	O
chronic	O
conditions	O
including	O
cardiovascular	O
diseases	O
(	O
CVD	O
),	O
obesity	O
,	O
osteoporosis	O
,	O
HIV	B-SPEC
infection	O
,	O
renal	O
failure	O
,	O
and	O
obstructive	O
pulmonary	O
diseases	O
.	O

Further	O
definition	O
of	O
the	O
exposures	O
responsible	O
for	O
the	O
sporadic	O
introductions	O
of	O
MERS	O
-	O
CoV	O
into	O
human	B-SPEC
populations	O
is	O
urgently	O
needed	O
.	O

TITLE	O
:	O
Pathogenic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
or	O
poly	O
(	O
I	O
:	O
C	O
)	O
induce	O
IL	O
-	O
33	O
in	O
hepatocytes	O
in	O
murine	B-SPEC
models	O
of	O
hepatitis	O
.	O

Although	O
,	O
the	O
IL	O
-	O
33	O
levels	O
increased	O
in	O
sera	O
of	O
viral	O
hepatitis	O
patients	O
in	O
human	B-SPEC
,	O
the	O
cellular	O
sources	O
of	O
IL	O
-	O
33	O
in	O
viral	O
hepatitis	O
remained	O
obscure	O
.	O

In	O
parallel	O
,	O
the	O
L2	O
-	O
MHV3	O
infection	O
in	O
mice	B-SPEC
induced	O
fulminant	O
hepatitis	O
associated	O
with	O
up	O
-	O
regulated	O
IL	O
-	O
33	O
expression	O
as	O
well	O
as	O
pro	O
-	O
inflammatory	O
cytokine	O
microenvironment	O
in	O
liver	O
.	O

We	O
conclusively	O
showed	O
that	O
MERS	O
-	O
CoV	O
can	O
establish	O
a	O
productive	O
infection	O
in	O
human	B-SPEC
macrophages	O
.	O

TITLE	O
:	O
The	O
occurrence	O
of	O
enteric	O
viruses	B-SPEC
in	O
Light	O
Turkey	B-SPEC
Syndrome	O
.	O

In	O
the	O
surveillance	O
study	O
,	O
we	O
selected	O
four	O
LTS	O
and	O
two	O
non	O
-	O
LTS	O
turkey	B-SPEC
flocks	O
in	O
Minnesota	O
and	O
collected	O
faecal	O
samples	O
at	O
2	O
,	O
3	O
,	O
5	O
and	O
8	O
-	O
weeks	O
of	O
age	O
.	O

Astrovirus	O
,	O
rotavirus	B-SPEC
,	O
and	O
reovirus	B-SPEC
were	O
detected	O
alone	O
or	O
in	O
various	O
combinations	O
in	O
both	O
LTS	O
and	O
non	O
-	O
LTS	O
flocks	O
.	O

Virus	B-SPEC
shedding	O
in	O
both	O
groups	O
was	O
observed	O
for	O
up	O
to	O
nine	O
weeks	O
of	O
age	O
.	O

These	O
findings	O
suggest	O
that	O
viral	O
enteritis	O
at	O
an	O
early	O
age	O
may	O
set	O
up	O
conditions	O
for	O
the	O
development	O
of	O
LTS	O
in	O
adult	O
turkeys	B-SPEC
.	O

Dietary	O
vitamin	O
A	O
restriction	O
increases	O
marbling	O
in	O
feedlot	O
cattle	B-SPEC
;	O
however	O
,	O
its	O
effect	O
on	O
antibody	O
responses	O
to	O
vaccines	O
is	O
unknown	O
.	O

Incidence	O
of	O
infections	O
,	O
sepsis	B-SPEC
,	O
and	O
respiratory	O
parameters	O
were	O
recorded	O
.	O

Fecal	O
samples	O
at	O
enrollment	O
and	O
exit	O
were	O
tested	O
for	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
,	O
Cryptosporidium	B-SPEC
spp	O
.,	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
.	O

Immunohistochemical	O
testing	O
of	O
biopsy	O
specimens	O
and	O
postmortem	O
examination	O
are	O
the	O
standard	O
diagnostic	O
methods	O
,	O
although	O
direct	O
immunofluorescence	O
(	O
DIF	O
)	O
testing	O
to	O
detect	O
feline	B-SPEC
coronavirus	B-SPEC
in	O
macrophages	O
in	O
effusion	O
specimens	O
has	O
been	O
reported	O
to	O
have	O
100	O
%	O
specificity	O
and	O
has	O
been	O
recommended	O
as	O
an	O
antemortem	O
confirmatory	O
test	O
.	O

In	O
the	O
seven	O
cats	B-SPEC
where	O
FIP	O
was	O
ruled	O
out	O
at	O
postmortem	O
examination	O
,	O
DIF	O
was	O
negative	O
in	O
five	O
cases	O
and	O
positive	O
in	O
the	O
remaining	O
two	O
cases	O
.	O

ABSTRACT	O
:	O
The	O
high	O
mortality	O
associated	O
with	O
the	O
novel	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
raised	O
questions	O
about	O
the	O
possible	O
role	O
of	O
a	O
cytokine	O
storm	O
in	O
its	O
pathogenesis	O
.	O

No	O
other	O
investigated	O
species	B-SPEC
had	O
any	O
antibody	O
reactivity	O
to	O
MERS	O
-	O
CoV	O
.	O
While	O
seropositivity	O
does	O
not	O
exclude	O
the	O
possibility	O
of	O
infection	O
with	O
a	O
closely	O
related	O
virus	B-SPEC
,	O
our	O
data	O
highlight	O
the	O
need	O
to	O
attempt	O
detection	O
of	O
MERSCoV	O
or	O
related	O
coronaviruses	O
in	O
dromedary	B-SPEC
camels	B-SPEC
.	O

The	O
X	O
-	O
ray	B-SPEC
structure	O
of	O
SARS	O
-	O
CoV	O
3CLpro	O
bound	O
with	O
a	O
ML300	O
analog	O
highlights	O
a	O
unique	O
induced	O
-	O
fit	O
reorganization	O
of	O
the	O
S2	O
-	O
S4	O
binding	O
pockets	O
leading	O
to	O
the	O
first	O
sub	O
-	O
micromolar	O
noncovalent	O
3CLpro	O
inhibitors	O
retaining	O
a	O
single	O
amide	O
bond	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
seven	O
field	O
samples	O
that	O
showed	O
positive	O
in	O
PEDV	B-SPEC
detection	O
were	O
collected	O
from	O
different	O
farms	O
of	O
Fujian	O
province	O
from	O
2010	O
to	O
2012	O
.	O

In	O
contrast	O
,	O
when	O
mice	B-SPEC
were	O
infected	O
with	O
800	O
PFU	O
of	O
NL	O
/	O
602	O
virus	B-SPEC
,	O
minimal	O
weight	O
loss	O
was	O
observed	O
,	O
and	O
concentrations	O
of	O
cytokines	O
in	O
the	O
lung	O
were	O
significantly	O
lower	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
lethal	O
infectious	O
disease	O
affecting	O
domestic	O
and	O
wild	B-SPEC
cats	I-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
have	O
prepared	O
nine	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
that	O
recognize	O
feline	B-SPEC
TNF	O
-	O
alpha	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
TGEV	B-SPEC
infection	O
on	O
the	O
cell	O
cycle	O
of	O
host	O
cells	O
and	O
the	O
roles	O
of	O
p53	O
activation	O
in	O
this	O
process	O
.	O

The	O
results	O
showed	O
that	O
TGEV	B-SPEC
infection	O
induced	O
cell	O
cycle	O
arrest	O
at	O
S	O
and	O
G2	O
/	O
M	O
phases	O
in	O
both	O
asynchronous	O
and	O
synchronized	O
PK	O
-	O
15	O
and	O
ST	O
cells	O
,	O
while	O
UV	O
-	O
inactivated	O
TGEV	B-SPEC
lost	O
the	O
ability	O
of	O
induction	O
of	O
cell	O
cycle	O
arrest	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
emerged	O
to	O
cause	O
fatal	O
infections	O
in	O
patients	O
in	O
the	O
Middle	O
East	O
and	O
traveler	O
-	O
associated	O
secondary	O
cases	O
in	O
Europe	O
and	O
Africa	O
.	O

We	O
used	O
small	O
compound	O
-	O
based	O
forward	O
chemical	O
genetics	O
to	O
screen	O
a	O
chemical	O
library	O
of	O
1280	O
known	O
drugs	O
against	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
in	O
Biosafety	O
Level	O
-	O
2	O
laboratory	O
.	O

Similar	O
pathogens	O
,	O
including	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
,	O
are	O
also	O
frequently	O
detected	O
during	O
exacerbation	O
of	O
asthma	O
and	O
/	O
or	O
COPD	O
.	O

In	O
summary	O
,	O
the	O
assembly	O
of	O
IBV	B-SPEC
VLPs	O
with	O
M	O
and	O
S	O
proteins	O
provided	O
a	O
simple	O
strategy	O
for	O
generating	O
VLPs	O
for	O
coronaviruses	O
,	O
and	O
the	O
generated	O
IBV	B-SPEC
VLPs	O
laid	O
a	O
feasible	O
foundation	O
for	O
the	O
development	O
of	O
an	O
effective	O
vaccine	O
against	O
infection	O
of	O
IBV	B-SPEC
in	O
the	O
future	O
.	O

Therefore	O
,	O
the	O
HDAISWTHYHPW	O
peptide	O
sequence	O
has	O
a	O
potential	O
use	O
as	O
a	O
small	O
molecular	O
therapeutic	O
agent	O
against	O
TGEV	B-SPEC
infection	O
.	O

Patients	O
under	O
invasive	O
or	O
noninvasive	O
mechanical	O
ventilation	O
,	O
with	O
PaO2	O
/	O
FiO2	O
<	O
300	O
mmHg	O
regardless	O
of	O
the	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
level	O
,	O
and	O
acute	O
onset	O
of	O
new	O
or	O
increased	O
bilateral	O
infiltrates	O
or	O
opacities	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
were	O
screened	O
from	O
ICU	O
admission	O
up	O
to	O
discharge	O
.	O

Children	O
with	O
multiple	O
viral	O
findings	O
in	O
their	O
respiratory	O
secretions	O
were	O
older	O
than	O
those	O
with	O
a	O
single	O
detected	O
virus	B-SPEC
.	O

Pioneer	O
studies	O
identified	O
cathepsins	O
and	O
type	O
II	O
transmembrane	O
serine	O
proteases	O
as	O
cellular	O
activators	O
of	O
SARS	O
-	O
CoV	O
and	O
demonstrated	O
that	O
several	O
emerging	O
viruses	B-SPEC
might	O
exploit	O
these	O
enzymes	O
to	O
promote	O
their	O
spread	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
),	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
),	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
infections	O
in	O
children	O
with	O
sickle	O
cell	O
disease	O
have	O
not	O
been	O
well	O
studied	O
.	O

Co	O
-	O
infections	O
with	O
more	O
than	O
two	O
respiratory	O
viruses	B-SPEC
were	O
seen	O
in	O
seven	O
patients	O
,	O
all	O
in	O
patients	O
without	O
ACS	O
.	O

RESULTS	O
:	O
A	O
respiratory	O
virus	B-SPEC
was	O
detected	O
in	O
47	O
(	O
78	O
%)	O
patients	O
.	O

TITLE	O
:	O
The	O
Rivalta	O
'	O
s	O
test	O
as	O
a	O
diagnostic	O
variable	O
in	O
feline	B-SPEC
effusions	O
--	O
evaluation	O
of	O
optimum	O
reaction	O
and	O
storage	O
conditions	O
.	O

In	O
light	O
of	O
recent	O
functional	O
,	O
biochemical	O
and	O
structural	O
findings	O
,	O
we	O
review	O
the	O
inhibition	O
mechanisms	O
of	O
RLRs	O
recognition	O
of	O
dsRNA	O
displayed	O
by	O
a	O
number	O
of	O
highly	O
pathogenic	O
RNA	O
viruses	B-SPEC
with	O
different	O
disease	O
phenotypes	O
such	O
as	O
haemorrhagic	O
fever	O
(	O
Ebola	O
,	O
Marburg	O
,	O
Lassa	O
fever	O
,	O
Lujo	O
,	O
Machupo	O
,	O
Junin	O
,	O
Guanarito	O
,	O
Crimean	O
-	O
Congo	O
,	O
Rift	O
Valley	O
fever	O
,	O
dengue	O
),	O
severe	O
respiratory	O
disease	O
(	O
influenza	O
,	O
SARS	O
,	O
Hendra	O
,	O
Hantaan	O
,	O
Sin	O
Nombre	O
,	O
Andes	B-SPEC
)	O
and	O
encephalitis	O
(	O
Nipah	O
,	O
West	O
Nile	O
).	O

The	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
strains	O
underwent	O
evolutionary	O
divergence	O
,	O
which	O
can	O
be	O
classified	O
into	O
two	O
sublineages	O
.	O

The	O
results	O
provide	O
much	O
needed	O
information	O
to	O
devise	O
effective	O
preventive	O
and	O
control	O
strategies	O
against	O
PEDV	B-SPEC
in	O
the	O
United	O
States	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
characteristics	O
of	O
viral	O
spectrum	O
and	O
clinical	O
features	O
of	O
children	O
in	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
).	O

Fluorescence	O
quantitative	O
PCR	O
was	O
applied	O
to	O
detect	O
13	O
viruses	B-SPEC
from	O
CSF	O
and	O
to	O
analyze	O
the	O
clinical	O
data	O
of	O
positive	O
cases	O
.	O

But	O
none	O
from	O
87	O
healthy	O
controls	O
were	O
positive	O
for	O
any	O
respiratory	O
virus	B-SPEC
.	O

As	O
RNA	O
viruses	B-SPEC
may	O
coevolve	O
with	O
their	O
hosts	O
,	O
we	O
sought	O
to	O
investigate	O
the	O
closest	O
sister	O
taxon	O
to	O
bats	B-SPEC
,	O
the	O
Eulipotyphla	O
,	O
and	O
screened	O
European	O
hedgehogs	B-SPEC
(	O
Erinaceus	B-SPEC
europaeus	I-SPEC
)	O
from	O
Germany	O
for	O
CoV	O
by	O
nested	O
reverse	O
transcriptase	O
PCR	O
.	O

A	O
total	O
of	O
58	O
.	O
9	O
%	O
of	O
hedgehog	B-SPEC
fecal	O
specimens	O
were	O
positive	O
for	O
the	O
novel	O
CoV	O
(	O
EriCoV	O
)	O
at	O
7	O
.	O
9	O
log10	O
mean	O
RNA	O
copies	O
per	O
ml	O
.	O

Animal	B-SPEC
experiments	O
clearly	O
show	O
that	O
prone	O
positioning	O
delays	O
or	O
prevents	O
ventilation	O
-	O
induced	O
lung	O
injury	O
,	O
likely	O
due	O
in	O
large	O
part	O
to	O
more	O
homogeneously	O
distributed	O
stress	O
and	O
strain	O
.	O

GRFT	O
displays	O
no	O
human	B-SPEC
T	O
-	O
cell	O
mitogenic	O
activity	O
and	O
does	O
not	O
induce	O
production	O
of	O
proinflammatory	O
cytokines	O
in	O
treated	O
human	B-SPEC
cell	O
lines	O
.	O

These	O
studies	O
support	O
further	O
development	O
of	O
GRFT	O
as	O
a	O
systemic	O
antiviral	O
therapeutic	O
agent	O
against	O
enveloped	O
viruses	B-SPEC
,	O
although	O
deimmunizing	O
the	O
molecule	O
may	O
be	O
necessary	O
if	O
it	O
is	O
to	O
be	O
used	O
in	O
long	O
-	O
term	O
treatment	O
of	O
chronic	O
viral	O
infections	O
.	O

The	O
identification	O
of	O
asymptomatic	O
patients	O
and	O
mild	O
cases	O
among	O
family	B-SPEC
and	O
healthcare	O
worker	O
contacts	O
of	O
confirmed	O
cases	O
indicates	O
a	O
wider	O
spectrum	O
of	O
clinical	O
manifestation	O
of	O
the	O
disease	O
.	O

For	O
some	O
emerging	O
pathogens	O
the	O
bat	B-SPEC
origin	O
has	O
been	O
confirmed	O
(	O
such	O
as	O
lyssaviruses	B-SPEC
,	O
henipaviruses	B-SPEC
,	O
coronaviruses	O
),	O
for	O
other	O
it	O
has	O
been	O
suggested	O
(	O
filoviruses	O
).	O

Previous	O
work	O
on	O
the	O
infection	O
of	O
tissue	O
culture	O
cell	O
lines	O
with	O
the	O
betacoronaviruses	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
showed	O
that	O
they	O
generate	O
double	O
-	O
membrane	O
vesicles	O
(	O
DMVs	O
)	O
and	O
convoluted	O
membranes	O
as	O
part	O
of	O
a	O
reticular	O
membrane	O
network	O
.	O

We	O
have	O
studied	O
the	O
membrane	O
rearrangements	O
induced	O
by	O
an	O
important	O
poultry	O
pathogen	O
,	O
the	O
gammacoronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Significantly	O
,	O
spherules	O
contain	O
a	O
channel	O
connecting	O
their	O
interior	O
to	O
the	O
cytoplasm	O
and	O
strongly	O
resemble	O
confirmed	O
sites	O
of	O
RNA	O
synthesis	O
for	O
other	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
,	O
making	O
them	O
ideal	O
candidates	O
for	O
the	O
site	O
of	O
IBV	B-SPEC
RNA	O
synthesis	O
.	O

ABSTRACT	O
:	O
In	O
Germany	O
,	O
the	O
outbreak	O
of	O
the	O
novel	O
pandemic	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
A	O
(	O
H1N1	O
)	O
pdm09	O
caused	O
a	O
wave	O
of	O
high	O
activity	O
between	O
November	O
2009	O
and	O
January	O
2011	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
19	O
respiratory	O
pathogens	O
in	O
children	O
hospitalized	O
for	O
lower	O
respiratory	O
tract	O
infections	O
during	O
the	O
winter	O
influenza	O
seasons	O
of	O
2009	O
/	O
2010	O
and	O
2010	O
/	O
2011	O
and	O
to	O
observe	O
a	O
possible	O
impact	O
of	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
on	O
the	O
epidemiology	O
of	O
other	O
epidemic	O
viruses	B-SPEC
.	O

The	O
emergence	O
of	O
the	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
may	O
have	O
been	O
influenced	O
the	O
epidemiology	O
of	O
other	O
epidemic	O
viruses	B-SPEC
,	O
such	O
as	O
the	O
RSV	B-SPEC
and	O
hMPV	B-SPEC
.	O

The	O
RSV	B-SPEC
and	O
hMPV	B-SPEC
epidemics	O
of	O
2009	O
/	O
2010	O
erupted	O
several	O
weeks	O
later	O
than	O
expected	O
based	O
on	O
data	O
collected	O
in	O
the	O
PID	O
-	O
ARI	O
-	O
Network	O
during	O
the	O
past	O
10	O
years	O
,	O
whereas	O
in	O
the	O
2010	O
/	O
2011	O
influenza	O
season	O
they	O
occurred	O
as	O
expected	O
.	O

ABSTRACT	O
:	O
The	O
clinical	O
and	O
laboratory	O
findings	O
in	O
puppies	O
naturally	O
infected	O
with	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
and	O
/	O
or	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
)	O
were	O
compared	O
with	O
findings	O
in	O
uninfected	O
puppies	O
.	O

Using	O
TIMP	O
-	O
1	O
deficient	O
mice	B-SPEC
,	O
the	O
present	O
data	O
demonstrate	O
an	O
increase	O
rather	O
than	O
a	O
decrease	O
in	O
CD4	O
	O
T	O
cell	O
accumulation	O
within	O
the	O
perivascular	O
space	O
during	O
JHMV	O
infection	O
.	O

According	O
to	O
a	O
meta	B-SPEC
-	O
analysis	O
,	O
enteral	O
nutrition	O
initiated	O
within	O
24	O
hours	O
of	O
admission	O
improves	O
the	O
outcome	O
of	O
AP	O
compared	O
with	O
later	O
initiation	O
of	O
enteral	O
nutrition	O
.	O

TITLE	O
:	O
Transcriptome	O
analysis	O
of	O
chicken	B-SPEC
kidney	O
tissues	O
following	O
coronavirus	B-SPEC
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
.	O

However	O
,	O
the	O
molecular	O
antiviral	O
mechanisms	O
of	O
chickens	B-SPEC
to	O
IBV	B-SPEC
infection	O
remain	O
poorly	O
understood	O
.	O

IBV	B-SPEC
infection	O
contributed	O
to	O
differential	O
expression	O
of	O
1777	O
genes	O
,	O
of	O
which	O
876	O
were	O
up	O
-	O
regulated	O
and	O
901	O
down	O
-	O
regulated	O
in	O
the	O
kidney	O
compared	O
to	O
those	O
of	O
control	O
chickens	B-SPEC
and	O
103	O
associated	O
with	O
immune	O
and	O
inflammatory	O
responses	O
may	O
play	O
important	O
roles	O
in	O
the	O
host	O
defense	O
response	O
during	O
IBV	B-SPEC
infection	O
.	O

Diverse	O
SARS	O
-	O
like	O
coronaviruses	O
(	O
SL	O
-	O
CoVs	O
)	O
have	O
now	O
been	O
reported	O
from	O
bats	B-SPEC
in	O
China	O
,	O
Europe	O
and	O
Africa	O
,	O
but	O
none	O
is	O
considered	O
a	O
direct	O
progenitor	O
of	O
SARS	O
-	O
CoV	O
because	O
of	O
their	O
phylogenetic	O
disparity	O
from	O
this	O
virus	B-SPEC
and	O
the	O
inability	O
of	O
their	O
spike	O
proteins	O
to	O
use	O
the	O
SARS	O
-	O
CoV	O
cellular	O
receptor	O
molecule	O
,	O
the	O
human	B-SPEC
angiotensin	O
converting	O
enzyme	O
II	O
(	O
ACE2	O
).	O

These	O
viruses	B-SPEC
are	O
far	O
more	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
than	O
any	O
previously	O
identified	O
bat	B-SPEC
coronaviruses	O
,	O
particularly	O
in	O
the	O
receptor	O
binding	O
domain	O
of	O
the	O
spike	O
protein	O
.	O

However	O
,	O
reversion	O
was	O
found	O
at	O
all	O
mutated	O
sites	O
within	O
five	O
virus	B-SPEC
passages	O
.	O

(	O
ii	O
)	O
When	O
the	O
uORF	O
was	O
fused	O
with	O
genomic	O
(	O
main	O
)	O
ORF1	O
by	O
converting	O
three	O
in	O
-	O
frame	O
stop	O
codons	O
to	O
nonstop	O
codons	O
,	O
a	O
uORF	O
-	O
ORF1	O
fusion	O
protein	O
was	O
made	O
,	O
and	O
virus	B-SPEC
replicated	O
at	O
WT	O
levels	O
.	O

(	O
iii	O
)	O
When	O
uAUG	O
-	O
eliminating	O
deletions	O
of	O
20	O
,	O
30	O
,	O
or	O
51	O
nucleotides	O
(	O
nt	O
)	O
were	O
made	O
within	O
stem	O
-	O
loop	O
4	O
,	O
viable	O
but	O
debilitated	O
virus	B-SPEC
was	O
recovered	O
.	O

These	O
results	O
together	O
suggest	O
that	O
the	O
uORF	O
represses	O
ORF1	O
translation	O
yet	O
plays	O
a	O
beneficial	O
but	O
nonessential	O
role	O
in	O
coronavirus	B-SPEC
replication	O
in	O
cell	O
culture	O
.	O

We	O
then	O
conduct	O
a	O
comprehensive	O
phylogenetic	O
analysis	O
of	O
the	O
genera	O
Alpha	O
-	O
and	O
Betacoronavirus	B-SPEC
,	O
to	O
show	O
that	O
bats	B-SPEC
harbour	O
more	O
CoV	O
diversity	O
than	O
other	O
mammalian	B-SPEC
hosts	O
and	O
are	O
widely	O
represented	O
in	O
most	O
,	O
but	O
not	O
all	O
parts	O
of	O
the	O
tree	O
of	O
mammalian	B-SPEC
CoVs	O
.	O

We	O
then	O
present	O
evidence	O
for	O
a	O
zoonotic	O
origin	O
of	O
four	O
of	O
the	O
six	O
known	O
human	B-SPEC
CoVs	O
(	O
HCoV	O
),	O
three	O
of	O
which	O
likely	O
involved	O
bats	B-SPEC
,	O
namely	O
SARS	O
-	O
CoV	O
,	O
MERS	O
-	O
CoV	O
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
;	O
compare	O
the	O
available	O
data	O
on	O
CoV	O
pathogenesis	O
in	O
bats	B-SPEC
to	O
that	O
in	O
other	O
mammalian	B-SPEC
hosts	O
;	O
and	O
discuss	O
hypotheses	O
on	O
the	O
putative	O
insect	B-SPEC
origins	O
of	O
CoV	O
ancestors	O
.	O

This	O
study	O
fills	O
a	O
substantive	O
gap	O
in	O
the	O
knowledge	O
on	O
bat	B-SPEC
-	O
CoV	O
ecology	O
in	O
Italy	O
,	O
and	O
extends	O
the	O
current	O
knowledge	O
on	O
clade	O
2c	O
betacoronaviruses	O
with	O
new	O
sequences	O
obtained	O
from	O
bats	B-SPEC
that	O
have	O
not	O
been	O
previously	O
described	O
as	O
hosts	O
of	O
these	O
viruses	B-SPEC
.	O

Concomitant	O
with	O
this	O
,	O
the	O
human	B-SPEC
population	O
has	O
been	O
growing	O
steadily	O
.	O

Coronaviruses	O
,	O
like	O
many	O
other	O
viruses	B-SPEC
,	O
have	O
evolved	O
mechanisms	O
to	O
evade	O
this	O
innate	O
response	O
,	O
ensuring	O
their	O
survival	O
.	O

As	O
it	O
has	O
been	O
demonstrated	O
previously	O
that	O
ORF7	O
is	O
essential	O
for	O
efficient	O
replication	O
in	O
vitro	O
and	O
virulence	O
in	O
vivo	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
),	O
the	O
role	O
of	O
this	O
ORF	O
in	O
the	O
evasion	O
of	O
the	O
IFN	O
-	O
	O
antiviral	O
response	O
was	O
investigated	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
viruses	B-SPEC
associated	O
with	O
the	O
2013	O
disease	O
outbreak	O
among	O
swine	B-SPEC
in	O
the	O
United	O
States	O
.	O

Obtaining	O
a	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
isolate	O
that	O
can	O
grow	O
efficiently	O
in	O
cell	O
culture	O
is	O
critical	O
for	O
investigating	O
pathogenesis	O
and	O
developing	O
diagnostic	O
assays	O
and	O
for	O
vaccine	O
development	O
.	O

Phylogenetic	O
analyses	O
using	O
different	O
genes	O
of	O
PEDV	B-SPEC
suggested	O
that	O
the	O
full	O
-	O
length	O
spike	O
gene	O
or	O
the	O
S1	O
portion	O
is	O
appropriate	O
for	O
sequencing	O
to	O
study	O
the	O
genetic	O
relatedness	O
of	O
these	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
etiological	O
agent	O
of	O
a	O
respiratory	O
disease	O
that	O
has	O
a	O
10	O
%	O
mortality	O
rate	O
.	O

These	O
data	O
indicated	O
that	O
activation	O
of	O
the	O
NF	O
-	O
B	O
signaling	O
pathway	O
represents	O
a	O
major	O
contribution	O
to	O
the	O
inflammation	O
induced	O
after	O
SARS	O
-	O
CoV	O
infection	O
and	O
that	O
NF	O
-	O
B	O
inhibitors	O
are	O
promising	O
antivirals	O
in	O
infections	O
caused	O
by	O
SARS	O
-	O
CoV	O
and	O
potentially	O
other	O
pathogenic	O
human	B-SPEC
coronaviruses	O
.	O

Contrasting	O
the	O
mild	O
encephalitis	O
and	O
100	O
%	O
survival	O
of	O
MHV	B-SPEC
-	O
A59	O
-	O
infected	O
wild	O
-	O
type	O
(	O
wt	O
)	O
mice	B-SPEC
,	O
nearly	O
60	O
%	O
of	O
infected	O
Ifit2	O
(-/-)	O
mice	B-SPEC
exhibited	O
severe	O
encephalitis	O
and	O
succumbed	O
between	O
6	O
and	O
8	O
days	O
postinfection	O
.	O

Molecular	O
investigation	O
indicated	O
that	O
bats	B-SPEC
in	O
Saudi	O
Arabia	O
are	O
infected	O
with	O
several	O
alphacoronaviruses	O
and	O
betacoronaviruses	O
.	O

Real	O
time	O
RT	O
-	O
qPCR	O
was	O
developed	O
for	O
further	O
transcriptional	O
profiling	O
of	O
three	O
genes	O
(	O
PD	O
-	O
1	O
,	O
PD	O
-	O
L1	O
and	O
A3H	O
)	O
in	O
infected	O
CRFK	O
cells	O
and	O
Peripheral	O
Blood	O
Mononuclear	O
Cells	O
(	O
PBMCs	O
)	O
from	O
healthy	O
and	O
FIP	O
-	O
diseased	O
cats	B-SPEC
.	O

Real	O
time	O
RT	O
-	O
qPCR	O
developed	O
focusing	O
on	O
2	O
up	O
-	O
regulated	O
genes	O
(	O
PD	O
-	O
L1	O
and	O
A3H	O
)	O
together	O
with	O
an	O
apoptosis	O
associated	O
gene	O
PD	O
-	O
1	O
expressions	O
in	O
FIPV	O
infected	O
CRFK	O
cells	O
and	O
in	O
PBMCs	O
from	O
healthy	O
and	O
FIP	O
diagnosed	O
cats	B-SPEC
produced	O
concordant	O
results	O
with	O
transcriptome	O
data	O
.	O

Recent	O
studies	O
have	O
provided	O
encouraging	O
results	O
in	O
treating	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infections	O
in	O
lung	O
transplant	O
recipients	O
,	O
serious	O
parainfluenza	O
virus	B-SPEC
and	O
adenovirus	B-SPEC
infections	O
in	O
immunocompromised	O
hosts	O
,	O
and	O
rhinovirus	B-SPEC
colds	O
in	O
outpatient	O
asthmatics	O
.	O

NIV	O
failure	O
was	O
associated	O
with	O
active	O
cancer	B-SPEC
,	O
shock	O
,	O
moderate	O
/	O
severe	O
ARDS	O
,	O
lower	O
Glasgow	O
coma	B-SPEC
score	O
and	O
lower	O
positive	O
end	O
-	O
expiratory	O
pressure	O
level	O
at	O
NIV	O
initiation	O
.	O

In	O
this	O
Review	O
,	O
we	O
describe	O
the	O
emergence	O
and	O
identification	O
of	O
novel	O
human	B-SPEC
coronaviruses	O
over	O
the	O
past	O
10	O
years	O
,	O
discuss	O
their	O
key	O
biological	O
features	O
,	O
including	O
tropism	O
and	O
receptor	O
use	O
,	O
and	O
summarize	O
approaches	O
for	O
developing	O
broadly	O
effective	O
vaccines	O
.	O

To	O
date	O
,	O
114	O
human	B-SPEC
cases	O
of	O
MERS	O
-	O
CoV	O
have	O
been	O
reported	O
,	O
with	O
54	O
fatalities	O
.	O

Animal	B-SPEC
models	O
for	O
MERS	O
-	O
CoV	O
infection	O
of	O
humans	B-SPEC
are	O
needed	O
to	O
elucidate	O
MERS	O
pathogenesis	O
and	O
to	O
develop	O
vaccines	O
and	O
antivirals	O
.	O

TITLE	O
:	O
Acute	O
effects	O
of	O
estradiol	O
on	O
lung	O
inflammation	O
due	O
to	O
intestinal	O
ischemic	O
insult	O
in	O
male	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
type	O
II	O
transmembrane	O
serine	O
proteases	O
TMPRSS2	O
and	O
HAT	O
can	O
cleave	O
and	O
activate	O
the	O
spike	O
protein	O
(	O
S	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
for	O
membrane	O
fusion	O
.	O

Furthermore	O
,	O
a	O
single	O
amino	O
acid	O
change	O
in	O
the	O
viral	O
S	O
protein	O
modulated	O
virus	B-SPEC
-	O
induced	O
neuropathology	O
in	O
mice	B-SPEC
from	O
an	O
encephalitis	O
to	O
a	O
neuropathology	O
characterized	O
by	O
flaccid	O
paralysis	O
,	O
which	O
involves	O
glutamate	O
excitotoxicity	O
.	O

ABSTRACT	O
:	O
Arenaviruses	B-SPEC
and	O
hantaviruses	B-SPEC
cause	O
severe	O
human	B-SPEC
disease	O
.	O

ERGIC	O
-	O
53	O
binds	O
to	O
arenavirus	B-SPEC
GPs	O
through	O
a	O
lectin	O
-	O
independent	O
mechanism	O
,	O
traffics	O
to	O
arenavirus	B-SPEC
budding	O
sites	O
,	O
and	O
is	O
incorporated	O
into	O
virions	O
.	O

Thus	O
,	O
we	O
have	O
identified	O
a	O
class	B-SPEC
of	O
pathogen	O
-	O
derived	O
ERGIC	O
-	O
53	O
ligands	O
,	O
a	O
lectin	O
-	O
independent	O
basis	O
for	O
their	O
association	O
with	O
ERGIC	O
-	O
53	O
,	O
and	O
a	O
role	O
for	O
ERGIC	O
-	O
53	O
in	O
the	O
propagation	O
of	O
several	O
highly	O
pathogenic	O
RNA	O
virus	B-SPEC
families	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
quantification	O
of	O
the	O
extent	O
of	O
the	O
epidemic	O
,	O
surveillance	O
biases	O
,	O
and	O
transmissibility	O
.	O

The	O
authors	O
discuss	O
a	O
coronavirus	B-SPEC
-	O
associated	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
which	O
was	O
detected	O
in	O
Hungary	O
in	O
2005	O
and	O
highlight	O
its	O
significance	O
in	O
2013	O
.	O

Using	O
synthetic	O
genomics	O
and	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
replicons	O
(	O
VRPs	O
)	O
expressing	O
spike	O
and	O
nucleocapsid	O
proteins	O
from	O
MERS	O
-	O
CoV	O
and	O
other	O
human	B-SPEC
and	O
bat	B-SPEC
CoVs	O
,	O
we	O
characterize	O
the	O
antigenic	O
responses	O
(	O
using	O
Western	O
blot	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
)	O
and	O
serologic	O
responses	O
(	O
using	O
neutralization	O
assays	O
)	O
against	O
2	O
MERS	O
-	O
CoV	O
isolates	O
in	O
comparison	O
with	O
those	O
of	O
other	O
human	B-SPEC
and	O
bat	B-SPEC
CoVs	O
.	O

TITLE	O
:	O
[	O
Acute	O
respiratory	O
failure	O
due	O
to	O
Mycoplasma	B-SPEC
pneumonia	O
].	O

ABSTRACT	O
:	O
Respiratory	O
infections	O
due	O
to	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
are	O
typically	O
mild	O
and	O
subacute	O
.	O

The	O
only	O
pathogen	O
identified	O
by	O
PCR	O
on	O
BAL	O
and	O
serology	O
was	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
.	O

CONCLUSIONS	O
:	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
may	O
be	O
responsible	O
for	O
severe	O
respiratory	O
illness	O
in	O
the	O
form	O
of	O
bronchiolitis	O
.	O

The	O
Proteus	B-SPEC
syndrome	O
is	O
a	O
very	O
rare	O
cause	O
of	O
pulmonary	O
emphysema	O
.	O

The	O
RTC	O
directs	O
and	O
coordinates	O
processes	O
in	O
order	B-SPEC
to	O
replicate	O
and	O
transcribe	O
the	O
coronavirus	B-SPEC
genome	O
,	O
a	O
single	O
-	O
stranded	O
,	O
positive	O
-	O
sense	O
RNA	O
of	O
outstanding	O
length	O
(	O
27	O
-	O
32kilobases	O
).	O

TITLE	O
:	O
Cell	O
-	O
based	O
antiviral	O
screening	O
against	O
coronaviruses	O
:	O
developing	O
virus	B-SPEC
-	O
specific	O
and	O
broad	O
-	O
spectrum	O
inhibitors	O
.	O

In	O
this	O
article	O
we	O
review	O
cell	O
-	O
based	O
assays	O
using	O
infectious	O
virus	B-SPEC
(	O
BSL	O
-	O
3	O
)	O
and	O
surrogate	O
assays	O
(	O
BSL	O
-	O
2	O
)	O
that	O
can	O
be	O
implemented	O
to	O
accelerate	O
antiviral	O
development	O
against	O
MERS	O
-	O
CoV	O
and	O
future	O
emergent	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
MERS	O
-	O
CoV	O
(	O
NCoV	O
,	O
HCoV	O
-	O
EMC	O
/	O
2012	O
),	O
originating	O
from	O
the	O
Middle	O
-	O
East	O
,	O
has	O
been	O
discovered	O
.	O

TITLE	O
:	O
Akt2	O
deficiency	O
protects	O
from	O
acute	O
lung	O
injury	O
via	O
alternative	O
macrophage	O
activation	O
and	O
miR	O
-	O
146a	O
induction	O
in	O
mice	B-SPEC
.	O

In	O
older	O
birds	B-SPEC
,	O
field	O
evidence	O
indicates	O
the	O
possible	O
involvement	O
of	O
TCoV	O
in	O
egg	O
-	O
production	O
drops	O
in	O
turkey	B-SPEC
hens	O
.	O

Three	O
-	O
week	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
were	O
intraocularly	O
immunized	O
with	O
the	O
IBV	B-SPEC
K40	O
/	O
09	O
strain	O
at	O
10	O
(	O
3	O
.	O
5	O
)	O
50	O
%	O
egg	O
infective	O
dose	O
(	O
EID50	O
).	O

Our	O
results	O
suggest	O
that	O
IBV	B-SPEC
K40	O
/	O
09	O
could	O
be	O
useful	O
to	O
ensure	O
IBV	B-SPEC
vaccine	O
effectiveness	O
owing	O
to	O
its	O
cross	O
-	O
protective	O
ability	O
.	O

We	O
reviewed	O
available	O
data	O
from	O
MERS	O
-	O
CoV	O
case	O
reports	O
,	O
and	O
compared	O
this	O
with	O
data	O
on	O
kinetics	O
of	O
shedding	O
and	O
immune	O
response	O
from	O
published	O
literature	O
on	O
other	O
human	B-SPEC
coronaviruses	O
(	O
hCoVs	O
).	O

TITLE	O
:	O
Development	O
and	O
characterization	O
of	O
a	O
recombinant	O
infectious	O
bronchitis	O
virus	B-SPEC
expressing	O
the	O
ectodomain	O
region	O
of	O
S1	O
gene	O
of	O
H120	O
strain	O
.	O

The	O
continual	O
introduction	O
of	O
new	O
IBV	B-SPEC
serotypes	O
requires	O
alternative	O
strategies	O
for	O
the	O
production	O
of	O
timely	O
and	O
safe	O
vaccines	O
against	O
the	O
emergence	O
of	O
variants	O
.	O

Many	O
viruses	B-SPEC
such	O
as	O
poliovirus	B-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
inhibit	O
protein	O
import	O
into	O
the	O
nucleus	O
,	O
whereas	O
viruses	B-SPEC
such	O
as	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
target	O
and	O
disrupt	O
host	O
mRNA	O
nuclear	O
export	O
.	O

Conversely	O
,	O
many	O
viruses	B-SPEC
co	O
-	O
opt	O
nucleocytoplasmic	O
trafficking	O
to	O
facilitate	O
transport	O
of	O
viral	O
RNAs	O
.	O

Interestingly	O
,	O
both	O
groups	O
of	O
Thai	O
PEDV	B-SPEC
isolates	O
had	O
a	O
4	O
-	O
aa	O
(	O
GENQ	O
)	O
insertion	O
between	O
positions	O
55	O
and	O
56	O
,	O
a	O
1	O
-	O
aa	O
insertion	O
between	O
positions	O
135	O
and	O
136	O
,	O
and	O
a	O
2	O
-	O
aa	O
deletion	O
between	O
positions	O
155	O
and	O
156	O
,	O
making	O
them	O
identical	O
to	O
the	O
Korean	O
KNU	O
series	O
and	O
isolates	O
responsible	O
for	O
outbreaks	O
in	O
China	O
in	O
recent	O
years	O
.	O

ABSTRACT	O
:	O
Since	O
2010	O
,	O
porcine	B-SPEC
epidemic	O
diarrhea	O
has	O
re	O
-	O
emerged	O
with	O
devastating	O
impact	O
on	O
the	O
swine	B-SPEC
-	O
raising	O
industry	O
in	O
central	O
China	O
.	O

Together	O
,	O
these	O
findings	O
may	O
be	O
useful	O
for	O
understanding	O
the	O
epidemiology	O
of	O
PEDV	B-SPEC
and	O
may	O
be	O
relevant	O
for	O
designing	O
of	O
new	O
and	O
more	O
efficacious	O
vaccines	O
.	O

ABSTRACT	O
:	O
The	O
identification	O
of	O
pathogens	O
of	O
viral	O
(	O
Rotavirus	B-SPEC
,	O
Coronavirus	B-SPEC
),	O
parasitic	O
(	O
Toxocara	B-SPEC
spp	O
.)	O
and	O
bacterial	O
(	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Salmonella	B-SPEC
spp	O
.,	O
Rhodococcus	B-SPEC
equi	I-SPEC
)	O
origin	O
shed	O
in	O
feces	O
,	O
and	O
the	O
virulence	O
profile	O
of	O
R	B-SPEC
.	I-SPEC
equi	I-SPEC
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
isolates	O
were	O
investigated	O
in	O
200	O
samples	O
of	O
sand	O
obtained	O
from	O
40	O
parks	O
,	O
located	O
in	O
central	O
region	O
of	O
state	O
of	O
Sao	O
Paulo	O
,	O
Brazil	O
,	O
using	O
different	O
diagnostic	O
methods	O
.	O

None	O
of	O
the	O
R	B-SPEC
.	I-SPEC
equi	I-SPEC
isolates	O
showed	O
a	O
virulent	O
(	O
vapA	O
gene	O
)	O
or	O
intermediately	O
virulent	O
(	O
vapB	O
gene	O
)	O
profiles	O
.	O

and	O
Rotavirus	B-SPEC
isolates	O
were	O
identified	O
in	O
the	O
samples	O
of	O
sand	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
characterizing	O
mammalian	B-SPEC
reovirus	B-SPEC
DNA	O
vaccines	O
applied	O
to	O
a	O
mouse	B-SPEC
model	O
.	O

The	O
L10H	O
chickens	B-SPEC
as	O
well	O
as	O
the	O
L10L	O
chickens	B-SPEC
also	O
showed	O
an	O
increased	O
number	O
of	O
CD4	O
-	O
CD8	O
-	O
	O
T	O
-	O
cells	O
when	O
an	O
MBL	O
ligand	O
was	O
added	O
to	O
the	O
vaccine	O
,	O
most	O
pronouncedly	O
after	O
the	O
first	O
vaccination	O
.	O

The	O
patients	O
in	O
the	O
treatment	O
group	O
were	O
administered	O
with	O
CQCQD	O
by	O
gastric	O
perfusion	O
(	O
50	O
mL	O
/	O
2	O
h	O
)	O
and	O
retention	O
enema	B-SPEC
(	O
200	O
mL	O
/	O
6	O
h	O
)	O
for	O
7	O
days	O
.	O

ABSTRACT	O
:	O
Since	O
February	O
2013	O
,	O
a	O
novel	O
reassortant	O
H7N9	O
virus	B-SPEC
associated	O
with	O
human	B-SPEC
deaths	O
,	O
but	O
no	O
apparent	O
outbreaks	O
in	O
poultry	O
and	O
wild	O
birds	B-SPEC
has	O
emerged	O
in	O
eastern	O
China	O
.	O

Cross	O
species	B-SPEC
poultry	O
-	O
to	O
-	O
person	O
transmission	O
of	O
this	O
new	O
reassortant	O
avian	B-SPEC
influenza	O
H7N9	O
virus	B-SPEC
can	O
result	O
in	O
severe	O
and	O
fatal	O
respiratory	O
disease	O
like	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
presents	O
a	O
novel	O
emerging	O
threat	O
to	O
public	O
health	O
worldwide	O
.	O

Compared	O
with	O
RCoV	O
infection	O
in	O
control	O
animals	B-SPEC
,	O
PMN	O
-	O
depleted	O
rats	B-SPEC
had	O
worsened	O
disease	O
with	O
weight	O
loss	O
,	O
clinical	O
signs	O
,	O
mortality	O
and	O
prolonged	O
pulmonary	O
viral	O
replication	O
.	O

ABSTRACT	O
:	O
An	O
emerging	O
respiratory	O
infectious	O
disease	O
with	O
high	O
mortality	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Interestingly	O
,	O
data	O
from	O
animal	B-SPEC
models	O
show	O
that	O
IFN	O
-	O
	O
contributes	O
to	O
host	O
control	O
of	O
viruses	B-SPEC
infecting	O
these	O
sites	O
,	O
including	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
rotavirus	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
employed	O
a	O
new	O
dataset	O
of	O
1725	O
viral	O
siRNAs	O
with	O
experimentally	O
verified	O
quantitative	O
efficacies	O
tested	O
under	O
heterogeneous	O
experimental	O
conditions	O
and	O
targeting	O
as	O
many	O
as	O
37	O
important	O
human	B-SPEC
viruses	B-SPEC
including	O
HIV	B-SPEC
,	O
Influenza	O
,	O
HCV	B-SPEC
,	O
HBV	B-SPEC
,	O
SARS	O
etc	O
.	O

The	O
genes	O
in	O
the	O
1	O
-	O
Mb	O
windows	O
surrounding	O
each	O
single	O
nucleotide	O
polymorphism	O
with	O
significant	O
effect	O
for	O
the	O
antibody	O
level	O
against	O
IBV	B-SPEC
were	O
associated	O
with	O
many	O
biological	O
processes	O
or	O
pathways	O
related	O
to	O
immunity	O
,	O
such	O
as	O
the	O
defense	O
response	O
and	O
mTOR	O
signaling	O
pathway	O
.	O

This	O
study	O
suggested	O
that	O
the	O
chicken	B-SPEC
genome	O
has	O
several	O
important	O
loci	O
affecting	O
the	O
immune	O
response	O
against	O
IBV	B-SPEC
,	O
and	O
increases	O
our	O
knowledge	O
of	O
how	O
to	O
control	O
outbreaks	O
of	O
infectious	O
bronchitis	O
.	O

In	O
the	O
first	O
case	O
(	O
a	O
65	O
-	O
year	O
-	O
old	O
man	B-SPEC
),	O
high	O
levels	O
of	O
anti	O
-	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
antibodies	O
(	O
IgG	O
and	O
IgA	O
)	O
were	O
detected	O
on	O
admission	O
,	O
and	O
the	O
anti	O
-	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
IgA	O
level	O
rose	B-SPEC
by	O
Day	O
30	O
.	O

TITLE	O
:	O
Epidemiology	O
of	O
severe	O
sepsis	B-SPEC
.	O

People	O
of	O
older	O
age	O
,	O
male	O
gender	O
,	O
black	O
race	O
,	O
and	O
preexisting	O
chronic	O
health	O
conditions	O
are	O
particularly	O
prone	O
to	O
develop	O
severe	O
sepsis	B-SPEC
;	O
hence	O
prevention	O
strategies	O
should	O
be	O
targeted	O
at	O
these	O
vulnerable	O
populations	O
in	O
future	O
studies	O
.	O

TITLE	O
:	O
BacMam	O
virus	B-SPEC
-	O
based	O
surface	O
display	O
of	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
S1	O
glycoprotein	O
confers	O
strong	O
protection	O
against	O
virulent	O
IBV	B-SPEC
challenge	O
in	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
serology	O
in	O
major	O
livestock	O
species	B-SPEC
in	O
an	O
affected	O
region	O
in	O
Jordan	O
,	O
June	O
to	O
September	O
2013	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
seroprevalence	O
in	O
domestic	O
livestock	O
in	O
Saudi	O
Arabia	O
,	O
2010	O
to	O
2013	O
.	O

ABSTRACT	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
infection	O
can	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
infants	O
.	O

We	O
tested	O
for	O
the	O
presence	O
of	O
MERS	O
-	O
CoV	O
in	O
dromedary	B-SPEC
camels	B-SPEC
from	O
a	O
farm	O
in	O
Qatar	O
linked	O
to	O
two	O
human	B-SPEC
cases	O
of	O
the	O
infection	O
in	O
October	O
,	O
2013	O
.	O

TITLE	O
:	O
Yeast	B-SPEC
-	O
expressed	O
recombinant	O
protein	O
of	O
the	O
receptor	O
-	O
binding	O
domain	O
in	O
SARS	O
-	O
CoV	O
spike	O
protein	O
with	O
deglycosylated	O
forms	O
as	O
a	O
SARS	O
vaccine	O
candidate	O
.	O

More	O
importantly	O
,	O
RBD219	O
-	O
N1	O
induced	O
significantly	O
stronger	O
RBD	O
-	O
specific	O
antibody	O
responses	O
and	O
a	O
higher	O
level	O
of	O
neutralizing	O
antibodies	O
in	O
immunized	O
mice	B-SPEC
than	O
RBD193	O
-	O
WT	O
,	O
RBD193	O
-	O
N1	O
,	O
RBD193	O
-	O
N3	O
,	O
or	O
RBD219	O
-	O
WT	O
.	O

During	O
2013	O
,	O
two	O
large	O
randomized	O
controlled	O
trials	O
comparing	O
HFOV	O
with	O
a	O
conventional	O
lung	O
-	O
protective	O
ventilation	O
were	O
published	O
-	O
the	O
Oscillation	O
for	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Treated	O
Early	O
(	O
OSCILLATE	O
)	O
and	O
the	O
Oscillation	O
in	O
ARDS	O
(	O
OSCAR	B-SPEC
)	O
trials	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
all	O
the	O
IBV	B-SPEC
isolates	O
were	O
very	O
similar	O
and	O
probably	O
had	O
a	O
common	O
origin	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
symptoms	O
similar	O
to	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
yet	O
involving	O
an	O
additional	O
component	O
of	O
acute	O
renal	O
failure	O
(	O
ARF	O
)	O
according	O
to	O
several	O
published	O
case	O
reports	O
.	O

In	O
-	O
situ	O
histological	O
staining	O
of	O
the	O
respective	O
cellular	O
receptors	O
for	O
MERS	O
-	O
and	O
SARS	O
-	O
Coronavirus	B-SPEC
showed	O
highly	O
similar	O
staining	O
patterns	O
with	O
a	O
focus	O
of	O
a	O
receptor	O
-	O
specific	O
signal	O
in	O
kidney	O
epithelial	O
cells	O
.	O

Probing	O
the	O
host	O
factors	O
contributing	O
to	O
disease	O
severity	O
,	O
we	O
found	O
that	O
lower	O
levels	O
of	O
plasma	O
inflammatory	O
cytokines	O
on	O
hospital	O
admission	O
correlated	O
with	O
faster	O
recovery	O
in	O
18	O
patients	O
with	O
A	O
/	O
H7N9	O
influenza	B-SPEC
virus	I-SPEC
,	O
whereas	O
high	O
concentrations	O
of	O
(	O
in	O
particular	O
)	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
macrophage	O
inflammatory	O
protein	O
-	O
1	O
were	O
predictive	O
of	O
a	O
less	O
favorable	O
or	O
fatal	O
outcome	O
.	O

We	O
performed	O
an	O
up	O
-	O
to	O
-	O
date	O
meta	B-SPEC
-	O
analysis	O
on	O
this	O
topic	O
and	O
elucidated	O
the	O
effect	O
of	O
prone	O
positioning	O
on	O
overall	O
mortality	O
and	O
associated	O
complications	O
.	O

ABSTRACT	O
:	O
Despite	O
advances	O
in	O
antibiotic	O
therapy	O
and	O
intensive	O
care	O
,	O
the	O
mortality	O
caused	O
by	O
systemic	O
inflammatory	O
response	O
syndrome	O
and	O
severe	O
sepsis	B-SPEC
remains	O
high	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
poses	O
a	O
severe	O
threat	O
to	O
the	O
poultry	O
industry	O
and	O
causes	O
heavy	O
economic	O
losses	O
worldwide	O
.	O

The	O
chimeric	O
VLPs	O
elicited	O
significantly	O
higher	O
S1	O
-	O
specific	O
antibody	O
responses	O
in	O
intramuscularly	O
immunized	O
mice	B-SPEC
and	O
chickens	B-SPEC
than	O
inactivated	O
IBV	B-SPEC
viruses	B-SPEC
.	O

The	O
highest	O
positivity	O
rate	O
was	O
observed	O
in	O
patients	O
under	O
18	O
years	O
old	O
(	O
p	O
<	O
0	O
.	O
001	O
);	O
picornaviruses	B-SPEC
were	O
the	O
most	O
frequent	O
viruses	B-SPEC
detected	O
over	O
the	O
year	O
.	O

TITLE	O
:	O
A	O
life	O
-	O
threatening	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
:	O
a	O
previously	O
healthy	O
infant	O
with	O
bilateral	O
spontaneous	O
pneumothorax	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

This	O
paper	O
examined	O
the	O
current	O
status	O
of	O
and	O
developments	O
in	O
China	O
'	O
s	O
response	O
to	O
emerging	O
communicable	O
diseases	O
from	O
the	O
outbreak	O
of	O
SARS	O
in	O
2003	O
to	O
the	O
outbreak	O
of	O
H7N9	O
virus	B-SPEC
infection	O
in	O
2013	O
.	O

ABSTRACT	O
:	O
Whereas	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
associated	O
with	O
severe	O
disease	O
,	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
HCoV	O
-	O
HKU1	O
)	O
commonly	O
circulates	O
in	O
the	O
human	B-SPEC
populations	O
causing	O
generally	O
milder	O
illness	O
.	O

Prevalence	O
of	O
Co	O
,	O
Gi	O
and	O
Tr	O
was	O
higher	O
in	O
pedigree	O
cats	B-SPEC
compared	O
to	O
non	O
-	O
pedigree	O
cats	B-SPEC
(	O
DSH	O
)	O
and	O
prevalence	O
decreased	O
with	O
increasing	O
age	O
for	O
Co	O
,	O
Pa	O
,	O
Gi	O
,	O
Cr	O
and	O
Tr	O
.	O

Co	O
-	O
infection	O
was	O
common	O
:	O
	O
2	O
enteropathogens	O
were	O
detected	O
in	O
62	O
.	O
5	O
%	O
of	O
cats	B-SPEC
,	O
and	O
13	O
.	O
3	O
%	O
of	O
cats	B-SPEC
had	O
	O
4	O
enteropathogens	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
extracts	O
of	O
Ah	O
,	O
Ns	O
and	O
Cs	O
on	O
the	O
replication	O
of	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
and	O
on	O
the	O
expression	O
of	O
TRP	O
genes	O
during	O
coronavirus	B-SPEC
infection	O
,	O
HeLa	O
-	O
CEACAM1a	O
(	O
HeLa	O
-	O
epithelial	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecule	O
1a	O
)	O
cells	O
were	O
inoculated	O
with	O
MHV	B-SPEC
-	O
A59	O
(	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
-	O
A59	O
)	O
at	O
moi	O
of	O
30	O
.	O

The	O
virus	B-SPEC
load	O
decreased	O
when	O
any	O
of	O
the	O
Ah	O
,	O
Ns	O
or	O
Cs	O
extracts	O
was	O
added	O
to	O
the	O
CoV	O
infected	O
cells	O
with	O
Ah	O
extract	O
treatment	O
leading	O
to	O
undetectable	O
virus	B-SPEC
load	O
for	O
both	O
6	O
and	O
8	O
hpi	O
.	O

TITLE	O
:	O
Occurrence	O
and	O
phylogenetic	O
analysis	O
of	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
in	O
outbreaks	O
of	O
respiratory	O
disease	O
in	O
Norway	O
.	O

The	O
currently	O
circulating	O
BRSV	B-SPEC
could	O
be	O
divided	O
into	O
two	O
different	O
strains	O
that	O
were	O
present	O
in	O
the	O
same	O
geographical	O
area	O
at	O
the	O
same	O
time	O
.	O

ABSTRACT	O
:	O
Emerging	O
and	O
reemerging	O
viral	O
diseases	O
of	O
livestock	O
and	O
human	B-SPEC
beings	O
are	O
in	O
sharp	O
rise	O
in	O
recent	O
years	O
.	O

Several	O
viral	O
diseases	O
of	O
livestock	O
such	O
as	O
bluetongue	O
,	O
peste	O
des	O
petits	O
ruminants	B-SPEC
,	O
camel	B-SPEC
pox	O
,	O
equine	B-SPEC
infectious	O
anaemia	O
,	O
chicken	B-SPEC
anaemia	O
and	O
sheep	B-SPEC
-	O
associated	O
malignant	O
catarrhal	O
fever	O
are	O
crossing	O
their	O
traditional	O
boundaries	O
.	O

Hemorrhage	O
,	O
multiple	O
organ	O
failure	O
syndrome	O
(	O
MOFS	O
),	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
and	O
sepsis	B-SPEC
are	O
the	O
most	O
dangerous	O
sequelae	O
.	O

Using	O
publicly	O
available	O
infectious	O
disease	O
time	O
series	O
data	O
,	O
we	O
analyzed	O
the	O
related	O
co	O
-	O
expression	O
structure	O
of	O
the	O
transcriptome	O
and	O
proteome	O
in	O
response	O
to	O
SARS	O
-	O
CoV	O
infection	O
in	O
mice	B-SPEC
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
use	O
a	O
real	O
-	O
time	O
PCR	O
diarrhea	O
panel	O
to	O
survey	O
the	O
frequencies	O
of	O
pathogens	O
and	O
co	O
-	O
infections	O
in	O
owned	O
dogs	B-SPEC
attended	O
in	O
a	O
veterinary	O
hospital	O
with	O
and	O
without	O
diarrhea	O
,	O
as	O
well	O
the	O
frequency	O
in	O
different	O
countries	O
.	O

Feces	O
samples	O
were	O
tested	O
for	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	O
coronavirus	B-SPEC
,	O
canine	O
parvovirus	B-SPEC
type	O
2	O
(	O
CPV	B-SPEC
-	O
2	O
),	O
Clostridium	B-SPEC
perfringens	I-SPEC
alpha	O
toxin	O
(	O
CPA	O
),	O
Cryptosporidium	B-SPEC
spp	O
.,	O
Giardia	B-SPEC
spp	O
.,	O
and	O
Salmonella	B-SPEC
spp	O
.	O

Overall	O
,	O
71	O
/	O
104	O
(	O
68	O
.	O
3	O
%)	O
dogs	B-SPEC
with	O
diarrhea	O
were	O
positive	O
for	O
at	O
least	O
one	O
pathogen	O
:	O
a	O
single	O
infection	O
in	O
39	O
/	O
71	O
dogs	B-SPEC
(	O
54	O
.	O
9	O
%)	O
and	O
co	O
-	O
infections	O
in	O
32	O
/	O
71	O
dogs	B-SPEC
(	O
45	O
.	O
1	O
%),	O
including	O
21	O
/	O
32	O
dogs	B-SPEC
(	O
65	O
.	O
6	O
%)	O
with	O
dual	O
,	O
5	O
/	O
32	O
(	O
15	O
.	O
6	O
%)	O
with	O
triple	O
,	O
and	O
6	O
/	O
32	O
(	O
18	O
.	O
8	O
%)	O
with	O
quadruple	O
infections	O
.	O

Whereas	O
the	O
healthy	O
dogs	B-SPEC
had	O
only	O
single	O
infections	O
,	O
about	O
half	O
the	O
diarrheic	O
dogs	B-SPEC
had	O
co	O
-	O
infections	O
.	O

Currently	O
,	O
vaccination	O
against	O
IBV	B-SPEC
is	O
only	O
partially	O
protective	O
;	O
therefore	O
,	O
better	O
preventions	O
and	O
treatments	O
are	O
needed	O
.	O

Finally	O
,	O
S	B-SPEC
.	I-SPEC
nigra	I-SPEC
extract	O
-	O
treated	O
virions	O
were	O
visualized	O
by	O
transmission	O
electron	O
microscopy	O
with	O
negative	O
staining	O
.	O

Infection	O
at	O
a	O
low	O
MOI	O
reduced	O
viral	O
titers	O
by	O
six	O
orders	O
of	O
magnitude	O
and	O
pretreatment	O
of	O
virus	B-SPEC
was	O
necessary	O
,	O
but	O
not	O
sufficient	O
,	O
for	O
full	O
virus	B-SPEC
inhibition	O
.	O

The	O
environmental	O
origin	O
of	O
MERS	O
-	O
CoV	O
is	O
as	O
yet	O
unknown	O
;	O
however	O
,	O
its	O
genome	O
sequence	O
is	O
closely	O
related	O
to	O
those	O
of	O
two	O
bat	B-SPEC
coronaviruses	O
,	O
named	O
BtCoV	O
-	O
HKU4	O
and	O
BtCoV	O
-	O
HKU5	O
,	O
which	O
were	O
derived	O
from	O
Chinese	O
bat	B-SPEC
samples	O
.	O

TITLE	O
:	O
Mutant	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
-	O
induced	O
apoptosis	O
in	O
the	O
hippocampus	B-SPEC
.	O

In	O
addition	O
,	O
Mu	O
-	O
3	O
infection	O
caused	O
marked	O
apoptotic	O
lesions	O
in	O
the	O
hippocampal	O
region	O
,	O
particularly	O
in	O
the	O
CA2	O
and	O
CA3	O
subregions	O
,	O
in	O
the	O
brains	O
of	O
all	O
infected	O
mice	B-SPEC
.	O

RESULTS	O
:	O
Prevention	O
against	O
type	O
II	O
FIPV	O
79	O
-	O
1146	O
strain	O
-	O
induced	O
FIP	O
was	O
slightly	O
better	O
in	O
specific	O
pathogen	O
-	O
free	O
cats	B-SPEC
treated	O
with	O
NP7	O
and	O
NP8	O
with	O
fCpG	O
-	O
ODNs	O
.	O

Outcomes	O
included	O
the	O
number	O
of	O
days	O
on	O
mechanical	O
ventilation	O
,	O
days	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
),	O
days	O
in	O
the	O
hospital	O
,	O
and	O
rates	O
of	O
pneumonia	O
,	O
sepsis	B-SPEC
,	O
tracheostomy	O
,	O
chest	O
tube	O
placement	O
,	O
and	O
death	O
.	O

The	O
developed	O
isothermal	O
real	O
-	O
time	O
RT	O
-	O
RPA	O
is	O
ideal	O
for	O
rapid	O
mobile	O
molecular	O
MERS	O
-	O
CoV	O
monitoring	O
in	O
acute	O
patients	O
and	O
may	O
also	O
facilitate	O
the	O
search	O
for	O
the	O
animal	B-SPEC
reservoir	O
of	O
MERS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Screening	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
hospital	O
patients	O
and	O
their	O
healthcare	O
worker	O
and	O
family	B-SPEC
contacts	O
:	O
a	O
prospective	O
descriptive	O
study	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
viral	O
diseases	O
are	O
common	O
and	O
cats	B-SPEC
can	O
be	O
presented	O
with	O
a	O
variety	O
of	O
clinical	O
manifestations	O
.	O

Ocular	O
disease	O
associated	O
with	O
viral	O
pathogens	O
is	O
not	O
unusual	O
,	O
particularly	O
with	O
viruses	B-SPEC
causing	O
upper	O
respiratory	O
tract	O
disease	O
in	O
cats	B-SPEC
,	O
such	O
as	O
feline	B-SPEC
herpesvirus	I-SPEC
type	I-SPEC
1	I-SPEC
and	O
feline	B-SPEC
calicivirus	I-SPEC
.	O

Other	O
viruses	B-SPEC
,	O
such	O
as	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
and	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
can	O
cause	O
uveitis	O
,	O
while	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
can	O
induce	O
ocular	O
lymphosarcoma	O
.	O

At	O
present	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
aberrant	O
immune	O
responses	O
triggered	O
by	O
HP	O
-	O
PRRSV	B-SPEC
infection	O
are	O
closely	O
related	O
to	O
acute	O
lung	O
injury	O
(	O
ALI	O
),	O
and	O
especially	O
the	O
pathological	O
changes	O
in	O
lung	O
vascular	O
system	O
are	O
of	O
particular	O
significance	O
.	O

TITLE	O
:	O
Structure	O
-	O
based	O
discovery	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
fusion	O
inhibitor	O
.	O

ABSTRACT	O
:	O
Since	O
September	O
2012	O
,	O
170	O
confirmed	O
infections	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
been	O
reported	O
to	O
the	O
World	O
Health	O
Organization	O
,	O
including	O
72	O
deaths	O
.	O

TITLE	O
:	O
Stillbirth	O
during	O
infection	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Mutations	O
were	O
introduced	O
into	O
SARS	O
-	O
CoV	O
NSP16	O
within	O
the	O
conserved	O
KDKE	O
motif	O
and	O
effectively	O
attenuated	O
the	O
resulting	O
SARS	O
-	O
CoV	O
mutant	O
viruses	B-SPEC
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Several	O
viruses	B-SPEC
,	O
including	O
SARS	O
-	O
CoV	O
,	O
utilize	O
virally	O
encoded	O
2	O
'-	O
O	O
-	O
MTases	O
to	O
camouflage	O
and	O
obscure	O
their	O
viral	O
RNA	O
from	O
host	O
cell	O
sensing	O
machinery	O
,	O
thus	O
preventing	O
recognition	O
and	O
activation	O
of	O
cell	O
intrinsic	O
defense	O
pathways	O
.	O

For	O
SARS	O
-	O
CoV	O
,	O
the	O
absence	O
of	O
this	O
2	O
'-	O
O	O
-	O
MTase	O
activity	O
results	O
in	O
significant	O
attenuation	O
characterized	O
by	O
decreased	O
viral	O
replication	O
,	O
reduced	O
weight	O
loss	O
,	O
and	O
limited	O
breathing	O
dysfunction	O
in	O
mice	B-SPEC
.	O

The	O
results	O
indicate	O
that	O
both	O
MDA5	O
,	O
a	O
recognition	O
molecule	O
,	O
and	O
the	O
IFIT	O
family	B-SPEC
play	O
an	O
important	O
role	O
in	O
mediating	O
this	O
attenuation	O
with	O
restored	O
virulence	O
observed	O
in	O
their	O
absence	O
.	O

RESULTS	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
was	O
detected	O
in	O
7	O
.	O
4	O
%	O
(	O
41	O
/	O
556	O
)	O
moderate	O
-	O
to	O
-	O
severe	O
ILI	O
episodes	O
in	O
elderly	O
adults	O
.	O

TITLE	O
:	O
Flavivirus	B-SPEC
RNA	O
methylation	O
.	O

This	O
concept	O
has	O
recently	O
been	O
proved	O
with	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
and	O
dengue	B-SPEC
virus	I-SPEC
.	O

Multiplex	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
was	O
undertaken	O
on	O
archived	O
nasopharyngeal	O
aspirates	O
from	O
HIV	B-SPEC
-	O
infected	O
and	O
-	O
uninfected	O
children	O
(<	O
2	O
years	O
age	O
)	O
hospitalized	O
for	O
LRTI	O
,	O
who	O
had	O
been	O
previously	O
investigated	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
parainfluenza	O
I	O
-	O
III	O
,	O
adenovirus	B-SPEC
and	O
influenza	O
A	O
/	O
B	O
.	O
At	O
least	O
one	O
of	O
these	O
viruses	B-SPEC
were	O
identified	O
in	O
274	O
(	O
53	O
.	O
0	O
%)	O
of	O
517	O
and	O
in	O
509	O
(	O
54	O
.	O
0	O
%)	O
of	O
943	O
LRTI	O
-	O
episodes	O
in	O
HIV	B-SPEC
-	O
infected	O
and	O
-	O
uninfected	O
children	O
,	O
respectively	O
.	O

Human	B-SPEC
rhinovirus	I-SPEC
was	O
the	O
most	O
prevalent	O
in	O
HIV	B-SPEC
-	O
infected	O
(	O
31	O
.	O
7	O
%)	O
and	O
-	O
uninfected	O
children	O
(	O
32	O
.	O
0	O
%),	O
followed	O
by	O
CoV	O
-	O
OC43	O
(	O
12	O
.	O
2	O
%)	O
and	O
hBoV	O
(	O
9	O
.	O
5	O
%)	O
in	O
HIV	B-SPEC
-	O
infected	O
;	O
and	O
by	O
hBoV	O
(	O
13	O
.	O
3	O
%)	O
and	O
WUPyV	O
(	O
11	O
.	O
9	O
%)	O
in	O
HIV	B-SPEC
-	O
uninfected	O
children	O
.	O

Polyomavirus	B-SPEC
-	O
KI	O
(	O
8	O
.	O
9	O
%	O
vs	O
.	O
4	O
.	O
8	O
%;	O
p	O
=	O
0	O
.	O
002	O
)	O
and	O
CoV	O
-	O
OC43	O
(	O
12	O
.	O
2	O
%	O
vs	O
.	O
3	O
.	O
6	O
%;	O
p	O
<	O
0	O
.	O
001	O
)	O
were	O
more	O
prevalent	O
in	O
HIV	B-SPEC
-	O
infected	O
than	O
-	O
uninfected	O
children	O
.	O

RESULTS	O
:	O
At	O
least	O
one	O
of	O
these	O
viruses	B-SPEC
were	O
identified	O
in	O
274	O
(	O
53	O
.	O
0	O
%)	O
of	O
517	O
and	O
in	O
509	O
(	O
54	O
.	O
0	O
%)	O
of	O
943	O
LRTI	O
-	O
episodes	O
in	O
HIV	B-SPEC
-	O
infected	O
and	O
-	O
uninfected	O
children	O
,	O
respectively	O
.	O

Although	O
one	O
half	O
of	O
the	O
patients	O
reported	O
respiratory	O
symptoms	O
,	O
the	O
prevalence	O
of	O
respiratory	O
viruses	B-SPEC
was	O
within	O
the	O
range	O
of	O
that	O
previously	O
described	O
in	O
adult	O
asymptomatic	O
patients	O
outside	O
the	O
homeless	O
community	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
the	O
small	O
molecule	O
is	O
a	O
mixed	O
inhibitor	O
of	O
cathepsin	O
L	O
.	O
Our	O
broad	O
-	O
spectrum	O
antiviral	O
small	O
molecule	O
appears	O
to	O
be	O
an	O
ideal	O
candidate	O
for	O
future	O
optimization	O
and	O
development	O
into	O
a	O
potent	O
antiviral	O
against	O
SARS	O
-	O
CoV	O
and	O
Ebola	O
,	O
Hendra	O
,	O
and	O
Nipah	O
viruses	B-SPEC
.	O

Coronavirus	B-SPEC
N	O
proteins	O
contain	O
two	O
structurally	O
distinct	O
RNA	O
-	O
binding	O
domains	O
,	O
an	O
unusual	O
characteristic	O
among	O
RNA	O
viruses	B-SPEC
.	O

Through	O
analysis	O
of	O
viral	O
RNA	O
that	O
was	O
packaged	O
into	O
virions	O
we	O
identified	O
the	O
second	O
of	O
the	O
two	O
RNA	O
-	O
binding	O
domains	O
as	O
a	O
principal	O
determinant	O
of	O
MHV	B-SPEC
packaging	O
signal	O
recognition	O
.	O

Only	O
Sepsis	B-SPEC
-	O
Related	O
Organ	O
Failure	O
Assessment	O
score	O
could	O
be	O
identified	O
as	O
an	O
independent	O
predictor	O
of	O
extracorporeal	O
lung	O
support	O
.	O

TITLE	O
:	O
Hantaviruses	B-SPEC
and	O
cardiopulmonary	O
syndrome	O
in	O
South	O
America	O
.	O

ABSTRACT	O
:	O
Hantavirus	B-SPEC
(	O
Bunyaviridae	B-SPEC
)	O
cardiopulmonary	O
syndrome	O
(	O
HCPS	O
)	O
is	O
an	O
emerging	O
health	O
problem	O
in	O
South	O
America	O
due	O
to	O
urban	O
growth	O
and	O
to	O
the	O
expansion	O
of	O
agriculture	O
and	O
cattle	B-SPEC
-	O
raising	O
areas	O
into	O
ecosystems	O
containing	O
most	O
of	O
the	O
species	B-SPEC
of	O
Sigmodontinae	B-SPEC
rodents	B-SPEC
that	O
act	O
as	O
hantavirus	B-SPEC
reservoirs	O
.	O

TITLE	O
:	O
Suppression	O
of	O
innate	O
antiviral	O
response	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
M	O
protein	O
is	O
mediated	O
through	O
the	O
first	O
transmembrane	O
domain	O
.	O

It	O
is	O
responsible	O
for	O
huge	O
economic	O
losses	O
by	O
causing	O
winter	O
dysentery	O
in	O
adult	O
dairy	O
cattle	B-SPEC
and	O
respiratory	O
and	O
intestinal	O
tract	O
infections	O
leading	O
to	O
pneumo	O
-	O
enteritis	O
in	O
young	O
calves	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
in	O
2002	O
/	O
2003	O
and	O
the	O
recent	O
disease	O
cases	O
with	O
a	O
new	O
human	B-SPEC
coronavirus	I-SPEC
(	O
originally	O
designated	O
EMC	O
-	O
CoV	O
,	O
recently	O
renamed	O
MERS	O
-	O
CoV	O
)	O
have	O
put	O
the	O
focus	O
onto	O
the	O
virus	B-SPEC
family	B-SPEC
Coronaviridae	I-SPEC
.	O

Importantly	O
,	O
mutations	O
that	O
alter	O
DUB	O
activity	O
but	O
not	O
viral	O
protease	O
activity	O
have	O
been	O
identified	O
and	O
arteriviruses	B-SPEC
expressing	O
DUB	O
mutants	O
stimulated	O
higher	O
levels	O
of	O
acute	O
inflammatory	O
cytokines	O
after	O
infection	O
.	O

Further	O
understanding	O
of	O
the	O
multifunctional	O
nature	O
of	O
the	O
Nidovirus	B-SPEC
PLP	O
/	O
DUBs	O
may	O
facilitate	O
vaccine	O
development	O
.	O

In	O
our	O
previous	O
in	O
vivo	O
studies	O
,	O
these	O
viruses	B-SPEC
proved	O
to	O
show	O
the	O
characters	O
of	O
low	O
virulent	O
or	O
avirulent	O
FCoV	O
phenotypes	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
cause	O
of	O
death	O
in	O
215	O
cattle	B-SPEC
on	O
20	O
long	O
-	O
haul	O
live	O
export	O
voyages	O
from	O
Australia	O
to	O
the	O
Middle	O
East	O
,	O
Russia	O
,	O
and	O
China	O
was	O
investigated	O
between	O
2010	O
and	O
2012	O
using	O
gross	O
,	O
histologic	O
,	O
and	O
/	O
or	O
molecular	O
pathology	O
techniques	O
.	O

A	O
quantitative	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
assay	O
was	O
used	O
to	O
detect	O
nucleic	O
acids	O
from	O
viruses	B-SPEC
and	O
bacteria	B-SPEC
known	O
to	O
be	O
associated	O
with	O
respiratory	O
disease	O
in	O
cattle	B-SPEC
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
Betacoronavirus	B-SPEC
1	I-SPEC
),	O
Bovine	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
,	O
Bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
1	I-SPEC
and	O
2	O
,	O
Bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
Bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
3	I-SPEC
,	O
Histophilus	B-SPEC
somni	I-SPEC
,	O
Mycoplasma	B-SPEC
bovis	I-SPEC
,	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
,	O
and	O
Pasteurella	B-SPEC
multocida	I-SPEC
.	O

Two	O
thirds	O
(	O
130	O
/	O
195	O
)	O
of	O
animals	B-SPEC
from	O
which	O
lung	O
samples	O
were	O
collected	O
had	O
histologic	O
changes	O
and	O
/	O
or	O
positive	O
qRT	O
-	O
PCR	O
results	O
indicative	O
of	O
infectious	O
lung	O
disease	O
:	O
93	O
out	O
of	O
130	O
(	O
72	O
%)	O
had	O
evidence	O
of	O
bacterial	O
infection	O
,	O
4	O
(	O
3	O
%)	O
had	O
viral	O
infection	O
,	O
and	O
29	O
(	O
22	O
%)	O
had	O
mixed	O
bacterial	O
and	O
viral	O
infections	O
,	O
and	O
for	O
4	O
(	O
3	O
%)	O
the	O
causative	O
organism	O
could	O
not	O
be	O
identified	O
.	O

ABSTRACT	O
:	O
Licorice	B-SPEC
is	O
a	O
leguminous	O
plant	B-SPEC
of	O
glycyrrhiza	B-SPEC
.	O

Why	O
MERS	O
-	O
CoV	O
causes	O
severe	O
disease	O
in	O
human	B-SPEC
is	O
unclear	O
,	O
and	O
one	O
possibility	O
is	O
that	O
MERS	O
-	O
CoV	O
is	O
particularly	O
efficient	O
in	O
counteracting	O
host	O
immunity	O
,	O
including	O
the	O
sensing	O
of	O
virus	B-SPEC
invasion	O
.	O

TITLE	O
:	O
Cell	O
adhesion	O
as	O
a	O
novel	O
approach	O
to	O
determining	O
the	O
cellular	O
binding	O
motif	O
on	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
a	O
yeast	B-SPEC
-	O
based	O
system	O
for	O
identifying	O
and	O
screening	O
inhibitors	O
against	O
coronavirus	B-SPEC
N7	O
-	O
MTase	O
using	O
both	O
96	O
-	O
well	O
and	O
384	O
-	O
well	O
microtiter	O
plates	O
.	O

The	O
MTase	O
inhibitors	O
previously	O
identified	O
by	O
in	O
vitro	O
biochemical	O
assays	O
were	O
tested	O
,	O
and	O
some	O
,	O
such	O
as	O
sinefungin	O
,	O
effectively	O
suppressed	O
N7	O
-	O
MTase	O
in	O
the	O
yeast	B-SPEC
system	O
.	O

TITLE	O
:	O
Spread	O
,	O
circulation	O
,	O
and	O
evolution	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

The	O
size	O
of	O
the	O
population	O
infected	O
with	O
MERS	O
-	O
CoV	O
showed	O
a	O
gradual	O
increase	O
to	O
June	O
2013	O
,	O
followed	O
by	O
a	O
decline	O
,	O
possibly	O
due	O
to	O
increased	O
surveillance	O
and	O
infection	O
control	O
measures	O
combined	O
with	O
a	O
basic	O
reproduction	O
number	O
(	O
R0	O
)	O
for	O
the	O
virus	B-SPEC
that	O
is	O
less	O
than	O
1	O
.	O

The	O
observation	O
of	O
phylogenetically	O
related	O
MERS	O
-	O
CoV	O
in	O
geographically	O
diverse	O
locations	O
must	O
be	O
taken	O
into	O
account	O
in	O
efforts	O
to	O
identify	O
the	O
animal	B-SPEC
source	O
and	O
transmission	O
of	O
the	O
virus	B-SPEC
.	O

We	O
used	O
a	O
prototype	O
coronavirus	B-SPEC
--	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)--	O
to	O
develop	O
a	O
conditional	O
biotinylation	O
assay	O
that	O
enables	O
the	O
specific	O
identification	O
and	O
biochemical	O
characterization	O
of	O
viral	O
S	O
proteins	O
on	O
virions	O
that	O
mediated	O
membrane	O
fusion	O
with	O
the	O
target	O
cell	O
.	O

MERS	O
is	O
a	O
frequently	O
fatal	O
disease	O
that	O
is	O
caused	O
by	O
a	O
zoonotic	O
CoV	O
.	O
The	O
animals	B-SPEC
transmitting	O
MERS	O
-	O
CoV	O
to	O
humans	B-SPEC
are	O
not	O
yet	O
known	O
.	O

We	O
compared	O
the	O
receptors	O
of	O
humans	B-SPEC
and	O
Middle	O
Eastern	O
animals	B-SPEC
and	O
found	O
that	O
human	B-SPEC
,	O
camel	B-SPEC
,	O
and	O
horse	B-SPEC
receptors	O
sensitized	O
cells	O
to	O
MERS	O
-	O
CoV	O
infection	O
more	O
robustly	O
than	O
goat	B-SPEC
and	O
bat	B-SPEC
receptors	O
.	O

TITLE	O
:	O
""""	O
Don	O
'	O
t	O
forget	O
the	O
migrants	O
""":"	O
exploring	O
preparedness	O
and	O
response	O
strategies	O
to	O
combat	O
the	O
potential	O
spread	O
of	O
MERS	O
-	O
CoV	O
virus	B-SPEC
through	O
migrant	O
workers	O
in	O
Sri	O
Lanka	B-SPEC
.	O

E	B-SPEC
.	I-SPEC
coli	I-SPEC
ESBL	O
does	O
not	O
require	O
contact	O
isolation	O
anymore	O
.	O

TITLE	O
:	O
Community	O
-	O
Acquired	O
Pneumonia	O
in	O
HIV	B-SPEC
-	O
Infected	O
Individuals	O
.	O

Rates	O
of	O
pneumonia	O
decrease	O
with	O
the	O
use	O
of	O
antiretroviral	O
therapy	O
but	O
continue	O
to	O
be	O
higher	O
than	O
in	O
HIV	B-SPEC
uninfected	O
individuals	O
.	O

In	O
the	O
current	O
paper	O
,	O
we	O
present	O
two	O
diabetic	O
patients	O
with	O
cystic	O
fibrosis	O
,	O
who	O
are	O
treated	O
with	O
automated	O
peritoneal	O
dialysis	B-SPEC
and	O
suffered	O
from	O
episodic	O
lower	O
limb	O
infarction	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
replication	O
is	O
cyclophilin	O
A	O
-	O
dependent	O
and	O
inhibited	O
by	O
non	O
-	O
immunosuppressive	O
cyclosporine	O
A	O
-	O
derivatives	O
including	O
Alisporivir	O
.	O

The	O
mean	O
age	O
was	O
46	O
.	O
5	O
days	O
and	O
the	O
odds	O
of	O
being	O
infected	O
with	O
Giardia	B-SPEC
spp	O
.	O

The	O
present	O
review	O
focuses	O
on	O
the	O
biology	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infection	O
and	O
the	O
pathogenesis	O
and	O
pathological	O
features	O
of	O
FIP	O
.	O

Therefore	O
,	O
we	O
examined	O
tonsils	O
for	O
the	O
presence	O
of	O
respiratory	O
viruses	B-SPEC
'	O
nucleic	O
acids	O
in	O
children	O
with	O
OSA	B-SPEC
,	O
and	O
in	O
children	O
without	O
OSA	B-SPEC
(	O
undergoing	O
surgery	O
for	O
recurrent	O
throat	O
infections	O
(	O
RI	O
)).	O

Respiratory	O
viruses	B-SPEC
nucleic	O
acids	O
(	O
24	O
detections	O
)	O
were	O
observed	O
in	O
17	O
(	O
50	O
%)	O
OSA	B-SPEC
samples	O
.	O

Viruses	B-SPEC
detected	O
,	O
based	O
on	O
frequency	O
were	O
Rhinovirus	B-SPEC
,	O
Adenovirus	B-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
and	O
corona	B-SPEC
virus	B-SPEC
.	O

This	O
knowledge	O
can	O
support	O
the	O
rational	O
design	O
of	O
a	O
mouse	B-SPEC
-	O
adapted	O
MERS	O
-	O
CoV	O
for	O
rapid	O
assessment	O
of	O
therapeutics	O
.	O

TITLE	O
:	O
Unique	O
reassortant	O
of	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
associated	O
with	O
severe	O
disease	O
emerging	O
in	O
Hong	O
Kong	O
.	O

The	O
other	O
internal	O
genes	O
NP	O
and	O
PA	O
genes	O
are	O
more	O
closely	O
related	O
to	O
those	O
of	O
non	B-SPEC
-	I-SPEC
A	I-SPEC
(	O
H7N9	O
)	O
avian	B-SPEC
influenza	O
A	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Genetic	O
variability	O
and	O
phylogeny	O
of	O
current	O
Chinese	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strains	O
based	O
on	O
spike	O
,	O
ORF3	O
,	O
and	O
membrane	O
genes	O
.	O

TITLE	O
:	O
[	O
Adverse	O
reactions	O
to	O
human	B-SPEC
papillomavirus	I-SPEC
vaccine	O
in	O
the	O
Valencian	O
Community	O
(	O
2007	O
-	O
2011	O
)].	O

Reporting	O
rates	O
of	O
syncope	B-SPEC
or	O
loss	O
of	O
consciousness	O
and	O
seizures	O
with	O
qHPV	O
vaccine	O
were	O
17	O
and	O
3	O
.	O
2	O
per	O
100	O
,	O
000	O
doses	O
administered	O
,	O
respectively	O
,	O
and	O
15	O
and	O
1	O
.	O
6	O
for	O
syncope	B-SPEC
or	O
loss	O
of	O
consciousness	O
and	O
syncopal	O
seizures	O
occurred	O
on	O
the	O
day	O
of	O
vaccination	O
.	O

RESULTS	O
:	O
The	O
clinical	O
symptoms	O
most	O
frequently	O
reported	O
were	O
dizziness	O
,	O
headache	O
,	O
and	O
syncope	B-SPEC
.	O

TITLE	O
:	O
Evaluation	O
of	O
the	O
AdvanSure	O
	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
compared	O
with	O
culture	O
and	O
Seeplex	O
RV15	O
for	O
simultaneous	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Recently	O
,	O
AdvanSure	O
	O
kit	O
based	O
on	O
multiplex	O
real	O
-	O
time	O
PCR	O
was	O
developed	O
for	O
simultaneous	O
detection	O
of	O
14	O
respiratory	O
viruses	B-SPEC
(	O
RVs	O
).	O

One	O
hundred	O
twelve	O
of	O
114	O
culture	O
-	O
positive	O
samples	O
were	O
positive	O
by	O
AdvanSure	O
except	O
2	O
samples	O
(	O
1	O
adenovirus	B-SPEC
,	O
1	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
[	O
RSV	B-SPEC
]).	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
that	O
causes	O
a	O
severe	O
lower	O
respiratory	O
tract	O
infection	O
in	O
humans	B-SPEC
,	O
emerged	O
in	O
the	O
Middle	O
East	O
region	O
in	O
2012	O
.	O

Within	O
a	O
few	O
days	O
,	O
the	O
same	O
virus	B-SPEC
was	O
detected	O
in	O
a	O
Qatari	O
patient	O
receiving	O
intensive	O
care	O
in	O
a	O
London	O
hospital	O
,	O
a	O
situation	O
reminiscent	O
of	O
the	O
role	O
air	O
travel	O
played	O
in	O
the	O
spread	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
.	O

PBFIPV	O
-	O
DF	O
-	O
2	O
infection	O
induced	O
significantly	O
lower	O
virus	B-SPEC
neutralization	O
titers	O
than	O
its	O
parent	O
virus	B-SPEC
,	O
and	O
lacked	O
the	O
second	O
phase	O
of	O
viremia	O
and	O
development	O
of	O
fatal	O
course	O
of	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
and	O
severe	O
sepsis	B-SPEC
(	O
SS	O
)	O
are	O
possible	O
complications	O
in	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
).	O

TITLE	O
:	O
Development	O
and	O
evaluation	O
of	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
assay	O
for	O
the	O
detection	O
of	O
the	O
fathead	B-SPEC
minnow	I-SPEC
nidovirus	B-SPEC
.	O

A	O
quantitative	O
RT	O
-	O
LAMP	O
of	O
FHMNV	O
with	O
a	O
high	O
correlation	O
coefficient	O
(	O
r	O
(	O
2	O
)=	O
0	O
.	O
9926	O
)	O
was	O
also	O
developed	O
and	O
the	O
result	O
of	O
quantitation	O
of	O
viral	O
copies	O
in	O
tissue	O
samples	O
of	O
infected	O
fish	B-SPEC
showed	O
that	O
the	O
viral	O
loads	O
of	O
the	O
infected	O
fish	B-SPEC
tissue	O
samples	O
reached	O
up	O
to	O
4	O
.	O
7	O
	O
10	O
(	O
10	O
)	O
copies	O
per	O
mg	O
.	O

The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
recently	O
identified	O
as	O
the	O
causative	O
agent	O
of	O
a	O
severe	O
pneumonia	O
.	O

TITLE	O
:	O
Coronaviruses	O
:	O
important	O
emerging	O
human	B-SPEC
pathogens	O
.	O

ABSTRACT	O
:	O
The	O
identification	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
reaffirmed	O
the	O
importance	O
of	O
understanding	O
how	O
coronaviruses	O
emerge	O
,	O
infect	O
,	O
and	O
cause	O
disease	O
.	O

By	O
comparing	O
what	O
is	O
known	O
about	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
to	O
what	O
has	O
recently	O
been	O
found	O
for	O
MERS	O
-	O
CoV	O
,	O
researchers	O
are	O
discovering	O
similarities	O
and	O
differences	O
that	O
may	O
be	O
important	O
for	O
pathogenesis	O
.	O

TITLE	O
:	O
The	O
host	O
protease	O
TMPRSS2	O
plays	O
a	O
major	O
role	O
in	O
in	O
vivo	O
replication	O
of	O
emerging	O
H7N9	O
and	O
seasonal	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	O
)	O
is	O
a	O
leading	O
pathogen	O
that	O
infects	O
and	O
kills	O
many	O
humans	B-SPEC
every	O
year	O
.	O

Infection	O
with	O
Plasmodium	B-SPEC
falciparum	I-SPEC
is	O
responsible	O
for	O
most	O
of	O
the	O
morbidity	O
and	O
mortality	O
.	O

Preliminary	O
biological	O
evaluation	O
indicated	O
that	O
most	O
of	O
the	O
compounds	O
exhibited	O
marked	O
inhibitory	O
activity	O
against	O
wild	O
-	O
type	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IIIB	O
.	O

CONCLUSIONS	O
:	O
These	O
data	O
provide	O
evidence	O
that	O
mouse	B-SPEC
susceptibility	O
to	O
MHV	B-SPEC
-	O
3	O
-	O
induced	O
FH	O
may	O
rely	O
on	O
C5a	O
/	O
C5aR	O
interactions	O
,	O
for	O
which	O
ERK1	O
/	O
2	O
and	O
p38	O
pathways	O
participate	O
in	O
up	O
-	O
regulating	O
Fgl2	O
expression	O
.	O

The	O
expressed	O
protein	O
,	O
used	O
in	O
ELISA	O
,	O
effectively	O
detected	O
chicken	B-SPEC
anti	O
-	O
IBV	B-SPEC
antibodies	O
with	O
high	O
specificity	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
cause	O
respiratory	O
disease	O
in	O
humans	B-SPEC
that	O
can	O
range	O
from	O
mild	O
to	O
severe	O
.	O

However	O
,	O
the	O
pathogenesis	O
of	O
pulmonary	O
coronavirus	B-SPEC
infections	O
is	O
poorly	O
understood	O
.	O

Although	O
an	O
abundance	O
of	O
memory	O
CD4	O
(+)	O
T	O
cells	O
at	O
mucosal	O
sites	O
render	O
them	O
highly	O
susceptible	O
to	O
HIV	B-SPEC
infection	O
,	O
the	O
gut	O
and	O
not	O
the	O
lung	O
experiences	O
severe	O
and	O
sustained	O
CD4	O
(+)	O
T	O
cell	O
depletion	O
and	O
tissue	O
disruption	O
.	O

Pyrrolidine	O
dithiocarbamate	O
,	O
a	O
STAT	O
/	O
NF	O
-	O
B	O
inhibitor	O
and	O
free	O
radical	O
scavenger	B-SPEC
,	O
was	O
administered	O
systemically	O
to	O
a	O
subset	O
of	O
mice	B-SPEC
to	O
determine	O
whether	O
this	O
altered	O
the	O
muscle	O
contraction	O
response	O
.	O

Attenuated	O
IBV	B-SPEC
(	O
aIBV	O
group	O
)	O
or	O
vehicle	O
(	O
control	O
group	O
)	O
was	O
injected	O
into	O
the	O
oviductal	O
magnum	O
lumen	O
of	O
White	O
Leghorn	O
laying	O
hens	O
.	O

These	O
results	O
suggest	O
that	O
IBV	B-SPEC
infection	O
causes	O
disorder	O
of	O
eggshell	O
formation	O
by	O
disturbing	O
gene	O
expression	O
of	O
collagen	O
type	O
I	O
in	O
the	O
isthmus	O
and	O
CaBP	O
-	O
D28K	O
in	O
the	O
uterus	O
,	O
probably	O
via	O
the	O
effects	O
of	O
substances	O
from	O
cytotoxic	O
cells	O
and	O
proinflammatory	O
cytokines	O
.	O

Recombination	O
events	O
coupled	O
with	O
the	O
accumulation	O
of	O
mutations	O
in	O
the	O
ck	O
/	O
CH	O
/	O
LJL	O
/	O
111054	O
genome	O
may	O
account	O
for	O
its	O
increased	O
virulence	O
in	O
specific	O
-	O
pathogen	O
free	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Distinguishing	O
Between	O
Reservoir	O
Exposure	O
and	O
Human	B-SPEC
-	O
to	O
-	O
Human	B-SPEC
Transmission	O
for	O
Emerging	O
Pathogens	O
Using	O
Case	O
Onset	O
Data	O
.	O

Furthermore	O
,	O
it	O
was	O
shown	O
that	O
in	O
the	O
murine	B-SPEC
CNS	O
,	O
neurons	O
are	O
the	O
main	O
target	O
of	O
infection	O
,	O
which	O
causes	O
these	O
essential	O
cells	O
to	O
undergo	O
degeneration	O
and	O
eventually	O
die	O
by	O
some	O
form	O
of	O
programmed	O
cell	O
death	O
after	O
virus	B-SPEC
infection	O
.	O

We	O
aimed	O
to	O
determine	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
nasal	O
carriage	O
rate	O
among	O
pilgrims	O
performing	O
the	O
2013	O
Hajj	O
and	O
to	O
describe	O
the	O
compliance	O
with	O
the	O
Saudi	O
Ministry	O
of	O
Health	O
vaccine	O
recommendations	O
.	O

It	O
was	O
only	O
in	O
a	O
model	O
of	O
coronavirus	B-SPEC
-	O
induced	O
demyelinating	O
encephalomyelitis	O
that	O
we	O
detected	O
an	O
accumulation	O
of	O
oxidised	O
phospholipids	O
,	O
which	O
was	O
comparable	O
in	O
extent	O
to	O
that	O
in	O
MS	O
.	O

In	O
both	O
,	O
MS	O
and	O
coronavirus	B-SPEC
-	O
induced	O
encephalomyelitis	O
,	O
this	O
was	O
associated	O
with	O
massive	O
microglial	O
and	O
macrophage	O
activation	O
,	O
accompanied	O
by	O
the	O
expression	O
of	O
the	O
NADPH	O
oxidase	O
subunit	O
p22phox	O
but	O
only	O
sparse	O
expression	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
(	O
iNOS	O
).	O

In	O
comparison	O
with	O
SARS	O
,	O
patients	O
with	O
MERS	O
are	O
older	O
with	O
male	O
predominance	O
,	O
more	O
comorbid	O
illness	O
and	O
relatively	O
lower	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
potential	O
.	O

Immature	O
immune	O
system	O
and	O
lack	O
of	O
fully	O
established	O
microbiota	B-SPEC
at	O
birth	O
predispose	O
neonatal	O
piglets	O
to	O
infection	O
with	O
enteric	O
pathogens	O
.	O

The	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
Enterococcus	B-SPEC
spp	O
.,	O
C	B-SPEC
.	I-SPEC
perfringens	I-SPEC
and	O
C	B-SPEC
.	I-SPEC
difficile	I-SPEC
in	O
the	O
pathogenesis	O
of	O
neonatal	O
porcine	B-SPEC
diarrhea	O
with	O
no	O
established	O
casual	O
agents	O
.	O

However	O
,	O
Enterococcus	B-SPEC
spp	O
.	O
was	O
primarily	O
detected	O
in	O
the	O
diarrheic	O
piglets	O
.	O

We	O
also	O
identified	O
two	O
nuclear	O
export	O
signals	O
(	O
NES	B-SPEC
,	O
aa221	O
-	O
236	O
,	O
and	O
325	O
-	O
364	O
),	O
however	O
,	O
only	O
the	O
nuclear	O
export	O
signal	O
(	O
aa325	O
-	O
364	O
)	O
was	O
found	O
to	O
be	O
functional	O
in	O
the	O
context	O
of	O
the	O
full	O
-	O
length	O
N	O
protein	O
.	O

TITLE	O
:	O
Viral	O
lung	O
infections	O
:	O
epidemiology	O
,	O
virology	O
,	O
clinical	O
features	O
,	O
and	O
management	O
of	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
).	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
has	O
jumped	O
species	B-SPEC
barrier	O
and	O
caused	O
severe	O
human	B-SPEC
infections	O
.	O

These	O
daily	O
loss	O
rates	O
dissipate	O
to	O
the	O
following	O
days	O
with	O
an	O
e	O
-	O
folding	O
time	O
of	O
about	O
28	O
days	O
,	O
reflecting	O
the	O
public	O
perception	O
on	O
the	O
risk	O
of	O
contacting	O
SARS	O
virus	B-SPEC
when	O
traveling	O
with	O
the	O
underground	O
system	O
(	O
the	O
residual	O
fear	O
).	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
increasing	O
MHV	B-SPEC
-	O
3	O
titers	O
were	O
coincident	O
with	O
increased	O
PLP2	O
mRNA	O
and	O
decreased	O
ISGylation	O
over	O
the	O
course	O
of	O
infection	O
.	O

In	O
patients	O
with	O
sepsis	B-SPEC
,	O
an	O
imbalance	O
between	O
MMPs	O
and	O
their	O
tissue	O
inhibitors	O
(	O
TIMPs	O
)	O
has	O
been	O
associated	O
with	O
impaired	O
survival	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
molecular	O
characterization	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
in	O
influenza	O
a	O
negative	O
sample	O
in	O
Thailand	O
.	O

Real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
to	O
detect	O
hMPV	B-SPEC
infection	O
.	O

We	O
demonstrated	O
the	O
prevalence	O
of	O
hMPV	B-SPEC
subgenotype	O
B1	O
circulating	O
in	O
Thailand	O
during	O
2011	O
.	O

TITLE	O
:	O
Antibodies	O
against	O
MERS	O
coronavirus	B-SPEC
in	O
dromedary	B-SPEC
camels	B-SPEC
,	O
United	O
Arab	O
Emirates	O
,	O
2003	O
and	O
2013	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
caused	O
an	O
ongoing	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
tract	O
infection	O
in	O
humans	B-SPEC
in	O
the	O
Arabian	O
Peninsula	O
since	O
2012	O
.	O

ABSTRACT	O
:	O
In	O
2013	O
,	O
a	O
novel	O
betacoronavirus	B-SPEC
was	O
identified	O
in	O
fecal	O
samples	O
from	O
dromedaries	B-SPEC
in	O
Dubai	O
,	O
United	O
Arab	O
Emirates	O
.	O

A	O
novel	O
alphacoronavirus	B-SPEC
sequence	O
was	O
detected	O
in	O
guano	O
from	O
roosts	O
of	O
M	B-SPEC
.	I-SPEC
tuberculata	I-SPEC
bats	B-SPEC
in	O
pristine	O
indigenous	O
forest	O
on	O
a	O
remote	O
offshore	O
island	O
(	O
Codfish	O
Island	O
).	O

To	O
evaluate	O
the	O
in	O
-	O
vitro	O
efficacy	O
of	O
hydrogen	O
peroxide	O
vapour	O
(	O
HPV	O
),	O
a	O
vapour	O
-	O
phase	O
disinfection	O
method	O
,	O
for	O
the	O
inactivation	O
of	O
a	O
number	O
of	O
structurally	O
distinct	O
viruses	B-SPEC
of	O
importance	O
in	O
the	O
healthcare	O
,	O
veterinary	O
and	O
public	O
sectors	O
.	O

The	O
viruses	B-SPEC
were	O
dried	O
on	O
stainless	O
steel	O
discs	O
in	O
20	O
-	O
or	O
40	O
-	O
L	O
aliquots	O
and	O
exposed	O
to	O
HPV	O
produced	O
by	O
a	O
Clarus	O
L	O
generator	O
(	O
Bioquell	O
,	O
Horsham	O
,	O
PA	O
,	O
USA	O
)	O
in	O
a	O
0	O
.	O
2	O
-	O
m	O
(	O
3	O
)	O
environmental	O
chamber	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
Fast	O
Technology	O
Analysis	O
(	O
FTA	O
)	O
Cards	O
as	O
an	O
improved	O
method	O
for	O
specimen	O
collection	O
and	O
shipment	O
targeting	O
viruses	B-SPEC
associated	O
with	O
Bovine	B-SPEC
Respiratory	O
Disease	O
Complex	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
improve	O
the	O
analytic	O
quality	O
of	O
respiratory	O
specimens	O
collected	O
from	O
cattle	B-SPEC
for	O
nucleic	O
acid	O
-	O
based	O
diagnosis	O
,	O
a	O
study	O
was	O
undertaken	O
to	O
verify	O
realtime	O
PCR	O
efficiency	O
of	O
specimens	O
collected	O
and	O
stabilized	O
on	O
FTA	O
Cards	O
,	O
filter	O
paper	O
which	O
is	O
treated	O
chemically	O
.	O

No	O
significant	O
difference	O
(	O
P	O
	O
0	O
.	O
05	O
)	O
was	O
observed	O
in	O
realtime	O
PCR	O
cycle	O
threshold	O
values	O
over	O
the	O
temperature	O
range	O
and	O
time	O
storage	O
conditions	O
for	O
Bovine	B-SPEC
Viral	I-SPEC
Diarrhea	I-SPEC
virus	I-SPEC
,	O
Bovine	B-SPEC
Respiratory	I-SPEC
Syncytial	I-SPEC
virus	I-SPEC
,	O
Bovine	B-SPEC
Coronavirus	B-SPEC
,	O
and	O
Bovine	B-SPEC
Herpesvirus	B-SPEC
I	O
.	O
The	O
four	O
viruses	B-SPEC
evaluated	O
in	O
the	O
study	O
are	O
associated	O
with	O
Bovine	B-SPEC
Respiratory	O
Disease	O
Complex	O
where	O
improvements	O
in	O
ease	O
and	O
reliability	O
of	O
specimen	O
collection	O
and	O
shipping	O
would	O
enhance	O
the	O
diagnostic	O
quality	O
of	O
specimens	O
collected	O
in	O
the	O
field	O
,	O
and	O
ultimately	O
improve	O
diagnostic	O
efficiency	O
.	O

When	O
allocated	O
to	O
serology	O
-	O
matched	O
recipients	O
,	O
kidney	O
transplantation	O
from	O
donors	O
with	O
hepatitis	B-SPEC
C	I-SPEC
may	O
result	O
in	O
an	O
excellent	O
short	O
-	O
term	O
outcome	O
and	O
a	O
significant	O
reduction	O
of	O
time	O
on	O
the	O
waiting	O
list	O
.	O

These	O
data	O
demonstrate	O
that	O
PEDV	B-SPEC
co	O
-	O
infection	O
-	O
induced	O
chlamydial	O
persistence	O
/	O
stress	O
is	O
reversible	O
and	O
suggest	O
that	O
this	O
induction	O
(	O
i	O
)	O
does	O
not	O
require	O
viral	O
replication	O
in	O
host	O
cells	O
;	O
and	O
(	O
ii	O
)	O
does	O
not	O
require	O
de	O
novo	O
host	O
or	O
viral	O
protein	O
synthesis	O
.	O

Reovirus	B-SPEC
pathogenicity	O
has	O
been	O
associated	O
with	O
virus	B-SPEC
-	O
induced	O
apoptosis	O
in	O
cultured	O
cells	O
and	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Cross	O
-	O
species	B-SPEC
transmission	O
of	O
zoonotic	O
coronaviruses	O
(	O
CoVs	O
)	O
can	O
result	O
in	O
pandemic	O
disease	O
outbreaks	O
.	O

Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
),	O
identified	O
in	O
2012	O
,	O
has	O
caused	O
182	O
cases	O
to	O
date	O
,	O
with	O
~	O
43	O
%	O
mortality	O
,	O
and	O
no	O
small	O
animal	B-SPEC
model	O
has	O
been	O
reported	O
.	O

MERS	O
-	O
CoV	O
and	O
Pipistrellus	B-SPEC
bat	B-SPEC
coronavirus	B-SPEC
(	O
BtCoV	O
)	O
strain	O
HKU5	O
of	O
Betacoronavirus	B-SPEC
(	O
	O
-	O
CoV	O
)	O
subgroup	O
2c	O
share	O
>	O
65	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
in	O
several	O
regions	O
,	O
including	O
nonstructural	O
protein	O
5	O
(	O
nsp5	O
)	O
and	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
which	O
are	O
significant	O
drug	O
and	O
vaccine	O
targets	O
.	O

ABSTRACT	O
:	O
More	O
than	O
a	O
decade	O
after	O
the	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
/	O
2003	O
the	O
occurrence	O
of	O
a	O
novel	O
CoV	O
termed	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
CoV	O
challenges	O
researchers	O
and	O
public	O
health	O
authorities	O
.	O

In	O
order	B-SPEC
to	O
improve	O
preparedness	O
and	O
responsiveness	O
during	O
future	O
outbreaks	O
of	O
novel	O
CoVs	O
,	O
information	O
and	O
problems	O
regarding	O
serological	O
diagnosis	O
that	O
occurred	O
during	O
the	O
SARS	O
-	O
CoV	O
should	O
be	O
acknowledged	O
.	O

ABSTRACT	O
:	O
This	O
investigation	O
aimed	O
to	O
determine	O
if	O
there	O
was	O
a	O
relationship	O
between	O
the	O
production	O
of	O
eggs	O
with	O
poor	O
internal	O
quality	O
,	O
as	O
measured	O
by	O
poor	O
Haugh	O
units	O
,	O
by	O
Australian	O
layer	O
flocks	O
and	O
the	O
detection	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
the	O
hens	O
.	O

Detection	O
of	O
IBV	B-SPEC
in	O
a	O
flock	O
,	O
the	O
farm	O
type	O
and	O
flock	O
size	O
were	O
identified	O
as	O
potential	O
risk	O
factors	O
for	O
the	O
production	O
of	O
eggs	O
with	O
poor	O
Haugh	O
units	O
.	O

ABSTRACT	O
:	O
Zinc	O
(	O
Zn	O
)	O
supplementation	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
diarrhea	O
and	O
to	O
protect	O
animals	B-SPEC
from	O
intestinal	O
diseases	O
,	O
but	O
the	O
mechanisms	O
of	O
this	O
protective	O
effect	O
against	O
virus	B-SPEC
infection	O
in	O
vivo	O
have	O
not	O
yet	O
been	O
elucidated	O
.	O

Broilers	O
were	O
more	O
susceptible	O
to	O
infection	O
than	O
SPF	O
chickens	B-SPEC
,	O
and	O
seroconversion	O
was	O
detected	O
in	O
all	O
of	O
the	O
chicks	O
.	O

Interestingly	O
,	O
the	O
remaining	O
four	O
samples	O
(	O
8	O
.	O
2	O
%)	O
clustered	O
into	O
a	O
new	O
IBV	B-SPEC
variant	O
genotype	O
(	O
Brazil	O
-	O
II	O
or	O
BR	O
-	O
II	O
),	O
divergent	O
from	O
the	O
BR	O
-	O
I	O
.	O
A	O
unique	O
nucleotide	O
sequence	O
insertion	O
coding	O
for	O
five	O
amino	O
acid	O
residues	O
was	O
observed	O
in	O
all	O
the	O
Brazilian	O
variant	O
viruses	B-SPEC
(	O
BR	O
-	O
I	O
and	O
BR	O
-	O
II	O
genotypes	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
Arkansas	O
-	O
type	O
vaccine	O
failure	O
in	O
commercial	O
broilers	O
.	O

Of	O
the	O
vaccine	O
types	O
used	O
,	O
the	O
Arkansas	O
(	O
Ark	O
)-	O
type	O
virus	B-SPEC
is	O
most	O
frequently	O
reisolated	O
from	O
vaccinated	O
broilers	O
.	O

In	O
this	O
study	O
,	O
we	O
examine	O
routes	O
of	O
vaccine	O
administration	O
using	O
multiple	O
IBV	B-SPEC
types	O
including	O
Ark	O
in	O
an	O
effort	O
to	O
understand	O
why	O
Ark	O
vaccines	O
do	O
not	O
provide	O
good	O
protection	O
and	O
persist	O
in	O
commercial	O
broilers	O
.	O

Also	O
,	O
Ark	O
vaccine	O
virus	B-SPEC
was	O
not	O
efficacious	O
in	O
1	O
-	O
day	O
-	O
old	O
broilers	O
when	O
sprayed	O
using	O
a	O
hatchery	O
spray	O
cabinet	O
,	O
but	O
it	O
gave	O
good	O
protection	O
when	O
administrated	O
by	O
eyedrop	O
inoculation	O
.	O

These	O
experiments	O
provided	O
key	O
findings	O
that	O
can	O
be	O
used	O
to	O
direct	O
efforts	O
for	O
improving	O
the	O
efficacy	O
of	O
IBV	B-SPEC
Ark	O
-	O
type	O
vaccines	O
given	O
in	O
the	O
hatchery	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
viral	O
infections	O
in	O
cats	B-SPEC
in	O
southwestern	O
Poland	O
in	O
the	O
years	O
2006	O
to	O
2010	O
.	O

The	O
presence	O
of	O
antibodies	O
or	O
antigens	O
was	O
assessed	O
in	O
samples	O
from	O
all	O
cats	B-SPEC
.	O

10	O
-	O
150	O
copies	O
vRNA	O
/	O
microL	O
of	O
sample	O
for	O
most	O
of	O
the	O
viral	O
targets	O
tested	O
in	O
this	O
panel	O
except	O
RSV	B-SPEC
(	O
400	O
copies	O
vRNA	O
/	O
microL	O
of	O
sample	O
).	O

To	O
test	O
plans	O
that	O
were	O
developed	O
for	O
mass	O
prophylaxis	O
scenarios	O
,	O
in	O
April	O
2013	O
the	O
Cook	O
Country	O
Department	O
of	O
Public	O
Health	O
(	O
CCDPH	O
)	O
and	O
the	O
Triple	O
Community	O
(	O
TripCom	O
)	O
Medical	O
Reserve	O
Corps	O
(	O
MRC	O
)	O
executed	O
a	O
full	O
-	O
scale	O
mass	O
prophylaxis	O
exercise	O
in	O
response	O
to	O
a	O
simulated	O
anthrax	B-SPEC
bioterrorism	O
attack	O
.	O

In	O
addition	O
to	O
the	O
different	O
regional	O
camel	B-SPEC
festivals	O
in	O
neighboring	O
countries	O
,	O
Hafr	O
Al	O
-	O
Batin	O
has	O
the	O
biggest	O
camel	B-SPEC
market	O
in	O
the	O
entire	O
Kingdom	B-SPEC
and	O
hosts	O
an	O
annual	O
camel	B-SPEC
festival	O
.	O

We	O
used	O
unbiased	O
sequencing	O
methods	O
for	O
virus	B-SPEC
discovery	O
in	O
shorebird	O
samples	O
from	O
the	O
Delaware	O
Bay	O
,	O
USA	O
;	O
an	O
important	O
feeding	O
ground	O
for	O
thousands	O
of	O
migratory	O
birds	B-SPEC
.	O

TITLE	O
:	O
Acute	O
respiratory	O
viral	O
infections	O
in	O
pediatric	O
cancer	B-SPEC
patients	O
undergoing	O
chemotherapy	O
.	O

Fever	O
in	O
neutropenic	O
patients	O
was	O
observed	O
in	O
13	O
%,	O
of	O
which	O
four	O
(	O
30	O
.	O
7	O
)	O
were	O
positive	O
for	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Association	O
of	O
radiologic	O
findings	O
with	O
mortality	O
in	O
patients	O
with	O
avian	B-SPEC
influenza	O
H7N9	O
pneumonia	O
.	O

ABSTRACT	O
:	O
The	O
novel	O
H7N9	O
virus	B-SPEC
causes	O
severe	O
illness	O
,	O
including	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
with	O
high	O
rates	O
of	O
mortality	O
.	O

The	O
in	O
vitro	O
antiviral	O
properties	O
of	O
five	O
circular	O
Triple	O
-	O
Helix	O
Forming	O
Oligonucleotide	O
(	O
TFO	O
)	O
RNAs	O
(	O
TFO1	O
to	O
TFO5	O
),	O
which	O
target	O
the	O
different	O
regions	O
of	O
virulent	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
strain	O
FIPV	O
WSU	O
79	O
-	O
1146	O
genome	O
,	O
were	O
tested	O
in	O
FIPV	O
-	O
infected	O
Crandell	O
-	O
Rees	O
Feline	B-SPEC
Kidney	O
(	O
CRFK	O
)	O
cells	O
.	O

ABSTRACT	O
:	O
This	O
review	O
focuses	O
on	O
current	O
knowledge	O
of	O
traditional	O
Chinese	O
herbs	O
on	O
prevention	O
and	O
treatment	O
of	O
viral	O
respiratory	O
infections	O
,	O
especially	O
caused	O
by	O
Severe	O
Acute	O
Respiratory	O
Syndromes	O
(	O
SARS	O
)	O
virus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Further	O
analysis	O
showed	O
that	O
alpha	O
-	O
and	O
betacoronaviruses	O
have	O
different	O
circulation	O
and	O
transmission	O
dynamics	O
in	O
bat	B-SPEC
populations	O
.	O

Notably	O
,	O
full	O
genomic	O
sequencing	O
and	O
antigenic	O
study	O
demonstrated	O
that	O
LYRa11	O
is	O
phylogenetically	O
and	O
antigenically	O
closely	O
related	O
to	O
SARS	O
CoV	O
.	O
Recombination	O
analyses	O
indicate	O
that	O
LYRa11	O
is	O
a	O
recombinant	O
from	O
certain	O
bat	B-SPEC
SARS	O
-	O
like	O
CoVs	O
circulating	O
in	O
Yunnan	O
Province	O
.	O

TITLE	O
:	O
Typical	O
or	O
atypical	O
pneumonia	O
and	O
severe	O
acute	O
respiratory	O
symptoms	O
in	O
PICU	B-SPEC
.	O

Streptococcus	B-SPEC
pneumoniae	I-SPEC
was	O
not	O
isolated	O
in	O
this	O
girl	O
with	O
'	O
typical	O
'	O
pneumonia	O
by	O
symptomatology	O
and	O
chest	O
radiography	O
,	O
but	O
tracheal	O
aspirate	O
identified	O
MP	O
instead	O
.	O

This	O
distinction	O
was	O
mediated	O
by	O
mouse	B-SPEC
phagocytic	O
cells	O
(	O
monocyte	O
-	O
derived	O
infiltrating	O
macrophages	O
and	O
partially	O
alveolar	O
macrophages	O
,	O
but	O
not	O
neutrophils	O
),	O
as	O
demonstrated	O
both	O
by	O
adoptive	O
transfer	O
from	O
donors	O
and	O
by	O
immunological	O
depletion	O
of	O
selected	O
cell	O
types	O
.	O

The	O
etiological	O
identification	O
rate	O
in	O
50	O
patients	O
for	O
bacteria	B-SPEC
,	O
viruses	B-SPEC
and	O
mixed	O
virus	B-SPEC
-	O
bacteria	B-SPEC
combination	O
by	O
PCR	O
were	O
62	O
%,	O
4	O
%,	O
32	O
%,	O
respectively	O
and	O
60	O
%	O
in	O
55	O
patients	O
by	O
bacterial	O
culture	O
method	O
.	O

A	O
pathogenicity	O
study	O
in	O
2	O
-	O
week	O
-	O
old	O
chickens	B-SPEC
found	O
that	O
N1	O
/	O
08	O
had	O
similar	O
pathogenicity	O
for	O
chicken	B-SPEC
respiratory	O
tissues	O
to	O
that	O
reported	O
for	O
subgroup	O
2	O
strains	O
rather	O
than	O
subgroup	O
3	O
strains	O
.	O

Interestingly	O
,	O
compound	O
4e	O
could	O
inhibit	O
not	O
only	O
HBsAg	O
and	O
HBeAg	O
secretions	O
but	O
also	O
HBV	B-SPEC
DNA	O
replication	O
with	O
SI	O
values	O
of	O
20	O
.	O
3	O
,	O
125	O
.	O
0	O
and	O
104	O
.	O
9	O
.	O

ABSTRACT	O
:	O
Objective	O
:	O
We	O
aimed	O
to	O
identify	O
the	O
role	O
of	O
major	O
respiratory	O
viruses	B-SPEC
in	O
the	O
aetiology	O
of	O
human	B-SPEC
nasal	O
polyps	O
using	O
polymerase	O
chain	O
reaction	O
technique	O
.	O

Results	O
:	O
In	O
the	O
control	O
group	O
,	O
the	O
human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
rhinovirus	I-SPEC
were	O
diagnosed	O
in	O
one	O
of	O
the	O
patients	O
and	O
the	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
in	O
another	O
.	O

Vaccination	O
strategies	O
for	O
coronaviruses	O
have	O
involved	O
live	O
attenuated	O
virus	B-SPEC
,	O
recombinant	O
viruses	B-SPEC
,	O
non	O
-	O
replicative	O
virus	B-SPEC
-	O
like	O
particles	O
expressing	O
coronavirus	B-SPEC
proteins	O
or	O
DNA	O
plasmids	O
expressing	O
coronavirus	B-SPEC
genes	O
.	O

ABSTRACT	O
:	O
Most	O
coronaviruses	O
cause	O
respiratory	O
or	O
intestinal	O
infections	O
in	O
their	O
animal	B-SPEC
or	O
human	B-SPEC
host	O
.	O

A	O
phenomenon	O
in	O
common	O
with	O
other	O
strains	O
was	O
that	O
nucleotide	O
(	O
nt	O
)	O
655	O
of	O
the	O
spike	O
(	O
S	O
)	O
gene	O
was	O
G	O
,	O
and	O
a	O
common	O
change	O
in	O
nt	O
1753	O
of	O
the	O
S	O
gene	O
was	O
a	O
T	O
-	O
to	O
-	O
G	O
mutation	O
that	O
caused	O
a	O
serine	O
-	O
to	O
-	O
alanine	O
mutation	O
at	O
amino	O
acid	O
585	O
,	O
which	O
is	O
in	O
the	O
region	O
of	O
the	O
main	O
major	O
antigenic	O
sites	O
A	O
and	O
B	O
of	O
the	O
TGEV	B-SPEC
S	O
protein	O
.	O

Within	O
this	O
study	O
an	O
optimal	O
protocol	O
for	O
freeze	O
-	O
drying	O
that	O
allows	O
safe	O
and	O
effective	O
preservation	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infectious	O
material	O
was	O
developed	O
.	O

Surprisingly	O
,	O
conducted	O
analysis	O
showed	O
that	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
virions	O
are	O
exquisitely	O
stable	O
in	O
liquid	O
media	O
and	O
can	O
be	O
stored	O
also	O
without	O
preservatives	O
at	O
ambient	O
temperature	O
for	O
up	O
to	O
14	O
days	O
.	O

ABSTRACT	O
:	O
IFNs	O
are	O
a	O
family	B-SPEC
of	O
cytokines	O
that	O
are	O
essential	O
for	O
the	O
antiviral	O
response	O
in	O
vertebrates	B-SPEC
.	O

In	O
contrast	O
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
uses	O
IFN	O
-	O
induced	O
human	B-SPEC
IFITM2	O
or	O
IFITM3	O
as	O
an	O
entry	O
factor	O
to	O
facilitate	O
its	O
infection	O
of	O
host	O
cells	O
.	O

Reverse	O
genetics	O
analyses	O
suggest	O
that	O
the	O
structural	O
motifs	O
critical	O
for	O
the	O
IFITM	O
proteins	O
'	O
enhancement	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
are	O
distinct	O
from	O
those	O
required	O
for	O
inhibiting	O
infection	O
by	O
other	O
viruses	B-SPEC
.	O

Based	O
on	O
their	O
S	O
gene	O
sequence	O
similarities	O
,	O
Canadian	O
IBVs	O
could	O
be	O
divided	O
into	O
nine	O
genotypes	O
belonging	O
to	O
four	O
groups	O
:	O
Canadian	O
variant	O
virus	B-SPEC
,	O
strain	O
Qu_mv	O
;	O
the	O
classic	O
,	O
vaccine	O
-	O
like	O
viruses	B-SPEC
,	O
Connecticut	O
and	O
Massachusetts	O
;	O
US	O
variant	O
-	O
like	O
virus	B-SPEC
strains	O
,	O
California	B-SPEC
1734	O
/	O
04	O
,	O
California	B-SPEC
99	O
,	O
CU_82792	O
,	O
Pennsylvania	O
1220	O
/	O
98	O
and	O
Pennsylvania	O
Wolg	O
/	O
98	O
;	O
and	O
non	O
-	O
Canadian	O
,	O
non	O
-	O
US	O
virus	B-SPEC
,	O
strain	O
4	O
/	O
91	O
.	O

It	O
appears	O
that	O
IBV	B-SPEC
strain	O
4	O
/	O
91	O
has	O
now	O
become	O
endemic	O
in	O
Ontario	O
and	O
the	O
need	O
for	O
4	O
/	O
91	O
-	O
type	O
vaccines	O
must	O
be	O
evaluated	O
.	O

To	O
provide	O
information	O
regarding	O
the	O
health	O
status	O
of	O
the	O
canine	O
population	O
in	O
Vila	B-SPEC
do	O
Maio	O
,	O
Maio	O
Island	O
,	O
Cape	O
Verde	O
,	O
53	O
rectal	O
swabs	O
were	O
collected	O
from	O
53	O
stray	O
dogs	B-SPEC
during	O
2010	O
and	O
93	O
rectal	O
swabs	O
and	O
88	O
blood	O
samples	O
were	O
collected	O
from	O
125	O
stray	O
dogs	B-SPEC
in	O
2011	O
.	O

This	O
study	O
discloses	O
the	O
data	O
obtained	O
in	O
a	O
molecular	O
and	O
serological	O
epidemiological	O
surveillance	O
carried	O
out	O
in	O
urban	O
populations	O
of	O
stray	O
and	O
domestic	O
animals	B-SPEC
.	O

Antibodies	O
against	O
canine	O
parvovirus	B-SPEC
were	O
detected	O
in	O
71	O
.	O
6	O
%	O
(	O
63	O
/	O
88	O
)	O
blood	O
samples	O
and	O
the	O
seroprevalence	O
found	O
for	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
was	O
51	O
.	O
1	O
%	O
(	O
45	O
/	O
88	O
).	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
investigated	O
an	O
acute	O
outbreak	O
of	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
on	O
a	O
farm	O
of	O
127	O
pigs	B-SPEC
in	O
Jilin	O
province	O
,	O
China	O
.	O

Porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
was	O
detected	O
in	O
suckling	O
and	O
weaning	O
pigs	B-SPEC
by	O
RT	O
-	O
PCR	O
assays	O
.	O

These	O
results	O
may	O
provide	O
some	O
insights	O
into	O
the	O
genotype	O
of	O
the	O
etiological	O
agent	O
responsible	O
for	O
the	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
outbreak	O
and	O
could	O
also	O
provide	O
a	O
comparative	O
view	O
of	O
the	O
genomics	O
of	O
the	O
five	O
structural	O
proteins	O
of	O
PHEV	O
.	O

The	O
recombinant	O
virus	B-SPEC
showed	O
somewhat	O
-	O
reduced	O
pathogenicity	O
compared	O
to	O
the	O
parental	O
lentogenic	O
LaSota	O
strain	O
but	O
effectively	O
elicited	O
hemagglutination	O
inhibition	O
antibodies	O
against	O
NDV	B-SPEC
and	O
protected	O
chickens	B-SPEC
against	O
lethal	O
challenge	O
with	O
virulent	O
NDV	B-SPEC
/	O
CA02	O
.	O

Thus	O
we	O
found	O
differences	O
in	O
mucosal	O
antibody	O
induction	O
and	O
selection	O
and	O
persistence	O
of	O
vaccine	O
viruses	B-SPEC
between	O
two	O
ArkDPI	O
-	O
derived	O
vaccines	O
from	O
different	O
manufacturers	O
.	O

TITLE	O
:	O
Possible	O
involvement	O
of	O
infection	O
with	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
,	O
but	O
not	O
NL63	O
,	O
in	O
Kawasaki	O
disease	O
.	O

The	O
serological	O
test	O
supported	O
no	O
involvement	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
but	O
suggested	O
the	O
possible	O
involvement	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
in	O
the	O
development	O
of	O
Kawasaki	O
disease	O
.	O

Although	O
the	O
catalytic	O
activity	O
of	O
the	O
ACE2	O
,	O
APN	O
,	O
and	O
DPP4	O
peptidases	O
is	O
not	O
required	O
for	O
virus	B-SPEC
entry	O
,	O
co	O
-	O
expression	O
of	O
other	O
host	O
proteases	O
allows	O
efficient	O
viral	O
entry	O
.	O

In	O
addition	O
,	O
evolutionary	O
conservation	O
of	O
these	O
receptors	O
may	O
permit	B-SPEC
interspecies	O
transmissions	O
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
M	O
co	O
-	O
expression	O
with	O
either	O
N	O
or	O
E	O
is	O
sufficient	O
for	O
producing	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
),	O
although	O
at	O
a	O
lower	O
level	O
compared	O
to	O
M	O
,	O
N	O
and	O
E	O
co	O
-	O
expression	O
.	O

TITLE	O
:	O
Amino	O
acid	O
changes	O
in	O
the	O
spike	O
protein	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
correlate	O
with	O
systemic	O
spread	O
of	O
virus	B-SPEC
from	O
the	O
intestine	O
and	O
not	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

TITLE	O
:	O
Discovery	O
of	O
novel	O
diarylpyrimidines	O
as	O
potent	O
HIV	B-SPEC
NNRTIs	O
via	O
a	O
structure	O
-	O
guided	O
core	O
-	O
refining	O
approach	O
.	O

ABSTRACT	O
:	O
Most	O
patients	O
infected	O
with	O
avian	B-SPEC
H7N9	O
influenza	B-SPEC
virus	I-SPEC
develop	O
severe	O
disease	O
,	O
including	O
respiratory	O
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
multi	O
-	O
organ	O
failure	O
.	O

The	O
virus	B-SPEC
was	O
termed	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
is	O
taken	O
notice	O
of	O
important	O
coronavirus	B-SPEC
caused	O
severe	O
diseases	O
to	O
human	B-SPEC
after	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Bioinformatics	O
insight	O
into	O
the	O
spike	O
glycoprotein	O
gene	O
of	O
field	O
porcine	B-SPEC
epidemic	O
diarrhea	O
strains	O
during	O
2011	O
-	O
2013	O
in	O
Guangdong	O
,	O
China	O
.	O

This	O
explains	O
why	O
there	O
have	O
been	O
constant	O
but	O
infrequent	O
outbreaks	O
recently	O
in	O
comparison	O
to	O
late	O
2010	O
in	O
which	O
PEDV	B-SPEC
outbreaks	O
were	O
more	O
frequent	O
and	O
severe	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
emerging	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
a	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
-	O
like	O
disease	O
with	O
	O
43	O
%	O
mortality	O
.	O

ABSTRACT	O
:	O
The	O
recently	O
identified	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
and	O
fatal	O
acute	O
respiratory	O
illness	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
quasispecies	O
that	O
include	O
homologues	O
of	O
human	B-SPEC
isolates	O
revealed	O
through	O
whole	O
-	O
genome	O
analysis	O
and	O
virus	B-SPEC
cultured	O
from	O
dromedary	B-SPEC
camels	B-SPEC
in	O
Saudi	O
Arabia	O
.	O

If	O
humans	B-SPEC
are	O
truly	O
infected	O
only	O
with	O
clonal	O
virus	B-SPEC
populations	O
,	O
we	O
must	O
entertain	O
a	O
model	O
for	O
interspecies	O
transmission	O
of	O
MERS	O
-	O
CoV	O
wherein	O
only	O
specific	O
genotypes	O
are	O
capable	O
of	O
passing	O
bottleneck	O
selection	O
.	O

E	O
gene	O
encodes	O
a	O
small	O
multifunctional	O
protein	O
that	O
possesses	O
ion	O
channel	O
(	O
IC	O
)	O
activity	O
,	O
an	O
important	O
function	O
in	O
virus	B-SPEC
-	O
host	O
interaction	O
.	O

After	O
serial	O
infections	O
,	O
mutant	O
viruses	B-SPEC
,	O
in	O
general	O
,	O
incorporated	O
compensatory	O
mutations	O
within	O
E	O
gene	O
that	O
rendered	O
active	O
ion	O
channels	O
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
human	B-SPEC
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
from	O
a	O
large	O
nonimmune	O
antibody	O
library	O
that	O
target	O
MERS	O
-	O
CoV	O
.	O
One	O
of	O
the	O
antibodies	O
,	O
m336	O
,	O
neutralized	O
the	O
virus	B-SPEC
with	O
exceptional	O
potency	O
.	O

Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
RSV	B-SPEC
A	O
,	O
HRV	O
,	O
coronavirus	B-SPEC
OC43	O
,	O
and	O
adenovirus	B-SPEC
were	O
detected	O
more	O
frequently	O
in	O
sputum	O
samples	O
than	O
in	O
nasopharyngeal	O
swabs	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

ABSTRACT	O
:	O
The	O
ferret	B-SPEC
is	O
an	O
excellent	O
model	O
for	O
many	O
human	B-SPEC
infectious	O
diseases	O
including	O
influenza	O
,	O
SARS	O
-	O
CoV	O
,	O
henipavirus	B-SPEC
and	O
pneumococcal	O
infections	O
.	O

Using	O
these	O
assays	O
,	O
the	O
expression	O
of	O
each	O
of	O
the	O
tested	O
genes	O
could	O
be	O
detected	O
in	O
ferret	B-SPEC
lymph	O
node	O
cells	O
stimulated	O
with	O
mitogens	O
or	O
infected	O
with	O
influenza	B-SPEC
virus	I-SPEC
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Acute	O
Respiratory	O
Infections	O
(	O
ARI	O
)	O
are	O
some	O
of	O
the	O
most	O
common	O
human	B-SPEC
diseases	O
worldwide	O
.	O

When	O
ranked	O
according	O
to	O
frequency	O
of	O
occurrence	O
,	O
the	O
pattern	O
of	O
co	O
-	O
pathogens	O
was	O
similar	O
to	O
that	O
of	O
the	O
primary	O
pathogens	O
,	O
with	O
the	O
exception	O
of	O
human	B-SPEC
bocavirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
.	O

TITLE	O
:	O
Inhibition	O
of	O
foamy	B-SPEC
virus	I-SPEC
reverse	O
transcriptase	O
by	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
RNase	O
H	O
inhibitors	O
.	O

Thus	O
,	O
we	O
examined	O
whether	O
PFV	O
RNase	O
H	O
can	O
serve	O
as	O
an	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RNase	O
H	O
model	O
for	O
inhibitor	O
interaction	O
studies	O
.	O

Aspiration	O
was	O
more	O
common	O
in	O
men	O
with	O
alcohol	O
abuse	O
history	O
and	O
a	O
lower	O
Glasgow	O
Coma	B-SPEC
Scale	O
who	O
were	O
admitted	O
from	O
a	O
nursing	O
home	O
.	O

and	O
L	B-SPEC
.	I-SPEC
intracellularis	I-SPEC
was	O
detected	O
in	O
12	O
turkey	B-SPEC
flocks	O
.	O

Reovirus	B-SPEC
and	O
HEV	B-SPEC
were	O
not	O
detected	O
in	O
this	O
survey	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
a	O
49	O
-	O
year	O
-	O
old	O
Japanese	O
man	B-SPEC
,	O
who	O
was	O
admitted	O
to	O
our	O
hospital	O
because	O
of	O
severe	O
dyspnea	O
.	O

PCR	O
for	O
16	O
respiratory	O
viruses	B-SPEC
was	O
performed	O
on	O
nasopharyngeal	O
aspirates	O
collected	O
during	O
77	O
paediatric	O
pulmonologist	O
-	O
defined	O
exacerbations	O
.	O

Children	O
with	O
virus	B-SPEC
-	O
positive	O
exacerbations	O
were	O
more	O
likely	O
to	O
require	O
hospitalisation	O
(	O
59	O
%	O
vs	O
32	O
.	O
5	O
%	O
(	O
p	O
=	O
0	O
.	O
02	O
))	O
and	O
have	O
fever	O
(	O
OR	O
3	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
2	O
to	O
11	O
.	O
1	O
),	O
hypoxia	O
(	O
OR	O
25	O
.	O
5	O
,	O
95	O
%	O
CI	O
2	O
.	O
0	O
to	O
322	O
.	O
6	O
),	O
chest	O
signs	O
(	O
OR	O
3	O
.	O
3	O
,	O
95	O
%	O
CI	O
1	O
.	O
1	O
to	O
10	O
.	O
2	O
)	O
and	O
raised	O
CRP	O
(	O
OR	O
4	O
.	O
7	O
,	O
95	O
%	O
CI	O
1	O
.	O
7	O
to	O
13	O
.	O
1	O
)	O
when	O
compared	O
with	O
virus	B-SPEC
-	O
negative	O
exacerbations	O
.	O

We	O
report	O
here	O
a	O
case	O
of	O
a	O
young	O
man	B-SPEC
affected	O
by	O
multiple	O
pathological	O
symptomatic	O
vertebral	O
fractures	O
at	O
the	O
thoraco	O
-	O
lumbar	O
junction	O
,	O
secondary	O
to	O
a	O
well	O
controlled	O
but	O
severe	O
form	O
of	O
sickle	O
cell	O
disease	O
.	O

ABSTRACT	O
:	O
Since	O
mid	O
-	O
March	O
2014	O
,	O
the	O
frequency	O
with	O
which	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
have	O
been	O
reported	O
has	O
increased	O
,	O
with	O
the	O
majority	O
of	O
recent	O
cases	O
reported	O
from	O
Saudi	O
Arabia	O
and	O
United	O
Arab	O
Emirates	O
(	O
UAE	O
).	O

The	O
human	B-SPEC
MERS	O
fatality	O
rate	O
of	O
	O
30	O
%	O
is	O
alarmingly	O
high	O
,	O
even	O
though	O
many	O
deaths	O
were	O
associated	O
with	O
underlying	O
medical	O
conditions	O
.	O

Given	O
the	O
development	O
times	O
and	O
manufacturing	O
requirements	O
for	O
new	O
products	O
,	O
repurposing	O
of	O
existing	O
drugs	O
is	O
likely	O
the	O
only	O
solution	O
for	O
outbreaks	O
due	O
to	O
emerging	O
viruses	B-SPEC
.	O

SARS	O
and	O
MERS	O
are	O
manifested	O
as	O
severe	O
atypical	O
pneumonia	O
associated	O
with	O
high	O
morbidity	O
and	O
mortality	O
in	O
humans	B-SPEC
.	O

Interestingly	O
,	O
the	O
acute	O
phase	O
of	O
SARS	O
in	O
humans	B-SPEC
is	O
associated	O
with	O
a	O
severe	O
reduction	O
in	O
the	O
number	O
of	O
T	O
cells	O
in	O
the	O
blood	O
.	O

The	O
results	O
illustrated	O
distinct	O
approaches	O
utilized	O
by	O
each	O
virus	B-SPEC
to	O
antagonize	O
the	O
global	O
ISG	O
response	O
.	O

We	O
report	O
the	O
case	O
of	O
an	O
18	O
-	O
year	O
-	O
old	O
male	O
driver	O
who	O
strayed	O
from	O
the	O
road	O
and	O
fell	O
15	O
m	O
into	O
a	O
backyard	O
by	O
landing	O
on	O
the	O
roof	O
of	O
its	O
car	B-SPEC
.	O

TITLE	O
:	O
Design	O
,	O
synthesis	O
,	O
and	O
biological	O
evaluation	O
of	O
1	O
,	O
3	O
-	O
diarylpropenones	O
as	O
dual	O
inhibitors	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
.	O

A	O
reliable	O
monitoring	O
of	O
ongoing	O
treatments	O
is	O
certainly	O
helpful	O
to	O
provide	O
appropriate	O
intervention	O
,	O
correctly	O
schedule	O
chest	O
X	O
-	O
ray	B-SPEC
and	O
CT	O
-	O
scan	O
,	O
and	O
optimize	O
ECMO	O
weaning	O
.	O

We	O
used	O
data	O
from	O
two	O
ARDS	O
randomised	O
controlled	O
trials	O
(	O
ARMA	B-SPEC
trial	O
and	O
ALVEOLI	O
trial	O
),	O
sponsored	O
by	O
the	O
National	O
Heart	O
,	O
Lung	O
,	O
and	O
Blood	O
Institute	O
.	O

Independent	O
latent	O
class	B-SPEC
models	O
indicated	O
that	O
a	O
two	O
-	O
class	B-SPEC
(	O
ie	O
,	O
two	O
subphenotype	O
)	O
model	O
was	O
the	O
best	O
fit	O
for	O
both	O
cohorts	O
.	O

Analysis	O
of	O
the	O
whole	O
human	B-SPEC
-	O
derived	O
virus	B-SPEC
and	O
15	O
%	O
of	O
the	O
camel	B-SPEC
-	O
derived	O
virus	B-SPEC
sequence	O
yielded	O
nucleotide	O
polymorphism	O
signatures	O
suggestive	O
of	O
cross	O
-	O
species	B-SPEC
transmission	O
.	O

TITLE	O
:	O
Identification	O
of	O
	O
-	O
fodrin	O
as	O
an	O
autoantigen	O
in	O
experimental	O
coronavirus	B-SPEC
retinopathy	O
(	O
ECOR	O
).	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
JHM	O
strain	O
induces	O
a	O
biphasic	O
disease	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
that	O
consists	O
of	O
an	O
acute	O
retinitis	O
followed	O
by	O
progression	O
to	O
a	O
chronic	O
retinal	O
degeneration	O
with	O
autoimmune	O
reactivity	O
.	O

	O
-	O
Fodrin	O
protein	O
was	O
used	O
for	O
further	O
analysis	O
and	O
western	O
blot	O
reactivity	O
was	O
seen	O
only	O
in	O
sera	O
from	O
virus	B-SPEC
infected	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

The	O
phase	O
of	O
T	O
cell	O
-	O
dependent	O
,	O
antibody	O
-	O
independent	O
control	O
of	O
infectious	O
virus	B-SPEC
was	O
associated	O
with	O
a	O
similar	O
recruitment	O
of	O
naive	O
/	O
early	O
-	O
activated	O
IgD	O
(+)	O
IgM	O
(+)	O
B	O
cells	O
into	O
both	O
the	O
brain	O
and	O
spinal	O
cord	O
.	O

We	O
postulate	O
that	O
the	O
higher	O
-	O
order	B-SPEC
structure	O
promotes	O
(+)-	O
strand	O
synthesis	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
the	O
PEDV	B-SPEC
-	O
encoded	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
also	O
inhibits	O
Sendai	B-SPEC
virus	I-SPEC
-	O
induced	O
IFN	O
-	O
	O
production	O
,	O
IFN	O
-	O
stimulated	O
gene	O
expression	O
,	O
and	O
activation	O
of	O
the	O
transcription	O
factors	O
IFN	O
regulatory	O
factor	O
3	O
(	O
IRF3	O
)	O
and	O
NF	O
-	O
B	O
.	O
We	O
also	O
found	O
that	O
N	O
protein	O
significantly	O
impedes	O
the	O
activation	O
of	O
the	O
IFN	O
-	O
	O
promoter	O
stimulated	O
by	O
TBK1	O
or	O
its	O
upstream	O
molecules	O
(	O
RIG	O
-	O
I	O
,	O
MDA5	O
,	O
IPS	B-SPEC
-	O
1	O
,	O
and	O
TRAF3	O
)	O
but	O
does	O
not	O
counteract	O
its	O
activation	O
by	O
IRF3	O
.	O

Here	O
,	O
we	O
identify	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
as	O
a	O
novel	O
PEDV	B-SPEC
-	O
encoded	O
interferon	O
(	O
IFN	O
)	O
antagonist	O
and	O
demonstrate	O
that	O
N	O
protein	O
antagonizes	O
IFN	O
production	O
by	O
sequestering	O
the	O
interaction	O
between	O
IRF3	O
and	O
TBK1	O
,	O
a	O
critical	O
step	O
in	O
type	O
I	O
IFN	O
signaling	O
.	O

TITLE	O
:	O
Targeting	O
membrane	O
-	O
bound	O
viral	O
RNA	O
synthesis	O
reveals	O
potent	O
inhibition	O
of	O
diverse	O
coronaviruses	O
including	O
the	O
middle	O
East	O
respiratory	O
syndrome	O
virus	B-SPEC
.	O

TITLE	O
:	O
Full	O
-	O
genome	O
sequence	O
of	O
human	B-SPEC
betacoronavirus	B-SPEC
2c	O
jordan	O
-	O
n3	O
/	O
2012	O
after	O
serial	O
passage	O
in	O
Mammalian	B-SPEC
cells	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
role	O
of	O
sialic	O
acids	O
in	O
serotype	O
I	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
infections	O
was	O
studied	O
in	O
feline	B-SPEC
intestinal	O
epithelial	O
cell	O
cultures	O
.	O

Of	O
32	O
evaluable	O
patients	O
,	O
6	O
(	O
18	O
.	O
8	O
%)	O
had	O
a	O
tricuspid	O
regurgitation	O
velocity	O
	O
2	O
.	O
6	O
m	O
/	O
s	O
,	O
and	O
this	O
feature	O
was	O
associated	O
with	O
anemia	B-SPEC
(	O
P	O
=	O
0	O
.	O
044	O
).	O

TITLE	O
:	O
Papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
inhibitory	O
effects	O
of	O
cinnamic	O
amides	O
from	O
Tribulus	B-SPEC
terrestris	I-SPEC
fruits	O
.	O

In	O
this	O
protein	O
we	O
identified	O
one	O
epitope	O
WDYPKCDRA	O
is	O
highly	O
immunogenic	O
and	O
100	O
%	O
conserved	O
among	O
all	O
available	O
human	B-SPEC
coronavirus	I-SPEC
strains	O
.	O

ABSTRACT	O
:	O
Activin	O
A	O
and	O
its	O
binding	O
protein	O
follistatin	O
(	O
FS	O
)	O
are	O
increased	O
in	O
inflammatory	O
disorders	O
and	O
sepsis	B-SPEC
.	O

Purified	O
anti	O
-	O
viral	O
IgGs	O
,	O
but	O
not	O
other	O
soluble	O
factor	O
(	O
s	O
)	O
from	O
heat	O
-	O
inactivated	O
mouse	B-SPEC
immune	O
serum	O
,	O
were	O
sufficient	O
to	O
enhance	O
infection	O
.	O

TITLE	O
:	O
Identification	O
and	O
genotyping	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
-	O
associated	O
single	O
nucleotide	O
polymorphisms	O
in	O
the	O
feline	B-SPEC
interferon	O
-	O
	O
gene	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
an	O
immune	O
-	O
mediated	O
,	O
highly	O
lethal	O
disease	O
caused	O
by	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infection	O
.	O

TITLE	O
:	O
Uncomplicated	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
in	O
pregnancy	O
associated	O
with	O
mortality	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
contemporaneous	O
treatment	O
of	O
acute	O
uncomplicated	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
and	O
the	O
onset	O
of	O
ARDS	O
on	O
day	O
3	O
in	O
this	O
patient	O
implies	O
a	O
possible	O
but	O
unconfirmed	O
association	O
with	O
death	O
in	O
this	O
patient	O
.	O

Furthermore	O
,	O
the	O
reduction	O
in	O
cell	O
numbers	O
in	O
the	O
spleens	O
of	O
wild	O
-	O
type	O
mice	B-SPEC
after	O
infection	O
was	O
not	O
observed	O
in	O
the	O
infected	O
Fut9	O
(-/-)	O
mice	B-SPEC
.	O

Immunofluoresence	O
assays	O
indicated	O
that	O
inhibition	O
of	O
PEDV	B-SPEC
infection	O
by	O
peptide	O
H	O
was	O
independent	O
of	O
pAPN	O
.	O

IL	O
-	O
27	O
and	O
its	O
receptor	O
mRNA	O
are	O
both	O
upregulated	O
in	O
the	O
CNS	O
during	O
acute	O
encephalomyelitis	O
induced	O
by	O
the	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
and	O
sustained	O
during	O
viral	O
persistence	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
is	O
a	O
highly	O
contagious	O
viral	O
disease	O
with	O
economic	O
effects	O
on	O
poultry	O
agribusiness	O
.	O

Infectious	O
bronchitis	O
virus	B-SPEC
is	O
classified	O
into	O
different	O
serotypes	O
and	O
genotypes	O
(	O
vaccine	O
strains	O
and	O
field	O
variants	O
).	O

Serologic	O
data	O
indicated	O
that	O
MERS	O
-	O
CoV	O
was	O
circulating	O
in	O
the	O
camels	B-SPEC
but	O
not	O
in	O
the	O
patient	O
before	O
the	O
human	B-SPEC
infection	O
occurred	O
.	O

ABSTRACT	O
:	O
Transplantation	O
of	O
major	O
histocompatibility	O
complex	O
-	O
mismatched	O
mouse	B-SPEC
neural	O
precursor	O
cells	O
(	O
NPCs	O
)	O
into	O
mice	B-SPEC
persistently	O
infected	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
results	O
in	O
rapid	O
rejection	O
that	O
is	O
mediated	O
,	O
in	O
part	O
,	O
by	O
T	O
cells	O
.	O

Herein	O
,	O
we	O
demonstrate	O
that	O
the	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
-	O
expressing	O
-	O
activating	O
receptor	O
NKG2D	O
participates	O
in	O
transplanted	O
allogeneic	O
NPC	O
rejection	O
in	O
mice	B-SPEC
persistently	O
infected	O
with	O
JHMV	O
.	O

Cultured	O
NPCs	O
derived	O
from	O
C57BL	O
/	O
6	O
(	O
H	O
-	O
2	O
(	O
b	O
)	O
)	O
mice	B-SPEC
express	O
the	O
NKG2D	O
ligand	O
retinoic	O
acid	O
early	O
precursor	O
transcript	O
(	O
RAE	O
)-	O
1	O
but	O
expression	O
was	O
dramatically	O
reduced	O
upon	O
differentiation	O
into	O
either	O
glia	B-SPEC
or	O
neurons	O
.	O

Transplantation	O
of	O
C57BL	O
/	O
6	O
-	O
derived	O
NPCs	O
into	O
JHMV	O
-	O
infected	O
BALB	O
/	O
c	O
(	O
H	O
-	O
2	O
(	O
d	O
)	O
)	O
mice	B-SPEC
resulted	O
in	O
infiltration	O
of	O
NKG2D	O
(+)	O
CD49b	O
(+)	O
NK	O
cells	O
and	O
treatment	O
with	O
blocking	O
antibody	O
specific	O
for	O
NKG2D	O
increased	O
survival	O
of	O
allogeneic	O
NPCs	O
.	O

Animal	B-SPEC
studies	O
identified	O
rhesus	B-SPEC
macaques	I-SPEC
but	O
not	O
hamsters	B-SPEC
,	O
ferrets	B-SPEC
,	O
or	O
mice	B-SPEC
to	O
be	O
susceptible	O
for	O
MERS	O
-	O
CoV	O
.	O
Here	O
,	O
we	O
investigated	O
the	O
role	O
of	O
DPP4	O
in	O
this	O
observed	O
species	B-SPEC
tropism	O
.	O

Cell	O
lines	O
of	O
human	B-SPEC
and	O
nonhuman	O
primate	B-SPEC
origin	O
were	O
permissive	O
of	O
MERS	O
-	O
CoV	O
,	O
whereas	O
hamster	B-SPEC
,	O
ferret	B-SPEC
,	O
or	O
mouse	B-SPEC
cell	O
lines	O
were	O
not	O
,	O
despite	O
the	O
presence	O
of	O
DPP4	O
.	O

Expression	O
of	O
human	B-SPEC
DPP4	O
in	O
nonsusceptible	O
BHK	O
and	O
ferret	B-SPEC
cells	O
enabled	O
MERS	O
-	O
CoV	O
replication	O
,	O
whereas	O
expression	O
of	O
hamster	B-SPEC
or	O
ferret	B-SPEC
DPP4	O
did	O
not	O
.	O

The	O
inability	O
of	O
MERS	O
-	O
CoV	O
to	O
infect	O
commonly	O
used	O
animal	B-SPEC
models	O
,	O
such	O
as	O
hamster	B-SPEC
,	O
mice	B-SPEC
,	O
and	O
ferrets	B-SPEC
,	O
indicates	O
the	O
presence	O
of	O
a	O
species	B-SPEC
barrier	O
.	O

We	O
show	O
that	O
the	O
MERS	O
-	O
CoV	O
receptor	O
DPP4	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
observed	O
species	B-SPEC
tropism	O
of	O
MERS	O
-	O
CoV	O
and	O
subsequently	O
identified	O
the	O
amino	O
acids	O
in	O
DPP4	O
responsible	O
for	O
this	O
restriction	O
.	O

ABSTRACT	O
:	O
Genetic	O
variation	O
between	O
diverse	O
mouse	B-SPEC
species	B-SPEC
is	O
well	O
-	O
characterized	O
,	O
yet	O
existing	O
knowledge	O
of	O
the	O
mouse	B-SPEC
transcriptome	O
comes	O
largely	O
from	O
one	O
mouse	B-SPEC
strain	O
(	O
C57BL	O
/	O
6J	O
).	O

Gene	O
transcription	O
is	O
dynamic	O
and	O
condition	O
-	O
specific	O
;	O
therefore	O
,	O
to	O
better	O
understand	O
the	O
mouse	B-SPEC
transcriptional	O
response	O
to	O
respiratory	O
virus	B-SPEC
infection	O
,	O
we	O
infected	O
the	O
eight	O
founder	O
strains	O
of	O
the	O
Collaborative	O
Cross	O
with	O
either	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
or	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
sequenced	O
lung	O
RNA	O
samples	O
at	O
2	O
and	O
4	O
days	O
after	O
infection	O
.	O

We	O
found	O
numerous	O
instances	O
of	O
transcripts	O
that	O
were	O
not	O
present	O
in	O
the	O
C57BL	O
/	O
6J	O
reference	O
annotation	O
,	O
indicating	O
that	O
a	O
nontrivial	O
proportion	O
of	O
the	O
mouse	B-SPEC
genome	O
is	O
transcribed	O
but	O
poorly	O
annotated	O
.	O

We	O
also	O
found	O
that	O
respiratory	O
virus	B-SPEC
infection	O
induced	O
differential	O
expression	O
of	O
4287	O
splicing	O
junctions	O
,	O
resulting	O
in	O
strain	O
-	O
specific	O
isoform	O
expression	O
.	O

Here	O
,	O
we	O
show	O
that	O
GAPDH	O
has	O
an	O
anti	O
-	O
inflammatory	O
function	O
by	O
using	O
a	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
,	O
sepsis	B-SPEC
-	O
related	O
severe	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
mouse	B-SPEC
model	O
,	O
which	O
is	O
referred	O
to	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
in	O
two	O
returning	O
travellers	O
in	O
the	O
Netherlands	O
,	O
May	O
2014	O
.	O

The	O
MHV	B-SPEC
spike	O
protein	O
(	O
S	O
)	O
is	O
a	O
major	O
virulence	O
determinant	O
which	O
in	O
addition	O
to	O
binding	O
to	O
cellular	O
receptors	O
to	O
mediate	O
cell	O
entry	O
and	O
facilitate	O
virus	B-SPEC
spread	O
to	O
adjacent	O
cells	O
by	O
cell	O
-	O
cell	O
fusion	O
,	O
also	O
is	O
a	O
molecular	O
mimic	O
of	O
the	O
FcRII	O
receptor	O
.	O

These	O
findings	O
highlight	O
the	O
huge	O
proportion	O
of	O
CAP	O
of	O
viral	O
origin	O
,	O
the	O
high	O
number	O
of	O
co	O
-	O
infection	O
by	O
multiple	O
viruses	B-SPEC
and	O
the	O
low	O
number	O
of	O
bacterial	O
CAP	O
,	O
notably	O
in	O
children	O
under	O
5	O
years	O
,	O
and	O
address	O
the	O
need	O
to	O
re	O
-	O
evaluate	O
the	O
indications	O
of	O
empiric	O
antimicrobial	O
treatment	O
in	O
this	O
age	O
group	O
.	O

In	O
order	B-SPEC
to	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
epidemiology	O
of	O
MERS	O
CoV	O
,	O
further	O
investigation	O
is	O
warranted	O
.	O

TITLE	O
:	O
Detection	O
and	O
genetic	O
characterization	O
of	O
Canine	O
parvovirus	B-SPEC
and	O
Canine	O
coronavirus	B-SPEC
strains	O
circulating	O
in	O
district	O
of	O
Tirana	O
in	O
Albania	O
.	O

The	O
most	O
frequently	O
detected	O
CPV	B-SPEC
type	O
was	O
2a	O
,	O
whereas	O
IIa	O
was	O
the	O
predominant	O
CCoV	O
subtype	O
.	O

ABSTRACT	O
:	O
The	O
geographic	O
spread	O
and	O
rapid	O
increase	O
in	O
the	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
during	O
the	O
past	O
two	O
months	O
have	O
raised	O
concern	O
about	O
its	O
pandemic	O
potential	O
.	O

ABSTRACT	O
:	O
Animal	B-SPEC
hoarders	O
accumulate	O
animals	B-SPEC
in	O
over	O
-	O
crowded	O
conditions	O
without	O
adequate	O
nutrition	O
,	O
sanitation	O
,	O
and	O
veterinary	O
care	O
.	O

A	O
subset	O
of	O
cats	B-SPEC
exhibiting	O
signs	O
of	O
upper	O
respiratory	O
disease	O
or	O
diarrhea	O
had	O
been	O
tested	O
for	O
infections	O
by	O
PCR	O
and	O
fecal	O
flotation	O
for	O
treatment	O
planning	O
.	O

The	O
seroprevalence	O
of	O
FeLV	O
and	O
FIV	B-SPEC
were	O
8	O
%	O
and	O
8	O
%,	O
respectively	O
.	O

There	O
was	O
no	O
effect	O
on	O
mortality	O
with	O
granulocyte	O
-	O
macrophage	O
colony	O
stimulating	O
factor	O
,	O
late	O
low	O
-	O
dose	O
methylprednisolone	O
,	O
neutrophil	O
elastase	O
inhibitors	O
,	O
intravenous	O
salbutamol	O
,	O
surfactant	O
,	O
or	O
N	O
-	O
acetylcysteine	O
;	O
each	O
meta	B-SPEC
-	O
analysis	O
included	O
	O
1	O
trial	O
published	O
after	O
2003	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
Pneumocystis	B-SPEC
jirovecii	I-SPEC
pneumonia	O
(	O
2010	O
-	O
2013	O
):	O
the	O
first	O
Croatian	O
report	O
.	O

TITLE	O
:	O
Surfactant	O
protein	O
A	O
genetic	O
variants	O
associate	O
with	O
severe	O
respiratory	O
insufficiency	O
in	O
pandemic	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
infection	O
.	O

Although	O
there	O
have	O
been	O
no	O
reported	O
infections	O
since	O
2004	O
,	O
the	O
extremely	O
pathogenic	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
as	O
the	O
causative	O
agent	O
of	O
SARS	O
,	O
has	O
recently	O
been	O
identified	O
in	O
animals	B-SPEC
,	O
showing	O
the	O
potential	O
for	O
the	O
re	O
-	O
emergence	O
of	O
this	O
disease	O
.	O

We	O
report	O
the	O
first	O
case	O
of	O
human	B-SPEC
infection	O
with	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
in	O
Shenzhen	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
,	O
is	O
an	O
enveloped	O
,	O
positive	O
-	O
sense	O
,	O
single	O
-	O
stranded	O
RNA	O
virus	B-SPEC
,	O
which	O
causes	O
severe	O
diarrhea	O
and	O
dehydration	O
in	O
suckling	O
pigs	B-SPEC
.	O

Interestingly	O
,	O
comparative	O
genome	O
analysis	O
of	O
recent	O
Korean	O
PEDV	B-SPEC
isolates	O
and	O
other	O
strains	O
revealed	O
that	O
the	O
complete	O
genome	O
sequences	O
of	O
recent	O
Korean	O
strains	O
were	O
almost	O
identical	O
(	O
99	O
.	O
9	O
%)	O
to	O
those	O
of	O
the	O
US	O
PEDV	B-SPEC
strains	O
isolated	O
in	O
2013	O
.	O

These	O
RNA	O
-	O
dependent	O
functions	O
are	O
necessary	O
for	O
replication	O
of	O
many	O
human	B-SPEC
disease	O
-	O
causing	O
viruses	B-SPEC
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
pseudoparticle	O
virus	B-SPEC
neutralisation	O
test	O
(	O
ppNT	O
)	O
and	O
a	O
conventional	O
microneutralisation	O
(	O
MN	O
)	O
assay	O
are	O
specific	O
for	O
detecting	O
antibodies	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
when	O
used	O
in	O
seroepidemiological	O
studies	O
in	O
animals	B-SPEC
.	O

A	O
protocol	O
-	O
driven	O
ventilation	O
using	O
goal	O
-	O
oriented	O
structural	O
programming	O
was	O
implemented	O
and	O
used	O
for	O
4	O
hours	O
in	O
seven	O
pigs	B-SPEC
with	O
lavage	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

In	O
48	O
cases	O
(	O
7	O
.	O
0	O
%	O
of	O
the	O
686	O
enrolled	O
patients	O
;	O
12	O
.	O
6	O
%	O
of	O
the	O
381	O
in	O
whom	O
a	O
virus	B-SPEC
was	O
detected	O
)	O
the	O
presence	O
of	O
a	O
coronavirus	B-SPEC
demonstrated	O
.	O

ABSTRACT	O
:	O
In	O
late	O
2013	O
,	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
recurred	O
in	O
South	O
Korea	O
.	O

ABSTRACT	O
:	O
Eight	O
different	O
tests	O
for	O
antibodies	O
to	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
were	O
evaluated	O
for	O
attributes	O
that	O
are	O
important	O
in	O
situations	O
in	O
veterinary	O
practice	O
.	O

Using	O
the	O
method	O
of	O
GST	O
pull	O
-	O
down	O
with	O
the	O
nucleocapsid	O
(	O
N	O
),	O
N	O
protein	O
was	O
found	O
to	O
interact	O
with	O
swine	B-SPEC
testes	O
(	O
ST	O
)	O
cells	O
elongation	O
factor	O
1	O
-	O
alpha	O
(	O
EF1A	O
),	O
an	O
essential	O
component	O
of	O
the	O
translational	O
machinery	O
with	O
an	O
important	O
role	O
in	O
cells	O
.	O

Adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
complication	O
of	O
B	B-SPEC
.	I-SPEC
microti	I-SPEC
infection	O
and	O
generally	O
presents	O
later	O
in	O
the	O
course	O
of	O
the	O
disease	O
.	O

In	O
conclusion	O
,	O
clinically	O
healthy	O
dogs	B-SPEC
can	O
carry	O
respiratory	O
pathogens	O
and	O
could	O
act	O
as	O
sources	O
of	O
infection	O
for	O
susceptible	O
dogs	B-SPEC
.	O

TITLE	O
:	O
[	O
A	O
novel	O
one	O
-	O
tube	O
multiplex	O
RT	O
-	O
PCR	O
assay	O
for	O
simultaneous	O
detection	O
of	O
six	O
human	B-SPEC
coronaviruses	O
].	O

To	O
determine	O
whether	O
AKAP7	O
could	O
substitute	O
for	O
a	O
viral	O
2	O
',	O
5	O
'-	O
PDE	O
,	O
we	O
inserted	O
AKAP7	O
cDNA	O
into	O
an	O
MHV	B-SPEC
genome	O
with	O
an	O
inactivated	O
ns2	O
gene	O
.	O

We	O
suggest	O
the	O
possibility	O
that	O
viral	O
acquisition	O
of	O
the	O
host	O
AKAP7	O
PDE	O
domain	O
might	O
have	O
occurred	O
during	O
evolution	O
,	O
allowing	O
diverse	O
RNA	O
viruses	B-SPEC
to	O
antagonize	O
the	O
RNase	O
L	O
pathway	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
genetic	O
diversity	O
analysis	O
of	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
among	O
adult	O
patients	O
with	O
acute	O
respiratory	O
infections	O
in	O
Beijing	O
,	O
2012	O
.	O

Phylogenetic	O
analysis	O
based	O
on	O
neighbour	O
-	O
joining	O
method	O
showed	O
that	O
at	O
least	O
three	O
distinct	O
clusters	O
(	O
A	O
,	O
B	O
,	O
C	O
/	O
D	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
strains	O
were	O
circulating	O
among	O
adult	O
patients	O
with	O
ARI	O
in	O
Beijing	O
.	O

In	O
conclusion	O
,	O
we	O
herein	O
describe	O
the	O
prevalence	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
among	O
adult	O
patients	O
and	O
provide	O
substantial	O
evidence	O
for	O
the	O
genetic	O
diversity	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
circulating	O
in	O
Beijing	O
.	O

IBV	B-SPEC
NSP6	O
also	O
limited	O
autophagosome	O
and	O
omegasome	O
expansion	O
in	O
response	O
to	O
starvation	O
and	O
Torin1	O
and	O
could	O
therefore	O
limit	O
the	O
size	O
of	O
autophagosomes	O
induced	O
following	O
inhibition	O
of	O
MTOR	O
signaling	O
,	O
as	O
well	O
as	O
those	O
induced	O
independently	O
by	O
the	O
NSP6	O
protein	O
itself	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
the	O
papain	O
-	O
like	O
protease	O
of	O
MERS	O
coronavirus	B-SPEC
reveals	O
unusual	O
,	O
potentially	O
druggable	O
active	O
-	O
site	O
features	O
.	O

Treatment	O
of	O
mice	B-SPEC
with	O
a	O
different	O
vaccine	O
consisting	O
of	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
expressing	O
MDP	O
and	O
tuftsin	O
stimulated	O
humoral	O
and	O
cellular	O
immune	O
responses	O
.	O

Increased	O
IgG	O
and	O
IgA	O
resulted	O
in	O
the	O
activation	O
of	O
TGEV	B-SPEC
-	O
neutralising	O
antibody	O
activity	O
in	O
vitro	O
.	O

This	O
review	O
makes	O
an	O
attempt	O
to	O
summarize	O
the	O
published	O
knowledge	O
on	O
SARS	O
-	O
CoV	O
accessory	O
proteins	O
,	O
with	O
an	O
emphasis	O
on	O
their	O
involvement	O
in	O
virus	B-SPEC
-	O
host	O
interaction	O
.	O

TITLE	O
:	O
Antibiotic	O
treatment	O
following	O
a	O
dog	B-SPEC
bite	O
in	O
an	O
immunocompromized	O
patient	O
in	O
order	B-SPEC
to	O
prevent	O
Capnocytophaga	B-SPEC
canimorsus	I-SPEC
infection	O
:	O
a	O
case	O
report	O
.	O

ABSTRACT	O
:	O
Capnocytophaga	B-SPEC
canimorsus	I-SPEC
is	O
a	O
commensal	O
bacterium	B-SPEC
found	O
in	O
the	O
saliva	O
of	O
dogs	B-SPEC
and	O
cats	B-SPEC
.	O

The	O
prophylactic	O
application	O
of	O
antibiotics	O
after	O
a	O
dog	B-SPEC
bite	O
should	O
be	O
considered	O
in	O
high	O
-	O
risk	O
individuals	O
with	O
immune	O
deficiency	O
in	O
order	B-SPEC
to	O
prevent	O
both	O
Capnocytophyga	O
canimorsus	O
sepsis	B-SPEC
and	O
serious	O
nosocomial	O
complications	O
.	O

CONCLUSIONS	O
:	O
Severe	O
Capnocytophaga	B-SPEC
canimorsus	I-SPEC
sepsis	B-SPEC
may	O
be	O
complicated	O
by	O
life	O
-	O
threatening	O
nosocomial	O
infection	O
in	O
immunocompromized	O
patients	O
.	O

TITLE	O
:	O
Analysis	O
of	O
S1	O
gene	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
isolated	O
in	O
southern	O
China	O
during	O
2011	O
-	O
2012	O
.	O

Therefore	O
,	O
long	O
-	O
term	O
continuing	O
surveillance	O
is	O
significantly	O
important	O
for	O
prevention	O
and	O
control	O
of	O
IBV	B-SPEC
infection	O
.	O

Inoculation	O
with	O
the	O
virus	B-SPEC
caused	O
a	O
significant	O
neural	O
deficit	O
in	O
mice	B-SPEC
with	O
an	O
average	O
clinical	O
symptom	O
score	O
of	O
2	O
.	O
6	O
	O
0	O
.	O
5	O
at	O
2	O
wk	O
.	O

The	O
antibodies	O
strongly	O
recognized	O
the	O
recombinant	O
S1	O
protein	O
from	O
cell	O
lysates	O
and	O
supernatants	O
of	O
S1	O
-	O
expressing	O
cells	O
,	O
whereas	O
they	O
bound	O
weakly	O
to	O
the	O
authentic	O
S	O
protein	O
of	O
PEDV	B-SPEC
vaccine	O
strain	O
SM98	O
-	O
1	O
.	O

TITLE	O
:	O
CpG	O
-	O
ODNs	O
induced	O
changes	O
in	O
cytokine	O
/	O
chemokines	O
genes	O
expression	O
associated	O
with	O
suppression	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
replication	O
in	O
chicken	B-SPEC
lungs	O
.	O

Alteration	O
of	O
cytokines	O
profiles	O
through	O
manipulation	O
of	O
the	O
innate	O
immune	O
system	O
by	O
innate	O
immune	O
stimulants	O
may	O
be	O
helpful	O
in	O
inhibiting	O
virus	B-SPEC
replication	O
in	O
otherwise	O
permissive	O
cells	O
.	O

CpG	O
ODN	O
and	O
PBS	O
inoculated	O
embryos	O
were	O
challenged	O
with	O
virulent	O
IBV	B-SPEC
on	O
the	O
19th	O
ED	O
.	O

The	O
impact	O
of	O
other	O
respiratory	O
viruses	B-SPEC
was	O
19	O
.	O
4	O
%,	O
and	O
the	O
most	O
commonly	O
detected	O
viruses	B-SPEC
were	O
human	B-SPEC
rhinovirus	I-SPEC
/	O
enterovirus	B-SPEC
and	O
influenza	O
A	O
(	O
H3N2	O
).	O

Moreover	O
,	O
several	O
N	O
-	O
benzylidenequinolinamines	O
showed	O
an	O
interesting	O
activity	O
against	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
(	O
RSV	B-SPEC
)	O
at	O
concentrations	O
between	O
12	O
and	O
26	O
M	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
investigated	O
from	O
nasopharyngeal	O
swabs	O
of	O
76	O
patients	O
diagnosed	O
with	O
atypical	O
pneumonia	O
and	O
64	O
healthy	O
controls	O
using	O
the	O
CLART	O
Pneumovir	O
(	O
Genomica	O
,	O
Spain	O
)	O
kit	O
and	O
from	O
10	O
mL	O
blood	O
samples	O
of	O
the	O
same	O
subjects	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
emergence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
mid	O
-	O
2012	O
,	O
there	O
has	O
been	O
controversy	O
over	O
the	O
respiratory	O
precaution	O
recommendations	O
in	O
different	O
guidelines	O
from	O
various	O
international	O
bodies	O
.	O

Importantly	O
,	O
the	O
variant	O
PEDV	B-SPEC
caused	O
significantly	O
less	O
mortality	O
in	O
piglets	O
than	O
the	O
virulent	O
PEDV	B-SPEC
,	O
based	O
on	O
clinical	O
observations	O
.	O

TITLE	O
:	O
Sensitivity	O
of	O
SARS	O
/	O
MERS	O
CoV	O
to	O
interferons	O
and	O
other	O
drugs	O
based	O
on	O
achievable	O
serum	O
concentrations	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Volume	O
of	O
fluids	O
administered	O
during	O
resuscitation	O
for	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
and	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
the	O
volume	O
of	O
intravenous	O
(	O
IV	O
)	O
fluids	O
administered	O
in	O
the	O
resuscitative	O
phase	O
of	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
and	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

RESULTS	O
:	O
Among	O
296	O
patients	O
hospitalized	O
for	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
75	O
(	O
25	O
.	O
3	O
%)	O
developed	O
ARDS	O
.	O

Exploratory	O
post	O
hoc	O
meta	B-SPEC
-	O
analysis	O
showed	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
pooled	O
odds	O
of	O
mortality	O
following	O
treatment	O
,	O
compared	O
with	O
placebo	O
or	O
no	O
therapy	O
(	O
odds	O
ratio	O
,	O
0	O
.	O
25	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
.	O
14	O
-.	O
45	O
;	O
I	O
(	O
2	O
)	O
=	O
0	O
%).	O

Studies	O
were	O
commonly	O
of	O
low	O
or	O
very	O
low	O
quality	O
,	O
lacked	O
control	O
groups	O
,	O
and	O
at	O
moderate	O
or	O
high	O
risk	O
of	O
bias	B-SPEC
.	O

This	O
therapy	O
should	O
be	O
studied	O
within	O
the	O
context	O
of	O
a	O
well	O
-	O
designed	O
clinical	O
trial	O
or	O
other	O
formal	O
evaluation	O
,	O
including	O
for	O
treatment	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
CoV	O
infection	O
.	O

Although	O
MERS	O
-	O
CoV	O
cases	O
occur	O
mainly	O
on	O
the	O
Arabian	O
Peninsula	O
,	O
the	O
data	O
from	O
this	O
study	O
together	O
with	O
serologic	O
and	O
molecular	O
investigations	O
of	O
African	O
camels	B-SPEC
indicate	O
that	O
the	O
initial	O
host	O
switch	O
from	O
bats	B-SPEC
may	O
have	O
taken	O
place	O
in	O
Africa	O
.	O

With	O
regard	O
to	O
pandemic	O
preparedness	O
,	O
it	O
is	O
important	O
that	O
procedures	O
are	O
in	O
place	O
to	O
respond	O
rapidly	O
and	O
produce	O
tailor	O
made	O
vaccines	O
against	O
these	O
respiratory	O
viruses	B-SPEC
on	O
short	O
notice	O
.	O

TITLE	O
:	O
Patterns	O
of	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
in	O
nasal	O
swabs	O
from	O
calves	O
in	O
Ireland	O
:	O
a	O
retrospective	O
study	O
.	O

One	O
or	O
more	O
viruses	B-SPEC
were	O
detected	O
in	O
34	O
.	O
6	O
per	O
cent	O
of	O
submissions	O
,	O
with	O
BoCV	O
detected	O
most	O
frequently	O
(	O
22	O
.	O
9	O
per	O
cent	O
),	O
followed	O
by	O
BRSV	B-SPEC
(	O
11	O
.	O
6	O
per	O
cent	O
),	O
PI3	O
V	O
(	O
7	O
.	O
0	O
per	O
cent	O
),	O
BoHV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
6	O
.	O
1	O
per	O
cent	O
)	O
and	O
BVDV	B-SPEC
(	O
5	O
.	O
0	O
per	O
cent	O
).	O

TITLE	O
:	O
Surveillance	O
of	O
diarrhea	O
-	O
causing	O
pathogens	O
in	O
dairy	O
and	O
beef	O
cows	B-SPEC
in	O
Yamagata	O
Prefecture	O
,	O
Japan	O
from	O
2002	O
to	O
2011	O
.	O

Clinical	O
symptoms	O
(	O
duration	O
of	O
epidemic	O
,	O
hematochezia	O
and	O
complications	O
)	O
caused	O
by	O
bovine	B-SPEC
rotavirus	B-SPEC
infection	O
were	O
milder	O
than	O
those	O
caused	O
by	O
bovine	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Between	O
April	O
2012	O
and	O
June	O
2014	O
,	O
820	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
been	O
reported	O
in	O
the	O
Arabian	O
Peninsula	O
,	O
Europe	O
,	O
North	O
Africa	O
,	O
Southeast	O
Asia	O
,	O
the	O
Middle	O
East	O
,	O
and	O
the	O
United	O
States	O
.	O

Apgar	O
score	O
<	O
4	O
,	O
male	O
gender	O
,	O
Score	O
for	O
Neonatal	O
Acute	O
Physiology	O
Perinatal	O
Extension	O
(	O
SNAPPE	O
II	O
),	O
respiratory	O
distress	O
syndrome	O
(	O
RDS	O
),	O
late	O
sepsis	B-SPEC
(	O
LS	O
),	O
mechanical	O
ventilation	O
(	O
MV	O
),	O
surfactant	O
(<	O
2	O
h	O
of	O
life	O
),	O
and	O
time	O
of	O
MV	O
.	O

TITLE	O
:	O
Travel	O
implications	O
of	O
emerging	O
coronaviruses	O
:	O
SARS	O
and	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
emergence	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
of	O
the	O
Middle	O
East	O
Syndrome	O
Cornavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
caused	O
widespread	O
fear	O
and	O
concern	O
for	O
their	O
potential	O
threat	O
to	O
global	O
health	O
security	O
.	O

The	O
identification	O
of	O
both	O
the	O
intermediate	O
host	O
and	O
the	O
exact	O
route	O
of	O
transmission	O
of	O
MERS	O
-	O
CoV	O
is	O
crucial	O
for	O
the	O
subsequent	O
prevention	O
of	O
the	O
introduction	O
of	O
the	O
virus	B-SPEC
into	O
the	O
human	B-SPEC
population	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	O
betacoronavirus	B-SPEC
that	O
has	O
been	O
circulating	O
in	O
the	O
Arabian	O
Peninsula	O
since	O
2012	O
and	O
causing	O
severe	O
respiratory	O
infections	O
in	O
humans	B-SPEC
.	O

In	O
addition	O
,	O
IBV	B-SPEC
Ark	O
-	O
type	O
vaccines	O
may	O
induce	O
suboptimal	O
mucosal	O
immune	O
responses	O
,	O
contributing	O
to	O
the	O
prevalence	O
and	O
persistence	O
of	O
the	O
Ark	O
serotype	O
.	O

TITLE	O
:	O
Investigating	O
turkey	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
circulating	O
in	O
the	O
Southeastern	O
United	O
States	O
and	O
Arkansas	O
during	O
2012	O
and	O
2013	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
specific	O
memory	O
CD8	O
T	O
cells	O
provide	O
substantial	O
protection	O
from	O
lethal	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

We	O
demonstrate	O
that	O
memory	O
CD8	O
T	O
cells	O
specific	O
for	O
a	O
single	O
immunodominant	O
epitope	O
(	O
S436	O
or	O
S525	O
)	O
substantially	O
protected	O
8	O
-	O
to	O
10	O
-	O
month	O
-	O
old	O
mice	B-SPEC
from	O
lethal	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
trachea	B-SPEC
,	O
jugular	O
vein	O
and	O
femoral	O
artery	O
of	O
anesthetized	O
adult	O
rats	B-SPEC
were	O
cannulated	O
.	O

A	O
dose	O
of	O
OA	O
(	O
30	O
-	O
90	O
microL	O
;	O
iv	O
)	O
was	O
injected	O
in	O
each	O
animal	B-SPEC
and	O
changes	O
in	O
respiratory	O
frequency	O
(	O
RF	O
),	O
heart	O
rate	O
(	O
HR	O
)	O
and	O
mean	O
arterial	O
pressure	O
(	O
MAP	O
)	O
were	O
recorded	O
.	O

Recovered	O
organisms	O
were	O
enumerated	O
by	O
qPCR	O
except	O
for	O
C	B-SPEC
.	I-SPEC
jejuni	I-SPEC
,	O
which	O
was	O
quantified	O
by	O
culture	O
.	O

Using	O
bootstrapping	O
techniques	O
combined	O
with	O
Analysis	O
of	O
Variance	O
,	O
recovery	O
efficiencies	O
were	O
found	O
to	O
differ	O
among	O
the	O
pathogen	O
types	O
tested	O
at	O
the	O
two	O
lowest	O
turbidity	O
levels	O
;	O
however	O
,	O
for	O
a	O
given	O
pathogen	O
type	O
turbidity	O
did	O
not	O
affect	O
recovery	O
except	O
for	O
C	B-SPEC
.	I-SPEC
jejuni	I-SPEC
.	O

Adenovirus	B-SPEC
(	O
2	O
.	O
07	O
%),	O
hMPV	B-SPEC
(	O
2	O
.	O
78	O
%)	O
and	O
bocaviruses	B-SPEC
(	O
0	O
.	O
56	O
%)	O
appear	O
to	O
be	O
rare	O
causative	O
agents	O
of	O
AECOPD	O
.	O

Seven	O
of	O
the	O
eight	O
analyzed	O
viruses	B-SPEC
had	O
a	O
higher	O
prevalence	O
in	O
LRT	O
samples	O
.	O

Respiratory	O
viruses	B-SPEC
are	O
frequently	O
detected	O
in	O
both	O
URT	O
and	O
LRT	O
samples	O
in	O
AECOPD	O
with	O
rhino	O
-/	O
enteroviruses	B-SPEC
,	O
RSV	B-SPEC
and	O
influenza	B-SPEC
viruses	I-SPEC
the	O
most	O
prevalent	O
viruses	B-SPEC
.	O

We	O
showed	O
that	O
camels	B-SPEC
sampled	O
in	O
different	O
regions	O
in	O
Kenya	O
during	O
1992	O
-	O
2013	O
have	O
antibodies	O
against	O
this	O
virus	B-SPEC
.	O

High	O
densities	O
of	O
camel	B-SPEC
populations	O
correlated	O
with	O
increased	O
seropositivity	O
and	O
might	O
be	O
a	O
factor	O
in	O
predicting	O
long	O
-	O
term	O
virus	B-SPEC
maintenance	O
.	O

TITLE	O
:	O
Placement	O
of	O
a	O
caudal	O
vena	O
cava	O
stent	O
for	O
treatment	O
of	O
Budd	O
-	O
Chiari	O
-	O
like	O
syndrome	O
in	O
a	O
4	O
-	O
month	O
-	O
old	O
Ragdoll	O
cat	B-SPEC
.	O

TITLE	O
:	O
Faecal	O
virome	O
of	O
cats	B-SPEC
in	O
an	O
animal	B-SPEC
shelter	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
metagenomics	O
-	O
derived	O
feline	B-SPEC
enteric	O
virome	O
in	O
the	O
faeces	O
of	O
25	O
cats	B-SPEC
from	O
a	O
single	O
shelter	O
in	O
California	B-SPEC
.	O

More	O
than	O
90	O
%	O
of	O
the	O
recognizable	O
viral	O
reads	O
were	O
related	O
to	O
mammalian	B-SPEC
viruses	B-SPEC
and	O
the	O
rest	O
to	O
bacterial	O
viruses	B-SPEC
.	O

Six	O
previously	O
known	O
viruses	B-SPEC
were	O
also	O
identified	O
:	O
feline	B-SPEC
coronavirus	B-SPEC
type	O
1	O
,	O
felid	B-SPEC
herpes	O
1	O
,	O
feline	B-SPEC
calicivirus	I-SPEC
,	O
feline	B-SPEC
norovirus	B-SPEC
,	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
and	O
picobirnavirus	B-SPEC
.	O

Therefore	O
,	O
the	O
objective	O
of	O
this	O
paper	O
is	O
to	O
describe	O
the	O
cases	O
and	O
deaths	O
caused	O
by	O
the	O
new	O
coronavirus	B-SPEC
.	O

The	O
expression	O
of	O
genes	O
involved	O
in	O
immune	O
pathways	O
in	O
adult	O
bees	B-SPEC
indicates	O
that	O
IAPV	O
infection	O
triggers	O
active	O
immune	O
responses	O
.	O

Compared	O
with	O
control	O
subjects	O
,	O
infections	O
with	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
OR	O
=	O
5	O
.	O
15	O
,	O
95	O
%	O
CI	O
=	O
2	O
.	O
24	O
-	O
11	O
.	O
78	O
),	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
OR	O
=	O
6	O
.	O
16	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
77	O
-	O
21	O
.	O
65	O
)	O
and	O
combine	O
HCoVs	O
(	O
OR	O
=	O
2	O
.	O
36	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
5	O
=	O
3	O
.	O
72	O
)	O
were	O
associated	O
with	O
upper	O
respiratory	O
tract	O
infections	O
.	O

HCoVs	O
were	O
found	O
to	O
be	O
seasonally	O
dependent	O
with	O
significant	O
detections	O
in	O
the	O
harmattan	O
season	O
(	O
mainly	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
and	O
wet	O
season	O
(	O
mainly	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
).	O

RESULTS	O
:	O
Out	O
of	O
1	O
,	O
213	O
subjects	O
recruited	O
,	O
150	O
(	O
12	O
.	O
4	O
%)	O
were	O
positive	O
for	O
one	O
or	O
more	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
mainly	O
infects	O
younger	O
children	O
and	O
causes	O
cough	O
,	O
fever	O
,	O
rhinorrhoea	O
,	O
bronchiolitis	O
and	O
croup	O
.	O

Imaging	O
enabled	O
us	O
to	O
examine	O
the	O
cranium	O
,	O
as	O
the	O
family	B-SPEC
refused	O
cerebral	O
dissection	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
member	O
of	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
,	O
is	O
a	O
causative	O
agent	O
of	O
porcine	B-SPEC
enteric	O
disease	O
characterized	O
by	O
acute	O
watery	O
diarrhea	O
and	O
dehydration	O
in	O
sucking	O
piglet	O
.	O

Animal	B-SPEC
study	O
demonstrated	O
that	O
both	O
recombinant	O
viruses	B-SPEC
induced	O
measurable	O
anti	O
-	O
DTMUV	O
neutralizing	O
antibodies	O
in	O
ducks	B-SPEC
.	O

TITLE	O
:	O
Nucleic	O
acid	O
-	O
based	O
differential	O
diagnostic	O
assays	O
for	O
feline	B-SPEC
coronavirus	B-SPEC
.	O

These	O
results	O
suggest	O
that	O
this	O
molecular	O
approach	O
provides	O
a	O
rapid	O
and	O
reliable	O
way	O
to	O
detect	O
FCoV	O
,	O
especially	O
in	O
feline	B-SPEC
clinical	O
specimens	O
.	O

The	O
most	O
commonly	O
detected	O
virus	B-SPEC
was	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
32	O
.	O
6	O
%),	O
followed	O
by	O
influenza	B-SPEC
virus	I-SPEC
(	O
26	O
.	O
8	O
%).	O

Although	O
both	O
SARS	O
and	O
MERS	O
are	O
caused	O
by	O
coronaviruses	O
,	O
SARS	O
was	O
characterized	O
by	O
efficient	O
human	B-SPEC
transmission	O
and	O
relatively	O
low	O
mortality	O
rate	O
.	O

For	O
on	O
-	O
farm	O
detection	O
of	O
PEDV	B-SPEC
RNA	O
in	O
feed	O
,	O
paint	O
rollers	B-SPEC
were	O
used	O
to	O
collect	O
material	O
from	O
at	O
-	O
risk	O
feed	O
bins	O
from	O
3	O
clinically	O
affected	O
breeding	O
herds	O
.	O

For	O
the	O
purpose	O
of	O
a	O
Positive	O
control	O
,	O
piglets	O
were	O
allowed	O
to	O
ingest	O
feed	O
spiked	O
with	O
stock	O
PEDV	B-SPEC
(	O
Ct	O
=	O
18	O
.	O
23	O
)	O
while	O
the	O
negative	O
control	O
group	O
received	O
PEDV	B-SPEC
-	O
free	O
feed	O
.	O

One	O
hundred	O
mechanically	O
ventilated	O
patients	O
with	O
severe	O
sepsis	B-SPEC
,	O
septic	O
shock	O
,	O
acute	O
lung	O
injury	O
(	O
ALI	O
),	O
and	O
/	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
underwent	O
bronchoscopy	O
with	O
unilateral	O
BAL	O
.	O

In	O
contrast	O
,	O
the	O
presence	O
of	O
E	O
protein	O
activated	O
a	O
pathogenic	O
inflammatory	O
response	O
that	O
may	O
cause	O
death	O
in	O
animal	B-SPEC
models	O
and	O
in	O
humans	B-SPEC
.	O

Interestingly	O
,	O
a	O
comprehensive	O
collection	O
of	O
SARS	O
-	O
CoVs	O
in	O
which	O
these	O
motifs	O
have	O
been	O
modified	O
elicited	O
full	O
and	O
long	O
-	O
term	O
protection	O
even	O
in	O
old	O
mice	B-SPEC
,	O
making	O
those	O
deletion	O
mutants	O
promising	O
vaccine	O
candidates	O
.	O

Coronaviruses	O
(	O
CoVs	O
)	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
CoV	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
are	O
important	O
human	B-SPEC
pathogens	O
;	O
however	O
,	O
macropinocytosis	O
during	O
CoV	O
infection	O
has	O
not	O
been	O
investigated	O
.	O

MHV	B-SPEC
-	O
induced	O
macropinocytosis	O
requires	O
fusogenic	O
spike	O
protein	O
on	O
the	O
cell	O
surface	O
and	O
is	O
dependent	O
on	O
epidermal	O
growth	O
factor	O
receptor	O
activation	O
.	O

Importance	O
:	O
RNA	O
viruses	B-SPEC
are	O
infamous	O
for	O
their	O
ability	O
to	O
evolve	O
in	O
response	O
to	O
selective	O
pressure	O
,	O
such	O
as	O
the	O
presence	O
of	O
antiviral	O
drugs	O
.	O

Here	O
,	O
we	O
exploit	O
a	O
biosafety	O
level	O
2	O
(	O
BSL	O
-	O
2	O
)	O
chimeric	O
Sindbis	B-SPEC
virus	I-SPEC
system	O
to	O
evaluate	O
protease	O
activities	O
and	O
the	O
efficacy	O
of	O
inhibitors	O
directed	O
against	O
the	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
a	O
biosafety	O
level	O
3	O
(	O
BSL	O
-	O
3	O
)	O
pathogen	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
discovered	O
September	O
2012	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
).	O

RESULTS	O
:	O
The	O
RT	O
-	O
LAMP	O
assay	O
was	O
capable	O
of	O
detecting	O
as	O
few	O
as	O
3	O
.	O
4	O
copies	O
of	O
MERS	O
-	O
CoV	O
RNA	O
,	O
and	O
was	O
highly	O
specific	O
,	O
with	O
no	O
cross	O
-	O
reaction	O
to	O
other	O
respiratory	O
viruses	B-SPEC
.	O

We	O
did	O
a	O
prospective	O
,	O
matched	O
,	O
case	O
-	O
control	O
study	O
in	O
Niger	B-SPEC
between	O
Aug	O
1	O
,	O
2001	O
,	O
and	O
Oct	O
31	O
,	O
2006	O
,	O
in	O
children	O
younger	O
than	O
12	O
years	O
to	O
assess	O
risk	O
factors	O
for	O
acute	O
noma	O
.	O

The	O
clinical	O
features	O
of	O
the	O
patient	O
included	O
relapsing	O
oral	O
thrush	B-SPEC
due	O
to	O
Candida	B-SPEC
,	O
cutaneous	O
infections	O
and	O
upper	O
and	O
lower	O
respiratory	O
tract	O
infections	O
,	O
followed	O
by	O
a	O
locally	O
severe	O
necrotic	O
genital	O
herpetic	O
lesion	O
.	O

ABSTRACT	O
:	O
Mounting	O
reports	O
on	O
severe	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
from	O
across	O
the	O
globe	O
have	O
raised	O
concerns	O
among	O
the	O
scientific	O
community	O
.	O

Immunization	O
of	O
piglets	O
with	O
these	O
TGEV	B-SPEC
vectors	O
led	O
to	O
partial	O
protection	O
against	O
a	O
challenge	O
with	O
a	O
virulent	O
PRRSV	B-SPEC
strain	O
,	O
as	O
immunized	O
animals	B-SPEC
showed	O
reduced	O
clinical	O
signs	O
and	O
lung	O
damage	O
.	O

Further	O
investigations	O
of	O
the	O
benefits	O
and	O
effects	O
of	O
ECMO	O
need	O
to	O
be	O
undertaken	O
in	O
order	B-SPEC
to	O
facilitate	O
the	O
implementation	O
of	O
this	O
technology	O
on	O
a	O
larger	O
scale	O
.	O

Mutation	O
of	O
individual	O
cysteine	O
clusters	O
in	O
the	O
cysteine	O
-	O
rich	O
motif	O
of	O
S	O
revealed	O
that	O
all	O
cysteines	O
must	O
be	O
replaced	O
to	O
abolish	O
acylation	O
and	O
incorporation	O
of	O
S	O
into	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLP	O
).	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
characterize	O
a	O
murine	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
abiding	O
by	O
the	O
Berlin	O
definition	O
of	O
human	B-SPEC
ARDS	O
and	O
guidelines	O
for	O
animal	B-SPEC
models	O
of	O
ARDS	O
.	O

Infection	O
and	O
replication	O
of	O
PEDV	B-SPEC
in	O
the	O
respiratory	O
tract	O
from	O
naturally	O
PEDV	B-SPEC
-	O
infected	O
piglets	O
were	O
examined	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
immunohistochemistry	O
,	O
and	O
virus	B-SPEC
re	O
-	O
isolation	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
emerged	O
in	O
North	O
America	O
in	O
April	O
2013	O
and	O
has	O
since	O
been	O
identified	O
in	O
30	O
U	O
.	O
S	O
.	O
States	O
,	O
Canada	O
and	O
Mexico	O
.	O

TITLE	O
:	O
The	O
PDZ	O
-	O
binding	O
motif	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
envelope	O
protein	O
is	O
a	O
determinant	O
of	O
viral	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
A	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
lacking	O
the	O
envelope	O
(	O
E	O
)	O
protein	O
is	O
attenuated	O
in	O
vivo	O
.	O

Elimination	O
of	O
SARS	O
-	O
CoV	O
E	O
protein	O
PBM	O
by	O
using	O
reverse	O
genetics	O
caused	O
a	O
reduction	O
in	O
the	O
deleterious	O
exacerbation	O
of	O
the	O
immune	O
response	O
triggered	O
during	O
infection	O
with	O
the	O
parental	O
virus	B-SPEC
and	O
virus	B-SPEC
attenuation	O
.	O

Cellular	O
protein	O
syntenin	O
was	O
identified	O
to	O
bind	O
the	O
E	O
protein	O
PBM	O
during	O
SARS	O
-	O
CoV	O
infection	O
by	O
using	O
three	O
complementary	O
strategies	O
,	O
yeast	B-SPEC
two	O
-	O
hybrid	O
,	O
reciprocal	O
coimmunoprecipitation	O
and	O
confocal	O
microscopy	O
assays	O
.	O

Active	O
p38	O
MAPK	O
was	O
reduced	O
in	O
lungs	O
of	O
mice	B-SPEC
infected	O
with	O
SARS	O
-	O
CoVs	O
lacking	O
E	O
protein	O
PBM	O
as	O
compared	O
with	O
the	O
parental	O
virus	B-SPEC
,	O
leading	O
to	O
a	O
decreased	O
expression	O
of	O
inflammatory	O
cytokines	O
and	O
to	O
virus	B-SPEC
attenuation	O
.	O

TITLE	O
:	O
DESC1	O
and	O
MSPL	O
activate	O
influenza	O
A	O
viruses	B-SPEC
and	O
emerging	O
coronaviruses	O
for	O
host	O
cell	O
entry	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
these	O
proteases	O
support	O
the	O
spread	O
of	O
all	O
influenza	B-SPEC
virus	I-SPEC
subtypes	O
previously	O
pandemic	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
compare	O
unilateral	O
lung	O
and	O
traditional	O
lung	O
recruitment	O
maneuver	O
(	O
RM	O
)	O
in	O
animals	B-SPEC
with	O
unilateral	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
implementing	O
independent	O
lung	O
ventilation	O
,	O
and	O
to	O
explore	O
the	O
rational	O
mechanical	O
ventilation	O
strategy	O
for	O
unilateral	O
lung	O
lesions	O
.	O

There	O
were	O
20	O
pigs	B-SPEC
in	O
each	O
group	O
.	O

This	O
study	O
describes	O
399	O
microRNAs	O
identified	O
by	O
deep	O
sequencing	O
of	O
small	O
RNA	O
isolated	O
from	O
tissues	O
of	O
the	O
Black	B-SPEC
flying	I-SPEC
fox	I-SPEC
,	O
Pteropus	B-SPEC
alecto	I-SPEC
,	O
a	O
confirmed	O
natural	O
reservoir	O
of	O
the	O
human	B-SPEC
pathogens	O
Hendra	B-SPEC
virus	I-SPEC
and	O
Australian	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
.	O

MicroRNAs	O
are	O
likely	O
to	O
play	O
major	O
roles	O
in	O
regulating	O
virus	B-SPEC
-	O
host	O
interaction	O
in	O
bats	B-SPEC
,	O
via	O
dampening	O
of	O
inflammatory	O
responses	O
(	O
limiting	O
the	O
effects	O
of	O
immunopathology	O
),	O
and	O
directly	O
limiting	O
the	O
extent	O
of	O
viral	O
replication	O
,	O
either	O
through	O
restricting	O
the	O
availability	O
of	O
essential	O
factors	O
or	O
by	O
controlling	O
apoptosis	O
.	O

This	O
in	O
turn	O
will	O
facilitate	O
the	O
development	O
of	O
antiviral	O
strategies	O
for	O
use	O
in	O
humans	B-SPEC
and	O
other	O
species	B-SPEC
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
key	O
features	O
of	O
the	O
preparedness	O
for	O
the	O
2014	O
Hajj	O
and	O
Umra	O
,	O
review	O
the	O
recent	O
impact	O
of	O
emerging	O
viruses	B-SPEC
such	O
as	O
Ebola	O
in	O
West	O
Africa	O
and	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
affected	O
countries	O
,	O
and	O
highlight	O
the	O
updated	O
requirements	O
and	O
the	O
required	O
vaccines	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
of	O
the	O
detection	O
of	O
different	O
fragment	O
IBV	B-SPEC
-	O
like	O
genes	O
in	O
wild	O
bird	B-SPEC
populations	O
.	O

In	O
serum	O
samples	O
from	O
experimentally	O
infected	O
pigs	B-SPEC
(	O
n	O
=	O
35	O
),	O
anti	O
-	O
IgG	O
PEDV	B-SPEC
antibodies	O
were	O
detected	O
as	O
early	O
as	O
7	O
days	O
post	O
-	O
infection	O
.	O

Conditioned	O
medium	O
collected	O
from	O
an	O
in	O
vitro	O
lipopolysaccharide	O
-	O
induced	O
airway	O
epithelial	O
cell	O
injury	O
model	O
using	O
human	B-SPEC
A549	O
alveolar	O
cells	O
was	O
subsequently	O
added	O
at	O
increasing	O
concentrations	O
(	O
no	O
conditioned	O
,	O
2	O
%,	O
5	O
%,	O
10	O
%,	O
15	O
%,	O
25	O
%,	O
and	O
50	O
%)	O
to	O
a	O
rat	B-SPEC
mixed	O
brain	O
cell	O
culture	O
containing	O
both	O
astrocytes	O
and	O
neurons	O
.	O

Our	O
findings	O
demonstrated	O
that	O
human	B-SPEC
epithelial	O
pulmonary	O
cells	O
stimulated	O
with	O
bacterial	O
lipopolysaccharide	O
release	O
inflammatory	O
mediators	O
that	O
are	O
able	O
to	O
induce	O
a	O
translational	O
clinically	O
relevant	O
and	O
harmful	O
response	O
in	O
brain	O
cells	O
.	O

Infected	O
animals	B-SPEC
were	O
treated	O
with	O
increasing	O
doses	O
(	O
1	O
,	O
3	O
and	O
10	O
mg	O
/	O
kg	O
)	O
of	O
FTY720	O
and	O
morbidity	O
and	O
mortality	O
recorded	O
.	O

Reduced	O
neuroinflammation	O
in	O
FTY720	O
-	O
treated	O
mice	B-SPEC
correlated	O
with	O
increased	O
retention	O
of	O
T	O
lymphocytes	O
within	O
draining	O
cervical	O
lymph	O
nodes	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

In	O
this	O
study	O
,	O
we	O
inoculated	O
three	O
Japanese	O
draft	O
horses	B-SPEC
with	O
an	O
ECoV	O
-	O
positive	O
diarrheic	O
fecal	O
sample	O
to	O
confirm	O
infection	O
after	O
inoculation	O
and	O
to	O
investigate	O
the	O
clinical	O
course	O
and	O
virus	B-SPEC
shedding	O
patterns	O
of	O
ECoV	O
.	O
Virus	B-SPEC
neutralization	O
tests	O
showed	O
that	O
all	O
three	O
horses	B-SPEC
became	O
infected	O
with	O
ECoV	O
.	O
Two	O
of	O
the	O
three	O
horses	B-SPEC
developed	O
clinical	O
signs	O
similar	O
to	O
those	O
observed	O
during	O
ECoV	O
outbreaks	O
,	O
including	O
fever	O
,	O
anorexia	O
,	O
and	O
gastrointestinal	O
dysfunction	O
.	O

The	O
quaternary	O
structure	O
and	O
substrate	O
preferences	O
of	O
MERS	O
-	O
CoV	O
PLpro	O
were	O
determined	O
and	O
compared	O
to	O
those	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
PLpro	O
,	O
revealing	O
prominent	O
differences	O
between	O
these	O
closely	O
related	O
enzymes	O
.	O

This	O
study	O
demonstrates	O
that	O
UPR	O
activation	O
constitutes	O
a	O
major	O
aspect	O
of	O
coronavirus	B-SPEC
-	O
host	O
interactions	O
.	O

Manipulations	O
of	O
the	O
coronavirus	B-SPEC
-	O
induced	O
UPR	O
may	O
provide	O
novel	O
therapeutic	O
targets	O
for	O
the	O
control	O
of	O
coronavirus	B-SPEC
infection	O
and	O
pathogenesis	O
.	O

Modeling	O
of	O
the	O
interaction	O
between	O
the	O
MERS	O
-	O
CoV	O
spike	O
glycoprotein	O
and	O
its	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
predicted	O
comparable	O
interaction	O
energies	O
in	O
common	B-SPEC
marmosets	I-SPEC
and	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
During	O
the	O
first	O
year	O
of	O
enhanced	O
MERS	O
coronavirus	B-SPEC
surveillance	O
in	O
England	O
,	O
77	O
persons	O
traveling	O
from	O
the	O
Middle	O
East	O
had	O
acute	O
respiratory	O
illness	O
and	O
were	O
tested	O
for	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Mutations	O
of	O
3c	O
and	O
spike	O
protein	O
genes	O
correlate	O
with	O
the	O
occurrence	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

Studies	O
shows	O
that	O
patient	O
-	O
related	O
risk	O
factors	O
,	O
such	O
as	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(	O
COPD	O
),	O
age	O
older	O
than	O
60	O
years	O
,	O
American	O
Society	O
of	O
Anesthesiologists	O
ASA	O
class	B-SPEC
of	O
II	O
or	O
higher	O
,	O
obesity	O
,	O
functional	O
dependence	O
,	O
and	O
congestive	O
heart	O
failure	O
,	O
increase	O
the	O
risk	O
for	O
postoperative	O
pulmonary	O
complications	O
.	O

A	O
total	O
of	O
310	O
chicken	B-SPEC
sera	O
samples	O
were	O
tested	O
using	O
the	O
commercial	O
IDEXX	O
kit	O
along	O
with	O
the	O
assay	O
developed	O
.	O

The	O
similarity	O
of	O
virus	B-SPEC
tropism	O
and	O
replication	O
competence	O
of	O
human	B-SPEC
and	O
dromedary	B-SPEC
MERS	O
-	O
CoV	O
from	O
the	O
Arabian	O
peninsula	O
,	O
and	O
genetically	O
diverse	O
dromedary	B-SPEC
viruses	B-SPEC
from	O
Egypt	O
,	O
in	O
ex	O
-	O
vivo	O
cultures	O
of	O
the	O
human	B-SPEC
respiratory	O
tract	O
suggests	O
that	O
dromedary	B-SPEC
viruses	B-SPEC
from	O
Saudi	O
Arabia	O
and	O
Egypt	O
are	O
probably	O
infectious	O
to	O
human	B-SPEC
beings	O
.	O

TITLE	O
:	O
The	O
impact	O
of	O
cardiac	O
dysfunction	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
mortality	O
in	O
mechanically	O
ventilated	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
:	O
an	O
observational	O
study	O
.	O

Despite	O
severe	O
epidemic	O
outbreaks	O
on	O
several	O
occasions	O
and	O
lack	O
of	O
antiviral	O
drug	O
,	O
not	O
much	O
progress	O
has	O
been	O
made	O
with	O
regard	O
to	O
an	O
epitope	O
-	O
based	O
vaccine	O
designed	O
for	O
HCoV	O
.	O
In	O
this	O
study	O
,	O
a	O
computational	O
approach	O
was	O
adopted	O
to	O
identify	O
a	O
multiepitope	O
vaccine	O
candidate	O
against	O
this	O
virus	B-SPEC
that	O
could	O
be	O
suitable	O
to	O
trigger	O
a	O
significant	O
immune	O
response	O
.	O

The	O
peptide	O
sequence	O
could	O
interact	O
with	O
as	O
many	O
as	O
16	O
human	B-SPEC
leukocyte	O
antigens	O
(	O
HLAs	O
)	O
and	O
showed	O
high	O
cumulative	O
population	O
coverage	O
,	O
ranging	O
from	O
75	O
.	O
68	O
%	O
to	O
90	O
.	O
73	O
%.	O

ABSTRACT	O
:	O
This	O
study	O
describes	O
the	O
epidemiology	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Saudi	O
Arabia	O
.	O

New	O
viral	O
respiratory	O
tract	O
infections	O
with	O
epidemic	O
potential	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
H1N1	O
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
,	O
require	O
development	O
of	O
new	O
antiviral	O
agents	O
.	O

We	O
report	O
a	O
patient	O
with	O
life	O
-	O
threatening	O
PVL	O
-	O
expressing	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
-	O
associated	O
pneumonia	O
who	O
was	O
rescued	O
using	O
extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
).	O

CONCLUSIONS	O
:	O
This	O
case	O
demonstrates	O
that	O
early	O
induction	O
of	O
ECMO	O
support	O
can	O
be	O
a	O
reasonable	O
therapeutic	O
option	O
for	O
PVL	O
-	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
-	O
associated	O
pneumonia	O
.	O

The	O
high	O
cost	O
of	O
life	O
-	O
long	O
HAART	O
and	O
the	O
emergence	O
of	O
drug	O
resistance	O
among	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
-	O
infected	O
individuals	O
have	O
brought	O
renewed	O
pressure	O
for	O
the	O
discovery	O
of	O
novel	O
antivirals	O
and	O
alternative	O
medicines	O
.	O

TITLE	O
:	O
Immunogenicity	O
of	O
an	O
adenoviral	B-SPEC
-	O
based	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
vaccine	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

MERS	O
-	O
CoV	O
has	O
infected	O
dromedary	B-SPEC
camel	B-SPEC
populations	O
in	O
the	O
Middle	O
East	O
at	O
high	O
rates	O
,	O
representing	O
an	O
immediate	O
source	O
of	O
human	B-SPEC
infection	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
develop	O
a	O
method	O
of	O
prioritizing	O
98	O
zoonoses	O
derived	O
from	O
animal	B-SPEC
pathogens	O
in	O
Japan	O
and	O
to	O
involve	O
four	O
major	O
groups	O
of	O
stakeholders	O
:	O
researchers	O
,	O
physicians	O
,	O
public	O
health	O
officials	O
,	O
and	O
citizens	O
.	O

Whereas	O
several	O
nsp7	O
mutations	O
affected	O
virus	B-SPEC
replication	O
to	O
a	O
limited	O
extent	O
,	O
the	O
replacement	O
of	O
two	O
nsp8	O
residues	O
(	O
P183	O
and	O
R190	O
)	O
essential	O
for	O
interaction	O
with	O
nsp12	O
and	O
a	O
third	O
(	O
K58	O
)	O
critical	O
for	O
the	O
interaction	O
of	O
the	O
polymerase	O
complex	O
with	O
RNA	O
were	O
all	O
lethal	O
to	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Rapid	O
and	O
sensitive	O
detection	O
of	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
by	O
one	O
-	O
tube	O
reverse	O
transcription	O
-	O
insulated	O
isothermal	O
polymerase	O
chain	O
reaction	O
.	O

In	O
this	O
study	O
,	O
reverse	O
transcription	O
iiPCR	O
(	O
RT	O
-	O
iiPCR	O
)	O
was	O
developed	O
to	O
facilitate	O
point	O
-	O
of	O
-	O
need	O
diagnosis	O
of	O
CDV	B-SPEC
infection	O
.	O

CDV	B-SPEC
RT	O
-	O
iiPCR	O
generated	O
positive	O
signals	O
from	O
CDV	B-SPEC
,	O
but	O
not	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
,	O
canine	O
parvovirus	B-SPEC
,	O
canine	B-SPEC
herpesvirus	I-SPEC
,	O
canine	B-SPEC
adenovirus	I-SPEC
2	O
,	O
canine	O
influenza	B-SPEC
virus	I-SPEC
(	O
subtype	O
H3N8	O
),	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
,	O
and	O
canine	O
respiratory	O
coronavirus	B-SPEC
.	O

The	O
MHV	B-SPEC
-	O
3	O
infected	O
C5aR	O
(-/-)	O
mice	B-SPEC
exhibited	O
reduced	O
numbers	O
of	O
infiltrated	O
inflammatory	O
CD11b	O
(+)	O
cells	O
and	O
a	O
reduced	O
expression	O
of	O
TNF	O
-	O
	O
and	O
FGL2	O
.	O

ABSTRACT	O
:	O
Varicella	B-SPEC
-	I-SPEC
zoster	I-SPEC
virus	I-SPEC
infection	O
can	O
lead	O
to	O
severe	O
illness	O
in	O
immunocompromised	O
patients	O
.	O

We	O
then	O
provide	O
an	O
in	O
-	O
depth	O
literature	O
review	O
to	O
summarise	O
the	O
known	O
mechanisms	O
by	O
which	O
RNA	O
viruses	B-SPEC
of	O
the	O
families	O
Flaviviridae	B-SPEC
and	O
Coronaviridae	B-SPEC
evade	O
sensing	O
through	O
STING	O
.	O

TITLE	O
:	O
Effect	O
of	O
integrated	O
traditional	O
Chinese	O
medicine	O
and	O
western	O
medicine	O
on	O
the	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
A	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
reason	O
is	O
that	O
in	O
recent	O
decades	O
,	O
infectious	O
diseases	O
such	O
as	O
HIV	B-SPEC
/	O
SIDA	B-SPEC
,	O
SARS	O
and	O
Influenza	O
have	O
shown	O
that	O
we	O
need	O
new	O
approaches	O
and	O
concepts	O
in	O
order	B-SPEC
to	O
understand	O
how	O
biological	O
emergencies	O
and	O
health	O
alerts	O
deploy	O
new	O
scales	O
of	O
action	O
.	O

The	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
has	O
resulted	O
in	O
severe	O
human	B-SPEC
respiratory	O
disease	O
with	O
high	O
death	O
rates	O
.	O

Their	O
zoonotic	O
origins	O
highlight	O
the	O
likelihood	O
of	O
reemergence	O
or	O
further	O
evolution	O
into	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
pathogens	O
.	O

The	O
relative	O
synonymous	O
codon	O
usage	O
value	O
of	O
each	O
codon	O
revealed	O
that	O
codon	O
usage	O
bias	B-SPEC
exists	O
and	O
that	O
PEDV	B-SPEC
tends	O
to	O
use	O
codons	O
that	O
end	O
in	O
T	O
.	O
The	O
mean	O
ENC	O
value	O
of	O
47	O
.	O
91	O
indicates	O
that	O
the	O
codon	O
usage	O
bias	B-SPEC
is	O
low	O
.	O

This	O
was	O
further	O
confirmed	O
by	O
a	O
principal	O
component	O
analysis	O
between	O
the	O
codon	O
compositions	O
and	O
the	O
axis	B-SPEC
values	O
.	O

Additionally	O
,	O
gene	O
function	O
and	O
geographic	O
distribution	O
also	O
influence	O
the	O
codon	O
usage	O
bias	B-SPEC
to	O
a	O
degree	O
.	O

TITLE	O
:	O
[	O
Dromedary	B-SPEC
camels	B-SPEC
and	O
Middle	O
East	O
respiratory	O
syndrome	O
:	O
MERS	O
coronavirus	B-SPEC
in	O
the	O
'	O
ship	O
of	O
the	O
desert	O
'].	O

Although	O
dromedary	B-SPEC
camels	B-SPEC
appear	O
to	O
be	O
the	O
most	O
important	O
source	O
in	O
primary	O
cases	O
,	O
nosocomial	O
transmission	O
has	O
proved	O
to	O
be	O
a	O
major	O
cause	O
of	O
secondary	O
infections	O
.	O

In	O
this	O
review	O
,	O
we	O
will	O
discuss	O
a	O
variety	O
of	O
viral	O
infections	O
,	O
including	O
HIV	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
LCMV	B-SPEC
,	O
HCV	B-SPEC
,	O
RSV	B-SPEC
,	O
and	O
others	O
,	O
where	O
myeloid	O
cells	O
influence	O
the	O
control	O
and	O
clearance	O
of	O
the	O
virus	B-SPEC
from	O
the	O
host	O
,	O
as	O
well	O
as	O
the	O
severity	O
and	O
resolution	O
of	O
tissue	O
damage	O
,	O
via	O
the	O
activities	O
of	O
iNOS	O
and	O
/	O
or	O
Arg1	O
.	O

Among	O
8	O
,	O
358	O
admissions	O
to	O
the	O
medical	O
emergency	O
department	O
,	O
1	O
,	O
713	O
patients	O
presented	O
with	O
an	O
incident	O
admission	O
of	O
sepsis	B-SPEC
of	O
any	O
severity	O
,	O
median	O
age	O
72	O
years	O
(	O
5	O
-	O
95	O
%;	O
range	O
,	O
26	O
-	O
91	O
yr	O
),	O
793	O
(	O
46	O
.	O
3	O
%)	O
were	O
men	O
,	O
728	O
(	O
42	O
.	O
5	O
%)	O
presented	O
with	O
a	O
Charlson	O
comorbidity	O
index	O
greater	O
than	O
2	O
,	O
621	O
(	O
36	O
.	O
3	O
%)	O
were	O
admitted	O
with	O
sepsis	B-SPEC
,	O
1	O
,	O
071	O
(	O
62	O
.	O
5	O
%)	O
with	O
severe	O
sepsis	B-SPEC
,	O
and	O
21	O
(	O
1	O
.	O
2	O
%)	O
with	O
septic	O
shock	O
.	O

For	O
the	O
purpose	O
of	O
a	O
positive	O
control	O
,	O
a	O
separate	O
group	O
of	O
piglets	O
was	O
allowed	O
to	O
ingest	O
non	O
-	O
treated	O
(	O
Sal	O
CURB	O
-	O
free	O
)	O
feed	O
also	O
spiked	O
with	O
stock	O
PEDV	B-SPEC
(	O
Ct	O
=	O
25	O
.	O
22	O
).	O

Clinical	O
signs	O
of	O
PEDV	B-SPEC
infection	O
(	O
vomiting	O
and	O
diarrhea	O
)	O
and	O
viral	O
shedding	O
in	O
feces	O
were	O
observed	O
in	O
the	O
positive	O
control	O
group	O
2	O
-	O
3	O
days	O
post	O
-	O
consumption	O
of	O
non	O
-	O
treated	O
feed	O
.	O

In	O
contrast	O
,	O
no	O
evidence	O
of	O
infection	O
was	O
observed	O
in	O
pigs	B-SPEC
fed	O
Sal	O
CURB	O
-	O
treated	O
feed	O
or	O
in	O
the	O
negative	O
controls	O
throughout	O
the	O
14	O
-	O
day	O
study	O
period	O
.	O

TITLE	O
:	O
Overlapping	O
and	O
distinct	O
molecular	O
determinants	O
dictating	O
the	O
antiviral	O
activities	O
of	O
TRIM56	O
against	O
flaviviruses	B-SPEC
and	O
coronavirus	B-SPEC
.	O

Altogether	O
,	O
TRIM56	O
is	O
a	O
versatile	O
antiviral	O
host	O
factor	O
that	O
confers	O
resistance	O
to	O
YFV	B-SPEC
,	O
DENV2	O
,	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
through	O
overlapping	O
and	O
distinct	O
molecular	O
determinants	O
.	O

The	O
differing	O
molecular	O
determinants	O
appear	O
to	O
accommodate	O
distinct	O
antiviral	O
mechanisms	O
TRIM56	O
adopts	O
to	O
target	O
different	O
families	O
of	O
viruses	B-SPEC
;	O
while	O
TRIM56	O
curbs	O
intracellular	O
YFV	B-SPEC
/	O
DENV2	O
RNA	O
replication	O
,	O
it	O
acts	O
at	O
a	O
later	O
step	O
in	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
life	O
cycle	O
.	O

Employing	O
a	O
retroviral	B-SPEC
vector	O
system	O
for	O
analysis	O
of	O
coronavirus	B-SPEC
entry	O
,	O
we	O
investigated	O
the	O
susceptibility	O
of	O
human	B-SPEC
-	O
adapted	O
and	O
emerging	O
coronaviruses	O
to	O
inhibition	O
by	O
IFITM	O
proteins	O
.	O

Genetic	O
testing	O
was	O
done	O
on	O
107	O
of	O
the	O
111	O
infected	O
cats	B-SPEC
.	O

RESULTS	O
:	O
Three	O
cases	O
of	O
human	B-SPEC
infection	O
with	O
a	O
new	O
reassortment	O
avian	B-SPEC
influenza	O
A	O
(	O
H10N8	O
)	O
virus	B-SPEC
were	O
described	O
,	O
of	O
which	O
two	O
were	O
fatal	O
cases	O
,	O
and	O
one	O
was	O
severe	O
case	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
the	O
importance	O
of	O
the	O
innate	O
immune	O
response	O
and	O
the	O
development	O
of	O
lung	O
pathology	O
following	O
human	B-SPEC
coronavirus	I-SPEC
infection	O
.	O

HEV	B-SPEC
was	O
detected	O
between	O
April	O
and	O
November	O
,	O
with	O
a	O
peak	O
of	O
prevalence	O
in	O
summer	O
and	O
autumn	O
.	O

The	O
leading	O
five	O
viruses	B-SPEC
that	O
resulted	O
in	O
ILI	O
Shijiazhuang	O
in	O
2011	O
were	O
HEV	B-SPEC
,	O
ADV	O
,	O
RSV	B-SPEC
-	O
A	O
,	O
HRV	O
,	O
and	O
FluA	O
,	O
and	O
these	O
viruses	B-SPEC
have	O
different	O
epidemiological	O
features	O
.	O

LPS	O
-	O
induced	O
acute	O
lung	O
inflammation	O
was	O
significantly	O
exacerbated	O
in	O
Spred	O
-	O
2	O
(-/-)	O
mice	B-SPEC
compared	O
with	O
WT	O
mice	B-SPEC
,	O
as	O
indicated	O
by	O
the	O
numbers	O
of	O
infiltrating	O
leukocytes	O
,	O
levels	O
of	O
alveolar	O
TNF	O
-	O
	O
,	O
CXCL2	O
and	O
CCL2	O
in	O
a	O
later	O
phase	O
,	O
and	O
lung	O
pathology	O
.	O

Nasopharyngeal	O
swabs	O
were	O
obtained	O
and	O
tested	O
for	O
viruses	B-SPEC
in	O
symptomatic	O
residents	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
harbor	O
many	O
viruses	B-SPEC
,	O
which	O
are	O
periodically	O
transmitted	O
to	O
humans	B-SPEC
resulting	O
in	O
outbreaks	O
of	O
disease	O
(	O
e	O
.	O
g	O
.,	O
Ebola	O
,	O
SARS	O
-	O
CoV	O
).	O

Recently	O
,	O
influenza	B-SPEC
virus	I-SPEC
-	O
like	O
sequences	O
were	O
identified	O
in	O
bats	B-SPEC
;	O
however	O
,	O
the	O
viruses	B-SPEC
could	O
not	O
be	O
cultured	O
.	O

This	O
discovery	O
aroused	O
great	O
interest	O
in	O
understanding	O
the	O
evolutionary	O
history	O
and	O
pandemic	O
potential	O
of	O
bat	B-SPEC
-	O
influenza	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
non	O
-	O
structural	O
protein	O
16	O
:	O
evasion	O
,	O
attenuation	O
,	O
and	O
possible	O
treatments	O
.	O

Sixty	O
-	O
three	O
,	O
3	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
were	O
randomly	O
allocated	O
into	O
control	O
(	O
n	O
=	O
27	O
)	O
and	O
challenged	O
(	O
n	O
=	O
36	O
)	O
groups	O
.	O

The	O
objective	O
of	O
this	O
cross	O
-	O
sectional	O
analysis	O
was	O
to	O
assess	O
the	O
association	O
between	O
alcohol	O
intake	O
and	O
prevalent	O
human	B-SPEC
papillomavirus	I-SPEC
(	O
HPV	B-SPEC
)	O
infection	O
among	O
US	O
men	O
enrolled	O
in	O
the	O
HPV	B-SPEC
in	O
Men	O
(	O
HIM	O
)	O
study	O
using	O
quantitative	O
alcohol	O
intake	O
measured	O
from	O
a	O
Food	O
Frequency	O
Questionnaire	O
.	O

TITLE	O
:	O
Distinct	O
characteristics	O
and	O
complex	O
evolution	O
of	O
PEDV	B-SPEC
strains	O
,	O
North	O
America	O
,	O
May	O
2013	O
-	O
February	O
2014	O
.	O

Limited	O
availability	O
of	O
PEDV	B-SPEC
complete	O
genomes	O
worldwide	O
has	O
impeded	O
our	O
understanding	O
of	O
PEDV	B-SPEC
introduction	O
into	O
the	O
United	O
States	O
.	O

Additionally	O
,	O
plasma	O
collected	O
from	O
PEDV	B-SPEC
infected	O
pigs	B-SPEC
at	O
peak	O
disease	O
did	O
not	O
contain	O
infectious	O
PEDV	B-SPEC
.	O

These	O
findings	O
suggest	O
that	O
the	O
risk	O
for	O
PEDV	B-SPEC
transmission	O
through	O
commercially	O
produced	O
SDPP	O
is	O
minimal	O
.	O

Nevertheless	O
,	O
for	O
almost	O
three	O
decades	O
now	O
,	O
data	O
reported	O
in	O
the	O
scientific	O
literature	O
has	O
also	O
demonstrated	O
that	O
,	O
like	O
it	O
was	O
described	O
for	O
other	O
human	B-SPEC
viruses	B-SPEC
,	O
coronaviruses	O
have	O
neuroinvasive	O
capacities	O
since	O
they	O
can	O
spread	O
from	O
the	O
respiratory	O
tract	O
to	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
).	O

Herein	O
,	O
we	O
present	O
host	O
and	O
viral	O
factors	O
that	O
participate	O
in	O
the	O
regulation	O
of	O
the	O
possible	O
pathogenic	O
processes	O
associated	O
with	O
CNS	O
infection	O
by	O
human	B-SPEC
coronaviruses	O
and	O
we	O
try	O
to	O
decipher	O
the	O
intricate	O
interplay	O
between	O
virus	B-SPEC
and	O
host	O
target	O
cells	O
in	O
order	B-SPEC
to	O
characterize	O
their	O
role	O
in	O
the	O
virus	B-SPEC
life	O
cycle	O
as	O
well	O
as	O
in	O
the	O
capacity	O
of	O
the	O
cell	O
to	O
respond	O
to	O
viral	O
invasion	O
.	O

Mycoplasma	B-SPEC
pneumoniae	I-SPEC
was	O
detected	O
by	O
PCR	O
in	O
only	O
3	O
.	O
2	O
%	O
of	O
these	O
patients	O
(	O
4	O
/	O
125	O
).	O

The	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
is	O
the	O
main	O
determinant	O
of	O
viral	O
entry	O
,	O
and	O
although	O
it	O
was	O
previously	O
shown	O
that	O
MERS	O
-	O
CoV	O
S	O
can	O
be	O
activated	O
by	O
various	O
proteases	O
,	O
the	O
details	O
of	O
the	O
mechanisms	O
of	O
proteolytic	O
activation	O
of	O
fusion	O
are	O
still	O
incompletely	O
characterized	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
pantropic	O
CCoV	O
-	O
II	O
in	O
puppies	O
from	O
Latin	O
America	O
and	O
our	O
findings	O
highlight	O
that	O
CCoV	O
should	O
be	O
included	O
as	O
a	O
differential	O
diagnosis	O
when	O
dogs	B-SPEC
present	O
with	O
clinical	O
signs	O
and	O
lesions	O
typically	O
seen	O
with	O
canine	O
parvovirus	B-SPEC
infection	O
.	O

Costs	O
were	O
taken	O
from	O
the	O
average	O
price	O
paid	O
by	O
the	O
Brazilian	O
Unified	O
Health	O
System	O
(	O
Sistema	O
nico	O
de	O
Sade	O
;	O
SUS	B-SPEC
)	O
over	O
three	O
months	O
in	O
2011	O
.	O

Until	O
now	O
there	O
is	O
no	O
recorded	O
clinically	O
effective	O
antiviral	O
chemotherapeutic	O
agent	O
for	O
treatment	O
of	O
diseases	O
caused	O
by	O
PEDV	B-SPEC
.	O

Among	O
independently	O
significant	O
variables	O
,	O
shock	O
,	O
severe	O
anaemia	O
,	O
bradycardia	O
,	O
Glasgow	O
coma	B-SPEC
scale	O
(	O
GCS	O
)	O
of	O
less	O
than	O
eight	O
and	O
refractory	O
seizures	O
were	O
found	O
to	O
be	O
significant	O
and	O
other	O
variables	O
like	O
respiratory	O
failure	O
,	O
multiorgan	O
dysfunction	O
syndrome	O
and	O
abnormal	O
coagulation	O
profile	O
were	O
found	O
insignificant	O
on	O
full	O
model	O
of	O
multivariate	O
regression	O
analysis	O
.	O

TITLE	O
:	O
Clinical	O
aspects	O
and	O
outcomes	O
of	O
70	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
:	O
a	O
single	O
-	O
center	O
experience	O
in	O
Saudi	O
Arabia	O
.	O

Inclusion	O
criteria	O
were	O
articles	O
published	O
from	O
1995	O
to	O
2007	O
;	O
in	O
English	O
,	O
Spanish	O
and	O
Portuguese	O
;	O
studies	O
in	O
the	O
human	B-SPEC
model	O
and	O
with	O
no	O
gender	O
restriction	O
.	O

In	O
conclusion	O
,	O
the	O
virulent	O
SHXB	O
could	O
severely	O
impair	O
immature	O
Mo	O
-	O
DCs	O
,	O
which	O
might	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
virulent	O
TGEV	B-SPEC
in	O
vivo	O
.	O

Interactions	O
of	O
the	O
viral	O
replicase	O
complex	O
with	O
cis	B-SPEC
-	O
acting	O
RNA	O
elements	O
located	O
in	O
the	O
5	O
'	O
and	O
3	O
'-	O
terminal	O
genome	O
regions	O
ensure	O
the	O
specific	O
replication	O
of	O
viral	O
RNA	O
.	O

We	O
report	O
two	O
cases	O
of	O
ARDS	O
and	O
multiple	O
organ	O
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
secondary	O
to	O
varicella	B-SPEC
-	I-SPEC
zoster	I-SPEC
virus	I-SPEC
pneumonia	O
.	O

The	O
severity	O
form	O
of	O
the	O
disease	O
is	O
caused	O
,	O
mainly	O
by	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
and	O
may	O
occur	O
together	O
with	O
cerebral	O
,	O
kidney	O
,	O
pulmonary	O
,	O
hematologic	O
,	O
circulatory	O
and	O
hepatic	O
complications	O
.	O

Finally	O
,	O
knockdown	O
of	O
Beclin1	O
partially	O
reverses	O
PLP2	O
-	O
TM	O
'	O
s	O
inhibitory	O
effect	O
on	O
innate	O
immunity	O
which	O
resulting	O
in	O
decreased	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
H9N2	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
(	O
AIVs	O
)	O
have	O
repeatedly	O
caused	O
infections	O
in	O
mammals	B-SPEC
even	O
humans	B-SPEC
in	O
many	O
countries	O
.	O

The	O
results	O
suggest	O
that	O
H9N2	O
viral	O
infection	O
induces	O
a	O
typical	O
ALI	O
in	O
mice	B-SPEC
that	O
resembles	O
the	O
common	O
features	O
of	O
ALI	O
.	O

RESULTS	O
:	O
H9N2	O
-	O
AIV	O
-	O
infected	O
mice	B-SPEC
exhibited	O
severe	O
respiratory	O
syndrome	O
,	O
with	O
a	O
mortality	O
rate	O
of	O
50	O
%.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
frequencies	O
for	O
a	O
large	O
range	O
of	O
respiratory	O
viruses	B-SPEC
using	O
a	O
sensitive	O
molecular	O
detection	O
technique	O
in	O
specimens	O
from	O
outpatients	O
of	O
all	O
ages	O
with	O
ARIs	O
.	O

Through	O
a	O
multiplex	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
,	O
88	O
(	O
54	O
.	O
3	O
%)	O
positive	O
samples	O
were	O
detected	O
;	O
the	O
most	O
prevalent	O
respiratory	O
viral	O
pathogens	O
were	O
influenza	O
,	O
human	B-SPEC
rhinovirus	I-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
).	O

TITLE	O
:	O
Disease	O
associated	O
with	O
equine	B-SPEC
coronavirus	B-SPEC
infection	O
and	O
high	O
case	O
fatality	O
rate	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
coronavirus	B-SPEC
(	O
ECoV	O
)	O
is	O
associated	O
with	O
clinical	O
disease	O
in	O
adult	O
horses	B-SPEC
.	O

Twelve	O
non	O
-	O
cases	O
drank	O
unpasteurized	O
camel	B-SPEC
milk	O
and	O
had	O
contact	O
with	O
camels	B-SPEC
.	O

Exposure	O
to	O
MERS	O
-	O
CoV	O
via	O
direct	O
contact	O
with	O
animals	B-SPEC
or	O
dairy	O
products	O
seems	O
unlikely	O
for	O
the	O
two	O
Dutch	O
cases	O
.	O

Likewise	O
,	O
the	O
presence	O
of	O
putative	O
G4	O
-	O
sequences	O
has	O
been	O
reported	O
in	O
various	O
viruses	B-SPEC
genomes	O
[	O
e	O
.	O
g	O
.,	O
Human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	O
),	O
papillomavirus	B-SPEC
(	O
HPV	O
)].	O

Advantages	O
and	O
disadvantages	O
of	O
the	O
available	O
techniques	O
for	O
measuring	O
protection	O
against	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
challenge	O
are	O
discussed	O
,	O
including	O
the	O
definition	O
of	O
protection	O
itself	O
.	O

One	O
third	O
(	O
29	O
.	O
8	O
%)	O
of	O
the	O
participants	O
acquired	O
	O
1	O
virus	B-SPEC
,	O
particularly	O
rhinovirus	B-SPEC
(	O
14	O
.	O
0	O
%),	O
coronavirus	B-SPEC
E229	O
(	O
12	O
.	O
4	O
%),	O
and	O
influenza	O
A	O
(	O
H3N2	O
)	O
virus	B-SPEC
(	O
6	O
.	O
2	O
%)	O
while	O
in	O
Saudi	O
Arabia	O
.	O

TITLE	O
:	O
Characterization	O
of	O
cellular	O
and	O
humoral	O
immune	O
responses	O
after	O
IBV	B-SPEC
infection	O
in	O
chicken	B-SPEC
lines	O
differing	O
in	O
MBL	O
serum	O
concentration	O
.	O

were	O
higher	O
for	O
noninfected	O
L10L	O
chickens	B-SPEC
than	O
for	O
the	O
other	O
chickens	B-SPEC
.	O

Furthermore	O
,	O
at	O
week	O
3	O
p	O
.	O
i	O
.,	O
the	O
number	O
of	O
monocytes	O
was	O
higher	O
in	O
infected	O
and	O
noninfected	O
L10H	O
chickens	B-SPEC
than	O
in	O
the	O
infected	O
and	O
noninfected	O
L10L	O
chickens	B-SPEC
.	O

However	O
,	O
MBL	O
did	O
not	O
appear	O
to	O
influence	O
the	O
humoral	O
immune	O
response	O
after	O
IBV	B-SPEC
infection	O
in	O
this	O
study	O
.	O

HIV	B-SPEC
-	I-SPEC
1	I-SPEC
induces	O
comorbidities	O
relationship	O
with	O
many	O
other	O
diseases	O
,	O
particularly	O
strong	O
correlation	O
with	O
the	O
neurological	O
,	O
cancer	B-SPEC
,	O
metabolic	O
and	O
immunological	O
diseases	O
.	O

In	O
our	O
study	O
,	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
stimulated	O
with	O
LPS	O
to	O
induce	O
ALI	O
.	O

TITLE	O
:	O
[	O
Conditions	O
for	O
the	O
transmission	O
of	O
Hantavirus	B-SPEC
in	O
Rio	O
Negro	O
,	O
Argentina	B-SPEC
].	O

TITLE	O
:	O
Inhibition	O
of	O
endoplasmic	O
reticulum	O
-	O
resident	O
glucosidases	O
impairs	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
spike	O
protein	O
-	O
mediated	O
entry	O
by	O
altering	O
the	O
glycan	O
processing	O
of	O
angiotensin	O
I	O
-	O
converting	O
enzyme	O
2	O
.	O

However	O
,	O
alteration	O
of	O
N	O
-	O
linked	O
glycans	O
of	O
ACE2	O
impaired	O
its	O
ability	O
to	O
support	O
the	O
transduction	O
of	O
SARS	O
-	O
CoV	O
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
spike	O
glycoprotein	O
-	O
pseudotyped	O
lentiviral	O
particles	O
by	O
disruption	O
of	O
the	O
viral	O
envelope	O
protein	O
-	O
triggered	O
membrane	O
fusion	O
.	O

TITLE	O
:	O
Lack	O
of	O
detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
mild	O
and	O
severe	O
respiratory	O
infections	O
in	O
Catalonia	O
,	O
northeastern	O
Spain	O
.	O

In	O
this	O
study	O
,	O
liquid	O
chromatography	O
-	O
tandem	O
mass	O
spectrometry	O
coupled	O
to	O
isobaric	O
tags	O
for	O
relative	O
and	O
absolute	O
quantification	O
labeling	O
was	O
used	O
to	O
quantitatively	O
identify	O
differentially	O
expressed	O
cellular	O
proteins	O
after	O
TGEV	B-SPEC
infection	O
in	O
PK	O
-	O
15	O
cells	O
.	O

This	O
study	O
for	O
the	O
first	O
time	O
reveals	O
that	O
TGEV	B-SPEC
induces	O
interferon	O
signaling	O
from	O
the	O
point	O
of	O
proteomic	O
analysis	O
.	O

The	O
lungs	O
of	O
the	O
3	O
dogs	B-SPEC
submitted	O
for	O
necropsy	O
were	O
diffusely	O
and	O
severely	O
reddened	O
due	O
to	O
hyperemia	O
and	O
hemorrhage	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
upregulates	O
genes	O
involved	O
in	O
innate	O
immune	O
responses	O
.	O

Protein	O
analysis	O
of	O
spinal	O
cord	O
extracts	O
taken	O
from	O
mice	B-SPEC
6	O
days	O
post	O
-	O
inoculation	O
,	O
the	O
time	O
of	O
peak	O
inflammation	O
,	O
reveals	O
robust	O
expression	O
of	O
IFN	O
-	O
	O
,	O
IL	O
-	O
12	O
and	O
mKC	O
.	O

ABSTRACT	O
:	O
Beneficial	O
effects	O
of	O
high	O
-	O
flow	O
nasal	O
cannula	B-SPEC
(	O
HFNC	O
)	O
oxygen	O
on	O
oxygenation	O
and	O
respiratory	O
parameters	O
have	O
been	O
reported	O
in	O
a	O
small	O
number	O
of	O
subjects	O
with	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
).	O

ABSTRACT	O
:	O
Enveloped	O
viruses	B-SPEC
need	O
to	O
fuse	O
with	O
a	O
host	O
cell	O
membrane	O
in	O
order	B-SPEC
to	O
deliver	O
their	O
genome	O
into	O
the	O
host	O
cell	O
.	O

Using	O
recombinant	O
MHVs	O
expressing	O
reporter	O
genes	O
as	O
well	O
as	O
a	O
novel	O
,	O
replication	O
-	O
independent	O
fusion	O
assay	O
we	O
confirmed	O
the	O
importance	O
of	O
clathrin	O
-	O
mediated	O
endocytosis	O
and	O
demonstrated	O
that	O
trafficking	O
of	O
MHV	B-SPEC
to	O
lysosomes	O
is	O
required	O
for	O
fusion	O
and	O
productive	O
entry	O
to	O
occur	O
.	O

Nevertheless	O
,	O
MHV	B-SPEC
was	O
shown	O
to	O
be	O
less	O
sensitive	O
to	O
perturbation	O
of	O
endosomal	O
pH	O
than	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
which	O
fuse	O
in	O
early	O
and	O
late	O
endosomes	O
,	O
respectively	O
.	O

Our	O
results	O
indicate	O
that	O
entry	O
of	O
MHV	B-SPEC
depends	O
on	O
proteolytic	O
processing	O
of	O
its	O
fusion	O
protein	O
S	O
by	O
lysosomal	O
proteases	O
.	O

Also	O
entry	O
of	O
feline	B-SPEC
CoV	O
was	O
shown	O
to	O
depend	O
on	O
trafficking	O
to	O
lysosomes	O
and	O
processing	O
by	O
lysosomal	O
proteases	O
.	O

TITLE	O
:	O
Activation	O
of	O
the	O
chicken	B-SPEC
type	O
I	O
interferon	O
response	O
by	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
.	O

Finally	O
,	O
we	O
show	O
that	O
,	O
despite	O
the	O
lack	O
of	O
activation	O
of	O
the	O
IFN	O
response	O
during	O
the	O
early	O
phase	O
of	O
IBV	B-SPEC
infection	O
,	O
the	O
signaling	O
of	O
nonself	O
dsRNA	O
through	O
both	O
MDA5	O
and	O
TLR3	O
remains	O
intact	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
.	O

Taken	O
together	O
,	O
this	O
study	O
provides	O
the	O
first	O
comprehensive	O
analysis	O
of	O
host	O
-	O
virus	B-SPEC
interactions	O
of	O
a	O
Gammacoronavirus	B-SPEC
with	O
avian	B-SPEC
innate	O
immune	O
responses	O
.	O

TITLE	O
:	O
Role	O
of	O
the	O
lipid	O
rafts	O
in	O
the	O
life	O
cycle	O
of	O
canine	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Based	O
on	O
a	O
bioinformatics	O
analysis	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavvirus	O
(	O
MERS	O
-	O
CoV	O
)	O
S	O
protein	O
,	O
we	O
synthesized	O
a	O
panel	O
of	O
peptides	O
coupled	O
to	O
keyhole	O
limpet	B-SPEC
haemocyanin	O
and	O
used	O
them	O
to	O
raise	O
antibodies	O
in	O
rabbits	B-SPEC
.	O

No	O
virus	B-SPEC
-	O
specific	O
bacterial	O
profile	O
was	O
discovered	O
,	O
but	O
comparative	O
analysis	O
of	O
healthy	O
adults	O
and	O
patients	O
identified	O
a	O
bacterium	B-SPEC
specific	O
to	O
young	O
patients	O
,	O
M	B-SPEC
.	I-SPEC
nonliquefaciens	I-SPEC
.	O

Two	O
hypotheses	O
may	O
explain	O
temporal	O
and	O
spatial	O
pulses	O
of	O
virus	B-SPEC
shedding	O
in	O
bat	B-SPEC
populations	O
:	O
episodic	O
shedding	O
from	O
persistently	O
infected	O
bats	B-SPEC
or	O
transient	O
epidemics	O
that	O
occur	O
as	O
virus	B-SPEC
is	O
transmitted	O
among	O
bat	B-SPEC
populations	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
2012	O
resulted	O
in	O
an	O
increased	O
concern	O
of	O
the	O
spread	O
of	O
the	O
infection	O
globally	O
.	O

Among	O
recombinant	O
spike	O
S1	O
,	O
S2	O
,	O
S3	O
,	O
and	O
nucleocapsid	O
N	O
protein	O
of	O
PEDV	B-SPEC
,	O
S3	O
protein	O
presented	O
the	O
highest	O
antibody	O
level	O
in	O
the	O
K	O
/	O
K	O
group	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
15	O
respiratory	O
viruses	B-SPEC
in	O
children	O
with	O
acute	O
respiratory	O
tract	O
infections	O
(	O
ARTIs	O
)	O
using	O
multiplex	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
and	O
to	O
analyze	O
the	O
clinical	O
and	O
epidemiological	O
features	O
of	O
these	O
viruses	B-SPEC
.	O

Current	O
data	O
on	O
approved	O
and	O
novel	O
treatments	O
for	O
non	O
-	O
influenza	O
respiratory	O
viruses	B-SPEC
such	O
as	O
MERS	O
-	O
CoV	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
rhinoviruses	B-SPEC
and	O
the	O
challenges	O
of	O
treating	O
immunocompromised	O
patients	O
with	O
respiratory	O
infections	O
was	O
highlighted	O
.	O

Multivariate	O
logistic	O
analysis	O
showed	O
that	O
aspiration	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
6	O
.	O
390	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
046	O
-	O
19	O
.	O
953	O
,	O
P	O
=	O
0	O
.	O
001	O
],	O
history	O
of	O
alcohol	O
(	O
OR	O
=	O
4	O
.	O
854	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
730	O
-	O
13	O
.	O
617	O
,	O
P	O
=	O
0	O
.	O
003	O
),	O
sepsis	B-SPEC
(	O
OR	O
=	O
2	O
.	O
859	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
507	O
-	O
5	O
.	O
425	O
,	O
P	O
=	O
0	O
.	O
001	O
),	O
pneumonia	O
(	O
OR	O
=	O
2	O
.	O
822	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
640	O
-	O
4	O
.	O
855	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHEII	O
)	O
score	O
(	O
OR	O
=	O
1	O
.	O
050	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
007	O
-	O
1	O
.	O
094	O
,	O
P	O
=	O
0	O
.	O
022	O
)	O
were	O
significantly	O
associated	O
with	O
increased	O
risk	O
of	O
ARDS	O
occurence	O
.	O

TITLE	O
:	O
Tailoring	O
subunit	O
vaccine	O
immunity	O
with	O
adjuvant	O
combinations	O
and	O
delivery	O
routes	O
using	O
the	O
Middle	O
East	O
respiratory	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
receptor	O
-	O
binding	O
domain	O
as	O
an	O
antigen	O
.	O

Different	O
vaccination	O
regimens	O
were	O
compared	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
immunized	O
3	O
times	O
intramuscularly	O
(	O
i	O
.	O
m	O
.)	O
with	O
a	O
vaccine	O
containing	O
10	O
g	O
of	O
recombinant	O
MERS	O
-	O
CoV	O
RBD	O
in	O
combination	O
with	O
either	O
aluminium	O
hydroxide	O
(	O
alum	O
)	O
alone	O
,	O
alum	O
and	O
polyriboinosinic	O
acid	O
(	O
poly	O
I	O
:	O
C	O
)	O
or	O
alum	O
and	O
cysteine	O
-	O
phosphate	O
-	O
guanine	O
(	O
CpG	O
)	O
oligodeoxynucleotides	O
(	O
ODN	O
).	O

We	O
aimed	O
to	O
study	O
the	O
occurrence	O
of	O
Bartonella	B-SPEC
bacteremia	O
among	O
dromedaries	B-SPEC
in	O
Israel	O
.	O

Sequence	O
analysis	O
of	O
the	O
gltA	O
and	O
rpoB	O
revealed	O
	O
96	O
%	O
identity	O
to	O
B	B-SPEC
.	I-SPEC
bovis	I-SPEC
,	O
a	O
previously	O
suggested	O
cutoff	O
value	O
for	O
sequence	O
-	O
based	O
differentiation	O
of	O
Bartonella	B-SPEC
spp	O
.,	O
suggesting	O
that	O
this	O
approach	O
does	O
not	O
have	O
sufficient	O
discriminatory	O
power	O
for	O
differentiating	O
ruminant	B-SPEC
-	O
related	O
Bartonella	B-SPEC
spp	O
.	O

Patients	O
with	O
virus	B-SPEC
-	O
confirmed	O
common	O
cold	O
(	O
n	O
=	O
254	O
,	O
verum	O
126	O
,	O
placebo	O
128	O
)	O
were	O
included	O
and	O
the	O
following	O
parameters	O
were	O
appraised	O
:	O
duration	O
of	O
disease	O
,	O
number	O
of	O
patients	O
with	O
relapses	O
,	O
number	O
of	O
respiratory	O
viruses	B-SPEC
and	O
viral	O
titers	O
at	O
inclusion	O
(	O
visit	O
1	O
)	O
compared	O
to	O
days	O
3	O
-	O
5	O
(	O
visit	O
2	O
).	O

In	O
both	O
studies	O
,	O
virus	B-SPEC
-	O
confirmed	O
common	O
cold	O
was	O
caused	O
by	O
three	O
main	O
virus	B-SPEC
subtypes	O
:	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
46	O
%),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
25	O
%)	O
and	O
influenza	O
A	O
(	O
14	O
%)	O
virus	B-SPEC
.	O

The	O
reduced	O
duration	O
of	O
disease	O
was	O
3	O
days	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
the	O
number	O
of	O
relapses	O
was	O
three	O
times	O
less	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
carrageenan	O
treated	O
corona	B-SPEC
-	O
virus	B-SPEC
-	O
infected	O
patients	O
compared	O
to	O
control	O
patients	O
.	O

Administration	O
of	O
carrageenan	O
nasal	O
spray	O
in	O
children	O
as	O
well	O
as	O
in	O
adults	O
suffering	O
from	O
virus	B-SPEC
-	O
confirmed	O
common	O
cold	O
reduced	O
duration	O
of	O
disease	O
,	O
increased	O
viral	O
clearance	O
and	O
reduced	O
relapses	O
of	O
symptoms	O
.	O

Furthermore	O
,	O
a	O
greater	O
proportion	O
of	O
patients	O
with	O
virus	B-SPEC
-	O
positive	O
exacerbations	O
received	O
IV	O
antibiotics	O
.	O

The	O
potential	O
mechanisms	O
of	O
virus	B-SPEC
-	O
induced	O
bronchiectasis	O
exacerbations	O
merit	O
further	O
investigations	O
.	O

Furthermore	O
,	O
a	O
greater	O
proportion	O
of	O
patients	O
with	O
virus	B-SPEC
-	O
positive	O
exacerbations	O
received	O
IV	O
antibiotics	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
are	O
the	O
most	O
frequent	O
cause	O
of	O
respiratory	O
disease	O
in	O
children	O
.	O

In	O
this	O
work	O
,	O
we	O
used	O
a	O
metagenomic	O
approach	O
and	O
deep	O
sequencing	O
to	O
examine	O
respiratory	O
samples	O
from	O
children	O
with	O
lower	O
and	O
upper	O
respiratory	O
tract	O
infections	O
that	O
had	O
been	O
previously	O
found	O
negative	O
for	O
6	O
bacteria	B-SPEC
and	O
15	O
respiratory	O
viruses	B-SPEC
by	O
PCR	O
.	O

In	O
this	O
case	O
,	O
in	O
22	O
of	O
the	O
25	O
sequenced	O
libraries	O
at	O
least	O
one	O
respiratory	O
virus	B-SPEC
was	O
identified	O
,	O
while	O
in	O
all	O
other	O
,	O
but	O
one	O
,	O
pathogenic	O
bacteria	B-SPEC
were	O
detected	O
.	O

In	O
addition	O
,	O
viruses	B-SPEC
less	O
frequently	O
associated	O
to	O
respiratory	O
infections	O
were	O
also	O
found	O
.	O

Serum	O
samples	O
from	O
400	O
pigs	B-SPEC
vaccinated	O
against	O
PEDV	B-SPEC
strain	O
SM98P	O
were	O
collected	O
from	O
78	O
farms	O
in	O
Korea	O
.	O

The	O
region	O
of	O
the	O
S	O
protein	O
may	O
have	O
a	O
stronger	O
neutralizing	O
KPEDV	O
-	O
9	O
epitope	O
and	O
could	O
be	O
useful	O
for	O
the	O
evaluation	O
of	O
future	O
PEDV	B-SPEC
vaccine	O
efficacy	O
.	O

Chest	O
x	O
-	O
rays	B-SPEC
showed	O
bilateral	O
lung	O
infiltrates	O
with	O
air	O
bronchograms	O
,	O
whereas	O
the	O
urine	O
antigen	O
test	O
resulted	O
positive	O
for	O
Legionella	B-SPEC
pneumophila	I-SPEC
.	O

Here	O
we	O
provide	O
experimental	O
support	O
for	O
camels	B-SPEC
as	O
a	O
reservoir	O
for	O
MERS	O
-	O
CoV	O
.	O
We	O
inoculated	O
3	O
adult	O
camels	B-SPEC
with	O
a	O
human	B-SPEC
isolate	O
of	O
MERS	O
-	O
CoV	O
and	O
a	O
transient	O
,	O
primarily	O
upper	O
respiratory	O
tract	O
infection	O
developed	O
in	O
each	O
of	O
the	O
3	O
animals	B-SPEC
.	O

Nipah	B-SPEC
virus	I-SPEC
emerged	O
a	O
few	O
years	O
later	O
,	O
causing	O
respiratory	O
infections	O
and	O
encephalitis	O
in	O
Southeast	O
Asia	O
,	O
with	O
case	O
fatality	O
rates	O
ranging	O
from	O
40	O
%	O
to	O
more	O
than	O
90	O
%.	O

Concordance	O
using	O
Bland	O
and	O
Altman	O
method	O
demonstrated	O
bias	B-SPEC
and	O
large	O
limits	O
of	O
agreement	O
during	O
the	O
increase	O
(-	O
0	O
.	O
5	O
cmH2O	O
/	O
L	O
;	O
-	O
25	O
to	O
24	O
cmH2O	O
/	O
L	O
)	O
and	O
during	O
the	O
decrease	O
in	O
PEEP	O
(-	O
0	O
.	O
3	O
cmH2O	O
/	O
L	O
;	O
-	O
21	O
to	O
20	O
cmH2O	O
/	O
L	O
).	O

TITLE	O
:	O
Novel	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
variant	O
with	O
large	O
genomic	O
deletion	O
,	O
South	O
Korea	O
.	O

We	O
conducted	O
a	O
large	O
-	O
scale	O
investigation	O
of	O
the	O
incidence	O
of	O
PEDV	B-SPEC
in	O
pigs	B-SPEC
with	O
diarrhea	O
in	O
South	O
Korea	O
and	O
consequently	O
identified	O
and	O
characterized	O
a	O
novel	O
PEDV	B-SPEC
variant	O
with	O
a	O
large	O
genomic	O
deletion	O
.	O

Detection	O
of	O
BoCV	O
clade	O
2	O
in	O
beef	O
cattle	B-SPEC
in	O
Oklahoma	O
is	O
consistent	O
with	O
recovery	O
of	O
BoCV	O
clade	O
2	O
from	O
the	O
respiratory	O
tract	O
of	O
postweaned	O
beef	O
calves	O
that	O
had	O
respiratory	O
disease	O
signs	O
or	O
were	O
healthy	O
.	O

Further	O
investigations	O
on	O
the	O
ecology	O
of	O
BoCV	O
in	O
cattle	B-SPEC
are	O
important	O
,	O
as	O
BoCV	O
may	O
be	O
an	O
emerging	O
disease	O
beyond	O
the	O
initial	O
descriptions	O
.	O

For	O
MHV	B-SPEC
,	O
this	O
domain	O
has	O
now	O
been	O
shown	O
to	O
promote	O
multiple	O
types	O
of	O
disease	O
,	O
including	O
hepatitis	O
and	O
encephalitis	O
.	O

It	O
is	O
an	O
important	O
determinant	O
of	O
viral	O
host	O
range	O
and	O
cross	O
-	O
species	B-SPEC
infection	O
and	O
a	O
primary	O
target	O
for	O
antiviral	O
intervention	O
.	O

Coronaviruses	O
recognize	O
a	O
variety	O
of	O
host	O
receptors	O
,	O
infect	O
many	O
hosts	O
,	O
and	O
are	O
health	O
threats	O
to	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

The	O
highest	O
case	O
fatality	O
was	O
due	O
to	O
pneumocystis	B-SPEC
jirovecii	I-SPEC
pneumonia	O
(	O
2	O
/	O
4	O
)	O
and	O
pulmonary	O
tuberculosis	O
(	O
2	O
/	O
7	O
).	O

In	O
this	O
study	O
,	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
)	O
was	O
combined	O
with	O
a	O
vertical	O
flow	O
(	O
VF	O
)	O
nucleic	O
acid	O
detection	O
strip	O
to	O
detect	O
PEDV	B-SPEC
.	O

The	O
emergence	O
of	O
deadly	O
human	B-SPEC
coronaviruses	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
bolstered	O
research	O
in	O
these	O
viral	O
and	O
often	O
zoonotic	O
pathogens	O
.	O

While	O
coronavirus	B-SPEC
cell	O
and	O
tissue	O
tropism	O
,	O
host	O
range	O
,	O
and	O
pathogenesis	O
are	O
initially	O
controlled	O
by	O
interactions	O
between	O
the	O
spike	O
envelope	O
glycoprotein	O
and	O
host	O
cell	O
receptor	O
,	O
it	O
is	O
becoming	O
increasingly	O
apparent	O
that	O
proteolytic	O
activation	O
of	O
spike	O
by	O
host	O
cell	O
proteases	O
also	O
plays	O
a	O
critical	O
role	O
.	O

Sequences	O
of	O
793B	O
viruses	B-SPEC
detected	O
in	O
chickens	B-SPEC
,	O
vaccinated	O
with	O
either	O
of	O
the	O
two	O
commonly	O
used	O
793B	O
type	O
vaccines	O
were	O
almost	O
identical	O
to	O
sequences	O
of	O
one	O
or	O
other	O
of	O
these	O
vaccines	O
.	O

ABSTRACT	O
:	O
Several	O
countries	O
in	O
the	O
Middle	O
East	O
and	O
around	O
22	O
countries	O
worldwide	O
have	O
reported	O
cases	O
of	O
human	B-SPEC
infection	O
with	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Data	O
from	O
repeated	O
laboratory	O
testing	O
of	O
respiratory	O
samples	O
received	O
at	O
the	O
Saudi	O
Arabian	O
virology	O
reference	O
laboratory	O
in	O
Jeddah	O
,	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
from	O
September	O
1	O
,	O
2012	O
to	O
September	O
31	O
,	O
2013	O
were	O
recorded	O
.	O

TITLE	O
:	O
The	O
avian	B-SPEC
coronavirus	I-SPEC
spike	O
protein	O
.	O

IBV	B-SPEC
causes	O
a	O
highly	O
contagious	O
disease	O
affecting	O
the	O
respiratory	O
tract	O
and	O
,	O
depending	O
on	O
the	O
strain	O
,	O
other	O
tissues	O
including	O
the	O
reproductive	O
and	O
urogenital	O
tract	O
.	O

The	O
control	O
of	O
IBV	B-SPEC
in	O
the	O
field	O
is	O
hampered	O
by	O
the	O
many	O
different	O
strains	O
circulating	O
worldwide	O
and	O
the	O
limited	O
protection	O
across	O
strains	O
due	O
to	O
serotype	O
diversity	O
.	O

Structural	O
studies	O
have	O
established	O
the	O
basis	O
for	O
understanding	O
receptor	O
recognition	O
diversity	O
in	O
CoV	O
,	O
its	O
evolution	O
and	O
the	O
adaptation	O
of	O
this	O
virus	B-SPEC
family	B-SPEC
to	O
different	O
hosts	O
.	O

CoV	O
responsible	O
for	O
recent	O
outbreaks	O
have	O
extraordinary	O
potential	O
for	O
cross	O
-	O
species	B-SPEC
transmission	O
;	O
their	O
RBD	O
bear	B-SPEC
large	O
platforms	O
specialized	O
in	O
recognition	O
of	O
receptors	O
from	O
different	O
species	B-SPEC
,	O
which	O
facilitates	O
host	O
-	O
to	O
-	O
host	O
circulation	O
and	O
adaptation	O
to	O
man	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
entry	O
inhibitors	O
targeting	O
spike	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
replication	O
of	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
was	O
studied	O
in	O
a	O
line	O
of	O
pigs	B-SPEC
possessing	O
a	O
severe	O
combined	O
immunodeficiency	O
(	O
SCID	O
).	O

The	O
most	O
significant	O
change	O
was	O
a	O
W99R	O
substitution	O
in	O
GP2	O
,	O
which	O
was	O
present	O
in	O
the	O
inoculum	O
at	O
a	O
frequency	O
of	O
35	O
%,	O
but	O
eventually	O
disappeared	O
from	O
all	O
pigs	B-SPEC
regardless	O
of	O
immune	O
status	O
.	O

However	O
,	O
anti	O
-	O
coronavirus	B-SPEC
drugs	O
currently	O
are	O
not	O
available	O
.	O

Since	O
the	O
NIH	O
Clinical	O
Collection	O
consists	O
of	O
compounds	O
that	O
have	O
already	O
been	O
through	O
clinical	O
trials	O
,	O
these	O
small	O
molecule	O
inhibitors	O
have	O
a	O
great	O
potential	O
for	O
rapid	O
development	O
as	O
anti	O
-	O
coronavirus	B-SPEC
drugs	O
.	O

Virus	B-SPEC
yields	O
were	O
higher	O
from	O
macaque	B-SPEC
cells	O
than	O
from	O
baboon	B-SPEC
cells	O
.	O

Here	O
,	O
we	O
report	O
identification	O
of	O
critical	O
residues	O
on	O
hDPP4	O
for	O
RBD	O
binding	O
and	O
virus	B-SPEC
entry	O
through	O
analysis	O
of	O
a	O
panel	O
of	O
hDPP4	O
mutants	O
.	O

The	O
largest	O
groups	O
of	O
these	O
contigs	O
matched	O
to	O
Picobirnaviridae	B-SPEC
,	O
Circoviridae	B-SPEC
,	O
Picornaviridae	B-SPEC
,	O
Parvoviridae	B-SPEC
,	O
Astroviridae	B-SPEC
and	O
Hepeviridae	B-SPEC
.	O

In	O
this	O
study	O
we	O
followed	O
144	O
wild	O
Mallards	B-SPEC
across	O
an	O
autumn	O
season	O
in	O
a	O
natural	O
stopover	O
site	O
and	O
constructed	O
infection	O
histories	O
of	O
IAV	O
,	O
APMV	B-SPEC
-	O
1	O
and	O
CoV	O
.	O
There	O
was	O
a	O
high	O
prevalence	O
of	O
IAV	O
,	O
comprising	O
of	O
27	O
subtype	O
combinations	O
,	O
while	O
APMV	B-SPEC
-	O
1	O
had	O
a	O
comparatively	O
low	O
prevalence	O
(	O
with	O
a	O
peak	O
of	O
2	O
%)	O
and	O
limited	O
strain	O
variation	O
,	O
similar	O
to	O
previous	O
findings	O
.	O

Avian	B-SPEC
CoVs	O
were	O
common	O
,	O
with	O
prevalence	O
up	O
to	O
12	O
%,	O
and	O
sequence	O
analysis	O
identified	O
different	O
putative	O
genetic	O
lineages	O
.	O

Additional	O
new	O
respiratory	O
viruses	B-SPEC
detected	O
during	O
follow	O
-	O
up	O
of	O
these	O
15	O
patients	O
included	O
rhinovirus	B-SPEC
(	O
3	O
),	O
metapneumovirus	B-SPEC
(	O
2	O
),	O
coronavirus	B-SPEC
(	O
1	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
1	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
1	O
),	O
and	O
adenovirus	B-SPEC
(	O
1	O
).	O

RESULTS	O
:	O
The	O
initial	O
study	O
sample	O
was	O
positive	O
in	O
15	O
patients	O
with	O
the	O
following	O
respiratory	O
viruses	B-SPEC
:	O
rhinovirus	B-SPEC
(	O
6	O
),	O
metapneumovirus	B-SPEC
(	O
1	O
),	O
coronavirus	B-SPEC
(	O
2	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
2	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
2	O
),	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
2	O
).	O

TITLE	O
:	O
Survivability	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
bovine	B-SPEC
plasma	O
submitted	O
to	O
spray	O
drying	O
processing	O
and	O
held	O
at	O
different	O
time	O
by	O
temperature	O
storage	O
conditions	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
plasma	O
was	O
inoculated	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
at	O
an	O
average	O
final	O
titer	O
of	O
4	O
.	O
2	O
log10	O
TCID50	O
/	O
mL	O
to	O
determine	O
the	O
effect	O
of	O
spray	O
drying	O
on	O
viral	O
inactivation	O
.	O

In	O
summary	O
,	O
PEDV	B-SPEC
was	O
not	O
infectious	O
on	O
cell	O
culture	O
within	O
7	O
days	O
when	O
stored	O
at	O
room	O
temperature	O
and	O
within	O
21	O
days	O
when	O
stored	O
at	O
refrigerated	O
temperature	O
.	O

ABSTRACT	O
:	O
Newly	O
emerging	O
human	B-SPEC
viruses	B-SPEC
such	O
as	O
Ebola	B-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
,	O
and	O
HIV	B-SPEC
likely	O
originate	O
within	O
an	O
extant	O
population	O
of	O
viruses	B-SPEC
in	O
nonhuman	O
hosts	O
and	O
acquire	O
the	O
ability	O
to	O
infect	O
and	O
cause	O
disease	O
in	O
humans	B-SPEC
.	O

We	O
propose	O
that	O
Patience	O
evolved	O
primarily	O
among	O
lower	O
-	O
GC	O
hosts	O
and	O
that	O
the	O
disparities	O
between	O
its	O
genomic	O
profile	O
and	O
that	O
of	O
M	B-SPEC
.	I-SPEC
smegmatis	I-SPEC
presented	O
only	O
a	O
minimal	O
barrier	O
to	O
host	O
expansion	O
.	O

The	O
different	O
steps	O
are	O
:	O
incubation	O
with	O
the	O
serum	O
sample	O
,	O
secondary	O
antibodies	O
and	O
fluorescent	O
reporters	O
and	O
finally	O
washing	O
to	O
remove	O
any	O
non	O
-	O
specifically	O
bound	O
species	B-SPEC
.	O

These	O
data	O
suggest	O
that	O
serological	O
evidence	O
of	O
zoonotic	O
transmission	O
of	O
MERS	O
-	O
CoV	O
was	O
not	O
common	O
among	O
animal	B-SPEC
workers	O
in	O
Southern	O
Saudi	O
Arabia	O
during	O
July	O
2012	O
.	O

While	O
significant	O
beneficial	O
effects	O
on	O
infection	O
rates	O
and	O
the	O
lengths	O
of	O
ICU	O
and	O
hospital	O
stays	O
have	O
concordantly	O
been	O
identified	O
in	O
three	O
recent	O
meta	B-SPEC
-	O
analyses	O
on	O
non	O
-	O
ICU	O
surgical	O
patients	O
,	O
the	O
level	O
of	O
evidence	O
is	O
not	O
so	O
clear	O
for	O
critically	O
ill	O
patients	O
.	O

Three	O
meta	B-SPEC
-	O
analyses	O
published	O
in	O
2012	O
or	O
2013	O
explored	O
data	O
on	O
the	O
ICU	O
population	O
.	O

TITLE	O
:	O
Mutations	O
across	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
nsp4	O
alter	O
virus	B-SPEC
fitness	O
and	O
membrane	O
modifications	O
.	O

Coronaviruses	O
induce	O
double	O
-	O
membrane	O
vesicles	O
(	O
DMVs	O
),	O
but	O
the	O
role	O
of	O
DMVs	O
in	O
replication	O
and	O
virus	B-SPEC
fitness	O
remains	O
unclear	O
.	O

The	O
results	O
support	O
the	O
hypothesis	O
that	O
DMV	O
morphology	O
and	O
numbers	O
are	O
not	O
key	O
determinants	O
of	O
virus	B-SPEC
fitness	O
.	O

A	O
series	O
of	O
217	O
samples	O
from	O
patients	O
aged	O
37	O
.	O
7	O
(	O
SD	O
	O
30	O
.	O
4	O
)]	O
with	O
seasonal	O
influenza	O
A	O
viruses	B-SPEC
(	O
SeasFluA	O
)	O
identified	O
between	O
06	O
/	O
2011	O
and	O
06	O
/	O
2012	O
in	O
NW	O
England	O
were	O
tested	O
for	O
hCoV	O
and	O
hBoV	O
using	O
RT	O
-	O
PCR	O
.	O

A	O
higher	O
proportion	O
(	O
61	O
.	O
5	O
%;	O
8	O
/	O
13	O
)	O
of	O
SeasFluA	O
/	O
hBoV	O
co	O
-	O
infections	O
were	O
identified	O
in	O
patients	O
that	O
were	O
admitted	O
either	O
to	O
a	O
general	O
ward	O
or	O
the	O
intensive	O
care	O
unit	O
compared	O
to	O
44	O
.	O
3	O
%	O
(	O
66	O
/	O
149	O
)	O
of	O
single	O
SeasFlu	O
A	O
virus	B-SPEC
infections	O
(	O
OR	O
2	O
.	O
5	O
95	O
%	O
CI	O
0	O
.	O
67	O
-	O
9	O
.	O
34	O
,	O
p	O
=	O
0	O
.	O
17	O
).	O

Exposure	O
to	O
poultry	O
and	O
fomites	O
are	O
considered	O
the	O
likely	O
sources	O
of	O
infection	O
for	O
H7N9	O
,	O
H5N1	O
,	O
and	O
H10N8	O
,	O
with	O
limited	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
in	O
close	O
contacts	O
.	O

The	O
S2	O
subunit	O
of	O
the	O
S	O
glycoprotein	O
of	O
SARS	O
-	O
CoV	O
carries	O
out	O
fusion	O
between	O
the	O
virus	B-SPEC
and	O
the	O
host	O
cells	O
.	O

To	O
decrease	O
diarrhoea	O
problems	O
among	O
neonatal	O
calves	O
,	O
a	O
standard	O
protocol	O
was	O
tested	O
on	O
13	O
herds	O
(	O
treatment	O
group	O
)	O
where	O
both	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
and	O
either	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
or	O
rota	O
-	O
or	O
coronavirus	B-SPEC
were	O
identified	O
as	O
being	O
involved	O
,	O
the	O
other	O
11	O
herds	O
served	O
as	O
control	O
group	O
.	O

No	O
significant	O
differences	O
between	O
control	O
and	O
treatment	O
group	O
were	O
observed	O
in	O
the	O
percentage	O
of	O
calves	O
excreting	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
,	O
both	O
before	O
and	O
at	O
the	O
end	O
of	O
the	O
trial	O
.	O

TITLE	O
:	O
[	O
Pulse	O
indicator	B-SPEC
continuous	O
cardiac	O
output	O
measurement	O
-	O
guided	O
treatment	O
aids	O
two	O
pediatric	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
complicated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

According	O
to	O
the	O
initial	O
data	O
of	O
PiCCO	O
,	O
EVLWI	O
was	O
9	O
ml	O
/	O
kg	O
,	O
GEDVI	O
was	O
519	O
ml	O
/	O
m	O
,	O
the	O
oxygenation	O
index	O
was	O
298	O
mmHg	O
,	O
the	O
bedside	O
chest	O
X	O
-	O
ray	B-SPEC
showed	O
decreased	O
permeability	O
and	O
PEEP	O
was	O
adjusted	O
to	O
5	O
cmHO	O
,	O
suggesting	O
the	O
existence	O
of	O
ARDS	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
evaluate	O
the	O
peptide	O
P34	O
for	O
its	O
in	O
vitro	O
antiviral	O
properties	O
against	O
canine	B-SPEC
adenovirus	I-SPEC
type	O
2	O
(	O
CAV	B-SPEC
-	O
2	O
),	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
canine	O
parvovirus	B-SPEC
type	O
2	O
(	O
CPV	B-SPEC
-	O
2	O
),	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
(	O
EAV	B-SPEC
),	O
equine	B-SPEC
influenza	B-SPEC
virus	I-SPEC
(	O
EIV	O
),	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
)	O
and	O
feline	B-SPEC
herpesvirus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
FHV	O
-	O
1	O
).	O

When	O
observation	O
bias	B-SPEC
is	O
assumed	O
to	O
account	O
for	O
the	O
fact	O
that	O
all	O
reported	O
zoonotic	O
cases	O
are	O
severe	O
,	O
but	O
only	O
	O
57	O
%	O
of	O
secondary	O
cases	O
are	O
symptomatic	O
,	O
the	O
average	O
reproduction	O
number	O
of	O
MERS	O
-	O
CoV	O
is	O
estimated	O
to	O
be	O
0	O
.	O
45	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
29	O
-	O
0	O
.	O
61	O
).	O

Adjusting	O
previously	O
published	O
estimates	O
for	O
observation	O
bias	B-SPEC
confirms	O
a	O
strong	O
support	O
for	O
the	O
average	O
R	O
<	O
1	O
in	O
the	O
first	O
stage	O
of	O
the	O
outbreak	O
in	O
2013	O
and	O
thus	O
,	O
transmissibility	O
of	O
secondary	O
cases	O
of	O
MERS	O
-	O
CoV	O
remained	O
well	O
below	O
the	O
epidemic	O
threshold	O
.	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
papain	O
like	O
protease	O
can	O
inhibit	O
IRF3	O
at	O
a	O
post	O
activation	O
step	O
that	O
requires	O
deubiquitination	O
activity	O
.	O

Different	O
approaches	O
of	O
several	O
researchers	O
for	O
the	O
identification	O
of	O
cellular	O
interaction	O
candidates	O
relevant	O
for	O
coronavirus	B-SPEC
replication	O
are	O
summarized	O
.	O

These	O
results	O
may	O
help	O
in	O
the	O
future	O
to	O
identify	O
the	O
role	O
of	O
cellular	O
proteins	O
during	O
coronavirus	B-SPEC
assembly	O
at	O
the	O
ER	O
-	O
Golgi	O
intermediate	O
compartment	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
four	O
major	O
diarrhea	O
-	O
causing	O
pathogens	O
in	O
calves	O
:	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
,	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
).	O

Hence	O
,	O
control	O
of	O
cryptosporidiosis	O
is	O
important	O
not	O
only	O
for	O
pre	O
-	O
weaned	O
calves	O
,	O
but	O
also	O
for	O
human	B-SPEC
health	O
.	O

TITLE	O
:	O
Spherules	O
and	O
IBV	B-SPEC
.	O

We	O
have	O
begun	O
to	O
extend	O
this	O
work	O
using	O
recombinant	O
IBVs	O
,	O
which	O
are	O
chimera	O
of	O
different	O
virus	B-SPEC
strains	O
to	O
study	O
the	O
role	O
of	O
viral	O
proteins	O
in	O
the	O
induction	O
of	O
membrane	O
rearrangements	O
.	O

Cellular	O
and	O
local	O
immunity	O
induced	O
by	O
administration	O
of	O
NDV	B-SPEC
,	O
aMPV	O
or	O
IBV	B-SPEC
vaccines	O
(	O
individually	O
or	O
together	O
)	O
showed	O
significant	O
increase	O
in	O
CD4	O
+,	O
CD8	O
+	O
and	O
IgA	O
bearing	O
B	O
-	O
cells	O
in	O
the	O
trachea	B-SPEC
compared	O
to	O
the	O
unvaccinated	O
group	O
.	O

TITLE	O
:	O
Culturing	O
of	O
respiratory	O
viruses	B-SPEC
in	O
well	O
-	O
differentiated	O
pseudostratified	O
human	B-SPEC
airway	O
epithelium	O
as	O
a	O
tool	O
to	O
detect	O
unknown	O
viruses	B-SPEC
.	O

Here	O
,	O
we	O
propose	O
a	O
method	O
that	O
relies	O
on	O
virus	B-SPEC
culturing	O
combined	O
with	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
sequencing	O
techniques	O
.	O

The	O
virus	B-SPEC
in	O
the	O
harvest	O
can	O
be	O
used	O
to	O
characterize	O
the	O
viral	O
genome	O
sequence	O
and	O
cell	O
tropism	O
,	O
but	O
also	O
provides	O
progeny	O
virus	B-SPEC
to	O
initiate	O
experiments	O
to	O
fulfill	O
the	O
Koch	O
'	O
s	O
postulates	O
.	O

bioinformatics	O
analysis	O
of	O
our	O
kinome	O
data	O
,	O
including	O
pathway	O
overrepresentation	O
analysis	O
(	O
ORA	O
)	O
and	O
functional	O
network	O
analysis	O
,	O
suggested	O
that	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
)/	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
phosphoinositol	O
3	O
-	O
kinase	O
(	O
PI3K	O
)/	O
serine	O
-	O
threonine	O
kinase	O
(	O
AKT	O
)/	O
mammalian	B-SPEC
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
signaling	O
responses	O
were	O
specifically	O
modulated	O
in	O
response	O
to	O
MERS	O
-	O
CoV	O
infection	O
in	O
vitro	O
throughout	O
the	O
course	O
of	O
infection	O
.	O

TITLE	O
:	O
Immunology	O
of	O
bats	B-SPEC
and	O
their	O
viruses	B-SPEC
:	O
challenges	O
and	O
opportunities	O
.	O

The	O
SF1	O
helicase	O
protein	O
of	O
viruses	B-SPEC
classified	O
in	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
is	O
encoded	O
in	O
replicase	O
open	O
reading	O
frame	O
1b	O
(	O
ORF1b	O
),	O
which	O
is	O
translated	O
to	O
give	O
rise	O
to	O
a	O
large	O
polyprotein	O
following	O
a	O
ribosomal	O
frameshift	O
from	O
the	O
upstream	O
ORF1a	O
.	O

In	O
contrast	O
,	O
among	O
the	O
five	O
Birman	O
FIP	O
cat	B-SPEC
-	O
associated	O
SNPs	O
,	O
no	O
genotype	O
or	O
allele	O
showed	O
significant	O
differences	O
between	O
our	O
FIP	O
and	O
non	O
-	O
FIP	O
groups	O
.	O

ABSTRACT	O
:	O
Background	O
:	O
Bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
pose	O
a	O
potential	O
risk	O
to	O
human	B-SPEC
health	O
and	O
are	O
the	O
focus	O
of	O
increasing	O
scientific	O
interest	O
.	O

Fecal	O
samples	O
were	O
collected	O
from	O
bats	B-SPEC
across	O
Hungary	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
qRT	O
-	O
PCR	O
data	O
with	O
the	O
use	O
of	O
universal	O
and	O
type	O
-	O
specific	O
primers	O
and	O
probe	O
sets	O
for	O
IBV	B-SPEC
detection	O
and	O
compared	O
those	O
data	O
with	O
challenge	O
-	O
virus	B-SPEC
detection	O
in	O
embryonated	O
eggs	O
to	O
determine	O
if	O
the	O
two	O
methods	O
of	O
evaluating	O
vaccine	O
efficacy	O
are	O
comparable	O
.	O

Only	O
the	O
Ark	O
-	O
DPI	O
-	O
spedcific	O
assay	O
on	O
the	O
SmartCycler	O
II	O
and	O
the	O
Ark	O
-	O
DPI	O
-,	O
Mass41	O
-,	O
and	O
DE072	O
/	O
GA98	O
-	O
(	O
for	O
detection	O
of	O
GA98	O
virus	B-SPEC
only	O
)	O
specific	O
assays	O
on	O
the	O
ABI	O
7500	O
were	O
comparable	O
in	O
sensitivity	O
to	O
virus	B-SPEC
detection	O
in	O
eggs	O
.	O

We	O
found	O
that	O
a	O
number	O
of	O
variables	O
,	O
including	O
the	O
virus	B-SPEC
type	O
examined	O
,	O
primers	O
and	O
probe	O
efficiency	O
and	O
stability	O
,	O
and	O
assay	O
conditions	O
,	O
including	O
thermocycler	O
platform	O
,	O
can	O
affect	O
the	O
data	O
obtained	O
from	O
qRT	O
-	O
PCR	O
assays	O
.	O

ABSTRACT	O
:	O
Although	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
epidemic	O
was	O
controlled	O
by	O
nonvaccine	O
measures	O
,	O
coronaviruses	O
remain	O
a	O
major	O
threat	O
to	O
human	B-SPEC
health	O
.	O

The	O
design	O
of	O
optimal	O
coronavirus	B-SPEC
vaccines	O
therefore	O
remains	O
a	O
priority	O
.	O

Such	O
vaccines	O
present	O
major	O
challenges	O
:	O
coronavirus	B-SPEC
immunity	O
often	O
wanes	O
rapidly	O
,	O
individuals	O
needing	O
to	O
be	O
protected	O
include	O
the	O
elderly	O
,	O
and	O
vaccines	O
may	O
exacerbate	O
rather	O
than	O
prevent	O
coronavirus	B-SPEC
lung	O
immunopathology	O
.	O

While	O
all	O
vaccines	O
protected	O
against	O
lethal	O
infection	O
,	O
addition	O
of	O
adjuvant	O
significantly	O
increased	O
serum	O
neutralizing	O
-	O
antibody	O
titers	O
and	O
reduced	O
lung	O
virus	B-SPEC
titers	O
on	O
day	O
3	O
postchallenge	O
.	O

TITLE	O
:	O
Successful	O
use	O
of	O
daily	O
intravenous	O
infusion	O
of	O
C1	O
esterase	O
inhibitor	O
concentrate	O
in	O
the	O
treatment	O
of	O
a	O
hereditary	O
angioedema	O
patient	O
with	O
ascites	O
,	O
hypovolemic	O
shock	O
,	O
sepsis	B-SPEC
,	O
renal	O
and	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Estimation	O
of	O
nasal	O
shedding	O
and	O
seroprevalence	O
of	O
organisms	O
known	O
to	O
be	O
associated	O
with	O
bovine	B-SPEC
respiratory	O
disease	O
in	O
Australian	O
live	O
export	O
cattle	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	B-SPEC
)	O
OC43	O
is	O
the	O
most	O
prevalent	O
HCoV	B-SPEC
in	O
respiratory	O
tract	O
infections	O
.	O

A	O
profound	O
drop	O
in	O
the	O
absolute	O
count	O
of	O
blood	O
lymphocytes	O
occurred	O
around	O
2	O
weeks	O
post	O
-	O
infection	O
(	O
p	O
.	O
i	O
.)	O
in	O
cats	B-SPEC
with	O
rapid	O
disease	O
,	O
while	O
the	O
decrease	O
was	O
delayed	O
in	O
the	O
one	O
cat	B-SPEC
that	O
survived	O
for	O
6	O
weeks	O
.	O

The	O
absolute	O
lymphocyte	O
count	O
of	O
the	O
surviving	O
cat	B-SPEC
remained	O
within	O
normal	O
range	O
.	O

Furthermore	O
,	O
the	O
function	O
of	O
vimentin	O
cytoskeleton	O
in	O
ST	O
cells	O
during	O
TGEV	B-SPEC
infection	O
was	O
examined	O
.	O

A	O
serious	O
complication	O
consisted	O
of	O
one	O
or	O
more	O
of	O
the	O
following	O
occurrences	O
:	O
acute	O
lung	O
injury	O
/	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
kidney	O
injury	O
,	O
cardiac	O
arrest	O
with	O
cardiopulmonary	O
resuscitation	O
,	O
decubitus	O
ulcer	O
,	O
deep	O
vein	O
thrombosis	O
,	O
enterocutaneous	O
fistula	O
,	O
extremity	O
compartment	O
syndrome	O
,	O
mortality	O
,	O
myocardial	O
infarction	O
,	O
pneumonia	O
,	O
pulmonary	O
embolism	O
,	O
severe	O
sepsis	B-SPEC
,	O
stroke	O
/	O
cerebral	O
vascular	O
accident	O
,	O
unplanned	O
intubation	O
,	O
or	O
unplanned	O
return	O
to	O
operating	O
room	O
.	O

TITLE	O
:	O
Seasonal	O
variation	O
in	O
Guillain	O
-	O
Barr	O
syndrome	O
:	O
a	O
systematic	O
review	O
,	O
meta	B-SPEC
-	O
analysis	O
and	O
Oxfordshire	O
cohort	O
study	O
.	O

Asymptomatic	O
virus	B-SPEC
-	O
negative	O
children	O
vaccinated	O
with	O
a	O
live	O
virus	B-SPEC
vaccine	O
had	O
elevated	O
MxA	O
protein	O
levels	O
(	O
240	O
[	O
120	O
-	O
540	O
]	O
g	O
/	O
L	O
),	O
but	O
significantly	O
lower	O
than	O
children	O
with	O
an	O
acute	O
respiratory	O
infection	O
,	O
who	O
had	O
not	O
received	O
vaccinations	O
(	O
740	O
[	O
350	O
-	O
1425	O
]	O
g	O
/	O
L	O
;	O
p	O
<	O
0	O
.	O
001	O
).	O

Herein	O
,	O
we	O
report	O
a	O
case	O
of	O
MERS	O
CoV	O
pneumonia	O
with	O
a	O
successful	O
outcome	O
in	O
a	O
patient	O
recently	O
diagnosed	O
with	O
HIV	B-SPEC
.	O

TITLE	O
:	O
Thiopurine	O
analogs	O
and	O
mycophenolic	O
acid	O
synergistically	O
inhibit	O
the	O
papain	O
-	O
like	O
protease	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
cases	O
without	O
documented	O
contact	O
with	O
another	O
human	B-SPEC
MERS	O
-	O
CoV	O
case	O
make	O
up	O
61	O
%	O
(	O
517	O
/	O
853	O
)	O
of	O
all	O
reported	O
cases	O
.	O

However	O
,	O
only	O
a	O
small	O
proportion	O
of	O
the	O
primary	O
cases	O
have	O
reported	O
contact	O
with	O
camels	B-SPEC
.	O

Inflammatory	O
leukocyte	O
infiltrations	O
,	O
hemorrhages	O
and	O
fibrosis	O
of	O
alveolar	O
walls	O
can	O
be	O
observed	O
2	O
-	O
11	O
days	O
after	O
MHV	B-SPEC
-	O
A59	O
infection	O
.	O

In	O
Brazil	O
,	O
patients	O
with	O
severe	O
scorpion	B-SPEC
envenoming	O
have	O
mainly	O
cardiovascular	O
events	O
,	O
including	O
acute	O
heart	O
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
shock	O
,	O
death	O
is	O
rare	O
.	O

Here	O
,	O
we	O
report	O
that	O
development	O
of	O
a	O
transgenic	O
mouse	B-SPEC
model	O
expressing	O
porcine	B-SPEC
APN	O
which	O
is	O
susceptible	O
to	O
porcine	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

Infection	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
severe	O
respiratory	O
distress	O
in	O
infected	O
patients	O
.	O

No	O
effective	O
vaccine	O
or	O
treatment	O
has	O
yet	O
been	O
approved	O
for	O
either	O
virus	B-SPEC
.	O

ChRCoV	O
HKU24	O
occupied	O
a	O
deep	O
branch	O
at	O
the	O
root	O
of	O
members	O
of	O
Betacoronavirus	B-SPEC
1	I-SPEC
,	O
being	O
distinct	O
from	O
murine	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
.	O

Its	O
N	O
-	O
terminal	O
domain	O
(	O
NTD	O
)	O
demonstrated	O
higher	O
sequence	O
identity	O
to	O
the	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	B-SPEC
)	O
NTD	O
than	O
to	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
NTD	O
,	O
with	O
3	O
of	O
4	O
critical	O
sugar	O
-	O
binding	O
residues	O
in	O
BCoV	B-SPEC
and	O
2	O
of	O
14	O
contact	O
residues	O
at	O
the	O
MHV	B-SPEC
NTD	O
/	O
murine	B-SPEC
CEACAM1a	O
interface	O
being	O
conserved	O
.	O

Using	O
the	O
spike	O
polypeptide	O
-	O
based	O
Western	O
blot	O
assay	O
,	O
we	O
showed	O
that	O
only	O
Norway	B-SPEC
rats	I-SPEC
and	O
two	O
oriental	B-SPEC
house	I-SPEC
rats	I-SPEC
from	O
Guangzhou	O
,	O
China	O
,	O
were	O
infected	O
by	O
ChRCoV	O
HKU24	O
.	O

The	O
unique	O
genome	O
features	O
and	O
phylogenetic	O
analysis	O
supported	O
the	O
suggestion	O
that	O
ChRCoV	O
HKU24	O
represents	O
a	O
novel	O
CoV	O
species	B-SPEC
,	O
occupying	O
a	O
deep	O
branch	O
at	O
the	O
root	O
of	O
members	O
of	O
Betacoronavirus	B-SPEC
1	I-SPEC
and	O
being	O
distinct	O
from	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

Nevertheless	O
,	O
ChRCoV	O
HKU24	O
possessed	O
genome	O
characteristics	O
that	O
resemble	O
those	O
of	O
both	O
Betacoronavirus	B-SPEC
1	I-SPEC
and	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

Our	O
data	O
suggest	O
that	O
ChRCoV	O
HKU24	O
represents	O
the	O
murine	B-SPEC
origin	O
of	O
Betacoronavirus	B-SPEC
1	I-SPEC
,	O
with	O
interspecies	O
transmission	O
from	O
rodents	B-SPEC
to	O
other	O
mammals	B-SPEC
having	O
occurred	O
centuries	O
ago	O
,	O
before	O
the	O
emergence	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
OC43	O
in	O
the	O
late	O
1800s	O
.	O

Rodents	B-SPEC
are	O
likely	O
an	O
important	O
reservoir	O
for	O
ancestors	O
of	O
lineage	O
A	O
CoVs	O
.	O

TITLE	O
:	O
The	O
SARS	O
-	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
:	O
structure	O
,	O
function	O
and	O
inhibition	O
by	O
designed	O
antiviral	O
compounds	O
.	O

The	O
recent	O
emergence	O
of	O
the	O
deadly	O
human	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
sobering	O
reminder	O
that	O
new	O
and	O
deadly	O
coronaviruses	O
can	O
emerge	O
at	O
any	O
time	O
with	O
the	O
potential	O
to	O
become	O
pandemics	O
.	O

As	O
reported	O
,	O
lithium	O
chloride	O
(	O
LiCl	O
)	O
can	O
efficiently	O
impair	O
the	O
replication	O
of	O
a	O
variety	O
of	O
viruses	B-SPEC
,	O
including	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Recent	O
annual	O
applications	O
for	O
this	O
elective	O
have	O
been	O
as	O
high	O
as	O
44	O
out	O
of	O
a	O
class	B-SPEC
of	O
200	O
students	O
.	O

To	O
meet	O
this	O
need	O
,	O
our	O
research	O
group	O
is	O
currently	O
developing	O
a	O
multiple	O
vital	O
-	O
signs	O
based	O
infection	O
screening	O
system	O
that	O
can	O
perform	O
human	B-SPEC
medical	O
inspections	O
within	O
15	O
seconds	O
.	O

In	O
November	O
2011	O
,	O
May	O
2012	O
and	O
May	O
2013	O
milk	O
samples	O
from	O
four	O
homebred	O
primiparous	O
cows	B-SPEC
were	O
collected	O
in	O
75	O
to	O
65	O
OM	O
and	O
69	O
to	O
62	O
CM	O
herds	O
.	O

The	O
prevalence	O
of	O
positive	O
herds	O
ranged	O
from	O
73	O
.	O
4	O
%	O
to	O
82	O
.	O
3	O
%	O
for	O
BRSV	B-SPEC
and	O
from	O
76	O
.	O
8	O
%	O
to	O
85	O
.	O
3	O
%	O
for	O
BoCV	O
among	O
OM	O
and	O
CM	O
herds	O
,	O
over	O
the	O
three	O
sampling	O
occasions	O
.	O

TITLE	O
:	O
Antigenic	O
relationships	O
among	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
strains	O
.	O

Biologically	O
,	O
PEDV	B-SPEC
strain	O
CV777	O
induced	O
greater	O
cell	O
fusion	O
in	O
Vero	O
cells	O
than	O
did	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
strains	O
.	O

Identification	O
of	O
PEDV	B-SPEC
-	O
or	O
TGEV	B-SPEC
-	O
specific	O
antigenic	O
regions	O
allows	O
the	O
development	O
of	O
more	O
specific	O
immunoassays	O
for	O
each	O
virus	B-SPEC
.	O

We	O
constructed	O
reverse	O
genetic	O
systems	O
for	O
JHM	O
.	O
SD	O
and	O
JHM	O
.	O
WU	O
and	O
,	O
utilizing	O
these	O
full	O
-	O
length	O
cDNA	O
clones	O
,	O
constructed	O
chimeric	O
viruses	B-SPEC
and	O
mapped	O
the	O
virulence	O
factors	O
involved	O
in	O
liver	O
tropism	O
.	O

We	O
found	O
that	O
very	O
small	O
changes	O
in	O
coronavirus	B-SPEC
proteins	O
can	O
profoundly	O
affect	O
tropism	O
and	O
virulence	O
.	O

Furthermore	O
,	O
the	O
hepatotropism	O
of	O
MHV	B-SPEC
-	O
JHM	O
depends	O
not	O
on	O
the	O
spike	O
protein	O
and	O
viral	O
entry	O
but	O
rather	O
on	O
a	O
combination	O
of	O
the	O
structural	O
protein	O
M	O
and	O
nonstructural	O
replicase	O
-	O
associated	O
proteins	O
nsp1	O
and	O
nsp13	O
,	O
which	O
are	O
conserved	O
among	O
betacoronaviruses	O
.	O

Nevertheless	O
,	O
all	O
generally	O
agree	O
that	O
a	O
transgenic	O
mouse	B-SPEC
model	O
expressing	O
the	O
DPP4	O
receptor	O
is	O
needed	O
for	O
MERS	O
-	O
CoV	O
research	O
.	O

TITLE	O
:	O
The	O
seasonality	O
of	O
respiratory	O
viruses	B-SPEC
in	O
patients	O
with	O
chronic	O
rhinosinusitis	O
.	O

ABSTRACT	O
:	O
Virulent	O
biotypes	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
),	O
commonly	O
referred	O
to	O
as	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
),	O
can	O
result	O
in	O
the	O
development	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
typically	O
fatal	O
immune	O
mediated	O
disease	O
for	O
which	O
there	O
is	O
currently	O
no	O
effective	O
antiviral	O
treatment	O
.	O

These	O
activities	O
limit	O
infection	O
in	O
cultured	O
cells	O
by	O
many	O
viruses	B-SPEC
,	O
including	O
dengue	O
virus	B-SPEC
,	I-SPEC
Ebola	I-SPEC
virus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Lung	O
injury	O
and	O
respiratory	O
distress	O
syndrome	O
are	O
frequent	O
symptoms	O
observed	O
in	O
the	O
most	O
severe	O
cases	O
of	O
scorpion	B-SPEC
envenomation	O
.	O

Pulmonary	O
edema	O
,	O
as	O
assessed	O
by	O
the	O
levels	O
of	O
EBD	O
extravasation	O
,	O
was	O
completely	O
inhibited	O
in	O
compound	O
48	O
/	O
80	O
-	O
treated	O
animals	B-SPEC
.	O

Here	O
,	O
we	O
evaluated	O
the	O
response	O
of	O
3	O
-	O
day	O
-	O
old	O
piglets	O
born	O
to	O
sows	O
exposed	O
seven	O
months	O
earlier	O
to	O
a	O
mild	O
strain	O
of	O
PEDv	B-SPEC
to	O
challenge	O
with	O
a	O
virulent	O
PEDv	B-SPEC
isolate	O
.	O

To	O
explain	O
the	O
substrate	O
specificities	O
,	O
we	O
have	O
solved	O
the	O
crystal	O
structure	O
of	O
PLpro	O
from	O
IBV	B-SPEC
at	O
2	O
.	O
15	O
-	O
	O
resolution	O
.	O

A	O
model	O
of	O
ubiquitin	O
-	O
bound	O
IBV	B-SPEC
CoV	O
PLpro	O
brings	O
out	O
key	O
differences	O
in	O
substrate	O
binding	O
sites	O
of	O
PLpros	O
.	O

Particularly	O
,	O
we	O
analyzed	O
secretion	O
of	O
type	O
I	O
and	O
type	O
III	O
interferons	O
(	O
IFNs	O
)	O
by	O
APCs	O
,	O
i	O
.	O
e	O
.,	O
B	O
cells	O
,	O
macrophages	O
,	O
monocyte	O
-	O
derived	O
/	O
myeloid	O
dendritic	O
cells	O
(	O
MDDCs	O
/	O
mDCs	O
),	O
and	O
by	O
plasmacytoid	O
dendritic	O
cells	O
(	O
pDCs	O
)	O
of	O
human	B-SPEC
and	O
murine	B-SPEC
origin	O
after	O
inoculation	O
with	O
MERS	O
-	O
CoV	O
.	O
Production	O
of	O
large	O
amounts	O
of	O
type	O
I	O
and	O
III	O
IFNs	O
was	O
induced	O
exclusively	O
in	O
human	B-SPEC
pDCs	O
,	O
which	O
were	O
significantly	O
higher	O
than	O
IFN	O
induction	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
.	O
Of	O
note	O
,	O
IFNs	O
were	O
secreted	O
in	O
the	O
absence	O
of	O
productive	O
replication	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
a	O
respiratory	O
disease	O
with	O
a	O
mortality	O
rate	O
of	O
10	O
%.	O

To	O
analyze	O
the	O
host	O
responses	O
leading	O
to	O
rSARS	O
-	O
CoV	O
-	O
MA15	O
-	O
E	O
*	O
attenuation	O
,	O
differences	O
in	O
gene	O
expression	O
elicited	O
by	O
the	O
native	O
and	O
mutant	O
viruses	B-SPEC
in	O
the	O
lungs	O
of	O
infected	O
mice	B-SPEC
were	O
determined	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
necrotic	O
ear	O
syndrome	O
(	O
PNES	O
)	O
in	O
pigs	B-SPEC
has	O
been	O
reported	O
as	O
an	O
increasing	O
health	O
problem	O
in	O
many	O
countries	O
with	O
intensive	O
pig	B-SPEC
farming	O
.	O

Five	O
flocks	O
were	O
positive	O
for	O
aMPV	O
subtype	O
B	O
.	O
Though	O
no	O
disease	O
was	O
witnessed	O
at	O
the	O
time	O
of	O
sampling	O
,	O
identified	O
viruses	B-SPEC
including	O
variant	O
IBV	B-SPEC
strains	O
,	O
may	O
still	O
pose	O
a	O
threat	O
for	O
both	O
backyard	O
and	O
commercial	O
poultry	O
in	O
Oman	O
.	O

Three	O
survived	O
and	O
two	O
died	O
:	O
one	O
hydrops	B-SPEC
fetalis	O
neonate	O
born	O
at	O
gestational	O
week	O
30	O
died	O
at	O
age	O
5	O
days	O
,	O
and	O
another	O
died	O
eventually	O
from	O
acute	O
gastroenteritis	O
40	O
days	O
after	O
leaving	O
hospital	O
at	O
the	O
age	O
of	O
155	O
days	O
with	O
complete	O
remission	O
.	O

In	O
tackling	O
both	O
new	O
and	O
old	O
viruses	B-SPEC
as	O
they	O
emerge	O
,	O
humanized	O
mice	B-SPEC
will	O
continue	O
to	O
be	O
an	O
indispensable	O
tool	O
.	O

TITLE	O
:	O
Cluster	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infections	O
in	O
Iran	O
,	O
2014	O
.	O

We	O
newly	O
synthesized	O
pyrrolyl	O
derivatives	O
that	O
exhibited	O
good	O
potency	O
against	O
IN	O
and	O
a	O
moderate	O
inhibition	O
of	O
the	O
RNase	O
H	O
function	O
of	O
RT	O
,	O
confirming	O
the	O
possibility	O
of	O
developing	O
dual	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IN	O
/	O
RNase	O
H	O
inhibitors	O
and	O
obtaining	O
new	O
information	O
for	O
the	O
further	O
development	O
of	O
more	O
effective	O
dual	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
inhibitors	O
.	O

ABSTRACT	O
:	O
We	O
present	O
here	O
a	O
rapid	O
immunochromatographic	O
assay	O
for	O
the	O
detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
antigen	O
in	O
the	O
nasal	O
swabs	O
of	O
dromedary	B-SPEC
camels	B-SPEC
.	O

The	O
results	O
suggest	O
that	O
the	O
assay	O
developed	O
here	O
is	O
a	O
useful	O
tool	O
for	O
the	O
rapid	O
diagnosis	O
and	O
epidemiological	O
surveillance	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
dromedary	B-SPEC
camels	B-SPEC
.	O

An	O
outbreak	O
of	O
a	O
severe	O
respiratory	O
disease	O
--	O
fibrinous	O
pleuropneumonia	B-SPEC
syndrome	O
,	O
most	O
likely	O
caused	O
by	O
Mycoplasma	B-SPEC
ovipneumoniae	I-SPEC
--	O
led	O
to	O
a	O
marked	O
population	O
decline	O
.	O

TITLE	O
:	O
Canine	B-SPEC
adenovirus	I-SPEC
type	O
1	O
in	O
a	O
fennec	B-SPEC
fox	I-SPEC
(	O
Vulpes	B-SPEC
zerda	I-SPEC
).	O

ABSTRACT	O
:	O
A	O
10	O
-	O
mo	O
-	O
old	O
female	O
fennec	B-SPEC
fox	I-SPEC
(	O
Vulpes	B-SPEC
zerda	I-SPEC
)	O
with	O
drooling	O
suddenly	O
died	O
and	O
was	O
examined	O
postmortem	O
.	O

CAdV	O
-	O
1	O
was	O
confirmed	O
by	O
virus	B-SPEC
isolation	O
and	O
nucleotide	O
sequencing	O
.	O

TITLE	O
:	O
Update	O
on	O
the	O
epidemiology	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
,	O
and	O
guidance	O
for	O
the	O
public	O
,	O
clinicians	O
,	O
and	O
public	O
health	O
authorities	O
-	O
January	O
2015	O
.	O

ABSTRACT	O
:	O
CDC	O
continues	O
to	O
work	O
with	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
and	O
other	O
partners	O
to	O
closely	O
monitor	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
globally	O
and	O
to	O
better	O
understand	O
the	O
risks	O
to	O
public	O
health	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
an	O
emerging	O
infectious	O
disease	O
caused	O
by	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
has	O
garnered	O
worldwide	O
attention	O
as	O
a	O
consequence	O
of	O
its	O
continuous	O
spread	O
and	O
pandemic	O
potential	O
,	O
making	O
the	O
development	O
of	O
effective	O
vaccines	O
a	O
high	O
priority	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
shown	O
to	O
serve	O
as	O
natural	O
reservoirs	O
for	O
numerous	O
emerging	O
viruses	B-SPEC
including	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Of	O
the	O
7	O
,	O
803	O
nasal	O
swabs	O
tested	O
in	O
the	O
epidemiological	O
survey	O
,	O
MERS	O
-	O
CoV	O
nucleic	O
acid	O
was	O
detected	O
by	O
real	O
-	O
time	O
PCR	O
in	O
a	O
total	O
of	O
126	O
(	O
1	O
.	O
6	O
%)	O
camels	B-SPEC
.	O

Positive	O
camels	B-SPEC
were	O
detected	O
at	O
the	O
borders	O
with	O
Saudi	O
Arabia	O
and	O
Oman	O
and	O
in	O
camels	B-SPEC
'	O
slaughter	O
houses	O
.	O

Among	O
the	O
infectious	O
agents	O
,	O
only	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
(	O
odds	O
ratio	O
[	O
OR	O
]	O
=	O
2	O
.	O
6	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
3	O
-	O
5	O
.	O
6	O
;	O
P	O
=	O
0	O
.	O
02	O
),	O
BRV	O
(	O
OR	O
=	O
2	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
3	O
-	O
5	O
.	O
9	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
co	O
-	O
infection	O
with	O
more	O
than	O
one	O
agent	O
(	O
compared	O
with	O
mono	O
-	O
infection	O
:	O
OR	O
=	O
2	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
3	O
-	O
4	O
.	O
8	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
were	O
associated	O
with	O
increased	O
odds	O
of	O
liquid	O
faeces	O
in	O
calves	O
which	O
were	O
9	O
to	O
21	O
days	O
old	O
.	O

TITLE	O
:	O
Glycosylation	O
of	O
mouse	B-SPEC
DPP4	O
plays	O
a	O
role	O
in	O
inhibiting	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

These	O
results	O
provide	O
insight	O
into	O
DPP4	O
species	B-SPEC
-	O
specific	O
differences	O
impacting	O
MERS	O
-	O
CoV	O
host	O
range	O
and	O
may	O
inform	O
MERS	O
-	O
CoV	O
mouse	B-SPEC
model	O
development	O
.	O

Consistently	O
,	O
nanomolar	O
concentrations	O
of	O
the	O
cardiotonic	O
steroids	O
ouabain	O
and	O
bufalin	O
,	O
which	O
are	O
known	O
not	O
to	O
affect	O
the	O
transport	O
function	O
of	O
Na	O
(+),	O
K	O
(+)-	O
ATPase	O
,	O
inhibited	O
infection	O
of	O
cells	O
with	O
MHV	B-SPEC
,	O
FIPV	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
CoV	O
,	O
and	O
VSV	O
,	O
but	O
not	O
IAV	O
,	O
when	O
the	O
compounds	O
were	O
present	O
during	O
virus	B-SPEC
inoculation	O
.	O

All	O
children	O
aged	O
1	O
month	O
to	O
15	O
years	O
admitted	O
to	O
the	O
participating	O
PICUs	B-SPEC
in	O
the	O
study	O
period	O
.	O

TITLE	O
:	O
On	O
the	O
biased	O
nucleotide	O
composition	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
RNA	O
genome	O
.	O

Most	O
strikingly	O
,	O
the	O
high	O
U	O
and	O
low	O
C	O
proportions	O
are	O
quite	O
variable	O
and	O
act	O
like	O
communicating	O
vessels	O
,	O
C	O
goes	B-SPEC
down	O
when	O
U	O
goes	B-SPEC
up	O
and	O
vice	O
versa	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
:	O
An	O
emerging	O
coronavirus	B-SPEC
infection	O
tracked	O
by	O
the	O
crowd	O
.	O

Further	O
studies	O
are	O
required	O
to	O
explore	O
the	O
mechanism	O
of	O
the	O
antiviral	O
effect	O
of	O
LiCl	O
on	O
PPV	B-SPEC
infection	O
in	O
vivo	O
.	O

Analysis	O
of	O
the	O
selection	O
patterns	O
of	O
PEDV	B-SPEC
isolated	O
in	O
Korea	O
indicated	O
positive	O
selection	O
of	O
nine	O
nonsynonymous	O
sites	O
in	O
the	O
S	O
and	O
N	O
proteins	O
and	O
negative	O
selection	O
at	O
97	O
sites	O
for	O
all	O
of	O
the	O
proteins	O
.	O

Employing	O
a	O
pathogenic	O
animal	B-SPEC
model	O
of	O
SARS	O
-	O
CoV	O
infection	O
,	O
we	O
demonstrated	O
that	O
viral	O
spread	O
and	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
is	O
driven	O
by	O
serine	O
rather	O
than	O
cysteine	O
proteases	O
and	O
can	O
be	O
effectively	O
prevented	O
by	O
camostat	O
.	O

TITLE	O
:	O
Phylodynamic	O
analysis	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
South	O
America	O
.	O

We	O
obtained	O
full	O
-	O
length	O
sequences	O
of	O
the	O
S1	O
coding	O
region	O
and	O
N	O
gene	O
of	O
IBV	B-SPEC
field	O
isolates	O
from	O
Uruguay	O
and	O
Argentina	B-SPEC
,	O
and	O
performed	O
Phylodynamic	O
analysis	O
to	O
characterize	O
the	O
strains	O
and	O
estimate	O
the	O
time	O
of	O
the	O
most	O
recent	O
common	O
ancestor	O
.	O

We	O
found	O
amino	O
acid	O
differences	O
located	O
at	O
44	O
positions	O
across	O
an	O
alignment	O
of	O
the	O
six	O
virus	B-SPEC
translatomes	O
and	O
,	O
at	O
21	O
of	O
these	O
positions	O
,	O
the	O
differences	O
fully	O
or	O
partially	O
discriminated	O
between	O
the	O
genomes	O
derived	O
from	O
the	O
faecal	O
samples	O
and	O
the	O
genomes	O
derived	O
from	O
the	O
tissue	O
lesion	O
samples	O
.	O

In	O
this	O
study	O
,	O
two	O
amino	O
acid	O
differences	O
fully	O
discriminated	O
the	O
two	O
classes	O
of	O
genomes	O
:	O
these	O
were	O
both	O
located	O
in	O
the	O
S2	O
domain	O
of	O
the	O
virus	B-SPEC
surface	O
glycoprotein	O
gene	O
.	O

Meanwhile	O
,	O
based	O
on	O
the	O
ORF3	O
gene	O
,	O
all	O
of	O
the	O
PEDV	B-SPEC
isolates	O
could	O
be	O
separated	O
into	O
3	O
genogroups	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
variant	O
PEDV	B-SPEC
strain	O
spread	O
wildly	O
in	O
mid	O
-	O
eastern	O
China	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
RIG	O
-	O
I	O
,	O
STAT	O
-	O
1	O
and	O
IFN	O
-	O
beta	O
in	O
the	O
horseshoe	B-SPEC
bat	I-SPEC
.	O

Our	O
results	O
demonstrated	O
that	O
bat	B-SPEC
RIG	O
-	O
I	O
,	O
STAT	O
-	O
1	O
and	O
IFN	O
-	O
	O
showed	O
close	O
homology	O
with	O
human	B-SPEC
,	O
mouse	B-SPEC
,	O
pig	B-SPEC
and	O
rhesus	B-SPEC
monkey	I-SPEC
.	O

These	O
results	O
imply	O
the	O
possibility	O
that	O
PEDV	B-SPEC
infection	O
may	O
proceed	O
by	O
lateral	O
spread	O
of	O
virus	B-SPEC
in	O
intestinal	O
epithelial	O
cells	O
.	O

The	O
results	O
indicate	O
the	O
division	O
of	O
isolates	O
into	O
two	O
different	O
genotypes	O
of	O
IBV	B-SPEC
within	O
the	O
province	O
,	O
Massachusetts	O
(	O
Mass	O
)-	O
like	O
and	O
QX	O
-	O
like	O
.	O

This	O
study	O
offers	O
the	O
first	O
published	O
consolidation	O
of	O
IBV	B-SPEC
isolates	O
from	O
an	O
area	O
of	O
South	O
Africa	O
and	O
identifies	O
variation	O
within	O
the	O
IBV	B-SPEC
population	O
of	O
the	O
broiler	O
flock	O
within	O
the	O
study	O
area	O
over	O
a	O
2	O
-	O
year	O
period	O
.	O

TITLE	O
:	O
High	O
prevalence	O
of	O
common	O
respiratory	O
viruses	B-SPEC
and	O
no	O
evidence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
Hajj	O
pilgrims	O
returning	O
to	O
Ghana	O
,	O
2013	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
in	O
2012	O
on	O
the	O
Arabian	O
Peninsula	O
and	O
has	O
caused	O
severe	O
respiratory	O
disease	O
with	O
more	O
than	O
800	O
laboratory	O
-	O
confirmed	O
cases	O
.	O

Tests	O
were	O
positive	O
for	O
at	O
least	O
one	O
of	O
the	O
viruses	B-SPEC
other	O
than	O
MERS	O
-	O
CoV	O
in	O
179	O
(	O
21	O
.	O
3	O
%)	O
of	O
all	O
pilgrims	O
,	O
with	O
22	O
.	O
4	O
%	O
detection	O
in	O
symptomatic	O
vs	O
.	O
17	O
.	O
6	O
%	O
detection	O
in	O
asymptomatic	O
pilgrims	O
.	O

Properties	O
of	O
aptamers	O
allow	O
detecting	O
virus	B-SPEC
infected	O
cells	O
or	O
viruses	B-SPEC
themselves	O
and	O
make	O
them	O
competitive	O
to	O
monoclonal	O
antibodies	O
.	O

In	O
the	O
present	O
study	O
,	O
11	O
complete	O
genomes	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
field	O
isolates	O
from	O
China	O
were	O
determined	O
and	O
analyzed	O
.	O

Frequently	O
occurring	O
mutations	O
were	O
observed	O
,	O
which	O
suggested	O
that	O
full	O
understanding	O
of	O
the	O
genomic	O
and	O
epidemiological	O
characteristics	O
is	O
critical	O
in	O
the	O
fight	O
against	O
PEDV	B-SPEC
epidemics	O
.	O

Since	O
3CLpro	O
is	O
functionally	O
and	O
structurally	O
conserved	O
among	O
these	O
viruses	B-SPEC
and	O
essential	O
for	O
viral	O
replication	O
,	O
3CLpro	O
is	O
considered	O
a	O
potential	O
target	O
for	O
the	O
design	O
of	O
antiviral	O
drugs	O
with	O
broad	O
-	O
spectrum	O
activities	O
against	O
these	O
distinct	O
and	O
highly	O
important	O
viral	O
infections	O
.	O

Overall	O
,	O
our	O
study	O
provides	O
the	O
first	O
insight	O
into	O
a	O
structural	O
platform	O
for	O
anti	O
-	O
FIPV	O
and	O
anti	O
-	O
FCV	B-SPEC
drug	O
development	O
.	O

Introducing	O
mutations	O
into	O
a	O
protein	O
or	O
virus	B-SPEC
can	O
have	O
either	O
direct	O
or	O
indirect	O
effects	O
on	O
function	O
.	O

Our	O
results	O
identify	O
the	O
coronavirus	B-SPEC
Ubl	O
domain	O
as	O
a	O
novel	O
modulator	O
of	O
viral	O
protease	O
stability	O
and	O
reveal	O
manipulating	O
the	O
Ubl	O
domain	O
as	O
a	O
new	O
approach	O
for	O
attenuating	O
coronavirus	B-SPEC
replication	O
and	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
Pneumonia	O
is	O
a	O
most	O
common	O
human	B-SPEC
disease	O
and	O
a	O
leading	O
cause	O
of	O
death	O
from	O
infectious	O
pathology	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
characterize	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
nucleocapsid	O
protein	O
.	O

After	O
Hajj	O
participation	O
,	O
these	O
viruses	B-SPEC
were	O
isolated	O
among	O
pilgrims	O
from	O
all	O
countries	O
,	O
with	O
few	O
exceptions	O
.	O

Proportion	O
of	O
rhinovirus	B-SPEC
was	O
higher	O
in	O
patients	O
with	O
excluded	O
CAP	O
compared	O
with	O
other	O
diagnostic	O
categories	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

Viruses	B-SPEC
seem	O
common	O
in	O
adults	O
attending	O
emergency	O
departments	O
with	O
suspected	O
CAP	O
.	O

However	O
,	O
no	O
clinical	O
report	O
on	O
arbekacin	O
treatment	O
of	O
a	O
human	B-SPEC
infection	O
with	O
a	O
multidrug	O
-	O
resistant	O
Pseudomonas	B-SPEC
has	O
appeared	O
to	O
date	O
.	O

We	O
encountered	O
a	O
case	O
of	O
pneumonia	O
caused	O
by	O
a	O
Pseudomonas	B-SPEC
strain	O
producing	O
a	O
metallo	O
-	O
beta	O
-	O
lactamase	O
;	O
the	O
patient	O
was	O
successfully	O
treated	O
with	O
arbekacin	O
.	O

The	O
causative	O
organism	O
was	O
a	O
strain	O
of	O
Pseudomonas	B-SPEC
putida	I-SPEC
that	O
produced	O
a	O
metallo	O
-	O
beta	O
-	O
lactamase	O
.	O

Although	O
it	O
is	O
essential	O
to	O
optimize	O
cardiac	O
preload	O
to	O
maintain	O
tissue	O
perfusion	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
,	O
the	O
optimal	O
preload	O
remains	O
unknown	O
.	O

Ninety	O
-	O
three	O
mechanically	O
ventilated	O
patients	O
with	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
sepsis	B-SPEC
were	O
enrolled	O
for	O
subgroup	O
analysis	O
in	O
a	O
multicenter	O
,	O
prospective	O
,	O
observational	O
study	O
.	O

However	O
,	O
GEDI	O
was	O
not	O
significantly	O
different	O
between	O
patients	O
with	O
SVV	B-SPEC
	O
13	O
%	O
and	O
SVV	B-SPEC
>	O
13	O
%	O
in	O
the	O
non	O
-	O
SIMD	O
group	O
on	O
the	O
day	O
of	O
enrollment	O
and	O
both	O
groups	O
on	O
day	O
2	O
.	O

The	O
presentation	O
of	O
E2S	O
-	O
like	O
,	O
SARS	O
spike	O
protein	O
-	O
like	O
,	O
or	O
toxin	O
-	O
like	O
domains	O
by	O
the	O
N10	O
and	O
N11	O
proteins	O
in	O
these	O
emerging	O
viruses	B-SPEC
may	O
indicate	O
that	O
H17N10	O
and	O
H18N11	O
sialidase	O
-	O
facilitated	O
cell	O
entry	O
has	O
been	O
supplemented	O
or	O
replaced	O
by	O
sialidase	O
-	O
independent	O
receptor	O
binding	O
to	O
an	O
expanded	O
cell	O
population	O
that	O
may	O
include	O
neurons	O
and	O
T	O
-	O
cells	O
.	O

TITLE	O
:	O
Analysis	O
of	O
cathepsin	O
and	O
furin	O
proteolytic	O
enzymes	O
involved	O
in	O
viral	O
fusion	O
protein	O
activation	O
in	O
cells	O
of	O
the	O
bat	B-SPEC
reservoir	O
host	O
.	O

ABSTRACT	O
:	O
Canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
)	O
is	O
one	O
of	O
the	O
most	O
common	O
causes	O
of	O
acute	O
haemorrhagic	O
enteritis	O
in	O
young	O
dogs	B-SPEC
,	O
while	O
clinical	O
diagnosis	O
is	O
often	O
indecisive	O
.	O

The	O
sensitivity	O
of	O
the	O
Quicking	O
rapid	O
diagnostic	O
test	O
compared	O
to	O
PCR	O
in	O
the	O
total	O
number	O
of	O
samples	O
,	O
in	O
samples	O
from	O
non	O
-	O
vaccinated	O
dogs	B-SPEC
and	O
in	O
samples	O
tested	O
directly	O
after	O
collection	O
were	O
22	O
.	O
22	O
%	O
(	O
95	O
%	O
CI	O
:	O
13	O
.	O
27	O
-	O
33	O
.	O
57	O
%),	O
26	O
.	O
67	O
%	O
(	O
95	O
%	O
CI	O
:	O
16	O
.	O
08	O
-	O
39	O
.	O
66	O
%)	O
and	O
76	O
.	O
47	O
%	O
(	O
95	O
%	O
CI	O
:	O
50	O
.	O
10	O
-	O
93	O
.	O
04	O
%)	O
respectively	O
,	O
while	O
the	O
specificity	O
of	O
the	O
test	O
was	O
100	O
%	O
in	O
any	O
case	O
.	O

Blood	O
samples	O
were	O
obtained	O
at	O
I	O
,	O
2	O
,	O
5	O
,	O
and	O
12	O
weeks	O
for	O
determination	O
of	O
serum	O
neutralization	O
antibody	O
titers	O
against	O
the	O
vaccine	O
viruses	B-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
and	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
.	O

The	O
full	O
-	O
length	O
coding	O
genome	O
sequence	O
was	O
26	O
,	O
985	O
nucleotides	O
long	O
with	O
11	O
open	O
reading	O
frames	O
and	O
no	O
hemagglutinin	O
-	O
esterase	O
gene	O
:	O
a	O
genome	O
organization	O
identical	O
to	O
that	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
[	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)-	O
replicase	O
(	O
ORFs	O
1a	O
,	O
1ab	O
)-	O
spike	O
(	O
S	O
)	O
protein	O
-	O
ORF3	O
(	O
ORFs	O
3a	O
,	O
3b	O
)-	O
small	O
envelop	O
(	O
E	O
or	O
3c	O
)	O
protein	O
-	O
membrane	O
(	O
M	O
)	O
protein	O
-	O
ORF5	O
(	O
ORFs	O
4b	O
,	O
4c	O
,	O
5a	O
,	O
5b	O
)-	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
(	O
ORFs	O
N	O
and	O
6b	O
)-	O
3	O
'	O
UTR	O
].	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
),	O
enveloped	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
,	O
are	O
characterized	O
by	O
club	O
-	O
like	O
spikes	O
that	O
project	O
from	O
their	O
surface	O
,	O
an	O
unusually	O
large	O
RNA	O
genome	O
,	O
and	O
a	O
unique	O
replication	O
strategy	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
from	O
guinea	B-SPEC
fowl	I-SPEC
using	O
metagenomics	O
.	O

ABSTRACT	O
:	O
Chicken	B-SPEC
kidney	O
(	O
CK	O
)	O
cell	O
cultures	O
have	O
historically	O
proved	O
useful	O
for	O
the	O
assay	O
of	O
a	O
number	O
of	O
viruses	B-SPEC
including	O
coronaviruses	O
.	O

A	O
technique	O
for	O
the	O
preparation	O
of	O
such	O
cell	O
cultures	O
,	O
using	O
a	O
combination	O
of	O
manual	O
and	O
trypsin	O
disaggregation	O
of	O
kidneys	O
dissected	O
from	O
2	O
-	O
to	O
3	O
-	O
week	O
-	O
old	O
birds	B-SPEC
is	O
described	O
.	O

TITLE	O
:	O
Characterization	O
of	O
human	B-SPEC
coronaviruses	O
on	O
well	O
-	O
differentiated	O
human	B-SPEC
airway	O
epithelial	O
cell	O
cultures	O
.	O

This	O
diversity	O
of	O
genotypes	O
provides	O
a	O
mechanism	O
in	O
which	O
a	O
virus	B-SPEC
population	O
can	O
evolve	O
and	O
adapt	O
to	O
a	O
changing	O
environment	O
.	O

ABSTRACT	O
:	O
As	O
obligate	O
intracellular	O
parasites	O
,	O
viruses	B-SPEC
need	O
to	O
cross	O
the	O
plasma	O
membrane	O
and	O
deliver	O
their	O
genome	O
inside	O
the	O
cell	O
.	O

ABSTRACT	O
:	O
Single	O
particle	O
tracking	O
(	O
SPT	O
)	O
of	O
individual	O
virion	O
fusion	O
with	O
host	O
cell	O
membranes	O
using	O
total	O
internal	O
reflection	O
microscopy	O
(	O
TIRFM	O
)	O
is	O
a	O
powerful	O
technique	O
for	O
quantitatively	O
characterizing	O
virus	B-SPEC
-	O
host	O
interactions	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
last	O
2	O
decades	O
,	O
yeast	B-SPEC
two	O
-	O
hybrid	O
became	O
an	O
invaluable	O
technique	O
to	O
decipher	O
protein	O
-	O
protein	O
interaction	O
networks	O
.	O

There	O
are	O
no	O
effective	O
vaccines	O
or	O
treatment	O
available	O
,	O
and	O
the	O
virus	B-SPEC
virulence	O
determinants	O
and	O
pathogenesis	O
are	O
not	O
fully	O
understood	O
.	O

TITLE	O
:	O
Quantification	O
of	O
interferon	O
signaling	O
in	O
avian	B-SPEC
cells	O
.	O

TITLE	O
:	O
Studying	O
the	O
dynamics	O
of	O
coronavirus	B-SPEC
replicative	O
structures	O
.	O

MAb	O
2D1	O
reacted	O
with	O
S	O
protein	O
of	O
PEDV	B-SPEC
specifically	O
.	O

TITLE	O
:	O
Development	O
and	O
characterization	O
of	O
neutralizing	O
monoclonal	O
antibodies	O
against	O
the	O
S1	O
subunit	O
protein	O
of	O
QX	O
-	O
like	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
strain	O
Sczy3	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
in	O
chickens	B-SPEC
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

These	O
two	O
MAbs	O
showed	O
positive	O
reaction	O
with	O
IBV	B-SPEC
in	O
Western	O
blot	O
,	O
and	O
the	O
isotype	O
were	O
both	O
IgM	O
.	O

TITLE	O
:	O
(	O
3Z	O
)-	O
3	O
-(	O
2	O
-[	O
4	O
-(	O
aryl	O
)-	O
1	O
,	O
3	O
-	O
thiazol	O
-	O
2	O
-	O
yl	O
]	O
hydrazin	O
-	O
1	O
-	O
ylidene	O
)-	O
2	O
,	O
3	O
-	O
dihydro	O
-	O
1H	O
-	O
indol	O
-	O
2	O
-	O
one	O
derivatives	O
as	O
dual	O
inhibitors	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
.	O

ABSTRACT	O
:	O
The	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
Reverse	O
Transcriptase	O
(	O
RT	O
)	O
is	O
a	O
validated	O
and	O
deeply	O
explored	O
biological	O
target	O
for	O
the	O
treatment	O
of	O
AIDS	O
.	O

We	O
designed	O
and	O
synthesised	O
a	O
new	O
generation	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
inhibitors	O
,	O
based	O
on	O
the	O
(	O
3Z	O
)-	O
3	O
-(	O
2	O
-[	O
4	O
-(	O
aryl	O
)-	O
1	O
,	O
3	O
-	O
thiazol	O
-	O
2	O
-	O
yl	O
]	O
hydrazin	O
-	O
1	O
-	O
ylidene	O
)-	O
2	O
,	O
3	O
-	O
dihydro	O
-	O
1H	O
-	O
indol	O
-	O
2	O
-	O
one	O
scaffold	O
.	O

Nasal	O
swabs	O
from	O
RT	O
-	O
PCR	O
positive	O
camels	B-SPEC
(	O
Ct	O
values	O
12	O
.	O
9	O
-	O
32	O
.	O
2	O
)	O
yielded	O
reliable	O
sequence	O
information	O
in	O
14	O
samples	O
.	O

We	O
collected	O
and	O
tested	O
73	O
nasopharyngeal	O
specimens	O
;	O
of	O
which	O
,	O
2	O
,	O
were	O
positive	O
for	O
human	B-SPEC
Coronavirus	I-SPEC
OC43	O
and	O
1	O
for	O
influenza	B-SPEC
C	I-SPEC
virus	I-SPEC
.	O

Compared	O
with	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
(	O
n	O
=	O
163	O
),	O
the	O
odds	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
cases	O
classified	O
as	O
severely	O
ill	O
(	O
n	O
=	O
1416	O
)	O
were	O
1	O
.	O
9	O
(	O
P	O
=	O
.	O
0006	O
),	O
.	O
5	O
(	O
P	O
=	O
.	O
001	O
),	O
and	O
1	O
.	O
3	O
times	O
(	O
P	O
=	O
.	O
1	O
)	O
as	O
likely	O
to	O
present	O
as	O
cerebral	O
,	O
acute	O
respiratory	O
distress	O
,	O
and	O
renal	O
syndromes	O
,	O
respectively	O
.	O

Most	O
human	B-SPEC
coronaviruses	O
commonly	O
cause	O
relatively	O
mild	O
respiratory	O
illnesses	O
;	O
however	O
two	O
zoonotic	O
coronaviruses	O
,	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
,	O
can	O
cause	O
severe	O
illness	O
and	O
death	O
.	O

The	O
focus	O
of	O
this	O
review	O
is	O
the	O
functional	O
analysis	O
of	O
conserved	O
RNA	O
secondary	O
structures	O
in	O
the	O
5	O
'	O
and	O
3	O
'	O
of	O
the	O
betacoronavirus	B-SPEC
genomes	O
.	O

In	O
addition	O
to	O
p	O
-	O
HAP	O
,	O
four	O
derivatives	O
of	O
p	O
-	O
HAP	O
were	O
also	O
isolated	O
from	O
A	B-SPEC
.	I-SPEC
capillaris	I-SPEC
by	O
various	O
chromatographic	O
methods	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
four	O
derivatives	O
of	O
erythrocentaurin	O
(	O
ET	O
)	O
were	O
synthesized	O
and	O
evaluated	O
for	O
their	O
anti	O
-	O
HBV	B-SPEC
activities	O
on	O
HepG	O
2	O
.	O
2	O
.	O
15	O
cell	O
line	O
in	O
vitro	O
.	O

Medicinal	O
plants	B-SPEC
are	O
a	O
rich	O
source	O
of	O
chemical	O
diversity	O
and	O
can	O
be	O
used	O
to	O
identify	O
novel	O
scaffolds	O
to	O
be	O
further	O
developed	O
by	O
chemical	O
modifications	O
.	O

Among	O
the	O
S	B-SPEC
.	I-SPEC
chinensis	I-SPEC
fruit	O
lignans	O
,	O
Schisandrin	O
B	O
and	O
Deoxyschizandrin	O
selectively	O
inhibited	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
-	O
associated	O
DNA	O
polymerase	O
activity	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
porcine	B-SPEC
deltacoronavirus	O
from	O
pigs	B-SPEC
with	O
diarrhea	O
in	O
the	O
United	O
States	O
.	O

Altogether	O
,	O
34	O
/	O
112	O
ASS	B-SPEC
patients	O
had	O
received	O
Rtx	O
;	O
24	O
/	O
34	O
had	O
severe	O
ILD	O
and	O
>	O
12	O
months	O
follow	O
-	O
up	O
post	O
-	O
Rtx	O
(	O
median	O
52	O
months	O
).	O

The	O
mortality	O
rate	O
in	O
the	O
Rtx	O
-	O
treated	O
group	O
was	O
comparable	O
to	O
that	O
of	O
the	O
remaining	O
ASS	B-SPEC
cohort	O
(	O
25	O
/	O
78	O
deceased	O
;	O
32	O
%).	O

ABSTRACT	O
:	O
The	O
study	O
aimed	O
to	O
evaluate	O
cell	O
surface	O
mobilisation	O
of	O
CD107a	O
as	O
a	O
general	O
activation	O
marker	O
on	O
chicken	B-SPEC
cytotoxic	O
T	O
cells	O
(	O
CTL	O
).	O

ABSTRACT	O
:	O
This	O
study	O
aims	O
to	O
retrospectively	O
evaluate	O
pediatric	O
Guillain	O
-	O
Barr	O
syndrome	O
cases	O
in	O
a	O
tertiary	O
center	O
in	O
Istanbul	O
,	O
Turkey	B-SPEC
.	O

CONCLUSIONS	O
:	O
HIV	B-SPEC
infected	O
patients	O
with	O
ARDS	O
and	O
MDR	O
bacterial	O
VAP	O
whose	O
HIV	B-SPEC
replication	O
is	O
controlled	O
by	O
ART	O
could	O
be	O
successfully	O
managed	O
with	O
ECMO	O
.	O

TITLE	O
:	O
Inhibitor	O
recognition	O
specificity	O
of	O
MERS	O
-	O
CoV	O
papain	O
-	O
like	O
protease	O
may	O
differ	O
from	O
that	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
blocking	O
loop	O
2	O
(	O
BL2	O
)	O
structure	O
differs	O
significantly	O
from	O
that	O
of	O
SARS	O
-	O
CoV	O
PLpro	O
,	O
where	O
it	O
has	O
been	O
proven	O
to	O
play	O
a	O
crucial	O
role	O
in	O
SARS	O
-	O
CoV	O
PLpro	O
inhibitor	O
binding	O
.	O

Human	B-SPEC
bocavirus	I-SPEC
,	O
with	O
its	O
four	O
separate	O
lineages	O
,	O
discovered	O
in	O
2005	O
,	O
has	O
been	O
linked	O
to	O
acute	O
respiratory	O
tract	O
infections	O
and	O
gastrointestinal	O
complications	O
.	O

This	O
review	O
will	O
detail	O
the	O
most	O
current	O
clinical	O
and	O
epidemiological	O
findings	O
to	O
all	O
respiratory	O
viruses	B-SPEC
discovered	O
since	O
2001	O
.	O

ABSTRACT	O
:	O
This	O
study	O
is	O
to	O
investigate	O
the	O
effect	O
of	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
against	O
broad	O
-	O
spectrum	O
respiratory	O
viruses	B-SPEC
in	O
vitro	O
.	O

In	O
this	O
study	O
,	O
the	O
therapeutic	O
index	O
of	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
anti	O
-	O
HPIV	O
was	O
1476	O
.	O
63	O
,	O
the	O
therapeutic	O
index	O
of	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
anti	O
-	O
RSV	B-SPEC
was	O
141	O
.	O
37	O
,	O
the	O
therapeutic	O
index	O
of	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
anti	O
-	O
coronavirus	B-SPEC
was	O
more	O
than	O
2820	O
.	O
76	O
,	O
and	O
the	O
antiviral	O
effect	O
of	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
was	O
better	O
than	O
ribavirin	O
(	O
RBV	O
).	O

The	O
origin	O
and	O
virulence	O
of	O
this	O
novel	O
porcine	B-SPEC
coronavirus	B-SPEC
are	O
not	O
known	O
.	O

Collectively	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
PdCV	O
caused	O
severe	O
gastrointestinal	O
diseases	O
in	O
swine	B-SPEC
.	O

Porcine	B-SPEC
coronaviruses	O
(	O
CoVs	O
)	O
are	O
major	O
viral	O
infectious	O
diseases	O
of	O
swine	B-SPEC
.	O

Examples	O
of	O
porcine	B-SPEC
CoVs	O
include	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
),	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
and	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
).	O

The	O
combination	O
of	O
anti	O
-	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
)	O
immunoglobulin	O
and	O
entecavir	O
was	O
initiated	O
for	O
anti	O
-	O
HBV	B-SPEC
therapy	O
.	O

TITLE	O
:	O
Structure	O
-	O
guided	O
design	O
and	O
optimization	O
of	O
dipeptidyl	O
inhibitors	O
of	O
norovirus	B-SPEC
3CL	O
protease	O
.	O

Structure	O
-	O
activity	O
relationships	O
and	O
biochemical	O
,	O
X	O
-	O
ray	B-SPEC
crystallographic	O
,	O
cell	O
-	O
based	O
,	O
and	O
in	O
vivo	O
studies	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
in	O
vivo	O
systemic	O
and	O
mucosal	O
antigen	O
-	O
specific	O
immune	O
responses	O
induced	O
by	O
a	O
single	O
intramuscular	O
or	O
intragastric	O
administration	O
of	O
recombinant	O
adenoviral	B-SPEC
type	O
5	O
(	O
Ad5	O
)	O
or	O
type	O
41	O
(	O
Ad41	O
)	O
-	O
based	O
vaccines	O
expressing	O
the	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
.	O

RESULTS	O
:	O
In	O
February	O
2008	O
,	O
on	O
board	O
a	O
bulk	O
carrier	O
with	O
a	O
cargo	O
of	O
peas	B-SPEC
,	O
a	O
56	O
-	O
year	O
-	O
old	O
seafarer	O
with	O
intense	O
abdominal	O
and	O
chest	O
pains	O
,	O
associated	O
with	O
dizziness	O
,	O
was	O
rescued	O
by	O
helicopter	O
80	O
miles	O
away	O
from	O
the	O
coast	O
.	O

General	O
hygiene	O
measures	O
such	O
as	O
regular	O
hand	O
washing	O
before	O
and	O
after	O
touching	O
animals	B-SPEC
and	O
avoiding	O
contact	O
with	O
sick	O
animals	B-SPEC
in	O
the	O
epidemic	O
areas	O
,	O
should	O
be	O
adhered	O
to	O
.	O

Sporadic	O
human	B-SPEC
cases	O
of	O
avian	B-SPEC
A	O
(	O
H5N6	O
),	O
A	O
(	O
H10N8	O
)	O
and	O
A	O
(	O
H6N1	O
)	O
have	O
also	O
emerged	O
.	O

ABSTRACT	O
:	O
Although	O
widespread	O
vaccination	O
against	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
)	O
has	O
been	O
conducted	O
for	O
many	O
decades	O
,	O
several	O
canine	O
distemper	O
outbreaks	O
in	O
vaccinated	O
animals	B-SPEC
have	O
been	O
reported	O
frequently	O
.	O

The	O
specific	O
CDV	B-SPEC
-	O
H	O
RT	O
-	O
LAMP	O
assay	O
provides	O
a	O
simple	O
,	O
rapid	O
,	O
and	O
sensitive	O
tool	O
for	O
the	O
detection	O
of	O
canines	O
infected	O
with	O
wild	O
-	O
type	O
CDV	B-SPEC
from	O
canines	O
vaccinated	O
with	O
attenuated	O
vaccine	O
.	O

In	O
the	O
present	O
study	O
,	O
in	O
-	O
depth	O
phylogenetic	O
and	O
Bayesian	O
phylogeographic	O
studies	O
were	O
conducted	O
to	O
investigate	O
the	O
evolutionary	O
dynamics	O
of	O
AvCoVs	O
detected	O
in	O
wild	O
and	O
synanthropic	O
birds	B-SPEC
.	O

Furthermore	O
,	O
the	O
analysis	O
inferred	O
an	O
increase	O
in	O
the	O
AvCoV	O
dynamic	O
demographic	O
population	O
in	O
different	O
wild	O
and	O
synanthropic	O
bird	B-SPEC
species	B-SPEC
,	O
suggesting	O
that	O
birds	B-SPEC
may	O
be	O
potential	O
new	O
hosts	O
responsible	O
for	O
spreading	O
this	O
virus	B-SPEC
.	O

Aside	O
from	O
Ebola	O
,	O
other	O
trends	O
in	O
the	O
infection	O
prevention	O
and	O
control	O
literature	O
covered	O
in	O
this	O
article	O
include	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
,	O
universal	O
versus	O
targeted	O
interventions	O
,	O
faecal	O
microbiota	B-SPEC
transplantation	O
,	O
whole	O
genome	O
sequencing	O
,	O
carbapenem	O
-	O
resistant	O
Enterobacteriaceae	B-SPEC
,	O
and	O
some	O
aspects	O
of	O
environmental	O
science	O
.	O

TITLE	O
:	O
Targeting	O
N	O
-	O
glycan	O
cryptic	O
sugar	O
moieties	O
for	O
broad	O
-	O
spectrum	O
virus	B-SPEC
neutralization	O
:	O
progress	O
in	O
identifying	O
conserved	O
molecular	O
targets	O
in	O
viruses	B-SPEC
of	O
distinct	O
phylogenetic	O
origins	O
.	O

The	O
former	O
is	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
specific	O
;	O
the	O
latter	O
is	O
broadly	O
reactive	O
and	O
is	O
able	O
to	O
neutralize	O
viruses	B-SPEC
of	O
distinct	O
phylogenetic	O
origins	O
,	O
such	O
as	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
human	B-SPEC
cytomegalovirus	I-SPEC
(	O
HCMV	O
).	O

Host	O
shifts	O
resulted	O
in	O
dramatic	O
variation	O
in	O
virulence	O
,	O
with	O
benign	O
infections	O
in	O
some	O
species	B-SPEC
and	O
rapid	O
death	O
in	O
others	O
.	O

The	O
immunochromotagraphic	O
urinary	O
antigen	O
test	O
has	O
improved	O
the	O
diagnostic	O
yield	O
for	O
the	O
aetiology	O
of	O
CAP	O
,	O
and	O
initial	O
data	O
demonstrate	O
that	O
a	O
novel	O
multiplex	O
urinary	O
antigen	O
test	O
will	O
further	O
increase	O
the	O
sensitivity	O
for	O
detection	O
of	O
S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
.	O

Of	O
1105	O
stool	O
samples	O
available	O
,	O
viral	O
RNA	O
/	O
DNA	O
was	O
detected	O
in	O
247	O
(	O
26	O
.	O
2	O
%)	O
of	O
941	O
pediatric	O
samples	O
(	O
median	O
age	O
=	O
2	O
.	O
97	O
years	O
,	O
54	O
%	O
male	O
)	O
with	O
28	O
(	O
3	O
.	O
0	O
%)	O
positive	O
for	O
more	O
than	O
one	O
virus	B-SPEC
.	O

In	O
contrast	O
,	O
zVAD	O
did	O
not	O
reduce	O
apoptosis	O
of	O
lung	O
epithelial	O
cells	O
and	O
did	O
not	O
affect	O
the	O
degree	O
of	O
lung	O
injury	O
,	O
permeability	O
,	O
and	O
viral	O
titers	O
in	O
PVM	B-SPEC
disease	O
.	O

59	O
unique	O
miRNAs	O
displayed	O
significant	O
differentially	O
expression	O
between	O
the	O
normal	O
and	O
TGEV	B-SPEC
-	O
infected	O
ST	O
cell	O
samples	O
:	O
15	O
miRNAs	O
were	O
significantly	O
up	O
-	O
regulated	O
and	O
44	O
were	O
significantly	O
down	O
-	O
regulated	O
.	O

We	O
analyzed	O
the	O
differential	O
protein	O
profile	O
of	O
PEDV	B-SPEC
-	O
infected	O
Vero	O
E6	O
cells	O
using	O
mass	O
spectrometry	O
and	O
an	O
isobaric	O
tag	O
for	O
relative	O
and	O
absolute	O
quantification	O
.	O

Our	O
findings	O
provide	O
valuable	O
insight	O
into	O
PEDV	B-SPEC
-	O
Vero	O
E6	O
cell	O
interactions	O
.	O

The	O
emerging	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
causes	O
severe	O
pulmonary	O
disease	O
with	O
multiorgan	O
involvement	O
and	O
a	O
high	O
fatality	O
rate	O
.	O

Meta	B-SPEC
-	O
analysis	O
comparing	O
HFOV	O
with	O
CV	O
revealed	O
no	O
evidence	O
of	O
effect	O
on	O
mortality	O
at	O
28	O
to	O
30	O
days	O
of	O
age	O
or	O
at	O
approximately	O
term	O
equivalent	O
age	O
.	O

Herein	O
,	O
the	O
self	O
-	O
assembly	O
of	O
TK9	O
,	O
a	O
nine	O
-	O
residue	O
peptide	O
of	O
the	O
extra	O
membrane	O
C	O
-	O
terminal	O
tail	O
of	O
the	O
SARS	O
corona	B-SPEC
virus	B-SPEC
envelope	O
,	O
and	O
its	O
variants	O
were	O
characterized	O
through	O
biophysical	O
,	O
spectroscopic	O
,	O
and	O
simulated	O
studies	O
,	O
and	O
it	O
was	O
confirmed	O
that	O
the	O
structure	O
of	O
these	O
peptides	O
influences	O
their	O
aggregation	O
propensity	O
,	O
hence	O
,	O
mimicking	O
amyloid	O
proteins	O
.	O

Moreover	O
,	O
PEDV	B-SPEC
infects	O
cells	O
from	O
pig	B-SPEC
,	O
human	B-SPEC
,	O
monkey	B-SPEC
,	O
and	O
bat	B-SPEC
.	O

These	O
results	O
support	O
the	O
idea	B-SPEC
of	O
bats	B-SPEC
as	O
an	O
evolutionary	O
origin	O
for	O
PEDV	B-SPEC
,	O
implicate	O
PEDV	B-SPEC
as	O
a	O
potential	O
threat	O
to	O
other	O
species	B-SPEC
,	O
and	O
suggest	O
antiviral	O
strategies	O
to	O
control	O
its	O
spread	O
.	O

Compared	O
to	O
the	O
PEDV	B-SPEC
CV777	O
strain	O
,	O
CH	O
/	O
JX	O
-	O
1	O
/	O
2013	O
and	O
CH	O
/	O
JX	O
-	O
2	O
/	O
2013	O
had	O
some	O
unique	O
genetic	O
characteristics	O
in	O
the	O
proximal	O
region	O
of	O
the	O
5	O
-	O
UTRs	O
.	O

Multiple	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
mutations	O
were	O
observed	O
in	O
the	O
ORF1a	O
/	O
b	O
,	O
S	O
,	O
ORF3	O
,	O
E	O
,	O
M	O
and	O
N	O
genes	O
among	O
the	O
current	O
field	O
PEDV	B-SPEC
strains	O
when	O
compared	O
to	O
the	O
CV777	O
strain	O
.	O

While	O
bats	B-SPEC
may	O
be	O
the	O
primary	O
reservoir	O
for	O
both	O
viruses	B-SPEC
,	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
likely	O
crossed	O
into	O
humans	B-SPEC
from	O
civets	B-SPEC
in	O
China	O
,	O
and	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
transmitted	O
from	O
camels	B-SPEC
in	O
the	O
Middle	O
East	O
.	O

Animal	B-SPEC
models	O
are	O
needed	O
to	O
evaluate	O
countermeasures	O
against	O
emerging	O
viruses	B-SPEC
.	O

With	O
SARS	O
-	O
CoV	O
,	O
several	O
animal	B-SPEC
species	B-SPEC
were	O
permissive	O
to	O
infection	O
.	O

In	O
2003	O
,	O
similar	O
virus	B-SPEC
(	O
SARS	O
)	O
hit	O
Canada	O
and	O
resulted	O
in	O
a	O
reform	O
of	O
Canada	O
'	O
s	O
public	O
health	O
system	O
and	O
creation	O
of	O
a	O
Canadian	O
Agency	O
for	O
Public	O
Health	O
,	O
similar	O
to	O
the	O
US	O
Centers	O
for	O
Disease	O
Control	O
(	O
CDC	O
).	O

TITLE	O
:	O
A	O
novel	O
dromedary	B-SPEC
camel	B-SPEC
enterovirus	B-SPEC
in	O
the	O
family	B-SPEC
Picornaviridae	I-SPEC
from	O
dromedaries	B-SPEC
in	O
the	O
Middle	O
East	O
.	O

Analysis	O
of	O
two	O
DcEV	O
genomes	O
showed	O
that	O
DcEV	O
was	O
clustered	O
with	O
other	O
species	B-SPEC
of	O
the	O
genus	B-SPEC
Enterovirus	I-SPEC
and	O
was	O
most	O
closely	O
related	O
to	O
and	O
possessed	O
highest	O
amino	O
acid	O
identities	O
to	O
the	O
species	B-SPEC
Enterovirus	B-SPEC
E	O
and	O
Enterovirus	B-SPEC
F	O
found	O
in	O
cattle	B-SPEC
.	O

Subsequent	O
hunting	O
for	O
novel	O
coronaviruses	O
(	O
CoVs	O
)	O
led	O
to	O
the	O
discovery	O
of	O
two	O
additional	O
human	B-SPEC
and	O
over	O
40	O
animal	B-SPEC
CoVs	O
,	O
including	O
the	O
prototype	O
lineage	O
C	O
betacoronaviruses	O
,	O
Tylonycteris	B-SPEC
bat	B-SPEC
CoV	O
HKU4	O
and	O
Pipistrellus	B-SPEC
bat	B-SPEC
CoV	O
HKU5	O
;	O
these	O
are	O
phylogenetically	O
closely	O
related	O
to	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
CoV	O
,	O
which	O
has	O
affected	O
more	O
than	O
1	O
,	O
000	O
patients	O
with	O
over	O
35	O
%	O
fatality	O
since	O
its	O
emergence	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
The	O
ability	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
to	O
infect	O
small	O
animal	B-SPEC
species	B-SPEC
may	O
be	O
restricted	O
given	O
the	O
fact	O
that	O
mice	B-SPEC
,	O
ferrets	B-SPEC
,	O
and	O
hamsters	B-SPEC
were	O
shown	O
to	O
resist	O
MERS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
,	O
the	O
largest	O
RNA	O
viruses	B-SPEC
,	O
have	O
a	O
complex	O
program	O
of	O
RNA	O
synthesis	O
that	O
entails	O
genome	O
replication	O
and	O
transcription	O
of	O
subgenomic	O
mRNAs	O
.	O

We	O
initiated	O
a	O
dissection	O
of	O
MHV	B-SPEC
nsp3	O
aimed	O
at	O
identifying	O
those	O
activities	O
or	O
structures	O
in	O
this	O
huge	O
molecule	O
that	O
are	O
essential	O
to	O
replicase	O
activity	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Corona	B-SPEC
Virus	B-SPEC
(	O
MERS	O
CoV	O
):	O
The	O
next	O
steps	O
.	O

TITLE	O
:	O
Candidate	O
new	O
rotavirus	B-SPEC
species	B-SPEC
in	O
sheltered	O
dogs	B-SPEC
,	O
Hungary	O
.	O

ABSTRACT	O
:	O
Despite	O
a	O
regional	O
decline	O
in	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
infections	O
during	O
2013	O
-	O
14	O
,	O
cases	O
at	O
a	O
Florida	O
hospital	O
were	O
more	O
severe	O
than	O
those	O
during	O
2009	O
-	O
10	O
.	O

Influenza	B-SPEC
virus	I-SPEC
B	O
,	O
enterovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
and	O
parainfluenza	O
virus	B-SPEC
4	O
were	O
rarely	O
detected	O
(<	O
1	O
%).	O

During	O
PEDV	B-SPEC
infection	O
,	O
NF	O
-	O
B	O
p65	O
was	O
found	O
to	O
translocate	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
,	O
and	O
PEDV	B-SPEC
-	O
dependent	O
NF	O
-	O
B	O
activity	O
was	O
associated	O
with	O
viral	O
dose	O
and	O
active	O
replication	O
.	O

Using	O
small	O
interfering	O
RNAs	O
to	O
screen	O
different	O
mRNA	O
components	O
of	O
the	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
or	O
RIG	O
-	O
I	O
-	O
like	O
receptor	O
signalling	O
pathways	O
,	O
we	O
demonstrated	O
that	O
TLR2	O
,	O
TLR3	O
and	O
TLR9	O
contribute	O
to	O
NF	O
-	O
B	O
activation	O
in	O
response	O
to	O
PEDV	B-SPEC
infection	O
,	O
but	O
not	O
RIG	O
-	O
I	O
.	O
By	O
screening	O
PEDV	B-SPEC
structural	O
proteins	O
for	O
their	O
ability	O
to	O
induce	O
NF	O
-	O
B	O
activities	O
,	O
we	O
found	O
that	O
PEDV	B-SPEC
nucleocapsid	O
protein	O
(	O
N	O
)	O
could	O
activate	O
NF	O
-	O
B	O
and	O
that	O
the	O
central	O
region	O
of	O
N	O
was	O
essential	O
for	O
NF	O
-	O
B	O
activation	O
.	O

Biological	O
plausibility	O
of	O
aerosol	O
transmission	O
is	O
evaluated	O
for	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
and	O
norovirus	B-SPEC
and	O
discussed	O
for	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
,	O
influenza	O
,	O
and	O
Ebola	B-SPEC
virus	I-SPEC
.	O

The	O
pathogenesis	O
of	O
BP	O
in	O
dogs	B-SPEC
is	O
complex	O
and	O
the	O
role	O
of	O
canine	O
respiratory	O
viruses	B-SPEC
has	O
not	O
been	O
fully	O
evaluated	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
clinical	O
variables	O
between	O
BP	O
dogs	B-SPEC
with	O
and	O
without	O
a	O
viral	O
co	O
-	O
infection	O
.	O

TITLE	O
:	O
Middle	O
Eastern	O
Respiratory	O
Syndrome	O
Corona	B-SPEC
Virus	B-SPEC
(	O
MERS	O
CoV	O
):	O
case	O
reports	O
from	O
a	O
tertiary	O
care	O
hospital	O
in	O
Saudi	O
Arabia	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
a	O
new	O
human	B-SPEC
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
).	O

It	O
was	O
identified	O
to	O
be	O
approximately	O
32	O
kDa	O
as	O
a	O
His	O
-	O
tagged	O
fusion	O
protein	O
and	O
can	O
bind	O
IBV	B-SPEC
positive	O
serum	O
by	O
western	O
blot	O
analysis	O
.	O

The	O
risk	O
of	O
skidding	O
and	O
epidemiological	O
complications	O
conditionally	O
designated	O
as	O
high	O
,	O
moderate	O
and	O
minimal	O
risk	O
importation	O
of	O
measles	B-SPEC
virus	I-SPEC
-	O
Rate	O
was	O
considered	O
as	O
high	O
.	O

Moderate	O
risk	O
of	O
importation	O
was	O
determined	O
for	O
poliomyelitis	O
due	O
to	O
wild	O
poliovirus	B-SPEC
,	O
Lassa	O
fever	O
,	O
cholera	O
,	O
plague	O
,	O
and	O
the	O
minimal	O
--	O
for	O
Dengue	O
fever	O
,	O
yellow	O
fever	O
,	O
the	O
Middle	O
East	O
and	O
respiratory	O
syndrome	O
,	O
diseases	O
caused	O
by	O
viruses	B-SPEC
Marburg	O
and	O
Ebola	O
.	O

TITLE	O
:	O
Serotype	O
shift	O
of	O
a	O
793	O
/	O
B	O
genotype	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
by	O
natural	O
recombination	O
.	O

A	O
SimPlot	O
analysis	O
of	O
the	O
complete	O
genomic	O
sequence	O
,	O
which	O
was	O
confirmed	O
by	O
a	O
phylogenetic	O
analysis	O
and	O
nucleotide	O
similarities	O
using	O
the	O
corresponding	O
gene	O
fragments	O
,	O
suggested	O
that	O
isolate	O
ck	O
/	O
CH	O
/	O
LHLJ	O
/	O
140906	O
emerged	O
from	O
multiple	O
recombination	O
events	O
between	O
parental	O
IBV	B-SPEC
strains	O
4	O
/	O
91	O
and	O
H120	O
.	O

Although	O
the	O
isolate	O
ck	O
/	O
CH	O
/	O
LHLJ	O
/	O
140906	O
had	O
slightly	O
higher	O
S1	O
amino	O
acid	O
sequence	O
identity	O
to	O
strain	O
4	O
/	O
91	O
(	O
88	O
.	O
2	O
%)	O
than	O
to	O
strain	O
H120	O
(	O
86	O
%),	O
the	O
serotype	O
of	O
the	O
virus	B-SPEC
was	O
more	O
closely	O
related	O
to	O
that	O
of	O
the	O
H120	O
strain	O
(	O
32	O
%	O
antigenic	O
relatedness	O
)	O
than	O
to	O
the	O
4	O
/	O
91	O
strain	O
(	O
15	O
%	O
antigenic	O
relatedness	O
).	O

By	O
immunohistochemistry	O
,	O
PEDV	B-SPEC
antigens	O
were	O
evident	O
in	O
enterocytes	O
lining	O
the	O
villous	O
epithelium	O
.	O

Our	O
results	O
suggest	O
a	O
possible	O
involvement	O
of	O
structurally	O
impaired	O
TJ	O
and	O
AJ	O
in	O
the	O
pathogenesis	O
of	O
PEDV	B-SPEC
,	O
potentially	O
leading	O
to	O
secondary	O
bacterial	O
infections	O
.	O

The	O
TNC	O
was	O
higher	O
(	O
P	O
<	O
.	O
001	O
),	O
and	O
BASO	O
and	O
DIFF	O
counts	O
were	O
lower	O
(	O
P	O
<	O
.	O
001	O
and	O
P	O
<	O
.	O
05	O
)	O
in	O
FIP	O
than	O
in	O
non	O
-	O
FIP	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
H1N1	O
virus	B-SPEC
strain	O
was	O
associated	O
with	O
the	O
pandemic	O
outbreak	O
of	O
febrile	O
respiratory	O
infections	O
worldwide	O
in	O
2009	O
,	O
however	O
in	O
August	O
2010	O
,	O
the	O
WHO	O
announced	O
that	O
the	O
world	O
had	O
entered	O
the	O
postpandemic	O
period	O
.	O

ABSTRACT	O
:	O
Blastomyces	B-SPEC
dermatitidis	I-SPEC
is	O
a	O
dimorphic	O
fungus	B-SPEC
endemic	O
to	O
North	O
America	O
capable	O
of	O
causing	O
fatal	O
respiratory	O
failure	O
.	O

Patients	O
in	O
this	O
group	O
had	O
a	O
higher	O
incidence	O
of	O
pneumonia	O
and	O
/	O
or	O
atelectasis	O
on	O
chest	O
X	O
-	O
Ray	B-SPEC
(	O
21	O
.	O
7	O
%	O
vs	O
.	O
1	O
.	O
9	O
%,	O
P	O
=.	O
002	O
),	O
worse	O
response	O
to	O
bronchodilator	O
treatment	O
with	O
nebulized	O
adrenaline	O
(	O
69	O
,	O
5	O
%	O
vs	O
.	O
28	O
,	O
1	O
%,	O
P	O
=.	O
016	O
),	O
more	O
need	O
for	O
respiratory	O
assistance	O
(	O
high	O
flow	O
oxygen	O
therapy	O
(	O
17	O
.	O
4	O
%	O
vs	O
.	O
7	O
.	O
7	O
%,	O
p	O
=.	O
016	O
),	O
or	O
non	O
-	O
invasive	O
mechanical	O
ventilation	O
(	O
13	O
%	O
vs	O
.	O
5	O
.	O
8	O
%,	O
P	O
=.	O
034	O
),	O
and	O
more	O
admissions	O
to	O
the	O
PICU	B-SPEC
(	O
26	O
.	O
1	O
%	O
vs	O
.	O
6	O
.	O
8	O
%,	O
P	O
=.	O
007	O
).	O

ABSTRACT	O
:	O
Transpulmonary	O
bubble	O
transit	O
(	O
TPBT	O
)	O
detected	O
with	O
contrast	O
echocardiography	O
is	O
reported	O
as	O
a	O
sign	O
of	O
intrapulmonary	O
shunt	O
during	O
cirrhosis	O
or	O
exercise	O
in	O
healthy	O
humans	B-SPEC
.	O

We	O
aimed	O
to	O
do	O
a	O
nationwide	O
serosurvey	O
in	O
Saudi	O
Arabia	O
to	O
establish	O
the	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
,	O
both	O
in	O
the	O
general	O
population	O
and	O
in	O
populations	O
of	O
individuals	O
who	O
have	O
maximum	O
exposure	O
to	O
camels	B-SPEC
.	O

Along	O
with	O
progress	O
in	O
MERS	O
animal	B-SPEC
model	O
development	O
,	O
these	O
obstacles	O
can	O
be	O
circumvented	O
or	O
at	O
least	O
mitigated	O
.	O

Here	O
we	O
optimized	O
the	O
doses	O
of	O
S377	O
-	O
588	O
-	O
Fc	O
using	O
MF59	O
as	O
an	O
adjuvant	O
in	O
order	B-SPEC
to	O
elicit	O
strong	O
immune	O
responses	O
with	O
minimal	O
amount	O
of	O
antigen	O
.	O

At	O
the	O
time	O
of	O
the	O
initial	O
presentation	O
to	O
the	O
hospital	O
,	O
serological	O
signs	O
of	O
acute	O
infection	O
with	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	B-SPEC
)	O
were	O
present	O
;	O
EBV	B-SPEC
viremia	O
with	O
atypical	O
serological	O
response	O
persisted	O
during	O
two	O
-	O
year	O
follow	O
up	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
also	O
known	O
as	O
porcine	B-SPEC
coronavirus	B-SPEC
HKU15	O
,	O
was	O
first	O
detected	O
in	O
North	O
America	O
in	O
early	O
2014	O
and	O
associated	O
with	O
enteric	O
disease	O
in	O
pigs	B-SPEC
,	O
resulting	O
in	O
an	O
urgent	O
need	O
to	O
further	O
investigate	O
the	O
ecology	O
of	O
this	O
virus	B-SPEC
.	O

Among	O
355	O
arbitrarily	O
selected	O
serum	O
samples	O
collected	O
in	O
2014	O
and	O
originating	O
from	O
51	O
farms	O
across	O
18	O
U	O
.	O
S	O
.	O
states	O
,	O
anti	O
-	O
PDCoV	O
IgG	O
antibodies	O
were	O
detected	O
in	O
8	O
.	O
7	O
%	O
of	O
the	O
samples	O
and	O
in	O
25	O
.	O
5	O
%	O
of	O
the	O
farms	O
whereas	O
anti	O
-	O
PEDV	B-SPEC
IgG	O
was	O
detected	O
in	O
22	O
.	O
8	O
%	O
of	O
the	O
samples	O
and	O
in	O
54	O
.	O
9	O
%	O
of	O
the	O
farms	O
.	O

Despite	O
proven	O
,	O
effective	O
biosecurity	O
practices	O
,	O
multiple	O
sites	O
and	O
production	O
stages	O
,	O
within	O
and	O
across	O
designated	O
production	O
flows	O
in	O
an	O
Ohio	O
swine	B-SPEC
operation	O
broke	O
with	O
confirmed	O
PEDV	B-SPEC
in	O
January	O
2014	O
,	O
leading	O
the	O
producer	O
and	O
attending	O
veterinarian	O
to	O
investigate	O
the	O
route	O
of	O
introduction	O
.	O

In	O
addition	O
,	O
feed	O
pellets	O
collected	O
from	O
unopened	O
bags	O
at	O
the	O
affected	O
sites	O
tested	O
positive	O
for	O
PEDV	B-SPEC
using	O
RT	O
-	O
PCR	O
.	O

PEDV	B-SPEC
was	O
isolated	O
from	O
a	O
pig	B-SPEC
with	O
diarrhea	O
and	O
complete	O
genome	O
sequencing	O
found	O
>	O
99	O
%	O
nucleotide	O
identity	O
to	O
other	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
.	O

Six	O
new	O
bat	B-SPEC
CoV	O
reservoirs	O
were	O
identified	O
in	O
our	O
study	O
,	O
namely	O
Cynopterus	B-SPEC
sphinx	I-SPEC
,	O
Taphozous	B-SPEC
melanopogon	I-SPEC
,	O
Hipposideros	B-SPEC
lekaguli	O
,	O
Rhinolophus	B-SPEC
shameli	I-SPEC
,	O
Scotophilus	B-SPEC
heathii	I-SPEC
and	O
Megaderma	B-SPEC
lyra	I-SPEC
.	O

These	O
data	O
suggest	O
that	O
bat	B-SPEC
CoV	O
lineages	O
are	O
not	O
strictly	O
concordant	O
with	O
their	O
hosts	O
.	O

Our	O
phylogenetic	O
data	O
indicates	O
high	O
diversity	O
and	O
a	O
complex	O
ecology	O
of	O
CoVs	O
in	O
bats	B-SPEC
sampled	O
from	O
specific	O
areas	O
in	O
eastern	O
regions	O
of	O
Thailand	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
an	O
important	O
pig	B-SPEC
pathogen	O
that	O
can	O
cause	O
vomiting	O
,	O
diarrhea	O
,	O
and	O
dehydration	O
,	O
leading	O
to	O
serious	O
damage	O
to	O
the	O
swine	B-SPEC
industry	O
worldwide	O
.	O

Under	O
the	O
optimized	O
conditions	O
for	O
detection	O
of	O
PEDV	B-SPEC
RNA	O
,	O
the	O
nanoPCR	O
assay	O
was	O
100	O
-	O
fold	O
more	O
sensitive	O
than	O
a	O
conventional	O
RT	O
-	O
PCR	O
assay	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
demonstrate	O
the	O
application	O
of	O
a	O
nanoPCR	O
assay	O
for	O
the	O
detection	O
of	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
The	O
ratio	O
of	O
Th17	O
/	O
Treg	O
cells	O
as	O
a	O
risk	O
indicator	B-SPEC
in	O
early	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Outpatients	O
with	O
ARI	O
were	O
assayed	O
for	O
presence	O
of	O
18	O
viruses	B-SPEC
using	O
multiplex	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
MRT	O
-	O
PCR	O
)	O
to	O
simultaneously	O
detect	O
multiple	O
viruses	B-SPEC
.	O

Among	O
935	O
patients	O
,	O
60	O
%	O
tested	O
positive	O
for	O
a	O
single	O
virus	B-SPEC
,	O
9	O
%	O
tested	O
positive	O
for	O
	O
1	O
virus	B-SPEC
and	O
287	O
(	O
31	O
%)	O
tested	O
negative	O
.	O

Though	O
Madagascar	O
is	O
home	O
to	O
44	O
bat	B-SPEC
species	B-SPEC
(	O
41	O
insectivorous	O
and	O
3	O
frugivorous	O
)	O
of	O
which	O
34	O
are	O
endemic	O
,	O
no	O
data	O
exists	O
concerning	O
the	O
circulation	O
of	O
CoVs	O
in	O
the	O
island	O
'	O
s	O
chiropteran	O
fauna	O
.	O

From	O
351	O
frugivorous	O
bats	B-SPEC
,	O
we	O
detected	O
14	O
coronaviruses	O
from	O
two	O
endemic	O
bats	B-SPEC
species	B-SPEC
,	O
of	O
which	O
13	O
viruses	B-SPEC
were	O
identified	O
from	O
Pteropus	B-SPEC
rufus	I-SPEC
and	O
one	O
from	O
Eidolon	B-SPEC
dupreanum	O
,	O
giving	O
an	O
overall	O
prevalence	O
of	O
4	O
.	O
5	O
%.	O

The	O
natural	O
co	O
-	O
infection	O
of	O
HEV	B-SPEC
and	O
PCV2	O
in	O
pigs	B-SPEC
in	O
China	O
has	O
rarely	O
been	O
reported	O
.	O

CONCLUSIONS	O
:	O
HEV	B-SPEC
and	O
PCV2	O
co	O
-	O
infection	O
in	O
piglets	O
was	O
detected	O
in	O
four	O
out	O
of	O
seven	O
dead	O
pigs	B-SPEC
from	O
two	O
pig	B-SPEC
farms	O
in	O
Hebei	O
,	O
China	O
,	O
producing	O
severe	O
pathological	O
changes	O
.	O

Curcumin	O
,	O
extracted	O
from	O
turmeric	B-SPEC
,	O
exhibits	O
broad	O
anti	O
-	O
inflammatory	O
properties	O
through	O
down	O
-	O
regulating	O
inflammatory	O
cytokines	O
.	O

Meanwhile	O
,	O
compound	O
c26	O
reduced	O
the	O
LPS	O
-	O
induced	O
inflammatory	O
gene	O
expression	O
in	O
human	B-SPEC
pulmonary	O
epithelial	O
cells	O
.	O

Furthermore	O
,	O
the	O
phylogenetic	O
analysis	O
indicated	O
that	O
the	O
TGEV	B-SPEC
-	O
HX	O
strain	O
was	O
more	O
similar	O
to	O
the	O
TGEV	B-SPEC
Purdue	O
cluster	O
than	O
to	O
the	O
Miller	O
cluster	O
.	O

Haemophilus	B-SPEC
species	B-SPEC
bacteria	B-SPEC
pneumonia	O
in	O
trauma	O
patients	O
is	O
associated	O
with	O
high	O
rates	O
of	O
transient	O
hypoxemia	O
and	O
a	O
high	O
tracheostomy	O
rate	O
,	O
although	O
subsequent	O
outcomes	O
are	O
not	O
affected	O
.	O

ABSTRACT	O
:	O
It	O
is	O
well	O
known	O
that	O
many	O
viruses	B-SPEC
use	O
heparan	O
sulfate	O
as	O
the	O
initial	O
attachment	O
factor	O
.	O

The	O
inhibitory	O
effects	O
on	O
FIPV	O
infection	O
of	O
these	O
2	O
peptides	O
on	O
other	O
type	O
I	O
and	O
type	O
II	O
FIPV	O
strains	O
,	O
feline	B-SPEC
herpesvirus	I-SPEC
(	O
FHV	O
),	O
and	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
)	O
were	O
also	O
examined	O
.	O

The	O
result	O
of	O
phylogenetic	O
analysis	O
of	O
the	O
S	O
gene	O
showed	O
that	O
all	O
the	O
Taiwan	O
PEDV	B-SPEC
strains	O
were	O
closely	O
related	O
to	O
the	O
non	O
-	O
S	O
INDEL	O
strains	O
from	O
US	O
,	O
Canada	O
and	O
China	O
,	O
suggesting	O
a	O
common	O
ancestor	O
for	O
these	O
strains	O
.	O

As	O
compared	O
with	O
the	O
historic	O
PEDVs	O
and	O
CV777	O
-	O
based	O
vaccine	O
strains	O
,	O
the	O
nine	O
Taiwan	O
PEDV	B-SPEC
variants	O
shared	O
almost	O
the	O
same	O
genetic	O
signatures	O
as	O
the	O
global	O
non	O
-	O
S	O
INDEL	O
strains	O
,	O
including	O
a	O
series	O
of	O
insertions	O
,	O
deletions	O
and	O
mutations	O
in	O
the	O
amino	O
terminal	O
as	O
well	O
as	O
identical	O
mutations	O
in	O
the	O
neutralizing	O
epitopes	O
of	O
the	O
S	O
gene	O
.	O

The	O
information	O
settings	O
all	O
took	O
place	O
within	O
the	O
College	O
of	O
Nursing	O
,	O
Princess	O
Nourah	O
University	O
,	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

The	O
delayed	O
and	O
/	O
or	O
lower	O
antibody	O
response	O
combined	O
with	O
lower	O
IgG	O
avidity	O
indices	O
coincided	O
with	O
increased	O
tracheal	O
inflammation	O
and	O
depletion	O
of	O
tracheal	O
epithelia	O
cells	O
and	O
goblet	O
cells	O
upon	O
IBV	B-SPEC
field	O
strain	O
challenge	O
.	O

ABSTRACT	O
:	O
The	O
family	B-SPEC
Coronaviridae	I-SPEC
represents	O
a	O
diverse	O
group	O
of	O
vertebrate	B-SPEC
RNA	O
viruses	B-SPEC
,	O
all	O
with	O
genomes	O
greater	O
than	O
26	O
,	O
000	O
nt	O
.	O

The	O
multisystemic	O
granulomatous	O
lesions	O
were	O
suggestive	O
of	O
ferret	B-SPEC
systemic	I-SPEC
coronavirus	I-SPEC
(	O
FRSCV	O
).	O

To	O
the	O
authors	O
'	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
ocular	O
lesions	O
in	O
a	O
ferret	B-SPEC
with	O
systemic	O
coronavirus	B-SPEC
disease	O
,	O
suggesting	O
that	O
ferrets	B-SPEC
presented	O
with	O
similar	O
ocular	O
lesions	O
should	O
also	O
be	O
evaluated	O
for	O
evidence	O
of	O
coronavirus	B-SPEC
infection	O
.	O

In	O
addition	O
,	O
monitoring	O
molecular	O
changes	O
in	O
the	O
virus	B-SPEC
can	O
help	O
elucidate	O
chains	O
of	O
transmission	O
and	O
identify	O
mutations	O
that	O
might	O
influence	O
virus	B-SPEC
transmission	O
efficiency	O
.	O

Three	O
truncated	O
segments	O
(	O
S	O
(	O
1	O
-	O
291	O
),	O
S	O
(	O
277	O
-	O
794	O
)	O
and	O
S	O
(	O
548	O
-	O
868	O
))	O
of	O
the	O
S	O
gene	O
of	O
PHEV	O
and	O
the	O
NCAM	O
gene	O
were	O
cloned	O
individually	O
into	O
the	O
Escherichia	B-SPEC
coli	I-SPEC
expression	O
vectors	O
and	O
yeast	B-SPEC
two	O
-	O
hybrid	O
expression	O
vectors	O
.	O

This	O
study	O
highlights	O
the	O
high	O
prevalence	O
of	O
IBV	B-SPEC
in	O
poultry	O
farms	O
in	O
Morocco	O
and	O
confirms	O
its	O
continuous	O
dynamic	O
changes	O
and	O
evolution	O
.	O

Pigs	B-SPEC
were	O
monitored	O
for	O
clinical	O
signs	O
and	O
PEDV	B-SPEC
RNA	O
titers	O
in	O
feces	O
and	O
serum	O
.	O

Severe	O
watery	O
diarrhea	O
and	O
atrophic	O
enteritis	O
with	O
moderate	O
to	O
high	O
PEDV	B-SPEC
RNA	O
titers	O
in	O
feces	O
(	O
7	O
.	O
5	O
-	O
12	O
.	O
2	O
log10	O
GE	O
/	O
ml	O
)	O
and	O
low	O
viral	O
RNA	O
titers	O
in	O
serum	O
(	O
5	O
.	O
6	O
-	O
8	O
.	O
6	O
log10	O
GE	O
/	O
ml	O
)	O
were	O
observed	O
in	O
all	O
inoculated	O
nursing	O
piglets	O
at	O
PIDs	O
1	O
-	O
5	O
.	O

ABSTRACT	O
:	O
Clinical	O
disease	O
associated	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
in	O
nave	O
pigs	B-SPEC
is	O
well	O
chronicled	O
;	O
however	O
,	O
information	O
on	O
endemic	O
PEDV	B-SPEC
infection	O
is	O
limited	O
.	O

Pigs	B-SPEC
S1	O
and	O
S2	O
were	O
PEDV	B-SPEC
-	O
positive	O
within	O
24	O
hours	O
of	O
commingling	O
.	O

All	O
PG	O
/	O
C	O
pigs	B-SPEC
were	O
PEDV	B-SPEC
PCR	O
-	O
negative	O
post	O
-	O
challenge	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
highly	O
pathogenic	O
virus	B-SPEC
that	O
causes	O
severe	O
respiratory	O
illness	O
accompanied	O
by	O
multi	O
-	O
organ	O
dysfunction	O
,	O
resulting	O
in	O
a	O
case	O
fatality	O
rate	O
of	O
approximately	O
40	O
%.	O

ABSTRACT	O
:	O
Pantropic	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
was	O
first	O
detected	O
in	O
young	O
dogs	B-SPEC
in	O
Italy	O
in	O
2005	O
,	O
but	O
the	O
complete	O
genome	O
sequence	O
of	O
this	O
virus	B-SPEC
had	O
not	O
yet	O
been	O
determined	O
.	O

Under	O
PCV	B-SPEC
mode	O
,	O
compared	O
with	O
the	O
initial	O
level	O
of	O
tidal	O
volume	O
(	O
V	O
T	O
),	O
ARF	O
patients	O
showed	O
30	O
.	O
0	O
%	O
and	O
27	O
.	O
8	O
%	O
decrease	O
at	O
1	O
min	O
and	O
10	O
min	O
,	O
respectively	O
.	O

Additionally	O
,	O
microbiota	B-SPEC
from	O
LPS	O
-	O
treated	O
mice	B-SPEC
intensified	O
IL	O
-	O
6	O
-	O
induced	O
lung	O
inflammation	O
in	O
naive	O
mice	B-SPEC
.	O

For	O
years	O
,	O
the	O
diagnosis	O
of	O
viral	O
pneumonia	O
was	O
based	O
on	O
cell	O
culture	O
and	O
antigen	O
detection	O
,	O
but	O
since	O
the	O
introduction	O
of	O
polymerase	O
chain	O
reaction	O
techniques	O
in	O
the	O
clinical	O
setting	O
,	O
identification	O
of	O
these	O
pathogens	O
has	O
increased	O
and	O
new	O
microorganisms	O
such	O
as	O
human	B-SPEC
bocavirus	I-SPEC
have	O
been	O
discovered	O
.	O

As	O
avian	B-SPEC
influenza	O
subtype	O
H9	O
is	O
associated	O
with	O
human	B-SPEC
infections	O
,	O
the	O
implications	O
of	O
our	O
findings	O
from	O
a	O
public	O
health	O
context	O
remain	O
to	O
be	O
investigated	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Infections	O
in	O
Pediatric	O
Outpatients	O
with	O
Febrile	O
Respiratory	O
Tract	O
Infections	O
in	O
Hiroshima	O
,	O
Japan	O
,	O
over	O
a	O
3	O
-	O
Year	O
Period	O
.	O

We	O
identified	O
15	O
coronavirus	B-SPEC
-	O
positive	O
specimens	O
:	O
eight	O
with	O
OC43	O
,	O
5	O
with	O
NL63	O
,	O
2	O
with	O
HKU1	O
,	O
and	O
none	O
with	O
229E	O
.	O

The	O
objective	O
of	O
this	O
study	O
is	O
to	O
develop	O
a	O
rapid	O
,	O
sensitive	O
,	O
and	O
real	O
-	O
time	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
)	O
method	O
for	O
the	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
less	O
equipped	O
laboratories	O
.	O

RESULTS	O
:	O
The	O
optimal	O
reaction	O
condition	O
of	O
the	O
current	O
real	O
-	O
time	O
RT	O
-	O
LAMP	O
for	O
PEDV	B-SPEC
was	O
62	O
	O
C	O
for	O
45	O
min	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
important	O
reservoirs	O
for	O
several	O
viruses	B-SPEC
,	O
many	O
of	O
which	O
cause	O
lethal	O
infections	O
in	O
humans	B-SPEC
but	O
have	O
reduced	O
pathogenicity	O
in	O
bats	B-SPEC
.	O

Using	O
next	O
-	O
generation	O
transcriptome	O
sequencing	O
(	O
mRNA	O
-	O
seq	O
),	O
we	O
profiled	O
the	O
transcriptional	O
response	O
of	O
Pteropus	B-SPEC
vampyrus	I-SPEC
bat	B-SPEC
kidney	O
(	O
PVK	O
)	O
cells	O
to	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
an	O
avian	B-SPEC
paramyxovirus	I-SPEC
known	O
to	O
elicit	O
a	O
strong	O
innate	O
immune	O
response	O
in	O
mammalian	B-SPEC
cells	O
.	O

The	O
Pteropus	B-SPEC
genus	B-SPEC
is	O
a	O
known	O
reservoir	O
of	O
Nipah	B-SPEC
virus	I-SPEC
(	O
NiV	O
)	O
and	O
Hendra	B-SPEC
virus	I-SPEC
(	O
HeV	B-SPEC
).	O

Although	O
several	O
vaccines	O
against	O
these	O
viruses	B-SPEC
are	O
commercially	O
available	O
there	O
is	O
room	O
for	O
improvement	O
,	O
especially	O
in	O
the	O
case	O
of	O
PRRSV	B-SPEC
.	O

In	O
addition	O
,	O
the	O
DUB	O
-	O
negative	O
virus	B-SPEC
provided	O
a	O
similar	O
degree	O
of	O
protection	O
against	O
clinical	O
disease	O
as	O
its	O
DUB	O
-	O
positive	O
parental	O
counterpart	O
.	O

TITLE	O
:	O
Genetic	O
manipulation	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
recovered	O
from	O
a	O
full	O
-	O
length	O
infectious	O
cDNA	O
clone	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
acute	O
diarrhoea	O
and	O
dehydration	O
in	O
swine	B-SPEC
of	O
all	O
ages	O
,	O
with	O
significant	O
mortality	O
in	O
neonatal	O
pigs	B-SPEC
.	O

When	O
a	O
functional	O
ORF3	O
gene	O
was	O
restored	O
,	O
the	O
recombinant	O
virus	B-SPEC
could	O
not	O
be	O
rescued	O
,	O
suggesting	O
that	O
ORF3	O
could	O
suppress	O
PEDV	B-SPEC
replication	O
in	O
vitro	O
.	O

The	O
more	O
unusual	O
viral	O
diseases	O
,	O
Ebola	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
and	O
Chikungunha	O
virus	B-SPEC
,	O
receive	O
media	O
attention	O
but	O
present	O
minimal	O
risk	O
to	O
the	O
state	O
,	O
while	O
the	O
annual	O
influenza	O
epidemic	O
continues	O
to	O
plague	O
us	O
all	O
.	O

Here	O
,	O
we	O
describe	O
the	O
establishment	O
of	O
tissue	O
-	O
like	O
assemblies	O
for	O
human	B-SPEC
lung	O
and	O
neuronal	O
tissue	O
that	O
we	O
infected	O
with	O
a	O
variety	O
of	O
viruses	B-SPEC
including	O
the	O
respiratory	O
pathogens	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
(	O
PIV3	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
SARS	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
as	O
well	O
as	O
the	O
human	B-SPEC
neurotropic	O
herpesvirus	B-SPEC
,	O
varicella	B-SPEC
-	I-SPEC
zoster	I-SPEC
virus	I-SPEC
(	O
VZV	B-SPEC
).	O

RESULTS	O
:	O
Eighty	O
-	O
four	O
articles	O
met	O
inclusion	O
criteria	O
,	O
including	O
1	O
controlled	O
clinical	O
trial	O
,	O
3	O
animal	B-SPEC
studies	O
,	O
and	O
80	O
case	O
reports	O
or	O
case	O
series	O
,	O
yielding	O
an	O
overall	O
very	O
low	O
quality	O
of	O
evidence	O
for	O
all	O
recommendations	O
.	O

ABSTRACT	O
:	O
Since	O
May	O
2013	O
,	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
have	O
devastated	O
the	O
U	O
.	O
S	O
.	O
swine	B-SPEC
industry	O
,	O
causing	O
immense	O
economic	O
losses	O
.	O

TITLE	O
:	O
Adenovirus	B-SPEC
pneumonia	O
complicated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
case	O
report	O
.	O

ABSTRACT	O
:	O
Apart	O
from	O
sporadic	O
exported	O
cases	O
,	O
the	O
occurrence	O
of	O
Ebola	O
,	O
Marburg	O
and	O
Lassa	B-SPEC
virus	I-SPEC
diseases	O
is	O
limited	O
to	O
the	O
African	O
continent	O
.	O

The	O
severity	O
of	O
C5a	O
-	O
ALI	O
was	O
aggravated	O
in	O
C5	O
-	O
deficient	O
mice	B-SPEC
.	O

The	O
dromedary	B-SPEC
camel	B-SPEC
is	O
the	O
intermediate	O
host	O
of	O
MERS	O
-	O
CoV	O
,	O
but	O
the	O
transmission	O
cycle	O
is	O
not	O
fully	O
understood	O
.	O

Hospitalization	O
for	O
bronchiolitis	O
(	O
ICD	O
-	O
9	O
code	O
466	O
.	O
1	O
)	O
during	O
the	O
first	O
year	O
of	O
life	O
was	O
assessed	O
through	O
phone	O
interview	O
at	O
the	O
end	O
of	O
the	O
RSV	B-SPEC
season	O
(	O
November	O
-	O
March	O
)	O
and	O
at	O
the	O
completion	O
of	O
the	O
first	O
year	O
of	O
life	O
.	O

TITLE	O
:	O
Genomic	O
Analysis	O
of	O
15	O
Human	B-SPEC
Coronaviruses	O
OC43	O
(	O
HCoV	O
-	O
OC43s	O
)	O
Circulating	O
in	O
France	O
from	O
2001	O
to	O
2013	O
Reveals	O
a	O
High	O
Intra	O
-	O
Specific	O
Diversity	O
with	O
New	O
Recombinant	O
Genotypes	O
.	O

The	O
association	O
of	O
these	O
different	O
clusters	O
of	O
genes	O
in	O
our	O
specimens	O
led	O
to	O
the	O
description	O
of	O
thirteen	O
genetically	O
distinct	O
genotypes	O
,	O
among	O
which	O
eight	O
recombinant	O
viruses	B-SPEC
were	O
discovered	O
.	O

Among	O
the	O
9	O
phages	O
selected	O
that	O
specifically	O
bound	O
to	O
rS	O
-	O
AD	O
,	O
the	O
phage	O
bearing	O
the	O
peptide	O
TLNMHLFPFHTG	O
bound	O
with	O
the	O
highest	O
affinity	O
and	O
was	O
subsequently	O
used	O
to	O
develop	O
a	O
phage	O
-	O
based	O
ELISA	O
for	O
TGEV	B-SPEC
.	O

Previously	O
,	O
it	O
was	O
shown	O
that	O
MyD88	O
,	O
an	O
adaptor	O
protein	O
necessary	O
for	O
signaling	O
by	O
multiple	O
TLRs	O
,	O
is	O
a	O
required	O
component	O
of	O
the	O
innate	O
immune	O
response	O
to	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
infection	O
in	O
vivo	O
.	O

In	O
contrast	O
,	O
mice	B-SPEC
deficient	O
in	O
the	O
TLR3	O
/	O
TLR4	O
adaptor	O
TRIF	O
are	O
highly	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
infection	O
,	O
showing	O
increased	O
weight	O
loss	O
,	O
mortality	O
,	O
reduced	O
lung	O
function	O
,	O
increased	O
lung	O
pathology	O
,	O
and	O
higher	O
viral	O
titers	O
.	O

Distinct	O
alterations	O
in	O
inflammation	O
were	O
present	O
in	O
TRIF	O
(-/-)	O
mice	B-SPEC
infected	O
with	O
SARS	O
-	O
CoV	O
,	O
including	O
excess	O
infiltration	O
of	O
neutrophils	O
and	O
inflammatory	O
cell	O
types	O
that	O
correlate	O
with	O
increased	O
pathology	O
of	O
other	O
known	O
causes	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
including	O
influenza	B-SPEC
virus	I-SPEC
infections	O
.	O

In	O
the	O
last	O
15	O
years	O
,	O
the	O
emergence	O
of	O
highly	O
pathogenic	O
coronaviruses	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
has	O
caused	O
significant	O
disease	O
accompanied	O
by	O
high	O
mortality	O
rates	O
in	O
human	B-SPEC
populations	O
,	O
but	O
no	O
approved	O
therapeutic	O
treatments	O
or	O
vaccines	O
currently	O
exist	O
.	O

RESULTS	O
:	O
In	O
February	O
-	O
March	O
2013	O
the	O
number	O
of	O
children	O
protected	O
by	O
antibodies	O
against	O
influenza	O
decreased	O
,	O
and	O
circulation	O
of	O
influenza	B-SPEC
viruses	I-SPEC
A	O
/	O
H3N2	O
and	O
A	O
/	O
H1N1	O
/	O
pdm09	O
was	O
detected	O
.	O

ABSTRACT	O
:	O
Tissue	O
factor	O
(	O
TF	O
)	O
and	O
tissue	O
factor	O
pathway	O
inhibitor	O
(	O
TFPI	O
)	O
play	O
a	O
central	O
role	O
in	O
the	O
endothelial	O
permeability	O
regulation	O
and	O
dysfunction	O
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
sepsis	B-SPEC
and	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
).	O

TITLE	O
:	O
Complete	O
genome	O
characterization	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
Vietnam	O
.	O

The	O
use	O
of	O
high	O
-	O
flow	O
nasal	O
cannula	B-SPEC
is	O
a	O
promising	O
treatment	O
for	O
respiratory	O
disease	O
;	O
however	O
,	O
at	O
this	O
time	O
,	O
the	O
efficacy	O
of	O
high	O
-	O
flow	O
nasal	O
cannula	B-SPEC
compared	O
with	O
noninvasive	O
positive	O
pressure	O
ventilation	O
is	O
unknown	O
.	O

PubMed	O
,	O
EMBASE	O
,	O
CINAHL	O
,	O
SCOPUS	B-SPEC
,	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
from	O
inception	O
until	O
January	O
2013	O
using	O
the	O
following	O
keywords	O
in	O
various	O
combinations	O
:	O
ARDS	O
,	O
treatment	O
,	O
nitric	O
oxide	O
,	O
heliox	O
,	O
steroids	O
,	O
surfactant	O
,	O
etanercept	O
,	O
prostaglandin	O
therapy	O
,	O
inhaled	O
beta	O
adrenergic	O
receptor	O
agonists	O
,	O
N	O
-	O
acetylcysteine	O
,	O
ipratroprium	O
bromide	O
,	O
dornase	O
,	O
plasminogen	O
activators	O
,	O
fibrinolytics	O
or	O
other	O
anticoagulants	O
,	O
and	O
children	O
.	O

Serotyping	O
and	O
genotyping	O
are	O
the	O
common	O
methods	O
of	O
classification	O
of	O
IBV	B-SPEC
strains	O
.	O

ABSTRACT	O
:	O
A	O
number	O
of	O
emerging	O
and	O
re	O
-	O
emerging	O
viruses	B-SPEC
have	O
caused	O
epidemics	O
or	O
pandemics	O
of	O
infectious	O
diseases	O
leading	O
to	O
major	O
devastations	O
throughout	O
human	B-SPEC
history	O
.	O

TITLE	O
:	O
Understanding	O
the	O
T	O
cell	O
immune	O
response	O
in	O
SARS	O
coronavirus	B-SPEC
infection	O
.	O

However	O
,	O
recent	O
studies	O
in	O
mice	B-SPEC
suggest	O
the	O
importance	O
of	O
T	O
cells	O
in	O
viral	O
clearance	O
during	O
SARS	O
-	O
CoV	O
infection	O
.	O

This	O
review	O
covers	O
the	O
available	O
literature	O
on	O
the	O
emerging	O
importance	O
of	O
T	O
cell	O
responses	O
in	O
SARS	O
-	O
CoV	O
infection	O
,	O
particularly	O
on	O
the	O
mapping	O
of	O
cytotoxic	O
T	O
lymphocyte	O
(	O
CTL	O
)	O
epitopes	O
,	O
longevity	O
,	O
polyfunctionality	O
and	O
human	B-SPEC
leukocyte	O
antigen	O
(	O
HLA	O
)	O
association	O
as	O
well	O
as	O
their	O
potential	O
implications	O
on	O
treatment	O
and	O
vaccine	O
development	O
.	O

Depletion	O
of	O
the	O
antiviral	O
double	O
-	O
stranded	O
RNA	O
-	O
activated	O
protein	O
kinase	O
(	O
PKR	O
)	O
enhanced	O
virus	B-SPEC
replication	O
in	O
the	O
primary	O
screen	O
,	O
and	O
validation	O
experiments	O
confirmed	O
increased	O
SARS	O
-	O
CoV	O
protein	O
expression	O
and	O
virus	B-SPEC
production	O
upon	O
PKR	O
depletion	O
.	O

Our	O
screen	O
identified	O
a	O
variety	O
of	O
hits	O
and	O
will	O
form	O
the	O
basis	O
for	O
more	O
detailed	O
follow	O
-	O
up	O
studies	O
that	O
should	O
contribute	O
to	O
a	O
better	O
understanding	O
of	O
SARS	O
-	O
CoV	O
replication	O
and	O
coronavirus	B-SPEC
-	O
host	O
interactions	O
in	O
general	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
nsp10	O
/	O
nsp16	O
Methyltransferase	O
Can	O
Be	O
Targeted	O
by	O
nsp10	O
-	O
Derived	O
Peptide	O
In	O
Vitro	O
and	O
In	O
Vivo	O
To	O
Reduce	O
Replication	O
and	O
Pathogenesis	O
.	O

Based	O
on	O
our	O
current	O
and	O
previous	O
studies	O
,	O
we	O
designed	O
a	O
peptide	O
(	O
TP29	O
)	O
from	O
the	O
sequence	O
of	O
the	O
interaction	O
interface	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nsp10	O
and	O
demonstrated	O
that	O
the	O
peptide	O
inhibits	O
the	O
2	O
'-	O
O	O
-	O
MTase	O
activity	O
of	O
different	O
coronaviruses	O
in	O
biochemical	O
assays	O
and	O
the	O
viral	O
replication	O
in	O
MHV	B-SPEC
infection	O
and	O
SARS	O
-	O
CoV	O
replicon	O
models	O
.	O

We	O
demonstrate	O
that	O
a	O
peptide	O
derived	O
from	O
the	O
nsp16	O
-	O
interacting	O
domain	O
of	O
MHV	B-SPEC
nsp10	O
could	O
inhibit	O
2	O
'-	O
O	O
-	O
MTase	O
activity	O
of	O
different	O
coronaviruses	O
in	O
vitro	O
and	O
viral	O
replication	O
of	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
replicon	O
in	O
cell	O
culture	O
,	O
and	O
it	O
could	O
strongly	O
inhibit	O
virus	B-SPEC
replication	O
and	O
pathogenesis	O
in	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

As	O
with	O
coronavirus	B-SPEC
transcripts	O
,	O
arterivirus	B-SPEC
mRNAs	O
are	O
assumed	O
to	O
possess	O
a	O
5	O
'	O
cap	O
although	O
no	O
candidate	O
MTases	O
have	O
been	O
identified	O
thus	O
far	O
.	O

Only	O
one	O
invariant	O
and	O
several	O
partially	O
conserved	O
,	O
predominantly	O
aromatic	O
residues	O
were	O
identified	O
in	O
nsp12	O
,	O
which	O
may	O
adopt	O
a	O
structure	O
with	O
alternating	O
	O
-	O
helices	B-SPEC
and	O
	O
-	O
strands	O
,	O
an	O
organization	O
also	O
found	O
in	O
known	O
MTases	O
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
functional	O
domain	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
receptor	O
.	O

ABSTRACT	O
:	O
A	O
2	O
-	O
year	O
-	O
old	O
male	O
ferret	B-SPEC
was	O
presented	O
with	O
central	O
nervous	O
system	O
signs	O
.	O

Both	O
community	O
-	O
acquired	O
and	O
hospital	O
-	O
acquired	O
cases	O
have	O
been	O
reported	O
with	O
little	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
reported	O
in	O
the	O
community	O
.	O

An	O
OR	O
gate	O
that	O
coordinately	O
triggered	O
on	O
viral	O
amplicons	O
further	O
guaranteed	O
fail	O
-	O
safe	O
virus	B-SPEC
detection	O
.	O

Of	O
the	O
100	O
HCPs	O
tested	O
during	O
the	O
summer	O
,	O
37	O
tested	O
positive	O
for	O
at	O
least	O
1	O
bacterium	B-SPEC
,	O
and	O
4	O
tested	O
positive	O
for	O
a	O
viral	O
agent	O
.	O

No	O
FDA	O
-	O
approved	O
drug	O
therapy	O
currently	O
exists	O
for	O
treatment	O
of	O
humans	B-SPEC
with	O
ARDS	O
.	O

There	O
is	O
accumulating	O
evidence	O
in	O
rodents	B-SPEC
and	O
humans	B-SPEC
suggesting	O
that	O
extracellular	O
histones	O
are	O
strong	O
drivers	O
of	O
inflammation	O
and	O
tissue	O
damage	O
.	O

The	O
distances	O
between	O
DdCoV	O
and	O
CdCoV	O
are	O
large	O
enough	O
to	O
separate	O
them	O
into	O
different	O
species	B-SPEC
within	O
the	O
genus	B-SPEC
Gammacoronavirus	B-SPEC
.	O

In	O
conclusion	O
,	O
this	O
study	O
shed	O
novel	O
insight	O
into	O
the	O
genetic	O
diversity	O
,	O
evolution	O
,	O
distribution	O
,	O
and	O
taxonomy	O
of	O
the	O
coronaviruses	O
circulating	O
in	O
chickens	B-SPEC
and	O
ducks	B-SPEC
.	O

Thus	O
,	O
receptor	O
expression	O
patterns	O
can	O
define	O
viral	O
tissue	O
tropism	O
and	O
might	O
to	O
some	O
extent	O
predict	O
the	O
susceptibility	O
of	O
a	O
host	O
to	O
a	O
particular	O
virus	B-SPEC
.	O

Avian	B-SPEC
coronaviruses	O
are	O
economically	O
important	O
viruses	B-SPEC
for	O
the	O
poultry	O
industry	O
.	O

However	O
,	O
there	O
were	O
no	O
reports	O
of	O
mild	O
pathogenicity	O
of	O
a	O
variant	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
China	O
.	O

There	O
is	O
a	O
paucity	O
of	O
data	O
regarding	O
detection	O
and	O
characterisation	O
of	O
gastroenteritis	O
viruses	B-SPEC
,	O
particularly	O
novel	O
viruses	B-SPEC
,	O
in	O
porcines	O
in	O
Ireland	O
.	O

TITLE	O
:	O
Anthrax	B-SPEC
lethal	O
toxin	O
-	O
induced	O
lung	O
injury	O
and	O
treatment	O
by	O
activating	O
MK2	O
.	O

We	O
also	O
studied	O
the	O
interactions	O
between	O
MVs	O
and	O
human	B-SPEC
monocytes	O
and	O
human	B-SPEC
alveolar	O
epithelial	O
type	O
2	O
cells	O
.	O

Cases	O
of	O
CoV	O
infection	O
occurring	O
in	O
HSCT	O
and	O
hematologic	O
malignancy	O
patients	O
were	O
identified	O
and	O
the	O
clinical	O
characteristics	O
of	O
these	O
cases	O
were	O
compared	O
to	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Among	O
these	O
patients	O
,	O
CoV	O
was	O
detected	O
in	O
9	O
.	O
7	O
%	O
of	O
unique	O
infection	O
episodes	O
,	O
with	O
only	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
RhV	O
/	O
EnV	O
)	O
infection	O
being	O
more	O
common	O
.	O

We	O
evaluated	O
the	O
capability	O
of	O
disinfectants	O
to	O
both	O
inactivate	O
PEDV	B-SPEC
and	O
sufficiently	O
damage	O
viral	O
RNA	O
beyond	O
RT	O
-	O
PCR	O
detection	O
.	O

Ultimately	O
,	O
viable	O
PEDV	B-SPEC
was	O
not	O
detected	O
following	O
application	O
of	O
each	O
of	O
the	O
tested	O
disinfectants	O
,	O
however	O
in	O
most	O
cases	O
RT	O
-	O
PCR	O
detection	O
of	O
viral	O
RNA	O
remained	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
common	O
variants	O
across	O
the	O
nuclear	O
factor	O
erythroid	O
2	O
-	O
like	O
2	O
(	O
NFE2L2	O
)	O
gene	O
contribute	O
to	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Our	O
study	O
indicates	O
viral	O
CAP	O
is	O
an	O
underestimated	O
disease	O
and	O
points	O
out	O
hMPV	B-SPEC
as	O
a	O
new	O
important	O
target	O
for	O
the	O
prevention	O
of	O
childhood	O
CAP	O
.	O

ABSTRACT	O
:	O
Infections	O
caused	O
by	O
respiratory	O
viruses	B-SPEC
sometimes	O
occur	O
as	O
epidemias	O
or	O
pandemias	O
and	O
are	O
an	O
important	O
public	O
health	O
problem	O
in	O
the	O
whole	O
world	O
.	O

Influenza	B-SPEC
virus	I-SPEC
type	I-SPEC
A	I-SPEC
and	O
B	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
adenovirus	B-SPEC
and	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
-	O
3	O
were	O
investigated	O
using	O
shell	O
-	O
vial	O
cell	O
culture	O
method	O
and	O
direct	O
fluorescent	O
antibody	O
test	O
and	O
/	O
or	O
multiplex	O
PCR	O
test	O
.	O

ABSTRACT	O
:	O
Middle	O
east	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
recently	O
identified	O
as	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
known	O
to	O
infect	O
human	B-SPEC
with	O
high	O
mortality	O
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
Receptor	O
-	O
Binding	O
Domain	O
of	O
the	O
Spike	O
Glycoprotein	O
of	O
Human	B-SPEC
Betacoronavirus	B-SPEC
HKU1	O
.	O

To	O
identify	O
the	O
receptor	O
-	O
binding	O
domain	O
in	O
the	O
spike	O
of	O
human	B-SPEC
	O
-	O
CoV	O
HKU1	O
in	O
group	O
A	O
,	O
we	O
generated	O
and	O
mapped	O
a	O
panel	O
of	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
to	O
the	O
ectodomain	O
of	O
HKU1	O
spike	O
protein	O
.	O

Preincubation	O
of	O
HTBE	O
cells	O
with	O
a	O
truncated	O
HKU1	O
S	O
protein	O
that	O
includes	O
the	O
C	O
domain	O
blocked	O
infection	O
with	O
HKU1	O
virus	B-SPEC
,	O
but	O
preincubation	O
of	O
cells	O
with	O
truncated	O
S	O
protein	O
containing	O
only	O
the	O
NTD	O
did	O
not	O
block	O
infection	O
.	O

VSRs	O
have	O
been	O
widely	O
studied	O
for	O
plant	B-SPEC
and	O
insect	B-SPEC
viruses	B-SPEC
,	O
but	O
only	O
a	O
few	O
have	O
been	O
defined	O
for	O
mammalian	B-SPEC
viruses	B-SPEC
currently	O
.	O

We	O
also	O
outline	O
military	O
-	O
specific	O
initiatives	O
in	O
(	O
i	O
)	O
surveillance	O
,	O
(	O
ii	O
)	O
vaccine	O
development	O
and	O
policy	O
,	O
(	O
iii	O
)	O
novel	O
influenza	O
and	O
coronavirus	B-SPEC
diagnostic	O
test	O
development	O
and	O
surveillance	O
methods	O
,	O
(	O
iv	O
)	O
influenza	B-SPEC
virus	I-SPEC
transmission	O
and	O
severity	O
prediction	O
modeling	O
efforts	O
,	O
and	O
(	O
v	O
)	O
evaluation	O
and	O
implementation	O
of	O
nonvaccine	O
,	O
nonpharmacologic	O
interventions	O
.	O

Respiratory	O
secretions	O
were	O
tested	O
for	O
nucleic	O
acids	O
of	O
a	O
panel	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Viral	O
etiology	O
was	O
determined	O
using	O
conventional	O
cell	O
culture	O
and	O
a	O
commercial	O
respiratory	O
virus	B-SPEC
panel	O
fast	O
assay	O
(	O
xTAG	O
RVP	O
),	O
capable	O
of	O
detecting	O
19	O
different	O
respiratory	O
viruses	B-SPEC
and	O
subtype	O
targets	O
.	O

The	O
diagnosis	O
of	O
hantavirus	B-SPEC
infections	O
in	O
humans	B-SPEC
is	O
based	O
on	O
clinical	O
and	O
epidemiological	O
information	O
as	O
well	O
as	O
laboratory	O
tests	O
.	O

We	O
review	O
diagnosis	O
for	O
hantavirus	B-SPEC
infections	O
based	O
on	O
serology	O
,	O
PCR	O
,	O
immunochemistry	O
and	O
virus	B-SPEC
culture	O
.	O

TITLE	O
:	O
The	O
dynamics	O
of	O
Chinese	O
variant	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
production	O
in	O
Vero	O
cells	O
and	O
intestines	O
of	O
2	O
-	O
day	O
old	O
piglets	O
.	O

HCP	O
-	O
related	O
infections	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
Ebola	O
,	O
and	O
SARS	O
have	O
been	O
reported	O
among	O
1	O
-	O
27	O
%,	O
2	O
.	O
5	O
-	O
12	O
%,	O
and	O
11	O
-	O
57	O
%	O
of	O
total	O
cases	O
,	O
respectively	O
.	O

The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
PEDV	B-SPEC
consists	O
of	O
the	O
S1	O
and	O
S2	O
domains	O
,	O
responsible	O
for	O
virus	B-SPEC
binding	O
and	O
fusion	O
,	O
respectively	O
.	O

Passive	O
immunization	O
by	O
oral	O
administration	O
of	O
egg	O
yolk	O
antibodies	O
(	O
IgY	O
)	O
obtained	O
from	O
immunized	O
chickens	B-SPEC
provides	O
an	O
alternative	O
source	O
of	O
specific	O
antibodies	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
PEDV	B-SPEC
in	O
newborn	O
piglets	O
.	O

TITLE	O
:	O
Acute	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
:	O
Temporal	O
Lung	O
Changes	O
Observed	O
on	O
the	O
Chest	O
Radiographs	O
of	O
55	O
Patients	O
.	O

The	O
primary	O
source	O
of	O
the	O
virus	B-SPEC
is	O
infected	O
camels	B-SPEC
in	O
several	O
countries	O
in	O
the	O
Arabian	O
peninsula	O
.	O

We	O
also	O
found	O
that	O
treatment	O
of	O
cells	O
with	O
5	O
-	O
NT	O
decreased	O
the	O
infectivity	O
of	O
alphavirus	B-SPEC
chikungunya	B-SPEC
virus	I-SPEC
and	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

Identification	O
of	O
well	O
-	O
characterized	O
small	O
molecules	O
that	O
modulate	O
viral	O
infection	O
can	O
accelerate	O
development	O
of	O
antiviral	O
therapeutics	O
while	O
also	O
providing	O
new	O
tools	O
to	O
increase	O
our	O
understanding	O
of	O
the	O
cellular	O
processes	O
that	O
underlie	O
virus	B-SPEC
-	O
mediated	O
cell	O
injury	O
.	O

The	O
antiviral	O
properties	O
of	O
5	O
-	O
NT	O
suggest	O
that	O
serotonin	O
receptor	O
signaling	O
is	O
an	O
important	O
regulator	O
of	O
infection	O
by	O
diverse	O
virus	B-SPEC
families	O
and	O
illuminate	O
a	O
potential	O
new	O
drug	O
target	O
.	O

Results	O
showed	O
that	O
the	O
recombinant	O
S1	O
protein	O
was	O
highly	O
glycosylated	O
,	O
and	O
the	O
neutralizing	O
antigenicity	O
of	O
recombinant	O
S1	O
protein	O
was	O
lower	O
than	O
that	O
of	O
inactivated	O
virus	B-SPEC
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
characterize	O
disease	O
and	O
viral	O
detection	O
associated	O
with	O
an	O
original	O
North	O
American	O
PEDV	B-SPEC
isolate	O
inoculated	O
in	O
neonatal	O
piglets	O
.	O

Thirty	O
-	O
six	O
1	O
-	O
day	O
-	O
old	O
cesarean	O
-	O
derived	O
and	O
colostrum	O
-	O
deprived	O
piglets	O
were	O
randomly	O
assigned	O
to	O
the	O
control	O
(	O
n	O
=	O
16	O
)	O
or	O
challenged	O
group	O
(	O
n	O
=	O
20	O
);	O
the	O
latter	O
were	O
orogastrically	O
inoculated	O
with	O
1	O
ml	O
of	O
US	O
/	O
Iowa	O
/	O
18984	O
/	O
2013	O
PEDV	B-SPEC
isolate	O
titered	O
at	O
1	O
	O
10	O
(	O
3	O
)	O
plaque	O
-	O
forming	O
units	O
per	O
milliliter	O
.	O

An	O
indirect	O
ELISA	O
assay	O
suggested	O
that	O
when	O
mice	B-SPEC
were	O
vaccinated	O
with	O
rSPV	O
-	O
SA	O
,	O
the	O
level	O
of	O
IgG	O
against	O
TGEV	B-SPEC
was	O
enhanced	O
dramatically	O
.	O

TITLE	O
:	O
PCR	O
-	O
based	O
retrospective	O
evaluation	O
of	O
diagnostic	O
samples	O
for	O
emergence	O
of	O
porcine	B-SPEC
deltacoronavirus	O
in	O
US	O
swine	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
1734	O
clinical	O
samples	O
(	O
903	O
cases	O
)	O
submitted	O
to	O
the	O
Iowa	O
State	O
University	O
Veterinary	O
Diagnostic	O
Laboratory	O
(	O
ISU	O
VDL	O
)	O
for	O
enteric	O
disease	O
diagnosis	O
between	O
October	O
2012	O
and	O
December	O
2013	O
were	O
tested	O
retrospectively	O
for	O
PDCoV	O
using	O
a	O
virus	B-SPEC
-	O
specific	O
real	O
-	O
time	O
reverse	O
transcription	O
(	O
RT	O
)	O
PCR	O
targeting	O
conserved	O
region	O
of	O
the	O
membrane	O
gene	O
.	O

Our	O
results	O
suggest	O
that	O
reduced	O
cellular	O
immune	O
function	O
during	O
the	O
winter	O
may	O
have	O
increased	O
honey	B-SPEC
bee	I-SPEC
'	O
s	O
susceptibility	O
to	O
DWV	B-SPEC
.	O

The	O
20	O
,	O
54	O
,	O
and	O
87th	O
generations	O
of	O
CEK	O
-	O
adapted	O
IBV	B-SPEC
-	O
Sczy3	O
strains	O
were	O
used	O
to	O
infect	O
CEK	O
cells	O
,	O
and	O
then	O
nucleic	O
copy	O
numbers	O
in	O
the	O
samples	O
of	O
supernatant	O
collected	O
at	O
12	O
,	O
24	O
,	O
36	O
,	O
48	O
,	O
60	O
,	O
and	O
72	O
h	O
were	O
detected	O
.	O

ABSTRACT	O
:	O
Neurotropic	O
coronavirus	B-SPEC
induces	O
an	O
acute	O
encephalomyelitis	O
accompanied	O
by	O
focal	O
areas	O
of	O
demyelination	O
distributed	O
randomly	O
along	O
the	O
spinal	O
column	O
.	O

The	O
formation	O
of	O
discrete	O
foci	O
of	O
demyelination	O
in	O
IL	O
-	O
10	O
sufficient	O
mice	B-SPEC
correlated	O
with	O
IL	O
-	O
10	O
receptor	O
expression	O
exclusively	O
on	O
astrocytes	O
in	O
areas	O
of	O
demyelination	O
suggesting	O
a	O
critical	O
role	O
for	O
IL	O
-	O
10	O
signaling	O
to	O
astrocytes	O
in	O
limiting	O
expansion	O
of	O
initial	O
areas	O
of	O
white	O
matter	O
damage	O
.	O

TITLE	O
:	O
Brief	O
Report	O
:	O
Incubation	O
Period	O
Duration	O
and	O
Severity	O
of	O
Clinical	O
Disease	O
Following	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

Current	O
strains	O
were	O
clearly	O
different	O
from	O
isolates	O
found	O
in	O
the	O
1980s	O
and	O
were	O
closely	O
related	O
to	O
a	O
PEDV	B-SPEC
variant	O
found	O
in	O
the	O
US	O
in	O
2014	O
.	O

Additionally	O
,	O
disruption	O
of	O
the	O
secretory	O
pathway	O
by	O
IBV	B-SPEC
E	O
correlates	O
with	O
a	O
form	O
that	O
is	O
likely	O
monomeric	O
,	O
suggesting	O
that	O
the	O
effects	O
on	O
the	O
secretory	O
pathway	O
are	O
independent	O
of	O
E	O
ion	O
channel	O
activity	O
.	O

Here	O
,	O
we	O
present	O
biochemical	O
evidence	O
for	O
two	O
distinct	O
oligomeric	O
forms	O
of	O
IBV	B-SPEC
E	O
,	O
one	O
essential	O
for	O
assembly	O
and	O
the	O
other	O
with	O
a	O
role	O
in	O
disruption	O
of	O
the	O
secretory	O
pathway	O
.	O

CNS	O
infection	O
by	O
neurotropic	O
coronavirus	B-SPEC
with	O
replication	O
confined	O
to	O
the	O
brain	O
and	O
spinal	O
cord	O
induces	O
protective	O
IFN	O
-	O
	O
/	O
	O
via	O
Myd88	O
-	O
independent	O
activation	O
of	O
melanoma	O
differentiation	O
-	O
associated	O
gene	O
5	O
(	O
MDA5	O
).	O

The	O
results	O
demonstrate	O
a	O
crucial	O
role	O
for	O
Myd88	O
both	O
in	O
early	O
induction	O
of	O
innate	O
immune	O
responses	O
during	O
coronavirus	B-SPEC
-	O
induced	O
encephalomyelitis	O
and	O
in	O
specifically	O
promoting	O
protective	O
CD4	O
T	O
cell	O
activation	O
.	O

Human	B-SPEC
infections	O
by	O
simian	O
viruses	B-SPEC
represent	O
increasing	O
public	O
health	O
concerns	O
.	O

Sequence	O
comparison	O
and	O
phylogenetic	O
studies	O
have	O
thus	O
clearly	O
showed	O
that	O
the	O
emergence	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
and	O
HIV	B-SPEC
-	I-SPEC
2	I-SPEC
in	O
humans	B-SPEC
have	O
resulted	O
from	O
several	O
independent	O
interspecies	O
transmissions	O
of	O
different	O
SIV	B-SPEC
types	O
from	O
Chimpanzees	B-SPEC
and	O
African	O
monkeys	B-SPEC
(	O
including	O
sooty	B-SPEC
mangabeys	I-SPEC
),	O
respectively	O
,	O
probably	O
during	O
the	O
first	O
part	O
of	O
the	O
last	O
century	O
.	O

Indeed	O
,	O
the	O
origin	O
of	O
most	O
HTLV	O
-	O
1	O
subtypes	O
appears	O
to	O
be	O
linked	O
to	O
interspecies	O
transmission	O
between	O
STLV	O
-	O
1	O
-	O
infected	O
monkeys	B-SPEC
and	O
humans	B-SPEC
,	O
followed	O
by	O
variable	O
periods	O
of	O
evolution	O
in	O
the	O
human	B-SPEC
host	O
.	O

Using	O
MERSpv	O
-	O
St16	O
,	O
we	O
demonstrated	O
the	O
inability	O
of	O
rat	B-SPEC
DPP4	O
to	O
serve	O
as	O
a	O
functional	O
receptor	O
for	O
MERS	O
-	O
CoV	O
,	O
suggesting	O
that	O
rats	B-SPEC
are	O
not	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
host	O
innate	O
immune	O
response	O
either	O
clears	O
invading	O
viruses	B-SPEC
or	O
allows	O
the	O
adaptive	O
immune	O
system	O
to	O
establish	O
an	O
effective	O
antiviral	O
response	O
.	O

Since	O
the	O
first	O
identification	O
of	O
Middle	O
Eastern	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
the	O
virus	B-SPEC
has	O
infected	O
1289	O
humans	B-SPEC
with	O
approximately	O
40	O
%	O
mortalities	O
.	O

It	O
caused	O
human	B-SPEC
infection	O
resulting	O
in	O
severe	O
respiratory	O
disease	O
.	O

The	O
percent	O
of	O
SARI	O
cases	O
that	O
tested	O
positive	O
for	O
influenza	O
ranged	O
from	O
7	O
-	O
17	O
%	O
depending	O
on	O
age	O
group	O
,	O
year	O
,	O
province	O
and	O
HIV	B-SPEC
status	O
.	O

In	O
2010	O
,	O
there	O
were	O
an	O
estimated	O
21	O
,	O
555	O
total	O
severe	O
influenza	O
cases	O
in	O
HIV	B-SPEC
-	O
uninfected	O
individuals	O
and	O
13	O
,	O
876	O
in	O
HIV	B-SPEC
-	O
infected	O
individuals	O
.	O

Cytomegalovirus	B-SPEC
(	O
CMV	B-SPEC
)	O
pneumonia	O
was	O
recognized	O
in	O
as	O
many	O
as	O
4	O
cases	O
and	O
coronavirus	B-SPEC
pulmonary	O
infection	O
was	O
diagnosed	O
in	O
one	O
case	O
,	O
whereas	O
Pneumocystis	B-SPEC
jiroveci	I-SPEC
was	O
identified	O
as	O
a	O
co	O
-	O
pathogen	O
in	O
one	O
CMV	B-SPEC
-	O
infected	O
patient	O
.	O

We	O
decided	O
to	O
further	O
investigate	O
the	O
evolution	O
of	O
OAS1	O
in	O
primates	B-SPEC
by	O
characterizing	O
intra	O
-	O
specific	O
variation	O
in	O
four	O
species	B-SPEC
commonly	O
used	O
as	O
models	O
in	O
infectious	O
disease	O
research	O
:	O
the	O
rhesus	B-SPEC
macaque	I-SPEC
,	O
the	O
cynomolgus	O
macaque	B-SPEC
,	O
the	O
olive	B-SPEC
baboon	I-SPEC
,	O
and	O
the	O
Guinea	B-SPEC
baboon	I-SPEC
.	O

Here	O
,	O
we	O
used	O
51	O
respiratory	O
samples	O
from	O
32	O
patients	O
with	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
for	O
virus	B-SPEC
isolation	O
in	O
Vero	O
B4	O
and	O
Caco	O
-	O
2	O
cells	O
.	O

microRNAs	O
(	O
miRNAs	O
)	O
are	O
a	O
novel	O
class	B-SPEC
of	O
small	O
non	O
-	O
coding	O
RNAs	O
which	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
numerous	O
biological	O
processes	O
such	O
as	O
viral	O
infection	O
and	O
cell	O
apoptosis	O
.	O

Accumulating	O
data	O
show	O
that	O
miRNAs	O
are	O
involved	O
in	O
the	O
process	O
of	O
coronavirus	B-SPEC
infection	O
such	O
as	O
replication	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

However	O
,	O
the	O
link	O
between	O
miRNAs	O
and	O
TGEV	B-SPEC
infection	O
is	O
unknown	O
.	O

Porcine	B-SPEC
epidemic	O
diarrhoea	O
with	O
non	O
-	O
lethal	O
effects	O
in	O
piglets	O
was	O
identified	O
in	O
Tottori	O
prefecture	O
in	O
October	O
2014	O
.	O

Phylogenetic	O
analysis	O
indicated	O
that	O
the	O
Tottori2	O
PEDV	B-SPEC
strain	O
might	O
have	O
been	O
derived	O
from	O
the	O
current	O
PEDV	B-SPEC
strains	O
circulating	O
in	O
domestic	B-SPEC
pigs	I-SPEC
.	O

We	O
test	O
the	O
power	O
of	O
this	O
approach	O
using	O
simulated	O
data	O
and	O
find	O
that	O
the	O
method	O
is	O
sensitive	O
to	O
bias	B-SPEC
in	O
the	O
estimates	O
of	O
branch	O
lengths	O
,	O
which	O
tends	O
to	O
occur	O
when	O
using	O
underparameterized	O
clock	O
models	O
.	O

We	O
illustrate	O
the	O
performance	O
of	O
our	O
method	O
using	O
empirical	O
data	O
sets	O
from	O
coronaviruses	O
,	O
simian	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
killer	B-SPEC
whales	I-SPEC
,	O
and	O
marine	O
turtles	B-SPEC
.	O

TITLE	O
:	O
Rapid	O
quantitation	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
by	O
Virus	B-SPEC
Counter	O
.	O

TITLE	O
:	O
Effective	O
Apical	O
Infection	O
of	O
Differentiated	O
Human	B-SPEC
Bronchial	O
Epithelial	O
Cells	O
and	O
Induction	O
of	O
Proinflammatory	O
Chemokines	O
by	O
the	O
Highly	O
Pneumotropic	O
Human	B-SPEC
Adenovirus	B-SPEC
Type	O
14p1	O
.	O

Interestingly	O
,	O
IP	O
-	O
10	O
has	O
already	O
been	O
described	O
as	O
a	O
marker	O
for	O
severe	O
respiratory	O
infections	O
e	O
.	O
g	O
.	O
by	O
influenza	B-SPEC
virus	I-SPEC
A	O
H5N1	O
.	O

Human	B-SPEC
-	O
bat	B-SPEC
interactions	O
in	O
rural	O
Ghana	O
are	O
frequent	O
and	O
diverse	O
.	O

The	O
aeration	O
score	O
of	O
the	O
lung	O
at	O
T1	O
,	O
T2	O
,	O
T3	O
,	O
T4	O
was	O
significantly	O
reduced	O
than	O
T0	O
all	O
,	O
the	O
ventilation	O
situation	O
of	O
mainly	O
areas	O
was	O
improved	O
after	O
2	O
h	O
PPV	B-SPEC
(	O
P	O
<	O
0	O
.	O
05	O
),	O
4	O
h	O
later	O
it	O
was	O
not	O
distinguished	O
(	O
P	O
>	O
0	O
.	O
05	O
);	O
the	O
value	O
of	O
PaO	O
(	O
2	O
),	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
was	O
greater	O
at	O
T1	O
,	O
T2	O
,	O
T3	O
,	O
T4	O
than	O
T0	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
the	O
value	O
of	O
the	O
oxygen	O
fraction	O
was	O
significant	O
increased	O
at	O
T2	O
than	O
T1	O
(	O
t	O
=	O
2	O
.	O
840	O
,	O
P	O
<	O
0	O
.	O
05	O
);	O
the	O
number	O
of	O
patients	O
with	O
oxygen	O
fractions	O
>	O
300	O
mmHg	O
after	O
5	O
days	O
PPV	B-SPEC
was	O
65	O
(	O
83	O
.	O
3	O
%);	O
there	O
were	O
30	O
(	O
38	O
.	O
5	O
%)	O
patients	O
free	O
of	O
mechanical	O
ventilation	O
after	O
7	O
days	O
;	O
the	O
28	O
-	O
day	O
mortality	O
was	O
7	O
(	O
8	O
.	O
97	O
%).	O

Thus	O
recent	O
decades	O
have	O
seen	O
a	O
most	O
dramatic	O
change	O
with	O
the	O
emergence	O
globally	O
also	O
of	O
new	O
viral	O
infections	O
-	O
notably	O
human	B-SPEC
immunodeficiency	O
viruses	B-SPEC
(	O
HIV	B-SPEC
)	O
-	O
and	O
the	O
appearance	O
of	O
some	O
other	O
dangerous	O
and	O
sometimes	O
lethal	O
infections	O
formerly	O
seen	O
mainly	O
in	O
,	O
and	O
reported	O
from	O
,	O
resource	O
-	O
poor	O
areas	O
especially	O
in	O
parts	O
of	O
Asia	O
,	O
Latin	O
America	O
and	O
Africa	O
.	O

Patients	O
fulfilling	O
the	O
Infectious	O
Disease	O
Society	O
of	O
America	O
criteria	O
of	O
sepsis	B-SPEC
within	O
the	O
medical	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
were	O
included	O
over	O
two	O
years	O
.	O

An	O
ideal	O
animal	B-SPEC
model	O
should	O
reflect	O
the	O
clinical	O
signs	O
,	O
viral	O
replication	O
and	O
pathology	O
seen	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Clinical	O
and	O
laboratory	O
features	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
--	O
a	O
retrospective	O
study	O
of	O
231	O
confirmed	O
cases	O
(	O
2000	O
-	O
2010	O
).	O

In	O
our	O
study	O
,	O
a	O
5	O
'	O
long	O
terminal	O
repeat	O
/	O
gag	B-SPEC
region	O
-	O
based	O
reverse	O
transcription	O
insulated	O
isothermal	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
iiPCR	O
)	O
was	O
developed	O
to	O
amplify	O
all	O
known	O
FIV	B-SPEC
strains	O
to	O
facilitate	O
point	O
-	O
of	O
-	O
need	O
FIV	B-SPEC
diagnosis	O
.	O

The	O
established	O
reaction	O
did	O
not	O
amplify	O
any	O
nontargeted	O
feline	B-SPEC
pathogens	O
,	O
including	O
Felid	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
,	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
Feline	B-SPEC
calicivirus	I-SPEC
,	O
Feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
,	O
Mycoplasma	B-SPEC
haemofelis	I-SPEC
,	O
and	O
Chlamydophila	B-SPEC
felis	I-SPEC
.	O

This	O
is	O
the	O
first	O
description	O
of	O
enteric	O
FCV	B-SPEC
and	O
FNoV	O
in	O
South	O
America	O
.	O

To	O
date	O
,	O
there	O
are	O
no	O
effective	O
vaccines	O
or	O
antiviral	O
treatments	O
available	O
that	O
are	O
capable	O
of	O
limiting	O
the	O
pathogenesis	O
of	O
any	O
human	B-SPEC
coronaviral	O
infection	O
.	O

The	O
rising	O
tide	O
of	O
sepsis	B-SPEC
due	O
to	O
bacterial	O
,	O
fungal	O
and	O
viral	O
infections	O
cannot	O
be	O
stemmed	O
by	O
current	O
antimicrobial	O
therapies	O
and	O
supportive	O
measures	O
.	O

Microvascular	O
endothelial	O
injury	O
underlies	O
sepsis	B-SPEC
-	O
associated	O
hypotension	O
,	O
edema	O
,	O
disseminated	O
intravascular	O
coagulation	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
acute	O
kidney	O
injury	O
.	O

As	O
sepsis	B-SPEC
cases	O
rose	B-SPEC
from	O
387	O
330	O
in	O
1996	O
to	O
1	O
.	O
1	O
million	O
in	O
2011	O
,	O
and	O
are	O
estimated	O
to	O
reach	O
2	O
million	O
by	O
2020	O
in	O
the	O
US	O
,	O
mortality	O
due	O
to	O
sepsis	B-SPEC
approaches	O
that	O
of	O
heart	O
attacks	O
and	O
exceeds	O
deaths	O
from	O
stroke	O
.	O

All	O
coding	O
regions	O
of	O
the	O
isolate	O
were	O
sequenced	O
and	O
compared	O
with	O
130	O
complete	O
genome	O
sequences	O
of	O
IBV	B-SPEC
and	O
TCoV	O
,	O
downloaded	O
from	O
ViPR	O
.	O

Rhesus	B-SPEC
macaques	I-SPEC
develop	O
a	O
mild	O
to	O
moderate	O
respiratory	O
disease	O
upon	O
inoculation	O
,	O
reminiscent	O
of	O
milder	O
MERS	O
cases	O
,	O
whereas	O
marmosets	B-SPEC
develop	O
a	O
moderate	O
to	O
severe	O
respiratory	O
disease	O
,	O
recapitulating	O
the	O
severe	O
disease	O
observed	O
in	O
some	O
patients	O
.	O

The	O
success	O
rat	B-SPEC
of	O
recovery	O
was	O
82	O
.	O
2	O
%	O
(	O
23	O
/	O
28	O
).	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
Korean	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
KNU	O
-	O
141112	O
.	O

The	O
inactivated	O
KNU	O
-	O
141112	O
virus	B-SPEC
was	O
found	O
to	O
mediate	O
potent	O
neutralizing	O
antibody	O
responses	O
in	O
immunized	O
guinea	B-SPEC
pigs	I-SPEC
.	O

Animal	B-SPEC
studies	O
showed	O
that	O
KNU	O
-	O
141112	O
virus	B-SPEC
causes	O
severe	O
diarrhea	O
and	O
vomiting	O
,	O
fecal	O
shedding	O
,	O
and	O
acute	O
atrophic	O
enteritis	O
,	O
indicating	O
that	O
strain	O
KNU	O
-	O
141112	O
is	O
highly	O
enteropathogenic	O
in	O
the	O
natural	O
host	O
.	O

Antibodies	O
were	O
only	O
detected	O
in	O
those	O
with	O
contact	O
,	O
suggesting	O
dromedary	B-SPEC
exposure	O
as	O
a	O
risk	O
factor	O
for	O
infection	O
.	O

The	O
lopinavir	O
/	O
ritonavir	O
-	O
treated	O
and	O
interferon	O
-	O
1b	O
-	O
treated	O
animals	B-SPEC
had	O
better	O
outcome	O
than	O
the	O
untreated	O
animals	B-SPEC
,	O
with	O
improved	O
clinical	O
(	O
mean	O
clinical	O
scores	O
	O
50	O
.	O
9	O
%-	O
95	O
.	O
0	O
%	O
and	O
	O
weight	O
loss	O
than	O
the	O
untreated	O
animals	B-SPEC
),	O
radiological	O
(	O
minimal	O
pulmonary	O
infiltrates	O
),	O
and	O
pathological	O
(	O
mild	O
bronchointerstitial	O
pneumonia	O
)	O
findings	O
,	O
and	O
lower	O
mean	O
viral	O
loads	O
in	O
necropsied	O
lung	O
(	O
0	O
.	O
59	O
-	O
1	O
.	O
06	O
log10	O
copies	O
/	O
glyceraldehyde	O
3	O
-	O
phosphate	O
dehydrogenase	O
[	O
GAPDH	O
];	O
P	O
<	O
.	O
050	O
)	O
and	O
extrapulmonary	O
(	O
0	O
.	O
11	O
-	O
1	O
.	O
29	O
log10	O
copies	O
/	O
GAPDH	O
;	O
P	O
<	O
.	O
050	O
in	O
kidney	O
)	O
tissues	O
.	O

Of	O
the	O
three	O
types	O
of	O
liposomes	O
tested	O
,	O
only	O
cationic	O
liposomes	O
had	O
substantial	O
endothelial	O
uptake	O
,	O
with	O
human	B-SPEC
cells	O
taking	O
up	O
10	O
-	O
fold	O
more	O
liposomes	O
than	O
their	O
pig	B-SPEC
counterparts	O
;	O
however	O
,	O
non	O
-	O
specific	O
cellular	O
activation	O
prohibited	O
their	O
use	O
as	O
immunosuppressive	O
agents	O
.	O

Indeed	O
,	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
and	O
the	O
CoVs	O
OC43	O
and	O
229E	O
were	O
found	O
in	O
the	O
brains	O
of	O
SARS	O
patients	O
and	O
multiple	O
sclerosis	O
patients	O
,	O
respectively	O
.	O

The	O
two	O
groups	O
were	O
again	O
vaccinated	O
with	O
CR88	O
at	O
14	O
days	O
of	O
age	O
(	O
doa	B-SPEC
).	O

Using	O
immunohistochemistry	O
to	O
examine	O
changes	O
in	O
the	O
number	O
of	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
cells	O
in	O
the	O
trachea	B-SPEC
,	O
it	O
was	O
found	O
that	O
overall	O
patterns	O
of	O
CD8	O
(+)	O
cells	O
were	O
dominant	O
compared	O
to	O
those	O
of	O
CD4	O
(+)	O
cells	O
in	O
the	O
two	O
vaccinated	O
groups	O
.	O

We	O
previously	O
showed	O
that	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
could	O
infect	O
human	B-SPEC
macrophages	O
and	O
dendritic	O
cells	O
and	O
induce	O
cytokine	O
dysregulation	O
.	O

TITLE	O
:	O
Structure	O
-	O
activity	O
relationship	O
studies	O
on	O
quinoxalin	O
-	O
2	O
(	O
1H	O
)-	O
one	O
derivatives	O
containing	O
thiazol	O
-	O
2	O
-	O
amine	O
against	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
leading	O
to	O
the	O
discovery	O
of	O
BH6870	O
.	O

ABSTRACT	O
:	O
Both	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
are	O
zoonotic	O
pathogens	O
that	O
crossed	O
the	O
species	B-SPEC
barriers	O
to	O
infect	O
humans	B-SPEC
.	O

Here	O
,	O
we	O
summarize	O
the	O
progress	O
made	O
in	O
the	O
past	O
decade	O
in	O
understanding	O
the	O
cross	O
-	O
species	B-SPEC
transmission	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
by	O
focusing	O
on	O
the	O
features	O
of	O
the	O
S	O
protein	O
,	O
its	O
receptor	O
-	O
binding	O
characteristics	O
,	O
and	O
the	O
cleavage	O
process	O
involved	O
in	O
priming	O
.	O

We	O
confirmed	O
feline	B-SPEC
-	O
specificity	O
by	O
cross	O
-	O
challenging	O
the	O
primers	O
against	O
10	O
different	O
species	B-SPEC
of	O
terrestrial	O
,	O
aquatic	O
and	O
plant	B-SPEC
origins	O
in	O
the	O
presence	O
of	O
a	O
141	O
-	O
bp	O
site	O
of	O
an	O
18S	O
rRNA	O
gene	O
as	O
a	O
universal	O
eukaryotic	O
control	O
.	O

TITLE	O
:	O
Changes	O
in	O
the	O
Swine	B-SPEC
Gut	O
Microbiota	B-SPEC
in	O
Response	O
to	O
Porcine	B-SPEC
Epidemic	O
Diarrhea	O
Infection	O
.	O

The	O
gut	O
microbiota	B-SPEC
may	O
play	O
a	O
critical	O
role	O
in	O
the	O
gut	O
health	O
of	O
the	O
host	O
.	O

We	O
observed	O
significant	O
differences	O
in	O
microbiota	B-SPEC
between	O
the	O
control	O
and	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)-	O
infected	O
groups	O
at	O
both	O
the	O
phylum	B-SPEC
and	O
genus	B-SPEC
level	O
.	O

However	O
,	O
the	O
balance	O
between	O
Wnt3a	O
and	O
Wnt5a	O
signaling	O
pathway	O
in	O
the	O
lung	O
of	O
rats	B-SPEC
with	O
endotoxic	O
shock	O
has	O
not	O
been	O
determined	O
.	O

The	O
possibility	O
of	O
vaccine	O
interference	O
after	O
simultaneous	O
combined	O
vaccination	O
with	O
Arkansas	O
(	O
Ark	O
)	O
and	O
Massachusetts	O
(	O
Mass	O
)-	O
type	O
vaccines	O
was	O
evaluated	O
in	O
an	O
effort	O
to	O
explain	O
the	O
high	O
prevalence	O
of	O
Ark	O
-	O
type	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
vaccinated	O
chickens	B-SPEC
.	O

Only	O
Mass	O
vaccine	O
was	O
detected	O
in	O
tears	O
of	O
sentinel	O
birds	B-SPEC
introduced	O
into	O
groups	O
receiving	O
both	O
vaccines	O
.	O

Receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
analysis	O
was	O
performed	O
using	O
swine	B-SPEC
serum	O
samples	O
(	O
iELISA	O
n	O
=	O
1486	O
,	O
bELISA	O
n	O
=	O
1186	O
,	O
FMIA	O
n	O
=	O
1420	O
).	O

No	O
cross	O
-	O
reactivity	O
with	O
the	O
closely	O
related	O
coronaviruses	O
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
or	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
was	O
noted	O
with	O
these	O
assays	O
.	O

All	O
three	O
assays	O
detected	O
seroconversion	O
of	O
nave	O
animals	B-SPEC
within	O
6	O
-	O
9	O
days	O
post	O
exposure	O
.	O

CONCLUSIONS	O
:	O
Well	O
-	O
validated	O
iELISA	O
,	O
bELISA	O
and	O
FMIA	O
assays	O
for	O
the	O
detection	O
of	O
PEDV	B-SPEC
antibodies	O
were	O
developed	O
and	O
showed	O
good	O
correlation	O
with	O
IFA	O
and	O
each	O
other	O
.	O

Based	O
on	O
the	O
pathophysiology	O
of	O
this	O
disease	O
,	O
many	O
candidate	O
genes	O
have	O
been	O
evaluated	O
as	O
potential	O
modifiers	O
in	O
patient	O
,	O
as	O
well	O
as	O
in	O
animal	B-SPEC
models	O
,	O
of	O
ARDS	O
.	O

The	O
three	O
isolates	O
were	O
found	O
genetically	O
highly	O
distant	O
from	O
known	O
avian	B-SPEC
IBV	B-SPEC
based	O
on	O
partial	O
sequences	O
of	O
their	O
S1	O
genes	O
:	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I01	O
/	O
2011	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
01	O
),	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I30	O
/	O
2010	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
30	O
),	O
and	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I38	O
/	O
2013	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
38	O
),	O
nucleotide	O
sequence	O
identities	O
reached	O
89	O
.	O
5	O
%	O
to	O
90	O
.	O
9	O
%	O
among	O
the	O
three	O
isolates	O
.	O

RESULTS	O
:	O
The	O
three	O
isolates	O
were	O
found	O
genetically	O
highly	O
distant	O
from	O
known	O
avian	B-SPEC
IBV	B-SPEC
based	O
on	O
partial	O
sequences	O
of	O
their	O
S1	O
genes	O
:	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I01	O
/	O
2011	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
01	O
),	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I30	O
/	O
2010	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
30	O
),	O
and	O
gammaCoV	O
/	O
chicken	B-SPEC
/	O
Morocco	O
/	O
I38	O
/	O
2013	O
(	O
IBV	B-SPEC
/	O
Morocco	O
/	O
38	O
),	O
nucleotide	O
sequence	O
identities	O
reached	O
89	O
.	O
5	O
%	O
to	O
90	O
.	O
9	O
%	O
among	O
the	O
three	O
isolates	O
.	O

An	O
immunoadhesin	O
based	O
on	O
the	O
receptor	O
for	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
ICAM	O
-	O
1	O
,	O
potently	O
blocks	O
infection	O
of	O
human	B-SPEC
cells	O
by	O
one	O
of	O
the	O
major	O
causes	O
of	O
the	O
common	O
cold	O
.	O

We	O
developed	O
and	O
validated	O
an	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
based	O
on	O
the	O
recombinant	O
membrane	O
(	O
M	O
)	O
protein	O
of	O
PEDV	B-SPEC
.	O

He	O
had	O
been	O
suspected	O
to	O
suffer	O
from	O
infection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
by	O
the	O
Disease	O
Control	O
Department	O
of	O
South	O
Korea	O
,	O
but	O
no	O
specific	O
treatment	O
was	O
given	O
.	O

Pleural	O
effusion	O
was	O
rapidly	O
increased	O
during	O
the	O
first	O
week	O
as	O
shown	O
by	O
chest	O
X	O
-	O
ray	B-SPEC
films	O
,	O
and	O
it	O
began	O
to	O
be	O
absorbed	O
gradually	O
in	O
the	O
second	O
week	O
,	O
but	O
it	O
was	O
not	O
completely	O
absorbed	O
until	O
discharge	O
.	O

Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
isolated	O
from	O
dromedaries	B-SPEC
is	O
genetically	O
and	O
phenotypically	O
similar	O
to	O
viruses	B-SPEC
from	O
humans	B-SPEC
.	O

We	O
summarize	O
current	O
understanding	O
of	O
the	O
ecology	O
of	O
MERS	O
-	O
CoV	O
in	O
animals	B-SPEC
and	O
transmission	O
at	O
the	O
animal	B-SPEC
-	O
human	B-SPEC
interface	O
.	O

TITLE	O
:	O
Corticosteroid	O
Therapy	O
for	O
Patients	O
Hospitalized	O
With	O
Community	O
-	O
Acquired	O
Pneumonia	O
:	O
A	O
Systematic	O
Review	O
and	O
Meta	B-SPEC
-	O
analysis	O
.	O

A	O
high	O
sensitivity	O
to	O
polymer	O
of	O
swine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
was	O
noted	O
.	O

ABSTRACT	O
:	O
Malaria	O
is	O
the	O
most	O
important	O
parasitic	O
diseases	O
of	O
humans	B-SPEC
and	O
one	O
of	O
the	O
leading	O
causes	O
of	O
morbidity	O
and	O
mortality	O
in	O
tropical	O
countries	O
.	O

Earlier	O
Plasmodium	B-SPEC
vivax	I-SPEC
was	O
considered	O
as	O
a	O
benign	O
infection	O
,	O
but	O
now	O
it	O
is	O
recognized	O
as	O
a	O
cause	O
of	O
severe	O
malarial	O
disease	O
.	O

We	O
describe	O
26	O
GPA	O
patients	O
with	O
	O
1	O
tracheal	O
(	O
mainly	O
subglottic	O
,	O
SGS	O
)	O
and	O
/	O
or	O
bronchial	O
stenosis	B-SPEC
(	O
ses	O
)	O
(	O
BS	O
(	O
s	O
)).	O
Sixteen	O
patients	O
had	O
solitary	O
SGS	O
and	O
10	O
had	O
	O
1	O
BS	O
(	O
s	O
).	O

A	O
survey	O
is	O
carried	O
out	O
on	O
101	O
fecal	O
samples	O
from	O
diarrheic	O
young	O
and	O
adult	O
cattle	B-SPEC
during	O
the	O
3	O
-	O
year	O
period	O
from	O
i	O
)	O
one	O
large	O
dairy	O
herd	O
,	O
ii	O
)	O
four	O
small	O
herds	O
and	O
iii	O
)	O
three	O
nasal	O
and	O
paired	O
fecal	O
samples	O
from	O
calves	O
with	O
symptoms	O
of	O
respiratory	O
disease	O
.	O

BToV	O
should	O
be	O
regarded	O
as	O
a	O
relevant	O
pathogen	O
for	O
cattle	B-SPEC
that	O
plays	O
a	O
synergistic	O
role	O
in	O
mixed	O
enteric	O
infections	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
identification	O
of	O
horseshoe	B-SPEC
bats	I-SPEC
as	O
the	O
reservoir	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
related	O
coronaviruses	O
(	O
SARSr	O
-	O
CoVs	O
),	O
the	O
origin	O
of	O
SARS	O
-	O
CoV	O
ORF8	O
,	O
which	O
contains	O
the	O
29	O
-	O
nucleotide	O
signature	O
deletion	O
among	O
human	B-SPEC
strains	O
,	O
remains	O
obscure	O
.	O

Although	O
these	O
two	O
betacoronaviruses	O
displayed	O
lower	O
similarities	O
than	O
SARSr	O
-	O
Rs	O
-	O
BatCoV	O
RsSHC014	O
and	O
Rs3367	O
in	O
S	O
protein	O
to	O
civet	B-SPEC
SARSr	O
-	O
CoVs	O
,	O
their	O
ORF8	O
proteins	O
demonstrated	O
exceptionally	O
high	O
(	O
80	O
.	O
4	O
to	O
81	O
.	O
3	O
%)	O
amino	O
acid	O
identities	O
to	O
that	O
of	O
human	B-SPEC
/	O
civet	B-SPEC
SARSr	O
-	O
CoVs	O
,	O
compared	O
to	O
SARSr	O
-	O
BatCoVs	O
from	O
other	O
horseshoe	B-SPEC
bats	I-SPEC
(	O
23	O
.	O
2	O
to	O
37	O
.	O
3	O
%).	O

SARS	O
-	O
CoV	O
ORF8	O
originated	O
from	O
SARSr	O
-	O
CoVs	O
of	O
greater	B-SPEC
horseshoe	I-SPEC
bats	I-SPEC
through	O
recombination	O
,	O
which	O
may	O
be	O
important	O
for	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
coronavirus	B-SPEC
has	O
been	O
responsible	O
for	O
several	O
outbreaks	O
of	O
disease	O
in	O
the	O
United	O
States	O
and	O
Japan	O
.	O

The	O
performance	O
of	O
BE	O
-	O
ELISA	O
was	O
evaluated	O
,	O
and	O
showed	O
95	O
.	O
4	O
%	O
coincidence	O
ratio	O
with	O
the	O
whole	O
virus	B-SPEC
based	O
-	O
ELISA	O
(	O
IDEXX	O
).	O

The	O
performance	O
of	O
BE	O
-	O
ELISA	O
was	O
evaluated	O
,	O
and	O
showed	O
95	O
.	O
4	O
%	O
coincidence	O
ratio	O
with	O
the	O
whole	O
virus	B-SPEC
based	O
-	O
ELISA	O
(	O
IDEXX	O
).	O

ABSTRACT	O
:	O
The	O
full	O
genome	O
sequence	O
of	O
a	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
identified	O
from	O
cultured	O
and	O
isolated	O
in	O
Vero	O
cells	O
.	O

TITLE	O
:	O
Safety	O
and	O
efficacy	O
of	O
an	O
attenuated	O
Chinese	O
QX	O
-	O
like	O
infectious	O
bronchitis	O
virus	B-SPEC
strain	O
as	O
a	O
candidate	O
vaccine	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
respiratory	O
and	O
urogenital	O
disease	O
of	O
chickens	B-SPEC
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
results	O
revealed	O
that	O
the	O
attenuated	O
strain	O
has	O
a	O
clear	O
decrease	O
in	O
pathogenicity	O
for	O
specific	O
-	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chickens	B-SPEC
compared	O
with	O
the	O
parent	O
strain	O
.	O

The	O
virus	B-SPEC
resulted	O
in	O
less	O
than	O
1000	O
infected	O
cases	O
and	O
355	O
deaths	O
.	O

TITLE	O
:	O
[	O
The	O
prevalence	O
of	O
the	O
human	B-SPEC
rhinoviruses	B-SPEC
and	O
coronaviruses	O
circulating	O
in	O
the	O
Moscow	O
region	O
during	O
2007	O
-	O
2012	O
].	O

We	O
previously	O
reported	O
two	O
human	B-SPEC
monoclonal	O
antibodies	O
that	O
target	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
spike	O
and	O
exhibit	O
strong	O
neutralization	O
activity	O
against	O
live	O
and	O
pesudotyped	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
this	O
study	O
,	O
porcine	B-SPEC
small	O
intestinal	O
epithelial	O
cells	O
(	O
IECs	O
),	O
the	O
target	O
cells	O
of	O
PEDV	B-SPEC
,	O
were	O
used	O
as	O
the	O
infection	O
model	O
in	O
vitro	O
to	O
identify	O
the	O
possible	O
molecular	O
mechanisms	O
of	O
PEDV	B-SPEC
-	O
inhibition	O
IFN	O
-	O
	O
production	O
.	O

Taken	O
together	O
,	O
our	O
data	O
demonstrated	O
for	O
the	O
first	O
time	O
that	O
PEDV	B-SPEC
infection	O
of	O
its	O
target	O
cell	O
line	O
,	O
IECs	O
,	O
inhibited	O
dsRNA	O
-	O
mediated	O
IFN	O
-	O
	O
production	O
by	O
blocking	O
the	O
activation	O
of	O
IPS	B-SPEC
-	O
1	O
in	O
RIG	O
-	O
I	O
-	O
mediated	O
pathway	O
.	O

TITLE	O
:	O
The	O
Virus	B-SPEC
-	O
Host	O
Interplay	O
:	O
Biogenesis	O
of	O
+	O
RNA	O
Replication	O
Complexes	O
.	O

Infectious	O
status	O
was	O
demonstrated	O
for	O
the	O
3	O
viruses	B-SPEC
,	O
and	O
in	O
the	O
case	O
of	O
IAV	O
and	O
PRRSV	B-SPEC
,	O
viruses	B-SPEC
were	O
isolated	O
from	O
particles	O
larger	O
than	O
2	O
.	O
1	O
m	O
.	O

TITLE	O
:	O
A	O
synthetic	O
consensus	O
anti	O
-	O
spike	O
protein	O
DNA	O
vaccine	O
induces	O
protective	O
immunity	O
against	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
nonhuman	O
primates	B-SPEC
.	O

Since	O
its	O
identification	O
,	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
linked	O
to	O
more	O
than	O
1372	O
infections	O
manifesting	O
with	O
severe	O
morbidity	O
and	O
,	O
often	O
,	O
mortality	O
(	O
about	O
495	O
deaths	O
)	O
in	O
the	O
Arabian	O
Peninsula	O
,	O
Europe	O
,	O
and	O
,	O
most	O
recently	O
,	O
the	O
United	O
States	O
.	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
has	O
been	O
documented	O
,	O
with	O
nosocomial	O
transmission	O
appearing	O
to	O
be	O
an	O
important	O
route	O
of	O
infection	O
.	O

Awareness	O
of	O
an	O
individual	O
'	O
s	O
knowledge	O
and	O
being	O
able	O
to	O
predict	O
his	O
or	O
her	O
behavior	O
is	O
crucial	O
when	O
evaluating	O
clinical	O
preparedness	O
for	O
pandemics	O
with	O
a	O
highly	O
pathogenic	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Since	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
first	O
emerged	O
,	O
the	O
California	B-SPEC
Department	O
of	O
Public	O
Health	O
has	O
coordinated	O
efforts	O
to	O
identify	O
possible	O
cases	O
in	O
travelers	O
to	O
California	B-SPEC
,	O
USA	O
,	O
from	O
affected	O
areas	O
.	O

Observed	O
low	O
rates	O
of	O
virus	B-SPEC
transmission	O
and	O
the	O
psychological	O
effect	O
of	O
contact	O
monitoring	O
indicate	O
that	O
thoughtful	O
assessment	O
of	O
close	O
contacts	O
is	O
prudent	O
and	O
must	O
be	O
guided	O
by	O
clinical	O
and	O
epidemiologic	O
risk	O
factors	O
.	O

CEK	O
adaptation	O
shifted	O
the	O
virus	B-SPEC
population	O
towards	O
homogeneity	O
in	O
S	O
.	O
The	O
changes	O
achieved	O
in	O
the	O
S1	O
gene	O
in	O
CEKp7	O
were	O
maintained	O
after	O
a	O
back	O
-	O
passage	O
in	O
ECE	O
.	O

This	O
observation	O
is	O
interesting	O
and	O
may	O
provide	O
some	O
insight	O
into	O
the	O
mechanism	O
behind	O
infectious	O
bronchitis	O
virus	B-SPEC
attenuation	O
.	O

In	O
combination	O
with	O
software	O
analysis	O
for	O
the	O
prediction	O
of	O
B	O
cell	O
epitopes	O
,	O
aa	O
201	O
-	O
212	O
exhibited	O
characteristics	O
of	O
a	O
linear	O
epitope	O
on	O
the	O
PEDV	B-SPEC
S1	O
protein	O
.	O

TITLE	O
:	O
A	O
novel	O
astrovirus	O
from	O
dromedaries	B-SPEC
in	O
the	O
Middle	O
East	O
.	O

The	O
low	O
Ka	O
/	O
Ks	O
ratios	O
(	O
number	O
of	O
non	O
-	O
synonymous	O
substitutions	O
per	O
non	O
-	O
synonymous	O
site	O
to	O
number	O
of	O
synonymous	O
substitutions	O
per	O
synonymous	O
site	O
)	O
of	O
the	O
four	O
ORFs	O
in	O
the	O
DcAstV	O
genomes	O
supported	O
the	O
suggestion	O
that	O
dromedaries	B-SPEC
are	O
the	O
natural	O
reservoir	O
where	O
AstV	O
is	O
stably	O
evolving	O
.	O

In	O
humans	B-SPEC
,	O
ARDS	O
is	O
very	O
well	O
defined	O
by	O
a	O
list	O
of	O
clinical	O
parameters	O
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
has	O
long	O
served	O
as	O
a	O
model	O
system	O
for	O
the	O
study	O
of	O
coronaviruses	O
.	O

Non	O
-	O
structural	O
protein	O
3	O
(	O
nsp3	O
)	O
is	O
the	O
largest	O
nsp	O
in	O
the	O
coronavirus	B-SPEC
genome	O
,	O
and	O
it	O
contains	O
multiple	O
functional	O
domains	O
that	O
are	O
required	O
for	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
This	O
research	O
aimed	O
to	O
develop	O
an	O
oral	O
vaccine	O
for	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
based	O
on	O
the	O
TGEV	B-SPEC
N	O
gene	O
expressed	O
in	O
an	O
attenuated	O
Salmonella	B-SPEC
typhimurium	O
vector	O
and	O
aimed	O
to	O
evaluate	O
the	O
vaccine	O
'	O
s	O
immune	O
response	O
in	O
piglets	O
.	O

After	O
it	O
was	O
identified	O
via	O
RT	O
-	O
PCR	O
and	O
double	O
digestion	O
,	O
the	O
screened	O
recombinant	O
bacteria	B-SPEC
presenting	O
pVAX	O
-	O
N	O
were	O
named	O
SL7207	O
(	O
pVAX	O
-	O
N	O
).	O

To	O
evaluate	O
the	O
safety	O
and	O
stability	O
of	O
the	O
developed	O
vaccine	O
,	O
different	O
dosages	O
(	O
5	O
	O
10	O
(	O
8	O
),	O
1	O
	O
10	O
(	O
9	O
),	O
and	O
2	O
	O
10	O
(	O
9	O
)	O
CFU	O
/	O
mice	B-SPEC
)	O
of	O
SL7207	O
(	O
pVAX	O
-	O
N	O
)	O
were	O
inoculated	O
to	O
6	O
-	O
week	O
-	O
old	O
mice	B-SPEC
.	O

The	O
combination	O
supports	O
a	O
multiplexed	O
Luminex	O
-	O
based	O
respiratory	O
panel	O
that	O
potentially	O
differentiates	O
influenza	B-SPEC
viruses	I-SPEC
A	O
and	O
B	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
),	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
,	O
detecting	O
as	O
few	O
as	O
10	O
MERS	O
virions	O
in	O
a	O
20	O
-	O
l	O
sample	O
.	O

In	O
the	O
last	O
few	O
decades	O
,	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
has	O
been	O
extensively	O
studied	O
,	O
but	O
knowledge	O
of	O
immune	O
responses	O
to	O
virulent	O
or	O
vaccine	O
strains	O
of	O
IBVs	O
remains	O
limited	O
.	O

TITLE	O
:	O
First	O
Case	O
of	O
Systemic	O
Coronavirus	B-SPEC
Infection	O
in	O
a	O
Domestic	B-SPEC
Ferret	I-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
)	O
in	O
Peru	O
.	O

TITLE	O
:	O
Discovery	O
of	O
an	O
essential	O
nucleotidylating	O
activity	O
associated	O
with	O
a	O
newly	O
delineated	O
conserved	O
domain	O
in	O
the	O
RNA	O
polymerase	O
-	O
containing	O
protein	O
of	O
all	O
nidoviruses	B-SPEC
.	O

Most	O
likely	O
this	O
was	O
the	O
invariant	O
lysine	O
of	O
the	O
newly	O
identified	O
domain	O
,	O
named	O
nidovirus	B-SPEC
RdRp	O
-	O
associated	O
nucleotidyltransferase	O
(	O
NiRAN	O
),	O
whose	O
substitution	O
with	O
alanine	O
severely	O
diminished	O
the	O
described	O
binding	O
.	O

Both	O
groups	O
had	O
the	O
same	O
frequency	O
of	O
upper	O
respiratory	O
and	O
gastrointestinal	O
symptoms	O
and	O
had	O
the	O
same	O
incidence	O
of	O
admission	O
to	O
the	O
PICU	B-SPEC
,	O
intravenous	O
immunoglobulin	O
-	O
resistant	O
disease	O
,	O
and	O
coronary	O
artery	O
lesions	O
.	O

The	O
parameters	O
of	O
the	O
iELISA	O
were	O
optimized	O
,	O
and	O
the	O
cutoff	O
value	O
determined	O
as	O
0	O
.	O
259	O
by	O
analyzing	O
optical	O
density	O
(	O
OD	O
)	O
values	O
of	O
80	O
PEDV	B-SPEC
negative	O
sera	O
confirmed	O
by	O
western	O
blot	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
represent	O
highly	O
pathogenic	O
human	B-SPEC
CoVs	O
that	O
share	O
a	O
property	O
to	O
inhibit	O
host	O
gene	O
expression	O
at	O
the	O
posttranscriptional	O
level	O
.	O

Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
highly	O
pathogenic	O
human	B-SPEC
CoV	O
that	O
emerged	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
)	O
are	O
enveloped	O
,	O
spherical	O
,	O
single	O
-	O
stranded	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
causing	O
mainly	O
respiratory	O
and	O
intestinal	O
infections	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
.	O

In	O
our	O
study	O
,	O
according	O
to	O
phylogenetic	O
analysis	O
of	O
partial	O
N	O
gene	O
segment	O
,	O
isolate	O
ANK	O
/	O
1079	O
/	O
2014	O
has	O
taken	O
place	O
within	O
clade	O
A	O
.	O
In	O
conclusion	O
,	O
MERS	O
-	O
CoV	O
appears	O
to	O
have	O
limited	O
circulation	O
in	O
Arabian	O
Peninsula	O
and	O
Middle	O
-	O
Eastern	O
countries	O
,	O
it	O
should	O
be	O
considered	O
in	O
mind	O
that	O
travel	O
-	O
related	O
cases	O
may	O
export	O
the	O
virus	B-SPEC
outside	O
these	O
regions	O
leading	O
autochtonous	O
infections	O
in	O
the	O
other	O
parts	O
of	O
the	O
world	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
high	O
fever	O
,	O
cough	O
,	O
acute	O
respiratory	O
tract	O
infection	O
and	O
multiorgan	O
dysfunction	O
that	O
may	O
eventually	O
lead	O
to	O
the	O
death	O
of	O
the	O
infected	O
individuals	O
.	O

The	O
occurrence	O
of	O
the	O
virus	B-SPEC
was	O
first	O
reported	O
in	O
the	O
Middle	O
East	O
and	O
it	O
subsequently	O
spread	O
to	O
several	O
parts	O
of	O
the	O
world	O
.	O

Notably	O
,	O
the	O
recent	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
'	O
superspreading	O
'	O
of	O
MERS	O
-	O
CoV	O
in	O
hospitals	O
in	O
South	O
Korea	O
has	O
raised	O
a	O
major	O
global	O
health	O
concern	O
.	O

End	O
-	O
point	O
neutralizing	O
assay	O
performed	O
in	O
chicken	B-SPEC
embro	O
kidney	O
(	O
CEK	O
)	O
cells	O
revealed	O
that	O
the	O
neutralization	O
titer	O
of	O
6A12	O
and	O
1D5	O
against	O
Sczy3	O
reached	O
1	O
:	O
44	O
.	O
7	O
and	O
1	O
:	O
40	O
.	O
6	O
,	O
respectively	O
.	O

TITLE	O
:	O
The	O
dilemma	O
of	O
rare	O
events	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
North	O
America	O
.	O

From	O
originally	O
causing	O
a	O
relatively	O
mild	O
and	O
sporadic	O
disease	O
,	O
PEDV	B-SPEC
has	O
been	O
more	O
recently	O
associated	O
with	O
severe	O
outbreaks	O
of	O
diarrheal	O
disease	O
in	O
Asia	O
,	O
and	O
subsequently	O
North	O
America	O
.	O

ABSTRACT	O
:	O
A	O
male	O
domestic	B-SPEC
ferret	I-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
),	O
which	O
was	O
purchased	O
from	O
outside	O
of	O
Japan	O
at	O
13	O
weeks	O
of	O
age	O
,	O
was	O
euthanized	O
at	O
18	O
months	O
of	O
age	O
because	O
of	O
poor	O
health	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
a	O
devastating	O
disease	O
in	O
livestock	O
industry	O
.	O

A	O
little	O
was	O
known	O
regarding	O
the	O
status	O
of	O
gut	O
microbiota	B-SPEC
after	O
piglets	O
infected	O
by	O
PEDV	B-SPEC
.	O

In	O
this	O
study	O
,	O
aided	O
by	O
metagenome	O
sequencing	O
technology	O
,	O
gut	O
microbiota	B-SPEC
profiles	O
in	O
feces	O
of	O
viral	O
diarrhea	O
(	O
VD	O
)	O
and	O
viral	O
control	O
(	O
VC	O
)	O
piglets	O
were	O
investigated	O
.	O

Furthermore	O
,	O
25	O
genera	O
were	O
significantly	O
different	O
between	O
VC	O
and	O
VD	O
piglets	O
at	O
the	O
genus	B-SPEC
level	O
.	O

Among	O
the	O
25	O
genera	O
,	O
Leptotrichia	B-SPEC
belonging	O
to	O
Fusobacteria	B-SPEC
was	O
remarkably	O
lower	O
in	O
VC	O
piglets	O
than	O
in	O
VD	O
piglets	O
.	O

RESULTS	O
:	O
The	O
highest	O
affinity	O
clone	O
to	O
ORF6	O
displayed	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
NPIPB3	O
(	O
nuclear	O
pore	O
complex	O
interacting	O
protein	O
family	B-SPEC
,	O
member	O
B3	O
;	O
also	O
named	O
as	O
phosphatidylinositol	O
-	O
3	O
-	O
kinase	O
-	O
related	O
kinase	O
SMG	O
-	O
1	O
isoform	O
1	O
homolog	O
).	O

The	O
aim	O
of	O
this	O
mini	O
-	O
review	O
is	O
to	O
give	O
a	O
short	O
overview	O
of	O
some	O
,	O
but	O
not	O
all	O
,	O
adjuvant	O
therapeutic	O
strategies	O
for	O
pneumonia	O
and	O
its	O
most	O
important	O
complications	O
,	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
briefly	O
discuss	O
future	O
perspectives	O
.	O

To	O
exploit	O
the	O
possibility	O
of	O
using	O
RNA	O
interference	O
(	O
RNAi	O
)	O
as	O
a	O
strategy	O
against	O
PEDV	B-SPEC
infection	O
,	O
five	O
shRNA	O
-	O
expressing	O
plasmids	O
targeting	O
the	O
N	O
,	O
M	O
,	O
and	O
S	O
genes	O
of	O
PEDV	B-SPEC
were	O
constructed	O
and	O
transfected	O
into	O
Vero	O
cells	O
.	O

This	O
is	O
the	O
case	O
,	O
for	O
instance	O
,	O
of	O
rabies	B-SPEC
virus	I-SPEC
and	O
other	O
Lyssavirus	B-SPEC
(	O
Family	B-SPEC
Rhabdoviridae	I-SPEC
),	O
Nipah	O
and	O
Hendra	O
viruses	B-SPEC
(	O
Paramyxoviridae	B-SPEC
),	O
Ebola	O
and	O
Marburg	B-SPEC
viruses	I-SPEC
(	O
Filoviridae	B-SPEC
),	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
(	O
Coronaviridae	B-SPEC
).	O

The	O
various	O
bioecology	O
of	O
the	O
different	O
bat	B-SPEC
populations	O
allows	O
exchange	O
of	O
virus	B-SPEC
between	O
migrating	O
and	O
non	O
-	O
migrating	O
conspecific	O
species	B-SPEC
.	O

in	O
order	B-SPEC
to	O
understand	O
the	O
mechanisms	O
of	O
disease	O
emergence	O
,	O
to	O
try	O
to	O
foresee	O
and	O
,	O
perhaps	O
,	O
to	O
prevent	O
viral	O
emergences	O
beforehand	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
E	O
protein	O
transports	O
calcium	O
ions	O
and	O
activates	O
the	O
NLRP3	O
inflammasome	O
.	O

In	O
both	O
cohorts	O
,	O
RSV	B-SPEC
was	O
the	O
most	O
frequent	O
pathogen	O
(	O
52	O
.	O
9	O
%	O
and	O
36	O
.	O
1	O
%	O
of	O
the	O
cohorts	O
,	O
respectively	O
).	O

The	O
nanoparticles	O
were	O
also	O
therapeutically	O
beneficial	O
in	O
vivo	O
in	O
both	O
systemic	O
and	O
pulmonary	O
murine	B-SPEC
models	O
replicating	O
inflammatory	O
features	O
of	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

For	O
parainfluenza	O
virus	B-SPEC
2	O
only	O
it	O
was	O
10	O
(	O
5	O
)	O
copies	O
/	O
ml	O
.	O

The	O
probability	O
of	O
occurrence	O
of	O
MERS	O
outbreaks	O
larger	O
than	O
the	O
South	O
Korean	O
cluster	O
(	O
n	O
=	O
186	O
)	O
is	O
of	O
the	O
order	B-SPEC
of	O
1	O
%.	O

The	O
autopsy	O
findings	O
suggested	O
that	O
the	O
main	O
cause	O
of	O
death	O
was	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
but	O
cytomegalovirus	B-SPEC
(	O
CMV	B-SPEC
)	O
infection	O
was	O
also	O
noted	O
in	O
multiple	O
organs	O
.	O
.	O

Inhibiting	O
complement	O
could	O
prove	O
an	O
attractive	O
strategy	O
for	O
preventing	O
sepsis	B-SPEC
-	O
induced	O
fibrosis	O
of	O
the	O
lung	O
.	O

TITLE	O
:	O
The	O
ns12	O
.	O
9	O
Accessory	O
Protein	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
Is	O
a	O
Viroporin	O
Involved	O
in	O
Virion	O
Morphogenesis	O
and	O
Pathogenesis	O
.	O

AKI	O
was	O
defined	O
by	O
Acute	O
Kidney	O
Injury	O
Network	O
creatinine	O
and	O
dialysis	B-SPEC
criteria	O
.	O

Of	O
759	O
patients	O
with	O
sepsis	B-SPEC
,	O
AKI	O
developed	O
in	O
326	O
(	O
43	O
%).	O

TITLE	O
:	O
Intratracheal	O
exposure	O
of	O
common	B-SPEC
marmosets	I-SPEC
to	O
MERS	O
-	O
CoV	O
Jordan	O
-	O
n3	O
/	O
2012	O
or	O
MERS	O
-	O
CoV	O
EMC	O
/	O
2012	O
isolates	O
does	O
not	O
result	O
in	O
lethal	O
disease	O
.	O

Development	O
of	O
countermeasures	O
is	O
ongoing	O
;	O
however	O
,	O
an	O
animal	B-SPEC
model	O
that	O
faithfully	O
recapitulates	O
human	B-SPEC
disease	O
has	O
yet	O
to	O
be	O
defined	O
.	O

A	O
partial	O
genomic	O
sequence	O
of	O
a	O
murine	B-SPEC
coronavirus	I-SPEC
was	O
identified	O
,	O
and	O
the	O
whole	O
genome	O
(	O
31428	O
bp	O
)	O
of	O
the	O
coronavirus	B-SPEC
was	O
subsequently	O
sequenced	O
using	O
PCR	O
cloning	O
techniques	O
.	O

No	O
type	O
D	O
retroviruses	B-SPEC
were	O
found	O
.	O

The	O
positive	O
rate	O
of	O
CPV	B-SPEC
-	O
2	O
and	O
the	O
distribution	O
of	O
the	O
new2a	O
,	O
new2b	O
and	O
2c	O
types	O
exhibited	O
differences	O
among	O
regions	O
,	O
seasons	O
,	O
and	O
ages	O
.	O

The	O
partial	O
S1	O
gene	O
regions	O
of	O
BCoVs	O
(	O
An	O
-	O
4	O
and	O
An	O
-	O
11	O
)	O
detected	O
in	O
feces	O
samples	O
from	O
two	O
herd	O
-	O
mate	B-SPEC
dairy	O
calves	O
were	O
compared	O
.	O

Replication	O
-	O
competent	O
recombinant	O
measles	B-SPEC
virus	I-SPEC
(	O
MV	O
)	O
expressing	O
foreign	O
antigens	O
constitutes	O
a	O
promising	O
tool	O
to	O
induce	O
protective	O
immunity	O
against	O
corresponding	O
pathogens	O
.	O

In	O
vivo	O
,	O
immunization	O
of	O
type	O
I	O
interferon	O
receptor	O
-	O
deficient	O
(	O
IFNAR	O
(-/-))-	O
CD46Ge	O
mice	B-SPEC
with	O
2	O
	O
10	O
(	O
5	O
)	O
50	O
%	O
tissue	O
culture	O
infective	O
doses	O
of	O
MVvac2	O
-	O
CoV	O
-	O
S	O
(	O
H	O
)	O
or	O
MVvac2	O
-	O
CoV	O
-	O
solS	O
(	O
H	O
)	O
in	O
a	O
prime	O
-	O
boost	O
regimen	O
induced	O
robust	O
levels	O
of	O
both	O
MV	O
-	O
and	O
MERS	O
-	O
CoV	O
-	O
neutralizing	O
antibodies	O
.	O

This	O
report	O
raises	O
concern	O
regarding	O
the	O
potential	O
severity	O
of	O
pulmonary	O
Burkholderia	B-SPEC
cepacia	I-SPEC
complex	I-SPEC
infection	O
and	O
the	O
need	O
to	O
broaden	O
clinicians	O
'	O
suspicion	O
for	O
Cepacia	O
syndrome	O
.	O

Biochemical	O
studies	O
showed	O
that	O
kuwanon	O
-	O
L	O
is	O
able	O
to	O
inhibit	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IN	O
catalytic	O
activity	O
in	O
the	O
absence	O
and	O
in	O
the	O
presence	O
of	O
LEDGF	O
/	O
p75	O
protein	O
,	O
the	O
IN	O
dimerization	O
,	O
and	O
the	O
IN	O
/	O
LEDGF	O
binding	O
.	O

Kuwanon	O
-	O
L	O
also	O
inhibited	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
in	O
cell	O
cultures	O
.	O

TITLE	O
:	O
Jubanines	O
F	O
-	O
J	O
,	O
cyclopeptide	O
alkaloids	O
from	O
the	O
roots	O
of	O
Ziziphus	B-SPEC
jujuba	I-SPEC
.	O

ABSTRACT	O
:	O
Five	O
Ib	O
-	O
type	O
cyclopeptide	O
alkaloids	O
,	O
jubanines	O
F	O
-	O
J	O
(	O
1	O
-	O
5	O
),	O
and	O
three	O
known	O
compounds	O
,	O
nummularine	O
B	O
(	O
6	O
),	O
daechuine	O
-	O
S3	O
(	O
7	O
),	O
and	O
mucronine	O
K	O
(	O
8	O
)	O
were	O
isolated	O
from	O
the	O
roots	O
of	O
Ziziphus	B-SPEC
jujuba	I-SPEC
.	O

Compounds	O
1	O
-	O
3	O
,	O
and	O
6	O
were	O
evaluated	O
for	O
their	O
antiviral	O
activity	O
against	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

Serial	O
lactate	O
monitoring	O
is	O
associated	O
with	O
a	O
decrease	O
in	O
major	O
pulmonary	O
complications	O
in	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

We	O
show	O
that	O
wild	O
-	O
type	O
mice	B-SPEC
infected	O
with	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
-	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
),	O
a	O
model	O
for	O
viral	O
FH	O
,	O
manifest	O
with	O
severe	O
disease	O
and	O
high	O
mortality	O
in	O
association	O
with	O
a	O
significant	O
elevation	O
in	O
IL	O
-	O
1	O
expression	O
in	O
the	O
serum	O
and	O
liver	O
.	O

We	O
compared	O
trends	O
in	O
viruses	B-SPEC
between	O
early	O
and	O
late	O
influenza	O
seasons	O
.	O

Furthermore	O
,	O
GO	O
inactivated	O
both	O
viruses	B-SPEC
by	O
structural	O
destruction	O
prior	O
to	O
viral	O
entry	O
.	O

Analysis	O
of	O
antibodies	O
from	O
69	O
healthy	O
humans	B-SPEC
suggests	O
an	O
important	O
role	O
of	O
the	O
V	O
(	O
D	O
)	O
J	O
recombination	O
-	O
generated	O
junctional	O
and	O
allele	O
-	O
specific	O
residues	O
for	O
achieving	O
high	O
affinity	O
of	O
binding	O
at	O
such	O
low	O
levels	O
of	O
somatic	O
hypermutation	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
maleopimaric	O
and	O
quinopimaric	O
acids	O
'	O
derivatives	O
modified	O
in	O
the	O
E	O
-	O
ring	O
,	O
at	O
the	O
carbonyl	O
-	O
and	O
carboxyl	O
-	O
groups	O
were	O
synthesized	O
and	O
evaluated	O
for	O
their	O
activity	O
in	O
vitro	O
against	O
respiratory	O
viruses	B-SPEC
(	O
influenza	O
;	O
rhinovirus	B-SPEC
;	O
adenovirus	B-SPEC
;	O
and	O
SARS	O
),	O
papilloma	O
virus	B-SPEC
,	O
and	O
hepatitis	O
B	O
and	O
C	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
unique	O
clinical	O
case	O
about	O
an	O
18	O
-	O
year	O
-	O
old	O
woman	O
,	O
immediately	O
post	O
-	O
partum	O
after	O
an	O
urgent	O
C	O
-	O
section	O
,	O
who	O
survived	O
severe	O
sepsis	B-SPEC
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
)	O
and	O
was	O
successfully	O
treated	O
with	O
11	O
different	O
antibiotics	O
,	O
massive	O
blood	O
transfusions	O
and	O
repetitive	O
surgeries	O
and	O
was	O
on	O
extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
support	O
for	O
22	O
days	O
.	O

Bone	O
marrow	O
stromal	O
antigen	O
2	O
(	O
BST	O
-	O
2	O
;	O
also	O
known	O
as	O
CD317	O
or	O
tetherin	O
)	O
was	O
initially	O
identified	O
to	O
be	O
a	O
pre	O
-	O
B	O
-	O
cell	O
growth	O
promoter	O
,	O
but	O
it	O
also	O
inhibits	O
the	O
release	O
of	O
virions	O
of	O
the	O
retrovirus	B-SPEC
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
by	O
tethering	O
budding	O
virions	O
to	O
the	O
host	O
cell	O
membrane	O
.	O

Further	O
work	O
has	O
shown	O
that	O
BST	O
-	O
2	O
restricts	O
the	O
release	O
of	O
many	O
other	O
viruses	B-SPEC
,	O
including	O
the	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
hCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
),	O
and	O
the	O
genomes	O
of	O
many	O
of	O
these	O
viruses	B-SPEC
encode	O
BST	O
-	O
2	O
antagonists	O
to	O
overcome	O
BST	O
-	O
2	O
restriction	O
.	O

TITLE	O
:	O
Evidence	O
for	O
an	O
Ancestral	O
Association	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
229E	I-SPEC
with	O
Bats	B-SPEC
.	O

These	O
data	O
suggested	O
an	O
evolutionary	O
origin	O
of	O
229E	O
-	O
related	O
CoVs	O
in	O
hipposiderid	O
bats	B-SPEC
,	O
hypothetically	O
with	O
camelids	O
as	O
intermediate	O
hosts	O
preceding	O
the	O
establishment	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

Our	O
evolutionary	O
analyses	O
show	O
that	O
animal	B-SPEC
and	O
human	B-SPEC
viruses	B-SPEC
are	O
genetically	O
closely	O
related	O
,	O
can	O
exchange	O
genetic	O
material	O
,	O
and	O
form	O
a	O
single	O
viral	O
species	B-SPEC
.	O

It	O
was	O
concluded	O
that	O
maternal	O
antibodies	O
begin	O
to	O
decrease	O
after	O
the	O
1st	O
month	O
and	O
that	O
the	O
possible	O
first	O
exposure	O
of	O
calves	O
to	O
respiratory	O
viruses	B-SPEC
is	O
after	O
the	O
2nd	O
month	O
.	O

As	O
a	O
result	O
,	O
there	O
is	O
a	O
need	O
to	O
develop	O
technologies	O
that	O
can	O
meet	O
the	O
heavy	O
demand	O
of	O
an	O
all	O
-	O
embedded	O
,	O
inexpensive	O
,	O
specific	O
and	O
fast	O
biosensing	O
for	O
the	O
detection	O
and	O
screening	O
of	O
pathogens	O
in	O
active	O
or	O
latent	O
forms	O
to	O
offer	O
quick	O
diagnosis	O
and	O
early	O
treatments	O
in	O
order	B-SPEC
to	O
avoid	O
disease	O
aggravation	O
and	O
unnecessary	O
late	O
treatment	O
costs	O
.	O

ABSTRACT	O
:	O
A	O
new	O
chemical	O
inhibitor	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
helicase	O
,	O
7	O
-	O
ethyl	O
-	O
8	O
-	O
mercapto	O
-	O
3	O
-	O
methyl	O
-	O
3	O
,	O
7	O
-	O
dihydro	O
-	O
1H	O
-	O
purine	O
-	O
2	O
,	O
6	O
-	O
dione	B-SPEC
,	O
was	O
identified	O
.	O

Chronic	O
respiratory	O
symptoms	O
with	O
pulmonary	O
infiltrates	O
on	O
radiography	O
,	O
positive	O
milk	O
precipitins	O
and	O
resolution	O
of	O
findings	O
upon	O
removal	O
of	O
cow	B-SPEC
'	O
s	O
milk	O
constitute	O
the	O
main	O
features	O
.	O

Furthermore	O
,	O
oxidative	O
stress	O
,	O
probably	O
via	O
lipid	O
peroxidation	O
,	O
was	O
found	O
to	O
induce	O
PLA2G2D	O
expression	O
in	O
mice	B-SPEC
and	O
in	O
human	B-SPEC
monocyte	O
-	O
derived	O
macrophages	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
describe	O
the	O
resistance	O
of	O
IBV	B-SPEC
to	O
IFN	O
and	O
the	O
potential	O
role	O
of	O
accessory	O
proteins	O
herein	O
.	O

We	O
analyzed	O
the	O
evolution	O
of	O
the	O
spike	O
(	O
S	O
)	O
gene	O
in	O
betacoronaviruses	O
(	O
betaCoVs	O
)	O
isolated	O
from	O
different	O
mammals	B-SPEC
,	O
in	O
bat	B-SPEC
coronavirus	B-SPEC
populations	O
,	O
as	O
well	O
as	O
in	O
MERS	O
-	O
CoV	O
strains	O
from	O
the	O
current	O
outbreak	O
.	O

During	O
the	O
most	O
recent	O
evolution	O
of	O
MERS	O
-	O
CoV	O
,	O
adaptive	O
mutations	O
in	O
the	O
HR1	O
(	O
Q	O
/	O
R	O
/	O
H1020	O
)	O
arose	O
in	O
camels	B-SPEC
or	O
in	O
a	O
previous	O
host	O
and	O
spread	O
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

This	O
information	O
is	O
important	O
for	O
future	O
PEDV	B-SPEC
challenge	O
studies	O
and	O
validation	O
of	O
PEDV	B-SPEC
vaccines	O
.	O

Improved	O
global	O
awareness	O
,	O
together	O
with	O
improved	O
hygiene	O
practices	O
in	O
healthcare	O
facilities	O
,	O
has	O
been	O
highlighted	O
as	O
key	O
strategies	O
in	O
controlling	O
the	O
spread	O
of	O
MERS	O
-	O
CoV	O
.	O
This	O
study	O
tested	O
the	O
in	O
vitro	O
efficacy	O
of	O
three	O
formulations	O
of	O
povidone	O
iodine	O
(	O
PVP	O
-	O
I	O
:	O
4	O
%	O
PVP	O
-	O
I	O
skin	O
cleanser	O
,	O
7	O
.	O
5	O
%	O
PVP	O
-	O
I	O
surgical	O
scrub	O
,	O
and	O
1	O
%	O
PVP	O
-	O
I	O
gargle	O
/	O
mouthwash	O
)	O
against	O
a	O
reference	O
virus	B-SPEC
(	O
Modified	O
vaccinia	B-SPEC
virus	I-SPEC
Ankara	O
,	O
MVA	O
)	O
and	O
MERS	O
-	O
CoV	O
.	O
According	O
to	O
EN14476	O
,	O
a	O
standard	O
suspension	O
test	O
was	O
used	O
to	O
assess	O
virucidal	O
activity	O
against	O
MVA	O
and	O
large	O
volume	O
plating	O
was	O
used	O
for	O
MERS	O
-	O
CoV	O
.	O
All	O
products	O
were	O
tested	O
under	O
clean	O
(	O
0	O
.	O
3	O
g	O
/	O
L	O
bovine	B-SPEC
serum	O
albumin	O
,	O
BSA	O
)	O
and	O
dirty	O
conditions	O
(	O
3	O
.	O
0	O
g	O
/	O
L	O
BSA	O
+	O
3	O
.	O
0	O
mL	O
/	O
L	O
erythrocytes	O
),	O
with	O
application	O
times	O
of	O
15	O
,	O
30	O
,	O
and	O
60	O
s	O
for	O
MVA	O
,	O
and	O
15	O
s	O
for	O
MERS	O
-	O
CoV	O
.	O
The	O
products	O
were	O
tested	O
undiluted	O
,	O
1	O
:	O
10	O
and	O
1	O
:	O
100	O
diluted	O
against	O
MVA	O
,	O
and	O
undiluted	O
against	O
MERS	O
-	O
CoV	O
.	O
A	O
reduction	O
in	O
virus	B-SPEC
titer	O
of	O
	O
4	O
log10	O
(	O
corresponding	O
to	O
an	O
inactivation	O
of	O
	O
99	O
.	O
99	O
%)	O
was	O
regarded	O
as	O
evidence	O
of	O
virucidal	O
activity	O
.	O

Mice	B-SPEC
deficient	O
in	O
MDA5	O
expression	O
(	O
MDA5	O
(-/-)	O
mice	B-SPEC
)	O
experienced	O
more	O
severe	O
disease	O
following	O
MHV	B-SPEC
infection	O
,	O
with	O
reduced	O
survival	O
,	O
increased	O
spread	O
of	O
virus	B-SPEC
to	O
additional	O
sites	O
of	O
infection	O
,	O
and	O
more	O
extensive	O
liver	O
damage	O
than	O
did	O
wild	O
-	O
type	O
mice	B-SPEC
.	O

RESULTS	O
:	O
A	O
total	O
of	O
4	O
protein	O
groups	O
between	O
the	O
normal	O
cells	O
and	O
the	O
Calu	O
-	O
3	O
cells	O
infected	O
by	O
IAV	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
or	O
swine	B-SPEC
influenza	O
were	O
identified	O
.	O

TITLE	O
:	O
Conservation	O
of	O
nucleotide	O
sequences	O
for	O
molecular	O
diagnosis	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
2015	O
.	O

The	O
present	O
study	O
was	O
performed	O
to	O
assess	O
the	O
protocols	O
used	O
for	O
the	O
molecular	O
diagnosis	O
of	O
MERS	O
-	O
CoV	O
by	O
analyzing	O
the	O
nucleotide	O
sequences	O
of	O
viruses	B-SPEC
detected	O
between	O
2012	O
and	O
2015	O
,	O
including	O
sequences	O
from	O
the	O
large	O
outbreak	O
in	O
eastern	O
Asia	O
in	O
2015	O
.	O

TITLE	O
:	O
Plant	B-SPEC
-	O
derived	O
H7	O
VLP	O
vaccine	O
elicits	O
protective	O
immune	O
response	O
against	O
H7N9	O
influenza	B-SPEC
virus	I-SPEC
in	O
mice	B-SPEC
and	O
ferrets	B-SPEC
.	O

Infection	O
with	O
this	O
virus	B-SPEC
often	O
caused	O
severe	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
resulting	O
in	O
a	O
case	O
fatality	O
rate	O
>	O
35	O
%.	O

Here	O
,	O
we	O
describe	O
the	O
rapid	O
(	O
19	O
days	O
)	O
development	O
of	O
a	O
plant	B-SPEC
-	O
derived	O
VLP	O
vaccine	O
based	O
on	O
the	O
hemagglutinin	O
sequence	O
of	O
influenza	O
H7N9	O
A	O
/	O
Hangzhou	O
/	O
1	O
/	O
2013	O
.	O

In	O
ferrets	B-SPEC
,	O
we	O
also	O
measured	O
H7	O
-	O
specific	O
cell	O
-	O
mediated	O
immunity	O
.	O

In	O
ferrets	B-SPEC
,	O
a	O
single	O
immunization	O
with	O
the	O
alum	O
-	O
adjuvanted	O
H7	O
VLP	O
vaccine	O
induced	O
strong	O
humoral	O
and	O
CMI	O
responses	O
with	O
antigen	O
-	O
specific	O
activation	O
of	O
CD3	O
(+)	O
T	O
cells	O
.	O

Regardless	O
,	O
these	O
data	O
are	O
very	O
promising	O
for	O
the	O
rapid	O
production	O
of	O
an	O
immunogenic	O
and	O
protective	O
vaccine	O
against	O
this	O
potentially	O
pandemic	O
virus	B-SPEC
.	O

TITLE	O
:	O
ORF8	O
-	O
Related	O
Genetic	O
Evidence	O
for	O
Chinese	O
Horseshoe	B-SPEC
Bats	I-SPEC
as	O
the	O
Source	O
of	O
Human	B-SPEC
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
an	O
enteric	O
coronaviral	O
infection	O
that	O
causes	O
severe	O
morbidity	O
and	O
mortality	O
in	O
suckling	O
pigs	B-SPEC
,	O
but	O
less	O
severe	O
disease	O
in	O
older	O
pigs	B-SPEC
.	O

The	O
control	O
pigs	B-SPEC
not	O
inoculated	O
with	O
PEDV	B-SPEC
did	O
not	O
show	O
any	O
clinical	O
signs	O
and	O
no	O
detectable	O
fecal	O
or	O
serum	O
PEDV	B-SPEC
RNA	O
.	O

CD3	O
+	O
CD4	O
+	O
T	O
cell	O
frequencies	O
were	O
significantly	O
higher	O
in	O
ileum	O
of	O
suckling	O
pigs	B-SPEC
than	O
in	O
weaned	O
pigs	B-SPEC
,	O
whereas	O
there	O
was	O
no	O
difference	O
in	O
CD3	O
+	O
CD8	O
+	O
T	O
cell	O
frequencies	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
M	O
protein	O
blocks	O
cell	O
cycle	O
progression	O
at	O
S	O
-	O
phase	O
and	O
its	O
subcellular	O
localization	O
in	O
the	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
caused	O
by	O
virulent	O
strains	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
highly	O
contagious	O
enteric	O
disease	O
of	O
swine	B-SPEC
characterized	O
by	O
severe	O
enteritis	O
,	O
vomiting	O
,	O
and	O
watery	O
diarrhea	O
.	O

Five	O
pooled	O
tissue	O
suspensions	O
of	O
50	O
layer	O
birds	B-SPEC
and	O
one	O
reference	O
Massachusetts	O
vaccine	O
strain	O
were	O
inoculated	O
into	O
specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
chicken	B-SPEC
egg	O
for	O
isolation	O
of	O
IBV	B-SPEC
.	O

Reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
was	O
carried	O
out	O
using	O
post	O
inoculated	O
allontoic	O
fluid	O
to	O
amplify	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
S1	O
subunit	O
of	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
Different	O
host	O
genetic	O
variants	O
may	O
be	O
related	O
to	O
the	O
virulence	O
and	O
transmissibility	O
of	O
pandemic	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
,	O
influencing	O
events	O
such	O
as	O
binding	O
of	O
the	O
virus	B-SPEC
to	O
the	O
entry	O
receptor	O
on	O
the	O
cell	O
of	O
infected	O
individuals	O
and	O
the	O
host	O
immune	O
response	O
.	O

TITLE	O
:	O
Effect	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Infectious	O
Doses	O
on	O
Infection	O
Outcomes	O
in	O
Nave	O
Conventional	O
Neonatal	O
and	O
Weaned	O
Pigs	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
and	O
Demonstration	O
of	O
the	O
Value	O
of	O
a	O
Lethal	O
Mouse	B-SPEC
Model	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
and	O
Disease	O
.	O

ABSTRACT	O
:	O
Characterized	O
animal	B-SPEC
models	O
are	O
needed	O
for	O
studying	O
the	O
pathogenesis	O
of	O
and	O
evaluating	O
medical	O
countermeasures	O
for	O
persisting	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
.	O

Here	O
,	O
we	O
further	O
characterized	O
a	O
lethal	O
transgenic	O
mouse	B-SPEC
model	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
disease	O
that	O
globally	O
expresses	O
human	B-SPEC
CD26	O
(	O
hCD26	O
)/	O
DPP4	O
.	O

This	O
further	O
-	O
characterized	O
transgenic	O
mouse	B-SPEC
model	O
will	O
be	O
useful	O
for	O
advancing	O
MERS	O
research	O
.	O

This	O
study	O
investigates	O
the	O
combined	O
effects	O
of	O
age	O
and	O
HIV	B-SPEC
serostatus	O
on	O
WMH	O
and	O
DTI	O
measures	O
,	O
as	O
well	O
as	O
the	O
relationships	O
between	O
these	O
white	O
matter	O
measures	O
,	O
in	O
88	O
HIV	B-SPEC
seropositive	O
(	O
HIV	O
+)	O
and	O
49	O
seronegative	O
(	O
HIV	B-SPEC
-)	O
individuals	O
aged	O
23	O
-	O
79	O
years	O
.	O

Similarly	O
,	O
significant	O
age	O
by	O
HIV	B-SPEC
interactions	O
were	O
found	O
indicating	O
stronger	O
associations	O
between	O
older	O
age	O
and	O
decreased	O
FA	O
in	O
the	O
posterior	O
limbs	O
of	O
the	O
internal	O
capsules	O
,	O
cerebral	O
peduncles	O
,	O
and	O
anterior	O
corona	B-SPEC
radiata	O
in	O
HIV	O
+	O
vs	O
.	O
HIV	B-SPEC
-	O
participants	O
.	O

The	O
interactive	O
effects	O
of	O
HIV	B-SPEC
and	O
age	O
were	O
stronger	O
with	O
respect	O
to	O
whole	O
-	O
brain	O
WMH	O
than	O
for	O
any	O
of	O
the	O
FA	O
measures	O
.	O

Cold	O
medicines	O
and	O
infectious	O
agents	O
such	O
as	O
viruses	B-SPEC
or	O
other	O
microbes	O
are	O
both	O
important	O
in	O
triggering	O
the	O
onset	O
of	O
SJS	O
/	O
TEN	O
with	O
SOCs	O
.	O

Although	O
the	O
functions	O
of	O
the	O
S	O
protein	O
have	O
been	O
well	O
studied	O
,	O
the	O
factors	O
shaping	O
synonymous	O
codon	O
usage	O
bias	B-SPEC
and	O
nucleotide	O
composition	O
in	O
the	O
S	O
gene	O
have	O
not	O
been	O
reported	O
yet	O
.	O

Interestingly	O
,	O
no	O
association	O
of	O
aromaticity	O
,	O
degree	O
of	O
hydrophobicity	O
,	O
and	O
aliphatic	O
index	O
was	O
observed	O
with	O
the	O
codon	O
usage	O
variation	O
in	O
IBV	B-SPEC
S	O
genes	O
.	O

The	O
study	O
represents	O
a	O
comprehensive	O
analysis	O
of	O
IBV	B-SPEC
S	O
gene	O
codon	O
usage	O
patterns	O
and	O
provides	O
a	O
basic	O
understanding	O
of	O
the	O
codon	O
usage	O
bias	B-SPEC
.	O

Using	O
genetically	O
diverse	O
animals	B-SPEC
from	O
incipient	O
lines	O
of	O
the	O
Collaborative	O
Cross	O
mouse	B-SPEC
panel	O
,	O
we	O
demonstrate	O
a	O
greatly	O
expanded	O
range	O
of	O
phenotypes	O
relative	O
to	O
classical	O
mouse	B-SPEC
models	O
of	O
SARS	O
-	O
CoV	O
infection	O
including	O
lung	O
pathology	O
,	O
weight	O
loss	O
and	O
viral	O
titer	O
.	O

This	O
is	O
due	O
to	O
both	O
mortality	O
(	O
either	O
directly	O
provoked	O
by	O
IBV	B-SPEC
itself	O
or	O
due	O
to	O
subsequent	O
bacterial	O
infection	O
)	O
and	O
lost	O
egg	O
production	O
.	O

Tracheal	O
tissue	O
was	O
examined	O
from	O
control	O
and	O
infected	O
birds	B-SPEC
at	O
2	O
,	O
3	O
and	O
4	O
days	O
post	O
-	O
infection	O
in	O
birds	B-SPEC
known	O
to	O
be	O
either	O
susceptible	O
or	O
resistant	O
to	O
the	O
virus	B-SPEC
.	O

These	O
putative	O
resistance	O
genes	O
can	O
be	O
used	O
as	O
targets	O
for	O
future	O
genetic	O
and	O
functional	O
studies	O
to	O
prove	O
a	O
causative	O
link	O
with	O
resistance	O
to	O
IBV	B-SPEC
.	O

S1	O
gene	O
sequencing	O
has	O
been	O
used	O
for	O
molecular	O
epidemiological	O
studies	O
and	O
genotypic	O
characterization	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

This	O
study	O
demonstrates	O
a	O
constant	O
evolution	O
of	O
IBV	B-SPEC
in	O
Iran	O
,	O
demonstrating	O
the	O
need	O
for	O
continuous	O
monitoring	O
and	O
development	O
of	O
new	O
vaccines	O
based	O
on	O
indigenous	O
viruses	B-SPEC
.	O

This	O
might	O
explain	O
why	O
the	O
Saudi	O
Ministry	O
of	O
Health	O
is	O
using	O
social	O
media	O
platforms	O
alongside	O
various	O
other	O
media	O
platforms	O
in	O
a	O
large	O
-	O
scale	O
public	O
awareness	O
campaign	O
to	O
educate	O
at	O
-	O
risk	O
communities	O
about	O
the	O
recently	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
the	O
Republic	O
of	O
Korea	O
started	O
from	O
the	O
index	O
case	O
who	O
developed	O
fever	O
after	O
returning	O
from	O
the	O
Middle	O
East	O
.	O

Many	O
papers	O
have	O
been	O
produced	O
specifically	O
,	O
since	O
the	O
outbreak	O
of	O
carbapenem	O
-	O
resistant	O
Enterobacteriaceae	B-SPEC
in	O
2013	O
.	O

The	O
susceptibility	O
of	O
2	O
-,	O
7	O
-,	O
12	O
-,	O
30	O
-,	O
and	O
52	O
-	O
wk	O
-	O
old	O
turkeys	B-SPEC
to	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	B-SPEC
)	O
and	O
turkey	B-SPEC
astrovirus	I-SPEC
(	O
TAstV	O
)	O
was	O
evaluated	O
,	O
as	O
well	O
as	O
the	O
effect	O
of	O
combined	O
infection	O
of	O
TAstV	O
and	O
TCoV	B-SPEC
in	O
2	O
-	O
wk	O
-	O
old	O
poults	O
and	O
turkey	B-SPEC
hens	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
recently	O
identified	O
virus	B-SPEC
causing	O
severe	O
viral	O
respiratory	O
illness	O
in	O
people	O
.	O

Methods	O
Total	O
RNA	O
was	O
extracted	O
from	O
effusion	O
samples	O
from	O
20	O
cats	B-SPEC
with	O
confirmed	O
FIP	O
and	O
23	O
cats	B-SPEC
with	O
other	O
diseases	O
.	O

A	O
phylogenetic	O
analysis	O
based	O
on	O
the	O
spike	O
gene	O
showed	O
that	O
the	O
38	O
Japanese	O
PEDV	B-SPEC
strains	O
were	O
classified	O
into	O
two	O
PEDV	B-SPEC
types	O
:	O
the	O
North	O
American	O
type	O
with	O
high	O
virulence	O
(	O
n	O
=	O
34	O
)	O
and	O
the	O
INDEL	O
type	O
(	O
n	O
=	O
4	O
).	O

In	O
partially	O
protected	O
birds	B-SPEC
we	O
observed	O
clinical	O
signs	O
and	O
detected	O
challenge	O
virus	B-SPEC
;	O
however	O
,	O
the	O
ciliated	O
epithelium	O
was	O
intact	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
vaccinated	O
chicken	B-SPEC
flocks	O
continues	O
to	O
cause	O
enormous	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
in	O
Iran	O
.	O

Specimens	O
of	O
trachea	B-SPEC
,	O
kidney	O
,	O
and	O
cecal	O
tonsil	O
were	O
collected	O
from	O
250	O
suspected	O
flocks	O
(	O
more	O
than	O
2500	O
samples	O
)	O
and	O
identified	O
between	O
2010	O
and	O
2014	O
.	O

The	O
majority	O
of	O
flocks	O
(	O
67	O
.	O
6	O
%)	O
experienced	O
infection	O
with	O
an	O
IBV	B-SPEC
variant	O
unrelated	O
to	O
the	O
vaccine	O
strains	O
.	O

Specifically	O
,	O
the	O
pyrido	O
[	O
2	O
,	O
3	O
-	O
g	O
]	O
quinoxalinone	O
nucleus	O
was	O
found	O
endowed	O
with	O
high	O
potency	O
against	O
several	O
pathogenic	O
RNA	O
viruses	B-SPEC
as	O
etiological	O
agents	O
of	O
important	O
veterinary	O
and	O
human	B-SPEC
pathologies	O
.	O

After	O
MHV	B-SPEC
-	O
3	O
infection	O
,	O
the	O
proportions	O
of	O
DN	O
T	O
cells	O
increased	O
significantly	O
in	O
BALB	O
/	O
cJ	O
mice	B-SPEC
,	O
and	O
splenic	O
DN	O
T	O
cells	O
expressing	O
high	O
levels	O
of	O
CD69	O
were	O
recruited	O
by	O
MHV	B-SPEC
-	O
3	O
-	O
infected	O
hepatocytes	O
to	O
the	O
liver	O
.	O

Following	O
MHV	B-SPEC
-	O
3	O
infection	O
,	O
membrane	O
mfgl2	O
expression	O
and	O
functional	O
procoagulant	O
activity	O
increased	O
remarkably	O
in	O
the	O
DN	O
T	O
cells	O
.	O

Of	O
the	O
31	O
strains	O
,	O
24	O
were	O
H120	O
-	O
like	O
and	O
two	O
were	O
M41	O
-	O
like	O
isolates	O
as	O
determined	O
by	O
complete	O
genomic	O
sequence	O
analysis	O
,	O
indicating	O
that	O
most	O
of	O
the	O
IBV	B-SPEC
isolates	O
were	O
likely	O
the	O
reisolated	O
vaccine	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
an	O
acute	O
infectious	O
disease	O
of	O
the	O
respiratory	O
system	O
caused	O
by	O
the	O
new	O
betacoronavirus	B-SPEC
(	O
MERS	O
coronavirus	B-SPEC
,	O
MERS	O
-	O
CoV	O
),	O
which	O
shows	O
high	O
mortality	O
rates	O
.	O

However	O
,	O
the	O
antifungal	O
activity	O
of	O
(	O
R	O
,	O
R	O
)-	O
17	O
	O
HCl	O
against	O
Puccinia	B-SPEC
sorghi	I-SPEC
is	O
slightly	O
lower	O
than	O
that	O
of	O
(	O
R	O
,	O
R	O
)-	O
17	O
.	O

There	O
is	O
a	O
need	O
for	O
small	O
-	O
animal	B-SPEC
models	O
of	O
MERS	O
,	O
but	O
mice	B-SPEC
are	O
not	O
susceptible	O
to	O
MERS	O
because	O
murine	B-SPEC
dpp4	O
does	O
not	O
serve	O
as	O
a	O
receptor	O
.	O

These	O
new	O
mouse	B-SPEC
models	O
of	O
MERS	O
-	O
CoV	O
should	O
be	O
useful	O
for	O
investigation	O
of	O
early	O
disease	O
mechanisms	O
and	O
therapeutic	O
interventions	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
a	O
spectrum	O
of	O
illness	O
.	O

We	O
evaluated	O
whether	O
cycle	O
threshold	O
(	O
Ct	O
)	O
values	O
(	O
which	O
are	O
inversely	O
related	O
to	O
virus	B-SPEC
load	O
)	O
were	O
associated	O
with	O
clinical	O
severity	O
in	O
patients	O
from	O
Saudi	O
Arabia	O
whose	O
nasopharyngeal	O
specimens	O
tested	O
positive	O
for	O
this	O
virus	B-SPEC
by	O
real	O
-	O
time	O
reverse	O
transcription	O
PCR	O
.	O

More	O
data	O
are	O
needed	O
to	O
determine	O
whether	O
modulation	O
of	O
virus	B-SPEC
load	O
by	O
therapeutic	O
agents	O
affects	O
clinical	O
outcomes	O
.	O

ABSTRACT	O
:	O
Pathogenic	O
viral	O
infections	O
pose	O
major	O
health	O
risks	O
to	O
humans	B-SPEC
and	O
livestock	O
due	O
to	O
viral	O
infection	O
-	O
associated	O
illnesses	O
such	O
as	O
chronic	O
or	O
acute	O
inflammation	O
in	O
crucial	O
organs	O
and	O
systems	O
,	O
malignant	O
and	O
benign	O
lesions	O
.	O

Outbreaks	O
of	O
emerging	O
lethal	O
viruses	B-SPEC
,	O
such	O
as	O
Ebola	B-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
virus	B-SPEC
,	O
could	O
lead	O
to	O
epidemics	O
or	O
even	O
pandemics	O
if	O
they	O
are	O
not	O
effectively	O
controlled	O
.	O

Surface	O
protection	O
and	O
disinfection	O
against	O
microorganisms	O
,	O
including	O
viruses	B-SPEC
,	O
is	O
performed	O
by	O
sanitization	O
of	O
the	O
skin	O
surface	O
through	O
hand	O
washing	O
with	O
soap	O
and	O
water	O
,	O
surface	O
disinfectants	O
,	O
and	O
hand	O
sanitizers	O
,	O
particularly	O
alcohol	O
-	O
based	O
hand	O
sanitizers	O
.	O

There	O
is	O
a	O
need	O
for	O
a	O
novel	O
approach	O
to	O
protect	O
humans	B-SPEC
and	O
livestock	O
from	O
infections	O
of	O
pathogenic	O
viruses	B-SPEC
that	O
is	O
broadly	O
effective	O
,	O
long	O
-	O
lasting	O
(	O
persistent	O
),	O
non	O
-	O
toxic	O
,	O
and	O
environment	O
-	O
friendly	O
.	O

This	O
reduced	O
Ad14p1	O
E1B	O
20K	O
expression	O
caused	O
a	O
loss	O
-	O
of	O
-	O
function	O
phenotype	O
of	O
Ad	O
-	O
infected	O
cell	O
corpses	O
that	O
,	O
in	O
contrast	O
to	O
cells	O
infected	O
with	O
wt	O
Ad14	O
,	O
either	O
failed	O
to	O
repress	O
or	O
increased	O
NF	O
-	O
B	O
-	O
dependent	O
,	O
proinflammatory	O
cytokine	O
responses	O
of	O
responder	O
human	B-SPEC
alveolar	O
macrophages	O
.	O

This	O
is	O
the	O
first	O
time	O
that	O
the	O
SSC	O
method	O
has	O
been	O
used	O
for	O
the	O
evolution	O
study	O
of	O
IBV	B-SPEC
.	O

A	O
diffuse	O
comet	B-SPEC
tail	O
sign	O
or	O
a	O
consolidation	O
score	O
	O
6	O
and	O
a	O
lung	O
ultrasound	O
score	O
<	O
25	O
were	O
observed	O
in	O
four	O
patients	O
.	O

The	O
most	O
common	O
cause	O
of	O
mortality	O
in	O
the	O
""""	O
early	O
period	O
""""	O
was	O
uncontrolled	O
bleeding	O
,	O
in	O
the	O
""""	O
late	O
period	O
""""	O
mortality	O
was	O
caused	O
by	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Although	O
acute	O
pneumonia	O
complicated	O
by	O
hemolytic	O
anemia	B-SPEC
was	O
suspected	O
,	O
IPH	O
was	O
finally	O
diagnosed	O
on	O
bronchoscopy	O
.	O

Viral	O
RNA	O
was	O
extracted	O
from	O
25	O
nasopharyngeal	O
samples	O
for	O
detection	O
of	O
influenza	O
A	O
,	O
B	O
and	O
C	O
;	O
parainfluenza	O
1	O
-	O
4	O
;	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
OC43	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
rhinovirus	B-SPEC
.	O

Both	O
multiplex	O
one	O
-	O
step	O
RT	O
-	O
PCR	O
and	O
RT	O
-	O
Bst	O
PCR	O
were	O
used	O
to	O
compare	O
their	O
performances	O
for	O
detection	O
of	O
virus	B-SPEC
sequences	O
.	O

RT	O
-	O
Bst	O
and	O
RT	O
-	O
Bst	O
PCR	O
can	O
be	O
used	O
as	O
alternative	O
approaches	O
to	O
reverse	O
transcription	O
and	O
one	O
-	O
step	O
RT	O
-	O
PCR	O
,	O
respectively	O
,	O
for	O
sequence	O
-	O
independent	O
amplification	O
of	O
RNA	O
virus	B-SPEC
sequences	O
and	O
a	O
larger	O
scale	O
analysis	O
of	O
this	O
new	O
diagnostic	O
approach	O
is	O
warranted	O
.	O

TITLE	O
:	O
Comparative	O
Genomic	O
Analysis	O
of	O
Classical	O
and	O
Variant	O
Virulent	O
Parental	O
/	O
Attenuated	O
Strains	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
.	O

After	O
comparison	O
of	O
the	O
variation	O
characteristic	O
of	O
classical	O
,	O
variant	O
virulent	O
/	O
attenuated	O
strains	O
,	O
it	O
was	O
found	O
that	O
attenuation	O
of	O
PEDV	B-SPEC
virus	B-SPEC
was	O
associated	O
with	O
9	O
-	O
26	O
amino	O
acid	O
(	O
aa	O
)	O
changes	O
in	O
open	O
reading	O
frames	O
(	O
ORF	O
)	O
1a	O
/	O
b	O
and	O
S	O
protein	O
,	O
early	O
termination	O
in	O
ORF3	O
,	O
1	O
-	O
3	O
aa	O
changes	O
in	O
E	O
,	O
M	O
and	O
N	O
protein	O
and	O
some	O
nucleotide	O
sequences	O
'	O
synonymous	O
mutations	O
.	O

Deletions	O
in	O
the	O
carboxy	O
-	O
terminal	O
region	O
of	O
nsp1	O
protein	O
led	O
to	O
higher	O
host	O
interferon	O
responses	O
and	O
virus	B-SPEC
attenuation	O
.	O

TITLE	O
:	O
Differential	O
effect	O
of	O
cholesterol	O
on	O
type	O
I	O
and	O
II	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

RESULTS	O
:	O
The	O
58	O
infants	O
experienced	O
the	O
following	O
:	O
hypoxemia	O
,	O
100	O
%;	O
ARDS	O
,	O
21	O
%;	O
sepsis	B-SPEC
,	O
34	O
%;	O
pneumothorax	O
,	O
14	O
%;	O
MODS	O
,	O
16	O
%;	O
and	O
intracranial	O
infection	O
,	O
9	O
%.	O

TITLE	O
:	O
The	O
imperative	O
to	O
develop	O
a	O
human	B-SPEC
vaccine	O
for	O
the	O
Hendra	B-SPEC
virus	I-SPEC
in	O
Australia	O
.	O

We	O
performed	O
a	O
retrospective	O
nationwide	O
survey	O
to	O
clarify	O
the	O
current	O
status	O
of	O
RSV	B-SPEC
disease	O
among	O
infants	O
with	O
hematological	O
malignancies	O
.	O

Clinical	O
course	O
,	O
treatment	O
,	O
and	O
outcome	O
of	O
patients	O
with	O
hematological	O
malignancies	O
who	O
suffered	O
from	O
RSV	B-SPEC
infections	O
at	O
the	O
age	O
of	O
<	O
24	O
months	O
during	O
anti	O
-	O
tumor	O
therapy	O
from	O
April	O
2006	O
to	O
March	O
2009	O
were	O
investigated	O
by	O
sending	O
a	O
questionnaire	O
to	O
all	O
member	O
institutions	O
of	O
the	O
Japanese	O
Pediatric	O
Leukemia	O
/	O
Lymphoma	O
Study	O
Group	O
(	O
JPLSG	O
).	O

In	O
the	O
absence	O
of	O
RSV	B-SPEC
-	O
specific	O
therapy	O
,	O
effective	O
prevention	O
and	O
treatment	O
strategies	O
for	O
severe	O
RSV	B-SPEC
disease	O
must	O
be	O
investigated	O
.	O

Among	O
the	O
tested	O
2	O
,	O
4	O
,	O
6	O
-	O
trisubstituted	O
TAZ	O
derivatives	O
,	O
we	O
reconfirmed	O
that	O
a	O
C3	O
-	O
symmetrical	O
TAZ	O
derivative	O
,	O
4e	O
,	O
shows	O
the	O
highest	O
level	O
of	O
anti	O
-	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
activity	O
with	O
a	O
good	O
selectivity	O
index	O
.	O

TITLE	O
:	O
[	O
Sequencing	O
and	O
Phylogenetic	O
Analyses	O
of	O
Structural	O
and	O
Accessory	O
Proteins	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
from	O
the	O
First	O
Imported	O
Case	O
in	O
China	O
,	O
2015	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
genetic	O
character	O
and	O
origin	O
of	O
the	O
first	O
imported	O
infection	O
case	O
of	O
middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
named	O
as	O
MERS	O
-	O
CoV_China	O
GD01	O
),	O
RNA	O
was	O
extracted	O
from	O
swabs	O
of	O
this	O
patient	O
followed	O
by	O
RT	O
-	O
PCR	O
amplification	O
.	O

Future	O
studies	O
must	O
build	O
upon	O
larger	O
-	O
scale	O
collaborations	O
,	O
but	O
also	O
strictly	O
adhere	O
to	O
the	O
highest	O
evidence	O
-	O
based	O
principles	O
in	O
study	O
design	O
,	O
in	O
order	B-SPEC
to	O
reduce	O
research	O
waste	O
and	O
provide	O
clinically	O
translatable	O
evidence	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
syndrome	O
characterized	O
by	O
diffuse	O
pulmonary	O
edema	O
and	O
severe	O
hypoxemia	O
that	O
usually	O
occurs	O
after	O
an	O
injury	O
such	O
as	O
sepsis	B-SPEC
,	O
aspiration	O
and	O
pneumonia	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
PEDV	B-SPEC
ORF3	O
encodes	O
an	O
ion	O
channel	O
protein	O
.	O

Furthermore	O
,	O
the	O
attenuated	O
PEDV	B-SPEC
rather	O
than	O
virulent	O
PEDV	B-SPEC
could	O
grow	O
better	O
in	O
ORF3	O
-	O
expressing	O
Vero	O
cells	O
.	O

The	O
expression	O
level	O
of	O
the	O
PEDV	B-SPEC
nucleocapsid	O
protein	O
also	O
increased	O
.	O

The	O
nucleotide	O
sequences	O
of	O
the	O
N	O
genes	O
of	O
Anhui	O
PEDV	B-SPEC
strains	O
were	O
95	O
.	O
9	O
-	O
99	O
.	O
9	O
%	O
homologous	O
with	O
each	O
other	O
,	O
and	O
the	O
deduced	O
amino	O
acid	O
sequences	O
were	O
92	O
.	O
5	O
-	O
99	O
.	O
8	O
%	O
homologous	O
.	O

Compared	O
with	O
the	O
PEDV	B-SPEC
reference	O
strains	O
,	O
the	O
Anhui	O
PEDV	B-SPEC
field	O
strains	O
had	O
94	O
.	O
1	O
-	O
99	O
.	O
5	O
%	O
nucleotide	O
sequence	O
homology	O
in	O
the	O
N	O
gene	O
and	O
91	O
.	O
2	O
-	O
97	O
.	O
5	O
%	O
amino	O
acid	O
mutation	O
homology	O
in	O
the	O
N	O
protein	O
.	O

TITLE	O
:	O
Knowledge	O
,	O
attitudes	O
and	O
practices	O
concerning	O
Middle	O
East	O
respiratory	O
syndrome	O
among	O
Umrah	O
and	O
Hajj	O
pilgrims	O
in	O
Samsun	O
,	O
Turkey	B-SPEC
,	O
2015	O
.	O

ABSTRACT	O
:	O
In	O
2012	O
,	O
a	O
new	O
betacoronavirus	B-SPEC
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
was	O
identified	O
in	O
humans	B-SPEC
.	O

Using	O
a	O
molecular	O
cDNA	O
infectious	O
clone	O
to	O
generate	O
a	O
corresponding	O
recombinant	O
virus	B-SPEC
,	O
we	O
show	O
for	O
the	O
first	O
time	O
that	O
such	O
point	O
mutation	O
in	O
the	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
S	O
glycoprotein	O
creates	O
a	O
functional	O
cleavage	O
site	O
between	O
the	O
S1	O
and	O
S2	O
portions	O
of	O
the	O
S	O
protein	O
.	O

Here	O
,	O
we	O
show	O
that	O
cystine	O
knot	O
	O
-	O
amylase	O
inhibitors	O
named	O
alstotides	O
discovered	O
from	O
the	O
Alstonia	B-SPEC
scholaris	I-SPEC
plant	B-SPEC
of	O
the	O
Apocynaceae	B-SPEC
family	B-SPEC
display	O
antiviral	O
activity	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
CoV	O
underscores	O
the	O
threat	O
of	O
cross	O
-	O
species	B-SPEC
transmission	O
events	O
leading	O
to	O
outbreaks	O
in	O
humans	B-SPEC
.	O

The	O
recent	O
outbreak	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
has	O
led	O
to	O
1	O
338	O
laboratory	O
-	O
confirmed	O
cases	O
in	O
26	O
countries	O
worldwide	O
as	O
reported	O
till	O
19	O
June	O
,	O
2015	O
.	O

We	O
report	O
here	O
that	O
pathogenic	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
remained	O
infectious	O
in	O
a	O
human	B-SPEC
lung	O
cell	O
culture	O
model	O
following	O
at	O
least	O
5	O
days	O
of	O
persistence	O
on	O
a	O
range	O
of	O
common	O
nonbiocidal	O
surface	O
materials	O
,	O
including	O
polytetrafluoroethylene	O
(	O
Teflon	O
;	O
PTFE	O
),	O
polyvinyl	O
chloride	O
(	O
PVC	O
),	O
ceramic	O
tiles	O
,	O
glass	O
,	O
silicone	O
rubber	O
,	O
and	O
stainless	O
steel	O
.	O

TITLE	O
:	O
A	O
rare	O
cause	O
of	O
acute	O
flaccid	O
paralysis	O
:	O
Human	B-SPEC
coronaviruses	O
.	O

Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
cause	O
common	O
cold	O
,	O
upper	O
and	O
lower	O
respiratory	O
tract	O
disease	O
,	O
but	O
in	O
the	O
literature	O
presentation	O
with	O
the	O
lower	O
respiratory	O
tract	O
infection	O
and	O
AFP	O
has	O
not	O
been	O
reported	O
previously	O
.	O

Medical	O
records	O
of	O
cats	B-SPEC
diagnosed	O
with	O
endogenous	O
uveitis	O
at	O
North	O
Carolina	O
State	O
University	O
'	O
s	O
College	O
of	O
Veterinary	O
Medicine	O
(	O
NCSU	O
-	O
CVM	O
)	O
or	O
Animal	B-SPEC
Eye	O
Care	O
Associates	O
of	O
Cary	O
,	O
NC	O
between	O
2003	O
and	O
2015	O
were	O
reviewed	O
.	O

Serology	O
was	O
consistently	O
completed	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	O
),	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
FIV	B-SPEC
),	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
),	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
and	O
Bartonella	B-SPEC
spp	O
.	O

Neoplasia	O
was	O
diagnosed	O
in	O
six	O
cats	B-SPEC
(	O
5	O
.	O
0	O
%).	O

Activation	O
and	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
recruitment	O
of	O
myelin	O
-	O
specific	O
CD4	O
T	O
cells	O
was	O
analyzed	O
by	O
flow	O
cytometry	O
during	O
encephalomyelitis	O
induced	O
by	O
a	O
glia	B-SPEC
tropic	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
disease	O
outbreaks	O
and	O
epidemics	O
such	O
as	O
those	O
due	O
to	O
SARS	O
,	O
influenza	O
,	O
measles	O
,	O
tuberculosis	O
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
have	O
raised	O
concern	O
about	O
the	O
airborne	O
transmission	O
of	O
pathogens	O
in	O
indoor	O
environments	O
.	O

RESULTS	O
:	O
One	O
hundred	O
ninety	O
-	O
nine	O
LRT	O
samples	O
collected	O
during	O
the	O
3	O
weeks	O
following	O
diagnosis	O
yielded	O
virus	B-SPEC
RNA	O
in	O
93	O
%	O
of	O
tests	O
.	O

RESULTS	O
:	O
In	O
the	O
animal	B-SPEC
model	O
,	O
recruitment	O
caused	O
a	O
significant	O
decrease	O
in	O
dynamic	O
strain	O
(	O
from	O
[	O
mean	O
	O
SD	O
]	O
0	O
.	O
4	O
	O
0	O
.	O
12	O
to	O
0	O
.	O
25	O
	O
0	O
.	O
07	O
,	O
P	O
<	O
0	O
.	O
01	O
),	O
while	O
increasing	O
the	O
static	O
component	O
.	O

Klebsiella	B-SPEC
pneumoniae	I-SPEC
was	O
detected	O
in	O
both	O
stumps	O
of	O
the	O
transected	O
right	O
optic	O
nerve	O
.	O

The	O
novel	O
N9	O
sequences	O
were	O
most	O
closely	O
related	O
to	O
gene	O
sequences	O
of	O
N9	O
derived	O
from	O
ducks	B-SPEC
H11N9	O
in	O
2011	O
in	O
Jiangxi	O
and	O
H2N9	O
sequences	O
from	O
Hong	O
Kong	O
in	O
2010	O
,	O
in	O
China	O
,	O
and	O
therefore	O
they	O
may	O
share	O
a	O
common	O
ancestor	O
.	O

The	O
present	O
study	O
indicates	O
a	O
strong	O
astrocytic	O
response	O
,	O
including	O
the	O
presence	O
of	O
many	O
less	O
differentiated	O
vimentin	O
-	O
positive	O
astrocytes	O
and	O
gitter	O
cells	O
positive	O
for	O
RCA	O
-	O
1	O
in	O
severe	O
lesions	O
in	O
the	O
CNS	O
of	O
cats	B-SPEC
with	O
FIP	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
the	O
kinetics	O
of	O
serologic	O
responses	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
by	O
using	O
virus	B-SPEC
neutralization	O
and	O
MERS	O
-	O
CoV	O
S1	O
IgG	O
ELISA	O
tests	O
.	O

Sepsis	B-SPEC
patients	O
with	O
multiorgan	O
dysfunction	O
syndrome	O
and	O
/	O
or	O
shock	O
(	O
original	O
study	O
)	O
were	O
regrouped	O
based	O
on	O
the	O
presence	O
or	O
the	O
absence	O
of	O
concurrent	O
hepatobiliary	O
dysfunction	O
and	O
disseminated	O
intravascular	O
coagulation	O
as	O
features	O
of	O
macrophage	O
activation	O
syndrome	O
.	O

TITLE	O
:	O
Inhibitors	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
attachment	O
:	O
The	O
discovery	O
and	O
structure	O
-	O
activity	O
relationships	O
of	O
tetrahydroisoquinolines	O
as	O
replacements	O
for	O
the	O
piperazine	O
benzamide	O
in	O
the	O
3	O
-	O
glyoxylyl	O
6	O
-	O
azaindole	O
pharmacophore	O
.	O

TITLE	O
:	O
Spatial	O
and	O
temporal	O
epidemiology	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
in	O
the	O
Midwest	O
and	O
Southeast	O
regions	O
of	O
the	O
United	O
States	O
.	O

In	O
contrast	O
for	O
semiempirical	O
methods	O
,	O
the	O
errors	O
strongly	O
diversify	O
if	O
one	O
goes	B-SPEC
from	O
gas	O
phase	O
to	O
COSMO	B-SPEC
or	O
QM	O
/	O
MM	O
.	O

These	O
results	O
will	O
contribute	O
to	O
understanding	O
the	O
epidemiology	O
of	O
the	O
disease	O
in	O
Japan	O
and	O
will	O
ultimately	O
aid	O
in	O
designing	O
and	O
implementing	O
effective	O
prevention	O
and	O
control	O
strategies	O
in	O
Japan	O
and	O
other	O
regions	O
epidemically	O
infected	O
by	O
the	O
PED	O
virus	B-SPEC
.	O

However	O
,	O
the	O
severity	O
of	O
clinical	O
signs	O
,	O
mortality	O
(	O
0	O
-	O
75	O
%)	O
and	O
fecal	O
PEDV	B-SPEC
RNA	O
shedding	O
titers	O
varied	O
among	O
the	O
four	O
S	O
-	O
INDEL	O
Iowa106	O
-	O
inoculated	O
litters	O
.	O

In	O
addition	O
,	O
almost	O
half	O
of	O
the	O
population	O
remains	O
unaware	O
that	O
bats	B-SPEC
and	O
camels	B-SPEC
are	O
the	O
most	O
likely	O
sources	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Surveillance	O
for	O
severe	O
acute	O
respiratory	O
infections	O
in	O
Southern	O
Arizona	B-SPEC
,	O
2010	O
-	O
2014	O
.	O

Staff	O
completed	O
a	O
standard	O
form	O
and	O
collected	O
a	O
nasopharyngeal	O
swab	O
which	O
was	O
tested	O
for	O
selected	O
respiratory	O
viruses	B-SPEC
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

Among	O
the	O
49	O
influenza	O
-	O
positive	O
specimens	O
,	O
76	O
%	O
were	O
influenza	O
A	O
(	O
19	O
H3N2	O
,	O
17	O
H1N1pdm09	O
,	O
and	O
1	O
not	O
subtyped	O
),	O
and	O
24	O
%	O
were	O
influenza	O
B	O
.	O
Influenza	B-SPEC
viruses	I-SPEC
were	O
a	O
frequent	O
cause	O
of	O
SARI	O
in	O
hospitalized	O
patients	O
in	O
Southern	O
Arizona	B-SPEC
.	O

ABSTRACT	O
:	O
Recent	O
outbreaks	O
of	O
deadly	O
infectious	O
diseases	O
,	O
such	O
as	O
Ebola	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
have	O
motivated	O
the	O
research	O
for	O
accurate	O
,	O
rapid	O
diagnostics	O
that	O
can	O
be	O
administered	O
at	O
the	O
point	O
of	O
care	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
deadly	O
disease	O
that	O
effects	O
both	O
domestic	O
and	O
wild	B-SPEC
cats	I-SPEC
and	O
is	O
caused	O
by	O
a	O
mutation	O
in	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
that	O
allows	O
the	O
virus	B-SPEC
to	O
replicate	O
in	O
macrophages	O
.	O

RSV	B-SPEC
,	O
PIVs	O
and	O
coronaviruses	O
were	O
most	O
prevalent	O
in	O
infants	O
less	O
than	O
6	O
months	O
old	O
,	O
whereas	O
MPV	B-SPEC
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
were	O
more	O
prominent	O
in	O
children	O
aged	O
7	O
-	O
24	O
and	O
25	O
-	O
60	O
months	O
,	O
respectively	O
.	O

TITLE	O
:	O
Transmission	O
of	O
SARS	O
and	O
MERS	O
coronaviruses	O
and	O
influenza	B-SPEC
virus	I-SPEC
in	O
healthcare	O
settings	O
:	O
the	O
possible	O
role	O
of	O
dry	O
surface	O
contamination	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
with	O
pandemic	O
potential	O
including	O
H1N1	O
,	O
H5N1	O
,	O
and	O
H5N7	O
influenza	B-SPEC
viruses	I-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)/	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronaviruses	O
(	O
CoV	O
)	O
have	O
emerged	O
in	O
recent	O
years	O
.	O

SARS	O
-	O
CoV	O
,	O
MERS	O
-	O
CoV	O
,	O
and	O
influenza	B-SPEC
virus	I-SPEC
can	O
survive	O
on	O
surfaces	O
for	O
extended	O
periods	O
,	O
sometimes	O
up	O
to	O
months	O
.	O

Our	O
data	O
suggest	O
that	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
replicate	O
poorly	O
in	O
human	B-SPEC
macrophages	O
and	O
MDDCs	O
,	O
but	O
MERS	O
-	O
CoV	O
is	O
nonetheless	O
capable	O
of	O
inducing	O
a	O
readily	O
detectable	O
host	O
innate	O
immune	O
response	O
.	O

We	O
present	O
a	O
39	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
presented	O
with	O
a	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
related	O
to	O
an	O
alveolar	O
hemorrhage	O
associated	O
with	O
a	O
persistent	O
penis	O
ulcer	O
and	O
a	O
genital	O
lymphedema	O
.	O

TITLE	O
:	O
Retrospective	O
testing	O
and	O
case	O
series	O
study	O
of	O
porcine	B-SPEC
delta	O
coronavirus	B-SPEC
in	O
U	O
.	O
S	O
.	O
swine	B-SPEC
herds	O
.	O

TITLE	O
:	O
Inferring	O
the	O
hosts	O
of	O
coronavirus	B-SPEC
using	O
dual	O
statistical	O
models	O
based	O
on	O
nucleotide	O
composition	O
.	O

In	O
order	B-SPEC
to	O
assess	O
their	O
threat	O
to	O
humans	B-SPEC
,	O
we	O
explored	O
to	O
infer	O
the	O
potential	O
hosts	O
of	O
coronaviruses	O
using	O
a	O
dual	O
-	O
model	O
approach	O
based	O
on	O
nineteen	O
parameters	O
computed	O
from	O
spike	O
genes	O
of	O
coronaviruses	O
.	O

TITLE	O
:	O
Sepsis	B-SPEC
and	O
ARDS	O
:	O

TITLE	O
:	O
Attenuation	O
mechanism	O
of	O
virulent	O
infectious	O
bronchitis	O
virus	B-SPEC
strain	O
with	O
QX	O
genotype	O
by	O
continuous	O
passage	O
in	O
chicken	B-SPEC
embryos	O
.	O

ABSTRACT	O
:	O
The	O
virulent	O
isolate	O
SDZB0808	O
of	O
QX	O
-	O
type	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
continuously	O
passaged	O
in	O
chicken	B-SPEC
embryos	O
for	O
110	O
generations	O
.	O

These	O
finding	O
suggest	O
that	O
significant	O
genetic	O
events	O
outside	O
of	O
the	O
spike	O
region	O
have	O
contributed	O
to	O
the	O
evolution	O
of	O
PEDV	B-SPEC
.	O

However	O
,	O
accessing	O
particular	O
-	O
1	O
PRF	O
stimulator	O
information	O
represents	O
a	O
bottle	O
-	O
neck	O
in	O
combating	O
the	O
emerging	O
epidemic	O
viral	O
pathogens	O
such	O
as	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
An	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
,	O
designated	O
as	O
ck	O
/	O
CH	O
/	O
LGX	O
/	O
130530	O
,	O
was	O
isolated	O
from	O
an	O
IBV	B-SPEC
strain	O
H120	O
-	O
vaccinated	O
chicken	B-SPEC
in	O
this	O
study	O
.	O

The	O
patient	O
was	O
a	O
32	O
-	O
year	O
-	O
old	O
Chinese	O
man	B-SPEC
with	O
severe	O
heroin	O
intoxication	O
complicated	O
by	O
acute	O
pulmonary	O
edema	O
and	O
respiratory	O
insufficiency	O
,	O
shock	O
,	O
myocardial	O
damage	O
and	O
cardiac	O
insufficiency	O
,	O
rhabdomyolysis	O
and	O
acute	O
renal	O
insufficiency	O
,	O
acute	O
liver	O
injury	O
and	O
hepatic	O
insufficiency	O
,	O
toxic	O
leukoencephalopathy	O
,	O
and	O
hypoglycemia	O
.	O

TITLE	O
:	O
Feasibility	O
,	O
safety	O
,	O
clinical	O
,	O
and	O
laboratory	O
effects	O
of	O
convalescent	O
plasma	O
therapy	O
for	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
:	O
a	O
study	O
protocol	O
.	O

LPS	O
exposure	O
induces	O
the	O
production	O
of	O
harmful	O
reactive	O
oxygen	O
species	B-SPEC
,	O
and	O
the	O
resultant	O
oxidant	O
injury	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
both	O
severe	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

Finally	O
,	O
imatinib	O
completely	O
prevented	O
mortality	O
in	O
an	O
in	O
vivo	O
,	O
intravenous	O
LPS	O
mouse	B-SPEC
model	O
of	O
endotoxemia	O
and	O
lung	O
injury	O
.	O

TITLE	O
:	O
Prediction	O
and	O
identification	O
of	O
novel	O
IBV	B-SPEC
S1	O
protein	O
derived	O
CTL	O
epitopes	O
in	O
chicken	B-SPEC
.	O

Four	O
epitopes	O
(	O
P8SRIQTATDP	O
,	O
P9SRNATGSQP	O
,	O
P18GAYAVVNV	O
,	O
and	O
P19SRIQTATQP	O
)	O
were	O
identified	O
to	O
stimulate	O
CD8	O
(+)	O
T	O
cell	O
proliferation	O
and	O
IFN	O
-	O
	O
secretion	O
,	O
indicating	O
their	O
efficacy	O
as	O
CTL	O
epitopes	O
in	O
chicken	B-SPEC
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
an	O
altered	O
lipid	O
composition	O
of	O
lung	O
tissue	O
and	O
BAL	O
fluid	O
,	O
partially	O
ascribed	O
to	O
oedema	O
and	O
lipoprotein	O
infiltration	O
,	O
is	O
a	O
characteristic	O
feature	O
of	O
murine	B-SPEC
MA	O
-	O
ALI	O
/	O
ARDS	O
and	O
possibly	O
contribute	O
to	O
lung	O
dysfunction	O
.	O

ABSTRACT	O
:	O
Development	O
an	O
effective	O
vaccine	O
against	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
urgent	O
and	O
limited	O
information	O
is	O
available	O
on	O
vaccination	O
in	O
nonhuman	O
primate	B-SPEC
(	O
NHP	O
)	O
model	O
.	O

Besides	O
,	O
rRBD	O
vaccination	O
alleviated	O
pneumonia	O
with	O
evidence	O
of	O
reduced	O
tissue	O
impairment	O
and	O
clinical	O
manifestation	O
in	O
monkeys	B-SPEC
.	O

MERS	O
-	O
CoV	O
IgG	O
sero	O
-	O
positivity	O
gradually	O
increased	O
in	O
dromedary	B-SPEC
calves	O
with	O
increasing	O
age	O
,	O
with	O
positivity	O
rates	O
of	O
75	O
%	O
at	O
zero	O
to	O
three	O
months	O
,	O
79	O
%	O
at	O
four	O
months	O
,	O
89	O
%	O
at	O
five	O
to	O
six	O
months	O
,	O
and	O
90	O
%	O
at	O
seven	O
to	O
twelve	O
months	O
.	O

Topics	O
addressed	O
include	O
;	O
transformation	O
and	O
expression	O
systems	O
,	O
plant	B-SPEC
bioreactors	O
,	O
safety	O
concerns	O
,	O
and	O
various	O
opportunities	O
to	O
produce	O
topical	O
applications	O
and	O
health	O
supplements	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
a	O
reservoir	O
for	O
a	O
diverse	O
range	O
of	O
viruses	B-SPEC
,	O
including	O
coronaviruses	O
(	O
CoVs	O
).	O

The	O
fixed	O
-	O
effect	O
model	O
was	O
adopted	O
in	O
our	O
meta	B-SPEC
-	O
analysis	O
.	O

Although	O
traditional	O
detection	O
methods	O
for	O
respiratory	O
viruses	B-SPEC
have	O
had	O
little	O
clinical	O
utility	O
,	O
modern	O
viral	O
screening	O
techniques	O
that	O
use	O
molecular	O
sequencing	O
are	O
now	O
both	O
rapid	O
and	O
feasible	O
,	O
which	O
makes	O
analysis	O
of	O
the	O
paranasal	O
sinus	O
microbiome	O
more	O
accessible	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
outbreak	O
has	O
originated	O
from	O
a	O
failure	O
in	O
the	O
national	O
quarantine	O
system	O
in	O
the	O
Republic	O
of	O
Korea	O
as	O
most	O
basic	O
role	O
of	O
protecting	O
the	O
safety	O
and	O
lives	O
of	O
its	O
citizens	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
first	O
emerged	O
in	O
the	O
United	O
States	O
in	O
2013	O
,	O
spread	O
throughout	O
the	O
U	O
.	O
S	O
.	O
hog	O
population	O
.	O

To	O
assess	O
these	O
impacts	O
,	O
this	O
article	O
reviews	O
the	O
timeline	O
of	O
PEDV	B-SPEC
in	O
the	O
United	O
States	O
and	O
the	O
corresponding	O
impacts	O
.	O

PEDV	B-SPEC
is	O
a	O
supply	O
-	O
impacting	O
disease	O
and	O
is	O
not	O
demand	O
inhibiting	O
,	O
as	O
pork	O
demand	O
remained	O
strong	O
since	O
PEDV	B-SPEC
first	O
appeared	O
.	O

Independent	O
of	O
the	O
definition	O
used	O
for	O
identification	O
of	O
ARDS	O
patients	O
,	O
reported	O
population	O
-	O
based	O
incidence	O
of	O
ARDS	O
is	O
an	O
order	B-SPEC
of	O
magnitude	O
lower	O
in	O
Europe	O
than	O
in	O
the	O
USA	O
.	O

A	O
potent	O
anti	O
-	O
HCV	B-SPEC
drug	O
,	O
sofosbuvir	O
with	O
high	O
cure	O
rates	O
has	O
been	O
approved	O
.	O

Here	O
,	O
we	O
report	O
a	O
novel	O
dual	O
inhibition	O
mechanism	O
targeting	O
CoV	O
main	O
protease	O
(	O
M	O
(	O
pro	O
))	O
from	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
),	O
which	O
leads	O
to	O
lethal	O
systemic	O
granulomatous	O
disease	O
in	O
cats	B-SPEC
.	O

NEMO	O
is	O
cleaved	O
at	O
glutamine	O
231	O
(	O
Q231	O
)	O
by	O
PEDV	B-SPEC
,	O
and	O
this	O
cleavage	O
impaired	O
the	O
ability	O
of	O
NEMO	O
to	O
activate	O
downstream	O
IFN	O
production	O
and	O
to	O
act	O
as	O
a	O
signaling	O
adaptor	O
of	O
the	O
RIG	O
-	O
I	O
/	O
MDA5	O
pathway	O
.	O

Structural	O
analysis	O
suggests	O
that	O
several	O
key	O
residues	O
outside	O
the	O
catalytic	O
sites	O
of	O
PEDV	B-SPEC
nsp5	O
probably	O
impact	O
NEMO	O
cleavage	O
by	O
modulating	O
potential	O
interactions	O
of	O
nsp5	O
with	O
their	O
substrates	O
.	O

Thus	O
,	O
NEMO	O
probably	O
represents	O
a	O
prime	O
target	O
for	O
3C	O
or	O
3C	O
-	O
like	O
proteinases	O
of	O
different	O
viruses	B-SPEC
.	O

A	O
critical	O
assessment	O
of	O
the	O
residues	O
important	O
to	O
these	O
processes	O
provides	O
insights	O
into	O
the	O
correlation	O
between	O
dimerization	O
and	O
catalysis	O
within	O
the	O
coronaviral	O
Mpro	O
family	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
respiratory	O
disease	O
complex	O
(	O
PRDC	O
)	O
is	O
one	O
of	O
the	O
most	O
important	O
health	O
concerns	O
for	O
pig	B-SPEC
producers	O
and	O
can	O
involve	O
multiple	O
viral	O
and	O
bacterial	O
pathogens	O
.	O

In	O
this	O
study	O
,	O
a	O
novel	O
prototype	O
automated	O
microarray	O
that	O
integrates	O
and	O
automates	O
all	O
steps	O
of	O
post	O
-	O
PCR	O
microarray	O
processing	O
for	O
the	O
simultaneous	O
detection	O
and	O
typing	O
of	O
eight	O
bacteria	B-SPEC
and	O
viruses	B-SPEC
commonly	O
associated	O
with	O
PRDC	O
is	O
described	O
along	O
with	O
associated	O
multiplex	O
reverse	O
transcriptase	O
PCR	O
.	O

Comprehensive	O
information	O
on	O
the	O
levels	O
and	O
duration	O
of	O
effector	O
/	O
memory	O
IgA	O
and	O
IgG	O
antibody	O
secreting	O
B	O
cell	O
response	O
in	O
the	O
intestines	O
and	O
lymphoid	O
organs	O
of	O
PEDV	B-SPEC
-	O
infected	O
sows	O
,	O
and	O
their	O
association	O
with	O
specific	O
antibody	O
levels	O
in	O
clinical	O
samples	O
such	O
as	O
plasma	O
,	O
oral	O
fluid	O
,	O
and	O
feces	O
is	O
important	O
.	O

ABSTRACT	O
:	O
Reintroduction	O
is	O
a	O
growing	O
field	O
in	O
the	O
conservation	O
of	O
endangered	O
species	B-SPEC
.	O

The	O
majority	O
of	O
samples	O
returned	O
negative	O
results	O
,	O
with	O
the	O
exception	O
of	O
two	O
individuals	O
that	O
tested	O
positive	O
for	O
C	B-SPEC
.	I-SPEC
psittaci	I-SPEC
in	O
the	O
first	O
sampling	O
and	O
for	O
Ascaridia	B-SPEC
spp	O
.	O

Phylogenetic	O
analyses	O
demonstrate	O
that	O
the	O
viruses	B-SPEC
in	O
Nigeria	O
are	O
genetically	O
distinct	O
from	O
those	O
reported	O
in	O
the	O
Arabian	O
peninsula	O
.	O

In	O
addition	O
,	O
results	O
show	O
that	O
MHV	B-SPEC
infection	O
impairs	O
Cx43	O
expression	O
in	O
addition	O
to	O
gap	O
junction	O
communication	O
in	O
primary	O
astrocytes	O
.	O

This	O
case	O
report	O
illustrates	O
the	O
importance	O
of	O
considering	O
FRSCV	O
infection	O
as	O
a	O
differential	O
diagnosis	O
in	O
young	O
,	O
debilitated	O
ferrets	B-SPEC
with	O
abdominal	O
masses	O
and	O
other	O
supporting	O
clinical	O
signs	O
.	O

In	O
addition	O
to	O
the	O
implementation	O
of	O
hygiene	O
measures	O
to	O
limit	O
further	O
camel	B-SPEC
-	O
to	O
-	O
human	B-SPEC
and	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmissions	O
,	O
vaccine	O
-	O
mediated	O
reduction	O
of	O
MERS	O
-	O
CoV	O
spread	O
from	O
the	O
animal	B-SPEC
reservoir	O
may	O
be	O
envisaged	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
causes	O
transmissible	O
gastroenteritis	O
(	O
TGE	O
),	O
especially	O
in	O
newborn	O
piglets	O
,	O
which	O
severely	O
threatens	O
the	O
worldwide	O
pig	B-SPEC
industry	O
.	O

Viability	O
assays	O
revealed	O
that	O
(+)-	O
catechin	O
treatment	O
exerted	O
a	O
dose	O
-	O
dependent	O
rescue	O
effect	O
in	O
TGEV	B-SPEC
-	O
infected	O
ST	O
cells	O
,	O
and	O
this	O
result	O
was	O
only	O
obtained	O
with	O
the	O
post	O
-	O
treatment	O
application	O
of	O
(+)-	O
catechin	O
.	O

ABSTRACT	O
:	O
Middle	O
Eastern	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
spread	O
rapidly	O
across	O
much	O
of	O
the	O
Middle	O
East	O
,	O
but	O
no	O
quantitative	O
mapping	O
of	O
transmission	O
risk	O
has	O
been	O
developed	O
to	O
date	O
.	O

We	O
compare	O
the	O
environmental	O
breadth	O
of	O
conditions	O
under	O
which	O
cases	O
have	O
reported	O
camel	B-SPEC
contacts	O
with	O
that	O
of	O
the	O
broader	O
population	O
of	O
all	O
cases	O
,	O
to	O
assess	O
whether	O
camel	B-SPEC
-	O
associated	O
cases	O
occur	O
under	O
a	O
more	O
restricted	O
set	O
of	O
environmental	O
circumstances	O
.	O

We	O
confirm	O
the	O
idea	B-SPEC
that	O
climatic	O
dimensions	O
of	O
camel	B-SPEC
-	O
associated	O
cases	O
are	O
more	O
constrained	O
and	O
less	O
variable	O
than	O
the	O
broader	O
suite	O
of	O
case	O
occurrences	O
;	O
hence	O
,	O
camel	B-SPEC
exposure	O
may	O
be	O
a	O
key	O
limiting	O
element	O
in	O
MERS	O
-	O
CoV	O
transmission	O
.	O

ABSTRACT	O
:	O
The	O
enteric	O
disease	O
of	O
swine	B-SPEC
recognized	O
in	O
the	O
early	O
1970s	O
in	O
Europe	O
was	O
initially	O
described	O
as	O
""""	O
epidemic	O
viral	O
diarrhea	O
""""	O
and	O
is	O
now	O
termed	O
""""	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
")""."	O

More	O
information	O
about	O
the	O
virus	B-SPEC
and	O
the	O
disease	O
is	O
still	O
necessary	O
for	O
the	O
development	O
of	O
effective	O
vaccines	O
and	O
control	O
strategies	O
.	O

TITLE	O
:	O
Bat	B-SPEC
origin	O
of	O
human	B-SPEC
coronaviruses	O
.	O

Moreover	O
,	O
intermediate	O
hosts	O
are	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
transmission	O
and	O
emergence	O
of	O
these	O
coronaviruses	O
from	O
bats	B-SPEC
to	O
humans	B-SPEC
.	O

Understanding	O
the	O
bat	B-SPEC
origin	O
of	O
human	B-SPEC
coronaviruses	O
is	O
helpful	O
for	O
the	O
prediction	O
and	O
prevention	O
of	O
another	O
pandemic	O
emergence	O
in	O
the	O
future	O
.	O

Although	O
data	O
from	O
clinical	O
,	O
in	O
vitro	O
and	O
ex	O
vivo	O
studies	O
suggested	O
the	O
potential	O
for	O
virus	B-SPEC
dissemination	O
,	O
extrapulmonary	O
involvement	O
in	O
MERS	O
patients	O
has	O
not	O
been	O
ascertained	O
due	O
to	O
the	O
lack	O
of	O
autopsy	O
study	O
.	O

In	O
MERS	O
-	O
CoV	O
permissive	O
animal	B-SPEC
models	O
,	O
although	O
viral	O
RNA	O
can	O
be	O
detected	O
from	O
multiple	O
organs	O
of	O
the	O
affected	O
animals	B-SPEC
,	O
the	O
brain	O
of	O
human	B-SPEC
DPP4	O
-	O
transgenic	O
mouse	B-SPEC
was	O
the	O
only	O
extrapulmonary	O
organ	O
from	O
which	O
the	O
infectious	O
virus	B-SPEC
can	O
be	O
recovered	O
.	O

TITLE	O
:	O
CDC42	O
Use	O
in	O
Viral	O
Cell	O
Entry	O
Processes	O
by	O
RNA	O
Viruses	B-SPEC
.	O

However	O
,	O
virus	B-SPEC
strains	O
from	O
South	O
Korea	O
showed	O
strain	O
-	O
specific	O
variations	O
.	O

ABSTRACT	O
:	O
The	O
advent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
the	O
21st	O
century	O
and	O
the	O
recent	O
outbreak	O
of	O
Middle	O
-	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
highlight	O
the	O
importance	O
of	O
coronaviruses	O
(	O
CoVs	O
)	O
as	O
human	B-SPEC
pathogens	O
,	O
emphasizing	O
the	O
need	O
for	O
development	O
of	O
novel	O
antiviral	O
strategies	O
to	O
combat	O
acute	O
respiratory	O
infections	O
caused	O
by	O
CoVs	O
.	O

Three	O
additional	O
HCP	O
in	O
this	O
dialysis	B-SPEC
unit	O
had	O
serologic	O
evidence	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

This	O
study	O
examined	O
the	O
mechanism	O
underlying	O
this	O
phenomenon	O
by	O
measuring	O
the	O
expression	O
of	O
antiviral	O
genes	O
-	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
	O
)	O
and	O
GTPase	O
myxovirus	O
resistance	O
1	O
(	O
MX1	O
)-	O
in	O
G6PD	O
-	O
knockdown	O
cells	O
upon	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
and	O
enterovirus	B-SPEC
71	O
(	O
EV71	O
)	O
infection	O
.	O

Precisely	O
how	O
virus	B-SPEC
transmits	O
to	O
humans	B-SPEC
remains	O
unknown	O
but	O
close	O
and	O
lengthy	O
exposure	O
appears	O
to	O
be	O
a	O
requirement	O
.	O

Quantitative	O
real	O
-	O
time	O
PCR	O
data	O
revealed	O
the	O
inhibitory	O
effect	O
of	O
2	O
on	O
genes	O
encoding	O
essential	O
structural	O
proteins	O
(	O
GP6	O
nucleocapsid	O
,	O
GP2	O
spike	O
,	O
and	O
GP5	O
membrane	O
)	O
for	O
PEDV	B-SPEC
replication	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Detection	O
limits	O
and	O
quantification	O
cycle	O
(	O
Cq	O
)	O
values	O
of	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
were	O
assayed	O
for	O
PEDV	B-SPEC
samples	O
and	O
positive	O
controls	O
for	O
both	O
gN	O
and	O
gS	O
.	O
The	O
limit	O
of	O
detection	O
for	O
the	O
gN	O
assay	O
was	O
10	O
(-	O
6	O
)	O
(	O
mean	O
Cq	O
:	O
39	O
.	O
82	O
	O
0	O
.	O
30	O
)	O
and	O
10	O
(-	O
5	O
)	O
(	O
mean	O
Cq	O
:	O
39	O
.	O
39	O
	O
0	O
.	O
72	O
)	O
for	O
the	O
gS	O
assay	O
with	O
PEDV	B-SPEC
strain	O
USA	O
/	O
Colorado	O
/	O
2013	O
.	O

PEDV	B-SPEC
could	O
be	O
detected	O
in	O
rectal	O
swabs	O
from	O
all	O
pigs	B-SPEC
for	O
~	O
2	O
weeks	O
postinfection	O
at	O
which	O
time	O
the	O
prevalence	O
began	O
to	O
decrease	O
until	O
all	O
pigs	B-SPEC
were	O
RT	O
-	O
PCR	O
negative	O
by	O
5	O
weeks	O
postinfection	O
.	O

ABSTRACT	O
:	O
Data	O
on	O
the	O
management	O
,	O
clinical	O
course	O
,	O
and	O
outcome	O
of	O
critical	O
patients	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
are	O
scarce	O
.	O

Subjects	O
intubated	O
for	O
management	O
of	O
ARDS	O
from	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
pneumonia	O
and	O
ARDS	O
during	O
the	O
April	O
-	O
May	O
2014	O
outbreak	O
were	O
included	O
.	O

In	O
cats	B-SPEC
without	O
effusion	O
,	O
a	O
definitive	O
diagnosis	O
can	O
only	O
be	O
achieved	O
post	O
mortem	O
or	O
with	O
invasive	O
methods	O
.	O

ABSTRACT	O
:	O
In	O
May	O
2015	O
,	O
an	O
imported	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
occurred	O
in	O
China	O
,	O
so	O
rapid	O
and	O
reliable	O
diagnosis	O
of	O
suspected	O
cases	O
was	O
necessary	O
.	O

Laboratory	O
biosafety	O
preparedness	O
included	O
class	B-SPEC
II	O
biosafety	O
cabinets	O
(	O
100	O
%);	O
separated	O
pre	O
-	O
PCR	O
,	O
PCR	O
,	O
and	O
post	O
-	O
PCR	O
rooms	O
(	O
88	O
.	O
6	O
%);	O
negative	O
pressure	O
pretreatment	O
rooms	O
(	O
48	O
.	O
6	O
%);	O
and	O
negative	O
pressure	O
sputum	O
collection	O
rooms	O
(	O
20	O
.	O
0	O
%).	O

ABSTRACT	O
:	O
We	O
compared	O
the	O
mechanisms	O
of	O
porcine	B-SPEC
delatacoronavirus	O
(	O
PDCoV	O
)	O
induced	O
death	O
of	O
infected	O
enterocytes	O
in	O
vivo	O
and	O
infected	O
LLC	O
porcine	B-SPEC
kidney	O
(	O
LLC	O
-	O
PK	O
)	O
and	O
swine	B-SPEC
testicular	O
(	O
ST	O
)	O
cells	O
in	O
vitro	O
.	O

Thus	O
,	O
PDCoV	O
does	O
not	O
induce	O
apoptosis	O
in	O
the	O
infected	O
intestinal	O
enterocytes	O
in	O
vivo	O
,	O
but	O
in	O
two	O
infected	O
cell	O
lines	O
of	O
swine	B-SPEC
origin	O
,	O
LLC	O
-	O
PK	O
and	O
ST	O
cells	O
.	O

For	O
a	O
scenario	O
to	O
be	O
plausible	O
,	O
it	O
had	O
to	O
explain	O
:	O
contamination	O
of	O
a	O
person	O
or	O
product	O
in	O
the	O
source	O
country	O
,	O
its	O
transit	O
and	O
entry	O
to	O
the	O
United	O
States	O
,	O
rapid	O
dispersal	O
across	O
a	O
wide	O
geographic	O
area	O
,	O
and	O
exposure	O
/	O
infection	O
of	O
pigs	B-SPEC
.	O

It	O
had	O
to	O
be	O
compatible	O
with	O
findings	O
of	O
swine	B-SPEC
herd	O
investigations	O
and	O
research	O
studies	O
.	O

Seasonal	O
outbreaks	O
of	O
WD	O
in	O
adult	O
cattle	B-SPEC
occur	O
mainly	O
in	O
dairy	O
cows	B-SPEC
.	O

This	O
study	O
describes	O
the	O
molecular	O
detection	O
of	O
BCoV	O
in	O
a	O
diarrhea	O
outbreak	O
in	O
beef	O
cattle	B-SPEC
steers	O
(	O
Nellore	O
)	O
raised	O
on	O
pasture	O
in	O
Parana	O
,	O
southern	O
Brazil	O
.	O

This	O
is	O
the	O
first	O
report	O
demonstrating	O
the	O
presence	O
of	O
PEDV	B-SPEC
in	O
Austria	O
.	O

The	O
virus	B-SPEC
was	O
probably	O
introduced	O
by	O
purchasing	O
piglets	O
from	O
a	O
German	O
source	O
,	O
which	O
underlines	O
the	O
significance	O
of	O
trans	O
-	O
boundary	O
animal	B-SPEC
trade	O
for	O
the	O
distribution	O
of	O
highly	O
contagious	O
diseases	O
,	O
such	O
as	O
PED	O
.	O

The	O
pathogen	O
detection	O
capabilities	O
hosted	O
on	O
Pathosphere	O
were	O
tested	O
by	O
analyzing	O
pathogen	O
-	O
containing	O
samples	O
sequenced	O
by	O
NGS	O
with	O
both	O
spiked	O
human	B-SPEC
samples	O
as	O
well	O
as	O
human	B-SPEC
and	O
zoonotic	O
host	O
backgrounds	O
.	O

TITLE	O
:	O
Gray	O
and	O
white	O
matter	O
alterations	O
in	O
early	O
HIV	B-SPEC
-	O
infected	O
patients	O
:	O
Combined	O
voxel	O
-	O
based	O
morphometry	O
and	O
tract	O
-	O
based	O
spatial	O
statistics	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
both	O
the	O
gray	O
matter	O
(	O
GM	O
)	O
and	O
whiter	O
matter	O
(	O
WM	O
)	O
alterations	O
in	O
a	O
homogeneous	O
cohort	O
of	O
early	O
HIV	B-SPEC
-	O
infected	O
patients	O
by	O
combining	O
voxel	O
-	O
based	O
morphometry	O
(	O
VBM	O
)	O
and	O
tract	O
-	O
based	O
spatial	O
statistics	O
(	O
TBSS	O
).	O

Twenty	O
-	O
six	O
HIV	B-SPEC
and	O
26	O
control	O
subjects	O
enrolled	O
in	O
this	O
study	O
with	O
3D	O
T1	O
and	O
diffusion	O
-	O
tensor	O
imaging	O
acquired	O
on	O
a	O
3	O
.	O
0T	O
Siemens	O
scanner	O
.	O

CONCLUSIONS	O
:	O
Our	O
results	O
indicate	O
that	O
structural	O
brain	O
alterations	O
occurred	O
early	O
in	O
HIV	B-SPEC
-	O
infected	O
patients	O
.	O

Rhesus	B-SPEC
macaques	I-SPEC
developed	O
mild	O
disease	O
,	O
and	O
common	B-SPEC
marmosets	I-SPEC
exhibited	O
moderate	O
to	O
severe	O
,	O
potentially	O
lethal	O
,	O
disease	O
.	O

In	O
marmosets	B-SPEC
,	O
the	O
pneumonia	O
was	O
more	O
extensive	O
,	O
with	O
development	O
of	O
severe	O
airway	O
lesions	O
.	O

Importantly	O
,	O
recombinant	O
PEDV	B-SPEC
was	O
rapidly	O
transmitted	O
to	O
uninoculated	O
pigs	B-SPEC
via	O
indirect	O
contact	O
,	O
demonstrating	O
virulence	O
and	O
efficient	O
transmission	O
while	O
replicating	O
phenotypes	O
seen	O
in	O
the	O
wild	O
-	O
type	O
virus	B-SPEC
.	O

icPEDV	O
-	O
ORF3	O
-	O
RFP	O
replicated	O
efficiently	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
was	O
efficiently	O
transmitted	O
among	O
pigs	B-SPEC
,	O
and	O
produced	O
lethal	O
disease	O
outcomes	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
emerging	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
encodes	O
the	O
conserved	O
macro	O
domain	O
within	O
non	O
-	O
structural	O
protein	O
3	O
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
the	O
association	O
between	O
presence	O
of	O
respiratory	O
pathogens	O
and	O
development	O
of	O
Canine	O
Infectious	O
Respiratory	O
Disease	O
Complex	O
(	O
CIRDC	O
)	O
in	O
dogs	B-SPEC
in	O
5	O
Canadian	O
small	O
animal	B-SPEC
clinics	O
.	O

In	O
total	O
,	O
86	O
dogs	B-SPEC
were	O
tested	O
using	O
a	O
commercial	O
PCR	O
respiratory	O
panel	O
;	O
64	O
dogs	B-SPEC
were	O
considered	O
as	O
cases	O
and	O
22	O
were	O
control	O
dogs	B-SPEC
matched	O
by	O
veterinary	O
clinic	O
.	O

Furthermore	O
,	O
81	O
%	O
of	O
case	O
dogs	B-SPEC
tested	O
positive	O
for	O
Mycoplasma	B-SPEC
cynos	I-SPEC
,	O
compared	O
with	O
73	O
%	O
of	O
control	O
dogs	B-SPEC
.	O

Canine	O
respiratory	O
corona	B-SPEC
virus	B-SPEC
(	O
CRCoV	O
)	O
was	O
detected	O
in	O
no	O
control	O
dogs	B-SPEC
compared	O
with	O
9	O
.	O
4	O
%	O
of	O
clinical	O
dogs	B-SPEC
.	O

No	O
animals	B-SPEC
were	O
positive	O
for	O
any	O
influenza	B-SPEC
virus	I-SPEC
type	I-SPEC
A	I-SPEC
present	O
in	O
the	O
diagnostic	O
panel	O
.	O

Blood	O
samples	O
were	O
collected	O
at	O
intervals	O
for	O
the	O
detection	O
of	O
anti	O
-	O
IBV	B-SPEC
antibodies	O
.	O

These	O
results	O
provided	O
new	O
evidence	O
that	O
PEDV	B-SPEC
strains	O
circulating	O
in	O
China	O
underwent	O
recombination	O
between	O
vaccine	O
and	O
field	O
strains	O
,	O
suggesting	O
that	O
recombination	O
contributes	O
to	O
the	O
genetic	O
diversity	O
of	O
PEDV	B-SPEC
.	O

Throat	O
samples	O
from	O
107	O
hospitalized	O
patients	O
with	O
pneumonia	O
and	O
175	O
outpatients	O
with	O
influenza	O
-	O
like	O
illness	O
were	O
examined	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
assays	O
with	O
virus	B-SPEC
-	O
specific	O
primers	O
,	O
and	O
then	O
virus	B-SPEC
-	O
positive	O
specimens	O
were	O
confirmed	O
by	O
sequencing	O
the	O
polymerase	O
chain	O
reaction	O
products	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
was	O
identified	O
in	O
8	O
.	O
4	O
%	O
(	O
9	O
/	O
107	O
)	O
of	O
hospitalized	O
patients	O
with	O
pneumonia	O
,	O
but	O
not	O
found	O
in	O
outpatients	O
with	O
influenza	O
-	O
like	O
illness	O
.	O

Seasonal	O
prevalence	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
was	O
late	O
winter	O
,	O
overlapping	O
the	O
highest	O
peak	O
of	O
the	O
influenza	O
A	O
/	O
H1N1	O
epidemic	O
during	O
December	O
2010	O
to	O
March	O
2011	O
in	O
Taiwan	O
.	O

Co	O
-	O
infection	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
influenza	O
A	O
/	O
H1N1	O
was	O
detected	O
in	O
three	O
hospitalized	O
patients	O
.	O

Clinical	O
manifestation	O
analysis	O
indicated	O
that	O
the	O
main	O
symptoms	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
included	O
fever	O
(	O
88	O
.	O
9	O
%),	O
cough	O
(	O
77	O
.	O
8	O
%),	O
and	O
pneumonia	O
(	O
100	O
%).	O

These	O
data	O
,	O
in	O
conjunction	O
with	O
diagnostic	O
reports	O
,	O
were	O
used	O
to	O
estimate	O
the	O
time	O
required	O
for	O
the	O
herd	O
to	O
produce	O
PEDV	B-SPEC
PCR	O
negative	O
pigs	B-SPEC
and	O
the	O
production	O
loss	O
.	O

Of	O
the	O
429	O
infected	O
herds	O
that	O
achieved	O
the	O
stable	O
state	O
of	O
weaning	O
PEDV	B-SPEC
PCR	O
negative	O
pigs	B-SPEC
,	O
the	O
median	O
time	O
was	O
28	O
weeks	O
,	O
ranging	O
from	O
7	O
to	O
64	O
weeks	O
.	O

When	O
co	O
-	O
infections	O
were	O
evaluated	O
,	O
a	O
statistically	O
significant	O
difference	O
was	O
found	O
only	O
for	O
C	B-SPEC
.	I-SPEC
perfringens	I-SPEC
2	O
and	O
C	B-SPEC
.	I-SPEC
suis	I-SPEC
(	O
p	O
=	O
0	O
.	O
014	O
).	O

TITLE	O
:	O
A	O
new	O
vinyl	O
selenone	O
-	O
based	O
domino	O
approach	O
to	O
spirocyclopropyl	O
oxindoles	O
endowed	O
with	O
anti	O
-	O
HIV	B-SPEC
RT	O
activity	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
ns2	O
phosphodiesterase	O
domain	O
that	O
antagonizes	O
RNase	O
L	O
activation	O
.	O

Here	O
,	O
we	O
present	O
the	O
crystal	O
structure	O
of	O
the	O
MHV	B-SPEC
ns2	O
PDE	O
domain	O
and	O
demonstrate	O
a	O
PDE	O
fold	O
similar	O
to	O
that	O
of	O
the	O
cellular	O
protein	O
,	O
a	O
kinase	O
anchoring	O
protein	O
7	O
central	O
domain	O
(	O
AKAP7	O
(	O
CD	O
))	O
and	O
rotavirus	B-SPEC
VP3	O
carboxy	O
-	O
terminal	O
domain	O
.	O

Common	O
clinical	O
manifestations	O
included	O
cough	O
(	O
14	O
cases	O
),	O
gasping	O
(	O
13	O
cases	O
),	O
dyspnea	O
(	O
9	O
cases	O
),	O
fever	O
(	O
6	O
cases	O
),	O
hoarseness	O
(	O
4	O
cases	O
),	O
laryngeal	O
stridor	O
(	O
4	O
cases	O
)	O
and	O
abnormality	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
(	O
including	O
fuzzy	O
lung	O
texture	O
,	O
patchy	O
shadow	O
and	O
consolidation	O
)	O
(	O
12	O
cases	O
).	O

ABSTRACT	O
:	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
is	O
recognized	O
as	O
an	O
important	O
agent	O
of	O
pneumonia	O
in	O
pediatric	O
population	O
.	O

A	O
case	O
of	O
a	O
girl	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
bilateral	O
pleural	O
effusion	O
secondary	O
to	O
pneumonia	O
due	O
to	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
is	O
described	O
,	O
with	O
good	O
recovery	O
after	O
appropriate	O
use	O
of	O
methylprednisolone	O
and	O
clarythromicyn	O
.	O

TITLE	O
:	O
Impact	O
of	O
Mated	O
Female	O
Nonproductive	O
Days	O
in	O
Breeding	O
Herd	O
after	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Outbreak	O
.	O

However	O
,	O
limited	O
information	O
on	O
the	O
productivity	O
values	O
of	O
gilts	O
and	O
sows	O
infected	O
with	O
PEDV	B-SPEC
is	O
available	O
.	O

Elevated	O
levels	O
of	O
CXCL1	O
did	O
not	O
influence	O
the	O
generation	O
of	O
virus	B-SPEC
-	O
specific	O
T	O
cells	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
control	O
of	O
JHMV	O
replication	O
compared	O
with	O
control	O
mice	B-SPEC
,	O
indicating	O
that	O
T	O
cell	O
infiltration	O
into	O
the	O
CNS	O
is	O
CXCL1	O
-	O
independent	O
.	O

ABSTRACT	O
:	O
Type	O
I	O
interferons	O
(	O
IFN	O
-	O
	O
/	O
	O
)	O
are	O
the	O
major	O
components	O
of	O
the	O
innate	O
immune	O
response	O
of	O
hosts	O
,	O
and	O
in	O
turn	O
many	O
viruses	B-SPEC
have	O
evolved	O
to	O
modulate	O
the	O
host	O
response	O
during	O
infection	O
.	O

Crenatoside	O
,	O
a	O
phenylethanoid	O
glycoside	O
from	O
Pogostemon	B-SPEC
cablin	I-SPEC
Benth	O
,	O
which	O
has	O
been	O
shown	O
as	O
a	O
novel	O
effective	O
NA	O
inhibitor	O
previously	O
,	O
is	O
considered	O
as	O
the	O
leading	O
compound	O
for	O
our	O
further	O
SARs	O
studies	O
.	O

Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
and	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
)	O
were	O
never	O
isolated	O
in	O
Hajj	O
pilgrims	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
spread	O
in	O
humans	B-SPEC
across	O
wide	O
geographical	O
areas	O
in	O
short	O
periods	O
of	O
time	O
,	O
resulting	O
in	O
high	O
levels	O
of	O
morbidity	O
and	O
mortality	O
.	O

Two	O
reviewers	O
screened	O
all	O
identified	O
records	O
against	O
the	O
protocol	O
,	O
undertook	O
risk	O
of	O
bias	B-SPEC
assessments	O
and	O
extracted	O
data	O
using	O
a	O
piloted	O
form	O
.	O

This	O
review	O
focuses	O
on	O
the	O
fierce	O
arms	O
race	O
between	O
host	O
innate	O
antiviral	O
immunity	O
and	O
emerging	O
human	B-SPEC
coronaviruses	O
.	O

Particularly	O
,	O
the	O
host	O
pathogen	O
recognition	O
receptors	O
and	O
the	O
signal	O
transduction	O
pathways	O
to	O
mount	O
an	O
effective	O
antiviral	O
response	O
against	O
SARS	O
and	O
MERS	O
coronavirus	B-SPEC
infection	O
are	O
discussed	O
.	O

ABSTRACT	O
:	O
Objectives	O
Diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
remains	O
challenging	O
,	O
especially	O
in	O
cats	B-SPEC
without	O
effusions	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
a	O
comprehensive	O
review	O
.	O

However	O
,	O
based	O
on	O
the	O
new	O
Atlanta	B-SPEC
classification	O
criteria	O
,	O
there	O
were	O
686	O
cases	O
(	O
29	O
.	O
8	O
%)	O
with	O
acute	O
respiratory	O
failure	O
,	O
129	O
cases	O
(	O
5	O
.	O
6	O
%)	O
with	O
acute	O
renal	O
failure	O
,	O
107	O
cases	O
(	O
4	O
.	O
6	O
%)	O
with	O
circulatory	O
failure	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
analyzed	O
the	O
spike	O
genes	O
and	O
ORF3	O
genes	O
of	O
seven	O
PEDV	B-SPEC
strains	O
detected	O
in	O
Philippine	O
pigs	B-SPEC
in	O
June	O
2014	O
.	O

TITLE	O
:	O
Surface	O
vimentin	O
is	O
critical	O
for	O
the	O
cell	O
entry	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
caused	O
a	O
global	O
panic	O
due	O
to	O
its	O
high	O
morbidity	O
and	O
mortality	O
during	O
2002	O
and	O
2003	O
.	O

To	O
compare	O
the	O
two	O
methods	O
,	O
we	O
used	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
PCR	O
,	O
which	O
had	O
the	O
lowest	O
limit	O
of	O
detection	O
for	O
propagated	O
IBV	B-SPEC
.	O

TITLE	O
:	O
New	O
Atlanta	B-SPEC
Classification	O
of	O
acute	O
pancreatitis	O
in	O
intensive	O
care	O
unit	O
:	O
Complications	O
and	O
prognosis	O
.	O

Eleven	O
of	O
the	O
new	O
compounds	O
were	O
tested	O
and	O
found	O
active	O
against	O
influenza	O
A	O
neuraminidase	O
virus	B-SPEC
(	O
H3N2	O
).	O

Mayo	B-SPEC
Clinic	O
,	O
Rochester	O
,	O
MN	O
.	O

Eight	O
uninfected	O
and	O
infected	O
birds	B-SPEC
from	O
each	O
line	O
were	O
euthanized	O
at	O
1	O
and	O
3	O
weeks	O
post	O
infection	O
.	O

RESULTS	O
:	O
Comparing	O
uninfected	O
L10H	O
and	O
L10L	O
birds	B-SPEC
,	O
we	O
identified	O
1698	O
and	O
1424	O
differentially	O
expressed	O
(	O
DE	O
)	O
genes	O
at	O
weeks	O
1	O
and	O
3	O
,	O
respectively	O
.	O

TITLE	O
:	O
Detection	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
strains	O
similar	O
to	O
Japan	O
in	O
Taiwan	O
.	O

Remarkably	O
,	O
factors	O
linked	O
to	O
free	O
-	O
ranging	O
behaviour	O
of	O
dogs	B-SPEC
were	O
associated	O
with	O
the	O
exposure	O
for	O
all	O
pathogens	O
detected	O
.	O

RESULTS	O
:	O
Widespread	O
exposure	O
to	O
canine	O
parvovirus	B-SPEC
(	O
97	O
%),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
15	O
%)	O
and	O
canine	B-SPEC
adenovirus	I-SPEC
(	O
27	O
%)	O
was	O
detected	O
,	O
but	O
none	O
for	O
canine	O
coronavirus	B-SPEC
.	O

Faecal	O
shedding	O
lasted	O
for	O
28	O
-	O
56	O
days	O
,	O
but	O
virus	B-SPEC
shed	O
during	O
this	O
stage	O
was	O
less	O
infectious	O
in	O
enterocyte	O
cultures	O
and	O
affected	O
by	O
mutations	O
.	O

These	O
data	O
indicate	O
that	O
FECV	B-SPEC
can	O
infect	O
immune	O
cells	O
even	O
in	O
the	O
absence	O
of	O
intestinal	O
replication	O
and	O
raise	O
the	O
hypothesis	O
that	O
the	O
gradual	O
adaptation	O
to	O
these	O
cells	O
can	O
allow	O
non	O
-	O
enterotropic	O
mutants	O
to	O
arise	O
.	O

Two	O
groups	O
of	O
NHPs	O
were	O
treated	O
with	O
either	O
a	O
human	B-SPEC
anti	O
-	O
MERS	O
monoclonal	O
antibody	O
3B11	O
-	O
N	O
or	O
E410	O
-	O
N	O
,	O
an	O
anti	O
-	O
HIV	B-SPEC
antibody	O
.	O

Evolution	O
analysis	O
showed	O
that	O
the	O
Kenyan	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
isolates	O
were	O
under	O
purifying	O
selection	O
.	O

RESULTS	O
:	O
The	O
prevalence	O
of	O
HCoV	O
infection	O
was	O
as	O
follows	O
:	O
out	O
of	O
the	O
417	O
specimens	O
,	O
35	O
(	O
8	O
.	O
4	O
%)	O
were	O
positive	O
for	O
HCoV	O
,	O
comprising	O
10	O
(	O
2	O
.	O
4	O
%)	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
12	O
(	O
2	O
.	O
9	O
%)	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
9	O
(	O
2	O
.	O
1	O
%)	O
HCoV	O
-	O
HKU1	O
,	O
and	O
4	O
(	O
1	O
%)	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

RESULTS	O
:	O
Monocytes	O
producing	O
siRNA	O
efficiently	O
inhibit	O
IBV	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
In	O
Saudi	O
Arabia	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
named	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
isolated	O
in	O
2012	O
from	O
patients	O
with	O
severe	O
respiratory	O
symptoms	O
.	O

TITLE	O
:	O
Immunogenicity	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
M	O
gene	O
delivered	O
by	O
attenuated	O
Salmonella	B-SPEC
typhimurium	O
in	O
mice	B-SPEC
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
inoculated	O
orally	O
with	O
SL7207	O
(	O
pVAX	O
-	O
M	O
)	O
at	O
different	O
dosages	O
to	O
evaluate	O
safety	O
of	O
the	O
vaccines	O
.	O

TITLE	O
:	O
Isolation	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
from	O
a	O
Patient	O
of	O
the	O
2015	O
Korean	O
Outbreak	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
pathogenicity	O
differences	O
of	O
the	O
US	O
PEDV	B-SPEC
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
strains	O
in	O
conventional	O
neonatal	O
piglets	O
under	O
experimental	O
infections	O
.	O

This	O
trend	O
makes	O
it	O
all	O
the	O
more	O
imperative	O
for	O
ethical	O
principles	O
and	O
procedures	O
to	O
be	O
implemented	O
in	O
future	O
planning	O
and	O
responses	O
to	O
outbreaks	O
in	O
order	B-SPEC
to	O
promote	O
perceptions	O
of	O
legitimacy	O
and	O
civic	O
participation	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
implicated	O
as	O
important	O
reservoir	O
hosts	O
of	O
alpha	O
-	O
and	O
betacoronaviruses	O
.	O

ABSTRACT	O
:	O
We	O
analyzed	O
a	O
multi	O
-	O
drug	O
resistant	O
(	O
MR	O
)	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
(	O
RT	O
),	O
subcloned	O
from	O
a	O
patient	O
-	O
derived	O
subtype	O
CRF02_AG	O
,	O
harboring	O
45	O
amino	O
acid	O
exchanges	O
,	O
amongst	O
them	O
four	O
thymidine	O
analog	O
mutations	O
(	O
TAMs	O
)	O
relevant	O
for	O
high	O
-	O
level	O
AZT	O
(	O
azidothymidine	O
)	O
resistance	O
by	O
AZTMP	O
excision	O
(	O
M41L	O
,	O
D67N	O
,	O
T215Y	O
,	O
K219E	O
)	O
as	O
well	O
as	O
four	O
substitutions	O
of	O
the	O
AZTTP	O
discrimination	O
pathway	O
(	O
A62V	O
,	O
V75I	O
,	O
F116Y	O
and	O
Q151M	O
).	O

(	O
Saururaceae	B-SPEC
)	O
and	O
three	O
of	O
its	O
constituent	O
flavonoids	O
(	O
quercetin	O
,	O
quercitrin	O
and	O
rutin	O
)	O
against	O
murine	B-SPEC
coronavirus	I-SPEC
and	O
dengue	B-SPEC
virus	I-SPEC
(	O
DENV	O
).	O

Cinanserin	O
hydrochloride	O
was	O
also	O
tested	O
against	O
MHV	B-SPEC
.	O

A	O
recombinant	O
form	O
of	O
the	O
7b	O
protein	O
was	O
expressed	O
as	O
a	O
fusion	O
protein	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
purified	O
by	O
immobilized	O
metal	O
affinity	O
chromatography	O
and	O
used	O
as	O
immunogen	O
.	O

Despite	O
immediate	O
initiation	O
of	O
treatment	O
and	O
elimination	O
of	O
virus	B-SPEC
in	O
subsequent	O
tests	O
,	O
the	O
progressive	O
lung	O
failure	O
led	O
to	O
death	O
7	O
d	O
after	O
onset	O
of	O
fever	O
with	O
massive	O
lung	O
bleeding	O
as	O
a	O
consequence	O
of	O
diffuse	O
alveolar	O
hemorrhage	O
.	O

Pathogenesis	O
following	O
infection	O
with	O
these	O
viruses	B-SPEC
is	O
characterized	O
by	O
a	O
marked	O
delay	O
in	O
the	O
induction	O
of	O
Type	O
I	O
interferon	O
(	O
IFN	O
I	O
)	O
and	O
,	O
subsequently	O
,	O
by	O
a	O
poor	O
adaptive	O
immune	O
response	O
.	O

Therapies	O
that	O
expedite	O
IFN	O
I	O
induction	O
as	O
well	O
as	O
interventions	O
that	O
antagonize	O
immunoevasive	O
virus	B-SPEC
proteins	O
are	O
thus	O
promising	O
candidates	O
for	O
immune	O
modulation	O
.	O

ABSTRACT	O
:	O
The	O
list	O
of	O
extrapulmonary	O
manifestations	O
due	O
to	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
infection	O
can	O
be	O
classified	O
according	O
to	O
the	O
following	O
three	O
possible	O
mechanisms	O
derived	O
from	O
the	O
established	O
biological	O
activity	O
of	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
;	O
(	O
1	O
)	O
a	O
direct	O
type	O
in	O
which	O
the	O
bacterium	B-SPEC
is	O
present	O
at	O
the	O
site	O
of	O
inflammation	O
and	O
local	O
inflammatory	O
cytokines	O
induced	O
by	O
the	O
bacterium	B-SPEC
play	O
an	O
important	O
role	O
(	O
2	O
)	O
an	O
indirect	O
type	O
in	O
which	O
the	O
bacterium	B-SPEC
is	O
not	O
present	O
at	O
the	O
site	O
of	O
inflammation	O
and	O
immune	O
modulations	O
,	O
such	O
as	O
autoimmunity	O
or	O
formation	O
of	O
immune	O
complexes	O
,	O
play	O
an	O
important	O
role	O
,	O
and	O
(	O
3	O
)	O
a	O
vascular	O
occlusion	O
type	O
in	O
which	O
obstruction	O
of	O
blood	O
flow	O
induced	O
either	O
directly	O
or	O
indirectly	O
by	O
the	O
bacterium	B-SPEC
plays	O
an	O
important	O
role	O
.	O

Continuing	O
nosological	O
confusion	O
on	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
-	O
induced	O
mucositis	O
(	O
without	O
skin	O
lesions	O
),	O
which	O
may	O
be	O
called	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
-	O
associated	O
mucositis	O
or	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
-	O
induced	O
rash	O
and	O
mucositis	O
separately	O
from	O
Stevens	O
-	O
Johnson	O
syndrome	O
,	O
is	O
argued	O
in	O
the	O
dermatological	O
manifestations	O
.	O

TITLE	O
:	O
The	O
Membrane	O
Protein	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Functions	O
as	O
a	O
Novel	O
Cytosolic	O
Pathogen	O
-	O
Associated	O
Molecular	O
Pattern	O
To	O
Promote	O
Beta	O
Interferon	O
Induction	O
via	O
a	O
Toll	O
-	O
Like	O
-	O
Receptor	O
-	O
Related	O
TRAF3	O
-	O
Independent	O
Mechanism	O
.	O

TITLE	O
:	O
Fatal	O
pulmonary	O
Kaposi	O
sarcoma	O
in	O
an	O
HIV	B-SPEC
seronegative	O
AIDS	O
patient	O
.	O

ABSTRACT	O
:	O
Although	O
HIV	B-SPEC
antibody	O
tests	O
have	O
been	O
widely	O
accepted	O
in	O
clinical	O
diagnosis	O
of	O
HIV	B-SPEC
infection	O
,	O
they	O
may	O
not	O
be	O
sufficient	O
to	O
diagnose	O
all	O
subjects	O
with	O
HIV	B-SPEC
infection	O
.	O

Except	O
negative	O
result	O
of	O
antibody	O
test	O
in	O
the	O
well	O
-	O
known	O
""""	O
acute	O
window	O
phase	O
""","	O
in	O
rare	O
cases	O
,	O
patients	O
do	O
not	O
develop	O
HIV	B-SPEC
antibodies	O
despite	O
demonstrable	O
infection	O
.	O

TITLE	O
:	O
Dysregulated	O
Type	O
I	O
Interferon	O
and	O
Inflammatory	O
Monocyte	O
-	O
Macrophage	O
Responses	O
Cause	O
Lethal	O
Pneumonia	O
in	O
SARS	O
-	O
CoV	O
-	O
Infected	O
Mice	B-SPEC
.	O

Using	O
mice	B-SPEC
infected	O
with	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
)-	O
CoV	O
,	O
we	O
show	O
that	O
robust	O
virus	B-SPEC
replication	O
accompanied	O
by	O
delayed	O
type	O
I	O
interferon	O
(	O
IFN	O
-	O
I	O
)	O
signaling	O
orchestrates	O
inflammatory	O
responses	O
and	O
lung	O
immunopathology	O
with	O
diminished	O
survival	O
.	O

This	O
delayed	O
IFN	O
-	O
I	O
signaling	O
promotes	O
the	O
accumulation	O
of	O
pathogenic	O
inflammatory	O
monocyte	O
-	O
macrophages	O
(	O
IMMs	O
),	O
resulting	O
in	O
elevated	O
lung	O
cytokine	O
/	O
chemokine	O
levels	O
,	O
vascular	O
leakage	O
,	O
and	O
impaired	O
virus	B-SPEC
-	O
specific	O
T	O
cell	O
responses	O
.	O

Genetic	O
ablation	O
of	O
the	O
IFN	O
-	O
	O
receptor	O
(	O
IFNAR	O
)	O
or	O
IMM	O
depletion	O
protects	O
mice	B-SPEC
from	O
lethal	O
infection	O
,	O
without	O
affecting	O
viral	O
load	O
.	O

Asthma	O
was	O
the	O
most	O
common	O
co	O
-	O
morbidity	O
affecting	O
5	O
(	O
10	O
.	O
4	O
%)	O
of	O
the	O
48	O
cases	O
with	O
an	O
identified	O
virus	B-SPEC
.	O

Preterm	O
infants	O
had	O
a	O
significantly	O
higher	O
rate	O
of	O
RSV	B-SPEC
infection	O
than	O
other	O
respiratory	O
viruses	B-SPEC
(	O
8	O
of	O
21	O
;	O
38	O
%	O
vs	O
3	O
of	O
27	O
;	O
11	O
.	O
1	O
%)	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

TITLE	O
:	O
A	O
Comparative	O
Review	O
of	O
Animal	B-SPEC
Models	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

Although	O
the	O
clinical	O
presentation	O
of	O
human	B-SPEC
MERS	O
-	O
CoV	O
infection	O
has	O
been	O
documented	O
,	O
many	O
facets	O
of	O
this	O
emerging	O
disease	O
are	O
still	O
unknown	O
and	O
could	O
be	O
studied	O
with	O
animal	B-SPEC
models	O
.	O

TITLE	O
:	O
Meeting	O
report	O
:	O
4th	O
ISIRV	O
antiviral	O
group	O
conference	O
:	O
Novel	O
antiviral	O
therapies	O
for	O
influenza	O
and	O
other	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
and	O
Newcastle	O
disease	O
(	O
ND	O
)	O
are	O
common	O
viral	O
diseases	O
of	O
chickens	B-SPEC
,	O
which	O
are	O
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
respectively	O
.	O

However	O
,	O
conventional	O
live	O
attenuated	O
vaccines	O
are	O
expensive	O
and	O
result	O
in	O
the	O
inability	O
to	O
differentiate	O
between	O
infected	O
and	O
vaccinated	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Corynebacterium	B-SPEC
ulcerans	I-SPEC
is	O
a	O
bacterium	B-SPEC
able	O
to	O
infect	O
humans	B-SPEC
by	O
inducing	O
a	O
disease	O
close	O
to	O
diphtheria	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
3C	O
-	O
like	O
proteinase	O
(	O
SARS	O
-	O
3CLpro	O
),	O
which	O
is	O
the	O
main	O
proteinase	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
,	O
is	O
essential	O
to	O
the	O
virus	B-SPEC
life	O
cycle	O
.	O

Mixed	O
infections	O
with	O
more	O
than	O
one	O
species	B-SPEC
of	O
parasite	O
can	O
occur	O
;	O
they	O
commonly	O
involve	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
with	O
the	O
attendant	O
risks	O
of	O
severe	O
malaria	O
.	O

P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
and	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
(	O
depending	O
upon	O
the	O
product	O
)	O
malaria	O
can	O
be	O
diagnosed	O
almost	O
as	O
accurately	O
using	O
rapid	O
diagnostic	O
tests	O
(	O
RDTs	O
)	O
which	O
detect	O
plasmodial	O
antigens	O
.	O

Patients	O
treated	O
with	O
intravenous	O
quinine	B-SPEC
require	O
careful	O
monitoring	O
for	O
hypoglycemia	O
.	O

The	O
adoption	O
of	O
an	O
internationally	O
accepted	O
viral	O
nomenclature	O
is	O
crucial	O
for	O
future	O
studies	O
of	O
IBV	B-SPEC
epidemiology	O
and	O
evolution	O
,	O
and	O
the	O
classification	O
scheme	O
presented	O
here	O
can	O
be	O
updated	O
and	O
revised	O
novel	O
S1	O
sequences	O
should	O
become	O
available	O
.	O

Further	O
studies	O
are	O
needed	O
and	O
should	O
include	O
the	O
isolation	O
and	O
full	O
-	O
length	O
molecular	O
characterization	O
of	O
IBV	B-SPEC
in	O
this	O
region	O
.	O

The	O
assembly	O
of	O
coronavirus	B-SPEC
virions	O
entails	O
concerted	O
interactions	O
among	O
the	O
viral	O
structural	O
proteins	O
and	O
the	O
RNA	O
genome	O
.	O

After	O
3	O
-	O
6	O
hours	O
of	O
induction	O
of	O
ALI	O
by	O
IV	O
endotoxin	O
and	O
mechanical	O
ventilation	O
(	O
MV	O
),	O
young	O
female	O
piglets	O
were	O
allocated	O
to	O
five	O
groups	O
(	O
n	O
=	O
5	O
):	O
ALI	O
-	O
MV	O
,	O
ALI	O
treated	O
with	O
MV	O
;	O
ALI	O
-	O
EC	O
,	O
ALI	O
treated	O
with	O
both	O
MV	O
and	O
venovenous	O
extracorporeal	O
membrane	O
oxygenation	O
;	O
ALI	O
-	O
EC	O
-	O
T	O
,	O
ALI	O
-	O
EC	O
protocol	O
plus	O
intratracheal	O
type	O
II	O
alveolar	O
epithelial	O
cell	O
transplant	O
;	O
CON	O
-	O
MV	O
,	O
healthy	O
animals	B-SPEC
treated	O
with	O
MV	O
;	O
and	O
CON	O
-	O
EC	O
-	O
T	O
,	O
healthy	O
animals	B-SPEC
treated	O
with	O
venovenous	O
extracorporeal	O
membrane	O
oxygenation	O
.	O

ABSTRACT	O
:	O
We	O
analyzed	O
data	O
for	O
170	O
patients	O
in	O
South	O
Korea	O
who	O
had	O
laboratory	O
-	O
confirmed	O
infection	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Investigations	O
into	O
the	O
origin	O
of	O
MERS	O
-	O
CoV	O
have	O
focused	O
on	O
two	O
potential	O
reservoirs	O
:	O
bats	B-SPEC
and	O
camels	B-SPEC
.	O

ABSTRACT	O
:	O
Objectives	O
Feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
)	O
exist	O
as	O
two	O
biotypes	O
,	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
and	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
.	O

The	O
Mo	O
/	O
Mas	O
that	O
infiltrate	O
the	O
meninges	O
after	O
infection	O
with	O
the	O
neuropathogenic	O
murine	B-SPEC
coronavirus	I-SPEC
strain	O
srr7	O
are	O
an	O
initial	O
target	O
of	O
infection	O
.	O

CONCLUSIONS	O
:	O
The	O
use	O
of	O
NIV	O
is	O
the	O
predominant	O
treatment	O
in	O
patients	O
with	O
hypercapnic	O
respiratory	O
failure	O
but	O
close	O
monitoring	O
is	O
necessary	O
in	O
order	B-SPEC
not	O
to	O
miss	O
the	O
indications	O
for	O
intubation	O
and	O
invasive	O
ventilation	O
.	O

For	O
the	O
M	O
protein	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
production	O
in	O
plants	B-SPEC
,	O
while	O
for	O
plant	B-SPEC
-	O
derived	O
N	O
protein	O
we	O
demonstrate	O
that	O
it	O
is	O
recognized	O
by	O
sera	O
of	O
patients	O
from	O
the	O
SARS	O
outbreak	O
in	O
Hong	O
Kong	O
in	O
2003	O
.	O

To	O
test	O
and	O
develop	O
novel	O
analgesics	O
,	O
validated	O
burn	O
-	O
relevant	O
animal	B-SPEC
models	O
of	O
pain	O
are	O
indispensable	O
.	O

To	O
date	O
,	O
no	O
single	O
animal	B-SPEC
model	O
optimally	O
mimics	O
the	O
complex	O
pathophysiology	O
and	O
pain	O
that	O
a	O
human	B-SPEC
burn	O
patient	O
experiences	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
RNA	O
endoribonuclease	O
nsp11	O
belongs	O
to	O
the	O
XendoU	O
superfamily	B-SPEC
and	O
plays	O
a	O
crucial	O
role	O
in	O
arterivirus	B-SPEC
replication	O
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
genetic	O
diversity	O
,	O
temporal	O
distribution	O
,	O
population	O
history	O
and	O
clinical	O
symptoms	O
of	O
betacoronavirus	B-SPEC
infections	O
in	O
Kuala	O
Lumpur	O
,	O
Malaysia	O
between	O
2012	O
and	O
2013	O
.	O

A	O
total	O
of	O
48	O
/	O
2060	O
(	O
2	O
.	O
4	O
%)	O
specimens	O
were	O
tested	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
1	O
.	O
3	O
%)	O
and	O
HCoV	O
-	O
HKU1	O
(	O
1	O
.	O
1	O
%).	O

Correlation	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	O
-	O
HKU1	O
with	O
the	O
severity	O
of	O
respiratory	O
symptoms	O
was	O
not	O
observed	O
.	O

Two	O
novel	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
genetic	O
lineages	O
were	O
identified	O
,	O
warranting	O
further	O
investigation	O
on	O
their	O
genotypic	O
and	O
phenotypic	O
characteristics	O
.	O

Many	O
studies	O
suggest	O
that	O
the	O
N	O
protein	O
interaction	O
with	O
nsp3	O
plays	O
a	O
critical	O
role	O
in	O
the	O
virus	B-SPEC
replication	O
early	O
in	O
infection	O
.	O

The	O
amino	O
acid	O
sequences	O
of	O
MHV	B-SPEC
N	O
and	O
nsp3	O
proteins	O
have	O
similarity	O
between	O
human	B-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

The	O
correct	O
detection	O
of	O
CDV	B-SPEC
had	O
been	O
achieved	O
in	O
ten	O
out	O
of	O
eleven	O
positive	O
cases	O
(	O
90	O
.	O
9	O
%)	O
upon	O
initial	O
investigation	O
,	O
but	O
the	O
presence	O
of	O
bacterial	O
pathogens	O
,	O
like	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
(	O
10	O
cases	O
)	O
and	O
P	B-SPEC
.	I-SPEC
multocida	I-SPEC
(	O
17	O
cases	O
)	O
had	O
been	O
missed	O
in	O
all	O
but	O
one	O
case	O
.	O

We	O
studied	O
the	O
timecourse	O
of	O
positive	O
and	O
negative	O
-	O
sense	O
genomic	O
and	O
subgenomic	O
viral	O
RNA	O
production	O
and	O
the	O
relative	O
translation	O
efficiencies	O
of	O
the	O
different	O
virus	B-SPEC
ORFs	O
.	O

TITLE	O
:	O
Sharing	O
experiences	O
from	O
a	O
reference	O
laboratory	O
in	O
the	O
public	O
health	O
response	O
for	O
Ebola	O
viral	O
disease	O
,	O
MERS	O
-	O
CoV	O
and	O
H7N9	O
influenza	B-SPEC
virus	I-SPEC
investigations	O
.	O

TITLE	O
:	O
Coexistence	O
of	O
multiple	O
coronaviruses	O
in	O
several	O
bat	B-SPEC
colonies	O
in	O
an	O
abandoned	O
mineshaft	O
.	O

HCoVs	O
were	O
detected	O
in	O
77	O
(	O
0	O
.	O
93	O
%)	O
of	O
the	O
samples	O
by	O
a	O
pan	B-SPEC
-	O
HCoV	O
RT	O
-	O
PCR	O
assay	O
.	O

Moreover	O
,	O
melanoma	O
differentiation	O
-	O
associated	O
protein	O
5	O
(	O
MDA5	O
),	O
laboratory	O
of	O
genetics	O
and	O
physiology	O
2	O
(	O
LGP2	O
),	O
stimulator	O
of	O
IFN	O
genes	O
(	O
STING	O
),	O
and	O
mitochondrial	O
antiviral	O
signaling	O
protein	O
(	O
MAVS	O
),	O
as	O
well	O
as	O
TANK	O
binding	O
kinase	O
1	O
(	O
TBK1	O
),	O
inhibitor	O
of	O
kappaB	O
kinase	O
(	O
IKK	O
)	O
	O
,	O
IKK	O
,	O
IKK	O
,	O
IFN	O
regulatory	O
factor	O
(	O
IRF	O
)	O
7	O
,	O
nuclear	O
factor	O
of	O
kappaB	O
(	O
NF	O
-	O
B	O
),	O
IFN	O
-	O
	O
,	O
IFN	O
-	O
	O
,	O
various	O
interleukins	O
(	O
ILs	O
),	O
and	O
macrophage	O
inflammatory	O
protein	O
-	O
1	O
(	O
MIP	O
-	O
1	O
)	O
were	O
significantly	O
upregulated	O
in	O
the	O
trachea	B-SPEC
and	O
downregulated	O
in	O
the	O
kidney	O
.	O

These	O
results	O
suggested	O
that	O
the	O
TLR	O
and	O
MDA5	O
signaling	O
pathways	O
and	O
innate	O
immune	O
cytokine	O
were	O
induced	O
after	O
IBV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Transmission	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
among	O
health	O
care	O
workers	O
(	O
HCWs	O
)	O
and	O
patients	O
has	O
been	O
documented	O
with	O
mortality	O
rate	O
approximating	O
36	O
%.	O

To	O
further	O
study	O
the	O
in	O
-	O
depth	O
influence	O
of	O
spatial	O
configuration	O
and	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
conformation	O
of	O
the	O
molecules	O
on	O
their	O
anti	O
-	O
TMV	B-SPEC
activities	O
and	O
related	O
structure	O
-	O
activity	O
relationship	O
(	O
SAR	O
),	O
a	O
series	O
of	O
D	O
-	O
ring	O
opened	O
derivatives	O
3	O
,	O
4	O
,	O
5a	O
-	O
5j	O
,	O
6	O
,	O
and	O
7	O
,	O
chiral	O
13a	O
-	O
and	O
/	O
or	O
14	O
-	O
substituted	O
phenanthroindolizidine	O
analogues	O
10	O
-	O
12	O
and	O
18	O
-	O
20	O
,	O
and	O
their	O
enantiomers	O
ent	O
-	O
10	O
-	O
ent	O
-	O
12	O
and	O
ent	O
-	O
18	O
-	O
ent	O
-	O
20	O
were	O
synthesized	O
and	O
evaluated	O
for	O
their	O
anti	O
-	O
TMV	B-SPEC
activities	O
.	O

A	O
survey	O
assessing	O
strategies	O
for	O
RSV	B-SPEC
and	O
other	O
non	O
-	O
influenza	O
respiratory	O
viral	O
infections	O
was	O
sent	O
to	O
13	O
centers	O
.	O

The	O
clinical	O
spectrum	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
ranges	O
from	O
an	O
asymptomatic	O
or	O
mild	O
respiratory	O
illness	O
to	O
severe	O
pneumonia	O
and	O
multi	O
-	O
organ	O
failure	O
;	O
overall	O
mortality	O
is	O
around	O
35	O
.	O
7	O
%.	O

MERS	O
-	O
CoV	O
serosurveys	O
are	O
needed	O
to	O
investigate	O
possible	O
unrecognized	O
human	B-SPEC
infections	O
in	O
Africa	O
.	O

These	O
unexpected	O
findings	O
suggest	O
that	O
MERS	O
-	O
CoV	O
adaptation	O
in	O
humans	B-SPEC
may	O
be	O
driven	O
by	O
host	O
immunological	O
pressure	O
.	O

Cofilin	O
is	O
involved	O
in	O
F	O
-	O
actin	O
reorganization	O
and	O
TGEV	B-SPEC
entry	O
.	O

Inhibition	O
of	O
EGFR	O
and	O
PI3K	O
decreases	O
the	O
entry	O
of	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
HKU1	O
is	O
a	O
human	B-SPEC
betacoronavirus	B-SPEC
that	O
causes	O
mild	O
yet	O
prevalent	O
respiratory	O
disease	O
,	O
and	O
is	O
related	O
to	O
the	O
zoonotic	O
SARS	O
and	O
MERS	O
betacoronaviruses	O
,	O
which	O
have	O
high	O
fatality	O
rates	O
and	O
pandemic	O
potential	O
.	O

Serological	O
test	O
was	O
carried	O
out	O
using	O
sera	O
or	O
plasma	O
of	O
ferrets	B-SPEC
in	O
Japan	O
.	O

A	O
single	O
Black	B-SPEC
-	I-SPEC
headed	I-SPEC
Gull	I-SPEC
represented	O
the	O
only	O
positive	O
sample	O
from	O
the	O
order	B-SPEC
Charadriiformes	B-SPEC
.	O

TITLE	O
:	O
Hypomagnesaemia	O
in	O
suckler	O
cows	B-SPEC
.	O

After	O
challenge	O
with	O
a	O
homologous	O
virulent	O
IBV	B-SPEC
strain	O
at	O
21	O
days	O
post	O
-	O
immunization	O
,	O
vaccinated	O
groups	O
showed	O
significant	O
differences	O
in	O
the	O
percentage	O
of	O
birds	B-SPEC
with	O
clinical	O
signs	O
,	O
as	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
as	O
the	O
two	O
covalent	O
-	O
vaccination	O
groups	O
and	O
the	O
rDEV	O
-	O
S	O
group	O
provided	O
better	O
protection	O
than	O
the	O
rDEV	O
-	O
N	O
-	O
or	O
rDEV	O
-	O
S1	O
-	O
vaccinated	O
group	O
.	O

Unfortunately	O
,	O
there	O
are	O
currently	O
no	O
effective	O
antiviral	O
therapy	O
to	O
contain	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

TITLE	O
:	O
Guillain	O
-	O
Barr	O
Syndrome	O
outbreak	O
associated	O
with	O
Zika	B-SPEC
virus	I-SPEC
infection	O
in	O
French	O
Polynesia	O
:	O
a	O
case	O
-	O
control	O
study	O
.	O

Because	O
Zika	B-SPEC
virus	I-SPEC
is	O
spreading	O
rapidly	O
across	O
the	O
Americas	O
,	O
at	O
risk	O
countries	O
need	O
to	O
prepare	O
for	O
adequate	O
intensive	O
care	O
beds	O
capacity	O
to	O
manage	O
patients	O
with	O
Guillain	O
-	O
Barr	O
syndrome	O
.	O

Firstly	O
,	O
we	O
transduced	O
different	O
dosage	O
of	O
DPP4	O
(	O
high	O
or	O
low	O
)	O
into	O
mice	B-SPEC
,	O
and	O
then	O
challenged	O
them	O
with	O
MERS	O
-	O
CoV	O
in	O
order	B-SPEC
to	O
establish	O
the	O
model	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
is	O
a	O
severe	O
disease	O
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
that	O
affects	O
fowl	O
flocks	O
worldwide	O
.	O

CONCLUSIONS	O
:	O
This	O
sharing	O
suggests	O
that	O
in	O
case	O
of	O
pathogenicity	O
MERS	O
-	O
CoV	O
is	O
more	O
closely	O
related	O
to	O
HKU5	O
bat	B-SPEC
-	O
CoV	O
than	O
HKU4	O
bat	B-SPEC
-	O
CoV	O
.	O
The	O
conserved	O
epitopes	O
indicates	O
their	O
evolutionary	O
relationship	O
and	O
ancestry	O
of	O
pathogenicity	O
.	O

The	O
continuing	O
threat	O
posed	O
by	O
pandemic	O
influenza	O
as	O
well	O
as	O
the	O
emergence	O
of	O
novel	O
respiratory	O
viruses	B-SPEC
also	O
capable	O
of	O
producing	O
severe	O
acute	O
lung	O
injury	O
such	O
as	O
SARS	O
-	O
CoV	O
,	O
MERS	O
-	O
CoV	O
,	O
and	O
enterovirus	B-SPEC
D68	O
,	O
highlights	O
the	O
need	O
for	O
an	O
understanding	O
of	O
the	O
immune	O
mechanisms	O
that	O
contribute	O
to	O
virus	B-SPEC
elimination	O
and	O
immune	O
-	O
mediated	O
injury	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
.	O

Here	O
we	O
report	O
the	O
case	O
of	O
a	O
45	O
year	O
old	O
male	O
who	O
was	O
a	O
victim	O
of	O
severe	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
culminating	O
into	O
ARDS	O
,	O
prior	O
to	O
the	O
initiation	O
of	O
anti	O
-	O
malarial	O
therapy	O
.	O

To	O
evaluate	O
PEDV	B-SPEC
viability	O
over	O
time	O
,	O
ingredients	O
were	O
organized	O
into	O
1	O
of	O
4	O
batches	O
of	O
samples	O
,	O
each	O
batch	O
representing	O
a	O
specific	O
segment	O
of	O
transport	O
.	O

AIVs	O
capable	O
of	O
infecting	O
humans	B-SPEC
include	O
a	O
highly	O
pathogenic	O
AIV	O
H5N1	O
,	O
first	O
detected	O
in	O
humans	B-SPEC
in	O
1997	O
,	O
and	O
a	O
low	O
pathogenic	O
AIV	O
H7N9	O
,	O
reported	O
in	O
humans	B-SPEC
in	O
2013	O
.	O

Ongoing	O
circulation	O
of	O
H5N1	O
and	O
H7N9	O
viruses	B-SPEC
in	O
wild	O
birds	B-SPEC
and	O
poultry	O
,	O
and	O
their	O
ability	O
to	O
infect	O
humans	B-SPEC
emphasizes	O
their	O
epidemic	O
and	O
pandemic	O
potential	O
and	O
poses	O
a	O
public	O
health	O
threat	O
.	O

Partial	O
cell	O
-	O
mediated	O
immunity	O
against	O
similar	O
internal	O
AI	O
genes	O
,	O
as	O
well	O
as	O
virus	B-SPEC
interference	O
between	O
AI	O
and	O
vNDV	O
,	O
could	O
be	O
an	O
explanation	O
for	O
this	O
.	O

The	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
of	O
the	O
derivatives	O
had	O
been	O
discussed	O
,	O
which	O
were	O
useful	O
for	O
developing	O
phenylpropanoid	O
derivatives	O
as	O
novel	O
anti	O
-	O
HBV	B-SPEC
agents	O
.	O

The	O
S	O
proteins	O
are	O
the	O
main	O
structural	O
proteins	O
of	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
capable	O
of	O
inducing	O
neutralizing	O
antibodies	O
in	O
vivo	O
.	O

TITLE	O
:	O
Deletion	O
Variants	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
from	O
Humans	B-SPEC
,	O
Jordan	O
,	O
2015	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
the	O
porcine	B-SPEC
neonatal	O
Fc	O
receptor	O
(	O
pFcRn	O
)	O
was	O
expressed	O
in	O
a	O
model	O
of	O
normal	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
(	O
IPEC	O
-	O
J2	O
)	O
as	O
well	O
as	O
in	O
kidney	O
cells	O
(	O
PK	O
-	O
15	O
),	O
and	O
pFcRn	O
was	O
mainly	O
distributed	O
in	O
the	O
apical	O
side	O
of	O
the	O
polarized	O
IPEC	O
-	O
J2	O
cells	O
.	O

ABSTRACT	O
:	O
Piglet	O
diarrhea	O
epidemics	O
result	O
in	O
major	O
economic	O
losses	O
for	O
the	O
swine	B-SPEC
industry	O
.	O

TITLE	O
:	O
Critically	O
ill	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

Explain	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Risk	O
:	O
a	O
Prospective	O
Cohort	O
Study	O
of	O
Patients	O
with	O
Severe	O
Sepsis	B-SPEC
.	O

In	O
this	O
study	O
,	O
low	O
levels	O
of	O
adiponectin	O
were	O
not	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
ARDS	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

We	O
discuss	O
the	O
implications	O
for	O
the	O
channel	O
function	O
in	O
the	O
bacterial	O
porins	O
PorA	O
(	O
N	B-SPEC
.	I-SPEC
meningitidis	I-SPEC
)	O
and	O
OmpF	O
(	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
)	O
and	O
the	O
viroporin	O
SARS	O
-	O
CoV	O
E	O
.	O

Immunized	O
piglets	O
with	O
B	O
.	O
subtilis	O
CotGSG	O
could	O
significantly	O
elevate	O
the	O
specific	O
SIgA	B-SPEC
titers	O
in	O
feces	O
,	O
IgG	O
titers	O
and	O
neutralizing	O
antibodies	O
in	O
serum	O
.	O

We	O
recently	O
characterized	O
the	O
Gttingen	O
Minipigs	O
,	O
a	O
breed	O
well	O
characterized	O
concerning	O
the	O
presence	O
of	O
zoonotic	O
microorganisms	O
and	O
found	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
HEV	B-SPEC
)	O
and	O
porcine	B-SPEC
cytomegalovirus	I-SPEC
(	O
PCMV	O
)	O
in	O
some	O
animals	B-SPEC
.	O

TITLE	O
:	O
NMR	O
assignments	O
of	O
the	O
macro	O
domain	O
from	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Aggressive	O
diagnostic	O
efforts	O
showed	O
sero	O
-	O
positivity	O
for	O
Legionella	B-SPEC
IgM	O
.	O
The	O
patient	O
recovered	O
following	O
antibiotic	O
therapy	O
and	O
cesarean	O
delivery	O
.	O

The	O
present	O
study	O
reports	O
the	O
case	O
of	O
a	O
62	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
-	O
type	O
MM	O
who	O
was	O
treated	O
with	O
bortezomib	O
,	O
thalidomide	O
and	O
dexamethasone	O
.	O

Baseline	O
endocan	O
concentrations	O
are	O
higher	O
in	O
hypertensive	O
patients	O
with	O
critical	O
coronary	O
artery	O
stenosis	B-SPEC
.	O

TITLE	O
:	O
Evolution	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
China	O
over	O
the	O
past	O
two	O
decades	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
is	O
a	O
highly	O
contagious	O
disease	O
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
that	O
affects	O
poultry	O
production	O
worldwide	O
.	O

The	O
earliest	O
IBV	B-SPEC
in	O
China	O
was	O
found	O
to	O
have	O
existed	O
in	O
the	O
early	O
1900s	O
,	O
and	O
continues	O
to	O
evolve	O
at	O
a	O
rate	O
of	O
approximately	O
10	O
-	O
5	O
substitutions	O
per	O
site	O
per	O
year	O
.	O

From	O
2010	O
to	O
2013	O
,	O
observational	O
data	O
were	O
collected	O
in	O
Lao	O
PDR	O
from	O
markets	O
selling	O
wildlife	O
,	O
including	O
information	O
on	O
volume	O
,	O
form	O
,	O
species	B-SPEC
and	O
price	O
of	O
wildlife	O
;	O
market	O
biosafety	O
and	O
visitor	O
origin	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
severe	O
diseases	O
in	O
poultry	O
with	O
significant	O
economic	O
consequences	O
to	O
the	O
poultry	O
industry	O
in	O
Iran	O
.	O

Our	O
findings	O
indicate	O
the	O
circulation	O
of	O
at	O
least	O
three	O
genotypes	O
of	O
IB	O
viruses	B-SPEC
(	O
Massachusetts	O
,	O
793	O
/	O
B	O
,	O
and	O
variant	O
2	O
)	O
among	O
poultry	O
flocks	O
.	O

SAE	O
is	O
considered	O
to	O
include	O
all	O
types	O
of	O
brain	O
dysfunction	O
,	O
including	O
delirium	O
,	O
coma	B-SPEC
,	O
seizure	O
,	O
and	O
focal	O
neurological	O
signs	O
.	O

Nasopharyngeal	O
samples	O
were	O
tested	O
for	O
17	O
respiratory	O
viruses	B-SPEC
using	O
a	O
multiplex	O
polymerase	O
chain	O
reaction	O
.	O

Most	O
patients	O
without	O
any	O
underlying	O
diseases	O
remain	O
asymptomatic	O
or	O
develop	O
mild	O
clinical	O
disease	O
,	O
but	O
some	O
patients	O
require	O
critical	O
care	O
for	O
mechanical	O
ventilation	O
,	O
dialysis	B-SPEC
and	O
other	O
organ	O
support	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PdCV	O
)	O
cause	O
indistinguishable	O
clinical	O
signs	O
and	O
pathological	O
changes	O
in	O
swine	B-SPEC
.	O

We	O
provide	O
the	O
first	O
evidence	O
that	O
conserved	O
epitope	O
(	O
s	O
)	O
on	O
the	O
respective	O
viral	O
nucleocapsid	O
proteins	O
cross	O
-	O
react	O
with	O
each	O
other	O
although	O
virus	B-SPEC
neutralization	O
cross	O
-	O
reactivity	O
was	O
not	O
observed	O
.	O

The	O
recombinant	O
Lactobacillus	B-SPEC
elicited	O
specific	O
systemic	O
and	O
mucosal	O
immune	O
responses	O
.	O

Recombinant	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
had	O
a	O
strong	O
potentiating	O
effect	O
on	O
the	O
cellular	O
immunity	O
induced	O
by	O
the	O
oral	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
vaccine	O
.	O

However	O
,	O
during	O
TGEV	B-SPEC
infection	O
,	O
the	O
systemic	O
and	O
local	O
immune	O
responses	O
switched	O
from	O
Th1	O
to	O
Th2	O
-	O
based	O
immune	O
responses	O
.	O

RNA	O
was	O
extracted	O
from	O
chicken	B-SPEC
tissues	O
,	O
subjected	O
to	O
IBV	B-SPEC
S1	O
RT	O
-	O
PCR	O
,	O
and	O
sequenced	O
.	O

In	O
picornavirus	B-SPEC
-	O
infected	O
cells	O
,	O
lipids	O
are	O
exchanged	O
at	O
membrane	O
contact	O
sites	O
between	O
ROs	O
and	O
other	O
organelles	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
the	O
first	O
highly	O
pathogenic	O
human	B-SPEC
coronavirus	I-SPEC
to	O
emerge	O
since	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
.	O

We	O
found	O
that	O
MERS	O
-	O
CoV	O
NS4b	O
and	O
homologs	O
from	O
related	O
lineage	O
C	O
bat	B-SPEC
betacoronaviruses	O
BtCoV	O
-	O
SC2013	O
(	O
SC2013	O
)	O
and	O
BtCoV	O
-	O
HKU5	O
(	O
HKU5	O
)	O
are	O
members	O
of	O
the	O
2H	O
-	O
phosphoesterase	O
(	O
2H	O
-	O
PE	O
)	O
enzyme	O
family	B-SPEC
with	O
phosphodiesterase	O
(	O
PDE	O
)	O
activity	O
.	O

Feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
causes	O
inapparent	O
or	O
mild	O
enteritis	O
in	O
cats	B-SPEC
,	O
but	O
a	O
highly	O
fatal	O
disease	O
,	O
called	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
can	O
arise	O
through	O
mutation	O
of	O
FECV	B-SPEC
to	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
).	O

Compliance	O
with	O
a	O
set	O
of	O
sepsis	B-SPEC
management	O
bundles	O
was	O
associated	O
with	O
better	O
outcomes	O
.	O

In	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
the	O
proportion	O
and	O
effect	O
on	O
outcome	O
was	O
not	O
uniform	O
among	O
infection	O
sites	O
.	O

TITLE	O
:	O
Autophagy	O
Negatively	O
Regulates	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
Replication	O
.	O

ABSTRACT	O
:	O
Autophagy	O
is	O
an	O
evolutionarily	O
ancient	O
pathway	O
that	O
has	O
been	O
shown	O
to	O
be	O
important	O
in	O
the	O
innate	O
immune	O
defense	O
against	O
several	O
viruses	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
by	O
changing	O
4	O
amino	O
acids	O
in	O
hamster	B-SPEC
DPP4	O
,	O
this	O
protein	O
functions	O
as	O
a	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
This	O
work	O
is	O
vital	O
in	O
the	O
development	O
of	O
new	O
small	O
-	O
animal	B-SPEC
models	O
,	O
which	O
will	O
broaden	O
our	O
understanding	O
of	O
MERS	O
-	O
CoV	O
and	O
be	O
instrumental	O
in	O
the	O
development	O
of	O
countermeasures	O
.	O

Through	O
amino	O
acid	O
sequence	O
analysis	O
of	O
S	O
proteins	O
of	O
representative	O
CoVs	O
,	O
we	O
identified	O
a	O
common	O
region	O
as	O
a	O
possible	O
FP	O
(	O
pFP	O
)	O
that	O
shares	O
the	O
characteristics	O
of	O
FPs	O
of	O
class	B-SPEC
I	O
viral	O
fusion	O
proteins	O
,	O
including	O
high	O
Ala	O
/	O
Gly	O
content	O
,	O
intermediate	O
hydrophobicity	O
,	O
and	O
few	O
charged	O
residues	O
.	O

Spleen	O
,	O
kidney	O
,	O
and	O
intestine	O
tissue	O
along	O
with	O
fecal	O
and	O
intestinal	O
lavage	O
samples	O
were	O
obtained	O
from	O
50	O
one	O
-	O
to	O
five	O
-	O
week	O
-	O
old	O
alpacas	B-SPEC
and	O
analyzed	O
for	O
the	O
presence	O
of	O
parasites	O
,	O
bacteria	B-SPEC
,	O
and	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
replicates	O
in	O
the	O
small	O
intestine	O
and	O
induces	O
enteritis	O
and	O
watery	O
diarrhea	O
.	O

The	O
TGEV	B-SPEC
-	O
specific	O
IgA	O
level	O
in	O
the	O
intestinal	O
tract	O
and	O
the	O
TGEV	B-SPEC
-	O
specific	O
IgG	O
level	O
in	O
serum	O
significantly	O
increased	O
following	O
immunization	O
with	O
ITGEV	O
plus	O
CpG	O
DNA	O
(	O
P	O
	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
S1	O
domain	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
spike	O
protein	O
as	O
a	O
vaccine	O
antigen	O
.	O

Affinity	O
tagged	O
PEDV	B-SPEC
S1	O
protein	O
was	O
expressed	O
in	O
a	O
secretory	O
form	O
in	O
yeast	B-SPEC
,	O
insect	B-SPEC
and	O
mammalian	B-SPEC
cells	O
to	O
identify	O
the	O
most	O
suitable	O
production	O
system	O
.	O

PEDV	B-SPEC
-	O
specific	O
immune	O
responses	O
in	O
sera	O
and	O
colostrum	O
of	O
the	O
sow	O
and	O
piglets	O
were	O
assayed	O
by	O
ELISA	O
and	O
virus	B-SPEC
neutralization	O
assays	O
.	O

Thus	O
,	O
vaccination	O
with	O
S1	O
subunit	O
vaccine	O
failed	O
to	O
provide	O
complete	O
protection	O
to	O
suckling	O
piglets	O
after	O
challenge	O
exposure	O
,	O
and	O
further	O
improvements	O
are	O
needed	O
for	O
the	O
development	O
of	O
a	O
subunit	O
vaccine	O
that	O
fully	O
protects	O
against	O
PEDV	B-SPEC
infection	O
.	O

For	O
the	O
primary	O
analysis	O
,	O
the	O
risk	O
of	O
bias	B-SPEC
was	O
low	O
in	O
three	O
studies	O
and	O
unclear	O
in	O
five	O
studies	O
;	O
the	O
overall	O
quality	O
of	O
evidence	O
was	O
very	O
low	O
due	O
to	O
imprecision	O
,	O
inconsistency	O
,	O
indirectness	O
and	O
methodologic	O
limitations	O
.	O

A	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
was	O
isolated	O
in	O
cell	O
culture	O
in	O
this	O
study	O
.	O

Three	O
groups	O
of	O
PEDV	B-SPEC
-	O
negative	O
,	O
3	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
(	O
five	O
pigs	B-SPEC
per	O
group	O
)	O
were	O
inoculated	O
orally	O
with	O
a	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
prototype	O
isolate	O
(	O
previously	O
isolated	O
in	O
our	O
lab	O
),	O
an	O
S	O
-	O
INDEL	O
-	O
variant	O
isolate	O
or	O
virus	B-SPEC
-	O
negative	O
culture	O
medium	O
.	O

Serum	O
samples	O
collected	O
at	O
0	O
,	O
7	O
,	O
14	O
,	O
21	O
and	O
28	O
days	O
post	O
inoculation	O
were	O
evaluated	O
by	O
the	O
following	O
PEDV	B-SPEC
serological	O
assays	O
:	O
1	O
)	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
assays	O
using	O
the	O
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
strains	O
as	O
indicator	B-SPEC
viruses	B-SPEC
;	O
2	O
)	O
virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
tests	O
against	O
the	O
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
viruses	B-SPEC
;	O
3	O
)	O
PEDV	B-SPEC
prototype	O
strain	O
whole	O
virus	B-SPEC
based	O
ELISA	O
;	O
4	O
)	O
PEDV	B-SPEC
prototype	O
strain	O
S1	O
-	O
based	O
ELISA	O
;	O
and	O
5	O
)	O
PEDV	B-SPEC
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
S1	O
-	O
based	O
ELISA	O
.	O

The	O
current	O
serological	O
assays	O
based	O
on	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
prototype	O
strain	O
can	O
detect	O
antibodies	O
against	O
both	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
strains	O
.	O

RESULTS	O
:	O
A	O
U	O
.	O
S	O
.	O
PEDV	B-SPEC
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
was	O
isolated	O
in	O
cell	O
culture	O
in	O
this	O
study	O
.	O

Electron	O
microscopy	O
and	O
immunoelectron	O
microscopy	O
results	O
demonstrate	O
that	O
MERS	O
-	O
CoV	O
VLPs	O
are	O
structurally	O
similar	O
to	O
the	O
native	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
circulating	O
antibody	O
to	O
the	O
protection	O
of	O
nave	O
piglets	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
evaluated	O
using	O
a	O
passive	O
antibody	O
transfer	O
model	O
.	O

Piglets	O
were	O
orally	O
inoculated	O
with	O
PEDV	B-SPEC
(	O
USA	O
/	O
IN	O
/	O
2013	O
/	O
19338E	O
,	O
1	O
x	O
103	O
TCID50	O
per	O
piglet	O
)	O
24	O
hours	O
later	O
and	O
then	O
monitored	O
for	O
14	O
days	O
.	O

When	O
combined	O
with	O
previous	O
literature	O
on	O
PEDV	B-SPEC
,	O
it	O
can	O
be	O
concluded	O
that	O
both	O
systemic	O
antibodies	O
and	O
maternal	O
secretory	O
IgA	O
in	O
milk	O
contribute	O
to	O
the	O
protection	O
of	O
the	O
neonatal	O
pig	B-SPEC
against	O
PEDV	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
A	O
68	O
-	O
year	O
old	O
man	B-SPEC
diagnosed	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
presented	O
with	O
multiple	O
pneumonic	O
infiltrations	O
on	O
his	O
chest	O
X	O
-	O
ray	B-SPEC
,	O
and	O
the	O
patient	O
was	O
placed	O
on	O
a	O
mechanical	O
ventilator	O
because	O
of	O
progressive	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
Prone	O
position	O
ventilation	O
(	O
PPV	B-SPEC
)	O
improves	O
mortality	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
but	O
outcomes	O
following	O
its	O
use	O
in	O
lung	O
transplant	O
recipients	O
are	O
not	O
known	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
42	O
-	O
year	O
-	O
old	O
Caucasian	O
man	B-SPEC
who	O
presented	O
with	O
severe	O
ARDS	O
from	O
Bordetella	B-SPEC
pertussis	I-SPEC
,	O
5	O
years	O
after	O
bilateral	O
sequential	O
lung	O
transplant	O
for	O
cystic	O
fibrosis	O
.	O

Although	O
detailed	O
evaluation	O
on	O
phylogenetic	O
analysis	O
of	O
HMPV	B-SPEC
has	O
been	O
described	O
in	O
other	O
countries	O
,	O
there	O
are	O
no	O
data	O
from	O
Turkey	B-SPEC
on	O
this	O
subject	O
.	O

This	O
result	O
indicated	O
that	O
the	O
functional	O
constraints	O
on	O
F	O
and	O
N	O
genes	O
prevent	O
dramatic	O
aminoacid	O
changes	O
,	O
and	O
indicated	O
that	O
the	O
evolution	O
of	O
HMPV	B-SPEC
was	O
slow	O
.	O

In	O
addition	O
,	O
our	O
data	O
emphasized	O
that	O
the	O
HMPV	B-SPEC
prevalence	O
was	O
high	O
in	O
children	O
0	O
-	O
5	O
years	O
old	O
,	O
and	O
coinfections	O
were	O
common	O
with	O
the	O
other	O
respiratory	O
viruses	B-SPEC
such	O
as	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
3	O
,	O
rhinovirus	B-SPEC
and	O
enterovirus	B-SPEC
.	O

TITLE	O
:	O
The	O
close	O
genetic	O
relationship	O
of	O
lineage	O
D	O
Betacoronavirus	B-SPEC
from	O
Nigerian	O
and	O
Kenyan	O
straw	B-SPEC
-	I-SPEC
colored	I-SPEC
fruit	I-SPEC
bats	I-SPEC
(	O
Eidolon	B-SPEC
helvum	I-SPEC
)	O
is	O
consistent	O
with	O
the	O
existence	O
of	O
a	O
single	O
epidemiological	O
unit	O
across	O
sub	O
-	O
Saharan	O
Africa	O
.	O

In	O
this	O
study	O
,	O
coronavirus	B-SPEC
sequences	O
were	O
detected	O
using	O
a	O
nested	O
RT	O
-	O
PCR	O
targeting	O
440	O
bp	O
of	O
the	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
in	O
six	O
of	O
79	O
fecal	O
samples	O
collected	O
from	O
an	O
urban	O
colony	O
of	O
E	B-SPEC
.	I-SPEC
helvum	I-SPEC
in	O
Ibadan	O
,	O
Nigeria	O
.	O

Methods	O
Antibody	O
-	O
mediated	O
TRALI	O
was	O
experimentally	O
induced	O
in	O
mice	B-SPEC
by	O
lipopolysaccharide	O
priming	O
followed	O
by	O
the	O
administration	O
of	O
an	O
anti	O
-	O
MHC	O
I	O
mAb	O
.	O

When	O
less	O
severe	O
thrombocytopenia	O
was	O
induced	O
with	O
an	O
antiplatelet	O
mAb	O
,	O
TRALI	O
started	O
and	O
developed	O
similarly	O
as	O
in	O
control	O
mice	B-SPEC
,	O
but	O
hemorrhages	O
were	O
absent	O
.	O

Pigs	B-SPEC
in	O
treatments	O
2	O
and	O
4	O
were	O
inoculated	O
with	O
a	O
live	O
field	O
strain	O
of	O
PRRS	O
virus	B-SPEC
via	O
intramuscular	O
and	O
intranasal	O
routes	O
at	O
0	O
d	O
after	O
inoculation	O
(	O
dpi	O
).	O

Control	O
pigs	B-SPEC
remained	O
PRRS	O
and	O
PED	O
virus	B-SPEC
negative	O
throughout	O
the	O
study	O
.	O

Compared	O
with	O
control	O
pigs	B-SPEC
,	O
PRRS	O
infection	O
did	O
not	O
reduce	O
apparent	O
total	O
tract	O
digestibility	O
(	O
ATTD	O
)	O
of	O
nutrients	O
and	O
energy	O
.	O

Forty	O
-	O
two	O
gilts	O
(	O
16	O
.	O
8	O
	O
0	O
.	O
6	O
kg	O
BW	O
),	O
nave	O
for	O
PRRS	O
and	O
PED	O
,	O
were	O
selected	O
and	O
randomly	O
assigned	O
to	O
1	O
of	O
4	O
treatments	O
:	O
1	O
)	O
a	O
control	O
(	O
CON	O
;	O
=	O
6	O
),	O
2	O
)	O
PRRS	O
virus	B-SPEC
challenge	O
only	O
(	O
PRRS	O
;	O
=	O
12	O
),	O
3	O
)	O
PED	O
virus	B-SPEC
challenge	O
only	O
(;	O
=	O
12	O
),	O
or	O
4	O
)	O
coinfection	O
of	O
PRRS	O
+	O
PED	O
viruses	B-SPEC
(	O
PRP	O
;	O
=	O
12	O
).	O

Treatments	O
2	O
and	O
4	O
were	O
inoculated	O
with	O
a	O
live	O
field	O
strain	O
of	O
PRRS	O
virus	B-SPEC
on	O
d	O
0	O
after	O
inoculation	O
.	O

Fecal	O
quantitative	O
PCR	O
was	O
used	O
to	O
confirm	O
PED	O
virus	B-SPEC
infection	O
.	O

Interestingly	O
,	O
TER	O
was	O
increased	O
(	O
<	O
0	O
.	O
01	O
)	O
in	O
the	O
PRP	O
pigs	B-SPEC
.	O

TITLE	O
:	O
Sepsis	B-SPEC
and	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
Recent	O
Update	O
.	O

We	O
report	O
shedding	O
and	O
transmission	O
of	O
this	O
virus	B-SPEC
in	O
experimentally	O
infected	O
alpacas	B-SPEC
(	O
n	O
=	O
3	O
)	O
or	O
those	O
infected	O
by	O
contact	O
(	O
n	O
=	O
3	O
).	O

Experimentally	O
infected	O
animals	B-SPEC
were	O
protected	O
against	O
reinfection	O
,	O
and	O
those	O
infected	O
by	O
contact	O
were	O
partially	O
protected	O
.	O

The	O
trial	O
indicates	O
that	O
alpacas	B-SPEC
may	O
be	O
suitable	O
models	O
for	O
infection	O
and	O
shedding	O
dynamics	O
of	O
this	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Dromedaries	B-SPEC
in	O
Africa	O
and	O
elsewhere	O
carry	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

This	O
RVN	O
is	O
remarkably	O
similar	O
to	O
that	O
described	O
for	O
the	O
distantly	O
related	O
coronaviruses	O
(	O
also	O
order	B-SPEC
Nidovirales	I-SPEC
)	O
and	O
sets	O
them	O
apart	O
from	O
other	O
DMV	O
-	O
inducing	O
viruses	B-SPEC
analysed	O
to	O
date	O
.	O

We	O
review	O
here	O
the	O
current	O
knowledge	O
and	O
open	O
questions	O
on	O
arterivirus	B-SPEC
replication	O
organelles	O
and	O
discuss	O
them	O
in	O
the	O
light	O
of	O
the	O
latest	O
studies	O
on	O
other	O
DMV	O
-	O
inducing	O
viruses	B-SPEC
,	O
particularly	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Given	O
periodic	O
outbreaks	O
of	O
fatal	O
human	B-SPEC
infections	O
caused	O
by	O
coronaviruses	O
,	O
development	O
of	O
an	O
optimal	O
coronavirus	B-SPEC
vaccine	O
platform	O
capable	O
of	O
rapid	O
production	O
is	O
an	O
ongoing	O
priority	O
.	O

Detailed	O
methods	O
are	O
presented	O
for	O
expression	O
,	O
purification	O
,	O
and	O
release	O
testing	O
of	O
SARS	O
recombinant	O
spike	O
protein	O
antigen	O
,	O
followed	O
by	O
adjuvant	O
formulation	O
and	O
animal	B-SPEC
testing	O
.	O

The	O
methods	O
herein	O
described	O
for	O
rapid	O
development	O
of	O
a	O
highly	O
protective	O
SARS	O
vaccine	O
are	O
equally	O
suited	O
to	O
rapid	O
development	O
of	O
vaccines	O
against	O
other	O
fatal	O
human	B-SPEC
coronavirus	I-SPEC
infections	O
,	O
e	O
.	O
g	O
.,	O
the	O
MERS	O
coronavirus	B-SPEC
.	O

We	O
examined	O
whether	O
RA	O
assist	O
parenteral	O
vaccination	O
of	O
pigs	B-SPEC
could	O
improve	O
mucosal	O
immunity	O
.	O

From	O
April	O
2012	O
to	O
March	O
2013	O
,	O
507	O
children	O
,	O
aged	O
up	O
to	O
24	O
months	O
and	O
hospitalized	O
with	O
LRTI	O
in	O
one	O
of	O
the	O
participating	O
centers	O
at	O
Aracaj	O
,	O
Salvador	O
,	O
Recife	O
,	O
and	O
Macei	O
,	O
had	O
a	O
sample	O
of	O
nasopharyngeal	O
aspirate	O
collected	O
and	O
analyzed	O
for	O
the	O
following	O
viruses	B-SPEC
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
followed	O
by	O
hybridization	O
on	O
low	O
-	O
density	O
microarrays	O
:	O
RSV	B-SPEC
,	O
influenza	O
,	O
parainfluenza	O
,	O
adenovirus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
metapneumovirus	B-SPEC
,	O
bocavirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
.	O

Similar	O
to	O
PEDV	B-SPEC
infections	O
,	O
PDCoV	O
infections	O
also	O
cause	O
acute	O
,	O
severe	O
atrophic	O
enteritis	O
accompanied	O
by	O
transient	O
viremia	O
(	O
viral	O
RNA	O
)	O
that	O
leads	O
to	O
severe	O
diarrhea	O
and	O
/	O
or	O
vomiting	O
,	O
followed	O
by	O
dehydration	O
as	O
the	O
potential	O
cause	O
of	O
death	O
in	O
nursing	O
piglets	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
highly	O
transmissible	O
coronavirus	B-SPEC
that	O
causes	O
a	O
severe	O
enteric	O
disease	O
particularly	O
in	O
neonatal	O
piglets	O
.	O

In	O
this	O
study	O
,	O
a	O
rapid	O
method	O
for	O
detecting	O
PEDV	B-SPEC
was	O
developed	O
based	O
on	O
cross	O
-	O
priming	O
amplification	O
and	O
nucleic	O
acid	O
test	O
strip	O
(	O
CPA	O
-	O
NATS	O
).	O

It	O
was	O
also	O
successfully	O
applied	O
to	O
detecting	O
PEDV	B-SPEC
in	O
clinical	O
specimens	O
.	O

TITLE	O
:	O
Diagnostic	O
utility	O
of	O
cerebrospinal	O
fluid	O
immunocytochemistry	O
for	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
manifesting	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Methods	O
Prospectively	O
,	O
CSF	O
samples	O
of	O
41	O
cats	B-SPEC
were	O
investigated	O
,	O
including	O
cats	B-SPEC
with	O
histopathologically	O
confirmed	O
FIP	O
and	O
neurological	O
signs	O
(	O
n	O
=	O
10	O
),	O
cats	B-SPEC
with	O
confirmed	O
FIP	O
without	O
CNS	O
involvement	O
(	O
n	O
=	O
11	O
),	O
cats	B-SPEC
with	O
neurological	O
signs	O
but	O
another	O
confirmed	O
CNS	O
disease	O
(	O
n	O
=	O
17	O
),	O
and	O
cats	B-SPEC
without	O
neurological	O
signs	O
and	O
a	O
disease	O
other	O
than	O
FIP	O
(	O
n	O
=	O
3	O
).	O

In	O
cats	B-SPEC
with	O
other	O
CNS	O
disorders	O
,	O
11	O
/	O
17	O
had	O
macrophages	O
,	O
two	O
of	O
which	O
stained	O
positively	O
.	O

However	O
,	O
causal	O
association	O
is	O
yet	O
to	O
be	O
established	O
and	O
the	O
concomitant	O
role	O
of	O
bacteria	B-SPEC
as	O
a	O
co	O
-	O
infection	O
or	O
super	O
-	O
infection	O
needs	O
further	O
investigation	O
.	O

TITLE	O
:	O
Isolation	O
and	O
genetic	O
analysis	O
of	O
a	O
variant	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
China	O
.	O

The	O
mucosa	O
and	O
the	O
content	O
of	O
the	O
small	O
intestine	O
from	O
newborn	O
pre	O
-	O
weaned	O
piglets	O
with	O
diarrhea	O
were	O
tested	O
for	O
the	O
presence	O
of	O
PEDV	B-SPEC
by	O
molecular	O
and	O
morphologic	O
methods	O
,	O
and	O
found	O
to	O
be	O
positive	O
.	O

Novel	O
alphacoronaviruses	O
were	O
detected	O
in	O
the	O
species	B-SPEC
Rattus	B-SPEC
norvegicus	I-SPEC
,	O
Microtus	B-SPEC
agrestis	I-SPEC
,	O
Sorex	B-SPEC
araneus	I-SPEC
and	O
Myodes	B-SPEC
glareolus	I-SPEC
.	O

TITLE	O
:	O
Rapid	O
generation	O
of	O
a	O
human	B-SPEC
monoclonal	O
antibody	O
to	O
combat	O
Middle	O
East	O
respiratory	O
syndrome	O
.	O

TITLE	O
:	O
Epidemic	O
strain	O
YC2014	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
could	O
provide	O
piglets	O
against	O
homologous	O
challenge	O
.	O

Since	O
December	O
2010	O
,	O
a	O
large	O
-	O
scale	O
outbreak	O
of	O
diarrhea	O
has	O
been	O
observed	O
in	O
swine	B-SPEC
farms	O
in	O
China	O
.	O

The	O
immune	O
protective	O
efficiency	O
of	O
YC2014	O
were	O
determined	O
by	O
testing	O
PEDV	B-SPEC
neutralizing	O
antibodies	O
in	O
sera	O
,	O
the	O
colostrum	O
and	O
the	O
milk	O
on	O
7th	O
day	O
after	O
farrowing	O
of	O
the	O
immunized	O
sows	O
.	O

In	O
the	O
immune	O
protective	O
efficiency	O
tests	O
,	O
the	O
neutralizing	O
antibody	O
titers	O
in	O
sera	O
,	O
the	O
colostrum	O
and	O
the	O
milk	O
on	O
7th	O
day	O
after	O
farrowing	O
of	O
the	O
inactivated	O
YC2014	O
PEDV	B-SPEC
strain	O
immunized	O
group	O
were	O
significantly	O
higher	O
than	O
the	O
inactivated	O
CV777	O
immunized	O
group	O
and	O
the	O
inactivated	O
DR13	O
immunized	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

A	O
virus	B-SPEC
inhibition	O
assay	O
was	O
used	O
to	O
identify	O
the	O
antiviral	O
activity	O
of	O
GO	O
and	O
GO	O
-	O
Ag	O
.	O

Go	O
-	O
Ag	O
inhibited	O
25	O
%	O
of	O
infection	O
by	O
FCoV	O
and	O
23	O
%	O
by	O
IBDV	B-SPEC
,	O
whereas	O
GO	O
only	O
inhibited	O
16	O
%	O
of	O
infection	O
by	O
FCoV	O
but	O
showed	O
no	O
antiviral	O
activity	O
against	O
the	O
infection	O
by	O
IBDV	B-SPEC
.	O

In	O
this	O
study	O
,	O
an	O
easy	O
-	O
to	O
-	O
perform	O
SYBR	O
green	O
I	O
real	O
-	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
targeting	O
the	O
nucleocapsid	O
gene	O
of	O
IBV	B-SPEC
was	O
developed	O
and	O
compared	O
with	O
conventional	O
agarose	O
gel	O
-	O
based	O
RT	O
-	O
PCR	O
for	O
the	O
detection	O
of	O
IBV	B-SPEC
infection	O
.	O

The	O
SYBR	O
green	O
I	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
test	O
described	O
herein	O
can	O
be	O
used	O
to	O
rapidly	O
distinguish	O
IBV	B-SPEC
from	O
other	O
respiratory	O
pathogens	O
,	O
which	O
is	O
important	O
for	O
diagnosis	O
and	O
control	O
of	O
infectious	O
bronchitis	O
outbreaks	O
in	O
Morocco	O
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
viruses	B-SPEC
in	O
bovine	B-SPEC
respiratory	O
disease	O
(	O
BRD	O
)	O
cases	O
in	O
feedlots	O
,	O
including	O
bovine	B-SPEC
herpesvirus	I-SPEC
-	I-SPEC
1	I-SPEC
(	O
BoHV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
),	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
),	O
bovine	B-SPEC
coronaviruses	O
(	O
BoCV	O
)	O
and	O
parainfluenza	O
-	O
3	O
virus	B-SPEC
(	O
PI3V	O
).	O

SAIBK2	O
causes	O
severe	O
kidney	O
lesions	O
and	O
results	O
in	O
50	O
%	O
mortality	O
in	O
30	O
-	O
day	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
(	O
with	O
a	O
dose	O
of	O
10	O
(	O
5	O
)	O
EID50	O
/	O
0	O
.	O
1	O
mL	O
SAIBK2	O
per	O
chicken	B-SPEC
).	O

More	O
than	O
100	O
diferent	O
viruses	B-SPEC
are	O
associated	O
with	O
these	O
mammals	B-SPEC
,	O
particularly	O
Rhabdoviridae	B-SPEC
(	O
Lyssavirus	B-SPEC
like	O
rabies	B-SPEC
virus	I-SPEC
),	O
Paramyxoviridae	B-SPEC
(	O
like	O
Nipah	O
and	O
Hendra	O
viruses	B-SPEC
),	O
Filoviridae	B-SPEC
(	O
Ebola	O
and	O
Marburg	B-SPEC
viruses	I-SPEC
)	O
and	O
Coronavirida	O
(	O
viruses	B-SPEC
causing	O
SARS	O
and	O
MERS	O
).	O

ABSTRACT	O
:	O
cl	O
-	O
2	O
virus	B-SPEC
is	O
an	O
extremely	O
neurovirulent	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

However	O
,	O
during	O
the	O
initial	O
phase	O
of	O
infection	O
between	O
12	O
and	O
24	O
h	O
post	O
-	O
inoculation	O
(	O
hpi	O
),	O
the	O
viral	O
antigens	O
are	O
detected	O
only	O
in	O
the	O
meninges	O
,	O
followed	O
by	O
viral	O
spread	O
into	O
the	O
ventricular	O
wall	O
before	O
invasion	O
into	O
the	O
brain	O
parenchyma	O
,	O
indicating	O
that	O
the	O
viruses	B-SPEC
employ	O
a	O
passage	O
between	O
the	O
meninges	O
and	O
ventricular	O
wall	O
as	O
an	O
entry	O
route	O
into	O
the	O
brain	O
parenchyma	O
.	O

The	O
H7N9	O
virus	B-SPEC
was	O
detected	O
by	O
the	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
matrix	O
gene	O
target	O
,	O
while	O
other	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
subtyping	O
gene	O
targets	O
in	O
the	O
panel	O
remained	O
negative	O
.	O

RESULTS	O
:	O
The	O
results	O
of	O
colony	O
PCR	O
,	O
enzyme	O
digestion	O
and	O
sequencing	O
showed	O
that	O
the	O
VP8	O
-	O
S2	O
chimeric	O
antigen	O
has	O
been	O
successfully	O
cloned	O
and	O
sub	O
-	O
cloned	O
into	O
pGH	O
and	O
pET32a	O
(+).	O
The	O
results	O
showed	O
that	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
was	O
able	O
to	O
express	O
VP8	O
-	O
S2	O
protein	O
appropriately	O
.	O

CONCLUSIONS	O
:	O
The	O
results	O
of	O
this	O
study	O
showed	O
that	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
can	O
be	O
used	O
as	O
an	O
appropriate	O
host	O
to	O
produce	O
the	O
recombinant	O
VP8	O
-	O
S2	O
protein	O
.	O

Creating	O
a	O
functional	O
doctor	O
-	O
patient	O
-	O
psychologist	O
team	O
is	O
key	O
throughout	O
the	O
HIV	B-SPEC
-	O
positive	O
patient	O
'	O
s	O
existence	O
,	O
for	O
supporting	O
long	O
term	O
adherence	O
to	O
therapy	O
and	O
acceptance	O
of	O
the	O
diagnosis	O
.	O

This	O
case	O
highlights	O
the	O
need	O
for	O
a	O
strong	O
psychosocial	O
compartment	O
in	O
every	O
medical	O
center	O
that	O
deals	O
with	O
HIV	B-SPEC
-	O
infected	O
individuals	O
.	O

TITLE	O
:	O
Complete	O
Genome	O
Sequence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Isolated	O
from	O
a	O
Dromedary	B-SPEC
Camel	B-SPEC
in	O
Egypt	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
of	O
coronaviruses	O
in	O
Miniopterus	B-SPEC
fuliginosus	I-SPEC
bats	B-SPEC
.	O

Compared	O
with	O
pre	O
-	O
PPV	B-SPEC
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
,	O
cmH2O	O
,	O
1	O
cmH2O	O
=	O
0	O
.	O
098kPa	O
)	O
post	O
-	O
PPV	B-SPEC
was	O
significantly	O
higher	O
in	O
ILD	O
group	O
[	O
10	O
.	O
0	O
(	O
10	O
.	O
0	O
,	O
12	O
.	O
0	O
)	O
vs	O
.	O
10	O
.	O
0	O
(	O
9	O
.	O
2	O
,	O
12	O
.	O
0	O
),	O
P	O
<	O
0	O
.	O
05	O
],	O
and	O
respiratory	O
rate	O
(	O
RR	O
,	O
times	O
/	O
min	O
)	O
was	O
significantly	O
lower	O
in	O
non	O
-	O
ILD	O
group	O
[	O
24	O
.	O
5	O
(	O
22	O
.	O
0	O
,	O
27	O
.	O
0	O
)	O
vs	O
.	O
25	O
.	O
5	O
(	O
22	O
.	O
8	O
,	O
28	O
.	O
0	O
),	O
P	O
<	O
0	O
.	O
05	O
].	O

TITLE	O
:	O
Reverse	O
transcription	O
-	O
PCR	O
assays	O
for	O
the	O
differentiation	O
of	O
various	O
US	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strains	O
.	O

MERS	O
-	O
CoV	O
can	O
infect	O
multiple	O
host	O
species	B-SPEC
and	O
cause	O
severe	O
diseases	O
in	O
human	B-SPEC
.	O

In	O
an	O
attempt	O
to	O
develop	O
a	O
subunit	O
vaccine	O
for	O
PEDV	B-SPEC
,	O
we	O
cloned	O
two	O
different	O
fragments	O
of	O
S	O
protein	O
and	O
expressed	O
as	O
glutathione	O
S	O
-	O
transferase	O
(	O
GST	O
)-	O
tagged	O
fusion	O
proteins	O
,	O
namely	O
rGST	O
-	O
COE	O
and	O
rGST	O
-	O
S1D	O
,	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

Purified	O
proteins	O
were	O
detected	O
by	O
western	O
blot	O
using	O
mouse	B-SPEC
anti	O
-	O
GST	O
mAb	O
and	O
pig	B-SPEC
anti	O
-	O
PEDV	B-SPEC
immune	O
sera	O
.	O

Finally	O
,	O
immunization	O
of	O
mice	B-SPEC
with	O
10	O
g	O
of	O
purified	O
proteins	O
elicited	O
highly	O
potent	O
serum	O
IgG	O
and	O
serum	O
neutralizing	O
antibody	O
titers	O
.	O

There	O
is	O
a	O
crucial	O
need	O
for	O
an	O
effective	O
sample	O
preparation	O
technology	O
that	O
concentrates	O
viruses	B-SPEC
at	O
low	O
abundance	O
while	O
excluding	O
resident	O
analytes	O
that	O
may	O
interfere	O
with	O
detection	O
.	O

Here	O
,	O
the	O
roles	O
of	O
the	O
S	O
protein	O
ERRS	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
intracellular	O
trafficking	O
and	O
S	O
incorporation	O
into	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
are	O
described	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
current	O
situation	O
and	O
travel	O
-	O
associated	O
concerns	O
.	O

Following	O
mouse	B-SPEC
immunization	O
and	O
hybridoma	O
generation	O
,	O
we	O
selected	O
seven	O
hybridoma	O
clones	O
that	O
produced	O
mAbs	O
with	O
exclusive	O
reactivity	O
against	O
MERS	O
-	O
CoV	O
NP	O
.	O

TITLE	O
:	O
Monoclonal	O
Antibody	O
to	O
Bone	O
Marrow	O
Stromal	O
Cell	O
Antigen	O
2	O
Protein	O
of	O
Swine	B-SPEC
.	O

TITLE	O
:	O
Isolation	O
and	O
identification	O
of	O
group	B-SPEC
A	I-SPEC
rotaviruses	I-SPEC
among	O
neonatal	O
diarrheic	O
calves	O
,	O
Morocco	O
.	O

In	O
this	O
study	O
,	O
we	O
isolated	O
RVA	O
strains	O
from	O
NCD	O
clinical	O
samples	O
in	O
order	B-SPEC
to	O
support	O
RVA	O
disease	O
control	O
in	O
Morocco	O
.	O

TITLE	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Africa	O
:	O
a	O
review	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
worldwide	O
in	O
distribution	O
,	O
highly	O
infectious	O
,	O
and	O
extremely	O
difficult	O
to	O
control	O
because	O
it	O
has	O
extensive	O
genetic	O
diversity	O
,	O
a	O
short	O
generation	O
time	O
,	O
and	O
a	O
high	O
mutation	O
rate	O
.	O

IBV	B-SPEC
is	O
a	O
Gammacoronavirus	B-SPEC
,	O
single	O
-	O
stranded	O
,	O
and	O
positive	O
-	O
sense	O
RNA	O
virus	B-SPEC
.	O

Avian	B-SPEC
infectious	O
bronchitis	O
is	O
well	O
studied	O
in	O
European	O
countries	O
with	O
identification	O
of	O
a	O
large	O
number	O
of	O
IBV	B-SPEC
variants	O
,	O
whereas	O
in	O
African	O
countries	O
epidemiological	O
and	O
scientific	O
data	O
are	O
poor	O
and	O
not	O
updated	O
.	O

However	O
,	O
previous	O
studies	O
reported	O
that	O
an	O
IBV	B-SPEC
variant	O
continues	O
to	O
appear	O
regularly	O
in	O
Africa	O
,	O
as	O
currently	O
described	O
in	O
Morocco	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
PDCoV	O
infection	O
fails	O
to	O
induce	O
,	O
and	O
even	O
remarkably	O
inhibits	O
,	O
Sendai	B-SPEC
virus	I-SPEC
-	O
or	O
poly	O
(	O
I	O
:	O
C	O
)-	O
induced	O
IFN	O
-	O
	O
production	O
by	O
impeding	O
the	O
activation	O
of	O
transcription	O
factors	O
NF	O
-	O
B	O
and	O
IRF3	O
.	O

TITLE	O
:	O
A	O
combined	O
in	O
silico	O
/	O
in	O
vitro	O
approach	O
unveils	O
common	O
molecular	O
requirements	O
for	O
efficient	O
BVDV	B-SPEC
RdRp	O
binding	O
of	O
linear	O
aromatic	O
N	O
-	O
polycyclic	O
systems	O
.	O

A	O
coupled	O
in	O
silico	O
/	O
in	O
vitro	O
investigation	O
was	O
employed	O
to	O
formulate	O
a	O
molecular	O
rationale	O
explaining	O
the	O
notable	O
affinity	O
of	O
all	O
molecules	O
to	O
BVDV	B-SPEC
RNA	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
NS5B	O
.	O

The	O
agreement	O
between	O
predicted	O
and	O
experimental	O
data	O
confirmed	O
the	O
proposed	O
common	O
molecular	O
rationale	O
shared	O
by	O
molecules	O
characterized	O
by	O
different	O
chemical	O
scaffolds	O
in	O
binding	O
to	O
the	O
BVDV	B-SPEC
RdRp	O
,	O
ultimately	O
yielding	O
compound	O
6b	O
(	O
EC50	O
=	O
0	O
.	O
3	O
M	O
;	O
IC50	O
=	O
0	O
.	O
48	O
M	O
)	O
as	O
a	O
new	O
,	O
potent	O
inhibitor	O
of	O
this	O
Pestivirus	B-SPEC
.	O

PEDV	B-SPEC
RNA	O
was	O
detected	O
throughout	O
the	O
intestine	O
in	O
euthanized	O
animals	B-SPEC
at	O
4	O
days	O
post	O
-	O
inoculation	O
.	O

Seroconversion	O
against	O
PEDV	B-SPEC
occurred	O
in	O
all	O
surviving	O
infected	O
animals	B-SPEC
within	O
10	O
days	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
assess	O
any	O
effect	O
of	O
wild	O
and	O
vaccine	O
Australian	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
on	O
shell	O
colour	O
in	O
brown	O
-	O
shelled	O
eggs	O
.	O

TITLE	O
:	O
Ten	O
years	O
of	O
a	O
hantavirus	B-SPEC
disease	O
emergency	O
in	O
the	O
Federal	O
District	O
,	O
Brazil	O
.	O

TITLE	O
:	O
Isolation	O
and	O
Characterization	O
of	O
Dromedary	B-SPEC
Camel	B-SPEC
Coronavirus	B-SPEC
UAE	O
-	O
HKU23	O
from	O
Dromedaries	B-SPEC
of	O
the	O
Middle	O
East	O
:	O
Minimal	O
Serological	O
Cross	O
-	O
Reactivity	O
between	O
MERS	O
Coronavirus	B-SPEC
and	O
Dromedary	B-SPEC
Camel	B-SPEC
Coronavirus	B-SPEC
UAE	O
-	O
HKU23	O
.	O

Virus	B-SPEC
isolation	O
,	O
virus	B-SPEC
neutralization	O
testing	O
,	O
and	O
RT	O
-	O
PCR	O
were	O
employed	O
to	O
identify	O
the	O
causative	O
pathogen	O
,	O
while	O
sequence	O
alignment	O
was	O
used	O
to	O
analyze	O
gene	O
variations	O
of	O
the	O
S1	O
subunit	O
and	O
M	O
genes	O
.	O

Treatment	O
for	O
sepsis	B-SPEC
was	O
augmented	O
.	O

ABSTRACT	O
:	O
In	O
April	O
2014	O
,	O
a	O
surge	O
in	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
was	O
seen	O
in	O
Jeddah	O
,	O
Saudi	O
Arabia	O
.	O

The	O
PED	O
outbreak	O
increased	O
mortality	O
and	O
consequently	O
reduced	O
the	O
numbers	O
of	O
marketed	O
pigs	B-SPEC
.	O

We	O
found	O
a	O
known	O
inhibitor	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
3CL	O
(	O
pro	O
),	O
(	O
R	O
)-	O
16	O
,	O
to	O
have	O
inhibitor	O
activity	O
against	O
PEDV	B-SPEC
3CL	O
(	O
pro	O
),	O
despite	O
that	O
SARS	O
-	O
3CL	O
(	O
pro	O
)	O
and	O
PEDV	B-SPEC
3CL	O
(	O
pro	O
)	O
share	O
only	O
45	O
.	O
4	O
%	O
sequence	O
identity	O
.	O

Structural	O
comparison	O
reveals	O
that	O
the	O
majority	O
of	O
residues	O
involved	O
in	O
(	O
R	O
)-	O
16	O
binding	O
to	O
SARS	O
-	O
3CL	O
(	O
pro	O
)	O
are	O
conserved	O
in	O
PEDV	B-SPEC
-	O
3CL	O
(	O
pro	O
);	O
however	O
,	O
the	O
sequence	O
variation	O
and	O
positional	O
difference	O
in	O
the	O
loop	O
forming	O
the	O
S2	O
pocket	O
may	O
account	O
for	O
large	O
observed	O
difference	O
in	O
IC50	O
values	O
.	O

Furhermore	O
most	O
of	O
the	O
casualties	O
due	O
to	O
malaria	O
are	O
related	O
with	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
.	O

His	O
peripheral	O
blood	O
smear	O
revealed	O
ring	O
-	O
formed	O
trophozoites	O
and	O
banana	B-SPEC
-	O
shaped	O
gametocytes	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
.	O

Pre	O
-	O
treatment	O
with	O
the	O
phosphodiesterase	O
antagonist	O
pentoxifyllinum	O
(	O
PTX	O
)	O
obviously	O
attenuated	O
lung	O
injury	O
and	O
reduced	O
the	O
mortality	O
of	O
mice	B-SPEC
with	O
cecal	O
ligature	O
and	O
puncture	O
(	O
CLP	O
)	O
induced	O
ARDS	O
,	O
while	O
raising	O
cAMP	O
levels	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
demonstrated	O
to	O
be	O
natural	O
reservoirs	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
CoV	O
.	O
Faecal	O
samples	O
from	O
248	O
individuals	O
of	O
20	O
bat	B-SPEC
species	B-SPEC
were	O
tested	O
for	O
partial	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
of	O
CoV	O
and	O
57	O
faecal	O
samples	O
from	O
eight	O
bat	B-SPEC
species	B-SPEC
were	O
tested	O
positive	O
.	O

To	O
study	O
the	O
genetic	O
characteristics	O
of	O
PEDV	B-SPEC
strains	O
in	O
Chinese	O
mainland	O
,	O
a	O
total	O
of	O
603	O
clinical	O
samples	O
from	O
nine	O
provinces	O
/	O
districts	O
of	O
Chinese	O
mainland	O
from	O
January	O
2014	O
to	O
December	O
2015	O
were	O
collected	O
for	O
RT	O
-	O
PCR	O
detection	O
and	O
1	O
-	O
1323bp	O
of	O
S	O
gene	O
of	O
91	O
isolates	O
and	O
ORF3	O
gene	O
of	O
46	O
isolates	O
were	O
sequenced	O
.	O

The	O
404	O
-	O
472bp	O
of	O
S	O
gene	O
contained	O
the	O
three	O
genetic	O
markers	O
,	O
i	O
.	O
e	O
.,	O
""""	O
TAA	O
""""	O
insertion	O
at	O
404	O
-	O
405bp	O
,	O
""""	O
ACAGGT	O
""""	O
deletion	O
at	O
430	O
-	O
435bp	O
,	O
and	O
""""	O
ATA	B-SPEC
""""	O
deletion	O
at	O
455	O
-	O
457bp	O
can	O
be	O
used	O
to	O
differentiate	O
the	O
classical	O
and	O
variant	O
virulent	O
parental	O
/	O
attenuated	O
PEDV	B-SPEC
strains	O
and	O
help	O
us	O
to	O
learn	O
the	O
infectious	O
and	O
genetic	O
characteristics	O
of	O
PEDV	B-SPEC
strains	O
more	O
convenient	O
and	O
cheaper	O
.	O

Overall	O
,	O
22	O
contributions	O
covering	O
a	O
broad	O
array	O
of	O
diseases	O
are	O
featured	O
-	O
i	O
.	O
e	O
.	O
clonorchiasis	O
,	O
dengue	O
,	O
hepatitis	O
,	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
/	O
acquired	O
immune	O
deficiency	O
syndrome	O
(	O
HIV	B-SPEC
/	O
AIDS	O
),	O
H7N9	O
avian	B-SPEC
influenza	O
,	O
lymphatic	O
filariasis	O
,	O
malaria	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
rabies	O
,	O
schistosomiasis	O
and	O
tuberculosis	O
(	O
TB	O
).	O

Although	O
highly	O
pathogenic	O
to	O
their	O
spillover	O
hosts	O
,	O
bats	B-SPEC
harbor	O
these	O
viruses	B-SPEC
,	O
and	O
a	O
large	O
number	O
of	O
other	O
viruses	B-SPEC
,	O
with	O
little	O
or	O
no	O
clinical	O
signs	O
of	O
disease	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
isolated	O
and	O
serially	O
cultivated	O
a	O
Korean	O
PEDV	B-SPEC
epidemic	O
strain	O
,	O
KOR	O
/	O
KNU	O
-	O
141112	O
/	O
2014	O
,	O
in	O
Vero	O
cells	O
.	O

Therefore	O
,	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
produce	O
an	O
inactivated	O
PEDV	B-SPEC
vaccine	O
using	O
the	O
KNU	O
-	O
141112	O
strain	O
and	O
evaluate	O
its	O
effectiveness	O
in	O
neonatal	O
piglets	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
receptor	O
switch	O
explained	O
from	O
the	O
stereochemistry	O
of	O
protein	O
-	O
carbohydrate	O
interactions	O
and	O
a	O
single	O
mutation	O
.	O

ABSTRACT	O
:	O
Hemagglutinin	O
-	O
esterases	O
(	O
HEs	O
)	O
are	O
bimodular	O
envelope	O
proteins	O
of	O
orthomyxoviruses	B-SPEC
,	O
toroviruses	B-SPEC
,	O
and	O
coronaviruses	O
with	O
a	O
carbohydrate	O
-	O
binding	O
""""	O
lectin	O
""""	O
domain	O
appended	O
to	O
a	O
receptor	O
-	O
destroying	O
sialate	O
-	O
O	O
-	O
acetylesterase	O
"("""	O
esterase	O
""")."	O

This	O
specificity	O
shift	O
required	O
quasisynchronous	O
adaptations	O
in	O
the	O
Sia	B-SPEC
-	O
binding	O
sites	O
of	O
both	O
lectin	O
and	O
esterase	O
domains	O
.	O

Here	O
,	O
we	O
present	O
a	O
complete	O
structure	O
of	O
a	O
type	O
II	O
HE	O
with	O
a	O
receptor	O
analog	O
in	O
the	O
catalytic	O
site	O
and	O
identify	O
the	O
mutations	O
underlying	O
the	O
9	O
-	O
O	O
-	O
to	O
4	O
-	O
O	O
-	O
Ac	O
-	O
Sia	B-SPEC
substrate	O
switch	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
are	O
well	O
-	O
known	O
causes	O
of	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(	O
AE	O
-	O
COPD	O
)	O
and	O
also	O
important	O
pathogens	O
for	O
concomitant	O
pneumonia	O
in	O
COPD	O
(	O
CP	O
-	O
COPD	O
).	O

Additionally	O
,	O
several	O
serological	O
assays	O
have	O
been	O
developed	O
and	O
are	O
currently	O
used	O
for	O
the	O
detection	O
of	O
antibodies	O
against	O
PEDV	B-SPEC
.	O

After	O
MERS	O
-	O
CoV	O
infections	O
occurred	O
in	O
an	O
extended	O
family	B-SPEC
in	O
Saudi	O
Arabia	O
in	O
2014	O
,	O
relatives	O
were	O
tested	O
by	O
using	O
real	O
-	O
time	O
reverse	O
transcription	O
PCR	O
(	O
rRT	O
-	O
PCR	O
)	O
and	O
serologic	O
methods	O
.	O

Research	O
priorities	O
include	O
standardization	O
of	O
animal	B-SPEC
models	O
and	O
virus	B-SPEC
stocks	O
for	O
studying	O
disease	O
pathogenesis	O
and	O
efficacy	O
of	O
medical	O
countermeasures	O
;	O
development	O
of	O
MERS	O
-	O
CoV	O
diagnostics	O
;	O
improved	O
access	O
to	O
nonhuman	O
primates	B-SPEC
to	O
support	O
preclinical	O
research	O
;	O
studies	O
to	O
better	O
understand	O
and	O
control	O
MERS	O
-	O
CoV	O
disease	O
,	O
including	O
vaccination	O
studies	O
in	O
camels	B-SPEC
;	O
and	O
development	O
of	O
a	O
standardized	O
clinical	O
trial	O
protocol	O
.	O

Then	O
,	O
wild	O
-	O
type	O
and	O
RIP3	O
knock	O
-	O
out	O
mice	B-SPEC
were	O
induced	O
ARDS	O
with	O
30	O
mg	O
/	O
kg	O
LPS	O
.	O

A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
at	O
a	O
tertiary	O
care	O
hospital	O
,	O
and	O
assessed	O
inpatients	O
under	O
investigation	O
for	O
SARI	O
by	O
the	O
hospital	O
epidemiology	O
department	O
,	O
and	O
all	O
patients	O
who	O
had	O
nasopharyngeal	O
aspirates	O
collected	O
from	O
January	O
2012	O
to	O
December	O
2013	O
to	O
detect	O
respiratory	O
viruses	B-SPEC
(	O
RVs	O
).	O

TITLE	O
:	O
Extracorporeal	O
circuit	O
for	O
Panton	O
-	O
Valentine	O
leukocidin	O
-	O
producing	O
Staphylococcus	B-SPEC
aureus	I-SPEC
necrotizing	O
pneumonia	O
.	O

TITLE	O
:	O
Lactogenic	O
immunity	O
and	O
vaccines	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
):	O
Historical	O
and	O
current	O
concepts	O
.	O

In	O
this	O
study	O
,	O
consensus	O
primer	O
-	O
based	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reactions	O
(	O
RT	O
-	O
PCRs	O
)	O
and	O
high	O
-	O
throughput	O
sequencing	O
were	O
performed	O
to	O
investigate	O
viruses	B-SPEC
in	O
bat	B-SPEC
faecal	O
samples	O
collected	O
at	O
11	O
natural	O
bat	B-SPEC
habitat	O
sites	O
from	O
July	O
to	O
December	O
2015	O
in	O
Korea	O
.	O

Therefore	O
,	O
our	O
results	O
suggest	O
the	O
need	O
for	O
continuing	O
surveillance	O
and	O
additional	O
virological	O
studies	O
in	O
domestic	O
bat	B-SPEC
.	O

Senecavirus	B-SPEC
A	O
(	O
SV	O
-	O
A	O
)	O
formerly	O
known	O
as	O
Seneca	B-SPEC
Valley	I-SPEC
virus	I-SPEC
was	O
detected	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
)	O
from	O
serum	O
,	O
skin	O
and	O
faeces	O
of	O
piglets	O
and	O
from	O
serum	O
and	O
faeces	O
of	O
sows	O
.	O

ABSTRACT	O
:	O
The	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
pathways	O
,	O
which	O
are	O
central	O
building	O
blocks	O
in	O
the	O
intracellular	O
signaling	O
network	O
,	O
are	O
often	O
manipulated	O
by	O
viruses	B-SPEC
of	O
diverse	O
families	O
to	O
favor	O
their	O
replication	O
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
whether	O
activation	O
of	O
p38	O
MAPK	O
and	O
JNK	O
cascades	O
is	O
required	O
for	O
PEDV	B-SPEC
replication	O
.	O

The	O
greatest	O
seroconversion	O
rate	O
was	O
observed	O
in	O
horses	B-SPEC
with	O
clinical	O
signs	O
compatible	O
with	O
EqCoV	O
infection	O
and	O
EqCoV	O
qPCR	O
detection	O
in	O
feces	O
.	O

TITLE	O
:	O
Lack	O
of	O
transmission	O
among	O
healthcare	O
workers	O
in	O
contact	O
with	O
a	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
Thailand	O
.	O

ABSTRACT	O
:	O
A	O
hospital	O
-	O
associated	O
outbreak	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
reported	O
.	O

The	O
computationally	O
designed	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
validated	O
using	O
169	O
field	O
sera	O
,	O
whose	O
statuses	O
were	O
determined	O
by	O
a	O
PEDV	B-SPEC
-	O
specific	O
immunofluorescence	O
assay	O
.	O

Fifteen	O
newborn	O
piglets	O
were	O
divided	O
into	O
two	O
groups	O
of	O
7	O
-	O
8	O
piglets	O
each	O
and	O
inoculated	O
orally	O
with	O
one	O
of	O
PEDV	B-SPEC
isolates	O
maintained	O
at	O
the	O
eighth	O
passage	O
in	O
Vero	O
cell	O
culture	O
.	O

Although	O
all	O
PEDV	B-SPEC
-	O
inoculated	O
piglets	O
showed	O
acute	O
watery	O
diarrhoea	O
,	O
lethality	O
clearly	O
differed	O
between	O
both	O
PEDV	B-SPEC
-	O
inoculated	O
groups	O
.	O

Interactions	O
between	O
Mo	O
-	O
DCs	O
and	O
UV	O
-	O
PEDV	B-SPEC
significantly	O
stimulate	O
T	O
-	O
cell	O
proliferation	O
in	O
vitro	O
.	O

In	O
the	O
last	O
decade	O
,	O
interfering	O
with	O
microtubule	O
polymerization	O
,	O
a	O
potential	O
orientation	O
to	O
cause	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
has	O
become	O
a	O
promising	O
method	O
for	O
cancer	B-SPEC
therapy	O
.	O

Demographic	O
and	O
epidemiologic	O
data	O
were	O
obtained	O
from	O
enrolled	O
patients	O
after	O
which	O
nasopharyngeal	O
and	O
oropharyngeal	O
swabs	O
were	O
collected	O
,	O
and	O
processed	O
by	O
molecular	O
methods	O
for	O
the	O
presence	O
of	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Further	O
,	O
we	O
demonstrate	O
that	O
HTCC	O
polymers	O
with	O
different	O
degrees	O
of	O
substitution	O
act	O
as	O
effective	O
inhibitors	O
of	O
all	O
low	O
-	O
pathogenic	O
human	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
origin	O
and	O
animal	B-SPEC
reservoir	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
discovered	O
in	O
2012	O
and	O
is	O
responsible	O
for	O
acute	O
respiratory	O
syndrome	O
in	O
humans	B-SPEC
.	O

Our	O
previous	O
work	O
showed	O
that	O
in	O
addition	O
to	O
the	O
conserved	O
coronavirus	B-SPEC
double	O
membrane	O
vesicles	O
(	O
DMVs	O
),	O
Beau	O
-	O
R	O
,	O
an	O
apathogenic	O
strain	O
of	O
avian	B-SPEC
Gammacoronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
induces	O
regions	O
of	O
ER	O
that	O
are	O
zippered	O
together	O
and	O
tethered	O
open	O
-	O
necked	O
double	O
membrane	O
spherules	O
that	O
resemble	O
replication	O
organelles	O
induced	O
by	O
other	O
+	O
RNA	O
viruses	B-SPEC
.	O

However	O
,	O
coronavirus	B-SPEC
replicative	O
apparatus	O
clearly	O
has	O
the	O
plasticity	O
to	O
function	O
in	O
different	O
structural	O
contexts	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
is	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
of	O
poultry	O
caused	O
by	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

TITLE	O
:	O
Production	O
of	O
soluble	O
truncated	O
spike	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
from	O
inclusion	O
bodies	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
through	O
refolding	O
.	O

In	O
an	O
indirect	O
ELISA	O
,	O
purified	O
S25	O
-	O
229	O
showed	O
strong	O
reactivity	O
with	O
mouse	B-SPEC
anti	O
-	O
PEDV	B-SPEC
sera	O
.	O

ABSTRACT	O
:	O
MERS	O
coronavirus	B-SPEC
cases	O
notified	O
in	O
the	O
Middle	O
East	O
region	O
since	O
the	O
identification	O
of	O
the	O
virus	B-SPEC
in	O
2012	O
have	O
displayed	O
variations	O
in	O
time	O
and	O
across	O
geography	O
.	O

We	O
use	O
a	O
stochastic	O
modelling	O
of	O
the	O
time	O
series	O
of	O
case	O
incidence	O
in	O
the	O
Middle	O
East	O
region	O
to	O
estimate	O
time	O
-	O
and	O
space	O
-	O
dependent	O
zoonotic	O
and	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
parameters	O
.	O

TITLE	O
:	O
Immunization	O
with	O
inactivated	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
vaccine	O
leads	O
to	O
lung	O
immunopathology	O
on	O
challenge	O
with	O
live	O
virus	B-SPEC
.	O

This	O
study	O
was	O
performed	O
at	O
Mayo	B-SPEC
Clinic	O
,	O
Rochester	O
,	O
MN	O
,	O
in	O
years	O
2007	O
-	O
2009	O
.	O

MHV	B-SPEC
-	O
A59	O
provoked	O
a	O
comparable	O
mild	O
and	O
subclinical	O
hepatitis	O
in	O
WT	O
and	O
TLR2	O
KO	O
mice	B-SPEC
.	O

Intrahepatic	O
recruited	O
neutrophils	O
,	O
natural	O
killer	O
cells	O
,	O
natural	O
killer	O
T	O
cells	O
or	O
macrophages	O
rapidly	O
decreased	O
in	O
MHV3	O
-	O
infected	O
WT	O
mice	B-SPEC
whereas	O
they	O
were	O
sustained	O
in	O
MHV	B-SPEC
-	O
A59	O
-	O
infected	O
WT	O
mice	B-SPEC
and	O
MHV3	O
-	O
infected	O
TLR2	O
KO	O
.	O

40	O
one	O
-	O
day	O
-	O
old	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
were	O
divided	O
randomly	O
into	O
four	O
groups	O
.	O

Chickens	B-SPEC
in	O
each	O
group	O
were	O
monitored	O
for	O
14	O
days	O
post	O
-	O
infection	O
(	O
pi	O
).	O

Virus	B-SPEC
re	O
-	O
isolation	O
from	O
infected	O
organs	O
and	O
amplification	O
of	O
the	O
viral	O
RNA	O
by	O
real	O
-	O
time	O
PCR	O
proved	O
the	O
presence	O
of	O
the	O
virus	B-SPEC
in	O
lung	O
and	O
trachea	B-SPEC
of	O
infected	O
chicks	O
.	O

RESULTS	O
:	O
The	O
nucleoprotein	O
of	O
PDCoV	O
was	O
expressed	O
as	O
a	O
recombinant	O
protein	O
and	O
purified	O
for	O
use	O
as	O
an	O
antigen	O
to	O
immunize	O
mice	B-SPEC
for	O
polyclonal	O
,	O
hyperimmune	O
sera	O
and	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
production	O
.	O

ABSTRACT	O
:	O
Fecal	O
calprotectin	O
and	O
immunoglobulin	O
A	O
(	O
IgA	O
)	O
are	O
markers	O
of	O
intestinal	O
inflammation	O
and	O
immunity	O
in	O
adult	O
dogs	B-SPEC
.	O

Giardia	B-SPEC
intestinalis	I-SPEC
antigen	O
was	O
quantified	O
by	O
ELISA	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
encode	O
RNA	O
-	O
dependent	O
RNA	O
polymerases	O
(	O
RdRps	O
)	O
essential	O
for	O
genomic	O
replication	O
.	O

Fidelity	O
-	O
altering	O
mutations	O
previously	O
identified	O
in	O
coxsackie	O
virus	B-SPEC
B3	O
(	O
CVB3	O
)	O
were	O
mapped	O
onto	O
the	O
nsp12	O
-	O
RdRp	O
model	O
structure	O
and	O
then	O
engineered	O
into	O
the	O
MHV	B-SPEC
genome	O
with	O
[	O
nsp14	O
-	O
ExoN	O
(+)]	O
or	O
without	O
[	O
nsp14	O
-	O
ExoN	O
(-)]	O
ExoN	O
activity	O
.	O

By	O
doing	O
this	O
,	O
viruses	B-SPEC
limit	O
the	O
production	O
of	O
antiviral	O
proteins	O
and	O
increase	O
production	O
capacity	O
for	O
viral	O
proteins	O
.	O

Many	O
viruses	B-SPEC
inhibit	O
protein	O
synthesis	O
by	O
their	O
host	O
cell	O
to	O
enhance	O
virus	B-SPEC
replication	O
and	O
to	O
antagonize	O
antiviral	O
defense	O
mechanisms	O
.	O

Protection	O
was	O
dependent	O
on	O
interferon	O
-	O
	O
and	O
required	O
early	O
induction	O
of	O
robust	O
innate	O
and	O
virus	B-SPEC
-	O
specific	O
CD8	O
(+)	O
T	O
cell	O
responses	O
.	O

TITLE	O
:	O
Characterization	O
of	O
anti	O
-	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
neutralizing	O
activity	O
in	O
mammary	O
secretions	O
.	O

TITLE	O
:	O
Phylogenetic	O
and	O
antigenic	O
characterization	O
of	O
newly	O
isolated	O
porcine	B-SPEC
epidemic	O
diarrhea	O
viruses	B-SPEC
in	O
Japan	O
.	O

These	O
data	O
suggest	O
that	O
the	O
large	O
outbreak	O
of	O
PED	O
in	O
Japan	O
cannot	O
be	O
attributed	O
to	O
inefficient	O
vaccination	O
but	O
may	O
be	O
due	O
to	O
the	O
extremely	O
high	O
virulence	O
of	O
the	O
newly	O
appearing	O
viruses	B-SPEC
.	O

Prevention	O
of	O
virus	B-SPEC
spread	O
is	O
impeded	O
by	O
a	O
lack	O
of	O
basic	O
knowledge	O
concerning	O
viral	O
shedding	O
and	O
transmission	O
potential	O
in	O
individual	O
animals	B-SPEC
.	O

Fundamental	O
questions	O
about	O
circulating	O
viruses	B-SPEC
and	O
transmission	O
routes	O
remain	O
.	O

Among	O
87	O
cases	O
reported	O
during	O
February	O
2015	O
,	O
13	O
had	O
no	O
recognized	O
risks	O
for	O
secondary	O
acquisition	O
;	O
12	O
of	O
these	O
13	O
also	O
denied	O
camel	B-SPEC
contact	O
.	O

Our	O
identification	O
of	O
cases	O
without	O
recognized	O
risk	O
factors	O
but	O
with	O
similar	O
virus	B-SPEC
sequences	O
indicates	O
the	O
need	O
for	O
better	O
understanding	O
of	O
risk	O
factors	O
for	O
MERS	O
-	O
CoV	O
transmission	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
severe	O
sepsis	B-SPEC
remains	O
a	O
major	O
challenge	O
in	O
intensive	O
care	O
medicine	O
.	O

Lentiviral	O
packaged	O
Ace2	O
cDNA	O
or	O
Ace2	O
shRNA	O
was	O
intratracheally	O
administrated	O
into	O
the	O
lungs	O
of	O
male	O
SD	O
rats	B-SPEC
.	O

Therefore	O
,	O
many	O
different	O
antigenic	O
forms	O
,	O
serotypes	O
,	O
or	O
variant	O
strains	O
of	O
avian	B-SPEC
coronaviruses	O
(	O
AvCoV	O
)	O
exist	O
worldwide	O
.	O

ABSTRACT	O
:	O
On	O
the	O
basis	O
of	O
the	O
data	O
from	O
the	O
California	B-SPEC
Animal	B-SPEC
Health	O
and	O
Food	O
Safety	O
Laboratory	O
System	O
,	O
1444	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
cases	O
were	O
diagnosed	O
between	O
1997	O
and	O
2012	O
.	O

Epidemiologic	O
analyses	O
demonstrated	O
two	O
major	O
IB	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
outbreak	O
peaks	O
,	O
affecting	O
mainly	O
35	O
-	O
to	O
-	O
49	O
-	O
day	O
-	O
old	O
broiler	O
chickens	B-SPEC
.	O

In	O
IBV	B-SPEC
Cal	O
99	O
,	O
eight	O
different	O
subpopulations	O
were	O
detected	O
;	O
one	O
of	O
these	O
became	O
predominant	O
after	O
the	O
second	O
passage	O
.	O

Follow	O
-	O
up	O
samples	O
were	O
collected	O
from	O
children	O
who	O
tested	O
positive	O
for	O
one	O
or	O
more	O
respiratory	O
viruses	B-SPEC
.	O

At	O
least	O
one	O
respiratory	O
virus	B-SPEC
was	O
detected	O
in	O
samples	O
from	O
39	O
of	O
87	O
episodes	O
of	O
febrile	O
neutropenia	O
(	O
45	O
%),	O
with	O
rhinoviruses	B-SPEC
the	O
most	O
frequently	O
detected	O
.	O

The	O
same	O
virus	B-SPEC
was	O
detected	O
at	O
follow	O
-	O
up	O
in	O
one	O
coronavirus	B-SPEC
and	O
six	O
rhinovirus	B-SPEC
episodes	O
.	O

For	O
the	O
current	O
study	O
,	O
we	O
utilized	O
hNPCs	O
differentiated	O
from	O
a	O
human	B-SPEC
induced	O
pluripotent	O
cell	O
line	O
via	O
an	O
embryoid	O
body	O
intermediate	O
stage	O
(	O
EB	O
-	O
NPCs	O
).	O

TITLE	O
:	O
Single	O
-	O
dose	O
treatment	O
with	O
a	O
humanized	O
neutralizing	O
antibody	O
affords	O
full	O
protection	O
of	O
a	O
human	B-SPEC
transgenic	O
mouse	B-SPEC
model	O
from	O
lethal	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
coronavirus	B-SPEC
infection	O
.	O

The	O
relative	O
risk	O
of	O
sleep	O
-	O
related	O
APE	B-SPEC
increases	O
with	O
the	O
severity	O
of	O
OSA	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
January	O
2013	O
,	O
several	O
months	O
after	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
first	O
identified	O
in	O
Saudi	O
Arabia	O
,	O
Abu	O
Dhabi	O
,	O
United	O
Arab	O
Emirates	O
,	O
began	O
surveillance	O
for	O
MERS	O
-	O
CoV	O
.	O
We	O
analyzed	O
medical	O
chart	O
and	O
laboratory	O
data	O
collected	O
by	O
the	O
Health	O
Authority	O
-	O
Abu	O
Dhabi	O
during	O
January	O
2013	O
-	O
May	O
2014	O
.	O

The	O
virus	B-SPEC
replicates	O
extensively	O
and	O
almost	O
exclusively	O
in	O
the	O
epithelial	O
cells	O
of	O
the	O
small	O
intestine	O
resulting	O
in	O
villus	O
atrophy	O
,	O
malabsorption	O
and	O
severe	O
diarrhea	O
.	O

CV777	O
in	O
experimental	O
pigs	B-SPEC
caused	O
diarrheal	O
disease	O
and	O
mortality	O
rates	O
similar	O
to	O
those	O
later	O
encountered	O
in	O
Asia	O
and	O
more	O
recently	O
with	O
the	O
""""	O
original	O
""""	O
US	O
strains	O
even	O
though	O
genomic	O
typing	O
of	O
the	O
prototype	O
European	O
strain	O
have	O
shown	O
that	O
it	O
belongs	O
to	O
the	O
S	O
-	O
INDEL	O
strains	O
.	O

High	O
seroprevalences	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
and	O
the	O
high	O
virus	B-SPEC
prevalence	O
in	O
Saudi	O
Arabian	O
dromedary	B-SPEC
camels	B-SPEC
indicate	O
an	O
endemicity	O
of	O
the	O
virus	B-SPEC
in	O
the	O
Arabian	O
Peninsula	O
,	O
which	O
predates	O
the	O
2012	O
human	B-SPEC
MERS	O
index	O
case	O
.	O

This	O
supports	O
the	O
hypothesis	O
that	O
camel	B-SPEC
imports	O
from	O
Africa	O
are	O
not	O
of	O
significance	O
for	O
circulation	O
of	O
the	O
virus	B-SPEC
in	O
camel	B-SPEC
populations	O
of	O
the	O
Arabian	O
Peninsula	O
.	O

TITLE	O
:	O
From	O
SARS	O
to	O
Avian	B-SPEC
Influenza	O
:	O
The	O
Role	O
of	O
International	O
Factors	O
in	O
China	O
'	O
s	O
Approach	O
to	O
Infectious	O
Disease	O
Control	O
.	O

ABSTRACT	O
:	O
Dialysis	B-SPEC
disequilibrium	O
syndrome	O
(	O
DDS	O
)	O
is	O
a	O
neurological	O
disorder	O
with	O
varying	O
severity	O
that	O
is	O
postulated	O
to	O
be	O
associated	O
with	O
cerebral	O
oedema	O
.	O

Following	O
an	O
assessment	O
of	O
epidemiologic	O
risk	O
,	O
including	O
travel	O
to	O
countries	O
with	O
mosquitoes	B-SPEC
that	O
transmit	O
Zika	B-SPEC
virus	I-SPEC
,	O
patients	O
are	O
further	O
investigated	O
if	O
clinically	O
indicated	O
.	O

TITLE	O
:	O
A	O
Highly	O
Sensitive	O
Molecular	O
Detection	O
Platform	O
for	O
Robust	O
and	O
Facile	O
Diagnosis	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
Corona	B-SPEC
Virus	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
on	O
inanimate	O
surfaces	O
:	O
A	O
risk	O
for	O
health	O
care	O
transmission	O
.	O

Feed	O
samples	O
were	O
spiked	O
with	O
PEDV	B-SPEC
and	O
then	O
heated	O
to	O
120	O
-	O
145	O
	O
C	O
for	O
up	O
to	O
30	O
min	O
or	O
irradiated	O
at	O
0	O
-	O
50	O
kGy	O
.	O

On	O
the	O
view	O
of	O
the	O
interest	O
on	O
and	O
importance	O
of	O
CoVs	O
in	O
bats	B-SPEC
the	O
occurrence	O
and	O
molecular	O
characterization	O
of	O
CoV	O
were	O
conducted	O
in	O
bats	B-SPEC
from	O
Brazil	O
.	O

These	O
results	O
were	O
recapitulated	O
in	O
lean	O
mice	B-SPEC
with	O
experimentally	O
induced	O
hyperleptinemia	O
.	O

We	O
showed	O
that	O
this	O
peptide	O
ameliorates	O
collagen	O
-	O
induced	O
arthritis	O
in	O
DBA	O
/	O
1J	O
mice	B-SPEC
and	O
protects	O
against	O
bone	O
and	O
cartilage	O
damage	O
.	O

ABSTRACT	O
:	O
To	O
trace	O
the	O
possible	O
route	O
of	O
introduction	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
the	O
phylogenetic	O
relationships	O
of	O
PEDV	B-SPEC
strains	O
in	O
the	O
regions	O
of	O
epidemicity	O
in	O
the	O
Philippines	O
to	O
PEDV	B-SPEC
strains	O
that	O
are	O
endemic	O
in	O
other	O
countries	O
were	O
investigated	O
.	O

Search	O
terms	O
""""	O
MERS	O
""""	O
and	O
""""	O
Coronavirus	B-SPEC
""""	O
were	O
used	O
to	O
search	O
HealthMap	O
for	O
relevant	O
alerts	O
pertaining	O
to	O
MERS	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
Serratia	B-SPEC
marcescens	I-SPEC
changed	O
from	O
a	O
harmless	O
saprophytic	O
microorganism	O
to	O
an	O
important	O
opportunistic	O
human	B-SPEC
pathogen	O
.	O

We	O
present	O
a	O
case	O
of	O
a	O
community	O
-	O
acquired	O
Serratia	B-SPEC
marcescens	I-SPEC
bacteremia	O
leading	O
to	O
Respiratory	O
Distress	O
Syndrome	O
in	O
a	O
previously	O
healthy	O
51	O
-	O
year	O
-	O
old	O
man	B-SPEC
without	O
identifiable	O
risk	O
factors	O
.	O

This	O
study	O
warrants	O
further	O
investigations	O
into	O
molecular	O
epidemiology	O
and	O
genetic	O
evolution	O
of	O
the	O
PEDV	B-SPEC
in	O
Thailand	O
.	O

ABSTRACT	O
:	O
Objectives	O
The	O
goals	O
of	O
the	O
study	O
were	O
:	O
(	O
1	O
)	O
to	O
develop	O
and	O
evaluate	O
non	O
-	O
replicating	O
lentivirus	B-SPEC
vectors	O
coding	O
for	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)-	O
specific	O
micro	O
(	O
mi	O
)	O
RNA	O
as	O
a	O
potential	O
antiviral	O
therapy	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
);	O
(	O
2	O
)	O
to	O
assess	O
the	O
feasibility	O
of	O
transducing	O
hematopoietic	O
stem	O
cells	O
(	O
HSCs	O
)	O
with	O
ex	O
vivo	O
introduction	O
of	O
the	O
miRNA	O
-	O
expressing	O
lentivirus	B-SPEC
vector	O
;	O
and	O
(	O
3	O
)	O
to	O
assess	O
the	O
ability	O
of	O
the	O
expressed	O
miRNA	O
to	O
inhibit	O
FCoV	B-SPEC
replication	O
in	O
HSCs	O
in	O
vitro	O
.	O

Samples	O
from	O
camels	B-SPEC
and	O
humans	B-SPEC
underwent	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
quantitative	O
PCR	O
screening	O
to	O
detect	O
MERS	O
-	O
CoV	O
.	O
In	O
addition	O
,	O
sequencing	O
and	O
phylogenetic	O
analysis	O
of	O
partially	O
characterized	O
MERS	O
-	O
CoV	O
genome	O
fragments	O
obtained	O
from	O
camels	B-SPEC
were	O
performed	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
During	O
Pregnancy	O
:	O
A	O
Report	O
of	O
5	O
Cases	O
From	O
Saudi	O
Arabia	O
.	O

ABSTRACT	O
:	O
In	O
an	O
epidemiological	O
study	O
of	O
ferret	B-SPEC
coronaviruses	O
(	O
FRCoVs	O
),	O
novel	O
FRCoV	O
strains	O
(	O
Saitama	O
-	O
1	O
and	O
Aichi	O
-	O
1	O
)	O
were	O
detected	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
nucleotide	O
sequence	O
analysis	O
of	O
partial	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
genes	O
.	O

ABSTRACT	O
:	O
During	O
the	O
2015	O
outbreak	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
six	O
different	O
commercial	O
MERS	O
-	O
CoV	O
RNA	O
detection	O
kits	O
based	O
on	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
)	O
were	O
available	O
in	O
Korea	O
.	O

Extracted	O
RNAs	O
were	O
then	O
subjected	O
to	O
rRT	O
-	O
PCR	O
for	O
MERS	O
-	O
CoV	O
diagnosis	O
(	O
DiaPlex	O
Q	O
MERS	O
-	O
coronavirus	B-SPEC
,	O
SolGent	O
,	O
Korea	O
).	O

TITLE	O
:	O
Occurrence	O
of	O
canine	O
parvovirus	B-SPEC
in	O
dogs	B-SPEC
from	O
Henan	O
province	O
of	O
China	O
in	O
2009	O
-	O
2014	O
.	O

Factors	O
associated	O
with	O
morbidity	O
included	O
sampling	O
season	O
,	O
dog	B-SPEC
age	O
,	O
breed	O
,	O
vaccination	O
status	O
,	O
and	O
sex	O
.	O

We	O
showed	O
that	O
chloroquine	O
strongly	O
inhibited	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
replication	O
in	O
vitro	O
,	O
with	O
a	O
50	O
%	O
inhibitory	O
concentration	O
(	O
IC50	O
)	O
of	O
0	O
.	O
33	O
M	O
.	O
However	O
,	O
ribavirin	O
showed	O
inhibition	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
replication	O
only	O
at	O
high	O
concentrations	O
which	O
may	O
not	O
be	O
applicable	O
to	O
humans	B-SPEC
in	O
clinical	O
treatment	O
,	O
with	O
an	O
IC50	O
of	O
10	O
M	O
.	O
Furthermore	O
,	O
using	O
a	O
luciferase	O
-	O
based	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
screening	O
assay	O
,	O
we	O
identified	O
double	O
-	O
stranded	O
-	O
RNA	O
-	O
activated	O
protein	O
kinase	O
(	O
PKR	O
)	O
and	O
DEAD	O
box	O
RNA	O
helicases	O
(	O
DDX3X	O
)	O
that	O
exhibited	O
antiviral	O
activities	O
,	O
which	O
were	O
further	O
verified	O
by	O
the	O
use	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
-	O
WT	O
.	O

In	O
order	B-SPEC
to	O
prevent	O
ALI	O
/	O
ARDS	O
in	O
patients	O
with	O
sepsis	B-SPEC
,	O
countermeasures	O
for	O
NET	O
and	O
platelet	O
aggregation	O
should	O
be	O
pre	O
-	O
emptively	O
employed	O
and	O
confirmed	O
by	O
several	O
trials	O
.	O

Viruses	B-SPEC
have	O
evolved	O
the	O
capacity	O
to	O
overcome	O
the	O
protein	O
translation	O
shutoff	O
to	O
ensure	O
viral	O
protein	O
production	O
.	O

The	O
involvement	O
of	O
coronavirus	B-SPEC
-	O
induced	O
stress	O
responses	O
and	O
translational	O
control	O
in	O
viral	O
pathogenesis	O
will	O
also	O
be	O
briefly	O
discussed	O
.	O

During	O
virus	B-SPEC
infection	O
,	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
is	O
a	O
key	O
mediator	O
of	O
innate	O
antiviral	O
responses	O
.	O

Since	O
PEDV	B-SPEC
infection	O
-	O
induced	O
STAT1	O
degradation	O
was	O
evident	O
in	O
cells	O
pretreated	O
with	O
the	O
general	O
tyrosine	O
kinase	O
inhibitor	O
,	O
we	O
conclude	O
that	O
STAT1	O
degradation	O
is	O
independent	O
of	O
the	O
IFN	O
signaling	O
pathway	O
.	O

This	O
PEDV	B-SPEC
infection	O
-	O
induced	O
STAT1	O
degradation	O
contributes	O
to	O
PEDV	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
A	O
34	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
had	O
been	O
referred	O
to	O
our	O
hospital	O
was	O
diagnosed	O
with	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
).	O

We	O
present	O
a	O
case	O
of	O
fire	O
-	O
eater	O
'	O
s	O
pneumonia	O
in	O
a	O
28	O
-	O
year	O
-	O
old	O
white	O
man	B-SPEC
with	O
severe	O
pulmonary	O
complications	O
.	O

TITLE	O
:	O
Virus	B-SPEC
Infection	O
and	O
Titration	O
of	O
SARS	O
-	O
CoV	O
in	O
Mouse	B-SPEC
Lung	O
.	O

ABSTRACT	O
:	O
Two	O
critical	O
steps	O
when	O
investigating	O
an	O
animal	B-SPEC
model	O
of	O
a	O
virus	B-SPEC
infection	O
are	O
consistently	O
successfully	O
infecting	O
animals	B-SPEC
and	O
accurately	O
determining	O
viral	O
titers	O
in	O
tissue	O
throughout	O
the	O
course	O
of	O
infection	O
.	O

Here	O
we	O
discuss	O
in	O
detail	O
how	O
to	O
infect	O
mice	B-SPEC
with	O
SARS	O
-	O
CoV	O
and	O
then	O
quantify	O
the	O
titer	O
of	O
virus	B-SPEC
in	O
the	O
lung	O
.	O

In	O
2014	O
,	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
infection	O
spread	O
rapidly	O
in	O
the	O
USA	O
.	O

This	O
review	O
is	O
focused	O
in	O
the	O
host	O
cell	O
responses	O
to	O
enteric	O
porcine	B-SPEC
CoV	O
infection	O
and	O
the	O
viral	O
proteins	O
involved	O
in	O
pathogenesis	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
develop	O
and	O
validate	O
an	O
animal	B-SPEC
model	O
of	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
which	O
resembled	O
severe	O
ARDS	O
,	O
and	O
which	O
could	O
be	O
successfully	O
supported	O
with	O
ECMO	O
.	O

In	O
order	B-SPEC
to	O
respond	O
promptly	O
,	O
combinations	O
of	O
existing	O
IB	O
vaccines	O
are	O
frequently	O
tested	O
to	O
see	O
whether	O
they	O
can	O
provide	O
cross	O
-	O
protection	O
.	O

At	O
least	O
80	O
%	O
of	O
the	O
birds	B-SPEC
vaccinated	O
with	O
IB	O
H120	O
(	O
Mass	O
type	O
)	O
combined	O
with	O
IB	O
D274	O
(	O
Dutch	O
type	O
)	O
followed	O
by	O
a	O
QX	O
-	O
like	O
IB	O
vaccine	O
booster	O
or	O
vaccinated	O
with	O
a	O
combination	O
of	O
IB	O
H120	O
,	O
IB	O
D274	O
and	O
QX	O
-	O
like	O
IB	O
were	O
protected	O
against	O
a	O
challenge	O
with	O
IB	O
793B	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
respiratory	O
pathogen	O
with	O
a	O
high	O
mortality	O
rate	O
and	O
no	O
specific	O
treatments	O
available	O
to	O
date	O
.	O

Present	O
ongoing	O
epidemic	O
of	O
this	O
deadly	O
virus	B-SPEC
in	O
poultry	O
livestock	O
and	O
humans	B-SPEC
has	O
had	O
major	O
economic	O
and	O
health	O
repercussions	O
.	O

Diagnosis	O
is	O
mainly	O
clinical	O
,	O
aided	O
by	O
lab	O
features	O
like	O
lymphopaenia	O
and	O
non	O
-	O
specific	O
chest	O
X	O
-	O
ray	B-SPEC
findings	O
.	O

ABSTRACT	O
:	O
In	O
the	O
present	O
study	O
,	O
the	O
replication	O
kinetics	O
of	O
nephropathogenic	O
(	O
B1648	O
)	O
and	O
respiratory	O
(	O
Massachusetts	O
-	O
M41	O
)	O
IBV	B-SPEC
strains	O
were	O
compared	O
in	O
vitro	O
in	O
respiratory	O
mucosa	O
explants	O
and	O
blood	O
monocytes	O
(	O
KUL01	O
(+)	O
cells	O
),	O
and	O
in	O
vivo	O
in	O
chickens	B-SPEC
to	O
understand	O
why	O
some	O
IBV	B-SPEC
strains	O
have	O
a	O
kidney	O
tropism	O
.	O

Because	O
seroepidemiologic	O
studies	O
are	O
a	O
specific	O
type	O
of	O
observational	O
epidemiology	O
study	O
,	O
the	O
ROSES	B-SPEC
-	O
I	O
statement	O
is	O
built	O
upon	O
the	O
STROBE	O
guidelines	O
.	O

ABSTRACT	O
:	O
Idiopathic	O
pneumonia	O
syndrome	O
(	O
IPS	B-SPEC
)	O
is	O
an	O
acute	O
lung	O
dysfunction	O
of	O
non	O
-	O
infectious	O
aetiology	O
and	O
a	O
severe	O
complication	O
following	O
haematopoietic	O
stem	O
cell	O
transplantation	O
(	O
HSCT	O
).	O

TITLE	O
:	O
Standard	O
and	O
AEGIS	O
nicking	O
molecular	O
beacons	O
detect	O
amplicons	O
from	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Data	O
were	O
processed	O
with	O
Student	O
t	O
test	O
,	O
Wilcox	O
test	O
,	O
chi	O
-	O
square	O
test	O
and	O
or	O
Fisher	B-SPEC
'	O
s	O
exact	O
test	O
.	O

The	O
second	O
experiment	O
examined	O
the	O
specific	O
antibody	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
pullet	O
chicks	O
following	O
vaccination	O
against	O
IBV	B-SPEC
at	O
d	O
1	O
.	O

ABSTRACT	O
:	O
On	O
May	O
20th	O
2015	O
,	O
a	O
68	O
year	O
old	O
man	B-SPEC
was	O
the	O
first	O
to	O
be	O
diagnosed	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Corona	B-SPEC
Virus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Korea	O
.	O

Nevertheless	O
,	O
with	O
the	O
same	O
infecting	O
virus	B-SPEC
strain	O
,	O
Korea	O
experienced	O
the	O
largest	O
MERS	O
-	O
CoV	O
outbreak	O
outside	O
the	O
Arabian	O
Peninsula	O
,	O
primarily	O
due	O
to	O
the	O
different	O
characteristics	O
of	O
population	O
density	O
and	O
the	O
healthcare	O
system	O
.	O

Sepsis	B-SPEC
represents	O
a	O
serious	O
risk	O
factor	O
for	O
mortality	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

RESULTS	O
:	O
In	O
lung	O
tissue	O
interleukin	O
(	O
IL	O
)-	O
6	O
,	O
monocyte	O
chemo	O
attractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
)	O
and	O
granulocyte	O
-	O
colony	O
stimulating	O
factor	O
(	O
G	O
-	O
CSF	O
)	O
was	O
elevated	O
in	O
both	O
C5	O
-/-	O
mice	B-SPEC
and	O
wildtype	O
littermates	O
(	O
wt	O
),	O
whereas	O
caspase	O
-	O
3	O
was	O
reduced	O
in	O
lungs	O
after	O
DH	O
in	O
C5	O
-/-	O
mice	B-SPEC
.	O

We	O
suggest	O
that	O
noncanonical	O
autophagy	O
,	O
which	O
is	O
sensitive	O
to	O
treatment	O
with	O
brefeldin	O
A	O
,	O
may	O
converge	O
with	O
the	O
infectious	O
cycles	O
of	O
certain	O
DNA	O
and	O
RNA	O
viruses	B-SPEC
that	O
utilize	O
membrane	O
from	O
the	O
ER	O
and	O
cis	B-SPEC
-	O
Golgi	O
.	O

Here	O
,	O
we	O
report	O
that	O
the	O
macro	O
domain	O
from	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
HEV	B-SPEC
)	O
serves	O
as	O
an	O
ADP	O
-	O
ribose	O
-	O
protein	O
hydrolase	O
for	O
mono	O
-	O
ADP	O
-	O
ribose	O
(	O
MAR	O
)	O
and	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
(	O
PAR	O
)	O
chain	O
removal	O
(	O
de	O
-	O
MARylation	O
and	O
de	O
-	O
PARylation	O
,	O
respectively	O
)	O
from	O
mono	O
-	O
and	O
poly	O
(	O
ADP	O
)-	O
ribosylated	O
proteins	O
,	O
respectively	O
.	O

The	O
de	O
-	O
MARylation	O
activity	O
is	O
present	O
in	O
all	O
three	O
pathogenic	O
positive	O
-	O
sense	O
,	O
single	O
-	O
stranded	O
RNA	O
[(+)	O
ssRNA	O
]	O
virus	B-SPEC
families	O
which	O
carry	O
a	O
macro	O
domain	O
:	O
Coronaviridae	B-SPEC
(	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
),	O
Togaviridae	B-SPEC
(	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
),	O
and	O
Hepeviridae	B-SPEC
(	O
HEV	B-SPEC
),	O
indicating	O
that	O
it	O
might	O
be	O
a	O
significant	O
tropism	O
and	O
/	O
or	O
pathogenic	O
determinant	O
.	O

Human	B-SPEC
HeLa	O
cells	O
expressing	O
pAPN	O
and	O
pAPN	O
-	O
positive	O
porcine	B-SPEC
CPK	O
cells	O
failed	O
to	O
support	O
PEDV	B-SPEC
infection	O
,	O
but	O
were	O
susceptible	O
to	O
infection	O
by	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
which	O
utilizes	O
pAPN	O
as	O
a	O
functional	O
receptor	O
.	O

The	O
agency	O
used	O
established	O
systems	O
of	O
communication	O
and	O
partnerships	O
with	O
other	O
federal	O
agencies	O
to	O
quickly	O
provide	O
accurate	O
traveler	O
contact	O
information	O
to	O
states	O
and	O
jurisdictions	O
to	O
alert	O
contacts	O
of	O
potential	O
exposure	O
to	O
two	O
travelers	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
who	O
had	O
entered	O
the	O
United	O
States	O
on	O
commercial	O
flights	O
in	O
April	O
and	O
May	O
2014	O
.	O

ABSTRACT	O
:	O
The	O
highly	O
pathogenic	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
cause	O
significant	O
morbidity	O
and	O
morality	O
.	O

We	O
previously	O
screened	O
a	O
library	O
of	O
FDA	O
-	O
approved	O
drugs	O
for	O
inhibitors	O
of	O
coronavirus	B-SPEC
replication	O
in	O
which	O
we	O
identified	O
Abelson	O
(	O
Abl	O
)	O
kinase	O
inhibitors	O
,	O
including	O
the	O
anticancer	O
drug	O
imatinib	O
,	O
as	O
inhibitors	O
of	O
both	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
in	O
vitro	O
Here	O
we	O
show	O
that	O
the	O
anti	O
-	O
CoV	O
activity	O
of	O
imatinib	O
occurs	O
at	O
the	O
early	O
stages	O
of	O
infection	O
,	O
after	O
internalization	O
and	O
endosomal	O
trafficking	O
,	O
by	O
inhibiting	O
fusion	O
of	O
the	O
virions	O
at	O
the	O
endosomal	O
membrane	O
.	O

Both	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
are	O
zoonotic	O
infections	O
,	O
with	O
bats	B-SPEC
as	O
the	O
primary	O
source	O
.	O

In	O
this	O
study	O
,	O
the	O
molecular	O
cloning	O
,	O
expression	O
,	O
and	O
antiporcine	O
epidemic	O
diarrhea	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
activity	O
of	O
porcine	B-SPEC
IFN	O
-	O
3	O
(	O
poIFN	O
-	O
3	O
)	O
were	O
reported	O
.	O

Sequence	O
alignments	O
showed	O
that	O
poIFN	O
-	O
3	O
had	O
an	O
amino	O
acid	O
sequence	O
similarity	O
to	O
Ovis	B-SPEC
aries	I-SPEC
(	O
78	O
.	O
1	O
%),	O
Bos	B-SPEC
taurus	I-SPEC
(	O
76	O
.	O
0	O
%),	O
Tupaia	B-SPEC
belangeri	I-SPEC
(	O
71	O
.	O
3	O
%),	O
Equus	B-SPEC
caballus	I-SPEC
(	O
69	O
.	O
9	O
%),	O
and	O
Homo	B-SPEC
sapiens	I-SPEC
(	O
69	O
.	O
9	O
%).	O

In	O
this	O
report	O
,	O
we	O
identified	O
and	O
characterized	O
previously	O
unknown	O
and	O
diverse	O
genetic	O
clusters	O
of	O
bat	B-SPEC
coronaviruses	O
in	O
the	O
Atlantic	O
Forest	O
Biome	O
,	O
Brazil	O
.	O

Patients	O
with	O
rhinovirus	B-SPEC
had	O
lower	O
rates	O
(	O
20	O
%)	O
of	O
myalgia	O
(	O
p	O
=	O
0	O
.	O
043	O
).	O

Patients	O
with	O
influenza	B-SPEC
virus	I-SPEC
had	O
higher	O
rates	O
(	O
97	O
%)	O
of	O
elevated	O
CRP	O
(	O
p	O
=	O
0	O
.	O
016	O
).	O

Atypical	O
organisms	O
and	O
Bordetella	B-SPEC
pertussis	I-SPEC
were	O
negative	O
in	O
all	O
but	O
one	O
patient	O
.	O

MERS	O
cases	O
have	O
also	O
been	O
reported	O
in	O
the	O
later	O
phases	O
in	O
the	O
United	O
Kingdom	B-SPEC
,	O
France	O
,	O
Germany	O
,	O
Italy	O
,	O
Spain	O
,	O
and	O
Tunisia	O
.	O

The	O
high	O
mortality	O
rates	O
in	O
family	B-SPEC
-	O
based	O
and	O
hospital	O
-	O
based	O
outbreaks	O
were	O
reported	O
among	O
patients	O
with	O
comorbidities	O
such	O
as	O
diabetes	O
and	O
renal	O
failure	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
an	O
acute	O
and	O
highly	O
contagious	O
viral	O
respiratory	O
disease	O
of	O
chickens	B-SPEC
and	O
vaccination	O
is	O
the	O
main	O
method	O
for	O
disease	O
control	O
.	O

The	O
S1	O
protein	O
,	O
which	O
contains	O
several	O
virus	B-SPEC
neutralization	O
epitopes	O
,	O
is	O
considered	O
to	O
be	O
a	O
target	O
site	O
of	O
vaccine	O
development	O
.	O

TITLE	O
:	O
Therapeutic	O
potential	O
of	O
recombinant	O
thrombomodulin	O
for	O
lung	O
injury	O
after	O
pneumonectomy	O
via	O
inhibition	O
of	O
high	O
-	O
mobility	O
group	O
box	O
1	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
Sphingomyelin	O
synthase	O
2	O
affects	O
CD14	O
	O
associated	O
induction	O
of	O
NF	O
	O
B	O
by	O
lipopolysaccharides	O
in	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
the	O
predominant	O
component	O
of	O
the	O
outer	O
membrane	O
of	O
Gram	O
-	O
negative	O
bacteria	B-SPEC
,	O
which	O
can	O
cause	O
severe	O
inflammation	O
in	O
the	O
body	O
.	O

Our	O
phylogenetic	O
analysis	O
showed	O
that	O
10	O
of	O
the	O
55	O
South	O
China	O
PEDV	B-SPEC
strains	O
belonged	O
to	O
G1b	O
and	O
45	O
belonged	O
to	O
G2b	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
RNA	O
Helicases	O
of	O
ssRNA	O
(+)	O
Virus	B-SPEC
Belonging	O
to	O
Flaviviridae	B-SPEC
,	O
Coronaviridae	B-SPEC
and	O
Picornaviridae	B-SPEC
Families	O
.	O

The	O
constituents	O
of	O
garlic	B-SPEC
extract	O
were	O
detected	O
by	O
gas	O
chromatography	O
.	O

The	O
garlic	B-SPEC
extract	O
had	O
inhibitory	O
effects	O
on	O
IBV	B-SPEC
in	O
the	O
chickens	B-SPEC
embryo	O
.	O

Cryptosporidium	B-SPEC
oocysts	O
were	O
diagnosed	O
with	O
the	O
modified	O
Ziehl	O
-	O
Neelsen	O
staining	O
,	O
other	O
protozoa	O
with	O
the	O
SAFC	O
method	O
and	O
Eimeria	B-SPEC
oocysts	O
and	O
helminth	O
eggs	O
were	O
diagnosed	O
with	O
the	O
combined	O
sedimentation	O
/	O
floatation	O
test	O
.	O

Several	O
virus	B-SPEC
-	O
specific	O
features	O
will	O
be	O
described	O
,	O
but	O
also	O
some	O
general	O
conclusions	O
were	O
drawn	O
.	O

Without	O
exception	O
,	O
the	O
virus	B-SPEC
-	O
specific	O
nucleotide	O
bias	B-SPEC
was	O
enriched	O
in	O
the	O
unpaired	O
,	O
single	O
-	O
stranded	O
regions	O
of	O
the	O
RNA	O
genome	O
,	O
thus	O
creating	O
an	O
even	O
more	O
striking	O
virus	B-SPEC
-	O
specific	O
signature	O
.	O

In	O
general	O
,	O
the	O
nucleotide	O
bias	B-SPEC
was	O
the	O
major	O
determinant	O
of	O
the	O
virus	B-SPEC
-	O
specific	O
codon	O
usages	O
,	O
thus	O
limiting	O
a	O
role	O
for	O
codon	O
selection	O
and	O
translational	O
control	O
.	O

We	O
will	O
discuss	O
molecular	O
and	O
evolutionary	O
scenarios	O
that	O
may	O
be	O
responsible	O
for	O
the	O
diverse	O
nucleotide	O
biases	O
of	O
RNA	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Rational	O
design	O
of	O
a	O
synthetic	O
mammalian	B-SPEC
riboswitch	O
as	O
a	O
ligand	O
-	O
responsive	O
-	O
1	O
ribosomal	O
frame	O
-	O
shifting	O
stimulator	O
.	O

The	O
study	O
,	O
while	O
confirming	O
CPIV	O
as	O
the	O
main	O
responsible	O
for	O
CIRD	O
occurrence	O
,	O
highlights	O
the	O
increasing	O
role	O
of	O
recently	O
discovered	O
viruses	B-SPEC
,	O
such	O
as	O
CRCoV	O
and	O
CnPnV	O
,	O
for	O
which	O
effective	O
vaccines	O
are	O
not	O
available	O
in	O
the	O
market	O
.	O

TITLE	O
:	O
Wild	B-SPEC
boars	I-SPEC
harboring	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
may	O
play	O
an	O
important	O
role	O
as	O
a	O
PEDV	B-SPEC
reservoir	O
.	O

Two	O
hundred	O
eighty	O
seven	O
samples	O
from	O
wild	B-SPEC
boar	I-SPEC
(	O
Sus	B-SPEC
scrofa	I-SPEC
)	O
collected	O
in	O
South	O
Korea	O
during	O
2010	O
/	O
11	O
were	O
analyzed	O
using	O
RT	O
-	O
PCR	O
,	O
revealing	O
a	O
PEDV	B-SPEC
infection	O
rate	O
of	O
9	O
.	O
75	O
%	O
(	O
28	O
/	O
287	O
).	O

In	O
tests	O
of	O
MERS	O
-	O
CoV	O
-	O
infected	O
dromedaries	B-SPEC
,	O
we	O
found	O
viruses	B-SPEC
related	O
to	O
an	O
HCoV	O
,	O
known	O
as	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
in	O
5	O
.	O
6	O
%	O
of	O
1	O
,	O
033	O
animals	B-SPEC
.	O

Taken	O
together	O
,	O
our	O
results	O
strongly	O
indicate	O
that	O
FIPV	O
activates	O
ECs	O
to	O
increase	O
monocyte	O
adhesion	O
by	O
an	O
indirect	O
route	O
,	O
in	O
which	O
proinflammatory	O
factors	O
released	O
from	O
virus	B-SPEC
-	O
infected	O
monocytes	O
act	O
as	O
key	O
intermediates	O
.	O

TITLE	O
:	O
Status	O
of	O
vaccines	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
the	O
United	O
States	O
and	O
Canada	O
.	O

At	O
the	O
end	O
of	O
the	O
third	O
year	O
of	O
the	O
PEDV	B-SPEC
outbreak	O
,	O
most	O
US	O
sow	O
herds	O
have	O
been	O
infected	O
and	O
many	O
are	O
entering	O
into	O
an	O
endemic	O
disease	O
with	O
much	O
less	O
,	O
but	O
still	O
chronic	O
losses	O
.	O

Data	O
from	O
in	O
vitro	O
experiments	O
suggest	O
that	O
other	O
livestock	O
such	O
as	O
sheep	B-SPEC
,	O
goats	B-SPEC
,	O
and	O
horses	B-SPEC
might	O
also	O
contribute	O
to	O
viral	O
transmission	O
,	O
although	O
field	O
data	O
has	O
not	O
identified	O
any	O
seropositive	O
animals	B-SPEC
.	O

Minimal	O
or	O
no	O
virus	B-SPEC
shedding	O
was	O
detected	O
in	O
all	O
of	O
the	O
animals	B-SPEC
.	O

A	O
major	O
thrust	O
in	O
vaccine	O
research	O
focuses	O
on	O
developing	O
formulations	O
with	O
virus	B-SPEC
-	O
like	O
features	O
towards	O
enhancing	O
antigen	O
presentation	O
and	O
immune	O
processing	O
.	O

The	O
study	O
demonstrates	O
a	O
simple	O
yet	O
robust	O
method	O
in	O
bridging	O
viral	O
antigens	O
with	O
synthetic	O
nanoparticles	O
for	O
improved	O
vaccine	O
application	O
;	O
it	O
has	O
practical	O
implications	O
in	O
the	O
management	O
of	O
human	B-SPEC
viral	O
infections	O
as	O
well	O
as	O
in	O
animal	B-SPEC
agriculture	O
.	O

TITLE	O
:	O
Frequency	O
of	O
electrophoretic	O
changes	O
consistent	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
in	O
two	O
different	O
time	O
periods	O
(	O
2004	O
-	O
2009	O
vs	O
2013	O
-	O
2014	O
).	O

TITLE	O
:	O
From	O
Cells	O
to	O
Virus	B-SPEC
Particles	O
:	O
Quantitative	O
Methods	O
to	O
Monitor	O
RNA	O
Packaging	O
.	O

Since	O
RNA	O
packaging	O
impacts	O
on	O
several	O
essential	O
functions	O
of	O
retroviral	B-SPEC
replication	O
such	O
as	O
RNA	O
dimerization	O
,	O
translation	O
and	O
recombination	O
events	O
,	O
there	O
are	O
many	O
studies	O
that	O
require	O
the	O
determination	O
of	O
RNA	O
packaging	O
efficiency	O
and	O
/	O
or	O
RNA	O
packaging	O
ability	O
.	O

Studies	O
of	O
RNA	O
encapsidation	O
rely	O
upon	O
techniques	O
for	O
the	O
identification	O
and	O
quantification	O
of	O
RNA	O
species	B-SPEC
packaged	O
by	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
The	O
establishment	O
and	O
characteristics	O
of	O
cell	O
-	O
adapted	O
IBV	B-SPEC
strain	O
H120	O
.	O

This	O
study	O
may	O
have	O
important	O
implications	O
for	O
future	O
development	O
of	O
ORFV	O
-	O
vectored	O
vaccines	O
for	O
swine	B-SPEC
.	O

TITLE	O
:	O
Suppression	O
of	O
Virulent	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Proliferation	O
by	O
the	O
PI3K	O
/	O
Akt	O
/	O
GSK	O
-	O
3	O
/	O
	O
Pathway	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
recently	O
caused	O
high	O
mortality	O
in	O
suckling	O
piglets	O
with	O
subsequent	O
large	O
economic	O
losses	O
to	O
the	O
swine	B-SPEC
industry	O
.	O

TITLE	O
:	O
Discovery	O
of	O
a	O
Potent	O
Acyclic	O
,	O
Tripeptidic	O
,	O
Acyl	O
Sulfonamide	O
Inhibitor	O
of	O
Hepatitis	B-SPEC
C	I-SPEC
Virus	I-SPEC
NS3	O
Protease	O
as	O
a	O
Back	O
-	O
up	O
to	O
Asunaprevir	O
with	O
the	O
Potential	O
for	O
Once	O
-	O
Daily	O
Dosing	O
.	O

TITLE	O
:	O
Full	O
-	O
length	O
genome	O
sequencing	O
analysis	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
isolate	O
associated	O
with	O
nephropathogenic	O
infection	O
.	O

The	O
full	O
-	O
length	O
genome	O
sequence	O
of	O
the	O
isolate	O
was	O
27	O
,	O
714	O
nucleotides	O
long	O
,	O
and	O
the	O
genome	O
was	O
organized	O
similarly	O
to	O
classical	O
IBV	B-SPEC
strains	O
.	O

The	O
spike	O
glycoprotein	O
(	O
S	O
)	O
gene	O
had	O
the	O
greatest	O
similarity	O
to	O
the	O
nephropathogenic	O
BJ	O
strain	O
and	O
showed	O
an	O
8	O
amino	O
acid	O
insertion	O
(	O
YSNGNSDV	O
)	O
at	O
73	O
to	O
80	O
sites	O
and	O
3	O
amino	O
acid	O
deletion	O
at	O
sites	O
126	O
to	O
128	O
compared	O
to	O
the	O
IBV	B-SPEC
vaccine	O
strains	O
.	O

The	O
high	O
incidence	O
of	O
renal	O
failure	O
in	O
MERS	O
is	O
a	O
unique	O
clinical	O
feature	O
not	O
often	O
found	O
in	O
other	O
human	B-SPEC
coronavirus	I-SPEC
infections	O
(	O
3	O
,	O
4	O
).	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
:	O
Emergence	O
of	O
a	O
Pathogenic	O
Human	B-SPEC
Coronavirus	I-SPEC
.	O

I	O
further	O
discuss	O
the	O
evolution	O
of	O
these	O
two	O
critical	O
functions	O
of	O
coronavirus	B-SPEC
spike	O
proteins	O
,	O
receptor	O
recognition	O
and	O
membrane	O
fusion	O
,	O
in	O
the	O
context	O
of	O
the	O
corresponding	O
functions	O
from	O
other	O
viruses	B-SPEC
and	O
host	O
cells	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
demonstrate	O
the	O
pathogenicity	O
,	O
course	O
of	O
infection	O
,	O
virus	B-SPEC
kinetics	O
,	O
and	O
aerosol	O
transmission	O
of	O
PDCoV	O
using	O
87	O
conventional	O
piglets	O
and	O
their	O
9	O
dams	O
,	O
including	O
aerosol	O
and	O
contact	O
controls	O
to	O
emulate	O
field	O
conditions	O
.	O

ABSTRACT	O
:	O
Saudi	O
Arabia	O
was	O
affected	O
by	O
an	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Most	O
published	O
literature	O
on	O
therapeutics	O
for	O
MERS	O
are	O
in	O
vitro	O
experiments	O
,	O
animal	B-SPEC
studies	O
and	O
case	O
reports	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
viruses	B-SPEC
often	O
result	O
in	O
significant	O
morbidity	O
and	O
mortality	O
.	O

Seventeen	O
percent	O
of	O
the	O
coronavirus	B-SPEC
positive	O
samples	O
were	O
also	O
positive	O
for	O
other	O
respiratory	O
viruses	B-SPEC
,	O
such	O
as	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
(	O
RSV	B-SPEC
),	O
Parainfluenza	O
2	O
and	O
3	O
,	O
and	O
Rhinovirus	B-SPEC
.	O

These	O
droplets	O
or	O
droplet	O
nuclei	O
are	O
transported	O
by	O
expired	O
airflows	O
,	O
which	O
are	O
sometimes	O
affected	O
by	O
the	O
human	B-SPEC
body	O
plume	O
and	O
use	O
of	O
a	O
face	O
mask	O
,	O
as	O
well	O
as	O
room	O
airflow	O
.	O

(	O
5	O
)	O
The	O
differences	O
of	O
occurrence	O
rates	O
of	O
myocardial	O
damage	O
,	O
liver	O
injury	O
,	O
kidney	O
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
intracranial	O
hypertension	O
syndrome	O
,	O
stress	O
ulcer	O
,	O
coagulation	O
disorders	O
,	O
circulatory	O
dysfunction	O
,	O
severe	O
sepsis	B-SPEC
,	O
multiple	O
organ	O
dysfunction	O
(	O
MODS	O
)	O
among	O
the	O
three	O
groups	O
were	O
statistically	O
significant	O
(	O
	O
(	O
2	O
)=	O
8	O
.	O
826	O
,	O
17	O
.	O
864	O
,	O
49	O
.	O
061	O
,	O
96	O
.	O
221	O
,	O
106	O
.	O
918	O
,	O
80	O
.	O
559	O
,	O
30	O
.	O
355	O
,	O
99	O
.	O
183	O
,	O
196	O
.	O
412	O
,	O
133	O
.	O
887	O
,	O
154	O
.	O
239	O
,	O
9	O
.	O
206	O
,	O
P	O
all	O
<	O
0	O
.	O
01	O
).	O

IBV	B-SPEC
isolate	O
YN	O
is	O
a	O
virulent	O
strain	O
,	O
which	O
is	O
genetically	O
similar	O
to	O
most	O
of	O
the	O
prevalent	O
strains	O
in	O
China	O
.	O

TITLE	O
:	O
Risk	O
of	O
global	O
spread	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
via	O
the	O
air	O
transport	O
network	O
.	O

TITLE	O
:	O
Cross	O
-	O
sectional	O
survey	O
and	O
surveillance	O
for	O
influenza	B-SPEC
viruses	I-SPEC
and	O
MERS	O
-	O
CoV	O
among	O
Egyptian	O
pilgrims	O
returning	O
from	O
Hajj	O
during	O
2012	O
-	O
2015	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
estimate	O
influenza	B-SPEC
virus	I-SPEC
and	O
MERS	O
-	O
CoV	O
prevalence	O
among	O
Egyptian	O
pilgrims	O
returning	O
from	O
Hajj	O
.	O

The	O
Egyptian	O
variant	O
IBVs	O
also	O
contained	O
additional	O
N	O
-	O
glycosylation	O
sites	O
compared	O
to	O
the	O
classical	O
viruses	B-SPEC
.	O

T	O
cells	O
harvested	O
from	O
infected	O
mice	B-SPEC
were	O
used	O
to	O
examine	O
cytolytic	O
activity	O
,	O
cytokine	O
activity	O
,	O
and	O
expression	O
of	O
certain	O
chemokine	O
receptors	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
pathogen	O
,	O
first	O
recognized	O
in	O
2012	O
,	O
with	O
a	O
high	O
case	O
fatality	O
risk	O
,	O
no	O
vaccine	O
,	O
and	O
no	O
treatment	O
beyond	O
supportive	O
care	O
.	O

A	O
cross	O
-	O
sectional	O
study	O
using	O
a	O
self	O
-	O
reported	O
questionnaire	O
was	O
conducted	O
in	O
primary	O
care	O
settings	O
located	O
in	O
Riyadh	O
,	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
,	O
under	O
the	O
service	O
of	O
King	O
Abdulaziz	O
Medical	O
City	O
(	O
KAMC	O
).	O

AvCoV	O
-	O
IBV	B-SPEC
RNA	O
was	O
detected	O
in	O
41	O
(	O
83	O
.	O
6	O
%)	O
broiler	O
flocks	O
and	O
nine	O
(	O
64	O
.	O
2	O
%)	O
of	O
the	O
layer	O
flocks	O
by	O
TaqMan	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

In	O
addition	O
,	O
AvCoV	O
-	O
IBV	B-SPEC
RNA	O
was	O
detected	O
in	O
the	O
tracheas	O
27	O
/	O
30	O
(	O
90	O
%),	O
lungs	O
31	O
/	O
49	O
(	O
62	O
.	O
2	O
%),	O
caecal	O
tonsils	O
7	O
/	O
22	O
(	O
31	O
.	O
8	O
%),	O
and	O
kidneys	O
4	O
/	O
49	O
(	O
8	O
.	O
1	O
%)	O
of	O
broiler	O
flocks	O
examined	O
.	O

After	O
surveillance	O
carried	O
out	O
in	O
2009	O
and	O
2010	O
,	O
some	O
farmers	O
started	O
vaccinating	O
quail	O
with	O
the	O
Massachusetts	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
serotype	O
.	O

A	O
61	O
years	O
old	O
asplenic	O
man	B-SPEC
was	O
admitted	O
to	O
a	O
tertiary	O
referral	O
hospital	O
in	O
Sabah	O
,	O
Malaysia	O
,	O
with	O
severe	O
knowlesi	O
malaria	O
characterized	O
by	O
hyperparasitaemia	O
(	O
7	O
.	O
9	O
%),	O
jaundice	O
,	O
respiratory	O
distress	O
,	O
metabolic	O
acidosis	O
,	O
and	O
acute	O
kidney	O
injury	O
.	O

1	O
.	O
6	O
kb	O
),	O
generated	O
by	O
an	O
RT	O
-	O
PCR	O
specific	O
for	O
the	O
PEDV	B-SPEC
S	O
-	O
gene	O
,	O
indicated	O
a	O
very	O
close	O
similarity	O
(	O
ca	O
.	O

These	O
viruses	B-SPEC
(	O
with	O
an	O
RNA	O
genome	O
of	O
ca	O
.	O

Two	O
inoculated	O
pigs	B-SPEC
tested	O
at	O
PID	O
23	O
-	O
24	O
had	O
small	O
to	O
moderate	O
numbers	O
of	O
PDCoV	O
antigen	O
-	O
positive	O
cells	O
in	O
the	O
intestinal	O
lamina	O
propria	O
and	O
mesenteric	O
lymph	O
nodes	O
,	O
but	O
not	O
in	O
enterocytes	O
.	O

A	O
56	O
-	O
year	O
-	O
old	O
Japanese	O
woman	O
who	O
presented	O
with	O
severe	O
pneumonia	O
secondary	O
to	O
scleroderma	B-SPEC
was	O
treated	O
under	O
ventilator	O
support	O
because	O
of	O
acute	O
respiratory	O
failure	O
.	O

To	O
determine	O
the	O
prevalence	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
infection	O
among	O
patients	O
with	O
influenza	O
-	O
like	O
illness	O
,	O
5833	O
clinical	O
samples	O
from	O
nasopharyngeal	O
swabs	O
and	O
aspirates	O
collected	O
between	O
January	O
2012	O
and	O
December	O
2013	O
were	O
examined	O
.	O

Phylogenetic	O
trees	O
based	O
on	O
the	O
alignment	O
of	O
the	O
spike	O
(	O
S	O
)	O
gene	O
sequences	O
suggest	O
an	O
emergence	O
of	O
a	O
new	O
clade	O
for	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

Among	O
them	O
,	O
spiro	O
-	O
pyrazolopyridone	O
oxindoles	O
have	O
been	O
recently	O
reported	O
as	O
potent	O
inhibitors	O
of	O
dengue	B-SPEC
virus	I-SPEC
NS4B	O
,	O
leading	O
to	O
the	O
discovery	O
of	O
an	O
orally	O
bioavailable	O
preclinical	O
candidate	O
(	O
R	O
)-	O
44	O
with	O
excellent	O
in	O
vivo	O
efficacy	O
in	O
a	O
dengue	O
viremia	O
mouse	B-SPEC
model	O
.	O

ABSTRACT	O
:	O
Canine	O
infectious	O
respiratory	O
disease	O
complex	O
(	O
CIRDC	O
)	O
viruses	B-SPEC
have	O
been	O
detected	O
in	O
dogs	B-SPEC
with	O
respiratory	O
illness	O
.	O

Compared	O
to	O
the	O
three	O
-	O
antigen	O
test	O
kit	O
,	O
the	O
multiplex	O
PCR	O
assays	O
yielded	O
100	O
%	O
sensitivity	O
and	O
more	O
than	O
83	O
%	O
specificity	O
for	O
detection	O
of	O
CAdV	O
-	O
2	O
and	O
CDV	B-SPEC
,	O
but	O
not	O
for	O
CIV	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
is	O
a	O
devastating	O
swine	B-SPEC
enteric	O
disease	O
,	O
which	O
is	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
.	O

We	O
also	O
screened	O
by	O
PCR	O
urine	O
samples	O
,	O
faecal	O
samples	O
and	O
rectal	O
swabs	O
collected	O
from	O
six	O
species	B-SPEC
of	O
bats	B-SPEC
in	O
Singapore	O
between	O
2011	O
and	O
2014	O
,	O
all	O
of	O
which	O
were	O
negative	O
.	O

They	O
overlap	O
geographically	O
,	O
often	O
share	O
roosting	O
sites	O
and	O
have	O
been	O
witnessed	O
to	O
forage	O
on	O
the	O
same	O
plant	B-SPEC
.	O

Currently	O
,	O
few	O
bat	B-SPEC
cell	O
lines	O
have	O
been	O
developed	O
and	O
only	O
Tb1	O
-	O
Lu	O
,	O
derived	O
from	O
Tadarida	B-SPEC
brasiliensis	I-SPEC
is	O
commercially	O
available	O
.	O

In	O
order	B-SPEC
to	O
build	O
our	O
prediction	O
models	O
,	O
we	O
split	O
the	O
dataset	O
into	O
two	O
groups	O
.	O

ABSTRACT	O
:	O
To	O
clarify	O
the	O
possible	O
association	O
between	O
the	O
Zika	B-SPEC
virus	I-SPEC
(	O
ZIKV	O
)	O
and	O
microcephaly	O
and	O
understand	O
where	O
we	O
are	O
in	O
terms	O
of	O
research	O
and	O
the	O
debate	O
on	O
the	O
causation	O
between	O
mild	O
maternal	O
clinical	O
features	O
and	O
severe	O
fetal	O
microcephaly	O
.	O

We	O
detected	O
respiratory	O
viruses	B-SPEC
in	O
169	O
/	O
222	O
(	O
76	O
.	O
1	O
%)	O
samples	O
,	O
mostly	O
rhinovirus	B-SPEC
(	O
23	O
.	O
4	O
%),	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
21	O
.	O
2	O
%),	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
12	O
.	O
6	O
%),	O
coronavirus	B-SPEC
(	O
4	O
.	O
9	O
%)	O
and	O
Human	B-SPEC
metapneumovirus	I-SPEC
(	O
3	O
.	O
6	O
%).	O

TITLE	O
:	O
Identification	O
and	O
subcellular	O
localization	O
of	O
porcine	B-SPEC
deltacoronavirus	O
accessory	O
protein	O
NS6	O
.	O

Accessory	O
proteins	O
are	O
genus	B-SPEC
-	O
specific	O
for	O
coronavirus	B-SPEC
,	O
and	O
two	O
putative	O
accessory	O
proteins	O
,	O
NS6	O
and	O
NS7	O
,	O
are	O
predicted	O
to	O
be	O
encoded	O
by	O
PDCoV	O
;	O
however	O
,	O
this	O
remains	O
to	O
be	O
confirmed	O
experimentally	O
.	O

While	O
many	O
viruses	B-SPEC
are	O
known	O
to	O
employ	O
anti	O
-	O
immune	O
strategies	O
to	O
facilitate	O
their	O
replication	O
,	O
highly	O
pathogenic	O
virus	B-SPEC
infections	O
can	O
also	O
cause	O
an	O
excessive	O
immune	O
response	O
that	O
exacerbates	O
,	O
rather	O
than	O
reduces	O
pathogenicity	O
.	O

Though	O
we	O
have	O
reported	O
the	O
utility	O
of	O
this	O
approach	O
in	O
bacterial	O
and	O
cell	O
culture	O
studies	O
previously	O
,	O
this	O
is	O
the	O
first	O
comprehensive	O
study	O
to	O
confirm	O
that	O
network	O
topology	O
can	O
be	O
used	O
to	O
predict	O
phenotypes	O
in	O
mice	B-SPEC
with	O
experimental	O
validation	O
.	O

TITLE	O
:	O
Fatality	O
risks	O
for	O
nosocomial	O
outbreaks	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
the	O
Middle	O
East	O
and	O
South	O
Korea	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
poly	O
-	O
epitope	O
-	O
based	O
vaccine	O
protects	O
chickens	B-SPEC
from	O
acute	O
infection	O
.	O

Except	O
for	O
influenza	O
,	O
respiratory	O
virus	B-SPEC
prevalence	O
declined	O
with	O
age	O
.	O

While	O
the	O
IBV	B-SPEC
QX	O
population	O
dynamics	O
remained	O
constant	O
in	O
Spain	O
,	O
a	O
much	O
more	O
complex	O
pattern	O
was	O
evidenced	O
in	O
Italy	O
;	O
both	O
in	O
terms	O
of	O
viral	O
population	O
size	O
and	O
clinical	O
outbreak	O
frequency	O
.	O

Thus	O
,	O
a	O
robust	O
confirmation	O
about	O
the	O
efficacy	O
of	O
IBV	B-SPEC
vaccination	O
in	O
field	O
conditions	O
was	O
provided	O
.	O

ABSTRACT	O
:	O
A	O
case	O
control	O
study	O
to	O
better	O
characterize	O
the	O
clinical	O
features	O
,	O
laboratory	O
,	O
and	O
radiological	O
abnormalities	O
associated	O
with	O
MERS	O
-	O
CoV	O
infection	O
in	O
order	B-SPEC
to	O
help	O
with	O
early	O
identification	O
of	O
this	O
syndrome	O
from	O
other	O
respiratory	O
infections	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
has	O
generated	O
enormous	O
interest	O
in	O
the	O
biodiversity	O
,	O
genomics	O
and	O
cross	O
-	O
species	B-SPEC
transmission	O
potential	O
of	O
coronaviruses	O
,	O
especially	O
those	O
from	O
bats	B-SPEC
,	O
the	O
second	O
most	O
speciose	O
order	B-SPEC
of	O
mammals	B-SPEC
.	O

Herein	O
,	O
we	O
identified	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
provisionally	O
designated	O
Rousettus	B-SPEC
bat	B-SPEC
coronavirus	B-SPEC
GCCDC1	O
(	O
Ro	O
-	O
BatCoV	O
GCCDC1	O
),	O
in	O
the	O
rectal	O
swab	O
samples	O
of	O
Rousettus	B-SPEC
leschenaulti	I-SPEC
bats	B-SPEC
by	O
using	O
pan	B-SPEC
-	O
coronavirus	B-SPEC
RT	O
-	O
PCR	O
and	O
next	O
-	O
generation	O
sequencing	O
.	O

ABSTRACT	O
:	O
Various	O
animal	B-SPEC
models	O
of	O
lung	O
injury	O
exist	O
to	O
study	O
the	O
complex	O
pathomechanisms	O
of	O
human	B-SPEC
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
evaluate	O
future	O
therapies	O
.	O

Severe	O
lung	O
injury	O
with	O
a	O
reproducible	O
deterioration	O
of	O
pulmonary	O
gas	O
exchange	O
and	O
hemodynamics	O
can	O
be	O
induced	O
in	O
anesthetized	O
pigs	B-SPEC
using	O
repeated	O
lung	O
lavages	O
with	O
warmed	O
0	O
.	O
9	O
%	O
saline	O
(	O
50	O
ml	O
/	O
kg	O
body	O
weight	O
).	O

RNA	O
was	O
extracted	O
and	O
tested	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
for	O
the	O
presence	O
of	O
rotavirus	B-SPEC
,	O
norovirus	B-SPEC
,	O
astrovirus	O
,	O
torovirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
Two	O
Monoclonal	O
Antibodies	O
That	O
Recognize	O
Linker	O
Region	O
and	O
Carboxyl	O
Terminal	O
Domain	O
of	O
Coronavirus	B-SPEC
Nucleocapsid	O
Protein	O
.	O

Symptom	O
data	O
on	O
158	O
healthcare	O
workers	O
(	O
HCWs	O
)	O
with	O
a	O
laboratory	O
-	O
confirmed	O
respiratory	O
virus	B-SPEC
infection	O
were	O
collected	O
using	O
standardized	O
data	O
collection	O
forms	O
from	O
three	O
separate	O
studies	O
.	O

Mice	B-SPEC
that	O
received	O
injections	O
of	O
the	O
neutrophil	O
-	O
depleting	O
Ly6G	O
antibody	O
had	O
impaired	O
AT2	O
proliferation	O
24	O
and	O
72	O
h	O
after	O
acid	O
instillation	O
,	O
which	O
was	O
associated	O
with	O
decreased	O
reepithelialization	O
and	O
increased	O
alveolar	O
protein	O
concentration	O
72	O
h	O
after	O
injury	O
.	O

TITLE	O
:	O
Putative	O
Receptor	O
Binding	O
Domain	O
of	O
Bat	B-SPEC
-	O
Derived	O
Coronavirus	B-SPEC
HKU9	O
Spike	O
Protein	O
:	O
Evolution	O
of	O
Betacoronavirus	B-SPEC
Receptor	O
Binding	O
Motifs	O
.	O

ABSTRACT	O
:	O
The	O
majority	O
of	O
children	O
with	O
febrile	O
seizures	O
have	O
viral	O
infections	O
and	O
viruses	B-SPEC
were	O
detected	O
in	O
22	O
%	O
to	O
63	O
%	O
of	O
children	O
in	O
published	O
studies	O
.	O

Using	O
molecular	O
methods	O
,	O
viruses	B-SPEC
were	O
also	O
detected	O
in	O
asymptomatic	O
persons	O
.	O

ABSTRACT	O
:	O
We	O
determined	O
tissue	O
localization	O
,	O
shedding	O
patterns	O
,	O
virus	B-SPEC
carriage	O
,	O
antibody	O
response	O
,	O
and	O
aerosol	O
transmission	O
of	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
following	O
inoculation	O
of	O
4	O
-	O
week	O
-	O
old	O
feeder	O
pigs	B-SPEC
.	O

Although	O
disease	O
was	O
relatively	O
mild	O
and	O
transient	O
in	O
this	O
age	O
group	O
,	O
the	O
results	O
demonstrate	O
that	O
4	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
are	O
productively	O
infected	O
and	O
can	O
sustain	O
virus	B-SPEC
replication	O
for	O
several	O
weeks	O
.	O

Long	O
-	O
term	O
shedding	O
of	O
PEDV	B-SPEC
in	O
subclinically	O
affected	O
pigs	B-SPEC
should	O
be	O
considered	O
an	O
important	O
source	O
for	O
PEDV	B-SPEC
transmission	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
determine	O
knowledge	O
,	O
attitude	O
and	O
practice	O
of	O
airborne	O
and	O
droplet	O
isolation	O
precautions	O
among	O
Dental	O
Health	O
Professionals	O
(	O
DHPs	O
)	O
(	O
dental	O
students	O
,	O
interns	O
,	O
practitioners	O
and	O
auxiliaries	O
)	O
during	O
the	O
outbreak	O
of	O
MERS	O
(	O
Middle	O
East	O
Respiratory	O
Syndrome	O
),	O
corona	B-SPEC
virus	B-SPEC
infection	O
in	O
Riyadh	O
city	O
,	O
Saudi	O
Arabia	O
.	O

Younger	O
age	O
,	O
history	O
of	O
prematurity	O
,	O
chronic	O
comorbidity	O
and	O
thrombocytosis	O
are	O
predictors	O
of	O
severe	O
RSV	B-SPEC
ALRI	O
among	O
Malaysian	O
children	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
particles	O
serve	O
three	O
fundamentally	O
important	O
functions	O
in	O
infection	O
.	O

Genome	O
replication	O
and	O
transcription	O
is	O
mediated	O
by	O
a	O
multisubunit	O
protein	O
complex	O
comprised	O
of	O
more	O
than	O
a	O
dozen	O
virus	B-SPEC
-	O
encoded	O
proteins	O
.	O

Also	O
,	O
there	O
is	O
increasing	O
evidence	O
to	O
suggest	O
that	O
individual	O
cis	B-SPEC
-	O
acting	O
elements	O
may	O
be	O
part	O
of	O
higher	O
-	O
order	B-SPEC
RNA	O
structures	O
involving	O
long	O
-	O
range	O
and	O
dynamic	O
RNA	O
-	O
RNA	O
interactions	O
between	O
RNA	O
structural	O
elements	O
separated	O
by	O
thousands	O
of	O
nucleotides	O
in	O
the	O
viral	O
genome	O
.	O

TITLE	O
:	O
Viral	O
and	O
Cellular	O
mRNA	O
Translation	O
in	O
Coronavirus	B-SPEC
-	O
Infected	O
Cells	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
belongs	O
to	O
the	O
few	O
animal	B-SPEC
virus	B-SPEC
diseases	O
in	O
which	O
,	O
in	O
the	O
course	O
of	O
a	O
generally	O
harmless	O
persistent	O
infection	O
,	O
a	O
virus	B-SPEC
acquires	O
a	O
small	O
number	O
of	O
mutations	O
that	O
fundamentally	O
change	O
its	O
pathogenicity	O
,	O
invariably	O
resulting	O
in	O
a	O
fatal	O
outcome	O
.	O

Here	O
,	O
we	O
review	O
the	O
recent	O
progress	O
in	O
our	O
understanding	O
of	O
the	O
strategies	O
that	O
highly	O
pathogenic	O
coronaviruses	O
employ	O
to	O
escape	O
,	O
dampen	O
,	O
or	O
block	O
the	O
antiviral	O
interferon	O
response	O
in	O
human	B-SPEC
cells	O
.	O

There	O
are	O
many	O
types	O
of	O
vaccines	O
including	O
subunit	O
vaccines	O
,	O
whole	O
-	O
inactivated	O
virus	B-SPEC
,	O
vectored	O
,	O
and	O
live	O
-	O
attenuated	O
virus	B-SPEC
vaccines	O
,	O
each	O
of	O
which	O
featuring	O
specific	O
advantages	O
and	O
limitations	O
.	O

This	O
is	O
particularly	O
illustrated	O
over	O
the	O
last	O
15	O
years	O
by	O
the	O
emergence	O
of	O
two	O
zoonotic	O
CoVs	O
,	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
CoV	O
.	O
Due	O
to	O
their	O
inherent	O
genetic	O
variability	O
,	O
it	O
is	O
inevitable	O
that	O
new	O
cross	O
-	O
species	B-SPEC
transmission	O
events	O
of	O
these	O
enveloped	O
,	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
will	O
occur	O
.	O

Different	O
concepts	O
underlie	O
these	O
tropism	O
changes	O
at	O
the	O
cellular	O
,	O
tissue	O
,	O
and	O
host	O
species	B-SPEC
level	O
,	O
including	O
the	O
promiscuity	O
or	O
adaptability	O
of	O
S	O
proteins	O
to	O
orthologous	O
receptors	O
,	O
alterations	O
in	O
the	O
proteolytic	O
cleavage	O
activation	O
as	O
well	O
as	O
changes	O
in	O
the	O
S	O
protein	O
metastability	O
.	O

ABSTRACT	O
:	O
A	O
literature	O
review	O
of	O
publically	O
available	O
information	O
was	O
undertaken	O
to	O
summarize	O
current	O
understanding	O
and	O
gaps	O
in	O
knowledge	O
about	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
including	O
its	O
origin	O
,	O
transmission	O
,	O
effective	O
control	O
measures	O
and	O
management	O
.	O

Ctsl	O
-/-	O
mice	B-SPEC
infected	O
with	O
influenza	O
A	O
/	O
Puerto	O
Rico	O
/	O
8	O
/	O
34	O
(	O
H1N1	O
)	O
had	O
larger	O
lung	O
viral	O
loads	O
and	O
higher	O
mortality	O
than	O
infected	O
Ctsl	O
+/+	O
mice	B-SPEC
.	O

Most	O
deaths	O
occurred	O
during	O
the	O
second	O
week	O
of	O
infection	O
in	O
both	O
groups	O
of	O
mice	B-SPEC
.	O

The	O
histopathology	O
of	O
lung	O
inflammation	O
and	O
remodeling	O
in	O
survivors	O
was	O
similar	O
in	O
Ctsl	O
-/-	O
and	O
Ctsl	O
+/+	O
mice	B-SPEC
,	O
although	O
Ctsl	O
+/+	O
mice	B-SPEC
cleared	O
immunoreactive	O
virus	B-SPEC
sooner	O
.	O

Furthermore	O
,	O
Ctsl	O
-/-	O
mice	B-SPEC
had	O
profound	O
deficits	O
in	O
CD4	O
+	O
lymphocytes	O
before	O
and	O
after	O
infection	O
and	O
weaker	O
production	O
of	O
pathogen	O
-	O
specific	O
IgG	O
.	O
Thus	O
,	O
CTSL	O
appears	O
to	O
support	O
innate	O
as	O
well	O
as	O
adaptive	O
responses	O
,	O
which	O
confer	O
a	O
survival	O
advantage	O
on	O
mice	B-SPEC
infected	O
with	O
the	O
orthomyxovirus	B-SPEC
influenza	O
A	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
are	O
considered	O
widespread	O
among	O
cattle	B-SPEC
in	O
Norway	O
and	O
worldwide	O
.	O

Seropositivity	O
for	O
one	O
virus	B-SPEC
was	O
associated	O
with	O
increased	O
odds	O
of	O
seropositivity	O
for	O
the	O
other	O
virus	B-SPEC
.	O

Non	O
-	O
acutely	O
ill	O
children	O
undergoing	O
tonsillectomy	O
and	O
adenoidectomy	O
(	O
T	O
&	O
A	O
)	O
for	O
various	O
reasons	O
were	O
enrolled	O
prospectively	O
in	O
a	O
study	O
to	O
determine	O
the	O
frequency	O
of	O
asymptomatic	O
respiratory	O
viral	O
infections	O
in	O
each	O
lymphoid	O
tissue	O
and	O
to	O
relate	O
the	O
number	O
and	O
types	O
of	O
virus	B-SPEC
to	O
the	O
degree	O
of	O
airway	O
obstruction	O
.	O

Adenovirus	B-SPEC
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
at	O
71	O
.	O
1	O
%.	O

RESULTS	O
:	O
Viruses	B-SPEC
were	O
detected	O
in	O
70	O
.	O
9	O
%	O
of	O
tonsils	O
and	O
94	O
.	O
7	O
%	O
of	O
adenoids	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
currently	O
devastating	O
the	O
United	O
States	O
pork	O
industry	O
by	O
causing	O
an	O
80	O
-	O
100	O
%	O
fatality	O
rate	O
in	O
infected	O
piglets	O
.	O

Coronavirus	B-SPEC
spike	O
proteins	O
mediate	O
virus	B-SPEC
entry	O
into	O
cells	O
,	O
a	O
process	O
that	O
requires	O
the	O
spike	O
proteins	O
to	O
be	O
proteolytically	O
activated	O
.	O

We	O
found	O
that	O
the	O
PEDV	B-SPEC
spike	O
is	O
activated	O
by	O
lysosomal	O
cysteine	O
proteases	O
but	O
not	O
proprotein	O
convertases	O
or	O
cell	O
surface	O
serine	O
proteases	O
.	O

TITLE	O
:	O
Clinical	O
Isolates	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
229E	I-SPEC
Bypass	O
the	O
Endosome	O
for	O
Cell	O
Entry	O
.	O

In	O
this	O
scenario	O
,	O
one	O
of	O
the	O
most	O
interesting	O
aspects	O
is	O
that	O
probiotics	O
and	O
gut	O
microbiota	B-SPEC
modulation	O
could	O
deeply	O
improve	O
the	O
prevention	O
and	O
treatment	O
of	O
this	O
devastating	O
GI	O
pathology	O
.	O

Nidoviruses	B-SPEC
were	O
detected	O
in	O
27	O
.	O
4	O
%	O
of	O
the	O
pythons	B-SPEC
and	O
2	O
.	O
4	O
%	O
of	O
the	O
boas	B-SPEC
tested	O
.	O

These	O
viruses	B-SPEC
appear	O
to	O
be	O
relatively	O
common	O
among	O
snakes	B-SPEC
in	O
captivity	O
in	O
Europe	O
and	O
screening	O
for	O
these	O
viruses	B-SPEC
should	O
be	O
considered	O
in	O
the	O
clinical	O
work	O
-	O
up	O
.	O

The	O
objective	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
hydrocortisone	O
treatment	O
in	O
sepsis	B-SPEC
-	O
associated	O
ARDS	O
.	O

In	O
sepsis	B-SPEC
-	O
associated	O
ARDS	O
,	O
hydrocortisone	O
treatment	O
was	O
associated	O
with	O
a	O
significant	O
improvement	O
in	O
pulmonary	O
physiology	O
,	O
but	O
without	O
a	O
significant	O
survival	O
benefit	O
.	O

AIV	O
infection	O
of	O
macrophages	O
was	O
required	O
to	O
activate	O
T	O
lymphocytes	O
and	O
prior	O
in	O
vivo	O
exposure	O
of	O
chickens	B-SPEC
to	O
NP	O
AIV	O
plasmid	O
enhanced	O
responses	O
to	O
infected	O
macrophages	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
relationship	O
between	O
renal	O
injury	O
and	O
reinfection	O
that	O
is	O
caused	O
by	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
to	O
analyze	O
the	O
mechanism	O
of	O
renal	O
injury	O
.	O

No	O
MERS	O
vaccines	O
are	O
licensed	O
for	O
human	B-SPEC
use	O
,	O
reinforcing	O
the	O
urgency	O
to	O
develop	O
safe	O
and	O
efficacious	O
vaccines	O
to	O
prevent	O
MERS	O
.	O

TITLE	O
:	O
Discovery	O
of	O
novel	O
piperidine	O
-	O
substituted	O
indolylarylsulfones	O
as	O
potent	O
HIV	B-SPEC
NNRTIs	O
via	O
structure	O
-	O
guided	O
scaffold	O
morphing	O
and	O
fragment	O
rearrangement	O
.	O

Peak	O
incidence	O
of	O
viruses	B-SPEC
was	O
observed	O
during	O
February	O
-	O
March	O
and	O
September	O
-	O
November	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
symptom	O
duration	O
with	O
virus	B-SPEC
types	O
.	O

ABSTRACT	O
:	O
Similar	O
to	O
eukaryotic	O
mRNA	O
,	O
the	O
positive	O
-	O
strand	O
coronavirus	B-SPEC
genome	O
of	O
~	O
30	O
kilobases	O
is	O
5	O
'-	O
capped	O
and	O
3	O
'-	O
polyadenylated	O
.	O

Here	O
,	O
we	O
have	O
used	O
expert	O
-	O
opinion	O
elicitation	O
in	O
order	B-SPEC
to	O
obtain	O
ideas	O
on	O
relative	O
importance	O
of	O
MERS	O
-	O
CoV	O
risk	O
factors	O
and	O
estimates	O
of	O
transmission	O
risks	O
from	O
various	O
types	O
of	O
contact	O
between	O
humans	B-SPEC
and	O
dromedaries	B-SPEC
.	O

Details	O
and	O
radiographic	O
findings	O
were	O
noted	O
and	O
factors	O
associated	O
with	O
abnormal	O
X	O
-	O
rays	B-SPEC
were	O
analyzed	O
.	O

Patients	O
with	O
an	O
abnormal	O
chest	O
X	O
-	O
ray	B-SPEC
had	O
a	O
higher	O
requirement	O
of	O
noninvasive	O
ventilation	O
(	O
odds	O
ratio	O
[	O
OR	O
]:	O
13	O
.	O
98	O
;	O
95	O
%	O
confidence	O
interval	O
CI	O
:	O
5	O
.	O
89	O
-	O
33	O
.	O
16	O
),	O
invasive	O
ventilation	O
(	O
OR	O
:	O
18	O
.	O
07	O
;	O
95	O
%	O
CI	O
:	O
6	O
.	O
42	O
-	O
50	O
.	O
88	O
),	O
inotropes	O
(	O
OR	O
:	O
8	O
.	O
76	O
;	O
95	O
%	O
CI	O
:	O
4	O
.	O
35	O
-	O
17	O
.	O
62	O
),	O
higher	O
involvement	O
of	O
other	O
organ	O
systems	O
,	O
longer	O
duration	O
of	O
hospital	O
stay	O
(	O
3	O
.	O
18	O
	O
3	O
vs	O
.	O
7	O
.	O
27	O
	O
5	O
.	O
58	O
days	O
;	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
higher	O
mortality	O
(	O
OR	O
:	O
4	O
.	O
63	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
54	O
-	O
13	O
.	O
85	O
).	O

An	O
innovative	O
approach	O
is	O
aimed	O
to	O
identify	O
dual	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
inhibitors	O
,	O
small	O
molecules	O
that	O
can	O
inhibit	O
two	O
viral	O
functions	O
at	O
the	O
same	O
time	O
.	O

In	O
vivo	O
,	O
LPS	O
induced	O
Nur77	O
expression	O
in	O
lung	O
in	O
ARDS	O
rats	B-SPEC
.	O

TITLE	O
:	O
Isatin	O
thiazoline	O
hybrids	O
as	O
dual	O
inhibitors	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
.	O

TITLE	O
:	O
Risk	O
Factors	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
among	O
Healthcare	O
Personnel	O
.	O

ABSTRACT	O
:	O
Hemolytic	O
uremic	O
syndrome	O
(	O
HUS	O
)	O
is	O
a	O
thrombotic	O
microangiopathy	O
defined	O
by	O
thrombocytopenia	O
,	O
non	O
-	O
immune	O
microangiopathic	O
hemolytic	O
anemia	B-SPEC
and	O
acute	O
renal	O
failure	O
.	O

ABSTRACT	O
:	O
Since	O
2010	O
,	O
outbreaks	O
of	O
variant	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
have	O
swept	O
across	O
the	O
world	O
causing	O
substantial	O
economic	O
losses	O
.	O

The	O
patient	O
was	O
found	O
to	O
be	O
hypoxemic	O
with	O
a	O
PaO2	O
52	O
mmHg	O
and	O
bilateral	O
infiltrates	O
on	O
chest	O
x	O
-	O
ray	B-SPEC
.	O

Infiltrates	O
with	O
a	O
'	O
ground	O
-	O
glass	O
'	O
appearance	O
appreciated	O
on	O
HRCT	O
are	O
more	O
definitive	O
than	O
chest	O
x	O
-	O
ray	B-SPEC
.	O

The	O
most	O
common	O
viruses	B-SPEC
detected	O
included	O
metapneumovirus	B-SPEC
(	O
19	O
%),	O
rhinovirus	B-SPEC
(	O
15	O
%),	O
influenza	B-SPEC
virus	I-SPEC
C	O
(	O
9	O
%),	O
adenovirus	B-SPEC
(	O
7	O
%),	O
cytomegalovirus	B-SPEC
(	O
7	O
%)	O
and	O
coronavirus	B-SPEC
O43	O
(	O
5	O
.	O
6	O
%).	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
caused	O
several	O
hospital	O
outbreaks	O
,	O
including	O
a	O
major	O
outbreak	O
at	O
King	O
Abdulaziz	O
Medical	O
City	O
,	O
a	O
940	O
-	O
bed	O
tertiary	O
-	O
care	O
hospital	O
in	O
Riyadh	O
,	O
Saudi	O
Arabia	O
(	O
August	O
-	O
September	O
2015	O
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
first	O
emerged	O
in	O
the	O
United	O
States	O
in	O
2013	O
causing	O
high	O
mortality	O
and	O
morbidity	O
in	O
neonatal	O
piglets	O
with	O
immense	O
economic	O
losses	O
to	O
the	O
swine	B-SPEC
industry	O
.	O

PEDV	B-SPEC
is	O
an	O
alpha	O
-	O
coronavirus	B-SPEC
replicating	O
primarily	O
in	O
porcine	B-SPEC
intestinal	O
cells	O
.	O

It	O
is	O
well	O
documented	O
now	O
that	O
dromedary	B-SPEC
camels	B-SPEC
contract	O
the	O
infection	O
and	O
shed	O
the	O
virus	B-SPEC
without	O
notable	O
symptoms	O
,	O
and	O
such	O
animals	B-SPEC
had	O
been	O
infected	O
by	O
at	O
least	O
the	O
early	O
1980s	O
.	O

Here	O
,	O
this	O
article	O
reviews	O
the	O
published	O
studies	O
on	O
MERS	O
-	O
CoV	O
vaccines	O
with	O
more	O
focus	O
on	O
vaccines	O
tested	O
in	O
large	O
animals	B-SPEC
,	O
including	O
camels	B-SPEC
.	O

With	O
multiplex	O
PCR	O
testing	O
,	O
viruses	B-SPEC
were	O
identified	O
in	O
36	O
.	O
1	O
%	O
(	O
105	O
/	O
291	O
),	O
most	O
commonly	O
rhinovirus	B-SPEC
(	O
25	O
.	O
8	O
%)	O
and	O
coronavirus	B-SPEC
(	O
3	O
.	O
8	O
%).	O

Thus	O
,	O
by	O
sensitizing	O
viruses	B-SPEC
to	O
receptor	O
-	O
induced	O
conformational	O
changes	O
,	O
the	O
first	O
S	O
cleavages	O
expand	O
virus	B-SPEC
tropism	O
to	O
cell	O
types	O
that	O
are	O
relevant	O
to	O
lung	O
infection	O
,	O
and	O
therefore	O
may	O
be	O
significant	O
determinants	O
of	O
MERS	O
-	O
CoV	O
virulence	O
.	O

The	O
gene	O
encoding	O
PEDV	B-SPEC
N	O
protein	O
obtained	O
from	O
PEDV	B-SPEC
Thai	O
isolate	O
was	O
cloned	O
and	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

The	O
structures	O
of	O
PRRSV	B-SPEC
and	O
EAV	B-SPEC
endoribonucleases	O
are	O
similar	O
and	O
conserved	O
in	O
the	O
arterivirus	B-SPEC
,	O
but	O
they	O
are	O
greatly	O
different	O
from	O
that	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronaviruses	O
(	O
CoV	O
),	O
representing	O
important	O
human	B-SPEC
pathogens	O
in	O
the	O
Nidovirales	B-SPEC
order	B-SPEC
.	O

TITLE	O
:	O
Recombinant	O
Receptor	O
-	O
Binding	O
Domains	O
of	O
Multiple	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronaviruses	O
(	O
MERS	O
-	O
CoVs	O
)	O
Induce	O
Cross	O
-	O
Neutralizing	O
Antibodies	O
against	O
Divergent	O
Human	B-SPEC
and	O
Camel	B-SPEC
MERS	O
-	O
CoVs	O
and	O
Antibody	O
Escape	O
Mutants	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
binds	O
to	O
cellular	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)	O
via	O
the	O
spike	O
(	O
S	O
)	O
protein	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
).	O

They	O
induced	O
potent	O
neutralizing	O
antibodies	O
cross	O
-	O
neutralizing	O
17	O
MERS	O
pseudoviruses	O
expressing	O
S	O
proteins	O
of	O
representative	O
human	B-SPEC
and	O
camel	B-SPEC
MERS	O
-	O
CoV	O
strains	O
identified	O
during	O
the	O
2012	O
-	O
2015	O
outbreaks	O
,	O
5	O
MAb	O
escape	O
MERS	O
-	O
CoV	O
mutants	O
,	O
and	O
2	O
live	O
human	B-SPEC
MERS	O
-	O
CoV	O
strains	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
circovirus	I-SPEC
-	O
associated	O
disease	O
(	O
PCVAD	O
)	O
is	O
clinically	O
manifested	O
by	O
postweaning	O
multisystemic	O
wasting	O
syndrome	O
(	O
PMWS	O
),	O
respiratory	O
and	O
enteric	O
disease	O
,	O
reproductive	O
failure	O
,	O
and	O
porcine	B-SPEC
dermatitis	O
and	O
nephropathy	O
syndrome	O
(	O
PDNS	O
).	O

Porcine	B-SPEC
circovirus	I-SPEC
2	I-SPEC
(	O
PCV2	O
)	O
is	O
an	O
essential	O
component	O
of	O
PCVAD	O
,	O
although	O
an	O
etiologic	O
role	O
in	O
PDNS	O
is	O
not	O
well	O
established	O
.	O

Here	O
,	O
a	O
novel	O
porcine	B-SPEC
circovirus	I-SPEC
(	O
PCV3	O
)	O
that	O
is	O
distantly	O
related	O
to	O
known	O
circoviruses	O
was	O
identified	O
in	O
sows	O
with	O
porcine	B-SPEC
dermatitis	O
and	O
nephropathy	O
syndrome	O
(	O
PDNS	O
)	O
and	O
reproductive	O
failure	O
.	O

All	O
samples	O
were	O
seronegative	O
for	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
subtypes	O
H5	O
and	O
H7	O
and	O
infectious	B-SPEC
laryngotracheitis	I-SPEC
virus	I-SPEC
.	O

Babesia	B-SPEC
-	O
infected	O
individuals	O
had	O
a	O
regenerative	O
response	O
of	O
the	O
erythrocytic	O
lineage	O
,	O
an	O
active	O
inflammatory	O
response	O
and	O
hepatic	O
function	O
impairment	O
.	O

The	O
present	O
study	O
aimed	O
to	O
detect	O
viral	O
RNA	O
or	O
DNA	O
in	O
23	O
free	O
-	O
ranging	O
fur	O
seals	B-SPEC
on	O
the	O
northern	O
coastline	O
of	O
Rio	O
Grande	O
do	O
Sul	O
State	O
,	O
Brazil	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
severe	O
diarrhea	O
and	O
high	O
mortality	O
rates	O
in	O
newborn	O
piglets	O
,	O
leading	O
to	O
massive	O
losses	O
to	O
the	O
swine	B-SPEC
industry	O
worldwide	O
during	O
recent	O
epidemics	O
.	O

These	O
data	O
establish	O
that	O
an	O
inactivated	O
RABV	O
-	O
MERS	O
S	O
-	O
based	O
vaccine	O
may	O
be	O
effective	O
for	O
use	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
in	O
areas	O
where	O
MERS	O
-	O
CoV	O
is	O
endemic	O
.	O

Rabies	B-SPEC
virus	I-SPEC
-	O
based	O
vectors	O
have	O
been	O
proven	O
to	O
be	O
efficient	O
dual	O
vaccines	O
against	O
rabies	O
and	O
emergent	O
infectious	O
diseases	O
such	O
as	O
Ebola	B-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
A	O
Comparative	O
Study	O
of	O
Clinical	O
Presentation	O
and	O
Risk	O
Factors	O
for	O
Adverse	O
Outcome	O
in	O
Patients	O
Hospitalised	O
with	O
Acute	O
Respiratory	O
Disease	O
Due	O
to	O
MERS	O
Coronavirus	B-SPEC
or	O
Other	O
Causes	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
a	O
novel	O
duplex	O
nanoparticle	O
-	O
assisted	O
polymerase	O
chain	O
reaction	O
(	O
nanoPCR	O
)	O
assay	O
was	O
developed	O
to	O
detect	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Articles	O
were	O
excluded	O
if	O
participants	O
came	O
from	O
the	O
following	O
settings	O
:	O
post	O
-	O
operative	O
and	O
post	O
-	O
anaesthesia	O
care	O
units	O
(	O
PACU	B-SPEC
),	O
dementia	O
wards	O
,	O
long	O
-	O
term	O
care	O
settings	O
or	O
retirement	O
homes	O
,	O
or	O
delivery	O
rooms	O
.	O

For	O
this	O
reason	O
,	O
cDNAs	O
and	O
/	O
or	O
their	O
derivatives	O
must	O
be	O
tested	O
to	O
ensure	O
the	O
absence	O
of	O
infectious	O
virus	B-SPEC
and	O
/	O
or	O
viral	O
RNA	O
before	O
transfer	O
out	O
of	O
the	O
BSL	O
-	O
3	O
/	O
4	O
and	O
/	O
or	O
SA	O
laboratory	O
.	O

In	O
summary	O
,	O
we	O
describe	O
a	O
rapid	O
,	O
universal	O
standard	O
operating	O
procedure	O
that	O
generates	O
high	O
-	O
quality	O
NGS	O
libraries	O
free	O
of	O
infectious	O
virus	B-SPEC
and	O
infectious	O
viral	O
RNA	O
.	O

ABSTRACT	O
:	O
The	O
first	O
imported	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
in	O
China	O
recently	O
occurred	O
,	O
allowing	O
for	O
the	O
characterization	O
of	O
antibody	O
titers	O
in	O
a	O
series	O
of	O
the	O
patient	O
'	O
s	O
sera	O
using	O
the	O
following	O
methods	O
based	O
on	O
recombinant	O
viral	O
structural	O
antigens	O
:	O
inactivated	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
recombinant	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
,	O
or	O
fragments	O
of	O
S	O
)	O
ELISA	O
,	O
nucleoprotein	O
(	O
NP	O
)	O
ELISA	O
and	O
MERS	O
S	O
pseudovirus	O
particle	O
-	O
based	O
neutralization	O
test	O
(	O
ppNT	O
).	O

Our	O
findings	O
suggest	O
that	O
seasonal	O
influenza	O
A	O
(	O
H1N1	O
)	O
maintains	O
some	O
features	O
of	O
pandemic	O
viruses	B-SPEC
,	O
and	O
recommend	O
wider	O
use	O
of	O
vaccination	O
in	O
younger	O
adult	O
high	O
-	O
risk	O
patients	O
.	O

TITLE	O
:	O
Complete	O
Genome	O
Sequence	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
Isolated	O
from	O
Mexico	O
.	O

Levels	O
of	O
sPD	O
-	O
1	O
are	O
increased	O
in	O
both	O
the	O
serum	O
(	O
11	O
,	O
429	O
.	O
3	O
pg	O
/	O
mL	O
(	O
SD	O
2133	O
.	O
3	O
)	O
vs	O
.	O
8061	O
.	O
4	O
(	O
SD	O
4187	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
036	O
)	O
and	O
bronchial	O
alveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
(	O
6	O
,	O
311	O
.	O
1	O
pg	O
/	O
mL	O
(	O
SD	O
3758	O
.	O
0	O
)	O
vs	O
.	O
90	O
.	O
7	O
pg	O
/	O
mL	O
(	O
SD	O
202	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
002	O
)	O
of	O
humans	B-SPEC
with	O
ARDS	O
.	O

Similar	O
results	O
are	O
seen	O
in	O
the	O
serum	O
(	O
9396	O
.	O
1	O
pg	O
/	O
mL	O
(	O
SD	O
1546	O
.	O
0	O
)	O
vs	O
.	O
3464	O
.	O
5	O
pg	O
/	O
mL	O
(	O
SD	O
2511	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
BAL	O
fluid	O
(	O
2891	O
.	O
7	O
pg	O
/	O
mL	O
(	O
SD	O
868	O
.	O
1	O
)	O
vs	O
.	O
1385	O
.	O
9	O
pg	O
/	O
mL	O
(	O
SD	O
927	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
012	O
)	O
of	O
mice	B-SPEC
.	O

RESULTS	O
:	O
Levels	O
of	O
sPD	O
-	O
1	O
are	O
increased	O
in	O
both	O
the	O
serum	O
(	O
11	O
,	O
429	O
.	O
3	O
pg	O
/	O
mL	O
(	O
SD	O
2133	O
.	O
3	O
)	O
vs	O
.	O
8061	O
.	O
4	O
(	O
SD	O
4187	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
036	O
)	O
and	O
bronchial	O
alveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
(	O
6	O
,	O
311	O
.	O
1	O
pg	O
/	O
mL	O
(	O
SD	O
3758	O
.	O
0	O
)	O
vs	O
.	O
90	O
.	O
7	O
pg	O
/	O
mL	O
(	O
SD	O
202	O
.	O
8	O
),	O
p	O
=	O
0	O
.	O
002	O
)	O
of	O
humans	B-SPEC
with	O
ARDS	O
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	B-SPEC
)	O
is	O
an	O
important	O
pathogen	O
that	O
causes	O
enteritis	O
in	O
dogs	B-SPEC
,	O
but	O
there	O
is	O
no	O
information	O
on	O
CCoV	B-SPEC
infection	O
in	O
Vietnam	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
a	O
coronavirus	B-SPEC
that	O
causes	O
villus	O
atrophy	O
,	O
followed	O
by	O
crypt	O
hyperplasia	O
,	O
reduces	O
the	O
activities	O
of	O
intestinal	O
digestive	O
enzymes	O
,	O
and	O
disrupts	O
the	O
absorption	O
of	O
intestinal	O
nutrients	O
.	O

In	O
this	O
study	O
,	O
we	O
therefore	O
sought	O
to	O
evaluate	O
the	O
effects	O
of	O
TGEV	B-SPEC
infection	O
on	O
glucose	O
uptake	O
and	O
SGLT1	O
and	O
GLUT2	O
expression	O
.	O

On	O
day	O
3	O
,	O
the	O
patient	O
was	O
in	O
a	O
""""	O
brain	O
-	O
death	O
"""-"	O
like	O
state	O
with	O
deep	O
coma	B-SPEC
and	O
absent	O
brainstem	O
reflexes	O
.	O

TITLE	O
:	O
An	O
investigation	O
into	O
respiratory	O
tract	O
viruses	B-SPEC
in	O
children	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
or	O
wheezing	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
determine	O
the	O
frequencies	O
of	O
respiratory	O
tract	O
viruses	B-SPEC
in	O
patient	O
(	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
[	O
LRTI	O
]	O
or	O
wheezing	O
)	O
and	O
control	O
(	O
history	O
of	O
asthma	O
without	O
symptoms	O
)	O
groups	O
.	O

No	O
bocavirus	B-SPEC
,	O
metapneumovirus	B-SPEC
or	O
enterovirus	B-SPEC
was	O
found	O
in	O
any	O
specimen	O
.	O

Statistically	O
significant	O
differences	O
in	O
the	O
detection	O
of	O
influenza	B-SPEC
virus	I-SPEC
A	O
(	O
P	O
=	O
0	O
.	O
000	O
),	O
the	O
total	O
detection	O
of	O
parainfluenza	O
viruses	B-SPEC
(	O
P	O
=	O
0	O
.	O
008	O
)	O
and	O
coinfection	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
were	O
observed	O
between	O
the	O
patient	O
and	O
control	O
groups	O
.	O

In	O
this	O
study	O
,	O
we	O
describe	O
a	O
robust	O
porcine	B-SPEC
islet	O
-	O
screening	O
program	O
that	O
provides	O
a	O
high	O
level	O
of	O
confidence	O
in	O
the	O
microbiological	O
safety	O
of	O
porcine	B-SPEC
islets	O
suitable	O
for	O
clinical	O
trials	O
.	O

A	O
four	O
-	O
checkpoint	O
program	O
systematically	O
screens	O
the	O
donor	O
herd	O
(	O
Large	B-SPEC
White	I-SPEC
-	O
Yorkshire	O
	O
Landrace	O
F1	O
hybrid	O
animals	B-SPEC
),	O
individual	O
sentinel	O
and	O
pancreas	O
donor	O
animals	B-SPEC
and	O
,	O
critically	O
,	O
the	O
islet	O
macrobeads	O
themselves	O
.	O

Of	O
1207	O
monthly	O
samples	O
taken	O
from	O
random	O
animals	B-SPEC
over	O
a	O
2	O
-	O
year	O
period	O
,	O
only	O
a	O
single	O
positive	O
result	O
for	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
was	O
observed	O
,	O
demonstrating	O
the	O
high	O
level	O
of	O
biosecurity	O
maintained	O
in	O
the	O
source	O
herd	O
.	O

TITLE	O
:	O
Quantitative	O
structure	O
-	O
activity	O
relationship	O
and	O
molecular	O
docking	O
revealed	O
a	O
potency	O
of	O
anti	O
-	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
drugs	O
against	O
human	B-SPEC
corona	B-SPEC
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
number	O
of	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
were	O
reported	O
in	O
the	O
last	O
and	O
present	O
centuries	O
.	O

As	O
far	O
as	O
we	O
know	O
,	O
this	O
is	O
the	O
first	O
time	O
to	O
realize	O
the	O
detection	O
of	O
viral	O
antibodies	O
based	O
on	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
nanoparticles	O
.	O

monitoring	O
respiratory	O
viruses	B-SPEC
contributes	O
to	O
knowledge	O
about	O
periods	O
of	O
virus	B-SPEC
circulation	O
and	O
the	O
adoption	O
of	O
specific	O
control	O
measures	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
disease	O
is	O
rare	O
in	O
children	O
:	O
An	O
update	O
from	O
Saudi	O
Arabia	O
.	O

We	O
also	O
searched	O
MEDLINE	O
and	O
PubMed	O
for	O
the	O
keywords	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
,	O
MERS	O
-	O
CoV	O
in	O
combination	O
with	O
pediatric	O
,	O
children	O
,	O
childhood	O
,	O
infancy	O
and	O
pregnancy	O
from	O
the	O
initial	O
discovery	O
of	O
the	O
virus	B-SPEC
in	O
2012	O
to	O
2016	O
.	O

Mild	O
pneumonia	O
was	O
most	O
common	O
(	O
60	O
.	O
4	O
%)	O
with	O
HCoV	O
,	O
and	O
when	O
combined	O
with	O
RSV	B-SPEC
,	O
resulted	O
in	O
bronchiolitis	O
.	O

Pathogenic	O
IBV	B-SPEC
3575	O
/	O
08	O
was	O
isolated	O
from	O
broilers	O
vaccinated	O
with	O
the	O
attenuated	O
viral	O
vaccine	O
derived	O
from	O
a	O
Taiwan	O
strain	O
2575	O
/	O
98	O
.	O

Animal	B-SPEC
challenge	O
experiments	O
exhibited	O
strong	O
respiratory	O
and	O
renal	O
pathogenicity	O
for	O
3575	O
/	O
08	O
.	O

Because	O
no	O
cases	O
were	O
reported	O
in	O
the	O
United	O
States	O
during	O
2015	O
,	O
the	O
following	O
diseases	O
do	O
not	O
appear	O
in	O
this	O
early	O
release	O
table	O
:	O
anthrax	B-SPEC
;	O
dengue	O
hemorrhagic	O
fever	O
;	O
diphtheria	O
;	O
eastern	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
disease	O
,	O
nonneuroinvasive	O
;	O
poliomyelitis	O
,	O
paralytic	O
;	O
poliovirus	B-SPEC
infection	O
,	O
nonparalytic	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
disease	O
(	O
SARS	O
-	O
CoV	O
);	O
smallpox	B-SPEC
;	O
western	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
disease	O
,	O
neuroinvasive	O
and	O
nonneuroinvasive	O
;	O
yellow	O
fever	O
;	O
and	O
viral	O
hemorrhagic	O
fevers	O
.	O

PEDV	B-SPEC
was	O
detected	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
and	O
S1	O
and	O
ORF3	O
sequences	O
were	O
processed	O
by	O
the	O
Clustal	O
W	O
method	O
via	O
DNAMAN	O
8	O
software	O
,	O
and	O
phylogenetic	O
trees	O
were	O
constructed	O
by	O
the	O
neighbor	O
-	O
joining	O
method	O
using	O
MEGA	O
6	O
software	O
.	O

RESULTS	O
:	O
The	O
prevalence	O
of	O
PEDV	B-SPEC
was	O
92	O
.	O
25	O
%	O
and	O
was	O
detected	O
in	O
119	O
of	O
129	O
samples	O
,	O
with	O
94	O
.	O
03	O
%	O
(	O
63	O
of	O
67	O
)	O
of	O
pig	B-SPEC
farms	O
harbouring	O
the	O
disease	O
.	O

In	O
this	O
study	O
,	O
we	O
prepared	O
purified	O
equine	B-SPEC
F	O
(	O
ab	O
')	O

We	O
confirmed	O
the	O
clinical	O
utility	O
of	O
the	O
iROAD	O
assay	O
by	O
detecting	O
viral	O
RNAs	O
obtained	O
from	O
63	O
human	B-SPEC
respiratory	O
samples	O
.	O

TITLE	O
:	O
Multiple	O
molecular	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
and	O
associated	O
signs	O
of	O
airway	O
inflammation	O
in	O
racehorses	B-SPEC
.	O

Both	O
NS	O
and	O
tracheal	O
washes	O
(	O
TW	O
)	O
were	O
collected	O
monthly	O
on	O
52	O
Standardbred	O
racehorses	B-SPEC
at	O
training	O
,	O
over	O
27	O
consecutive	O
months	O
(	O
581	O
samples	O
).	O

Genome	O
for	O
7	O
/	O
10	O
viruses	B-SPEC
were	O
detected	O
at	O
least	O
once	O
throughout	O
the	O
study	O
;	O
up	O
to	O
4	O
different	O
viruses	B-SPEC
being	O
also	O
concomitantly	O
detected	O
.	O

Coughing	O
was	O
significantly	O
associated	O
with	O
TW	O
detection	O
of	O
EHV	B-SPEC
-	I-SPEC
2	I-SPEC
DNA	O
(	O
OR	O
3	O
.	O
1	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
ERBV	O
RNA	O
(	O
OR	O
5	O
.	O
3	O
;	O
P	O
<	O
0	O
.	O
001	O
).	O

Detection	O
of	O
EHV	B-SPEC
-	I-SPEC
2	I-SPEC
DNA	O
in	O
TW	O
was	O
also	O
significantly	O
associated	O
with	O
excess	O
tracheal	O
mucus	O
(	O
OR	O
2	O
.	O
1	O
;	O
P	O
=	O
0	O
.	O
02	O
).	O

The	O
resource	O
is	O
located	O
at	O
http	O
://	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
genome	O
/	O
viruses	B-SPEC
/	O
variation	O
/	O
and	O
includes	O
modules	O
for	O
seven	O
viral	O
groups	O
:	O
influenza	B-SPEC
virus	I-SPEC
,	O
Dengue	B-SPEC
virus	I-SPEC
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
Ebolavirus	B-SPEC
,	O
MERS	O
coronavirus	B-SPEC
,	O
Rotavirus	B-SPEC
A	I-SPEC
and	O
Zika	B-SPEC
virus	I-SPEC
Each	O
module	O
is	O
supported	O
by	O
pipelines	O
that	O
scan	O
newly	O
released	O
GenBank	O
records	O
,	O
annotate	O
genes	O
and	O
proteins	O
and	O
parse	O
sample	O
descriptors	O
and	O
then	O
map	O
them	O
to	O
controlled	O
vocabulary	O
.	O

This	O
manuscript	O
describes	O
a	O
series	O
of	O
features	O
and	O
functionalities	O
recently	O
added	O
to	O
the	O
Virus	B-SPEC
Variation	O
Resource	O
.	O

Concurrently	O
,	O
the	O
frequency	O
of	O
occurrence	O
of	O
the	O
wild	O
type	O
at	O
the	O
two	O
positions	O
was	O
only	O
6	O
.	O
5	O
%	O
	O
1	O
.	O
7	O
%	O
on	O
average	O
,	O
supporting	O
the	O
hypothesis	O
that	O
selection	O
pressure	O
exerted	O
by	O
the	O
host	O
immune	O
response	O
played	O
a	O
critical	O
role	O
in	O
shaping	O
genetic	O
variants	O
and	O
their	O
interaction	O
in	O
human	B-SPEC
MERS	O
-	O
CoVs	O
during	O
the	O
outbreak	O
.	O

To	O
determine	O
whether	O
other	O
animals	B-SPEC
are	O
potential	O
reservoirs	O
,	O
we	O
inoculated	O
MERS	O
-	O
CoV	O
into	O
llamas	B-SPEC
,	O
pigs	B-SPEC
,	O
sheep	B-SPEC
,	O
and	O
horses	B-SPEC
and	O
collected	O
nasal	O
and	O
rectal	O
swab	O
samples	O
at	O
various	O
times	O
.	O

The	O
presence	O
of	O
MERS	O
-	O
CoV	O
in	O
the	O
nose	O
of	O
pigs	B-SPEC
and	O
llamas	B-SPEC
was	O
confirmed	O
by	O
PCR	O
,	O
titration	O
of	O
infectious	O
virus	B-SPEC
,	O
immunohistochemistry	O
,	O
and	O
in	O
situ	O
hybridization	O
;	O
seroconversion	O
was	O
detected	O
in	O
animals	B-SPEC
of	O
both	O
species	B-SPEC
.	O

The	O
influence	O
of	O
the	O
increased	O
SNP	O
and	O
hydrophobic	O
properties	O
of	O
the	O
translated	O
proteins	O
on	O
the	O
vaccine	O
viruses	B-SPEC
'	O
virulence	O
is	O
unknown	O
.	O

Cyclosporin	O
A	O
(	O
CsA	O
),	O
a	O
cyclophilin	O
(	O
Cyp	O
)	O
inhibitor	O
,	O
inhibits	O
the	O
replication	O
of	O
FCoV	O
in	O
vitro	O
and	O
in	O
vivo	O
as	O
well	O
as	O
the	O
replication	O
of	O
human	B-SPEC
and	O
animal	B-SPEC
coronaviruses	O
.	O

ABSTRACT	O
:	O
Bronchitis	O
is	O
a	O
common	O
respiratory	O
tract	O
infection	O
of	O
humans	B-SPEC
mainly	O
caused	O
by	O
influenza	B-SPEC
virus	I-SPEC
,	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
.	O

Present	O
review	O
contains	O
ethnomedicines	O
of	O
total	O
55	O
plants	B-SPEC
from	O
different	O
countries	O
of	O
the	O
Himalayas	O
.	O

We	O
invite	O
the	O
attention	O
of	O
researchers	O
for	O
detailed	O
ethnopharmacological	O
and	O
phytochemical	O
studies	O
on	O
unexplored	O
plants	B-SPEC
used	O
to	O
treat	O
bronchitis	O
for	O
the	O
development	O
of	O
novel	O
antiviral	O
drugs	O
.	O

In	O
addition	O
,	O
antimicrobial	O
therapy	O
with	O
newer	O
macrolides	O
or	O
respiratory	O
fluoroquinolones	O
should	O
be	O
initiated	O
for	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
requiring	O
intensive	O
care	O
unit	O
admission	O
,	O
prior	O
to	O
laboratory	O
confirmation	O
of	O
diagnosis	O
,	O
especially	O
when	O
a	O
clinical	O
suspicion	O
of	O
Legionella	B-SPEC
infection	O
exists	O
.	O

To	O
better	O
understand	O
the	O
pathogenesis	O
mechanism	O
and	O
the	O
virus	B-SPEC
-	O
host	O
interaction	O
during	O
infection	O
with	O
both	O
PEDV	B-SPEC
YN13	O
and	O
YN144	O
strains	O
,	O
a	O
comparative	O
proteomic	O
analysis	O
was	O
carried	O
out	O
to	O
investigate	O
the	O
proteomic	O
changes	O
produced	O
in	O
the	O
primary	O
target	O
organ	O
,	O
using	O
isobaric	O
tags	O
for	O
relative	O
and	O
absolute	O
quantitation	O
(	O
iTRAQ	O
)	O
labeling	O
,	O
followed	O
by	O
liquid	O
chromatography	O
tandem	O
-	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
).	O

Following	O
vaccination	O
,	O
swabs	O
and	O
tissues	O
collected	O
at	O
intervals	O
were	O
pooled	O
and	O
RNA	O
was	O
extracted	O
for	O
detection	O
of	O
IBV	B-SPEC
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Drivers	O
of	O
airborne	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
pathogen	O
transmission	O
.	O

ABSTRACT	O
:	O
Airborne	O
pathogens	O
-	O
either	O
transmitted	O
via	O
aerosol	O
or	O
droplets	O
-	O
include	O
a	O
wide	O
variety	O
of	O
highly	O
infectious	O
and	O
dangerous	O
microbes	O
such	O
as	O
variola	B-SPEC
virus	I-SPEC
,	O
measles	B-SPEC
virus	I-SPEC
,	O
influenza	O
A	O
viruses	B-SPEC
,	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
,	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
,	O
and	O
Bordetella	B-SPEC
pertussis	I-SPEC
.	O

In	O
particular	O
,	O
we	O
propose	O
a	O
framework	O
of	O
drivers	O
facilitating	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
with	O
the	O
airspace	O
between	O
individuals	O
as	O
an	O
intermediate	O
stage	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
nidoviruses	B-SPEC
like	O
corona	B-SPEC
-	O
and	O
arteriviruses	B-SPEC
induces	O
a	O
reticulovesicular	O
network	O
of	O
interconnected	O
endoplasmic	O
reticulum	O
(	O
ER	O
)-	O
derived	O
double	O
-	O
membrane	O
vesicles	O
(	O
DMVs	O
)	O
and	O
other	O
membrane	O
structures	O
.	O

Our	O
approach	O
involved	O
ectopic	O
expression	O
of	O
arterivirus	B-SPEC
nonstructural	O
proteins	O
nsp2	O
and	O
nsp3	O
,	O
which	O
induce	O
DMV	O
formation	O
in	O
the	O
absence	O
of	O
other	O
viral	O
triggers	O
of	O
the	O
interferon	O
response	O
,	O
such	O
as	O
replicating	O
viral	O
RNA	O
.	O

IB	O
virus	B-SPEC
primarily	O
affects	O
respiratory	O
tract	O
,	O
but	O
strains	O
differ	O
in	O
their	O
tropism	O
for	O
such	O
other	O
target	O
organs	O
as	O
kidneys	O
and	O
alimentary	O
tract	O
.	O

ABSTRACT	O
:	O
Snakebites	O
by	O
exotic	O
venomous	O
snakes	B-SPEC
can	O
cause	O
serious	O
or	O
even	O
life	O
-	O
threatening	O
envenoming	O
.	O

TITLE	O
:	O
Diagnostic	O
evaluation	O
of	O
assays	O
for	O
detection	O
of	O
antibodies	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
pigs	B-SPEC
exposed	O
to	O
different	O
PEDV	B-SPEC
strains	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
ability	O
of	O
five	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISAs	O
)	O
to	O
detect	O
antibodies	O
against	O
different	O
PEDV	B-SPEC
strains	O
in	O
pig	B-SPEC
serum	O
.	O

Field	O
samples	O
from	O
herds	O
with	O
confirmed	O
or	O
unknown	O
PEDV	B-SPEC
exposure	O
were	O
also	O
used	O
.	O

HIV	B-SPEC
/	O
AIDS	O
,	O
SARS	O
and	O
H1N1	O
tested	O
global	O
response	O
,	O
and	O
in	O
each	O
case	O
coordination	O
proved	O
problematic	O
,	O
making	O
the	O
2013	O
-	O
2015	O
Ebola	O
epidemic	O
no	O
exception	O
.	O

Here	O
,	O
we	O
will	O
discuss	O
this	O
approach	O
with	O
a	O
focus	O
on	O
the	O
emerging	O
viral	O
pathogens	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
Ebola	B-SPEC
virus	I-SPEC
(	O
EBOV	O
),	O
and	O
monkeypox	B-SPEC
virus	I-SPEC
(	O
MPXV	O
)	O
from	O
the	O
context	O
of	O
clinical	O
presentation	O
,	O
immunological	O
and	O
molecular	O
features	O
of	O
the	O
diseases	O
,	O
and	O
OMICS	O
-	O
based	O
analyses	O
of	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
carry	O
and	O
shed	O
many	O
emerging	O
infectious	O
disease	O
agents	O
including	O
Ebola	B-SPEC
virus	I-SPEC
and	O
SARS	O
-	O
like	O
Coronaviruses	O
,	O
yet	O
they	O
rarely	O
display	O
clinical	O
symptoms	O
of	O
infection	O
.	O

Generally	O
,	O
human	B-SPEC
neutralizing	O
mAbs	O
targeting	O
RBD	O
are	O
more	O
potent	O
than	O
those	O
targeting	O
other	O
regions	O
of	O
S	O
protein	O
.	O

However	O
,	O
emergence	O
of	O
escape	O
mutant	O
viruses	B-SPEC
and	O
mAb	O
'	O
s	O
limitations	O
make	O
it	O
necessary	O
for	O
combining	O
neutralizing	O
mAbs	O
recognizing	O
different	O
neutralizing	O
epitopes	O
and	O
engineering	O
them	O
with	O
improved	O
efficacy	O
and	O
reduced	O
cost	O
.	O

TITLE	O
:	O
Update	O
on	O
therapeutic	O
options	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Although	O
different	O
characteristics	O
were	O
found	O
,	O
it	O
can	O
be	O
concluded	O
that	O
each	O
of	O
the	O
assays	O
used	O
can	O
detect	O
infection	O
of	O
pigs	B-SPEC
at	O
a	O
herd	O
level	O
by	O
either	O
the	O
early	O
European	O
strains	O
of	O
PEDV	B-SPEC
or	O
the	O
recently	O
circulating	O
strains	O
(	O
INDEL	O
and	O
non	O
-	O
INDEL	O
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
an	O
emerging	O
swine	B-SPEC
coronavirus	B-SPEC
that	O
causes	O
diarrhea	O
in	O
piglets	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
introduction	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
into	O
the	O
North	O
American	O
swine	B-SPEC
herd	O
has	O
highlighted	O
again	O
the	O
need	O
for	O
effective	O
vaccines	O
for	O
swine	B-SPEC
coronaviruses	O
.	O

We	O
identified	O
several	O
macrodomain	O
mutations	O
that	O
greatly	O
reduced	O
nsp3	O
'	O
s	O
de	O
-	O
ADP	O
-	O
ribosylation	O
activity	O
in	O
vitro	O
Next	O
,	O
we	O
created	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
strains	O
with	O
these	O
mutations	O
.	O

Using	O
a	O
coinfection	O
assay	O
,	O
we	O
found	O
that	O
inclusion	O
of	O
mutant	O
virus	B-SPEC
in	O
the	O
inoculum	O
protected	O
mice	B-SPEC
from	O
an	O
otherwise	O
lethal	O
SARS	O
-	O
CoV	O
infection	O
without	O
reducing	O
virus	B-SPEC
loads	O
,	O
indicating	O
that	O
the	O
changes	O
in	O
innate	O
immune	O
response	O
were	O
physiologically	O
significant	O
.	O

Understanding	O
the	O
mechanism	O
used	O
by	O
this	O
enzyme	O
to	O
promote	O
disease	O
will	O
open	O
up	O
novel	O
avenues	O
for	O
coronavirus	B-SPEC
therapies	O
and	O
give	O
further	O
insight	O
into	O
the	O
role	O
of	O
macrodomains	O
in	O
viral	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
membrane	O
(	O
M	O
)	O
protein	O
acts	O
as	O
a	O
dominant	O
immunogen	O
and	O
is	O
a	O
major	O
player	O
in	O
virus	B-SPEC
assembly	O
.	O

The	O
1C3	O
and	O
4C7	O
mAbs	O
both	O
reacted	O
with	O
the	O
native	O
TGEV	B-SPEC
M	O
protein	O
in	O
western	O
blotting	O
and	O
immunofluorescence	O
(	O
IFA	O
)	O
assays	O
.	O

Two	O
linear	O
epitopes	O
,	O
243YSTEART249	O
(	O
1C3	O
)	O
and	O
243YSTEARTDNLSEQEKLLHMV262	O
(	O
4C7	O
),	O
were	O
identified	O
in	O
the	O
endodomain	O
of	O
the	O
TGEV	B-SPEC
M	O
protein	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
nsp5	O
inhibits	O
interferon	O
-	O
	O
production	O
through	O
the	O
cleavage	O
of	O
NEMO	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
they	O
could	O
be	O
specifically	O
recognized	O
by	O
PEDV	B-SPEC
antisera	O
but	O
could	O
not	O
be	O
recognized	O
by	O
TGEV	B-SPEC
hyperimmune	O
antisera	O
.	O

Here	O
,	O
Sprague	O
Dawley	O
rats	B-SPEC
were	O
administered	O
a	O
single	O
dose	O
of	O
GRFT	O
at	O
10	O
or	O
20	O
mg	O
/	O
kg	O
by	O
intravenous	O
,	O
oral	O
,	O
and	O
subcutaneous	O
routes	O
,	O
respectively	O
,	O
and	O
serum	O
GRFT	O
levels	O
were	O
measured	O
at	O
select	O
time	O
points	O
.	O

TITLE	O
:	O
Polyphyletic	O
origin	O
of	O
MERS	O
coronaviruses	O
and	O
isolation	O
of	O
a	O
novel	O
clade	O
A	O
strain	O
from	O
dromedary	B-SPEC
camels	B-SPEC
in	O
the	O
United	O
Arab	O
Emirates	O
.	O

Indeed	O
,	O
a	O
high	O
PEEP	O
(	O
10	O
-	O
24	O
cm	O
HO	O
)	O
appears	O
to	O
be	O
a	O
life	O
-	O
saver	O
in	O
the	O
context	O
of	O
early	O
severe	O
diffuse	O
ARDS	O
;	O
c	O
)	O
tidal	O
volume	O
and	O
plateau	O
pressure	O
cannot	O
be	O
identical	O
for	O
all	O
patients	O
;	O
d	O
)	O
the	O
only	O
remaining	O
rationale	O
for	O
CMV	B-SPEC
and	O
muscle	O
relaxation	O
is	O
to	O
suppress	O
patient	O
-	O
ventilator	O
asynchrony	O
and	O
to	O
lower	O
VO2	O
,	O
during	O
the	O
acute	O
cardio	O
-	O
ventilatory	O
distress	O
.	O

Lineage	O
A	O
Betacoronavirus	B-SPEC
NS2	O
Proteins	O
and	O
the	O
Homologous	O
Torovirus	B-SPEC
Berne	O
pp1a	O
Carboxy	O
-	O
Terminal	O
Domain	O
Are	O
Phosphodiesterases	O
That	O
Antagonize	O
Activation	O
of	O
RNase	O
L	O
.	O
ABSTRACT	O
:	O
Viruses	B-SPEC
in	O
the	O
family	B-SPEC

Therefore	O
we	O
have	O
developed	O
modified	O
lavage	O
model	O
of	O
ARDS	O
in	O
the	O
pig	B-SPEC
.	O

However	O
,	O
the	O
association	O
between	O
OSA	B-SPEC
and	O
the	O
exacerbation	O
of	O
severe	O
asthma	O
remains	O
unclear	O
.	O

The	O
rates	O
of	O
OSA	B-SPEC
were	O
19	O
.	O
2	O
%	O
(	O
28	O
/	O
146	O
)	O
among	O
the	O
patients	O
with	O
asthma	O
and	O
9	O
.	O
6	O
%	O
(	O
15	O
/	O
157	O
)	O
among	O
the	O
control	O
individuals	O
(	O
p	O
=	O
0	O
.	O
016	O
).	O

This	O
phenomenon	O
could	O
be	O
extended	O
to	O
other	O
betacoronaviruses	O
utilizing	O
CTD1	O
of	O
the	O
S1	O
subunit	O
for	O
receptor	O
binding	O
,	O
which	O
provides	O
new	O
insights	O
into	O
the	O
intermediate	O
states	O
of	O
coronavirus	B-SPEC
pre	O
-	O
fusion	O
spike	O
trimer	O
during	O
infection	O
.	O

In	O
this	O
report	O
,	O
we	O
present	O
four	O
Kawasaki	O
disease	O
patients	O
infected	O
with	O
adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
OC43	O
/	O
HKU1	O
and	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
.	O

The	O
consensus	O
length	O
of	O
7513	O
bp	O
genome	O
sequence	O
of	O
Indian	O
isolate	O
of	O
chicken	B-SPEC
astrovirus	I-SPEC
was	O
obtained	O
after	O
assembly	O
of	O
14	O
,	O
121	O
high	O
quality	O
reads	O
.	O

The	O
capsid	O
structural	O
protein	O
of	O
CAstV	O
/	O
INDIA	O
/	O
ANAND	O
/	O
2016	O
showed	O
84	O
.	O
67	O
%	O
similarity	O
with	O
chicken	B-SPEC
astrovirus	I-SPEC
isolate	O
CAstV	O
/	O
GA2011	O
,	O
81	O
.	O
06	O
%	O
with	O
CAstV	O
/	O
4175	O
and	O
41	O
.	O
18	O
%	O
with	O
CAstV	O
/	O
Poland	O
/	O
G059	O
/	O
2014	O
isolates	O
.	O

To	O
infect	O
mice	B-SPEC
,	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
has	O
evolved	O
to	O
recognize	O
mouse	B-SPEC
CEACAM1a	O
(	O
mCEACAM1a	O
)	O
as	O
its	O
receptor	O
.	O

Furthermore	O
,	O
mice	B-SPEC
inoculated	O
with	O
sVLP	O
or	O
an	O
adjuvanted	O
sVLP	O
vaccine	O
elicited	O
T	O
-	O
helper	O
1	O
(	O
Th1	O
)	O
and	O
T	O
-	O
helper	O
2	O
(	O
Th2	O
)	O
cell	O
-	O
mediated	O
immunity	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
past	O
3	O
decades	O
,	O
and	O
similar	O
to	O
the	O
horse	B-SPEC
industry	O
,	O
fresh	O
embryo	O
transfer	O
has	O
been	O
widely	O
practiced	O
on	O
large	O
commercial	O
scales	O
in	O
different	O
camelid	O
species	B-SPEC
,	O
especially	O
the	O
dromedary	B-SPEC
camel	B-SPEC
and	O
alpaca	B-SPEC
.	O

Concurrent	O
infections	O
of	O
dengue	O
and	O
malaria	O
are	O
rare	O
due	O
to	O
the	O
different	O
habitats	O
of	O
its	O
vectors	O
and	O
activities	O
of	O
different	O
carrier	O
mosquitoes	B-SPEC
.	O

Plasmodium	B-SPEC
knowlesi	I-SPEC
is	O
also	O
a	O
common	O
cause	O
of	O
malaria	O
in	O
Malaysia	O
with	O
one	O
of	O
the	O
highest	O
rates	O
of	O
mortality	O
.	O

A	O
59	O
-	O
year	O
old	O
man	B-SPEC
staying	O
near	O
the	O
Belum	O
-	O
Temengor	O
rainforest	O
at	O
the	O
Malaysia	O
-	O
Thailand	O
border	O
was	O
admitted	O
with	O
fever	O
for	O
6	O
days	O
,	O
with	O
respiratory	O
distress	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
is	O
commonly	O
associated	O
with	O
respiratory	O
tract	O
infections	O
in	O
humans	B-SPEC
,	O
with	O
five	O
genetically	O
distinct	O
genotypes	O
(	O
A	O
to	O
E	O
)	O
described	O
so	O
far	O
.	O

Findings	O
related	O
to	O
waning	O
antibodies	O
and	O
re	O
-	O
infection	O
have	O
implications	O
for	O
camel	B-SPEC
vaccine	O
development	O
,	O
disease	O
management	O
and	O
zoonotic	O
threat	O
.	O

TITLE	O
:	O
Outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
Saudi	O
Arabia	O
:	O
a	O
retrospective	O
study	O
.	O

Historically	O
,	O
MVA	O
was	O
developed	O
by	O
serial	O
tissue	O
culture	O
passage	O
in	O
primary	O
chicken	B-SPEC
cells	O
of	O
vaccinia	B-SPEC
virus	I-SPEC
strain	O
Ankara	O
,	O
and	O
clinically	O
used	O
to	O
avoid	O
the	O
undesirable	O
side	O
effects	O
of	O
conventional	O
smallpox	B-SPEC
vaccination	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
ED	O
nurses	O
'	O
burnout	O
level	O
during	O
an	O
outbreak	O
of	O
MERS	O
-	O
CoV	O
and	O
to	O
identify	O
influencing	O
factors	O
in	O
order	B-SPEC
to	O
provide	O
basic	O
information	O
for	O
lowering	O
and	O
preventing	O
the	O
level	O
of	O
burnout	O
.	O

RESULTS	O
:	O
The	O
ED	O
nurses	O
'	O
burnout	O
was	O
affected	O
by	O
job	O
stress	O
(	O
	O
=	O
0	O
.	O
59	O
,	O
p	O
<.	O
001	O
),	O
poor	O
hospital	O
resources	O
for	O
the	O
treatment	O
of	O
MERS	O
-	O
CoV	O
(	O
	O
=	O
-	O
0	O
.	O
19	O
,	O
p	O
<.	O
001	O
)	O
and	O
poor	O
support	O
from	O
family	B-SPEC
and	O
friends	O
(	O
	O
=	O
-	O
0	O
.	O
14	O
,	O
p	O
<.	O
05	O
).	O

Infection	O
of	O
the	O
oviducts	O
with	O
ck	O
/	O
CH	O
/	O
LGX	O
/	O
111119	O
found	O
in	O
this	O
study	O
may	O
have	O
severe	O
implications	O
because	O
the	O
virus	B-SPEC
will	O
likely	O
induce	O
the	O
occurrence	O
of	O
false	O
layers	O
.	O

Virus	B-SPEC
-	O
induced	O
demyelination	O
has	O
similarities	O
to	O
the	O
human	B-SPEC
disease	O
multiple	O
sclerosis	O
.	O

However	O
,	O
unlike	O
autoimmune	O
disease	O
,	O
complete	O
suppression	O
would	O
result	O
in	O
unchecked	O
virus	B-SPEC
replication	O
,	O
generally	O
leading	O
to	O
more	O
severe	O
disease	O
.	O

The	O
establishment	O
of	O
this	O
animal	B-SPEC
model	O
of	O
pulmonary	O
ricinosis	O
should	O
help	O
in	O
the	O
pursuit	O
of	O
efficient	O
medical	O
countermeasures	O
specifically	O
tailored	O
to	O
deal	O
with	O
the	O
respiratory	O
deficiencies	O
stemming	O
from	O
ricin	O
-	O
induced	O
ARDS	O
.	O

We	O
selected	O
16	O
bovine	B-SPEC
respiratory	O
pathogens	O
(	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
3	I-SPEC
,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
D	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
rhinitis	O
A	O
virus	B-SPEC
,	O
bovine	B-SPEC
rhinitis	I-SPEC
B	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
,	O
bovine	B-SPEC
adenovirus	B-SPEC
3	O
,	O
bovine	B-SPEC
adenovirus	B-SPEC
7	O
,	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
,	O
Pasteurella	B-SPEC
multocida	I-SPEC
,	O
Histophilus	B-SPEC
somni	I-SPEC
,	O
Trueperella	B-SPEC
pyogenes	O
,	O
Mycoplasma	B-SPEC
bovis	I-SPEC
and	O
Ureaplasma	B-SPEC
diversum	I-SPEC
)	O
as	O
detection	O
targets	O
and	O
designed	O
novel	O
specific	O
primer	O
-	O
probe	O
sets	O
for	O
nine	O
of	O
them	O
.	O

Apart	O
from	O
direct	O
medical	O
,	O
psychological	O
,	O
and	O
quality	O
of	O
life	O
related	O
adverse	O
effects	O
of	O
obesity	O
,	O
many	O
indirect	O
medical	O
comorbidities	O
,	O
namely	O
,	O
obstructive	O
sleep	O
apnea	O
(	O
OSA	B-SPEC
),	O
obesity	O
hypoventilation	O
syndrome	O
(	O
OHS	O
),	O
diabetes	O
mellitus	O
(	O
DM	O
),	O
hypertension	O
(	O
HTN	O
),	O
and	O
metabolic	O
syndrome	O
,	O
imposes	O
a	O
significant	O
health	O
burden	O
on	O
the	O
individual	O
and	O
community	O
with	O
consequent	O
morbidity	O
and	O
mortality	O
.	O

Lastly	O
,	O
the	O
layer	O
-	O
by	O
-	O
layer	O
deposition	O
was	O
extended	O
to	O
release	O
the	O
TMV	B-SPEC
scaffolds	O
as	O
free	O
-	O
standing	O
biomembranes	O
.	O

Our	O
screening	O
of	O
bat	B-SPEC
samples	O
collected	O
in	O
Kenya	O
from	O
2007	O
to	O
2010	O
not	O
only	O
detected	O
RNA	O
from	O
several	O
novel	O
CoVs	O
but	O
,	O
more	O
significantly	O
,	O
identified	O
sequences	O
that	O
were	O
closely	O
related	O
to	O
human	B-SPEC
CoVs	O
NL63	O
and	O
229E	O
,	O
suggesting	O
that	O
these	O
two	O
human	B-SPEC
viruses	B-SPEC
originate	O
from	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
Ubiquitin	O
-	O
like	O
domain	O
2	O
(	O
Ubl2	O
)	O
is	O
immediately	O
adjacent	O
to	O
the	O
N	O
-	O
terminus	O
of	O
the	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
domain	O
in	O
coronavirus	B-SPEC
polyproteins	O
,	O
and	O
it	O
may	O
play	O
a	O
critical	O
role	O
in	O
protease	O
regulation	O
and	O
stability	O
as	O
well	O
as	O
in	O
viral	O
infection	O
.	O

TITLE	O
:	O
The	O
Important	O
Role	O
of	O
Lipid	O
Raft	O
-	O
Mediated	O
Attachment	O
in	O
the	O
Infection	O
of	O
Cultured	O
Cells	O
by	O
Coronavirus	B-SPEC
Infectious	O
Bronchitis	O
Virus	B-SPEC
Beaudette	O
Strain	O
.	O

However	O
,	O
the	O
exact	O
role	O
of	O
lipid	O
rafts	O
in	O
the	O
cellular	O
membrane	O
during	O
the	O
entry	O
of	O
IBV	B-SPEC
into	O
host	O
cells	O
is	O
still	O
unknown	O
.	O

Given	O
that	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
is	O
a	O
worldwide	O
religious	O
travel	O
destination	O
,	O
localised	O
outbreaks	O
may	O
have	O
massive	O
global	O
implications	O
and	O
effective	O
outbreak	O
preventive	O
measures	O
are	O
needed	O
.	O

This	O
structural	O
modification	O
provided	O
a	O
class	B-SPEC
of	O
compounds	O
which	O
projected	O
an	O
additional	O
vector	O
off	O
the	O
terminus	O
of	O
the	O
acylsulfonamide	O
functionality	O
as	O
a	O
means	O
to	O
drive	O
activity	O
.	O

Langmuir	O
binding	O
analysis	O
determined	O
how	O
the	O
immobilized	O
Ab	O
affinity	O
for	O
the	O
NP	O
-	O
Ab	O
/	O
NS1	O
was	O
impacted	O
by	O
corona	B-SPEC
formation	O
conditions	O
,	O
quantified	O
as	O
an	O
effective	O
dissociation	O
constant	O
,	O
K	O

ABSTRACT	O
:	O
A	O
previously	O
healthy	O
young	O
man	B-SPEC
with	O
a	O
rare	O
genetic	O
condition	O
presented	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
pneumonia	O
with	O
septic	O
shock	O
.	O

As	O
expected	O
,	O
all	O
samples	O
collected	O
from	O
equipment	O
surfaces	O
contained	O
PEDV	B-SPEC
RNA	O
after	O
production	O
of	O
the	O
contaminated	O
feed	O
.	O

RNA	O
extraction	O
and	O
RT	O
-	O
nPCR	O
for	O
FCoV	O
were	O
performed	O
on	O
thirty	O
-	O
two	O
samples	O
(	O
11	O
faeces	O
,	O
9	O
blood	O
,	O
8	O
effusions	O
,	O
and	O
4	O
lymph	O
nodes	O
)	O
collected	O
from	O
27	O
cats	B-SPEC
.	O

Antisera	O
against	O
vaccine	O
strains	O
H120	O
and	O
4	O
/	O
91	O
could	O
not	O
provide	O
effective	O
protection	O
against	O
CK	O
/	O
CH	O
/	O
2010	O
/	O
JT	O
-	O
1	O
in	O
virus	B-SPEC
neutralization	O
assays	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
surveillance	O
of	O
new	O
genotype	O
strains	O
of	O
IBV	B-SPEC
is	O
very	O
important	O
for	O
developing	O
more	O
effective	O
anti	O
-	O
IBV	B-SPEC
strategies	O
.	O

Methods	O
Samples	O
from	O
sick	O
(	O
n	O
=	O
96	O
)	O
and	O
dead	O
(	O
n	O
=	O
15	O
)	O
cats	B-SPEC
were	O
analysed	O
using	O
reverse	O
transcription	O
PCR	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
six	O
FmoPV	O
-	O
positive	O
cats	B-SPEC
showed	O
that	O
the	O
strains	O
were	O
grouped	O
into	O
cluster	O
D	O
and	O
had	O
high	O
similarity	O
(	O
98	O
.	O
5	O
-	O
100	O
%)	O
with	O
strains	O
from	O
Japan	O
and	O
Germany	O
.	O

KM91	O
and	O
the	O
early	O
and	O
NC1	O
viruses	B-SPEC
were	O
included	O
in	O
the	O
North	O
America	O
-	O
Europe	O
lineage	O
,	O
and	O
the	O
recurrent	O
QX	O
-	O
like	O
viruses	B-SPEC
were	O
included	O
in	O
the	O
China	O
lineage	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
is	O
the	O
causative	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
in	O
China	O
and	O
other	O
countries	O
,	O
is	O
responsible	O
for	O
serious	O
economic	O
losses	O
in	O
the	O
pork	O
industry	O
.	O

However	O
,	O
consistently	O
low	O
viral	O
titers	O
are	O
obtained	O
during	O
the	O
propagation	O
of	O
PEDV	B-SPEC
in	O
vitro	O
;	O
this	O
represents	O
a	O
challenge	O
to	O
molecular	O
analyses	O
of	O
the	O
virus	B-SPEC
and	O
vaccine	O
development	O
.	O

Recent	O
research	O
added	O
new	O
data	O
for	O
patients	O
with	O
septic	O
shock	O
and	O
other	O
target	O
groups	O
such	O
as	O
patients	O
with	O
severe	O
sepsis	B-SPEC
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
community	O
-	O
acquired	O
pneumonia	O
,	O
and	O
burns	O
.	O

TITLE	O
:	O
Middle	O
east	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
spike	O
glycoprotein	O
suppresses	O
macrophage	O
responses	O
via	O
DPP4	O
-	O
mediated	O
induction	O
of	O
IRAK	O
-	O
M	O
and	O
PPAR	O
.	O

However	O
,	O
despite	O
this	O
increased	O
knowledge	O
and	O
the	O
study	O
of	O
the	O
infections	O
caused	O
by	O
a	O
range	O
of	O
emerging	O
viruses	B-SPEC
,	O
the	O
therapeutic	O
options	O
still	O
remain	O
limited	O
.	O

This	O
review	O
aims	O
to	O
explore	O
alternative	O
experimental	O
strategies	O
for	O
treating	O
hypercytokinemia	O
induced	O
by	O
the	O
Ebola	O
,	O
avian	B-SPEC
influenza	O
and	O
Dengue	B-SPEC
viruses	I-SPEC
;	O
outlining	O
their	O
modes	O
of	O
action	O
,	O
summarizing	O
their	O
preclinical	O
assessments	O
and	O
potential	O
clinical	O
applications	O
.	O

Despite	O
recent	O
advances	O
in	O
defining	O
many	O
aspects	O
of	O
the	O
pathogenesis	O
of	O
sepsis	B-SPEC
-	O
related	O
MOD	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
there	O
are	O
currently	O
no	O
effective	O
pharmacological	O
or	O
cell	O
-	O
based	O
treatments	O
for	O
the	O
disease	O
.	O

Human	B-SPEC
and	O
animal	B-SPEC
studies	O
have	O
shown	O
that	O
pulmonary	O
thrombosis	O
is	O
common	O
in	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
,	O
and	O
preclinical	O
studies	O
have	O
shown	O
that	O
anticoagulation	O
may	O
improve	O
outcome	O
following	O
sepsis	B-SPEC
challenge	O
.	O

This	O
virus	B-SPEC
was	O
first	O
isolated	O
from	O
a	O
patient	O
who	O
died	O
from	O
severe	O
respiratory	O
illness	O
in	O
June	O
2012	O
in	O
Jeddah	O
,	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

This	O
in	O
situ	O
tag	O
was	O
tolerated	O
by	O
MHV	B-SPEC
and	O
did	O
not	O
affect	O
viral	O
replication	O
.	O

Twin	O
nasopharyngeal	O
/	O
oropharyngeal	O
swabs	O
collected	O
from	O
233	O
patients	O
admitted	O
with	O
an	O
acute	O
AECOPD	O
and	O
tested	O
for	O
respiratory	O
viruses	B-SPEC
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
and	O
B	O
,	O
parainfluenza	O
were	O
(	O
PIV	O
)	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
A	O
and	O
B	O
,	O
influenza	O
A	O
and	O
B	O
,	O
enterovirus	B-SPEC
,	O
corona	B-SPEC
NL65	O
,	O
OC43	O
,	O
and	O
229E	O
viruses	B-SPEC
,	O
adenovirus	B-SPEC
2	O
and	O
4	O
,	O
rhinovirus	B-SPEC
,	O
and	O
bocavirus	B-SPEC
,	O
by	O
duplex	O
real	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
using	O
CDC	O
approved	O
primers	O
and	O
probes	O
.	O

Bronchoalveolar	O
lavage	O
and	O
serological	O
test	O
were	O
positive	O
for	O
mycoplasma	B-SPEC
pneumonia	O
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
we	O
found	O
that	O
inhibition	O
of	O
endosomal	O
acidification	O
only	O
modestly	O
decreased	O
entry	O
,	O
and	O
overexpression	O
of	O
the	O
cell	O
surface	O
protease	O
TMPRSS2	O
greatly	O
enhanced	O
entry	O
,	O
of	O
the	O
highly	O
neurovirulent	O
MHV	B-SPEC
strain	O
JHM	O
.	O
SD	O
relative	O
to	O
their	O
effects	O
on	O
the	O
reference	O
strain	O
,	O
A59	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
one	O
of	O
the	O
main	O
causes	O
of	O
upper	O
respiratory	O
tract	O
infections	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
outbreak	O
in	O
South	O
Korea	O
,	O
2015	O
:	O
epidemiology	O
,	O
characteristics	O
and	O
public	O
health	O
implications	O
.	O

The	O
evaluation	O
of	O
the	O
effect	O
of	O
sesquiterpenoids	O
on	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
replication	O
showed	O
that	O
compounds	O
1	O
-	O
5	O
,	O
12	O
,	O
14	O
,	O
16	O
,	O
17	O
,	O
19	O
,	O
and	O
21	O
increased	O
cell	O
viability	O
against	O
cell	O
death	O
in	O
PEDV	B-SPEC
-	O
injected	O
cells	O
.	O

TITLE	O
:	O
Early	O
endonuclease	O
-	O
mediated	O
evasion	O
of	O
RNA	O
sensing	O
ensures	O
efficient	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
induced	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
lifethreatening	O
disorders	O
.	O

The	O
presented	O
results	O
will	O
provide	O
a	O
basis	O
for	O
further	O
investigations	O
in	O
camelids	O
,	O
especially	O
with	O
respect	O
to	O
the	O
role	O
of	O
the	O
immune	O
response	O
in	O
certain	O
infectious	O
diseases	O
,	O
which	O
harbor	O
a	O
considerable	O
risk	O
to	O
spill	O
over	O
to	O
other	O
species	B-SPEC
.	O

The	O
arteriviruses	B-SPEC
have	O
significantly	O
smaller	O
genomes	O
and	O
form	O
an	O
intriguing	O
package	O
with	O
the	O
coronaviruses	O
to	O
analyse	O
viral	O
RdRp	O
evolution	O
and	O
function	O
.	O

Since	O
glycyrrhizin	O
is	O
a	O
competitive	O
inhibitor	O
of	O
high	O
mobility	O
group	O
box	O
-	O
1	O
(	O
HMGB1	O
),	O
we	O
confirmed	O
that	O
TLR4	O
and	O
RAGE	O
(	O
associated	O
with	O
PEDV	B-SPEC
pathogenesis	O
during	O
the	O
infection	O
in	O
Vero	O
cells	O
.	O

TITLE	O
:	O
Psychobehavioural	O
responses	O
to	O
the	O
2014	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
novel	O
corona	B-SPEC
virus	B-SPEC
(	O
MERS	O
CoV	O
)	O
among	O
adults	O
in	O
two	O
shopping	O
malls	O
in	O
Jeddah	O
,	O
western	O
Saudi	O
Arabia	O
.	O

Peak	O
PEDV	B-SPEC
infection	O
was	O
noted	O
at	O
3	O
dpi	O
compared	O
with	O
4	O
dpi	O
for	O
PDCoV	O
pigs	B-SPEC
as	O
determined	O
by	O
fecal	O
swab	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
RT	O
-	O
PCR	O
).	O

ABSTRACT	O
:	O
Gulf	O
Cooperation	O
Council	O
(	O
GCC	O
)	O
countries	O
bear	B-SPEC
the	O
heaviest	O
brunt	O
of	O
MERS	O
-	O
CoV	O
.	O
This	O
study	O
aims	O
to	O
compare	O
public	O
awareness	O
and	O
practice	O
around	O
MERS	O
-	O
CoV	O
across	O
GCC	O
countries	O
.	O

TITLE	O
:	O
Two	O
Distinct	O
Genotypes	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhoea	I-SPEC
Virus	I-SPEC
in	O
Vaccinated	O
Pig	B-SPEC
Flocks	O
in	O
Shandong	O
Province	O
of	O
China	O
,	O
2012	O
-	O
2015	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
and	O
dromedaries	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
a	O
zoonotic	O
viral	O
disease	O
that	O
can	O
be	O
transmitted	O
from	O
dromedaries	B-SPEC
to	O
human	B-SPEC
beings	O
.	O

No	O
MERS	O
-	O
CoV	O
or	O
antibodies	O
against	O
the	O
virus	B-SPEC
have	O
been	O
detected	O
in	O
camelids	O
other	O
than	O
dromedaries	B-SPEC
.	O

Laboratory	O
diagnosis	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
dromedaries	B-SPEC
can	O
be	O
achieved	O
through	O
virus	B-SPEC
isolation	O
using	O
Vero	O
cells	O
,	O
RNA	O
detection	O
by	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcriptase	O
-	O
PCR	O
and	O
antigen	O
detection	O
using	O
respiratory	O
specimens	O
or	O
serum	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
seroprevalence	O
and	O
selective	O
risk	O
factors	O
for	O
ECoV	O
in	O
5247	O
healthy	O
adult	O
horses	B-SPEC
in	O
the	O
USA	O
,	O
using	O
a	O
recently	O
established	O
and	O
validated	O
IgG	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

TITLE	O
:	O
Interpatient	O
mutational	O
spectrum	O
of	O
human	B-SPEC
coronavirus	I-SPEC
-	O
OC43	O
revealed	O
by	O
illumina	O
sequencing	O
.	O

Two	O
coronavirus	B-SPEC
samples	O
were	O
genotype	O
B	O
and	O
two	O
were	O
genotype	O
D	O
,	O
clustering	O
with	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
strain	O
AY391777	O
in	O
neighbor	O
-	O
joining	O
tree	O
phylogenetic	O
analysis	O
.	O

Two	O
outer	O
-	O
spiral	O
primers	O
comprising	O
of	O
3	O
'	O
sequences	O
complementary	O
to	O
ASFV	B-SPEC
p72	O
gene	O
sequence	O
and	O
5	O
'	O
end	O
sequences	O
complementary	O
to	O
exogenous	O
gene	O
of	O
black	B-SPEC
widow	I-SPEC
alpha	O
-	O
latrotoxin	O
as	O
well	O
as	O
additional	O
ASFV	B-SPEC
specific	O
cross	O
-	O
linking	O
primer	O
.	O

The	O
aim	O
here	O
was	O
to	O
investigate	O
the	O
protective	O
role	O
of	O
epigallocatechin	O
gallate	O
(	O
EGCG	O
)	O
in	O
mitochondrial	O
DNA	O
(	O
mtDNA	O
)-	O
mediated	O
inflammatory	O
responses	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
a	O
rat	B-SPEC
model	O
of	O
thermal	O
injury	O
.	O

All	O
analyses	O
accounted	O
for	O
PICU	B-SPEC
as	O
a	O
cluster	O
variable	O
.	O

Diarrhetic	O
fecal	O
samples	O
from	O
20	O
Hunan	O
farm	O
piglets	O
were	O
tested	O
and	O
found	O
to	O
be	O
positive	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
by	O
RT	O
-	O
PCR	O
,	O
although	O
incubation	O
with	O
porcine	B-SPEC
kidney	O
(	O
PK	O
-	O
15	O
)	O
cells	O
failed	O
to	O
produce	O
infectious	O
PEDV	B-SPEC
.	O

In	O
Saudi	O
Arabia	O
recent	O
significant	O
hospital	O
outbreaks	O
,	O
including	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
have	O
resulted	O
from	O
lack	O
of	O
,	O
or	O
breakdown	O
in	O
,	O
infection	O
prevention	O
and	O
control	O
procedures	O
.	O

Recent	O
outbreaks	O
,	O
including	O
those	O
caused	O
by	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
Ebola	B-SPEC
virus	I-SPEC
,	O
have	O
highlighted	O
the	O
importance	O
of	O
infection	O
control	O
.	O

Analogous	O
to	O
picornavirus	B-SPEC
3C	O
protease	O
(	O
3C	O

Therefore	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
a	O
duplex	O
real	O
-	O
time	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
method	O
for	O
the	O
simultaneous	O
detection	O
of	O
these	O
viruses	B-SPEC
.	O

This	O
study	O
is	O
the	O
first	O
to	O
report	O
the	O
development	O
of	O
an	O
nsp	O
-	O
based	O
ELISA	O
to	O
detect	O
an	O
antibody	O
to	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
epidemiological	O
and	O
clinical	O
factors	O
predictive	O
of	O
the	O
case	O
fatality	O
rate	O
(	O
CFR	O
)	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
an	O
outbreak	O
in	O
Daejeon	O
,	O
the	O
Republic	O
of	O
Korea	O
.	O

TITLE	O
:	O
Intravenous	O
vitamin	O
C	O
as	O
adjunctive	O
therapy	O
for	O
enterovirus	B-SPEC
/	O
rhinovirus	B-SPEC
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
virus	B-SPEC
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
treated	O
with	O
parenteral	O
vitamin	O
C	O
in	O
a	O
patient	O
testing	O
positive	O
for	O
enterovirus	B-SPEC
/	O
rhinovirus	B-SPEC
on	O
viral	O
screening	O
.	O

This	O
report	O
outlines	O
the	O
first	O
use	O
of	O
high	O
dose	O
intravenous	O
vitamin	O
C	O
as	O
an	O
interventional	O
therapy	O
for	O
ARDS	O
,	O
resulting	O
from	O
enterovirus	B-SPEC
/	O
rhinovirus	B-SPEC
respiratory	O
infection	O
.	O

TITLE	O
:	O
Heat	O
shock	O
protein	O
70	O
in	O
lung	O
and	O
kidney	O
of	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
is	O
a	O
receptor	O
-	O
associated	O
protein	O
that	O
interacts	O
with	O
the	O
binding	O
domain	O
of	O
the	O
spike	O
protein	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
explore	O
the	O
effects	O
of	O
continuous	O
blood	O
purification	O
(	O
CBP	O
)	O
treatment	O
in	O
pigs	B-SPEC
affected	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

CBP	O
treatment	O
can	O
improve	O
the	O
organ	O
functions	O
of	O
pigs	B-SPEC
affected	O
with	O
endotoxin	O
-	O
induced	O
ARDS	O
and	O
protect	O
these	O
organs	O
to	O
some	O
extent	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
prompted	O
enhanced	O
surveillance	O
for	O
respiratory	O
infections	O
among	O
pilgrims	O
returning	O
from	O
the	O
Hajj	O
,	O
one	O
of	O
the	O
largest	O
annual	O
mass	O
gatherings	O
in	O
the	O
world	O
.	O

Furthermore	O
,	O
the	O
detection	O
of	O
parvovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
Giardia	B-SPEC
and	O
Cryptosporidium	B-SPEC
was	O
performed	O
in	O
all	O
samples	O
.	O

In	O
the	O
group	O
of	O
dogs	B-SPEC
with	O
diarrhoea	O
the	O
prevalence	O
of	O
DogCV	O
was	O
20	O
.	O
1	O
%	O
(	O
37	O
/	O
184	O
),	O
in	O
the	O
healthy	O
control	O
group	O
it	O
was	O
7	O
.	O
3	O
%	O
(	O
6	O
/	O
82	O
).	O

Evidence	O
of	O
DogCV	O
in	O
clinically	O
healthy	O
dogs	B-SPEC
appears	O
important	O
for	O
the	O
epidemiology	O
and	O
raises	O
questions	O
about	O
its	O
pathogenicity	O
.	O

At	O
the	O
adenoid	O
,	O
virus	B-SPEC
and	O
bacteria	B-SPEC
were	O
similarly	O
detected	O
in	O
both	O
OME	O
and	O
control	O
patients	O
.	O

Although	O
total	O
virus	B-SPEC
detection	O
was	O
not	O
statistically	O
different	O
from	O
controls	O
at	O
the	O
middle	O
ear	O
washes	O
(	O
p	O
=	O
0	O
.	O
065	O
),	O
adenovirus	B-SPEC
was	O
detected	O
in	O
higher	O
proportions	O
in	O
adenoid	O
samples	O
of	O
OME	O
patients	O
than	O
controls	O
(	O
p	O
=	O
0	O
.	O
019	O
).	O

The	O
characteristic	O
inflammatory	O
cells	O
in	O
the	O
lungs	O
of	O
rhesus	B-SPEC
macaques	I-SPEC
and	O
common	B-SPEC
marmosets	I-SPEC
were	O
eosinophils	O
and	O
neutrophils	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
has	O
been	O
endemic	O
causing	O
sporadic	O
outbreaks	O
in	O
Thailand	O
since	O
2007	O
.	O

Whether	O
or	O
not	O
the	O
introduction	O
of	O
exotic	O
strains	O
or	O
continual	O
evolution	O
of	O
existing	O
PEDV	B-SPEC
,	O
genetic	O
analyses	O
would	O
provide	O
a	O
more	O
understanding	O
in	O
its	O
evolutionary	O
pattern	O
.	O

In	O
the	O
study	O
,	O
117	O
complete	O
spike	O
gene	O
sequences	O
of	O
Thai	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
collected	O
from	O
2008	O
to	O
2015	O
were	O
clustered	O
along	O
with	O
95	O
references	O
of	O
PEDV	B-SPEC
spike	O
sequences	O
,	O
and	O
analyzed	O
with	O
the	O
US	O
sequences	O
dataset	O
(	O
n	O
=	O
99	O
).	O

These	O
results	O
are	O
a	O
prelude	O
to	O
advancements	O
in	O
mouse	B-SPEC
H1N1	O
influenza	B-SPEC
virus	I-SPEC
infection	O
biology	O
,	O
as	O
well	O
as	O
the	O
use	O
of	O
mice	B-SPEC
as	O
a	O
model	O
organism	O
for	O
human	B-SPEC
H1N1	O
influenza	B-SPEC
virus	I-SPEC
infection	O
studies	O
.	O

TITLE	O
:	O
Structure	O
of	O
human	B-SPEC
IFIT1	O
with	O
capped	O
RNA	O
reveals	O
adaptable	O
mRNA	O
binding	O
and	O
mechanisms	O
for	O
sensing	O
N1	O
and	O
N2	O
ribose	O
2	O
'-	O
O	O
methylations	O
.	O

This	O
study	O
was	O
conducted	O
with	O
the	O
PEDV	B-SPEC
-	O
infected	O
neonatal	O
piglet	O
model	O
to	O
determine	O
the	O
effect	O
of	O
NAC	O
supplementation	O
on	O
intestinal	O
function	O
.	O

In	O
multiple	O
infections	O
,	O
viral	O
load	O
cannot	O
be	O
used	O
to	O
differentiate	O
between	O
disease	O
causing	O
virus	B-SPEC
and	O
innocent	O
bystanders	O
.	O

As	O
clinicians	O
,	O
we	O
noticed	O
that	O
FN	O
was	O
recovered	O
from	O
PTA	O
patients	O
with	O
increasing	O
frequency	O
and	O
that	O
patients	O
infected	O
with	O
Fusobacterium	B-SPEC
necrophorum	I-SPEC
(	O
FN	O
)	O
seemed	O
to	O
be	O
more	O
severely	O
affected	O
than	O
patients	O
infected	O
with	O
other	O
bacteria	B-SPEC
.	O

Because	O
immune	O
suppression	O
is	O
a	O
major	O
component	O
in	O
the	O
pathology	O
of	O
FIP	O
,	O
we	O
hypothesized	O
that	O
treatment	O
with	O
an	O
immune	O
system	O
stimulant	O
would	O
increase	O
survival	O
times	O
of	O
cats	B-SPEC
with	O
dry	O
FIP	O
.	O

The	O
role	O
of	O
bacteria	B-SPEC
in	O
the	O
natural	O
history	O
of	O
asthma	O
is	O
also	O
beginning	O
to	O
be	O
better	O
understood	O
.	O

WHO	O
'	O
s	O
Immunization	O
,	O
Vaccine	O
and	O
Biologicals	O
(	O
IVB	O
)	O
department	O
is	O
actively	O
working	O
in	O
several	O
pathogen	O
areas	O
on	O
the	O
recommendation	O
of	O
PDVAC	O
,	O
as	O
well	O
as	O
continuing	O
horizon	O
scanning	O
for	O
advances	O
in	O
the	O
development	O
of	O
vaccines	O
that	O
may	O
benefit	O
low	O
and	O
middle	O
income	O
countries	O
(	O
LMICs	O
),	O
such	O
as	O
the	O
recent	O
licensure	O
of	O
the	O
enterovirus	B-SPEC
71	O
(	O
EV71	O
)	O
vaccine	O
in	O
China	O
.	O

ABSTRACT	O
:	O
A	O
fatal	O
case	O
of	O
meningoencephalitis	O
was	O
reported	O
in	O
a	O
13	O
-	O
year	O
-	O
old	O
Koninklijk	O
Warmbloed	O
Paard	O
Nederland	O
stallion	O
,	O
suspected	O
of	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
(	O
WNV	B-SPEC
)	O
infection	O
,	O
in	O
the	O
Piedmont	O
region	O
of	O
Italy	O
.	O

Phylogenetic	O
inference	O
revealed	O
that	O
the	O
isolate	O
belongs	O
to	O
H	B-SPEC
.	I-SPEC
gingivalis	I-SPEC
Lineage	O
3	O
.	O

One	O
hundred	O
PEDV	B-SPEC
-	O
nave	O
gilts	O
were	O
divided	O
into	O
two	O
groups	O
:	O
negative	O
(	O
Neg	O
)	O
and	O
feedback	O
(	O
FB	O
)	O
groups	O
.	O

ABSTRACT	O
:	O
Outbreaks	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
have	O
caused	O
great	O
economic	O
losses	O
to	O
the	O
global	O
pig	B-SPEC
industry	O
.	O

TITLE	O
:	O
The	O
Role	O
of	O
Human	B-SPEC
Parainfluenza	O
Virus	B-SPEC
Infections	O
in	O
the	O
Immunopathology	O
of	O
the	O
Respiratory	O
Tract	O
.	O

TITLE	O
:	O
Attenuation	O
of	O
an	O
original	O
US	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
PC22A	O
via	O
serial	O
cell	O
culture	O
passage	O
.	O

Rotavirus	B-SPEC
vaccines	O
administered	O
to	O
pregnant	O
cows	B-SPEC
are	O
commonly	O
used	O
to	O
provide	O
passive	O
immunity	O
that	O
protects	O
newborn	O
calves	O
from	O
the	O
clinical	O
disease	O
.	O

Enhancement	O
of	O
surveillance	O
of	O
circulating	O
RVA	O
strains	O
in	O
calves	O
across	O
Turkey	B-SPEC
is	O
needed	O
to	O
support	O
ongoing	O
vaccination	O
programs	O
.	O

TITLE	O
:	O
Michael	O
Acceptor	O
-	O
Based	O
Peptidomimetic	O
Inhibitor	O
of	O
Main	O
Protease	O
from	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
.	O

Severe	O
forms	O
represent	O
10	O
%	O
of	O
cases	O
of	O
Plasmodium	B-SPEC
falciparum	I-SPEC
malaria	O
.	O

For	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
),	O
agreement	O
with	O
TTW	O
was	O
moderate	O
for	O
NS	O
and	O
NPS	O
,	O
and	O
good	O
for	O
BAL	O
.	O

RESULTS	O
:	O
Agreement	O
among	O
TTW	O
and	O
NS	O
,	O
TTW	O
and	O
NPS	O
,	O
and	O
TTW	O
and	O
BAL	O
,	O
was	O
very	O
good	O
for	O
identification	O
of	O
P	B-SPEC
.	I-SPEC
multocida	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
haemolytica	I-SPEC
,	O
and	O
M	B-SPEC
.	I-SPEC
bovis	I-SPEC
.	O

TITLE	O
:	O
Respiratory	O
virus	B-SPEC
infection	O
after	O
allogeneic	O
hematopoietic	O
stem	O
cell	O
transplant	O
in	O
a	O
tropical	O
center	O
:	O
Predictive	O
value	O
of	O
the	O
immunodeficiency	O
scoring	O
index	O
.	O

RSV	B-SPEC
,	O
influenza	O
,	O
rhinovirus	B-SPEC
,	O
and	O
parainfluenza	O
were	O
the	O
most	O
common	O
viruses	B-SPEC
.	O

Receiver	O
operating	O
characteristic	O
analysis	O
showed	O
that	O
an	O
ISI	O
of	O
	O
8	O
predicted	O
pneumonia	O
with	O
a	O
positive	O
predictive	O
value	O
of	O
>	O
80	O
%	O
for	O
RVI	O
caused	O
by	O
RSV	B-SPEC
,	O
influenza	O
,	O
adenovirus	B-SPEC
,	O
and	O
parainfluenza	O
,	O
while	O
it	O
was	O
not	O
predictive	O
for	O
coronavirus	B-SPEC
and	O
rhinovirus	B-SPEC
.	O

So	O
far	O
,	O
data	O
on	O
ECoV	O
infection	O
in	O
horses	B-SPEC
remain	O
limited	O
to	O
the	O
USA	O
,	O
France	O
and	O
Japan	O
and	O
its	O
geographic	O
distribution	O
is	O
not	O
well	O
understood	O
.	O

TITLE	O
:	O
Development	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
clones	O
of	O
two	O
porcine	B-SPEC
epidemic	O
diarrhea	O
disease	O
virus	B-SPEC
isolates	O
with	O
different	O
virulence	O
.	O

ABSTRACT	O
:	O
The	O
recently	O
emerged	O
highly	O
virulent	O
variants	O
of	O
porcine	B-SPEC
epidemic	O
and	O
diarrhea	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
remain	O
a	O
huge	O
threat	O
to	O
the	O
worldwide	O
swine	B-SPEC
industry	O
.	O

Thus	O
,	O
we	O
have	O
successfully	O
established	O
a	O
convenient	O
platform	O
for	O
PEDV	B-SPEC
genome	O
manipulation	O
.	O

My	O
colleagues	O
and	O
I	O
are	O
currently	O
testing	O
PELs	O
loaded	O
with	O
numerous	O
candidate	O
drugs	O
in	O
mouse	B-SPEC
models	O
of	O
ARDS	O
,	O
and	O
we	O
are	O
testing	O
drug	O
distribution	O
in	O
live	O
pigs	B-SPEC
and	O
ex	O
vivo	O
human	B-SPEC
lungs	O
.	O

TITLE	O
:	O
The	O
papain	O
-	O
like	O
protease	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
has	O
deubiquitinating	O
activity	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
papain	O
-	O
like	O
proteases	O
(	O
PLPs	O
)	O
can	O
act	O
as	O
proteases	O
that	O
process	O
virus	B-SPEC
-	O
encoded	O
large	O
replicase	O
polyproteins	O
and	O
also	O
as	O
deubiquitinating	O
(	O
DUB	O
)	O
enzymes	O
.	O

Pigs	B-SPEC
do	O
not	O
recapitulate	O
human	B-SPEC
MERS	O
-	O
CoV	O
and	O
are	O
unlikely	O
to	O
constitute	O
a	O
reservoir	O
in	O
nature	O
.	O

Robust	O
,	O
extensive	O
,	O
and	O
timely	O
surveillance	O
is	O
critical	O
for	O
limiting	O
virus	B-SPEC
transmission	O
.	O

However	O
,	O
little	O
knowledge	O
exists	O
on	O
the	O
ability	O
of	O
porcine	B-SPEC
IL	O
-	O
22	O
(	O
pIL	O
-	O
22	O
)	O
to	O
fight	O
against	O
viral	O
infection	O
in	O
the	O
gut	O
.	O

TITLE	O
:	O
Urbanization	O
and	O
the	O
dynamics	O
of	O
RNA	O
viruses	B-SPEC
in	O
Mallards	B-SPEC
(	O
Anas	B-SPEC
platyrhynchos	I-SPEC
).	O

This	O
intra	O
-	O
annual	O
dataset	O
illustrates	O
that	O
these	O
RNA	O
viruses	B-SPEC
exhibit	O
similar	O
annual	O
patterns	O
to	O
IAV	O
,	O
suggesting	O
similar	O
ecological	O
factors	O
are	O
at	O
play	O
.	O

Respiratory	O
copathogens	O
were	O
detected	O
in	O
21	O
episodes	O
(	O
57	O
%),	O
including	O
viruses	B-SPEC
(	O
n	O
=	O
12	O
),	O
fungi	B-SPEC
(	O
n	O
=	O
10	O
),	O
and	O
bacteria	B-SPEC
(	O
n	O
=	O
8	O
).	O

TITLE	O
:	O
Structural	O
Characterization	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
NL63	I-SPEC
N	O
Protein	O
.	O

It	O
is	O
estimated	O
that	O
1	O
to	O
10	O
%	O
of	O
the	O
population	O
suffers	O
annually	O
from	O
cold	O
-	O
like	O
symptoms	O
related	O
to	O
infection	O
with	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
),	O
an	O
alphacoronavirus	B-SPEC
.	O

This	O
result	O
suggests	O
that	O
CES1	O
is	O
inhibited	O
by	O
dexamethasone	O
in	O
humans	B-SPEC
.	O

Importantly	O
,	O
both	O
constructs	O
induced	O
cross	O
-	O
neutralizing	O
Abs	O
against	O
multiple	O
strains	O
of	O
human	B-SPEC
and	O
camel	B-SPEC
origins	O
.	O

Among	O
the	O
virus	B-SPEC
-	O
positive	O
animals	B-SPEC
,	O
nasal	O
swabs	O
were	O
most	O
often	O
positive	O
(	O
97	O
.	O
6	O
%).	O

In	O
addition	O
,	O
145	O
domestic	O
animals	B-SPEC
and	O
109	O
bats	B-SPEC
were	O
sampled	O
.	O

Surveillance	O
for	O
avian	B-SPEC
influenza	O
and	O
Ebola	O
,	O
and	O
diagnosis	O
for	O
BSE	O
were	O
quoted	O
as	O
the	O
capacities	O
most	O
needed	O
.	O

Despite	O
extensive	O
research	O
on	O
the	O
relationship	O
between	O
autophagy	O
and	O
virus	B-SPEC
infection	O
,	O
the	O
concrete	O
role	O
of	O
autophagy	O
in	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
has	O
not	O
been	O
reported	O
.	O

Furthermore	O
,	O
autophagy	O
might	O
be	O
associated	O
with	O
the	O
expression	O
of	O
inflammatory	O
cytokines	O
and	O
have	O
a	O
positive	O
feedback	O
loop	O
with	O
the	O
NF	O
-	O
B	O
signaling	O
pathway	O
during	O
PEDV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
In	O
Egypt	O
,	O
currently	O
two	O
geographically	O
restricted	O
genotypes	O
of	O
the	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
are	O
circulating	O
with	O
detrimental	O
effects	O
for	O
poultry	O
industry	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
in	O
Thailand	O
was	O
first	O
detected	O
in	O
2015	O
.	O

Vaccination	O
of	O
specific	O
pathogen	O
-	O
free	O
chickens	B-SPEC
with	O
the	O
rLaSota	O
-	O
S1	O
strain	O
induced	O
NDV	B-SPEC
hemagglutination	O
inhibition	O
antibodies	O
,	O
and	O
it	O
protected	O
chickens	B-SPEC
from	O
challenge	O
with	O
virulent	O
NDV	B-SPEC
.	O

We	O
found	O
a	O
prevalence	O
of	O
PDCoV	O
(	O
21	O
.	O
8	O
%),	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
65	O
.	O
5	O
%),	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
0	O
%),	O
rotavirus	B-SPEC
group	I-SPEC
A	I-SPEC
(	O
25	O
.	O
0	O
%)	O
and	O
porcine	B-SPEC
kobuvirus	B-SPEC
(	O
68	O
.	O
7	O
%).	O

We	O
isolated	O
13	O
PDCoV	O
strains	O
and	O
discovered	O
that	O
PDCoV	O
infections	O
were	O
often	O
co	O
-	O
infections	O
with	O
kobuvirus	B-SPEC
rather	O
than	O
the	O
commonly	O
linked	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
.	O

Seven	O
CoVs	O
belonging	O
to	O
distinct	O
groups	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
CoVs	O
and	O
	O
-	O
CoVs	O
were	O
detected	O
in	O
samples	O
from	O
least	B-SPEC
horseshoe	I-SPEC
bats	I-SPEC
.	O

TITLE	O
:	O
The	O
NF	O
-	O
B	O
-	O
dependent	O
and	O
-	O
independent	O
transcriptome	O
and	O
chromatin	O
landscapes	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
-	O
infected	O
cells	O
.	O

Using	O
our	O
established	O
rat	B-SPEC
primary	O
type	O
I	O
-	O
like	O
alveolar	O
epithelial	O
cell	O
monolayer	O
stretch	O
model	O
and	O
in	O
vivo	O
rat	B-SPEC
mechanical	O
ventilation	O
that	O
mimics	O
the	O
alveolar	O
overdistension	O
seen	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
we	O
studied	O
epithelial	O
responses	O
to	O
mechanical	O
stress	O
.	O

We	O
compared	O
the	O
performance	O
of	O
2	O
size	O
-	O
differentiating	O
air	O
samplers	O
in	O
disease	O
outbreaks	O
that	O
occurred	O
in	O
swine	B-SPEC
and	O
poultry	O
facilities	O
.	O

Moreover	O
,	O
preincubation	O
of	O
these	O
viruses	B-SPEC
with	O
soluble	O
APN	O
or	O
pretreatment	O
of	O
APN	O
expressing	O
ST	O
cells	O
with	O
soluble	O
TGEV	B-SPEC
-	O
S1	O
blocked	O
TGEV	B-SPEC
infection	O
,	O
but	O
had	O
no	O
effect	O
on	O
infection	O
by	O
PEDV	B-SPEC
.	O

The	O
combined	O
observations	O
indicated	O
that	O
APN	O
is	O
not	O
required	O
for	O
PEDV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
In	O
the	O
last	O
decades	O
,	O
several	O
viruses	B-SPEC
emerged	O
,	O
as	O
the	O
consequence	O
of	O
cross	O
-	O
species	B-SPEC
passage	O
from	O
animal	B-SPEC
reservoirs	O
to	O
human	B-SPEC
being	O
.	O

The	O
nanoparticles	O
modified	O
with	O
amidated	O
TAT	O
peptide	O
(	O
NLpT	O
-	O
CA	O
and	O
NPpT	O
-	O
CA	O
)	O
avoided	O
interactions	O
with	O
LS174T	O
colon	O
cancer	B-SPEC
cells	O
and	O
J774A	O
.	O
1	O
macrophages	O
at	O
pH	O
7	O
.	O
4	O
but	O
restored	O
the	O
ability	O
to	O
interact	O
with	O
LS174T	O
cells	O
at	O
pH	O
6	O
.	O
5	O
,	O
delivering	O
paclitaxel	O
efficiently	O
to	O
the	O
cells	O
following	O
a	O
brief	O
contact	O
time	O
.	O

Clinical	O
microbiological	O
,	O
ventilation	O
and	O
other	O
pertinent	O
PICU	B-SPEC
data	O
were	O
collected	O
.	O

Co	O
-	O
detections	O
(>	O
1	O
respiratory	O
pathogens	O
isolated	O
)	O
occurred	O
in	O
62	O
/	O
237	O
(	O
26	O
.	O
2	O
%)	O
patients	O
and	O
were	O
associated	O
a	O
higher	O
rate	O
of	O
mechanical	O
ventilation	O
,	O
and	O
decreased	O
ventilator	O
and	O
PICU	B-SPEC
free	O
days	O
.	O

The	O
degree	O
of	O
sex	O
bias	B-SPEC
to	O
SARS	O
-	O
CoV	O
infection	O
increased	O
with	O
advancing	O
age	O
,	O
such	O
that	O
middle	O
-	O
aged	O
mice	B-SPEC
showed	O
much	O
more	O
pronounced	O
differences	O
compared	O
with	O
young	O
mice	B-SPEC
.	O

Current	O
evidence	O
suggests	O
that	O
insectivorous	O
bats	B-SPEC
are	O
likely	O
to	O
be	O
the	O
original	O
source	O
,	O
as	O
several	O
2c	O
CoVs	O
have	O
been	O
described	O
from	O
various	O
species	B-SPEC
in	O
the	O
family	B-SPEC

ABSTRACT	O
:	O
Nosocomial	O
transmission	O
is	O
an	O
important	O
characteristic	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

The	O
low	O
-	O
dose	O
PEDV	B-SPEC
-	O
infected	O
mash	O
had	O
6	O
.	O
8	O
	O
1	O
.	O
8	O
cycle	O
threshold	O
(	O
Ct	O
)	O
greater	O
(	O
<	O
0	O
.	O
05	O
)	O
PEDV	B-SPEC
than	O
the	O
high	O
-	O
dose	O
mash	O
.	O

ABSTRACT	O
:	O
The	O
effectiveness	O
of	O
biosecurity	O
methods	O
to	O
mitigate	O
the	O
transmission	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
via	O
farm	O
personnel	O
or	O
contaminated	O
fomites	O
is	O
poorly	O
understood	O
.	O

PEDV	B-SPEC
RNA	O
was	O
detected	O
from	O
rectal	O
swabs	O
of	O
experimentally	O
infected	O
(	O
INF	O
)	O
and	O
sentinel	O
pigs	B-SPEC
by	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
).	O

Virus	B-SPEC
shedding	O
in	O
INF	O
pigs	B-SPEC
peaked	O
at	O
1	O
day	O
post	O
infection	O
(	O
dpi	O
)	O
and	O
viral	O
RNA	O
levels	O
remained	O
elevated	O
through	O
19	O
dpi	O
.	O

In	O
addition	O
,	O
at	O
1	O
dpm	O
,	O
2	O
hair	O
/	O
face	O
swabs	O
from	O
MB	O
personnel	O
were	O
positive	O
;	O
however	O
,	O
transmission	O
of	O
virus	B-SPEC
was	O
not	O
detected	O
.	O

RESULTS	O
:	O
PEDV	B-SPEC
RNA	O
was	O
detected	O
from	O
rectal	O
swabs	O
of	O
experimentally	O
infected	O
(	O
INF	O
)	O
and	O
sentinel	O
pigs	B-SPEC
by	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
).	O

TITLE	O
:	O
Group	B-SPEC
A	I-SPEC
Rotaviruses	I-SPEC
in	O
Chinese	O
Bats	B-SPEC
:	O
Genetic	O
Composition	O
,	O
Serology	O
,	O
and	O
Evidence	O
for	O
Bat	B-SPEC
-	O
to	O
-	O
Human	B-SPEC
Transmission	O
and	O
Reassortment	O
.	O

Currently	O
,	O
8	O
RVA	O
strains	O
possessing	O
completely	O
novel	O
genotype	O
constellations	O
or	O
genotypes	O
possibly	O
originating	O
from	O
other	O
mammals	B-SPEC
have	O
been	O
identified	O
from	O
African	O
and	O
Chinese	O
bats	B-SPEC
.	O

However	O
,	O
all	O
the	O
data	O
were	O
mainly	O
based	O
on	O
detection	O
of	O
RVA	O
RNA	O
,	O
present	O
only	O
during	O
acute	O
infections	O
,	O
which	O
does	O
not	O
permit	B-SPEC
assessment	O
of	O
the	O
true	O
exposure	O
of	O
a	O
bat	B-SPEC
population	O
to	O
RVA	O
.	O

These	O
observations	O
provide	O
evidence	O
for	O
cross	O
-	O
species	B-SPEC
transmission	O
of	O
MSLH14	O
-	O
like	O
bat	B-SPEC
RVAs	O
to	O
humans	B-SPEC
,	O
highlighting	O
the	O
impact	O
of	O
bats	B-SPEC
as	O
reservoirs	O
of	O
RVAs	O
on	O
public	O
health	O
.	O

Current	O
vaccination	O
approaches	O
against	O
this	O
emerging	O
coronavirus	B-SPEC
are	O
only	O
partially	O
effective	O
,	O
though	O
natural	O
infection	O
protects	O
pigs	B-SPEC
against	O
reinfection	O
and	O
provides	O
lactogenic	O
immunity	O
to	O
suckling	O
piglets	O
.	O

Seropositivity	O
rates	O
were	O
higher	O
in	O
large	O
/	O
medium	O
herds	O
(	O
51	O
camels	B-SPEC
)	O
than	O
small	O
herds	O
(	O
p	O
=	O
0	O
.	O
061	O
),	O
in	O
camels	B-SPEC
raised	O
for	O
meat	O
or	O
milk	O
than	O
for	O
transport	O
(	O
p	O
=	O
0	O
.	O
01	O
),	O
and	O
in	O
nomadic	O
or	O
sedentary	O
herds	O
than	O
in	O
herds	O
with	O
a	O
mix	O
of	O
these	O
lifestyles	O
(	O
p	O
<	O
0	O
.	O
005	O
).	O

Emerging	O
infectious	O
diseases	O
are	O
defined	O
as	O
those	O
whose	O
incidence	O
in	O
humans	B-SPEC
has	O
increased	O
in	O
the	O
past	O
two	O
decades	O
or	O
threaten	O
to	O
increase	O
in	O
the	O
near	O
future	O
.	O

ABSTRACT	O
:	O
To	O
help	O
reveal	O
the	O
diversity	O
and	O
evolution	O
of	O
bat	B-SPEC
coronaviruses	O
we	O
collected	O
1067	O
bats	B-SPEC
from	O
21	O
species	B-SPEC
in	O
China	O
.	O

Some	O
camel	B-SPEC
-	O
related	O
activities	O
may	O
pose	O
a	O
higher	O
risk	O
of	O
MERS	O
-	O
CoV	O
infection	O
,	O
as	O
may	O
cross	O
-	O
border	O
movements	O
of	O
camels	B-SPEC
,	O
poor	O
hand	O
hygiene	O
,	O
and	O
overnight	O
hospital	O
stays	O
with	O
respiratory	O
complaints	O
.	O

TITLE	O
:	O
Expression	O
profiles	O
of	O
immune	O
mediators	O
in	O
feline	B-SPEC
Coronavirus	B-SPEC
-	O
infected	O
cells	O
and	O
clinical	O
samples	O
of	O
feline	B-SPEC
Coronavirus	B-SPEC
-	O
positive	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
Cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
continue	O
to	O
be	O
identified	O
and	O
with	O
a	O
lack	O
of	O
effective	O
clinical	O
treatment	O
and	O
no	O
preventative	O
strategies	O
,	O
treatment	O
using	O
convalescent	O
plasma	O
or	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
is	O
a	O
potential	O
quick	O
route	O
to	O
an	O
intervention	O
.	O

A	O
decrease	O
in	O
gross	O
pathology	O
was	O
found	O
only	O
in	O
the	O
mAb	O
-	O
treated	O
group	O
,	O
but	O
no	O
histological	O
differences	O
were	O
observed	O
between	O
treated	O
and	O
control	O
animals	B-SPEC
.	O

TITLE	O
:	O
Lithium	O
chloride	O
inhibits	O
early	O
stages	O
of	O
foot	B-SPEC
-	I-SPEC
and	I-SPEC
-	I-SPEC
mouth	I-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
FMDV	B-SPEC
)	O
replication	O
in	O
vitro	O
.	O

Therefore	O
,	O
the	O
alternative	O
strategy	O
of	O
applying	O
antiviral	O
agents	O
is	O
required	O
to	O
control	O
the	O
spread	O
of	O
FMDV	B-SPEC
in	O
outbreak	O
situations	O
.	O

In	O
this	O
study	O
,	O
our	O
findings	O
were	O
the	O
first	O
to	O
demonstrate	O
that	O
LiCl	O
inhibition	O
of	O
the	O
FMDV	B-SPEC
replication	O
.	O

We	O
screened	O
for	O
both	O
DNA	O
and	O
RNA	O
viruses	B-SPEC
;	O
specifically	O
,	O
astroviruses	O
(	O
AstVs	O
),	O
adenoviruses	B-SPEC
(	O
ADVs	O
),	O
caliciviruses	O
(	O
CalVs	O
),	O
coronaviruses	O
(	O
CoVs	O
),	O
flaviviruses	B-SPEC
,	O
filoviruses	O
,	O
paramyxoviruses	O
(	O
PMVs	O
),	O
polyomaviruses	B-SPEC
(	O
PYVs	O
)	O
and	O
rotaviruses	B-SPEC
.	O

Our	O
findings	O
confirm	O
the	O
presence	O
of	O
diverse	O
viruses	B-SPEC
in	O
Kenyan	O
bats	B-SPEC
while	O
providing	O
extended	O
knowledge	O
on	O
bat	B-SPEC
virus	B-SPEC
distribution	O
.	O

TITLE	O
:	O
Allosteric	O
inhibition	O
of	O
aminopeptidase	O
N	O
functions	O
related	O
to	O
tumor	O
growth	O
and	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Overactive	O
Epidermal	O
Growth	O
Factor	O
Receptor	O
Signaling	O
Leads	O
to	O
Increased	O
Fibrosis	O
after	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

It	O
affects	O
swine	B-SPEC
of	O
all	O
ages	O
causing	O
acute	O
diarrhoea	O
and	O
can	O
lead	O
to	O
severe	O
dehydration	O
and	O
death	O
in	O
suckling	O
piglets	O
.	O

ABSTRACT	O
:	O
Feed	O
contaminated	O
with	O
feces	O
from	O
infected	O
pigs	B-SPEC
is	O
believed	O
to	O
be	O
a	O
potential	O
route	O
of	O
transmission	O
of	O
porcine	B-SPEC
delta	O
coronavirus	B-SPEC
(	O
PDCoV	O
).	O

Both	O
Weibull	O
and	O
log	O
-	O
linear	O
kinetic	O
models	O
were	O
used	O
to	O
analyze	O
virus	B-SPEC
survival	O
curves	O
.	O

The	O
presence	O
of	O
a	O
tail	O
in	O
the	O
virus	B-SPEC
inactivation	O
curves	O
indicated	O
deviations	O
from	O
the	O
linear	O
behavior	O
and	O
hence	O
,	O
the	O
Weibull	O
model	O
was	O
chosen	O
for	O
characterizing	O
the	O
inactivation	O
responses	O
due	O
to	O
the	O
better	O
fit	O
.	O

At	O
recommended	O
concentrations	O
,	O
delta	O
values	O
(	O
days	O
to	O
decrease	O
virus	B-SPEC
concentration	O
by	O
1	O
log	O
)	O
ranged	O
from	O
0	O
.	O
62	O
-	O
1	O
.	O
72	O
days	O
,	O
but	O
there	O
were	O
no	O
differences	O
on	O
virus	B-SPEC
survival	O
among	O
feed	O
samples	O
with	O
or	O
without	O
additives	O
at	O
the	O
manufacturers	O
recommended	O
concentrations	O
.	O

ABSTRACT	O
:	O
In	O
May	O
of	O
2013	O
,	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
detected	O
in	O
swine	B-SPEC
for	O
the	O
first	O
time	O
in	O
North	O
America	O
.	O

Three	O
-	O
week	O
-	O
old	O
barrows	O
were	O
inoculated	O
intragastrically	O
with	O
5	O
mL	O
of	O
PEDV	B-SPEC
-	O
negative	O
feces	O
for	O
the	O
negative	O
control	O
,	O
5	O
mL	O
of	O
untreated	O
PEDV	B-SPEC
-	O
positive	O
feces	O
for	O
the	O
positive	O
control	O
,	O
and	O
5	O
mL	O
or	O
10	O
mL	O
of	O
PEDV	B-SPEC
-	O
positive	O
feces	O
that	O
was	O
subjected	O
to	O
treatment	O
with	O
a	O
1	O
:	O
16	O
or	O
1	O
:	O
32	O
concentrations	O
of	O
accelerated	O
hydrogen	O
peroxide	O
disinfectant	O
for	O
a	O
contact	O
time	O
of	O
30	O
min	O
at	O
20	O
	O
C	O
.	O

TITLE	O
:	O
Cross	O
-	O
sectional	O
survey	O
of	O
selected	O
enteric	O
viruses	B-SPEC
in	O
Polish	O
turkey	B-SPEC
flocks	O
between	O
2008	O
and	O
2011	O
.	O

The	O
present	O
study	O
aimed	O
at	O
determination	O
of	O
the	O
prevalence	O
of	O
four	O
enteric	O
viruses	B-SPEC
,	O
namely	O
astrovirus	O
,	O
coronavirus	B-SPEC
,	O
parvovirus	B-SPEC
and	O
rotavirus	B-SPEC
in	O
meat	O
-	O
type	O
turkey	B-SPEC
flocks	O
in	O
Poland	O
as	O
well	O
as	O
at	O
statistical	O
evaluation	O
of	O
the	O
occurrence	O
of	O
the	O
studied	O
viruses	B-SPEC
and	O
their	O
relationships	O
with	O
the	O
health	O
status	O
and	O
the	O
age	O
of	O
birds	B-SPEC
.	O

Two	O
hundred	O
and	O
seven	O
flocks	O
of	O
birds	B-SPEC
aged	O
1	O
-	O
20	O
weeks	O
originating	O
from	O
different	O
regions	O
of	O
the	O
country	O
were	O
investigated	O
between	O
2008	O
and	O
2011	O
.	O

Applied	O
statistical	O
methods	O
have	O
indicated	O
the	O
dependence	O
of	O
rotavirus	B-SPEC
infection	O
as	O
well	O
as	O
the	O
co	O
-	O
infection	O
with	O
multiple	O
viruses	B-SPEC
and	O
the	O
health	O
status	O
of	O
turkeys	B-SPEC
.	O

However	O
,	O
the	O
presented	O
results	O
provide	O
valuable	O
feedback	O
which	O
could	O
help	O
to	O
evaluate	O
the	O
role	O
of	O
some	O
enteric	O
viruses	B-SPEC
in	O
the	O
etiology	O
of	O
enteritis	O
in	O
turkey	B-SPEC
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
reportedly	O
induced	O
the	O
production	O
of	O
TGF	O
-	O
1	O
through	O
p38	O
MAPK	O
/	O
STAT3	O
-	O
meidated	O
Egr	O
-	O
1	O
-	O
dependent	O
activation	O
(	O
Sci	O
.	O

Furthermore	O
,	O
the	O
potential	O
emergence	O
of	O
highly	O
pathogenic	O
strains	O
of	O
influenza	B-SPEC
virus	I-SPEC
poses	O
a	O
significant	O
public	O
health	O
threat	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
DE	O
as	O
adjuvant	O
in	O
an	O
Ark	O
-	O
DPI	O
live	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccine	O
after	O
ocular	O
or	O
spray	O
application	O
.	O

In	O
this	O
work	O
,	O
we	O
provide	O
evidence	O
that	O
MERS	O
CoV	O
3CLpro	O
and	O
PLpro	O
are	O
subject	O
to	O
different	O
genetic	O
and	O
evolutionary	O
influences	O
that	O
shape	O
the	O
protein	O
sequence	O
,	O
codon	O
usage	O
pattern	O
,	O
and	O
codon	O
usage	O
bias	B-SPEC
.	O

TITLE	O
:	O
C	O
-	O
C	O
Motif	O
Chemokine	O
Ligand	O
2	O
(	O
CCL2	O
)	O
Mediates	O
Acute	O
Lung	O
Injury	O
Induced	O
by	O
Lethal	O
Influenza	O
H7N9	O
Virus	B-SPEC
.	O

The	O
results	O
suggested	O
a	O
close	O
association	O
between	O
C	O
-	O
C	O
motif	O
chemokine	O
ligand	O
2	O
(	O
CCL2	O
)	O
expressions	O
and	O
ALI	O
induced	O
by	O
a	O
lethal	O
H7N9	O
virus	B-SPEC
strain	O
(	O
A	O
/	O
Hebei	O
/	O
01	O
/	O
2013	O
).	O

This	O
is	O
a	O
syndrome	O
that	O
in	O
some	O
ways	O
mimics	O
severe	O
sepsis	B-SPEC
with	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
possibly	O
requiring	O
a	O
ventilator	O
and	O
vasopressor	O
support	O
.	O

To	O
address	O
these	O
limitations	O
,	O
we	O
examined	O
a	O
next	O
-	O
generation	O
sequencing	O
(	O
NGS	O
)	O
and	O
iterative	O
mapping	O
approach	O
for	O
virus	B-SPEC
detection	O
in	O
clinical	O
samples	O
.	O

These	O
results	O
demonstrate	O
that	O
this	O
NGS	O
pipeline	O
allows	O
to	O
detect	O
viruses	B-SPEC
which	O
were	O
not	O
identified	O
by	O
routine	O
diagnostic	O
assays	O
,	O
directly	O
from	O
clinical	O
samples	O
.	O

The	O
single	O
cat	B-SPEC
with	O
peripheral	O
blood	O
replication	O
had	O
a	O
unique	O
partial	O
M	O
gene	O
sequence	O
distinct	O
from	O
positive	O
controls	O
and	O
previously	O
published	O
FCoV	O
sequences	O
.	O

TITLE	O
:	O
Update	O
in	O
the	O
treatment	O
of	O
non	O
-	O
influenza	O
respiratory	O
virus	B-SPEC
infection	O
in	O
solid	O
organ	O
transplant	O
recipients	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
the	O
number	O
one	O
cause	O
of	O
lung	O
injury	O
in	O
adults	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
encode	O
multifunctional	O
papain	O
-	O
like	O
proteases	O
(	O
PLPs	O
)	O
that	O
have	O
the	O
ability	O
to	O
process	O
the	O
viral	O
polyprotein	O
to	O
facilitate	O
RNA	O
replication	O
and	O
antagonize	O
the	O
host	O
innate	O
immune	O
response	O
.	O

TITLE	O
:	O
Infectivity	O
of	O
an	O
Asymptomatic	O
Patient	O
With	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
shown	O
to	O
infect	O
both	O
humans	B-SPEC
and	O
dromedary	B-SPEC
camels	B-SPEC
using	O
dipeptidyl	O
peptidase	O
-	O
4	O
(	O
DPP4	O
)	O
as	O
its	O
receptor	O
.	O

In	O
the	O
insectivorous	O
bats	B-SPEC
,	O
however	O
,	O
DPP4	O
expression	O
in	O
epithelial	O
cells	O
of	O
the	O
respiratory	O
tract	O
was	O
almost	O
absent	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
a	O
porcine	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
which	O
causes	O
lethal	O
severe	O
watery	O
diarrhea	O
in	O
piglets	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
TGEV	B-SPEC
infection	O
activates	O
transcription	O
factors	O
NF	O
-	O
B	O
,	O
IRF3	O
and	O
AP	O
-	O
1	O
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
in	O
porcine	B-SPEC
kidney	O
cells	O
.	O

Further	O
investigations	O
are	O
needed	O
to	O
better	O
understand	O
the	O
right	O
level	O
of	O
anticoagulation	O
in	O
ECMO	O
,	O
and	O
the	O
factors	O
to	O
take	O
into	O
account	O
in	O
order	B-SPEC
to	O
manage	O
personalized	O
transfusion	O
practice	O
in	O
this	O
select	O
setting	O
.	O

Additionally	O
,	O
ileum	O
gas	O
was	O
detected	O
for	O
ten	O
of	O
the	O
sixteen	O
cases	O
in	O
the	O
upper	O
abdomen	O
during	O
assessment	O
with	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infectivity	O
in	O
human	B-SPEC
embryonic	O
kidney	O
cells	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
that	O
human	B-SPEC
embryonic	O
kidney	O
293	O
(	O
HEK293	O
)	O
cells	O
were	O
susceptible	O
to	O
infection	O
with	O
PEDV	B-SPEC
vaccine	O
strain	O
CV777	O
(	O
G1	O
subtype	O
)	O
and	O
field	O
isolate	O
LNCT2	O
(	O
G2	O
subtype	O
).	O

No	O
satellite	O
groups	O
were	O
observed	O
for	O
Mass	O
-	O
type	O
viruses	B-SPEC
,	O
which	O
is	O
consistent	O
with	O
no	O
persistence	O
of	O
this	O
vaccine	O
type	O
in	O
the	O
field	O
.	O

The	O
article	O
argues	O
that	O
to	O
realize	O
the	O
full	O
potential	O
of	O
a	O
transparent	O
disease	O
outbreak	O
reporting	O
process	O
,	O
there	O
is	O
a	O
need	O
for	O
a	O
human	B-SPEC
rights	O
framework	O
that	O
expressly	O
articulates	O
its	O
right	O
to	O
receive	O
reports	O
and	O
outlines	O
appropriate	O
behaviour	O
for	O
the	O
WHO	O
,	O
states	O
,	O
and	O
non	O
-	O
state	O
actors	O
.	O

HMPV	B-SPEC
was	O
the	O
most	O
predominant	O
virus	B-SPEC
.	O

There	O
are	O
no	O
peer	O
-	O
reviewed	O
publications	O
on	O
viral	O
infections	O
of	O
the	O
baboons	B-SPEC
of	O
KSA	O
.	O

The	O
biopolymer	O
was	O
obtained	O
by	O
crosslinking	O
of	O
chitosan	O
(	O
CHIT	O
)	O
with	O
genipin	O
,	O
a	O
nontoxic	O
compound	O
of	O
plant	B-SPEC
origin	O
,	O
in	O
inverted	O
emulsion	O
and	O
reacting	O
the	O
chitosan	O
nano	O
/	O
microspheres	O
obtained	O
(	O
CHIT	O
-	O
NS	O
/	O
MS	O
)	O
with	O
glycidyltrimethyl	O
-	O
ammonium	O
chloride	O
(	O
GTMAC	O
).	O

By	O
studying	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
caused	O
by	O
these	O
viruses	B-SPEC
and	O
performing	O
PCR	O
analyses	O
it	O
was	O
found	O
HTCC	O
-	O
NS	O
/	O
MS	O
strongly	O
adsorb	O
the	O
particles	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
virus	B-SPEC
,	O
moderately	O
adsorb	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
particles	O
,	O
but	O
do	O
not	O
adsorb	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
that	O
generate	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
intermediates	O
during	O
replication	O
,	O
yet	O
evade	O
detection	O
by	O
host	O
innate	O
immune	O
sensors	O
.	O

RESULTS	O
:	O
A	O
57	O
-	O
year	O
-	O
old	O
man	B-SPEC
rapidly	O
had	O
severe	O
vomiting	O
and	O
diarrhea	O
2	O
h	O
after	O
a	O
meal	O
.	O

TITLE	O
:	O
A	O
Novel	O
Porcine	B-SPEC
Model	O
of	O
Septic	O
Shock	O
Induced	O
by	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
due	O
to	O
Methicillin	O
-	O
resistant	O
ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
one	O
of	O
the	O
main	O
causes	O
of	O
mortality	O
in	O
critically	O
ill	O
patients	O
following	O
progression	O
to	O
septic	O
shock	O
.	O

TITLE	O
:	O
Deletion	O
of	O
a	O
197	O
-	O
Amino	O
-	O
Acid	O
Region	O
in	O
the	O
N	O
-	O
Terminal	O
Domain	O
of	O
Spike	O
Protein	O
Attenuates	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
in	O
Piglets	O
.	O

To	O
investigate	O
whether	O
infection	O
with	O
TC	O
-	O
PC177	O
can	O
induce	O
cross	O
-	O
protection	O
against	O
challenge	O
with	O
a	O
highly	O
virulent	O
PEDV	B-SPEC
strain	O
,	O
all	O
the	O
surviving	O
piglets	O
were	O
challenged	O
with	O
PC21A	O
at	O
3	O
weeks	O
postinoculation	O
.	O

To	O
investigate	O
whether	O
this	O
197	O
-	O
aa	O
deletion	O
was	O
the	O
determinant	O
for	O
the	O
attenuation	O
of	O
TC	O
-	O
PC177	O
,	O
we	O
generated	O
a	O
mutant	O
(	O
icPC22A	O
-	O
S1197	O
)	O
bearing	O
the	O
197	O
-	O
aa	O
deletion	O
from	O
an	O
infectious	O
cDNA	O
clone	O
of	O
the	O
highly	O
virulent	O
PEDV	B-SPEC
PC22A	O
strain	O
(	O
infectious	O
clone	O
PC22A	O
,	O
icPC22A	O
).	O

TITLE	O
:	O
ABSTRACT	O
:	O
At	O
different	O
time	O
points	O
spanning	O
6	O
months	O
,	O
three	O
adopted	O
feral	O
flea	B-SPEC
-	O
infested	O
cats	B-SPEC
,	O
residing	O
in	O
the	O
household	O
of	O
a	O
veterinary	O
technician	O
,	O
became	O
acutely	O
anorexic	O
,	O
lethargic	O
and	O
febrile	O
.	O

The	O
developed	O
assay	O
has	O
been	O
tested	O
on	O
numerous	O
field	O
samples	O
and	O
revealed	O
3	O
	O
15	O
%	O
prevalence	O
of	O
this	O
lineage	O
of	O
IBV	B-SPEC
in	O
Polish	O
chicken	B-SPEC
population	O
.	O

Aqueous	O
humor	O
samples	O
of	O
one	O
cat	B-SPEC
with	O
FIP	O
and	O
of	O
one	O
control	O
cat	B-SPEC
were	O
excluded	O
from	O
statistical	O
analysis	O
.	O

Our	O
studies	O
showed	O
that	O
IL	O
-	O
33	O
administration	O
in	O
a	O
MHV	B-SPEC
-	O
3	O
infection	O
promoted	O
survival	O
during	O
FH	O
,	O
with	O
a	O
significant	O
reduction	O
in	O
FGL2	O
expression	O
and	O
liver	O
inflammation	O
.	O

RESULTS	O
:	O
Flow	O
cytometry	O
markers	O
CD38	O
and	O
CD73	O
characterizing	O
murine	B-SPEC
Bmem	O
from	O
lymphoid	O
tissue	O
showed	O
more	O
diverse	O
expression	O
patterns	O
on	O
corresponding	O
CNS	O
-	O
derived	O
B	O
cell	O
subsets	O
.	O

Both	O
strains	O
have	O
a	O
common	O
genome	O
organization	O
in	O
the	O
order	B-SPEC
of	O
5	O
'-	O
UTR	O
-	O
1a	O
-	O
1b	O
-	O
S	O
-	O
3a	O
-	O
3b	O
-	O
E	O
-	O
M	O
-	O
4b	O
-	O
4c	O
-	O
5a	O
-	O
5b	O
-	O
N	O
-	O
6b	O
-	O
UTR	O
-	O
poly	O
(	O
A	O
)	O
tail	O
-	O
3	O
'.	O

Most	O
EIDs	O
appear	O
to	O
result	O
from	O
increased	O
contact	O
between	O
wildlife	O
and	O
humans	B-SPEC
,	O
especially	O
when	O
humans	B-SPEC
encroach	O
into	O
formerly	O
pristine	O
habitats	O
.	O

In	O
contrast	O
to	O
our	O
hypothesis	O
,	O
anthropogenic	O
habitat	O
disturbance	O
was	O
not	O
associated	O
with	O
corona	B-SPEC
-	O
and	O
astrovirus	O
detection	O
rates	O
in	O
fecal	O
samples	O
.	O

After	O
a	O
proposed	O
bat	B-SPEC
to	O
camel	B-SPEC
switching	O
event	O
,	O
transmission	O
of	O
MERS	O
-	O
CoV	O
to	O
humans	B-SPEC
is	O
likely	O
to	O
have	O
been	O
the	O
result	O
of	O
multiple	O
zoonotic	O
transfers	O
from	O
dromedary	B-SPEC
camels	B-SPEC
.	O

The	O
broad	O
-	O
spectrum	O
antiviral	O
nitazoxanide	O
has	O
been	O
shown	O
to	O
have	O
in	O
vitro	O
activity	O
against	O
MERS	O
-	O
CoV	O
.	O
Synthetic	O
peptides	O
and	O
candidate	O
vaccines	O
based	O
on	O
regions	O
of	O
the	O
spike	O
protein	O
have	O
shown	O
promise	O
in	O
rodent	B-SPEC
and	O
non	O
-	O
human	B-SPEC
primate	B-SPEC
models	O
.	O

This	O
study	O
might	O
contribute	O
to	O
an	O
understanding	O
of	O
the	O
pathogenesis	O
of	O
PEDV	B-SPEC
infection	O
and	O
aid	O
in	O
the	O
development	O
of	O
effective	O
preventive	O
and	O
control	O
vaccines	O
.	O

Herein	O
,	O
we	O
report	O
a	O
unique	O
CRCoV	O
strain	O
,	O
denoted	O
strain	O
BJ232	O
,	O
derived	O
from	O
a	O
CRCoV	O
-	O
positive	O
dog	B-SPEC
with	O
a	O
mild	O
respiratory	O
infection	O
.	O

Relieving	O
Ulk1	O
mRNA	O
repression	O
in	O
primary	O
cortical	O
neurons	O
by	O
miR	O
-	O
142	O
-	O
5p	O
antagomirs	O
or	O
replication	O
-	O
deficient	O
adenoviruses	B-SPEC
encoding	O
Ulk1	O
(	O
Ad5	O
-	O
Ulk1	O
),	O
which	O
improved	O
rescue	O
of	O
nerve	O
injury	O
,	O
restricted	O
viral	O
replication	O
,	O
and	O
increased	O
survival	O
rate	O
in	O
mice	B-SPEC
underlying	O
PHEV	O
infection	O
.	O

It	O
can	O
also	O
be	O
a	O
tool	O
for	O
decisions	O
concerning	O
patient	O
logistics	O
,	O
in	O
order	B-SPEC
to	O
minimize	O
exposure	O
of	O
susceptible	O
patients	O
and	O
personnel	O
.	O

Leukemia	O
inhibitory	O
factor	O
(	O
LIF	O
),	O
a	O
member	O
of	O
the	O
IL	O
-	O
6	O
cytokine	O
family	B-SPEC
,	O
is	O
a	O
critical	O
determinant	O
of	O
lung	O
tissue	O
protection	O
during	O
pneumonia	O
,	O
but	O
the	O
cellular	O
sources	O
of	O
LIF	O
and	O
the	O
signaling	O
pathways	O
leading	O
to	O
its	O
production	O
in	O
the	O
infected	O
lung	O
are	O
not	O
known	O
.	O

SPF	O
chickens	B-SPEC
were	O
divided	O
into	O
four	O
groups	O
(	O
n	O
=	O
20	O
).	O

TITLE	O
:	O
Genetic	O
variability	O
of	O
the	O
S1	O
subunit	O
of	O
enteric	O
and	O
respiratory	O
bovine	B-SPEC
coronavirus	B-SPEC
isolates	O
.	O

In	O
sum	O
,	O
we	O
identified	O
two	O
host	O
proteases	O
,	O
TMPRSS2	O
and	O
MSPL	O
,	O
which	O
may	O
provide	O
insights	O
and	O
a	O
novel	O
method	O
for	O
enhancing	O
viral	O
titers	O
,	O
expanding	O
virus	B-SPEC
production	O
,	O
and	O
improving	O
the	O
adaptability	O
of	O
PEDV	B-SPEC
isolates	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Data	O
from	O
in	O
-	O
vitro	O
,	O
animal	B-SPEC
,	O
and	O
human	B-SPEC
lung	O
injury	O
models	O
suggest	O
that	O
keratinocyte	O
growth	O
factor	O
(	O
KGF	O
)	O
might	O
be	O
beneficial	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Japanese	O
horse	B-SPEC
chestnut	O
(	O
seed	O
of	O
Aesculus	B-SPEC
turbinata	I-SPEC
)	O
contains	O
many	O
saponin	O
mixtures	O
,	O
called	O
escins	O
,	O
and	O
has	O
been	O
used	O
for	O
a	O
long	O
time	O
as	O
a	O
traditional	O
medicinal	O
plant	B-SPEC
.	O

Our	O
results	O
suggest	O
that	O
escin	O
derivatives	O
showed	O
strong	O
inhibitory	O
activities	O
on	O
PEDV	B-SPEC
replication	O
with	O
lowered	O
cytotoxicity	O
.	O

These	O
studies	O
propose	O
a	O
method	O
to	O
utilize	O
Japanese	O
horse	B-SPEC
chestnut	O
for	O
treating	O
PEDV	B-SPEC
and	O
to	O
increase	O
the	O
diversity	O
of	O
its	O
bioactive	O
compounds	O
.	O

We	O
found	O
that	O
the	O
CMR	O
data	O
analysis	O
supported	O
grouping	O
of	O
infectious	O
bats	B-SPEC
into	O
persistently	O
and	O
transiently	O
infectious	O
bats	B-SPEC
.	O

This	O
study	O
supports	O
the	O
role	O
of	O
CanineCV	O
as	O
a	O
co	O
-	O
pathogen	O
in	O
the	O
development	O
of	O
gastrointestinal	O
disease	O
,	O
mainly	O
acting	O
in	O
synergism	O
with	O
other	O
enteric	O
viruses	B-SPEC
.	O

These	O
results	O
highlight	O
the	O
potential	O
spillover	O
of	O
vaccine	O
-	O
viruses	B-SPEC
probably	O
due	O
to	O
extensive	O
use	O
of	O
live	O
-	O
attenuated	O
vaccines	O
in	O
the	O
commercial	O
poultry	O
,	O
and	O
close	O
interaction	O
between	O
domesticated	O
and	O
wild	O
bird	B-SPEC
populations	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
HKU1	O
is	O
a	O
pathogen	O
causing	O
acute	O
respiratory	O
illnesses	O
and	O
so	O
far	O
little	O
is	O
known	O
about	O
its	O
biology	O
.	O

ABSTRACT	O
:	O
A	O
genogroup	O
2b	O
(	O
G2b	O
)	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
Taiwan	O
Pintung	O
52	O
(	O
PEDVPT	O
)	O
strain	O
was	O
isolated	O
in	O
2014	O
.	O

Inactivation	O
kinetics	O
were	O
determined	O
using	O
the	O
Weibull	O
model	O
,	O
which	O
estimates	O
a	O
delta	O
value	O
indicating	O
the	O
time	O
necessary	O
to	O
reduce	O
virus	B-SPEC
concentration	O
by	O
1	O
log	O
.	O

High	O
delta	O
values	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
were	O
observed	O
in	O
soybean	B-SPEC
meal	O
for	O
PDCoV	O
(	O
42	O
.	O
04	O
days	O
)	O
and	O
TGEV	B-SPEC
(	O
42	O
.	O
00	O
days	O
).	O

There	O
was	O
a	O
moderate	O
correlation	O
between	O
moisture	O
content	O
and	O
the	O
delta	O
value	O
for	O
PDCoV	O
(	O
r	O
=	O
0	O
.	O
49	O
,	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
TGEV	B-SPEC
(	O
r	O
=	O
0	O
.	O
41	O
,	O
P	O
=	O
0	O
.	O
02	O
).	O

Co	O
-	O
crystallization	O
studies	O
further	O
revealed	O
critical	O
molecular	O
interactions	O
between	O
UbVs	O
and	O
MERS	O
-	O
CoV	O
or	O
CCHFV	B-SPEC
vDUBs	O
,	O
accounting	O
for	O
the	O
observed	O
binding	O
specificity	O
and	O
high	O
affinity	O
.	O

It	O
comprises	O
of	O
a	O
minimum	O
of	O
32	O
%	O
zinc	O
phosphide	O
which	O
is	O
highly	O
toxic	O
in	O
acute	O
exposures	O
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
Detection	O
of	O
alpha	O
-	O
and	O
betacoronaviruses	O
in	O
rodents	B-SPEC
from	O
Yunnan	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Rodents	B-SPEC
represent	O
the	O
most	O
diverse	O
mammals	B-SPEC
on	O
the	O
planet	O
and	O
are	O
important	O
reservoirs	O
of	O
human	B-SPEC
pathogens	O
.	O

In	O
this	O
study	O
,	O
we	O
collected	O
177	O
intestinal	O
samples	O
from	O
thress	O
species	B-SPEC
of	O
rodents	B-SPEC
in	O
Jianchuan	O
County	O
,	O
Yunnan	O
Province	O
,	O
China	O
.	O

Both	O
alphacoronaviruses	O
and	O
betacoronaviruses	O
were	O
detected	O
in	O
Apodemus	B-SPEC
chevrieri	I-SPEC
in	O
the	O
Yunnan	O
Province	O
of	O
China	O
,	O
indicating	O
that	O
Apodemus	B-SPEC
chevrieri	I-SPEC
is	O
an	O
important	O
host	O
for	O
coronavirus	B-SPEC
.	O

Murine	B-SPEC
models	O
are	O
commonly	O
used	O
to	O
study	O
the	O
pathogenesis	O
of	O
respiratory	O
viral	O
infections	O
,	O
and	O
in	O
vitro	O
studies	O
using	O
murine	B-SPEC
cells	O
provide	O
mechanistic	O
insight	O
into	O
the	O
pathogenesis	O
observed	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
A	O
total	O
130	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
were	O
identified	O
during	O
a	O
large	O
hospital	O
outbreak	O
in	O
Saudi	O
Arabia	O
;	O
87	O
patients	O
and	O
43	O
healthcare	O
workers	O
.	O

Presently	O
,	O
there	O
is	O
no	O
effective	O
PEDV	B-SPEC
vaccine	O
available	O
.	O

TITLE	O
:	O
Rapid	O
development	O
of	O
vaccines	O
against	O
emerging	O
pathogens	O
:	O
The	O
replication	O
-	O
deficient	O
simian	O
adenovirus	B-SPEC
platform	O
technology	O
.	O

In	O
order	B-SPEC
to	O
be	O
better	O
prepared	O
for	O
future	O
outbreaks	O
of	O
known	O
human	B-SPEC
pathogens	O
,	O
platform	O
technologies	O
to	O
accelerate	O
vaccine	O
development	O
should	O
be	O
employed	O
,	O
allowing	O
vaccine	O
developers	O
to	O
take	O
advantage	O
of	O
detailed	O
knowledge	O
of	O
the	O
vaccine	O
platform	O
and	O
facilitating	O
rapid	O
progress	O
to	O
clinical	O
trials	O
and	O
eventually	O
to	O
vaccine	O
stockpiles	O
.	O

ABSTRACT	O
:	O
MERS	O
-	O
CoV	O
infection	O
emerged	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
)	O
in	O
2012	O
and	O
has	O
spread	O
to	O
26	O
countries	O
.	O

In	O
this	O
study	O
,	O
we	O
collected	O
1004	O
samples	O
involving	O
10	O
bat	B-SPEC
species	B-SPEC
from	O
7	O
sites	O
from	O
April	O
2015	O
to	O
May	O
2016	O
,	O
and	O
examined	O
the	O
presence	O
of	O
viruses	B-SPEC
using	O
nucleic	O
acid	O
-	O
based	O
methods	O
.	O

The	O
agreement	O
between	O
an	O
automatic	O
nucleic	O
extraction	O
/	O
RT	O
-	O
iiPCR	O
system	O
and	O
virus	B-SPEC
isolation	O
to	O
detect	O
FeLV	O
in	O
plasma	O
or	O
serum	O
was	O
95	O
.	O
69	O
%	O
(	O
	O
=	O
0	O
.	O
95	O
)	O
and	O
98	O
.	O
67	O
%	O
(	O
	O
=	O
0	O
.	O
85	O
)	O
in	O
a	O
retrospective	O
(	O
n	O
=	O
116	O
)	O
and	O
a	O
prospective	O
(	O
n	O
=	O
150	O
)	O
study	O
,	O
respectively	O
.	O

This	O
was	O
an	O
observational	O
study	O
of	O
patients	O
with	O
VZV	B-SPEC
-	O
CAP	O
admitted	O
to	O
29	O
intensive	O
care	O
units	O
(	O
ICUs	O
)	O
from	O
January	O
1996	O
to	O
January	O
2015	O
.	O

Half	O
the	O
patients	O
received	O
mechanical	O
ventilation	O
within	O
1	O
(	O
1	O
-	O
2	O
)	O
day	O
following	O
ICU	O
admission	O
(	O
the	O
ratio	O
of	O
arterial	O
oxygen	O
partial	O
pressure	O
to	O
fractional	O
inspired	O
oxygen	O
(	O
PaO	O
Severe	O
VZV	B-SPEC
-	O
CAP	O
is	O
responsible	O
for	O
an	O
acute	O
pulmonary	O
involvement	O
associated	O
with	O
a	O
significant	O
morbidity	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
Emerging	O
viruses	B-SPEC
such	O
as	O
HIV	B-SPEC
,	O
dengue	O
,	O
influenza	O
A	O
,	O
SARS	O
coronavirus	B-SPEC
,	O
Ebola	O
,	O
and	O
other	O
viruses	B-SPEC
pose	O
a	O
significant	O
threat	O
to	O
human	B-SPEC
health	O
.	O

This	O
study	O
estimated	O
a	O
total	O
loss	O
of	O
51	O
L	O
/	O
cow	B-SPEC
during	O
the	O
study	O
period	O
,	O
from	O
7	O
d	O
before	O
to	O
19	O
d	O
after	O
a	O
reported	O
outbreak	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
with	O
a	O
recombinant	O
S	O
gene	O
detected	O
in	O
Hungary	O
,	O
2016	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
can	O
cause	O
a	O
severe	O
enteric	O
disease	O
affecting	O
pigs	B-SPEC
of	O
all	O
ages	O
.	O

The	O
present	O
report	O
describes	O
the	O
first	O
porcine	B-SPEC
epidemic	O
diarrhoea	O
outbreak	O
in	O
Hungary	O
after	O
many	O
years	O
and	O
gives	O
an	O
insight	O
into	O
the	O
genetics	O
of	O
the	O
Hungarian	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
A	O
reverse	O
genetics	O
system	O
for	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
based	O
on	O
targeted	O
RNA	O
recombination	O
.	O

The	O
in	O
ovo	B-SPEC
growth	O
kinetics	O
and	O
in	O
vivo	O
characteristics	O
of	O
the	O
recombinant	O
virus	B-SPEC
were	O
similar	O
to	O
those	O
of	O
the	O
parental	O
IBV	B-SPEC
strain	O
H52	O
.	O

TITLE	O
:	O
Blood	O
purification	O
with	O
continuous	O
veno	O
-	O
venous	O
hemofiltration	O
in	O
patients	O
with	O
sepsis	B-SPEC
or	O
ARDS	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

We	O
performed	O
a	O
meta	B-SPEC
-	O
analysis	O
of	O
randomized	O
trials	O
to	O
assess	O
if	O
blood	O
purification	O
with	O
continuous	O
veno	O
-	O
venous	O
hemofiltration	O
(	O
CVVH	O
)	O
reduces	O
mortality	O
in	O
these	O
settings	O
.	O

Overall	O
,	O
low	O
-	O
quality	O
evidence	O
indicates	O
that	O
blood	O
purification	O
with	O
CVVH	O
might	O
be	O
associated	O
with	O
a	O
significant	O
reduction	O
in	O
mortality	O
when	O
performed	O
in	O
patients	O
with	O
sepsis	B-SPEC
or	O
ARDS	O
.	O

TITLE	O
:	O
Computational	O
modeling	O
of	O
the	O
bat	B-SPEC
HKU4	O
coronavirus	B-SPEC
3CL	O
ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
virus	B-SPEC
that	O
poses	O
a	O
major	O
challenge	O
to	O
clinical	O
management	O
.	O

TITLE	O
:	O
Estimation	O
of	O
basic	O
reproduction	O
number	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
during	O
the	O
outbreak	O
in	O
South	O
Korea	O
,	O
2015	O
.	O

An	O
evaluation	O
of	O
basic	O
reproduction	O
number	O
using	O
epidemic	O
data	O
could	O
be	O
problematic	O
if	O
there	O
are	O
stochastic	O
fluctuations	O
in	O
the	O
early	O
phase	O
of	O
the	O
outbreak	O
,	O
or	O
if	O
the	O
report	O
is	O
not	O
accurate	O
and	O
there	O
is	O
bias	B-SPEC
in	O
the	O
data	O
.	O

It	O
is	O
worth	O
comparing	O
with	O
the	O
basic	O
reproductive	O
number	O
of	O
the	O
2014	O
Ebola	O
outbreak	O
in	O
West	O
Africa	O
including	O
Guinea	B-SPEC
,	O
Sierra	O
Leone	O
,	O
and	O
Liberia	O
,	O
which	O
had	O
values	O
of	O
1	O
.	O
5	O
-	O
2	O
.	O
5	O
.	O

TITLE	O
:	O
Two	O
novel	O
dromedary	B-SPEC
camel	B-SPEC
bocaparvoviruses	O
from	O
dromedaries	B-SPEC
in	O
the	O
Middle	O
East	O
with	O
unique	O
genomic	O
features	O
.	O

Among	O
667	O
adult	O
dromedaries	B-SPEC
and	O
72	O
dromedary	B-SPEC
calves	O
,	O
13	O
.	O
9	O
%	O
of	O
adult	O
dromedaries	B-SPEC
and	O
33	O
.	O
3	O
%	O
of	O
dromedary	B-SPEC
calves	O
were	O
positive	O
for	O
DBoV1	O
,	O
while	O
7	O
.	O
0	O
%	O
of	O
adult	O
dromedaries	B-SPEC
and	O
25	O
.	O
0	O
%	O
of	O
dromedary	B-SPEC
calves	O
were	O
positive	O
for	O
DBoV2	O
,	O
as	O
determined	O
by	O
PCR	O
.	O

Further	O
studies	O
will	O
be	O
crucial	O
to	O
understand	O
the	O
pathogenic	O
potential	O
of	O
DBoVs	O
in	O
this	O
unique	O
group	O
of	O
animals	B-SPEC
.	O

Coronavirus	B-SPEC
-	O
HKU1	O
has	O
been	O
described	O
predominantly	O
among	O
children	O
less	O
than	O
5	O
years	O
of	O
age	O
in	O
the	O
United	O
States	O
with	O
few	O
studies	O
characterizing	O
the	O
disease	O
spectrum	O
among	O
adults	O
.	O

Nasopharyngeal	O
specimens	O
of	O
patients	O
with	O
respiratory	O
symptoms	O
were	O
analyzed	O
for	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
by	O
NxTAG	O
Respiratory	O
Pathogen	O
Panel	O
multiplex	O
assay	O
from	O
February	O
7	O
,	O
2016	O
to	O
April	O
30	O
,	O
2016	O
.	O

TITLE	O
:	O
This	O
could	O
be	O
the	O
start	O
of	O
something	O
big	O
-	O
20	O
years	O
since	O
the	O
identification	O
of	O
bats	B-SPEC
as	O
the	O
natural	O
host	O
of	O
Hendra	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Hendra	B-SPEC
virus	I-SPEC
was	O
first	O
described	O
in	O
1994	O
in	O
Australia	O
,	O
causally	O
associated	O
with	O
a	O
cluster	O
of	O
fatal	O
equine	B-SPEC
and	O
human	B-SPEC
cases	O
at	O
a	O
thoroughbred	O
racing	O
stable	O
in	O
the	O
Brisbane	O
suburb	O
of	O
Hendra	O
.	O

Flying	O
-	O
foxes	O
were	O
considered	O
to	O
be	O
a	O
more	O
probable	O
source	O
of	O
the	O
novel	O
virus	B-SPEC
than	O
birds	B-SPEC
.	O

TITLE	O
:	O
Absence	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
in	O
feral	O
camels	B-SPEC
in	O
Australia	O
:	O
Implications	O
for	O
the	O
pathogen	O
'	O
s	O
origin	O
and	O
spread	O
.	O

Here	O
we	O
report	O
that	O
during	O
a	O
focussed	O
surveillance	O
study	O
,	O
no	O
serological	O
evidence	O
was	O
found	O
for	O
the	O
presence	O
of	O
MERS	O
-	O
CoV	O
in	O
the	O
camels	B-SPEC
in	O
the	O
Australian	O
population	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
still	O
causes	O
outbreaks	O
despite	O
public	O
awareness	O
and	O
implementation	O
of	O
health	O
care	O
measures	O
,	O
such	O
as	O
rapid	O
viral	O
diagnosis	O
and	O
patient	O
quarantine	O
.	O

TITLE	O
:	O
Searching	O
for	O
animal	B-SPEC
models	O
and	O
potential	O
target	O
species	B-SPEC
for	O
emerging	O
pathogens	O
:	O
Experience	O
gained	O
from	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
.	O

Coronaviruses	O
are	O
also	O
a	O
threat	O
for	O
humans	B-SPEC
,	O
as	O
evidenced	O
in	O
2002	O
/	O
2003	O
with	O
infection	O
by	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
which	O
caused	O
more	O
than	O
8000	O
human	B-SPEC
infections	O
with	O
10	O
%	O
fatality	O
rate	O
in	O
37	O
countries	O
.	O

Little	O
is	O
known	O
about	O
MERS	O
-	O
CoV	O
animal	B-SPEC
host	O
range	O
.	O

Advantages	O
and	O
limitations	O
of	O
different	O
animal	B-SPEC
models	O
are	O
evaluated	O
in	O
relation	O
to	O
viral	O
pathogenesis	O
and	O
transmission	O
studies	O
.	O

Consequently	O
,	O
the	O
expression	O
level	O
of	O
cSP	O
-	O
A	O
in	O
the	O
AIV	B-SPEC
+	I-SPEC
IBV	I-SPEC
co	O
-	O
infected	O
group	O
significantly	O
decreased	O
when	O
compared	O
to	O
the	O
AIV	O
-	O
infected	O
group	O
and	O
the	O
IBV	B-SPEC
-	O
infected	O
group	O
by	O
qRT	O
-	O
PCR	O
,	O
ELISA	O
,	O
and	O
IHC	O
analysis	O
.	O

TITLE	O
:	O
Genetic	O
,	O
antigenic	O
,	O
and	O
pathogenic	O
characteristics	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
viruses	B-SPEC
genotypically	O
related	O
to	O
793	O
/	O
B	O
in	O
China	O
.	O

TITLE	O
:	O
Analysis	O
of	O
antigenicity	O
and	O
pathogenicity	O
reveals	O
major	O
differences	O
among	O
QX	O
-	O
like	O
infectious	O
bronchitis	O
viruses	B-SPEC
and	O
other	O
serotypes	O
.	O

Virus	B-SPEC
infection	O
experiments	O
showed	O
that	O
SD	O
caused	O
high	O
mortality	O
with	O
strong	O
respiratory	O
and	O
renal	O
pathogenicity	O
in	O
chickens	B-SPEC
,	O
whereas	O
SZ	O
caused	O
milder	O
lesions	O
by	O
comparison	O
.	O

ABSTRACT	O
:	O
We	O
present	O
a	O
rare	O
case	O
of	O
pernicious	O
anemia	B-SPEC
presented	O
as	O
multi	O
-	O
organ	O
dysfunction	O
syndrome	O
,	O
later	O
found	O
to	O
have	O
pseudo	O
-	O
thrombotic	O
thrombocytopenic	O
purpura	B-SPEC
.	O

TITLE	O
:	O
A	O
spike	O
-	O
specific	O
whole	O
-	O
porcine	B-SPEC
antibody	O
isolated	O
from	O
a	O
porcine	B-SPEC
B	O
cell	O
that	O
neutralizes	O
both	O
genogroup	O
1	O
and	O
2	O
PEDV	B-SPEC
strains	O
.	O

Here	O
,	O
we	O
described	O
the	O
isolation	O
of	O
a	O
PEDV	B-SPEC
-	O
neutralizing	O
antibody	O
from	O
the	O
B	O
cell	O
of	O
a	O
vaccinated	O
pig	B-SPEC
.	O

The	O
results	O
of	O
these	O
studies	O
revealed	O
that	O
mutational	O
bias	B-SPEC
is	O
a	O
leading	O
force	O
shaping	O
codon	O
usage	O
in	O
this	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
outbreaks	O
of	O
respiratory	O
disease	O
in	O
swine	B-SPEC
at	O
agricultural	O
fairs	O
in	O
Michigan	O
,	O
USA	O
,	O
in	O
2015	O
raised	O
concern	O
for	O
potential	O
human	B-SPEC
exposure	O
to	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

Testing	O
ruled	O
out	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
and	O
identified	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
as	O
the	O
cause	O
of	O
influenza	O
-	O
like	O
illness	O
in	O
the	O
affected	O
swine	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
HKU15	O
is	O
a	O
deltacoronavirus	O
that	O
was	O
discovered	O
in	O
fecal	O
samples	O
of	O
pigs	B-SPEC
in	O
Hong	O
Kong	O
in	O
2012	O
.	O

The	O
three	O
viruses	B-SPEC
were	O
genetically	O
identical	O
,	O
thus	O
indicating	O
introduction	O
of	O
a	O
single	O
virus	B-SPEC
into	O
this	O
herd	O
.	O

ABSTRACT	O
:	O
The	O
majority	O
of	O
human	B-SPEC
emerging	O
infectious	O
diseases	O
are	O
zoonotic	O
,	O
with	O
viruses	B-SPEC
that	O
originate	O
in	O
wild	O
mammals	B-SPEC
of	O
particular	O
concern	O
(	O
for	O
example	O
,	O
HIV	B-SPEC
,	O
Ebola	O
and	O
SARS	O
).	O

We	O
then	O
show	O
that	O
phylogenetic	O
host	O
breadth	O
and	O
other	O
viral	O
traits	O
are	O
significant	O
predictors	O
of	O
zoonotic	O
potential	O
,	O
providing	O
a	O
novel	O
framework	O
to	O
assess	O
if	O
a	O
newly	O
discovered	O
mammalian	B-SPEC
virus	B-SPEC
could	O
infect	O
people	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
availability	O
of	O
several	O
anti	O
-	O
retrovirals	O
,	O
there	O
is	O
still	O
an	O
urgent	O
need	O
for	O
developing	O
novel	O
therapeutic	O
strategies	O
and	O
finding	O
new	O
drugs	O
against	O
underexplored	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
targets	O
.	O

TITLE	O
:	O
Discovery	O
of	O
a	O
Highly	O
Divergent	O
Coronavirus	B-SPEC
in	O
the	O
Asian	B-SPEC
House	I-SPEC
Shrew	I-SPEC
from	O
China	O
Illuminates	O
the	O
Origin	O
of	O
the	O
Alphacoronaviruses	O
.	O

ABSTRACT	O
:	O
Although	O
shrews	B-SPEC
are	O
one	O
of	O
the	O
largest	O
groups	O
of	O
mammals	B-SPEC
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
the	O
evolution	O
and	O
transmission	O
of	O
viral	O
pathogens	O
,	O
including	O
coronaviruses	O
(	O
CoVs	O
).	O

However	O
,	O
empiric	O
corticosteroid	O
failed	O
in	O
both	O
humans	B-SPEC
and	O
animal	B-SPEC
models	O
.	O

TITLE	O
:	O
Use	O
of	O
Sequence	O
-	O
Independent	O
,	O
Single	O
-	O
Primer	O
-	O
Amplification	O
(	O
SISPA	O
)	O
for	O
rapid	O
detection	O
,	O
identification	O
,	O
and	O
characterization	O
of	O
avian	B-SPEC
RNA	O
viruses	B-SPEC
.	O

The	O
anti	O
-	O
H5N1	O
entry	O
activities	O
were	O
determined	O
based	O
on	O
HA	O
/	O
HIV	B-SPEC
and	O
VSVG	O
/	O
HIV	B-SPEC
entry	O
assays	O
.	O

TITLE	O
:	O
Aortic	O
stenosis	B-SPEC
concomitant	O
with	O
microscopic	O
polyangiitis	O
:	O
a	O
challenge	O
in	O
medical	O
reasoning	O
and	O
thinking	O
.	O

Aortic	O
valve	O
stenosis	B-SPEC
(	O
AS	O
)	O
is	O
not	O
an	O
uncommon	O
disease	O
whose	O
etiology	O
varies	O
according	O
to	O
geographical	O
differences	O
and	O
the	O
patient	O
'	O
s	O
age	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
experimental	O
transmission	O
using	O
a	O
pig	B-SPEC
model	O
.	O

The	O
GDS04	O
strain	O
of	O
this	O
coronavirus	B-SPEC
shares	O
high	O
aa	O
identities	O
(>	O
90	O
%)	O
with	O
the	O
reported	O
bat	B-SPEC
-	O
HKU2	O
strains	O
in	O
Coronaviridae	B-SPEC
-	O
wide	O
conserved	O
domains	O
,	O
suggesting	O
that	O
the	O
GDS04	O
strain	O
belongs	O
to	O
the	O
same	O
species	B-SPEC
as	O
HKU2	O
.	O

We	O
show	O
that	O
a	O
nucleotide	O
prodrug	O
,	O
GS	O
-	O
5734	O
,	O
currently	O
in	O
clinical	O
development	O
for	O
treatment	O
of	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
,	O
can	O
inhibit	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
replication	O
in	O
multiple	O
in	O
vitro	O
systems	O
,	O
including	O
primary	O
human	B-SPEC
airway	O
epithelial	O
cell	O
cultures	O
with	O
submicromolar	O
IC	O

These	O
losses	O
were	O
associated	O
with	O
respiratory	O
problems	O
,	O
increase	O
of	O
condemnations	O
,	O
drops	O
in	O
egg	O
production	O
and	O
nephritis	O
in	O
breeders	O
,	O
laying	O
hens	O
and	O
broilers	O
due	O
to	O
infections	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

One	O
hundred	O
and	O
ninety	O
-	O
eight	O
of	O
the	O
tested	O
specimens	O
were	O
virus	B-SPEC
positive	O
(	O
69	O
.	O
7	O
%)	O
(	O
symptomatic	O
periods	O
,	O
149	O
/	O
196	O
,	O
76	O
.	O
0	O
%;	O
asymptomatic	O
periods	O
,	O
49	O
/	O
88	O
,	O
55	O
.	O
7	O
%).	O

Co	O
-	O
infection	O
with	O
two	O
or	O
more	O
viruses	B-SPEC
was	O
present	O
in	O
22	O
.	O
1	O
%;	O
18	O
.	O
4	O
%	O
of	O
the	O
samples	O
were	O
negative	O
.	O

TITLE	O
:	O
Determination	O
of	O
the	O
cell	O
tropism	O
of	O
serotype	O
1	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
using	O
the	O
spike	O
affinity	O
histochemistry	O
in	O
paraffin	O
-	O
embedded	O
tissues	O
.	O

In	O
this	O
study	O
,	O
we	O
focus	O
on	O
the	O
nsp14	O
protein	O
,	O
which	O
plays	O
a	O
key	O
role	O
in	O
virus	B-SPEC
replication	O
as	O
it	O
methylates	O
the	O
RNA	O
cap	O
structure	O
at	O
the	O
N7	O
position	O
of	O
the	O
guanine	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
and	O
Pulmonary	O
Tuberculosis	O
Coinfection	O
:	O
Implications	O
for	O
Infection	O
Control	O
.	O

TITLE	O
:	O
Impact	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
on	O
herd	O
and	O
individual	O
Berkshire	O
sow	O
productivity	O
.	O

Observational	O
research	O
seeking	O
to	O
answer	O
key	O
questions	O
on	O
the	O
ZIKV	O
should	O
consider	O
these	O
restrictions	O
and	O
take	O
precautions	O
to	O
minimize	O
bias	B-SPEC
in	O
an	O
effort	O
to	O
provide	O
reliable	O
and	O
valid	O
results	O
.	O

ELISA	O
and	O
negative	O
staining	O
electron	O
microscopy	O
showed	O
that	O
rcMBL	O
bound	O
directly	O
to	O
IBV	B-SPEC
,	O
resulting	O
in	O
the	O
aggregation	O
of	O
viral	O
particles	O
.	O

Furthermore	O
,	O
we	O
demonstrated	O
that	O
MBL	O
bound	O
specifically	O
to	O
the	O
spike	O
S1	O
protein	O
of	O
IBV	B-SPEC
which	O
mediates	O
viral	O
attachment	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
an	O
acute	O
and	O
highly	O
contagious	O
viral	O
disease	O
causing	O
severe	O
economic	O
losses	O
in	O
the	O
poultry	O
industry	O
.	O

Mortalities	O
were	O
only	O
recorded	O
in	O
mixed	O
AIV	O
-	O
H9N2	O
/	O
variant	O
IBV	B-SPEC
challenge	O
group	O
.	O

In	O
mixed	O
AIV	O
-	O
H9N2	O
/	O
IBV	B-SPEC
vaccine	O
challenge	O
,	O
severe	O
tracheitis	O
with	O
bronchial	O
cast	O
formation	O
was	O
observed	O
.	O

Interestingly	O
,	O
hemorrhage	O
and	O
atrophy	O
were	O
observed	O
in	O
thymus	B-SPEC
gland	O
of	O
birds	B-SPEC
challenged	O
with	O
single	O
AIV	O
-	O
H9N2	O
or	O
mixed	O
AIV	O
-	O
H9N2	O
/	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
new	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
variant	O
that	O
occurred	O
in	O
Korea	O
in	O
2014	O
.	O

ABSTRACT	O
:	O
The	O
macrodomains	O
are	O
a	O
multifunctional	O
protein	O
family	B-SPEC
that	O
function	O
as	O
receptors	O
and	O
enzymes	O
acting	O
on	O
poly	O
(	O
ADP	O
-	O
ribose	O
),	O
ADP	O
-	O
ribosylated	O
proteins	O
,	O
and	O
other	O
metabolites	O
of	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NAD	O

We	O
compared	O
clinical	O
disease	O
severity	O
and	O
sought	O
clinical	O
and	O
demographic	O
differences	O
between	O
infants	O
with	O
B	B-SPEC
.	I-SPEC
pertussis	I-SPEC
infection	O
alone	O
and	O
those	O
with	O
respiratory	O
viral	O
coinfections	O
.	O

Enrolled	O
children	O
fulfilled	O
the	O
following	O
criteria	O
:	O
(	O
1	O
)	O
PICU	B-SPEC
admission	O
;	O
(	O
2	O
)	O
age	O
of	O
1	O
month	O
to	O
16	O
years	O
;	O
(	O
3	O
)	O
diagnosis	O
of	O
infectious	O
pneumonia	O
and	O
respiratory	O
virus	B-SPEC
infection	O
;	O
and	O
(	O
4	O
)	O
development	O
of	O
severe	O
ARDS	O
within	O
72	O
h	O
after	O
PICU	B-SPEC
admission	O
.	O

The	O
serum	O
levels	O
of	O
inflammatory	O
mediators	O
on	O
the	O
day	O
of	O
PICU	B-SPEC
admission	O
were	O
examined	O
.	O

TITLE	O
:	O
Estimating	O
and	O
modelling	O
the	O
transmissibility	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
CoronaVirus	B-SPEC
during	O
the	O
2015	O
outbreak	O
in	O
the	O
Republic	O
of	O
Korea	O
.	O

The	O
intricate	O
relationship	O
between	O
bats	B-SPEC
and	O
their	O
ectoparasites	O
suggests	O
that	O
ectoparasites	O
might	O
serve	O
as	O
viral	O
vectors	O
,	O
but	O
evidence	O
to	O
date	O
is	O
scant	O
.	O

Using	O
next	O
-	O
generation	O
sequencing	O
,	O
we	O
discovered	O
a	O
novel	O
ledantevirus	O
(	O
mononegaviral	O
family	B-SPEC
Rhabdoviridae	I-SPEC
,	O
genus	B-SPEC
Ledantevirus	O
)	O
in	O
nycteribiid	O
bat	B-SPEC
flies	I-SPEC
infesting	O
pteropodid	O
bats	B-SPEC
in	O
western	O
Uganda	O
.	O

ABSTRACT	O
:	O
In	O
2015	O
,	O
the	O
largest	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
outside	O
the	O
Middle	O
East	O
occurred	O
in	O
South	O
Korea	O
.	O

This	O
first	O
case	O
in	O
South	O
Korea	O
became	O
a	O
super	O
-	O
spreader	O
because	O
of	O
improper	O
infection	O
control	O
measures	O
,	O
rather	O
than	O
variations	O
of	O
the	O
virus	B-SPEC
.	O

From	O
160	O
-	O
220days	O
of	O
age	O
,	O
gilts	O
were	O
exposed	O
daily	O
to	O
vasectomized	O
boars	B-SPEC
and	O
observed	O
for	O
behavioral	O
estrus	O
.	O

TITLE	O
:	O
Healthcare	O
infrastructure	O
capacity	O
to	O
respond	O
to	O
severe	O
acute	O
respiratory	O
infection	O
(	O
SARI	O
)	O
and	O
sepsis	B-SPEC
in	O
Vietnam	O
:	O
A	O
low	O
-	O
middle	O
income	O
country	O
.	O

The	O
limited	O
availability	O
of	O
relevant	O
structural	O
and	O
human	B-SPEC
resources	O
in	O
critical	O
care	O
units	O
around	O
Vietnam	O
makes	O
the	O
implementation	O
of	O
quality	O
critical	O
care	O
to	O
patients	O
with	O
SARI	O
and	O
sepsis	B-SPEC
,	O
according	O
international	O
guidelines	O
,	O
not	O
universally	O
possible	O
.	O

February	O
2013	O
,	O
an	O
elderly	O
man	B-SPEC
,	O
who	O
visited	O
Pakistan	O
and	O
KSA	O
,	O
was	O
confirmed	O
as	O
MRS	O
-	O
CoV	O
in	O
UK	O
.	O

The	O
four	O
downregulated	O
rno	O
	O
let	O
	O
7	O
family	B-SPEC
members	O
were	O
detected	O
to	O
have	O
numerous	O
co	O
	O
regulated	O
target	O
genes	O
and	O
synergistic	O
functions	O
.	O

TITLE	O
:	O
SURVEILLANCE	O
FOR	O
ANTIBODIES	O
AGAINST	O
SIX	O
CANINE	O
VIRUSES	B-SPEC
IN	O
WILD	O
RACCOONS	B-SPEC
(	O
PROCYON	B-SPEC
LOTOR	I-SPEC
)	O
IN	O
JAPAN	O
.	O

ABSTRACT	O
:	O
Raccoons	B-SPEC
(	O
Procyon	B-SPEC
lotor	I-SPEC
)	O
are	O
found	O
worldwide	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
emerged	O
in	O
the	O
US	O
is	O
known	O
to	O
suppress	O
the	O
type	O
I	O
interferons	O
response	O
during	O
infection	O
.	O

TITLE	O
:	O
Spatial	O
dynamics	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
spread	O
in	O
the	O
southern	O
Kyushu	O
,	O
Japan	O
.	O

Human	B-SPEC
samples	O
were	O
confirmed	O
by	O
plaque	O
reduction	O
neutralization	O
test	O
(	O
PRNT	O
).	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
)	O
are	O
enveloped	O
viruses	B-SPEC
and	O
rely	O
on	O
their	O
nucleocapsid	O
N	O
protein	O
to	O
incorporate	O
the	O
positive	O
-	O
stranded	O
genomic	O
RNA	O
into	O
the	O
virions	O
.	O

Interestingly	O
,	O
cytoplasmic	O
N	O
molecules	O
of	O
MHV	B-SPEC
-	O
infected	O
cells	O
constitutively	O
assemble	O
into	O
oligomers	O
through	O
a	O
process	O
that	O
does	O
not	O
require	O
binding	O
to	O
genomic	O
RNA	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
is	O
involved	O
mainly	O
in	O
enteric	O
infections	O
in	O
cattle	B-SPEC
.	O

With	O
the	O
intensification	O
of	O
globalization	O
and	O
increasing	O
gaps	O
between	O
countries	O
,	O
new	O
and	O
reemerging	O
health	O
threats	O
such	O
as	O
HIV	B-SPEC
/	O
AIDS	O
,	O
tuberculosis	O
,	O
influenza	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
Ebola	O
,	O
and	O
Zika	O
and	O
a	O
gradual	O
rethinking	O
on	O
security	O
concepts	O
framed	O
a	O
new	O
political	O
context	O
.	O

The	O
recent	O
WHO	O
Pandemic	O
Influenza	O
Framework	O
,	O
UN	O
High	O
Level	O
Framework	O
on	O
Prevention	O
and	O
Control	O
of	O
Noncommunicable	O
Diseases	O
,	O
and	O
the	O
WHO	O
Framework	O
Convention	O
on	O
Tobacco	B-SPEC
Control	O
are	O
some	O
of	O
the	O
examples	O
of	O
long	O
-	O
term	O
negotiation	O
processes	O
for	O
agreements	O
that	O
took	O
place	O
.	O

The	O
utility	O
of	O
this	O
platform	O
in	O
rapidly	O
developing	O
inactivated	O
whole	O
virus	B-SPEC
vaccines	O
against	O
pandemic	O
(-	O
like	O
)	O
influenza	B-SPEC
viruses	I-SPEC
and	O
other	O
emerging	O
viruses	B-SPEC
such	O
as	O
West	O
Nile	O
,	O
Chikungunya	O
,	O
Ross	O
River	O
and	O
SARS	O
is	O
reviewed	O
.	O

Our	O
results	O
reveal	O
that	O
under	O
the	O
assumed	O
conditions	O
,	O
the	O
SARS	O
coronavirus	B-SPEC
was	O
most	O
possible	O
to	O
have	O
spread	O
via	O
the	O
combined	O
long	O
-	O
range	O
airborne	O
and	O
fomite	O
routes	O
,	O
and	O
that	O
the	O
fomite	O
route	O
played	O
a	O
non	O
-	O
negligible	O
role	O
in	O
the	O
transmission	O
.	O

TITLE	O
:	O
Awareness	O
among	O
a	O
Saudi	O
Arabian	O
university	O
community	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
following	O
an	O
outbreak	O
.	O

The	O
multivariable	O
linear	O
regression	O
analysis	O
of	O
the	O
relationship	O
between	O
peak	O
cTnI	O
value	O
and	O
patient	O
group	O
,	O
age	O
,	O
sex	O
,	O
and	O
type	O
of	O
ACS	O
showed	O
that	O
the	O
presence	O
or	O
absence	O
of	O
OSA	B-SPEC
significantly	O
contributed	O
to	O
the	O
peak	O
cTnI	O
level	O
,	O
which	O
was	O
54	O
%	O
lower	O
in	O
patients	O
with	O
OSA	B-SPEC
than	O
in	O
those	O
without	O
OSA	B-SPEC
.	O

ABSTRACT	O
:	O
Infection	O
with	O
coronavirus	B-SPEC
rearranges	O
the	O
host	O
cell	O
membrane	O
to	O
assemble	O
a	O
replication	O
/	O
transcription	O
complex	O
in	O
which	O
replication	O
of	O
the	O
viral	O
genome	O
and	O
transcription	O
of	O
viral	O
mRNA	O
occur	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
purified	O
recombinant	O
spike	O
fragments	O
for	O
assessment	O
of	O
the	O
presence	O
of	O
serum	O
neutralizing	O
antibodies	O
against	O
a	O
variant	O
strain	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

We	O
found	O
that	O
,	O
while	O
glycosylation	O
plays	O
an	O
important	O
role	O
in	O
these	O
orthologs	O
,	O
additional	O
sequence	O
and	O
structural	O
determinants	O
impact	O
their	O
ability	O
to	O
act	O
as	O
functional	O
receptors	O
for	O
MERS	O
-	O
CoV	O
.	O
These	O
results	O
provide	O
insight	O
into	O
DPP4	O
species	B-SPEC
-	O
specific	O
differences	O
impacting	O
MERS	O
-	O
CoV	O
host	O
range	O
and	O
better	O
inform	O
our	O
understanding	O
of	O
virus	B-SPEC
-	O
receptor	O
interactions	O
associated	O
with	O
disease	O
emergence	O
and	O
host	O
susceptibility	O
.	O

We	O
evaluated	O
four	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
MERS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infections	O
who	O
showed	O
neurological	O
complications	O
during	O
MERS	O
treatment	O
.	O

We	O
retrospectively	O
explored	O
the	O
use	O
of	O
PPV	B-SPEC
in	O
acute	O
exacerbation	O
with	O
ILD	O
versus	O
those	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
severe	O
ARDS	O
).	O

Ten	O
multidisciplinary	O
PICUs	B-SPEC
in	O
Asia	O
.	O

Higher	O
category	O
of	O
severity	O
of	O
PARDS	O
was	O
associated	O
with	O
lower	O
ventilator	O
-	O
free	O
days	O
(	O
22	O
[	O
17	O
-	O
25	O
],	O
16	O
[	O
0	O
-	O
23	O
],	O
6	O
[	O
0	O
-	O
19	O
];	O
p	O
<	O
0	O
.	O
001	O
for	O
mild	O
,	O
moderate	O
,	O
and	O
severe	O
,	O
respectively	O
)	O
and	O
PICU	B-SPEC
free	O
days	O
(	O
19	O
[	O
11	O
-	O
24	O
],	O
15	O
[	O
0	O
-	O
22	O
],	O
5	O
[	O
0	O
-	O
20	O
];	O
p	O
<	O
0	O
.	O
001	O
for	O
mild	O
,	O
moderate	O
,	O
and	O
severe	O
,	O
respectively	O
).	O

Interestingly	O
the	O
polypeptide	O
sequences	O
of	O
the	O
native	O
strands	O
2	O
,	O
3	O
and	O
4	O
have	O
characteristics	O
of	O
	O
-	O
helices	B-SPEC
.	O

This	O
review	O
summarizes	O
the	O
prevalence	O
,	O
reservoirs	O
,	O
sources	O
of	O
human	B-SPEC
infection	O
and	O
control	O
regimes	O
of	O
common	O
bacterial	O
,	O
parasitic	O
and	O
viral	O
zoonoses	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
in	O
Egypt	O
.	O

TITLE	O
:	O
Coexistence	O
of	O
multiple	O
genotypes	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
with	O
novel	O
mutant	O
S	O
genes	O
in	O
the	O
Hubei	O
Province	O
of	O
China	O
in	O
2016	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
the	O
aetiologic	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhoea	O
(	O
PED	O
),	O
a	O
highly	O
contagious	O
enteric	O
disease	O
that	O
is	O
threatening	O
the	O
swine	B-SPEC
industry	O
globally	O
.	O

TITLE	O
:	O
Spatial	O
modelling	O
of	O
contribution	O
of	O
individual	O
level	O
risk	O
factors	O
for	O
mortality	O
from	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
the	O
Arabian	O
Peninsula	O
.	O

It	O
was	O
also	O
noted	O
that	O
replication	O
of	O
IBV	B-SPEC
M41	O
and	O
Conn	O
A5968	O
strains	O
in	O
macrophages	O
does	O
not	O
interfere	O
with	O
the	O
induction	O
of	O
type	O
1	O
IFN	O
activity	O
by	O
macrophages	O
.	O

TITLE	O
:	O
Sensitivity	O
and	O
specificity	O
of	O
a	O
real	O
-	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
detecting	O
feline	B-SPEC
coronavirus	B-SPEC
mutations	O
in	O
effusion	O
and	O
serum	O
/	O
plasma	O
of	O
cats	B-SPEC
to	O
diagnose	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)	O
exists	O
as	O
two	O
pathotypes	O
,	O
and	O
FCoV	B-SPEC
spike	O
gene	O
mutations	O
are	O
considered	O
responsible	O
for	O
the	O
pathotypic	O
switch	O
in	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
pathogenesis	O
.	O

TITLE	O
:	O
Comparative	O
Genomic	O
Analysis	O
MERS	O
CoV	O
Isolated	O
from	O
Humans	B-SPEC
and	O
Camels	B-SPEC
with	O
Special	O
Reference	O
to	O
Virus	B-SPEC
Encoded	O
Helicase	O
.	O

In	O
this	O
work	O
,	O
we	O
provide	O
comprehensive	O
analysis	O
of	O
238	O
MERS	O
CoV	O
full	O
genomes	O
comprised	O
of	O
human	B-SPEC
(	O
hMERS	O
)	O
and	O
camel	B-SPEC
(	O
cMERS	O
)	O
isolates	O
of	O
the	O
virus	B-SPEC
.	O

The	O
intricate	O
""""	O
host	O
-	O
pathogen	O
-	O
environment	O
""""	O
relationship	O
remains	O
the	O
key	O
to	O
understanding	O
the	O
emergence	O
/	O
re	O
-	O
emergence	O
of	O
pathogenic	O
viruses	B-SPEC
.	O

These	O
epidemics	O
or	O
pandemics	O
pose	O
a	O
major	O
threat	O
to	O
human	B-SPEC
health	O
.	O

TITLE	O
:	O
MicroRNA	O
transcriptome	O
analysis	O
in	O
chicken	B-SPEC
kidneys	O
in	O
response	O
to	O
differing	O
virulent	O
infectious	O
bronchitis	O
virus	B-SPEC
infections	O
.	O

To	O
understand	O
miRNA	O
regulation	O
in	O
chickens	B-SPEC
in	O
response	O
to	O
IBV	B-SPEC
infection	O
,	O
high	O
-	O
throughput	O
sequencing	O
was	O
performed	O
to	O
compare	O
the	O
small	O
RNA	O
libraries	O
from	O
the	O
kidneys	O
of	O
chicken	B-SPEC
infected	O
with	O
SCK2	O
,	O
SCDY2	O
and	O
LDT3	O
-	O
A	O
.	O
By	O
comparing	O
these	O
data	O
to	O
healthy	O
chickens	B-SPEC
,	O
a	O
total	O
of	O
58	O
differentially	O
expressed	O
(	O
DE	O
)	O
miRNAs	O
were	O
identified	O
.	O

These	O
results	O
are	O
significant	O
for	O
the	O
study	O
of	O
immune	O
responses	O
to	O
infection	O
with	O
different	O
virulent	O
IBVs	O
mediated	O
by	O
miRNAs	O
as	O
well	O
as	O
the	O
interaction	O
between	O
the	O
chicken	B-SPEC
host	O
and	O
IBV	B-SPEC
.	O

Ciliary	O
activity	O
of	O
the	O
epithelial	O
cells	O
in	O
the	O
bronchus	B-SPEC
of	O
precision	O
-	O
cut	O
lung	O
slices	O
was	O
measured	O
.	O

Co	O
-	O
infection	O
of	O
PCLS	O
reduced	O
virulence	O
of	O
both	O
virus	B-SPEC
species	B-SPEC
compared	O
to	O
mono	O
-	O
infection	O
.	O

Again	O
lower	O
titers	O
in	O
co	O
-	O
infection	O
groups	O
indicated	O
an	O
interference	O
of	O
the	O
two	O
RNA	O
viruses	B-SPEC
.	O

This	O
is	O
in	O
accordance	O
with	O
in	O
vivo	O
experiments	O
,	O
revealing	O
cell	O
innate	O
immune	O
answers	O
to	O
both	O
PRCoV	O
and	O
SIV	B-SPEC
that	O
are	O
able	O
to	O
restrict	O
the	O
virulence	O
and	O
pathogenicity	O
of	O
the	O
viruses	B-SPEC
.	O

TITLE	O
:	O
The	O
cholesterol	O
transport	O
inhibitor	O
U18666A	O
inhibits	O
type	O
I	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

U18666A	O
or	O
other	O
cholesterol	O
transport	O
inhibitor	O
may	O
be	O
considered	O
as	O
the	O
antiviral	O
drug	O
for	O
the	O
treatment	O
of	O
cats	B-SPEC
with	O
FIP	O
.	O

TITLE	O
:	O
Periurban	O
outbreaks	O
of	O
bovine	B-SPEC
calf	O
scours	O
in	O
Northern	O
India	O
caused	O
by	O
Cryptosporidium	B-SPEC
in	O
association	O
with	O
other	O
enteropathogens	O
.	O

In	O
the	O
present	O
study	O
,	O
faecal	O
samples	O
from	O
100	O
diarrhoeic	O
calves	O
randomly	O
picked	O
up	O
out	O
of	O
17	O
outbreaks	O
of	O
bovine	B-SPEC
calf	O
diarrhoea	O
in	O
periurban	O
Ludhiana	O
,	O
Punjab	O
in	O
Northern	O
India	O
were	O
subjected	O
to	O
conventional	O
(	O
microscopy	O
,	O
modified	O
Zeihl	O
-	O
Neelsen	O
(	O
mZN	O
)	O
staining	O
)	O
and	O
immunological	O
and	O
molecular	O
techniques	O
(	O
faecal	O
antigen	O
capture	O
ELISA	O
and	O
PCR	O
)	O
for	O
detection	O
of	O
primary	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
infection	O
as	O
well	O
as	O
other	O
frequently	O
reported	O
concurrent	O
pathogens	O
,	O
viz	O
.	O

After	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
,	O
IBV	B-SPEC
-	O
positive	O
samples	O
were	O
further	O
characterized	O
based	O
on	O
S1	O
gene	O
.	O

The	O
results	O
of	O
the	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
showed	O
that	O
52	O
.	O
16	O
%	O
of	O
flocks	O
were	O
IBV	B-SPEC
positive	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
the	O
history	O
and	O
epidemiology	O
of	O
this	O
novel	O
virus	B-SPEC
.	O

In	O
addition	O
,	O
we	O
evaluated	O
the	O
association	O
of	O
BACM	O
with	O
influenza	O
B	O
.	O
We	O
detected	O
specific	O
IgG	O
against	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
in	O
83	O
%	O
of	O
the	O
children	O
diagnosed	O
with	O
BCAM	O
.	O

TITLE	O
:	O
Human	B-SPEC
Metapneumovirus	I-SPEC
Infection	O
and	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
During	O
Pregnancy	O
.	O

Virus	B-SPEC
cross	O
-	O
neutralization	O
tests	O
,	O
using	O
CoV	O
/	O
ck	O
/	O
China	O
/	O
I0111	O
/	O
14	O
as	O
a	O
representative	O
,	O
showed	O
that	O
genotype	O
GI	O
-	O
29	O
was	O
antigenically	O
different	O
from	O
all	O
other	O
known	O
IBV	B-SPEC
types	O
,	O
thus	O
representing	O
a	O
novel	O
serotype	O
.	O

A	O
PEDV	B-SPEC
strain	O
was	O
isolated	O
from	O
the	O
intestinal	O
tract	O
of	O
diarrheic	O
piglets	O
from	O
a	O
pig	B-SPEC
farm	O
in	O
Jiangsu	O
Province	O
in	O
March	O
2016	O
,	O
termed	O
the	O
JS201603	O
isolate	O
.	O

The	O
isolated	O
virus	B-SPEC
was	O
confirmed	O
to	O
be	O
PEDV	B-SPEC
via	O
RT	O
-	O
PCR	O
,	O
electron	O
microscopy	O
,	O
a	O
cytopathic	O
effect	O
assay	O
and	O
sequence	O
analysis	O
.	O

The	O
animals	B-SPEC
showed	O
clinical	O
signs	O
of	O
acute	O
respiratory	O
disease	O
with	O
frothy	O
nasal	O
discharge	O
(	O
1	O
-	O
2	O
days	O
)	O
and	O
mortality	O
of	O
twenty	O
animals	B-SPEC
(	O
80	O
%)	O
within	O
48	O
hr	O
.	O

The	O
acute	O
manifestation	O
of	O
the	O
disease	O
indicates	O
high	O
susceptibility	O
of	O
this	O
vulnerable	O
wild	O
bovid	B-SPEC
species	B-SPEC
to	O
PPR	O
lineage	O
IV	O
.	O

TITLE	O
:	O
Evaluation	O
and	O
Clinical	O
Validation	O
of	O
Two	O
Field	O
-	O
Deployable	O
Reverse	O
Transcription	O
-	O
Insulated	O
Isothermal	O
PCR	O
Assays	O
for	O
the	O
Detection	O
of	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
.	O

The	O
analytical	O
sensitivity	O
of	O
RT	O
-	O
RPA	O
was	O
31	O
.	O
8	O
copies	O
in	O
vitro	O
transcribed	O
CDV	B-SPEC
RNA	O
,	O
which	O
is	O
10	O
times	O
lower	O
than	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Enhanced	O
inflammation	O
in	O
New	O
Zealand	O
white	O
rabbits	B-SPEC
when	O
MERS	O
-	O
CoV	O
reinfection	O
occurs	O
in	O
the	O
absence	O
of	O
neutralizing	O
antibody	O
.	O

The	O
rabbits	B-SPEC
developed	O
antibodies	O
against	O
viral	O
proteins	O
that	O
lacked	O
neutralizing	O
activity	O
and	O
the	O
animals	B-SPEC
were	O
not	O
protected	O
from	O
reinfection	O
.	O

Given	O
that	O
the	O
mechanisms	O
of	O
these	O
impairments	O
cannot	O
be	O
addressed	O
adequately	O
in	O
clinical	O
studies	O
,	O
we	O
characterized	O
cardiorespiratory	O
pathophysiology	O
from	O
birth	O
to	O
maturity	O
in	O
the	O
sickle	O
cell	O
disease	O
SAD	O
mouse	B-SPEC
model	O
.	O

TITLE	O
:	O
Neural	O
precursor	O
cells	O
derived	O
from	O
induced	O
pluripotent	O
stem	O
cells	O
exhibit	O
reduced	O
susceptibility	O
to	O
infection	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Astragalus	B-SPEC
polysaccharides	O
(	O
APS	O
)	O
are	O
biological	O
macromolecules	O
extracted	O
from	O
Astragalus	B-SPEC
species	B-SPEC
that	O
have	O
strong	O
immunoregulatory	O
properties	O
.	O

The	O
chickens	B-SPEC
in	O
all	O
groups	O
,	O
except	O
for	O
the	O
unvaccinated	O
control	O
group	O
,	O
were	O
vaccinated	O
with	O
an	O
IBV	B-SPEC
DNA	O
vaccine	O
.	O

At	O
14	O
,	O
28	O
,	O
and	O
42	O
days	O
after	O
the	O
first	O
vaccination	O
,	O
serum	O
anti	O
-	O
IBV	B-SPEC
antibody	O
titers	O
;	O
peripheral	O
lymphocyte	O
proliferation	O
;	O
and	O
the	O
mRNA	O
expression	O
of	O
IL	O
-	O
1	O
,	O
IL	O
-	O
2	O
,	O
IL	O
-	O
8	O
,	O
and	O
TNF	O
-	O
	O
in	O
the	O
spleen	O
were	O
assessed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
the	O
cell	O
counting	O
kit	O
-	O
8	O
(	O
CCK	O
-	O
8	O
),	O
and	O
real	O
time	O
quantitative	O
RT	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
),	O
respectively	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
natural	O
recombinant	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
between	O
Purdue	O
and	O
Miller	O
clusters	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
an	O
infective	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
that	O
causes	O
diarrhea	O
-	O
related	O
morbidity	O
and	O
mortality	O
in	O
piglets	O
.	O

These	O
results	O
provide	O
valuable	O
information	O
about	O
the	O
recombination	O
and	O
evolution	O
of	O
CoVs	O
and	O
will	O
facilitate	O
future	O
investigations	O
of	O
the	O
molecular	O
pathogenesis	O
of	O
TGEV	B-SPEC
.	O

TITLE	O
:	O
Clinicopathologic	O
Features	O
and	O
Magnetic	O
Resonance	O
Imaging	O
Findings	O
in	O
24	O
Cats	B-SPEC
With	O
Histopathologically	O
Confirmed	O
Neurologic	O
Feline	B-SPEC
Infectious	O
Peritonitis	O
.	O

Twenty	O
-	O
four	O
client	O
-	O
owned	O
cats	B-SPEC
with	O
histopathologic	O
confirmation	O
of	O
neurologic	O
FIP	O
.	O

All	O
24	O
cats	B-SPEC
were	O
euthanized	O
with	O
a	O
median	O
survival	O
time	O
of	O
14	O
days	O
(	O
range	O
,	O
2	O
-	O
115	O
)	O
from	O
onset	O
of	O
clinical	O
signs	O
.	O

ABSTRACT	O
:	O
OBJECTIVE	O
To	O
evaluate	O
the	O
effect	O
of	O
serum	O
antibody	O
abundance	O
against	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
on	O
BCV	B-SPEC
shedding	O
and	O
risk	O
of	O
bovine	B-SPEC
respiratory	O
disease	O
(	O
BRD	O
)	O
in	O
beef	O
calves	O
from	O
birth	O
through	O
the	O
first	O
5	O
weeks	O
in	O
a	O
feedlot	O
.	O

TITLE	O
:	O
Prolonged	O
Shedding	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
in	O
Hematopoietic	O
Cell	O
Transplant	O
Recipients	O
:	O
Risk	O
Factors	O
and	O
Viral	O
Genome	O
Evolution	O
.	O

No	O
differences	O
in	O
demographics	O
,	O
etiology	O
of	O
acute	O
pancreatitis	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
scores	O
,	O
or	O
development	O
of	O
pancreatic	O
necrosis	O
were	O
seen	O
between	O
patients	O
with	O
isolated	O
RF	O
Among	O
patients	O
with	O
SAP	O
per	O
the	O
Revised	O
Atlanta	B-SPEC
Classification	O
,	O
approximately	O
15	O
%	O
develop	O
isolated	O
RF	O
.	O

TITLE	O
:	O
Comparison	O
of	O
three	O
blood	O
transfusion	O
guidelines	O
applied	O
to	O
31	O
feline	B-SPEC
donors	O
to	O
minimise	O
the	O
risk	O
of	O
transfusion	O
-	O
transmissible	O
infections	O
.	O

Methods	O
Blood	O
samples	O
were	O
collected	O
from	O
31	O
cats	B-SPEC
enrolled	O
as	O
blood	O
donors	O
by	O
the	O
owners	O
'	O
voluntary	O
choice	O
over	O
a	O
period	O
of	O
approximately	O
1	O
year	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
important	O
reservoir	O
hosts	O
for	O
emerging	O
viruses	B-SPEC
,	O
including	O
coronaviruses	O
that	O
cause	O
diseases	O
in	O
people	O
.	O

We	O
detected	O
a	O
coronavirus	B-SPEC
in	O
the	O
intestines	O
of	O
53	O
/	O
174	O
hibernating	O
little	B-SPEC
brown	I-SPEC
bats	I-SPEC
(	O
Myotis	B-SPEC
lucifugus	I-SPEC
),	O
as	O
well	O
as	O
in	O
the	O
lungs	O
of	O
some	O
of	O
these	O
individuals	O
.	O

Analytical	O
specificity	O
was	O
evaluated	O
with	O
a	O
diverse	O
collection	O
of	O
16	O
respiratory	O
virus	B-SPEC
-	O
positive	O
clinical	O
specimens	O
and	O
14	O
respiratory	O
bacterial	O
isolates	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
invades	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
(	O
IECs	O
)	O
and	O
causes	O
diarrhea	O
and	O
dehydration	O
in	O
pigs	B-SPEC
.	O

Pathogens	O
such	O
as	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
the	O
Zika	B-SPEC
virus	I-SPEC
represent	O
either	O
new	O
viral	O
entities	O
or	O
viruses	B-SPEC
emergent	O
in	O
new	O
geographic	O
locales	O
and	O
characterized	O
by	O
novel	O
complications	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
canine	O
parvovirus	B-SPEC
and	O
canine	O
enteric	B-SPEC
coronavirus	I-SPEC
in	O
diarrheic	O
dogs	B-SPEC
on	O
the	O
island	O
of	O
St	O
.	O
Kitts	O
:	O
First	O
report	O
from	O
the	O
Caribbean	O
region	O
.	O

TITLE	O
:	O
Cellular	O
RNA	O
Helicase	O
DDX1	O
Is	O
Involved	O
in	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
nsp14	O
-	O
Induced	O
Interferon	O
-	O
Beta	O
Production	O
.	O

Unlike	O
most	O
CoVs	O
that	O
antagonize	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
production	O
,	O
previous	O
studies	O
showed	O
that	O
TGEV	B-SPEC
infection	O
induces	O
IFN	O
-	O
I	O
production	O
both	O

Sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
assessment	O
(	O
SOFA	O
)	O
scores	O
and	O
organ	O
support	O
-	O
free	O
days	O
were	O
used	O
as	O
the	O
secondary	O
variables	O
.	O

Our	O
results	O
implied	O
that	O
nsp1	O
was	O
a	O
highly	O
conserved	O
protein	O
of	O
PEDV	B-SPEC
and	O
exhibited	O
antagonistic	O
function	O
on	O
interferon	O
promoter	O
activity	O
.	O

Herein	O
,	O
PEDV	B-SPEC
isolate	O
85	O
-	O
7	O
could	O
proliferate	O
and	O
induce	O
cell	O
-	O
cell	O
fusion	O
in	O
a	O
trypsin	O
independent	O
manner	O
on	O
Vero	O
cells	O
,	O
and	O
eight	O
homologous	O
mutation	O
strains	O
were	O
screened	O
by	O
continuous	O
proliferation	O
in	O
the	O
absence	O
of	O
trypsin	O
on	O
Vero	O
cells	O
.	O

Comparative	O
analyses	O
of	O
their	O
genomic	O
variations	O
and	O
proliferation	O
characteristics	O
identified	O
a	O
single	O
mutation	O
within	O
the	O
S2	O
'	O
cleavage	O
site	O
between	O
C30	O
and	O
C40	O
mutants	O
:	O
the	O
substitution	O
of	O
conserved	O
arginine	O
(	O
R	O
)	O
by	O
a	O
glycine	B-SPEC
(	O
G	O
)	O
(	O
R895G	O
).	O

This	O
change	O
resulted	O
in	O
weaker	O
cell	O
-	O
cell	O
fusion	O
,	O
smaller	O
plaque	O
morphology	O
,	O
higher	O
virus	B-SPEC
titer	O
and	O
serious	O
microfilament	O
condensation	O
.	O

ABSTRACT	O
:	O
There	O
have	O
been	O
2040	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
27	O
countries	O
,	O
with	O
a	O
mortality	O
rate	O
of	O
34	O
.	O
9	O
%.	O

Moreover	O
,	O
A15	O
retained	O
good	O
inhibition	O
potency	O
against	O
three	O
non	O
-	O
nucleoside	O
RT	O
inhibitor	O
(	O
NNRTI	O
)-	O
resistant	O
enzymes	O
,	O
confirming	O
a	O
mode	O
of	O
action	O
unrelated	O
to	O
NNRTIs	O
and	O
suggesting	O
its	O
potential	O
as	O
a	O
lead	O
compound	O
for	O
development	O
of	O
new	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
dual	O
inhibitors	O
active	O
against	O
drug	O
-	O
resistant	O
viruses	B-SPEC
.	O

The	O
main	O
objectives	O
were	O
to	O
compare	O
two	O
different	O
ventilator	O
settings	O
on	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
growth	O
in	O
lung	O
tissue	O
and	O
the	O
development	O
of	O
lung	O
injury	O
.	O

RESULTS	O
:	O
The	O
protective	O
group	O
displayed	O
lower	O
numbers	O
of	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
lung	O
tissue	O
,	O
and	O
a	O
lower	O
wet	O
-	O
to	O
-	O
dry	O
ratio	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
than	O
the	O
control	O
group	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
characterized	O
by	O
an	O
innate	O
immune	O
response	O
and	O
the	O
following	O
immune	O
dysfunction	O
which	O
can	O
increase	O
the	O
emergence	O
of	O
secondary	O
infections	O
.	O

Ethyl	O
pyruvate	O
(	O
EP	O
)	O
has	O
multiple	O
immunoregulation	O
functions	O
in	O
several	O
serious	O
illnesses	O
,	O
such	O
as	O
burn	O
injury	O
,	O
severe	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
syndrome	O
.	O

Then	O
cytokines	O
including	O
lung	O
IL	O
-	O
6	O
,	O
IL	O
-	O
1	O
,	O
IL	O
-	O
10	O
and	O
plasma	O
HMGB1	O
,	O
apoptosis	O
of	O
splenic	O
immune	O
cells	O
and	O
Foxp3	O
level	O
on	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
were	O
studied	O
to	O
demonstrate	O
the	O
mechanisms	O
of	O
EP	O
administration	O
on	O
two	O
-	O
hit	O
mice	B-SPEC
.	O

We	O
found	O
that	O
the	O
susceptibility	O
of	O
septic	O
mice	B-SPEC
to	O
Secondary	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
pneumonia	O
could	O
be	O
down	O
-	O
regulated	O
by	O
ethyl	O
pyruvate	O
treatment	O
and	O
the	O
protective	O
effects	O
of	O
EP	O
may	O
via	O
decreasing	O
lung	O
IL	O
-	O
10	O
and	O
plasma	O
HMGB1	O
expression	O
,	O
inhibiting	O
the	O
function	O
of	O
Tregs	O
and	O
relieving	O
the	O
apoptosis	O
of	O
splenic	O
immune	O
cells	O
.	O

Despite	O
the	O
effort	O
of	O
scientific	O
studies	O
related	O
to	O
this	O
virus	B-SPEC
,	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
still	O
a	O
public	O
health	O
concern	O
.	O

Bioassay	O
results	O
indicated	O
that	O
some	O
compounds	O
exhibited	O
good	O
antiviral	O
activities	O
against	O
cucumber	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
CMV	B-SPEC
)	O
and	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
TMV	B-SPEC
)	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Clinically	O
,	O
in	O
young	O
immunocompetent	O
adults	O
,	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	O
)	O
usually	O
manifests	O
as	O
infectious	O
mononucleosis	O
(	O
IM	O
).	O

ABSTRACT	O
:	O
The	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O

The	O
presence	O
of	O
several	O
well	O
supported	O
epidemiological	O
links	O
among	O
distantly	O
related	O
Italian	O
regions	O
testifies	O
that	O
animal	B-SPEC
transportation	O
and	O
indirect	O
transmission	O
routes	O
rather	O
than	O
local	O
airborne	O
diffusion	O
contribute	O
to	O
the	O
QX	O
success	O
and	O
persistence	O
at	O
local	O
scale	O
.	O

The	O
antiviral	O
activity	O
of	O
MCD	O
on	O
porcine	B-SPEC
nidovirus	B-SPEC
infection	O
was	O
found	O
to	O
be	O
predominantly	O
exerted	O
when	O
used	O
as	O
a	O
treatment	O
pre	O
-	O
infection	O
or	O
prior	O
to	O
the	O
viral	O
entry	O
process	O
.	O

Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
cell	O
membrane	O
cholesterol	O
is	O
required	O
for	O
porcine	B-SPEC
nidovirus	B-SPEC
entry	O
into	O
cells	O
,	O
and	O
pharmacological	O
drugs	O
that	O
hamper	O
cholesterol	O
-	O
dependent	O
virus	B-SPEC
entry	O
may	O
have	O
antiviral	O
potential	O
against	O
porcine	B-SPEC
nidoviruses	B-SPEC
.	O

A	O
neonate	O
developed	O
severe	O
sepsis	B-SPEC
-	O
like	O
illness	O
with	O
HPeV3	O
as	O
the	O
only	O
pathogen	O
detected	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
belongs	O
to	O
the	O
alphacoronavirus	B-SPEC
of	O
the	O
Coronaviridae	B-SPEC
.	O

We	O
present	O
this	O
case	O
with	O
literature	O
review	O
for	O
the	O
CMV	B-SPEC
infection	O
associated	O
morbidity	O
and	O
mortality	O
among	O
immunocompetent	O
children	O
.	O

ABSTRACT	O
:	O
This	O
study	O
reports	O
on	O
two	O
Hanwoo	O
(	O
a	O
native	O
Korean	O
breed	O
of	O
cattle	B-SPEC
)	O
calves	O
,	O
a	O
3	O
-	O
and	O
6	O
-	O
month	O
-	O
old	O
presenting	O
with	O
diarrhea	O
,	O
anorexia	O
and	O
blindness	O
.	O

Tests	O
of	O
a	O
CoV	O
-	O
229E	O
laboratory	O
strain	O
under	O
conditions	O
that	O
simulated	O
the	O
ambient	O
light	O
,	O
temperature	O
,	O
and	O
relative	O
humidity	O
conditions	O
of	O
the	O
classroom	O
revealed	O
that	O
some	O
of	O
the	O
virus	B-SPEC
remained	O
viable	O
on	O
various	O
surfaces	O
for	O
7	O
days	O
,	O
suggesting	O
CoV	O
-	O
229E	O
is	O
relatively	O
stable	O
in	O
the	O
environment	O
.	O

The	O
results	O
reveal	O
that	O
the	O
three	O
IBV	B-SPEC
isolates	O
mainly	O
exhibited	O
mutations	O
in	O
the	O
hypervariable	O
regions	O
(	O
HVRs	O
)	O
of	O
the	O
S1	O
gene	O
and	O
protein	O
,	O
but	O
were	O
phylogenetically	O
and	O
serologically	O
closely	O
related	O
,	O
belonging	O
to	O
lineage	O
11	O
of	O
the	O
GI	O
genotype	O
,	O
the	O
former	O
BR	O
genotype	O
I	O
.	O
All	O
three	O
isolates	O
caused	O
persistent	O
infection	O
in	O
broiler	O
breeders	O
reared	O
in	O
the	O
field	O
,	O
despite	O
high	O
systemic	O
anti	O
-	O
IBV	B-SPEC
antibody	O
titres	O
,	O
and	O
exhibited	O
tropism	O
and	O
pathogenicity	O
for	O
the	O
trachea	B-SPEC
and	O
kidney	O
after	O
experimental	O
infection	O
in	O
SPF	O
chickens	B-SPEC
and	O
contact	O
birds	B-SPEC
.	O

In	O
addition	O
,	O
the	O
genetic	O
alterations	O
in	O
the	O
S1	O
gene	O
of	O
these	O
isolates	O
were	O
not	O
able	O
to	O
change	O
their	O
tissue	O
tropism	O
and	O
pathogenicity	O
,	O
but	O
did	O
seem	O
to	O
negatively	O
influence	O
the	O
effectiveness	O
of	O
the	O
host	O
immune	O
responses	O
against	O
these	O
viruses	B-SPEC
,	O
and	O
favour	O
viral	O
persistence	O
.	O

Using	O
IBV	B-SPEC
Arkansas	O
-	O
type	O
(	O
Ark	O
)	O
S	O
protein	O
histochemistry	O
,	O
we	O
show	O
that	O
extension	O
of	O
S1	O
with	O
the	O
S2	O
ectodomain	O
improves	O
binding	O
to	O
chicken	B-SPEC
tissues	O
.	O

Challenge	O
was	O
performed	O
with	O
virulent	O
Ark	O
IBV	B-SPEC
21days	O
after	O
boost	O
.	O

TITLE	O
:	O
Efficacy	O
of	O
a	O
3C	O
-	O
like	O
protease	O
inhibitor	O
in	O
treating	O
various	O
forms	O
of	O
acquired	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

At	O
the	O
time	O
of	O
writing	O
,	O
seven	O
cats	B-SPEC
were	O
in	O
disease	O
remission	O
.	O

In	O
this	O
study	O
,	O
we	O
performed	O
metagenomic	O
sequencing	O
analysis	O
on	O
nasopharyngeal	O
swab	O
samples	O
from	O
108	O
MERS	O
-	O
CoV	O
-	O
positive	O
dromedary	B-SPEC
camels	B-SPEC
from	O
a	O
live	O
animal	B-SPEC
market	O
in	O
Abu	O
Dhabi	O
,	O
United	O
Arab	O
Emirates	O
.	O

This	O
study	O
provides	O
a	O
comprehensive	O
survey	O
of	O
viruses	B-SPEC
in	O
the	O
virome	O
of	O
upper	O
respiratory	O
samples	O
in	O
camels	B-SPEC
that	O
have	O
extensive	O
contact	O
with	O
the	O
human	B-SPEC
population	O
.	O

Predictors	O
of	O
mortality	O
were	O
derived	O
from	O
a	O
multivariable	O
logistic	O
regression	O
and	O
included	O
age	O
,	O
Elixhauser	O
comorbidity	O
score	O
,	O
insurance	O
status	O
,	O
teaching	O
versus	O
nonteaching	O
hospital	O
,	O
and	O
cancer	B-SPEC
type	O
.	O

Ninety	O
-	O
five	O
drills	B-SPEC
(	O
53	O
measles	O
and	O
42	O
MERS	O
)	O
were	O
conducted	O
in	O
49	O
EDs	O
with	O
patients	O
masked	O
and	O
isolated	O
in	O
78	O
%	O
of	O
drills	B-SPEC
.	O

TITLE	O
:	O
Efficacy	O
and	O
immunogenicity	O
of	O
recombinant	O
swinepox	B-SPEC
virus	I-SPEC
expressing	O
the	O
truncated	O
S	O
protein	O
of	O
a	O
novel	O
isolate	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

Serum	O
IgA	O
titers	O
in	O
rSPV	O
-	O
St	O
-	O
vaccinated	O
animals	B-SPEC
were	O
significantly	O
higher	O
than	O
in	O
those	O
immunized	O
with	O
inactivated	O
vaccines	O
.	O

Serological	O
studies	O
could	O
help	O
to	O
assess	O
its	O
impact	O
on	O
humans	B-SPEC
or	O
wildlife	O
health	O
.	O

The	O
virus	B-SPEC
showed	O
closest	O
relationship	O
with	O
two	O
human	B-SPEC
pathogenic	O
viruses	B-SPEC
,	O
Colorado	B-SPEC
tick	I-SPEC
fever	I-SPEC
virus	I-SPEC
and	O
Eyach	B-SPEC
virus	I-SPEC
,	O
and	O
was	O
able	O
to	O
infect	O
various	O
human	B-SPEC
cell	O
lines	O
in	O
vitro	O
.	O

Recombination	O
analyses	O
with	O
other	O
gammacoronaviruses	O
revealed	O
that	O
Polish	O
GI	O
-	O
23	O
strain	O
may	O
originate	O
from	O
recombination	O
events	O
and	O
potential	O
donors	O
of	O
build	O
-	O
in	O
sequences	O
are	O
IBV	B-SPEC
of	O
GI	O
-	O
1	O
,	O
GI	O
-	O
13	O
and	O
G	O
-	O
19	O
lineages	O
(	O
Mass	O
-,	O
793B	O
-	O
and	O
QX	O
-	O
like	O
strains	O
,	O
respectively	O
).	O

Although	O
the	O
duration	O
of	O
ICU	O
stay	O
was	O
shortened	O
,	O
the	O
clinical	O
benefits	O
of	O
NAC	O
were	O
limited	O
for	O
ARDS	O
based	O
on	O
the	O
present	O
meta	B-SPEC
-	O
analysis	O
.	O

TITLE	O
:	O
Leader	O
sequences	O
of	O
coronavirus	B-SPEC
are	O
altered	O
during	O
infection	O
.	O

With	O
MERS	O
outbreaks	O
resulting	O
in	O
over	O
35	O
%	O
fatalities	O
and	O
now	O
spread	O
to	O
27	O
countries	O
,	O
MERS	O
-	O
CoV	O
poses	O
a	O
significant	O
ongoing	O
threat	O
to	O
global	O
human	B-SPEC
health	O
.	O

TITLE	O
:	O
Human	B-SPEC
Coronaviruses	O
:	O
A	O
Review	O
of	O
Virus	B-SPEC
-	O
Host	O
Interactions	O
.	O

The	O
activity	O
of	O
caspases	O
,	O
the	O
inhibitory	O
efficacy	O
of	O
caspase	O
-	O
inhibitors	O
and	O
the	O
expression	O
of	O
apoptotic	O
genes	O
further	O
suggested	O
the	O
activation	O
of	O
apoptosis	O
through	O
both	O
intrinsic	O
and	O
extrinsic	O
pathways	O
in	O
IBV	B-SPEC
-	O
infected	O
HD11	O
cells	O
.	O

This	O
work	O
performs	O
selection	O
of	O
synthetic	O
polymers	O
as	O
novel	O
broadly	O
active	O
agents	O
and	O
demonstrates	O
activity	O
of	O
these	O
polymers	O
against	O
Zika	O
,	O
Ebola	O
,	O
Lassa	O
,	O
Lyssa	B-SPEC
,	O
Rabies	O
,	O
Marburg	O
,	O
Ebola	O
,	O
influenza	O
,	O
herpes	O
simplex	O
,	O
and	O
human	B-SPEC
immunodeficiency	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
are	O
the	O
causative	O
agents	O
of	O
highly	O
fatal	O
acute	O
diarrhea	O
in	O
pigs	B-SPEC
,	O
resulting	O
in	O
enormous	O
losses	O
in	O
the	O
pig	B-SPEC
industry	O
worldwide	O
.	O

TITLE	O
:	O
Two	O
novel	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
recombinants	O
from	O
a	O
natural	O
recombinant	O
and	O
distinct	O
subtypes	O
of	O
PEDV	B-SPEC
variants	O
.	O

Genomic	O
comparison	O
showed	O
that	O
these	O
two	O
viruses	B-SPEC
share	O
the	O
highest	O
nucleotide	O
identities	O
(	O
99	O
.	O
10	O
%	O
and	O
98	O
.	O
79	O
%)	O
with	O
the	O
2011	O
ZMDZY	O
strain	O
,	O
but	O
only	O
96	O
.	O
65	O
%	O
and	O
96	O
.	O
50	O
%	O
nucleotide	O
identities	O
with	O
the	O
attenuated	O
CV777	O
strain	O
.	O

Amino	O
acid	O
alignment	O
of	O
spike	O
(	O
S	O
)	O
proteins	O
indicated	O
that	O
they	O
have	O
the	O
similar	O
mutation	O
,	O
insertion	O
and	O
deletion	O
pattern	O
as	O
other	O
Chinese	O
PEDV	B-SPEC
variants	O
but	O
also	O
contain	O
several	O
unique	O
substitutions	O
.	O

Phylogenetic	O
analysis	O
showed	O
that	O
2016	O
PEDV	B-SPEC
variants	O
belong	O
to	O
the	O
cluster	O
of	O
recombination	O
strains	O
but	O
form	O
a	O
new	O
branch	O
.	O

Remarkably	O
,	O
the	O
natural	O
recombinant	O
HNQX	O
-	O
3	O
isolate	O
serves	O
as	O
a	O
parental	O
virus	B-SPEC
for	O
both	O
natural	O
recombinants	O
identified	O
in	O
this	O
study	O
.	O

We	O
report	O
here	O
the	O
first	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
in	O
the	O
Kingdom	B-SPEC
of	O
Bahrain	O
in	O
a	O
Saudi	O
gentleman	O
who	O
was	O
admitted	O
electively	O
for	O
coronary	O
bypass	O
surgery	O
,	O
postoperatively	O
developed	O
an	O
acute	O
respiratory	O
illness	O
,	O
and	O
tested	O
positive	O
for	O
MERS	O
-	O
CoV	O
.	O
40	O
close	O
contacts	O
,	O
all	O
healthcare	O
workers	O
,	O
were	O
traced	O
and	O
followed	O
with	O
no	O
documented	O
secondary	O
cases	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
Hemagglutinating	O
Encephalomyelitis	O
Virus	B-SPEC
Enters	O
Neuro	O
-	O
2a	O
Cells	O
via	O
Clathrin	O
-	O
Mediated	O
Endocytosis	O
in	O
a	O
Rab5	O
-,	O
Cholesterol	O
-,	O
and	O
pH	O
-	O
Dependent	O
Manner	O
.	O

Protection	O
(	O
reduction	O
of	O
clinical	O
signs	O
and	O
viral	O
loads	O
)	O
assessed	O
5	O
days	O
postchallenge	O
showed	O
nonsignificant	O
differences	O
between	O
chickens	B-SPEC
primed	O
with	O
Mass	O
vaccine	O
and	O
boosted	O
with	O
rLS	O
/	O
IBV	B-SPEC
.	O
S2	O
-	O
4	O
/	O
91	O
and	O
chickens	B-SPEC
vaccinated	O
with	O
Mass	O
only	O
.	O

TITLE	O
:	O
Isolation	O
and	O
Molecular	O
Characterization	O
of	O
Novel	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Variants	O
from	O
Vaccinated	O
Broiler	O
Flocks	O
in	O
Egypt	O
.	O

Then	O
,	O
animals	B-SPEC
were	O
ventilated	O
on	O
a	O
conventional	O
mechanical	O
ventilator	O
with	O
a	O
respiratory	O
rate	O
(	O
RR	O
)	O
=	O
60	O
breaths	O
/	O
minute	O
and	O
PEEP	O
titrated	O
according	O
to	O
ARDS	O
Network	O
table	O
.	O

Future	O
studies	O
should	O
investigate	O
means	O
for	O
preventing	O
SARF	O
-	O
MV	O
in	O
critically	O
ill	O
cancer	B-SPEC
patients	O
,	O
which	O
may	O
have	O
an	O
impact	O
upon	O
outcomes	O
.	O

TITLE	O
:	O
Host	O
-	O
Feeding	O
Patterns	O
of	O
Culex	B-SPEC
stigmatosoma	O
(	O
Diptera	B-SPEC
:	O
Culicidae	B-SPEC
)	O
in	O
Southern	O
California	B-SPEC
.	O

stigmatosoma	O
bloodmeals	O
,	O
revealing	O
that	O
98	O
.	O
6	O
%	O
of	O
bloodmeals	O
were	O
from	O
birds	B-SPEC
,	O
1	O
.	O
2	O
%	O
from	O
three	O
mammal	B-SPEC
species	B-SPEC
,	O
and	O
a	O
single	O
bloodmeal	O
was	O
from	O
a	O
reptile	O
species	B-SPEC
.	O

The	O
clinical	O
manifestation	O
of	O
pulmonary	O
ricin	O
intoxication	O
in	O
animal	B-SPEC
models	O
is	O
closely	O
related	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
which	O
involves	O
pulmonary	O
proinflammatory	O
cytokine	O
upregulation	O
,	O
massive	O
neutrophil	O
infiltration	O
and	O
severe	O
edema	O
.	O

TITLE	O
:	O
Lianqinjiedu	O
decoction	O
attenuates	O
LPS	O
-	O
induced	O
inflammation	O
and	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
via	O
TLR4	O
/	O
NF	O
-	O
B	O
pathway	O
.	O

The	O
present	O
study	O
investigated	O
whether	O
Lianqinjiedu	O
(	O
LQJD	O
)	O
ameliorates	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
and	O
aimed	O
to	O
determine	O
the	O
anti	O
-	O
inflammatory	O
effects	O
of	O
LQJD	O
.	O

Samples	O
were	O
available	O
from	O
a	O
total	O
of	O
102	O
cats	B-SPEC
.	O

GFP	O
was	O
genetically	O
fused	O
to	O
the	O
N	O
-	O
terminal	O
part	O
of	O
protein	O
4a	O
,	O
from	O
which	O
it	O
is	O
released	O
during	O
translation	O
via	O
porcine	B-SPEC
teschovirus	I-SPEC
2A	O
peptide	O
activity	O
.	O

The	O
S	O
-	O
INDEL	O
-	O
inoculated	O
pigs	B-SPEC
had	O
lower	O
ileal	O
IgA	O
antibody	O
secreting	O
cells	O
,	O
serum	O
IgA	O
and	O
neutralizing	O
antibody	O
titers	O
compared	O
with	O
PC21A	O
-	O
inoculated	O
pigs	B-SPEC
.	O

To	O
study	O
glycocalyx	O
degradation	O
in	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
,	O
we	O
measured	O
plasma	O
levels	O
of	O
syndecan	O
-	O
1	O
,	O
a	O
marker	O
for	O
glycocalyx	O
degradation	O
.	O

Glycan	O
receptor	O
-	O
binding	O
sites	O
are	O
typically	O
located	O
in	O
exposed	O
regions	O
on	O
viral	O
surfaces	O
-	O
sites	O
that	O
are	O
also	O
generally	O
prone	O
to	O
binding	O
of	O
neutralizing	O
antibodies	O
that	O
directly	O
interfere	O
with	O
virus	B-SPEC
-	O
glycan	O
receptor	O
interactions	O
.	O

The	O
cELISA	O
detected	O
MERS	O
-	O
CoV	O
-	O
specific	O
antibodies	O
in	O
sera	O
from	O
MERS	O
-	O
CoV	O
-	O
infected	O
rats	B-SPEC
and	O
rabbits	B-SPEC
immunized	O
with	O
the	O
spike	O
protein	O
of	O
MERS	O
-	O
CoV	O
.	O
The	O
MAb	O
-	O
based	O
cELISA	O
was	O
validated	O
using	O
sera	O
from	O
Ethiopian	O
dromedary	B-SPEC
camels	B-SPEC
.	O

Relative	O
to	O
the	O
neutralization	O
test	O
,	O
the	O
cELISA	O
detected	O
MERS	O
-	O
CoV	O
-	O
specific	O
antibodies	O
in	O
66	O
Ethiopian	O
dromedary	B-SPEC
camels	B-SPEC
with	O
a	O
sensitivity	O
and	O
specificity	O
of	O
98	O
%	O
and	O
100	O
%,	O
respectively	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
genetic	O
diversity	O
and	O
molecular	O
epidemiology	O
of	O
field	O
strains	O
of	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
China	O
in	O
2016	O
-	O
2017	O
.	O

TITLE	O
:	O
A	O
novel	O
strain	O
of	O
porcine	B-SPEC
deltacoronavirus	O
in	O
Vietnam	O
.	O

We	O
confirmed	O
the	O
clinical	O
sensitivity	O
(>	O
90	O
%)	O
of	O
the	O
bio	O
-	O
optical	O
sensor	O
by	O
detecting	O
C	B-SPEC
.	I-SPEC
burnetii	I-SPEC
in	O
11	O
formalin	O
-	O
fixed	O
,	O
paraffin	O
-	O
embedded	O
liver	O
biopsy	O
samples	O
from	O
acute	O
Q	O
fever	O
hepatitis	O
patients	O
and	O
in	O
16	O
blood	O
plasma	O
samples	O
from	O
patients	O
in	O
which	O
Q	O
fever	O
is	O
the	O
cause	O
of	O
fever	O
of	O
unknown	O
origin	O
.	O

Although	O
several	O
studies	O
have	O
identified	O
MERS	O
-	O
CoV	O
proteins	O
as	O
innate	O
immune	O
antagonists	O
,	O
little	O
of	O
this	O
work	O
has	O
been	O
conducted	O
using	O
live	O
virus	B-SPEC
under	O
conditions	O
of	O
actual	O
infection	O
,	O
but	O
rather	O
with	O
ectopically	O
expressed	O
proteins	O
.	O

TITLE	O
:	O
Influenza	O
is	O
more	O
common	O
than	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
among	O
hospitalized	O
adult	O
Saudi	O
patients	O
.	O

Cigarette	O
smoke	O
exposure	O
(	O
quantified	O
using	O
plasma	O
cotinine	O
),	O
ARDS	O
development	O
,	O
and	O
other	O
clinical	O
parameters	O
were	O
correlated	O
with	O
lung	O
microbiota	B-SPEC
composition	O
.	O

TITLE	O
:	O
Identification	O
of	O
N	O
-	O
linked	O
glycosylation	O
sites	O
in	O
the	O
spike	O
protein	O
and	O
their	O
functional	O
impact	O
on	O
the	O
replication	O
and	O
infectivity	O
of	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
cell	O
culture	O
.	O

Further	O
characterization	O
of	O
these	O
and	O
other	O
uncharacterized	O
sites	O
may	O
reveal	O
novel	O
aspects	O
of	O
N	O
-	O
linked	O
glycosylation	O
in	O
coronavirus	B-SPEC
replication	O
and	O
pathogenesis	O
.	O

In	O
this	O
study	O
,	O
several	O
nsps	O
encoded	O
by	O
avian	B-SPEC
gammacoronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
screened	O
for	O
RNA	O
-	O
binding	O
activity	O
and	O
interaction	O
with	O
its	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
,	O
nsp12	O
.	O

This	O
study	O
identified	O
some	O
of	O
the	O
respiratory	O
viruses	B-SPEC
associated	O
with	O
ILI	O
in	O
Uganda	O
.	O

In	O
a	O
randomized	O
study	O
of	O
84	O
496	O
elderly	O
individuals	O
with	O
a	O
high	O
uptake	O
of	O
influenza	O
vaccination	O
,	O
PCV13	O
was	O
not	O
associated	O
with	O
a	O
statistically	O
significant	O
reduction	O
of	O
influenza	O
or	O
virus	B-SPEC
-	O
associated	O
CAP	O
.	O

RESULTS	O
:	O
Of	O
3209	O
episodes	O
of	O
suspected	O
pneumonia	O
,	O
viral	O
aetiology	O
was	O
tested	O
in	O
2917	O
and	O
proportions	O
with	O
influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
were	O
4	O
.	O
6	O
%,	O
2	O
.	O
5	O
%	O
and	O
3	O
.	O
1	O
%,	O
respectively	O
.	O

TITLE	O
:	O
Development	O
of	O
an	O
xTAG	O
-	O
multiplex	O
PCR	O
array	O
for	O
the	O
detection	O
of	O
four	O
avian	B-SPEC
respiratory	O
viruses	B-SPEC
.	O

Subsequently	O
,	O
it	O
was	O
re	O
-	O
designated	O
as	O
D	O
/	O
132	O
,	O
and	O
formed	O
a	O
new	O
serogroup	O
among	O
rotaviruses	B-SPEC
,	O
the	O
group	O
D	O
rotavirus	B-SPEC
(	O
RVD	O
).	O

The	O
humoral	O
immune	O
response	O
plays	O
a	O
critical	O
role	O
in	O
protection	O
from	O
the	O
influenza	B-SPEC
virus	I-SPEC
,	O
but	O
its	O
role	O
and	O
kinetics	O
in	O
H7N9	O
-	O
infected	O
patients	O
remain	O
to	O
be	O
determined	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
respiratory	O
viruses	B-SPEC
in	O
Iranian	O
patients	O
with	O
idiopathic	O
pulmonary	O
fibrosis	O
.	O

A	O
peripheral	O
iridotomy	O
was	O
placed	O
,	O
which	O
mildly	O
relieved	O
the	O
iris	B-SPEC
bowing	O
,	O
but	O
did	O
not	O
affect	O
the	O
IOP	O
or	O
inflammatory	O
reaction	O
.	O

PdCoV	O
S1	O
-	O
CTD	O
has	O
the	O
same	O
structural	O
fold	O
as	O
alphacoronavirus	B-SPEC
S1	O
-	O
CTDs	O
,	O
but	O
its	O
structure	O
differs	O
from	O
that	O
of	O
betacoronavirus	B-SPEC
S1	O
-	O
CTDs	O
.	O

TITLE	O
:	O
Tectonic	O
conformational	O
changes	O
of	O
a	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
promote	O
membrane	O
fusion	O
.	O

Clinical	O
outcomes	O
in	O
patients	O
with	O
sepsis	B-SPEC
-	O
related	O
ARDS	O
are	O
also	O
worse	O
,	O
associated	O
with	O
significantly	O
higher	O
28	O
-	O
day	O
and	O
60	O
-	O
day	O
mortality	O
rates	O
(	O
31	O
.	O
1	O
%	O
vs	O
.	O
16	O
.	O
3	O
%	O
and	O
38	O
.	O
2	O
%	O
vs	O
.	O
22	O
.	O
6	O
%,	O
respectively	O
).	O

The	O
second	O
strain	O
administration	O
together	O
with	O
the	O
common	O
Mass	O
priming	O
by	O
spray	O
at	O
the	O
hatchery	O
allows	O
saving	O
money	O
and	O
time	O
and	O
reducing	O
animal	B-SPEC
stress	O
.	O

TITLE	O
:	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
and	O
Other	O
Noninfluenza	O
Respiratory	O
Viruses	B-SPEC
in	O
Older	O
Adults	O
.	O

Other	O
noninfluenza	O
respiratory	O
viral	O
pathogens	O
include	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
adenovirus	B-SPEC
.	O

LCMS	O
/	O
MS	O
coupled	O
to	O
isobaric	O
tags	O
for	O
relative	O
and	O
absolute	O
quantification	O
(	O
iTRAQ	O
)	O
is	O
used	O
to	O
profile	O
expressed	O
proteins	O
in	O
IPEC	O
-	O
J2	O
cells	O
infected	O
by	O
TGEV	B-SPEC
alone	O
,	O
ETEC	O
K88	O
alone	O
,	O
and	O
by	O
both	O
agents	O
together	O
.	O

Even	O
after	O
4	O
subsequent	O
sequences	O
,	O
animal	B-SPEC
food	O
-	O
contact	O
surfaces	O
retained	O
viral	O
RNA	O
(	O
28	O
/	O
33	O
positive	O
samples	O
/	O
total	O
samples	O
),	O
with	O
conveying	O
system	O
being	O
more	O
contaminated	O
than	O
the	O
mixer	O
.	O

TITLE	O
:	O
Cell	O
attenuated	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
Zhejiang08	O
provides	O
effective	O
immune	O
protection	O
attributed	O
to	O
dendritic	O
cell	O
stimulation	O
.	O

However	O
,	O
classical	O
PEDV	B-SPEC
vaccine	O
strains	O
only	O
provide	O
limited	O
protection	O
against	O
emerging	O
strains	O
.	O

The	O
attenuated	O
virus	B-SPEC
induced	O
a	O
high	O
level	O
of	O
virus	B-SPEC
-	O
specific	O
neutralizing	O
antibodies	O
until	O
120	O
days	O
after	O
immunization	O
in	O
piglets	O
and	O
provided	O
complete	O
protection	O
when	O
challenged	O
with	O
an	O
emerging	O
virus	B-SPEC
strain	O
on	O
day	O
14	O
post	O
immunization	O
.	O

ABSTRACT	O
:	O
Outbreaks	O
of	O
diarrhea	O
in	O
newborn	O
piglets	O
without	O
detection	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
have	O
been	O
recorded	O
in	O
a	O
pig	B-SPEC
farm	O
in	O
southern	O
China	O
since	O
February	O
2017	O
.	O

Isolation	O
and	O
propagation	O
of	O
the	O
pathogen	O
in	O
cell	O
culture	O
resulted	O
in	O
discovery	O
of	O
a	O
novel	O
swine	B-SPEC
enteric	O
alphacoronavirus	B-SPEC
(	O
tentatively	O
named	O
SeACoV	O
)	O
related	O
to	O
the	O
bat	B-SPEC
coronavirus	I-SPEC
HKU2	I-SPEC
identified	O
in	O
the	O
same	O
region	O
a	O
decade	O
ago	O
.	O

The	O
SeACoV	O
-	O
S	O
domain	O
0	O
associated	O
with	O
enteric	O
tropism	O
had	O
an	O
extremely	O
high	O
variability	O
,	O
harboring	O
75	O
-	O
amino	O
-	O
acid	O
(	O
aa	O
)	O
substitutions	O
and	O
a	O
2	O
-	O
aa	O
insertion	O
,	O
compared	O
to	O
that	O
of	O
HKU2	O
,	O
which	O
is	O
likely	O
responsible	O
for	O
the	O
extended	O
host	O
range	O
or	O
cross	O
-	O
species	B-SPEC
transmission	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
longitudinal	O
impact	O
of	O
PEDV	B-SPEC
on	O
nursery	O
pig	B-SPEC
intestinal	O
function	O
and	O
integrity	O
.	O

Fifty	O
recently	O
-	O
weaned	O
,	O
5	O
-	O
week	O
-	O
old	O
barrows	O
and	O
gilts	O
(	O
BW	O
=	O
9	O
.	O
92	O
	O
0	O
.	O
49kg	O
)	O
were	O
sorted	O
based	O
on	O
body	O
weight	O
(	O
BW	O
)	O
and	O
sex	O
into	O
two	O
treatments	O
:	O
1	O
)	O
Control	O
or	O
2	O
)	O
PEDV	B-SPEC
inoculated	O
.	O

Total	O
acidic	O
mucins	O
,	O
particularly	O
sialomucin	O
,	O
were	O
reduced	O
in	O
PEDV	B-SPEC
pigs	B-SPEC
at	O
dpi	O
2	O
and	O
then	O
increased	O
compared	O
with	O
controls	O
at	O
dpi	O
7	O
and	O
14	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
Reproductive	I-SPEC
and	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
is	O
the	O
cause	O
of	O
severe	O
reproductive	O
and	O
respiratory	O
disease	O
in	O
swine	B-SPEC
worldwide	O
.	O

In	O
an	O
experimental	O
trial	O
in	O
growing	O
pigs	B-SPEC
,	O
no	O
overt	O
clinical	O
signs	O
or	O
pathology	O
were	O
observed	O
following	O
intranasal	O
inoculation	O
with	O
the	O
new	O
virus	B-SPEC
isolate	O
.	O

TITLE	O
:	O
Poly	O
(	O
d	O
,	O
l	O
-	O
lactide	O
-	O
co	O
-	O
glycolide	O
)	O
nanoparticle	O
-	O
entrapped	O
vaccine	O
induces	O
a	O
protective	O
immune	O
response	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
in	O
piglets	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
causes	O
80	O
-	O
100	O
%	O
mortality	O
in	O
neonatal	O
piglets	O
,	O
and	O
its	O
causative	O
agent	O
,	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
poses	O
an	O
important	O
threat	O
to	O
the	O
swine	B-SPEC
industry	O
worldwide	O
.	O

PEDV	B-SPEC
-	O
specific	O
IgG	O
and	O
IgA	O
antibody	O
titers	O
were	O
enhanced	O
in	O
pregnant	O
sows	O
immunized	O
with	O
PLGA	O
-	O
KAg	O
relative	O
to	O
the	O
titers	O
in	O
sows	O
inoculated	O
with	O
KAg	O
.	O

It	O
is	O
critical	O
to	O
detect	O
and	O
differentiate	O
two	O
genotypes	O
in	O
the	O
pork	O
industry	O
to	O
prevent	O
PEDV	B-SPEC
outbreaks	O
.	O

TITLE	O
:	O
NCp7	O
:	O
targeting	O
a	O
multitasking	O
protein	O
for	O
next	O
-	O
generation	O
anti	O
-	O
HIV	B-SPEC
drug	O
development	O
part	O
1	O
:	O
covalent	O
inhibitors	O
.	O

ABSTRACT	O
:	O
The	O
major	O
internal	O
component	O
of	O
the	O
HIV	B-SPEC
virion	O
core	O
is	O
the	O
nucleocapsid	O
protein	O
7	O
(	O
NCp7	O
),	O
a	O
small	O
,	O
highly	O
basic	O
protein	O
that	O
is	O
essential	O
for	O
multiple	O
stages	O
of	O
the	O
viral	O
replicative	O
cycle	O
,	O
and	O
whose	O
structure	O
is	O
preserved	O
in	O
all	O
viral	O
strains	O
,	O
including	O
clinical	O
isolates	O
from	O
therapy	O
-	O
experienced	O
patients	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
compared	O
the	O
efficiency	O
of	O
two	O
sequence	O
-	O
independent	O
approaches	O
[	O
sequence	O
-	O
independent	O
single	O
primer	O
amplification	O
(	O
SISPA	O
)	O
and	O
single	O
primer	O
isothermal	O
amplification	O
(	O
SPIA	O
,	O
represented	O
by	O
the	O
Ovation	O
kit	O
)]	O
coupled	O
with	O
high	O
-	O
throughput	O
sequencing	O
to	O
generate	O
the	O
full	O
-	O
length	O
genome	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
from	O
a	O
nasal	O
swab	O
.	O

TITLE	O
:	O
Discrepancies	O
between	O
feline	B-SPEC
coronavirus	B-SPEC
antibody	O
and	O
nucleic	O
acid	O
detection	O
in	O
effusions	O
of	O
cats	B-SPEC
with	O
suspected	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

Compared	O
to	O
MHV	B-SPEC
-	O
ExoN	O
(-)	O
P3	O
,	O
MHV	B-SPEC
-	O
ExoN	O
(-)	O
P250	O
demonstrated	O
enhanced	O
replication	O
and	O
increased	O
competitive	O
fitness	O
without	O
reversion	O
at	O
the	O
ExoN	O
(-)	O
active	O
site	O
.	O

These	O
results	O
demonstrate	O
the	O
potential	O
of	O
the	O
bivalent	O
pBH	O
-	O
S1	O
-	O
TM	O
-	O
1	O
-	O
EGFP	O
adenovirus	B-SPEC
construct	O
as	O
a	O
combination	O
vaccine	O
against	O
IB	O
and	O
mycoplasmosis	O
.	O

Using	O
Next	O
Generation	O
de	O
novo	O
sequencing	O
(	O
de	O
novo	O
NGS	O
)	O
on	O
pools	O
of	O
samples	O
from	O
case	O
animals	B-SPEC
within	O
all	O
herds	O
,	O
PKV	O
-	O
1	O
was	O
detected	O
in	O
four	O
herds	O
and	O
rotavirus	B-SPEC
A	I-SPEC
,	O
rotavirus	B-SPEC
C	I-SPEC
and	O
PTV	B-SPEC
were	O
detected	O
in	O
one	O
herd	O
each	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
identified	O
on	O
the	O
Arabian	O
Peninsula	O
in	O
2012	O
and	O
is	O
still	O
causing	O
cases	O
and	O
outbreaks	O
in	O
the	O
Middle	O
East	O
.	O

We	O
identified	O
sequences	O
from	O
market	O
camels	B-SPEC
nearly	O
identical	O
to	O
the	O
previously	O
reported	O
2015	O
German	O
case	O
who	O
visited	O
the	O
market	O
during	O
his	O
incubation	O
period	O
.	O

Our	O
study	O
expands	O
the	O
known	O
repertoire	O
of	O
camel	B-SPEC
MERS	O
-	O
CoVs	O
circulating	O
on	O
the	O
Arabian	O
Peninsula	O
.	O

Moreover	O
,	O
new	O
viral	O
subpopulations	O
were	O
also	O
found	O
in	O
vaccines	O
after	O
a	O
single	O
passage	O
in	O
chicken	B-SPEC
embryonated	O
eggs	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
Virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
,	O
which	O
is	O
a	O
devastating	O
viral	O
disease	O
and	O
causes	O
severe	O
economic	O
loss	O
to	O
the	O
swine	B-SPEC
industry	O
.	O

However	O
,	O
the	O
absence	O
of	O
RIG	O
-	O
I	O
in	O
chickens	B-SPEC
raises	O
the	O
question	O
of	O
whether	O
this	O
protein	O
influences	O
the	O
antiviral	O
immune	O
response	O
against	O
IBV	B-SPEC
infection	O
.	O

Isolate	O
I1101	O
/	O
16	O
and	O
strain	O
ck	O
/	O
CH	O
/	O
LJL	O
/	O
140901	O
shared	O
identical	O
amino	O
acids	O
in	O
almost	O
all	O
five	O
of	O
their	O
B	O
cell	O
epitopes	O
,	O
but	O
the	O
two	O
viruses	B-SPEC
had	O
a	O
serotype	O
relatedness	O
value	O
of	O
65	O
,	O
which	O
is	O
well	O
below	O
80	O
,	O
i	O
.	O
e	O
.,	O
the	O
lower	O
cutoff	O
value	O
for	O
viruses	B-SPEC
of	O
the	O
same	O
serotype	O
.	O

Subsequent	O
events	O
,	O
including	O
virus	B-SPEC
internalization	O
and	O
trafficking	O
,	O
remain	O
to	O
be	O
elucidated	O
.	O

miR	O
-	O
223	O
-/+	O
mice	B-SPEC
exhibited	O
more	O
severe	O
ALI	O
and	O
cytokine	O
dysregulation	O
.	O

The	O
findings	O
of	O
epidemiological	O
and	O
virological	O
studies	O
prompted	O
us	O
to	O
hypothesize	O
that	O
the	O
human	B-SPEC
gastrointestinal	O
tract	O
could	O
serve	O
as	O
an	O
alternative	O
route	O
to	O
acquire	O
MERS	O
-	O
CoV	O
infection	O
.	O

With	O
the	O
progression	O
of	O
the	O
enteric	O
infection	O
,	O
inflammation	O
,	O
virus	B-SPEC
-	O
positive	O
cells	O
,	O
and	O
live	O
viruses	B-SPEC
emerged	O
in	O
the	O
lung	O
tissues	O
,	O
indicating	O
the	O
development	O
of	O
sequential	O
respiratory	O
infection	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Nonstructural	O
Protein	O
16	O
Is	O
Necessary	O
for	O
Interferon	O
Resistance	O
and	O
Viral	O
Pathogenesis	O
.	O

Msr1	O
-	O
deficient	O
(	O
Msr1	O
Our	O
results	O
showed	O
that	O
Msr1	O
Msr1	O
promotes	O
the	O
pathogenesis	O
of	O
virus	B-SPEC
-	O
induced	O
FH	O
by	O
enhancing	O
induction	O
of	O
neutrophil	O
NETosis	O
and	O
subsequent	O
complement	O
activation	O
.	O

Here	O
,	O
we	O
systematically	O
describe	O
and	O
compare	O
the	O
distinctive	O
histopathological	O
features	O
of	O
established	O
models	O
of	O
acute	O
pneumonia	O
in	O
mice	B-SPEC
induced	O
by	O
Streptococcus	B-SPEC
(	O
S	O
.)	O
pneumoniae	O
,	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
Klebsiella	B-SPEC
pneumoniae	I-SPEC
,	O
Acinetobacter	B-SPEC
baumannii	I-SPEC
,	O
Legionella	B-SPEC
pneumophila	I-SPEC
,	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	B-SPEC
)	O
and	O
superinfection	O
of	O
IAV	B-SPEC
-	O
incuced	O
pneumonia	O
with	O
S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
.	O

Mortality	O
after	O
bacterial	O
challenge	O
in	O
IL	O
-	O
36	O
receptor	O
deficient	O
(	O
IL	O
-	O
36R	O
-/-)	O
mice	B-SPEC
and	O
IL	O
-	O
36	O
deficient	O
(	O
IL	O
-	O
36	O
-/-)	O
mice	B-SPEC
,	O
but	O
not	O
IL	O
-	O
36	O
deficient	O
mice	B-SPEC
,	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
wild	O
type	O
mice	B-SPEC
.	O

However	O
,	O
mutants	O
of	O
the	O
epidemic	O
strains	O
were	O
detected	O
,	O
suggesting	O
continuous	O
monitoring	O
of	O
the	O
human	B-SPEC
coronaviruses	O
is	O
in	O
need	O
among	O
cross	O
-	O
border	O
children	O
,	O
who	O
are	O
more	O
likely	O
to	O
get	O
infected	O
and	O
transmit	O
the	O
viruses	B-SPEC
across	O
the	O
border	O
easily	O
,	O
in	O
addition	O
to	O
the	O
general	O
public	O
.	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
coronavirus	I-SPEC
causes	O
infectious	O
bronchitis	O
(	O
IB	O
),	O
which	O
is	O
one	O
of	O
the	O
most	O
serious	O
diseases	O
affecting	O
the	O
avian	B-SPEC
industry	O
worldwide	O
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
,	O
unexpected	O
outbreaks	O
of	O
infectious	O
diseases	O
caused	O
by	O
emerging	O
and	O
re	O
-	O
emerging	O
viruses	B-SPEC
have	O
become	O
more	O
frequent	O
,	O
which	O
is	O
possibly	O
due	O
to	O
environmental	O
changes	O
.	O

ABSTRACT	O
:	O
Canine	O
infectious	O
respiratory	O
disease	O
(	O
CIRD	O
)	O
is	O
a	O
major	O
cause	O
of	O
morbidity	O
in	O
dogs	B-SPEC
worldwide	O
,	O
and	O
is	O
associated	O
with	O
a	O
number	O
of	O
new	O
and	O
emerging	O
pathogens	O
.	O

Gene	O
expression	O
analysis	O
from	O
animal	B-SPEC
models	O
or	O
from	O
patients	O
with	O
ARDS	O
,	O
sepsis	B-SPEC
or	O
trauma	O
show	O
an	O
enormous	O
number	O
of	O
differentially	O
expressed	O
genes	O
with	O
highly	O
significant	O
overlaps	O
between	O
the	O
various	O
conditions	O
.	O

In	O
addition	O
,	O
the	O
use	O
of	O
the	O
Co1	O
ligand	O
elicited	O
a	O
splenocyte	O
proliferative	O
response	O
more	O
effectively	O
in	O
comparison	O
with	O
the	O
COE	O
antigen	O
alone	O
and	O
supported	O
a	O
skewed	O
T	O
helper	O
2	O
type	O
of	O
immune	O
response	O
against	O
PEDV	B-SPEC
.	O

pPG	O
-	O
COE	O
-	O
Co1	O
/	O
L393	O
can	O
effectively	O
induce	O
mucosal	O
,	O
humoural	O
and	O
Th2	O
-	O
type	O
cellular	O
immune	O
responses	O
against	O
PEDV	B-SPEC
infection	O
via	O
oral	O
administration	O
.	O

One	O
of	O
the	O
PEDV	B-SPEC
strains	O
generated	O
in	O
this	O
study	O
(	O
designated	O
as	O
PEDV	B-SPEC
8aa	O
)	O
is	O
able	O
to	O
replicate	O
in	O
cells	O
without	O
any	O
protease	O
and	O
grows	O
to	O
a	O
high	O
titer	O
of	O
>	O
8	O
log	O
These	O
results	O
suggest	O
that	O
applying	O
selective	O
pressure	O
during	O
viral	O
passages	O
can	O
facilitate	O
attainment	O
of	O
viral	O
attenuation	O
and	O
that	O
PEDV	B-SPEC
8aa	O
warrants	O
further	O
investigation	O
as	O
an	O
attenuated	O
vaccine	O
.	O

Moreover	O
,	O
treatment	O
with	O
voriconazole	O
due	O
to	O
the	O
Aspergillus	B-SPEC
flavus	I-SPEC
and	O
meropenem	O
due	O
to	O
the	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
was	O
initiated	O
,	O
the	O
former	O
necessitating	O
discontinuation	O
of	O
rifampicin	O
.	O

In	O
other	O
species	B-SPEC
,	O
vaccination	O
is	O
associated	O
with	O
an	O
immediate	O
acute	O
-	O
phase	O
response	O
.	O

ABSTRACT	O
:	O
Mice	B-SPEC
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
develop	O
hepatitis	O
and	O
autoantibodies	O
(	O
autoAb	O
)	O
to	O
liver	O
and	O
kidney	O
fumarylacetoacetate	O
hydrolase	O
(	O
FAH	O
),	O
a	O
fact	O
closely	O
related	O
to	O
the	O
release	O
of	O
alarmins	O
such	O
as	O
uric	O
acid	O
and	O
/	O
or	O
high	O
-	O
mobility	O
group	O
box	O
protein	O
1	O
(	O
HMGB1	O
).	O

Results	O
showed	O
that	O
transaminase	O
levels	O
markedly	O
decreased	O
in	O
MHV	B-SPEC
-	O
A59	O
-	O
infected	O
mice	B-SPEC
treated	O
with	O
MAb	O
anti	O
-	O
IL	O
-	O
17A	O
whereas	O
plasmatic	O
Ig	O
concentration	O
sharply	O
increased	O
.	O

To	O
study	O
the	O
possible	O
immune	O
evasion	O
of	O
the	O
type	O
III	O
IFN	O
response	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
line	O
of	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
was	O
developed	O
as	O
a	O
cell	O
model	O
for	O
PEDV	B-SPEC
replication	O
.	O

Cell	O
entry	O
studies	O
demonstrated	O
that	O
three	O
newly	O
identified	O
SARSr	O
-	O
CoVs	O
with	O
different	O
S	O
protein	O
sequences	O
are	O
all	O
able	O
to	O
use	O
human	B-SPEC
ACE2	O
as	O
the	O
receptor	O
,	O
further	O
exhibiting	O
the	O
close	O
relationship	O
between	O
strains	O
in	O
this	O
cave	O
and	O
SARS	O
-	O
CoV	O
.	O
This	O
work	O
provides	O
new	O
insights	O
into	O
the	O
origin	O
and	O
evolution	O
of	O
SARS	O
-	O
CoV	O
and	O
highlights	O
the	O
necessity	O
of	O
preparedness	O
for	O
future	O
emergence	O
of	O
SARS	O
-	O
like	O
diseases	O
.	O

Infectivity	O
was	O
determined	O
by	O
detection	O
of	O
virus	B-SPEC
with	O
a	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
-	O
based	O
quantitative	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
qPCR	O
)	O
on	O
rectal	O
swabs	O
collected	O
from	O
the	O
inoculated	O
pigs	B-SPEC
on	O
days	O
three	O
and	O
seven	O
post	O
-	O
inoculation	O
.	O

Rectal	O
swabs	O
from	O
all	O
pigs	B-SPEC
within	O
the	O
positive	O
control	O
group	O
(	O
4	O
of	O
4	O
)	O
were	O
positive	O
for	O
PEDV	B-SPEC
by	O
RT	O
-	O
qPCR	O
.	O

While	O
screening	O
for	O
ADP	O
-	O
ribosylated	O
proteins	O
during	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
,	O
we	O
detected	O
a	O
~	O
55kDa	O
ADP	O
-	O
ribosylated	O
protein	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)-	O
infected	O
cells	O
and	O
in	O
virions	O
,	O
which	O
we	O
identified	O
as	O
the	O
viral	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

We	O
performed	O
a	O
qualitative	O
meta	B-SPEC
-	O
analysis	O
of	O
all	O
laboratory	O
confirmed	O
cases	O
worldwide	O
to	O
date	O
based	O
on	O
literature	O
,	O
with	O
emphasis	O
on	O
international	O
transmission	O
and	O
healthcare	O
associated	O
infections	O
.	O

Distribution	O
of	O
sequences	O
into	O
geographic	O
clusters	O
and	O
interleaving	O
of	O
MERS	O
-	O
CoV	O
sequences	O
from	O
camels	B-SPEC
among	O
those	O
isolated	O
from	O
humans	B-SPEC
indicated	O
that	O
multiple	O
zoonotic	O
introductions	O
occurred	O
in	O
endemic	O
nations	O
.	O

Of	O
the	O
11	O
countries	O
contacted	O
,	O
8	O
responded	O
:	O
Burkina	O
Faso	O
,	O
Cote	O
d	O
'	O
Ivoire	O
,	O
Mali	O
,	O
Mauritania	O
,	O
Niger	B-SPEC
,	O
Nigeria	O
,	O
Sierra	O
Leone	O
and	O
Togo	B-SPEC
.	O

These	O
viruses	B-SPEC
include	O
torovirus	B-SPEC
,	O
norovirus	B-SPEC
,	O
nebovirus	B-SPEC
,	O
astrovirus	O
,	O
kobuvirus	B-SPEC
,	O
and	O
enterovirus	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
Infection	O
with	O
ABSTRACT	O
:	O
Lemierre	O
'	O
s	O
syndrome	O
is	O
also	O
known	O
as	O
postangina	O
septicemia	O
,	O
which	O
is	O
commonly	O
caused	O
by	O

TITLE	O
:	O
An	O
Opportunistic	O
Pathogen	O
Afforded	O
Ample	O
Opportunities	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

To	O
date	O
,	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
has	O
been	O
inefficient	O
,	O
but	O
virus	B-SPEC
surveillance	O
,	O
characterisation	O
,	O
and	O
reporting	O
are	O
key	O
to	O
responding	O
to	O
any	O
future	O
change	O
.	O

The	O
cerebral	O
blood	O
perfusion	O
was	O
assessed	O
by	O
laser	B-SPEC
speckle	O
contrast	O
analysis	O
(	O
LASCA	O
)	O
using	O
a	O
PeriCam	O
PSI	O
system	O
.	O

We	O
report	O
a	O
family	B-SPEC
with	O
bilateral	O
VCP	O
affecting	O
four	O
male	O
members	O
in	O
two	O
generations	O
and	O
hence	O
suggesting	O
X	O
-	O
linked	O
recessive	O
inheritance	O
.	O

The	O
data	O
obtained	O
in	O
this	O
study	O
reveal	O
a	O
remarkable	O
degree	O
of	O
structural	O
and	O
functional	O
conservation	O
of	O
5	O
'-	O
terminal	O
RNA	O
structural	O
elements	O
across	O
coronavirus	B-SPEC
genus	B-SPEC
boundaries	O
.	O

TITLE	O
:	O
Age	O
is	O
a	O
predictor	O
of	O
a	O
small	O
decrease	O
in	O
lung	O
function	O
in	O
children	O
with	O
sickle	O
cell	O
anemia	B-SPEC
.	O

TITLE	O
:	O
A	O
multiplex	O
liquid	O
-	O
chip	O
assay	O
based	O
on	O
Luminex	O
xMAP	O
technology	O
for	O
simultaneous	O
detection	O
of	O
six	O
common	O
respiratory	O
viruses	B-SPEC
.	O

We	O
investigated	O
the	O
role	O
of	O
estradiol	O
on	O
the	O
generation	O
of	O
interleukin	O
(	O
IL	O
)-	O
1	O
,	O
IL	O
-	O
10	O
,	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
),	O
and	O
cytokine	O
-	O
induced	O
neutrophil	O
chemoattractant	O
1	O
(	O
CINC	O
-	O
1	O
)	O
in	O
a	O
female	O
rat	B-SPEC
model	O
of	O
intestinal	O
IR	O
.	O

In	O
this	O
study	O
ATII	O
cells	O
(	O
2	O
.	O
5	O
	O
10	O
ATII	O
cell	O
transplantation	O
promoted	O
recovery	O
of	O
lung	O
function	O
,	O
decrease	O
mortality	O
and	O
lung	O
inflammation	O
of	O
the	O
animals	B-SPEC
with	O
ALI	O
.	O

The	O
nanoparticles	O
were	O
incubated	O
in	O
various	O
simulated	O
gastric	O
and	O
intestinal	O
fluids	O
and	O
in	O
pig	B-SPEC
gastric	O
and	O
intestinal	O
fluids	O
.	O

In	O
summary	O
,	O
CPMV	B-SPEC
and	O
eVLPs	O
can	O
be	O
considered	O
promising	O
nanocarriers	O
for	O
applications	O
requiring	O
oral	O
delivery	O
,	O
given	O
their	O
chemical	O
,	O
physical	O
and	O
colloidal	O
stability	O
and	O
lack	O
of	O
protein	O
adsorption	O
from	O
the	O
environment	O
in	O
most	O
of	O
the	O
tested	O
conditions	O
.	O

TITLE	O
:	O
Definitive	O
diagnosis	O
in	O
suspected	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
cases	O
.	O

Most	O
of	O
studies	O
have	O
focused	O
on	O
molecular	O
and	O
pathogenic	O
characterization	O
of	O
PEDV	B-SPEC
,	O
whereas	O
there	O
were	O
limited	O
studies	O
in	O
understanding	O
the	O
role	O
of	O
gut	O
microbiota	B-SPEC
(	O
GM	O
)	O
in	O
viral	O
-	O
associated	O
diarrhea	O
.	O

Our	O
results	O
showed	O
that	O
PEDV	B-SPEC
caused	O
alternations	O
in	O
the	O
structure	O
and	O
abundance	O
of	O
GM	O
from	O
levels	O
of	O
phylum	B-SPEC
to	O
genus	B-SPEC
,	O
and	O
even	O
species	B-SPEC
.	O

In	O
addition	O
,	O
residual	O
replicating	O
or	O
live	O
virus	B-SPEC
after	O
inactivation	O
was	O
examined	O
by	O
passaging	O
in	O
the	O
permissive	O
Vero	O
E6	O
cells	O
.	O

ABSTRACT	O
:	O
In	O
Mexico	O
,	O
the	O
first	O
outbreaks	O
suggestive	O
of	O
the	O
circulation	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
were	O
identified	O
at	O
the	O
beginning	O
of	O
July	O
2013	O
.	O

To	O
identify	O
PEDV	B-SPEC
,	O
we	O
used	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
to	O
discriminate	O
between	O
non	O
-	O
INDEL	O
and	O
INDEL	O
strains	O
.	O

In	O
this	O
study	O
,	O
we	O
proposed	O
a	O
comparative	O
analysis	O
approach	O
and	O
built	O
a	O
model	O
to	O
simulate	O
outbreaks	O
of	O
3	O
different	O
in	O
-	O
flight	O
infections	O
in	O
a	O
similar	O
cabin	O
environment	O
,	O
that	O
is	O
,	O
influenza	O
A	O
H1N1	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
),	O
and	O
norovirus	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
a	O
highly	O
threatening	O
zoonotic	O
pathogen	O
since	O
its	O
outbreak	O
in	O
2012	O
.	O

The	O
S	O
protein	O
efficiently	O
incorporated	O
into	O
the	O
viral	O
envelope	O
and	O
mediated	O
cell	O
entry	O
through	O
binding	O
its	O
receptor	O
,	O
human	B-SPEC
DPP4	O
.	O

ABSTRACT	O
:	O
Cyclophilin	O
A	O
(	O
CypA	B-SPEC
)	O
is	O
an	O
important	O
host	O
factor	O
in	O
the	O
replication	O
of	O
a	O
variety	O
of	O
RNA	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
which	O
belongs	O
to	O
beta	O
group	O
of	O
coronavirus	B-SPEC
,	O
can	O
infect	O
multiple	O
host	O
species	B-SPEC
and	O
causes	O
severe	O
diseases	O
in	O
humans	B-SPEC
.	O

The	O
comparison	O
of	O
the	O
secondary	O
and	O
3DMMS	O
of	O
the	O
RBD	O
of	O
IT	O
-	O
batCoVs	O
with	O
MERS	O
,	O
HKU4	O
and	O
HKU5	O
bat	B-SPEC
sequences	O
showed	O
two	O
aa	O
deletions	O
located	O
in	O
a	O
region	O
corresponding	O
to	O
the	O
external	O
subdomain	O
of	O
MERS	O
-	O
RBD	O
in	O
IT	O
-	O
batCoV	O
and	O
HKU5	O
RBDs	O
.	O

We	O
report	O
a	O
case	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
occurring	O
in	O
a	O
previously	O
healthy	O
man	B-SPEC
successfully	O
treated	O
with	O
orally	O
administered	O
ribavirin	O
.	O

CONCLUSIONS	O
:	O
This	O
case	O
demonstrates	O
the	O
potential	O
usefulness	O
of	O
orally	O
administered	O
ribavirin	O
as	O
a	O
therapeutic	O
option	O
for	O
severe	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
,	O
at	O
least	O
in	O
an	O
immunocompetent	O
host	O
.	O

TITLE	O
:	O
Broad	O
-	O
spectrum	O
antiviral	O
activity	O
of	O
the	O
eIF4A	O
inhibitor	O
silvestrol	O
against	O
corona	B-SPEC
-	O
and	O
picornaviruses	B-SPEC
.	O

We	O
conditionally	O
deleted	O
the	O
Abca3	O
gene	O
in	O
AT2	O
cells	O
in	O
the	O
mature	O
mouse	B-SPEC
lung	O
.	O

Performing	O
surveillance	O
studies	O
within	O
a	O
specific	O
geographic	O
area	O
can	O
provide	O
awareness	O
of	O
viral	O
burden	O
where	O
bats	B-SPEC
roost	O
in	O
close	O
proximity	O
to	O
spillover	O
hosts	O
,	O
and	O
form	O
the	O
basis	O
for	O
the	O
appropriate	O
control	O
measures	O
against	O
potential	O
threats	O
for	O
public	O
health	O
and	O
optimal	O
management	O
of	O
bats	B-SPEC
and	O
their	O
habitats	O
.	O

Prospective	O
observational	O
study	O
was	O
performed	O
in	O
ICU	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
.	O

For	O
coronaviruses	O
,	O
this	O
critical	O
step	O
is	O
governed	O
by	O
the	O
virally	O
-	O
encoded	O
spike	O
(	O
S	O
)	O
protein	O
,	O
a	O
class	B-SPEC
I	O
viral	O
fusion	O
protein	O
that	O
has	O
several	O
unique	O
features	O
.	O

Furthermore	O
,	O
characterization	O
of	O
the	O
coronavirus	B-SPEC
fusion	O
peptide	O
(	O
FP	O
),	O
the	O
segment	O
of	O
the	O
fusion	O
protein	O
that	O
inserts	O
to	O
a	O
target	O
lipid	O
bilayer	O
during	O
membrane	O
fusion	O
,	O
has	O
revealed	O
its	O
particular	O
attributes	O
which	O
imparts	O
some	O
of	O
the	O
unusual	O
properties	O
of	O
the	O
S	O
protein	O
,	O
such	O
as	O
Ca	O

This	O
Account	O
will	O
build	O
toward	O
examples	O
of	O
in	O
vivo	O
studies	O
in	O
cardiovascular	O
disease	O
and	O
cancer	B-SPEC
models	O
,	O
including	O
diagnostic	O
studies	O
by	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
),	O
computed	O
tomography	O
(	O
CT	O
),	O
and	O
positron	O
emission	O
tomography	O
(	O
PET	O
).	O

TITLE	O
:	O
Development	O
of	O
a	O
recombinase	O
polymerase	O
amplification	O
combined	O
with	O
lateral	O
-	O
flow	O
dipstick	O
assay	O
for	O
detection	O
of	O
bovine	B-SPEC
ephemeral	I-SPEC
fever	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Construction	O
and	O
immunogenicity	O
analysis	O
of	O
Lactobacillus	B-SPEC
plantarum	I-SPEC
expressing	O
a	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
S	O
gene	O
fused	O
to	O
a	O
DC	O
-	O
targeting	O
peptide	O
.	O

Mice	B-SPEC
were	O
immunized	O
by	O
lavage	O
administration	O
of	O
the	O
recombinant	O
NC8	O
-	O
pSIP409	O
-	O
pgsA	O
'-	O
S	O
-	O
DCpep	O
,	O
which	O
was	O
observed	O
to	O
induce	O
DC	O
activation	O
and	O
high	O
production	O
of	O
sIgA	B-SPEC
and	O
IgG	O
antibodies	O
in	O
experimental	O
animals	B-SPEC
,	O
while	O
also	O
eliciting	O
production	O
of	O
significantly	O
more	O
IgA	O

Ten	O
years	O
later	O
,	O
a	O
second	O
highly	O
pathogenic	O
human	B-SPEC
CoV	O
,	O
MERS	O
-	O
CoV	O
,	O
emerged	O
in	O
the	O
Middle	O
East	O
and	O
has	O
spread	O
to	O
other	O
countries	O
in	O
Europe	O
,	O
North	O
Africa	O
,	O
North	O
America	O
and	O
Asia	O
.	O

Using	O
this	O
method	O
,	O
positive	O
hybridoma	O
clones	O
against	O
both	O
malachite	B-SPEC
green	O
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
are	O
selected	O
with	O
high	O
efficiency	O
.	O

Model	O
outputs	O
over	O
a	O
90	O
-	O
day	O
period	O
showed	O
that	O
the	O
number	O
of	O
infected	O
sows	O
in	O
a	O
dry	O
sow	O
house	O
peaked	O
within	O
a	O
week	O
after	O
disease	O
introduction	O
,	O
and	O
PEDV	B-SPEC
was	O
retained	O
on	O
the	O
farm	O
.	O

To	O
address	O
this	O
knowledge	O
gap	O
,	O
we	O
utilized	O
a	O
prime	O
-	O
boost	O
immunization	O
approach	O
to	O
induce	O
robust	O
memory	O
CD8	O
T	O
cell	O
responses	O
in	O
the	O
absence	O
of	O
RSV	B-SPEC
-	O
specific	O
CD4	O
T	O
cells	O
and	O
antibodies	O
.	O

These	O
results	O
demonstrate	O
that	O
in	O
contrast	O
to	O
other	O
respiratory	O
viruses	B-SPEC
,	O
RSV	B-SPEC
-	O
specific	O
memory	O
CD8	O
T	O
cells	O
can	O
induce	O
lethal	O
immunopathology	O
despite	O
mediating	O
enhanced	O
viral	O
clearance	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
past	O
decade	O
,	O
we	O
have	O
seen	O
an	O
alarming	O
number	O
of	O
high	O
-	O
profile	O
outbreaks	O
of	O
newly	O
emerging	O
and	O
re	O
-	O
emerging	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
which	O
first	O
broken	O
out	O
in	O
Jeddah	O
in	O
2012	O
,	O
causes	O
a	O
severe	O
acute	O
respiratory	O
illness	O
with	O
a	O
high	O
mortality	O
rate	O
.	O

We	O
found	O
that	O
MERS	O
human	B-SPEC
/	O
camel	B-SPEC
isolates	O
showed	O
a	O
low	O
codon	O
usage	O
bias	B-SPEC
.	O

TITLE	O
:	O
The	O
persistent	O
prevalence	O
and	O
evolution	O
of	O
cross	O
-	O
family	B-SPEC
recombinant	O
coronavirus	B-SPEC
GCCDC1	O
among	O
a	O
bat	B-SPEC
population	O
:	O
a	O
two	O
-	O
year	O
follow	O
-	O
up	O
.	O

A	O
total	O
of	O
7	O
.	O
2	O
%	O
of	O
samples	O
tested	O
positive	O
for	O
respiratory	O
viruses	B-SPEC
;	O
among	O
positive	O
samples	O
,	O
71	O
.	O
0	O
%	O
contained	O
rhinovirus	B-SPEC
,	O
and	O
21	O
.	O
5	O
%	O
contained	O
coronavirus	B-SPEC
.	O

Influenza	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
parainfluenza	O
virus	B-SPEC
were	O
also	O
detected	O
.	O

Down	O
syndrome	O
(	O
DS	O
),	O
a	O
common	O
genetic	O
disorder	O
associated	O
with	O
congenital	O
and	O
dysmorphic	O
features	O
,	O
has	O
recently	O
been	O
identified	O
as	O
an	O
independent	O
risk	O
factor	O
for	O
RSV	B-SPEC
-	O
associated	O
ALRI	O
requiring	O
hospitalisation	O
;	O
however	O
,	O
the	O
disease	O
burden	O
of	O
RSV	B-SPEC
-	O
associated	O
ALRI	O
in	O
this	O
population	O
has	O
not	O
yet	O
been	O
established	O
.	O

TITLE	O
:	O
Mitochondrial	O
bioenergy	O
alterations	O
in	O
avian	B-SPEC
HD11	O
macrophages	O
infected	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Coronavirus	B-SPEC
EndoU	O
is	O
encoded	O
within	O
the	O
sequence	O
of	O
nonstructural	O
protein	O
(	O
nsp	O
)	O
15	O
,	O
which	O
was	O
initially	O
identified	O
as	O
a	O
component	O
of	O
the	O
viral	O
replication	O
complex	O
.	O

Biochemical	O
and	O
structural	O
studies	O
revealed	O
the	O
enzymatic	O
nature	O
of	O
nsp15	O
/	O
EndoU	O
,	O
which	O
was	O
postulated	O
to	O
be	O
essential	O
for	O
the	O
unique	O
replication	O
cycle	O
of	O
viruses	B-SPEC
in	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
characterized	O
by	O
acute	O
hypoxic	O
respiratory	O
dysfunction	O
or	O
failure	O
,	O
is	O
a	O
manifestation	O
of	O
multiple	O
organ	O
failure	O
(	O
MOF	O
)	O
in	O
the	O
lung	O
,	O
which	O
often	O
caused	O
by	O
various	O
non	O
-	O
cardiac	O
reasons	O
,	O
included	O
severe	O
trauma	O
,	O
infection	O
,	O
shock	O
;	O
and	O
the	O
most	O
common	O
risk	O
factor	O
is	O
sepsis	B-SPEC
which	O
would	O
cause	O
uncontrolled	O
host	O
response	O
to	O
infecting	O
factors	O
.	O

Here	O
,	O
two	O
species	B-SPEC
of	O
murine	B-SPEC
malaria	O
,	O
the	O
lethal	O
Plasmodium	B-SPEC
berghei	I-SPEC
strain	O
NK65	O
and	O
self	O
-	O
healing	O
Plasmodium	B-SPEC
chabaudi	I-SPEC
strain	O
AS	O
which	O
differ	O
in	O
their	O
ability	O
to	O
cause	O
hepatopathy	O
and	O
/	O
or	O
ARDS	O
were	O
used	O
to	O
investigate	O
the	O
lipid	O
alterations	O
,	O
oxidative	O
damage	O
and	O
host	O
immune	O
response	O
during	O
the	O
infection	O
in	O
relation	O
to	O
parasite	O
load	O
and	O
accumulation	O
of	O
parasite	O
products	O
,	O
such	O
as	O
haemozoin	O
.	O

Established	O
models	O
of	O
severe	O
ARDS	O
(	O
rabbit	B-SPEC
,	O
pig	B-SPEC
)	O
were	O
used	O
.	O

Thirty	O
-	O
five	O
Wistar	B-SPEC
rats	I-SPEC
(	O
weight	O
	O
SD	O
,	O
310	O
	O
19	O
)	O
g	O
received	O
Escherichia	B-SPEC
coli	I-SPEC
lipopolysaccharide	O
(	O
LPS	O
)	O
intratracheally	O
.	O

After	O
24	O
h	O
,	O
the	O
animals	B-SPEC
were	O
anaesthetised	O
and	O
randomly	O
allocated	O
to	O
either	O
PCV	B-SPEC
(	O
n	O
=	O
14	O
)	O
or	O
PSV	O
(	O
n	O
=	O
14	O
)	O
groups	O
.	O

Ulinastatin	O
(	O
UTI	O
),	O
a	O
serine	O
protease	O
inhibitor	O
,	O
possesses	O
anti	O
-	O
inflammatory	O
properties	O
and	O
has	O
been	O
suggested	O
to	O
modulate	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
sepsis	B-SPEC
;	O
thus	O
,	O
it	O
is	O
now	O
widely	O
used	O
in	O
the	O
treatment	O
of	O
pancreatitis	O
,	O
sepsis	B-SPEC
,	O
and	O
septic	O
shock	O
.	O

TITLE	O
:	O
Loss	O
of	O
Cx43	O
-	O
Mediated	O
Functional	O
Gap	O
Junction	O
Communication	O
in	O
Meningeal	O
Fibroblasts	O
Following	O
Mouse	B-SPEC
Hepatitis	O
Virus	B-SPEC
Infection	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
MHV	B-SPEC
infection	O
can	O
directly	O
affect	O
expression	O
and	O
cellular	O
distribution	O
of	O
Cx43	O
resulting	O
in	O
loss	O
of	O
Cx43	O
-	O
mediated	O
GJIC	O
in	O
meningeal	O
fibroblasts	O
,	O
which	O
may	O
be	O
associated	O
with	O
altered	O
BBB	O
function	O
observed	O
in	O
acute	O
infection	O
.	O

ABSTRACT	O
:	O
After	O
Publication	O
of	O
the	O
article	O
[	O
1	O
],	O
it	O
has	O
been	O
brought	O
to	O
our	O
attention	O
that	O
an	O
author	O
'	O
s	O
name	B-SPEC
has	O
been	O
spelt	B-SPEC
incorrectly	O
.	O

Above	O
all	O
,	O
we	O
found	O
that	O
IFN	O
-	O
	O
also	O
have	O
an	O
effect	O
on	O
IBV	B-SPEC
infection	O
in	O
trachea	B-SPEC
besides	O
many	O
other	O
respiratory	O
virus	B-SPEC
.	O

Using	O
the	O
in	O
vitro	O
transcribed	O
PEDV	B-SPEC
RNA	O
as	O
template	O
,	O
the	O
analytical	O
sensitivity	O
was	O
23	O
copies	O
per	O
reaction	O
.	O

Identified	O
coronaviruses	O
were	O
related	O
to	O
pathogenic	O
human	B-SPEC
strains	O
and	O
the	O
paramyxovirus	O
belonged	O
to	O
the	O
recently	O
described	O
Jeilongvirus	O
genus	B-SPEC
.	O

We	O
employ	O
structured	O
coalescent	O
models	O
to	O
show	O
that	O
long	O
-	O
term	O
MERS	O
-	O
CoV	O
evolution	O
occurs	O
exclusively	O
in	O
camels	B-SPEC
,	O
whereas	O
humans	B-SPEC
act	O
as	O
a	O
transient	O
,	O
and	O
ultimately	O
terminal	O
host	O
.	O

Without	O
heretofore	O
unseen	O
evolution	O
of	O
host	O
tropism	O
,	O
MERS	O
-	O
CoV	O
is	O
unlikely	O
to	O
become	O
endemic	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
one	O
of	O
the	O
major	O
poultry	O
pathogens	O
of	O
global	O
importance	O
.	O

Meanwhile	O
,	O
IBV	B-SPEC
isolates	O
in	O
Group	O
2	O
(	O
IBS037A	O
/	O
2015	O
,	O
IBS037B	O
/	O
2015	O
,	O
IBS051	O
/	O
2015	O
,	O
and	O
IBS180	O
/	O
2015	O
)	O
were	O
91	O
.	O
62	O
%	O
and	O
89	O
.	O
09	O
%	O
identical	O
to	O
Malaysian	O
variant	O
strain	O
MH5365	O
/	O
95	O
(	O
EU086600	O
)	O
at	O
nucleotide	O
and	O
amino	O
acid	O
levels	O
,	O
respectively	O
.	O

TITLE	O
:	O
Quinoxaline	O
derivatives	O
as	O
new	O
inhibitors	O
of	O
coxsackievirus	B-SPEC
B5	O
.	O

Utilizing	O
a	O
systems	O
-	O
based	O
approach	O
,	O
we	O
examined	O
differential	O
regulation	O
of	O
IFN	O
-	O
	O
-	O
dependent	O
genes	O
following	O
infection	O
with	O
robust	O
respiratory	O
viruses	B-SPEC
including	O
influenza	B-SPEC
viruses	I-SPEC
[	O
A	O
/	O
influenza	O
/	O
Vietnam	O
/	O
1203	O
/	O
2004	O
(	O
H5N1	O
-	O
VN1203	O
)	O
and	O
A	O
/	O
influenza	O
/	O
California	B-SPEC
/	O
04	O
/	O
2009	O
(	O
H1N1	O
-	O
CA04	O
)]	O
and	O
coronaviruses	O
[	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)].	O

ABSTRACT	O
:	O
Although	O
bats	B-SPEC
are	O
known	O
to	O
harbor	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)-	O
related	O
viruses	B-SPEC
,	O
the	O
role	O
of	O
bats	B-SPEC
in	O
the	O
evolutionary	O
origin	O
and	O
pathway	O
remains	O
obscure	O
.	O

Our	O
findings	O
support	O
a	O
bat	B-SPEC
origin	O
of	O
MERS	O
-	O
CoV	O
and	O
suggest	O
that	O
bat	B-SPEC
CoV	O
spike	O
proteins	O
may	O
have	O
evolved	O
in	O
a	O
stepwise	O
manner	O
for	O
binding	O
to	O
hDPP4	O
.	O

To	O
examine	O
the	O
effect	O
of	O
an	O
early	O
compared	O
with	O
a	O
delayed	O
RRT	O
initiation	O
strategy	O
on	O
60	O
-	O
day	O
mortality	O
according	O
to	O
baseline	O
sepsis	B-SPEC
status	O
,	O
ARDS	O
status	O
,	O
and	O
severity	O
.	O

We	O
found	O
no	O
significant	O
influence	O
of	O
the	O
baseline	O
sepsis	B-SPEC
status	O
(	O
P	O
=	O
0	O
.	O
28	O
),	O
baseline	O
ARDS	O
status	O
(	O
P	O
=	O
0	O
.	O
94	O
),	O
and	O
baseline	O
severity	O
scores	O
(	O
P	O
=	O
0	O
.	O
77	O
and	O
P	O
=	O
0	O
.	O
46	O
for	O
SAPS	O
3	O
and	O
SOFA	O
,	O
respectively	O
)	O
on	O
the	O
comparison	O
of	O
60	O
-	O
day	O
mortality	O
according	O
to	O
RRT	O
initiation	O
strategy	O
.	O

Bat	B-SPEC
CoVs	O
exhibit	O
both	O
extensive	O
genetic	O
diversity	O
and	O
a	O
broad	O
geographic	O
range	O
,	O
indicative	O
of	O
a	O
long	O
-	O
standing	O
host	O
association	O
.	O

Co	O
-	O
phylogenetic	O
analyses	O
revealed	O
that	O
cross	O
-	O
species	B-SPEC
transmission	O
has	O
been	O
more	O
common	O
than	O
co	O
-	O
divergence	O
across	O
coronavirus	B-SPEC
evolution	O
as	O
a	O
whole	O
,	O
and	O
that	O
cross	O
-	O
species	B-SPEC
transmission	O
events	O
were	O
more	O
likely	O
between	O
sympatric	O
bat	B-SPEC
hosts	O
.	O

TITLE	O
:	O
Temporary	O
carriage	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
and	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
by	O
fomites	O
and	O
human	B-SPEC
nasal	O
mucosa	O
after	O
exposure	O
to	O
infected	O
calves	O
.	O

We	O
describe	O
the	O
common	O
clinical	O
manifestations	O
of	O
the	O
six	O
prototypic	O
organ	O
system	O
dysfunction	O
syndromes	O
of	O
severe	O
sepsis	B-SPEC
and	O
review	O
the	O
associated	O
epidemiology	O
and	O
suspected	O
pathophysiology	O
.	O

This	O
virus	B-SPEC
causes	O
enteric	O
disease	O
in	O
piglets	O
that	O
is	O
characterized	O
by	O
enteritis	O
and	O
diarrhoea	O
.	O

We	O
found	O
a	O
3	O
-	O
nt	O
insertion	O
in	O
the	O
spike	O
gene	O
in	O
four	O
strains	O
in	O
Tibetan	O
pigs	B-SPEC
.	O

A	O
PDCoV	O
strain	O
named	O
HB	O
-	O
BD	O
was	O
successfully	O
isolated	O
from	O
the	O
intestinal	O
contents	O
of	O
a	O
diarrhoeic	O
piglet	O
and	O
serially	O
propagated	O
in	O
swine	B-SPEC
testicular	O
(	O
ST	O
)	O
cells	O
for	O
>	O
40	O
passages	O
.	O

TITLE	O
:	O
Galectin	O
-	O
3	O
Enhances	O
Avian	B-SPEC
H5N1	O
Influenza	B-SPEC
A	I-SPEC
Virus	I-SPEC
-	O
Induced	O
Pulmonary	O
Inflammation	O
by	O
Promoting	O
NLRP3	O
Inflammasome	O
Activation	O
.	O

TITLE	O
:	O
Recombinant	O
live	O
attenuated	O
avian	B-SPEC
coronavirus	I-SPEC
vaccines	O
with	O
deletions	O
in	O
the	O
accessory	O
genes	O
3ab	O
and	O
/	O
or	O
5ab	O
protect	O
against	O
infectious	O
bronchitis	O
in	O
chickens	B-SPEC
.	O

Live	O
attenuated	O
viruses	B-SPEC
are	O
widely	O
used	O
in	O
both	O
the	O
broiler	O
and	O
layer	O
industry	O
because	O
of	O
their	O
efficacy	O
and	O
ability	O
to	O
be	O
mass	O
applied	O
.	O

Thus	O
,	O
genes	O
3ab	O
and	O
5ab	O
are	O
not	O
essential	O
for	O
replication	O
in	O
ovo	B-SPEC
.	O

Infection	O
with	O
PEDV	B-SPEC
causes	O
watery	O
diarrhea	O
and	O
up	O
to	O
100	O
%	O
mortality	O
in	O
piglets	O
,	O
particularly	O
for	O
highly	O
pathogenic	O
non	O
-	O
InDel	O
strains	O
circulating	O
in	O
the	O
US	O
.	O

Our	O
results	O
show	O
that	O
microglia	O
were	O
required	O
during	O
the	O
early	O
days	O
after	O
infection	O
to	O
limit	O
MHV	B-SPEC
replication	O
and	O
subsequent	O
morbidity	O
and	O
lethality	O
.	O

TITLE	O
:	O
Epidemiology	O
characteristics	O
of	O
human	B-SPEC
coronaviruses	O
in	O
patients	O
with	O
respiratory	O
infection	O
symptoms	O
and	O
phylogenetic	O
analysis	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
during	O
2010	O
-	O
2015	O
in	O
Guangzhou	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
is	O
one	O
of	O
the	O
most	O
common	O
causes	O
of	O
respiratory	O
tract	O
infection	O
throughout	O
the	O
world	O
.	O

To	O
investigate	O
the	O
epidemiological	O
and	O
genetic	O
variation	O
of	O
HCoV	O
in	O
Guangzhou	O
,	O
south	O
China	O
,	O
we	O
collected	O
totally	O
13048	O
throat	O
and	O
nasal	O
swab	O
specimens	O
from	O
adults	O
and	O
children	O
with	O
fever	O
and	O
acute	O
upper	O
respiratory	O
infection	O
symptoms	O
in	O
Gunazhou	O
,	O
south	O
China	O
between	O
July	O
2010	O
and	O
June	O
2015	O
,	O
and	O
the	O
epidemiological	O
features	O
of	O
HCoV	O
and	O
its	O
species	B-SPEC
were	O
studied	O
.	O

Specimens	O
were	O
screened	O
for	O
HCoV	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
,	O
and	O
7	O
other	O
common	O
respiratory	O
viruses	B-SPEC
were	O
tested	O
simultaneously	O
by	O
PCR	O
or	O
real	O
-	O
time	O
PCR	O
.	O

The	O
month	O
distribution	O
showed	O
that	O
totally	O
HCoV	O
was	O
prevalent	O
in	O
winter	O
,	O
but	O
differences	O
existed	O
in	O
different	O
species	B-SPEC
.	O

It	O
was	O
revealed	O
for	O
the	O
first	O
time	O
that	O
genotype	O
B	O
and	O
genotype	O
G	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
co	O
-	O
circulated	O
and	O
the	O
newly	O
defined	O
genotype	O
G	O
was	O
epidemic	O
as	O
a	O
dominant	O
genotype	O
during	O
2013	O
-	O
2014	O
in	O
Guanzhou	O
,	O
south	O
China	O
.	O

Markers	O
of	O
muscle	O
proteolysis	O
were	O
not	O
different	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
between	O
treatments	O
within	O
dpi	O
;	O
however	O
,	O
at	O
dpi	O
5	O
,	O
20S	O
proteasome	O
activity	O
was	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
longissimus	O
dorsi	O
of	O
PEDV	B-SPEC
pigs	B-SPEC
compared	O
with	O
Control	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
2010	O
,	O
new	O
Chinese	O
strains	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
clinically	O
more	O
severe	O
than	O
the	O
classical	O
strains	O
,	O
emerged	O
.	O

The	O
phylogeographic	O
study	O
revealed	O
the	O
emergence	O
of	O
the	O
Chinese	O
PEDV	B-SPEC
strains	O
,	O
followed	O
by	O
spreading	O
to	O
US	O
in	O
2013	O
,	O
from	O
US	O
to	O
Korea	O
,	O
and	O
later	O
the	O
introduction	O
of	O
PEDV	B-SPEC
to	O
Canada	O
,	O
Mexico	O
,	O
and	O
Ecuador	O
directly	O
from	O
the	O
US	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
acute	O
and	O
devastating	O
enteric	O
disease	O
in	O
suckling	O
piglets	O
and	O
results	O
in	O
huge	O
economic	O
losses	O
in	O
the	O
pig	B-SPEC
industry	O
worldwide	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
PEDV	B-SPEC
infection	O
stimulated	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
activation	O
,	O
which	O
has	O
been	O
linked	O
to	O
not	O
only	O
anticancer	O
therapeutics	O
,	O
but	O
also	O
antiviral	O
signaling	O
.	O

In	O
total	O
,	O
188	O
episodes	O
of	O
ARI	O
were	O
reported	O
,	O
being	O
rhinovirus	B-SPEC
the	O
most	O
frequently	O
detected	O
(	O
n	O
=	O
53	O
),	O
followed	O
by	O
influenza	O
A	O
(	O
H3	O
)	O
(	O
n	O
=	O
19	O
)	O
and	O
HBoV	O
(	O
n	O
=	O
14	O
).	O

""""	O
Age	O
""","	O
""""	O
HMPV	B-SPEC
""""	O
and	O
""""	O
Respiratory	O
disease	O
""""	O
showed	O
an	O
association	O
with	O
severe	O
infection	O
.	O

Similar	O
to	O
other	O
enteric	O
coronaviruses	O
,	O
such	O
as	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
these	O
emerging	O
swine	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
diseases	O
(	O
SECD	O
)	O
are	O
age	O
-	O
dependent	O
,	O
with	O
high	O
morbidity	O
and	O
mortality	O
in	O
neonatal	O
pigs	B-SPEC
.	O

All	O
newborn	O
piglets	O
were	O
challenged	O
with	O
the	O
genogroup	O
2	O
virus	B-SPEC
,	O
and	O
clinical	O
signs	O
were	O
monitored	O
for	O
7	O
days	O
post	O
challenge	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
has	O
been	O
reported	O
for	O
the	O
first	O
time	O
infecting	O
a	O
human	B-SPEC
being	O
since	O
2012	O
.	O

The	O
results	O
showed	O
a	O
high	O
percentage	O
of	O
dromedaries	B-SPEC
(	O
56	O
.	O
4	O
%)	O
had	O
evidence	O
for	O
nasal	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
particular	O
,	O
we	O
describe	O
how	O
a	O
microfluidic	O
assay	O
to	O
detect	O
HIV	B-SPEC
viral	O
RNA	O
was	O
converted	O
to	O
detect	O
Zika	B-SPEC
virus	I-SPEC
(	O
ZIKV	O
)	O
RNA	O
.	O

These	O
results	O
will	O
be	O
validated	O
in	O
further	O
experiments	O
with	O
well	O
-	O
characterized	O
ZIKV	O
human	B-SPEC
specimens	O
of	O
saliva	O
.	O

One	O
patient	O
died	O
from	O
Haemophilus	B-SPEC
influenzae	I-SPEC
co	O
-	O
infection	O
.	O

TITLE	O
:	O
An	O
epidemiological	O
investigation	O
of	O
the	O
early	O
phase	O
of	O
the	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
outbreak	O
in	O
Canadian	O
swine	B-SPEC
herds	O
in	O
2014	O
:	O
A	O
case	O
-	O
control	O
study	O
.	O

TITLE	O
:	O
Factors	O
associated	O
with	O
farm	O
-	O
level	O
infection	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
during	O
the	O
early	O
phase	O
of	O
the	O
epidemic	O
in	O
Japan	O
in	O
2013	O
and	O
2014	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
factors	O
that	O
caused	O
rapid	O
spread	O
during	O
the	O
early	O
phase	O
of	O
the	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
epidemic	O
in	O
Japan	O
in	O
2013	O
and	O
2014	O
.	O

TITLE	O
:	O
Investigation	O
of	O
three	O
outbreaks	O
of	O
Porcine	B-SPEC
Epidemic	O
Diarrhea	O
in	O
Germany	O
in	O
2016	O
demonstrates	O
age	O
dependent	O
differences	O
in	O
the	O
development	O
of	O
humoral	O
immune	O
response	O
.	O

The	O
virus	B-SPEC
strains	O
involved	O
in	O
the	O
recent	O
European	O
outbreaks	O
all	O
cluster	O
together	O
with	O
US	O
strains	O
(	O
S	O
INDEL	O
)	O
that	O
lead	O
to	O
less	O
severe	O
clinical	O
signs	O
.	O

Although	O
,	O
PEDV	B-SPEC
RNA	O
was	O
found	O
in	O
fecal	O
samples	O
of	O
all	O
piglets	O
,	O
13	O
piglets	O
did	O
not	O
demonstrate	O
antibodies	O
at	O
any	O
sampling	O
day	O
.	O

Forty	O
3	O
-	O
week	O
-	O
old	O
individually	O
housed	O
barrows	O
were	O
used	O
as	O
a	O
bioassay	O
to	O
determine	O
the	O
infectivity	O
of	O
PEDV	B-SPEC
after	O
treatment	O
with	O
either	O
a	O
1	O
:	O
100	O
or	O
1	O
:	O
600	O
dilution	O
of	O
a	O
peroxygen	O
-	O
based	O
disinfectant	O
with	O
10	O
or	O
30	O
min	O
of	O
contact	O
time	O
.	O

In	O
this	O
study	O
,	O
a	O
transcriptomic	O
shotgun	O
sequencing	O
(	O
RNA	O
-	O
Seq	O
)	O
procedure	O
was	O
used	O
to	O
study	O
gene	O
responses	O
against	O
PEDV	B-SPEC
infection	O
.	O

The	O
measles	O
vaccine	O
is	O
an	O
efficient	O
,	O
live	O
attenuated	O
,	O
replicating	O
virus	B-SPEC
that	O
has	O
been	O
safely	O
administered	O
to	O
2	O
billion	O
children	O
over	O
the	O
last	O
40	O
years	O
,	O
affording	O
life	O
-	O
long	O
protection	O
after	O
a	O
single	O
dose	O
.	O

Immunohistochemistry	O
(	O
IHC	O
)	O
for	O
feline	B-SPEC
coronavirus	B-SPEC
confirmed	O
the	O
diagnosis	O
in	O
all	O
26	O
cases	O
.	O

The	O
epidemiological	O
data	O
revealed	O
that	O
the	O
PEDV	B-SPEC
-	O
positive	O
rate	O
in	O
diarrhoea	O
specimens	O
was	O
28	O
.	O
93	O
%.	O

Phylogenetic	O
analysis	O
of	O
the	O
S	O
genes	O
showed	O
that	O
the	O
CH	O
-	O
JSYC	O
-	O
1	O
-	O
2016	O
strain	O
was	O
clustered	O
into	O
a	O
G2	O
-	O
a	O
subgroup	O
(	O
US	O
and	O
Asian	O
non	O
-	O
S	O
-	O
INDEL	O
),	O
and	O
other	O
seventeen	O
virus	B-SPEC
strains	O
was	O
clustered	O
into	O
a	O
new	O
subgroup	O
G2	O
-	O
b	O
(	O
Chinese	O
non	O
-	O
S	O
-	O
INDEL	O
).	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
been	O
recognized	O
as	O
a	O
highly	O
pathogenic	O
virus	B-SPEC
to	O
humans	B-SPEC
that	O
infects	O
the	O
respiratory	O
tract	O
and	O
is	O
associated	O
with	O
high	O
morbidity	O
and	O
mortality	O
.	O

We	O
found	O
that	O
229E	O
-	O
HR1P	O
and	O
229E	O
-	O
HR2P	O
could	O
interact	O
to	O
form	O
a	O
stable	O
six	O
-	O
helix	O
bundle	O
and	O
inhibit	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
spike	O
protein	O
-	O
mediated	O
cell	O
-	O
cell	O
fusion	O
with	O
IC	O

Here	O
,	O
we	O
detected	O
NETs	O
in	O
abundance	O
in	O
mouse	B-SPEC
models	O
of	O
severe	O
bacterial	O
pneumonia	O
/	O
acute	O
lung	O
injury	O
and	O
in	O
human	B-SPEC
subjects	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
from	O
pneumonia	O
or	O
sepsis	B-SPEC
.	O

Moreover	O
,	O
in	O
response	O
to	O
restimulation	O
with	O
the	O
PEDV	B-SPEC
COE	O
antigen	O
in	O
vitro	O
,	O
a	O
significant	O
difference	O
in	O
splenocyte	O
proliferation	O
response	O
and	O
Th2	O
-	O
associated	O
cytokine	O
IL	O
-	O
4	O
level	O
was	O
observed	O
in	O
the	O
group	O
of	O
mice	B-SPEC
orally	O
immunized	O
with	O
pPG	O
-	O
COE	O
-	O
Col	O
-	O
DCpep	O
/	O
L393	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
compared	O
to	O
the	O
groups	O
of	O
mice	B-SPEC
that	O
received	O
pPG	O
-	O
COE	O
-	O
Col	O
/	O
L393	O
and	O
pPG	O
-	O
COE	O
-	O
DCpep	O
/	O
L393	O
,	O
respectively	O
.	O

As	O
parts	O
of	O
the	O
innate	O
host	O
response	O
,	O
macrophages	O
and	O
cytokines	O
,	O
such	O
as	O
interleukin	O
(	O
IL	O
)-	O
1	O
,	O
are	O
critical	O
components	O
as	O
shown	O
in	O
other	O
host	O
-	O
virus	B-SPEC
infection	O
models	O
.	O

Since	O
information	O
on	O
the	O
importance	O
of	O
macrophages	O
and	O
IL	O
-	O
1	O
in	O
IBV	B-SPEC
infection	O
in	O
chickens	B-SPEC
is	O
limited	O
,	O
our	O
objective	O
was	O
to	O
determine	O
the	O
association	O
of	O
IL	O
-	O
1	O
,	O
originating	O
from	O
avian	B-SPEC
macrophages	O
and	O
IBV	B-SPEC
infection	O
in	O
the	O
trachea	B-SPEC
and	O
lung	O
.	O

Domain	O
D3	O
in	O
rSF	O
was	O
replaced	O
with	O
COE	O
domain	O
of	O
PEDV	B-SPEC
to	O
generate	O
rSF	O
-	O
COE	O
-	O
3D	O
.	O

It	O
can	O
cause	O
severe	O
diarrhea	O
disease	O
in	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
-	O
OC43	O
,	O
-	O
229E	O
,	O
-	O
NL63	O
and	O
-	O
HKU1	O
cause	O
upper	O
and	O
lower	O
respiratory	O
tract	O
infections	O
.	O

Prior	O
studies	O
have	O
shown	O
seasonal	O
patterns	O
of	O
HCoV	O
species	B-SPEC
and	O
annual	O
variation	O
in	O
species	B-SPEC
prevalence	O
but	O
national	O
circulation	O
patterns	O
in	O
the	O
US	O
have	O
not	O
yet	O
been	O
described	O
.	O

From	O
16	O
FIP	O
and	O
14	O
non	O
-	O
FIP	O
cats	B-SPEC
,	O
we	O
evaluated	O
retrospectively	O
the	O
sensitivity	O
,	O
specificity	O
,	O
and	O
likelihood	O
ratios	O
(	O
LRs	O
)	O
of	O
serum	O
protein	O
electrophoresis	O
,	O
	O

TITLE	O
:	O
Pathophysiology	O
of	O
heatstroke	O
in	O
dogs	B-SPEC
-	O
revisited	O
.	O

Functional	O
morphology	O
and	O
thermoregulatory	O
effectors	O
differences	O
between	O
dogs	B-SPEC
and	O
humans	B-SPEC
may	O
require	O
special	O
heatstroke	O
protective	O
adaptations	O
in	O
dogs	B-SPEC
,	O
however	O
,	O
the	O
risk	O
factors	O
for	O
developing	O
heatstroke	O
are	O
similar	O
in	O
both	O
.	O

Evoked	O
serious	O
complications	O
include	O
rhabdomyolysis	O
,	O
acute	O
kidney	O
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
ultimately	O
,	O
sepsis	B-SPEC
and	O
disseminated	O
intravascular	O
coagulation	O
.	O

Despite	O
significant	O
improvements	O
,	O
the	O
patient	O
expired	O
on	O
postoperative	O
day	O
15	O
,	O
due	O
to	O
an	O
overwhelming	O
intra	O
-	O
abdominal	O
sepsis	B-SPEC
.	O

Influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
parainfluenza	O
viruses	B-SPEC
and	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
as	O
well	O
as	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
were	O
detected	O
significantly	O
more	O
frequently	O
in	O
LRTI	O
patients	O
than	O
in	O
controls	O
.	O

Viral	O
sequences	O
similar	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
have	O
been	O
detected	O
in	O
bats	B-SPEC
,	O
and	O
filoviruses	O
such	O
as	O
Marburg	B-SPEC
virus	I-SPEC
have	O
been	O
isolated	O
from	O
bats	B-SPEC
,	O
providing	O
definitive	O
evidence	O
for	O
the	O
role	O
of	O
bats	B-SPEC
as	O
the	O
natural	O
host	O
reservoir	O
.	O

There	O
is	O
,	O
therefore	O
,	O
a	O
need	O
to	O
develop	O
additional	O
bat	B-SPEC
cell	O
lines	O
that	O
correspond	O
to	O
different	O
cell	O
types	O
,	O
including	O
less	O
represented	O
cell	O
types	O
such	O
as	O
immune	O
cells	O
,	O
and	O
culture	O
them	O
under	O
more	O
physiologically	O
relevant	O
conditions	O
to	O
study	O
virus	B-SPEC
host	O
interactions	O
and	O
for	O
virus	B-SPEC
isolation	O
.	O

TITLE	O
:	O
Detection	O
and	O
genetic	O
characterization	O
of	O
Mamastrovirus	B-SPEC
5	O
from	O
Brazilian	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
natural	O
reservoirs	O
for	O
several	O
highly	O
pathogenic	O
and	O
novel	O
viruses	B-SPEC
including	O
coronaviruses	O
(	O
CoVs	O
)	O
(	O
mainly	O
Alphacoronavirus	B-SPEC
and	O
Betacoronavirus	B-SPEC
).	O

Lyle	O
'	O
s	O
flying	B-SPEC
fox	I-SPEC
(	O
Pteropus	B-SPEC
lylei	I-SPEC
)'	O
s	O
roosts	O
and	O
foraging	O
sites	O
are	O
usually	O
in	O
the	O
proximity	O
to	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

Phylogenetic	O
analysis	O
of	O
conserved	O
RdRp	O
gene	O
revealed	O
that	O
the	O
detected	O
CoVs	O
belonged	O
to	O
group	O
D	O
betacoronavirus	B-SPEC
(	O
n	O
=	O
64	O
)	O
and	O
alphacoronavirus	B-SPEC
(	O
n	O
=	O
4	O
).	O

We	O
searched	O
MEDLINE	O
,	O
EMBASE	O
,	O
and	O
the	O
Cochrane	O
Database	O
of	O
Systematic	O
Reviews	O
from	O
2012	O
to	O
2017	O
focusing	O
on	O
randomized	O
clinical	O
trials	O
,	O
meta	B-SPEC
-	O
analyses	O
,	O
systematic	O
reviews	O
,	O
and	O
clinical	O
practice	O
guidelines	O
.	O

In	O
February	O
2017	O
,	O
a	O
PEDV	B-SPEC
variant	O
(	O
USA	O
/	O
OK10240	O
-	O
8	O
/	O
2017	O
)	O
was	O
identified	O
in	O
a	O
rectal	O
swab	O
from	O
a	O
sow	O
farm	O
in	O
Oklahoma	O
,	O
USA	O
.	O

The	O
virus	B-SPEC
can	O
trigger	O
severe	O
pneumonia	O
and	O
lead	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

To	O
obtain	O
a	O
better	O
understanding	O
of	O
the	O
molecular	O
events	O
at	O
the	O
earliest	O
time	O
points	O
,	O
we	O
used	O
RNA	O
-	O
Seq	O
to	O
quantify	O
and	O
compare	O
the	O
host	O
mRNA	O
and	O
miRNA	O
transcriptomes	O
induced	O
by	O
the	O
highly	O
pathogenic	O
influenza	O
A	O
H5N1	O
(	O
A	O
/	O
Vietnam	O
/	O
3212	O
/	O
04	O
)	O
or	O
low	O
virulent	O
H1N1	O
(	O
A	O
/	O
Hong	O
Kong	O
/	O
54	O
/	O
98	O
)	O
viruses	B-SPEC
in	O
human	B-SPEC
monocyte	O
-	O
derived	O
macrophages	O
at	O
1	O
-,	O
3	O
-,	O
and	O
6	O
-	O
h	O
post	O
infection	O
.	O

The	O
negative	O
regulators	O
of	O
interferon	O
signaling	O
,	O
the	O
suppressors	O
of	O
cytokine	O
signaling	O
,	O
SOCS	O
-	O
1	O
and	O
SOCS	O
-	O
3	O
,	O
were	O
found	O
to	O
be	O
markedly	O
up	O
-	O
regulated	O
in	O
the	O
initial	O
round	O
of	O
H5N1	O
virus	B-SPEC
replication	O
.	O

Elevated	O
levels	O
of	O
these	O
suppressors	O
could	O
lead	O
to	O
the	O
eventual	O
suppression	O
of	O
cellular	O
antiviral	O
genes	O
,	O
contributing	O
to	O
pathophysiology	O
of	O
H5N1	O
virus	B-SPEC
infection	O
.	O

Elevated	O
levels	O
of	O
these	O
suppressors	O
could	O
lead	O
to	O
the	O
eventual	O
suppression	O
of	O
cellular	O
antiviral	O
genes	O
,	O
contributing	O
to	O
pathophysiology	O
of	O
H5N1	O
virus	B-SPEC
infection	O
.	O

PED	O
,	O
characterized	O
by	O
acute	O
diarrhea	O
,	O
vomiting	O
,	O
dehydration	O
,	O
has	O
caused	O
serious	O
economic	O
losses	O
in	O
pig	B-SPEC
industry	O
worldwide	O
.	O

Taken	O
together	O
,	O
these	O
data	O
demonstrate	O
that	O
modulation	O
of	O
APN	O
expression	O
by	O
metalloprotease	O
ADAM17	O
regulates	O
PEDV	B-SPEC
infection	O
.	O

In	O
addition	O
,	O
mirroring	O
data	O
from	O
murine	B-SPEC
models	O
of	O
lung	O
injury	O
/	O
regeneration	O
,	O
peribronchiolar	O
basaloid	O
pods	O
(	O
previously	O
described	O
as	O
squamous	O
metaplasia	O
)	O
and	O
ciliated	O
bronchiolarization	O
were	O
identified	O
in	O
these	O
patients	O
and	O
in	O
39	O
%	O
of	O
57	O
historical	O
cases	O
with	O
diffuse	O
alveolar	O
damage	O
.	O

Higher	O
BVDV	B-SPEC
S	O
/	O
P	O
ratios	O
at	O
d	O
-	O
14	O
were	O
significantly	O
correlated	O
with	O
increased	O
changes	O
in	O
serological	O
responses	O
to	O
BHV	B-SPEC
-	I-SPEC
4	I-SPEC
over	O
the	O
peri	O
-	O
weaning	O
period	O
.	O

RESULTS	O
:	O
BRSV	B-SPEC
was	O
the	O
only	O
pathogen	O
which	O
demonstrated	O
clustering	O
by	O
pen	O
.	O

Studies	O
from	O
Europe	O
have	O
shown	O
that	O
coronaviruses	O
circulate	O
in	O
bats	B-SPEC
in	O
France	O
but	O
this	O
reflects	O
only	O
a	O
fraction	O
of	O
the	O
whole	O
diversity	O
.	O

We	O
used	O
the	O
rhesus	B-SPEC
macaque	I-SPEC
model	O
of	O
mild	O
MERS	O
to	O
investigate	O
whether	O
the	O
immune	O
response	O
plays	O
a	O
role	O
in	O
the	O
pathogenicity	O
in	O
relation	O
to	O
MERS	O
-	O
CoV	O
shedding	O
.	O

Despite	O
increased	O
viral	O
replication	O
,	O
pathology	O
in	O
the	O
lungs	O
was	O
significantly	O
lower	O
in	O
immunosuppressed	O
animals	B-SPEC
.	O

TITLE	O
:	O
Predictors	O
of	O
respiratory	O
failure	O
in	O
patients	O
with	O
Guillain	O
-	O
Barr	O
syndrome	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

TITLE	O
:	O
Full	O
-	O
length	O
genome	O
sequences	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
strain	O
CV777	O
;	O
Use	O
of	O
NGS	O
to	O
analyse	O
genomic	O
and	O
sub	O
-	O
genomic	O
RNAs	O
.	O

This	O
coronavirus	B-SPEC
has	O
been	O
widely	O
distributed	O
among	O
laboratories	O
and	O
has	O
been	O
passaged	O
both	O
within	O
pigs	B-SPEC
and	O
in	O
cell	O
culture	O
.	O

Cotransfection	O
of	O
cells	O
with	O
a	O
plasmid	O
expressing	O
VP24	O
cloned	O
from	O
a	O
virus	B-SPEC
isolated	O
during	O
the	O
last	O
2014	O
outbreak	O
led	O
to	O
the	O
inhibition	O
of	O
ISRE	O
transcription	O
,	O
quantified	O
by	O
a	O
luminescent	O
signal	O
.	O

These	O
findings	O
indicate	O
that	O
attenuated	O
IBV	B-SPEC
strain	O
SZ130	O
is	O
highly	O
safe	O
in	O
chicks	O
and	O
may	O
serve	O
as	O
an	O
effective	O
vaccine	O
against	O
the	O
threat	O
posed	O
by	O
QX	O
-	O
like	O
IBV	B-SPEC
strains	O
.	O

To	O
address	O
this	O
need	O
,	O
we	O
are	O
developing	O
a	O
subunit	O
recombinant	O
protein	O
vaccine	O
comprising	O
residues	O
377	O
-	O
588	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
which	O
,	O
when	O
formulated	O
with	O
the	O
AddaVax	O
adjuvant	O
,	O
it	O
induces	O
a	O
significant	O
neutralizing	O
antibody	O
response	O
and	O
protection	O
against	O
MERS	O
-	O
CoV	O
challenge	O
in	O
vaccinated	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
summarize	O
selected	O
meta	B-SPEC
-	O
analyses	O
and	O
trials	O
related	O
to	O
critical	O
care	O
pharmacotherapy	O
published	O
in	O
2017	O
.	O

A	O
set	O
of	O
primers	O
and	O
probes	O
,	O
CPV	B-SPEC
-	O
305F	O
/	O
CPV	B-SPEC
-	O
305R	O
and	O
CPV	B-SPEC
-	O
2	O
-	O
305P	O
(	O
for	O
CPV	B-SPEC
-	O
2	O
)/	O
CPV	B-SPEC
-	O
2a	O
-	O
305P	O
(	O
for	O
CPV	B-SPEC
-	O
2a	O
,	O
2b	O
and	O
2c	O
),	O
was	O
able	O
to	O
differentiate	O
CPV	B-SPEC
-	O
2	O
and	O
its	O
variants	O
(	O
CPV	B-SPEC
-	O
2a	O
,	O
2b	O
and	O
2c	O
).	O

TITLE	O
:	O
Longitudinal	O
Surveillance	O
of	O
Betacoronaviruses	O
in	O
Fruit	O
Bats	B-SPEC
in	O
Yunnan	O
Province	O
,	O
China	O
During	O
2009	O
-	O
2016	O
.	O

The	O
rapid	O
MERS	O
-	O
CoV	O
nucleocapsid	O
protein	O
detection	O
assay	O
was	O
tested	O
positive	O
in	O
24	O
(	O
88	O
.	O
9	O
%)	O
of	O
27	O
Tylonycteris	B-SPEC
bat	B-SPEC
CoV	O
HKU4	O
(	O
Ty	O
-	O
BatCoV	O
-	O
HKU4	O
)	O
RNA	O
-	O
positive	O
alimentary	O
samples	O
of	O
Tylonycteris	B-SPEC
pachypus	I-SPEC
and	O
4	O
(	O
19	O
.	O
0	O
%)	O
of	O
21	O
Pipistrellus	B-SPEC
bat	B-SPEC
CoV	O
HKU5	O
(	O
Pi	O
-	O
BatCoV	O
-	O
HKU5	O
)	O
RNA	O
-	O
positive	O
alimentary	O
samples	O
of	O
Pipistrellus	B-SPEC
abramus	I-SPEC
.	O

The	O
rapid	O
MERS	O
-	O
CoV	O
nucleocapsid	O
protein	O
detection	O
assay	O
is	O
able	O
to	O
rapidly	O
detect	O
lineage	O
C	O
betacoronaviruses	O
in	O
bats	B-SPEC
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
is	O
a	O
respiratory	O
pathogen	O
and	O
causes	O
severe	O
infections	O
with	O
nonspecific	O
symptoms	O
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
was	O
detected	O
by	O
direct	O
immunofluorescence	O
and	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

hMPV	B-SPEC
was	O
detected	O
in	O
109	O
patients	O
from	O
the	O
main	O
geographic	O
regions	O
of	O
the	O
southernmost	O
state	O
of	O
Brazil	O
,	O
presenting	O
similar	O
overall	O
prevalence	O
in	O
males	O
(	O
46	O
.	O
8	O
%)	O
and	O
females	O
(	O
53	O
.	O
2	O
%).	O

RESULTS	O
:	O
hMPV	B-SPEC
was	O
detected	O
in	O
109	O
patients	O
from	O
the	O
main	O
geographic	O
regions	O
of	O
the	O
southernmost	O
state	O
of	O
Brazil	O
,	O
presenting	O
similar	O
overall	O
prevalence	O
in	O
males	O
(	O
46	O
.	O
8	O
%)	O
and	O
females	O
(	O
53	O
.	O
2	O
%).	O

ABSTRACT	O
:	O
The	O
ever	O
-	O
increasing	O
speed	O
and	O
scope	O
of	O
human	B-SPEC
mobility	O
by	O
international	O
air	O
travel	O
has	O
led	O
to	O
a	O
global	O
transport	O
network	O
for	O
infectious	O
diseases	O
with	O
the	O
potential	O
to	O
introduce	O
pathogens	O
into	O
non	O
-	O
endemic	O
areas	O
,	O
and	O
to	O
facilitate	O
rapid	O
spread	O
of	O
novel	O
or	O
mutated	O
zoonotic	O
agents	O
.	O

TITLE	O
:	O
Importance	O
of	O
Neutralizing	O
Monoclonal	O
Antibodies	O
Targeting	O
Multiple	O
Antigenic	O
Sites	O
on	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Spike	O
Glycoprotein	O
To	O
Avoid	O
Neutralization	O
Escape	O
.	O

AvCoV	O
isolated	O
from	O
the	O
pigeon	B-SPEC
sample	O
caused	O
complete	O
tracheal	O
ciliostasis	O
over	O
a	O
longer	O
time	O
span	O
.	O

These	O
results	O
confirm	O
the	O
pathogenicity	O
of	O
Brazilian	O
variants	O
,	O
which	O
can	O
cause	O
disease	O
and	O
induce	O
gross	O
lesions	O
and	O
histopathological	O
changes	O
in	O
chickens	B-SPEC
.	O

TITLE	O
:	O
A	O
highly	O
pathogenic	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
type	O
1	O
(	O
PRRSV	B-SPEC
-	O
1	O
)	O
strongly	O
modulates	O
cellular	O
innate	O
and	O
adaptive	O
immune	O
subsets	O
upon	O
experimental	O
infection	O
.	O

The	O
exacerbation	O
of	O
general	O
and	O
respiratory	O
clinical	O
signs	O
has	O
been	O
attributed	O
not	O
only	O
to	O
an	O
efficient	O
replication	O
(	O
virulence	O
)	O
but	O
also	O
to	O
the	O
ability	O
to	O
dysregulate	O
viral	O
recognition	O
and	O
induce	O
mechanisms	O
of	O
immune	O
evasion	O
or	O
immune	O
enhancement	O
of	O
humoral	O
and	O
cellular	O
anti	O
-	O
viral	O
responses	O
differently	O
from	O
non	O
-	O
HP	O
PRRSV	B-SPEC
isolates	O
in	O
terms	O
of	O
intensity	O
and	O
temporal	O
onset	O
.	O

However	O
,	O
the	O
subcellular	O
localization	O
and	O
other	O
functions	O
of	O
the	O
TGEV	B-SPEC
nsp7	O
protein	O
are	O
still	O
unclear	O
.	O

ABSTRACT	O
:	O
For	O
three	O
decades	O
now	O
,	O
ionic	O
liquids	O
(	O
ILs	O
),	O
organic	O
salts	O
comprising	O
only	O
ions	O
,	O
have	O
emerged	O
as	O
a	O
new	O
class	B-SPEC
of	O
pharmaceuticals	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
belongs	O
to	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
,	O
and	O
is	O
named	O
for	O
the	O
crown	O
-	O
like	O
spikes	O
on	O
its	O
surface	O
.	O

Approximately	O
two	O
-	O
thirds	O
of	O
the	O
respondents	O
properly	O
identified	O
the	O
causative	O
agent	O
of	O
MERS	O
-	O
CoV	O
as	O
an	O
RNA	O
virus	B-SPEC
(	O
66	O
.	O
4	O
%,	O
n	O
=	O
225	O
)	O
that	O
is	O
enveloped	O
(	O
68	O
.	O
1	O
%,	O
n	O
=	O
231	O
).	O

TITLE	O
:	O
The	O
use	O
of	O
complementary	O
and	O
alternative	O
medicine	O
by	O
patients	O
with	O
cancer	B-SPEC
:	O
a	O
cross	O
-	O
sectional	O
survey	O
in	O
Saudi	O
Arabia	O
.	O

Although	O
CAM	O
use	O
can	O
be	O
beneficial	O
,	O
some	O
can	O
be	O
very	O
harmful	O
,	O
especially	O
for	O
cancer	B-SPEC
patients	O
.	O

However	O
,	O
this	O
class	B-SPEC
of	O
compounds	O
has	O
also	O
experienced	O
a	O
high	O
attrition	O
rate	O
in	O
clinical	O
trials	O
due	O
to	O
toxicity	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
the	O
utility	O
of	O
different	O
biochemical	O
and	O
cell	O
-	O
based	O
assays	O
and	O
provide	O
recommendations	O
for	O
assessing	O
toxicity	O
liability	O
before	O
entering	O
animal	B-SPEC
toxicity	O
studies	O
.	O

TITLE	O
:	O
A	O
Multicenter	O
Consortium	O
to	O
Define	O
the	O
Epidemiology	O
and	O
Outcomes	O
of	O
Pediatric	O
Solid	O
Organ	O
Transplant	O
Recipients	O
With	O
Inpatient	O
Respiratory	O
Virus	B-SPEC
Infection	O
.	O

Although	O
PEDV	B-SPEC
vaccines	O
have	O
been	O
used	O
widely	O
,	O
the	O
disease	O
has	O
swept	O
rapidly	O
across	O
the	O
county	O
,	O
and	O
is	O
commonly	O
observed	O
in	O
PED	O
-	O
vaccinated	O
farms	O
,	O
and	O
has	O
recurred	O
in	O
domestic	O
herds	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
disease	O
in	O
cats	B-SPEC
worldwide	O
.	O

RNA	O
was	O
extracted	O
from	O
body	O
cavity	O
effusion	O
samples	O
of	O
71	O
cats	B-SPEC
,	O
including	O
34	O
samples	O
from	O
cats	B-SPEC
with	O
a	O
definitive	O
diagnosis	O
of	O
FIP	O
,	O
and	O
37	O
samples	O
of	O
control	O
cats	B-SPEC
with	O
similar	O
clinical	O
signs	O
but	O
other	O
confirmed	O
diseases	O
.	O

TITLE	O
:	O
Detection	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
mutations	O
in	O
paraffin	O
-	O
embedded	O
tissues	O
in	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
and	O
controls	O
.	O

In	O
samples	O
of	O
three	O
control	O
cats	B-SPEC
and	O
in	O
seven	O
cats	B-SPEC
with	O
FIP	O
,	O
FCoV	O
was	O
found	O
,	O
but	O
genotyping	O
was	O
not	O
possible	O
owing	O
to	O
low	O
FCoV	O
RNA	O
concentrations	O
.	O

Streptococcus	B-SPEC
pneumoniae	I-SPEC
is	O
the	O
most	O
common	O
cause	O
of	O
bacterial	O
pneumonia	O
,	O
which	O
in	O
turn	O
is	O
the	O
leading	O
cause	O
of	O
ARDS	O
.	O

The	O
inclusion	O
of	O
antibiotic	O
treatment	O
in	O
preclinical	O
studies	O
of	O
acute	O
lung	O
injury	O
in	O
bacterial	O
pneumonia	O
may	O
enhance	O
clinical	O
relevance	O
,	O
particularly	O
for	O
future	O
studies	O
of	O
current	O
or	O
emerging	O
tobacco	B-SPEC
products	O
.	O

TITLE	O
:	O
Structure	O
-	O
guided	O
design	O
of	O
potent	O
and	O
permeable	O
inhibitors	O
of	O
MERS	O
coronavirus	B-SPEC
3CL	O
protease	O
that	O
utilize	O
a	O
piperidine	O
moiety	O
as	O
a	O
novel	O
design	O
element	O
.	O

Real	O
-	O
time	O
quantitative	O
PCR	O
and	O
indirect	O
immunofluorescence	O
assay	O
indicated	O
that	O
LiCl	O
effectively	O
inhibited	O
the	O
entry	O
and	O
replication	O
of	O
PEDV	B-SPEC
in	O
Vero	O
cells	O
.	O

The	O
expression	O
of	O
viral	O
RNA	O
and	O
protein	O
of	O
PEDV	B-SPEC
in	O
Vero	O
cells	O
was	O
suppressed	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
by	O
LiCl	O
.	O

The	O
complete	O
S	O
gene	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
4149	O
-	O
4158	O
bp	O
long	O
.	O

ABSTRACT	O
:	O
Dromedary	B-SPEC
camels	B-SPEC
have	O
been	O
implicated	O
consistently	O
as	O
the	O
source	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
human	B-SPEC
infections	O
and	O
attention	O
to	O
prevent	O
and	O
control	O
it	O
has	O
focused	O
on	O
camels	B-SPEC
.	O

For	O
two	O
of	O
these	O
viruses	B-SPEC
,	O
we	O
have	O
strong	O
evidence	O
suggesting	O
an	O
origin	O
in	O
major	O
livestock	O
species	B-SPEC
while	O
primordial	O
associations	O
for	O
all	O
four	O
viruses	B-SPEC
may	O
have	O
existed	O
with	O
bats	B-SPEC
and	O
rodents	B-SPEC
.	O

New	O
data	O
suggest	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
may	O
actually	O
be	O
transferred	O
from	O
dromedary	B-SPEC
camels	B-SPEC
similar	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
S	O
protein	O
-	O
induced	O
fusion	O
is	O
blocked	O
prior	O
to	O
hemifusion	O
by	O
Abl	O
kinase	O
inhibitors	O
.	O

We	O
have	O
shown	O
previously	O
that	O
an	O
Abelson	O
(	O
Abl	O
)	O
kinase	O
inhibitor	O
,	O
imatinib	O
,	O
significantly	O
reduces	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
viral	O
titres	O
and	O
prevents	O
endosomal	O
entry	O
by	O
HIV	B-SPEC
SARS	O
S	O
and	O
MERS	O
S	O
pseudotyped	O
virions	O
.	O

We	O
found	O
that	O
imatinib	O
and	O
two	O
specific	O
Abl	O
kinase	O
inhibitors	O
,	O
GNF2	O
and	O
GNF5	O
,	O
reduce	O
IBV	B-SPEC
titres	O
by	O
blocking	O
the	O
first	O
round	O
of	O
virus	B-SPEC
infection	O
.	O

Studying	O
the	O
effects	O
of	O
Abl	O
kinase	O
inhibitors	O
on	O
IBV	B-SPEC
will	O
be	O
useful	O
in	O
identifying	O
the	O
host	O
cell	O
pathways	O
required	O
for	O
coronavirus	B-SPEC
infection	O
.	O

We	O
present	O
a	O
6	O
-	O
month	O
-	O
old	O
male	O
infant	O
who	O
was	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
due	O
to	O
restlessness	O
,	O
severe	O
hypertension	O
,	O
anemia	B-SPEC
,	O
respiratory	O
distress	O
,	O
and	O
acute	O
kidney	O
injury	O
.	O

TITLE	O
:	O
The	O
discovery	O
of	O
novel	O
diarylpyri	O
(	O
mi	O
)	O
dine	O
derivatives	O
with	O
high	O
level	O
activity	O
against	O
a	O
wide	O
variety	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
strains	O
as	O
well	O
as	O
against	O
HIV	B-SPEC
-	I-SPEC
2	I-SPEC
.	O

We	O
administered	O
a	O
survey	O
to	O
169	O
organizations	O
in	O
order	B-SPEC
to	O
map	O
the	O
pattern	O
of	O
communication	O
and	O
response	O
networks	O
during	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
outbreak	O
.	O

Induction	O
of	O
autophagic	O
signals	O
promotes	O
EV	O
-	O
D68	O
replication	O
,	O
but	O
the	O
virus	B-SPEC
inhibits	O
the	O
downstream	O
degradative	O
steps	O
of	O
autophagy	O
in	O
multiple	O
ways	O
.	O

ABSTRACT	O
:	O
We	O
report	O
here	O
the	O
complete	O
genome	O
sequence	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
CN0601	O
/	O
14	O
strain	O
,	O
first	O
isolated	O
from	O
South	O
Korea	O
.	O

Babesia	B-SPEC
microti	I-SPEC
is	O
the	O
main	O
pathogen	O
causing	O
human	B-SPEC
disease	O
and	O
is	O
endemic	O
in	O
the	O
northeastern	O
and	O
upper	O
midwestern	O
parts	O
of	O
the	O
USA	O
.	O

TITLE	O
:	O
Phylodynamic	O
analysis	O
and	O
molecular	O
diversity	O
of	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
of	O
chickens	B-SPEC
in	O
Brazil	O
.	O

Brazil	O
is	O
one	O
of	O
the	O
biggest	O
poultry	O
producers	O
in	O
the	O
world	O
and	O
the	O
present	O
study	O
aimed	O
to	O
review	O
the	O
molecular	O
diversity	O
and	O
reconstruct	O
the	O
evolutionary	O
history	O
of	O
IBV	B-SPEC
in	O
the	O
country	O
.	O

Immune	O
reconstitution	O
inflammatory	O
syndrome	O
(	O
IRIS	B-SPEC
)	O
involves	O
excessive	O
inflammatory	O
response	O
to	O
a	O
pathogen	O
with	O
paradoxical	O
clinical	O
deterioration	O
following	O
HAART	O
initiation	O
and	O
may	O
present	O
as	O
severe	O
respiratory	O
failure	O
.	O

We	O
report	O
two	O
HIV	B-SPEC
-	O
positive	O
patients	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
from	O
IRIS	B-SPEC
necessitating	O
successful	O
veno	O
-	O
venous	O
ECMO	O
as	O
salvage	O
therapy	O
.	O

Overall	O
NIV	O
use	O
outside	O
the	O
PICUs	B-SPEC
was	O
15	O
.	O
5	O
%	O
on	O
the	O
ward	O
,	O
20	O
%	O
in	O
the	O
emergency	O
department	O
,	O
and	O
36	O
.	O
4	O
%	O
during	O
transport	O
.	O

NIV	O
use	O
in	O
asthma	O
was	O
less	O
frequent	O
in	O
Northern	O
European	O
units	O
in	O
comparison	O
to	O
Central	O
and	O
Southern	O
European	O
PICUs	B-SPEC
(	O
P	O
=	O
0	O
.	O
007	O
).	O

In	O
this	O
study	O
,	O
we	O
compared	O
the	O
effects	O
of	O
PED	O
vaccination	O
timing	O
and	O
frequency	O
for	O
its	O
efficacy	O
by	O
measuring	O
the	O
PED	O
virus	B-SPEC
-	O
specific	O
antibodies	O
.	O

TITLE	O
:	O
Reduction	O
of	O
soluble	O
dipeptidyl	O
peptidase	O
4	O
levels	O
in	O
plasma	O
of	O
patients	O
infected	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

We	O
hypothesized	O
,	O
that	O
mice	B-SPEC
pretreated	O
with	O
LPS	O
or	O
HCl	O
prior	O
to	O
VILI	O
and	O
thus	O
receiving	O
a	O
"("""	O
two	O
-	O
hit	O
injury	O
""")"	O
will	O
sustain	O
a	O
superadditive	O
lung	O
injury	O
when	O
compared	O
to	O
VILI	O
.	O

However	O
,	O
mice	B-SPEC
that	O
received	O
i	O
.	O
t	O
.	O

LPS	O
prior	O
to	O
VILI	O
showed	O
significantly	O
increased	O
inflammatory	O
lung	O
injury	O
compared	O
to	O
animals	B-SPEC
that	O
underwent	O
i	O
.	O
t	O
.	O

All	O
six	O
isolated	O
compounds	O
have	O
been	O
evaluated	O
firstly	O
for	O
the	O
inhibition	O
of	O
both	O
Human	B-SPEC
Immunodeficiency	I-SPEC
Virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
Reverse	O
Transcriptase	O
(	O
RT	O
)-	O
associated	O
DNA	O
Polymerase	O
(	O
RDDP	O
)	O
and	O
Ribonuclease	O
H	O
(	O
RNase	O
H	O
)	O
activities	O
,	O
for	O
the	O
inhibition	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
integrase	O
(	O
IN	O
)	O
in	O
biochemical	O
assays	O
,	O
and	O
also	O
for	O
their	O
effect	O
on	O
viral	O
replication	O
.	O

Traditionally	O
the	O
plant	B-SPEC
is	O
used	O
for	O
its	O
various	O
beneficial	O
properties	O
against	O
inflammation	O
,	O
pneumonia	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
muscular	O
sprain	O
,	O
stomach	O
ulcer	O
etc	O
.	O

Herbal	O
medicines	O
or	O
plant	B-SPEC
products	O
were	O
traditionally	O
being	O
used	O
for	O
treating	O
the	O
oxidative	O
stress	O
and	O
inflammation	O
related	O
diseases	O
in	O
diverse	O
communities	O
across	O
the	O
world	O
.	O

RESULTS	O
:	O
Herbal	O
medicines	O
or	O
plant	B-SPEC
products	O
were	O
traditionally	O
being	O
used	O
for	O
treating	O
the	O
oxidative	O
stress	O
and	O
inflammation	O
related	O
diseases	O
in	O
diverse	O
communities	O
across	O
the	O
world	O
.	O

PEDV	B-SPEC
and	O
PDCoV	O
data	O
stored	O
in	O
the	O
industry	O
DCP	O
database	O
were	O
imported	O
into	O
the	O
R	O
statistical	O
software	O
and	O
analysed	O
to	O
produce	O
weekly	O
frequency	O
of	O
incidence	O
counts	O
and	O
prevalence	O
counts	O
,	O
in	O
addition	O
to	O
yearly	O
herd	O
-	O
level	O
incidence	O
risk	O
and	O
prevalence	O
between	O
2014	O
and	O
2016	O
.	O

The	O
yearly	O
herd	O
-	O
level	O
incidence	O
risk	O
of	O
PEDV	B-SPEC
,	O
based	O
on	O
industry	O
data	O
,	O
was	O
13	O
.	O
5	O
%,	O
3	O
.	O
0	O
%	O
and	O
1	O
.	O
4	O
%	O
(	O
95	O
%	O
CI	O
:	O
11	O
.	O
1	O
-	O
16	O
.	O
2	O
,	O
2	O
.	O
0	O
-	O
4	O
.	O
2	O
,	O
0	O
.	O
8	O
-	O
2	O
.	O
3	O
),	O
while	O
the	O
yearly	O
herd	O
-	O
level	O
incidence	O
risk	O
of	O
PDCoV	O
was	O
1	O
.	O
1	O
%,	O
0	O
.	O
3	O
%,	O
and	O
0	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
5	O
-	O
2	O
.	O
2	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
9	O
,	O
0	O
.	O
0	O
-	O
0	O
.	O
5	O
),	O
for	O
2014	O
,	O
2015	O
and	O
2016	O
,	O
respectively	O
.	O

A	O
37	O
-	O
year	O
old	O
Caucasian	O
man	B-SPEC
returning	O
home	O
from	O
Angola	O
was	O
admitted	O
for	O
ovale	O
malaria	O
to	O
the	O
National	O
Institute	O
for	O
Infectious	O
Diseases	O
Lazzaro	O
Spallanzani	O
in	O
Rome	O
,	O
Italy	O
.	O

Mice	B-SPEC
were	O
transduced	O
with	O
Ad5	O
-	O
hDPP4	O
after	O
the	O
final	O
immunization	O
and	O
were	O
then	O
challenged	O
with	O
MERS	O
-	O
CoV	O
(	O
1	O
	O
10	O

TITLE	O
:	O
Fatal	O
swine	B-SPEC
acute	O
diarrhoea	O
syndrome	O
caused	O
by	O
an	O
HKU2	O
-	O
related	O
coronavirus	B-SPEC
of	O
bat	B-SPEC
origin	O
.	O

TITLE	O
:	O
PCR	O
array	O
profiling	O
of	O
antiviral	O
genes	O
in	O
human	B-SPEC
embryonic	O
kidney	O
cells	O
expressing	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
structural	O
and	O
accessory	O
proteins	O
.	O

ABSTRACT	O
:	O
Two	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
,	O
designated	O
as	O
CoV	O
/	O
ck	O
/	O
China	O
/	O
I0712	O
/	O
11	O
(	O
I0712	O
/	O
11	O
)	O
and	O
CoV	O
/	O
ck	O
/	O
China	O
/	O
I0108	O
/	O
17	O
(	O
I0108	O
/	O
17	O
),	O
were	O
isolated	O
from	O
diseased	O
chicken	B-SPEC
flocks	O
in	O
different	O
provinces	O
in	O
China	O
and	O
genotyped	O
as	O
Arkansas	O
(	O
Ark	O
)-	O
type	O
viruses	B-SPEC
with	O
three	O
other	O
Chinese	O
Ark	O
field	O
strains	O
,	O
the	O
Jilin	O
vaccine	O
strain	O
,	O
and	O
the	O
American	O
Ark	O
-	O
and	O
Ark	O
DPI	O
-	O
like	O
viruses	B-SPEC
.	O

Pathogenicity	O
testing	O
showed	O
that	O
Chinese	O
Ark	O
viruses	B-SPEC
had	O
comparable	O
virulence	O
to	O
that	O
of	O
the	O
Massachusetts	O
-	O
type	O
M41	O
strain	O
,	O
although	O
they	O
had	O
lower	O
affinity	O
for	O
the	O
kidneys	O
of	O
chickens	B-SPEC
than	O
the	O
M41	O
strain	O
had	O
.	O

No	O
clinical	O
signs	O
were	O
observed	O
apart	O
from	O
sneezing	O
in	O
chickens	B-SPEC
challenged	O
with	O
IBV	B-SPEC
,	O
MGC	O
+	O
IBV	B-SPEC
,	O
and	O
MG	O
+	O
IBV	B-SPEC
.	O

In	O
general	O
,	O
the	O
nonpathogenicity	O
of	O
M	B-SPEC
.	I-SPEC
gallinaceum	I-SPEC
in	O
chickens	B-SPEC
was	O
confirmed	O
,	O
but	O
it	O
was	O
able	O
to	O
aggravate	O
respiratory	O
disease	O
and	O
pathogen	O
proliferation	O
with	O
virulent	O
QX	O
-	O
like	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Genetic	O
and	O
Pathologic	O
Characterization	O
of	O
a	O
Novel	O
Recombinant	O
TC07	O
-	O
2	O
-	O
Type	O
Avian	B-SPEC
Infectious	O
Bronchitis	O
Virus	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
the	O
full	O
-	O
length	O
open	O
reading	O
frames	O
of	O
the	O
spike	O
(	O
S	O
)	O
and	O
nucleocapsid	O
(	O
N	O
)	O
genes	O
of	O
the	O
virus	B-SPEC
were	O
sequenced	O
and	O
analyzed	O
.	O

IBV	B-SPEC
belongs	O
to	O
the	O
genus	B-SPEC
Gammacoronavirus	B-SPEC
within	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
.	O

If	O
only	O
patients	O
that	O
survived	O
hospital	O
admission	O
are	O
included	O
in	O
the	O
model	O
,	O
variables	O
retained	O
are	O
:	O
age	O
=	O
1	O
.	O
03	O
per	O
year	O
(	O
1	O
.	O
02	O
-	O
1	O
.	O
05	O
),	O
cancer	B-SPEC
=	O
4	O
.	O
69	O
(	O
1	O
.	O
71	O
-	O
12	O
.	O
83	O
),	O
chronic	O
respiratory	O
disease	O
=	O
2	O
.	O
27	O
(	O
1	O
.	O
09	O
-	O
4	O
.	O
69	O
),	O
diabetes	O
mellitus	O
=	O
1	O
.	O
65	O
(	O
1	O
.	O
06	O
-	O
2	O
.	O
56	O
),	O

RESULTS	O
:	O
Two	O
different	O
models	O
were	O
developed	O
(	O
with	O
and	O
without	O
acute	O
-	O
illness	O
severity	O
scores	O
)	O
and	O
factors	O
independently	O
associated	O
with	O
5	O
-	O
year	O
mortality	O
were	O
[	O
adjusted	O
odds	O
ratio	O
(	O
95	O
%	O
confidence	O
interval	O
)]:	O
age	O
=	O
1	O
.	O
03	O
per	O
year	O
(	O
1	O
.	O
02	O
-	O
1	O
.	O
04	O
),	O
cancer	B-SPEC
=	O
4	O
.	O
36	O
(	O
1	O
.	O
65	O
-	O
11	O
.	O
53	O
),	O
no	O
comorbidities	O
=	O
0	O
.	O
4	O
(	O
0	O
.	O
26	O
-	O
0	O
.	O
62	O
),	O
Karnovsky	O
Index	O
<	O
70	O
=	O
2	O
.	O
25	O
(	O
1	O
.	O
48	O
-	O
3	O
.	O
40	O
),	O
SAPS	O
(	O
Simplified	O
Acute	O
Physiology	O
Score	O
)	O
II	O
=	O
1	O
.	O
05	O
per	O
point	O
(	O
1	O
.	O
03	O
-	O
1	O
.	O
07	O
),	O
positive	O
blood	O
cultures	O
=	O
1	O
.	O
57	O
(	O
1	O
.	O
01	O
-	O
2	O
.	O
44	O
)	O
and	O
infection	O
by	O
an	O
ESKAPE	O
pathogen	O
(	O
Enterococcus	B-SPEC
faecium	I-SPEC
,	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
Klebsiella	B-SPEC
pneumoniae	I-SPEC
,	O
Acinetobacter	B-SPEC
baumannii	I-SPEC
,	O
Pseudomonas	B-SPEC
aeroginosa	O
and	O
Enterobacter	B-SPEC
species	I-SPEC
)	O
=	O
1	O
.	O
61	O
(	O
1	O
.	O
00	O
-	O
2	O
.	O
60	O
);	O
and	O
in	O
the	O
second	O
model	O
[	O
without	O
SAPS	O
II	O
and	O
SOFA	O
(	O
Sequential	O
Organ	O
Failure	O
Assessment	O
)	O
scores	O
]:	O
age	O
=	O
1	O
.	O
04	O
per	O
year	O
(	O
1	O
.	O
03	O
-	O
1	O
.	O
05	O
),	O
cancer	B-SPEC
=	O
5	O
.	O
93	O
(	O
2	O
.	O
26	O
-	O
15	O
.	O
51	O
),	O
chronic	O
haematologic	O
disease	O
=	O
2	O
.	O
37	O
(	O
1	O
.	O
14	O
-	O
4	O
.	O
93	O
),	O
no	O
comorbidities	O
=	O
0	O
.	O
45	O
(	O
0	O
.	O
29	O
-	O
0	O
.	O
69	O
),	O
Karnovsky	O
Index	O
<	O
70	O
=	O
2	O
.	O
32	O
(	O
1	O
.	O
54	O
-	O
3	O
.	O
50	O
),	O
septic	O
shock	O
[	O
reference	O
is	O
infection	O
without	O
SIRS	O
(	O
Systemic	O
Inflammatory	O
Response	O
Syndrome	O
)]	O
=	O
3	O
.	O
77	O
(	O
1	O
.	O
80	O
-	O
7	O
.	O
89	O
)	O
and	O
infection	O
by	O
an	O
ESKAPE	O
pathogen	O
=	O
1	O
.	O
61	O
(	O
1	O
.	O
00	O
-	O
2	O
.	O
60	O
).	O

ABSTRACT	O
:	O
Infection	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
in	O
2012	O
as	O
an	O
important	O
respiratory	O
disease	O
with	O
high	O
fatality	O
rates	O
of	O
40	O
%-	O
60	O
%.	O

Studies	O
have	O
found	O
a	O
relationship	O
among	O
temperature	O
,	O
humidity	O
,	O
and	O
influenza	B-SPEC
virus	I-SPEC
incidence	O
,	O
transmission	O
,	O
or	O
survival	O
;	O
however	O
,	O
there	O
are	O
contradictory	O
claims	O
about	O
whether	O
absolute	O
humidity	O
(	O
AH	O
)	O
or	O
relative	O
humidity	O
(	O
RH	O
)	O
is	O
most	O
important	O
in	O
mediating	O
virus	B-SPEC
infectivity	O
.	O

TITLE	O
:	O
Viral	O
and	O
bacterial	O
investigations	O
on	O
the	O
aetiology	O
of	O
recurrent	O
pig	B-SPEC
neonatal	O
diarrhoea	O
cases	O
in	O
Spain	O
.	O

TITLE	O
:	O
Successful	O
Use	O
of	O
Veno	O
-	O
Venous	O
Extracorporeal	O
Membrane	O
Oxygenation	O
in	O
an	O
Adult	O
Patient	O
with	O
Sickle	O
Cell	O
Anemia	B-SPEC
and	O
Severe	O
Acute	O
Chest	O
Syndrome	O
.	O

TITLE	O
:	O
Resiquimod	O
enhances	O
mucosal	O
and	O
systemic	O
immunity	O
against	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
vaccine	O
in	O
the	O
chicken	B-SPEC
.	O

Specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
chicks	O
(	O
n	O
=	O
60	O
)	O
were	O
equally	O
divided	O
into	O
six	O
groups	O
at	O
two	O
weeks	O
of	O
age	O
and	O
immunized	O
with	O
either	O
inactivated	O
or	O
live	O
IBV	B-SPEC
vaccine	O
adjuvanted	O
with	O
or	O
without	O
R	O
-	O
848	O
.	O

Homologous	O
modeling	O
of	O
pAPN	O
with	O
the	O
S1	O
C	O
-	O
terminal	O
domain	O
(	O
S1	O
-	O
CTD	O
)	O
of	O
PDCoV	O
or	O
TGEV	B-SPEC
showed	O
that	O
TGEV	B-SPEC
S1	O
-	O
CTD	O
adopted	O
	O
-	O
turns	O
(	O
1	O
-	O
2	O
and	O
3	O
-	O
4	O
),	O
forming	O
the	O
tip	O
of	O
a	O
	O
-	O
barrel	O
,	O
to	O
recognize	O
pAPN	O
.	O

TITLE	O
:	O
Cameroonian	O
fruit	O
bats	B-SPEC
harbor	O
divergent	O
viruses	B-SPEC
,	O
including	O
rotavirus	B-SPEC
H	O
,	O
bastroviruses	O
,	O
and	O
picobirnaviruses	B-SPEC
using	O
an	O
alternative	O
genetic	O
code	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
during	O
human	B-SPEC
acute	O
respiratory	O
distress	O
syndrome	O
:	O
the	O
alveolar	O
macrophage	O
polarization	O
,	O
the	O
effect	O
of	O
alveolar	O
environment	O
on	O
macrophage	O
polarization	O
,	O
and	O
the	O
role	O
of	O
polarized	O
macrophages	O
on	O
epithelial	O
repair	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
continues	O
to	O
cause	O
frequent	O
hospital	O
outbreaks	O
in	O
Saudi	O
Arabia	O
,	O
with	O
emergency	O
departments	O
as	O
the	O
initial	O
site	O
of	O
the	O
spread	O
of	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
P3	O
-	O
P4	O
ureas	O
and	O
reverse	O
carbamates	O
as	O
potent	O
HCV	B-SPEC
NS3	O
protease	O
inhibitors	O
:	O
Effective	O
transposition	O
of	O
the	O
P4	O
hydrogen	O
bond	O
donor	O
.	O

It	O
inhibits	O
the	O
replication	O
of	O
many	O
viruses	B-SPEC
and	O
ultimately	O
promotes	O
apoptosis	O
of	O
infected	O
cells	O
,	O
contributing	O
to	O
the	O
control	O
of	O
virus	B-SPEC
spread	O
.	O

The	O
association	O
of	O
live	O
attenuated	O
Massachusetts	O
IBV	B-SPEC
and	O
IBV	B-SPEC
-	O
CS	O
vaccine	O
also	O
induced	O
strong	O
mucosal	O
immune	O
responses	O
,	O
though	O
a	O
switch	O
from	O
IgA	O
isotype	O
to	O
IgG	O
was	O
observed	O
,	O
and	O
IFN	O
gene	O
expression	O
peak	O
was	O
late	O
(	O
at	O
5	O
dpi	O
).	O

The	O
results	O
indicated	O
that	O
IBV	B-SPEC
-	O
CS	O
vaccine	O
administered	O
alone	O
or	O
associated	O
with	O
a	O
live	O
attenuated	O
heterologous	O
vaccine	O
induced	O
both	O
humoral	O
and	O
cell	O
-	O
mediated	O
immune	O
responses	O
at	O
the	O
primary	O
site	O
of	O
viral	O
replication	O
,	O
and	O
provided	O
an	O
effective	O
protection	O
against	O
IBV	B-SPEC
infection	O
at	O
local	O
(	O
trachea	B-SPEC
)	O
and	O
systemic	O
(	O
kidney	O
)	O
sites	O
.	O

Some	O
sequenced	O
shorebird	O
gammacoronaviruses	O
belonged	O
to	O
Charadriiformes	B-SPEC
lineages	O
,	O
but	O
others	O
were	O
more	O
closely	O
related	O
to	O
duck	B-SPEC
gammacoronaviruses	O
.	O

TITLE	O
:	O
APOBEC3	O
-	O
mediated	O
restriction	O
of	O
RNA	O
virus	B-SPEC
replication	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
risk	O
-	O
prediction	O
model	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
dialysis	B-SPEC
patients	O
.	O

Methods	O
This	O
two	O
-	O
center	O
retrospective	O
cohort	O
study	O
included	O
104	O
dialysis	B-SPEC
patients	O
who	O
were	O
suspected	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
diagnosed	O
with	O
rRT	O
-	O
PCR	O
between	O
September	O
2012	O
and	O
June	O
2016	O
at	O
King	O
Fahd	O
General	O
Hospital	O
in	O
Jeddah	O
and	O
King	O
Abdulaziz	O
Medical	O
City	O
in	O
Riyadh	O
.	O

Discussion	O
This	O
risk	O
-	O
prediction	O
model	O
in	O
dialysis	B-SPEC
patients	O
appears	O
to	O
depend	O
markedly	O
on	O
chest	O
pain	O
,	O
leukopenia	O
,	O
and	O
elevated	O
AST	O
.	O

TITLE	O
:	O
Epidemiology	O
of	O
sepsis	B-SPEC
in	O
intensive	O
care	O
units	O
in	O
Turkey	B-SPEC
:	O
a	O
multicenter	O
,	O
point	O
-	O
prevalence	O
study	O
.	O

According	O
to	O
SEPSIS	B-SPEC
-	O
III	O
,	O
104	O
(	O
6	O
.	O
9	O
%)	O
patients	O
had	O
septic	O
shock	O
(	O
mortality	O
rate	O
,	O
75	O
.	O
9	O
%).	O

Approximately	O
,	O
74	O
.	O
9	O
%,	O
39	O
.	O
1	O
%,	O
and	O
26	O
.	O
5	O
%	O
of	O
Acinetobacter	B-SPEC
,	O
Klebsiella	B-SPEC
,	O
and	O
Pseudomonas	B-SPEC
spp	O
.	O

RESULTS	O
:	O
Of	O
the	O
1499	O
patients	O
included	O
in	O
the	O
analysis	O
,	O
237	O
(	O
15	O
.	O
8	O
%)	O
had	O
infection	O
without	O
SIRS	O
,	O
163	O
(	O
10	O
.	O
8	O
%)	O
had	O
infection	O
with	O
SIRS	O
,	O
260	O
(	O
17	O
.	O
3	O
%)	O
had	O
severe	O
sepsis	B-SPEC
without	O
shock	O
,	O
and	O
203	O
(	O
13	O
.	O
5	O
%)	O
had	O
septic	O
shock	O
.	O

ABSTRACT	O
:	O
The	O
hallmark	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
disease	O
is	O
the	O
ability	O
to	O
cause	O
major	O
health	O
care	O
-	O
associated	O
nosocomial	O
outbreaks	O
with	O
superspreading	O
events	O
leading	O
to	O
massive	O
numbers	O
of	O
cases	O
and	O
excessive	O
morbidity	O
and	O
mortality	O
.	O

Thus	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
fecal	O
S100A12	O
concentrations	O
in	O
a	O
cohort	O
of	O
puppies	O
with	O
intestinal	O
parasites	O
(	O
Cystoisospora	B-SPEC
spp	O
.,	O
Toxocara	B-SPEC
canis	I-SPEC
,	O
Giardia	B-SPEC
sp	O
.)	O
and	O
viral	O
agents	O
that	O
are	O
frequently	O
encountered	O
and	O
known	O
to	O
cause	O
gastrointestinal	O
signs	O
in	O
dogs	B-SPEC
(	O
coronavirus	B-SPEC
,	O
parvovirus	B-SPEC
)	O
as	O
a	O
comparative	O
model	O
.	O

Fecal	O
samples	O
were	O
tested	O
for	O
Cystoisospora	B-SPEC
spp	O
.	O

ABSTRACT	O
:	O
Households	O
are	O
high	O
-	O
intensity	O
close	O
-	O
contact	O
environments	O
favorable	O
for	O
transmission	O
of	O
respiratory	O
viruses	B-SPEC
,	O
yet	O
little	O
is	O
known	O
for	O
low	O
-	O
income	O
settings	O
.	O

Of	O
16928	O
NPSs	O
tested	O
for	O
the	O
common	O
viruses	B-SPEC
,	O
4259	O
(	O
25	O
.	O
2	O
%)	O
were	O
positive	O
for	O
	O
1	O
target	O
;	O
596	O
(	O
13	O
.	O
8	O
%)	O
had	O
coinfections	O
.	O

On	O
average	O
,	O
each	O
household	O
and	O
individual	O
had	O
6	O
and	O
3	O
different	O
viruses	B-SPEC
detected	O
over	O
the	O
study	O
period	O
,	O
respectively	O
.	O

TITLE	O
:	O
Burden	O
and	O
Risk	O
Factors	O
for	O
Coronavirus	B-SPEC
Infections	O
in	O
Infants	O
in	O
Rural	O
Nepal	O
.	O

Of	O
the	O
296	O
HCoV	O
infections	O
detected	O
,	O
46	O
%	O
were	O
coinfections	O
with	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Here	O
,	O
we	O
screened	O
1	O
,	O
059	O
bat	B-SPEC
samples	O
from	O
at	O
least	O
30	O
bat	B-SPEC
species	B-SPEC
collected	O
in	O
different	O
regions	O
in	O
south	O
China	O
and	O
identified	O
89	O
strains	O
of	O
lineage	O
C	O
betacoronaviruses	O
,	O
including	O

Post	O
-	O
Hajj	O
cohort	O
studies	O
would	O
further	O
evaluate	O
the	O
impact	O
of	O
the	O
Hajj	O
on	O
the	O
acquisition	O
of	O
respiratory	O
viruses	B-SPEC
.	O

In	O
addition	O
,	O
data	O
on	O
animal	B-SPEC
movements	O
is	O
seldom	O
available	O
in	O
the	O
United	O
States	O
.	O

Using	O
observed	O
data	O
on	O
pig	B-SPEC
movements	O
during	O
the	O
initial	O
phase	O
of	O
the	O
PEDv	B-SPEC
epidemic	O
,	O
we	O
developed	O
a	O
network	O
-	O
based	O
and	O
spatially	O
explicit	O
epidemiological	O
model	O
that	O
simulates	O
the	O
spread	O
of	O
PEDv	B-SPEC
via	O
both	O
indirect	O
and	O
direct	O
movement	O
-	O
related	O
contact	O
in	O
order	B-SPEC
to	O
answer	O
unresolved	O
questions	O
concerning	O
factors	O
facilitating	O
between	O
-	O
farm	O
transmission	O
.	O

ABSTRACT	O
:	O
Infections	O
with	O
bat	B-SPEC
-	O
origin	O
coronaviruses	O
have	O
caused	O
severe	O
illness	O
in	O
humans	B-SPEC
by	O
'	O
host	O
jump	O
'.	O

TITLE	O
:	O
Cryo	O
-	O
EM	O
structure	O
of	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
spike	O
protein	O
reveals	O
structural	O
and	O
functional	O
evolution	O
of	O
coronavirus	B-SPEC
spike	O
proteins	O
.	O

Based	O
on	O
the	O
above	O
structural	O
and	O
functional	O
comparisons	O
,	O
we	O
propose	O
that	O
the	O
evolutionary	O
spectrum	O
of	O
coronavirus	B-SPEC
spikes	O
follows	O
the	O
order	B-SPEC
of	O
	O
-,	O
	O
-,	O
	O
-,	O
and	O
	O
-	O
genus	B-SPEC
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
are	O
responsible	O
for	O
respiratory	O
disease	O
and	O
diarrhea	O
in	O
cattle	B-SPEC
worldwide	O
.	O

TITLE	O
:	O
The	O
CD8	O
T	O
Cell	O
Response	O
to	O
Respiratory	O
Virus	B-SPEC
Infections	O
.	O

ABSTRACT	O
:	O
Humans	B-SPEC
are	O
highly	O
susceptible	O
to	O
infection	O
with	O
respiratory	O
viruses	B-SPEC
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
parainfluenza	O
virus	B-SPEC
.	O

TITLE	O
:	O
A	O
Mini	O
Review	O
of	O
the	O
Zoonotic	O
Threat	O
Potential	O
of	O
Influenza	B-SPEC
Viruses	I-SPEC
,	O
Coronaviruses	O
,	O
Adenoviruses	B-SPEC
,	O
and	O
Enteroviruses	B-SPEC
.	O

Among	O
the	O
recently	O
emerged	O
respiratory	O
pathogens	O
are	O
influenza	B-SPEC
viruses	I-SPEC
,	O
coronaviruses	O
,	O
enteroviruses	B-SPEC
,	O
and	O
adenoviruses	B-SPEC
.	O

As	O
the	O
genesis	O
of	O
these	O
emerging	O
viruses	B-SPEC
is	O
not	O
well	O
understood	O
and	O
their	O
detection	O
normally	O
occurs	O
after	O
they	O
have	O
crossed	O
over	O
and	O
adapted	O
to	O
man	B-SPEC
,	O
ideally	O
,	O
strategies	O
for	O
such	O
novel	O
virus	B-SPEC
detection	O
should	O
include	O
intensive	O
surveillance	O
at	O
the	O
human	B-SPEC
-	O
animal	B-SPEC
interface	O
,	O
particularly	O
if	O
one	O
believes	O
the	O
paradigm	O
that	O
many	O
novel	O
emerging	O
zoonotic	O
viruses	B-SPEC
first	O
circulate	O
in	O
animal	B-SPEC
populations	O
and	O
occasionally	O
infect	O
man	B-SPEC
before	O
they	O
fully	O
adapt	O
to	O
man	B-SPEC
;	O
early	O
detection	O
at	O
the	O
human	B-SPEC
-	O
animal	B-SPEC
interface	O
will	O
provide	O
earlier	O
warning	O
.	O

Therefore	O
,	O
we	O
evaluated	O
extracorporeal	O
virus	B-SPEC
and	O
glycoprotein	O
(	O
GP	O
)	O
elimination	O
by	O
lectin	O
affinity	O
plasmapheresis	O
(	O
LAP	O
).	O

TITLE	O
:	O
miR	O
-	O
146a	O
-	O
5p	O
promotes	O
replication	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
by	O
targeting	O
IRAK2	O
and	O
TNFRSF18	O
.	O

Finally	O
,	O
high	O
levels	O
of	O
exogenous	O
miR	O
-	O
146a	O
-	O
5p	O
in	O
HD11	O
cells	O
led	O
to	O
down	O
regulation	O
of	O
IL	O
-	O
1	O
receptor	O
associated	O
kinase	O
-	O
2	O
(	O
IRAK2	O
)	O
and	O
Tumor	O
necrosis	O
factor	O
receptor	O
superfamily	B-SPEC
member	O
18	O
(	O
TNFRSF18	O
)	O
genes	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
have	O
a	O
wide	O
host	O
range	O
and	O
can	O
cause	O
a	O
variety	O
of	O
diseases	O
with	O
varying	O
severity	O
in	O
different	O
animals	B-SPEC
.	O

In	O
this	O
review	O
,	O
we	O
will	O
focus	O
on	O
the	O
interaction	O
of	O
autophagy	O
and	O
viruses	B-SPEC
and	O
survey	O
how	O
human	B-SPEC
viruses	B-SPEC
exploit	O
multiple	O
steps	O
in	O
the	O
autophagy	O
pathway	O
to	O
help	O
viral	O
propagation	O
and	O
escape	O
immune	O
response	O
.	O

Only	O
human	B-SPEC
studies	O
with	O
>	O
20	O
participants	O
were	O
analysed	O
to	O
exclude	O
studies	O
with	O
low	O
representation	O
.	O

Plasma	O
phosphatidylcholine	O
(	O
PC	O
),	O
the	O
major	O
phospholipid	O
of	O
circulating	O
lipoproteins	O
,	O
is	O
synthesized	O
in	O
human	B-SPEC
liver	O
by	O
two	O
biologically	O
diverse	O
pathways	O
:	O
the	O
cytidine	O
diphosphocholine	O
(	O
CDP	O
):	O
choline	O
and	O
phosphatidylethanolamine	O

ABSTRACT	O
:	O
Passive	O
immunity	O
is	O
critical	O
for	O
protection	O
of	O
neonatal	O
piglets	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

One	O
of	O
the	O
two	O
groups	O
immunized	O
with	O
the	O
ORFV	O
-	O
PEDV	B-SPEC
-	O
S	O
recombinant	O
virus	B-SPEC
was	O
also	O
exposed	O
to	O
live	O
PEDV	B-SPEC
orally	O
on	O
day	O
31	O
post	O
-	O
immunization	O
(	O
pi	O
).	O

Piglets	O
born	O
to	O
gilts	O
that	O
received	O
ORFV	O
-	O
PEDV	B-SPEC
-	O
S	O
and	O
were	O
exposed	O
to	O
live	O
PEDV	B-SPEC
showed	O
stronger	O
NA	O
responses	O
and	O
lower	O
clinical	O
scores	O
when	O
compared	O
to	O
piglets	O
born	O
to	O
gilts	O
immunized	O
with	O
ORFV	O
-	O
PEDV	B-SPEC
-	O
S	O
alone	O
.	O

The	O
monthly	O
detection	O
rates	O
of	O
respiratory	O
viruses	B-SPEC
,	O
including	O
adenovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
,	O
and	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
were	O
collected	O
from	O
Korea	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
.	O

Cross	O
-	O
correlation	O
analysis	O
was	O
conducted	O
to	O
quantify	O
the	O
temporal	O
relationship	O
between	O
antibiotic	O
use	O
and	O
respiratory	O
virus	B-SPEC
activities	O
as	O
well	O
as	O
respiratory	O
infections	O
in	O
primary	O
clinics	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
incidence	O
,	O
risk	O
factors	O
,	O
clinical	O
course	O
,	O
and	O
outcome	O
of	O
ARDS	O
in	O
children	O
with	O
HMP	O
and	O
RSV	B-SPEC
.	O

We	O
also	O
assessed	O
risk	O
factors	O
,	O
clinical	O
course	O
,	O
and	O
outcomes	O
of	O
children	O
in	O
the	O
PICU	B-SPEC
with	O
HMP	O
or	O
RSV	B-SPEC
and	O
PARDS	O
or	O
non	O
-	O
PARDS	O
.	O

The	O
risk	O
factors	O
,	O
clinical	O
course	O
,	O
and	O
outcomes	O
were	O
similar	O
for	O
patients	O
with	O
PARDS	O
associated	O
with	O
HMP	O
and	O
RSV	B-SPEC
.	O

TITLE	O
:	O
Early	O
events	O
during	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
entry	O
to	O
the	O
cell	O
.	O

ABSTRACT	O
:	O
Respiratory	O
tract	O
viruses	B-SPEC
have	O
an	O
important	O
effect	O
on	O
morbidity	O
and	O
mortality	O
in	O
patients	O
with	O
febrile	O
neutropenia	O
(	O
FN	O
).	O

Parainfluenza	O
virus	B-SPEC
,	O
influenza	O
A	O
and	O
B	O
,	O
adenovirus	B-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
enterovirus	B-SPEC
,	O
bocavirus	B-SPEC
and	O
parechovirus	B-SPEC
were	O
the	O
remaining	O
detected	O
agents	O
.	O

The	O
precise	O
mechanism	O
of	O
HIV	B-SPEC
-	O
associated	O
white	O
matter	O
(	O
WM	O
)	O
injury	O
is	O
unknown	O
.	O

In	O
this	O
report	O
,	O
we	O
present	O
the	O
case	O
of	O
an	O
RSV	B-SPEC
-	O
associated	O
death	O
of	O
a	O
child	O
who	O
was	O
born	O
at	O
full	O
-	O
term	O
and	O
developed	O
normally	O
up	O
to	O
the	O
age	O
of	O
2	O
years	O
old	O
.	O

ABSTRACT	O
:	O
Information	O
on	O
the	O
duration	O
of	O
replicative	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
shedding	O
is	O
important	O
for	O
infection	O
control	O
.	O

The	O
detection	O
of	O
MERS	O
-	O
CoV	O
sub	O
-	O
genomic	O
mRNAs	O
indicates	O
that	O
the	O
virus	B-SPEC
is	O
replicative	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
are	O
the	O
most	O
common	O
causes	O
of	O
respiratory	O
infection	O
.	O

Viruses	B-SPEC
in	O
the	O
same	O
viral	O
family	B-SPEC
share	O
a	O
similar	O
pathogenesis	O
of	O
pneumonia	O
,	O
and	O
the	O
imaging	O
patterns	O
have	O
distinguishable	O
characteristics	O
.	O

Recently	O
,	O
new	O
viruses	B-SPEC
associated	O
with	O
recent	O
outbreaks	O
including	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
have	O
been	O
discovered	O
.	O

Intramuscularly	O
inoculated	O
mice	B-SPEC
were	O
necropsied	O
at	O
different	O
time	O
points	O
and	O
examined	O
by	O
histology	O
,	O
immunohistochemistry	O
and	O
real	O
-	O
time	O
PCR	O
.	O

These	O
primer	O
sets	O
were	O
highly	O
efficient	O
in	O
amplifying	O
target	O
sequences	O
derived	O
from	O
different	O
MERS	O
-	O
CoV	O
strains	O
,	O
including	O
camel	B-SPEC
MERS	O
-	O
CoV	O
.	O
In	O
addition	O
,	O
the	O
detection	O
efficacy	O
of	O
QProbe	O
RT	O
-	O
LAMP	O
was	O
comparable	O
to	O
that	O
of	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
using	O
clinical	O
specimens	O
from	O
patients	O
in	O
Saudi	O
Arabia	O
.	O

The	O
research	O
that	O
underpins	O
this	O
article	O
is	O
based	O
on	O
a	O
desk	O
-	O
based	O
literature	O
review	O
as	O
well	O
as	O
in	O
-	O
depth	O
field	O
interviews	O
with	O
individuals	O
working	O
in	O
HIV	B-SPEC
/	O
AIDS	O
-	O
focused	O
NGOs	O
in	O
China	O
.	O

An	O
internal	O
and	O
external	O
factor	O
was	O
identified	O
to	O
verify	O
the	O
argument	O
,	O
namely	O
(	O
1	O
)	O
the	O
reduction	O
of	O
international	O
financial	O
commitments	O
,	O
as	O
well	O
as	O
(	O
2	O
)	O
the	O
fragmentation	O
of	O
HIV	B-SPEC
/	O
AIDS	O
-	O
focused	O
NGO	O
community	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
has	O
recently	O
emerged	O
as	O
an	O
enteric	O
pathogen	O
that	O
can	O
cause	O
serious	O
vomiting	O
and	O
diarrhea	O
in	O
suckling	O
piglets	O
.	O

TITLE	O
:	O
Discovery	O
and	O
Sequence	O
Analysis	O
of	O
Four	O
Deltacoronaviruses	O
from	O
Birds	B-SPEC
in	O
the	O
Middle	O
East	O
Reveal	O
Interspecies	O
Jumping	O
with	O
Recombination	O
as	O
a	O
Potential	O
Mechanism	O
for	O
Avian	B-SPEC
-	O
to	O
-	O
Avian	B-SPEC
and	O
Avian	B-SPEC
-	O
to	O
-	O
Mammalian	B-SPEC
Transmission	O
.	O

To	O
explore	O
the	O
diversity	O
of	O
deltacoronaviruses	O
in	O
animals	B-SPEC
in	O
the	O
Middle	O
East	O
,	O
we	O
tested	O
fecal	O
samples	O
from	O
1	O
,	O
356	O
mammals	B-SPEC
and	O
birds	B-SPEC
in	O
Dubai	O
,	O
The	O
United	O
Arab	O
Emirates	O
.	O

Birds	B-SPEC
in	O
the	O
Middle	O
East	O
are	O
hosts	O
for	O
diverse	O
deltacoronaviruses	O
with	O
potential	O
for	O
interspecies	O
transmission	O
.	O

TITLE	O
:	O
Mutation	O
of	O
the	O
S	O
and	O
3c	O
genes	O
in	O
genomes	O
of	O
feline	B-SPEC
coronaviruses	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
--	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
has	O
caused	O
a	O
number	O
of	O
community	O
-	O
acquired	O
cases	O
and	O
health	O
care	O
associated	O
outbreaks	O
in	O
Saudi	O
Arabia	O
and	O
the	O
United	O
Arab	O
Emirates	O
(	O
UAE	O
)	O
as	O
well	O
as	O
sporadic	O
cases	O
in	O
other	O
countries	O
,	O
especially	O
in	O
the	O
Middle	O
East	O
.	O

Children	O
with	O
ARI	O
were	O
tested	O
for	O
influenza	B-SPEC
viruses	I-SPEC
by	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Pancreatitis	O
and	O
Systemic	O
Coronavirus	B-SPEC
Infection	O
in	O
a	O
Ferret	B-SPEC
(	O
ABSTRACT	O
:	O
A	O
1	O
-	O
y	O
-	O
old	O
spayed	O
female	O
ferret	B-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
)	O
was	O
referred	O
for	O
additional	O
diagnostic	O
evaluation	O
after	O
physical	O
examination	O
by	O
the	O
referring	O
veterinarian	O
revealed	O
a	O
cranial	O
abdominal	O
mass	O
.	O

ABSTRACT	O
:	O
A	O
long	O
-	O
term	O
animal	B-SPEC
experiment	O
involving	O
inoculation	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
was	O
conducted	O
to	O
verify	O
its	O
persistent	O
infection	O
in	O
cattle	B-SPEC
.	O

Using	O
multivariable	O
logistic	O
regression	O
,	O
we	O
modeled	O
the	O
association	O
between	O
age	O
,	O
education	O
,	O
frailty	O
,	O
durations	O
of	O
mechanical	O
ventilation	O
,	O
delirium	O
,	O
and	O
severe	O
sepsis	B-SPEC
with	O
the	O
odds	O
of	O
being	O
post	O
-	O
intensive	O
care	O
syndrome	O
free	O
.	O

TITLE	O
:	O
Role	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Viroporins	O
E	O
,	O
3a	O
,	O
and	O
8a	O
in	O
Replication	O
and	O
Pathogenesis	O
.	O

ABSTRACT	O
:	O
Four	O
types	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
variants	O
with	O
a	O
large	O
deletion	O
in	O
the	O
spike	O
protein	O
were	O
detected	O
,	O
together	O
with	O
the	O
original	O
US	O
PEDV	B-SPEC
,	O
from	O
pig	B-SPEC
fecal	O
and	O
oral	O
fluid	O
samples	O
collected	O
during	O
2016	O
-	O
2017	O
in	O
the	O
US	O
.	O

Compounds	O
V	O
and	O
VI	O
were	O
turned	O
out	O
be	O
active	O
compounds	O
towards	O
human	B-SPEC
cytomegalovirus	I-SPEC
for	O
both	O
normal	O
strain	O
(	O
AD169	O
)	O
as	O
well	O
as	O
resistant	O
isolate	O
(	O
GDGr	O
K17	O
).	O

METHODS	O
:	O
A	O
focused	O
set	O
of	O
thienyl	O
chalcone	O
derivaties	O
II	O
-	O
VI	O
was	O
screened	O
for	O
selected	O
viruses	B-SPEC
Hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
),	O
Herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
Human	B-SPEC
cytomegalovirus	I-SPEC
(	O
HCMV	O
),	O
Dengue	B-SPEC
virus	I-SPEC
2	O
(	O
DENV2	O
),	O
Influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
,	O
MERS	O
coronavirus	B-SPEC
,	O
Poliovirus	B-SPEC
1	O
(	O
PV	O
1	O
),	O
Rift	O
Valley	O
fever	O
(	O
RVF	O
),	O
Tacaribe	B-SPEC
virus	I-SPEC
(	O
TCRV	O
),	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
(	O
VEE	O
)	O
and	O
Zika	B-SPEC
virus	I-SPEC
(	O
ZIKV	O
)	O
using	O
the	O
National	O
Institute	O
of	O
Allergy	O
and	O
Infectious	O
Diseases	O
(	O
NIAID	O
)'	O
s	O
Division	O
of	O
Microbiology	O
and	O
Infectious	O
Diseases	O
(	O
DMID	O
)	O
antiviral	O
screening	O
program	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
consists	O
of	O
a	O
positive	O
-	O
sense	O
,	O
single	O
-	O
stranded	O
RNA	O
genome	O
and	O
four	O
structural	O
proteins	O
:	O
the	O
spike	O
,	O
envelope	O
,	O
membrane	O
,	O
and	O
nucleocapsid	O
protein	O
.	O

These	O
results	O
reveal	O
some	O
of	O
the	O
genetic	O
footprints	O
created	O
by	O
pathogens	O
in	O
the	O
human	B-SPEC
genome	O
that	O
may	O
have	O
left	O
lasting	O
marks	O
on	O
susceptibility	O
to	O
infectious	O
disease	O
.	O

PEDV	B-SPEC
infection	O
up	O
-	O
regulates	O
the	O
levels	O
of	O
p21	O
,	O
cdc2	O
,	O
cdk2	O
,	O
cdk4	O
,	O
Cyclin	O
A	O
protein	O
and	O
down	O
-	O
regulates	O
Cyclin	O
E	O
protein	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
demonstrate	O
that	O
the	O
p53	O
-	O
dependent	O
pathway	O
plays	O
an	O
important	O
role	O
in	O
PEDV	B-SPEC
induced	O
cell	O
cycle	O
arrest	O
and	O
beneficially	O
contributes	O
to	O
viral	O
infection	O
.	O

There	O
were	O
58	O
out	O
of	O
217	O
piglets	O
(	O
27	O
%)	O
have	O
PEDV	B-SPEC
infection	O
alone	O
whereas	O
the	O
remaining	O
159	O
(	O
73	O
%)	O
shed	O
2	O
up	O
to	O
9	O
different	O
viruses	B-SPEC
.	O

Interestingly	O
,	O
some	O
recent	O
studies	O
have	O
indicated	O
that	O
pAPN	O
is	O
not	O
a	O
functional	O
receptor	O
for	O
PEDV	B-SPEC
.	O

We	O
then	O
assayed	O
the	O
purified	O
target	O
proteins	O
through	O
immunogenicity	O
tests	O
,	O
PEDV	B-SPEC
binding	O
interference	O
assays	O
,	O
circular	O
dichroism	O
(	O
CD	O
)	O
measurements	O
,	O
pAPN	O
activity	O
assay	O
and	O
structural	O
determination	O
,	O
demonstrating	O
that	O
they	O
were	O
biologically	O
functional	O
.	O

TITLE	O
:	O
Molecular	O
dynamics	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
CoV	O
)	O
fusion	O
heptad	O
repeat	O
trimers	O
.	O

Analysis	O
of	O
HR1	O
-	O
HR2	O
inter	O
-	O
residue	O
contacts	O
and	O
interaction	O
energy	O
revealed	O
three	O
energy	O
scales	O
along	O
HR	O
helices	B-SPEC
.	O

ABSTRACT	O
:	O
Chimeric	O
antigen	O
receptor	O
(	O
CAR	B-SPEC
)	O
therapy	O
targeting	O
CD19	O
is	O
an	O
effective	O
treatment	O
for	O
refractory	O
B	O
cell	O
malignancies	O
,	O
especially	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O

RESULTS	O
:	O
In	O
this	O
study	O
,	O
we	O
developed	O
an	O
accurate	O
,	O
rapid	O
,	O
cost	O
-	O
effective	O
,	O
and	O
simple	O
RtF	O
-	O
RT	O
-	O
LAMP	O
assay	O
for	O
detecting	O
the	O
PEDV	B-SPEC
genome	O
targeting	O
M	O
gene	O
.	O

We	O
considered	O
two	O
scenarios	O
:	O
(	O
i	O
)	O
the	O
transmission	O
rate	O
among	O
camels	B-SPEC
is	O
time	O
-	O
varying	O
with	O
a	O
constant	O
spill	O
-	O
over	O
rate	O
from	O
camels	B-SPEC
to	O
human	B-SPEC
or	O
(	O
ii	O
)	O
the	O
spill	O
-	O
over	O
rate	O
is	O
time	O
-	O
varying	O
with	O
a	O
constant	O
transmission	O
rate	O
among	O
camels	B-SPEC
.	O

We	O
collected	O
107	O
faecal	O
samples	O
from	O
domestic	O
dogs	B-SPEC
with	O
obvious	O
diarrhoea	O
.	O

The	O
results	O
of	O
this	O
study	O
revealed	O
that	O
CaAstV	O
circulates	O
widely	O
in	O
diarrhoeic	O
dogs	B-SPEC
in	O
southwest	O
China	O
and	O
exhibits	O
unique	O
evolutionary	O
events	O
.	O

We	O
describe	O
the	O
germline	O
diversity	O
and	O
neutralizing	O
activity	O
of	O
13	O
potent	O
human	B-SPEC
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
that	O
target	O
the	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
.	O

In	O
order	B-SPEC
to	O
have	O
an	O
age	O
-	O
related	O
distribution	O
,	O
the	O
following	O
age	O
groups	O
were	O
implemented	O
:	O
(<	O
2	O
),	O
(	O
2	O
,	O
<	O
5	O
),	O
(	O
5	O
,	O
<	O
10	O
),	O
(	O
10	O
,	O
<	O
18	O
),	O
(	O
18	O
,	O
<	O
45	O
),	O
(	O
45	O
,	O
<	O
65	O
),	O
and	O
(	O
65	O
)	O
years	O
old	O
.	O

TITLE	O
:	O
Network	O
Analysis	O
of	O
MERS	O
Coronavirus	B-SPEC
within	O
Households	O
,	O
Communities	O
,	O
and	O
Hospitals	O
to	O
Identify	O
Most	O
Centralized	O
and	O
Super	O
-	O
Spreading	O
in	O
the	O
Arabian	O
Peninsula	O
,	O
2012	O
to	O
2016	O
.	O

The	O
transmission	O
connectivity	O
networks	O
of	O
people	O
infected	O
with	O
highly	O
contagious	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Saudi	O
Arabia	O
were	O
assessed	O
to	O
identify	O
super	O
-	O
spreading	O
events	O
among	O
the	O
infected	O
patients	O
between	O
2012	O
and	O
2016	O
.	O

The	O
seroprevalence	O
of	O
MERS	O
-	O
CoV	O
-	O
specific	O
antibodies	O
in	O
Israeli	O
dromedary	B-SPEC
camels	B-SPEC
is	O
unknown	O
.	O

The	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
in	O
Israeli	O
camels	B-SPEC
was	O
examined	O
in	O
71	O
camel	B-SPEC
sera	O
collected	O
from	O
four	O
farms	O
across	O
Israel	O
by	O
MERS	O
-	O
CoV	O
-	O
specific	O
microneutralization	O
(	O
Mnt	O
)	O
assay	O
and	O
confirmed	O
by	O
MERS	O
-	O
CoV	O
-	O
specific	O
immunofluorescence	O
assay	O
(	O
IFA	O
).	O

To	O
prepare	O
a	O
candidate	O
vaccine	O
against	O
the	O
prevalent	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
China	O
,	O
the	O
GI	O
-	O
19	O
/	O
QX	O
-	O
like	O
field	O
isolate	O
Sczy3	O
was	O
selected	O
as	O
the	O
progenitor	O
strain	O
and	O
attenuated	O
via	O
passaging	O
in	O
chicken	B-SPEC
embryo	O
kidney	O
(	O
CEK	O
)	O
cells	O
for	O
100	O
times	O
.	O

There	O
are	O
three	O
patterns	O
of	O
transmission	O
:	O
sporadic	O
community	O
cases	O
from	O
presumed	O
non	O
-	O
human	B-SPEC
exposure	O
,	O
family	B-SPEC
clusters	O
arising	O
from	O
contact	O
with	O
an	O
infected	O
family	B-SPEC
index	O
case	O
,	O
and	O
healthcare	O
-	O
acquired	O
infections	O
among	O
patients	O
and	O
from	O
patients	O
to	O
healthcare	O
workers	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
Hepatitis	B-SPEC
E	I-SPEC
Virus	I-SPEC
Spread	O
by	O
the	O
Natural	O
Compound	O
Silvestrol	O
.	O

ABSTRACT	O
:	O
Every	O
year	O
,	O
there	O
are	O
about	O
20	O
Mio	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
HEV	B-SPEC
)	O
infections	O
and	O
60	O
,	O
000	O
deaths	O
that	O
are	O
associated	O
with	O
HEV	B-SPEC
worldwide	O
.	O

Rodent	B-SPEC
models	O
of	O
ALI	O
/	O
ARDS	O
show	O
similar	O
clinical	O
signs	O
as	O
in	O
humans	B-SPEC
when	O
the	O
rodents	B-SPEC
are	O
infected	O
with	O
murine	B-SPEC

These	O
results	O
suggest	O
that	O
management	O
practices	O
for	O
unowned	O
cats	B-SPEC
are	O
inadequate	O
for	O
control	O
of	O
enteropathogens	O
and	O
that	O
the	O
presence	O
of	O
diarrhea	O
is	O
a	O
poor	O
indicator	B-SPEC
of	O
enteropathogen	O
carriage	O
.	O

Clinically	O
,	O
such	O
nasal	O
-	O
only	O
inoculation	O
of	O
MHV	B-SPEC
-	O
1	O
failed	O
to	O
cause	O
pneumonia	O
but	O
significantly	O
reduced	O
mortality	O
and	O
morbidity	O
of	O
lethal	O
pneumonia	O
caused	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
or	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

Besides	O
detecting	O
viruses	B-SPEC
,	O
the	O
technique	O
also	O
allowed	O
the	O
characterisation	O
of	O
host	O
mitochondrial	O
DNA	O
present	O
and	O
thus	O
identifying	O
host	O
species	B-SPEC
,	O
while	O
ribosomal	O
RNA	O
sequences	O
provided	O
insight	O
into	O
the	O
""""	O
ribosomal	O
activity	O
microbiome	O
""";"	O
of	O
gut	O
parasites	O
;	O
and	O
of	O
food	O
eaten	O
such	O
as	O
plants	B-SPEC
or	O
insects	B-SPEC
,	O
which	O
we	O
correlated	O
to	O
non	O
-	O
avian	B-SPEC
host	O
associated	O
viruses	B-SPEC
.	O

Genetically	O
distinct	O
genogroup	O
III	O
noroviruses	B-SPEC
were	O
detected	O
in	O
two	O
sample	O
pools	O
from	O
different	O
geographic	O
regions	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
was	O
detected	O
in	O
a	O
third	O
pool	O
of	O
samples	O
.	O

TITLE	O
:	O
Insights	O
into	O
recombination	O
-	O
like	O
events	O
leading	O
to	O
outbreaks	O
in	O
USA	O
through	O
a	O
retrospective	O
study	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
isolates	O
from	O
China	O
.	O

COPD	O
,	O
HIV	B-SPEC
infection	O
,	O
and	O
hematological	O
malignancy	O
were	O
associated	O
with	O
a	O
lower	O
likelihood	O
of	O
invasive	O
mechanical	O
ventilation	O
on	O
the	O
admission	O
day	O
.	O

ABSTRACT	O
:	O
A	O
68	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
to	O
our	O
ED	O
with	O
shortness	O
of	O
breath	O
,	O
weakness	O
,	O
and	O
a	O
25	O
-	O
lb	O
unintentional	O
weight	O
loss	O
.	O

A	O
bronchoscopy	O
with	O
BAL	O
and	O
transbronchial	O
biopsies	O
did	O
not	O
show	O
acute	O
cellular	O
rejection	O
,	O
but	O
the	O
BAL	O
fluid	O
was	O
positive	O
for	O
coronavirus	B-SPEC
.	O

Here	O
,	O
we	O
evaluated	O
the	O
prophylactic	O
and	O
therapeutic	O
efficacy	O
of	O
REGN3048	O
and	O
REGN3051	O
in	O
the	O
common	B-SPEC
marmoset	I-SPEC
model	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Insight	O
into	O
the	O
evolution	O
of	O
nidovirus	B-SPEC
endoribonuclease	O
based	O
on	O
the	O
finding	O
that	O
nsp15	O
from	O
porcine	B-SPEC
ABSTRACT	O
:	O
Nidovirus	B-SPEC
endoribonucleases	O
(	O
NendoUs	O
)	O
include	O
nonstructural	O
protein	O
15	O
(	O
nsp15	O
)	O
from	O
coronaviruses	O
and	O
nsp11	O
from	O
arteriviruses	B-SPEC
,	O
both	O
of	O
which	O
have	O
been	O
reported	O
to	O
participate	O
in	O
the	O
viral	O
replication	O
process	O
and	O
in	O
the	O
evasion	O
of	O
the	O
host	O
immune	O
system	O
.	O

Results	O
from	O
a	O
previous	O
study	O
of	O
coronaviruses	O
SARS	O
-	O
CoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
and	O
MHV	B-SPEC
nsp15	O
indicate	O
that	O
it	O
mainly	O
forms	O
a	O
functional	O
hexamer	O
,	O
whereas	O
nsp11	O
from	O
the	O
arterivirus	B-SPEC
PRRSV	B-SPEC
is	O
a	O
dimer	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
bat	B-SPEC
coronavirus	I-SPEC
HKU9	I-SPEC
both	O
can	O
utilize	O
GRP78	O
for	O
attachment	O
onto	O
host	O
cells	O
.	O

TITLE	O
:	O
Antiviral	O
drug	O
screening	O
by	O
assessing	O
epithelial	O
functions	O
and	O
innate	O
immune	O
responses	O
in	O
human	B-SPEC
3D	O
airway	O
epithelium	O
model	O
.	O

To	O
meet	O
the	O
pressing	O
need	O
of	O
safe	O
and	O
cost	O
-	O
efficient	O
PED	O
maternal	O
vaccines	O
against	O
PEDV	B-SPEC
variant	O
,	O
we	O
vaccinated	O
growing	O
piglets	O
with	O
a	O
flagellin	O
-	O
adjuvanted	O
PED	O
vaccine	O
rSF	O
-	O
COE	O
-	O
3D	O
by	O
injection	O
at	O
Houhai	O
acupoint	O
.	O

Our	O
result	O
revealed	O
that	O
the	O
attenuated	O
strain	O
presented	O
a	O
decreased	O
pathogenicity	O
in	O
1	O
-	O
day	O
-	O
old	O
chickens	B-SPEC
.	O

Although	O
ADRP	O
activity	O
has	O
not	O
been	O
formally	O
demonstrated	O
for	O
IBV	B-SPEC
nsp	O
3	O
,	O
Beaudette	O
fails	O
to	O
bind	O
ADP	O
-	O
ribose	O
.	O

1	O
/	O
96	O
strain	O
early	O
reached	O
high	O
titers	O
in	O
all	O
animals	B-SPEC
,	O
while	O
B	O
-	O
48	O
presence	O
was	O
less	O
constant	O
even	O
though	O
it	O
was	O
detected	O
in	O
almost	O
all	O
birds	B-SPEC
before	O
the	O
trial	O
end	O
.	O

Factors	O
attributable	O
for	O
ARDS	O
were	O
malaria	O
in	O
31	O
patients	O
(	O
26	O
.	O
72	O
%),	O
pneumonia	O
in	O
23	O
(	O
19	O
.	O
82	O
%),	O
sepsis	B-SPEC
in	O
20	O
(	O
17	O
.	O
2	O
%),	O
dengue	O
in	O
15	O
(	O
12	O
.	O
96	O
%),	O
undiagnosed	O
fever	O
in	O
13	O
(	O
11	O
.	O
1	O
%),	O
leptospirosis	O
in	O
7	O
(	O
6	O
.	O
03	O
%),	O
pancreatitis	O
in	O
3	O
(	O
2	O
.	O
58	O
%),	O
H1N1	O
infection	O
in	O
2	O
(	O
1	O
.	O
72	O
%),	O
urinary	O
tract	O
infection	O
(	O
UTI	O
)	O
in	O
1	O
(	O
0	O
.	O
86	O
%)	O
and	O
UTI	O
with	O
pyelonephritis	O
and	O
Dengue	O
in	O
1	O
(	O
0	O
.	O
86	O
%)	O
patients	O
.	O

TITLE	O
:	O
Live	O
-	O
attenuated	O
bivalent	O
measles	B-SPEC
virus	I-SPEC
-	O
derived	O
vaccines	O
targeting	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
induce	O
robust	O
and	O
multifunctional	O
T	O
cell	O
responses	O
against	O
both	O
viruses	B-SPEC
in	O
an	O
appropriate	O
mouse	B-SPEC
model	O
.	O

MV	B-SPEC

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
among	O
children	O
with	O
non	O
-	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
:	O
A	O
prospective	O
cohort	O
study	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
over	O
90	O
%	O
of	O
the	O
cases	O
,	O
out	O
of	O
which	O
70	O
%	O
had	O
multiple	O
viruses	B-SPEC
.	O

Previous	O
literature	O
suggests	O
that	O
the	O
TGEV	B-SPEC
nucleocapsid	O
protein	O
(	O
N	O
)	O
plays	O
a	O
significant	O
role	O
in	O
viral	O
transcriptional	O
process	O
,	O
however	O
,	O
there	O
is	O
a	O
need	O
to	O
examine	O
other	O
functions	O
of	O
TGEV	B-SPEC
N	O
protein	O
in	O
the	O
porcine	B-SPEC
intestinal	O
epithelial	O
cell	O
(	O
IEC	O
)	O
which	O
is	O
the	O
target	O
cell	O
of	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
Thus	O
far	O
,	O
no	O
human	B-SPEC
MERS	O
-	O
CoV	O
infections	O
have	O
been	O
reported	O
from	O
Israel	O
.	O

A	O
panzootic	O
starting	O
in	O
2010	O
renewed	O
interest	O
in	O
the	O
development	O
of	O
a	O
universal	O
vaccine	O
toward	O
PEDV	B-SPEC
.	O

However	O
,	O
a	O
lack	O
of	O
virus	B-SPEC
neutralization	O
led	O
to	O
a	O
redesign	O
of	O
the	O
vaccines	O
.	O

In	O
most	O
areas	O
of	O
Africa	O
,	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
is	O
essentially	O
absent	O
because	O
of	O
the	O
inherited	O
lack	O
of	O
Duffy	O
antigen	O
receptor	O
for	O
chemokines	O
on	O
the	O
surface	O
of	O
red	O
blood	O
cells	O
that	O
is	O
involved	O
in	O
the	O
parasite	O
invasion	O
of	O
erythrocytes	O
.	O

Sequence	O
comparison	O
among	O
QY16	O
and	O
other	O
IBV	B-SPEC
strains	O
was	O
conducted	O
and	O
its	O
results	O
demonstrate	O
that	O
the	O
S1	O
gene	O
of	O
QY16	O
has	O
the	O
highest	O
nucleotide	O
sequence	O
identity	O
with	O
that	O
of	O
4	O
/	O
91	O
,	O
and	O
the	O
other	O
part	O
of	O
its	O
genome	O
is	O
highly	O
similar	O
to	O
that	O
of	O
YX10	O
.	O

But	O
the	O
incidence	O
of	O
AKI	O
and	O
the	O
total	O
fluid	O
volume	O
during	O
EGDT	O
were	O
not	O
significantly	O
different	O
between	O
the	O
senior	O
group	O
and	O
the	O
younger	O
group	O
[	O
incidence	O
of	O
AKI	O
:	O
74	O
.	O
1	O
	O
(	O
152	O
/	O
205	O
)	O
vs	O
.	O
69	O
.	O
4	O
	O
(	O
213	O
/	O
307	O
),	O
total	O
fluid	O
volume	O
(	O
mL	O
):	O
2	O
769	O
	O
1	O
589	O
vs	O
.	O
2	O
804	O
	O
1	O
611	O
,	O
both	O
P	O
	O
0	O
.	O
05	O
].	O
Compared	O
with	O
the	O
control	O
group	O
,	O
the	O
incidence	O
of	O
ARDS	O
was	O
higher	O
in	O
the	O
high	O
-	O
PCT	O
group	O
[	O
86	O
.	O
4	O
	O
(	O
133	O
/	O
154	O
)	O
vs	O
.	O
78	O
.	O
5	O
	O
(	O
281	O
/	O
358	O
),	O
P	O
	O
0	O
.	O
05	O
].	O
But	O
the	O
incidences	O
of	O
AKI	O
and	O
cardiac	O
insufficiency	O
were	O
not	O
significantly	O
differentiated	O
between	O
the	O
high	O
-	O
PCT	O
group	O
and	O
the	O
control	O
group	O
[	O
77	O
.	O
9	O
	O
(	O
120	O
/	O
154	O
)	O
vs	O
.	O
68	O
.	O
4	O
	O
(	O
245	O
/	O
358	O
),	O
58	O
.	O
4	O
	O
(	O
90	O
/	O
154	O
)	O
vs	O
.	O
63	O
.	O
4	O
	O
(	O
227	O
/	O
358	O
),	O
both	O
P	O
	O
0	O
.	O
05	O
].	O
Multiple	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
risk	O
factors	O
of	O
increase	O
in	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
included	O
old	O
age	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
1	O
.	O
782	O
,	O
95	O
	O
confidence	O
interval	O
(	O
95	O
	O
CI	O
)	O
=	O
1	O
.	O
173	O
-	O
2	O
.	O
708	O
,	O
P	O
=	O
0	O
.	O
007	O
],	O
ARDS	O
(	O
OR	O
=	O
1	O
.	O
786	O
,	O
95	O
	O
CI	O
=	O
1	O
.	O
028	O
-	O
3	O
.	O
102	O
,	O
P	O
=	O
0	O
.	O
040	O
),	O
AKI	O
(	O
OR	O
=	O
1	O
.	O
878	O
,	O
95	O
	O
CI	O
=	O
1	O
.	O
145	O
-	O
3	O
.	O
079	O
,	O
P	O
=	O
0	O
.	O
012	O
),	O
and	O
cardiac	O
insufficiency	O
(	O
OR	O
=	O
4	O
.	O
177	O
,	O
95	O
	O
CI	O
=	O
2	O
.	O
505	O
-	O
6	O
.	O
966	O
,	O
P	O
=	O
0	O
.	O
000	O
),	O
except	O
for	O
gender	O
(	O
OR	O
=	O
1	O
.	O
112	O
,	O
95	O
	O
CI	O
=	O
0	O
.	O
736	O
-	O
1	O
.	O
680	O
,	O
P	O
=	O
0	O
.	O
614	O
).	O

ABSTRACT	O
:	O
We	O
reviewed	O
the	O
use	O
of	O
noninvasive	O
ventilation	O
(	O
NIV	O
)	O
versus	O
high	O
flow	O
nasal	O
cannula	B-SPEC
(	O
HFNC	O
)	O
oxygen	O
in	O
adult	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
).	O

By	O
using	O
in	O
vivo	O
studies	O
in	O
mice	B-SPEC
and	O
in	O
vitro	O
studies	O
in	O
cells	O
,	O
we	O
demonstrated	O
that	O
an	O
airway	O
injection	O
of	O
TCs	O
can	O
reduce	O
the	O
pulmonary	O
inflammatory	O
response	O
and	O
improve	O
the	O
lung	O
function	O
in	O
mice	B-SPEC
with	O
VILI	O
and	O
promote	O
the	O
proliferation	O
of	O
pulmonary	O
vascular	O
endothelial	O
cells	O
.	O

Samples	O
from	O
diseased	O
dogs	B-SPEC
were	O
more	O
frequently	O
seropositive	O
for	O
CRCoV	O
,	O
with	O
higher	O
POI	O
,	O
than	O
samples	O
from	O
healthy	O
dogs	B-SPEC
.	O

The	O
convenience	O
sampling	O
methodology	O
,	O
with	O
a	O
poor	O
match	O
between	O
the	O
populations	O
of	O
diseased	O
and	O
healthy	O
dogs	B-SPEC
in	O
terms	O
of	O
age	O
,	O
breed	O
and	O
use	O
,	O
together	O
with	O
the	O
relatively	O
small	O
sample	O
size	O
precluded	O
inference	O
of	O
any	O
causal	O
relationships	O
between	O
infection	O
with	O
a	O
given	O
pathogen	O
and	O
development	O
of	O
disease	O
.	O

TITLE	O
:	O
Axonal	O
Transport	O
Enables	O
Neuron	O
-	O
to	O
-	O
Neuron	O
Propagation	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
.	O

HCoV	O
-	O
induced	O
neuropathologies	O
in	O
humans	B-SPEC
are	O
difficult	O
to	O
diagnose	O
early	O
enough	O
to	O
allow	O
therapeutic	O
interventions	O
.	O

TITLE	O
:	O
Dimerization	O
of	O
Coronavirus	B-SPEC
nsp9	O
with	O
Diverse	O
Modes	O
Enhances	O
Its	O
Nucleic	O
Acid	O
Binding	O
Affinity	O
.	O

Meanwhile	O
,	O
PEDV	B-SPEC
nsp9	O
is	O
distinguished	O
by	O
the	O
presence	O
of	O
a	O
disulfide	O
bond	O
in	O
the	O
dimer	O
interface	O
.	O

Frequencies	O
of	O
virus	B-SPEC
-	O
specific	O
gamma	O
interferon	O
(	O
IFN	O
-	O
	O
)-	O
secreting	O
T	O
cells	O
were	O
lower	O
in	O
critically	O
ill	O
patients	O
requiring	O
ventilation	O
than	O
in	O
patients	O
without	O
ventilation	O
within	O
4	O
months	O
after	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
experienced	O
a	O
breakthrough	O
fungal	O
infection	O
caused	O
by	O
Geotrichum	B-SPEC
capitatum	I-SPEC
during	O
empirical	O
therapy	O
with	O
caspofungin	O
.	O

During	O
a	O
recurrence	O
of	O
fever	O
on	O
day	O
11	O
,	O
blood	O
cultures	O
were	O
found	O
to	O
be	O
positive	O
for	O
a	O
yeast	B-SPEC
-	O
like	O
organism	O
,	O
which	O
was	O
later	O
confirmed	O
by	O
mass	O
spectrometry	O
to	O
be	O
G	B-SPEC
.	I-SPEC
capitatum	I-SPEC
.	O

Here	O
,	O
we	O
investigate	O
whether	O
the	O
virus	B-SPEC
uses	O
the	O
canonical	O
autophagic	O
signaling	O
complex	O
,	O
consisting	O
of	O
the	O
ULK1	O
/	O
2	O
kinases	O
,	O
ATG13	O
,	O
RB1CC1	O
,	O
and	O
ATG101	O
,	O
to	O
activate	O
autophagy	O
.	O

This	O
demonstration	O
of	O
ULK1	O
-	O
independent	O
autophagic	O
signaling	O
is	O
novel	O
and	O
leads	O
to	O
a	O
model	O
by	O
which	O
the	O
virus	B-SPEC
is	O
signaling	O
to	O
generate	O
autophagosomes	O
downstream	O
of	O
ULK1	O
,	O
while	O
at	O
the	O
same	O
time	O
,	O
cleaving	O
cargo	O
receptors	O
,	O
which	O
may	O
affect	O
cargo	O
loading	O
and	O
autophagic	O
degradative	O
flux	O
.	O

TITLE	O
:	O
Differential	O
susceptibility	O
of	O
macrophages	O
to	O
serotype	O
II	O
feline	B-SPEC
coronaviruses	O
correlates	O
with	O
differences	O
in	O
the	O
viral	O
spike	O
protein	O
.	O

Previously	O
,	O
by	O
comparing	O
serotype	O
II	O
strains	O
FIPV	O
79	O
-	O
1146	O
and	O
FECV	B-SPEC
79	O
-	O
1683	O
and	O
recombinant	O
chimeric	O
forms	O
thereof	O
in	O
cultured	O
feline	B-SPEC
bone	O
marrow	O
macrophages	O
,	O
we	O
mapped	O
this	O
difference	O
to	O
the	O
C	O
-	O
terminal	O
part	O
of	O
the	O
viral	O
spike	O
(	O
S	O
)	O
protein	O
(	O
S2	O
).	O

ABSTRACT	O
:	O
A	O
novel	O
swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
Coronavirus	B-SPEC
(	O
SADS	O
-	O
CoV	O
)	O
that	O
causes	O
severe	O
diarrhea	O
in	O
suckling	O
piglets	O
was	O
identified	O
in	O
southern	O
China	O
in	O
2017	O
.	O

RESULTS	O
:	O
Quantitative	O
results	O
of	O
AIV	O
and	O
IBV	B-SPEC
co	O
-	O
infection	O
showed	O
that	O
interferences	O
between	O
the	O
two	O
viruses	B-SPEC
yielded	O
decreased	O
viral	O
growth	O
.	O

ABSTRACT	O
:	O
Binge	O
drinking	O
and	O
continued	O
alcohol	O
use	O
in	O
large	O
amounts	O
are	O
associated	O
with	O
many	O
health	O
problems	O
but	O
there	O
are	O
very	O
few	O
studies	O
on	O
the	O
effects	O
of	O
alcohol	O
intake	O
on	O
the	O
function	O
of	O
lung	O
,	O
the	O
effects	O
of	O
ethanol	O
on	O
lung	O
diseases	O
,	O
and	O
links	O
between	O
alcohol	O
consumption	O
and	O
lung	O
cancer	B-SPEC
.	O

The	O
pulmonary	O
effects	O
of	O
alcohol	O
misuse	O
are	O
many	O
but	O
further	O
investigations	O
into	O
the	O
mechanism	O
by	O
which	O
alcohol	O
might	O
predispose	O
to	O
lung	O
cancer	B-SPEC
are	O
necessary	O
.	O

Using	O
a	O
murine	B-SPEC
model	O
of	O
demyelination	O
induced	O
by	O
a	O
gliatropic	O
coronavirus	B-SPEC
,	O
in	O
which	O
BMDM	O
are	O
redundant	O
for	O
demyelination	O
,	O
we	O
herein	O
characterize	O
gene	O
expression	O
profiles	O
of	O
BMDM	O
versus	O
microglia	O
associated	O
with	O
demyelination	O
.	O

In	O
order	B-SPEC
to	O
better	O
understand	O
how	O
the	O
different	O
genotypes	O
of	O
IBV	B-SPEC
behave	O
spatially	O
and	O
temporally	O
,	O
we	O
used	O
geographic	O
information	O
system	O
-	O
based	O
mapping	O
coupled	O
with	O
spatial	O
and	O
spatial	O
-	O
temporal	O
statistics	O
to	O
identify	O
statistically	O
significant	O
clustering	O
of	O
multiple	O
strains	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
between	O
2008	O
and	O
2012	O
in	O
California	B-SPEC
.	O

The	O
conformational	O
structure	O
of	O
the	O
IBV	B-SPEC
spike	O
protein	O
was	O
predicted	O
from	O
a	O
homologous	O
protein	O
,	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
spike	O
.	O

Western	O
blotting	O
revealed	O
that	O
IBV	B-SPEC
TM86	O
spike	O
residues	O
686	O
-	O
723	O
were	O
antigenic	O
.	O

All	O
chickens	B-SPEC
were	O
inoculated	O
intranasally	O
with	O
inactivated	O
IBV	B-SPEC
vaccine	O
at	O
day	O
1	O
and	O
day	O
10	O
.	O

TITLE	O
:	O
Global	O
seasonal	O
occurrence	O
of	O
middle	O
east	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

We	O
obtained	O
the	O
data	O
on	O
the	O
prevalence	O
and	O
occurrence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
from	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
for	O
all	O
the	O
MERS	O
cases	O
reported	O
from	O
the	O
various	O
countries	O
and	O
their	O
allied	O
ministries	O
.	O

TITLE	O
:	O
Transcriptional	O
and	O
Translational	O
Landscape	O
of	O
Equine	B-SPEC
Torovirus	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
genus	B-SPEC

DPP4	O
was	O
mainly	O
expressed	O
by	O
human	B-SPEC
lymphocytes	O
and	O
dromedary	B-SPEC
monocytes	O
,	O
but	O
overall	O
the	O
expression	O
level	O
was	O
lower	O
in	O
dromedaries	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
central	O
goal	O
for	O
reintroduced	O
populations	O
of	O
threatened	O
wood	O
bison	B-SPEC
(	O
Bison	B-SPEC
bison	I-SPEC
athabascae	I-SPEC
)	O
is	O
to	O
maintain	O
them	O
free	O
of	O
diseases	O
of	O
concern	O
,	O
particularly	O
bovine	B-SPEC
tuberculosis	O
(	O
caused	O
by	O
Mycobacterium	B-SPEC
bovis	I-SPEC
)	O
and	O
brucellosis	O
(	O
caused	O
by	O
Brucella	B-SPEC
abortus	I-SPEC
).	O

Intramuscular	O
immunizations	O
of	O
mice	B-SPEC
and	O
piglets	O
with	O
the	O
S	O
-	O
Bac	O
and	O
S1	O
-	O
Bac	O
demonstrated	O
significantly	O
higher	O
levels	O
of	O
systemic	O
anti	O
-	O
PEDV	B-SPEC
S	O
-	O
specific	O
IgG	O
,	O
as	O
compared	O
with	O
control	O
group	O
.	O

The	O
highly	O
virulent	O
PEDV	B-SPEC
-	O
PT	O
strain	O
challenge	O
experiment	O
showed	O
that	O
piglets	O
immunized	O
with	O
S	O
-	O
Bac	O
and	O
S1	O
-	O
Bac	O
showed	O
milder	O
clinical	O
symptoms	O
with	O
significantly	O
less	O
fecal	O
viral	O
shedding	O
as	O
compared	O
with	O
non	O
-	O
immunized	O
control	O
piglets	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
infectious	O
bronchitis	O
,	O
which	O
results	O
in	O
considerable	O
economic	O
losses	O
.	O

TITLE	O
:	O
Variations	O
in	O
the	O
detection	O
of	O
anti	O
-	O
PEDV	B-SPEC
antibodies	O
in	O
serum	O
samples	O
using	O
three	O
diagnostic	O
tests	O
-	O
short	O
communication	O
.	O

ABSTRACT	O
:	O
Devastating	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
started	O
in	O
China	O
in	O
late	O
2010	O
and	O
rapidly	O
spread	O
to	O
North	O
America	O
and	O
Asia	O
causing	O
severe	O
diarrhea	O
and	O
high	O
mortality	O
in	O
neonatal	O
piglets	O
,	O
indicating	O
that	O
a	O
new	O
generation	O
of	O
vaccine	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
urgently	O
needed	O
.	O

PROCEDURES	O
Electronic	O
medical	O
records	O
were	O
reviewed	O
and	O
data	O
collected	O
regarding	O
cat	B-SPEC
characteristics	O
,	O
clinical	O
signs	O
,	O
cause	O
of	O
pleural	O
effusion	O
,	O
treatment	O
,	O
and	O
survival	O
status	O
at	O
discharge	O
from	O
the	O
hospital	O
.	O

All	O
infected	O
pigs	B-SPEC
shed	O
virus	B-SPEC
in	O
faeces	O
regardless	O
of	O
PEDV	B-SPEC
strain	O
with	O
9	O
of	O
30	O
pigs	B-SPEC
showing	O
intermittent	O
faecal	O
shedding	O
.	O

TITLE	O
:	O
Canine	O
respiratory	O
coronavirus	B-SPEC
employs	O
caveolin	O
-	O
1	O
-	O
mediated	O
pathway	O
for	O
internalization	O
to	O
HRT	O
-	O
18G	O
cells	O
.	O

Here	O
,	O
we	O
examined	O
entry	O
of	O
CRCoV	O
into	O
human	B-SPEC
rectal	O
tumor	O
cells	O
(	O
HRT	O
-	O
18G	O
cell	O
line	O
)	O
by	O
analyzing	O
co	O
-	O
localization	O
of	O
single	O
virus	B-SPEC
particles	O
with	O
cellular	O
markers	O
in	O
the	O
presence	O
or	O
absence	O
of	O
chemical	O
inhibitors	O
of	O
pathways	O
potentially	O
involved	O
in	O
virus	B-SPEC
entry	O
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
Flammulina	B-SPEC
velutipes	I-SPEC
mushroom	B-SPEC
waste	O
(	O
FVW	O
)	O
on	O
performance	O
,	O
immune	O
response	O
and	O
serum	O
immunity	O
in	O
growing	O
layer	O
hens	O
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
PEDV	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
on	O
type	O
III	O
IFN	O
-	O
	O
.	O

These	O
findings	O
might	O
help	O
increase	O
understanding	O
of	O
the	O
pathogenesis	O
of	O
PEDV	B-SPEC
and	O
its	O
mechanisms	O
for	O
evading	O
the	O
host	O
immune	O
response	O
.	O

TITLE	O
:	O
Heartfelt	O
sepsis	B-SPEC
:	O
microvascular	O
injury	O
due	O
to	O
genomic	O
storm	O
.	O

While	O
the	O
lungs	O
remain	O
the	O
principal	O
organ	O
of	O
interest	O
due	O
to	O
sepsis	B-SPEC
-	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
""""	O
septic	O
heart	O
""""	O
or	O
""""	O
septic	O
cardiomyopathy	O
""""	O
accelerates	O
sepsis	B-SPEC
'	O
transition	O
to	O
potentially	O
lethal	O
septic	O
shock	O
.	O

Using	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
CoV	O
mouse	B-SPEC
model	O
,	O
an	O
NSP16	O
mutant	O
vaccine	O
was	O
evaluated	O
for	O
protection	O
from	O
heterologous	O
challenge	O
,	O
efficacy	O
in	O
the	O
aging	O
host	O
,	O
and	O
potential	O
for	O
reversion	O
to	O
pathogenesis	O
.	O

Although	O
cases	O
of	O
smallpox	B-SPEC
still	O
occurred	O
,	O
they	O
were	O
far	O
fewer	O
than	O
expected	O
,	O
and	O
it	O
is	O
believed	O
that	O
the	O
vaccination	O
program	O
contributed	O
to	O
victory	O
in	O
the	O
War	O
of	O
Independence	O
.	O

Although	O
preventive	O
measures	O
and	O
the	O
development	O
of	O
drugs	O
have	O
provided	O
some	O
relief	O
from	O
the	O
burden	O
of	O
malaria	O
,	O
dengue	O
,	O
and	O
HIV	B-SPEC
,	O
the	O
US	O
military	O
continues	O
to	O
fund	O
research	O
and	O
development	O
of	O
prophylactic	O
vaccines	O
that	O
will	O
contribute	O
to	O
force	O
health	O
protection	O
and	O
global	O
health	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
Co	O
V	O
)	O
is	O
a	O
RNA	O
virus	B-SPEC
causing	O
serious	O
harm	O
to	O
people	O
.	O

In	O
order	B-SPEC
to	O
investigate	O
the	O
codon	O
usage	O
characteristics	O
and	O
influence	O
factors	O
,	O
codon	O
preference	O
and	O
multivariate	O
statistical	O
analysis	O
of	O
MERS	O
-	O
Co	O
V	O
9	O
gene	O
sequences	O
were	O
performed	O
by	O
using	O
Codon	O
W	O
,	O
CUSP	O
and	O
SPSS	O
software	O
,	O
getting	O
the	O
content	O
of	O
GC	O
at	O
three	O
positions	O
of	O
codons	O
,	O
ENC	O
(	O
Effective	O
number	O
of	O
codon	O
)	O
and	O
RSCU	O
(	O
Relative	O
synonymous	O
codon	O
usage	O
)	O
of	O
all	O
genes	O
.	O

However	O
,	O
in	O
November	O
2014	O
a	O
clinical	O
outbreak	O
of	O
PEDV	B-SPEC
was	O
diagnosed	O
in	O
a	O
fattener	O
farm	O
by	O
PCR	O
testing	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infects	O
pigs	B-SPEC
and	O
causes	O
an	O
enteric	O
disease	O
that	O
is	O
characterized	O
by	O
vomiting	O
and	O
watery	O
diarrhea	O
.	O

PEDV	B-SPEC
outbreaks	O
have	O
a	O
tremendous	O
financial	O
impact	O
on	O
the	O
worldwide	O
pork	O
industry	O
.	O

In	O
South	O
Korea	O
,	O
the	O
incidence	O
of	O
PEDV	B-SPEC
has	O
continued	O
despite	O
nationwide	O
use	O
of	O
attenuated	O
and	O
inactivated	O
vaccines	O
,	O
raising	O
questions	O
regarding	O
the	O
current	O
vaccines	O
'	O
efficacy	O
and	O
the	O
need	O
for	O
new	O
vaccine	O
development	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
isolated	O
a	O
new	O
Korean	O
PEDV	B-SPEC
epidemic	O
strain	O
,	O
PED	O
-	O
CUP	O
-	O
B2014	O
,	O
in	O
Vero	O
cells	O
.	O

We	O
conducted	O
quantification	O
of	O
infectious	O
virus	B-SPEC
or	O
viral	O
RNA	O
,	O
immunofluorescent	O
(	O
IF	O
)	O
staining	O
for	O
the	O
detection	O
of	O
PDCoV	O
antigens	O
,	O
and	O
TUNEL	O
assay	O
in	O
IPEC	O
-	O
J2	O
cells	O
inoculated	O
with	O
the	O
strain	O
OH	O
-	O
FD22	O
-	O
P8	O
grown	O
in	O
LLC	O
-	O
PK	O
cells	O
,	O
and	O
supplemented	O
with	O
10	O
g	O
/	O
ml	O
of	O
trypsin	O
in	O
the	O
cell	O
culture	O
medium	O
.	O

The	O
animal	B-SPEC
experiment	O
revealed	O
that	O
these	O
two	O
novel	O
strains	O
were	O
high	O
pathogenic	O
to	O
neonatal	O
pigs	B-SPEC
.	O

Whether	O
the	O
gut	O
microbiota	B-SPEC
plays	O
any	O
role	O
in	O
the	O
development	O
of	O
TRALI	O
is	O
currently	O
unknown	O
.	O

These	O
data	O
reveal	O
a	O
link	O
between	O
the	O
gut	O
flora	O
composition	O
and	O
the	O
development	O
of	O
antibody	O
-	O
mediated	O
TRALI	O
in	O
mice	B-SPEC
.	O

The	O
results	O
showed	O
that	O
the	O
swine	B-SPEC
epidemic	O
diarrhea	O
virus	B-SPEC
infection	O
had	O
a	O
significant	O
impact	O
on	O
the	O
level	O
of	O
miRNA	O
expression	O
in	O
PK	O
-	O
15	O
cells	O
,	O
thus	O
providing	O
a	O
new	O
idea	B-SPEC
for	O
the	O
further	O
study	O
of	O
the	O
miRNA	O
preparation	O
for	O
the	O
treatment	O
of	O
PEDV	B-SPEC
.	O

ABSTRACT	O
:	O
Respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
the	O
Middle	O
East	O
(	O
MERS	O
-	O
Co	O
V	O
)	O
has	O
caused	O
wide	O
attention	O
since	O
it	O
was	O
discovered	O
,	O
and	O
the	O
design	O
of	O
effective	O
vaccines	O
for	O
MERS	O
-	O
Co	O
V	O
becomes	O
a	O
hot	O
area	O
at	O
present	O
.	O

Here	O
,	O
we	O
report	O
a	O
unique	O
epitope	O
and	O
unusual	O
neutralizing	O
mechanism	O
of	O
the	O
isolated	O
human	B-SPEC
antibody	O
MERS	O
-	O
4	O
.	O

The	O
lung	O
injury	O
score	O
and	O
the	O
lung	O
wet	O
to	O
dry	O
(	O
W	O
/	O
D	O
)	O
ratio	O
in	O
lungs	O
were	O
significantly	O
reduced	O
in	O
septic	O
rats	B-SPEC
after	O
ER	O
stress	O
inhibition	O
.	O

However	O
,	O
some	O
laboratories	O
require	O
improved	O
assay	O
sensitivity	O
,	O
reduced	O
cross	O
contamination	O
of	O
samples	O
,	O
and	O
improved	O
speciation	O
of	O
coronavirus	B-SPEC
subtypes	O
for	O
potentially	O
complex	O
clinical	O
specimens	O
.	O

The	O
data	O
analyzed	O
refer	O
to	O
the	O
patient	O
,	O
event	O
,	O
type	O
of	O
resuscitation	O
performed	O
,	O
and	O
clinical	O
situation	O
after	O
resuscitation	O
and	O
at	O
arrival	O
to	O
the	O
PICU	B-SPEC
;	O
results	O
of	O
additional	O
tests	O
;	O
and	O
clinical	O
evolution	O
and	O
neurological	O
status	O
at	O
discharge	O
from	O
the	O
PICU	B-SPEC
(	O
categorized	O
as	O
death	O
,	O
severe	O
encephalopathy	O
,	O
or	O
normal	O
).	O

In	O
this	O
study	O
,	O
we	O
reexamined	O
furin	O
usage	O
by	O
MERS	O
-	O
CoV	O
using	O
a	O
real	O
-	O
time	O
PCR	O
-	O
based	O
virus	B-SPEC
cell	O
entry	O
assay	O
after	O
inhibition	O
of	O
cellular	O
proteases	O
.	O

Furthermore	O
,	O
a	O
virus	B-SPEC
cell	O
entry	O
assay	O
and	O
a	O
cell	O
-	O
cell	O
fusion	O
assay	O
provided	O
no	O
evidence	O
that	O
the	O
S	O
protein	O
was	O
activated	O
by	O
exogenous	O
furin	O
.	O

Knockout	O
of	O
CAPN5	O
and	O
CBLB	O
reduced	O
susceptibility	O
to	O
all	O
tested	O
HCV	B-SPEC
genotypes	O
,	O
but	O
not	O
to	O
other	O
enveloped	O
viruses	B-SPEC
such	O
as	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
Zika	B-SPEC
virus	I-SPEC
infection	O
is	O
associated	O
with	O
the	O
development	O
of	O
severe	O
neurological	O
disorders	O
in	O
adults	O
and	O
newborns	O
.	O

ABSTRACT	O
:	O
Picornaviruses	B-SPEC
,	O
one	O
of	O
the	O
major	O
causes	O
of	O
human	B-SPEC
diseases	O
ranging	O
from	O
the	O
common	O
cold	O
to	O
acute	O
flaccid	O
paralysis	O
,	O
have	O
a	O
short	O
cytosolic	O
lifecycle	O
that	O
,	O
in	O
cultured	O
cells	O
,	O
ends	O
in	O
cell	O
lysis	O
.	O

In	O
back	O
-	O
to	O
-	O
back	O
papers	O
recently	O
published	O
in	O
Cell	O
Reports	O
,	O
our	O
labs	O
investigated	O
a	O
basic	O
question	O
:	O
if	O
picornavirus	B-SPEC
particles	O
are	O
maturing	O
inside	O
amphisomes	O
,	O
then	O
how	O
are	O
they	O
avoiding	O
the	O
typical	O
degradative	O
fate	O
of	O
autophagic	O
cargo	O
and	O
exiting	O
the	O
cell	O
intact	O
?	O

The	O
current	O
work	O
emphasizes	O
on	O
the	O
discovery	O
process	O
of	O
the	O
chalcone	O
in	O
the	O
period	O
of	O
2016	O
to	O
2017	O
on	O
malaria	O
,	O
trypanosomiasis	O
,	O
leishmaniasis	O
,	O
filaria	B-SPEC
,	O
tuberculosis	O
,	O
netamodes	O
,	O
Human	B-SPEC
Immunodeficiency	I-SPEC
Virus	I-SPEC
(	O
HIV	B-SPEC
),	O
Tobacco	B-SPEC
Mosaic	I-SPEC
Virus	I-SPEC
(	O
TMV	B-SPEC
),	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
and	O
miscellaneous	O
conditions	O
.	O

TITLE	O
:	O
Effect	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
Structural	O
and	O
Accessory	O
Proteins	O
on	O
the	O
Transcriptional	O
Activation	O
of	O
Antiviral	O
Response	O
Elements	O
.	O

ABSTRACT	O
:	O
The	O
molecular	O
mechanisms	O
underlying	O
the	O
pathogenesis	O
of	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
infection	O
are	O
poorly	O
understood	O
.	O

The	O
expression	O
of	O
antiviral	O
genes	O
involved	O
in	O
the	O
type	O
I	O
IFN	O
and	O
NF	O
-	O
B	O
signaling	O
pathways	O
was	O
also	O
downregulated	O
in	O
the	O
presence	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
structural	O
or	O
accessory	O
proteins	O
.	O

The	O
expression	O
of	O
antiviral	O
genes	O
involved	O
in	O
the	O
type	O
I	O
IFN	O
and	O
NF	O
-	O
B	O
signaling	O
pathways	O
was	O
also	O
downregulated	O
in	O
the	O
presence	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
structural	O
or	O
accessory	O
proteins	O
.	O

Here	O
,	O
we	O
review	O
the	O
effect	O
of	O
cardiac	O
glycosides	O
on	O
viral	O
biology	O
and	O
the	O
mechanisms	O
by	O
which	O
these	O
drugs	O
impair	O
the	O
replication	O
of	O
this	O
array	O
of	O
different	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
(	O
hCoVs	O
)	O
in	O
the	O
last	O
two	O
decades	O
has	O
illuminated	O
their	O
potential	O
to	O
cause	O
high	O
morbidity	O
and	O
mortality	O
in	O
human	B-SPEC
populations	O
and	O
disrupt	O
global	O
economies	O
.	O

Although	O
we	O
recognize	O
that	O
results	O
obtained	O
in	O
robust	O
mouse	B-SPEC
models	O
require	O
evaluation	O
in	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
,	O
we	O
focus	O
this	O
review	O
on	O
the	O
current	O
state	O
of	O
hCoV	O
mouse	B-SPEC
models	O
,	O
their	O
use	O
as	O
tractable	O
complex	O
genetic	O
organisms	O
for	O
untangling	O
complex	O
hCoV	O
-	O
host	O
interactions	O
,	O
and	O
as	O
pathogenesis	O
models	O
for	O
preclinical	O
evaluation	O
of	O
novel	O
therapeutic	O
interventions	O
.	O

We	O
detected	O
HRV	O
,	O
coronavirus	B-SPEC
,	O
paramyxovirus	O
,	O
influenza	O
and	O
bocavirus	B-SPEC
with	O
the	O
FilmArray	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
platform	O
(	O
BioFire	O
Diagnostics	O
,	O
LLC	O
).	O

TITLE	O
:	O
Time	O
-	O
calibrated	O
phylogenomics	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
:	O
genome	O
-	O
wide	O
insights	O
into	O
the	O
spatio	O
-	O
temporal	O
dynamics	O
.	O

ABSTRACT	O
:	O
Viral	O
infectious	O
diseases	O
are	O
a	O
global	O
health	O
concern	O
,	O
as	O
is	O
evident	O
by	O
recent	O
outbreaks	O
of	O
the	O
middle	O
east	O
respiratory	O
syndrome	O
,	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
,	O
and	O
re	O
-	O
emerging	O
zika	O
,	O
dengue	O
,	O
and	O
chikungunya	O
fevers	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
was	O
initially	O
documented	O
in	O
Hong	O
Kong	O
and	O
later	O
in	O
the	O
United	O
States	O
,	O
South	O
Korea	O
,	O
and	O
Thailand	O
.	O

TITLE	O
:	O
Cholesterol	O
is	O
important	O
for	O
the	O
entry	O
process	O
of	O
porcine	B-SPEC
deltacoronavirus	O
.	O

To	O
determine	O
if	O
the	O
pathogens	O
adenovirus	B-SPEC
(	O
ADV	O
),	O
coronavirus	B-SPEC
(	O
CoV	O
),	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
(	O
EMCV	B-SPEC
),	O
enterovirus	B-SPEC
(	O
EV	O
),	O
influenza	O
A	O
-	O
D	O
(	O
IAV	O
,	O
IBV	B-SPEC
,	O
ICV	O
,	O
and	O
IDV	O
),	O
porcine	B-SPEC
circovirus	I-SPEC
2	I-SPEC
(	O
PCV2	O
),	O
and	O
porcine	B-SPEC
rotaviruses	B-SPEC
A	O
and	O
C	O
(	O
RVA	O
and	O
RVC	O
),	O
are	O
aerosolized	O
at	O
the	O
animal	B-SPEC
-	O
interface	O
,	O
and	O
if	O
humans	B-SPEC
working	O
in	O
these	O
environments	O
are	O
carrying	O
these	O
viruses	B-SPEC
in	O
their	O
nasal	O
airways	O
.	O

In	O
all	O
,	O
55	O
pig	B-SPEC
fecal	O
,	O
49	O
pig	B-SPEC
oral	O
or	O
water	O
,	O
45	O
bioaerosol	O
,	O
and	O
78	O
worker	O
nasal	O
wash	O
samples	O
were	O
collected	O
across	O
16	O
sites	O
.	O

A	O
/	O
H1N1pdm09	O
viruses	B-SPEC
analyzed	O
by	O
gene	O
sequencing	O
fell	O
into	O
genetic	O
groups	O
6B	O
and	O
6B	O
.	O
1	O
;	O
A	O
/	O
H3N2	O
viruses	B-SPEC
belonged	O
to	O
genetic	O
subclades	O
3C	O
.	O
3b	O
,	O
3C	O
.	O
3a	O
,	O
3C	O
.	O
2a	O
and	O
3C	O
.	O
2a1	O
;	O
B	O
/	O
Yamagata	O
lineage	O
viruses	B-SPEC
were	O
of	O
clade	O
3	O
and	O
B	O
/	O
Victoria	B-SPEC
lineage	O
viruses	B-SPEC
fell	O
in	O
clade1A	O
.	O

Dust	O
collected	O
following	O
mixing	O
of	O
PEDV	B-SPEC
contaminated	O
feed	O
had	O
detectable	O
PEDV	B-SPEC
RNA	O
(	O
Ct	O
=	O
29	O
.	O
4	O
)	O
and	O
was	O
infectious	O
.	O

Overall	O
,	O
the	O
use	O
of	O
rice	B-SPEC
hull	O
flushes	O
effectively	O
reduced	O
the	O
quantity	O
of	O
detectible	O
RNA	O
present	O
after	O
mixing	O
a	O
batch	O
of	O
PEDV	B-SPEC
-	O
positive	O
feed	O
.	O

ABSTRACT	O
:	O
Six	O
years	O
have	O
passed	O
since	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
a	O
newly	O
emerging	O
infectious	O
virus	B-SPEC
,	O
was	O
first	O
reported	O
in	O
2012	O
.	O

We	O
also	O
demonstrated	O
that	O
both	O
full	O
-	O
length	O
and	O
naturally	O
truncated	O
ORF3	O
proteins	O
could	O
interact	O
with	O
the	O
S	O
protein	O
but	O
with	O
different	O
binding	O
affinity	O
,	O
which	O
correlate	O
with	O
the	O
ability	O
of	O
the	O
protein	O
to	O
regulate	O
virus	B-SPEC
replication	O
in	O
cell	O
culture	O
.	O

TITLE	O
:	O
Herd	O
level	O
estimation	O
of	O
probability	O
of	O
disease	O
freedom	O
applied	O
on	O
the	O
Norwegian	O
control	O
program	O
for	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
national	O
control	O
program	O
against	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
was	O
launched	O
in	O
Norway	O
in	O
2016	O
.	O

Because	O
these	O
viruses	B-SPEC
are	O
endemic	O
,	O
the	O
rate	O
of	O
re	O
-	O
introduction	O
can	O
be	O
high	O
,	O
and	O
a	O
disease	O
-	O
free	O
status	O
will	O
become	O
more	O
uncertain	O
as	O
time	O
from	O
testing	O
elapses	O
.	O

Here	O
we	O
explored	O
the	O
possibilities	O
for	O
rationally	O
attenuating	O
IBV	B-SPEC
to	O
improve	O
our	O
knowledge	O
regarding	O
the	O
function	O
of	O
IBV	B-SPEC
accessory	O
proteins	O
and	O
for	O
the	O
development	O
of	O
next	O
-	O
generation	O
vaccines	O
with	O
the	O
recently	O
established	O
reverse	O
genetic	O
system	O
for	O
IBV	B-SPEC
H52	O
based	O
on	O
targeted	O
RNA	O
recombination	O
and	O
selection	O
of	O
recombinant	O
viruses	B-SPEC
in	O
embryonated	O
eggs	O
.	O

In	O
vitro	O
inoculation	O
of	O
chicken	B-SPEC
embryo	O
kidney	O
cells	O
with	O
recombinant	O
and	O
wild	O
-	O
type	O
viruses	B-SPEC
demonstrated	O
that	O
the	O
accessory	O
protein	O
5b	O
is	O
involved	O
in	O
the	O
delayed	O
activation	O
of	O
the	O
interferon	O
response	O
of	O
the	O
host	O
after	O
IBV	B-SPEC
infection	O
.	O

In	O
conclusion	O
,	O
individual	O
deletion	O
of	O
accessory	O
genes	O
in	O
IBV	B-SPEC
H52	O
resulted	O
in	O
mutant	O
viruses	B-SPEC
with	O
an	O
attenuated	O
phenotype	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
-(	O
MERS	O
-	O
CoV	O
)	O
infection	O
is	O
an	O
evolving	O
worldwide	O
health	O
crisis	O
.	O

Mice	B-SPEC
were	O
immunized	O
intranasally	O
with	O
the	O
inactivated	O
split	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
(	O
A	O
/	O
Shanghai	O
/	O
02	O
/	O
2013	O
)	O
vaccine	O
with	O
or	O
without	O
JY	O
.	O

The	O
immunogenicities	O
of	O
the	O
nasal	O
spray	O
H7N9	O
vaccine	O
and	O
intramuscular	O
vaccine	O
(	O
containing	O
only	O
the	O
inactivated	O
split	O
virus	B-SPEC
)	O
were	O
compared	O
in	O
mice	B-SPEC
.	O

Two	O
doses	O
of	O
the	O
nasal	O
spray	O
H7N9	O
vaccine	O
induced	O
higher	O
titers	O
of	O
HI	O
(	O
6	O
.	O
7	O
	O
0	O
.	O
67	O
vs	O
.	O
5	O
.	O
3	O
	O
1	O
.	O
16	O
,	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
anti	O
-	O
HA	O
IgG	O
in	O
sera	O
(	O
19	O
.	O
26	O
	O
0	O
.	O
67	O
vs	O
.	O
13	O
.	O
97	O
	O
0	O
.	O
82	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
of	O
anti	O
-	O
HA	O
sIgA	B-SPEC
(	O
7	O
.	O
13	O
	O
2	O
.	O
54	O
vs	O
.	O
0	O
,	O
P	O
=	O
0	O
.	O
0000	O
)	O
in	O
bronchoalveolar	O
lavage	O
fluid	O
(	O
BALF	O
)	O
than	O
one	O
dose	O
of	O
intramuscular	O
H7N9	O
vaccine	O
3	O
weeks	O
after	O
the	O
last	O
immunization	O
.	O

However	O
,	O
when	O
we	O
immunized	O
the	O
mice	B-SPEC
with	O
two	O
doses	O
of	O
both	O
vaccines	O
separately	O
,	O
the	O
nasal	O
spray	O
H7N9	O
vaccine	O
induced	O
higher	O
titers	O
of	O
anti	O
-	O
HA	O
IgG	O
(	O
19	O
.	O
26	O
	O
0	O
.	O
67	O
vs	O
.	O
17	O
.	O
56	O
	O
0	O
.	O
57	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
anti	O
-	O
HA	O
sIgA	B-SPEC
(	O
7	O
.	O
13	O
	O
2	O
.	O
54	O
vs	O
.	O
4	O
.	O
02	O
	O
0	O
.	O
33	O
,	O
P	O
=	O
0	O
.	O
0026	O
)	O
than	O
did	O
the	O
intramuscular	O
H7N9	O
vaccine	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
HI	O
titer	O
between	O
the	O
two	O
groups	O
(	O
P	O
=	O
0	O
.	O
3745	O
).	O

TITLE	O
:	O
Genomic	O
characterization	O
and	O
pathogenicity	O
of	O
a	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
strain	O
isolated	O
in	O
China	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
PHEV	O
/	O
2008	O
was	O
neurotropic	O
and	O
highly	O
pathogenic	O
to	O
4	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Laboratory	O
cats	B-SPEC
were	O
infected	O
with	O
a	O
serotype	O
I	O
cat	B-SPEC
-	O
passaged	O
field	O
strain	O
of	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
)	O
and	O
peritoneal	O
cells	O
harvested	O
2	O
-	O
3	O
weeks	O
later	O
at	O
onset	O
of	O
lymphopenia	O
,	O
fever	O
and	O
serositis	O
.	O

ABSTRACT	O
:	O
Antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
are	O
primarily	O
known	O
for	O
their	O
innate	O
immune	O
defense	O
against	O
invading	O
microorganisms	O
,	O
including	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Different	O
intestinal	O
tropism	O
of	O
the	O
G2b	O
Taiwan	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
-	O
Pintung	O
52	O
strain	O
in	O
conventional	O
7	O
-	O
day	O
-	O
old	O
piglets	O
.	O

However	O
,	O
from	O
January	O
2017	O
,	O
a	O
recombinant	O
variant	O
strain	O
,	O
containing	O
a	O
portion	O
of	O
the	O
Swine	B-SPEC
Enteric	B-SPEC
Coronavirus	I-SPEC
in	O
the	O
S1	O
gene	O
,	O
spread	O
and	O
almost	O
completely	O
outcompeted	O
the	O
previous	O
nonrecombinant	O
strain	O
.	O

In	O
total	O
,	O
14	O
.	O
1	O
%	O
of	O
the	O
environmental	O
swabs	O
collected	O
from	O
trucks	O
at	O
slaughterhouses	O
after	O
animals	B-SPEC
were	O
unloaded	O
tested	O
positive	O
for	O
PEDV	B-SPEC
before	O
the	O
trucks	O
were	O
cleaned	O
and	O
disinfected	O
,	O
and	O
46	O
%	O
remained	O
positive	O
after	O
cleaning	O
and	O
disinfection	O
processes	O
were	O
performed	O
.	O

This	O
study	O
indicates	O
that	O
trucks	O
can	O
have	O
an	O
important	O
role	O
in	O
the	O
spread	O
of	O
PEDV	B-SPEC
in	O
Italy	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
feed	O
batch	O
sequencing	O
methods	O
could	O
minimize	O
PEDV	B-SPEC
cross	O
-	O
contamination	O
.	O

Next	O
,	O
a	O
pathogenic	O
PEDV	B-SPEC
isolate	O
was	O
used	O
to	O
inoculate	O
49	O
.	O
5	O
kg	O
of	O
PEDV	B-SPEC
-	O
free	O
feed	O
to	O
form	O
the	O
positive	O
control	O
.	O

These	O
strong	O
antibody	O
responses	O
may	O
be	O
caused	O
by	O
affinity	O
maturation	O
as	O
a	O
result	O
of	O
repeated	O
exposure	O
to	O
the	O
virus	B-SPEC
or	O
by	O
the	O
fact	O
that	O
dromedaries	B-SPEC
-	O
apart	O
from	O
conventional	O
antibodies	O
-	O
have	O
relatively	O
unique	O
,	O
heavy	O
chain	O
-	O
only	O
antibodies	O
(	O
HCAbs	O
).	O

In	O
vitro	O
,	O
these	O
VHHs	O
efficiently	O
blocked	O
virus	B-SPEC
entry	O
at	O
picomolar	O
concentrations	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
re	O
-	O
emerged	O
in	O
China	O
in	O
October	O
2010	O
,	O
has	O
spread	O
rapidly	O
worldwide	O
.	O

The	O
BRDC	O
multiplex	O
PCR	O
-	O
microarray	O
assay	O
was	O
able	O
to	O
detect	O
and	O
differentiate	O
four	O
bacteria	B-SPEC
(	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
,	O
Histophilus	B-SPEC
somni	I-SPEC
,	O
Pasteurella	B-SPEC
multocida	I-SPEC
,	O
and	O
Mycoplasma	B-SPEC
bovis	I-SPEC
)	O
and	O
five	O
viruses	B-SPEC
[	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
-	O
3	O
,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
herpesvirus	I-SPEC
-	I-SPEC
1	I-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
and	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
)]	O
associated	O
with	O
BRDC	O
.	O

Although	O
MERS	O
-	O
CoV	O
is	O
enzootic	O
in	O
dromedaries	B-SPEC
in	O
Africa	O
as	O
well	O
as	O
the	O
Middle	O
East	O
,	O
zoonotic	O
disease	O
has	O
not	O
been	O
reported	O
in	O
Africa	O
.	O

Sterile	O
immunity	O
is	O
not	O
acquired	O
,	O
and	O
virus	B-SPEC
will	O
persist	O
primarily	O
in	O
white	O
matter	O
tracts	O
leading	O
to	O
chronic	O
neuroinflammation	O
and	O
demyelination	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
likely	O
originated	O
in	O
bats	B-SPEC
and	O
passed	O
to	O
humans	B-SPEC
through	O
dromedary	B-SPEC
camels	B-SPEC
;	O
however	O
,	O
the	O
genetic	O
mechanisms	O
underlying	O
cross	O
-	O
species	B-SPEC
adaptation	O
remain	O
poorly	O
understood	O
.	O

To	O
better	O
understand	O
the	O
species	B-SPEC
adaptability	O
of	O
MERS	O
-	O
CoV	O
,	O
we	O
identified	O
a	O
suboptimal	O
species	B-SPEC
-	O
derived	O
variant	O
of	O
DPP4	O
to	O
study	O
viral	O
adaption	O
.	O

Firstly	O
,	O
a	O
method	O
to	O
isolate	O
DCs	O
from	O
porcine	B-SPEC
PPs	O
was	O
established	O
,	O
in	O
which	O
the	O
purity	O
of	O
SWC3a	O
Our	O
findings	O
indicate	O
that	O
oral	O
administration	O
of	O
inactivated	O
PEDV	B-SPEC
activate	O
DCs	O
in	O
porcine	B-SPEC
Peyer	O
'	O
s	O
patches	O
and	O
inactivated	O
PEDV	B-SPEC
may	O
be	O
a	O
useful	O
and	O
safe	O
vaccine	O
to	O
trigger	O
adaptive	O
immunity	O
.	O

However	O
,	O
the	O
epidemiology	O
of	O
MERS	O
as	O
well	O
as	O
immune	O
responses	O
against	O
the	O
virus	B-SPEC
in	O
animal	B-SPEC
models	O
and	O
patients	O
are	O
still	O
not	O
well	O
understood	O
,	O
hindering	O
the	O
vaccine	O
and	O
therapeutic	O
developments	O
.	O

Clinical	O
variables	O
included	O
abnormal	O
respiratory	O
status	O
(	O
intubated	O
relative	O
risk	O
,	O
1	O
.	O
67	O
;	O
1	O
.	O
23	O
-	O
2	O
.	O
26	O
and	O
hypopnea	O
relative	O
risk	O
,	O
1	O
.	O
23	O
;	O
1	O
.	O
05	O
-	O
1	O
.	O
45	O
and	O
tachypnea	O
relative	O
risk	O
,	O
1	O
.	O
26	O
;	O
1	O
.	O
10	O
-	O
1	O
.	O
44	O
)	O
and	O
lower	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
(	O
relative	O
risk	O
,	O
5	O
.	O
61	O
for	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
3	O
vs	O
15	O
;	O
4	O
.	O
44	O
-	O
7	O
.	O
07	O
).	O

ABSTRACT	O
:	O
Infectious	O
Bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
genotype	O
Q1	O
was	O
detected	O
for	O
the	O
first	O
time	O
in	O
China	O
in	O
1996	O
,	O
and	O
then	O
spread	O
worldwide	O
.	O

TITLE	O
:	O
Development	O
and	O
application	O
of	O
an	O
indirect	O
ELISA	O
for	O
the	O
detection	O
of	O
antibodies	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
based	O
on	O
a	O
recombinant	O
spike	O
protein	O
.	O

Finally	O
,	O
the	O
S1	O
indirect	O
ELISA	O
was	O
applied	O
to	O
detect	O
serum	O
antibodies	O
of	O
3304	O
field	O
samples	O
collected	O
from	O
different	O
pig	B-SPEC
farms	O
in	O
eastern	O
China	O
,	O
and	O
it	O
presented	O
an	O
overall	O
substantial	O
agreement	O
on	O
the	O
PEDV	B-SPEC
infection	O
status	O
.	O

ABSTRACT	O
:	O
The	O
mechanisms	O
involved	O
in	O
virus	B-SPEC
-	O
induced	O
severe	O
hepatitis	O
have	O
not	O
been	O
fully	O
elucidated	O
.	O

The	O
model	O
of	O
FVH	O
was	O
established	O
by	O
intraperitoneal	O
injection	O
of	O
MHV	B-SPEC
-	O
3	O
into	O
Balb	O
/	O
cJ	O
mice	B-SPEC
.	O

These	O
results	O
demonstrated	O
that	O
	O
T	O
cells	O
might	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
MHV	B-SPEC
-	O
3	O
-	O
induced	O
FVH	O
through	O
the	O
effector	O
cytokines	O
TNF	O
-	O
	O
and	O
IFN	O
-	O
	O
.	O

TITLE	O
:	O
Structural	O
and	O
Biochemical	O
Characterization	O
of	O
Endoribonuclease	O
Nsp15	O
Encoded	O
by	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Nonstructural	O
protein	O
15	O
(	O
Nsp15	O
)	O
encoded	O
by	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
is	O
a	O
nidoviral	O
uridylate	O
-	O
specific	O
endoribonuclease	O
(	O
NendoU	O
)	O
that	O
plays	O
an	O
essential	O
role	O
in	O
the	O
life	O
cycle	O
of	O
the	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
the	O
influenza	B-SPEC
virus	I-SPEC
hemagglutinin	O
are	O
class	B-SPEC
I	O
viral	O
membrane	O
fusion	O
proteins	O
.	O

In	O
this	O
study	O
,	O
we	O
constructed	O
scIAV	O
-	O
S	O
,	O
a	O
single	O
-	O
cycle	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
pseudotyped	O
with	O
the	O
spike	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
and	O
demonstrated	O
that	O
this	O
virus	B-SPEC
could	O
infect	O
cultured	O
cells	O
and	O
trigger	O
massive	O
syncytium	O
formation	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
risk	O
of	O
hospitalization	O
from	O
different	O
viruses	B-SPEC
in	O
children	O
presenting	O
with	O
an	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
).	O

The	O
most	O
frequent	O
viruses	B-SPEC
detected	O
as	O
single	O
pathogens	O
were	O
RSV	B-SPEC
(	O
n	O
=	O
286	O
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
n	O
=	O
251	O
),	O
parainfluenza	O
viruses	B-SPEC
(	O
n	O
=	O
104	O
),	O
and	O
influenza	O
A	O
or	O
B	O
(	O
n	O
=	O
99	O
).	O

ABSTRACT	O
:	O
In	O
pregnancy	O
,	O
infection	O
with	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
may	O
produce	O
symptoms	O
similar	O
to	O
infection	O
with	O
seasonal	O
influenza	B-SPEC
virus	I-SPEC
.	O

In	O
this	O
study	O
,	O
four	O
sdAb	O
fragments	O
(	O
sdAb	O
-	O
Mc19	O
/	O
29	O
/	O
30	O
/	O
37	O
)	O
targeting	O
the	O
membrane	O
(	O
M	O
)	O
protein	O
of	O
PEDV	B-SPEC
were	O
selected	O
from	O
sdAb	O
library	O
that	O
was	O
constructed	O
through	O
M	O
protein	O
-	O
immunized	O
Camelus	B-SPEC
bactrianus	I-SPEC
.	O

The	O
selected	O
sdAb	O
-	O
Mcs	O
were	O
solubly	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

The	O
functional	O
characteristics	O
analysis	O
revealed	O
that	O
the	O
recombinant	O
sdAb	O
-	O
Mcs	O
have	O
excellent	O
binding	O
activity	O
and	O
specificity	O
to	O
M	O
protein	O
but	O
have	O
no	O
neutralizing	O
activity	O
to	O
PEDV	B-SPEC
.	O

The	O
observed	O
fluorescence	O
in	O
vero	O
cells	O
clearly	O
reflects	O
that	O
PEDV	B-SPEC
virions	O
can	O
be	O
reliably	O
recognized	O
and	O
labeled	O
by	O
the	O
nanoprobe	O
.	O

This	O
study	O
provided	O
a	O
novel	O
application	O
and	O
substantiated	O
the	O
suitability	O
of	O
sdAb	O
as	O
a	O
specific	O
binder	O
for	O
the	O
isolation	O
of	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Modulation	O
of	O
the	O
immune	O
response	O
by	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Enhanced	O
pathogenicity	O
of	O
low	O
-	O
pathogenic	O
H9N2	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
after	O
vaccination	O
with	O
infectious	O
bronchitis	O
live	O
attenuated	O
vaccine	O
.	O

Results	O
demonstrated	O
the	O
increase	O
in	O
pathogenicity	O
of	O
H9N2	O
AIV	O
,	O
especially	O
when	O
H9N2	O
-	O
infected	O
chicks	O
vaccinated	O
with	O
live	O
IBV	B-SPEC
vaccine	O
.	O

These	O
viruses	B-SPEC
are	O
particularly	O
dangerous	O
in	O
regions	O
associated	O
with	O
poor	O
development	O
indicators	O
and	O
high	O
vulnerability	O
.	O

Two	O
IBV	B-SPEC
isolates	O
,	O
IBV	B-SPEC
S40	O
and	O
IBV	B-SPEC
S61	O
are	O
related	O
to	O
Mass	O
reference	O
strains	O
(	O
Egypt	O
/	O
F	O
/	O
03	O
,	O
M41	O
,	O
H120	O
,	O
Ma5	O
,	O
and	O
M52	O
).	O

TITLE	O
:	O
Deposition	O
of	O
respiratory	O
virus	B-SPEC
pathogens	O
on	O
frequently	O
touched	O
surfaces	O
at	O
airports	O
.	O

Among	O
the	O
10	O
respiratory	O
virus	B-SPEC
findings	O
at	O
various	O
sites	O
,	O
the	O
viruses	B-SPEC
identified	O
were	O
:	O
rhinovirus	B-SPEC
(	O
4	O
/	O
10	O
,	O
40	O
%,	O
from	O
surfaces	O
);	O
coronavirus	B-SPEC
(	O
3	O
/	O
10	O
,	O
30	O
%,	O
from	O
surfaces	O
);	O
adenovirus	B-SPEC
(	O
2	O
/	O
10	O
,	O
20	O
%,	O
1	O
air	O
sample	O
,	O
1	O
surface	O
sample	O
);	O
influenza	O
A	O
(	O
1	O
/	O
10	O
,	O
10	O
%,	O
surface	O
sample	O
).	O

There	O
were	O
211	O
,	O
000	O
Indonesian	O
Hajj	O
pilgrims	O
going	O
to	O
Mecca	O
through	O
11	O
main	O
airports	O
in	O
2015	O
who	O
were	O
at	O
risk	O
of	O
contracting	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

qPCR	O
was	O
performed	O
to	O
analyze	O
PEDV	B-SPEC
binding	O
to	O
Vero	O
E6	O
cells	O
with	O
neutralizing	O
antibody	O
.	O

Here	O
,	O
we	O
conducted	O
a	O
retrospective	O
investigation	O
of	O
236	O
samples	O
from	O
45	O
swine	B-SPEC
farms	O
with	O
a	O
clinical	O
history	O
of	O
diarrheal	O
disease	O
to	O
evaluate	O
the	O
emergence	O
and	O
the	O
distribution	O
of	O
SADS	O
-	O
CoV	O
in	O
pigs	B-SPEC
in	O
China	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
papilloma	I-SPEC
virus	I-SPEC
(	O
HPV	O
)	O
is	O
a	O
necessary	O
cause	O
of	O
cervical	O
cancer	B-SPEC
and	O
is	O
also	O
closely	O
related	O
to	O
penile	O
cancer	B-SPEC
,	O
oropharyngeal	O
cancer	B-SPEC
,	O
and	O
anal	O
cancer	B-SPEC
in	O
males	O
.	O

We	O
obtained	O
samples	O
with	O
nylon	O
swabs	O
from	O
the	O
glans	O
penis	O
,	O
corona	B-SPEC
,	O
inner	O
layer	O
of	O
the	O
prepuce	O
and	O
penile	O
body	O
and	O
detected	O
different	O
types	O
of	O
HPV	O
infection	O
using	O
the	O
Hybribio	O
HPV	O
typing	O
kit	O
,	O
PCR	O
and	O
membrane	O
hybridization	O
.	O

TITLE	O
:	O
Comparative	O
Pathogenicity	O
of	O
Malaysian	O
QX	O
-	O
like	O
and	O
Variant	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Strains	O
in	O
Chickens	B-SPEC
at	O
Different	O
Age	O
of	O
Exposure	O
to	O
the	O
Viruses	B-SPEC
.	O

TITLE	O
:	O
Multiplex	O
Detection	O
of	O
Five	O
Canine	O
Viral	O
Pathogens	O
for	O
Dogs	B-SPEC
as	O
Laboratory	O
Animals	B-SPEC
by	O
the	O
Luminex	O
xTAG	O
Assay	O
.	O

Therefore	O
,	O
it	O
is	O
important	O
to	O
make	O
sure	O
that	O
the	O
dogs	B-SPEC
and	O
their	O
living	O
houses	O
are	O
special	O
pathogen	O
free	O
.	O

Among	O
them	O
,	O
23	O
.	O
4	O
%	O
were	O
viral	O
-	O
positive	O
by	O
mPCR	O
,	O
with	O
influenza	B-SPEC
virus	I-SPEC
most	O
prominent	O
followed	O
by	O
picornavirus	B-SPEC
.	O

Sialic	O
acid	O
,	O
proteases	O
,	O
and	O
low	O
pH	O
are	O
three	O
main	O
inducers	O
of	O
coronavirus	B-SPEC
infection	O
.	O

However	O
,	O
the	O
details	O
of	O
how	O
sialic	O
acid	O
and	O
low	O
pH	O
affect	O
virus	B-SPEC
binding	O
to	O
the	O
host	O
cell	O
are	O
not	O
determined	O
,	O
and	O
the	O
functions	O
of	O
the	O
proteases	O
are	O
unknown	O
.	O

Additionally	O
,	O
a	O
novel	O
procedure	O
for	O
chromatography	O
purification	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
VLPs	O
was	O
developed	O
.	O

TITLE	O
:	O
Clinical	O
and	O
Epidemiologic	O
Patterns	O
of	O
Chikungunya	B-SPEC
Virus	I-SPEC
Infection	O
and	O
Coincident	O
Arboviral	O
Disease	O
in	O
a	O
School	O
Cohort	O
in	O
Haiti	O
,	O
2014	O
-	O
2015	O
.	O

Synthesized	O
QDs	O
was	O
further	O
conjugated	O
with	O
anti	O
-	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
antibodies	O
of	O
coronavirus	B-SPEC
to	O
form	O
an	O
immunolink	O
at	O
the	O
presence	O
of	O
the	O
target	O
analyte	O
and	O
anti	O
-	O
IBV	B-SPEC
antibody	O
-	O
conjugated	O
magneto	O
-	O
plasmonic	O
nanoparticles	O
(	O
MPNPs	O
).	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
report	O
for	O
the	O
first	O
time	O
the	O
existence	O
of	O
complemented	O
palindromic	O
small	O
RNAs	O
(	O
cpsRNAs	O
)	O
and	O
propose	O
that	O
cpsRNAs	O
and	O
palindromic	O
small	O
RNAs	O
(	O
psRNAs	O
)	O
constitute	O
a	O
novel	O
class	B-SPEC
of	O
small	O
RNAs	O
.	O

The	O
first	O
discovered	O
19	O
-	O
nt	O
cpsRNA	O
UUAACAAGCUUGUUAAAGA	O
,	O
named	O
SARS	O
-	O
CoV	O
-	O
cpsR	O
-	O
19	O
,	O
was	O
detected	O
from	O
a	O
22	O
-	O
bp	O
DNA	O
complemented	O
palindrome	O
TCTTTAACAAGCTTGTTAAAGA	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
.	O

Researchers	O
can	O
use	O
cpsRNAs	O
to	O
study	O
the	O
infection	O
or	O
pathogenesis	O
of	O
pathogenic	O
viruses	B-SPEC
when	O
these	O
viruses	B-SPEC
are	O
not	O
available	O
.	O

Immediately	O
after	O
the	O
first	O
cerulein	O
injection	O
,	O
phosphate	O
-	O
buffered	O
saline	O
,	O
human	B-SPEC
serum	O
albumin	O
(	O
20	O
mg	O
/	O
kg	O
),	O
or	O
HRG	O
(	O
20	O
mg	O
/	O
kg	O
)	O
was	O
intravenously	O
injected	O
.	O

RESULTS	O
:	O
We	O
observed	O
significantly	O
decreased	O
plasma	O
HRG	O
levels	O
in	O
an	O
acute	O
pancreatitis	O
mouse	B-SPEC
model	O
.	O

In	O
terms	O
of	O
diseases	O
,	O
the	O
expert	O
panel	O
regarded	O
knowledge	O
of	O
Hendra	B-SPEC
virus	I-SPEC
,	O
Q	O
fever	O
,	O
Australian	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
(	O
ABLV	O
),	O
anthrax	B-SPEC
and	O

ABSTRACT	O
:	O
Hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
disease	O
progression	O
in	O
East	O
Asia	O
is	O
most	O
frequently	O
associated	O
with	O
genotype	O
C	O
(	O
HBV	B-SPEC
/	O
C	O
).	O

The	O
importance	O
of	O
MLeV	O
and	O
AAbV	O
for	O
understanding	O
nidovirus	B-SPEC
evolution	O
,	O
and	O
the	O
origin	O
of	O
terrestrial	O
nidoviruses	B-SPEC
are	O
discussed	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
was	O
detected	O
only	O
among	O
children	O
under	O
5	O
years	O
old	O
in	O
August	O
and	O
September	O
while	O
coronavirus	B-SPEC
was	O
present	O
in	O
all	O
age	O
groups	O
,	O
during	O
the	O
months	O
of	O
October	O
and	O
December	O
.	O

ABSTRACT	O
:	O
Bat	B-SPEC
populations	O
harbour	O
a	O
multitude	O
of	O
viruses	B-SPEC
;	O
some	O
of	O
these	O
are	O
pathogenic	O
or	O
potentially	O
pathogenic	O
in	O
other	O
animals	B-SPEC
or	O
humans	B-SPEC
.	O

Over	O
the	O
previous	O
centuries	O
,	O
global	O
pandemics	O
of	O
infectious	O
diseases	O
,	O
such	O
as	O
smallpox	B-SPEC
,	O
cholera	O
,	O
and	O
influenza	O
,	O
periodically	O
threatened	O
the	O
survival	O
of	O
entire	O
populations	O
.	O

The	O
herpesviruses	B-SPEC
identified	O
were	O
related	O
to	O
the	O
infectious	B-SPEC
laryngotracheitis	I-SPEC
virus	I-SPEC
(	O
Gallid	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
)	O
of	O
the	O
genus	B-SPEC
Iltovirus	I-SPEC
(	O
bootstrap	O
clade	O
support	O
=	O
99	O
%).	O

We	O
provide	O
information	O
about	O
the	O
diversity	O
of	O
viruses	B-SPEC
circulating	O
among	O
apparently	O
healthy	O
Neotropic	O
Cormorants	B-SPEC
.	O

The	O
immunized	O
chickens	B-SPEC
were	O
challenged	O
with	O
5x10	O
(	O
4	O
.	O
7	O
)	O
EID50	O
IBV	B-SPEC
M41	O
strain	O
.	O

Chickens	B-SPEC
immunized	O
with	O
IBV	B-SPEC
-	O
Flagellin	O
-	O
SAPN	O
had	O
a	O
significant	O
reduction	O
of	O
tracheal	O
virus	B-SPEC
shedding	O
and	O
lesser	O
tracheal	O
lesion	O
scores	O
than	O
did	O
negative	O
control	O
chickens	B-SPEC
.	O

No	O
cross	O
-	O
reaction	O
was	O
detected	O
with	O
antibodies	O
against	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
subtypes	O
(	O
H5	O
,	O
H7	O
,	O
and	O
H9	O
),	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
Marek	B-SPEC
'	I-SPEC
s	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
and	O
chicken	B-SPEC
anemia	I-SPEC
virus	I-SPEC
.	O

Clinicians	O
should	O
consider	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
for	O
patients	O
in	O
similar	O
settings	O
with	O
respiratory	O
disease	O
.	O

Mice	B-SPEC
were	O
twice	O
subcutaneously	O
injected	O
with	O
PEDV	B-SPEC
vaccine	O
including	O
high	O
,	O
medium	O
and	O
low	O
dosages	O
CVC1303	O
,	O
respectively	O
.	O

On	O
30th	O
day	O
after	O
the	O
second	O
immunization	O
,	O
sera	O
samples	O
were	O
collected	O
from	O
the	O
immunized	O
mice	B-SPEC
to	O
measure	O
PEDV	B-SPEC
-	O
specific	O
IgG	O
and	O
IgG	O
subclasses	O
levels	O
,	O
and	O
lymphocytes	O
were	O
isolated	O
to	O
detect	O
T	O
cell	O
subtype	O
and	O
intracellular	O
IL	O
-	O
4	O
and	O
IL	O
-	O
6	O
cytokine	O
productions	O
,	O
and	O
the	O
expressions	O
of	O
co	O
-	O
stimulatory	O
molecule	O
on	O
dendritic	O
cells	O
in	O
the	O
immunized	O
mice	B-SPEC
.	O

We	O
found	O
that	O
even	O
at	O
a	O
very	O
low	O
concentration	O
,	O
Caerin1	O
.	O
1	O
has	O
the	O
ability	O
to	O
destroy	O
the	O
integrity	O
of	O
the	O
virus	B-SPEC
particles	O
to	O
block	O
the	O
release	O
of	O
the	O
viruses	B-SPEC
,	O
resulting	O
in	O
a	O
considerable	O
decrease	O
in	O
PEDV	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
Influenza	B-SPEC
viruses	I-SPEC
and	O
rhinoviruses	B-SPEC
are	O
responsible	O
for	O
a	O
large	O
number	O
of	O
acute	O
respiratory	O
viral	O
infections	O
in	O
human	B-SPEC
populations	O
and	O
are	O
detected	O
as	O
copathogens	O
within	O
hosts	O
.	O

To	O
determine	O
how	O
coinfection	O
by	O
these	O
two	O
unrelated	O
respiratory	O
viruses	B-SPEC
affects	O
pathogenesis	O
,	O
we	O
established	O
a	O
mouse	B-SPEC
model	O
using	O
a	O
minor	O
serogroup	O
rhinovirus	B-SPEC
(	O
rhinovirus	B-SPEC
strain	O
1B	O
[	O
RV1B	O
])	O
and	O
mouse	B-SPEC
-	O
adapted	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
A	O
/	O
Puerto	O
Rico	O
/	O
8	O
/	O
1934	O
[	O
PR8	O
]).	O

ABSTRACT	O
:	O
Neurotropic	O
strains	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
induce	O
acute	O
inflammation	O
and	O
chronic	O
demyelination	O
in	O
the	O
spinal	O
cord	O
and	O
optic	O
nerves	O
mediated	O
by	O
axonal	O
spread	O
following	O
intracranial	O
inoculation	O
in	O
mice	B-SPEC
,	O
with	O
pathologic	O
features	O
similar	O
to	O
the	O
human	B-SPEC
demyelinating	O
disease	O
multiple	O
sclerosis	O
.	O

TGEV	B-SPEC
primarily	O
targets	O
and	O
infects	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
nutrient	O
absorption	O
.	O

However	O
,	O
the	O
effects	O
of	O
TGEV	B-SPEC
infection	O
on	O
nutrient	O
absorption	O
in	O
swine	B-SPEC
have	O
not	O
yet	O
been	O
investigated	O
.	O

Of	O
22	O
persons	O
,	O
all	O
washed	O
hands	O
after	O
handling	O
camels	B-SPEC
,	O
82	O
%	O
wore	O
gumboots	O
,	O
and	O
65	O
%	O
wore	O
overalls	O
/	O
dustcoats	O
.	O

ABSTRACT	O
:	O
Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	O
)	O
causes	O
severe	O
respiratory	O
infections	O
and	O
alveolar	O
epithelial	O
damage	O
resulting	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Isolate	O
LDL	O
/	O
150434	O
-	O
I	O
was	O
a	O
re	O
-	O
isolation	O
of	O
H120	O
vaccine	O
strain	O
that	O
was	O
introduced	O
into	O
the	O
chicken	B-SPEC
flock	O
by	O
vaccination	O
,	O
transmitted	O
between	O
chickens	B-SPEC
,	O
and	O
later	O
accumulated	O
several	O
genomic	O
mutations	O
.	O

Furthermore	O
,	O
synergistic	O
effects	O
on	O
pathogenicity	O
were	O
not	O
observed	O
when	O
the	O
different	O
types	O
co	O
-	O
infected	O
the	O
SPF	O
chickens	B-SPEC
.	O

However	O
,	O
the	O
isolates	O
persisted	O
in	O
the	O
respiratory	O
tracts	O
longer	O
in	O
combined	O
infected	O
birds	B-SPEC
than	O
those	O
in	O
individual	O
infected	O
birds	B-SPEC
.	O

While	O
no	O
MERS	O
-	O
CoV	O
infections	O
were	O
detected	O
,	O
10	O
.	O
36	O
%	O
of	O
patients	O
in	O
the	O
survey	O
were	O
infected	O
with	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
43	O
.	O
43	O
%),	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
(	O
44	O
.	O
95	O
%),	O
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
11	O
.	O
62	O
%)	O
viruses	B-SPEC
.	O

The	O
microspheres	O
coated	O
with	O
purified	O
recombinant	O
glycoprotein	O
D	O
(	O
gD	O
)	O
of	O
ILTV	B-SPEC
or	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
IBV	B-SPEC
were	O
incubated	O
with	O
serum	O
samples	O
.	O

The	O
simultaneous	O
quantification	O
of	O
ILTV	B-SPEC
and	O
IBV	B-SPEC
antibodies	O
were	O
achieved	O
through	O
the	O
interrogation	O
of	O
microspheres	O
by	O
Luminex	O
200	O
detection	O
system	O
.	O
.	O

Furthermore	O
,	O
neutralization	O
assays	O
demonstrated	O
that	O
serum	O
antibodies	O
in	O
coated	O
PEDV	B-SPEC
-	O
loaded	O
microspheres	O
groups	O
could	O
significantly	O
inhibit	O
virus	B-SPEC
infection	O
in	O
Vero	O
cells	O
,	O
compared	O
to	O
PEDV	B-SPEC
only	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Overall	O
,	O
our	O
results	O
indicate	O
that	O
the	O
coated	O
PEDV	B-SPEC
-	O
loaded	O
microspheres	O
might	O
serve	O
as	O
an	O
effective	O
way	O
to	O
induce	O
PEDV	B-SPEC
-	O
specific	O
mucosal	O
immunity	O
in	O
pigs	B-SPEC
against	O
PEDV	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
213	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
were	O
isolated	O
from	O
samples	O
collected	O
from	O
801	O
flocks	O
suspected	O
to	O
be	O
infected	O
with	O
IBV	B-SPEC
from	O
January	O
2016	O
to	O
December	O
2017	O
in	O
China	O
.	O

In	O
order	B-SPEC
to	O
prevent	O
P	O
-	O
SILI	O
,	O
patients	O
are	O
generally	O
heavily	O
sedated	O
and	O
receive	O
muscle	O
relaxation	O
,	O
resulting	O
in	O
a	O
slower	O
weaning	O
process	O
.	O

TITLE	O
:	O
Burden	O
of	O
exposure	O
to	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
,	O
and	O
intestinal	O
parasites	O
in	O
introduced	O
broiler	O
chickens	B-SPEC
on	O
the	O
Galapagos	O
.	O

Blood	O
serum	O
samples	O
were	O
tested	O
for	O
detection	O
of	O
antibodies	O
to	O
IBDV	B-SPEC
,	O
IBV	B-SPEC
,	O
NDV	B-SPEC
,	O
and	O
MG	O
by	O
using	O
an	O
IDEXX	O
Enzyme	O
-	O
linked	O
Immunosorbent	O
Assay	O
.	O

This	O
study	O
produced	O
evidence	O
that	O
exposure	O
to	O
IBDV	B-SPEC
,	O
IBV	B-SPEC
,	O
and	O
intestinal	O
parasites	O
in	O
broilers	O
on	O
Santa	O
Cruz	O
Island	O
and	O
San	O
Cristobal	O
Island	O
is	O
important	O
.	O

Whereas	O
the	O
variability	O
of	O
virulence	O
among	O
reservoir	O
-	O
borne	O
viruses	B-SPEC
is	O
unknown	O
,	O
it	O
is	O
generally	O
assumed	O
that	O
the	O
emergence	O
of	O
epidemic	O
viruses	B-SPEC
from	O
animal	B-SPEC
reservoirs	O
requires	O
human	B-SPEC
adaptation	O
.	O

Using	O
ectopically	O
-	O
expressed	O
PLP	O
variants	O
as	O
well	O
as	O
full	O
SARS	O
-	O
CoV	O
infectious	O
clones	O
chimerized	O
for	O
PLP	O
,	O
we	O
found	O
that	O
a	O
protease	O
-	O
independent	O
,	O
anti	O
-	O
IFN	O
function	O
exists	O
in	O
SARS	O
-	O
CoV	O
,	O
but	O
not	O
in	O
a	O
SARS	O
-	O
related	O
,	O
bat	B-SPEC
-	O
borne	O
virus	B-SPEC
.	O

The	O
presence	O
of	O
the	O
TGEV	B-SPEC
antigen	O
was	O
confirmed	O
by	O
monoclonal	O
specific	O
immunohistochemistry	O
,	O
and	O
final	O
confirmation	O
of	O
a	O
metabolically	O
-	O
active	O
virus	B-SPEC
was	O
performed	O
by	O
in	O
situ	O
hybridization	O
to	O
detect	O
a	O
TGE	O
mRNA	O
encoding	O
spike	O
protein	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
regulation	O
of	O
apoptosis	O
-	O
inducing	O
factor	O
(	O
AIF	O
)	O
on	O
TGEV	B-SPEC
-	O
induced	O
apoptotic	O
pathway	O
.	O

Furthermore	O
,	O
TGEV	B-SPEC
-	O
induced	O
apoptosis	O
was	O
blocked	O
by	O
combination	O
of	O
three	O
or	O
more	O
inhibitors	O
,	O
such	O
as	O
pan	B-SPEC
caspase	O
inhibitor	O
Z	O
-	O
VAD	O
-	O
FMK	O
,	O
NP	O
,	O
ABT	O
-	O
888	O
,	O
PDTC	O
,	O
PFT	O
-	O
	O
,	O
to	O
treat	O
PK	O
-	O
15	O
cells	O
.	O

Based	O
on	O
the	O
results	O
of	O
the	O
serologic	O
test	O
,	O
77	O
%,	O
45	O
%,	O
and	O
38	O
.	O
4	O
%	O
of	O
the	O
birds	B-SPEC
were	O
positive	O
for	O
NDV	B-SPEC
,	O
AIV	O
,	O
and	O
IBV	B-SPEC
,	O
respectively	O
.	O

In	O
the	O
RT	O
-	O
PCR	O
,	O
95	O
%	O
of	O
the	O
birds	B-SPEC
were	O
positive	O
for	O
one	O
of	O
the	O
three	O
viruses	B-SPEC
.	O

Finally	O
,	O
administration	O
of	O
rshDPP4	O
led	O
to	O
reduced	O
lung	O
virus	B-SPEC
titer	O
and	O
histopathology	O
.	O

RESULTS	O
:	O
hDPP4	O
+/+	O
mice	B-SPEC
were	O
unexpectedly	O
more	O
resistant	O
than	O
hDPP4	O
+/-	O
mice	B-SPEC
to	O
MERS	O
-	O
CoV	O
infection	O
,	O
as	O
judged	O
by	O
increased	O
LD50	O
,	O
reduced	O
lung	O
viral	O
infection	O
,	O
attenuated	O
morbidity	O
and	O
mortality	O
,	O
and	O
reduced	O
histopathology	O
.	O

Finally	O
,	O
administration	O
of	O
rshDPP4	O
led	O
to	O
reduced	O
lung	O
virus	B-SPEC
titer	O
and	O
histopathology	O
.	O

Moreover	O
,	O
purified	O
lysosomal	O
extracts	O
from	O
bat	B-SPEC
cells	O
cleave	O
cell	O
surface	O
-	O
expressed	O
coronavirus	B-SPEC
spikes	O
more	O
efficiently	O
than	O
their	O
counterparts	O
from	O
human	B-SPEC
cells	O
.	O

TITLE	O
:	O
First	O
outbreak	O
with	O
chimeric	O
swine	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
SeCoV	O
)	O
on	O
pig	B-SPEC
farms	O
in	O
Slovakia	O
-	O
lessons	O
to	O
learn	O
.	O

Inhibition	O
of	O
IFN	O
production	O
by	O
non	O
-	O
structural	O
and	O
structural	O
proteins	O
,	O
excluding	O
spike	O
protein	O
has	O
been	O
reported	O
in	O
many	O
coronavirus	B-SPEC
infections	O
.	O

TITLE	O
:	O
Simple	O
,	O
Rapid	O
and	O
Sensitive	O
Portable	O
Molecular	O
Diagnosis	O
of	O
SFTS	O
Virus	B-SPEC
Using	O
Reverse	O
Transcriptional	O
Loop	O
-	O
Mediated	O
Isothermal	O
Amplification	O
(	O
RT	O
-	O
LAMP	O
).	O

In	O
this	O
study	O
,	O
we	O
assessed	O
improvements	O
in	O
laboratory	O
practice	O
brought	O
about	O
by	O
the	O
implementation	O
of	O
the	O
rapid	O
test	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Sequencing	O
and	O
In	O
Silico	O
Multi	O
-	O
aspect	O
Analysis	O
of	O
S1	O
Glycoprotein	O
in	O
793	O
/	O
B	O
Serotype	O
of	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Isolated	O
From	O
Iran	O
in	O
2003	O
and	O
2011	O
.	O

TITLE	O
:	O
Detection	O
of	O
neutralizing	O
antibody	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
subclinically	O
infected	O
finishing	O
pigs	B-SPEC
.	O

Therefore	O
,	O
subclinically	O
infected	O
pigs	B-SPEC
should	O
be	O
considered	O
prior	O
to	O
shipment	O
.	O

Further	O
in	O
silico	O
studies	O
identified	O
the	O
key	O
molecular	O
interactions	O
between	O
those	O
compounds	O
and	O
the	O
3	O
-	O
chymotrypsin	O
-	O
like	O
protease	O
,	O
which	O
is	O
essential	O
to	O
the	O
intracellular	O
replication	O
of	O
the	O
virus	B-SPEC
,	O
supporting	O
the	O
hypothesis	O
that	O
the	O
protease	O
is	O
the	O
target	O
molecule	O
of	O
the	O
potential	O
antiviral	O
derivatives	O
.	O

It	O
has	O
a	O
long	O
half	O
-	O
life	O
in	O
the	O
soil	O
and	O
can	O
potentially	O
contaminate	O
humans	B-SPEC
and	O
animals	B-SPEC
through	O
food	O
.	O

ABSTRACT	O
:	O
The	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
poses	O
a	O
great	O
threat	O
to	O
the	O
global	O
swine	B-SPEC
industries	O
and	O
the	O
unreliable	O
protection	O
induced	O
by	O
the	O
currently	O
available	O
vaccines	O
remains	O
a	O
major	O
challenge	O
.	O

In	O
the	O
5	O
-	O
week	O
-	O
old	O
piglet	O
model	O
,	O
fecal	O
viral	O
shedding	O
was	O
observed	O
in	O
the	O
PEDVPT	O
-	O
P96	O
-	O
inoculated	O
piglets	O
,	O
whereas	O
those	O
inoculated	O
with	O
iPEDVPT	O
-	O
P96	O
showed	O
neither	O
detectable	O
fecal	O
viral	O
shedding	O
nor	O
PEDV	B-SPEC
-	O
associated	O
clinical	O
signs	O
.	O

Many	O
viruses	B-SPEC
affecting	O
equines	B-SPEC
are	O
also	O
important	O
human	B-SPEC
pathogens	O
.	O

Diseases	O
like	O
Eastern	O
equine	B-SPEC
encephalitis	O
(	O
EEE	O
),	O
Western	O
equine	B-SPEC
encephalitis	O
(	O
WEE	O
),	O
and	O
Venezuelan	O
-	O
equine	B-SPEC
encephalitis	O
(	O
VEE	O
)	O
are	O
highly	O
infectious	O
and	O
can	O
be	O
disseminated	O
as	O
aerosols	O
.	O

Vesicular	O
stomatitis	O
(	O
VS	O
)	O
is	O
prevalent	O
in	O
horses	B-SPEC
in	O
North	O
America	O
and	O
has	O
zoonotic	O
potential	O
causing	O
encephalitis	O
in	O
children	O
.	O

Since	O
its	O
first	O
outbreak	O
in	O
1994	O
,	O
53	O
disease	O
incidents	O
Equine	B-SPEC
viral	O
diseases	O
though	O
restricted	O
to	O
certain	O
geographical	O
areas	O
have	O
huge	O
impact	O
on	O
equine	B-SPEC
and	O
human	B-SPEC
health	O
.	O

ABSTRACT	O
:	O
We	O
tested	O
sera	O
of	O
24	O
free	O
-	O
ranging	O
European	B-SPEC
brown	I-SPEC
bears	I-SPEC
(	O
Ursus	B-SPEC
arctos	I-SPEC
)	O
from	O
six	O
regions	O
of	O
Slovakia	O
for	O
antibodies	O
to	O
10	O
viral	O
agents	O
.	O

The	O
other	O
was	O
a	O
61	O
-	O
year	O
-	O
old	O
man	B-SPEC
treated	O
with	O
fluconazole	O
and	O
then	O
amphotericin	O
for	O
3	O
weeks	O
,	O
with	O
progression	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
shock	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
remains	O
a	O
notable	O
disease	O
and	O
poses	O
a	O
significant	O
threat	O
to	O
global	O
public	O
health	O
.	O

The	O
Arabian	O
Peninsula	O
is	O
considered	O
a	O
major	O
global	O
epicentre	O
for	O
the	O
disease	O
and	O
the	O
virus	B-SPEC
has	O
crossed	O
regional	O
and	O
continental	O
boundaries	O
since	O
2012	O
.	O

TITLE	O
:	O
Evaluating	O
Extravascular	O
Lung	O
Water	O
in	O
Sepsis	B-SPEC
:	O
Three	O
Lung	O
-	O
Ultrasound	O
Techniques	O
Compared	O
against	O
Transpulmonary	O
Thermodilution	O
.	O

Among	O
them	O
are	O
filoviruses	O
(	O
e	O
.	O
g	O
.,	O
Marburg	O
,	O
Ebola	O
),	O
coronaviruses	O
(	O
e	O
.	O
g	O
.,	O
SARS	O
,	O
MERS	O
),	O
henipaviruses	B-SPEC
(	O
e	O
.	O
g	O
.,	O
Hendra	O
,	O
Nipah	O
)	O
which	O
share	O
the	O
common	O
features	O
that	O
they	O
are	O
all	O
RNA	O
viruses	B-SPEC
,	O
and	O
that	O
a	O
dysregulated	O
immune	O
response	O
is	O
an	O
important	O
contributor	O
to	O
the	O
tissue	O
damage	O
and	O
hence	O
pathogenicity	O
that	O
results	O
from	O
infection	O
in	O
humans	B-SPEC
.	O

Do	O
our	O
life	O
history	O
traits	O
make	O
us	O
susceptible	O
to	O
generating	O
damaging	O
immune	O
responses	O
to	O
RNA	O
viruses	B-SPEC
or	O
does	O
the	O
physiology	O
of	O
bats	B-SPEC
make	O
them	O
particularly	O
tolerant	O
or	O
resistant	O
?	O

ABSTRACT	O
:	O
A	O
61	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
by	O
ambulance	O
with	O
dyspnea	O
.	O

ABSTRACT	O
:	O
A	O
29	O
nucleotide	O
deletion	O
in	O
open	O
reading	O
frame	O
8	O
(	O
ORF8	O
)	O
is	O
the	O
most	O
obvious	O
genetic	O
change	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
during	O
its	O
emergence	O
in	O
humans	B-SPEC
.	O

In	O
spite	O
of	O
intense	O
study	O
,	O
it	O
remains	O
unclear	O
whether	O
the	O
deletion	O
actually	O
reflects	O
adaptation	O
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
Countrywide	O
Survey	O
for	O
MERS	O
-	O
Coronavirus	B-SPEC
Antibodies	O
in	O
Dromedaries	B-SPEC
and	O
Humans	B-SPEC
in	O
Pakistan	O
.	O

Samples	O
were	O
collected	O
from	O
animal	B-SPEC
markets	O
,	O
free	O
-	O
roaming	O
herds	O
and	O
abattoirs	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
infection	O
can	O
activate	O
NF	O
-	O
B	O
pathway	O
in	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
and	O
result	O
in	O
severe	O
inflammation	O
.	O

In	O
this	O
study	O
,	O
the	O
next	O
-	O
generation	O
sequencing	O
(	O
NGS	O
)	O
technology	O
was	O
used	O
to	O
analyze	O
the	O
profiles	O
of	O
mRNAs	O
,	O
miRNAs	O
,	O
and	O
circRNAs	O
in	O
Mock	O
-	O
and	O
TGEV	B-SPEC
-	O
infected	O
intestinal	O
porcine	B-SPEC
epithelial	O
cell	O
-	O
jejunum	O
2	O
(	O
IPEC	O
-	O
J2	O
)	O
cell	O
line	O
.	O

We	O
also	O
observed	O
that	O
overexpression	O
of	O
miR	O
-	O
22	O
led	O
to	O
a	O
reduction	O
of	O
p	O
-	O
IB	O
-	O
	O
and	O
accumulation	O
of	O
p65	O
in	O
nucleus	O
in	O
TGEV	B-SPEC
-	O
infected	O
IPEC	O
-	O
J2	O
cells	O
.	O

A	O
man	B-SPEC
in	O
his	O
50s	O
with	O
a	O
medical	O
history	O
notable	O
for	O
hypertension	O
was	O
transferred	O
to	O
our	O
institution	O
for	O
evaluation	O
of	O
refractory	O
hypoxemia	O
.	O

As	O
subepithelial	O
myofibroblasts	O
secrete	O
extracellular	O
matrix	O
and	O
growth	O
factors	O
contributing	O
to	O
the	O
attachment	O
,	O
proliferation	O
and	O
differentiation	O
of	O
epithelial	O
cells	O
,	O
co	O
-	O
cultures	O
of	O
primary	O
porcine	B-SPEC
enterocytes	O
(	O
ileocytes	O
and	O
colonocytes	O
)	O
with	O
myofibroblasts	O
were	O
developed	O
and	O
evaluated	O
for	O
their	O
susceptibility	O
to	O
enteric	O
viruses	B-SPEC
.	O

Chicken	B-SPEC
flocks	O
were	O
of	O
layers	O
(	O
n	O
=	O
98	O
),	O
broilers	O
(	O
n	O
=	O
15	O
),	O
breeders	O
(	O
n	O
=	O
3	O
)	O
and	O
undisclosed	O
(	O
n	O
=	O
2	O
).	O

IBV	B-SPEC
S1	O
gene	O
sequencing	O
identified	O
strains	O
as	O
793B	O
(	O
66	O
.	O
7	O
%),	O
Arkansas	O
(	O
23	O
.	O
8	O
%)	O
and	O
Massachusetts	O
(	O
9	O
.	O
5	O
%).	O

Herein	O
,	O
we	O
show	O
that	O
distinct	O
IAV	O
strains	O
reduced	O
the	O
functions	O
of	O
the	O
epithelial	O
sodium	O
channel	O
(	O
ENaC	O
)	O
and	O
the	O
cystic	O
fibrosis	O
transmembrane	O
regulator	O
(	O
CFTR	O
)	O
in	O
murine	B-SPEC
respiratory	O
and	O
alveolar	O
epithelia	O
in	O
vivo	O
,	O
as	O
assessed	O
by	O
measurements	O
of	O
nasal	O
potential	O
differences	O
and	O
single	O
-	O
cell	O
electrophysiology	O
.	O

Reduced	O
ENaC	O
and	O
CFTR	O
led	O
to	O
changes	O
in	O
airway	O
surface	O
liquid	O
morphology	O
of	O
human	B-SPEC
tracheobronchial	O
cultures	O
and	O
airways	O
of	O
IAV	O
-	O
infected	O
mice	B-SPEC
.	O

The	O
assay	O
was	O
able	O
to	O
distinguish	O
between	O
all	O
five	O
viral	O
agents	O
without	O
cross	O
-	O
reacting	O
with	O
other	O
non	O
-	O
target	O
pig	B-SPEC
viruses	B-SPEC
.	O

PCV2	O
was	O
detected	O
in	O
37	O
.	O
7	O
%	O
of	O
the	O
samples	O
,	O
PEDV	B-SPEC
and	O
RVC	O
each	O
in	O
4	O
.	O
3	O
%,	O
TGEV	B-SPEC
in	O
2	O
.	O
9	O
%,	O
and	O
RVA	O
was	O
detected	O
in	O
1	O
.	O
4	O
%	O
of	O
the	O
samples	O
tested	O
.	O

This	O
study	O
reports	O
the	O
detection	O
and	O
genetic	O
characterization	O
of	O
PAstV	O
,	O
PSaV	O
in	O
healthy	O
and	O
diarrheic	O
domestic	B-SPEC
pigs	I-SPEC
and	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
in	O
diarrheic	O
pigs	B-SPEC
of	O
different	O
age	O
groups	O
.	O

The	O
presence	O
of	O
PAstV	O
and	O
PSaV	O
was	O
studied	O
in	O
411	O
rectal	O
swabs	O
collected	O
from	O
healthy	O
(	O
n	O
=	O
251	O
)	O
and	O
diarrheic	O
(	O
n	O
=	O
160	O
)	O
pigs	B-SPEC
of	O
different	O
age	O
categories	O
:	O
suckling	O
(	O
n	O
=	O
143	O
),	O
weaned	O
(	O
n	O
=	O
147	O
)	O
and	O
fattening	O
(	O
n	O
=	O
121	O
)	O
animals	B-SPEC
on	O
farms	O
in	O
Slovakia	O
.	O

Analysis	O
of	O
partial	O
capsid	O
genome	O
sequences	O
of	O
the	O
PSaVs	O
indicated	O
that	O
virus	B-SPEC
strains	O
belonged	O
to	O
genogroup	O
GIII	O
.	O

Here	O
,	O
we	O
tested	O
the	O
prediction	O
that	O
little	B-SPEC
brown	I-SPEC
bats	I-SPEC
(	O
Myotis	B-SPEC
lucifugus	I-SPEC
)	O
co	O
-	O
infected	O
with	O
the	O
M	B-SPEC
.	I-SPEC
lucifugus	I-SPEC
coronavirus	B-SPEC
(	O
Myl	O
-	O
CoV	O
)	O
and	O
with	O
Pseudogymnoascus	B-SPEC
destructans	O
(	O
Pd	O
),	O
the	O
fungus	B-SPEC
that	O
causes	O
bat	B-SPEC
white	O
-	O
nose	O
syndrome	O
(	O
WNS	O
),	O
exhibit	O
different	O
disease	O
severity	O
,	O
viral	O
shedding	O
and	O
molecular	O
responses	O
than	O
bats	B-SPEC
infected	O
with	O
only	O
Myl	O
-	O
CoV	O
or	O
only	O
P	B-SPEC
.	I-SPEC
destructans	I-SPEC
.	O

Therefore	O
,	O
virulent	O
genotype	O
GII	O
PEDV	B-SPEC
strains	O
that	O
are	O
prevalent	O
in	O
the	O
field	O
should	O
be	O
isolated	O
and	O
used	O
to	O
develop	O
next	O
-	O
generation	O
vaccines	O
.	O

Intestinal	O
epithelial	O
cells	O
are	O
the	O
primary	O
target	O
cells	O
of	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
Ferret	B-SPEC
and	O
mink	B-SPEC
coronaviruses	O
typically	O
cause	O
catarrhal	O
diarrhea	O
in	O
ferrets	B-SPEC
and	O
minks	B-SPEC
,	O
respectively	O
.	O

In	O
recent	O
years	O
,	O
however	O
,	O
systemic	O
fatal	O
coronavirus	B-SPEC
infection	O
has	O
emerged	O
in	O
ferrets	B-SPEC
,	O
which	O
resembles	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
cats	B-SPEC
.	O

FIP	O
is	O
a	O
highly	O
fatal	O
systemic	O
disease	O
caused	O
by	O
a	O
virulent	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
in	O
cats	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
extended	O
our	O
previous	O
work	O
on	O
coronavirus	B-SPEC
inhibitors	O
and	O
investigated	O
the	O
structure	O
-	O
activity	O
relationships	O
of	O
a	O
focused	O
library	O
of	O
protease	O
inhibitors	O
for	O
ferret	B-SPEC
and	O
mink	B-SPEC
3CLpro	O
.	O

Emerging	O
literature	O
implicates	O
HTG	O
as	O
an	O
independent	O
indicator	B-SPEC
of	O
poor	O
prognosis	O
in	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
was	O
detected	O
in	O
30	O
.	O
9	O
%	O
of	O
th	O
tested	O
samples	O
.	O

A	O
predominance	O
of	O
the	O
rhinovirus	B-SPEC
infection	O
was	O
observed	O
in	O
this	O
study	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
coronavirus	B-SPEC
(	O
ECoV	O
)	O
is	O
a	O
recently	O
reported	O
enteric	O
disease	O
of	O
adult	O
horses	B-SPEC
.	O

Natural	O
infection	O
by	O
ECoV	O
has	O
been	O
reported	O
in	O
adult	O
horses	B-SPEC
worldwide	O
,	O
whereas	O
experimental	O
infection	O
has	O
only	O
been	O
reported	O
in	O
juvenile	O
horses	B-SPEC
.	O

The	O
RMK	O
revealed	O
the	O
lowest	O
detectability	O
for	O
HMPV	B-SPEC
and	O
PIV3	O
.	O

The	O
RPMK	O
was	O
most	O
applicable	O
for	O
the	O
metagenomic	O
analysis	O
of	O
viral	O
RNA	O
and	O
enabled	O
more	O
sensitive	O
identification	O
of	O
the	O
RNA	O
virus	B-SPEC
genome	O
in	O
respiratory	O
clinical	O
samples	O
.	O

ABSTRACT	O
:	O
ABO	O
blood	O
type	O
A	O
was	O
reported	O
to	O
correlate	O
with	O
an	O
increased	O
risk	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
white	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
major	O
trauma	O
compared	O
with	O
patients	O
with	O
other	O
blood	O
types	O
.	O

TITLE	O
:	O
From	O
cycloheptathiophene	O
-	O
3	O
-	O
carboxamide	O
to	O
oxazinone	O
-	O
based	O
derivatives	O
as	O
allosteric	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
ribonuclease	O
H	O
inhibitors	O
.	O

TITLE	O
:	O
YiQiFuMai	O
lyophilized	O
injection	O
attenuates	O
particulate	O
matter	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
via	O
TLR4	O
-	O
mTOR	O
-	O
autophagy	O
pathway	O
.	O

However	O
,	O
because	O
of	O
various	O
concerns	O
,	O
ECMO	O
has	O
rarely	O
been	O
used	O
in	O
patients	O
who	O
have	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
infection	O
with	O
or	O
without	O
acquired	O
immune	O
deficiency	O
syndrome	O
.	O

According	O
to	O
the	O
antigenic	O
differences	O
,	O
different	O
serotypes	O
of	O
the	O
virus	B-SPEC
do	O
not	O
cross	O
-	O
protect	O
.	O

TITLE	O
:	O
High	O
Prevalence	O
of	O
MERS	O
-	O
CoV	O
Infection	O
in	O
Camel	B-SPEC
Workers	O
in	O
Saudi	O
Arabia	O
.	O

However	O
,	O
the	O
majority	O
of	O
patients	O
do	O
not	O
describe	O
camel	B-SPEC
exposure	O
,	O
making	O
the	O
route	O
of	O
transmission	O
unclear	O
.	O

Although	O
virus	B-SPEC
transmission	O
from	O
CWs	O
has	O
not	O
been	O
formally	O
demonstrated	O
,	O
a	O
possible	O
explanation	O
for	O
repeated	O
MERS	O
outbreaks	O
is	O
that	O
CWs	O
develop	O
mild	O
disease	O
and	O
then	O
transmit	O
the	O
virus	B-SPEC
to	O
uninfected	O
individuals	O
.	O

PDCoV	O
causes	O
acute	O
diarrhea	O
and	O
vomiting	O
in	O
pigs	B-SPEC
,	O
resulting	O
in	O
significant	O
economic	O
losses	O
in	O
the	O
global	O
pork	O
industry	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
the	O
prevalence	O
and	O
spatial	O
distribution	O
of	O
Newcastle	O
disease	O
,	O
infectious	O
bronchitis	O
,	O
and	O
avian	B-SPEC
influenza	O
have	O
been	O
evaluated	O
in	O
commercial	O
broiler	O
farms	O
in	O
31	O
provinces	O
in	O
Iran	O
.	O

Previous	O
studies	O
reported	O
miRNA	O
involvement	O
in	O
viral	O
infection	O
;	O
however	O
,	O
their	O
role	O
in	O
regulating	O
PEDV	B-SPEC
infection	O
remains	O
unknown	O
.	O

The	O
diagnostic	O
performance	O
of	O
the	O
test	O
was	O
evaluated	O
by	O
receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
analysis	O
using	O
a	O
panel	O
of	O
829	O
known	O
sera	O
collected	O
from	O
different	O
commercial	O
pig	B-SPEC
farms	O
,	O
with	O
or	O
without	O
a	O
history	O
of	O
PED	O
presence	O
and	O
from	O
experimentally	O
infected	O
pigs	B-SPEC
.	O

Unlike	O
other	O
respiratory	O
viruses	B-SPEC
,	O
little	O
is	O
known	O
about	O
the	O
clinical	O
significance	O
of	O
human	B-SPEC
coronavirus	I-SPEC
infection	O
(	O
HCoV	O
)	O
in	O
this	O
population	O
.	O

Chief	O
among	O
such	O
threats	O
are	O
influenza	B-SPEC
viruses	I-SPEC
and	O
other	O
respiratory	O
pathogens	O
,	O
such	O
as	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
because	O
of	O
their	O
risk	O
of	O
high	O
transmissibility	O
and	O
acuity	O
of	O
illness	O
.	O

In	O
France	O
,	O
the	O
immune	O
status	O
of	O
the	O
pig	B-SPEC
population	O
against	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
expected	O
to	O
be	O
low	O
due	O
to	O
the	O
absence	O
of	O
circulation	O
of	O
the	O
virus	B-SPEC
since	O
the	O
80	O
'	O
s	O
and	O
a	O
compulsory	O
notification	O
of	O
PED	O
was	O
set	O
up	O
in	O
2014	O
.	O

Among	O
the	O
133	O
(	O
69	O
.	O
3	O
%)	O
subtyped	O
samples	O
,	O
all	O
influenza	O
A	O
were	O
subtype	O
H3	O
(	O
n	O
=	O
57	O
)	O
and	O
all	O
influenza	O
B	O
were	O
B	O
/	O
Victoria	B-SPEC
(	O
n	O
=	O
76	O
).	O

We	O
used	O
spherical	O
gold	O
nanoparticles	O
(	O
average	O
diameter	O
,	O
15	O
nm	O
)	O
as	O
a	O
platform	O
for	O
the	O
antigen	O
for	O
swine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Cell	O
apoptosis	O
induced	O
by	O
PEDV	B-SPEC
or	O
overexpression	O
non	O
-	O
structural	O
or	O
structural	O
proteins	O
was	O
measured	O
by	O
the	O
flow	O
cytometry	O
assay	O
.	O

In	O
infected	O
cells	O
,	O
PEDV	B-SPEC
-	O
induced	O
apoptosis	O
is	O
accompanied	O
by	O
nuclear	O
concentration	O
and	O
fragmentation	O
as	O
a	O
result	O
of	O
caspase	O
-	O
3	O
and	O
caspase	O
-	O
8	O
activation	O
and	O
AIFM1	O
and	O
PARP	O
cleavage	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
the	O
S1	O
proteins	O
from	O
various	O
coronavirus	B-SPEC
family	B-SPEC
members	O
such	O
as	O
TGEV	B-SPEC
,	O
IBV	B-SPEC
,	O
CCoV	O
,	O
SARS	O
and	O
MERS	O
could	O
also	O
induce	O
Vero	O
-	O
E6	O
cells	O
apoptosis	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
high	O
mortality	O
in	O
neonatal	O
piglets	O
.	O

These	O
data	O
suggest	O
that	O
the	O
deletion	O
of	O
both	O
motifs	O
can	O
reduce	O
the	O
virulence	O
of	O
PEDV	B-SPEC
in	O
piglets	O
.	O

TITLE	O
:	O
Diagnosis	O
of	O
non	O
-	O
effusive	O
feline	B-SPEC
infectious	O
peritonitis	O
by	O
reverse	O
transcriptase	O
quantitative	O
PCR	O
from	O
mesenteric	O
lymph	O
node	O
fine	O
-	O
needle	O
aspirates	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
reverse	O
transcriptase	O
quantitative	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
on	O
fine	O
-	O
needle	O
aspirates	O
(	O
FNAs	O
)	O
from	O
mesenteric	O
lymph	O
nodes	O
(	O
MLNs	O
)	O
collected	O
in	O
sterile	O
saline	O
for	O
the	O
purpose	O
of	O
diagnosing	O
non	O
-	O
effusive	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
cats	B-SPEC
.	O

First	O
,	O
the	O
ability	O
of	O
the	O
assay	O
to	O
detect	O
viral	O
RNA	O
in	O
MLN	O
FNA	O
preparations	O
compared	O
with	O
MLN	O
biopsy	O
preparations	O
was	O
assessed	O
in	O
matched	O
samples	O
from	O
eight	O
cats	B-SPEC
.	O

Consistently	O
,	O
eliminating	O
IL	O
-	O
33	O
decreased	O
the	O
levels	O
of	O
MMP2	O
and	O
MMP9	O
in	O
BALF	O
and	O
alleviated	O
lung	O
injury	O
in	O
ALI	O
rats	B-SPEC
.	O

The	O
therapeutic	O
potential	O
of	O
MSC	O
therapy	O
for	O
sepsis	B-SPEC
and	O
ARDS	O
has	O
been	O
demonstrated	O
in	O
multiple	O

We	O
developed	O
a	O
sealed	O
air	O
-	O
tight	O
chamber	O
in	O
which	O
plates	O
with	O
human	B-SPEC
alveolar	O
epithelial	O
immortalized	O
cells	O
could	O
be	O
exposed	O
to	O
a	O
precise	O
,	O
controlled	O
fraction	O
of	O
sevoflurane	O
or	O
isoflurane	O
using	O
a	O
continuous	O
gas	O
flow	O
provided	O
by	O
an	O
anesthetic	O
machine	O
circuit	O
.	O

TITLE	O
:	O
Hormonal	O
Regulation	O
of	O
Physiology	O
,	O
Innate	O
Immunity	O
and	O
Antibody	O
Response	O
to	O
H1N1	O
Influenza	B-SPEC
Virus	I-SPEC
Infection	O
During	O
Pregnancy	O
.	O

In	O
infants	O
in	O
rural	O
Nepal	O
,	O
repeated	O
respiratory	O
virus	B-SPEC
infections	O
were	O
frequent	O
,	O
and	O
we	O
found	O
no	O
decrease	O
in	O
illness	O
severity	O
with	O
repeated	O
infections	O
and	O
no	O
evidence	O
of	O
replacement	O
with	O
another	O
virus	B-SPEC
.	O

Vaccine	O
strategies	O
and	O
public	O
health	O
interventions	O
that	O
provide	O
durable	O
protection	O
in	O
the	O
first	O
6	O
months	O
of	O
life	O
could	O
decrease	O
the	O
burden	O
of	O
repeated	O
infections	O
by	O
multiple	O
respiratory	O
viruses	B-SPEC
,	O
particularly	O
in	O
low	O
-	O
resource	O
countries	O
.	O

Ninety	O
seven	O
(	O
32	O
.	O
3	O
%)	O
of	O
the	O
300	O
participants	O
were	O
tested	O
positive	O
for	O
any	O
virus	B-SPEC
,	O
most	O
common	O
being	O
influenza	B-SPEC
viruses	I-SPEC
(	O
n	O
=	O
33	O
,	O
11	O
%).	O

ABSTRACT	O
:	O
We	O
report	O
the	O
case	O
of	O
a	O
59	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
presented	O
to	O
the	O
University	O
of	O
Kentucky	O
Albert	O
B	O
.	O
Chandler	O
Medical	O
Center	O
(	O
Lexington	O
,	O
KY	O
,	O
USA	O
)	O
after	O
being	O
found	O
fallen	O
down	O
in	O
the	O
woods	O
.	O

This	O
manuscript	O
describes	O
a	O
readily	O
available	O
and	O
relatively	O
simple	O
adjunct	O
that	O
can	O
provide	O
partial	O
lung	O
support	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
complicated	O
by	O
severe	O
hypercapnia	O
and	O
acute	O
kidney	O
injury	O
requiring	O
dialysis	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
leads	O
to	O
healthcare	O
-	O
associated	O
transmission	O
to	O
patients	O
and	O
healthcare	O
workers	O
with	O
potentially	O
fatal	O
outcomes	O
.	O

In	O
conclusion	O
,	O
this	O
study	O
reveals	O
that	O
neboviruses	O
circulate	O
widely	O
in	O
dairy	O
cows	B-SPEC
in	O
China	O
and	O
exhibit	O
a	O
unique	O
evolution	O
of	O
RdRp	O
.	O

Although	O
the	O
delivery	O
of	O
CpG	O
ODNs	O
in	O
ovo	B-SPEC
at	O
embryo	O
day	O
(	O
ED	O
)	O
18	O
has	O
been	O
shown	O
to	O
reduce	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
loads	O
in	O
embryonic	O
chicken	B-SPEC
lungs	O
pre	O
-	O
hatch	O
,	O
whether	O
in	O
ovo	B-SPEC
delivered	O
CpG	O
ODNs	O
are	O
capable	O
of	O
protecting	O
chickens	B-SPEC
against	O
a	O
post	O
-	O
hatch	O
challenge	O
is	O
unknown	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
review	O
polygraphic	O
(	O
PG	O
)	O
findings	O
and	O
the	O
need	O
for	O
noninvasive	O
continuous	O
positive	O
airway	O
pressure	O
(	O
CPAP	O
)	O
or	O
noninvasive	O
ventilation	O
(	O
NIV	O
)	O
in	O
children	O
with	O
MPS	O
IVA	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
endemic	O
in	O
South	O
China	O
and	O
is	O
continuing	O
to	O
spread	O
worldwide	O
since	O
the	O
2003	O
outbreak	O
,	O
affecting	O
human	B-SPEC
population	O
of	O
37	O
countries	O
till	O
present	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
effect	O
of	O
neuromuscular	O
blocking	O
agents	O
(	O
NMBAs	O
)	O
on	O
adult	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
meta	B-SPEC
-	O
analysis	O
.	O

Systematic	O
reviews	O
&	O
meta	B-SPEC
-	O
analysis	O
,	O
level	O
III	O
.	O

We	O
characterized	O
its	O
growth	O
kinetics	O
and	O
pathogenicity	O
in	O
embryonated	O
eggs	O
,	O
and	O
its	O
tropism	O
and	O
persistence	O
in	O
different	O
tissues	O
from	O
chickens	B-SPEC
;	O
then	O
,	O
we	O
evaluated	O
pathogenicity	O
by	O
using	O
a	O
new	O
premature	O
reproductive	O
tract	O
pathogenicity	O
model	O
.	O

These	O
findings	O
provide	O
the	O
first	O
large	O
-	O
scale	O
survey	O
of	O
lncRNAs	O
associated	O
with	O
PEDV	B-SPEC
infection	O
,	O
specifically	O
the	O
lncRNAs	O
responsible	O
for	O
the	O
activation	O
of	O
the	O
immune	O
system	O
within	O
the	O
ileum	O
.	O

Principally	O
,	O
the	O
serotypes	O
are	O
identified	O
by	O
virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
tests	O
.	O

According	O
to	O
the	O
results	O
of	O
our	O
research	O
,	O
cross	O
-	O
protection	O
studies	O
are	O
necessary	O
for	O
the	O
design	O
of	O
a	O
proper	O
vaccination	O
program	O
for	O
IBV	B-SPEC
circulating	O
genotypes	O
in	O
Iran	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
low	O
dose	O
of	O
TGEV	B-SPEC
to	O
infect	O
p53	O
wild	O
-	O
type	O
PK	O
-	O
15	O
cells	O
(	O
WT	O
PK	O
-	O
15	O
cells	O
)	O
and	O
p53	O
deficient	O
cells	O
(	O
p53	O
-/-	O
PK	O
-	O
15	O
cells	O
),	O
to	O
investigate	O
the	O
modulation	O
of	O
IFN	O
signaling	O
and	O
virus	B-SPEC
replication	O
by	O
p53	O
.	O

FTc	O
,	O
mainly	O
indicator	B-SPEC
of	O
preload	O
,	O
showed	O
decreasing	O
trend	O
to	O
315	O
(	O
275	O
-	O
367	O
)	O
ms	O
at	O
30	O
min	O
post	O
prone	O
(	O
P	O
=	O
0	O
.	O
06	O
).	O

Control	O
birds	B-SPEC
that	O
were	O
not	O
vaccinated	O
for	O
IBV	B-SPEC
had	O
significantly	O
lower	O
IBV	B-SPEC
titers	O
on	O
day	O
21	O
compared	O
to	O
birds	B-SPEC
that	O
were	O
vaccinated	O
(	O
both	O
with	O
and	O
without	O
Aleta	O
).	O

TITLE	O
:	O
Infection	O
control	O
influence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
A	O
hospital	O
-	O
based	O
analysis	O
.	O

Influenza	O
A	O
and	O
B	O
viruses	B-SPEC
were	O
found	O
in	O
120	O
(	O
68	O
.	O
6	O
%)	O
and	O
55	O
(	O
31	O
.	O
4	O
%)	O
specimens	O
,	O
respectively	O
,	O
among	O
which	O
coinfections	O
were	O
found	O
in	O
106	O
(	O
60	O
.	O
6	O
%)	O
specimens	O
.	O

Viruses	B-SPEC
coinfected	O
frequently	O
with	O
influenza	B-SPEC
virus	I-SPEC
in	O
children	O
were	O
rhinovirus	B-SPEC
(	O
26	O
;	O
14	O
.	O
8	O
%),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
/	O
B	O
(	O
19	O
;	O
10	O
.	O
8	O
%),	O
adenovirus	B-SPEC
(	O
14	O
;	O
8	O
.	O
0	O
%),	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)-	O
HKU1	O
(	O
14	O
;	O
8	O
.	O
0	O
%),	O
CoV	B-SPEC
-	O
OC43	O
(	O
5	O
;	O
2	O
.	O
9	O
%),	O
CoV	B-SPEC
-	O
229E	O
(	O
2	O
;	O
1	O
.	O
1	O
%),	O
metapneumovirus	B-SPEC
A	O
/	O
B	O
(	O
5	O
;	O
2	O
.	O
9	O
%),	O
bocavirus	B-SPEC
(	O
6	O
;	O
3	O
.	O
4	O
%),	O
enterovirus	B-SPEC
(	O
5	O
;	O
2	O
.	O
9	O
%),	O
parainfluenza	O
virus	B-SPEC
-	O
1	O
(	O
3	O
;	O
1	O
.	O
7	O
%),	O
and	O
parainfluenza	O
virus	B-SPEC
-	O
3	O
(	O
2	O
;	O
1	O
.	O
1	O
%).	O

TITLE	O
:	O
Neutralizing	O
Monoclonal	O
Antibodies	O
as	O
Promising	O
Therapeutics	O
against	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

Investigators	O
have	O
modeled	O
asthma	O
exacerbations	O
by	O
infecting	O
mice	B-SPEC
with	O
allergic	O
airways	O
disease	O
.	O

TITLE	O
:	O
Underweight	O
,	O
overweight	O
,	O
and	O
obesity	O
as	O
independent	O
risk	O
factors	O
for	O
hospitalization	O
in	O
adults	O
and	O
children	O
from	O
influenza	O
and	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Increased	O
VN	O
titres	O
were	O
recorded	O
against	O
the	O
five	O
IBV	B-SPEC
challenge	O
strains	O
,	O
with	O
a	O
significantly	O
higher	O
level	O
of	O
protection	O
against	O
drops	O
in	O
egg	O
production	O
following	O
challenge	O
.	O

in	O
pigs	B-SPEC
and	O
day	O
4	O
p	O
.	O
i	O
.	O

and	O
moderate	O
loss	O
in	O
the	O
trachea	B-SPEC
on	O
days	O
4	O
and	O
24	O
p	O
.	O
i	O
.,	O
ciliation	O
of	O
respiratory	O
organs	O
in	O
llamas	B-SPEC
was	O
not	O
significantly	O
affected	O
.	O

Two	O
Massachusetts	O
(	O
Mass	O
)	O
variant	O
IBV	B-SPEC
isolates	O
recovered	O
from	O
commercial	O
layer	O
flocks	O
in	O
the	O
Western	O
Canadian	O
provinces	O
of	O
Alberta	B-SPEC
(	O
AB	O
)	O
and	O
Saskatchewan	O
(	O
SK	O
)	O
were	O
compared	O
genetically	O
and	O
evaluated	O
for	O
their	O
pathogenicity	O
,	O
tissue	O
distribution	O
and	O
ability	O
to	O
recruit	O
and	O
replicate	O
in	O
macrophages	O
.	O

Although	O
whole	O
genome	O
sequencing	O
of	O
these	O
two	O
Mass	O
IBV	B-SPEC
isolates	O
showed	O
low	O
similarity	O
with	O
the	O
M41	O
vaccinal	O
strain	O
,	O
they	O
had	O
an	O
identical	O
nucleotide	O
sequence	O
at	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
3a	O
,	O
3b	O
,	O
envelop	O
(	O
E	O
),	O
matrix	O
(	O
M	O
),	O
5a	O
and	O
5b	O
.	O

However	O
,	O
upon	O
experimental	O
infection	O
,	O
we	O
found	O
that	O
the	O
IBV	B-SPEC
isolate	O
originating	O
from	O
AB	O
was	O
different	O
to	O
the	O
one	O
that	O
originated	O
in	O
SK	O
due	O
to	O
higher	O
tracheal	O
lesion	O
scores	O
and	O
lower	O
lung	O
viral	O
replication	O
and	O
lower	O
genome	O
loads	O
in	O
cecal	O
tonsils	O
.	O

Further	O
studies	O
are	O
required	O
to	O
investigate	O
the	O
pathogenicity	O
of	O
these	O
two	O
Mass	O
variant	O
IBV	B-SPEC
isolates	O
in	O
laying	O
hens	O
.	O

TITLE	O
:	O
Replication	O
of	O
MERS	O
and	O
SARS	O
coronaviruses	O
in	O
bat	B-SPEC
cells	O
offers	O
insights	O
to	O
their	O
ancestral	O
origins	O
.	O

SARS	O
-	O
CoV	O
can	O
only	O
replicate	O
in	O
R	B-SPEC
.	I-SPEC
sinicus	I-SPEC
cells	O
,	O
while	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
cannot	O
replicate	O
in	O
any	O
bat	B-SPEC
cells	O
.	O

The	O
broad	O
cellular	O
tropism	O
of	O
MERS	O
-	O
CoV	O
should	O
prompt	O
further	O
exploration	O
of	O
host	O
diversity	O
of	O
related	O
viruses	B-SPEC
to	O
identify	O
its	O
ancestral	O
origin	O
.	O

This	O
paper	O
reports	O
the	O
(	O
previously	O
unknown	O
)	O
complete	O
genome	O
sequence	O
of	O
strain	O
D274	O
of	O
this	O
virus	B-SPEC
(	O
27	O
,	O
599	O
nucleotides	O
),	O
isolated	O
from	O
chickens	B-SPEC
in	O
The	O
Netherlands	O
in	O
1979	O
.	O

Human	B-SPEC
	O
-	O
defensin	O
-	O
2	O
and	O
	O
-	O
defensin	O
-	O
3	O
were	O
used	O
as	O
adjuvants	O
to	O
enhance	O
the	O
immune	O
response	O
of	O
MEVs	O
.	O

A	O
total	O
of	O
389	O
sera	O
were	O
tested	O
against	O
the	O
rN	O
in	O
ELISA	O
and	O
the	O
results	O
were	O
compared	O
with	O
those	O
of	O
the	O
commercial	O
IDEXX	O
IBV	B-SPEC
Ab	O
test	O
.	O

The	O
human	B-SPEC
sodium	O
iodide	O
symporter	O
(	O
hNIS	O
),	O
a	O
SPECT	O
and	O
positron	O
emission	O
tomography	O
reporter	O
gene	O
,	O
was	O
inserted	O
into	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
a	O
recently	O
emerged	O
virus	B-SPEC
that	O
can	O
cause	O
severe	O
respiratory	O
disease	O
and	O
death	O
in	O
afflicted	O
humans	B-SPEC
to	O
obtain	O
a	O
quantifiable	O
and	O
sensitive	O
marker	O
for	O
viral	O
replication	O
to	O
further	O
MERS	O
-	O
CoV	O
animal	B-SPEC
model	O
development	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
is	O
a	O
highly	O
neurotropic	O
virus	B-SPEC
that	O
causes	O
diffuse	O
neuronal	O
infection	O
with	O
neurological	O
damage	O
and	O
high	O
mortality	O
.	O

Respiratory	O
viruses	B-SPEC
are	O
detected	O
more	O
frequently	O
among	O
rural	O
dwellers	O
in	O
Pakistan	O
.	O

Clinically	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
associated	O
with	O
avian	B-SPEC
influenza	O
vi	O
-	O
rus	O
infection	O
is	O
more	O
severe	O
than	O
usual	O
,	O
which	O
mortality	O
rate	O
reaches	O
nearly	O
60	O
%.	O

Emerging	O
viral	O
pneumonias	O
such	O
as	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
and	O
avian	B-SPEC
influenza	O
H7N9	O
are	O
major	O
concerns	O
.	O

Since	O
multidrug	O
resistant	O
bacteria	B-SPEC
silently	O
spread	O
globally	O
by	O
infected	O
travelers	O
,	O
it	O
would	O
be	O
of	O
help	O
to	O
install	O
appropriate	O
isolation	O
precaution	O
for	O
travelers	O
with	O
history	O
of	O
hospital	O
admission	O
abroad	O
.	O

Overlapping	O
peptides	O
spanning	O
the	O
whole	O
MERS	O
-	O
CoV	O
N	O
polypeptide	O
were	O
used	O
to	O
identify	O
major	O
histocompatibility	O
complex	O
class	B-SPEC
I	O
/	O
II	O
-	O
restricted	O
T	O
cell	O
responses	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
immunized	O
with	O
MVA	O
-	O
MERS	O
-	O
N	O
.	O
We	O
have	O
identified	O
a	O
H2	O
-	O
d	O
restricted	O
decamer	O
peptide	O
epitope	O
in	O
the	O
MERS	O
-	O
N	O
protein	O
with	O
CD8	O
+	O
T	O
cell	O
antigenicity	O
.	O

ABSTRACT	O
:	O
Transcatheter	O
aortic	O
valve	O
replacement	O
is	O
indicated	O
for	O
severe	O
symptomatic	O
aortic	O
stenosis	B-SPEC
in	O
patients	O
who	O
have	O
a	O
very	O
high	O
or	O
prohibitive	O
surgical	O
risk	O
as	O
assessed	O
pre	O
-	O
procedurally	O
by	O
the	O
Society	O
of	O
Thoracic	O
Surgery	O
Risk	O
Score	O
,	O
EuroSCORE	O
(	O
II	O
),	O
frailty	O
testing	O
,	O
and	O
other	O
predictors	O
.	O

A	O
total	O
of	O
735	O
individuals	O
of	O
14	O
species	B-SPEC
were	O
reported	O
in	O
372	O
news	O
reports	O
,	O
mostly	O
rhesus	B-SPEC
macaques	I-SPEC
(	O

TITLE	O
:	O
Cytokine	O
-	O
Mediated	O
Tissue	O
Injury	O
in	O
Non	O
-	O
human	B-SPEC
Primate	B-SPEC
Models	O
of	O
Viral	O
Infections	O
.	O

A	O
total	O
of	O
792	O
camel	B-SPEC
plasma	O
samples	O
were	O
positive	O
by	O
ELISA	O
.	O

Only	O
11	O
camel	B-SPEC
nasal	O
swabs	O
were	O
positive	O
for	O
MERS	O
-	O
CoV	O
by	O
reverse	O
transcription	O
-	O
quantitative	O
PCR	O
.	O

Phylogenetic	O
analysis	O
of	O
whole	O
genome	O
sequences	O
showed	O
that	O
Kenyan	O
MERS	O
-	O
CoV	O
clustered	O
within	O
sub	O
-	O
clade	O
C2	O
,	O
which	O
is	O
associated	O
with	O
the	O
African	O
clade	O
,	O
but	O
did	O
not	O
contain	O
signature	O
deletions	O
of	O
orf4b	O
in	O
African	O
viruses	B-SPEC
.	O

Interestingly	O
,	O
although	O
most	O
of	O
the	O
recent	O
Italian	O
GI	O
-	O
16	O
strains	O
originated	O
from	O
ancestral	O
viruses	B-SPEC
detected	O
in	O
the	O
same	O
country	O
,	O
a	O
couple	O
were	O
closely	O
related	O
to	O
Chinese	O
ones	O
,	O
supporting	O
a	O
backward	O
viral	O
flow	O
from	O
China	O
to	O
Italy	O
.	O

Several	O
nucleic	O
acid	O
-	O
based	O
technologies	O
such	O
as	O
short	O
interfering	O
RNAs	O
(	O
siRNA	O
),	O
antisense	O
oligonucleotides	O
,	O
aptamers	O
,	O
deoxyribozymes	O
(	O
DNAzymes	O
),	O
and	O
ribozymes	O
have	O
been	O
studied	O
and	O
used	O
against	O
management	O
of	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
enteropathogenic	O
coronavirus	B-SPEC
that	O
causes	O
diarrhea	O
in	O
pigs	B-SPEC
,	O
and	O
is	O
associated	O
with	O
high	O
morbidity	O
and	O
mortality	O
in	O
sucking	O
piglets	O
.	O

Furthermore	O
,	O
the	O
function	O
of	O
EIF4A2	O
in	O
intestinal	O
cells	O
during	O
TGEV	B-SPEC
infection	O
was	O
examined	O
.	O

Within	O
the	O
gamma	O
-	O
CoVs	O
the	O
main	O
representative	O
is	O
avian	B-SPEC
coronavirus	I-SPEC
,	O
a	O
taxonomic	O
name	B-SPEC
which	O
includes	O
the	O
highly	O
contagious	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
in	O
chickens	B-SPEC
and	O
similar	O
viruses	B-SPEC
infecting	O
other	O
domestic	O
birds	B-SPEC
such	O
as	O
turkeys	B-SPEC
,	O
guinea	B-SPEC
fowls	I-SPEC
,	O
or	O
quails	O
.	O

Development	O
of	O
molecular	O
techniques	O
has	O
significantly	O
improved	O
knowledge	O
of	O
the	O
prevalence	O
of	O
CoVs	O
in	O
avian	B-SPEC
species	B-SPEC
.	O

The	O
methods	O
adopted	O
in	O
monitoring	O
studies	O
of	O
CoVs	O
in	O
different	O
avian	B-SPEC
species	B-SPEC
are	O
mainly	O
based	O
on	O
detection	O
of	O
conservative	O
regions	O
within	O
the	O
viral	O
replicase	O
,	O
nucleocapsid	O
genes	O
,	O
and	O
3	O
'	O
UTR	O
or	O
5	O
'	O
UTR	O
.	O

ABSTRACT	O
:	O
China	O
has	O
made	O
substantial	O
progress	O
in	O
tackling	O
its	O
HIV	B-SPEC
and	O
AIDS	O
epidemic	O
.	O

Both	O
infected	O
boars	B-SPEC
had	O
diarrhea	O
after	O
inoculation	O
and	O
shed	O
virus	B-SPEC
in	O
feces	O
.	O

In	O
the	O
pigs	B-SPEC
coinfected	O
with	O
icPC22A	O
and	O
icPC22A	O
-	O
S1197	O
,	O
icPC22A	O
replicated	O
to	O
a	O
higher	O
peak	O
titer	O
than	O
its	O
infection	O
of	O
pigs	B-SPEC
without	O
the	O
presence	O
of	O
icPC22A	O
-	O
S1197	O
.	O

Oral	O
inoculation	O
led	O
to	O
higher	O
levels	O
of	O
PEDV	B-SPEC
-	O
specific	O
IgA	O
antibodies	O
in	O
both	O
serum	O
and	O
gut	O
mucosal	O
sites	O
than	O
did	O
other	O
routes	O
of	O
inoculation	O
.	O

PEDV	B-SPEC
-	O
infected	O
pigs	B-SPEC
regardless	O
of	O
inoculation	O
routes	O
had	O
significantly	O
lower	O
NK	O
cell	O
frequencies	O
than	O
those	O
of	O
the	O
control	O
pigs	B-SPEC
at	O
14	O
dpi	O
.	O

Cases	O
presented	O
in	O
4	O
healthcare	O
facilities	O
in	O
Riyadh	O
,	O
Saudi	O
Arabia	O
:	O
a	O
tertiary	O
-	O
care	O
hospital	O
,	O
a	O
specialty	O
pulmonary	O
hospital	O
,	O
an	O
outpatient	O
clinic	O
,	O
and	O
an	O
outpatient	O
dialysis	B-SPEC
unit	O
.	O

ABSTRACT	O
:	O
Although	O
several	O
reports	O
suggest	O
that	O
the	O
entry	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
depends	O
on	O
lipid	O
rafts	O
and	O
low	O
pH	O
,	O
the	O
endocytic	O
route	O
and	O
intracellular	O
trafficking	O
are	O
unclear	O
.	O

By	O
using	O
chemical	O
inhibitors	O
,	O
RNA	O
interference	O
,	O
and	O
dominant	O
negative	O
mutants	O
,	O
we	O
observed	O
that	O
lipid	O
rafts	O
and	O
low	O
pH	O
was	O
indeed	O
required	O
for	O
virus	B-SPEC
entry	O
;	O
IBV	B-SPEC
mainly	O
utilized	O
the	O
clathrin	O
mediated	O
endocytosis	O
(	O
CME	O
)	O
for	O
entry	O
;	O
GTPase	O
dynamin	O
1	O
was	O
involved	O
in	O
virus	B-SPEC
containing	O
vesicle	O
scission	O
;	O
and	O
the	O
penetration	O
of	O
IBV	B-SPEC
into	O
cells	O
led	O
to	O
active	O
cytoskeleton	O
rearrangement	O
.	O

ABSTRACT	O
:	O
MERS	O
-	O
CoV	O
(	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
)	O
antibodies	O
were	O
detected	O
in	O
camels	B-SPEC
since	O
1983	O
,	O
but	O
the	O
first	O
human	B-SPEC
case	O
was	O
only	O
detected	O
in	O
2012	O
.	O

A	O
list	O
of	O
potential	O
human	B-SPEC
,	O
animal	B-SPEC
and	O
environmental	O
drivers	O
for	O
disease	O
emergence	O
were	O
identified	O
from	O
literature	O
.	O

The	O
transition	O
in	O
husbandry	O
leading	O
to	O
high	O
density	O
camel	B-SPEC
farming	O
along	O
with	O
increased	O
exposure	O
to	O
humans	B-SPEC
,	O
combined	O
with	O
the	O
increase	O
of	O
camel	B-SPEC
movement	O
for	O
the	O
racing	O
and	O
breeding	O
industry	O
,	O
have	O
led	O
to	O
a	O
convergence	O
of	O
factors	O
driving	O
spillover	O
of	O
MERS	O
-	O
CoV	O
from	O
camels	B-SPEC
to	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Survival	O
rates	O
for	O
pediatric	O
cancer	B-SPEC
have	O
steadily	O
improved	O
over	O
time	O
but	O
it	O
remains	O
a	O
significant	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
children	O
.	O

These	O
are	O
the	O
result	O
of	O
infections	O
with	O
a	O
heterogeneous	O
group	O
of	O
viruses	B-SPEC
including	O
RNA	O
viruses	B-SPEC
,	O
such	O
as	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
(	O
IV	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
),	O
metapneumovirus	B-SPEC
(	O
HMPV	B-SPEC
),	O
rhinovirus	B-SPEC
(	O
RhV	O
),	O
and	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

Prevention	O
remains	O
one	O
of	O
the	O
most	O
important	O
strategies	O
against	O
these	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Fine	O
Tuning	O
the	O
Cytokine	O
Storm	O
by	O
IFN	O
and	O
IL	O
-	O
10	O
Following	O
Neurotropic	O
Coronavirus	B-SPEC
Encephalomyelitis	O
.	O

ABSTRACT	O
:	O
The	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
is	O
vulnerable	O
to	O
several	O
viral	O
infections	O
including	O
herpes	O
viruses	B-SPEC
,	O
arboviruses	O
and	O
HIV	B-SPEC
to	O
name	B-SPEC
a	O
few	O
.	O

Both	O
innate	O
and	O
adaptive	O
immune	O
cells	O
work	O
in	O
coordination	O
to	O
control	O
virus	B-SPEC
replication	O
.	O

While	O
type	O
I	O
interferons	O
are	O
essential	O
to	O
limit	O
virus	B-SPEC
spread	O
associated	O
with	O
early	O
mortality	O
,	O
perforin	O
,	O
and	O
interferon	O
-	O
	O
promote	O
further	O
virus	B-SPEC
clearance	O
in	O
astrocytes	O
/	O
microglia	O
and	O
oligodendrocytes	O
,	O
respectively	O
.	O

Moreover	O
,	O
reduced	O
Poldip2	O
-	O
suppressed	O
LP	O
-	O
induced	O
vascular	O
cell	O
adhesion	O
molecule	O
(	O
VCAM	O
)-	O
1	O
induction	O
,	O
leukocyte	O
recruitment	O
,	O
and	O
mitochondrial	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
production	O

All	O
respiratory	O
specimens	O
from	O
patients	O
enrolled	O
through	O
SARI	O
surveillance	O
were	O
also	O
routinely	O
tested	O
by	O
multiplex	O
reverse	O
transcription	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
for	O
adenovirus	B-SPEC
;	O
enterovirus	B-SPEC
;	O
human	B-SPEC
metapneumovirus	I-SPEC
;	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
,	O
2	O
,	O
and	O
3	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
;	O
rhinovirus	B-SPEC
;	O
influenza	O
A	O
,	O
and	O
influenza	O
B	O
.	O
Human	B-SPEC
bocavirus	I-SPEC
,	O
hCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
and	O
hPyV	O
-	O
WU	O
were	O
detected	O
in	O
3	O
.	O
7	O
%	O
(	O
25	O
/	O
680	O
),	O
4	O
.	O
1	O
%	O
(	O
28	O
/	O
680	O
),	O
and	O
4	O
.	O
1	O
%	O
(	O
28	O
/	O
680	O
)	O
of	O
respiratory	O
specimens	O
,	O
respectively	O
.	O

Inclusion	O
of	O
laboratory	O
tests	O
for	O
hBoV	O
,	O
hCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
and	O
hPyV	O
-	O
WU	O
in	O
differential	O
testing	O
algorithms	O
for	O
surveillance	O
and	O
diagnostics	O
for	O
suspected	O
cases	O
of	O
respiratory	O
illness	O
of	O
unknown	O
cause	O
may	O
improve	O
our	O
understanding	O
of	O
the	O
etiology	O
of	O
SARI	O
,	O
especially	O
in	O
a	O
country	O
like	O
South	O
Africa	O
with	O
a	O
high	O
number	O
of	O
immune	O
compromised	O
persons	O
.	O

Several	O
animal	B-SPEC
models	O
have	O
been	O
established	O
to	O
study	O
disease	O
pathogenesis	O
and	O
to	O
develop	O
vaccines	O
and	O
therapeutic	O
agents	O
.	O

On	O
day	O
5	O
or	O
7	O
postinoculation	O
,	O
lungs	O
of	O
adult	O
Tg	O
mice	B-SPEC
contained	O
higher	O
levels	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
associated	O
with	O
migration	O
of	O
macrophages	O
.	O

She	O
had	O
lived	O
until	O
3	O
months	O
earlier	O
in	O
close	O
proximity	O
to	O
cattle	B-SPEC
in	O
her	O
home	O
in	O
Kabul	O
and	O
did	O
not	O
recall	O
eating	O
watercress	B-SPEC
or	O
other	O
leafy	O
plants	B-SPEC
associated	O
with	O

ABSTRACT	O
:	O
Viruses	B-SPEC
are	O
obligate	O
intracellular	O
microbes	O
that	O
exploit	O
the	O
host	O
metabolic	O
machineries	O
to	O
meet	O
their	O
biosynthetic	O
demands	O
,	O
making	O
these	O
host	O
pathways	O
potential	O
therapeutic	O
targets	O
.	O

Taupapillomavirus	B-SPEC
were	O
the	O
only	O
mammalian	B-SPEC
viral	O
nucleic	O
acids	O
detected	O
in	O
two	O
affected	O
dogs	B-SPEC
,	O
while	O
a	O
third	O
dog	B-SPEC
was	O
coinfected	O
with	O
low	O
levels	O
of	O
canine	O
parainfluenza	O
5	O
.	O

TITLE	O
:	O
Disease	O
features	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
and	O
enteric	O
salmonellosis	O
are	O
similar	O
in	O
horses	B-SPEC
.	O

Compare	O
the	O
clinical	O
features	O
of	O
ECoV	O
infection	O
with	O
enteric	O
salmonellosis	O
and	O
establish	O
a	O
disease	O
signature	O
to	O
increase	O
clinical	O
suspicion	O
of	O
ECoV	O
infection	O
in	O
adult	O
horses	B-SPEC
.	O

Horses	B-SPEC
were	O
divided	O
into	O
3	O
groups	O
based	O
on	O
fecal	O
diagnostic	O
test	O
results	O
:	O
ECoV	O
-	O
positive	O
,	O
Salmonella	B-SPEC
-	O
positive	O
,	O
or	O
unknown	O
diagnosis	O
(	O
UNK	O
).	O

However	O
,	O
when	O
the	O
C5a	O
-	O
C5aR1	O
axis	B-SPEC
was	O
blocked	O
by	O
an	O
anti	O
-	O
C5aR1	O
antibody	O
(	O
Ab	O
),	O
expression	O
of	O
caspase	O
-	O
1	O
and	O
IL	O
-	O
1	O
fell	O
.	O

ABSTRACT	O
:	O
Known	O
human	B-SPEC
coronaviruses	O
are	O
believed	O
to	O
have	O
originated	O
in	O
animals	B-SPEC
and	O
made	O
use	O
of	O
intermediate	O
hosts	O
for	O
transmission	O
to	O
humans	B-SPEC
.	O

This	O
study	O
aims	O
to	O
assess	O
the	O
possible	O
role	O
of	O
some	O
major	O
domestic	O
livestock	O
species	B-SPEC
as	O
intermediate	O
hosts	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

TITLE	O
:	O
Pathogenicity	O
and	O
immunogenicity	O
of	O
attenuated	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
PC22A	O
strain	O
in	O
conventional	O
weaned	O
pigs	B-SPEC
.	O

Compared	O
with	O
the	O
P120	O
group	O
,	O
pigs	B-SPEC
in	O
the	O
P100C4	O
group	O
had	O
a	O
more	O
rapid	O
decline	O
in	O
fecal	O
PEDV	B-SPEC
RNA	O
shedding	O
titers	O
,	O
higher	O
titers	O
of	O
serum	O
PEDV	B-SPEC
-	O
specific	O
IgG	O
,	O
IgA	O
,	O
and	O
VN	O
Abs	O
,	O
and	O
higher	O
numbers	O
of	O
intestinal	O
IgA	O
Ab	O
-	O
secreting	O
cells	O
.	O

RESULTS	O
:	O
Four	O
groups	O
of	O
40	O
-	O
day	O
-	O
old	O
weaned	O
pigs	B-SPEC
were	O
inoculated	O
orally	O
with	O
PEDV	B-SPEC
PC22A	O
-	O
P3	O
(	O
virulent	O
),	O
-	O
P100C4	O
,	O
-	O
P120	O
,	O
and	O
mock	O
,	O
respectively	O
,	O
and	O
challenged	O
with	O
the	O
P3	O
virus	B-SPEC
at	O
24	O
days	O
post	O
-	O
inoculation	O
(	O
dpi	O
).	O

The	O
rate	O
of	O
coinfection	O
was	O
34	O
%	O
and	O
rhinovirus	B-SPEC
was	O
the	O
most	O
common	O
of	O
the	O
multiple	O
pathogens	O
.	O

The	O
rate	O
of	O
coinfection	O
was	O
34	O
%	O
and	O
rhinovirus	B-SPEC
was	O
the	O
most	O
common	O
of	O
the	O
multiple	O
pathogens	O
.	O

The	O
mechanism	O
of	O
Griffithsin	O
'	O
s	O
action	O
against	O
PEDV	B-SPEC
involved	O
both	O
preventing	O
viral	O
attachment	O
to	O
host	O
cells	O
and	O
disrupting	O
cell	O
-	O
to	O
-	O
cell	O
transmission	O
;	O
its	O
dual	O
mode	O
of	O
action	O
distinguished	O
Griffithsin	O
from	O
most	O
other	O
antiviral	O
drugs	O
.	O

Six	O
8	O
-	O
week	O
-	O
old	O
mice	B-SPEC
were	O
immunized	O
with	O
the	O
recombinant	O
plasmid	O
pPI	O
-	O
2	O
.	O
EGFP	O
.	O
VP7	O
.	O
S	O
.	O
The	O
high	O
humoral	O
immune	O
responses	O
(	O
virus	B-SPEC
specific	O
antibody	O
)	O
and	O
cellular	O
immune	O
responses	O
(	O
IFN	O
-	O
	O
,	O
IL	O
-	O
4	O
,	O
and	O
spleen	O
lymphocyte	O
proliferation	O
)	O
were	O
evaluated	O
.	O

These	O
results	O
demonstrated	O
that	O
pPI	O
-	O
2	O
.	O
EGFP	O
.	O
VP7	O
.	O
S	O
possess	O
the	O
immunological	O
functions	O
of	O
the	O
VP7	O
proteins	O
of	O
PoRV	O
and	O
S	O
proteins	O
of	O
PEDV	B-SPEC
,	O
indicating	O
that	O
pPI	O
-	O
2	O
.	O
EGFP	O
.	O
VP7	O
.	O
S	O
is	O
a	O
candidate	O
vaccine	O
for	O
porcine	B-SPEC
rotaviral	O
infection	O
(	O
PoR	O
)	O
and	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
).	O

Although	O
the	O
IBVPR03	O
strain	O
is	O
S1	O
-	O
genotyped	O
as	O
Massachusetts	O
with	O
a	O
high	O
genomic	O
similarity	O
to	O
the	O
H	O
-	O
120	O
vaccine	O
strains	O
,	O
surprisingly	O
,	O
we	O
found	O
no	O
tropism	O
or	O
pathogenicity	O
to	O
the	O
trachea	B-SPEC
in	O
birds	B-SPEC
infected	O
with	O
this	O
strain	O
.	O

PICU	B-SPEC
at	O
a	O
large	O
,	O
tertiary	O
care	O
children	O
'	O
s	O
hospital	O
.	O

Some	O
of	O
the	O
strains	O
showed	O
comparable	O
antigenic	O
relatedness	O
,	O
pathogenicity	O
,	O
and	O
affinity	O
for	O
the	O
trachea	B-SPEC
and	O
kidneys	O
among	O
each	O
other	O
and	O
with	O
their	O
parental	O
viruses	B-SPEC
;	O
however	O
,	O
some	O
of	O
them	O
showed	O
varying	O
biological	O
characteristics	O
.	O

When	O
PEDV	B-SPEC
-	O
infected	O
Vero	O
cells	O
were	O
pretreated	O
with	O
S	O
-	O
layer	O
protein	O
,	O
rates	O
of	O
Vero	O
cell	O
apoptosis	O
were	O
markedly	O
decreased	O
and	O
cell	O
damage	O
was	O
significantly	O
reduced	O
,	O
as	O
evaluated	O
by	O
flow	O
cytometry	O
and	O
microscopy	O
.	O

In	O
addition	O
to	O
serving	O
as	O
an	O
obstacle	O
to	O
the	O
zoonotic	O
transmission	O
of	O
influenza	O
,	O
these	O
ISG15	O
species	B-SPEC
-	O
species	B-SPEC
differences	O
have	O
also	O
long	O
been	O
shown	O
to	O
have	O
an	O
impact	O
on	O
the	O
function	O
of	O
viral	O
deISGylases	O
.	O

In	O
this	O
study	O
,	O
single	O
chain	O
fragment	O
variable	O
(	O
scFv	O
)	O
antibodies	O
against	O
PEDV	B-SPEC
were	O
screened	O
from	O
the	O
porcine	B-SPEC
scFv	O
phage	O
display	O
library	O
.	O

TITLE	O
:	O
Two	O
critical	O
N	O
-	O
terminal	O
epitopes	O
of	O
the	O
nucleocapsid	O
protein	O
contribute	O
to	O
the	O
cross	O
-	O
reactivity	O
between	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

The	O
clinical	O
signs	O
and	O
pathogenesis	O
of	O
the	O
three	O
viruses	B-SPEC
are	O
similar	O
.	O

Severe	O
AKI	O
and	O
the	O
need	O
for	O
dialysis	B-SPEC
were	O
outcome	O
measures	O
from	O
comparative	O
analysis	O
with	O
clinical	O
characteristics	O
useful	O
for	O
AKI	O
risk	O
stratification	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
Lipidomic	O
Profile	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
-	O
Infected	O
Cells	O
:	O
Implications	O
for	O
Lipid	O
Metabolism	O
Remodeling	O
upon	O
Coronavirus	B-SPEC
Replication	O
.	O

ABSTRACT	O
:	O
Lipids	O
play	O
numerous	O
indispensable	O
cellular	O
functions	O
and	O
are	O
involved	O
in	O
multiple	O
steps	O
in	O
the	O
replication	O
cycle	O
of	O
viruses	B-SPEC
.	O

Infections	O
by	O
human	B-SPEC
-	O
pathogenic	O
coronaviruses	O
result	O
in	O
diverse	O
clinical	O
outcomes	O
,	O
ranging	O
from	O
self	O
-	O
limiting	O
flu	O
-	O
like	O
symptoms	O
to	O
severe	O
pneumonia	O
with	O
extrapulmonary	O
manifestations	O
.	O

Taken	O
together	O
,	O
our	O
study	O
demonstrated	O
that	O
host	O
lipid	O
metabolic	O
remodeling	O
was	O
significantly	O
associated	O
with	O
human	B-SPEC
-	O
pathogenic	O
coronavirus	B-SPEC
propagation	O
.	O

For	O
rapid	O
detection	O
of	O
PEDV	B-SPEC
,	O
a	O
new	O
immunochromatographic	O
assay	O
(	O
ICA	O
)	O
based	O
on	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
was	O
developed	O
in	O
this	O
study	O
.	O

CONCLUSIONS	O
:	O
Shedding	O
of	O
sVE	O
-	O
cadherin	O
is	O
associated	O
with	O
severe	O
acute	O
kidney	O
injury	O
and	O
with	O
more	O
severe	O
organ	O
dysfunction	O
in	O
patients	O
with	O
sepsis	B-SPEC
,	O
suggesting	O
that	O
breakdown	O
of	O
endothelial	O
adherens	O
junctions	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
organ	O
dysfunction	O
in	O
sepsis	B-SPEC
.	O

Here	O
we	O
provide	O
a	O
brief	O
review	O
of	O
the	O
latest	O
findings	O
in	O
bat	B-SPEC
viruses	B-SPEC
and	O
their	O
potential	O
risk	O
of	O
cross	O
-	O
species	B-SPEC
transmission	O
.	O

We	O
have	O
created	O
a	O
portable	O
,	O
lightweight	O
,	O
user	O
-	O
friendly	O
,	O
internet	O
-	O
enabled	O
,	O
open	O
-	O
source	O
,	O
command	O
-	O
line	O
genome	O
annotation	O
and	O
submission	O
package	O
to	O
facilitate	O
virus	B-SPEC
genome	O
submissions	O
to	O
NCBI	O
GenBank	O
.	O

Whether	O
these	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
human	B-SPEC
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
could	O
be	O
a	O
potential	O
therapeutic	O
target	O
is	O
unknown	O
.	O

We	O
evaluated	O
the	O
pathogenicity	O
of	O
the	O
PEDV	B-SPEC
strain	O
FJzz1	O
in	O
piglets	O
through	O
oral	O
and	O
intramuscular	O
infection	O
routes	O
.	O

This	O
study	O
shows	O
the	O
necessity	O
of	O
monitoring	O
the	O
molecular	O
epidemiology	O
and	O
the	O
etiological	O
characteristics	O
of	O
the	O
epidemic	O
PEDV	B-SPEC
isolates	O
,	O
which	O
may	O
help	O
better	O
control	O
the	O
PED	O
outbreaks	O
.	O

Occupational	O
risk	O
for	O
customs	O
officers	O
also	O
includes	O
noise	O
-	O
induced	O
hearing	O
loss	O
,	O
exposure	O
to	O
diesel	O
engine	O
emission	O
and	O
stored	O
tobacco	B-SPEC
and	O
occupational	O
stress	O
due	O
to	O
their	O
increased	O
time	O
-	O
schedule	O
and	O
decision	O
-	O
making	O
duties	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
results	O
from	O
infection	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

Finally	O
,	O
we	O
extracted	O
the	O
number	O
of	O
swine	B-SPEC
with	O
PEDV	B-SPEC
infection	O
from	O
the	O
obtained	O
studies	O
and	O
provided	O
information	O
that	O
permitted	O
us	O
to	O
estimate	O
the	O
prevalence	O
of	O
PEDV	B-SPEC
infection	O
in	O
pigs	B-SPEC
in	O
mainland	O
China	O
.	O

A	O
total	O
of	O
45	O
studies	O
(	O
including	O
data	O
from	O
15	O
,	O
990	O
pigs	B-SPEC
)	O
met	O
our	O
evaluation	O
criteria	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
PEDV	B-SPEC
among	O
pigs	B-SPEC
in	O
China	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
effect	O
of	O
detected	O
target	O
genes	O
,	O
nor	O
was	O
it	O
associated	O
with	O
date	O
of	O
study	O
publication	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
PEDV	B-SPEC
among	O
pigs	B-SPEC
in	O
China	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
effect	O
of	O
detected	O
target	O
genes	O
,	O
nor	O
was	O
it	O
associated	O
with	O
date	O
of	O
study	O
publication	O
.	O

In	O
this	O
review	O
,	O
the	O
different	O
bovine	B-SPEC
-	O
like	O
CoVs	O
that	O
have	O
been	O
identified	O
in	O
domesticated	O
ruminants	B-SPEC
(	O
water	B-SPEC
buffalo	I-SPEC
,	O
sheep	B-SPEC
,	O
goat	B-SPEC
,	O
dromedary	B-SPEC
camel	B-SPEC
,	O
llama	B-SPEC
and	O
alpaca	B-SPEC
)	O
and	O
wild	O
ruminants	B-SPEC
(	O
deer	B-SPEC
,	O
wild	O
cattle	B-SPEC
,	O
antelopes	O
,	O
giraffes	B-SPEC
and	O
wild	B-SPEC
goats	I-SPEC
)	O
are	O
discussed	O
in	O
terms	O
of	O
epidemiology	O
,	O
transmission	O
and	O
virus	B-SPEC
characteristics	O
.	O

ABSTRACT	O
:	O
Enveloped	O
viruses	B-SPEC
such	O
as	O
coronaviruses	O
or	O
influenza	B-SPEC
virus	I-SPEC
require	O
proteolytic	O
cleavage	O
of	O
their	O
fusion	O
protein	O
to	O
be	O
able	O
to	O
infect	O
the	O
host	O
cell	O
.	O

There	O
are	O
still	O
limited	O
data	O
about	O
distribution	O
of	O
acute	O
viral	O
respiratory	O
infections	O
in	O
children	O
with	O
cancer	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Global	O
Virus	B-SPEC
Network	O
(	O
GVN	O
)	O
was	O
established	O
in	O
2011	O
to	O
strengthen	O
research	O
and	O
responses	O
to	O
emerging	O
viral	O
causes	O
of	O
human	B-SPEC
disease	O
and	O
to	O
prepare	O
against	O
new	O
viral	O
pandemics	O
.	O

This	O
report	O
highlights	O
the	O
recent	O
accomplishments	O
of	O
GVN	O
researchers	O
in	O
several	O
important	O
areas	O
of	O
medical	O
virology	O
,	O
including	O
strategies	O
for	O
the	O
eradication	O
of	O
smallpox	B-SPEC
,	O
measles	O
,	O
polio	O
,	O
SARS	O
and	O
vector	O
-	O
borne	O
or	O
zoonotic	O
infections	O
,	O
emergence	O
and	O
intervention	O
strategies	O
for	O
retroviruses	B-SPEC
and	O
arboviruses	O
,	O
preparedness	O
for	O
outbreaks	O
of	O
Filo	O
-	O
and	O
other	O
hemophilic	O
viruses	B-SPEC
,	O
pathogenesis	O
,	O
impact	O
and	O
prevention	O
of	O
respiratory	O
viruses	B-SPEC
,	O
as	O
well	O
as	O
,	O
viruses	B-SPEC
affecting	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
.	O

ABSTRACT	O
:	O
Ornithobacterium	B-SPEC
rhinotracheale	I-SPEC
(	O
ORT	O
),	O
a	O
bacterium	B-SPEC
causing	O
respiratory	O
tract	O
infection	O
,	O
has	O
led	O
to	O
a	O
significant	O
problem	O
in	O
the	O
intensive	O
poultry	O
production	O
in	O
Egypt	O
.	O

Natural	O
initial	O
enteric	O
FCoV	O
infection	O
may	O
remain	O
subclinical	O
,	O
or	O
result	O
in	O
mild	O
enteric	O
signs	O
or	O
the	O
development	O
of	O
FIP	O
;	O
cats	B-SPEC
may	O
also	O
carry	O
the	O
virus	B-SPEC
systemically	O
with	O
no	O
adverse	O
effect	O
.	O

Among	O
cats	B-SPEC
without	O
FIP	O
,	O
there	O
were	O
few	O
differences	O
between	O
virus	B-SPEC
-	O
positive	O
and	O
virus	B-SPEC
-	O
negative	O
MLNs	O
;	O
however	O
,	O
TLR9	O
and	O
STAT2	O
expression	O
were	O
higher	O
with	O
infection	O
,	O
suggesting	O
a	O
direct	O
viral	O
effect	O
.	O

Accordingly	O
,	O
the	O
full	O
genome	O
sequence	O
was	O
retrieved	O
from	O
the	O
UK	O
rat	B-SPEC
coronavirus	B-SPEC
,	O
along	O
with	O
partial	O
genome	O
sequences	O
from	O
the	O
UK	O
field	B-SPEC
vole	I-SPEC
and	O
Poland	O
-	O
resident	O
bank	B-SPEC
vole	I-SPEC
CoVs	O
,	O
and	O
a	O
short	O
conserved	O
ORF1b	O
fragment	O
from	O
the	O
French	O
rabbit	B-SPEC
CoV	O
.	O
Genome	O
and	O
phylogenetic	O
analysis	O
showed	O
that	O
despite	O
their	O
diverse	O
geographic	O
origins	O
,	O
all	O
rodent	B-SPEC
alpha	O
-	O
CoVs	O
formed	O
a	O
single	O
monophyletic	O
group	O
and	O
shared	O
similar	O
features	O
,	O
such	O
as	O
the	O
same	O
gene	O
constellations	O
,	O
a	O
recombinant	O
beta	O
-	O
CoV	O
spike	O
gene	O
,	O
and	O
similar	O
core	O
transcriptional	O
regulatory	O
sequences	O
(	O
TRS	O
).	O

ABSTRACT	O
:	O
Coronaviruses	O
,	O
including	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
are	O
etiologically	O
associated	O
with	O
enteric	O
and	O
respiratory	O
disease	O
across	O
a	O
wide	O
range	O
of	O
mammalian	B-SPEC
and	O
avian	B-SPEC
species	B-SPEC
.	O

Serologic	O
tests	O
are	O
widely	O
accepted	O
and	O
used	O
to	O
detect	O
anti	O
-	O
PEDV	B-SPEC
antibodies	O
that	O
could	O
indicate	O
PEDV	B-SPEC
infection	O
or	O
vaccination	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
presence	O
of	O
unilateral	O
or	O
bilateral	O
diaphragmatic	O
paralysis	O
of	O
undetermined	O
aetiology	O
,	O
it	O
seems	O
relevant	O
to	O
perform	O
Lyme	O
serology	O
in	O
the	O
blood	O
and	O
,	O
in	O
positive	O
cases	O
,	O
to	O
follow	O
up	O
with	O
a	O
lumbar	O
puncture	O
in	O
order	B-SPEC
to	O
detect	O
intrathecal	O
IgG	O
synthesis	O
.	O

These	O
results	O
provide	O
a	O
structural	O
framework	O
for	O
understanding	O
coronavirus	B-SPEC
neutralization	O
by	O
human	B-SPEC
antibodies	O
and	O
shed	O
light	O
on	O
activation	O
of	O
coronavirus	B-SPEC
membrane	O
fusion	O
,	O
which	O
takes	O
place	O
through	O
a	O
receptor	O
-	O
driven	O
ratcheting	O
mechanism	O
.	O

Our	O
results	O
suggest	O
that	O
further	O
studies	O
on	O
whether	O
GkVs	O
infect	O
humans	B-SPEC
and	O
cause	O
respiratory	O
disease	O
are	O
needed	O
.	O

These	O
results	O
can	O
be	O
used	O
for	O
further	O
analysis	O
of	O
the	O
evolutionary	O
variability	O
,	O
prevalence	O
,	O
and	O
epidemiology	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

There	O
are	O
many	O
diseases	O
that	O
are	O
evaluated	O
using	O
an	O
ABG	O
which	O
include	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
severe	O
sepsis	B-SPEC
,	O
septic	O
shock	O
,	O
hypovolemic	O
shock	O
,	O
diabetic	O
ketoacidosis	O
,	O
renal	O
tubular	O
acidosis	O
,	O
acute	O
respiratory	O
failure	O
,	O
heart	O
failure	O
,	O
cardiac	O
arrest	O
,	O
asthma	O
and	O
inborn	O
errors	O
of	O
metabolism	O
.	O

While	O
we	O
did	O
not	O
detect	O
MERS	O
-	O
CoV	O
in	O
any	O
of	O
the	O
samples	O
,	O
several	O
other	O
viruses	B-SPEC
were	O
detected	O
in	O
50	O
.	O
8	O
%	O
of	O
the	O
cases	O
.	O

The	O
library	O
was	O
screened	O
with	O
four	O
rounds	O
of	O
biopanning	O
using	O
purified	O
TGEV	B-SPEC
antigen	O
,	O
and	O
scFv	O
antibodies	O
that	O
bound	O
to	O
TGEV	B-SPEC
were	O
obtained	O
.	O

<	O
strong	O
>	O
RESULTS	O
</	O
strong	O
>	O
We	O
found	O
the	O
HIPK1	O
was	O
elevated	O
in	O
ALI	O
model	O
mice	B-SPEC
while	O
interference	O
of	O
HIPK1	O
by	O
siRNA	O
attenuated	O
the	O
inflammation	O
and	O
oxidative	O
stress	O
indicators	O
(	O
H2O2	O
,	O
O	O
-	O
2	O
,	O
and	O
NO	O
).	O

A	O
clinical	O
evaluation	O
using	O
intestinal	O
tissue	O
and	O
fecal	O
samples	O
from	O
piglets	O
suffering	O
from	O
diarrhea	O
at	O
different	O
pig	B-SPEC
farms	O
in	O
China	O
revealed	O
that	O
the	O
singular	O
infection	O
rates	O
of	O
PEDV	B-SPEC
and	O
PCV3	O
were	O
43	O
.	O
94	O
%	O
(	O
29	O
/	O
66	O
)	O
and	O
16	O
.	O
67	O
%	O
(	O
11	O
/	O
66	O
),	O
respectively	O
,	O
while	O
the	O
co	O
-	O
infection	O
rate	O
of	O
PCV3	O
with	O
PEDV	B-SPEC
was	O
27	O
.	O
27	O
%	O
(	O
18	O
/	O
66	O
).	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
generated	O
by	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
economic	O
difficulties	O
for	O
livestock	O
farmers	O
.	O

TITLE	O
:	O
Potential	O
Intermediate	O
Hosts	O
for	O
Coronavirus	B-SPEC
Transmission	O
:	O
No	O
Evidence	O
of	O
Clade	O
2c	O
Coronaviruses	O
in	O
Domestic	O
Livestock	O
from	O
Ghana	O
.	O

The	O
presence	O
of	O
coronaviruses	O
,	O
closely	O
related	O
to	O
MERS	O
-	O
CoV	O
in	O
Ghanaian	O
bats	B-SPEC
,	O
presented	O
the	O
opportunity	O
to	O
test	O
the	O
hypothesis	O
of	O
transmissibility	O
of	O
this	O
virus	B-SPEC
through	O
domestic	O
livestock	O
species	B-SPEC
.	O

The	O
possible	O
interactions	O
between	O
livestock	O
and	O
bats	B-SPEC
in	O
31	O
household	O
farms	O
were	O
accessed	O
by	O
observation	O
and	O
interviews	O
with	O
farmers	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
a	O
major	O
disease	O
problem	O
for	O
the	O
poultry	O
industry	O
worldwide	O
.	O

The	O
currently	O
used	O
live	O
-	O
attenuated	O
vaccines	O
have	O
the	O
tendency	O
to	O
mutate	O
and	O
/	O
or	O
recombine	O
with	O
circulating	O
field	O
strains	O
resulting	O
in	O
the	O
emergence	O
of	O
vaccine	O
-	O
derived	O
variant	O
viruses	B-SPEC
.	O

All	O
rNDV	O
-	O
vectored	O
IBV	B-SPEC
vaccine	O
candidates	O
were	O
genetically	O
stable	O
,	O
slightly	O
attenuated	O
and	O
showed	O
growth	O
patterns	O
comparable	O
to	O
that	O
of	O
parental	O
rLaSota	O
virus	B-SPEC
.	O

TITLE	O
:	O
First	O
Complete	O
Genome	O
Sequence	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
HKU1	I-SPEC
from	O
a	O
Nonill	O
Bat	B-SPEC
Guano	O
Miner	O
in	O
Thailand	O
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
activates	O
the	O
NLRP3	O
inflammasome	O
remains	O
unknown	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
characteristics	O
of	O
acute	O
respiratory	O
virus	B-SPEC
infections	O
in	O
pediatric	O
cancer	B-SPEC
patients	O
.	O

Several	O
viruses	B-SPEC
cocirculated	O
within	O
the	O
same	O
period	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
being	O
the	O
most	O
common	O
(	O
45	O
.	O
45	O
%),	O
followed	O
by	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
;	O
26	O
%),	O
influenza	O
type	O
B	O
(	O
26	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
24	O
.	O
6	O
%),	O
and	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
;	O
24	O
.	O
6	O
%).	O

RESULTS	O
:	O
We	O
obtained	O
89	O
nasopharyngeal	O
swabs	O
from	O
patients	O
with	O
pediatric	O
cancer	B-SPEC
(	O
mean	O
age	O
,	O
5	O
.	O
8	O
	O
4	O
.	O
2	O
years	O
).	O

TITLE	O
:	O
Immunoprofiling	O
of	O
peripheral	O
blood	O
from	O
infectious	O
bronchitis	O
virus	B-SPEC
vaccinated	O
MHC	O
-	O
B	O
chicken	B-SPEC
lines	O
-	O
Monocyte	O
MHC	O
-	O
II	O
expression	O
as	O
a	O
potential	O
correlate	O
of	O
protection	O
.	O

To	O
find	O
correlates	O
of	O
IBV	B-SPEC
-	O
vaccine	O
-	O
induced	O
protection	O
,	O
hence	O
,	O
we	O
employed	O
a	O
flow	O
cytometric	O
assay	O
to	O
quantify	O
peripheral	O
leucocyte	O
subsets	O
and	O
expression	O
of	O
cell	O
surface	O
markers	O
of	O
six	O
different	O
non	O
-	O
vaccinated	O
and	O
vaccinated	O
Major	O
Histocompatibility	O
Complex	O
(	O
MHC	O
)	O
haplotypes	O
.	O

Non	O
-	O
vaccinated	O
and	O
vaccinated	O
MHC	O
haplotypes	O
presented	O
differential	O
leucocyte	O
composition	O
and	O
IBV	B-SPEC
viral	O
load	O
.	O

A	O
strong	O
effect	O
of	O
MHC	O
-	O
B	O
,	O
but	O
not	O
vaccination	O
,	O
on	O
several	O
leucocyte	O
subsets	O
resulted	O
in	O
positive	O
correlations	O
with	O
IBV	B-SPEC
viral	O
load	O
based	O
on	O
MHC	O
haplotype	O
ranking	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
the	O
naturally	O
occurring	O
flavonoid	O
kaempferol	O
(	O
KPF	O
)	O
reduces	O
endotoxin	O
-	O
induced	O
inflammatory	O
responses	O
in	O
mice	B-SPEC
.	O

17	O
.	O
5	O
%	O
of	O
samples	O
were	O
positive	O
for	O
respiratory	O
viruses	B-SPEC
.	O

Some	O
viruses	B-SPEC
circulated	O
predominantly	O
during	O
winter	O
,	O
whereas	O
others	O
were	O
found	O
year	O
round	O
.	O

TITLE	O
:	O
Genetic	O
characterization	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
in	O
Vietnam	O
.	O

TITLE	O
:	O
Forecasting	O
herd	O
-	O
level	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
frequency	O
trends	O
in	O
Ontario	O
(	O
Canada	O
).	O

We	O
infected	O
human	B-SPEC
and	O
bat	B-SPEC
(	O

In	O
this	O
study	O
,	O
we	O
detected	O
p53	O
upregulation	O
in	O
response	O
to	O
PEDV	B-SPEC
infection	O
.	O

Cloacal	O
/	O
throat	O
double	O
swabs	O
were	O
collected	O
from	O
60	O
birds	B-SPEC
at	O
each	O
farm	O
according	O
to	O
a	O
random	O
sampling	O
method	O
.	O

The	O
results	O
showed	O
that	O
the	O
method	O
could	O
simultaneously	O
detect	O
major	O
viruses	B-SPEC
infecting	O
farms	O
,	O
including	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
rotavirus	B-SPEC
G	I-SPEC
,	O
duck	B-SPEC
hepatitis	I-SPEC
B	I-SPEC
virus	I-SPEC
,	O
and	O
avian	B-SPEC
leukemia	O
virus	B-SPEC
subgroup	O
J	O
in	O
several	O
farms	O
.	O

Our	O
objective	O
was	O
to	O
determine	O
whether	O
systemically	O
healthy	O
horses	B-SPEC
and	O
horses	B-SPEC
with	O
gastrointestinal	O
disorders	O
shed	O
ECoV	O
in	O
their	O
feces	O
at	O
the	O
time	O
of	O
admission	O
to	O
a	O
referral	O
hospital	O
and	O
after	O
48	O
hours	O
of	O
stress	O
associated	O
with	O
hospitalization	O
.	O

One	O
-	O
hundred	O
thirty	O
adult	O
horses	B-SPEC
admitted	O
to	O
the	O
Washington	O
State	O
University	O
Veterinary	O
Teaching	O
Hospital	O
for	O
gastrointestinal	O
disease	O
(	O
n	O
=	O
65	O
)	O
or	O
for	O
imaging	O
under	O
anesthesia	O
(	O
n	O
=	O
65	O
)	O
that	O
were	O
hospitalized	O
for	O
48	O
hours	O
.	O

The	O
presence	O
of	O
ECoV	O
in	O
feces	O
of	O
hospitalized	O
adult	O
horses	B-SPEC
was	O
low	O
.	O

RESULTS	O
:	O
Only	O
1	O
of	O
258	O
fecal	O
samples	O
was	O
PCR	O
-	O
positive	O
for	O
ECoV	O
.	O
Electron	O
microscopy	O
identified	O
ECoV	O
-	O
like	O
particles	O
in	O
9	O
of	O
258	O
samples	O
,	O
parvovirus	B-SPEC
-	O
like	O
particles	O
in	O
4	O
of	O
258	O
samples	O
,	O
and	O
rotavirus	B-SPEC
-	O
like	O
particles	O
in	O
1	O
of	O
258	O
samples	O
.	O

Therapeutic	O
antibodies	O
are	O
key	O
tools	O
for	O
preventing	O
and	O
treating	O
MERS	O
-	O
CoV	O
infection	O
,	O
but	O
to	O
date	O
no	O
such	O
agents	O
have	O
been	O
approved	O
for	O
treatment	O
of	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
Management	O
of	O
cytokine	O
release	O
syndrome	O
and	O
neurotoxicity	O
in	O
chimeric	O
antigen	O
receptor	O
(	O
CAR	B-SPEC
)	O
T	O
cell	O
therapy	O
.	O

ABSTRACT	O
:	O
Chimeric	O
antigen	O
receptor	O
(	O
CAR	B-SPEC
)	O
T	O
cell	O
immunotherapy	O
has	O
demonstrated	O
remarkable	O
anti	O
-	O
tumor	O
activity	O
in	O
B	O
-	O
cell	O
malignancies	O
and	O
is	O
under	O
investigation	O
in	O
other	O
hematologic	O
malignancies	O
and	O
solid	O
tumors	O
.	O

While	O
highly	O
efficacious	O
,	O
post	O
-	O
infusion	O
T	O
cell	O
activity	O
often	O
results	O
in	O
massive	O
cytokine	O
release	O
precipitating	O
cytokine	O
release	O
syndrome	O
(	O
CRS	O
),	O
the	O
signature	O
toxicity	O
of	O
CAR	B-SPEC
T	O
cells	O
.	O

Antiviral	O
evaluation	O
revealed	O
appreciable	O
activity	O
against	O
Coxsackie	O
virus	B-SPEC
B4	O
,	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
Yellow	B-SPEC
Fever	I-SPEC
Virus	I-SPEC
and	O
Human	B-SPEC
Coronavirus	I-SPEC
(	O
229E	O
)	O
for	O
the	O
3	O
-	O
deoxy	O
compounds	O
12b	O
,	O
14	O
,	O
and	O
the	O
3	O
-	O
deoxy	O
-	O
3	O
-	O
methyl	O
18a	O
,	O
18c	O
,	O
18d	O
,	O
accompanied	O
by	O
low	O
cytotoxicity	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
has	O
emerged	O
and	O
spread	O
throughout	O
the	O
porcine	B-SPEC
industry	O
in	O
many	O
countries	O
over	O
the	O
last	O
6	O
years	O
.	O

Spray	O
drying	O
in	O
combination	O
with	O
storage	O
for	O
	O
2	O
weeks	O
at	O
20	O
	O
C	O
eliminated	O
infectivity	O
of	O
PEDV	B-SPEC
effectively	O
.	O

Here	O
,	O
we	O
report	O
significantly	O
dampened	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	O
in	O
bat	B-SPEC
primary	O
immune	O
cells	O
compared	O
to	O
human	B-SPEC
or	O
mouse	B-SPEC
counterparts	O
.	O

Our	O
results	O
elucidate	O
an	O
important	O
mechanism	O
through	O
which	O
bats	B-SPEC
dampen	O
inflammation	O
with	O
implications	O
for	O
longevity	O
and	O
unique	O
viral	O
reservoir	O
status	O
.	O

TITLE	O
:	O
Mucosal	O
immune	O
responses	O
induced	O
by	O
oral	O
administration	O
recombinant	O
ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
in	O
newborn	O
piglets	O
and	O
causes	O
substantial	O
economic	O
losses	O
in	O
the	O
world	O
.	O

TITLE	O
:	O
An	O
Overview	O
of	O
the	O
Most	O
Significant	O
Zoonotic	O
Viral	O
Pathogens	O
Transmitted	O
from	O
Animal	B-SPEC
to	O
Human	B-SPEC
in	O
Saudi	O
Arabia	O
.	O

Potential	O
management	O
strategies	O
for	O
these	O
viruses	B-SPEC
are	O
given	O
.	O

Future	O
studies	O
should	O
include	O
prospective	O
trials	O
using	O
contemporary	O
molecular	O
diagnostics	O
to	O
understand	O
the	O
true	O
epidemiology	O
,	O
clinical	O
spectrum	O
,	O
and	O
long	O
-	O
term	O
consequences	O
of	O
respiratory	O
viruses	B-SPEC
as	O
well	O
as	O
to	O
define	O
preventative	O
and	O
therapeutic	O
measures	O
.	O

TITLE	O
:	O
Correction	O
to	O
:	O
Genetic	O
Evidence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
Cov	O
)	O
and	O
Widespread	O
Seroprevalence	O
among	O
Camels	B-SPEC
in	O
Kenya	O
.	O

Multiplex	O
PCR	O
assays	O
were	O
performed	O
on	O
nasopharyngeal	O
swabs	O
to	O
detect	O
respiratory	O
viruses	B-SPEC
during	O
routine	O
visits	O
and	O
when	O
symptomatic	O
.	O

TITLE	O
:	O
[	O
The	O
role	O
of	O
nicotinamide	O
-	O
adenine	O
dinucleotide	O
phosphate	O
oxidase	O
NOX	O
family	B-SPEC
in	O
acute	O
lung	O
injury	O
].	O

This	O
review	O
mainly	O
describes	O
the	O
cell	O
distribution	O
,	O
activation	O
factors	O
,	O
and	O
its	O
relationship	O
with	O
the	O
occurrence	O
and	O
development	O
of	O
ALI	O
of	O
the	O
NOX	O
family	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
were	O
used	O
to	O
understand	O
the	O
impact	O
of	O
CAV	B-SPEC
on	O
secondary	O
infection	O
with	O
LPAI	O
-	O
H9N2	O
or	O
IB	O
viruses	B-SPEC
.	O

The	O
results	O
exhibit	O
that	O
chickens	B-SPEC
previously	O
infected	O
with	O
CAV	B-SPEC
produceconsiderablyhigher	O
titresof	O
LPAI	O
-	O
H9N2	O
or	O
IB	O
viruses	B-SPEC
in	O
the	O
oropharyngeal	O
swabs	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
tracheas	O
and	O
kidneys	O
.	O

Further	O
comparative	O
genomic	O
analysis	O
revealed	O
at	O
least	O
two	O
recombination	O
sites	O
that	O
replaced	O
the	O
spike	O
gene	O
in	O
a	O
lineage	O
18	O
within	O
genotype	O
I	O
(	O
GI	O
-	O
18	O
)-	O
like	O
virus	B-SPEC
with	O
an	O
as	O
-	O
yet	O
-	O
unidentified	O
sequence	O
,	O
likely	O
derived	O
from	O
another	O
IBV	B-SPEC
strain	O
,	O
resulting	O
a	O
novel	O
serotype	O
with	O
a	O
lower	O
affinity	O
to	O
the	O
respiratory	O
tract	O
in	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Repeated	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
infections	O
within	O
a	O
single	O
chicken	B-SPEC
farm	O
.	O

Protection	O
in	O
alpaca	B-SPEC
correlates	O
with	O
high	O
serum	O
neutralizing	O
antibody	O
titers	O
.	O

Lower	O
titers	O
of	O
serum	O
neutralizing	O
antibodies	O
correlate	O
with	O
delayed	O
and	O
significantly	O
reduced	O
shedding	O
in	O
the	O
nasal	O
turbinates	O
of	O
dromedary	B-SPEC
camels	B-SPEC
.	O

Direct	O
transmission	O
cycles	O
are	O
often	O
implicated	O
in	O
these	O
outbreaks	O
,	O
with	O
virus	B-SPEC
shed	O
in	O
bat	B-SPEC
feces	O
,	O
urine	O
,	O
and	O
saliva	O
.	O

Serosurveillance	O
and	O
viral	O
isolation	O
from	O
either	O
free	O
-	O
ranging	O
or	O
captive	O
bats	B-SPEC
are	O
described	O
in	O
relation	O
to	O
four	O
arboviral	O
groups	O
(	O

TITLE	O
:	O
The	O
crystal	O
structure	O
of	O
main	O
protease	O
from	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
in	O
complex	O
with	O
an	O
inhibitor	O
.	O

ABSTRACT	O
:	O
The	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
that	O
emerged	O
and	O
spread	O
throughout	O
Taiwan	O
in	O
2014	O
triggered	O
significant	O
concern	O
in	O
the	O
country	O
'	O
s	O
swine	B-SPEC
industry	O
.	O

Data	O
from	O
GIS	O
and	O
multiple	O
potential	O
infection	O
factors	O
were	O
used	O
to	O
pinpoint	O
cluster	O
dissemination	O
in	O
areas	O
with	O
large	O
numbers	O
of	O
swine	B-SPEC
farms	O
in	O
southern	O
Taiwan	O
.	O

TITLE	O
:	O
The	O
Etiological	O
Role	O
of	O
Common	O
Respiratory	O
Viruses	B-SPEC
in	O
Acute	O
Respiratory	O
Infections	O
in	O
Older	O
Adults	O
:	O
A	O
Systematic	O
Review	O
and	O
Meta	B-SPEC
-	O
analysis	O
.	O

This	O
review	O
supports	O
RSV	B-SPEC
,	O
Flu	O
,	O
PIV	O
,	O
HMPV	B-SPEC
,	O
AdV	O
,	O
RV	O
,	O
and	O
CoV	O
as	O
important	O
causes	O
of	O
ARI	O
in	O
older	O
adults	O
and	O
provides	O
quantitative	O
estimates	O
of	O
the	O
absolute	O
proportion	O
of	O
virus	B-SPEC
-	O
associated	O
ARI	O
cases	O
to	O
which	O
a	O
viral	O
cause	O
can	O
be	O
attributed	O
.	O

TITLE	O
:	O
Broad	O
-	O
spectrum	O
coronavirus	B-SPEC
antiviral	O
drug	O
discovery	O
.	O

Based	O
on	O
lessons	O
learned	O
from	O
SARS	O
and	O
MERS	O
outbreaks	O
,	O
lack	O
of	O
drugs	O
capable	O
of	O
pan	B-SPEC
-	O
coronavirus	B-SPEC
antiviral	O
activity	O
increases	O
the	O
vulnerability	O
of	O
public	O
health	O
systems	O
to	O
a	O
highly	O
pathogenic	O
coronavirus	B-SPEC
pandemic	O
.	O

ABSTRACT	O
:	O
Type	O
-	O
I	O
IFNs	O
(	O
IFN	O
-	O
I	O
)	O
provide	O
a	O
key	O
mediator	O
of	O
innate	O
antiviral	O
response	O
during	O
virus	B-SPEC
proliferation	O
.	O

ABSTRACT	O
:	O
Synthetic	O
cannabinoids	O
(	O
SCs	O
)	O
belong	O
to	O
the	O
group	O
of	O
new	O
psychoactive	O
substances	O
(	O
NPS	O
)	O
which	O
appear	O
sprayed	O
on	O
herbal	O
mixtures	O
on	O
the	O
""""	O
street	O
""""	O
drug	O
market	O
and	O
are	O
intended	O
for	O
smoking	O
like	O
marijuana	B-SPEC
.	O

In	O
the	O
same	O
population	O
9	O
.	O
0	O
%	O
of	O
horses	B-SPEC
tested	O
qPCR	O
-	O
positive	O
for	O
EHV	B-SPEC
-	I-SPEC
4	I-SPEC
,	O
6	O
.	O
1	O
%	O
for	O
EIV	O
,	O
4	O
.	O
3	O
%	O
for	O
The	O
present	O
study	O
results	O
showed	O
that	O
7	O
.	O
2	O
%	O
of	O
horses	B-SPEC
with	O
acute	O
onset	O
of	O
fever	O
tested	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
feces	O
,	O
highlighting	O
the	O
importance	O
of	O
testing	O
such	O
horses	B-SPEC
for	O
ECoV	O
in	O
feces	O
.	O

TITLE	O
:	O
N	O
-	O
Linked	O
glycosylation	O
of	O
the	O
membrane	O
protein	O
ectodomain	O
regulates	O
infectious	O
bronchitis	O
virus	B-SPEC
-	O
induced	O
ER	O
stress	O
response	O
,	O
apoptosis	O
and	O
pathogenesis	O
.	O

In	O
this	O
study	O
,	O
we	O
confirm	O
that	O
N	O
-	O
linked	O
glycosylation	O
occurs	O
at	O
two	O
predicted	O
sites	O
in	O
the	O
M	O
protein	O
ectodomain	O
of	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
Interplay	O
Between	O
Host	O
Innate	O
Immune	O
Responses	O
and	O
Porcine	B-SPEC
Enteric	O
Coronaviruses	O
.	O

ABSTRACT	O
:	O
Enteropathogenic	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
members	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
,	O
account	O
for	O
the	O
majority	O
of	O
lethal	O
watery	O
diarrhea	O
in	O
neonatal	O
pigs	B-SPEC
in	O
the	O
past	O
decade	O
.	O

In	O
our	O
study	O
,	O
the	O
S1	O
region	O
of	O
PEDV	B-SPEC
strain	O
CH	O
/	O
JLDH	O
/	O
2016	O
spike	O
gene	O
was	O
inserted	O
into	O
the	O
Lactococcus	B-SPEC
lactis	I-SPEC
expression	O
vector	O
,	O
pNZ8149	O
,	O
resulting	O
in	O
recombinant	O
plasmid	O
pNZ8149	O
-	O
S1	O
,	O
and	O
the	O
immunogenicity	O
of	O
recombinant	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
pNZ8149	O
-	O
S1	O
/	O
NZ3900	O
was	O
evaluated	O
in	O
mice	B-SPEC
.	O

After	O
immunization	O
,	O
significantly	O
higher	O
levels	O
of	O
anti	O
-	O
PEDV	B-SPEC
serum	O
IgG	O
antibodies	O
and	O
mucosal	O
sIgA	B-SPEC
antibodies	O
were	O
detected	O
in	O
mice	B-SPEC
orally	O
administered	O
with	O
pNZ8149	O
-	O
S1	O
/	O
NZ3900	O
,	O
compared	O
with	O
control	O
groups	O
pNZ8149	O
/	O
NZ3900	O
,	O
NZ3900	O
,	O
and	O
phosphate	O
buffered	O
saline	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

Lymphocyte	O
proliferation	O
assay	O
results	O
showed	O
that	O
the	O
recombinant	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
pNZ8149	O
-	O
S1	O
/	O
NZ3900	O
significantly	O
stimulated	O
the	O
proliferation	O
of	O
splenic	O
lymphocytes	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

The	O
incidence	O
of	O
thrombosis	O
was	O
correlated	O
with	O
risk	O
factors	O
such	O
as	O
coagulation	O
variables	O
(	O
mean	O
activated	O
partial	O
thromboplastin	O
time	O
	O
50	O
s	O
,	O
international	O
normalized	O
ratio	O
antithrombin	O
III	O
,	O
fibrinogen	O
,	O
plasma	O
-	O
free	O
hemoglobin	O
,	O
platelets	O
,	O
and	O
decline	O
in	O
D	O
-	O
dimer	O
	O
50	O
%	O
the	O
day	O
after	O
decannulation	O
),	O
cannula	B-SPEC
size	O
,	O
time	O
on	O
venovenous	O
extracorporeal	O
membrane	O
oxygenation	O
,	O
renal	O
failure	O
,	O
and	O
underlying	O
malignant	O
disease	O
.	O

However	O
,	O
it	O
is	O
still	O
not	O
known	O
whether	O
viruses	B-SPEC
are	O
responsible	O
for	O
the	O
symptoms	O
observed	O
in	O
sick	O
pilgrims	O
or	O
whether	O
they	O
only	O
colonize	O
sick	O
and	O
asymptomatic	O
pilgrims	O
.	O

Viruses	B-SPEC
were	O
identified	O
using	O
the	O
BioFire	O
FilmArray	O
109	O
pilgrims	O
were	O
included	O
.	O

Although	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
,	O
coronavirus	B-SPEC
229E	O
and	O
influenza	O
A	O
clearance	O
were	O
respectively	O
70	O
.	O
6	O
%,	O
71	O
.	O
4	O
%	O
and	O
100	O
%	O
on	O
return	O
,	O
overall	O
virus	B-SPEC
carriage	O
proportion	O
on	O
return	O
was	O
75	O
.	O
0	O
%	O
in	O
pilgrims	O
with	O
influenza	O
-	O
like	O
illness	O
and	O
44	O
.	O
0	O
%	O
in	O
those	O
who	O
have	O
never	O
experienced	O
this	O
symptoms	O
or	O
resolved	O
it	O

TITLE	O
:	O
Biological	O
characterization	O
and	O
pathogenicity	O
of	O
a	O
newly	O
isolated	O
Chinese	O
highly	O
virulent	O
genotype	O
GIIa	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
.	O

ABSTRACT	O
:	O
Since	O
2010	O
,	O
continual	O
outbreaks	O
of	O
highly	O
virulent	O
variants	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
belonging	O
to	O
genotype	O
GII	O
have	O
led	O
to	O
serious	O
economic	O
losses	O
for	O
the	O
Chinese	O
swine	B-SPEC
industry	O
.	O

TITLE	O
:	O
Endemic	O
infection	O
can	O
shape	O
exposure	O
to	O
novel	O
pathogens	O
:	O
Pathogen	O
co	O
-	O
occurrence	O
networks	O
in	O
the	O
Serengeti	O
lions	B-SPEC
.	O

ABSTRACT	O
:	O
Dromedary	B-SPEC
camels	B-SPEC
are	O
natural	O
host	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

The	O
segregation	O
of	O
camels	B-SPEC
from	O
other	O
livestock	O
in	O
farms	O
and	O
live	O
animal	B-SPEC
markets	O
may	O
need	O
to	O
be	O
considered	O
.	O

Knowledge	O
of	O
the	O
animal	B-SPEC
reservoir	O
of	O
MERS	O
-	O
CoV	O
is	O
essential	O
to	O
develop	O
intervention	O
and	O
control	O
measures	O
to	O
prevent	O
human	B-SPEC
infections	O
.	O

The	O
causative	O
spirochaete	B-SPEC
,	O
Borrelia	B-SPEC
recurrentis	I-SPEC
,	O
has	O
a	O
genome	O
so	O
similar	O
to	O
B	B-SPEC
.	I-SPEC
duttonii	I-SPEC
and	O
B	B-SPEC
.	I-SPEC
crocidurae	I-SPEC
(	O
causes	O
of	O
East	O
and	O
West	O
African	O
tick	B-SPEC
-	O
borne	O
relapsing	O
fever	O
),	O
that	O
they	O
are	O
now	O
regarded	O
as	O
merely	O
ecotypes	O
of	O
a	O
single	O
genomospecies	O
.	O

Between	O
blood	O
meals	O
,	O
body	B-SPEC
lice	I-SPEC
live	O
in	O
clothing	O
until	O
the	O
host	O
'	O
s	O
body	O
temperature	O
rises	O
or	O
falls	O
,	O
when	O
they	O
seek	O
a	O
new	O
abode	O
.	O

The	O
presence	O
of	O
influenza	B-SPEC
D	I-SPEC
virus	I-SPEC
(	O
IDV	O
),	O
bovine	B-SPEC
rhinitis	O
A	O
virus	B-SPEC
(	O
BRAV	O
),	O
bovine	B-SPEC
rhinitis	I-SPEC
B	I-SPEC
virus	I-SPEC
(	O
BRBV	O
),	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
and	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
was	O
associated	O
with	O
BRD	O
.	O

Agreement	O
between	O
identification	O
of	O
viruses	B-SPEC
in	O
nasal	O
swabs	O
and	O
tracheal	O
washes	O
was	O
generally	O
weak	O
,	O
indicating	O
that	O
sampling	O
location	O
may	O
affect	O
detection	O
of	O
infection	O
.	O

TITLE	O
:	O
Fulminant	O
Tritrichomonas	B-SPEC
foetus	I-SPEC
'	B-SPEC
feline	I-SPEC
genotype	O
'	O
infection	O
in	O
a	O
3	O
-	O
month	O
old	O
kitten	O
associated	O
with	O
viral	O
co	O
-	O
infection	O
.	O

ABSTRACT	O
:	O
Genome	O
sequencing	O
of	O
virus	B-SPEC
has	O
become	O
a	O
useful	O
tool	O
for	O
better	O
understanding	O
of	O
virus	B-SPEC
pathogenicity	O
and	O
epidemiological	O
surveillance	O
.	O

The	O
protocol	O
introduced	O
here	O
is	O
shown	O
to	O
be	O
robust	O
,	O
to	O
produce	O
a	O
reliable	O
sequence	O
,	O
and	O
could	O
be	O
applied	O
to	O
other	O
virus	B-SPEC
.	O

Homology	O
analysis	O
of	O
the	O
regions	O
corresponding	O
to	O
20	O
typical	O
strains	O
of	O
different	O
PEDV	B-SPEC
subtypes	O
showed	O
that	O
the	O
epitope	O
is	O
highly	O
conserved	O
.	O

TITLE	O
:	O
Severe	O
Gastric	O
Mycormycosis	O
Infection	O
Followed	O
by	O
Cytomegalovirus	B-SPEC
Pneumonia	O
in	O
a	O
Renal	O
Transplant	O
Recipient	O
:	O
A	O
Case	O
Report	O
and	O
Concise	O
Review	O
of	O
the	O
Literature	O
.	O

We	O
performed	O
successful	O
treatment	O
for	O
both	O
mucormycosis	O
and	O
CMV	B-SPEC
pneumonia	O
and	O
adjusted	O
the	O
tacrolimus	O
dose	O
accordingly	O
.	O

These	O
complications	O
are	O
mainly	O
caused	O
by	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
infection	O
and	O
are	O
major	O
causes	O
of	O
death	O
associated	O
with	O
malaria	O
.	O

Another	O
benefit	O
comes	O
from	O
its	O
versatility	O
as	O
it	O
can	O
be	O
applied	O
to	O
envelope	O
proteins	O
belonging	O
to	O
all	O
three	O
classes	O
of	O
viral	O
fusion	O
proteins	O
,	O
such	O
as	O
the	O
class	B-SPEC
I	O
influenza	O
hemagglutinin	O
(	O
HA	O
)	O
and	O
Ebola	B-SPEC
virus	I-SPEC
glycoprotein	O
(	O
GP	O
),	O
the	O
class	B-SPEC
II	O
Semliki	B-SPEC
forest	I-SPEC
virus	I-SPEC
E1	O
protein	O
,	O
or	O
the	O
class	B-SPEC
III	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
G	O
glycoprotein	O
.	O

Moreover	O
,	O
recombinant	O
PEDV	B-SPEC
viruses	B-SPEC
bearing	O
S	O
of	O
the	O
G2	O
strain	O
with	O
the	O
single	O
V672F	O
substitution	O
could	O
induce	O
extensive	O
syncytium	O
formation	O
and	O
replicate	O
efficiently	O
in	O
VeroE6	O
cells	O
stably	O
expressing	O
porcine	B-SPEC
aminopeptidase	O
N	O
(	O
VeroE6	O
-	O
APN	O
).	O

All	O
testicles	O
were	O
negative	O
at	O
immunohistochemistry	O
,	O
while	O
six	O
were	O
positive	O
at	O
nRT	O
-	O
PCR	O
for	O
FCoV	O
.	O
Serology	O
and	O
blood	O
PCR	O
results	O
suggest	O
that	O
the	O
virus	B-SPEC
was	O
present	O
in	O
the	O
environment	O
,	O
stimulating	O
transient	O
seroconversion	O
.	O

The	O
heavily	O
glycosylated	O
IBV	B-SPEC
spike	O
protein	O
is	O
responsible	O
for	O
binding	O
to	O
host	O
tissues	O
.	O

To	O
improve	O
the	O
recovery	O
of	O
enveloped	O
viruses	B-SPEC
,	O
several	O
modifications	O
in	O
the	O
elution	O
were	O
assayed	O
:	O
increasing	O
the	O
elution	O
pH	O
,	O
extending	O
glass	O
wool	O
and	O
eluent	O
contact	O
time	O
,	O
adding	O
a	O
detergent	O
,	O
or	O
performing	O
the	O
elution	O
by	O
recirculation	O
or	O
under	O
agitation	O
.	O

In	O
this	O
study	O
,	O
the	O
sample	O
was	O
positive	O
for	O
PEDV	B-SPEC
variant	O
strains	O
via	O
the	O
nano	O
-	O
nest	O
PCR	O
.	O

In	O
addition	O
,	O
the	O
strain	O
was	O
identified	O
via	O
electron	O
microscopy	O
observation	O
,	O
indirect	O
immunofluorescence	O
assay	O
and	O
infection	O
experiment	O
in	O
newborn	O
piglets	O
and	O
named	O
PEDV	B-SPEC
CH	O
/	O
JLDH	O
/	O
2016	O
strain	O
(	O
Accession	O
No	O
.	O
MF346935	O
).	O

ABSTRACT	O
:	O
Swine	B-SPEC
enteric	O
coronaviruses	O
(	O
SECoVs	O
),	O
including	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
coronavirus	B-SPEC
(	O
SADS	O
-	O
CoV	O
),	O
and	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
have	O
emerged	O
and	O
been	O
prevalent	O
in	O
pig	B-SPEC
populations	O
in	O
China	O
for	O
the	O
last	O
several	O
years	O
.	O

However	O
,	O
current	O
traditional	O
inactivated	O
and	O
attenuated	O
PEDV	B-SPEC
vaccines	O
are	O
of	O
limited	O
efficacy	O
against	O
circulating	O
PEDV	B-SPEC
variants	O
,	O
and	O
there	O
are	O
no	O
commercial	O
vaccines	O
for	O
prevention	O
of	O
PDCoV	O
and	O
SADS	O
-	O
CoV	O
.	O
RNA	O
interference	O
(	O
RNAi	O
)	O
is	O
a	O
powerful	O
tool	O
in	O
therapeutic	O
applications	O
to	O
inhibit	O
viral	O
replication	O
in	O
vitro	O
.	O

In	O
this	O
study	O
,	O
we	O
developed	O
a	O
small	O
interfering	O
RNA	O
generation	O
system	O
that	O
expressed	O
two	O
different	O
short	O
hairpin	O
RNAs	O
(	O
shRNAs	O
)	O
targeting	O
the	O
M	O
gene	O
of	O
PEDV	B-SPEC
and	O
SADS	O
-	O
CoV	O
and	O
the	O
N	O
gene	O
of	O
PDCoV	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
shRNA	O
molecules	O
significantly	O
restricted	O
the	O
expression	O
of	O
M	O
and	O
N	O
protein	O
,	O
and	O
impaired	O
the	O
replication	O
of	O
PEDV	B-SPEC
,	O
SADS	O
-	O
CoV	O
,	O
and	O
PDCoV	O
simultaneously	O
.	O

ABSTRACT	O
:	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
infection	O
induces	O
dramatic	O
and	O
permanent	O
alveolar	O
remodeling	O
mediated	O
by	O
p63	O

We	O
generated	O
rAd5	O
constructs	O
expressing	O
CD40	O
-	O
targeted	O
S1	O
fusion	O
protein	O
(	O
rAd5	O
-	O
S1	O
/	O
F	O
/	O
CD40L	O
),	O
untargeted	O
S1	O
(	O
rAd5	O
-	O
S1	O
),	O
and	O
Green	O
Fluorescent	O
Protein	O
(	O
rAd5	O
-	O
GFP	O
),	O
and	O
evaluated	O
their	O
efficacy	O
and	O
safety	O
in	O
human	B-SPEC
dipeptidyl	O
peptidase	O
4	O
transgenic	O
(	O
hDPP4	O
Tg	O
+)	O
mice	B-SPEC
.	O

However	O
,	O
rAd5	O
-	O
S1	O
-	O
but	O
not	O
rAd5	O
-	O
S1	O
/	O
F	O
/	O
CD40L	O
-	O
immunized	O
mice	B-SPEC
exhibited	O
marked	O
pulmonary	O
perivascular	O
hemorrhage	O
post	O
-	O
MERS	O
-	O
CoV	O
challenge	O
despite	O
the	O
observed	O
protection	O
.	O

Given	O
the	O
high	O
mortality	O
associated	O
with	O
ARDS	O
,	O
numerous	O
animal	B-SPEC
models	O
have	O
been	O
developed	O
to	O
support	O
translational	O
research	O
.	O

TITLE	O
:	O
Antagonism	O
of	O
dsRNA	O
-	O
Induced	O
Innate	O
Immune	O
Pathways	O
by	O
NS4a	O
and	O
NS4b	O
Accessory	O
Proteins	O
during	O
MERS	O
Coronavirus	B-SPEC
Infection	O
.	O

As	O
during	O
infection	O
by	O
other	O
viruses	B-SPEC
,	O
host	O
sensing	O
of	O
viral	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
induces	O
several	O
antiviral	O
pathways	O
.	O

TITLE	O
:	O
Identification	O
and	O
Characterization	O
of	O
a	O
Human	B-SPEC
Coronavirus	I-SPEC
229E	I-SPEC
Nonstructural	O
Protein	O
8	O
-	O
Associated	O
RNA	O
3	O
'-	O
Terminal	O
Adenylyltransferase	O
Activity	O
.	O

TITLE	O
:	O
Analysis	O
of	O
Coronavirus	B-SPEC
Temperature	O
-	O
Sensitive	O
Mutants	O
Reveals	O
an	O
Interplay	O
between	O
the	O
Macrodomain	O
and	O
Papain	O
-	O
Like	O
Protease	O
Impacting	O
Replication	O
and	O
Pathogenesis	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
during	O
virus	B-SPEC
infection	O
,	O
the	O
replicase	O
proteins	O
containing	O
the	O
MAC	B-SPEC
and	O
PLP2	O
mutations	O
were	O
more	O
rapidly	O
degraded	O
at	O
the	O
nonpermissive	O
temperature	O
than	O
were	O
the	O
wild	O
-	O
type	O
proteins	O
.	O

Half	O
of	O
the	O
samples	O
contained	O
at	O
least	O
one	O
examined	O
virus	B-SPEC
with	O
the	O
dominance	O
of	O
kobuvirus	B-SPEC
(	O
55	O
.	O
1	O
%)	O
followed	O
by	O
bocaviruses	B-SPEC
(	O
33	O
.	O
2	O
%)	O
and	O
rotavirus	B-SPEC
groups	O
A	O
and	O
C	O
together	O
(	O
20	O
.	O
9	O
%),	O
while	O
coronaviruses	O
including	O
PEDV	B-SPEC
were	O
not	O
found	O
in	O
this	O
set	O
of	O
samples	O
.	O

Statistical	O
analysis	O
showed	O
a	O
highly	O
significant	O
difference	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
in	O
the	O
frequency	O
of	O
single	O
infections	O
compared	O
to	O
mixed	O
ones	O
with	O
the	O
exception	O
of	O
weaned	O
pigs	B-SPEC
,	O
in	O
which	O
group	O
additionally	O
most	O
viruses	B-SPEC
were	O
detected	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
-	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
zoonotic	O
virus	B-SPEC
that	O
causes	O
severe	O
and	O
often	O
fatal	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

Collectively	O
,	O
these	O
antibodies	O
offer	O
new	O
ways	O
to	O
gain	O
humoral	O
protection	O
in	O
humans	B-SPEC
against	O
the	O
emerging	O
MERS	O
-	O
CoV	O
by	O
targeting	O
different	O
spike	O
protein	O
epitopes	O
and	O
functions	O
.	O

ABSTRACT	O
:	O
Respiratory	O
virus	B-SPEC
infections	O
in	O
hematologic	O
stem	O
cell	O
transplant	O
recipients	O
and	O
patients	O
with	O
hematologic	O
malignancies	O
are	O
increasingly	O
recognized	O
as	O
a	O
cause	O
of	O
significant	O
morbidity	O
and	O
mortality	O
.	O

TITLE	O
:	O
Arterivirus	B-SPEC
nsp4	O
Antagonizes	O
Interferon	O
Beta	O
Production	O
by	O
Proteolytically	O
Cleaving	O
NEMO	O
at	O
Multiple	O
Sites	O
.	O

Overall	O
,	O
the	O
most	O
prevalent	O
virus	B-SPEC
detected	O
was	O
RSV	B-SPEC
-	O
A	O
(	O
14	O
.	O
2	O
%)	O
followed	O
by	O
AdV	O
(	O
10	O
.	O
4	O
%)	O
and	O
IAV	O
(	O
10	O
.	O
4	O
%),	O
then	O
RSV	B-SPEC
-	O
B	O
(	O
6	O
.	O
2	O
%),	O
EV	O
(	O
4	O
.	O
2	O
%),	O
IBV	B-SPEC
(	O
2	O
.	O
2	O
%),	O
PIV	O
-	O
3	O
(	O
1	O
.	O
7	O
%),	O
CoV	O
(	O
1	O
.	O
0	O
%),	O
PIV	O
-	O
1	O
(	O
1	O
.	O
0	O
%),	O
PIV	O
-	O
4	O
(	O
0	O
.	O
7	O
%),	O
and	O
PIV	O
-	O
2	O
(	O
0	O
.	O
2	O
%).	O

For	O
single	O
virus	B-SPEC
or	O
different	O
combinations	O
of	O
two	O
viruses	B-SPEC
the	O
detection	O
limit	O
of	O
mRT	O
-	O
PCR	O
was	O
consistent	O
with	O
a	O
single	O
RT	O
-	O
PCR	O
wtith	O
1	O
	O
10	O

An	O
ARDS	O
model	O
was	O
induced	O
in	O
mice	B-SPEC
using	O
lipopolysaccharides	O
(	O
LPSs	O
).	O

Then	O
,	O
retroorbital	O
bleeding	O
was	O
carried	O
out	O
and	O
the	O
chest	O
was	O
rapidly	O
opened	O
to	O
collect	O
the	O
trachea	B-SPEC
and	O
tissues	O
from	O
both	O
lungs	O
for	O
testing	O
.	O

In	O
contrast	O
,	O
the	O
nasal	O
and	O
rectal	O
administration	O
of	O
CpG	O
ODN	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
before	O
LPS	O
immunization	O
did	O
not	O
appear	O
to	O
exhibit	O
any	O
significant	O
protective	O
effects	O
.	O

TITLE	O
:	O
Antecedent	O
infections	O
in	O
Fisher	B-SPEC
syndrome	O
:	O
sources	O
of	O
variation	O
in	O
clinical	O
characteristics	O
.	O

TITLE	O
:	O
Assessment	O
of	O
the	O
safety	O
and	O
efficacy	O
of	O
an	O
attenuated	O
live	O
vaccine	O
based	O
on	O
highly	O
virulent	O
genotype	O
2b	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
nursing	O
piglets	O
.	O

Altogether	O
,	O
our	O
data	O
demonstrated	O
that	O
the	O
attenuated	O
S	O
DEL5	O
/	O
ORF3	O
strain	O
guarantees	O
the	O
safety	O
to	O
host	O
animals	B-SPEC
with	O
no	O
reversion	O
to	O
virulence	O
and	O
is	O
suitable	O
as	O
an	O
effective	O
primary	O
live	O
vaccine	O
providing	O
durable	O
maternal	O
lactogenic	O
immunity	O
for	O
passive	O
piglet	O
protection	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
antiviral	O
effect	O
of	O
CH25H	O
and	O
25HC	O
on	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
causes	O
high	O
mortality	O
rates	O
in	O
newborn	O
piglets	O
with	O
severe	O
diarrhea	O
,	O
and	O
considerable	O
financial	O
loss	O
in	O
the	O
swine	B-SPEC
industry	O
worldwide	O
.	O

Our	O
results	O
showed	O
that	O
PEDV	B-SPEC
infection	O
downregulated	O
the	O
expression	O
of	O
CH25H	O
in	O
Vero	O
cells	O
.	O

4	O
and	O
1	O
-	O
3	O
years	O
of	O
age	O
(	O
marginally	O
significant	O
)	O
than	O
calves	O
<	O
1	O
year	O
;	O
and	O
camels	B-SPEC
raised	O
in	O
zero	O
grazing	O
and	O
semi	O
-	O
open	O
grazing	O
systems	O
than	O
those	O
raised	O
in	O
an	O
open	O
grazing	O
system	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
novel	O
linear	O
B	O
-	O
cell	O
epitope	O
within	O
the	O
collagenase	O
equivalent	O
domain	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
spike	O
glycoprotein	O
.	O

In	O
this	O
report	O
we	O
present	O
viral	O
metagenomic	O
data	O
from	O
bats	B-SPEC
collected	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
[	O
KSA	O
].	O

Additionally	O
,	O
we	O
discovered	O
a	O
bastro	O
-	O
like	O
virus	B-SPEC
(	O
Middle	O
East	O
Hepe	O
-	O
Astrovirus	O
),	O
with	O
a	O
genomic	O
organization	O
similar	O
to	O
Hepeviridae	B-SPEC
.	O

We	O
assessed	O
the	O
frequency	O
of	O
A	B-SPEC
.	I-SPEC
paragallinarum	I-SPEC
using	O
real	O
-	O
time	O
PCR	O
and	O
clinical	O
conditions	O
present	O
in	O
samples	O
from	O
such	O
flocks	O
submitted	O
to	O
the	O
California	B-SPEC
Animal	B-SPEC
Health	O
and	O
Food	O
Safety	O
Laboratory	O
System	O
(	O
Davis	O
,	O
CA	O
)	O
in	O
2018	O
.	O

The	O
main	O
goal	O
of	O
our	O
study	O
was	O
to	O
develop	O
a	O
safer	O
drug	O
;	O
a	O
surfactin	O
analogue	O
with	O
high	O
anti	O
-	O
PEDV	B-SPEC
activity	O
and	O
low	O
hemolytic	O
activity	O
.	O

TITLE	O
:	O
Genome	O
Organization	O
of	O
Canada	B-SPEC
Goose	I-SPEC
Coronavirus	B-SPEC
,	O
A	O
Novel	O
Species	B-SPEC
Identified	O
in	O
a	O
Mass	O
Die	O
-	O
off	O
of	O
Canada	O
Geese	B-SPEC
.	O

TITLE	O
:	O
Effect	O
of	O
Fc	O
Fusion	O
on	O
Folding	O
and	O
Immunogenicity	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Spike	O
Protein	O
.	O

TITLE	O
:	O
Recent	O
Aspects	O
on	O
the	O
Pathogenesis	O
Mechanism	O
,	O
Animal	B-SPEC
Models	O
and	O
Novel	O
Therapeutic	O
Interventions	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infections	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
zoonotic	O
virus	B-SPEC
considered	O
as	O
one	O
of	O
the	O
major	O
public	O
threat	O
with	O
a	O
total	O
number	O
of	O
2	O
298	O
laboratory	O
-	O
confirmed	O
cases	O
and	O
811	O
associated	O
deaths	O
reported	O
by	O
World	O
Health	O
Organization	O
as	O
of	O
January	O
2019	O
.	O

Thus	O
,	O
the	O
present	O
review	O
comprehensively	O
and	O
critically	O
illustrates	O
the	O
recent	O
aspects	O
on	O
the	O
epidemiology	O
of	O
the	O
virus	B-SPEC
,	O
the	O
structural	O
and	O
functional	O
features	O
of	O
the	O
viral	O
genome	O
,	O
viral	O
entry	O
and	O
transmission	O
,	O
major	O
mechanisms	O
of	O
pathogenesis	O
and	O
associated	O
virulent	O
factors	O
,	O
current	O
animal	B-SPEC
models	O
,	O
detection	O
methods	O
and	O
novel	O
strategies	O
for	O
the	O
development	O
of	O
vaccines	O
against	O
MERS	O
-	O
CoV	O
.	O
The	O
review	O
further	O
illustrates	O
the	O
molecular	O
and	O
computational	O
virtual	O
screening	O
platforms	O
which	O
provide	O
insights	O
for	O
the	O
identification	O
of	O
putative	O
drug	O
targets	O
and	O
novel	O
lead	O
molecules	O
toward	O
the	O
development	O
of	O
therapeutic	O
remedies	O
.	O

The	O
expression	O
of	O
visfatin	O
was	O
evaluated	O
in	O
ALI	O
patients	O
and	O
mouse	B-SPEC
sepsis	B-SPEC
models	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
major	O
etiological	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
around	O
the	O
world	O
.	O

For	O
the	O
assay	O
,	O
a	O
specific	O
RT	O
-	O
PSR	O
primer	O
pair	O
was	O
designed	O
against	O
a	O
conserved	O
region	O
in	O
PEDV	B-SPEC
ORF3	O
.	O

TITLE	O
:	O
Expression	O
profile	O
analysis	O
of	O
5	O
-	O
day	O
-	O
old	O
neonatal	O
piglets	O
infected	O
with	O
porcine	B-SPEC
Deltacoronavirus	O
.	O

The	O
genes	O
of	O
FABP	O
family	B-SPEC
members	O
in	O
the	O
PPAR	O
signaling	O
pathway	O
were	O
the	O
most	O
highly	O
altered	O
and	O
played	O
important	O
roles	O
in	O
metabolism	O
.	O

This	O
topic	O
has	O
been	O
brought	O
into	O
sharp	O
focus	O
in	O
recent	O
years	O
following	O
significant	O
outbreaks	O
of	O
viral	O
diseases	O
such	O
as	O
those	O
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
,	O
as	O
well	O
as	O
devastating	O
outbreaks	O
of	O
diseases	O
caused	O
by	O
the	O
Ebola	O
,	O
Marburg	O
,	O
Zika	O
and	O
Lassa	O
fever	O
viruses	B-SPEC
,	O
to	O
name	B-SPEC
only	O
a	O
few	O
examples	O
.	O

Bats	B-SPEC
are	O
reservoirs	O
for	O
a	O
high	O
diversity	O
of	O
coronaviruses	O
,	O
and	O
focused	O
surveillance	O
detected	O
several	O
strains	O
genetically	O
similar	O
to	O
MERS	O
-	O
coronavirus	B-SPEC
,	O
SARS	O
-	O
coronavirus	B-SPEC
,	O
and	O
the	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
NL63	O
.	O

The	O
bat	B-SPEC
fauna	O
of	O
central	O
Asia	O
,	O
which	O
link	O
China	O
to	O
eastern	O
Europe	O
,	O
are	O
relatively	O
less	O
studied	O
than	O
other	O
regions	O
of	O
the	O
world	O
.	O

We	O
assessed	O
worker	O
seroprevalence	O
in	O
2	O
slaughterhouses	O
and	O
1	O
live	O
-	O
animal	B-SPEC
market	O
in	O
Abu	O
Dhabi	O
,	O
United	O
Arab	O
Emirates	O
,	O
during	O
2014	O
-	O
2017	O
and	O
administered	O
an	O
epidemiologic	O
survey	O
in	O
2016	O
and	O
2017	O
.	O

Interpretation	O
of	O
molecular	O
diagnostic	O
assays	O
for	O
viruses	B-SPEC
must	O
be	O
informed	O
by	O
understanding	O
of	O
local	O
rates	O
of	O
asymptomatic	O
infection	O
by	O
such	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
oral	O
type	O
I	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)	O
infection	O
:	O
Antibody	O
-	O
dependent	O
enhancement	O
infection	O
of	O
cats	B-SPEC
with	O
type	O
I	O
FIPV	B-SPEC
via	O
the	O
oral	O
route	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
transmission	O
from	O
dromedaries	B-SPEC
to	O
humans	B-SPEC
has	O
resulted	O
in	O
major	O
outbreaks	O
in	O
the	O
Middle	O
East	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
rabbits	B-SPEC
to	O
further	O
characterize	O
the	O
transmission	O
potential	O
of	O
MERS	O
-	O
CoV	O
.	O
In	O
line	O
with	O
the	O
presence	O
of	O
MERS	O
-	O
CoV	O
receptor	O
in	O
the	O
rabbit	B-SPEC
nasal	O
epithelium	O
,	O
high	O
levels	O
of	O
viral	O
RNA	O
were	O
shed	O
from	O
the	O
nose	O
following	O
virus	B-SPEC
inoculation	O
.	O

Our	O
data	O
indicate	O
that	O
despite	O
relatively	O
high	O
viral	O
RNA	O
levels	O
produced	O
,	O
low	O
levels	O
of	O
infectious	O
virus	B-SPEC
are	O
excreted	O
in	O
the	O
upper	O
respiratory	O
tract	O
of	O
rabbits	B-SPEC
as	O
compared	O
to	O
dromedary	B-SPEC
camels	B-SPEC
,	O
thus	O
resulting	O
in	O
a	O
lack	O
of	O
viral	O
transmission	O
.	O

Among	O
the	O
identified	O
ORF3	O
-	O
interacting	O
proteins	O
,	O
the	O
vacuolar	O
protein	O
-	O
sorting	O
-	O
associated	O
protein	O
36	O
(	O
VPS36	O
)	O
was	O
assessed	O
for	O
its	O
role	O
in	O
PEDV	B-SPEC
replication	O
.	O

As	O
a	O
result	O
of	O
VPS36	O
-	O
ORF3	O
interaction	O
,	O
PEDV	B-SPEC
replication	O
was	O
substantially	O
suppressed	O
in	O
cells	O
overexpressing	O
VPS36	O
.	O

Anomalies	O
to	O
lung	O
endothelium	O
permeability	O
are	O
streaming	O
severe	O
consequences	O
towards	O
human	B-SPEC
health	O
,	O
often	O
associated	O
with	O
fatal	O
outcomes	O
.	O

The	O
current	O
study	O
employs	O
human	B-SPEC
and	O
bovine	B-SPEC
lung	O
microvascular	O
cells	O
,	O
as	O
well	O
as	O
pharmacologic	O
and	O
genetic	O
P53	O
modulators	O
to	O
demonstrate	O
the	O
negative	O
regulation	O
of	O
APE1	O
/	O
Ref1	O
by	O
P53	O
.	O

ABSTRACT	O
:	O
Swine	B-SPEC
enteric	O
coronaviruses	O
are	O
a	O
group	O
of	O
most	O
significant	O
pathogens	O
causing	O
diarrhea	O
in	O
piglets	O
with	O
similar	O
clinical	O
symptoms	O
and	O
pathological	O
changes	O
.	O

Our	O
previous	O
study	O
demonstrated	O
that	O
the	O
vasoactive	O
intestinal	O
peptide	O
(	O
VIP	O
)	O
is	O
mediated	O
by	O
lentivirus	B-SPEC
attenuates	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
ARDS	O
in	O
a	O
murine	B-SPEC
model	O
,	O
and	O
VIP	O
inhibits	O
the	O
release	O
of	O
interleukin	O
-	O
17A	O
(	O
IL	O
-	O
17A	O
)	O
from	O
activation	O
macrophages	O
.	O

ROS	O
and	O
p53	O
play	O
key	O
roles	O
in	O
regulating	O
many	O
kinds	O
of	O
cell	O
process	O
during	O
viral	O
infection	O
,	O
however	O
,	O
the	O
exact	O
function	O
in	O
PEDV	B-SPEC
-	O
induced	O
apoptosis	O
remains	O
unclear	O
.	O

ABSTRACT	O
:	O
Synthesis	O
of	O
the	O
negative	O
-	O
strand	O
((-)-	O
strand	O
)	O
counterpart	O
is	O
the	O
first	O
step	O
of	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
replication	O
;	O
however	O
,	O
the	O
detailed	O
mechanism	O
of	O
the	O
early	O
event	O
and	O
the	O
factors	O
involved	O
remain	O
to	O
be	O
determined	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
reveal	O
a	O
new	O
mechanism	O
by	O
which	O
SARS	O
-	O
CoV	O
ORF3a	O
protein	O
activates	O
NF	O
-	O
B	O
and	O
the	O
NLRP3	O
inflammasome	O
by	O
promoting	O
TRAF3	O
-	O
dependent	O
ubiquitination	O
of	O
p105	O
and	O
ASC	O
.-	O
Siu	O
,	O
K	O
.-	O
L	O
.,	O
Yuen	O
,	O
K	O
.-	O
S	O
.,	O
Castao	O
-	O
Rodriguez	O
,	O
C	O
.,	O
Ye	O
,	O
Z	O
.-	O
W	O
.,	O
Yeung	O
,	O
M	O
.-	O
L	O
.,	O
Fung	O
,	O
S	O
.-	O
Y	O
.,	O
Yuan	O
,	O
S	O
.,	O
Chan	O
,	O
C	O
.-	O
P	O
.,	O
Yuen	O
,	O
K	O
.-	O
Y	O
.,	O
Enjuanes	O
,	O
L	O
.,	O
Jin	O
,	O
D	O
.-	O
Y	O
.	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
ORF3a	O
protein	O
activates	O
the	O
NLRP3	O
inflammasome	O
by	O
promoting	O
TRAF3	O
-	O
dependent	O
ubiquitination	O
of	O
ASC	O
.	O

Thus	O
,	O
the	O
development	O
of	O
highly	O
effective	O
and	O
specific	O
antiviral	O
drugs	O
for	O
pre	O
-	O
exposure	O
prophylaxis	O
and	O
/	O
or	O
treatment	O
of	O
RSV	B-SPEC
infections	O
is	O
a	O
compelling	O
need	O
.	O

Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
pathological	O
lesions	O
in	O
the	O
chicken	B-SPEC
oviduct	O
.	O

TITLE	O
:	O
Attenuation	O
of	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
in	O
Eggs	O
Results	O
in	O
Different	O
Patterns	O
of	O
Genomic	O
Variation	O
across	O
Multiple	O
Replicates	O
.	O

All	O
four	O
final	O
egg	O
-	O
passaged	O
viruses	B-SPEC
were	O
attenuated	O

ABSTRACT	O
:	O
Transmission	O
in	O
hospital	O
settings	O
of	O
seasonal	O
influenza	B-SPEC
viruses	I-SPEC
and	O
novel	O
agents	O
such	O
as	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
well	O
-	O
described	O
but	O
poorly	O
understood	O
.	O

The	O
characterization	O
of	O
potentially	O
infectious	O
bio	O
-	O
aerosols	O
in	O
the	O
healthcare	O
setting	O
remains	O
an	O
important	O
yet	O
ill	O
-	O
defined	O
factor	O
in	O
the	O
transmission	O
of	O
respiratory	O
viruses	B-SPEC
.	O

We	O
sought	O
to	O
determine	O
the	O
distribution	O
of	O
influenza	B-SPEC
virus	I-SPEC
RNA	O
emitted	O
into	O
the	O
air	O
by	O
participants	O
with	O
laboratory	O
-	O
confirmed	O
influenza	O
,	O
and	O
whether	O
these	O
emissions	O
had	O
the	O
potential	O
to	O
reach	O
healthcare	O
workers	O
'	O
breathing	O
zones	O
.	O

A	O
more	O
substantial	O
study	O
is	O
required	O
to	O
identify	O
patient	O
determinants	O
of	O
virus	B-SPEC
emission	O
into	O
the	O
air	O
and	O
delineate	O
implications	O
for	O
evidence	O
-	O
based	O
policy	O
for	O
prevention	O
and	O
control	O
.	O

We	O
performed	O
a	O
multicenter	O
,	O
prospective	O
data	O
collection	O
study	O
and	O
retrospectively	O
analyzed	O
the	O
data	O
to	O
confirm	O
the	O
role	O
of	O
DIC	O
in	O
severe	O
sepsis	B-SPEC
.	O

Eligible	O
patients	O
were	O
ICU	O
patients	O
who	O
met	O
the	O
definitions	O
of	O
severe	O
sepsis	B-SPEC
,	O
and	O
1013	O
patients	O
were	O
included	O
.	O

In	O
the	O
first	O
two	O
decades	O
of	O
the	O
21st	O
century	O
,	O
we	O
have	O
born	O
witness	O
to	O
the	O
emergence	O
of	O
newly	O
recognized	O
coronaviruses	O
that	O
have	O
rapidly	O
spread	O
around	O
the	O
globe	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
)	O
and	O
Middle	O
Eastern	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
MERS	O
).	O

Viral	O
RNA	O
was	O
detected	O
in	O
10	O
.	O
8	O
%	O
(	O
38	O
)	O
samples	O
;	O
however	O
,	O
the	O
virus	B-SPEC
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
61	O
samples	O
tested	O
from	O
Scotland	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
a	O
leading	O
cause	O
of	O
morbidity	O
and	O
mortality	O
after	O
surgery	O
.	O

Data	O
were	O
extracted	O
from	O
a	O
secondary	O
analysis	O
of	O
an	O
international	O
point	O
prevalence	O
study	O
of	O
pediatric	O
severe	O
sepsis	B-SPEC
.	O

In	O
postsurgical	O
sepsis	B-SPEC
,	O
older	O
age	O
,	O
admission	O
from	O
the	O
hospital	O
ward	O
,	O
multiple	O
organ	O
dysfunction	O
syndrome	O
at	O
sepsis	B-SPEC
recognition	O
,	O
and	O
cardiovascular	O
and	O
respiratory	O
comorbidities	O
were	O
independent	O
risk	O
factors	O
for	O
death	O
.	O

In	O
medical	O
sepsis	B-SPEC
,	O
resource	O
-	O
limited	O
region	O
,	O
hospital	O
-	O
acquired	O
infection	O
,	O
multiple	O
organ	O
dysfunction	O
syndrome	O
at	O
sepsis	B-SPEC
recognition	O
,	O
higher	O
Pediatric	O
Index	O
of	O
Mortality	O
-	O
3	O
score	O
,	O
and	O
malignancy	O
were	O
independent	O
risk	O
factors	O
for	O
death	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
widely	O
known	O
as	O
natural	O
reservoir	O
hosts	O
of	O
zoonotic	O
diseases	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
caused	O
by	O
coronaviruses	O
(	O
CoVs	O
).	O

However	O
,	O
continuous	O
surveillance	O
and	O
genomic	O
characterization	O
of	O
coronaviruses	O
from	O
bats	B-SPEC
are	O
necessary	O
due	O
to	O
potential	O
risks	O
of	O
human	B-SPEC
infection	O
induced	O
by	O
genetic	O
mutation	O
.	O

No	O
cross	O
-	O
reactions	O
were	O
observed	O
with	O
canine	B-SPEC
adenovirus	I-SPEC
,	O
canine	O
coronavirus	B-SPEC
,	O
and	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
critical	O
genes	O
associated	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
virulence	O
,	O
we	O
compared	O
the	O
genome	O
sequences	O
of	O
virulent	O
YN	O
strain	O
and	O
its	O
attenuated	O
strain	O
aYN	O
.	O

We	O
present	O
X	O
-	O
ray	B-SPEC
structures	O
for	O
the	O
CavV	O
3C	O
-	O
like	O
protease	O
(	O
3CL	O

Therefore	O
,	O
effects	O
of	O
antioxidant	O
vitamins	O
such	O
as	O
	O
-	O
lipoic	O
acid	O
(	O
ALA	O
),	O
vitamin	O
E	O
(	O
VITE	O
),	O
and	O
C	O
(	O
VITC	O
)	O
were	O
investigated	O
on	O
oleic	O
acid	O
(	O
OA	O
)-	O
induced	O
ARDS	O
rat	B-SPEC
model	O
.	O

In	O
this	O
study	O
,	O
42	O
male	O
rats	B-SPEC
were	O
divided	O
to	O
seven	O
groups	O
named	O
control	O
,	O
OA	O
,	O
ALA	O
,	O
VITE	O
,	O
VITC	O
,	O
LDMP	O
,	O
and	O
HDMP	O
.	O

There	O
were	O
clear	O
seasonal	O
peaks	O
for	O
IFV	B-SPEC
,	O
RSV	B-SPEC
,	O
HRV	O
,	O
ADV	O
,	O
PIV	O
,	O
and	O
HMPV	B-SPEC
.	O

In	O
China	O
,	O
the	O
most	O
prevalent	O
IBV	B-SPEC
genotype	O
is	O
GI	O
-	O
19	O
/	O
QX	O
-	O
like	O
because	O
the	O
protective	O
efficiency	O
of	O
the	O
classical	O
IBV	B-SPEC
vaccine	O
is	O
low	O
,	O
and	O
new	O
GI	O
-	O
19	O
vaccines	O
are	O
under	O
development	O
.	O

TITLE	O
:	O
The	O
ER	O
stress	O
sensor	O
IRE1	O
and	O
MAP	O
kinase	O
ERK	O
modulate	O
autophagy	O
induction	O
in	O
cells	O
infected	O
with	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
infection	O
induces	O
the	O
generation	O
of	O
autophagosomes	O
,	O
and	O
certain	O
host	O
proteins	O
regulating	O
cellular	O
autophagy	O
are	O
hijacked	O
by	O
some	O
coronaviruses	O
to	O
facilitate	O
the	O
formation	O
of	O
double	O
membrane	O
vesicles	O
.	O

Moreover	O
,	O
the	O
ER	O
stress	O
sensor	O
inositol	O
requiring	O
enzyme	O
1	O
(	O
IRE1	O
),	O
but	O
not	O
its	O
substrate	O
X	O
-	O
box	O
protein	O
1	O
(	O
XBP1	O
),	O
was	O
also	O
essential	O
for	O
the	O
induction	O
of	O
autophagy	O
during	O
IBV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
A	O
flock	O
of	O
54	O
wk	O
-	O
old	O
layer	O
birds	B-SPEC
exhibiting	O
signs	O
of	O
respiratory	O
distress	O
,	O
greenish	O
diarrhea	O
,	O
and	O
drop	O
in	O
egg	O
production	O
was	O
investigated	O
.	O

In	O
addition	O
,	O
virus	B-SPEC
isolation	O
was	O
attempted	O
in	O
9	O
-	O
11	O
day	O
-	O
old	O
embryonating	O
chicken	B-SPEC
eggs	O
(	O
ECE	O
).	O

Besides	O
testing	O
for	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
samples	O
were	O
screened	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AIV	O
)	O
by	O
RT	O
-	O
qPCR	O
as	O
well	O
as	O
by	O
non	O
-	O
directed	O
cell	O
-	O
culture	O
approach	O
on	O
LMH	O
-	O
cells	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
Reproductive	I-SPEC
and	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Virus	I-SPEC
nsp11	O
Antagonizes	O
Type	O
I	O
Interferon	O
Signaling	O
by	O
Targeting	O
IRF9	O
.	O

TITLE	O
:	O
Effect	O
of	O
cat	B-SPEC
litters	O
on	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
of	O
cell	O
culture	O
and	O
cats	B-SPEC
.	O

Whether	O
it	O
is	O
possible	O
to	O
break	O
the	O
cycle	O
of	O
FCoV	O
infection	O
and	O
reinfection	O
using	O
cat	B-SPEC
litters	O
has	O
never	O
been	O
investigated	O
.	O

In	O
the	O
field	O
study	O
,	O
there	O
appeared	O
to	O
be	O
less	O
virus	B-SPEC
shedding	O
on	O
one	O
Fuller	O
'	O
s	O
earth	O
-	O
based	O
cat	B-SPEC
litter	O
.	O

To	O
compare	O
the	O
efficacy	O
of	O
indirect	O
immunofluorescence	O
technique	O
(	O
IIF	O
)	O
with	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
to	O
identify	O
respiratory	O
viruses	B-SPEC
in	O
children	O
hospitalized	O
for	O
ARI	O
.	O

PCR	O
also	O
included	O
the	O
detection	O
of	O
metapneumovirus	B-SPEC
,	O
enterovirus	B-SPEC
/	O
rhinovirus	B-SPEC
,	O
bocavirus	B-SPEC
and	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
Korean	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
NB1	O
.	O

ABSTRACT	O
:	O
In	O
Korea	O
,	O
for	O
the	O
past	O
30	O
years	O
(	O
1987	O
-	O
present	O
),	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
has	O
been	O
established	O
as	O
an	O
endemic	O
situation	O
in	O
which	O
multiple	O
genogroups	O
of	O
classical	O
G1	O
and	O
G2b	O
,	O
and	O
the	O
recently	O
introduced	O
pandemic	O
G2a	O
,	O
coexisted	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
like	O
illness	O
with	O
high	O
pathogenicity	O
and	O
mortality	O
due	O
to	O
the	O
lack	O
of	O
effective	O
therapeutics	O
.	O

Within	O
the	O
last	O
decade	O
,	O
increasing	O
reports	O
of	O
severe	O
influenza	O
pneumonia	O
resulting	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
complicated	O
by	O
Aspergillus	B-SPEC
infection	O
were	O
published	O
.	O

TITLE	O
:	O
Longitudinal	O
study	O
of	O
humoral	O
immunity	O
to	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
virus	B-SPEC
shedding	O
,	O
and	O
treatment	O
for	O
bovine	B-SPEC
respiratory	O
disease	O
in	O
pre	O
-	O
weaned	O
beef	O
calves	O
.	O

Between	O
herd	O
analyses	O
revealed	O
anti	O
-	O
BCV	B-SPEC
serum	O
antibody	O
abundance	O
did	O
not	O
associate	O
with	O
the	O
incidence	O
of	O
BRD	O
or	O
BCV	B-SPEC
shedding	O
,	O
though	O
these	O
measurements	O
may	O
have	O
been	O
hindered	O
by	O
the	O
long	O
periods	O
between	O
sample	O
collections	O
.	O

Antiviral	O
T	O
cell	O
responses	O
during	O
early	O
primary	O
infection	O
were	O
also	O
similar	O
between	O
cats	B-SPEC
that	O
developed	O
FIP	O
and	O
cats	B-SPEC
remaining	O
healthy	O
.	O

ABSTRACT	O
:	O
As	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
first	O
reported	O
by	O
Saudi	O
Arabia	O
in	O
2012	O
,	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
an	O
acute	O
human	B-SPEC
respiratory	O
syndrome	O
.	O

Epidemiological	O
investigations	O
identified	O
dromedary	B-SPEC
camels	B-SPEC
as	O
the	O
source	O
of	O
MERS	O
-	O
CoV	O
zoonotic	O
transmission	O
and	O
evidence	O
of	O
MERS	O
-	O
CoV	O
circulation	O
has	O
been	O
observed	O
throughout	O
the	O
original	O
range	O
of	O
distribution	O
.	O

These	O
data	O
are	O
similar	O
to	O
infections	O
reported	O
with	O
dromedary	B-SPEC
camel	B-SPEC
infections	O
and	O
indicate	O
that	O
Bactrians	O
are	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
and	O
given	O
their	O
overlapping	O
range	O
are	O
at	O
risk	O
of	O
introduction	O
and	O
establishment	O
of	O
MERS	O
-	O
CoV	O
within	O
the	O
Bactrian	B-SPEC
camel	I-SPEC
populations	O
.	O

ABSTRACT	O
:	O
Beta	O
-	O
defensins	O
contribute	O
to	O
host	O
innate	O
defense	O
against	O
various	O
pathogens	O
,	O
including	O
viruses	B-SPEC
,	O
although	O
the	O
details	O
of	O
their	O
roles	O
in	O
innate	O
immune	O
cells	O
are	O
unclear	O
.	O

Camel	B-SPEC
exposure	O
and	O
camel	B-SPEC
milk	O
ingestion	O
were	O
reported	O
in	O
64	O
%	O
each	O
,	O
and	O
the	O
majority	O
(	O
97	O
.	O
8	O
%)	O
of	O
those	O
with	O
camel	B-SPEC
exposures	O
had	O
camel	B-SPEC
milk	O
ingestion	O
.	O

Passive	O
transfer	O
of	O
immune	O
sera	O
to	O
nave	O
hDPP4	O
-	O
KI	O
mice	B-SPEC
also	O
provided	O
survival	O
advantages	O
from	O
lethal	O
MERS	O
-	O
CoV	O
-	O
MA	O
challenge	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
research	O
viral	O
etiology	O
by	O
applying	O
multiplex	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
Rt	O
-	O
PCR	O
)	O
method	O
in	O
autopsy	O
cases	O
who	O
have	O
been	O
considered	O
to	O
have	O
a	O
respiratory	O
infection	O
and	O
to	O
assess	O
whether	O
the	O
viruses	B-SPEC
detected	O
are	O
the	O
primary	O
cause	O
of	O
the	O
infection	O
and	O
whether	O
they	O
have	O
any	O
contributory	O
effect	O
on	O
the	O
mortality	O
together	O
with	O
histopathological	O
evidence	O
.	O

Overall	O
,	O
the	O
most	O
common	O
viral	O
agent	O
was	O
HRV	O
110	O
(	O
13	O
.	O
2	O
%)	O
followed	O
by	O
AdV	O
39	O
(	O
4	O
.	O
7	O
%)	O
and	O
RSV	B-SPEC
A	O
/	O
B	O
33	O
(	O
4	O
%).	O

In	O
pediatric	O
cases	O
the	O
rate	O
of	O
positive	O
results	O
for	O
respiratory	O
viruses	B-SPEC
was	O
31	O
.	O
8	O
%	O
and	O
in	O
adult	O
group	O
it	O
was	O
20	O
%	O
(	O
p	O
=	O
0	O
.	O
032	O
).	O

TITLE	O
:	O
Coronavirus	B-SPEC
envelope	O
protein	O
:	O
current	O
knowledge	O
.	O

The	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
2003	O
and	O
,	O
more	O
recently	O
,	O
Middle	O
-	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
has	O
demonstrated	O
the	O
lethality	O
of	O
CoVs	O
when	O
they	O
cross	O
the	O
species	B-SPEC
barrier	O
and	O
infect	O
humans	B-SPEC
.	O

Knowledge	O
concerning	O
the	O
epidemiology	O
,	O
circulation	O
pattern	O
,	O
and	O
evolutionary	O
kinetics	O
of	O
respiratory	O
viruses	B-SPEC
in	O
Saudi	O
Arabia	O
are	O
scant	O
,	O
with	O
the	O
available	O
literature	O
being	O
inconsistent	O
.	O

This	O
review	O
summarizes	O
the	O
available	O
data	O
on	O
the	O
epidemiology	O
and	O
evolution	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Camels	B-SPEC
also	O
carry	O
and	O
may	O
transmit	O
disease	O
-	O
causing	O
agents	O
to	O
humans	B-SPEC
and	O
other	O
animals	B-SPEC
.	O

This	O
hypothesis	O
was	O
tested	O
by	O
using	O
KO	O
piglets	O
that	O
were	O
challenged	O
with	O
PEDV	B-SPEC
.	O

The	O
low	O
pathogenicity	O
of	O
the	O
virus	B-SPEC
was	O
confirmed	O
by	O
the	O
intravenous	O
pathogenicity	O
index	O
assay	O
.	O

Medicinal	O
plants	B-SPEC
,	O
or	O
substances	O
derived	O
from	O
them	O
,	O
are	O
being	O
tested	O
as	O
options	O
in	O
the	O
prevention	O
of	O
infectious	O
diseases	O
such	O
as	O
IB	O
in	O
many	O
countries	O
.	O

In	O
further	O
studies	O
no	O
virus	B-SPEC
plaques	O
(	O
plaque	O
reduction	O
rate	O
100	O
%)	O
or	O
cytopathogenic	O
effect	O
(	O
decrease	O
of	O
TCID	O
Many	O
extracts	O
of	O
plants	B-SPEC
acted	O
against	O
IBV	B-SPEC
prior	O
to	O
and	O
during	O
infection	O
,	O
but	O
the	O
most	O
effective	O
were	O
those	O
of	O
M	B-SPEC
.	I-SPEC
piperita	I-SPEC
,	O
T	B-SPEC
.	I-SPEC
vulgaris	I-SPEC
and	O
D	O
.	O
canadense	O
.	O

PDCoV	O
N	O
protein	O
also	O
suppressed	O
the	O
activation	O
of	O
porcine	B-SPEC
IFN	O
-	O
	O
promoter	O
when	O
it	O
was	O
stimulated	O
by	O
porcine	B-SPEC
RLR	O
signaling	O
molecules	O
.	O

TITLE	O
:	O
Alphacoronavirus	B-SPEC
Detection	O
in	O
Lungs	O
,	O
Liver	O
,	O
and	O
Intestines	O
of	O
Bats	B-SPEC
from	O
Brazil	O
.	O

The	O
virus	B-SPEC
was	O
detected	O
not	O
only	O
in	O
intestines	O
but	O
also	O
in	O
lungs	O
and	O
liver	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
first	O
identified	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
and	O
related	O
infection	O
cases	O
have	O
been	O
reported	O
in	O
over	O
20	O
countries	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
alone	O
or	O
in	O
co	O
-	O
infection	O
with	O
rhinovirus	B-SPEC
C	O
is	O
a	O
risk	O
factor	O
for	O
severe	O
respiratory	O
disease	O
and	O
admission	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
:	O
A	O
one	O
-	O
year	O
study	O
in	O
Southeast	O
Brazil	O
.	O

ABSTRACT	O
:	O
Although	O
broad	O
knowledge	O
of	O
influenza	O
viral	O
pneumonia	O
has	O
been	O
established	O
,	O
the	O
significance	O
of	O
non	O
-	O
influenza	O
respiratory	O
viruses	B-SPEC
in	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
)	O
and	O
their	O
impact	O
on	O
clinical	O
outcomes	O
remains	O
unclear	O
,	O
especially	O
in	O
the	O
non	O
-	O
immunocompromised	O
adult	O
population	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
detected	O
by	O
molecular	O
methods	O
.	O

The	O
high	O
fatality	O
rate	O
(	O
35	O
.	O
4	O
%)	O
of	O
this	O
novel	B-SPEC
coronavirus	I-SPEC
and	O
its	O
persistent	O
wide	O
spread	O
infectiousness	O
in	O
animal	B-SPEC
reservoirs	O
have	O
generated	O
tremendous	O
global	O
public	O
health	O
concern	O
.	O

Thus	O
,	O
this	O
sub	O
-	O
cloned	O
IPI	O
-	O
FX	O
cell	O
line	O
is	O
an	O
ideal	O
cell	O
model	O
to	O
study	O
the	O
mechanisms	O
of	O
infection	O
,	O
particularly	O
co	O
-	O
infections	O
of	O
swine	B-SPEC
enteric	O
CoVs	O
.	O

To	O
test	O
the	O
neutralising	O
capacity	O
of	O
these	O
antisera	O
in	O
vivo	O
,	O
susceptibility	O
to	O
MERS	O
-	O
CoV	O
was	O
induced	O
in	O
naive	O
recipient	O
Balb	O
/	O
c	O
mice	B-SPEC
by	O
the	O
administration	O
of	O
an	O
adenovirus	B-SPEC
vector	O
expressing	O
the	O
human	B-SPEC
DPP4	O
receptor	O
(	O
Ad5	O
-	O
hDPP4	O
)	O
for	O
MERS	O
-	O
CoV	O
,	O
prior	O
to	O
the	O
passive	O
transfer	O
of	O
the	O
RBD	O
-	O
specific	O
murine	B-SPEC
antisera	O
to	O
the	O
transduced	O
mice	B-SPEC
.	O

Plasma	O
fractionators	O
were	O
the	O
first	O
to	O
introduce	O
NAT	O
testing	O
besides	O
pathogen	O
reduction	O
procedures	O
,	O
to	O
reduce	O
the	O
virus	B-SPEC
transmission	O
risk	O
through	O
their	O
products	O
.	O

A	O
detection	O
rate	O
of	O
2	O
-	O
3	O
%	O
was	O
recorded	O
for	O
mycoplasma	B-SPEC
pneumonia	O
,	O
adenoviruses	B-SPEC
,	O
human	B-SPEC
parainfluenza	O
viruses	B-SPEC
(	O
HPIVs	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
HMPV	B-SPEC
).	O

Here	O
,	O
the	O
epidemiology	O
of	O
viruses	B-SPEC
circulating	O
among	O
backyard	O
poultry	O
in	O
Vientiane	O
Province	O
was	O
assessed	O
to	O
guide	O
future	O
control	O
strategies	O
.	O

Qualitative	O
syntheses	O
determined	O
that	O
MERS	O
-	O
CoV	O
seroprevalence	O
increased	O
with	O
age	O
up	O
to	O
80	O
-	O
100	O
%	O
in	O
adult	O
dromedaries	B-SPEC
supporting	O
geographically	O
widespread	O
endemicity	O
of	O
MERS	O
-	O
CoV	O
in	O
dromedaries	B-SPEC
in	O
both	O
the	O
Arabian	O
Peninsula	O
and	O
countries	O
exporting	O
dromedaries	B-SPEC
from	O
Africa	O
.	O

Compounds	O
8	O
,	O
25	O
,	O
40	O
,	O
62	O
,	O
72	O
,	O
73	O
,	O
91	O
,	O
112	O
,	O
113	O
,	O
131	O
,	O
137	O
,	O
175	O
,	O
198	O
,	O
200	O
,	O
201	O
and	O
213	O
were	O
reported	O
in	O
the	O
literature	O
with	O
potent	O
antiviral	O
activity	O
against	O
CVB	O
,	O
SARS	O
,	O
RSV	B-SPEC
,	O
HCV	B-SPEC
,	O
HRV	O
,	O
VZV	B-SPEC
,	O
TMV	B-SPEC
,	O
FMDV	B-SPEC
,	O
DENV	O
,	O
YFV	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
Junin	B-SPEC
virus	I-SPEC
,	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
HSV	B-SPEC
,	O
VV	O
and	O
EBV	O
,	O
respectively	O
.	O

TITLE	O
:	O
Respiratory	O
virus	B-SPEC
associated	O
with	O
surgery	O
in	O
children	O
patients	O
.	O

We	O
analyzed	O
symptom	O
data	O
and	O
quantitative	O
viral	O
load	O
to	O
investigate	O
the	O
association	O
between	O
viruses	B-SPEC
,	O
symptoms	O
and	O
viral	O
quantity	O
in	O
qRT	O
-	O
PCR	O
-	O
positive	O
PSPs	O
.	O

The	O
study	O
was	O
carried	O
out	O
in	O
fourteen	O
Italian	O
PICUs	B-SPEC
after	O
dissemination	O
of	O
a	O
standardized	O
protocol	O
for	O
surfactant	O
administration	O
within	O
the	O
Italian	O
PICU	B-SPEC
network	O
.	O

A	O
shared	O
protocol	O
seems	O
to	O
be	O
a	O
good	O
option	O
to	O
obtain	O
the	O
same	O
criteria	O
of	O
enrollment	O
among	O
different	O
PICUs	B-SPEC
and	O
define	O
a	O
unique	O
way	O
of	O
use	O
and	O
administration	O
of	O
the	O
drug	O
for	O
future	O
studies	O
.	O

We	O
demonstrate	O
that	O
the	O
human	B-SPEC
PARPs	O
-	O
PARP10	O
,	O
PARP11	O
and	O
PARP15	O
as	O
well	O
as	O
a	O
highly	O
diverged	O
PARP	O
homologue	O
TRPT1	O
,	O
ADP	O
-	O
ribosylate	O
phosphorylated	O
ends	O
of	O
RNA	O
.	O

We	O
report	O
three	O
unrelated	O
children	O
with	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	B-SPEC
)	O
infection	O
manifesting	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
IAV	B-SPEC
-	O
ARDS	O
),	O
heterozygous	O
for	O
rare	O

Results	O
showed	O
that	O
GSLS	O
promoted	O
significantly	O
higher	O
NDV	B-SPEC
-	O
and	O
IBV	B-SPEC
-	O
specific	O
antibody	O
responses	O
with	O
the	O
highest	O
antibody	O
response	O
detected	O
in	O
GSLS	O
-	O
Se	O
group	O
.	O

Here	O
a	O
novel	O
series	O
of	O
dendrimers	O
with	O
divalent	O
and	O
tetravalent	O
branched	O
arms	O
,	O
instead	O
of	O
the	O
trivalent	O
ones	O
present	O
on	O
the	O
prototype	O
,	O
has	O
been	O
synthesized	O
and	O
its	O
activity	O
against	O
HIV	B-SPEC
,	O
EV71	O
and	O
a	O
panel	O
of	O
16	O
different	O
viruses	B-SPEC
and	O
other	O
pathogens	O
has	O
been	O
determined	O
.	O

TITLE	O
:	O
First	O
autochthonous	O
case	O
of	O
clinical	O
Hepatozoon	B-SPEC
felis	I-SPEC
infection	O
in	O
a	O
domestic	B-SPEC
cat	I-SPEC
in	O
Central	O
Europe	O
.	O

TITLE	O
:	O
High	O
incidence	O
of	O
rhinovirus	B-SPEC
infection	O
in	O
children	O
with	O
community	O
-	O
acquired	O
pneumonia	O
from	O
a	O
city	O
in	O
the	O
Brazilian	O
pre	O
-	O
Amazon	B-SPEC
region	O
.	O

Viruses	B-SPEC
were	O
detected	O
in	O
43	O
%	O
of	O
CAP	O
patients	O
.	O

RSV	B-SPEC
,	O
adenovirus	B-SPEC
,	O
FluA	O
,	O
and	O
coinfections	O
were	O
identified	O
in	O
14	O
%,	O
14	O
%,	O
5	O
%,	O
and	O
15	O
%	O
of	O
children	O
with	O
viral	O
infection	O
,	O
respectively	O
.	O

TITLE	O
:	O
Broad	O
spectrum	O
antiviral	O
remdesivir	O
inhibits	O
human	B-SPEC
endemic	O
and	O
zoonotic	O
deltacoronaviruses	O
with	O
a	O
highly	O
divergent	O
RNA	O
dependent	O
RNA	O
polymerase	O
.	O

Currently	O
,	O
there	O
are	O
no	O
approved	O
therapeutics	O
for	O
any	O
human	B-SPEC
CoV	O
presenting	O
a	O
clear	O
unmet	O
medical	O
need	O
.	O

TITLE	O
:	O
Effect	O
of	O
adeno	B-SPEC
-	I-SPEC
associated	I-SPEC
virus	I-SPEC
(	O
AAV	O
)-	O
mediated	O
overexpression	O
of	O
PEPCK	O
-	O
M	O
(	O
Pck2	O
)	O
on	O
Clenbuterol	O
-	O
induced	O
muscle	O
growth	O
.	O

A	O
contralateral	O
limb	O
design	O
was	O
employed	O
,	O
such	O
that	O
each	O
mouse	B-SPEC
served	O
as	O
its	O
own	O
control	O
(	O
injected	O
with	O
a	O
GFP	O
-	O
only	O
expressing	O
AAV1	O
,	O
labelled	O
AAV	O
-	O
GFP	O
).	O

AAV	O
-	O
Pck2	O
overexpression	O
in	O
leg	O
muscles	O
of	O
male	O
C57BL6	O
/	O
J	O
mice	B-SPEC
for	O
4	O
weeks	O
(	O
6	O
-	O
10	O
weeks	O
of	O
age	O
)	O
increased	O
Pck2	O
mRNA	O
(~	O
100	O
-	O
fold	O
),	O
protein	O
(	O
not	O
quantifiable	O
)	O
and	O
enzyme	O
activity	O
(~	O
3	O
-	O
fold	O
).	O

However	O
AAV	O
-	O
Pck2	O
overexpression	O
reduced	O
TA	O
muscle	O
weights	O
(	O
p	O
=	O
0	O
.	O
0434	O
),	O
particularly	O
in	O
the	O
Control	O
(	O
vehicle	O
treated	O
)	O
mice	B-SPEC
(	O
p	O
=	O
0	O
.	O
059	O
for	O
AAV	O
x	O
Clenbuterol	O
interaction	O
)	O
and	O
increased	O
the	O
expression	O
of	O
Seryl	O
-	O
tRNA	O
Synthetase	O
(	O
Sars	O
)	O
mRNA	O
(	O
p	O
=	O
0	O
.	O
0477	O
).	O

ABSTRACT	O
:	O
This	O
report	O
discusses	O
the	O
neurological	O
involvement	O
in	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
infection	O
in	O
neonates	O
.	O

The	O
majority	O
of	O
MBL	O
-	O
positive	O
EACs	O
express	O
the	O
CD83	O
antigen	O
,	O
providing	O
evidence	O
that	O
coronavirus	B-SPEC
infection	O
facilitated	O
the	O
maturation	O
of	O
dendritic	O
cell	O
precursors	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterisation	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
in	O
Hungary	O
-	O
Short	O
communication	O
.	O

In	O
order	B-SPEC
to	O
determine	O
the	O
extent	O
of	O
this	O
change	O
,	O
an	O
attempt	O
was	O
made	O
to	O
isolate	O
the	O
recombinant	O
PEDV	B-SPEC
.	O

This	O
suggests	O
that	O
these	O
recombinant	O
PEDV	B-SPEC
are	O
circulating	O
in	O
this	O
area	O
and	O
may	O
spread	O
to	O
other	O
parts	O
of	O
the	O
continent	O
.	O

Overall	O
,	O
we	O
demonstrate	O
complex	O
virome	O
structures	O
across	O
host	O
species	B-SPEC
that	O
co	O
-	O
exist	O
in	O
multi	O
-	O
species	B-SPEC
aggregations	O
.	O

RESULTS	O
:	O
(	O
1	O
)	O
SII	O
caused	O
increases	O
in	O
Qshunt	O
more	O
so	O
in	O
APRV	O
than	O
CMV	B-SPEC
group	O
.	O

Anesthetized	O
female	O
Yorkshire	O
pigs	B-SPEC
(	O
n	O
=	O
14	O
)	O
received	O
smoke	O
inhalation	O
injury	O
(	O
SII	O
)	O
and	O
40	O
%	O
total	O
body	O
surface	O
area	O
thermal	O
burns	O
.	O

TITLE	O
:	O
Early	O
Vaccination	O
of	O
Chickens	B-SPEC
Induces	O
Suboptimal	O
Immunity	O
Against	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
.	O

TITLE	O
:	O
Effectiveness	O
of	O
an	O
education	O
health	O
programme	O
about	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
tested	O
during	O
travel	O
consultations	O
.	O

ABSTRACT	O
:	O
We	O
aimed	O
to	O
evaluate	O
the	O
level	O
of	O
knowledge	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
among	O
Hajj	O
pilgrims	O
before	O
and	O
after	O
an	O
education	O
health	O
programme	O
during	O
international	O
vaccine	O
consultations	O
in	O
France	O
.	O

Despite	O
multiple	O
studies	O
in	O
humans	B-SPEC
there	O
is	O
no	O
consensus	O
on	O
the	O
optimal	O
therapy	O
for	O
MERS	O
-	O
CoV	O
.	O
Randomized	O
clinical	O
trials	O
are	O
needed	O
and	O
potential	O
therapies	O
should	O
be	O
evaluated	O
only	O
in	O
such	O
clinical	O
trials	O
.	O

Different	O
types	O
of	O
PPEPPE	O
made	O
of	O
more	O
breathable	O
material	O
may	O
not	O
lead	O
to	O
more	O
contamination	O
spots	B-SPEC
on	O
the	O
trunk	O
(	O
Mean	O
Difference	O
(	O
MD	O
)	O
1	O
.	O
60	O
(	O
95	O
%	O
Confidence	O
Interval	O
(	O
CI	O
)	O
-	O
0	O
.	O
15	O
to	O
3	O
.	O
35	O
)	O
than	O
more	O
water	O
repellent	O
material	O
but	O
may	O
have	O
greater	O
user	O
satisfaction	O
(	O
MD	O
-	O
0	O
.	O
46	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
84	O
to	O
-	O
0	O
.	O
08	O
,	O
scale	O
of	O
1	O
to	O
5	O
).	O
Gowns	O
may	O
protect	O
better	O
against	O
contamination	O
than	O
aprons	O
(	O
MD	O
large	O
patches	O
-	O
1	O
.	O
36	O
95	O
%	O
CI	O
-	O
1	O
.	O
78	O
to	O
-	O
0	O
.	O
94	O
).	O
The	O
use	O
of	O
a	O
powered	O
air	O
-	O
purifying	O
respirator	O
may	O
protect	O
better	O
than	O
a	O
simple	O
ensemble	O
of	O
PPE	O
without	O
such	O
respirator	O
(	O
Relative	O
Risk	O
(	O
RR	O
)	O
0	O
.	O
27	O
;	O
95	O
%	O
CI	O
0	O
.	O
17	O
to	O
0	O
.	O
43	O
).	O
Five	O
different	O
PPE	O
ensembles	O
(	O
such	O
as	O
gown	O
vs	O
.	O
coverall	O
,	O
boots	O
with	O
or	O
without	O
covers	O
,	O
hood	O
vs	O
.	O
cap	O
,	O
length	O
and	O
number	O
of	O
gloves	O
)	O
were	O
evaluated	O
in	O
one	O
study	O
,	O
but	O
there	O
were	O
no	O
event	O
data	O
available	O
for	O
compared	O
groups	O
.	O

There	O
is	O
particular	O
controversy	O
over	O
the	O
importance	O
of	O
aerosol	O
transmission	O
and	O
whether	O
airborne	O
precautions	O
should	O
be	O
recommended	O
for	O
some	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Epidemiology	O
of	O
Pediatric	O
Severe	O
Sepsis	B-SPEC
in	O
Main	O
PICU	B-SPEC
Centers	O
in	O
Southwest	O
China	O
.	O

ABSTRACT	O
:	O
To	O
estimate	O
the	O
prevalence	O
,	O
management	O
,	O
and	O
outcomes	O
of	O
pediatric	O
severe	O
sepsis	B-SPEC
in	O
the	O
main	O
PICUs	B-SPEC
in	O
Southwest	O
China	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
and	O
avian	B-SPEC
metapneumovirus	I-SPEC
in	O
Greece	O
.	O

A	O
total	O
of	O
106	O
broiler	O
and	O
layer	O
farms	O
,	O
including	O
10	O
backyard	O
and	O
96	O
commercial	O
flocks	O
,	O
were	O
sampled	O
between	O
March	O
2016	O
and	O
May	O
2017	O
,	O
and	O
the	O
obtained	O
tracheal	O
swabs	O
were	O
tested	O
for	O
IBV	B-SPEC
and	O
aMPV	O
using	O
RT	O
-	O
PCR	O
based	O
techniques	O
followed	O
by	O
sequencing	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
unique	O
variant	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Tunisia	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
)	O
are	O
both	O
important	O
viruses	B-SPEC
seriously	O
affecting	O
poultry	O
industry	O
worldwide	O
.	O

Primers	O
targeted	O
the	O
5	O
'-	O
untranslated	O
region	O
(	O
5	O
'-	O
UTR	O
)	O
of	O
IBV	B-SPEC
genome	O
and	O
the	O
conserved	O
region	O
of	O
NDV	B-SPEC
large	O
polymerase	O
gene	O
(	O
LP	O
).	O

Furthermore	O
,	O
when	O
detecting	O
IBV	B-SPEC
and	O
NDV	B-SPEC
simultaneously	O
,	O
the	O
lowest	O
detection	O
limit	O
was	O
the	O
same	O
as	O
that	O
of	O
the	O
single	O
detection	O
assays	O
.	O

The	O
diagnosis	O
of	O
infections	O
is	O
of	O
critical	O
importance	O
to	O
public	O
health	O
,	O
but	O
also	O
in	O
vaccine	O
development	O
in	O
order	B-SPEC
to	O
track	O
incident	O
infections	O
during	O
clinical	O
trials	O
,	O
to	O
differentiate	O
natural	O
infection	O
responses	O
from	O
those	O
that	O
are	O
vaccine	O
-	O
related	O
and	O
,	O
if	O
called	O
for	O
by	O
study	O
design	O
,	O
to	O
exclude	O
subjects	O
with	O
prior	O
exposure	O
from	O
vaccine	O
efficacy	O
trials	O
.	O

The	O
expression	O
of	O
ZO	O
-	O
1	O
,	O
ZO	O
-	O
2	O
,	O
Occludin	O
,	O
and	O
Claudin	O
-	O
4	O
in	O
the	O
intestine	O
tissue	O
was	O
significantly	O
lower	O
(	O
p	O
	O
0	O
.	O
05	O
)	O
in	O
PEDV	B-SPEC
-	O
infected	O
than	O
in	O
normal	O
piglets	O
.	O

In	O
PEDV	B-SPEC
-	O
infected	O
IPEC	O
-	O
J2	O
cells	O
,	O
the	O
mRNA	O
expression	O
of	O
the	O
six	O
tight	O
junction	O
proteins	O
showed	O
a	O
downward	O
trend	O
;	O
in	O
particular	O
,	O
the	O
expression	O
of	O
the	O
Occludin	O
and	O
Claudin	O
-	O
4	O
genes	O
was	O
significantly	O
lower	O
(	O
p	O
	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
A	O
high	O
diversity	O
of	O
corona	B-SPEC
-	O
and	O
paramyxoviruses	O
have	O
been	O
detected	O
in	O
different	O
bat	B-SPEC
species	B-SPEC
at	O
study	O
sites	O
worldwide	O
,	O
including	O
Africa	O
,	O
however	O
no	O
biosurveillance	O
studies	O
from	O
Rwanda	O
have	O
been	O
reported	O
.	O

In	O
this	O
study	O
,	O
samples	O
from	O
bats	B-SPEC
collected	O
from	O
caves	O
in	O
Ruhengeri	O
,	O
Rwanda	O
,	O
were	O
tested	O
for	O
the	O
presence	O
of	O
corona	B-SPEC
-	O
and	O
paramyxoviral	O
RNA	O
using	O
reverse	O
transcription	O
PCR	O
assays	O
.	O

In	O
addition	O
to	O
morphological	O
identification	O
of	O
bat	B-SPEC
species	B-SPEC
,	O
we	O
also	O
did	O
molecular	O
confirmation	O
of	O
species	B-SPEC
identities	O
,	O
contributing	O
to	O
the	O
known	O
genetic	O
database	O
available	O
for	O
African	O
bat	B-SPEC
species	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
set	O
priorities	O
for	O
efficient	O
control	O
of	O
acute	O
respiratory	O
tract	O
infection	O
(	O
ARTI	O
)	O
in	O
Africa	O
,	O
it	O
is	O
necessary	O
to	O
have	O
accurate	O
estimate	O
of	O
its	O
burden	O
,	O
especially	O
among	O
HIV	B-SPEC
-	O
infected	O
populations	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
and	O
risk	O
factors	O
for	O
pulmonary	O
complications	O
after	O
curative	O
resection	O
in	O
otherwise	O
healthy	O
elderly	O
patients	O
with	O
early	O
stage	O
lung	O
cancer	B-SPEC
.	O

PICU	B-SPEC
in	O
Songklanagarind	O
Hospital	O
,	O
Songkhla	O
,	O
Thailand	O
.	O

MERS	O
-	O
CoV	O
is	O
common	O
in	O
dromedaries	B-SPEC
throughout	O
the	O
Middle	O
East	O
,	O
North	O
Africa	O
,	O
and	O
East	O
Africa	O
as	O
evidenced	O
by	O
neutralizing	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
;	O
however	O
,	O
human	B-SPEC
cases	O
have	O
remained	O
limited	O
to	O
the	O
Middle	O
East	O
.	O

TITLE	O
:	O
A	O
heterologous	O
'	O
prime	O
-	O
boost	O
'	O
anti	O
-	O
PEDV	B-SPEC
immunization	O
for	O
pregnant	O
sows	O
protects	O
neonatal	O
piglets	O
through	O
lactogenic	O
immunity	O
against	O
PEDV	B-SPEC
.	O

It	O
causes	O
enteritis	O
in	O
swine	B-SPEC
of	O
all	O
ages	O
and	O
is	O
often	O
fatal	O
in	O
neonatal	O
piglets	O
.	O

Dendritic	O
cells	O
(	O
DCs	O
)	O
are	O
specialised	O
cells	O
responsible	O
for	O
sampling	O
antigens	O
and	O
presenting	O
them	O
to	O
T	O
cells	O
,	O
which	O
also	O
play	O
an	O
essential	O
role	O
in	O
recognising	O
and	O
neutralising	O
viruses	B-SPEC
.	O

Here	O
,	O
microarrays	O
of	O
mRNAs	O
,	O
miRNAs	O
,	O
and	O
lncRNAs	O
were	O
globally	O
performed	O
to	O
analyse	O
how	O
avian	B-SPEC
DCs	O
respond	O
to	O
IBV	B-SPEC
.	O

First	O
,	O
we	O
found	O
that	O
IBV	B-SPEC
stimulation	O
did	O
not	O
enhance	O
the	O
maturation	O
ability	O
of	O
avian	B-SPEC
DCs	O
.	O

Interestingly	O
,	O
inactivated	O
IBV	B-SPEC
was	O
better	O
able	O
than	O
IBV	B-SPEC
to	O
induce	O
DC	O
maturation	O
and	O
activate	O
lymphocytes	O
.	O

Gene	O
Ontology	O
analysis	O
suggested	O
that	O
cellular	O
macromolecule	O
and	O
protein	O
location	O
(	O
GO	O
-	O
BP	O
)	O
and	O
transcription	O
factor	O
binding	O
(	O
GO	O
-	O
MF	O
)	O
were	O
abundant	O
in	O
IBV	B-SPEC
-	O
stimulated	O
avian	B-SPEC
DCs	O
.	O

Further	O
analysis	O
showed	O
that	O
the	O
actin	O
cytoskeleton	O
and	O
MAPK	O
signal	O
pathway	O
were	O
related	O
to	O
the	O
target	O
genes	O
of	O
IBV	B-SPEC
-	O
stimulated	O
miRNAs	O
.	O

RESULTS	O
:	O
First	O
,	O
we	O
found	O
that	O
IBV	B-SPEC
stimulation	O
did	O
not	O
enhance	O
the	O
maturation	O
ability	O
of	O
avian	B-SPEC
DCs	O
.	O

Conditions	O
at	O
the	O
time	O
of	O
death	O
were	O
sepsis	B-SPEC
(	O
25	O
),	O
pneumonia	O
(	O
16	O
),	O
AKI	O
(	O
15	O
),	O
bleeding	O
disorders	O
(	O
11	O
),	O
neurological	O
complications	O
(	O
10	O
),	O
ARDS	O
(	O
10	O
),	O
CKD	O
(	O
4	O
),	O
AKI	O
in	O
addition	O
to	O
CKD	O
(	O
3	O
).	O

Sepsis	B-SPEC
was	O
the	O
most	O
common	O
cause	O
of	O
death	O
and	O
,	O
together	O
with	O
sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
,	O
was	O
the	O
most	O
common	O
condition	O
at	O
the	O
time	O
of	O
death	O
.	O

Conditions	O
at	O
the	O
time	O
of	O
death	O
were	O
sepsis	B-SPEC
(	O
25	O
),	O
pneumonia	O
(	O
16	O
),	O
AKI	O
(	O
15	O
),	O
bleeding	O
disorders	O
(	O
11	O
),	O
neurological	O
complications	O
(	O
10	O
),	O
ARDS	O
(	O
10	O
),	O
CKD	O
(	O
4	O
),	O
AKI	O
in	O
addition	O
to	O
CKD	O
(	O
3	O
).	O

Variable	O
Ventilation	O
Is	O
Equally	O
Effective	O
as	O
Conventional	O
Pressure	O
Control	O
Ventilation	O
for	O
Optimizing	O
Lung	O
Function	O
in	O
a	O
Rabbit	B-SPEC
Model	O
of	O
ARDS	O
.	O

Although	O
the	O
application	O
of	O
a	O
ventilation	O
pattern	O
based	O
on	O
variations	O
in	O
physiological	O
breathing	O
(	O
PVV	B-SPEC
)	O
is	O
beneficial	O
for	O
healthy	O
lungs	O
,	O
its	O
value	O
in	O
the	O
presence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
has	O
not	O
been	O
characterized	O
.	O

TITLE	O
:	O
Genotyping	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Iran	O
:	O
Detection	O
of	O
D274	O
and	O
changing	O
in	O
the	O
genotypes	O
rate	O
.	O

ABSTRACT	O
:	O
The	O
interaction	O
between	O
a	O
low	O
pathogenic	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
A	O
/	O
CK	O
/	O
TUN	O
/	O
145	O
/	O
2012	O
),	O
a	O
H9N2	O
Tunisian	O
isolate	O
,	O
and	O
a	O
vaccine	O
strain	O
(	O
H120	O
)	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
,	O
administered	O
simultaneously	O
or	O
sequentially	O
three	O
days	O
apart	O
to	O
chicks	O
during	O
20	O
days	O
,	O
was	O
evaluated	O
using	O
ELISA	O
antibody	O
levels	O
,	O
quantitative	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
analyses	O
and	O
histopathology	O
examination	O
.	O

Second	O
,	O
we	O
have	O
determined	O
the	O
amount	O
of	O
specific	O
antibodies	O
in	O
sera	O
of	O
chick	O
'	O
s	O
infected	O
with	O
AIV	O
alone	O
,	O
IBV	B-SPEC
alone	O
,	O
mixed	O
AIV	O
+	O
IBV	B-SPEC
,	O
IBV	B-SPEC
then	O
AIV	O
or	O
AIV	O
IBV	B-SPEC
3	O
days	O
later	O
using	O
an	O
ELISA	O
test	O
.	O

TITLE	O
:	O
Impact	O
of	O
nutritional	O
stress	O
on	O
the	O
honeybee	B-SPEC
colony	O
health	O
.	O

Eligible	O
patients	O
were	O
randomized	O
into	O
(	O
1	O
)	O
SGMT	O
,	O
comprised	O
a	O
sleep	O
study	O
during	O
the	O
index	O
admission	O
and	O
continuous	O
positive	O
airway	O
pressure	O
and	O
behavioral	O
therapy	O
for	O
those	O
with	O
at	O
least	O
mild	O
OSA	B-SPEC
or	O
(	O
2	O
)	O
standard	O
therapy	O
.	O

Continuous	O
positive	O
airway	O
pressure	O
and	O
a	O
positional	O
pillow	O
were	O
prescribed	O
to	O
57	O
(	O
91	O
%)	O
and	O
6	O
(	O
9	O
%)	O
patients	O
with	O
OSA	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
different	O
microbiota	B-SPEC
from	O
the	O
cecal	O
mucosa	O
and	O
cecal	O
contents	O
between	O
healthy	O
and	O
PEDV	B-SPEC
-	O
infected	O
piglets	O
.	O

TITLE	O
:	O
Spatiotemporal	O
Clustering	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
Incidence	O
in	O
Saudi	O
Arabia	O
,	O
2012	O
-	O
2019	O
.	O

TITLE	O
:	O
Effect	O
of	O
intervention	O
practices	O
to	O
control	O
the	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
outbreak	O
during	O
the	O
first	O
epidemic	O
year	O
(	O
2013	O
-	O
2014	O
)	O
on	O
time	O
to	O
absence	O
of	O
clinical	O
signs	O
and	O
the	O
number	O
of	O
dead	O
piglets	O
per	O
sow	O
in	O
Japan	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
an	O
emerging	O
and	O
/	O
or	O
re	O
-	O
emerging	O
disease	O
of	O
pigs	B-SPEC
in	O
several	O
countries	O
,	O
with	O
high	O
morbidity	O
and	O
mortality	O
in	O
suckling	O
piglets	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
case	O
of	O
severe	O
Guillain	O
-	O
Barre	O
syndrome	O
(	O
GBS	O
)	O
associated	O
with	O
chronic	O
active	O
hepatitis	B-SPEC
C	I-SPEC
and	O
mixed	O
cryoglobulinemia	O
(	O
MC	O
).	O

Porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strain	O
responsible	O
for	O
the	O
outbreak	O
was	O
of	O
the	O
S	O
-	O
INDEL	O
genotype	O
,	O
much	O
the	O
same	O
as	O
other	O
European	O
PEDV	B-SPEC
strains	O
.	O

The	O
seroprevalence	O
across	O
PEDV	B-SPEC
-	O
positive	O
holdings	O
was	O
up	O
to	O
82	O
.	O
8	O
%.	O

We	O
identified	O
an	O
optimal	O
spatial	O
arrangement	O
of	O
these	O
patches	O
on	O
certain	O
dendrimers	O
that	O
enabled	O
their	O
interaction	O
with	O
human	B-SPEC
adenovirus	B-SPEC
5	O
(	O
Ad5	O
).	O

Importantly	O
,	O
AIV	O
brings	O
about	O
severe	O
threat	O
to	O
human	B-SPEC
public	O
health	O
.	O

Therefore	O
,	O
a	O
novel	O
method	O
that	O
can	O
distinguish	O
these	O
viruses	B-SPEC
quickly	O
and	O
simultaneously	O
is	O
urgently	O
needed	O
.	O

In	O
the	O
ICU	O
,	O
particularly	O
during	O
the	O
winter	O
season	O
,	O
influenza	O
should	O
be	O
suspected	O
not	O
only	O
in	O
patients	O
with	O
typical	O
symptoms	O
and	O
epidemiology	O
,	O
but	O
also	O
in	O
patients	O
with	O
severe	O
pneumonia	O
,	O
ARDS	O
,	O
sepsis	B-SPEC
with	O
or	O
without	O
bacterial	O
co	O
-	O
infection	O
,	O
as	O
well	O
as	O
in	O
patients	O
with	O
encephalitis	O
,	O
myocarditis	O
,	O
and	O
rhabdomyolysis	O
.	O

The	O
fibrinogen	O
level	O
and	O
antithrombin	O
activity	O
should	O
be	O
reconsidered	O
as	O
unique	O
biomarkers	O
for	O
sepsis	B-SPEC
and	O
sepsis	B-SPEC
-	O
induced	O
DIC	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
activation	O
of	O
pituitary	O
axis	B-SPEC
early	O
after	O
ICU	O
admission	O
in	O
patients	O
with	O
critical	O
illnesses	O
of	O
different	O
etiology	O
and	O
its	O
association	O
with	O
outcome	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
provide	O
preliminary	O
data	O
on	O
the	O
fecal	O
microbiota	B-SPEC
composition	O
in	O
healthy	O
cats	B-SPEC
compared	O
to	O
FCoV	O
-	O
infected	O
cats	B-SPEC
,	O
with	O
and	O
without	O
FIP	O
.	O

Although	O
there	O
were	O
no	O
taxa	O
significantly	O
linked	O
to	O
the	O
different	O
conditions	O
,	O
some	O
peculiar	O
patterns	O
were	O
recognized	O
:	O
Firmicutes	B-SPEC
was	O
always	O
the	O
most	O
represented	O
phylum	B-SPEC
,	O
followed	O
by	O
Bacteroidetes	B-SPEC
and	O
Actinobacteria	B-SPEC
.	O

TITLE	O
:	O
Characteristics	O
and	O
outcome	O
of	O
viral	O
pneumonia	O
caused	O
by	O
influenza	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
infections	O
:	O
A	O
4	O
-	O
year	O
experience	O
from	O
a	O
tertiary	O
care	O
center	O
.	O

TITLE	O
:	O
Increasing	O
the	O
translation	O
of	O
mouse	B-SPEC
models	O
of	O
MERS	O
coronavirus	B-SPEC
pathogenesis	O
through	O
kinetic	O
hematological	O
analysis	O
.	O

MERS	O
-	O
CoV	O
lung	O
titer	O
peaked	O
2	O
days	O
post	O
infection	O
concurrent	O
with	O
lymphopenia	O
and	O
neutrophilia	O
in	O
peripheral	O
blood	O
,	O
two	O
phenomena	O
also	O
observed	O
in	O
MERS	O
-	O
CoV	O
infection	O
of	O
humans	B-SPEC
.	O

The	O
92	O
.	O
8	O
%	O
of	O
the	O
28	O
patients	O
with	O
severe	O
CAP	O
due	O
to	O
human	B-SPEC
metapneumovirus	I-SPEC
were	O
detected	O
during	O
the	O
first	O
half	O
of	O
the	O
year	O
.	O

Three	O
different	O
genotypes	O
of	O
IBV	B-SPEC
were	O
detected	O
,	O
but	O
none	O
was	O
an	O
unknown	O
variant	O
.	O

A	O
45	O
-	O
year	O
-	O
old	O
man	B-SPEC
was	O
hospitalized	O
for	O
acute	O
decompensated	O
heart	O
failure	O
and	O
acute	O
kidney	O
injury	O
with	O
hyperkalemia	O
.	O

The	O
rTGEV	O
-	O
RS	O
-	O
SPEDV	O
virus	B-SPEC
protected	O
against	O
challenge	O
with	O
a	O
virulent	O
PEDV	B-SPEC
strain	O
,	O
reducing	O
challenge	O
virus	B-SPEC
titers	O
in	O
jejunum	O
and	O
leading	O
to	O
undetectable	O
challenge	O
virus	B-SPEC
RNA	O
levels	O
in	O
feces	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
further	O
study	O
the	O
role	O
of	O
long	O
-	O
lasting	O
neurodegeneration	O
on	O
the	O
development	O
of	O
neurogenic	O
bladder	O
dysfunction	O
in	O
mice	B-SPEC
with	O
corona	B-SPEC
-	O
virus	B-SPEC
induced	O
encephalitis	O
(	O
CIE	O
).	O

This	O
study	O
provides	O
important	O
information	O
about	O
the	O
antigenic	O
diversity	O
of	O
PEDV	B-SPEC
circulating	O
in	O
the	O
endemic	O
areas	O
,	O
which	O
arises	O
from	O
continuous	O
non	O
-	O
lethal	O
mutations	O
to	O
ensure	O
viral	O
fitness	O
in	O
the	O
host	O
environment	O
.	O

TITLE	O
:	O
Safety	O
and	O
immunogenicity	O
of	O
an	O
anti	O
-	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
DNA	O
vaccine	O
:	O
a	O
phase	O
1	O
,	O
open	O
-	O
label	O
,	O
single	O
-	O
arm	O
,	O
dose	O
-	O
escalation	O
trial	O
.	O

TITLE	O
:	O
Peptide	O
-	O
Protein	O
Interaction	O
Studies	O
of	O
Antimicrobial	O
Peptides	O
Targeting	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Spike	O
Protein	O
:	O

Recent	O
studies	O
suggest	O
that	O
daytime	O
sleepiness	O
may	O
indicate	O
a	O
more	O
severe	O
OSA	B-SPEC
phenotype	O
with	O
regard	O
to	O
cardiovascular	O
risk	O
.	O

A	O
41	O
-	O
year	O
-	O
old	O
man	B-SPEC
had	O
undergone	O
cervical	O
laminoplasty	O
for	O
ossification	O
of	O
the	O
posterior	O
longitudinal	O
ligament	O
and	O
thoracic	O
laminectomy	O
for	O
ossification	O
of	O
the	O
posterior	O
longitudinal	O
ligament	O
and	O
ossification	O
of	O
the	O
ligamentum	O
flavum	O
in	O
the	O
prone	O
position	O
.	O

The	O
studied	O
isolate	O
(	O
IBV	B-SPEC
/	O
CK	O
/	O
EG	O
/	O
Fadllah	O
-	O
10	O
/	O
2019	O
)	O
emerged	O
as	O
a	O
result	O
of	O
recombination	O
between	O
the	O
variant	O
group	O
(	O
Egy	O
/	O
var	O
I	O
genotype	O
,	O
GI	O
-	O
23	O
lineage	O
)	O
as	O
a	O
major	O
parent	O
and	O
the	O
CR88	O
variant	O
vaccine	O
strain	O
(	O
4	O
/	O
91	O
genotype	O
,	O
GI	O
-	O
13	O
lineage	O
)	O
as	O
minor	O
parent	O
.	O

TITLE	O
:	O
Glycine	B-SPEC
29	O
Is	O
Critical	O
for	O
Conformational	O
Changes	O
of	O
the	O
Spike	O
Glycoprotein	O
of	O
Mouse	B-SPEC
Hepatitis	O
Virus	B-SPEC
A59	O
Triggered	O
by	O
either	O
Receptor	O
Binding	O
or	O
High	O
pH	O
.	O
ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
uses	O
its	O
N	O
-	O
terminal	O
domain	O
(	O
NTD	O
)	O
of	O
the	O
viral	O
spike	O
(	O
S	O
)	O
protein	O
to	O
bind	O
the	O
host	O
receptor	O
mouse	B-SPEC
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecule	O
1a	O
(	O
mCEACAM1a	O
)	O
and	O
mediate	O
virus	B-SPEC
entry	O
.	O

TITLE	O
:	O
Characterization	O
and	O
evolution	O
of	O
the	O
coronavirus	B-SPEC
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
HLJBY	O
isolated	O
in	O
China	O
.	O

ABSTRACT	O
:	O
A	O
strain	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
namely	O
HLJBY	O
,	O
was	O
isolated	O
in	O
Heilongjiang	O
province	O
,	O
China	O
.	O

To	O
provide	O
insight	O
into	O
the	O
understanding	O
of	O
the	O
phylogenetic	O
and	O
the	O
current	O
epidemiological	O
status	O
of	O
PEDV	B-SPEC
,	O
PEDV	B-SPEC
HLJBY	O
was	O
compared	O
with	O
CV777	O
and	O
other	O
PEDV	B-SPEC
strains	O
deposited	O
in	O
the	O
GenBank	O
.	O

The	O
highest	O
nucleotide	O
identity	O
was	O
99	O
.	O
9	O
%	O
compared	O
with	O
PEDV	B-SPEC
-	O
SX	O
/	O
China	O
/	O
2017	O
strain	O
,	O
and	O
the	O
lowest	O
nucleotide	O
identity	O
was	O
60	O
.	O
0	O
%	O
compared	O
with	O
PEDV	B-SPEC
/	O
Belgorod	O
/	O
dom	O
/	O
2008	O
strain	O
.	O

ORF3	O
protein	O
of	O
both	O
HLJBY	O
strain	O
and	O
PEDV	B-SPEC
-	O
SX	O
/	O
China	O
/	O
2017	O
strain	O
consists	O
of	O
91	O
aa	O
,	O
with	O
133	O
aa	O
deletions	O
at	O
their	O
C	O
'	O
end	O
in	O
relation	O
to	O
the	O
other	O
tested	O
PEDV	B-SPEC
strains	O
.	O

In	O
ST	O
and	O
IPEC	O
-	O
J2	O
cells	O
,	O
TGEV	B-SPEC
exhibited	O
a	O
dose	O
-	O
dependent	O
inhibition	O
of	O
NF	O
-	O
B	O
activity	O
.	O

In	O
addition	O
,	O
our	O
results	O
showed	O
that	O
PEDV	B-SPEC
ORF3	O
could	O
induce	O
the	O
autophagy	O
through	O
inducing	O
conversion	O
of	O
LC3	O
-	O
I	O
to	O
LC3	O
-	O
II	O
,	O
but	O
couldn	O
'	O
t	O
influence	O
the	O
apoptosis	O
.	O

Rhinovirus	B-SPEC
and	O
coronavirus	B-SPEC
were	O
the	O
most	O
frequently	O
detected	O
viruses	B-SPEC
during	O
AECOPD	O
visits	O
,	O
accounting	O
for	O
35	O
.	O
7	O
%	O
and	O
25	O
.	O
9	O
%	O
of	O
all	O
viral	O
infections	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	O
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
manifestation	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
human	B-SPEC
lung	O
are	O
induced	O
by	O
inflammatory	O
cytokines	O
and	O
endogenous	O
factors	O
such	O
as	O
miRNAs	O
.	O

In	O
vivo	O
,	O
miR	O
-	O
150	O
decreased	O
total	O
cell	O
and	O
neutrophil	O
counts	O
,	O
and	O
production	O
of	O
inflammatory	O
cytokines	O
interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
tumor	O
necrosis	O
factor	O
-	O
	O
(	O
TNF	O
-	O
	O
)	O
as	O
well	O
as	O
levels	O
of	O
total	O
protein	O
,	O
albumin	O
and	O
IgM	O
in	O
the	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
in	O
LPS	O
-	O
induced	O
ALI	O
mice	B-SPEC
.	O

TITLE	O
:	O
The	O
C	O
-	O
terminal	O
domain	O
of	O
the	O
MERS	O
coronavirus	B-SPEC
M	O
protein	O
contains	O
a	O
ABSTRACT	O
:	O
Coronavirus	B-SPEC
M	O
proteins	O
represent	O
the	O
major	O
protein	O
component	O
of	O
the	O
viral	O
envelope	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
intracellular	O
trafficking	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
M	O
protein	O
.	O

The	O
results	O
revealed	O
that	O
HY	O
had	O
a	O
good	O
anti	O
-	O
IBV	B-SPEC
effect	O
when	O
HY	O
directly	O
treated	O
the	O
IBV	B-SPEC
-	O
infected	O
cells	O
,	O
and	O
virus	B-SPEC
infectivity	O
decreased	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Furthermore	O
,	O
HY	O
inhibited	O
IBV	B-SPEC
-	O
induced	O
apoptosis	O
in	O
CEK	O
cells	O
,	O
and	O
significantly	O
reduced	O
the	O
mRNA	O
expression	O
levels	O
of	O
Fas	O
,	O
FasL	O
,	O
JNK	O
,	O
Bax	O
,	O
Caspase	O
3	O
,	O
and	O
Caspase	O
8	O
,	O
and	O
significantly	O
increased	O
Bcl	O
-	O
2	O
mRNA	O
expression	O
level	O
in	O
CEK	O
cells	O
.	O

ABSTRACT	O
:	O
Anticoagulant	O
therapy	O
has	O
seldom	O
been	O
achieved	O
in	O
randomized	O
trials	O
targeting	O
nonspecific	O
overall	O
sepsis	B-SPEC
patients	O
.	O

However	O
,	O
ITP	O
in	O
association	O
with	O
coronavirus	B-SPEC
infection	O
has	O
not	O
previously	O
been	O
reported	O
.	O

However	O
,	O
whether	O
cats	B-SPEC
might	O
become	O
naturally	O
infected	O
with	O
CoVs	O
of	O
other	O
species	B-SPEC
is	O
unknown	O
.	O

The	O
mean	O
age	O
of	O
the	O
patients	O
was	O
68	O
.	O
28	O
	O
9	O
.	O
59	O
years	O
in	O
the	O
virus	B-SPEC
-	O
positive	O
group	O
and	O
68	O
.	O
20	O
	O
8	O
.	O
27	O
years	O
in	O
the	O
virus	B-SPEC
-	O
negative	O
group	O
(	O
p	O
=	O
0	O
.	O
963	O
).	O

The	O
length	O
of	O
hospital	O
stay	O
was	O
longer	O
in	O
the	O
virus	B-SPEC
-	O
positive	O
group	O
than	O
in	O
the	O
virus	B-SPEC
-	O
negative	O
group	O
(	O
p	O
=	O
0	O
.	O
012	O
).	O

Improvements	O
in	O
human	B-SPEC
,	O
medical	O
,	O
and	O
sociological	O
resources	O
in	O
local	O
will	O
contribute	O
to	O
reducing	O
the	O
mortality	O
of	O
ARDS	O
in	O
Vietnam	O
.	O

Autotitrating	O
CPAP	O
for	O
OSA	B-SPEC
for	O
3	O
months	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
in	O
humans	B-SPEC
can	O
cause	O
asymptomatic	O
to	O
fatal	O
lower	O
respiratory	O
lung	O
disease	O
.	O

Using	O
in	O
-	O
house	O
S1	O
ELISA	O
and	O
protein	O
microarray	O
,	O
we	O
demonstrate	O
that	O
most	O
PCR	O
-	O
confirmed	O
MERS	O
-	O
CoV	O
case	O
-	O
patients	O
with	O
mild	O
infections	O
seroconverted	O
;	O
nonetheless	O
,	O
some	O
of	O
these	O
samples	O
did	O
not	O
have	O
detectable	O
levels	O
of	O
virus	B-SPEC
-	O
neutralizing	O
antibodies	O
.	O

In	O
general	O
,	O
the	O
potential	O
vaccine	O
candidates	O
can	O
be	O
classified	O
into	O
six	O
types	O
:	O
viral	O
vector	O
-	O
based	O
vaccine	O
,	O
DNA	O
vaccine	O
,	O
subunit	O
vaccine	O
,	O
nanoparticle	O
-	O
based	O
vaccine	O
,	O
inactivated	O
-	O
whole	O
virus	B-SPEC
vaccine	O
and	O
live	O
-	O
attenuated	O
vaccine	O
,	O
which	O
are	O
discussed	O
in	O
detail	O
.	O

Ten	O
fragments	O
contiguously	O
spanning	O
the	O
complete	O
IBV	B-SPEC
genome	O
were	O
amplified	O
and	O
cloned	O
into	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
genome	O
by	O
homologous	O
recombination	O
.	O

The	O
full	O
-	O
length	O
genomic	O
cDNA	O
was	O
transcribed	O
in	O
vitro	O
,	O
and	O
its	O
transcript	O
was	O
transfected	O
into	O
BHK	O
-	O
21	O
/	O
N	O
cells	O
that	O
could	O
stably	O
express	O
IBV	B-SPEC
N	O
protein	O
.	O

Furthermore	O
,	O
by	O
using	O
long	O
reads	O
that	O
did	O
not	O
require	O
an	O
assembly	O
step	O
,	O
we	O
were	O
able	O
to	O
identify	O
,	O
in	O
infected	O
cells	O
,	O
diverse	O
and	O
novel	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
sg	O
RNAs	O
that	O
remain	O
to	O
be	O
characterized	O
.	O

Our	O
results	O
provide	O
a	O
basis	O
for	O
the	O
identification	O
of	O
dual	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IN	O
and	O
RT	O
RNase	O
H	O
inhibitors	O
compounds	O
.	O

In	O
this	O
work	O
,	O
the	O
7b	O
gene	O
was	O
amplified	O
from	O
51	O
domestic	B-SPEC
cat	I-SPEC
plasma	O
samples	O
by	O
semi	O
-	O
nested	O
PCR	O
and	O
tested	O
through	O
phylogenetic	O
and	O
phylogeographical	O
approaches	O
.	O

When	O
incorporated	O
into	O
bone	O
marrow	O
/	O
liver	O
/	O
thymus	B-SPEC
humanized	O
mice	B-SPEC
,	O
lung	O
implants	O
are	O
repopulated	O
with	O
autologous	O
human	B-SPEC
hematopoietic	O
cells	O
.	O

The	O
four	O
endemic	O
human	B-SPEC
CoVs	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	O
-	O
HKU1	O
)	O
mainly	O
cause	O
mild	O
respiratory	O
tract	O
infections	O
.	O

Currently	O
,	O
there	O
are	O
no	O
effective	O
treatments	O
or	O
vaccines	O
available	O
to	O
control	O
PDCoV	O
.	O
To	O
study	O
the	O
potential	O
of	O
RNA	O
interference	O
(	O
RNAi	O
)	O
as	O
a	O
strategy	O
against	O
PDCoV	O
infection	O
,	O
two	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)-	O
expressing	O
plasmids	O
(	O
pGenesil	O
-	O
M	O
and	O
pGenesil	O
-	O
N	O
)	O
that	O
targeted	O
the	O
M	O
and	O
N	O
genes	O
of	O
PDCoV	O
were	O
constructed	O
and	O
transfected	O
separately	O
into	O
swine	B-SPEC
testicular	O
(	O
ST	O
)	O
cells	O
,	O
which	O
were	O
then	O
infected	O
with	O
PDCoV	O
strain	O
HB	O
-	O
BD	O
.	O

The	O
potential	O
of	O
the	O
plasmids	O
to	O
inhibit	O
PDCoV	O
replication	O
was	O
evaluated	O
by	O
cytopathic	O
effect	O
,	O
virus	B-SPEC
titers	O
,	O
and	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
assay	O
.	O

Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
infection	O
was	O
found	O
in	O
83	O
.	O
1	O
%	O
of	O
the	O
patients	O
.	O

Among	O
the	O
8	O
viruses	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
(	O
4	O
.	O
8	O
%	O
for	O
1	O
%	O
respiratory	O
viral	O
infection	O
increase	O
,	O
95	O
%	O
CI	O
1	O
.	O
6	O
to	O
8	O
.	O
1	O
,	O
P	O
=	O
.	O
003	O
),	O
coronavirus	B-SPEC
(	O
9	O
.	O
2	O
%,	O
3	O
.	O
9	O
to	O
14	O
.	O
8	O
,	O
P	O
<	O
.	O
001	O
),	O
and	O
metapneumovirus	B-SPEC
(	O
44	O
%,	O
2	O
.	O
0	O
to	O
103	O
.	O
4	O
,	O
P	O
=	O
.	O
038	O
)	O
were	O
associated	O
with	O
increased	O
number	O
of	O
incident	O
RA	O
.	O

ABSTRACT	O
:	O
Commercial	O
broilers	O
are	O
commonly	O
exposed	O
to	O
gaseous	O
ammonia	B-SPEC
(	O
NH	O

TITLE	O
:	O
Porcine	B-SPEC
IL	O
-	O
12	O
plasmid	O
as	O
an	O
adjuvant	O
improves	O
the	O
cellular	O
and	O
humoral	O
immune	O
responses	O
of	O
DNA	O
vaccine	O
targeting	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
spike	O
gene	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

The	O
pVAX1	O
-(	O
TGEV	B-SPEC
-	O
S1	O
)	O
and	O
pVAX1	O
-(	O
pIL	O
-	O
12	O
)	O
vectors	O
were	O
transfected	O
into	O
BHK	O
-	O
21	O
cells	O
and	O
expressed	O
in	O
vitro	O
.	O

Transfection	O
of	O
different	O
cell	O
types	O
with	O
FCoV	O
3b	O
fused	O
to	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
or	O
3	B-SPEC
	I-SPEC
FLAG	I-SPEC
confirmed	O
localization	O
of	O
FCoV	O
3b	O
in	O
the	O
mitochondria	O
and	O
nucleoli	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
acute	O
diarrhea	O
in	O
suckling	O
piglets	O
.	O

PDCoV	O
-	O
infected	O
suckling	O
piglets	O
were	O
characterized	O
with	O
thin	O
and	O
transparent	O
intestinal	O
walls	O
from	O
colon	O
to	O
caecum	B-SPEC
,	O
spot	B-SPEC
hemorrhage	O
at	O
mesentery	O
and	O
intestinal	O
bleeding	O
.	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
is	O
well	O
documented	O
through	O
contact	O
with	O
an	O
active	O
infected	O
patient	O
or	O
some	O
silently	O
infected	O
persons	O
.	O

Outbreaks	O
within	O
family	B-SPEC
clusters	O
have	O
been	O
reported	O
,	O
whereby	O
some	O
blood	O
relative	O
patients	O
were	O
infected	O
through	O
their	O
wives	O
in	O
the	O
same	O
house	O
were	O
not	O
infected	O
.	O

This	O
will	O
reduce	O
the	O
shedding	O
of	O
the	O
virus	B-SPEC
into	O
the	O
environment	O
,	O
and	O
thus	O
the	O
risk	O
of	O
human	B-SPEC
infection	O
can	O
be	O
mitigated	O
.	O

The	O
structures	O
of	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
display	O
unusual	O
peptide	O
presentation	O
features	O
in	O
that	O
the	O
bat	B-SPEC
-	O
specific	O
3	O
-	O
amino	O
acid	O
(	O
aa	O
)	O
insertion	O
enables	O
the	O
tight	O
""""	O
surface	O
anchoring	O
""""	O
of	O
the	O
P1	O
-	O
Asp	O
in	O
pocket	O
A	O
of	O
bat	B-SPEC
MHC	O
I	O
.	O
As	O
the	O
classical	O
primary	O
anchoring	O
positions	O
,	O
the	O
B	O
and	O
F	O
pockets	O
of	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
also	O
show	O
unconventional	O
conformations	O
,	O
which	O
contribute	O
to	O
unusual	O
peptide	O
motifs	O
and	O
distinct	O
peptide	O
presentation	O
.	O

Notably	O
,	O
the	O
features	O
of	O
bat	B-SPEC
MHC	O
I	O
may	O
be	O
shared	O
by	O
MHC	O
I	O
from	O
various	O
marsupials	O
.	O

Overexpression	O
of	O
exogenous	O
G3BP1	O
,	O
on	O
the	O
other	O
hand	O
,	O
lowered	O
virus	B-SPEC
replication	O
by	O
100	O
-	O
fold	O
compared	O
to	O
vector	O
control	O
.	O

An	O
increase	O
in	O
the	O
levels	O
of	O
mRNAs	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
such	O
as	O
interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
)	O
and	O
tumor	O
necrosis	O
factor	O
-	O
	O
(	O
TNF	O
-	O
	O
)	O
was	O
also	O
observed	O
in	O
PEDV	B-SPEC
-	O
infected	O
G3BP1	O
depleted	O
cells	O
compared	O
to	O
PEDV	B-SPEC
-	O
infected	O
control	O
cells	O
.	O

TITLE	O
:	O
Peptides	O
with	O
16R	O
in	O
S2	O
protein	O
showed	O
broad	O
reactions	O
with	O
sera	O
against	O
different	O
types	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
RNA	O
viruses	B-SPEC
carry	O
out	O
selective	O
packaging	O
of	O
their	O
genomes	O
in	O
a	O
variety	O
of	O
ways	O
,	O
many	O
involving	O
a	O
genomic	O
packaging	O
signal	O
.	O

Despite	O
some	O
limitations	O
,	O
small	O
animal	B-SPEC
models	O
of	O
pneumonia	O
and	O
the	O
mechanistic	O
insights	O
they	O
produce	O
are	O
likely	O
to	O
continue	O
to	O
play	O
an	O
important	O
role	O
in	O
generating	O
new	O
therapeutic	O
targets	O
.	O

We	O
then	O
did	O
a	O
series	O
of	O
experiments	O
in	O
mice	B-SPEC
in	O
which	O
we	O
systematically	O
varied	O
the	O
pneumococcal	O
inoculum	O
and	O
the	O
timing	O
of	O
antibiotics	O
while	O
measuring	O
systemic	O
and	O
lung	O
-	O
specific	O
end	O
points	O
,	O
producing	O
a	O
range	O
of	O
models	O
that	O
mirrors	O
the	O
spectrum	O
of	O
pneumococcal	O
lung	O
disease	O
in	O
patients	O
,	O
from	O
mild	O
self	O
-	O
resolving	O
infection	O
to	O
severe	O
pneumonia	O
refractory	O
to	O
antibiotics	O
.	O

The	O
addition	O
of	O
fluid	O
resuscitation	O
to	O
the	O
model	O
improved	O
renal	O
function	O
but	O
worsened	O
the	O
severity	O
of	O
lung	O
injury	O
based	O
on	O
direct	O
measurements	O
of	O
pulmonary	O
edema	O
and	O
lung	O
compliance	O
,	O
analogous	O
to	O
patients	O
with	O
pneumonia	O
and	O
sepsis	B-SPEC
who	O
develop	O
ARDS	O
following	O
fluid	O
administration	O
.	O

ABSTRACT	O
:	O
Widespread	O
geographic	O
movement	O
and	O
extensive	O
comingling	O
of	O
exhibition	O
swine	B-SPEC
facilitates	O
the	O
spread	O
and	O
transmission	O
of	O
infectious	O
pathogens	O
.	O

Nasal	O
samples	O
were	O
collected	O
from	O
2862	O
pigs	B-SPEC
at	O
102	O
exhibitions	O
and	O
tested	O
for	O
five	O
pathogens	O
.	O

This	O
case	O
report	O
describes	O
an	O
early	O
presentation	O
of	O
a	O
cat	B-SPEC
with	O
primarily	O
neurologic	O
FIP	O
,	O
with	O
molecular	O
characterization	O
of	O
the	O
virus	B-SPEC
within	O
various	O
tissues	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
newly	O
identified	O
coronavirus	B-SPEC
of	O
pigs	B-SPEC
that	O
was	O
first	O
reported	O
in	O
Hong	O
Kong	O
in	O
2012	O
.	O

However	O
,	O
the	O
primary	O
element	O
influencing	O
the	O
codon	O
bias	B-SPEC
of	O
PDCoVs	O
was	O
natural	O
selection	O
.	O

,	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
become	O
a	O
global	O
concern	O
due	O
to	O
the	O
high	O
morbidity	O
and	O
mortality	O
of	O
individuals	O
infected	O
with	O
the	O
virus	B-SPEC
.	O

Like	O
other	O
coronaviruses	O
,	O
PDCoV	O
encodes	O
at	O
least	O
three	O
accessory	O
or	O
species	B-SPEC
-	O
specific	O
proteins	O
;	O
however	O
,	O
the	O
biological	O
roles	O
of	O
these	O
proteins	O
in	O
PDCoV	O
replication	O
remain	O
undetermined	O
.	O

Diabetic	O
mice	B-SPEC
also	O
had	O
lower	O
levels	O
of	O
Tnfa	O
,	O
Il6	O
,	O
Il12b	O
,	O
and	O
Arg1	O
expression	O
and	O
higher	O
levels	O
of	O
Il17a	O
expression	O
.	O

TITLE	O
:	O
Broad	O
Cross	O
-	O
Species	B-SPEC
Infection	O
of	O
Cultured	O
Cells	O
by	O
Bat	B-SPEC
HKU2	O
-	O
Related	O
Swine	B-SPEC
Acute	O
Diarrhea	O
Syndrome	O
Coronavirus	B-SPEC
and	O
Identification	O
of	O
Its	O
Replication	O
in	O
Murine	B-SPEC
Dendritic	O
Cells	O
ABSTRACT	O
:	O
Outbreaks	O
of	O
severe	O
diarrhea	O
in	O
neonatal	O
piglets	O
in	O
Guangdong	O
,	O
China	O
,	O
in	O
2017	O
resulted	O
in	O
the	O
isolation	O
and	O
discovery	O
of	O
a	O
novel	O
swine	B-SPEC
enteric	O
alphacoronavirus	B-SPEC
(	O
SeACoV	O
)	O
derived	O
from	O
the	O
species	B-SPEC

TITLE	O
:	O
Risk	O
of	O
Introduction	O
of	O
Infectious	O
Animal	B-SPEC
Diseases	O
for	O
Europe	O
Based	O
on	O
the	O
Health	O
Situation	O
of	O
North	O
Africa	O
and	O
the	O
Arabian	O
Peninsula	O
.	O

In	O
dogs	B-SPEC
,	O
Salmonella	B-SPEC
spp	O
.	O

Among	O
the	O
phenolic	O
acid	O
constituents	O
in	O
Sambucus	B-SPEC
FormosanaNakai	O
extract	O
,	O
caffeic	O
acid	O
,	O
chlorogenic	O
acid	O
and	O
gallic	O
acid	O
sustained	O
the	O
anti	O
-	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
activity	O
that	O
was	O
ranked	O
in	O
the	O
following	O
order	B-SPEC
of	O
virus	B-SPEC
yield	O
reduction	O
:	O
caffeic	O
acid	O
(	O
IC	O

Further	O
studies	O
are	O
necessary	O
to	O
investigate	O
the	O
role	O
of	O
aquatic	O
bird	B-SPEC
	O
-	O
CoVs	O
in	O
the	O
epidemiology	O
of	O
	O
-	O
CoVs	O
in	O
swine	B-SPEC
and	O
terrestrial	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
convergence	O
of	O
humans	B-SPEC
,	O
animals	B-SPEC
and	O
our	O
shared	O
environment	O
results	O
in	O
a	O
dynamic	O
in	O
which	O
the	O
health	O
of	O
each	O
group	O
is	O
inextricably	O
linked	O
.	O

The	O
primary	O
purpose	O
of	O
this	O
mechanism	O
is	O
to	O
provide	O
a	O
comprehensive	O
,	O
strategic	O
approach	O
to	O
concurrent	O
and	O
future	O
health	O
challenges	O
that	O
are	O
facing	O
public	O
and	O
animal	B-SPEC
heath	O
,	O
including	O
environmental	O
impacts	O
.	O

Specific	O
complications	O
of	O
PVL	O
-	O
SA	O
infections	O
were	O
venous	O
thrombosis	O
(	O
n	O
=	O
2	O
),	O
sepsis	B-SPEC
(	O
n	O
=	O
5	O
),	O
respiratory	O
failure	O
(	O
n	O
=	O
5	O
),	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
3	O
).	O

In	O
6	O
out	O
of	O
10	O
patients	O
a	O
history	O
suggestive	O
for	O
PVL	O
-	O
SA	O
colonization	O
in	O
the	O
patient	O
or	O
close	O
family	B-SPEC
members	O
before	O
hospital	O
admission	O
was	O
identified	O
.	O

We	O
investigated	O
the	O
mucosal	O
immune	O
response	O
against	O
FECV	B-SPEC
in	O
an	O
endemically	O
infected	O
breeding	O
colony	O
over	O
a	O
seven	O
-	O
month	O
period	O
.	O

Significant	O
FECV	B-SPEC
-	O
specific	O
mucosal	O
T	O
cell	O
IFN	O
responses	O
were	O
not	O
detected	O
in	O
any	O
of	O
the	O
three	O
groups	O
.	O

ABSTRACT	O
:	O
Novel	O
tick	B-SPEC
-	O
borne	O
phleboviruses	B-SPEC
in	O
the	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
is	O
a	O
serious	O
and	O
highly	O
contagious	O
disease	O
caused	O
by	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

About	O
1	O
-	O
day	O
-	O
old	O
specific	O
pathogen	O
-	O
free	O
White	O
Leghorn	O
chickens	B-SPEC
inoculated	O
with	O
CK	O
/	O
CH	O
/	O
JS	O
/	O
TAHY	O
at	O
105	O
.	O
5	O
EID50	O
exhibited	O
clinical	O
signs	O
including	O
coughing	O
,	O
sneezing	O
,	O
nasal	O
discharge	O
,	O
and	O
tracheal	O
vocalization	O
accompanied	O
by	O
depression	O
with	O
84	O
%	O
mortality	O
and	O
100	O
%	O
morbidity	O
.	O

IBV	B-SPEC
-	O
specific	O
antibodies	O
appeared	O
at	O
10	O
D	O
post	O
-	O
infection	O
.	O

Chickens	B-SPEC
vaccinated	O
with	O
a	O
CK	O
/	O
CH	O
/	O
JS	O
/	O
TAHY	O
oil	O
-	O
emulsion	O
vaccine	O
showed	O
26	O
.	O
7	O
%	O
morbidity	O
and	O
3	O
%	O
mortality	O
indicating	O
a	O
protective	O
effect	O
.	O

ABSTRACT	O
:	O
Experimental	O
data	O
suggest	O
that	O
intravenous	O
vitamin	O
C	O
may	O
attenuate	O
inflammation	O
and	O
vascular	O
injury	O
associated	O
with	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

To	O
determine	O
the	O
effect	O
of	O
intravenous	O
vitamin	O
C	O
infusion	O
on	O
organ	O
failure	O
scores	O
and	O
biological	O
markers	O
of	O
inflammation	O
and	O
vascular	O
injury	O
in	O
patients	O
with	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

In	O
this	O
preliminary	O
study	O
of	O
patients	O
with	O
sepsis	B-SPEC
and	O
ARDS	O
,	O
a	O
96	O
-	O
hour	O
infusion	O
of	O
vitamin	O
C	O
compared	O
with	O
placebo	O
did	O
not	O
significantly	O
improve	O
organ	O
dysfunction	O
scores	O
or	O
alter	O
markers	O
of	O
inflammation	O
and	O
vascular	O
injury	O
.	O

Further	O
research	O
is	O
needed	O
to	O
evaluate	O
the	O
potential	O
role	O
of	O
vitamin	O
C	O
for	O
other	O
outcomes	O
in	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
newly	O
emerged	O
swine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
affecting	O
pigs	B-SPEC
of	O
all	O
ages	O
and	O
causing	O
diarrhea	O
problems	O
.	O

ABSTRACT	O
:	O
The	O
entry	O
mechanism	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
remains	O
unclear	O
,	O
especially	O
the	O
virus	B-SPEC
receptor	O
.	O

In	O
the	O
current	O
study	O
,	O
the	O
effect	O
of	O
overexpression	O
,	O
silencing	O
,	O
antibody	O
inhibition	O
,	O
and	O
co	O
-	O
expression	O
with	O
porcine	B-SPEC
aminopeptidase	O
N	O
(	O
pAPN	O
)	O
of	O
integrin	O
v3	O
on	O
PEDV	B-SPEC
infection	O
was	O
investigated	O
and	O
analyzed	O
in	O
African	B-SPEC
green	I-SPEC
monkey	I-SPEC
Vero	O
E6	O
cells	O
and	O
porcine	B-SPEC
intestinal	O
epithelial	O
cells	O
(	O
IECs	O
)	O
using	O
the	O
classical	O
strain	O
CV777	O
and	O
variant	O
strain	O
HM2017	O
of	O
PEDV	B-SPEC
.	O

Integrin	O
v3	O
significantly	O
enhanced	O
the	O
replication	O
of	O
the	O
classical	O
and	O
variant	O
strains	O
of	O
PEDV	B-SPEC
in	O
Vero	O
E6	O
cells	O
and	O
IECs	O
.	O

ABSTRACT	O
:	O
Diarrhea	O
is	O
one	O
of	O
the	O
major	O
causes	O
of	O
neonatal	O
mortality	O
in	O
pigs	B-SPEC
.	O

TITLE	O
:	O
Circular	O
RNA	O
CircEZH2	O
Suppresses	O
Transmissible	O
Gastroenteritis	O
Coronavirus	B-SPEC
-	O
induced	O
Opening	O
of	O
Mitochondrial	O
Permeability	O
Transition	O
Pore	O
via	O
Targeting	O
MiR	O
-	O
22	O
in	O
IPEC	O
-	O
J2	O
.	O

Silencing	O
IL	O
-	O
6	O
promoted	O
TGEV	B-SPEC
-	O
induced	O
mPTP	O
opening	O
and	O
inhibited	O
NF	O
-	O
B	O
pathway	O
.	O

This	O
study	O
aimed	O
to	O
detect	O
unidentified	O
viruses	B-SPEC
using	O
HTS	O
approach	O
in	O
negative	O
samples	O
of	O
nasopharynx	O
/	O
tracheal	O
secretions	O
by	O
the	O
standard	O
RT	O
-	O
qPCR	O
collected	O
in	O
the	O
Federal	O
District	O
,	O
Brazil	O
.	O

70	O
/	O
142	O
(	O
49	O
.	O
3	O
%)	O
environmental	B-SPEC
samples	I-SPEC
collected	O
were	O
positive	O
for	O
at	O
least	O
one	O
respiratory	O
pathogen	O
.	O

The	O
virus	B-SPEC
interference	O
phenomenon	O
goes	B-SPEC
against	O
the	O
basic	O
assumption	O
of	O
the	O
test	O
-	O
negative	O
vaccine	O
effectiveness	O
study	O
that	O
vaccination	O
does	O
not	O
change	O
the	O
risk	O
of	O
infection	O
with	O
other	O
respiratory	O
illness	O
,	O
thus	O
potentially	O
biasing	O
vaccine	O
effectiveness	O
results	O
in	O
the	O
positive	O
direction	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
virus	B-SPEC
interference	O
by	O
comparing	O
respiratory	O
virus	B-SPEC
status	O
among	O
Department	O
of	O
Defense	O
personnel	O
based	O
on	O
their	O
influenza	O
vaccination	O
status	O
.	O

Comparing	O
vaccinated	O
to	O
non	O
-	O
vaccinated	O
patients	O
,	O
the	O
adjusted	O
odds	O
ratio	O
for	O
non	O
-	O
flu	O
viruses	B-SPEC
was	O
0	O
.	O
97	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
86	O
,	O
1	O
.	O
09	O
;	O
p	O
=	O
0	O
.	O
60	O
).	O

RESULTS	O
:	O
We	O
compared	O
vaccination	O
status	O
of	O
2880	O
people	O
with	O
non	O
-	O
influenza	O
respiratory	O
viruses	B-SPEC
to	O
3240	O
people	O
with	O
pan	B-SPEC
-	O
negative	O
results	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
presence	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
(	O
ECoV	O
)	O
in	O
clinical	O
samples	O
submitted	O
to	O
a	O
diagnostic	O
laboratory	O
in	O
Ireland	O
.	O

These	O
data	O
suggest	O
that	O
immune	O
phenotypes	O
might	O
be	O
leveraged	O
to	O
identify	O
humans	B-SPEC
at	O
highest	O
risk	O
of	O
adverse	O
clinical	O
outcomes	O
upon	O
infection	O
,	O
who	O
may	O
most	O
benefit	O
from	O
intensive	O
clinical	O
interventions	O
,	O
in	O
addition	O
to	O
providing	O
insight	O
for	O
rational	O
vaccine	O
design	O
.	O

We	O
then	O
used	O
comprehensive	O
preinfection	O
immunophenotyping	O
to	O
identify	O
global	O
baseline	O
immune	O
correlates	O
of	O
protection	O
from	O
mortality	O
to	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Health	O
risk	O
assessment	O
at	O
mass	O
gatherings	O
:	O
a	O
report	O
of	O
the	O
camel	B-SPEC
festival	O
in	O
Saudi	O
Arabia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
frequency	O
of	O
detection	O
and	O
molecular	O
characteristics	O
of	O
enteric	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
infections	O
in	O
cattle	B-SPEC
,	O
alpaca	B-SPEC
,	O
and	O
llama	B-SPEC
herds	O
bred	O
in	O
family	B-SPEC
-	O
based	O
farms	O
in	O
Brazil	O
and	O
Peru	O
.	O

This	O
study	O
characterised	O
CoV	O
strains	O
from	O
dairy	O
cattle	B-SPEC
herds	O
in	O
the	O
state	O
of	O
Rio	O
de	O
Janeiro	O
,	O
Brazil	O
,	O
and	O
indicated	O
that	O
this	O
virus	B-SPEC
is	O
spread	O
among	O
the	O
state	O
herds	O
.	O

Phylogenetic	O
analysis	O
showed	O
high	O
identity	O
between	O
CoV	O
strains	O
detected	O
in	O
calves	O
and	O
alpacas	B-SPEC
.	O

These	O
difficulties	O
include	O
ventilation	O
issues	O
,	O
hypoxemia	O
(	O
especially	O
as	O
related	O
to	O
recirculation	O
or	O
low	O
ECMO	O
-	O
flow	O
-	O
to	O
-	O
cardiac	O
-	O
output	O
ratio	O
),	O
sepsis	B-SPEC
,	O
malfunctioning	O
critical	O
circuit	O
components	O
,	O
lack	O
of	O
clarity	O
regarding	O
optimal	O
hemoglobin	O
levels	O
,	O
hematological	O
/	O
anticoagulation	O
complications	O
,	O
and	O
right	O
ventricular	O
(	O
RV	O
)	O
dysfunction	O
.	O

These	O
findings	O
may	O
indicate	O
co	O
-	O
infection	O
with	O
MERS	O
-	O
CoV	O
and	O
a	O
HKU8r	O
-	O
CoV	O
in	O
camels	B-SPEC
.	O

We	O
failed	O
to	O
find	O
molecular	O
evidence	O
of	O
an	O
HKU8r	O
-	O
CoV	O
or	O
a	O
putative	O
recombinant	O
virus	B-SPEC
.	O

88	O
nasopharyngeal	O
swabs	O
from	O
63	O
patients	O
from	O
the	O
Bergen	O
COPD	O
Exacerbation	O
Study	O
(	O
2006	O
-	O
2010	O
)	O
were	O
analysed	O
by	O
mNGS	O
and	O
in	O
-	O
house	O
qPCR	O
for	O
respiratory	O
viruses	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
present	O
evidence	O
suggesting	O
that	O
recombinant	O
IBV	B-SPEC
with	O
a	O
mutant	O
S2	O
'	O
site	O
(	O
furin	O
-	O
S2	O
'	O
site	O
)	O
leads	O
to	O
higher	O
mortality	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
Novel	O
Betacoronavirus	B-SPEC
(	O
ABSTRACT	O
:	O
While	O
dromedaries	B-SPEC
are	O
the	O
immediate	O
animal	B-SPEC
source	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
epidemic	O
,	O
viruses	B-SPEC
related	O
to	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
also	O
been	O
found	O
in	O
bats	B-SPEC
as	O
well	O
as	O
hedgehogs	B-SPEC
.	O

We	O
generated	O
influenza	B-SPEC
virus	I-SPEC
reads	O
down	O
to	O
a	O
limit	O
of	O
detection	O
of	O
10	O

Bats	B-SPEC
are	O
likely	O
an	O
important	O
reservoir	O
for	O
SARS	O
-	O
CoV	O
.	O
SARS	O
-	O
like	O
CoVs	O
have	O
been	O
detected	O
in	O
horseshoe	B-SPEC
bats	I-SPEC
and	O
civet	B-SPEC
cats	I-SPEC
.	O

Here	O
,	O
we	O
found	O
that	O
PSN	O
exhibits	O
anti	O
-	O
inflammatory	O
effects	O
and	O
alleviates	O
heat	O
-	O
killed	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
HKMRSA	O
)-	O
induced	O
pneumonia	O
.	O

TITLE	O
:	O
The	O
immune	O
response	O
of	O
young	O
turkeys	B-SPEC
to	O
haemorrhagic	O
enteritis	O
virus	B-SPEC
infection	O
at	O
different	O
levels	O
and	O
sources	O
of	O
methionine	O
in	O
the	O
diet	O
.	O

The	O
source	O
of	O
this	O
amino	O
acid	O
appears	O
not	O
be	O
as	O
important	O
as	O
its	O
dose	O
,	O
because	O
value	O
of	O
the	O
analysed	O
parameters	O
did	O
not	O
differ	O
significantly	O
between	O
turkeys	B-SPEC
receiving	O
feeds	O
with	O
DLM	O
or	O
MHA	O
.	O

ABSTRACT	O
:	O
Ecthyma	O
gangrenosum	O
is	O
a	O
rare	O
physical	O
exam	O
finding	O
pathognomonic	O
for	O
severe	O
bacteremia	O
and	O
typically	O
associated	O
with	O
pseudomonal	O
sepsis	B-SPEC
.	O

Then	O
,	O
its	O
efficacy	O
as	O
a	O
vaccine	O
candidate	O
was	O
evaluated	O
in	O
4	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
.	O

(	O
RESULTS	O
:	O
197	O
biopsy	O
samples	O
were	O
collected	O
from	O
dogs	B-SPEC
with	O
UMRD	O
(	O
n	O
=	O
172	O
)	O
or	O
CHD	O
(	O
25	O
).	O

The	O
most	O
common	O
pathogens	O
in	O
dogs	B-SPEC
with	O
UMRD	O
were	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	O
coronavirus	B-SPEC
,	O
canine	O
parvovirus	B-SPEC
2	O
,	O
and	O

ABSTRACT	O
:	O
The	O
highly	O
virulent	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
emerged	O
in	O
China	O
in	O
2010	O
.	O

With	O
the	O
successful	O
development	O
of	O
reverse	O
genetics	O
systems	O
for	O
PEDV	B-SPEC
,	O
we	O
also	O
discuss	O
how	O
to	O
use	O
them	O
to	O
generate	O
promising	O
LAV	O
candidates	O
that	O
are	O
safe	O
,	O
effective	O
and	O
genetically	O
stable	O
.	O

TITLE	O
:	O
Identification	O
of	O
novel	O
proteolytically	O
inactive	O
mutations	O
in	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
using	O
a	O
combined	O
approach	O
.	O

TITLE	O
:	O
Epidemiological	O
status	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
2019	O
:	O
an	O
update	O
from	O
January	O
1	O
to	O
March	O
31	O
,	O
2019	O
.	O

Males	O
in	O
comparison	O
to	O
females	O
had	O
a	O
1	O
.	O
5	O
-	O
fold	O
increased	O
chance	O
(	O
adjusted	O
OR	O
=	O
1	O
.	O
5	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
3	O
-	O
1	O
.	O
8	O
])	O
of	O
death	O
related	O
to	O
MERS	O
-	O
CoV	O
infection	O
;	O
1	O
.	O
05	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
1	O
-	O
3	O
.	O
3	O
],	O
1	O
.	O
05	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
2	O
-	O
2	O
.	O
8	O
]	O
and	O
1	O
.	O
06	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
2	O
-	O
2	O
.	O
0	O
]	O
for	O
those	O
who	O
had	O
exposure	O
to	O
camels	B-SPEC
,	O
camel	B-SPEC
milk	O
consumption	O
,	O
and	O
close	O
contact	O
with	O
MERS	O
-	O
CoV	O
cases	O
,	O
respectively	O
.	O

The	O
patient	O
was	O
a	O
34	O
years	O
old	O
male	O
who	O
presented	O
with	O
a	O
reduced	O
level	O
of	O
consciousness	O
and	O
acute	O
hearing	O
loss	O
after	O
suicidal	O
ingestion	O
of	O
40	O
mg	O
of	O
methadone	O
while	O
experiencing	O
family	B-SPEC
-	O
related	O
stresses	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infects	O
ciliated	O
epithelial	O
cells	O
in	O
the	O
chicken	B-SPEC
respiratory	O
tract	O
.	O

We	O
also	O
show	O
that	O
MHV	B-SPEC
replication	O
induced	O
the	O
expression	O
of	O
other	O
genes	O
known	O
to	O
be	O
downstream	O
of	O
AhR	O
in	O
macrophages	O
and	O
dendritic	O
cells	O
and	O
in	O
livers	O
of	O
infected	O
mice	B-SPEC
.	O

Furthermore	O
,	O
while	O
indoleamine	O
2	O
,	O
3	O
-	O
dioxygenase	O
(	O
IDO1	O
)	O
drives	O
AhR	O
activation	O
in	O
other	O
settings	O
,	O
MHV	B-SPEC
infection	O
induced	O
equal	O
expression	O
of	O
downstream	O
genes	O
in	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
IDO1	O

TITLE	O
:	O
A	O
Minimally	O
Replicative	O
Vaccine	O
Protects	O
Vaccinated	O
Piglets	O
Against	O
Challenge	O
With	O
the	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
.	O

In	O
this	O
study	O
,	O
detection	O
of	O
2	O
viruses	B-SPEC
did	O
not	O
significantly	O
increase	O
hospitalizations	O
compared	O
with	O
single	O
virus	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
COV	O
)	O
is	O
the	O
main	O
cause	O
of	O
lung	O
and	O
kidney	O
infections	O
in	O
developing	O
countries	O
such	O
as	O
Saudi	O
Arabia	O
and	O
South	O
Korea	O
.	O

Infectious	O
camels	B-SPEC
with	O
active	O
naturally	O
acquired	O
MERS	O
-	O
CoV	O
infection	O
,	O
were	O
co	O
-	O
housed	O
with	O
the	O
vaccinated	O
camels	B-SPEC
at	O
a	O
ratio	O
of	O
1	O
:	O
2	O
(	O
infected	O
:	O
vaccinated	O
);	O
nasal	O
discharge	O
and	O
virus	B-SPEC
titres	O
were	O
monitored	O
for	O
14	O
days	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
important	O
pathogens	O
that	O
cause	O
upper	O
respiratory	O
tract	O
infections	O
and	O
have	O
neuroinvasive	O
abilities	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
dynamic	O
infection	O
process	O
of	O
CoVs	O
in	O
vivo	O
,	O
and	O
there	O
are	O
currently	O
no	O
specific	O
antiviral	O
drugs	O
to	O
prevent	O
or	O
treat	O
HCoV	O
infection	O
.	O

We	O
found	O
that	O
rOC43	O
-	O
ns2DelRluc	O
was	O
fatal	O
to	O
suckling	O
mice	B-SPEC
after	O
intranasal	O
inoculation	O
,	O
and	O
that	O
viral	O
titers	O
and	O
Rluc	O
expression	O
were	O
detected	O
in	O
the	O
brains	O
and	O
spinal	O
cords	O
of	O
mice	B-SPEC
infected	O
with	O
rOC43	O
-	O
ns2DelRluc	O
.	O

Furthermore	O
,	O
the	O
Rluc	O
readout	O
correlated	O
with	O
the	O
HCoV	O
replication	O
ability	O
and	O
protein	O
expression	O
,	O
which	O
allowed	O
quantification	O
of	O
antiviral	O
activity	O
in	O
live	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
MERS	O
-	O
CoV	O
,	O
a	O
highly	O
pathogenic	O
virus	B-SPEC
in	O
humans	B-SPEC
,	O
is	O
associated	O
with	O
high	O
morbidity	O
and	O
case	O
fatality	O
.	O

Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
widespread	O
avian	B-SPEC
coronavirus	I-SPEC
,	O
whose	O
control	O
relies	O
mainly	O
on	O
extensive	O
vaccine	O
administration	O
.	O

In	O
the	O
present	O
work	O
,	O
a	O
molecular	O
epidemiology	O
study	O
was	O
performed	O
to	O
evaluate	O
the	O
potential	O
role	O
of	O
homologous	O
vaccination	O
in	O
driving	O
IBV	B-SPEC
evolution	O
.	O

Pets	O
,	O
livestock	O
and	O
humans	B-SPEC
can	O
be	O
carriers	O
of	O
Cryptosporidium	B-SPEC
spp	O
.	O

Blocking	O
MERS	O
-	O
CoV	O
zoonotic	O
transmission	O
from	O
dromedary	B-SPEC
camels	B-SPEC
,	O
the	O
animal	B-SPEC
reservoir	O
,	O
could	O
potentially	O
reduce	O
the	O
number	O
of	O
primary	O
human	B-SPEC
cases	O
.	O

Importantly	O
,	O
it	O
just	O
took	O
one	O
week	O
to	O
construct	O
the	O
recombinant	O
PEDV	B-SPEC
rAJ1102	O
-	O
ORF3	O
-	O
EGFP	O
using	O
this	O
method	O
,	O
providing	O
a	O
more	O
efficient	O
platform	O
for	O
PEDV	B-SPEC
genome	O
manipulation	O
,	O
which	O
could	O
also	O
be	O
applied	O
to	O
other	O
RNA	O
viruses	B-SPEC
.	O

Human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
serology	O
was	O
positive	O
in	O
4	O
cases	O
(	O
17	O
%).	O

A	O
binary	O
logistic	O
regression	O
test	O
was	O
used	O
to	O
identify	O
the	O
risk	O
factors	O
for	O
sepsis	B-SPEC
-	O
3	O
.	O

Reassessment	O
of	O
sepsis	B-SPEC
should	O
be	O
considered	O
at	O
day	O
8	O
of	O
hospital	O
stay	O
or	O
day	O
4	O
postoperatively	O
.	O

There	O
were	O
severe	O
panics	O
caused	O
by	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
-	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
.	O

Therefore	O
,	O
researches	O
targeting	O
these	O
viruses	B-SPEC
have	O
been	O
required	O
.	O

We	O
report	O
an	O
8	O
-	O
month	O
-	O
old	O
boy	O
,	O
who	O
presented	O
with	O
recurrent	O
fever	O
,	O
mild	O
to	O
moderate	O
anemia	B-SPEC
,	O
and	O
severe	O
neutropenia	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
first	O
case	O
of	O
human	B-SPEC
infection	O
by	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Saudi	O
Arabia	O
in	O
June	O
2012	O
,	O
more	O
than	O
2260	O
cases	O
of	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
and	O
803	O
related	O
deaths	O
have	O
been	O
reported	O
since	O
the	O
16th	O
of	O
October	O
2018	O
.	O

TITLE	O
:	O
Genome	O
Sequences	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
OC43	O
and	O
NL63	O
,	O
Associated	O
with	O
Respiratory	O
Infections	O
in	O
Kilifi	O
,	O
Kenya	O
.	O

Samples	O
were	O
examined	O
by	O
RT	O
-	O
PCR	O
targeting	O
the	O
FCoV	O
In	O
20	O
/	O
20	O
cats	B-SPEC
,	O
FCoV	O
with	O
In	O
these	O
20	O
cats	B-SPEC
with	O
FIP	O
,	O
FCoVs	O
with	O
RESULTS	O
:	O
In	O
20	O
/	O
20	O
cats	B-SPEC
,	O
FCoV	O
with	O

Healthcare	O
facility	O
transmission	O
and	O
by	O
extension	O
community	O
transmission	O
,	O
the	O
main	O
amplifier	O
of	O
persistent	O
outbreaks	O
,	O
can	O
be	O
prevented	O
through	O
early	O
identification	O
and	O
isolation	O
of	O
infected	O
humans	B-SPEC
.	O

TITLE	O
:	O
Diagnosis	O
of	O
Feline	B-SPEC
Infectious	O
Peritonitis	O
:	O
A	O
Review	O
of	O
the	O
Current	O
Literature	O
.	O

We	O
found	O
that	O
12	O
/	O
100	O
camel	B-SPEC
handlers	O
and	O
their	O
family	B-SPEC
members	O
in	O
Pakistan	O
,	O
a	O
country	O
with	O
extensive	O
camel	B-SPEC
MERS	O
-	O
CoV	O
infection	O
,	O
were	O
seropositive	O
,	O
indicating	O
that	O
MERS	O
-	O
CoV	O
infection	O
of	O
these	O
populations	O
extends	O
beyond	O
the	O
Arabian	O
Peninsula	O
.	O

ABSTRACT	O
:	O
We	O
tested	O
samples	O
collected	O
from	O
camels	B-SPEC
,	O
camel	B-SPEC
workers	O
,	O
and	O
other	O
animals	B-SPEC
in	O
Sudan	O
and	O
Qatar	O
in	O
2015	O
and	O
2017	O
for	O
evidence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

ABSTRACT	O
:	O
Time	O
to	O
antibiotic	O
administration	O
is	O
a	O
key	O
element	O
in	O
sepsis	B-SPEC
care	O
;	O
however	O
,	O
it	O
is	O
difficult	O
to	O
implement	O
sepsis	B-SPEC
care	O
bundles	O
.	O

Despite	O
higher	O
comorbidities	O
in	O
the	O
SOT	O
group	O
,	O
conditional	O
logistic	O
regression	O
showed	O
that	O
in	O
-	O
hospital	O
mortality	O
for	O
sepsis	B-SPEC
in	O
SOT	O
patients	O
was	O
similar	O
compared	O
with	O
non	O
-	O
SOT	O
patients	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
=	O
1	O
.	O
14	O
[	O
95	O
%	O
confidence	O
interval	O
{	O
CI	O
},	O
0	O
.	O
95	O
-	O
1	O
.	O
37	O
],	O
P	O
=	O
.	O
161	O
).	O

and	O
Scopus	B-SPEC
were	O
searched	O
using	O
specific	O
terms	O
.	O

TITLE	O
:	O
Mortalin	O
restricts	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
entry	O
by	O
downregulating	O
clathrin	O
-	O
mediated	O
endocytosis	O
.	O

The	O
target	O
molecules	O
5a	O
-	O
q	O
were	O
synthesized	O
and	O
evaluated	O
for	O
their	O
anti	O
-	O
HIV	B-SPEC
activities	O
and	O
cytotoxicities	O
in	O
MT	O
-	O
4	O
cells	O
.	O

ABSTRACT	O
:	O
Host	O
population	O
size	O
,	O
density	O
,	O
immune	O
status	O
,	O
age	O
structure	O
,	O
and	O
contact	O
rates	O
are	O
critical	O
elements	O
of	O
virus	B-SPEC
epidemiology	O
.	O

We	O
conducted	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
for	O
16	O
respiratory	O
viruses	B-SPEC
,	O
nested	O
RT	O
-	O
PCR	O
-	O
based	O
typing	O
of	O
rhinoviruses	B-SPEC
(	O
HRVs	O
),	O
and	O
collected	O
clinical	O
symptoms	O
.	O

If	O
complement	O
regulatory	O
protein	O
such	O
as	O
endothelial	O
CD59	O
is	O
underexpressed	O
,	O
MAC	B-SPEC
may	O
also	O
cause	O
pulmonary	O
vascular	O
injury	O
to	O
the	O
innocent	O
bystander	O
endothelial	O
cell	O
of	O
host	O
and	O
provokes	O
endotheliopathy	O
that	O
causes	O
inflammation	O
and	O
pulmonary	O
vascular	O
microthrombosis	O
,	O
leading	O
to	O
ARDS	O
.	O

TITLE	O
:	O
Human	B-SPEC
bocavirus	I-SPEC
in	O
children	O
hospitalized	O
for	O
acute	O
respiratory	O
tract	O
infection	O
in	O
Rome	O
.	O

Seven	O
children	O
(	O
11	O
.	O
6	O
%)	O
required	O
admission	O
to	O
the	O
paediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
for	O
respiratory	O
failure	O
.	O

When	O
compared	O
with	O
HBoV	O
detection	O
alone	O
,	O
the	O
co	O
-	O
detection	O
of	O
RSV	B-SPEC
and	O
HBoV	O
was	O
associated	O
with	O
male	O
sex	O
(	O
P	O
=	O
0	O
.	O
013	O
),	O
younger	O
age	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
and	O
lower	O
blood	O
neutrophil	O
count	O
(	O
P	O
=	O
0	O
.	O
032	O
).	O

When	O
compared	O
with	O
HBoV	O
detection	O
alone	O
,	O
the	O
co	O
-	O
detection	O
of	O
RSV	B-SPEC
and	O
HBoV	O
was	O
associated	O
with	O
male	O
sex	O
(	O
P	O
=	O
0	O
.	O
013	O
),	O
younger	O
age	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
and	O
lower	O
blood	O
neutrophil	O
count	O
(	O
P	O
=	O
0	O
.	O
032	O
).	O

Multiplex	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
for	O
detection	O
of	O
the	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
BackgroundMiddle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
remains	O
a	O
major	O
concern	O
for	O
global	O
public	O
health	O
.	O

We	O
found	O
that	O
the	O
spike	O
protein	O
of	O
PDF2180	O
-	O
CoV	O
,	O
a	O
MERS	O
-	O
like	O
virus	B-SPEC
found	O
in	O
a	O
Ugandan	O
bat	B-SPEC
,	O
could	O
mediate	O
infection	O
of	O
Vero	O
and	O
human	B-SPEC
cells	O
in	O
the	O
presence	O
of	O
exogenous	O
trypsin	O
.	O

Known	O
coronaviruses	O
detected	O
included	O
the	O
betacorona	O
viruses	B-SPEC
:	O
Kenya	O
bat	B-SPEC
coronaviruses	O
,	O
Eidolon	B-SPEC
bat	B-SPEC
coronavirus	B-SPEC
,	O
and	O
Bat	B-SPEC
coronavirus	I-SPEC
HKU9	I-SPEC
,	O
as	O
well	O
as	O
an	O
alphacoronavirus	B-SPEC
,	O
Chaerephon	B-SPEC
Bat	B-SPEC
coronavirus	B-SPEC
.	O

Review	O
of	O
published	O
animal	B-SPEC
and	O
human	B-SPEC
data	O
regarding	O
the	O
history	O
,	O
pathophysiology	O
,	O
clinical	O
effects	O
and	O
management	O
of	O
chlorine	O
exposure	O
.	O

Polyclonal	O
antisera	O
against	O
the	O
three	O
recombinant	O
proteins	O
were	O
produced	O
in	O
rabbits	B-SPEC
and	O
mice	B-SPEC
.	O

All	O
three	O
antisera	O
were	O
able	O
to	O
inhibit	O
PDCoV	O
infection	O
in	O
vitro	O
,	O
as	O
determined	O
by	O
virus	B-SPEC
neutralization	O
assay	O
,	O
fluorescent	O
focus	O
neutralization	O
assay	O
,	O
and	O
plaque	O
-	O
reduction	O
neutralization	O
.	O

TITLE	O
:	O
Recent	O
Research	O
on	O
Occupational	O
Animal	B-SPEC
Exposures	O
and	O
Health	O
Risks	O
:	O
A	O
Narrative	O
Review	O
.	O

Swine	B-SPEC
worker	O
exposure	O
to	O
porcine	B-SPEC
coronavirus	B-SPEC
and	O
emerging	O
influenza	O
A	O
viruses	B-SPEC
was	O
documented	O
in	O
China	O
.	O

Occupational	O
injury	O
studies	O
highlighted	O
the	O
struggles	O
of	O
Latino	O
animal	B-SPEC
workers	O
in	O
the	O
USA	O
.	O

TITLE	O
:	O
Molecular	O
Mechanism	O
for	O
Antibody	O
-	O
Dependent	O
Enhancement	O
of	O
Coronavirus	B-SPEC
Entry	O
.	O

So	O
,	O
this	O
work	O
was	O
designed	O
to	O
identify	O
the	O
emergence	O
of	O
any	O
another	O
recombinant	O
virus	B-SPEC
in	O
Jeddah	O
,	O
Saudi	O
Arabia	O
.	O

The	O
nucleotide	O
sequence	O
identity	O
ranged	O
from	O
65	O
.	O
7	O
%	O
to	O
99	O
.	O
8	O
%	O
among	O
all	O
the	O
samples	O
collected	O
from	O
human	B-SPEC
and	O
camels	B-SPEC
from	O
various	O
locations	O
in	O
the	O
Kingdom	B-SPEC
.	O

TITLE	O
:	O
Epidemiological	O
study	O
of	O
pediatric	O
severe	O
sepsis	B-SPEC
in	O
Argentina	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
sepsis	B-SPEC
(	O
SS	O
)	O
is	O
one	O
of	O
the	O
leading	O
causes	O
of	O
pediatric	O
mortality	O
in	O
Argentina	B-SPEC
.	O

Patients	O
with	O
a	O
higher	O
mortality	O
were	O
those	O
who	O
were	O
coming	O
from	O
rural	O
areas	O
,	O
had	O
comorbidities	O
at	O
the	O
time	O
of	O
admission	O
or	O
a	O
history	O
of	O
cancer	B-SPEC
,	O
had	O
shock	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
were	O
administered	O
low	O
-	O
dose	O
corticosteroids	O
or	O
vasoactive	O
drugs	O
or	O
more	O
than	O
60	O
ml	O
/	O
kg	O
of	O
fluid	O
in	O
the	O
first	O
hour	O
and	O
in	O
the	O
first	O
6hours	O
,	O
and	O
had	O
severe	O
malnutrition	O
.	O

TITLE	O
:	O
Feline	B-SPEC
Infectious	O
Peritonitis	O
as	O
a	O
Systemic	O
Inflammatory	O
Disease	O
:	O
Contribution	O
of	O
Liver	O
and	O
Heart	O
to	O
the	O
Pathogenesis	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
-	O
Encoded	O
ORF8b	O
Inhibits	O
RIG	O
-	O
I	O
-	O
Like	O
Receptors	O
in	O
a	O
Differential	O
Mechanism	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
belongs	O
to	O
the	O
beta	O
coronavirus	B-SPEC
subfamily	B-SPEC
and	O
causes	O
severe	O
morbidity	O
and	O
mortality	O
in	O
humans	B-SPEC
especially	O
when	O
infected	O
patients	O
have	O
underlying	O
diseases	O
such	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(	O
COPD	O
).	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
infection	O
into	O
established	O
hDDP4	O
-	O
transgenic	B-SPEC
mice	I-SPEC
accelerates	O
lung	O
damage	O
via	O
activation	O
of	O
the	O
pro	O
-	O
inflammatory	O
response	O
and	O
pulmonary	O
fibrosis	O
.	O

Unlike	O
human	B-SPEC
dipeptidyl	O
peptidase	O
4	O
(	O
hDPP4	O
),	O
a	O
receptor	O
for	O
MERS	O
-	O
CoV	O
,	O
mouse	B-SPEC
DPP4	O
(	O
mDPP4	O
)	O
failed	O
to	O
support	O
MERS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
have	O
reported	O
on	O
aristeromycin	O
(	O
1	O
)	O
and	O
6	O
'-	O
fluorinated	O
-	O
aristeromycin	O
analogues	O
(	O
2	O
),	O
which	O
are	O
active	O
against	O
RNA	O
viruses	B-SPEC
such	O
as	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Zika	B-SPEC
virus	I-SPEC
(	O
ZIKV	O
),	O
and	O
Chikungunya	B-SPEC
virus	I-SPEC
(	O
CHIKV	O
).	O

Between	O
Aug	O
10	O
,	O
2016	O
,	O
and	O
May	O
3	O
,	O
2018	O
,	O
we	O
collected	O
samples	O
from	O
1196	O
imported	O
camels	B-SPEC
,	O
of	O
which	O
868	O
originated	O
from	O
Sudan	O
and	O
328	O
from	O
Djibouti	O
,	O
and	O
between	O
May	O
1	O
,	O
and	O
June	O
25	O
,	O
2018	O
,	O
we	O
collected	O
samples	O
from	O
472	O
local	O
camels	B-SPEC
,	O
of	O
which	O
189	O
were	O
from	O
Riyadh	O
and	O
283	O
were	O
from	O
Jeddah	O
,	O
Saudi	O
Arabia	O
.	O

Virus	B-SPEC
prevalence	O
was	O
higher	O
in	O
local	O
camels	B-SPEC
than	O
in	O
imported	O
camels	B-SPEC
(	O
224	O
[	O
47	O
	O
5	O
%]	O
of	O
472	O
vs	O
157	O
[	O
13	O
	O
1	O
%]	O
of	O
1196	O
;	O
p	O
<	O
0	O
	O
0001	O
).	O

Arabian	O
strains	O
of	O
the	O
virus	B-SPEC
should	O
be	O
tested	O
for	O
changes	O
in	O
virulence	O
and	O
transmissibility	O
.	O

Common	O
six	O
viruses	B-SPEC
associated	O
with	O
CIRDC	O
were	O
detected	O
in	O
both	O
groups	O
with	O
CIV	B-SPEC
and	O
CRCoV	O
being	O
predominantly	O
found	O
.	O

Moreover	O
,	O
the	O
clinical	O
severity	O
level	O
was	O
notably	O
related	O
to	O
the	O
age	O
of	O
infected	O
dogs	B-SPEC
,	O
but	O
not	O
to	O
the	O
vaccination	O
status	O
,	O
sex	O
and	O
transmission	O
route	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
caused	O
by	O
the	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
),	O
a	O
highly	O
virulent	O
mutant	O
form	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
).	O

ABSTRACT	O
:	O
Diabetes	O
mellitus	O
and	O
hypertension	O
are	O
recognized	O
risk	O
factors	O
for	O
severe	O
clinical	O
outcomes	O
,	O
including	O
death	O
,	O
associated	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

Among	O
32	O
virus	B-SPEC
-	O
infected	O
patients	O
in	O
Saudi	O
Arabia	O
,	O
severity	O
of	O
illness	O
and	O
frequency	O
of	O
death	O
corresponded	O
closely	O
with	O
presence	O
of	O
multiple	O
and	O
more	O
severe	O
underlying	O
conditions	O
.	O

Furthermore	O
,	O
pIL	O
-	O
11	O
was	O
found	O
to	O
inhibit	O
viral	O
infection	O
by	O
preventing	O
PEDV	B-SPEC
-	O
mediated	O
apoptosis	O
of	O
cells	O
by	O
activating	O
the	O
IL	O
-	O
11	O
/	O
STAT3	O
signaling	O
pathway	O
.	O

Our	O
data	O
suggest	O
that	O
IL	O
-	O
11	O
is	O
a	O
newfound	O
PEDV	B-SPEC
-	O
inducible	O
cytokine	O
,	O
and	O
its	O
production	O
enhances	O
the	O
anti	O
-	O
apoptosis	O
ability	O
of	O
epithelial	O
cells	O
against	O
PEDV	B-SPEC
infection	O
.	O

TITLE	O
:	O
Herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
and	O
Cytomegalovirus	B-SPEC
reactivation	O
among	O
severe	O
ARDS	O
patients	O
under	O
veno	O
-	O
venous	O
ECMO	O
.	O

The	O
virus	B-SPEC
can	O
bind	O
host	O
-	O
cell	O
carbohydrates	O
as	O
well	O
as	O
proteinaceous	O
receptors	O
.	O

These	O
reverse	O
genetic	O
systems	O
include	O
targeted	O
recombination	O
,	O
in	O
vitro	O
ligation	O
,	O
vaccinia	B-SPEC
virus	I-SPEC
vectors	O
,	O
and	O
bacterial	O
artificial	O
chromosomes	O
(	O
BACs	O
).	O

ABSTRACT	O
:	O
RNA	O
virus	B-SPEC
encodes	O
a	O
helicase	O
essential	O
for	O
viral	O
RNA	O
transcription	O
and	O
replication	O
when	O
the	O
genome	O
size	O
is	O
larger	O
than	O
7	O
kb	O
.	O

TITLE	O
:	O
Antigen	O
Capture	O
Enzyme	O
-	O
Linked	O
Immunosorbent	O
Assay	O
for	O
Detecting	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
in	O
Humans	B-SPEC
.	O

Though	O
the	O
gold	O
standard	O
for	O
diagnosing	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
is	O
still	O
nucleic	O
acid	O
amplification	O
test	O
(	O
NAAT	O
)	O
of	O
the	O
up	O
-	O
E	O
region	O
,	O
an	O
antigen	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
could	O
also	O
be	O
of	O
use	O
for	O
early	O
diagnosis	O
in	O
less	O
developed	O
locations	O
.	O

MERS	O
-	O
CoV	O
infection	O
leads	O
to	O
a	O
variety	O
of	O
clinical	O
outcomes	O
in	O
humans	B-SPEC
ranging	O
from	O
asymptomatic	O
and	O
mild	O
infection	O
to	O
severe	O
acute	O
lung	O
injury	O
and	O
multi	O
-	O
organ	O
failure	O
and	O
death	O
.	O

In	O
this	O
chapter	O
,	O
we	O
describe	O
the	O
isolation	O
,	O
amplification	O
,	O
and	O
titration	O
of	O
MERS	O
-	O
CoV	O
,	O
as	O
well	O
as	O
detailed	O
MN	O
assay	O
to	O
measure	O
nAb	O
levels	O
in	O
sera	O
from	O
different	O
mammalian	B-SPEC
species	B-SPEC
.	O

This	O
assay	O
is	O
extremely	O
safe	O
and	O
useful	O
alternative	O
to	O
live	O
virus	B-SPEC
-	O
based	O
assay	O
without	O
the	O
need	O
for	O
high	O
containment	O
facilities	O
.	O

TITLE	O
:	O
Genetically	O
Engineering	O
a	O
Susceptible	O
Mouse	B-SPEC
Model	O
for	O
MERS	O
-	O
CoV	O
-	O
Induced	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Identification	O
of	O
human	B-SPEC
dipeptidyl	O
peptidase	O
IV	O
(	O
hDPP4	O
)	O
as	O
the	O
receptor	O
for	O
MERS	O
-	O
CoV	O
infection	O
opened	O
the	O
door	O
for	O
genetic	O
engineering	O
of	O
mice	B-SPEC
.	O

TITLE	O
:	O
Development	O
of	O
a	O
Mouse	B-SPEC
-	O
Adapted	O
MERS	O
Coronavirus	B-SPEC
.	O

SADS	O
-	O
CoV	O
also	O
blocked	O
poly	O
(	O
I	O
:	O
C	O
)-	O
induced	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
IRF	O
-	O
3	O
and	O
NF	O
-	O
B	O
.	O
Furthermore	O
,	O
SADS	O
-	O
CoV	O
did	O
not	O
interfere	O
with	O
the	O
activity	O
of	O
IFN	O
-	O
	O
promoter	O
stimulated	O
by	O
IRF3	O
,	O
TBK1	O
and	O
IKK	O
,	O
but	O
counteracted	O
its	O
activation	O
induced	O
by	O
IPS	B-SPEC
-	O
1	O
and	O
RIG	O
-	O
I	O
.	O
Collectively	O
,	O
this	O
study	O
is	O
the	O
first	O
investigation	O
that	O
shows	O
interactions	O
between	O
SADS	O
-	O
CoV	O
and	O
the	O
host	O
innate	O
immunity	O
,	O
which	O
provides	O
information	O
of	O
the	O
molecular	O
mechanisms	O
underlying	O
SASD	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Severe	O
lower	O
respiratory	O
tract	O
infection	O
caused	O
by	O
adenovirus	B-SPEC
is	O
well	O
described	O
in	O
immunocompromised	O
hosts	O
and	O
can	O
cause	O
significant	O
morbidity	O
and	O
mortality	O
.	O

Adenovirus	B-SPEC
type	O
7	O
was	O
identified	O
in	O
bronchoalveolar	O
lavages	O
and	O
plasma	O
samples	O
of	O
both	O
patients	O
,	O
each	O
of	O
whom	O
received	O
cidofovir	O
.	O

Positive	O
adenovirus	B-SPEC
polymerase	O
chain	O
reaction	O
results	O
can	O
support	O
a	O
diagnosis	O
of	O
severe	O
lower	O
respiratory	O
tract	O
adenovirus	B-SPEC
infection	O
in	O
patients	O
with	O
a	O
clinically	O
compatible	O
syndrome	O
and	O
no	O
other	O
identified	O
aetiology	O
,	O
with	O
higher	O
viral	O
loads	O
being	O
associated	O
with	O
worse	O
prognosis	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
is	O
a	O
pathogen	O
causing	O
a	O
lethal	O
infectious	O
disease	O
in	O
cats	B-SPEC
,	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

This	O
hypothesis	O
was	O
supported	O
by	O
analysis	O
of	O
the	O
S1	O
gene	O
fragments	O
of	O
the	O
two	O
PhCoVs	O
isolated	O
in	O
the	O
current	O
study	O
,	O
as	O
well	O
as	O
PhCoVs	O
isolated	O
in	O
the	O
UK	O
and	O
selected	O
IBV	B-SPEC
strains	O
.	O

This	O
study	O
aims	O
to	O
evaluate	O
the	O
molecular	O
epidemiology	O
of	O
respiratory	O
viruses	B-SPEC
among	O
Malaysian	O
children	O
with	O
confirmed	O
respiratory	O
infections	O
between	O
July	O
2014	O
and	O
July	O
2015	O
.	O

No	O
coronavirus	B-SPEC
was	O
detected	O
among	O
children	O
between	O
3	O
and	O
5	O
years	O
old	O
.	O

Co	O
-	O
infection	O
caused	O
by	O
2	O
or	O
3	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
52	O
patients	O
(	O
13	O
.	O
2	O
%).	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
caused	O
by	O
virulent	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
is	O
the	O
leading	O
infectious	O
cause	O
of	O
death	O
in	O
cats	B-SPEC
.	O

Mechanistically	O
,	O
the	O
nsp5	O
-	O
mediated	O
NEMO	O
cleavage	O
disrupted	O
the	O
recruitment	O
of	O
the	O
TRAF	O
family	B-SPEC
member	O
-	O
associated	O
NF	O
-	O
B	O
activator	O
(	O
TANK	O
)	O
to	O
NEMO	O
,	O
which	O
reduced	O
the	O
phosphorylation	O
of	O
interferon	O
regulatory	O
factor	O
3	O
(	O
IRF3	O
),	O
leading	O
to	O
the	O
inhibition	O
of	O
type	O
I	O
IFN	O
production	O
.	O

Indeed	O
,	O
the	O
exoribonuclease	O
activity	O
carried	O
by	O
the	O
arenavirus	B-SPEC
nucleoprotein	O
seems	O
to	O
counteract	O
the	O
innate	O
immunity	O
antiviral	O
response	O
while	O
the	O
exoribonuclease	O
activity	O
carried	O
by	O
the	O
coronavirus	B-SPEC
nsp14	O
protein	O
is	O
likely	O
involved	O
in	O
a	O
unique	O
RNA	O
repair	O
mechanism	O
.	O

It	O
is	O
important	O
to	O
characterize	O
a	O
virus	B-SPEC
at	O
the	O
nucleotide	O
level	O
to	O
discover	O
the	O
virus	B-SPEC
'	O
s	O
genomic	O
sequence	O
variations	O
and	O
similarities	O
relative	O
to	O
other	O
viruses	B-SPEC
that	O
could	O
have	O
an	O
impact	O
on	O
the	O
functions	O
of	O
its	O
genes	O
and	O
proteins	O
.	O

A	O
modulated	O
lipidic	O
corona	B-SPEC
,	O
as	O
well	O
as	O
,	O
an	O
additional	O
coat	O
with	O
vitamin	O
E	O
were	O
used	O
to	O
extend	O
the	O
drug	O
release	O
enhance	O
the	O
macrophage	O
uptake	O
.	O

Therapeutic	O
LPV	O
/	O
RTV	O
-	O
IFNb	O
improves	O
pulmonary	O
function	O
but	O
does	O
not	O
reduce	O
virus	B-SPEC
replication	O
or	O
severe	O
lung	O
pathology	O
.	O

We	O
evaluated	O
the	O
association	O
of	O
RBV	O
/	O
rIFN	O
with	O
90	O
-	O
day	O
mortality	O
and	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
RNA	O
clearance	O
using	O
marginal	O
structural	O
modeling	O
to	O
account	O
for	O
baseline	O
and	O
time	O
-	O
varying	O
confounders	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
experience	O
with	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
in	O
children	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
transitioned	O
from	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
due	O
to	O
refractory	O
hypoxemia	O
and	O
to	O
assess	O
factors	O
associated	O
with	O
survival	O
and	O
also	O
compare	O
outcomes	O
of	O
patients	O
who	O
were	O
managed	O
with	O
early	O
HFOV	O
(	O
within	O
24	O
h	O
of	O
intubation	O
)	O
vs	O
.	O
late	O
HFOV	O
.	O

ABSTRACT	O
:	O
Calf	O
diarrhea	O
causes	O
severe	O
economic	O
losses	O
in	O
the	O
cattle	B-SPEC
industry	O
worldwide	O
.	O

Our	O
study	O
identifies	O
a	O
considerable	O
seroprevalence	O
for	O
BCoV	O
in	O
Ghana	O
and	O
provides	O
further	O
support	O
for	O
the	O
spillover	O
of	O
BCoV	O
to	O
small	O
ruminants	B-SPEC
in	O
settings	O
with	O
mixed	O
husbandry	O
and	O
limited	O
separation	O
between	O
species	B-SPEC
.	O

ABSTRACT	O
:	O
Emerging	O
viruses	B-SPEC
like	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Crimean	B-SPEC
-	I-SPEC
Congo	I-SPEC
haemorrhagic	I-SPEC
fever	I-SPEC
virus	I-SPEC
(	O
CCHFV	B-SPEC
)	O
and	O
Nipah	B-SPEC
virus	I-SPEC
(	O
NiV	O
)	O
have	O
been	O
identified	O
to	O
pose	O
a	O
potential	O
threat	O
to	O
transfusion	O
safety	O
.	O

Since	O
HEV	B-SPEC
has	O
a	O
polypurine	O
-	O
free	O
5	O
'-	O
UTR	O
that	O
folds	O
into	O
a	O
stable	O
hairpin	O
structure	O
,	O
we	O
hypothesized	O
that	O
RNA	O
clamping	O
by	O
Silvestrol	O
and	O
its	O
derivatives	O
may	O
also	O
occur	O
in	O
a	O
polypurine	O
-	O
independent	O
but	O
structure	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
the	O
HEV	B-SPEC
5	O
'-	O
UTR	O
conferred	O
sensitivity	O
towards	O
Silvestrol	O
but	O
not	O
to	O
CR	O
-	O
31	O
-	O
B	O
(-).	O

However	O
,	O
if	O
an	O
exposed	O
polypurine	O
stretch	O
was	O
introduced	O
into	O
the	O
HEV	B-SPEC
5	O
'-	O
UTR	O
,	O
CR	O
-	O
31	O
-	O
B	O
(-)	O
became	O
an	O
active	O
inhibitor	O
comparable	O
to	O
Silvestrol	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
porcine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
that	O
causes	O
watery	O
diarrhea	O
,	O
vomiting	O
,	O
and	O
frequently	O
death	O
in	O
piglets	O
,	O
causing	O
serious	O
economic	O
losses	O
to	O
the	O
pig	B-SPEC
industry	O
.	O

These	O
results	O
may	O
help	O
explain	O
the	O
immunological	O
and	O
pathological	O
changes	O
associated	O
with	O
porcine	B-SPEC
deltacorononirus	O
infection	O
.	O

Adult	O
patients	O
with	O
severe	O
sepsis	B-SPEC
caused	O
by	O
non	O
-	O
pulmonary	O
infection	O
were	O
included	O
,	O
and	O
the	O
primary	O
outcome	O
was	O
having	O
ARDS	O
,	O
defined	O
as	O
meeting	O
the	O
Berlin	O
definition	O
on	O
the	O
first	O
or	O
fourth	O
day	O
of	O
screening	O
.	O

There	O
has	O
been	O
no	O
molecular	O
surveillance	O
data	O
to	O
describe	O
the	O
epidemiology	O
of	O
GCOVs	O
in	O
avian	B-SPEC
species	B-SPEC
.	O

The	O
challenged	O
mice	B-SPEC
were	O
observed	O
for	O
14	O
consecutive	O
days	O
and	O
necropsied	O
on	O
days	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
9	O
to	O
analyze	O
viral	O
load	O
,	O
histopathology	O
,	O
viral	O
antigen	O
distribution	O
,	O
and	O
cytokines	O
in	O
tissues	O
.	O

MERS	O
-	O
CoV	O
aerosol	O
-	O
infected	O
mice	B-SPEC
with	O
an	O
incubation	O
period	O
of	O
5	O
-	O
7	O
days	O
showed	O
weight	O
loss	O
on	O
days	O
7	O
-	O
11	O
,	O
obvious	O
lung	O
lesions	O
on	O
day	O
7	O
,	O
high	O
viral	O
loads	O
in	O
the	O
lungs	O
on	O
days	O
3	O
-	O
9	O
and	O
in	O
the	O
brain	O
on	O
days	O
7	O
-	O
9	O
,	O
and	O
60	O
%	O
survival	O
.	O

hDPP4	O
transgenic	B-SPEC
mice	I-SPEC
were	O
successfully	O
infected	O
with	O
MERS	O
-	O
CoV	O
aerosols	O
via	O
an	O
animal	B-SPEC
nose	O
-	O
only	O
exposure	O
device	O
,	O
and	O
aerosol	O
-	O
and	O
instillation	O
-	O
infected	O
mice	B-SPEC
simulated	O
the	O
clinical	O
symptoms	O
of	O
moderate	O
diffuse	O
interstitial	O
pneumonia	O
.	O

This	O
review	O
summarizes	O
currently	O
available	O
and	O
novel	O
emerging	O
diagnostic	O
methods	O
for	O
the	O
detection	O
of	O
common	O
respiratory	O
viruses	B-SPEC
,	O
such	O
as	O
influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
human	B-SPEC
adenovirus	B-SPEC
,	O
and	O
human	B-SPEC
rhinovirus	I-SPEC
.	O

Multiplex	O
assays	O
for	O
simultaneous	O
detection	O
of	O
multiple	O
respiratory	O
viruses	B-SPEC
are	O
also	O
described	O
.	O

It	O
is	O
anticipated	O
that	O
such	O
data	O
will	O
assist	O
researchers	O
and	O
clinicians	O
to	O
develop	O
appropriate	O
diagnostic	O
strategies	O
for	O
timely	O
and	O
effective	O
detection	O
of	O
respiratory	O
virus	B-SPEC
infections	O
.	O

Here	O
,	O
four	O
different	O
S	O
subunit	O
proteins	O
,	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
;	O
358	O
-	O
606	O
aa	O
),	O
S1	O
(	O
1	O
-	O
751	O
aa	O
),	O
S2	O
(	O
752	O
-	O
1296	O
aa	O
),	O
and	O
STM	O
(	O
1	O
-	O
1296	O
aa	O
),	O
were	O
generated	O
using	O
the	O
baculoviral	B-SPEC
system	O
and	O
immunized	O
in	O
mice	B-SPEC
to	O
develop	O
neutralizing	O
antibodies	O
.	O

A	O
new	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
test	O
has	O
recently	O
been	O
developed	O
that	O
targets	O
the	O
spike	O
protein	O
region	O
of	O
the	O
FIP	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)	O
and	O
can	O
identify	O
specific	O
mutations	O
(	O
M1030L	O
or	O
S1032A	O
),	O
the	O
presence	O
of	O
which	O
indicates	O
a	O
shift	O
from	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FeCV	B-SPEC
)	O
to	O
FIPV	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
targets	O
the	O
intestinal	O
mucosa	O
in	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
are	O
a	O
common	O
cause	O
of	O
respiratory	O
tract	O
infection	O
(	O
RTI	O
),	O
particularly	O
in	O
neonates	O
and	O
children	O
.	O

For	O
children	O
younger	O
than	O
5	O
years	O
,	O
RSV	B-SPEC
and	O
RV	O
were	O
most	O
prevalent	O
;	O
for	O
children	O
older	O
than	O
5	O
years	O
,	O
FluA	O
and	O
ADV	O
were	O
the	O
most	O
frequently	O
detected	O
.	O

Next	O
to	O
its	O
association	O
with	O
BCV	B-SPEC
,	O
M	B-SPEC
.	I-SPEC
haemolytica	I-SPEC
was	O
more	O
frequently	O
detected	O
in	O
herds	O
with	O
5	O
to	O
10	O
animals	B-SPEC
per	O
pen	O
[	O
OR	O
=	O
8	O
.	O
0	O
(	O
1	O
.	O
4	O
-	O
46	O
.	O
9	O
)]	O
compared	O
with	O
<	O
5	O
animals	B-SPEC
,	O
and	O
in	O
herds	O
with	O
sawdust	O
as	O
bedding	O
[	O
OR	O
=	O
18	O
.	O
3	O
(	O
1	O
.	O
8	O
-	O
191	O
.	O
6	O
)].	O

RESULTS	O
:	O
Of	O
67	O
patients	O
with	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
infection	O
,	O
HAI	O
antibody	O
titers	O
reached	O
40	O
on	O
average	O
11	O
days	O
after	O
illness	O
onset	O
and	O
peaked	O
at	O
a	O
titer	O
of	O
290	O
after	O
three	O
months	O
,	O
and	O
average	O
titers	O
of	O
	O
80	O
and	O
	O
40	O
were	O
present	O
until	O
11	O
months	O
and	O
22	O
months	O
respectively	O
.	O

Hematologic	O
analysis	O
results	O
were	O
generally	O
unremarkable	O
,	O
and	O
serologic	O
tests	O
for	O
exposure	O
to	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
FeLV	O
,	O
FIV	B-SPEC
,	O
and	O
Ticks	B-SPEC
were	O
manually	O
removed	O
,	O
and	O
the	O
patient	O
received	O
supportive	O
care	O
and	O
fipronil	O
treatment	O
.	O

Identified	O
tick	B-SPEC
species	B-SPEC
included	O
To	O
the	O
authors	O
'	O
knowledge	O
,	O
tick	B-SPEC
paralysis	O
has	O
not	O
previously	O
been	O
reported	O
in	O
felids	B-SPEC
outside	O
Australia	O
.	O

TITLE	O
:	O
Illness	O
Severity	O
in	O
Hospitalized	O
Influenza	O
Patients	O
by	O
Virus	B-SPEC
Type	O
and	O
Subtype	O
,	O
Spain	O
,	O
2010	O
-	O
2017	O
.	O

ABSTRACT	O
:	O
We	O
conducted	O
a	O
retrospective	O
cohort	O
study	O
to	O
assess	O
the	O
effect	O
of	O
influenza	B-SPEC
virus	I-SPEC
type	O
and	O
subtype	O
on	O
disease	O
severity	O
among	O
hospitalized	O
influenza	O
patients	O
in	O
Spain	O
.	O

We	O
performed	O
a	O
meta	B-SPEC
-	O
analysis	O
of	O
randomized	O
controlled	O
trials	O
(	O
RCTs	O
)	O
to	O
evaluate	O
its	O
effect	O
on	O
mortality	O
.	O

YF	O
was	O
confirmed	O
by	O
Rt	O
-	O
PCR	O
and	O
positive	O
serology	O
was	O
obtained	O
for	O
leptospira	B-SPEC
by	O
ELISA	O
and	O
microagglutination	O
.	O

The	O
results	O
show	O
that	O
the	O
rabies	B-SPEC
virus	I-SPEC
vector	O
-	O
based	O
vaccine	O
can	O
induce	O
remarkably	O
earlier	O
antibody	O
response	O
and	O
higher	O
levels	O
of	O
cellular	O
immunity	O
than	O
the	O
GEM	O
particles	O
vector	O
.	O

For	O
the	O
29	O
serum	O
samples	O
from	O
Bactrian	B-SPEC
camels	I-SPEC
in	O
Dubai	O
tested	O
by	O
the	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
S	O
-	O
ELISA	O
)	O
and	O
neutralization	O
antibody	O
test	O
,	O
14	O
(	O
48	O
%)	O
and	O
12	O
(	O
41	O
%),	O
respectively	O
,	O
were	O
positive	O
for	O
MERS	O
-	O
CoV	O
antibodies	O
.	O

Different	O
from	O
both	O
MERS	O
-	O
CoV	O
and	O
SARS	O
-	O
CoV	O
,	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
the	O
seventh	O
member	O
of	O
the	O
family	B-SPEC
of	O
coronaviruses	O
that	O
infect	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
coronavirus	B-SPEC
which	O
infects	O
chickens	B-SPEC
and	O
causes	O
severe	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
worldwide	O
.	O

Further	O
studies	O
need	O
to	O
be	O
performed	O
to	O
determine	O
whether	O
this	O
recombinant	O
IBV	B-SPEC
strain	O
is	O
pathogenic	O
and	O
whether	O
it	O
is	O
transmitted	O
between	O
chickens	B-SPEC
and	O
turkeys	B-SPEC
.	O

Phylogenetic	O
analysis	O
of	O
these	O
five	O
patients	O
'	O
RT	O
-	O
PCR	O
amplicons	O
and	O
two	O
full	O
genomes	O
by	O
next	O
-	O
generation	O
sequencing	O
showed	O
that	O
this	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
is	O
closest	O
to	O
the	O
bat	B-SPEC
severe	O
acute	O
respiatory	O
syndrome	O
(	O
SARS	O
)-	O
related	O
coronaviruses	O
found	O
in	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
.	O

ABSTRACT	O
:	O
A	O
recent	O
cluster	O
of	O
pneumonia	O
cases	O
in	O
Wuhan	O
,	O
China	O
,	O
was	O
caused	O
by	O
a	O
novel	O
betacoronavirus	B-SPEC
,	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

The	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
caused	O
clusters	O
of	O
severe	O
respiratory	O
illness	O
similar	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
was	O
associated	O
with	O
ICU	O
admission	O
and	O
high	O
mortality	O
.	O

Her	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
was	O
E3V3M5	O
on	O
admission	O
.	O

TITLE	O
:	O
The	O
2019	O
-	O
new	O
coronavirus	B-SPEC
epidemic	O
:	O
Evidence	O
for	O
virus	B-SPEC
evolution	O
.	O

Fast	O
unconstrained	O
Bayesian	O
approximation	O
analysis	O
shows	O
that	O
the	O
nucleocapsid	O
and	O
the	O
spike	O
glycoprotein	O
have	O
some	O
sites	O
under	O
positive	O
pressure	O
,	O
whereas	O
homology	O
modeling	O
revealed	O
some	O
molecular	O
and	O
structural	O
differences	O
between	O
the	O
viruses	B-SPEC
.	O

Phylogenetic	O
and	O
single	O
amino	O
acid	O
polymorphism	O
analyses	O
showed	O
that	O
this	O
outbreak	O
was	O
associated	O
with	O
two	O
subgenotypes	O
(	O
C3	O
and	O
B	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

TITLE	O
:	O
Discovery	O
of	O
Bat	B-SPEC
Coronaviruses	O
through	O
Surveillance	O
and	O
Probe	O
Capture	O
-	O
Based	O
Next	O
-	O
Generation	O
Sequencing	O
.	O

Active	O
surveillance	O
is	O
both	O
urgent	O
and	O
essential	O
to	O
predict	O
and	O
mitigate	O
the	O
emergence	O
of	O
these	O
viruses	B-SPEC
in	O
humans	B-SPEC
.	O

We	O
discovered	O
nine	O
full	O
genomes	O
of	O
bat	B-SPEC
CoVs	O
in	O
this	O
study	O
and	O
revealed	O
great	O
genetic	O
diversity	O
for	O
eight	O
of	O
them	O
.	O

These	O
analyses	O
provide	O
insights	O
into	O
the	O
receptor	O
usage	O
,	O
cell	O
entry	O
,	O
host	O
cell	O
infectivity	O
and	O
animal	B-SPEC
origin	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
may	O
help	O
epidemic	O
surveillance	O
and	O
preventive	O
measures	O
against	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O

Three	O
general	O
methods	O
,	O
which	O
include	O
existing	O
broad	O
-	O
spectrum	O
antiviral	O
drugs	O
using	O
standard	O
assays	O
,	O
screening	O
of	O
a	O
chemical	O
library	O
containing	O
many	O
existing	O
compounds	O
or	O
databases	O
,	O
and	O
the	O
redevelopment	O
of	O
new	O
specific	O
drugs	O
based	O
on	O
the	O
genome	O
and	O
biophysical	O
understanding	O
of	O
individual	O
coronaviruses	O
,	O
are	O
used	O
to	O
discover	O
the	O
potential	O
antiviral	O
treatment	O
of	O
human	B-SPEC
pathogen	O
coronavirus	B-SPEC
.	O

Our	O
results	O
could	O
be	O
useful	O
for	O
designing	O
effective	O
prevention	O
strategies	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
China	O
and	O
beyond	O
.	O

Prospective	O
observational	O
study	O
of	O
children	O
fulfilling	O
criteria	O
of	O
SIRS	O
and	O
their	O
progression	O
to	O
sepsis	B-SPEC
,	O
severe	O
sepsis	B-SPEC
,	O
and	O
septic	O
shock	O
(	O
clinically	O
and	O
biochemically	O
)	O
was	O
conducted	O
at	O
a	O
tertiary	O
care	O
center	O
.	O

ABSTRACT	O
:	O
An	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
that	O
began	O
in	O
Wuhan	O
,	O
China	O
,	O
has	O
spread	O
rapidly	O
,	O
with	O
cases	O
now	O
confirmed	O
in	O
multiple	O
countries	O
.	O

We	O
report	O
the	O
first	O
case	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
confirmed	O
in	O
the	O
United	O
States	O
and	O
describe	O
the	O
identification	O
,	O
diagnosis	O
,	O
clinical	O
course	O
,	O
and	O
management	O
of	O
the	O
case	O
,	O
including	O
the	O
patient	O
'	O
s	O
initial	O
mild	O
symptoms	O
at	O
presentation	O
with	O
progression	O
to	O
pneumonia	O
on	O
day	O
9	O
of	O
illness	O
.	O

Respiratory	O
samples	O
were	O
tested	O
for	O
respiratory	O
viruses	B-SPEC
and	O
MERS	O
-	O
CoV	O
using	O
an	O
in	O
-	O
house	O
RT	O
-	O
PCR	O
assay	O
.	O

These	O
genomic	O
features	O
and	O
their	O
potential	O
association	O
with	O
virus	B-SPEC
characteristics	O
and	O
virulence	O
in	O
humans	B-SPEC
need	O
further	O
attention	O
.	O

Samples	O
were	O
tested	O
for	O
MERS	O
-	O
CoV	O
S1	O
-	O
specific	O
antibodies	O
(	O
Abs	O
)	O
by	O
ELISA	O
and	O
confirmed	O
by	O
testing	O
for	O
neutralizing	O
Abs	O
(	O
nAbs	O
)	O
using	O
both	O
pseudotyped	O
and	O
live	O
virus	B-SPEC
neutralization	O
assays	O
.	O

They	O
cause	O
moderate	O
to	O
severe	O
respiratory	O
and	O
intestinal	O
infections	O
in	O
humans	B-SPEC
.	O

2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
was	O
detected	O
in	O
all	O
patients	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

Notably	O
,	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
was	O
closely	O
related	O
(	O
with	O
88	O
%	O
identity	O
)	O
to	O
two	O
bat	B-SPEC
-	O
derived	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
coronaviruses	O
,	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZC45	O
and	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZXC21	O
,	O
collected	O
in	O
2018	O
in	O
Zhoushan	O
,	O
eastern	O
China	O
,	O
but	O
were	O
more	O
distant	O
from	O
SARS	O
-	O
CoV	O
(	O
about	O
79	O
%)	O
and	O
MERS	O
-	O
CoV	O
(	O
about	O
50	O
%).	O

The	O
future	O
evolution	O
,	O
adaptation	O
,	O
and	O
spread	O
of	O
this	O
virus	B-SPEC
warrant	O
urgent	O
investigation	O
.	O

Alpha	O
-	O
coronaviruses	O
and	O
beta	O
-	O
coronaviruses	O
can	O
infect	O
mammals	B-SPEC
and	O
gamma	O
-	O
coronaviruses	O
and	O
delta	O
-	O
coronaviruses	O
tend	O
to	O
infect	O
birds	B-SPEC
,	O
but	O
some	O
of	O
them	O
can	O
also	O
be	O
transmitted	O
to	O
mammals	B-SPEC
.	O

ABSTRACT	O
:	O
Since	O
Dec	O
31	O
,	O
2019	O
,	O
the	O
Chinese	O
city	O
of	O
Wuhan	O
has	O
reported	O
an	O
outbreak	O
of	O
atypical	O
pneumonia	O
caused	O
by	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

TITLE	O
:	O
Camelid	O
type	O
I	O
interferons	O
:	O
Identification	O
and	O
functional	O
characterization	O
of	O
interferon	O
alpha	O
from	O
the	O
dromedary	B-SPEC
camel	B-SPEC
(	O
Camelus	B-SPEC
dromedarius	I-SPEC
).	O

Recombinant	O
IFN	O
-	O
1	O
protein	O
was	O
produced	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
purified	O
from	O
inclusion	O
bodies	O
.	O

TITLE	O
:	O
Neuromuscular	O
blockade	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
of	O
randomized	O
controlled	O
trials	O
.	O

He	O
had	O
just	O
returned	O
home	O
from	O
work	O
as	O
a	O
cabinetmaker	O
,	O
where	O
he	O
experienced	O
inhalational	O
exposure	O
to	O
hydrocarbons	O
and	O
solvents	O
,	O
and	O
had	O
smoked	O
a	O
marijuana	B-SPEC
cigarette	O
.	O

RESULTS	O
:	O
Eighty	O
-	O
five	O
of	O
1272	O
PICU	B-SPEC
admissions	O
(	O
6	O
.	O
7	O
%)	O
met	O
the	O
criteria	O
for	O
PARDS	O
and	O
were	O
included	O
.	O

TITLE	O
:	O
Measures	O
for	O
diagnosing	O
and	O
treating	O
infections	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
responsible	O
for	O
a	O
pneumonia	O
outbreak	O
originating	O
in	O
Wuhan	O
,	O
China	O
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
early	O
-	O
stage	O
importation	O
risk	O
to	O
Europe	O
,	O
January	O
2020	O
.	O

The	O
United	O
Kingdom	B-SPEC
,	O
Germany	O
and	O
France	O
are	O
at	O
highest	O
risk	O
.	O

TITLE	O
:	O
The	O
Novel	B-SPEC
Coronavirus	I-SPEC
:	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
Coronavirus	I-SPEC
,	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
has	O
been	O
identified	O
as	O
the	O
causal	O
pathogen	O
of	O
an	O
ongoing	O
epidemic	O
,	O
with	O
the	O
first	O
cases	O
reported	O
in	O
Wuhan	O
,	O
China	O
,	O
last	O
December	O
2019	O
,	O
and	O
has	O
since	O
spread	O
to	O
other	O
countries	O
worldwide	O
,	O
included	O
Europe	O
and	O
very	O
recently	O
Italy	O
.	O

In	O
this	O
short	O
report	O
,	O
phylogenetic	O
reconstruction	O
was	O
used	O
to	O
better	O
understand	O
the	O
transmission	O
dynamics	O
of	O
the	O
virus	B-SPEC
from	O
its	O
first	O
introduction	O
in	O
China	O
focusing	O
on	O
the	O
more	O
recent	O
evidence	O
of	O
infection	O
in	O
a	O
couple	O
of	O
Chinese	O
tourists	O
arrived	O
in	O
Italy	O
on	O
23rd	O
January	O
2020	O
and	O
labeled	O
as	O
Coronavirus	B-SPEC
Italian	O
cases	O
.	O

In	O
conclusion	O
,	O
this	O
report	O
suggests	O
that	O
further	O
spread	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
epidemic	O
was	O
supported	O
by	O
human	B-SPEC
mobility	O
and	O
that	O
quarantine	O
of	O
suspected	O
or	O
diagnosed	O
cases	O
is	O
useful	O
to	O
prevent	O
further	O
transmission	O
.	O

TITLE	O
:	O
Immunoinformatics	O
-	O
aided	O
identification	O
of	O
T	O
cell	O
and	O
B	O
cell	O
epitopes	O
in	O
the	O
surface	O
glycoprotein	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
ABSTRACT	O
:	O
The	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
outbreak	O
has	O
caused	O
a	O
large	O
number	O
of	O
deaths	O
with	O
thousands	O
of	O
confirmed	O
cases	O
worldwide	O
,	O
especially	O
in	O
East	O
Asia	O
.	O

ABSTRACT	O
:	O
The	O
epidemic	O
of	O
the	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
has	O
presented	O
as	O
a	O
grim	O
and	O
complex	O
situation	O
recently	O
.	O

TITLE	O
:	O
[	O
Diagnosis	O
and	O
clinical	O
management	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
infection	O
:	O
an	O
operational	O
recommendation	O
of	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
(	O
V2	O
.	O
0	O
)].	O

The	O
clinical	O
features	O
include	O
fever	O
,	O
coughing	O
,	O
shortness	O
of	O
breath	O
,	O
and	O
inflammatory	O
pulmonary	O
infiltration	O
revealed	O
by	O
X	O
ray	B-SPEC
.	O

TITLE	O
:	O
[	O
Efficient	O
management	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
by	O
efficient	O
prevention	O
and	O
control	O
in	O
scientific	O
manner	O
].	O

Antiviral	O
drugs	O
commonly	O
used	O
in	O
clinical	O
practice	O
,	O
including	O
neuraminidase	O
inhibitors	O
(	O
oseltamivir	O
,	O
paramivir	O
,	O
zanamivir	O
,	O
etc	O
.),	O
ganciclovir	O
,	O
acyclovir	O
and	O
ribavirin	O
,	O
are	O
invalid	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
not	O
recommended	O
.	O

TITLE	O
:	O
[	O
Early	O
detection	O
and	O
disease	O
assessment	O
of	O
patients	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
].	O

TITLE	O
:	O
[	O
Pulmonary	O
rehabilitation	O
guidelines	O
in	O
the	O
principle	O
of	O
4S	O
for	O
patients	O
infected	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)].	O

ABSTRACT	O
:	O
The	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
from	O
Wuhan	O
,	O
China	O
is	O
currently	O
recognized	O
as	O
a	O
public	O
health	O
emergency	O
of	O
global	O
concern	O
.	O

We	O
identified	O
three	O
phylogenetic	O
clusters	O
using	O
the	O
Bayesian	O
inference	O
framework	O
and	O
three	O
transmission	O
clusters	O
using	O
transmission	O
network	O
analysis	O
,	O
with	O
only	O
one	O
cluster	O
identified	O
by	O
both	O
methods	O
using	O
the	O
above	O
genome	O
sequences	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
strains	O
.	O

We	O
confirm	O
high	O
sequence	O
similarity	O
(>	O
99	O
%)	O
between	O
all	O
sequenced	O
2019	O
-	O
nCoVs	O
genomes	O
available	O
,	O
with	O
the	O
closest	O
BCoV	O
sequence	O
sharing	O
96	O
.	O
2	O
%	O
sequence	O
identity	O
,	O
confirming	O
the	O
notion	O
of	O
a	O
zoonotic	O
origin	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Despite	O
the	O
low	O
heterogeneity	O
of	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
genomes	O
,	O
we	O
could	O
identify	O
at	O
least	O
two	O
hypervariable	O
genomic	O
hotspots	O
,	O
one	O
of	O
which	O
is	O
responsible	O
for	O
a	O
Serine	O
/	O
Leucine	O
variation	O
in	O
the	O
viral	O
ORF8	O
-	O
encoded	O
protein	O
.	O

TITLE	O
:	O
Emerging	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
Pneumonia	O
.	O

Materials	O
and	O
MethodsFifty	O
-	O
one	O
patients	O
(	O
25	O
men	O
and	O
26	O
women	O
;	O
age	O
range	O
16	O
-	O
76	O
years	O
)	O
with	O
laboratory	O
-	O
confirmed	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
by	O
using	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
underwent	O
thin	O
-	O
section	O
CT	O
.	O

ABSTRACT	O
:	O
This	O
is	O
the	O
first	O
epidemiological	O
report	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
acute	O
respiratory	O
disease	O
infections	O
reported	O
in	O
Australia	O
at	O
19	O
:	O
00	O
Australian	O
Eastern	O
Daylight	O
Time	O
[	O
AEDT	O
]	O
1	O
February	O
2020	O
.	O

It	O
includes	O
data	O
on	O
Australian	O
cases	O
notified	O
during	O
the	O
week	O
26	O
January	O
to	O
1	O
February	O
2020	O
and	O
in	O
the	O
previous	O
week	O
(	O
19	O
to	O
25	O
January	O
2020	O
),	O
the	O
international	O
situation	O
and	O
current	O
information	O
on	O
the	O
severity	O
,	O
transmission	O
and	O
spread	O
of	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

TITLE	O
:	O
Fatal	O
fulminant	O
hemolysis	O
-	O
associated	O
pulmonary	O
embolism	O
in	O
mixed	O
-	O
type	O
autoimmune	O
hemolytic	O
anemia	B-SPEC
:	O
A	O
case	O
report	O
.	O

In	O
rare	O
cases	O
,	O
AIHA	O
is	O
comorbid	O
with	O
other	O
immunological	O
disorders	O
;	O
for	O
instance	O
,	O
when	O
AIHA	O
is	O
complicated	O
with	O
immunologic	O
thrombocytopenic	O
purpura	B-SPEC
(	O
ITP	O
)	O
it	O
is	O
called	O
Evans	O
Syndrome	O
(	O
ES	O
).	O

A	O
66	O
-	O
year	O
-	O
old	O
man	B-SPEC
was	O
diagnosed	O
with	O
ES	O
after	O
autologous	O
stem	O
cell	O
transplantation	O
for	O
malignant	O
lymphoma	O
.	O

This	O
guideline	O
includes	O
the	O
guideline	O
methodology	O
,	O
epidemiological	O
characteristics	O
,	O
disease	O
screening	O
and	O
population	O
prevention	O
,	O
diagnosis	O
,	O
treatment	O
and	O
control	O
(	O
including	O
traditional	O
Chinese	O
Medicine	O
),	O
nosocomial	O
infection	O
prevention	O
and	O
control	O
,	O
and	O
disease	O
nursing	O
of	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Moreover	O
,	O
we	O
also	O
provide	O
a	O
whole	O
process	O
of	O
a	O
successful	O
treatment	O
case	O
of	O
the	O
severe	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infected	O
pneumonia	O
and	O
experience	O
and	O
lessons	O
of	O
hospital	O
rescue	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infections	O
.	O

ABSTRACT	O
:	O
In	O
December	O
2019	O
,	O
a	O
viral	O
pneumonia	O
outbreak	O
caused	O
by	O
a	O
novel	O
betacoronavirus	B-SPEC
,	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
began	O
in	O
Wuhan	O
,	O
China	O
.	O

In	O
this	O
single	O
-	O
center	O
case	O
series	O
of	O
138	O
hospitalized	O
patients	O
with	O
confirmed	O
NCIP	O
in	O
Wuhan	O
,	O
China	O
,	O
presumed	O
hospital	O
-	O
related	O
transmission	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
was	O
suspected	O
in	O
41	O
%	O
of	O
patients	O
,	O
26	O
%	O
of	O
patients	O
received	O
ICU	O
care	O
,	O
and	O
mortality	O
was	O
4	O
.	O
3	O
%.	O

Samples	O
from	O
two	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
-	O
infected	O
patients	O
were	O
positive	O
in	O
the	O
tests	O
.	O

Samples	O
from	O
two	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
-	O
infected	O
patients	O
were	O
positive	O
in	O
the	O
tests	O
.	O

This	O
study	O
employs	O
an	O
integrative	O
review	O
approach	O
to	O
summarize	O
the	O
minimal	O
evidence	O
on	O
effectiveness	O
of	O
travel	O
bans	O
to	O
decrease	O
the	O
spread	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
Middle	O
Eastern	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
(	O
EVD	O
),	O
and	O
Zika	B-SPEC
virus	I-SPEC
disease	O
(	O
ZVD	O
).	O

ABSTRACT	O
:	O
A	O
zoonotic	O
coronavirus	B-SPEC
,	O
tentatively	O
labeled	O
as	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
by	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
),	O
has	O
been	O
identified	O
as	O
the	O
causative	O
agent	O
of	O
the	O
viral	O
pneumonia	O
outbreak	O
in	O
Wuhan	O
,	O
China	O
,	O
at	O
the	O
end	O
of	O
2019	O
.	O

All	O
passengers	O
were	O
screened	O
upon	O
arrival	O
in	O
Japan	O
for	O
symptoms	O
consistent	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
and	O
tested	O
for	O
presence	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
[	O
Expert	O
consensus	O
for	O
bronchoscopy	O
during	O
the	O
epidemic	O
of	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
infection	O
(	O
Trial	O
version	O
)].	O

However	O
,	O
conducting	O
bronchoscopy	O
on	O
patients	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
a	O
high	O
-	O
risk	O
procedure	O
in	O
which	O
health	O
care	O
workers	O
are	O
directly	O
exposed	O
to	O
the	O
virus	B-SPEC
,	O
and	O
the	O
protection	O
and	O
operation	O
procedures	O
need	O
to	O
be	O
strictly	O
regulated	O
.	O

This	O
statement	O
is	O
based	O
on	O
the	O
Novel	B-SPEC
Coronavirus	I-SPEC
Infection	O
Pneumonia	O
Diagnosis	O
and	O
Treatment	O
Standards	O
(	O
the	O
fourth	O
edition	O
)	O
(	O
National	O
Health	O
Committee	O
)	O
and	O
other	O
previous	O
diagnosis	O
and	O
treatment	O
strategies	O
for	O
pediatric	O
virus	B-SPEC
infections	O
.	O

Based	O
on	O
the	O
clinical	O
data	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
),	O
as	O
well	O
as	O
the	O
dada	O
from	O
previous	O
clinical	O
studies	O
and	O
the	O
recommendations	O
from	O
the	O
Extracorporeal	O
Life	O
Support	O
Organization	O
(	O
ELSO	O
),	O
the	O
committee	O
board	O
of	O
the	O
Chinese	O
Society	O
of	O
Extracorporeal	O
Life	O
Support	O
(	O
CSECLS	O
)	O
made	O
this	O
recommendations	O
to	O
guide	O
clinical	O
ECMO	O
application	O
in	O
the	O
patients	O
with	O
NCP	O
.	O

As	O
no	O
specific	O
therapies	O
are	O
available	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
early	O
containment	O
and	O
prevention	O
of	O
further	O
spread	O
will	O
be	O
crucial	O
to	O
stop	O
the	O
ongoing	O
outbreak	O
and	O
to	O
control	O
this	O
novel	O
infectious	O
thread	O
.	O

In	O
murine	B-SPEC
lung	O
vascular	O
endothelial	O
cells	O
(	O
MLECs	O
)	O
we	O
further	O
confirmed	O
that	O
RUS	O
(	O
1	O
mol	O
/	O
L	O
)	O
markedly	O
ameliorated	O
MLECs	O
apoptosis	O
by	O
suppressing	O
TLR4	O
signaling	O
.	O

Griffithsin	O
(	O
GRFT	O
)	O
is	O
high	O
-	O
mannose	O
oligosaccharide	O
binding	O
lectin	O
that	O
has	O
shown	O
in	O
vivo	O
broad	O
-	O
spectrum	O
activity	O
against	O
viruses	B-SPEC
including	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
1	I-SPEC
,	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
and	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
in	O
vitro	O
antiviral	O
activities	O
of	O
GRFT	O
and	O
its	O
synthetic	O
trimeric	O
tandemer	O
(	O
3mG	O
)	O
against	O
NiV	O
and	O
other	O
viruses	B-SPEC
from	O
across	O
4	O
virus	B-SPEC
families	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
as	O
a	O
model	O
to	O
study	O
EIC	O
.	O

ABSTRACT	O
:	O
The	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
)	O
continues	O
to	O
spread	O
throughout	O
the	O
country	O
,	O
and	O
the	O
prevention	O
and	O
control	O
of	O
the	O
epidemic	O
has	O
entered	O
a	O
critical	O
period	O
.	O

TITLE	O
:	O
Genomic	O
Characterization	O
and	O
Phylogenetic	O
Classification	O
of	O
Bovine	B-SPEC
Coronaviruses	O
Through	O
Whole	O
Genome	O
Sequence	O
Analysis	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	B-SPEC
)	O
is	O
zoonotically	O
transmissible	O
among	O
species	B-SPEC
,	O
since	O
BCoV	B-SPEC
-	O
like	O
viruses	B-SPEC
have	O
been	O
detected	O
in	O
wild	O
ruminants	B-SPEC
and	O
humans	B-SPEC
.	O

BCoV	O
causing	O
enteric	O
and	O
respiratory	O
disease	O
is	O
widespread	O
in	O
cattle	B-SPEC
farms	O
worldwide	O
;	O
however	O
,	O
limited	O
information	O
is	O
available	O
regarding	O
the	O
molecular	O
characterization	O
of	O
BCoV	O
because	O
of	O
its	O
large	O
genome	O
size	O
,	O
despite	O
its	O
significant	O
economic	O
impact	O
.	O

TITLE	O
:	O
Estimation	O
of	O
the	O
Transmission	O
Risk	O
of	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
Its	O
Implication	O
for	O
Public	O
Health	O
Interventions	O
.	O

We	O
assessed	O
the	O
required	O
expertise	O
and	O
capacity	O
for	O
molecular	O
detection	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
specialised	O
laboratories	O
in	O
30	O
European	O
Union	O
/	O
European	O
Economic	O
Area	O
(	O
EU	O
/	O
EEA	O
)	O
countries	O
.	O

CoV	O
infection	O
requires	O
spike	O
proteins	O
,	O
which	O
bind	O
viruses	B-SPEC
to	O
host	O
cell	O
receptors	O
and	O
catalyze	O
virus	B-SPEC
-	O
cell	O
membrane	O
fusion	O
.	O

Live	O
virus	B-SPEC
was	O
detected	O
in	O
saliva	O
by	O
viral	O
culture	O
.	O

Saliva	O
is	O
a	O
promising	O
non	O
-	O
invasive	O
specimen	O
for	O
diagnosis	O
,	O
monitoring	O
,	O
and	O
infection	O
control	O
in	O
patients	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

In	O
this	O
article	O
,	O
we	O
provide	O
a	O
preliminary	O
phylodynamic	O
and	O
phylogeographic	O
analysis	O
of	O
this	O
new	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Some	O
patients	O
with	O
positive	O
chest	O
CT	O
findings	O
may	O
present	O
with	O
negative	O
results	O
of	O
real	O
time	O
reverse	O
-	O
transcription	O
-	O
polymerase	O
chain	O
-	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
for	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

TITLE	O
:	O
[	O
Perinatal	O
and	O
neonatal	O
management	O
plan	O
for	O
prevention	O
and	O
control	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
infection	O
(	O
1st	O
Edition	O
)].	O

ABSTRACT	O
:	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
has	O
been	O
spreading	O
in	O
China	O
since	O
December	O
2019	O
.	O

TITLE	O
:	O
[	O
Management	O
plan	O
for	O
prevention	O
and	O
control	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
among	O
children	O
in	O
Xiangya	O
Hospital	O
of	O
Central	O
South	O
University	O
].	O

Anti	O
-	O
PDCoV	O
IgA	O
antibodies	O
in	O
152	O
serum	O
samples	O
and	O
65	O
milk	O
samples	O
collected	O
from	O
six	O
farms	O
that	O
had	O
experienced	O
diarrhea	O
outbreaks	O
within	O
previous	O
last	O
two	O
years	O
were	O
detected	O
by	O
this	O
assay	O
,	O
and	O
62	O
.	O
5	O
%	O
of	O
the	O
serum	O
samples	O
and	O
100	O
%	O
of	O
the	O
milk	O
samples	O
were	O
positive	O
for	O
PDCoV	O
.	O
The	O
indirect	O
ELISA	O
method	O
established	O
in	O
this	O
study	O
will	O
provide	O
a	O
convenient	O
tool	O
for	O
measurement	O
of	O
serum	O
and	O
milk	O
IgA	O
levels	O
against	O
PDCoV	O
in	O
pig	B-SPEC
herds	O
,	O
rapid	O
detection	O
of	O
PDCoV	O
infection	O
in	O
pigs	B-SPEC
,	O
and	O
evaluation	O
of	O
the	O
immunogenicity	O
of	O
vaccines	O
.	O

TITLE	O
:	O
Practical	O
recommendations	O
for	O
critical	O
care	O
and	O
anesthesiology	O
teams	O
caring	O
for	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
patients	O
.	O

TITLE	O
:	O
Straining	O
the	O
System	O
:	O
Novel	B-SPEC
Coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
and	O
Preparedness	O
for	O
Concomitant	O
Disasters	O
.	O

As	O
of	O
January	O
31	O
,	O
2020	O
,	O
CDC	O
had	O
responded	O
to	O
clinical	O
inquiries	O
from	O
public	O
health	O
officials	O
and	O
health	O
care	O
providers	O
to	O
assist	O
in	O
evaluating	O
approximately	O
650	O
persons	O
thought	O
to	O
be	O
at	O
risk	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Reanalysis	O
of	O
the	O
epidemic	O
curve	O
from	O
the	O
initial	O
cluster	O
of	O
cases	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
December	O
2019	O
indicates	O
substantial	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
six	O
of	O
the	O
20	O
patients	O
in	O
the	O
WORI	O
group	O
:	O
influenza	O
AH3	O
(	O
n	O
=	O
2	O
),	O
parainfluenza	O
virus	B-SPEC
1	O
/	O
3	O
(	O
n	O
=	O
2	O
),	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
n	O
=	O
2	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
n	O
=	O
1	O
)	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
n	O
=	O
1	O
).	O

Simultaneous	O
detection	O
of	O
two	O
viruses	B-SPEC
was	O
recorded	O
in	O
two	O
samples	O
in	O
both	O
groups	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
the	O
presence	O
of	O
common	O
respiratory	O
viruses	B-SPEC
in	O
the	O
lower	O
respiratory	O
tract	O
without	O
causing	O
symptomatic	O
infection	O
,	O
even	O
in	O
carefully	O
collected	O
lower	O
samples	O
.	O

It	O
may	O
also	O
be	O
considered	O
for	O
a	O
wider	O
range	O
of	O
coronaviruses	O
,	O
including	O
the	O
currently	O
emerging	O
novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O

The	O
manifestations	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
are	O
diverse	O
.	O

While	O
several	O
etiological	O
studies	O
have	O
begun	O
to	O
reveal	O
the	O
specific	O
biological	O
features	O
of	O
this	O
virus	B-SPEC
,	O
the	O
epidemic	O
characteristics	O
need	O
to	O
be	O
elucidated	O
.	O

TITLE	O
:	O
Novel	B-SPEC
Coronavirus	I-SPEC
Pneumonia	O
Outbreak	O
in	O
2019	O
:	O
Computed	O
Tomographic	O
Findings	O
in	O
Two	O
Cases	O
.	O

TITLE	O
:	O
Systemic	O
BK	B-SPEC
Virus	I-SPEC
Infection	O
in	O
a	O
Pediatric	O
Patient	O
With	O
Severe	O
Combined	O
Immunodeficiency	O
.	O

Analysis	O
of	O
the	O
literature	O
failed	O
to	O
show	O
any	O
previous	O
case	O
of	O
BKV	B-SPEC
pancreatitis	O
.	O

World	O
Health	O
Organization	O
(	O
WHO	O
)	O
announced	O
that	O
the	O
outbreaks	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
have	O
constituted	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
.	O

Increased	O
levels	O
of	O
IBV	B-SPEC
-	O
specific	O
antibodies	O
were	O
detected	O
in	O
the	O
serum	O
of	O
the	O
rH120	O
-	O
S1	O
/	O
YZ	O
-	O
vaccinated	O
animals	B-SPEC
14	O
days	O
post	O
-	O
vaccination	O
.	O

With	O
high	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
rate	O
(	O
R0	O
),	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
has	O
quickly	O
spread	O
in	O
China	O
and	O
other	O
countries	O
,	O
resulting	O
in	O
34	O
,	O
953	O
confirmed	O
cases	O
and	O
725	O
deaths	O
as	O
of	O
8	O
February	O
2020	O
,	O
thus	O
calling	O
for	O
urgent	O
development	O
of	O
therapeutics	O
and	O
prophylactics	O
.	O

SIGNIFICANCE	O
AND	O
IMPACT	O
OF	O
THE	O
STUDY	O
:	O
The	O
noncoding	O
upstream	O
and	O
downstream	O
flanks	O
of	O
coronavirus	B-SPEC
genomes	O
allow	O
for	O
rapid	O
classification	O
of	O
novel	O
Betacoronavirus	B-SPEC
species	B-SPEC
and	O
correct	O
identification	O
of	O
genetic	O
relationships	O
.	O

Although	O
bats	B-SPEC
are	O
the	O
likely	O
natural	O
host	O
of	O
2019_nCoV	O
,	O
the	O
exact	O
bat	B-SPEC
species	B-SPEC
that	O
serves	O
as	O
the	O
natural	O
host	O
of	O
the	O
virus	B-SPEC
remains	O
as	O
yet	O
unknown	O
.	O

Chinese	O
bat	B-SPEC
species	B-SPEC
with	O
commercial	O
value	O
were	O
identified	O
as	O
natural	O
reservoirs	O
of	O
coronaviruses	O
and	O
are	O
used	O
in	O
Traditional	O
Chinese	O
Medicine	O
.	O

Animal	B-SPEC
studies	O
have	O
shown	O
that	O
RAS	O
inhibitors	O
could	O
effectively	O
relieve	O
symptoms	O
of	O
acute	O
severe	O
pneumonia	O
and	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Unveiling	O
patterns	O
of	O
viral	O
pathogen	O
infection	O
in	O
free	O
-	O
ranging	O
carnivores	B-SPEC
of	O
northern	O
Portugal	O
using	O
a	O
complementary	O
methodological	O
approach	O
.	O

Our	O
study	O
identified	O
CPV	B-SPEC
DNA	O
in	O
all	O
carnivore	O
species	B-SPEC
with	O
an	O
overall	O
prevalence	O
of	O
91	O
.	O
9	O
%.	O

Long	O
non	O
-	O
coding	O
RNAs	O
(	O
lncRNAs	O
)	O
are	O
known	O
to	O
be	O
important	O
regulators	O
during	O
virus	B-SPEC
infection	O
.	O

Our	O
study	O
indicates	O
that	O
samples	O
incubated	O
with	O
NT	O
particles	O
had	O
detectable	O
levels	O
of	O
infectious	O
VEEV	B-SPEC
in	O
blood	O
equal	O
to	O
or	O
greater	O
than	O
samples	O
without	O
NT	O
treatment	O
across	O
all	O
temperatures	O
.	O

ABSTRACT	O
:	O
The	O
epidemiological	O
history	O
and	O
clinical	O
characteristics	O
of	O
7	O
cases	O
of	O
COVID	O
-	O
19	O
and	O
1	O
case	O
of	O
close	O
contact	O
in	O
the	O
first	O
family	B-SPEC
aggregation	O
epidemic	O
of	O
COVID	O
-	O
19	O
in	O
Gansu	O
Province	O
were	O
analyzed	O
.	O

We	O
evaluated	O
the	O
performance	O
of	O
a	O
PEDV	B-SPEC
imaging	O
cytometry	O
-	O
based	O
high	O
-	O
throughput	O
neutralization	O
test	O
(	O
HTNT	O
)	O
and	O
compared	O
the	O
HTNT	O
to	O
a	O
fluorescent	O
focus	O
neutralization	O
(	O
FFN	O
)	O
assay	O
using	O
serum	O
samples	O
from	O
pigs	B-SPEC
of	O
known	O
PEDV	B-SPEC
infection	O
status	O
(	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
an	O
acute	O
,	O
highly	O
infectious	O
and	O
contagious	O
viral	O
disease	O
of	O
chickens	B-SPEC
caused	O
by	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
belonging	O
to	O
the	O
genus	B-SPEC
Coronavirus	B-SPEC
and	O
family	B-SPEC
Coronaviridae	I-SPEC
.	O

An	O
in	O
ovo	B-SPEC
model	O
was	O
employed	O
to	O
study	O
the	O
antiviral	O
activity	O
of	O
TLR	O
ligands	O
(	O
Pam3CSK4	O
,	O
LPS	O
and	O
CpG	O
ODN	O
)	O
on	O
replication	O
of	O
IBV	B-SPEC
.	O

A	O
total	O
of	O
7	O
trials	O
enrolling	O
1598	O
patients	O
were	O
finally	O
included	O
in	O
this	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
epidemiological	O
evidence	O
has	O
shown	O
a	O
potential	O
transmission	O
of	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
during	O
the	O
incubation	O
period	O
.	O

TITLE	O
:	O
Fatal	O
encephalitis	O
associated	O
with	O
coronavirus	B-SPEC
OC43	O
in	O
an	O
immunocompromised	O
child	O
.	O

ABSTRACT	O
:	O
A	O
child	O
with	O
pre	O
-	O
B	O
acute	O
lymphoblastic	O
leukaemia	O
(	O
ALL	O
)	O
developed	O
fatal	O
encephalitis	O
associated	O
with	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
).	O

During	O
chemotherapy	O
the	O
child	O
had	O
a	O
persistent	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
respiratory	O
infection	O
and	O
later	O
developed	O
progressive	O
encephalitis	O
.	O

Strengthened	O
surveillance	O
was	O
implemented	O
in	O
France	O
on	O
10	O
January	O
2020	O
in	O
order	B-SPEC
to	O
identify	O
imported	O
cases	O
early	O
and	O
prevent	O
secondary	O
transmission	O
.	O

TITLE	O
:	O
Outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
):	O
What	O
is	O
the	O
role	O
of	O
radiologists	O
?	O

TITLE	O
:	O
Important	O
roles	O
of	O
dietary	O
taurine	O
,	O
creatine	O
,	O
carnosine	O
,	O
anserine	O
and	O
4	O
-	O
hydroxyproline	O
in	O
human	B-SPEC
nutrition	O
and	O
health	O
.	O

TITLE	O
:	O
2019	B-SPEC
Novel	I-SPEC
coronavirus	I-SPEC
:	O
where	O
we	O
are	O
and	O
what	O
we	O
know	O
.	O

ABSTRACT	O
:	O
This	O
guideline	O
is	O
applicable	O
to	O
the	O
health	O
protection	O
requirements	O
of	O
large	O
indoor	O
stadiums	O
which	O
are	O
reconstructed	O
as	O
treatment	O
sites	O
for	O
the	O
Novel	B-SPEC
Coronavirus	I-SPEC
Pneumonia	O
(	O
NPC	O
)	O
patients	O
with	O
mild	O
symptoms	O
during	O
the	O
outbreak	O
.	O

TITLE	O
:	O
Antibodies	O
to	O
coronaviruses	O
are	O
higher	O
in	O
older	O
compared	O
with	O
younger	O
adults	O
and	O
binding	O
antibodies	O
are	O
more	O
sensitive	O
than	O
neutralizing	O
antibodies	O
in	O
identifying	O
coronavirus	B-SPEC
-	O
associated	O
illnesses	O
.	O

ABSTRACT	O
:	O
This	O
is	O
the	O
third	O
epidemiological	O
report	O
for	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
previously	O
known	O
as	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
from	O
the	O
virus	B-SPEC
now	O
known	O
as	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
reported	O
in	O
Australia	O
as	O
at	O
19	O
:	O
00	O
Australian	O
Eastern	O
Daylight	O
Time	O
[	O
AEDT	O
]	O
15	O
February	O
2020	O
.	O

Diagnostic	O
systems	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
were	O
developed	O
with	O
urgency	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
)	O
has	O
become	O
a	O
public	O
health	O
emergency	O
in	O
China	O
.	O

ABSTRACT	O
:	O
The	O
exported	O
cases	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
infection	O
that	O
were	O
confirmed	O
outside	O
China	O
provide	O
an	O
opportunity	O
to	O
estimate	O
the	O
cumulative	O
incidence	O
and	O
confirmed	O
case	O
fatality	O
risk	O
(	O
cCFR	O
)	O
in	O
mainland	O
China	O
.	O

Here	O
we	O
found	O
that	O
treating	O
the	O
patients	O
diagnosed	O
as	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
with	O
chloroquine	O
might	O
improve	O
the	O
success	O
rate	O
of	O
treatment	O
,	O
shorten	O
hospital	O
stay	O
and	O
improve	O
patient	O
outcome	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
clinical	O
characteristics	O
of	O
patients	O
in	O
Zhejiang	O
province	O
,	O
China	O
,	O
infected	O
with	O
the	O
2019	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
responsible	O
for	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
covid	O
-	O
2019	O
).	O

We	O
also	O
provide	O
biophysical	O
and	O
structural	O
evidence	O
that	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
S	O
protein	O
binds	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
with	O
higher	O
affinity	O
than	O
does	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
S	O
.	O
Additionally	O
,	O
we	O
tested	O
several	O
published	O
SARS	O
-	O
CoV	O
RBD	O
-	O
specific	O
monoclonal	O
antibodies	O
and	O
found	O
that	O
they	O
do	O
not	O
have	O
appreciable	O
binding	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
S	O
,	O
suggesting	O
that	O
antibody	O
cross	O
-	O
reactivity	O
may	O
be	O
limited	O
between	O
the	O
two	O
RBDs	O
.	O

Electronic	O
medical	O
records	O
including	O
demographics	O
,	O
clinical	O
manifestation	O
,	O
comorbidities	O
,	O
laboratory	O
data	O
,	O
and	O
radiological	O
materials	O
of	O
140	O
hospitalized	O
COVID	O
-	O
19	O
patients	O
,	O
with	O
confirmed	O
result	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
viral	O
infection	O
,	O
were	O
extracted	O
and	O
analyzed	O
.	O

Detailed	O
clinical	O
investigation	O
of	O
140	O
hospitalized	O
COVID	O
-	O
19	O
cases	O
suggests	O
eosinopenia	O
together	O
with	O
lymphopenia	O
may	O
be	O
a	O
potential	O
indicator	B-SPEC
for	O
diagnosis	O
.	O

Moreover	O
,	O
it	O
is	O
necessary	O
to	O
carry	O
out	O
meticulous	O
and	O
individualized	O
clinical	O
management	O
for	O
lung	O
cancer	B-SPEC
patients	O
to	O
effectively	O
protect	O
the	O
patients	O
from	O
COVID	O
-	O
19	O
.	O

ABSTRACT	O
:	O
Influenza	O
-	O
related	O
severe	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
severe	O
threats	O
to	O
human	B-SPEC
health	O
.	O

The	O
meta	B-SPEC
-	O
analysis	O
results	O
showed	O
that	O
corticosteroid	O
therapy	O
was	O
associated	O
with	O
significantly	O
higher	O
mortality	O
(	O
OR	O
1	O
.	O
53	O
,	O
95	O
%	O
CI	O
[	O
1	O
.	O
16	O
,	O
2	O
.	O
01	O
])	O
and	O
incidence	O
of	O
nosocomial	O
infection	O
(	O
OR	O
3	O
.	O
15	O
,	O
95	O
%	O
CI	O
[	O
1	O
.	O
54	O
,	O
6	O
.	O
45	O
]).	O

Finally	O
,	O
antibodies	O
and	O
small	O
molecular	O
inhibitors	O
that	O
can	O
block	O
the	O
interaction	O
of	O
ACE2	O
with	O
RBD	O
should	O
be	O
developed	O
to	O
combat	O
the	O
virus	B-SPEC
.	O

However	O
,	O
public	O
health	O
authorities	O
should	O
keep	O
monitoring	O
the	O
situation	O
closely	O
,	O
as	O
the	O
more	O
we	O
can	O
learn	O
about	O
this	O
novel	O
virus	B-SPEC
and	O
its	O
associated	O
outbreak	O
,	O
the	O
better	O
we	O
can	O
respond	O
.	O

ABSTRACT	O
:	O
Last	O
December	O
2019	O
,	O
a	O
new	O
virus	B-SPEC
,	O
named	O
novel	B-SPEC
Coronavirus	I-SPEC
(	O
COVID	O
-	O
2019	O
)	O
causing	O
many	O
cases	O
of	O
severe	O
pneumonia	O
was	O
reported	O
in	O
Wuhan	O
,	O
China	O
.	O

The	O
Open	O
Reading	O
Frame	O
1ab	O
(	O
ORF1ab	O
)	O
of	O
COVID	O
-	O
2019	O
has	O
been	O
analyzed	O
to	O
evidence	O
the	O
presence	O
of	O
mutation	O
caused	O
by	O
selective	O
pressure	O
on	O
the	O
virus	B-SPEC
.	O

Position	O
723	O
in	O
the	O
COVID	O
-	O
2019	O
has	O
a	O
serine	O
instead	O
a	O
glycine	B-SPEC
residue	O
,	O
while	O
at	O
aminoacidic	O
position	O
1010	O
a	O
proline	O
instead	O
an	O
isoleucine	O
.	O

The	O
positive	O
selective	O
pressure	O
could	O
account	O
for	O
some	O
clinical	O
features	O
of	O
this	O
virus	B-SPEC
compared	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Bat	B-SPEC
SARS	O
-	O
like	O
CoV	O
.	O
The	O
stabilizing	O
mutation	O
falling	O
in	O
the	O
endosome	O
-	O
associated	O
-	O
protein	O
-	O
like	O
domain	O
of	O
the	O
nsp2	O
protein	O
could	O
account	O
for	O
COVID	O
-	O
2019	O
high	O
ability	O
of	O
contagious	O
,	O
while	O
the	O
destabilizing	O
mutation	O
in	O
nsp3	O
proteins	O
could	O
suggest	O
a	O
potential	O
mechanism	O
differentiating	O
COVID	O
-	O
2019	O
from	O
SARS	O
.	O

Here	O
,	O
we	O
analyzed	O
processing	O
of	O
the	O
coronavirus	B-SPEC
nsp7	O
-	O
10	O
region	O
using	O
native	O
mass	O
spectrometry	O
showing	O
consumption	O
of	O
substrate	O
,	O
rise	O
and	O
fall	O
of	O
intermediate	O
products	O
and	O
complexation	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
continues	O
to	O
cause	O
frequent	O
outbreaks	O
in	O
hospitals	O
in	O
Saudi	O
Arabia	O
.	O

The	O
ability	O
of	O
the	O
virus	B-SPEC
to	O
cause	O
severe	O
disease	O
or	O
death	O
was	O
the	O
most	O
frequently	O
reported	O
reason	O
for	O
worry	O
by	O
physicians	O
(	O
89	O
.	O
7	O
%)	O
and	O
non	O
-	O
physicians	O
(	O
87	O
.	O
2	O
%).	O

TITLE	O
:	O
[	O
Thinking	O
of	O
treatment	O
strategies	O
for	O
colorectal	O
cancer	B-SPEC
patients	O
in	O
tumor	O
hospitals	O
under	O
the	O
background	O
of	O
coronavirus	B-SPEC
pneumonia	O
].	O

The	O
current	O
situation	O
of	O
prevention	O
and	O
control	O
of	O
new	O
coronavirus	B-SPEC
pneumonia	O
is	O
severe	O
.	O

Referring	O
to	O
the	O
""""	O
Diagnosis	O
and	O
Treatment	O
Scheme	O
for	O
NCP	O
(	O
Trial	O
Version	O
4	O
and	O
5	O
")"""	O
and	O
combining	O
the	O
actual	O
practice	O
situation	O
in	O
our	O
hospital	O
with	O
the	O
""""	O
Summary	O
of	O
New	O
Coronavirus	B-SPEC
Files	O
of	O
Shanghai	O
Renji	O
Hospital	O
""","	O
we	O
summarize	O
how	O
to	O
carry	O
out	O
the	O
clinical	O
practice	O
of	O
colorectal	O
surgery	O
under	O
the	O
situation	O
of	O
the	O
prevention	O
and	O
control	O
of	O
the	O
NCP	O
epidemiology	O
,	O
meanwhile	O
under	O
such	O
situation	O
aiming	O
the	O
procedure	O
of	O
diagnose	O
and	O
treatment	O
for	O
emergency	O
patients	O
with	O
colorectal	O
tumor	O
,	O
we	O
share	O
the	O
experiences	O
of	O
the	O
diagnosis	O
of	O
colorectal	O
tumor	O
,	O
the	O
management	O
of	O
patients	O
with	O
colorectal	O
cancer	B-SPEC
who	O
are	O
scheduled	O
to	O
be	O
admitted	O
for	O
surgery	O
,	O
the	O
protection	O
of	O
wards	O
,	O
the	O
perioperative	O
management	O
.	O

Is	O
there	O
an	O
intermediate	O
animal	B-SPEC
reservoir	O
?	O

Here	O
,	O
we	O
systematically	O
investigated	O
the	O
role	O
of	O
trypsin	O
in	O
PDCoV	O
replication	O
including	O
cell	O
entry	O
,	O
cell	O
-	O
to	O
-	O
cell	O
membrane	O
fusion	O
and	O
virus	B-SPEC
release	O
.	O

Furthermore	O
,	O
unlike	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
in	O
which	O
trypsin	O
is	O
important	O
for	O
the	O
release	O
of	O
virus	B-SPEC
from	O
infected	O
cells	O
,	O
PDCoV	O
release	O
was	O
not	O
affected	O
by	O
trypsin	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
case	O
of	O
Chlamydia	B-SPEC
abortus	I-SPEC
in	O
a	O
woman	O
in	O
rural	O
France	O
who	O
was	O
pregnant	O
,	O
developed	O
severe	O
generalized	O
infection	O
,	O
and	O
suffered	O
fetal	O
loss	O
.	O

TITLE	O
:	O
Chest	O
CT	O
Findings	O
in	O
Patients	O
with	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
and	O
its	O
Relationship	O
with	O
Clinical	O
Features	O
.	O

TITLE	O
:	O
Sepsis	B-SPEC
Management	O
in	O
Resource	O
-	O
limited	O
Settings	O
ABSTRACT	O
:	O
In	O
this	O
chapter	O
we	O
discuss	O
recommendations	O
on	O
the	O
identification	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
indications	O
for	O
mechanical	O
ventilation	O
,	O
and	O
strategies	O
for	O
lung	O
-	O
protective	O
ventilation	O
in	O
resource	O
-	O
limited	O
settings	O
.	O

ABSTRACT	O
:	O
COVID	O
-	O
19	O
is	O
a	O
viral	O
respiratory	O
illness	O
caused	O
by	O
a	O
new	O
coronavirus	B-SPEC
called	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

The	O
World	O
Health	O
Organization	O
declared	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
outbreak	O
a	O
global	O
public	O
health	O
emergency	O
.	O

This	O
issue	O
has	O
rapidly	O
reviewed	O
and	O
published	O
articles	O
describing	O
COVID	O
-	O
19	O
,	O
including	O
the	O
drug	O
treatment	O
options	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
its	O
clinical	O
characteristics	O
,	O
and	O
therapies	O
involving	O
a	O
combination	O
of	O
Chinese	O
and	O
Western	O
medicine	O
,	O
the	O
efficacy	O
of	O
chloroquine	O
phosphate	O
in	O
the	O
treatment	O
of	O
COVID	O
-	O
19	O
associated	O
pneumonia	O
according	O
to	O
clinical	O
studies	O
,	O
and	O
reflections	O
on	O
the	O
system	O
of	O
reserve	O
medical	O
supplies	O
for	O
public	O
health	O
emergencies	O
.	O

TITLE	O
:	O
Risk	O
Assessment	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
COVID	O
-	O
19	O
Outbreaks	O
Outside	O
China	O
.	O

RDV	B-SPEC
is	O
a	O
nucleotide	O
analog	O
inhibitor	O
of	O
RNA	O
-	O
dependent	O
RNA	O
polymerases	O
(	O
RdRps	O
).	O

Unfortunately	O
,	O
there	O
are	O
few	O
tools	O
available	O
to	O
functionally	O
test	O
these	O
viruses	B-SPEC
for	O
their	O
ability	O
to	O
infect	O
humans	B-SPEC
,	O
which	O
has	O
severely	O
hampered	O
efforts	O
to	O
predict	O
the	O
next	O
zoonotic	O
viral	O
outbreak	O
.	O

Here	O
,	O
we	O
developed	O
an	O
approach	O
to	O
rapidly	O
screen	O
lineage	O
B	O
betacoronaviruses	O
,	O
such	O
as	O
SARS	O
-	O
CoV	O
and	O
the	O
recent	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
for	O
receptor	O
usage	O
and	O
their	O
ability	O
to	O
infect	O
cell	O
types	O
from	O
different	O
species	B-SPEC
.	O

We	O
show	O
that	O
host	O
protease	O
processing	O
during	O
viral	O
entry	O
is	O
a	O
significant	O
barrier	O
for	O
several	O
lineage	O
B	O
viruses	B-SPEC
and	O
that	O
bypassing	O
this	O
barrier	O
allows	O
several	O
lineage	O
B	O
viruses	B-SPEC
to	O
enter	O
human	B-SPEC
cells	O
through	O
an	O
unknown	O
receptor	O
.	O

TITLE	O
:	O
[	O
The	O
treatment	O
proposal	O
for	O
the	O
patients	O
with	O
breast	O
diseases	O
in	O
the	O
central	O
epidemic	O
area	O
of	O
2019	O
coronavirus	B-SPEC
disease	O
].	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
occurred	O
in	O
Wuhan	O
,	O
Hubei	O
province	O
of	O
China	O
,	O
at	O
the	O
end	O
of	O
2019	O
,	O
and	O
spread	O
rapidly	O
across	O
the	O
country	O
.	O

AVNP2	O
inactivates	O
viruses	B-SPEC
,	O
such	O
as	O
the	O
H1N1	O
and	O
H5N1influenza	O
viruses	B-SPEC
and	O
even	O
the	O
SARS	O
coronavirus	B-SPEC
,	O
while	O
it	O
inhibits	O
bacteria	B-SPEC
,	O
such	O
as	O
MRSA	O
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

The	O
decreased	O
expression	O
of	O
inflammatory	O
factors	O
(	O
IL	O
-	O
1	O
,	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
	O
)	O
by	O
Western	O
blotting	O
assay	O
and	O
ELISA	O
,	O
angiogenesis	O
protein	O
(	O
VEGF	O
)	O
by	O
Western	O
blotting	O
assay	O
and	O
other	O
related	O
proteins	O
(	O
BDNF	O
,	O
NF	O
-	O
B	O
,	O
iNOS	O
and	O
COX	O
-	O
2	O
)	O
by	O
Western	O
blotting	O
assay	O
in	O
peri	O
-	O
tumour	O
tissue	O
indicated	O
that	O
AVNP2	O
could	O
control	O
tumour	O
-	O
associated	O
inflammation	O
,	O
thus	O
efficiently	O
ameliorating	O
the	O
local	O
inflammatory	O
condition	O
and	O
,	O
to	O
some	O
extent	O
,	O
inhibiting	O
angiogenesis	O
in	O
C6	O
-	O
bearing	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
being	O
highly	O
virulent	O
and	O
contagious	O
in	O
piglets	O
,	O
has	O
caused	O
significant	O
damage	O
to	O
the	O
pork	O
industries	O
of	O
many	O
countries	O
worldwide	O
.	O

Due	O
to	O
the	O
increasing	O
number	O
of	O
cases	O
in	O
China	O
and	O
outside	O
China	O
,	O
the	O
WHO	O
declared	O
coronavirus	B-SPEC
as	O
a	O
global	O
health	O
emergency	O
.	O

As	O
the	O
virus	B-SPEC
is	O
a	O
newly	O
emerging	O
pathogen	O
,	O
many	O
questions	O
remain	O
unanswered	O
regarding	O
the	O
virus	B-SPEC
'	O
s	O
reservoirs	O
,	O
pathogenesis	O
,	O
transmissibility	O
,	O
and	O
much	O
more	O
is	O
unknown	O
.	O

The	O
collaborative	O
efforts	O
of	O
researchers	O
are	O
needed	O
to	O
fill	O
the	O
knowledge	O
gaps	O
about	O
this	O
new	O
virus	B-SPEC
,	O
to	O
develop	O
the	O
proper	O
diagnostic	O
tools	O
,	O
and	O
effective	O
treatment	O
to	O
combat	O
this	O
infection	O
.	O

This	O
virus	B-SPEC
causes	O
acute	O
lung	O
symptoms	O
,	O
leading	O
to	O
a	O
condition	O
that	O
has	O
been	O
named	O
as	O
""""	O
coronavirus	B-SPEC
disease	O
2019	O
""""	O
(	O
COVID	O
-	O
19	O
).	O

TITLE	O
:	O
[	O
What	O
are	O
the	O
highlights	O
of	O
""""	O
Diagnosis	O
and	O
treatment	O
of	O
Disease	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
infection	O
suitable	O
for	O
Military	O
support	O
Hubei	O
medical	O
team	O
"""]."	O

This	O
article	O
will	O
make	O
a	O
proper	O
interpretation	O
in	O
order	B-SPEC
to	O
understand	O
the	O
guideline	O
better	O
and	O
help	O
guide	O
the	O
diagnosis	O
and	O
treatment	O
of	O
diseases	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
assess	O
the	O
presence	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
tears	O
and	O
conjunctival	O
secretions	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
-	O
infected	O
patients	O
.	O

TITLE	O
:	O
Composition	O
and	O
divergence	O
of	O
coronavirus	B-SPEC
spike	O
proteins	O
and	O
host	O
ACE2	O
receptors	O
predict	O
potential	O
intermediate	O
hosts	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

However	O
,	O
the	O
intermediate	O
host	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
is	O
still	O
unclear	O
.	O

TITLE	O
:	O
[	O
Health	O
management	O
of	O
breast	O
cancer	B-SPEC
patients	O
outside	O
the	O
hospital	O
during	O
the	O
outbreak	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
].	O

The	O
breast	O
cancer	B-SPEC
patients	O
should	O
synthetically	O
consider	O
the	O
epidemic	O
prevention	O
situation	O
of	O
inhabitance	O
,	O
the	O
disease	O
stage	O
and	O
previous	O
therapeutic	O
schedule	O
to	O
decide	O
the	O
next	O
therapeutic	O
schedule	O
.	O

TITLE	O
:	O
Correlation	O
of	O
Chest	O
CT	O
and	O
RT	O
-	O
PCR	O
Testing	O
in	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
China	O
:	O
A	O
Report	O
of	O
1014	O
Cases	O
.	O

TITLE	O
:	O
Assessing	O
the	O
Impact	O
of	O
Reduced	O
Travel	O
on	O
Exportation	O
Dynamics	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
Infection	O
(	O
COVID	O
-	O
19	O
).	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
is	O
a	O
highly	O
contagious	O
disease	O
.	O

ABSTRACT	O
:	O
An	O
ongoing	O
outbreak	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
in	O
Wuhan	O
,	O
China	O
since	O
December	O
2019	O
has	O
led	O
to	O
31	O
,	O
516	O
infected	O
persons	O
and	O
638	O
deaths	O
across	O
25	O
countries	O
(	O
till	O
16	O
:	O
00	O
on	O
February	O
7	O
,	O
2020	O
).	O

Moreover	O
,	O
by	O
linking	O
seamlessly	O
with	O
related	O
databases	O
in	O
CNCB	O
/	O
NGDC	O
,	O
2019nCoVR	O
offers	O
virus	B-SPEC
data	O
submission	O
and	O
sharing	O
services	O
for	O
raw	O
sequence	O
reads	O
and	O
assembled	O
sequences	O
.	O

Although	O
the	O
virus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
nucleic	O
acid	O
RT	O
-	O
PCR	O
test	O
has	O
become	O
the	O
standard	O
method	O
for	O
diagnosis	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
,	O
these	O
real	O
-	O
time	O
PCR	O
test	O
kits	O
have	O
many	O
limitations	O
.	O

SARS	O
-	O
CoV	O
and	O
MERSCoV	O
are	O
particularly	O
pathogenic	O
in	O
humans	B-SPEC
and	O
are	O
associated	O
with	O
high	O
mortality	O
.	O

Esophageal	O
cancer	B-SPEC
is	O
a	O
common	O
malignant	O
tumor	O
in	O
China	O
and	O
most	O
of	O
the	O
patients	O
are	O
in	O
the	O
middle	O
and	O
advanced	O
stage	O
when	O
diagnosed	O
,	O
with	O
immunosuppressive	O
and	O
poor	O
prognosis	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
and	O
Pregnancy	O
:	O
What	O
obstetricians	O
need	O
to	O
know	O
.	O

Although	O
these	O
measures	O
might	O
not	O
prevent	O
widespread	O
transmission	O
of	O
the	O
virus	B-SPEC
in	O
the	O
United	O
States	O
,	O
they	O
are	O
being	O
implemented	O
to	O
1	O
)	O
slow	O
the	O
spread	O
of	O
illness	O
;	O
2	O
)	O
provide	O
time	O
to	O
better	O
prepare	O
state	O
and	O
local	O
health	O
departments	O
,	O
health	O
care	O
systems	O
,	O
businesses	O
,	O
educational	O
organizations	O
,	O
and	O
the	O
general	O
public	O
in	O
the	O
event	O
that	O
widespread	O
transmission	O
occurs	O
;	O
and	O
3	O
)	O
better	O
characterize	O
COVID	O
-	O
19	O
to	O
guide	O
public	O
health	O
recommendations	O
and	O
the	O
development	O
and	O
deployment	O
of	O
medical	O
countermeasures	O
,	O
including	O
diagnostics	O
,	O
therapeutics	O
,	O
and	O
vaccines	O
.	O

As	O
more	O
is	O
learned	O
about	O
this	O
novel	O
virus	B-SPEC
and	O
this	O
outbreak	O
,	O
CDC	O
will	O
rapidly	O
incorporate	O
new	O
knowledge	O
into	O
guidance	O
for	O
action	O
by	O
CDC	O
,	O
state	O
and	O
local	O
health	O
departments	O
,	O
health	O
care	O
providers	O
,	O
and	O
communities	O
.	O

TITLE	O
:	O
Preliminary	O
Identification	O
of	O
Potential	O
Vaccine	O
Targets	O
for	O
the	O
COVID	O
-	O
19	O
Coronavirus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
Based	O
on	O
SARS	O
-	O
CoV	O
Immunological	O
Studies	O
.	O

We	O
aimed	O
to	O
report	O
the	O
imaging	O
and	O
clinical	O
characteristics	O
of	O
these	O
patients	O
infected	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
Guangzhou	O
,	O
China	O
.	O

Several	O
studies	O
on	O
the	O
clinical	O
characteristics	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
were	O
collected	O
for	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
was	O
0	O
.	O
148	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
046	O
,	O
0	O
.	O
296	O
),	O
the	O
incidence	O
of	O
abnormal	O
chest	O
computer	O
tomography	O
(	O
CT	O
)	O
was	O
0	O
.	O
966	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
921	O
,	O
0	O
.	O
993	O
),	O
the	O
percentage	O
of	O
severe	O
cases	O
in	O
all	O
infected	O
cases	O
was	O
0	O
.	O
181	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
127	O
,	O
0	O
.	O
243	O
),	O
and	O
the	O
case	O
fatality	O
rate	O
of	O
patients	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
was	O
0	O
.	O
043	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
027	O
,	O
0	O
.	O
061	O
).	O

TITLE	O
:	O
Clinical	O
trial	O
analysis	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
therapy	O
registered	O
in	O
China	O
.	O

Genetically	O
,	O
it	O
is	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
The	O
situation	O
is	O
getting	O
worse	O
and	O
worse	O
,	O
therefore	O
,	O
there	O
is	O
an	O
urgent	O
need	O
for	O
designing	O
a	O
suitable	O
peptide	O
vaccine	O
component	O
against	O
the	O
SARS	B-SPEC
-	I-SPEC
COV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

TITLE	O
:	O
[	O
Treatment	O
strategies	O
of	O
Budd	O
-	O
Chiari	O
syndrome	O
during	O
the	O
epidemic	O
period	O
of	O
2019	O
coronavirus	B-SPEC
disease	O
].	O

ABSTRACT	O
:	O
We	O
aimed	O
to	O
report	O
the	O
clinical	O
characteristics	O
of	O
imported	O
coronavirus	B-SPEC
disease	O
-	O
19	O
(	O
COVID	O
-	O
19	O
)	O
in	O
Jiangsu	O
Province	O
.	O

The	O
ongoing	O
outbreak	O
presents	O
a	O
challenge	O
for	O
modelers	O
,	O
as	O
limited	O
data	O
are	O
available	O
on	O
the	O
early	O
growth	O
trajectory	O
,	O
and	O
the	O
epidemiological	O
characteristics	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
are	O
yet	O
to	O
be	O
fully	O
elucidated	O
.	O

TITLE	O
:	O
Potential	O
Rapid	O
Diagnostics	O
,	O
Vaccine	O
and	O
Therapeutics	O
for	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
):	O

TITLE	O
:	O
[	O
Recommendations	O
for	O
the	O
regulation	O
of	O
medical	O
practices	O
of	O
burn	O
treatment	O
during	O
the	O
outbreak	O
of	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
].	O

ABSTRACT	O
:	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
is	O
one	O
of	O
the	O
beta	O
coronaviruses	O
and	O
was	O
identified	O
as	O
the	O
pathogen	O
of	O
the	O
severe	O
""""	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
")"""	O
in	O
2019	O
.	O

China	O
has	O
formally	O
included	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
the	O
statutory	O
notification	O
and	O
control	O
system	O
for	O
infectious	O
diseases	O
according	O
to	O
the	O

The	O
virus	B-SPEC
was	O
named	O
as	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
by	O
International	O
Committee	O
on	O
Taxonomy	O
of	O
Viruses	B-SPEC
on	O
11	O
February	O
,	O
2020	O
.	O

TITLE	O
:	O
A	O
Well	O
Infant	O
with	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
with	O
High	O
Viral	O
Load	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
zoonotic	O
disease	O
.	O

Furthermore	O
,	O
spatial	O
correlations	O
between	O
MERS	O
-	O
CoV	O
cases	O
and	O
camel	B-SPEC
sex	O
,	O
age	O
and	O
dairy	O
status	O
were	O
significant	O
.	O

ABSTRACT	O
:	O
The	O
December	O
,	O
2019	O
coronavirus	B-SPEC
disease	O
outbreak	O
has	O
seen	O
many	O
countries	O
ask	O
people	O
who	O
have	O
potentially	O
come	O
into	O
contact	O
with	O
the	O
infection	O
to	O
isolate	O
themselves	O
at	O
home	O
or	O
in	O
a	O
dedicated	O
quarantine	O
facility	O
.	O

The	O
follow	O
-	O
up	O
with	O
chest	O
X	O
-	O
Rays	B-SPEC
and	O
CT	O
scans	O
was	O
also	O
included	O
,	O
showing	O
a	O
progressive	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

A	O
novel	B-SPEC
coronavirus	I-SPEC
was	O
identified	O
as	O
the	O
causative	O
agent	O
and	O
was	O
subsequently	O
termed	O
COVID	O
-	O
19	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
).	O

Considered	O
a	O
relative	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
COVID	O
-	O
19	O
is	O
caused	O
by	O
a	O
betacoronavirus	B-SPEC
named	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
that	O
affects	O
the	O
lower	O
respiratory	O
tract	O
and	O
manifests	O
as	O
pneumonia	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
First	O
case	O
of	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
pneumonia	O
in	O
Taiwan	O
.	O

TITLE	O
:	O
In	O
silico	O
screening	O
of	O
Chinese	O
herbal	O
medicines	O
with	O
the	O
potential	O
to	O
directly	O
inhibit	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
.	O

Of	O
the	O
natural	O
compounds	O
screened	O
,	O
13	O
that	O
exist	O
in	O
traditional	O
Chinese	O
medicines	O
were	O
also	O
found	O
to	O
have	O
potential	O
anti	O
-	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
activity	O
.	O

TITLE	O
:	O
Corona	B-SPEC
Virus	B-SPEC
International	O
Public	O
Health	O
Emergencies	O
:	O
Implications	O
for	O
Radiology	O
Management	O
.	O

There	O
is	O
currently	O
a	O
lack	O
of	O
pathologic	O
data	O
on	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
)	O
pneumonia	O
,	O
or	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
from	O
autopsy	O
or	O
biopsy	O
.	O

ABSTRACT	O
:	O
An	O
ongoing	O
outbreak	O
of	O
severe	O
respiratory	O
pneumonia	O
associated	O
with	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
has	O
recently	O
emerged	O
in	O
China	O
.	O

The	O
treatment	O
strategy	O
for	O
children	O
with	O
Coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
is	O
based	O
on	O
adult	O
experience	O
.	O

ABSTRACT	O
:	O
The	O
2019	O
Coronavirus	B-SPEC
epidemic	O
,	O
provisionally	O
called	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
was	O
first	O
identified	O
in	O
Wuhan	O
,	O
China	O
,	O
in	O
persons	O
exposed	O
to	O
a	O
seafood	O
or	O
wet	O
market	O
.	O

Using	O
data	O
obtained	O
from	O
similar	O
coronaviruses	O
,	O
e	O
.	O
g	O
.	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
experts	O
are	O
confident	O
that	O
70	O
%	O
ethanol	O
and	O
0	O
.	O
1	O
%	O
sodium	O
hypochlorite	O
should	O
inactivate	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Novel	O
Insights	O
Into	O
Immune	O
Systems	O
of	O
Bats	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
originating	O
in	O
Wuhan	O
,	O
China	O
presents	O
a	O
potential	O
respiratory	O
viral	O
pandemic	O
to	O
the	O
world	O
population	O
.	O

Ultimately	O
,	O
the	O
outbreak	O
could	O
be	O
controlled	O
with	O
a	O
protective	O
vaccine	O
to	O
prevent	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
clinical	O
and	O
CT	O
features	O
associated	O
with	O
severe	O
and	O
critical	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
pneumonia	O
.	O

TITLE	O
:	O
Eco	O
-	O
Virological	O
Preliminary	O
Study	O
of	O
Potentially	O
Emerging	O
Pathogens	O
in	O
Hedgehogs	B-SPEC
(	O
ABSTRACT	O
:	O
The	O
Western	B-SPEC
European	I-SPEC
Hedgehog	I-SPEC
(	O

First	O
,	O
for	O
administrative	O
control	O
,	O
in	O
order	B-SPEC
to	O
lower	O
patient	O
attendance	O
,	O
text	O
messages	O
with	O
an	O
enquiry	O
phone	O
number	O
were	O
sent	O
to	O
patients	O
to	O
reschedule	O
appointments	O
or	O
arrange	O
drug	O
refill	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
an	O
effort	O
to	O
compile	O
and	O
analyze	O
epidemiological	O
outbreak	O
information	O
on	O
COVID	O
-	O
19	O
based	O
on	O
the	O
several	O
open	O
datasets	O
on	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
provided	O
by	O
the	O
Johns	O
Hopkins	O
University	O
,	O
World	O
Health	O
Organization	O
,	O
Chinese	O
Center	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
National	O
Health	O
Commission	O
,	O
and	O
DXY	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
has	O
become	O
a	O
public	O
health	O
emergency	O
of	O
major	O
international	O
concern	O
.	O

When	O
changed	O
from	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
to	O
APRV	O
,	O
there	O
was	O
an	O
expected	O
increase	O
in	O
the	O
SpO	O
The	O
results	O
of	O
this	O
study	O
support	O
the	O
hypothesis	O
that	O
APRV	O
may	O
offer	O
potential	O
clinical	O
advantages	O
for	O
ventilatory	O
management	O
and	O
may	O
be	O
considered	O
as	O
an	O
alternative	O
rescue	O
mechanical	O
ventilation	O
mode	O
in	O
pediatric	O
ARDS	O
patients	O
refractory	O
to	O
conventional	O
ventilation	O
.	O

TITLE	O
:	O
Differential	O
diagnosis	O
of	O
illness	O
in	O
patients	O
under	O
investigation	O
for	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
Italy	O
,	O
February	O
2020	O
.	O

TITLE	O
:	O
Angiotensin	O
receptor	O
blockers	O
as	O
tentative	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
therapeutics	O
.	O

Moreover	O
,	O
vaccines	O
based	O
on	O
viral	O
-	O
encoded	O
peptides	O
may	O
not	O
be	O
effective	O
against	O
future	O
coronavirus	B-SPEC
epidemics	O
,	O
as	O
virus	B-SPEC
mutations	O
could	O
make	O
them	O
futile	O
.	O

The	O
median	O
number	O
of	O
intra	O
-	O
host	O
variants	O
was	O
1	O
-	O
4	O
in	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infected	O
patients	O
,	O
which	O
ranged	O
between	O
0	O
and	O
51	O
in	O
different	O
samples	O
.	O

RESULTS	O
:	O
From	O
day	O
1	O
to	O
day	O
42	O
,	O
forty	O
-	O
two	O
(	O
3	O
.	O
3	O
%)	O
of	O
1275	O
patients	O
fulfilling	O
active	O
(	O
n	O
=	O
29	O
)	O
and	O
enhanced	O
laboratory	O
surveillance	O
(	O
n	O
=	O
13	O
)	O
confirmed	O
to	O
have	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
.	O

The	O
emergence	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
2019	O
in	O
Wuhan	O
,	O
China	O
marked	O
the	O
third	O
highly	O
pathogenic	O
coronavirus	B-SPEC
infecting	O
humans	B-SPEC
in	O
the	O
21st	O
century	O
.	O

In	O
this	O
study	O
,	O
we	O
review	O
observational	O
clinical	O
data	O
linking	O
development	O
of	O
CMV	B-SPEC
reactivation	O
with	O
worse	O
outcomes	O
in	O
patients	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
discuss	O
potential	O
biologically	O
plausible	O
mechanisms	O
for	O
a	O
causal	O
association	O
,	O
and	O
summarize	O
results	O
of	O
initial	O
interventional	O
trials	O
that	O
examined	O
the	O
effects	O
of	O
CMV	B-SPEC
prevention	O
.	O

ABSTRACT	O
:	O
In	O
late	O
December	O
,	O
2019	O
,	O
an	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
in	O
Wuhan	O
,	O
China	O
was	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
newly	O
named	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

TITLE	O
:	O
COVID	O
-	O
19	O
(	O
Novel	B-SPEC
Coronavirus	I-SPEC
2019	O
)	O
-	O
recent	O
trends	O
.	O

This	O
study	O
aimed	O
at	O
investigating	O
the	O
global	O
prevalence	O
,	O
biological	O
and	O
clinical	O
characteristics	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
Wuhan	O
China	O
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
outbreaks	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Disease	O
2019	O
outbreak	O
:	O
preparedness	O
and	O
readiness	O
of	O
countries	O
in	O
the	O
Eastern	O
Mediterranean	O
Region	O
.	O

The	O
feature	O
of	O
high	O
infectiousness	O
for	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
led	O
to	O
an	O
upward	O
trend	O
,	O
and	O
government	O
measures	O
contributed	O
to	O
the	O
temporary	O
rebound	O
and	O
declines	O
.	O

A	O
cluster	O
tree	O
was	O
developed	O
from	O
the	O
profiles	O
retrieved	O
from	O
the	O
presence	O
and	O
absence	O
of	O
homologs	O
of	O
ten	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
proteins	O
.	O

The	O
phylogenetic	O
profiling	O
cluster	O
of	O
homolog	O
proteins	O
of	O
one	O
annotated	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
protein	O
against	O
other	O
genome	O
sequences	O
revealed	O
two	O
clades	O
of	O
ten	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
proteins	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
are	O
RNA	O
viruses	B-SPEC
that	O
have	O
become	O
a	O
major	O
public	O
health	O
concern	O
since	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
-	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
outbreak	O
in	O
2002	O
.	O

Their	O
social	O
characteristics	O
include	O
nuclear	O
family	B-SPEC
migration	O
(	O
84	O
%),	O
migration	O
with	O
families	O
of	O
3	O
-	O
4	O
members	O
(	O
71	O
%),	O
a	O
rural	O
household	O
registration	O
(	O
85	O
%),	O
and	O
working	O
or	O
doing	O
business	O
(	O
84	O
%)	O
as	O
the	O
main	O
reason	O
for	O
migration	O
.	O

While	O
human	B-SPEC
strains	O
of	O
Coronavirus	B-SPEC
are	O
associated	O
with	O
about	O
15	O
%	O
of	O
cases	O
of	O
the	O
common	O
cold	O
,	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
may	O
present	O
with	O
varying	O
degrees	O
of	O
severity	O
,	O
from	O
flu	O
-	O
like	O
symptoms	O
to	O
death	O
.	O

The	O
costs	O
of	O
the	O
epidemic	O
are	O
not	O
limited	O
to	O
medical	O
aspects	O
,	O
as	O
the	O
virus	B-SPEC
has	O
led	O
to	O
significant	O
sociological	O
,	O
psychological	O
and	O
economic	O
effects	O
globally	O
.	O

TITLE	O
:	O
The	O
Novel	B-SPEC
Coronavirus	I-SPEC
-	O
A	O
Snapshot	O
of	O
Current	O
Knowledge	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
lethal	O
zoonotic	O
pathogen	O
that	O
was	O
first	O
identified	O
in	O
humans	B-SPEC
in	O
Saudi	O
Arabia	O
and	O
Jordan	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
The	O
ongoing	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
,	O
emerged	O
in	O
Wuhan	O
,	O
China	O
in	O
the	O
end	O
of	O
2019	O
,	O
has	O
claimed	O
more	O
than	O
2600	O
lives	O
as	O
of	O
24	O
February	O
2020	O
and	O
posed	O
a	O
huge	O
threat	O
to	O
global	O
public	O
health	O
.	O

Here	O
,	O
we	O
determined	O
the	O
seroepidemiological	O
situation	O
of	O
the	O
MERS	O
-	O
CoV	O
in	O
imported	O
camels	B-SPEC
and	O
their	O
traders	O
in	O
Upper	O
Egypt	O
.	O

These	O
results	O
highlighted	O
the	O
importance	O
of	O
close	O
contact	O
tracing	O
and	O
longitudinally	O
surveillance	O
via	O
virus	B-SPEC
nucleic	O
acid	O
tests	O
.	O

ABSTRACT	O
:	O
Recent	O
publications	O
have	O
brought	O
attention	O
to	O
the	O
possible	O
benefit	O
of	O
chloroquine	O
,	O
a	O
broadly	O
used	O
antimalarial	O
drug	O
,	O
in	O
the	O
treatment	O
of	O
patients	O
infected	O
by	O
the	O
novel	O
emerged	O
coronavirus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

ABSTRACT	O
:	O
The	O
following	O
trends	O
emerged	O
in	O
international	O
critical	O
care	O
practice	O
in	O
2019	O
:	O
increasing	O
analysis	O
to	O
phenotypes	O
of	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
increasing	O
evidences	O
of	O
early	O
initiating	O
of	O
vasopressors	O
and	O
antibiotics	O
for	O
septic	O
shock	O
,	O
also	O
including	O
the	O
early	O
furosemide	O
stress	O
test	O
for	O
critically	O
ill	O
patients	O
with	O
acute	O
kidney	O
injury	O
(	O
AKI	O
).	O

A	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
related	O
pangolin	O
coronavirus	B-SPEC
GX_P2V	O
/	O
pangolin	O
/	O
2017	O
/	O
Guangxi	O
was	O
described	O
.	O

The	O
pangolin	O
coronavirus	B-SPEC
model	O
was	O
used	O
to	O
identify	O
drug	O
candidates	O
for	O
treating	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

The	O
virus	B-SPEC
has	O
since	O
rapidly	O
spread	O
to	O
all	O
provinces	O
and	O
autonomous	O
regions	O
of	O
China	O
,	O
and	O
to	O
countries	O
outside	O
of	O
China	O
.	O

The	O
effectiveness	O
of	O
adjunctive	O
glucocorticoid	O
therapy	O
uses	O
in	O
the	O
management	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infected	O
patients	O
with	O
severe	O
lower	O
respiratory	O
tract	O
infections	O
is	O
not	O
clear	O
,	O
and	O
warrants	O
further	O
investigation	O
.	O

Oral	O
and	O
parenteral	O
glucocorticoids	O
have	O
been	O
used	O
in	O
the	O
management	O
of	O
severe	O
respiratory	O
symptoms	O
in	O
coronavirus	B-SPEC
-	O
infected	O
patients	O
in	O
the	O
past	O
.	O

On	O
February	O
11	O
,	O
2020	O
,	O
the	O
WHO	O
Director	O
-	O
General	O
,	O
Dr	O
.	O
Tedros	O
Adhanom	O
Ghebreyesus	O
,	O
announced	O
that	O
the	O
disease	O
caused	O
by	O
this	O
new	O
CoV	O
was	O
a	O
""""	O
COVID	O
-	O
19	O
","""	O
which	O
is	O
the	O
acronym	O
of	O
""""	O
coronavirus	B-SPEC
disease	O
2019	O
"""."	O

TITLE	O
:	O
Detection	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
by	O
RT	O
-	O
PCR	O
in	O
Stool	O
Specimen	O
from	O
Asymptomatic	O
Child	O
,	O
China	O
.	O

The	O
child	O
was	O
virus	B-SPEC
positive	O
in	O
stool	O
specimens	O
for	O
at	O
least	O
an	O
additional	O
9	O
days	O
.	O

TITLE	O
:	O
In	O
Vitro	O
Antiviral	O
Activity	O
and	O
Projection	O
of	O
Optimized	O
Dosing	O
Design	O
of	O
Hydroxychloroquine	O
for	O
the	O
Treatment	O
of	O
Severe	B-SPEC
Acute	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

Persons	O
with	O
confirmed	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
outside	O
Hubei	O
province	O
,	O
China	O
.	O

Evidence	O
of	O
intrauterine	O
vertical	O
transmission	O
was	O
assessed	O
by	O
testing	O
for	O
the	O
presence	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
amniotic	O
fluid	O
,	O
cord	O
blood	O
,	O
and	O
neonatal	O
throat	O
swab	O
samples	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
is	O
a	O
single	O
-	O
stranded	O
RNA	O
coronavirus	B-SPEC
that	O
causes	O
nervous	O
dysfunction	O
in	O
the	O
infected	O
hosts	O
and	O
leads	O
to	O
widespread	O
alterations	O
in	O
the	O
host	O
transcriptome	O
by	O
modulating	O
specific	O
microRNA	O
(	O
miRNA	O
)	O
levels	O
.	O

Pharyngeal	O
swab	O
specimens	O
were	O
collected	O
from	O
9	O
of	O
the	O
10	O
neonates	O
1	O
to	O
9	O
days	O
after	O
birth	O
for	O
nucleic	O
acid	O
amplification	O
tests	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
all	O
of	O
which	O
showed	O
negative	O
results	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
there	O
has	O
been	O
an	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
in	O
China	O
.	O

Two	O
cases	O
of	O
neonates	O
with	O
positive	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
tests	O
have	O
been	O
reported	O
.	O

Recent	O
studies	O
(	O
Huang	O
et	O
al	O
.,	O
Chan	O
et	O
al	O
.,	O
and	O
Zhou	O
et	O
al	O
.)	O
have	O
provided	O
timely	O
insights	O
into	O
its	O
origin	O
and	O
ability	O
to	O
spread	O
among	O
humans	B-SPEC
,	O
informing	O
infection	O
prevention	O
and	O
control	O
practices	O
.	O

More	O
critically	O
,	O
there	O
have	O
been	O
reports	O
about	O
the	O
possibility	O
of	O
this	O
virus	B-SPEC
to	O
transmit	O
even	O
before	O
a	O
virus	B-SPEC
-	O
carrying	O
person	O
to	O
show	O
symptoms	O
.	O

We	O
evaluated	O
the	O
performance	O
of	O
a	O
molecular	O
assay	O
for	O
the	O
detection	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
on	O
a	O
high	O
-	O
throughput	O
platform	O
,	O
the	O
cobas	O
6800	O
,	O
using	O
the	O
'	O
open	O
channel	O
'	O
for	O
integration	O
of	O
a	O
laboratory	O
-	O
developed	O
assay	O
.	O

TITLE	O
:	O
Rapid	O
establishment	O
of	O
laboratory	O
diagnostics	O
for	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
Bavaria	O
,	O
Germany	O
,	O
February	O
2020	O
.	O

ABSTRACT	O
:	O
There	O
'	O
s	O
an	O
outbreak	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
since	O
December	O
2019	O
,	O
first	O
in	O
China	O
,	O
and	O
currently	O
with	O
more	O
than	O
80	O
thousand	O
confirmed	O
infection	O
globally	O
in	O
29	O
countries	O
till	O
March	O
2	O
,	O
2020	O
.	O

Identification	O
,	O
isolation	O
and	O
caring	O
for	O
patients	O
early	O
are	O
essential	O
to	O
limit	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
including	O
reducing	O
secondary	O
infections	O
among	O
close	O
contacts	O
and	O
health	O
care	O
workers	O
,	O
preventing	O
transmission	O
amplification	O
events	O
.	O

CONCLUSIONS	O
:	O
The	O
new	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
epidemic	O
is	O
mainly	O
associated	O
with	O
respiratory	O
disease	O
and	O
few	O
extrapulmonary	O
signs	O
.	O

Despite	O
the	O
given	O
treatment	O
,	O
her	O
body	O
temperature	O
rose	B-SPEC
to	O
39	O
.	O
2	O
	O
C	O
and	O
she	O
was	O
referred	O
to	O
our	O
clinic	O
for	O
further	O
evaluation	O
.	O

TITLE	O
:	O
Identification	O
of	O
coronavirus	B-SPEC
sequences	O
in	O
carp	B-SPEC
cDNA	O
from	O
Wuhan	O
,	O
China	O
.	O

We	O
isolated	O
virus	B-SPEC
from	O
nasopharyngeal	O
and	O
oropharyngeal	O
specimens	O
from	O
this	O
patient	O
and	O
characterized	O
the	O
viral	O
sequence	O
,	O
replication	O
properties	O
,	O
and	O
cell	O
culture	O
tropism	O
.	O

We	O
also	O
deposited	O
the	O
virus	B-SPEC
into	O
2	O
virus	B-SPEC
repositories	O
,	O
making	O
it	O
broadly	O
available	O
to	O
the	O
public	O
health	O
and	O
research	O
communities	O
.	O

ABSTRACT	O
:	O
Approximately	O
60	O
%	O
of	O
all	O
human	B-SPEC
pathogens	O
and	O
75	O
%	O
of	O
emerging	O
infectious	O
diseases	O
are	O
zoonotic	O
(	O
of	O
animal	B-SPEC
origin	O
).	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
OC43	O
and	O
other	O
respiratory	O
viruses	B-SPEC
from	O
acute	O
respiratory	O
infections	O
of	O
Egyptian	O
children	O
.	O

ABSTRACT	O
:	O
We	O
need	O
to	O
understand	O
and	O
quantify	O
the	O
dominant	O
variables	O
that	O
govern	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
outbreak	O
,	O
rather	O
than	O
relying	O
exclusively	O
on	O
confirmed	O
cases	O
and	O
their	O
geospatial	O
spread	O
.	O

CONCLUSIONS	O
:	O
The	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
caused	O
similar	O
onsets	O
to	O
other	O
pneumonias	O
.	O

TITLE	O
:	O
Rapid	O
Identification	O
of	O
Potential	O
Inhibitors	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
Main	O
Protease	O
by	O
Deep	O
Docking	O
of	O
1	O
.	O
3	O
Billion	O
Compounds	O
.	O

How	O
Is	O
the	O
World	O
Responding	O
to	O
the	O
2019	O
Coronavirus	B-SPEC
Disease	O
Compared	O
with	O
the	O
2014	O
West	O
African	O
Ebola	O
Epidemic	O
?	O

TITLE	O
:	O
Possible	O
therapeutic	O
role	O
of	O
a	O
highly	O
standardized	O
mixture	O
of	O
active	O
compounds	O
derived	O
from	O
cultured	O
Lentinula	B-SPEC
edodes	I-SPEC
mycelia	O
(	O
AHCC	O
)	O
in	O
patients	O
infected	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
.	O

Our	O
study	O
focused	O
on	O
the	O
detection	O
and	O
molecular	O
characterization	O
of	O
pCCoV	O
strains	O
circulating	O
in	O
Italy	O
during	O
the	O
period	O
2014	O
-	O
2017	O
in	O
autochthonous	O
dogs	B-SPEC
,	O
in	O
dogs	B-SPEC
imported	O
from	O
eastern	O
Europe	O
or	O
illegally	O
imported	O
from	O
an	O
unknown	O
country	O
.	O

TITLE	O
:	O
Estimating	O
the	O
reproductive	O
number	O
and	O
the	O
outbreak	O
size	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
using	O
mathematical	O
model	O
in	O
Republic	O
of	O
Korea	O
.	O

ABSTRACT	O
:	O
Mass	O
gathering	O
(	O
MG	O
)	O
medicine	O
emerged	O
against	O
the	O
backdrop	O
of	O
the	O
2009	O
pandemic	O
H1N1	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
(	O
PHEIC	O
)	O
when	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
)	O
hosted	O
the	O
largest	O
annual	O
mass	O
gathering	O
of	O
over	O
3	O
million	O
pilgrims	O
from	O
180	O
plus	O
countries	O
.	O

Interview	O
transcripts	O
were	O
coded	O
using	O
an	O
inductive	O
qualitative	O
content	O
analysis	O
method	O
,	O
specifically	O
focusing	O
on	O
recommendations	O
from	O
participants	O
on	O
how	O
to	O
improve	O
risk	O
communication	O
to	O
family	B-SPEC
physicians	O
in	O
the	O
event	O
of	O
a	O
future	O
public	O
health	O
crisis	O
.	O

These	O
included	O
having	O
a	O
single	O
trusted	O
source	O
of	O
information	O
;	O
having	O
timely	O
and	O
succinct	O
communication	O
;	O
having	O
consideration	O
for	O
learners	O
;	O
ensuring	O
access	O
to	O
information	O
for	O
all	O
physicians	O
;	O
improving	O
public	O
health	O
and	O
family	B-SPEC
medicine	O
collaboration	O
;	O
having	O
crisis	O
information	O
for	O
patients	O
;	O
and	O
creating	O
communication	O
infrastructure	O
before	O
a	O
crisis	O
occurs	O
.	O

TITLE	O
:	O
Enhanced	O
isolation	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
by	O
TMPRSS2	O
-	O
expressing	O
cells	O
.	O

Here	O
,	O
we	O
show	O
that	O
a	O
TMPRSS2	O
-	O
expressing	O
VeroE6	O
cell	O
line	O
is	O
highly	O
susceptible	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
,	O
making	O
it	O
useful	O
for	O
isolating	O
and	O
propagating	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
There	O
is	O
a	O
new	O
public	O
health	O
crises	O
threatening	O
the	O
world	O
with	O
the	O
emergence	O
and	O
spread	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
or	O
the	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

Diagnosis	O
is	O
by	O
demonstration	O
of	O
the	O
virus	B-SPEC
in	O
respiratory	O
secretions	O
by	O
special	O
molecular	O
tests	O
.	O

TITLE	O
:	O
Soluble	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
:	O
a	O
potential	O
approach	O
for	O
coronavirus	B-SPEC
infection	O
therapy	O
?	O

In	O
this	O
short	O
communication	O
,	O
we	O
performed	O
phylogenetic	O
-	O
structural	O
sequence	O
analysis	O
of	O
pp1ab	O
protein	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

The	O
analysis	O
showed	O
that	O
the	O
viral	O
pp1ab	O
has	O
not	O
changed	O
in	O
most	O
isolates	O
throughout	O
the	O
outbreak	O
time	O
,	O
but	O
interestingly	O
a	O
deletion	O
of	O
8	O
aa	O
in	O
the	O
virulence	O
factor	O
nonstructural	O
protein	O
1	O
was	O
found	O
in	O
a	O
virus	B-SPEC
isolated	O
from	O
a	O
Japanese	O
patient	O
that	O
did	O
not	O
display	O
critical	O
symptoms	O
.	O

TITLE	O
:	O
The	O
potential	O
chemical	O
structure	O
of	O
anti	O
-	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
.	O

Establishment	O
of	O
the	O
reference	O
sequence	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
could	O
benefit	O
not	O
only	O
biological	O
study	O
of	O
this	O
virus	B-SPEC
but	O
also	O
diagnosis	O
,	O
clinical	O
monitoring	O
and	O
intervention	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
in	O
the	O
future	O
.	O

TITLE	O
:	O
Risk	O
Factors	O
Associated	O
With	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
and	O
Death	O
in	O
Patients	O
With	O
Coronavirus	B-SPEC
Disease	O
2019	O
Pneumonia	O
in	O
Wuhan	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
that	O
was	O
first	O
reported	O
in	O
Wuhan	O
,	O
China	O
,	O
and	O
has	O
subsequently	O
spread	O
worldwide	O
.	O

As	O
we	O
are	O
in	O
the	O
midst	O
of	O
an	O
ongoing	O
pandemic	O
of	O
COVID	O
-	O
19	O
,	O
scientists	O
are	O
struggling	O
to	O
understand	O
how	O
it	O
resembles	O
and	O
differs	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
at	O
the	O
genomic	O
and	O
transcriptomic	O
level	O
.	O

ABSTRACT	O
:	O
In	O
light	O
of	O
the	O
emergence	O
of	O
the	O
new	O
coronavirus	B-SPEC
in	O
China	O
,	O
Emeritus	O
Professor	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
when	O
the	O
first	O
case	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
was	O
identified	O
in	O
the	O
city	O
of	O
Wuhan	O
in	O
the	O
Hubei	O
Province	O
of	O
China	O
,	O
the	O
epidemic	O
has	O
generated	O
tens	O
of	O
thousands	O
of	O
cases	O
throughout	O
China	O
.	O

TITLE	O
:	O
Bacteriophage	B-SPEC
Based	O
Biosensors	O
:	O
Trends	O
,	O
Outcomes	O
and	O
Challenges	O
.	O

The	O
docking	O
pose	O
revealed	O
the	O
involvement	O
of	O
the	O
SBD	O
of	O
GRP78	O
and	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
the	O
coronavirus	B-SPEC
spike	O
protein	O
in	O
recognition	O
of	O
the	O
host	O
cell	O
receptor	O
.	O

Our	O
results	O
show	O
that	O
the	O
daily	O
risk	O
of	O
exporting	O
at	O
least	O
a	O
single	O
SARS	B-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
case	O
from	O
mainland	O
China	O
via	O
international	O
travel	O
exceeded	O
95	O
%	O
on	O
January	O
13	O
,	O
2020	O
.	O

Through	O
scRNA	O
-	O
seq	O
data	O
analyses	O
,	O
we	O
identified	O
the	O
organs	O
at	O
risk	O
,	O
such	O
as	O
lung	O
,	O
heart	O
,	O
esophagus	O
,	O
kidney	O
,	O
bladder	O
,	O
and	O
ileum	O
,	O
and	O
located	O
specific	O
cell	O
types	O
(	O
i	O
.	O
e	O
.,	O
type	O
II	O
alveolar	O
cells	O
(	O
AT2	O
),	O
myocardial	O
cells	O
,	O
proximal	O
tubule	O
cells	O
of	O
the	O
kidney	O
,	O
ileum	O
and	O
esophagus	O
epithelial	O
cells	O
,	O
and	O
bladder	O
urothelial	O
cells	O
),	O
which	O
are	O
vulnerable	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

This	O
study	O
may	O
provide	O
potential	O
clues	O
for	O
further	O
investigation	O
of	O
the	O
pathogenesis	O
and	O
route	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Health	O
professions	O
preventing	O
and	O
controlling	O
Coronavirus	B-SPEC
Disease	O
2019	O
are	O
prone	O
to	O
skin	O
and	O
mucous	O
membrane	O
injury	O
,	O
which	O
may	O
cause	O
acute	O
and	O
chronic	O
dermatitis	O
,	O
secondary	O
infection	O
and	O
aggravation	O
of	O
underlying	O
skin	O
diseases	O
.	O

Median	O
duration	O
of	O
viral	O
shedding	O
was	O
20	O
	O
0	O
days	O
(	O
IQR	O
17	O
	O
0	O
-	O
24	O
	O
0	O
)	O
in	O
survivors	O
,	O
but	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
was	O
detectable	O
until	O
death	O
in	O
non	O
-	O
survivors	O
.	O

It	O
is	O
now	O
the	O
critical	O
stage	O
to	O
fight	O
against	O
the	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
-	O
19	O
(	O
COVI	O
-	O
19	O
)	O
involves	O
humans	B-SPEC
as	O
well	O
as	O
animals	B-SPEC
and	O
may	O
cause	O
serious	O
damage	O
to	O
the	O
respiratory	O
tract	O
,	O
including	O
the	O
lung	O
:	O
coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
).	O

TITLE	O
:	O
An	O
update	O
on	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
outbreak	O
.	O

To	O
analyze	O
the	O
clinical	O
characteristics	O
of	O
elderly	O
patients	O
with	O
new	O
-	O
type	O
coronavirus	B-SPEC
pneumonia	O
(	O
COVID	O
-	O
19	O
).	O

The	O
estimated	O
median	O
duration	O
of	O
fever	O
in	O
all	O
the	O
patients	O
with	O
fever	O
was	O
10	O
days	O
(	O
95	O
confidential	O
intervals	O
[	O
CIs	B-SPEC
]:	O
8	O
-	O
11	O
days	O
)	O
after	O
onset	O
of	O
symptoms	O
.	O

After	O
14	O
days	O
,	O
15	O
(	O
94	O
%)	O
of	O
16	O
and	O
9	O
(	O
52	O
	O
9	O
%)	O
of	O
17	O
,	O
respectively	O
,	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
could	O
not	O
be	O
detected	O
(	O
p	O
<	O
0	O
	O
05	O
).	O

ABSTRACT	O
:	O
Since	O
January	O
23rd	O
2020	O
,	O
stringent	O
measures	O
for	O
controlling	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
epidemics	O
have	O
been	O
gradually	O
enforced	O
and	O
strengthened	O
in	O
mainland	O
China	O
.	O

Most	O
infected	O
cases	O
have	O
been	O
quarantined	O
or	O
put	O
in	O
suspected	O
class	B-SPEC
,	O
which	O
has	O
been	O
ignored	O
in	O
existing	O
models	O
.	O

TITLE	O
:	O
Equine	B-SPEC
Coronavirus	B-SPEC
-	O
Associated	O
Colitis	O
in	O
Horses	B-SPEC
:	O
A	O
Retrospective	O
Study	O
.	O

Although	O
there	O
are	O
multiple	O
reports	O
of	O
ECoV	O
outbreaks	O
,	O
less	O
is	O
known	O
about	O
the	O
clinical	O
presentation	O
of	O
individual	O
horses	B-SPEC
during	O
a	O
nonoutbreak	O
situation	O
.	O

Interestingly	O
,	O
4	O
of	O
5	O
horses	B-SPEC
had	O
moderate	O
to	O
severe	O
diarrhea	O
,	O
3	O
had	O
abnormal	O
large	O
colon	O
ultrasonography	O
,	O
2	O
had	O
transient	O
ventricular	O
tachycardia	O
and	O
2	O
had	O
clinicopathologic	O
evidence	O
of	O
liver	O
dysfunction	O
.	O

On	O
11	O
February	O
2020	O
the	O
WHO	O
assigned	O
it	O
the	O
name	B-SPEC
of	O
SARS	O
-	O
CoV2	O
and	O
COVID	O
-	O
19	O
(	O
SARS	O
-	O
CoV2	O
and	O
COVID	O
-	O
19	O
).	O

Adults	O
represent	O
the	O
population	O
with	O
the	O
highest	O
infection	O
rate	O
;	O
however	O
,	O
neonates	O
,	O
children	O
,	O
and	O
elderly	O
patients	O
can	O
also	O
be	O
infected	O
by	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
As	O
an	O
atypical	O
pneumonia	O
began	O
to	O
appear	O
in	O
December	O
2019	O
,	O
Zhou	O
et	O
al	O
.	O
worked	O
with	O
remarkable	O
speed	O
to	O
identify	O
the	O
associated	O
virus	B-SPEC
,	O
determine	O
its	O
relationship	O
to	O
animal	B-SPEC
viruses	B-SPEC
,	O
and	O
evaluate	O
factors	O
conferring	O
infection	O
susceptibility	O
and	O
resistance	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
comorbidities	O
in	O
the	O
novel	O
Wuhan	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
infection	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
aim	O
of	O
the	O
meta	B-SPEC
-	O
analysis	O
was	O
to	O
assess	O
the	O
prevalence	O
of	O
comorbidities	O
in	O
the	O
COVID	O
-	O
19	O
infection	O
patients	O
and	O
the	O
risk	O
of	O
underlying	O
diseases	O
in	O
severe	O
patients	O
compared	O
to	O
non	O
-	O
severe	O
patients	O
.	O

RESULTS	O
:	O
Eight	O
studies	O
were	O
included	O
in	O
the	O
meta	B-SPEC
-	O
analysis	O
,	O
including	O
46248	O
infected	O
patients	O
.	O

Viral	O
load	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
radiography	O
and	O
eosinophil	O
improved	O
continuously	O
in	O
3	O
-	O
14	O
,	O
6	O
-	O
8	O
and	O
7	O
-	O
9	O
days	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)-	O
infected	O
pneumonia	O
(	O
COVID	O
-	O
19	O
)	O
occurred	O
in	O
Wuhan	O
,	O
and	O
rapidly	O
spread	O
throughout	O
China	O
.	O

ABSTRACT	O
:	O
The	O
epidemic	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
,	O
later	O
named	O
as	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
is	O
still	O
gradually	O
spreading	O
worldwide	O
.	O

Coinfection	O
with	O
SARS	B-SPEC
-	I-SPEC
COV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
other	O
viruses	B-SPEC
has	O
been	O
discussed	O
as	O
well	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
first	O
case	O
of	O
coronavirus	B-SPEC
disease19	O
(	O
COVID	O
-	O
19	O
)	O
was	O
reported	O
in	O
Wuhan	O
,	O
China	O
,	O
as	O
of	O
March	O
2	O
,	O
2020	O
,	O
the	O
total	O
number	O
of	O
confirmed	O
cases	O
of	O
COVID	O
-	O
19	O
was	O
89	O
,	O
069	O
cases	O
in	O
67	O
countries	O
and	O
regions	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
one	O
of	O
the	O
major	O
etiological	O
agents	O
of	O
viral	O
enteritis	O
and	O
fetal	O
diarrhea	O
in	O
suckling	O
piglets	O
.	O

Our	O
early	O
estimates	O
suggest	O
that	O
the	O
CFR	O
of	O
COVID	O
-	O
19	O
is	O
lower	O
than	O
the	O
previous	O
coronavirus	B-SPEC
epidemics	O
caused	O
by	O
SARS	O
-	O
CoV	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

TITLE	O
:	O
COVID	O
-	O
19	O
in	O
the	O
Shadows	O
of	O
MERS	O
-	O
CoV	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

This	O
virus	B-SPEC
causes	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
).	O

ABSTRACT	O
:	O
From	O
December	O
2019	O
to	O
February	O
2020	O
,	O
2019	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
has	O
caused	O
a	O
serious	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
Wuhan	O
,	O
China	O
.	O

These	O
43	O
persons	O
under	O
investigation	O
and	O
all	O
32	O
asymptomatic	O
health	O
-	O
care	O
personnel	O
tested	O
negative	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
spread	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
has	O
already	O
taken	O
on	O
pandemic	O
proportions	O
,	O
affecting	O
over	O
100	O
countries	O
in	O
a	O
matter	O
of	O
weeks	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
prevent	O
cross	O
-	O
infection	O
in	O
the	O
operating	O
room	O
during	O
emergency	O
procedures	O
for	O
patients	O
with	O
confirmed	O
or	O
suspected	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
by	O
following	O
anesthesia	O
management	O
protocols	O
,	O
and	O
to	O
document	O
clinical	O
-	O
and	O
anesthesia	O
-	O
related	O
characteristics	O
of	O
these	O
patients	O
.	O

TITLE	O
:	O
Composition	O
of	O
human	B-SPEC
-	O
specific	O
slow	O
codons	O
and	O
slow	O
di	O
-	O
codons	O
in	O
SARS	O
-	O
CoV	O
and	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
are	O
lower	O
than	O
other	O
coronaviruses	O
suggesting	O
a	O
faster	O
protein	O
synthesis	O
rate	O
of	O
SARS	O
-	O
CoV	O
and	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
ABSTRACT	O
:	O
Translation	O
of	O
a	O
genetic	O
codon	O
without	O
a	O
cognate	O
tRNA	O
gene	O
is	O
affected	O
by	O
both	O
the	O
cognate	O
tRNA	O
availability	O
and	O
the	O
interaction	O
with	O
non	O
-	O
cognate	O
isoacceptor	O
tRNAs	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
a	O
novel	O
infectious	O
disease	O
with	O
lack	O
of	O
established	O
laboratory	O
markers	O
available	O
to	O
evaluate	O
illness	O
severity	O
.	O

An	O
electronic	O
search	O
in	O
Medline	O
,	O
Scopus	B-SPEC
and	O
Web	O
of	O
Science	O
was	O
performed	O
to	O
identify	O
studies	O
reporting	O
data	O
on	O
platelet	O
count	O
in	O
COVID	O
-	O
19	O
patients	O
.	O

We	O
performed	O
a	O
systematic	O
literature	O
review	O
with	O
meta	B-SPEC
-	O
analysis	O
,	O
using	O
three	O
databases	O
to	O
assess	O
clinical	O
,	O
laboratory	O
,	O
imaging	O
features	O
,	O
and	O
outcomes	O
of	O
COVID	O
-	O
19	O
confirmed	O
cases	O
.	O

As	O
this	O
virus	B-SPEC
spreads	O
globally	O
,	O
countries	O
need	O
to	O
urgently	O
prepare	O
human	B-SPEC
resources	O
,	O
infrastructure	O
and	O
facilities	O
to	O
treat	O
severe	O
COVID	O
-	O
19	O
.	O

TITLE	O
:	O
Substantial	O
undocumented	O
infection	O
facilitates	O
the	O
rapid	O
dissemination	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV2	O
).	O

Here	O
we	O
report	O
that	O
GA	O
inhibits	O
Herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
by	O
inhibition	O
of	O
both	O
fusion	O
and	O
viral	O
protein	O
synthesis	O
.	O

Data	O
showing	O
inhibition	O
of	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
CMV	B-SPEC
replication	O
,	O
when	O
GA	O
is	O
administered	O
post	O
-	O
infection	O
,	O
suggest	O
a	O
possible	O
secondary	O
mechanism	O
targeting	O
protein	O
and	O
DNA	O
synthesis	O
.	O

ABSTRACT	O
:	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
originated	O
in	O
Wuhan	O

Importantly	O
,	O
and	O
similar	O
to	O
pregnancies	O
with	O
SARS	O
and	O
MERS	O
,	O
there	O
were	O
no	O
confirmed	O
cases	O
of	O
intrauterine	O
transmission	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
from	O
mothers	O
with	O
COVID	O
-	O
19	O
to	O
their	O
fetuses	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
2019	O
)	O
has	O
been	O
recognized	O
as	O
a	O
global	O
threat	O
,	O
and	O
several	O
studies	O
are	O
being	O
conducted	O
using	O
various	O
mathematical	O
models	O
to	O
predict	O
the	O
probable	O
evolution	O
of	O
this	O
epidemic	O
.	O

TITLE	O
:	O
Who	O
needs	O
a	O
Corona	B-SPEC
?	O

In	O
this	O
work	O
,	O
we	O
searched	O
the	O
homologous	O
templates	O
of	O
all	O
nonstructural	O
and	O
structural	O
proteins	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Among	O
the	O
nonstructural	O
proteins	O
,	O
the	O
leader	O
protein	O
(	O
nsp1	O
),	O
the	O
papain	O
-	O
like	O
protease	O
(	O
nsp3	O
),	O
the	O
nsp4	O
,	O
the	O
3C	O
-	O
like	O
protease	O
(	O
nsp5	O
),	O
the	O
nsp7	O
,	O
the	O
nsp8	O
,	O
the	O
nsp9	O
,	O
the	O
nsp10	O
,	O
the	O
RNA	O
-	O
directed	O
RNA	O
polymerase	O
(	O
nsp12	O
),	O
the	O
helicase	O
(	O
nsp13	O
),	O
the	O
guanine	O
-	O
N7	O
methyltransferase	O
(	O
nsp14	O
),	O
the	O
uridylate	O
-	O
specific	O
endoribonuclease	O
(	O
nsp15	O
),	O
the	O
2	O
'-	O
O	O
-	O
methyltransferase	O
(	O
nsp16	O
),	O
and	O
the	O
ORF7a	O
protein	O
could	O
be	O
built	O
on	O
the	O
basis	O
of	O
homology	O
templates	O
.	O

We	O
failed	O
to	O
identify	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
all	O
the	O
products	O
of	O
conception	O
and	O
the	O
newborns	O
.	O

The	O
application	O
of	O
the	O
model	O
is	O
illustrated	O
with	O
a	O
case	O
study	O
based	O
on	O
the	O
outbreak	O
of	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
Wuhan	O
,	O
China	O
.	O

TITLE	O
:	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
Disease	O
(	O
COVID	O
-	O
19	O
):	O
Paving	O
the	O
Road	O
for	O
Rapid	O
Detection	O
and	O
Point	O
-	O
of	O
-	O
Care	O
Diagnostics	O
.	O

ABSTRACT	O
:	O
We	O
believe	O
a	O
point	O
-	O
of	O
-	O
care	O
(	O
PoC	O
)	O
device	O
for	O
the	O
rapid	O
detection	O
of	O
the	O
2019	B-SPEC
novel	I-SPEC
Coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
is	O
crucial	O
and	O
urgently	O
needed	O
.	O

With	O
this	O
perspective	O
,	O
we	O
give	O
suggestions	O
regarding	O
a	O
potential	O
candidate	O
for	O
the	O
rapid	O
detection	O
of	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
as	O
well	O
as	O
factors	O
for	O
the	O
preparedness	O
and	O
response	O
to	O
the	O
outbreak	O
of	O
the	O
COVID	O
-	O
19	O
.	O

In	O
this	O
scoping	O
review	O
,	O
65	O
research	O
articles	O
published	O
before	O
31	O
January	O
2020	O
were	O
analyzed	O
and	O
discussed	O
to	O
better	O
understand	O
the	O
epidemiology	O
,	O
causes	O
,	O
clinical	O
diagnosis	O
,	O
prevention	O
and	O
control	O
of	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
A	O
Sequence	O
Homology	O
and	O
Bioinformatic	O
Approach	O
Can	O
Predict	O
Candidate	O
Targets	O
for	O
Immune	O
Responses	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

This	O
includes	O
SARS	O
-	O
CoV	O
,	O
which	O
has	O
high	O
sequence	O
similarity	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
is	O
the	O
best	O
-	O
characterized	O
coronavirus	B-SPEC
in	O
terms	O
of	O
epitope	O
responses	O
.	O

The	O
independent	O
identification	O
of	O
the	O
same	O
regions	O
using	O
two	O
approaches	O
reflects	O
the	O
high	O
probability	O
that	O
these	O
regions	O
are	O
promising	O
targets	O
for	O
immune	O
recognition	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

Due	O
to	O
the	O
extensive	O
spread	O
and	O
high	O
transmission	O
ability	O
of	O
the	O
COVID	O
-	O
19	O
,	O
there	O
is	O
a	O
possibility	O
of	O
virus	B-SPEC
infections	O
among	O
malaria	O
cases	O
during	O
the	O
medical	O
care	O
-	O
seeking	O
behaviors	O
and	O
among	O
healthcare	O
professionals	O
during	O
clinical	O
diagnosis	O
and	O
treatment	O
,	O
sample	O
collection	O
and	O
testing	O
and	O
epidemiological	O
surveys	O
.	O

ABSTRACT	O
:	O
Severe	O
and	O
critical	O
coronavirus	B-SPEC
pneumonia	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
often	O
occurs	O
in	O
elder	B-SPEC
patients	O
with	O
multiple	O
comorbidities	O
,	O
and	O
severe	O
hypoxemia	O
events	O
are	O
an	O
important	O
factor	O
in	O
the	O
deterioration	O
of	O
some	O
cases	O
.	O

TITLE	O
:	O
Rapidly	O
increasing	O
cumulative	O
incidence	O
of	O
coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
in	O
the	O
European	O
Union	O
/	O
European	O
Economic	O
Area	O
and	O
the	O
United	O
Kingdom	B-SPEC
,	O
1	O
January	O
to	O
15	O
March	O
2020	O
.	O

ABSTRACT	O
:	O
It	O
appears	O
inevitable	O
that	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
will	O
continue	O
to	O
spread	O
.	O

TITLE	O
:	O
Human	B-SPEC
Umbilical	O
Cord	O
-	O
Derived	O
Mesenchymal	O
Stem	O
Cells	O
for	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Scaling	O
for	O
doses	O
was	O
required	O
by	O
Taiwan	O
Food	O
and	O
Drug	O
Administration	O
as	O
follows	O
:	O
the	O
first	O
three	O
patients	O
received	O
low	O
-	O
dose	O
human	B-SPEC
umbilical	O
cord	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
(	O
1	O
.	O
0	O
	O
10	O
cells	O
/	O
kg	O
),	O
the	O
next	O
three	O
patients	O
with	O
intermediate	O
dose	O
(	O
5	O
.	O
0	O
	O
10	O
cells	O
/	O
kg	O
),	O
and	O
the	O
final	O
three	O
patients	O
with	O
high	O
dose	O
(	O
1	O
.	O
0	O
	O
10	O
cells	O
/	O
kg	O
)	O
between	O
December	O
2017	O
and	O
August	O
2019	O
.	O

Adenovirus	B-SPEC
infections	O
occur	O
mainly	O
in	O
infants	O
and	O
children	O
under	O
5	O
years	O
of	O
age	O
and	O
represent	O
2	O
to	O
5	O
%	O
of	O
respiratory	O
diseases	O
among	O
pediatric	O
patients	O
.	O

ARDS	O
is	O
a	O
serious	O
pulmonary	O
inflammatory	O
process	O
with	O
alveolar	O
damage	O
and	O
hypoxemic	O
respiratory	O
failure	O
;	O
Adenovirus	B-SPEC
pneumonia	O
in	O
children	O
may	O
manifest	O
as	O
severe	O
pulmonary	O
morbidity	O
and	O
respiratory	O
failure	O
that	O
may	O
require	O
prolonged	O
mechanical	O
ventilation	O
.	O

TITLE	O
:	O
Super	O
-	O
sensitive	O
multi	O
-	O
fluorophore	O
RNA	O
-	O
FISH	B-SPEC
for	O
early	O
virus	B-SPEC
detection	O
and	O
flow	O
-	O
FISH	B-SPEC
using	O
click	O
chemistry	O
.	O

This	O
is	O
particularly	O
needed	O
for	O
the	O
early	O
detection	O
of	O
virus	B-SPEC
infections	O
as	O
now	O
required	O
for	O
Corona	B-SPEC
diagnostic	O
.	O

This	O
review	O
sums	O
up	O
the	O
current	O
knowledge	O
on	O
the	O
virus	B-SPEC
,	O
its	O
transmission	O
and	O
its	O
worldwide	O
molecular	O
epidemiology	O
,	O
on	O
the	O
physiopathology	O
of	O
the	O
disease	O
and	O
the	O
control	O
measures	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
encode	O
multiple	O
interferon	O
antagonists	O
that	O
modulate	O
the	O
host	O
response	O
to	O
virus	B-SPEC
replication	O
.	O

We	O
used	O
transcriptomics	O
approaches	O
to	O
compare	O
the	O
scope	O
and	O
kinetics	O
of	O
the	O
host	O
response	O
to	O
the	O
wild	O
-	O
type	O
,	O
DUBmut	O
,	O
and	O
EndoUmut	O
viruses	B-SPEC
in	O
infected	O
macrophages	O
.	O

We	O
found	O
that	O
the	O
EndoUmut	O
virus	B-SPEC
activates	O
a	O
focused	O
response	O
predominantly	O
involving	O
type	O
I	O
interferons	O
and	O
interferon	O
-	O
related	O
genes	O
,	O
whereas	O
the	O
WT	O
and	O
DUBmut	O
viruses	B-SPEC
more	O
broadly	O
stimulate	O
upregulation	O
of	O
over	O
2	O
,	O
800	O
genes	O
,	O
including	O
networks	O
associated	O
with	O
activating	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
),	O
and	O
the	O
proinflammatory	O
response	O
associated	O
with	O
viral	O
pathogenesis	O
.	O

Unlike	O
other	O
acute	O
infectious	O
diseases	O
progressing	O
to	O
sepsis	B-SPEC
,	O
the	O
severe	O
courses	O
of	O
COVID19	O
seemingly	O
show	O
prolonged	O
progression	O
from	O
onset	O
of	O
first	O
symptoms	O
to	O
life	O
-	O
threatening	O
deterioration	O
of	O
(	O
primarily	O
)	O
lung	O
function	O
.	O

TITLE	O
:	O
AI	O
-	O
Driven	O
Tools	O
for	O
Coronavirus	B-SPEC
Outbreak	O
:	O
Need	O
of	O
Active	O
Learning	O
and	O
Cross	O
-	O
Population	O
Train	O
/	O
Test	O
Models	O
on	O
Multitudinal	O
/	O
Multimodal	O
Data	O
.	O

Here	O
we	O
highlight	O
nine	O
most	O
important	O
research	O
questions	O
concerning	O
virus	B-SPEC
transmission	O
,	O
asymptomatic	O
and	O
presymptomatic	O
virus	B-SPEC
shedding	O
,	O
diagnosis	O
,	O
treatment	O
,	O
vaccine	O
development	O
,	O
origin	O
of	O
virus	B-SPEC
and	O
viral	O
pathogenesis	O
.	O

Microscopic	O
examination	O
of	O
the	O
mixed	O
wheat	B-SPEC
flour	O
revealed	O
the	O
presence	O
of	O
large	O
numbers	O
of	O
live	O
dust	B-SPEC
mites	I-SPEC
.	O

TITLE	O
:	O
Transmission	O
potential	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
onboard	O
the	O
diamond	O
Princess	O
Cruises	O
Ship	O
,	O
2020	O
.	O

Our	O
phylogenetic	O
reconstructions	O
suggest	O
possible	O
multiple	O
introduction	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

TITLE	O
:	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
:	O
The	O
Identify	O
-	O
Isolate	O
-	O
Inform	O
(	O
3I	O
)	O
Tool	O
Applied	O
to	O
a	O
Novel	O
Emerging	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
closely	O
related	O
to	O
MERS	O
-	O
CoV	O
and	O
SARS	O
-	O
CoV	O
that	O
was	O
first	O
reported	O
in	O
Wuhan	O
City	O
,	O
Hubei	O
Province	O
,	O
China	O
in	O
December	O
2019	O
.	O

As	O
of	O
January	O
2020	O
,	O
cases	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
are	O
continuing	O
to	O
be	O
reported	O
in	O
other	O
Eastern	O
Asian	O
countries	O
as	O
well	O
as	O
in	O
the	O
United	O
States	O
,	O
Europe	O
,	O
Australia	O
,	O
and	O
numerous	O
other	O
countries	O
.	O

TITLE	O
:	O
COVID	O
-	O
2019	O
and	O
Pregnancy	O
:	O
A	O
plea	B-SPEC
for	O
transparent	O
reporting	O
of	O
all	O
cases	O
.	O

ABSTRACT	O
:	O
Background	O
Coronavirus	B-SPEC
disease	O
has	O
widely	O
spread	O
all	O
over	O
the	O
world	O
since	O
the	O
beginning	O
of	O
2020	O
.	O

ABSTRACT	O
:	O
Viral	O
infectivity	O
depends	O
on	O
interactions	O
between	O
components	O
of	O
the	O
host	O
cell	O
plasma	O
membrane	O
and	O
the	O
virus	B-SPEC
envelope	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
many	O
naturally	O
derived	O
substances	O
,	O
such	O
as	O
cyclodextrin	O
and	O
sterols	O
,	O
could	O
reduce	O
the	O
infectivity	O
of	O
many	O
types	O
of	O
viruses	B-SPEC
,	O
including	O
the	O
coronavirus	B-SPEC
family	B-SPEC
,	O
through	O
interference	O
with	O
lipid	O
-	O
dependent	O
attachment	O
to	O
human	B-SPEC
host	O
cells	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
was	O
first	O
reported	O
in	O
Wuhan	O
,	O
China	O
,	O
in	O
December	O
2019	O
,	O
and	O
has	O
since	O
spread	O
globally	O
,	O
resulting	O
in	O
>	O
95	O
,	O
000	O
confirmed	O
COVID	O
-	O
19	O
cases	O
worldwide	O
by	O
March	O
5	O
,	O
2020	O
(	O
1	O
).	O

The	O
World	O
Health	O
Organization	O
has	O
announced	O
a	O
pandemic	O
infection	O
with	O
an	O
unknown	O
species	B-SPEC
of	O
coronavirus	B-SPEC
called	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

Spreading	O
mainly	O
through	O
the	O
droplet	O
route	O
,	O
the	O
virus	B-SPEC
causes	O
mild	O
symptoms	O
in	O
the	O
majority	O
of	O
cases	O
,	O
the	O
most	O
common	O
being	O
:	O
fever	O
(	O
80	O
%),	O
dry	O
cough	O
(	O
56	O
%),	O
fatigue	O
(	O
22	O
%)	O
and	O
muscle	O
pain	O
(	O
7	O
%);	O
less	O
common	O
symptoms	O
include	O
a	O
sore	O
throat	O
,	O
a	O
runny	O
nose	O
,	O
diarrhea	O
,	O
hemoptysis	O
and	O
chills	O
.	O

Prolonged	O
anemia	B-SPEC
after	O
treatment	O
can	O
be	O
a	O
consequence	O
of	O
artemisine	O
usage	O
as	O
well	O
as	O
a	O
severe	O
malaria	O
sequel	O
.	O

(	O
3	O
)	O
The	O
colorectal	O
cancer	B-SPEC
patients	O
with	O
suspected	O
or	O
confirmed	O
COVID	O
-	O
19	O
should	O
be	O
placed	O
in	O
the	O
isolated	O
room	O
with	O
separate	O
medical	O
devices	O
,	O
and	O
the	O
operative	O
room	O
with	O
negative	O
pressure	O
(	O
under	O
-	O
5	O
Pa	O
)	O
must	O
be	O
separated	O
.	O

TITLE	O
:	O
[	O
Chemotherapy	O
strategy	O
for	O
colorectal	O
cancer	B-SPEC
under	O
the	O
outbreak	O
of	O
corona	B-SPEC
virus	B-SPEC
disease	O
2019	O
].	O

ABSTRACT	O
:	O
This	O
is	O
the	O
seventh	O
epidemiological	O
report	O
for	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
reported	O
in	O
Australia	O
as	O
at	O
19	O
:	O
00	O
Australian	O
Eastern	O
Daylight	O
Time	O
[	O
AEDT	O
]	O
14	O
March	O
2020	O
.	O

The	O
median	O
incubation	O
period	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
was	O
4	O
days	O
(	O
IQR	O
3	O
-	O
6	O
).	O

ABSTRACT	O
:	O
The	O
large	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
that	O
started	O
in	O
Wuhan	O
,	O
China	O
has	O
now	O
spread	O
to	O
many	O
countries	O
worldwide	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
familial	O
cluster	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
to	O
evidence	O
that	O
a	O
potential	O
transmission	O
of	O
the	O
COVID	O
-	O
19	O
during	O
the	O
incubation	O
period	O
.	O

However	O
,	O
there	O
are	O
currently	O
no	O
effective	O
drugs	O
targeting	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
/	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

This	O
work	O
aims	O
to	O
share	O
strategies	O
and	O
candidate	O
antigens	O
to	O
develop	O
safe	O
and	O
effective	O
vaccines	O
against	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

However	O
,	O
PMX	O
-	O
HP	O
has	O
seldom	O
achieved	O
expectations	O
in	O
randomized	O
trials	O
targeting	O
nonspecific	O
overall	O
sepsis	B-SPEC
patients	O
.	O

In	O
Patient	O
1	O
,	O
he	O
died	O
6	O
days	O
after	O
being	O
admitted	O
to	O
the	O
PICU	B-SPEC
on	O
the	O
28th	O
day	O
from	O
onset	O
.	O

We	O
demonstrate	O
PRESCIENT	O
'	O
s	O
ability	O
to	O
identify	O
Abs	O
that	O
neutralize	O
a	O
model	O
viral	O
agent	O
,	O
Murine	B-SPEC
coronavirus	I-SPEC
(	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
),	O
which	O
causes	O
high	O
mortality	O
rates	O
in	O
experimentally	O
infected	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
),	O
caused	O
by	O
infection	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
has	O
swept	O
across	O
31	O
provinces	O
in	O
China	O
and	O
over	O
40	O
countries	O
worldwide	O
.	O

The	O
most	O
common	O
underlying	O
disease	O
was	O
hematologic	O
malignancies	O
(	O
47	O
.	O
4	O
%),	O
followed	O
by	O
colorectal	O
cancer	B-SPEC
(	O
21	O
%)	O
and	O
lung	O
cancer	B-SPEC
(	O
15	O
.	O
8	O
%).	O

This	O
presentation	O
reviews	O
the	O
current	O
laboratory	O
methods	O
available	O
for	O
testing	O
coronaviruses	O
by	O
focusing	O
on	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
going	O
on	O
in	O
Wuhan	O
.	O

TITLE	O
:	O
Point	O
-	O
of	O
-	O
Care	O
Lung	O
Ultrasound	O
findings	O
in	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
-	O
19	O
pnemoniae	O
:	O
a	O
case	O
report	O
and	O
potential	O
applications	O
during	O
COVID	O
-	O
19	O
outbreak	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
has	O
recently	O
spread	O
worldwide	O
and	O
been	O
declared	O
a	O
pandemic	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
infection	O
emerged	O
in	O
Wuhan	O
,	O
China	O
on	O
December	O
2019	O
.	O

The	O
S1	O
protein	O
of	O
Pangolin	O
-	O
CoV	O
is	O
much	O
more	O
closely	O
related	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
than	O
to	O
RaTG13	O
.	O

ABSTRACT	O
:	O
At	O
the	O
end	O
of	O
2019	O
,	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
),	O
a	O
fast	O
-	O
spreading	O
respiratory	O
disease	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
was	O
reported	O
in	O
Wuhan	O
,	O
China	O
and	O
has	O
now	O
affected	O
over	O
123	O
countries	O
globally	O
[...].	O

On	O
January	O
7	O
,	O
2020	O
,	O
the	O
Chinese	O
authorities	O
identified	O
as	O
a	O
causative	O
agent	O
of	O
the	O
outbreak	O
a	O
new	O
type	O
of	O
virus	B-SPEC
of	O
the	O
Coronaviridiae	O
family	B-SPEC
,	O
called	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

There	O
is	O
not	O
specific	O
treatment	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
which	O
is	O
why	O
the	O
fundamental	O
aspects	O
are	O
to	O
establish	O
adequate	O
prevention	O
measures	O
and	O
support	O
treatment	O
and	O
management	O
of	O
complications	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
main	O
protease	O
provides	O
a	O
basis	O
for	O
design	O
of	O
improved	O
	O
-	O
ketoamide	O
inhibitors	O
.	O

TITLE	O
:	O
Profiling	O
Early	O
Humoral	O
Response	O
to	O
Diagnose	O
Novel	B-SPEC
Coronavirus	I-SPEC
Disease	O
(	O
COVID	O
-	O
19	O
).	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
China	O
(	O
SARS	B-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
that	O
began	O
in	O
December	O
2019	O
presents	O
a	O
significant	O
and	O
urgent	O
threat	O
to	O
global	O
health	O
.	O

Studies	O
were	O
identified	O
using	O
large	O
-	O
circulation	O
international	O
journals	O
found	O
in	O
two	O
electronic	O
databases	O
:	O
Scopus	B-SPEC
and	O
Embase	O
.	O

SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
may	O
use	O
co	O
-	O
receptors	O
/	O
auxiliary	O
proteins	O
as	O
ACE2	O
partner	O
to	O
facilitate	O
the	O
virus	B-SPEC
entry	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
causing	O
novel	B-SPEC
coronavirus	I-SPEC
-	O
infected	O
pneumonia	O
(	O
NCIP	O
),	O
has	O
affected	O
the	O
lives	O
of	O
71	O
,	O
429	O
people	O
globally	O
.	O

Angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
the	O
receptor	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
but	O
only	O
ACE2s	O
of	O
certain	O
species	B-SPEC
can	O
be	O
utilized	O
by	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
that	O
started	O
in	O
Wuhan	O
,	O
Hubei	O
province	O
,	O
China	O
in	O
December	O
2019	O
has	O
now	O
extended	O
across	O
the	O
globe	O
with	O
>	O
100	O
,	O
000	O
cases	O
and	O
3	O
,	O
000	O
deaths	O
reported	O
in	O
93	O
countries	O
as	O
of	O
7	O
March	O
2020	O
.	O

ABSTRACT	O
:	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
causes	O
the	O
recent	O
global	O
COVID	O
-	O
19	O
public	O
health	O
emergency	O
.	O

TITLE	O
:	O
What	O
needs	O
to	O
be	O
done	O
to	O
control	O
the	O
spread	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
?	O

Coronavirus	B-SPEC
(	O
CoV	O
)	O
is	O
a	O
group	O
of	O
enveloped	O
RNA	O
viruses	B-SPEC
causing	O
diseases	O
in	O
both	O
human	B-SPEC
and	O
animals	B-SPEC
.	O

The	O
structural	O
proteins	O
encounter	O
cellular	O
membranes	O
at	O
both	O
entry	O
and	O
exit	O
of	O
the	O
virus	B-SPEC
while	O
the	O
nonstructural	O
proteins	O
reorganize	O
cellular	O
membranes	O
to	O
benefit	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Although	O
initially	O
considered	O
relatively	O
harmless	O
pathogens	O
,	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
nowadays	O
known	O
to	O
be	O
associated	O
with	O
more	O
severe	O
clinical	O
complications	O
.	O

There	O
were	O
9	O
family	B-SPEC
members	O
,	O
including	O
8	O
laboratory	O
-	O
confirmed	O
with	O
COVID	O
-	O
19	O
,	O
and	O
a	O
6	O
-	O
year	O
-	O
old	O
child	O
had	O
no	O
evidence	O
of	O
infection	O
.	O

For	O
this	O
reason	O
China	O
put	O
in	O
place	O
drastic	O
containment	O
measures	O
for	O
the	O
virus	B-SPEC
spreading	O
.	O

ABSTRACT	O
:	O
In	O
December	O
,	O
2019	O
,	O
a	O
series	O
of	O
pneumonia	O
cases	O
in	O
Wuhan	O
,	O
China	O
,	O
was	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
Covid	O
-	O
19	O
)	O
[	O
1	O
-	O
2	O
],	O
has	O
become	O
a	O
global	O
health	O
concern	O
[	O
3	O
].	O

Here	O
we	O
provide	O
a	O
personal	O
viewpoint	O
representing	O
different	O
jurisdictions	O
from	O
around	O
the	O
world	O
in	O
order	B-SPEC
to	O
outline	O
the	O
impact	O
of	O
the	O
current	O
COVID	O
-	O
19	O
pandemic	O
on	O
organ	O
transplantation	O
.	O

TITLE	O
:	O
Lopinavir	O
/	O
ritonavir	O
combination	O
therapy	O
amongst	O
symptomatic	O
coronavirus	B-SPEC
disease	O
2019	O
patients	O
in	O
India	O
:	O
Protocol	O
for	O
restricted	O
public	O
health	O
emergency	O
use	O
.	O

Once	O
the	O
virus	B-SPEC
establishes	O
transmission	O
within	O
the	O
community	O
,	O
quarantine	O
of	O
symptomatics	O
may	O
have	O
a	O
meaningful	O
impact	O
on	O
disease	O
burden	O
.	O

COVID	O
-	O
19	O
is	O
among	O
a	O
family	B-SPEC
of	O
viruses	B-SPEC
-	O
called	O
coronaviruses	O
-	O
that	O
can	O
affect	O
both	O
humans	B-SPEC
and	O
animals	B-SPEC
(	O
Zhu	O
et	O
al	O
.,	O
2020	O
).	O

ABSTRACT	O
:	O
Infection	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
coronavirus	B-SPEC
,	O
and	O
the	O
disease	O
this	O
agent	O
may	O
induce	O
,	O
are	O
a	O
cause	O
of	O
notable	O
concern	O
for	O
the	O
general	O
population	O
and	O
,	O
of	O
course	O
,	O
among	O
our	O
professionals	O
and	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
has	O
posed	O
a	O
serious	O
threat	O
to	O
global	O
public	O
health	O
,	O
calling	O
for	O
the	O
development	O
of	O
safe	O
and	O
effective	O
prophylactics	O
and	O
therapeutics	O
against	O
infection	O
of	O
its	O
causative	O
agent	O
,	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
also	O
known	O
as	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

SARS	O
-	O
CoV	O
RBD	O
-	O
specific	O
antibodies	O
could	O
cross	O
-	O
react	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
RBD	O
protein	O
,	O
and	O
SARS	O
-	O
CoV	O
RBD	O
-	O
induced	O
antisera	O
could	O
cross	O
-	O
neutralize	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
suggesting	O
the	O
potential	O
to	O
develop	O
SARS	O
-	O
CoV	O
RBD	O
-	O
based	O
vaccines	O
for	O
prevention	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
COVID	O
-	O
19	O
(	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
)	O
has	O
significantly	O
resulted	O
in	O
a	O
large	O
number	O
of	O
psychological	O
consequences	O
.	O

ABSTRACT	O
:	O
This	O
article	O
reports	O
the	O
diagnosis	O
and	O
treatment	O
of	O
twin	O
girls	O
who	O
were	O
diagnosed	O
with	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
in	O
Hunan	O
Province	O
,	O
China	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Disease	O
(	O
COVID	O
-	O
19	O
):	O
Spectrum	O
of	O
CT	O
Findings	O
and	O
Temporal	O
Progression	O
of	O
the	O
Disease	O
.	O

ABSTRACT	O
:	O
Since	O
its	O
identification	O
in	O
December	O
2019	O
,	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
has	O
infected	O
125	O
,	O
048	O
persons	O
globally	O
with	O
cases	O
identified	O
in	O
118	O
countries	O
across	O
all	O
continents	O

Given	O
the	O
lack	O
of	O
specific	O
anti	O
-	O
viral	O
therapies	O
,	O
the	O
current	O
management	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronaviruses	O
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
is	O
mainly	O
supportive	O
,	O
even	O
though	O
several	O
compounds	O
are	O
now	O
under	O
investigation	O
for	O
the	O
treatment	O
of	O
this	O
life	O
-	O
threatening	O
disease	O
.	O

However	O
,	O
the	O
increasing	O
knowledge	O
about	O
the	O
pathophysiology	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
is	O
leading	O
to	O
consider	O
some	O
anti	O
-	O
rheumatic	O
drugs	O
as	O
potential	O
treatment	O
options	O
for	O
the	O
management	O
of	O
COVID	O
-	O
19	O
.	O

LH	O
significantly	O
inhibited	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
replication	O
in	O
Vero	O
E6	O
cells	O
and	O
markedly	O
reduced	O
pro	O
-	O
inflammatory	O
cytokines	O
(	O
TNF	O
-	O
	O
,	O
IL	O
-	O
6	O
,	O
CCL	O
-	O
2	O
/	O
MCP	O
-	O
1	O
and	O
CXCL	O
-	O
10	O
/	O
IP	O
-	O
10	O
)	O
production	O
at	O
the	O
mRNA	O
levels	O
.	O

In	O
this	O
study	O
,	O
Swedish	O
privately	O
-	O
owned	O
dogs	B-SPEC
with	O
characteristic	O
signs	O
of	O
canine	O
infectious	O
respiratory	O
disease	O
(	O
n	O
=	O
88	O
)	O
were	O
screened	O
for	O
CRCoV	O
and	O
13	O
positive	O
samples	O
(	O
14	O
.	O
7	O
%,	O
8	O
.	O
4	O
-	O
23	O
.	O
7	O
%	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)])	O
were	O
further	O
sequenced	O
.	O

There	O
is	O
a	O
growing	O
understanding	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
the	O
virology	O
,	O
epidemiology	O
and	O
clinical	O
management	O
strategies	O
.	O

However	O
,	O
no	O
anti	O
-	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
drug	O
or	O
vaccine	O
has	O
been	O
officially	O
approved	O
due	O
to	O
the	O
absence	O
of	O
adequate	O
evidence	O
.	O

Temporins	O
are	O
the	O
smallest	O
(	O
AMPs	O
)	O
found	O
in	O
nature	O
and	O
are	O
highly	O
active	O
against	O
gram	B-SPEC
-	I-SPEC
positive	I-SPEC
bacteria	I-SPEC
.	O

TITLE	O
:	O
Structural	O
,	O
glycosylation	O
and	O
antigenic	O
variation	O
between	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
and	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
limit	O
of	O
detection	O
for	O
this	O
assay	O
was	O
determined	O
as	O
22	O
.	O
1	O
and	O
43	O
.	O
2	O
for	O
human	B-SPEC
and	O
mouse	B-SPEC
serum	O
samples	O
respectively	O
using	O
a	O
panel	O
of	O
120	O
negative	O
samples	O
.	O

The	O
cutoff	O
values	O
were	O
set	O
as	O
30	O
and	O
50	O
for	O
human	B-SPEC
and	O
mouse	B-SPEC
serum	O
samples	O
,	O
respectively	O
.	O

To	O
contain	O
the	O
virus	B-SPEC
,	O
early	O
detection	O
of	O
imported	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
cases	O
is	O
critical	O
.	O

TITLE	O
:	O
The	O
Battle	O
Against	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
):	O
Emergency	O
Management	O
and	O
Infection	O
Control	O
in	O
a	O
Radiology	O
Department	O
.	O

He	O
depicts	O
the	O
clinical	O
course	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
.	O

TITLE	O
:	O
The	O
different	O
clinical	O
characteristics	O
of	O
corona	B-SPEC
virus	B-SPEC
disease	O
cases	O
between	O
children	O
and	O
their	O
families	O
in	O
China	O
-	O
the	O
character	O
of	O
children	O
with	O
COVID	O
-	O
19	O
.	O

Although	O
angiotensin	O
II	O
type	O
1	O
receptor	O
blockers	O
have	O
been	O
shown	O
to	O
upregulate	O
ACE2	O
in	O
experimental	O
animals	B-SPEC
,	O
the	O
evidence	O
is	O
not	O
always	O
consistent	O
and	O
differs	O
among	O
the	O
diverse	O
angiotensin	O
II	O
type	O
1	O
receptor	O
blockers	O
and	O
differing	O
organs	O
.	O

Moreover	O
,	O
there	O
are	O
no	O
data	O
to	O
support	O
the	O
notion	O
that	O
ACE	O
inhibitor	O
or	O
angiotensin	O
II	O
type	O
1	O
receptor	O
blocker	O
administration	O
facilitates	O
coronavirus	B-SPEC
entry	O
by	O
increasing	O
ACE2	O
expression	O
in	O
either	O
animals	B-SPEC
or	O
humans	B-SPEC
.	O

Seven	O
clusters	O
for	O
human	B-SPEC
coronaviruses	O
(	O
229E	O
,	O
NL63	O
,	O
OC43	O
,	O
HKU1	O
,	O
MERS	O
-	O
CoV	O
,	O
SARS	O
-	O
CoV	O
,	O
and	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
were	O
found	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
in	O
a	O
paucisymptomatic	O
patient	O
:	O
epidemiological	O
and	O
clinical	O
challenge	O
in	O
settings	O
with	O
limited	O
community	O
transmission	O
,	O
Italy	O
,	O
February	O
2020	O
.	O

However	O
,	O
using	O
Q	O
-	O
UEL	O
systems	O
to	O
access	O
relevant	O
and	O
emerging	O
literature	O
,	O
and	O
to	O
interact	O
with	O
standard	O
publically	O
available	O
bioinformatics	O
tools	O
on	O
the	O
Internet	O
,	O
did	O
help	O
quickly	O
identify	O
sequences	O
of	O
amino	O
acids	O
that	O
are	O
well	O
conserved	O
across	O
many	O
coronaviruses	O
including	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
KRSFIEDLLFNKV	O
was	O
found	O
to	O
be	O
particularly	O
well	O
conserved	O
in	O
this	O
study	O
and	O
corresponds	O
to	O
the	O
region	O
around	O
one	O
of	O
the	O
known	O
cleavage	O
sites	O
of	O
the	O
SARS	O
virus	B-SPEC
that	O
are	O
believed	O
to	O
be	O
required	O
for	O
virus	B-SPEC
activation	O
for	O
cell	O
entry	O
.	O

SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
is	O
a	O
coronavirus	B-SPEC
associated	O
with	O
the	O
epidemiological	O
outbreak	O
in	O
late	O
2019	O
.	O

Changes	O
in	O
the	O
viral	O
proteins	O
that	O
function	O
as	O
ligands	O
of	O
the	O
host	O
receptor	O
may	O
promote	O
the	O
spillover	O
between	O
species	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
has	O
resulted	O
in	O
considerable	O
morbidity	O
and	O
mortality	O
worldwide	O
since	O
December	O
2019	O
.	O

ABSTRACT	O
:	O
The	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
(	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
)	O
epidemic	O
has	O
spread	O
to	O
virtually	O
every	O
continent	O
in	O
the	O
world	O
.	O

ABSTRACT	O
:	O
To	O
systematically	O
analyze	O
CT	O
findings	O
during	O
the	O
early	O
and	O
progressive	O
stages	O
of	O
natural	O
course	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
and	O
also	O
to	O
explore	O
possible	O
changes	O
in	O
pulmonary	O
parenchymal	O
abnormalities	O
during	O
these	O
two	O
stages	O
.	O

Measures	O
taken	O
in	O
China	O
are	O
currently	O
proven	O
to	O
reduce	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
successfully	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
was	O
declared	O
a	O
pandemic	O
by	O
the	O
World	O
Health	O
Organization	O
on	O
11	O
March	O
2020	O
because	O
of	O
its	O
rapid	O
worldwide	O
spread	O
.	O

Greater	O
knowledge	O
of	O
the	O
disease	O
,	O
which	O
is	O
caused	O
by	O
the	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	O
-	O
CoV2	O
),	O
will	O
help	O
us	O
to	O
prioritise	O
our	O
limited	O
health	O
resources	O
.	O

TITLE	O
:	O
The	O
Trial	O
of	O
Chloroquine	O
in	O
the	O
Treatment	O
of	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
	O
COVID	O
-	O
19	O
	O
and	O
Its	O
Research	O
Progress	O
in	O
Forensic	O
Toxicology	O
.	O

The	O
antimalarial	O
drug	O
Chloroquine	O
phosphate	O
which	O
has	O
already	O
been	O
approved	O
is	O
confirmed	O
to	O
have	O
an	O
anti	O
-	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
effect	O
and	O
has	O
been	O
included	O
in	O
diagnostic	O
and	O
therapeutic	O
guidelines	O
.	O

